Shares Number,Volume,Net Income,Dividends,Employee Amount,Previous Close,Analysts,Price Target,Earnings Date,Symbol,Company Name,Market Cap,Stock Price,Revenue,MA20,MA50,MA200,20-Day Percent Change,100-Day Percent Change,News1,News2,News3,News4,News5,combined_news,sentiment,Sentiment_News1,Sentiment_News2,Sentiment_News3,Sentiment_News4,Sentiment_News5
15.20B,"29,834,257",101.96B,$1.00,"161,000",226.84,Buy,236.31,"Aug 1, 2024",AAPL,Apple Inc.,"3,448.91B",226.84,385.60B,3.57%,3.46%,18.01%,+1.99%,+33.56%,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings","Masimo CEO shared confidential documents with investor before release, documents show","Keep an eye on Meta, says KKM’s Jeff Kilburg",What to expect from Apple’s ‘It’s Glowtime’ event,"Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings Masimo CEO shared confidential documents with investor before release, documents show Keep an eye on Meta, says KKM’s Jeff Kilburg What to expect from Apple’s ‘It’s Glowtime’ event",1,1,0,1,1,1
24.58B,"310,565,961",42.60B,$0.04,"29,600",129.37,Strong Buy,136.74,"Aug 28, 2024",NVDA,NVIDIA Corporation,"3,179.31B",129.37,79.77B,11.25%,6.18%,48.36%,+7.34%,+42.73%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,"Cramer: There isn’t an AI bubble, just intense demand and very little supply",Jim Cramer deep dives into the weakness in chipmakers,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability This semiconductor ETF just had its worst week since 2020. Here’s what’s next Cramer: There isn’t an AI bubble, just intense demand and very little supply Jim Cramer deep dives into the weakness in chipmakers Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street",1,1,0,0,0,1
7.43B,"10,814,122",88.14B,$3.00,"228,000",416.79,Strong Buy,493.97,"Jul 30, 2024",MSFT,Microsoft Corporation,"3,098.02B",416.79,245.12B,0.18%,-4.65%,1.01%,-1.85%,-3.51%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,"Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett",Wells Fargo’s top picks in September include this tech giant and pharma leader,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett Wells Fargo’s top picks in September include this tech giant and pharma leader Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit",1,1,1,1,1,1
12.31B,"11,634,952",87.66B,$0.80,"182,381",167.43,Buy,200.36,"Jul 23, 2024",GOOG,Alphabet Inc.,"2,048.89B",167.43,328.28B,0.15%,-5.46%,5.88%,-5.00%,+6.86%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,YouTube group The Try Guys quickly found success in launching subscription model,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings",Top 10 people most likely to reach trillionaire status,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability YouTube group The Try Guys quickly found success in launching subscription model Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings Top 10 people most likely to reach trillionaire status",0,1,0,1,0,0
12.31B,"10,831,461",87.66B,$0.80,"182,502",165.62,Buy,199.27,"Jul 23, 2024",GOOGL,Alphabet Inc.,"2,038.78B",165.62,328.28B,0.18%,-5.56%,5.79%,-5.07%,+6.79%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,YouTube group The Try Guys quickly found success in launching subscription model,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings",Top 10 people most likely to reach trillionaire status,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability YouTube group The Try Guys quickly found success in launching subscription model Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings Top 10 people most likely to reach trillionaire status",0,1,0,1,0,0
10.50B,"21,904,019",44.42B,-1,"1,525,000",177.04,Strong Buy,218.51,"Oct 24, 2024",AMZN,"Amazon.com, Inc.","1,858.14B",177.04,604.33B,-0.13%,-5.58%,0.79%,-8.65%,-7.71%,Wells Fargo report: Amazon was 2023′s top apparel and footwear seller,OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit,Google’s second antitrust trial could help shape the future of online ads,Buy levels for 3 industrial stocks that benefit from AI boom and sector megatrends,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions","Wells Fargo report: Amazon was 2023′s top apparel and footwear seller OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit Google’s second antitrust trial could help shape the future of online ads Buy levels for 3 industrial stocks that benefit from AI boom and sector megatrends AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions",1,1,1,1,1,0
2.53B,"9,547,234",51.43B,$2.00,"67,317",528.00,Strong Buy,557.90,"Jul 31, 2024",META,"Meta Platforms, Inc.","1,335.74B",528.00,149.78B,1.60%,3.14%,15.29%,+8.83%,-2.00%,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Keep an eye on Meta, says KKM’s Jeff Kilburg",Top 10 people most likely to reach trillionaire status,OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit,Google’s second antitrust trial could help shape the future of online ads,"Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Keep an eye on Meta, says KKM’s Jeff Kilburg Top 10 people most likely to reach trillionaire status OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit Google’s second antitrust trial could help shape the future of online ads",1,1,1,0,1,1
4.65B,"18,441,771",10.27B,$2.10,"20,000",166.36,Strong Buy,178.79,"Sep 5, 2024",AVGO,Broadcom Inc.,774.39B,166.36,42.62B,4.35%,0.33%,22.27%,-1.56%,+18.09%,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,"Cramer: There isn’t an AI bubble, just intense demand and very little supply",Jim Cramer deep dives into the weakness in chipmakers,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Three-Stock Lunch: Broadcom, 3M, & Bowlero","This semiconductor ETF just had its worst week since 2020. Here’s what’s next Cramer: There isn’t an AI bubble, just intense demand and very little supply Jim Cramer deep dives into the weakness in chipmakers Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Three-Stock Lunch: Broadcom, 3M, & Bowlero",0,0,0,0,1,1
3.19B,"58,057,446",12.39B,-1,"140,473",220.32,Hold,202.12,"Oct 16, 2024",TSLA,"Tesla, Inc.",703.84B,220.32,95.32B,-0.79%,-4.32%,2.91%,-11.34%,+24.77%,"Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here",Oppenheimer’s picks for a Republican or Democratic election sweep,Top 10 people most likely to reach trillionaire status,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","U.S. markets, public companies are a growing target for Russian hackers","Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here Oppenheimer’s picks for a Republican or Democratic election sweep Top 10 people most likely to reach trillionaire status Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more U.S. markets, public companies are a growing target for Russian hackers",0,1,0,0,1,0
443.34M,"1,274,188",7.17B,$4.64,"316,000",879.21,Buy,819.89,"Sep 26, 2024",COST,Costco Wholesale Corporation,389.78B,879.21,253.70B,6.85%,6.74%,22.45%,+8.04%,+24.43%,"Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell",Jim Cramer recommends buying Costco stock as a port in September’s market storm,"Friday, September 6, 2024: Cramer says this chipmaker is a buy despite its post-earnings drawdown",Cramer’s Mad Dash: Costco,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell Jim Cramer recommends buying Costco stock as a port in September’s market storm Friday, September 6, 2024: Cramer says this chipmaker is a buy despite its post-earnings drawdown Cramer’s Mad Dash: Costco Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more",1,1,1,0,1,1
393.20M,"1,239,512",7.23B,$6.57,"42,416",907.26,Buy,"1,147.80","Oct 16, 2024",ASML,ASML Holding N.V.,360.37B,907.26,27.26B,0.68%,-7.04%,0.20%,-5.19%,-9.33%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more","Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Dutch take on U.S. export controls, controlling shipments of some ASML machines","European stocks end week down 2.5%, worst since early August slump",U.S. rolls out new chip-related export controls as China makes industry advances,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Dutch take on U.S. export controls, controlling shipments of some ASML machines European stocks end week down 2.5%, worst since early August slump U.S. rolls out new chip-related export controls as China makes industry advances",1,1,1,1,1,1
429.16M,"1,302,657",7.09B,-1,"13,000",686.73,Buy,687.67,"Oct 16, 2024",NFLX,"Netflix, Inc.",294.72B,686.73,36.30B,7.02%,5.71%,19.15%,+8.83%,+7.49%,"Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett",Bill Gates says this is the No. 1 unsolvable problem facing today’s young people,NFL team sales are likely to stall as valuations soar,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry","Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett Bill Gates says this is the No. 1 unsolvable problem facing today’s young people NFL team sales are likely to stall as valuations soar Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry",1,1,1,1,1,1
1.55B,"2,350,366",6.44B,$1.48,"89,900",86.66,Buy,88.80,"Jul 25, 2024",AZN,AstraZeneca PLC,268.01B,86.66,49.13B,5.33%,8.76%,21.74%,+10.37%,+29.52%,AstraZeneca says staff detained in China amid reports of drug-import investigation,India and Singapore agree to cooperate on chips as countries seek to strengthen partnership,India’s Modi expected to usher in new era of bilateral agreements in Singapore visit,Biden administration releases prices of 10 drugs in Medicare talks,These low-volatility stocks have a winning record and are attractively valued,AstraZeneca says staff detained in China amid reports of drug-import investigation India and Singapore agree to cooperate on chips as countries seek to strengthen partnership India’s Modi expected to usher in new era of bilateral agreements in Singapore visit Biden administration releases prices of 10 drugs in Medicare talks These low-volatility stocks have a winning record and are attractively valued,0,0,0,0,0,0
1.62B,"49,697,991",1.35B,-1,"26,000",154.98,Strong Buy,195.93,"Jul 30, 2024",AMD,"Advanced Micro Devices, Inc.",250.83B,154.98,23.28B,5.50%,-2.35%,-4.52%,+1.30%,-14.12%,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,Why Broadcom stock is tumbling after an earnings beat — and how to play the dip,"S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022","These are the top stocks to own for rest of the year, per Wolfe Research",CNBC Daily Open: Rate cuts need to start before inflation’s 2%,"This semiconductor ETF just had its worst week since 2020. Here’s what’s next Why Broadcom stock is tumbling after an earnings beat — and how to play the dip S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022 These are the top stocks to own for rest of the year, per Wolfe Research CNBC Daily Open: Rate cuts need to start before inflation’s 2%",1,0,1,0,0,0
443.40M,"1,385,944",5.08B,-1,"29,945",558.30,Buy,599.31,"Sep 12, 2024",ADBE,Adobe Inc.,247.55B,558.30,20.43B,4.70%,4.01%,3.97%,+1.61%,+15.55%,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings",The latest jobs report leaves stocks in a tough spot heading into the new week,"Chips get crushed, and clues in the jobs report for Modelo brewer Constellation","These are the top stocks to own for rest of the year, per Wolfe Research","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings The latest jobs report leaves stocks in a tough spot heading into the new week Chips get crushed, and clues in the jobs report for Modelo brewer Constellation These are the top stocks to own for rest of the year, per Wolfe Research Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",0,0,0,0,0,1
1.37B,"3,437,038",9.52B,$5.42,"318,000",175.87,Buy,186.00,"Oct 8, 2024",PEP,"PepsiCo, Inc.",241.57B,175.87,92.05B,0.83%,3.49%,3.13%,+0.72%,+2.83%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",How the Cowboys went from losing $1 million a month to topping the NFL in value,Beyond Meat to launch new steak alternative as it focuses on health,Jim Cramer expresses regret over BlackRock and gives his views on 3 other stocks,Delta chief operations officer departing for another company,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box How the Cowboys went from losing $1 million a month to topping the NFL in value Beyond Meat to launch new steak alternative as it focuses on health Jim Cramer expresses regret over BlackRock and gives his views on 3 other stocks Delta chief operations officer departing for another company",1,1,0,1,1,0
1.17B,"2,467,115",9.46B,$2.60,"67,000",198.58,Strong Buy,196.11,"Jul 31, 2024",TMUS,"T-Mobile US, Inc.",231.70B,198.58,79.10B,5.95%,10.82%,22.06%,+10.49%,+25.01%,This ETF’s 2024 gains nearly match the Nasdaq Composite — with less volatility,Cramer says a carrier war could boost demand for the expected AI-enabled iPhone,These stocks outperformed in August. Here’s where they’re expected to go,Top Wall Street analysts are upbeat about the potential of these 3 stocks ,These low-volatility stocks have a winning record and are attractively valued,This ETF’s 2024 gains nearly match the Nasdaq Composite — with less volatility Cramer says a carrier war could boost demand for the expected AI-enabled iPhone These stocks outperformed in August. Here’s where they’re expected to go Top Wall Street analysts are upbeat about the potential of these 3 stocks  These low-volatility stocks have a winning record and are attractively valued,1,0,1,1,1,0
477.50M,"1,106,510",6.40B,$5.56,"66,323",465.74,Buy,487.10,"Oct 24, 2024",LIN,Linde plc,222.39B,465.74,32.82B,4.13%,5.96%,8.97%,+4.26%,+1.75%,"Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde","Wednesday, August 28, 2024: Cramer says this industrial stock could be a ‘Harris trade’",Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,Linde price target raised to $550 from $523 at Jefferies,Linde (LIN): New Sell Recommendation for This Basic Materials Giant,"Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde Wednesday, August 28, 2024: Cramer says this industrial stock could be a ‘Harris trade’ Cramer updates his takes on all 32 portfolio stocks and grades earnings reports Linde price target raised to $550 from $523 at Jefferies Linde (LIN): New Sell Recommendation for This Basic Materials Giant",1,1,1,0,1,1
4.03B,"9,792,080",10.32B,$1.60,"84,900",50.74,Buy,56.06,"Aug 14, 2024",CSCO,"Cisco Systems, Inc.",204.42B,50.74,53.80B,6.42%,7.28%,4.39%,+2.89%,+2.68%,"Final Trades: Apple, Cisco, Kinetik Holdings and the 2-Year Treasury","Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier","Palo Alto Networks finally gets back on track — delivering solid earnings, outlook",Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Final Trades: Apple, Cisco, Kinetik Holdings and the 2-Year Treasury Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier Palo Alto Networks finally gets back on track — delivering solid earnings, outlook Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",0,1,0,0,0,0
1.39B,"102,084,589",13.60B,-1,"17,403",139.87,Strong Buy,211.11,"Aug 26, 2024",PDD,PDD Holdings Inc.,194.25B,139.87,41.11B,-29.65%,-29.80%,-28.29%,-30.82%,-24.35%,Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps,There is ‘lack of confidence’ in market on Chinese banks’ balance sheets,PDD just gave markets the latest warning on China’s consumer,Investors ‘left waiting’ for China’s market recovery: KraneShares CIO,CNBC Daily Open: Nvidia beating expectations isn’t enough,Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps There is ‘lack of confidence’ in market on Chinese banks’ balance sheets PDD just gave markets the latest warning on China’s consumer Investors ‘left waiting’ for China’s market recovery: KraneShares CIO CNBC Daily Open: Nvidia beating expectations isn’t enough,0,1,0,0,0,0
1.11B,"6,928,933",8.71B,$3.40,"50,000",173.50,Buy,205.21,"Jul 31, 2024",QCOM,QUALCOMM Incorporated,193.28B,173.50,37.35B,3.81%,-7.14%,4.13%,-5.03%,+0.19%,AI gadgets have been a bust so far. Apple aims to change that,Qualcomm says it’s working on mixed reality smart glasses with Samsung and Google,Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip,"CNBC Daily Open: Nvidia sinks and data’s weak, but stay strong",S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September,"AI gadgets have been a bust so far. Apple aims to change that Qualcomm says it’s working on mixed reality smart glasses with Samsung and Google Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip CNBC Daily Open: Nvidia sinks and data’s weak, but stay strong S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September",1,0,0,1,0,0
913.05M,"5,531,968",5.28B,$5.20,"34,000",209.88,Hold,199.48,"Oct 22, 2024",TXN,Texas Instruments Incorporated,191.63B,209.88,16.09B,6.84%,6.35%,18.80%,+1.93%,+24.02%,Dividend stocks are expected to pop as the Fed lowers rates. How to choose them,"Intel has hired Morgan Stanley, other advisers for activist defense","Stocks making the biggest moves midday: Target, JD.com, Macy’s and more","Wednesday’s rapid-fire: Toll Brothers, Target, Macy’s, American Express, Texas Instruments",Jim Cramer says Toll Brothers can benefit from shortage of $1 million new homes,"Dividend stocks are expected to pop as the Fed lowers rates. How to choose them Intel has hired Morgan Stanley, other advisers for activist defense Stocks making the biggest moves midday: Target, JD.com, Macy’s and more Wednesday’s rapid-fire: Toll Brothers, Target, Macy’s, American Express, Texas Instruments Jim Cramer says Toll Brothers can benefit from shortage of $1 million new homes",0,0,0,1,1,0
537.33M,"1,716,778",3.13B,$9.00,"26,700",328.80,Buy,323.21,"Aug 6, 2024",AMGN,Amgen Inc.,176.67B,328.80,30.93B,0.16%,1.25%,10.42%,-0.90%,+22.06%,"Final Trades: Intuit, Amgen, the INDY and URNM",Eli Lilly CEO: People on GLP-1 weight loss drugs eat 800 calories less per day,Biden administration releases prices of 10 drugs in Medicare talks,These low-volatility stocks have a winning record and are attractively valued,Piper Sandler Sticks to Their Buy Rating for Amgen (AMGN),"Final Trades: Intuit, Amgen, the INDY and URNM Eli Lilly CEO: People on GLP-1 weight loss drugs eat 800 calories less per day Biden administration releases prices of 10 drugs in Medicare talks These low-volatility stocks have a winning record and are attractively valued Piper Sandler Sticks to Their Buy Rating for Amgen (AMGN)",1,1,0,0,0,0
279.55M,"1,907,131",2.96B,$4.16,"18,200",619.85,Buy,696.96,"Aug 22, 2024",INTU,Intuit Inc.,173.28B,619.85,16.29B,-1.71%,-1.85%,0.57%,-4.68%,-2.94%,A September trading strategy from Goldman that nets an 18% return on average,"Final Trades: Intuit, Amgen, the INDY and URNM","3-Stock Lunch: Uber, Intuit & Cava","Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more",Intuit CEO Sasan Goodarzi goes one-on-one with Jim Cramer,"A September trading strategy from Goldman that nets an 18% return on average Final Trades: Intuit, Amgen, the INDY and URNM 3-Stock Lunch: Uber, Intuit & Cava Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more Intuit CEO Sasan Goodarzi goes one-on-one with Jim Cramer",1,0,1,1,1,1
355.35M,"1,165,092",2.09B,-1,"13,676",486.55,Buy,444.14,"Oct 17, 2024",ISRG,"Intuitive Surgical, Inc.",172.90B,486.55,7.57B,3.58%,7.14%,24.32%,+8.46%,+24.16%,Friday’s big stock stories: What’s likely to move the market in the next trading session,Intuitive Surgical (ISRG) Receives a Buy from BTIG,Intuitive Surgical price target raised to $494 from $469 at BTIG,Intuitive Surgical price target raised to $560 from $512 at Citi,Intuitive Surgical price target raised to $515 from $475 at RBC Capital,Friday’s big stock stories: What’s likely to move the market in the next trading session Intuitive Surgical (ISRG) Receives a Buy from BTIG Intuitive Surgical price target raised to $494 from $469 at BTIG Intuitive Surgical price target raised to $560 from $512 at Citi Intuitive Surgical price target raised to $515 from $475 at RBC Capital,0,0,0,0,0,0
824.40M,"6,696,957",7.45B,$1.60,"34,000",202.67,Buy,225.15,"Aug 15, 2024",AMAT,"Applied Materials, Inc.",167.08B,202.67,26.85B,-0.95%,-10.41%,0.88%,-9.10%,-7.20%,These stocks have the most riding on Nvidia’s results with highest correlation,"Final Trades: Amazon, Applied Materials and Home Depot","Stocks making biggest moves midday: Rocket Lab, H&R Block and more",10 things to watch in the stock market Friday including more bullishness on Lilly,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","These stocks have the most riding on Nvidia’s results with highest correlation Final Trades: Amazon, Applied Materials and Home Depot Stocks making biggest moves midday: Rocket Lab, H&R Block and more 10 things to watch in the stock market Friday including more bullishness on Lilly Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",0,1,0,1,0,0
3.87B,"11,120,225",15.09B,$1.24,"186,000",39.82,Buy,47.02,"Oct 24, 2024",CMCSA,Comcast Corporation,154.20B,39.82,121.11B,1.51%,3.29%,-1.93%,-3.25%,-2.37%,Automakers are getting back into advertising’s biggest arena: NFL,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry","NBC ripped up its Olympics playbook for 2024 — so far, it paid off",A look at the behind-the-scenes business of Hollywood studio lot tours,"Automakers are getting back into advertising’s biggest arena: NFL Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry NBC ripped up its Olympics playbook for 2024 — so far, it paid off A look at the behind-the-scenes business of Hollywood studio lot tours",0,0,1,1,0,0
1.05B,"5,991,731",424.00M,-1,"7,096",135.63,Buy,130.00,"Jul 31, 2024",ARM,Arm Holdings plc,142.14B,135.63,3.50B,5.22%,-12.13%,17.00%,-13.07%,+0.40%,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded",Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip,Nvidia $279 billion wipeout — the biggest in U.S. history — drags down global chip stocks,Slowdown in Nvidia’s sales growth spooks chip stocks in U.S. and Asia,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip Nvidia $279 billion wipeout — the biggest in U.S. history — drags down global chip stocks Slowdown in Nvidia’s sales growth spooks chip stocks in U.S. and Asia",1,1,1,1,1,1
1.25B,"978,653",4.52B,$2.04,"86,088",56.21,Buy,57.50,"Jul 25, 2024",SNY,Sanofi,140.76B,56.21,50.44B,5.61%,10.10%,14.98%,+8.30%,+18.75%,"Healthy Returns: The combination Covid, flu shot race is heating up",Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer,Buy Rating Affirmed for Sanofi on Strong Clinical Trial Outcomes and Promising MS Drug Pipeline,Sanofi (SNY) Gets a Hold from TD Cowen,Deutsche Bank Sticks to Its Sell Rating for Sanofi (SNYNF),"Healthy Returns: The combination Covid, flu shot race is heating up Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer Buy Rating Affirmed for Sanofi on Strong Clinical Trial Outcomes and Promising MS Drug Pipeline Sanofi (SNY) Gets a Hold from TD Cowen Deutsche Bank Sticks to Its Sell Rating for Sanofi (SNYNF)",1,1,1,1,1,1
649.67M,"1,717,257",5.78B,$4.32,"95,000",202.48,Buy,225.00,"Jul 25, 2024",HON,Honeywell International Inc.,131.55B,202.48,37.33B,2.92%,-0.87%,2.36%,+0.12%,+3.98%,"Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell",Jim Cramer’s top 10 things to watch in the stock market Friday,"Monday, August 26, 2024: Cramer explains why he’s ‘concerned’ ahead of this chipmaker’s earnings",Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,Honeywell initiated with an Equal Weight at Morgan Stanley,"Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell Jim Cramer’s top 10 things to watch in the stock market Friday Monday, August 26, 2024: Cramer explains why he’s ‘concerned’ ahead of this chipmaker’s earnings Cramer updates his takes on all 32 portfolio stocks and grades earnings reports Honeywell initiated with an Equal Weight at Morgan Stanley",0,1,0,0,0,1
107.93M,"174,148",4.32B,-1,"13,450","1,199.12",Buy,"1,091.83","Aug 1, 2024",REGN,"Regeneron Pharmaceuticals, Inc.",129.43B,"1,199.12",13.49B,5.72%,10.10%,24.55%,+11.13%,+27.22%,Election 2024: Where To Put Your Money Ahead of the Vote,RBC Capital Keeps Their Buy Rating on Regeneron (REGN),"QQQ ETF Update, 8/29/2024 ",Regeneron announces EC approved Ordspono for adults,Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma,"Election 2024: Where To Put Your Money Ahead of the Vote RBC Capital Keeps Their Buy Rating on Regeneron (REGN) QQQ ETF Update, 8/29/2024  Regeneron announces EC approved Ordspono for adults Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma",1,1,0,0,0,1
33.52M,"217,547",5.03B,$35.00,"23,600","3,830.58",Buy,"4,063.00","Aug 1, 2024",BKNG,Booking Holdings Inc.,128.42B,"3,830.58",22.40B,8.20%,2.23%,8.03%,+4.93%,+8.23%,"Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier","Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20%",Travelers are finally cracking under the pressure of high costs,"Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20% Travelers are finally cracking under the pressure of high costs",1,0,1,1,1,0
258.10M,"762,054",-489.90M,-1,"5,400",481.24,Buy,495.82,"Aug 1, 2024",VRTX,Vertex Pharmaceuticals Incorporated,124.21B,481.24,10.34B,-0.02%,-0.25%,11.82%,-1.21%,+20.42%,"Lightning Round: Chipotle is likely done going down, says Jim Cramer",Cramer’s Lightning Round: Builders FirstSource ‘can go higher’,"Ride out future market volatility with all-weather stocks, Bank of America says",Evercore ISI Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),Vertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline Uncertainty,"Lightning Round: Chipotle is likely done going down, says Jim Cramer Cramer’s Lightning Round: Builders FirstSource ‘can go higher’ Ride out future market volatility with all-weather stocks, Bank of America says Evercore ISI Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX) Vertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline Uncertainty",0,0,0,1,0,0
1.11B,"24,264,183",-1.54B,$0.46,"43,000",102.85,Strong Buy,157.42,"Sep 25, 2024",MU,"Micron Technology, Inc.",114.04B,102.85,21.37B,-1.96%,-16.75%,-5.68%,-13.62%,-23.24%,Wednesday’s stock stories: What’s likely to move the market in the next session,"Three-Stock Lunch: Boeing, Micron, Redfin","Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more","Dow closes 600 points lower to begin September, S&P 500 drops 2%",Morgan Stanley is bullish on 3 stocks from a corner of the semiconductor sector,"Wednesday’s stock stories: What’s likely to move the market in the next session Three-Stock Lunch: Boeing, Micron, Redfin Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Dow closes 600 points lower to begin September, S&P 500 drops 2% Morgan Stanley is bullish on 3 stocks from a corner of the semiconductor sector",0,0,1,1,1,1
323.80M,"3,144,385",2.58B,-1,"13,948",350.75,Buy,371.26,"Aug 19, 2024",PANW,"Palo Alto Networks, Inc.",113.57B,350.75,8.03B,5.91%,6.03%,13.80%,+7.92%,+30.27%,"Palo Alto CEO on CrowdStrike fallout, IBM deal and cybersecurity issues",These stocks typically have the best and worst Septembers,Jim Cramer’s top 10 things to watch in the stock market Wednesday,Can tech stocks go up with rates coming down? Here’s why we think so,It’s been nearly a year since we took profits in Lilly. We’re due for another trim,"Palo Alto CEO on CrowdStrike fallout, IBM deal and cybersecurity issues These stocks typically have the best and worst Septembers Jim Cramer’s top 10 things to watch in the stock market Wednesday Can tech stocks go up with rates coming down? Here’s why we think so It’s been nearly a year since we took profits in Lilly. We’re due for another trim",0,0,0,0,0,0
496.49M,"2,528,087",1.66B,$3.68,"26,000",228.39,Buy,243.52,"Aug 21, 2024",ADI,"Analog Devices, Inc.",113.39B,228.39,9.70B,6.36%,2.51%,13.40%,-1.82%,+16.64%,These stocks have the most riding on Nvidia’s results with highest correlation,"Retail earnings lift other boats — plus, stocks take negative jobs update in stride","Stocks making the biggest moves midday: Target, JD.com, Macy’s and more","S&P 500, Nasdaq close higher as Fed minutes lift investors’ hopes for a September rate cut","Why we’ve raised cash into the rally — plus, earnings insights on 2 of our stocks","These stocks have the most riding on Nvidia’s results with highest correlation Retail earnings lift other boats — plus, stocks take negative jobs update in stride Stocks making the biggest moves midday: Target, JD.com, Macy’s and more S&P 500, Nasdaq close higher as Fed minutes lift investors’ hopes for a September rate cut Why we’ve raised cash into the rally — plus, earnings insights on 2 of our stocks",1,1,1,1,1,0
130.38M,"1,109,642",3.83B,$8.00,"17,200",847.37,Strong Buy,983.19,"Oct 16, 2024",LRCX,Lam Research Corporation,110.48B,847.37,14.91B,-1.41%,-13.60%,-7.39%,-12.61%,-16.88%,"Lightning Round: Buy Lam Research slowly, not all at once",Cramer’s Lightning Round: ‘I like’ GE Vernova,Trade Tracker: Stephanie Link trims Lam Research,Lam Research Appoints New Board Members with Diverse Expertise,Unusually active option classes on open August 30th,"Lightning Round: Buy Lam Research slowly, not all at once Cramer’s Lightning Round: ‘I like’ GE Vernova Trade Tracker: Stephanie Link trims Lam Research Lam Research Appoints New Board Members with Diverse Expertise Unusually active option classes on open August 30th",0,0,0,0,0,0
407.80M,"776,708",3.75B,$5.60,"64,000",269.60,Hold,262.82,"Jul 31, 2024",ADP,"Automatic Data Processing, Inc.",109.94B,269.60,19.20B,4.33%,9.37%,12.53%,+3.83%,+11.37%,Salesforce CEO explains how customers use new platform ‘Agentforce’,Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech,ADP price target raised to $285 from $250 at JPMorgan,,,Salesforce CEO explains how customers use new platform ‘Agentforce’ Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech ADP price target raised to $285 from $250 at JPMorgan,0,0,0,0,-1,-1
134.43M,"667,647",2.76B,$5.80,"15,230",817.84,Buy,805.55,"Jul 24, 2024",KLAC,KLA Corporation,109.94B,817.84,9.81B,4.70%,0.96%,18.04%,-2.28%,+17.78%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Wednesday’s stock stories: What’s likely to move the market in the next session,"Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more","Dow closes 600 points lower to begin September, S&P 500 drops 2%",KLA Corp. raises quarterly dividend 17% to $1.70 from $1.45 per share,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Wednesday’s stock stories: What’s likely to move the market in the next session Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Dow closes 600 points lower to begin September, S&P 500 drops 2% KLA Corp. raises quarterly dividend 17% to $1.70 from $1.45 per share",0,1,0,1,1,0
1.13B,"10,812,035",4.07B,$2.28,"381,000",94.02,Buy,99.18,"Jul 30, 2024",SBUX,Starbucks Corporation,106.54B,94.02,36.48B,16.21%,23.43%,12.10%,+22.26%,+9.73%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box","4 simple steps to ‘make yourself indispensable’ at work, says bestselling author",Best Buy is the stock of the summer — plus 2 more encouraging economic updates,These stocks outperformed in August. Here’s where they’re expected to go,Jim Cramer: Starbucks’ stock will shoot higher under incoming CEO Brian Niccol,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box 4 simple steps to ‘make yourself indispensable’ at work, says bestselling author Best Buy is the stock of the summer — plus 2 more encouraging economic updates These stocks outperformed in August. Here’s where they’re expected to go Jim Cramer: Starbucks’ stock will shoot higher under incoming CEO Brian Niccol",1,1,1,0,1,0
50.70M,"181,637",1.40B,-1,"58,313","2,000.31",Strong Buy,"2,089.09","Aug 1, 2024",MELI,"MercadoLibre, Inc.",101.41B,"2,000.31",17.11B,8.30%,16.94%,24.94%,+19.55%,+32.86%,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,"MercadoLibre initiated with an Overweight, called a ‘Top Pick’ at Cantor","MercadoLibre price target raised to $2,350 from $2,300 at Susquehanna","MercadoLibre price target raised to $2,250 from $2,100 at Jefferies",StockTok: Meta revises limits on ad data to assuage CMA scrutiny,"Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call MercadoLibre initiated with an Overweight, called a ‘Top Pick’ at Cantor MercadoLibre price target raised to $2,350 from $2,300 at Susquehanna MercadoLibre price target raised to $2,250 from $2,100 at Jefferies StockTok: Meta revises limits on ad data to assuage CMA scrutiny",1,1,1,1,0,1
1.24B,"2,897,238",1.05B,$3.08,"18,000",76.72,Buy,81.81,"Aug 8, 2024",GILD,"Gilead Sciences, Inc.",95.52B,76.72,27.81B,2.48%,6.77%,5.30%,+3.29%,+12.91%,Gilead alleges it uncovered a drug-counterfeiting operation at 2 NYC pharmacies,Gilead Sciences: A Balanced Hold Rating Amidst Growth Potential and Market Challenges,Gilead price target raised to $74 from $72 at RBC Capital,Gilead Sciences (GILD) Gets a Hold from RBC Capital,Gilead put volume heavy and directionally bearish,Gilead alleges it uncovered a drug-counterfeiting operation at 2 NYC pharmacies Gilead Sciences: A Balanced Hold Rating Amidst Growth Potential and Market Challenges Gilead price target raised to $74 from $72 at RBC Capital Gilead Sciences (GILD) Gets a Hold from RBC Capital Gilead put volume heavy and directionally bearish,0,0,1,0,0,1
1.34B,"3,498,847",3.95B,$1.88,"91,000",71.23,Strong Buy,79.59,"Jul 30, 2024",MDLZ,"Mondelez International, Inc.",95.15B,71.23,35.98B,1.86%,5.19%,1.42%,+4.24%,+4.79%,"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies",Cheap stocks to buy for the long term during the volatility,Turn to these dividend growers as the Fed cuts rates,"Jim Cramer prefers Mondelez over this food peer — plus, his take on 4 more stocks",Jim Cramer’s top 10 things to watch in the stock market Monday,"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies Cheap stocks to buy for the long term during the volatility Turn to these dividend growers as the Fed cuts rates Jim Cramer prefers Mondelez over this food peer — plus, his take on 4 more stocks Jim Cramer’s top 10 things to watch in the stock market Monday",0,0,0,0,0,0
4.28B,"57,358,323",975.00M,$0.50,"124,800",20.54,Hold,32.96,"Aug 1, 2024",INTC,Intel Corporation,87.83B,20.54,55.12B,-8.05%,-28.46%,-46.23%,-36.21%,-49.34%,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Jim Cramer’s top 10 things to watch in the stock market Friday,Nvidia says it didn’t receive antitrust subpoena from DOJ,"Cramer says ‘don’t be a hero’ on Nvidia, downplays AI spending concerns and DOJ probe","This semiconductor ETF just had its worst week since 2020. Here’s what’s next Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Jim Cramer’s top 10 things to watch in the stock market Friday Nvidia says it didn’t receive antitrust subpoena from DOJ Cramer says ‘don’t be a hero’ on Nvidia, downplays AI spending concerns and DOJ probe",0,0,1,0,0,0
153.61M,"916,354",1.50B,-1,"20,300",539.39,Strong Buy,641.00,"Aug 21, 2024",SNPS,"Synopsys, Inc.",82.86B,539.39,6.48B,-1.72%,-8.24%,-5.97%,-8.66%,-11.38%,Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings,Cramer’s Stop Trading: Synopsys,Cramer looks at reasons for the market decline and provides new views on 3 stocks,Synopsys CEO on Q3 earnings,"This little-known chip design stock benefits from AI, Bank of America says","Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings Cramer’s Stop Trading: Synopsys Cramer looks at reasons for the market decline and provides new views on 3 stocks Synopsys CEO on Q3 earnings This little-known chip design stock benefits from AI, Bank of America says",0,1,0,0,0,1
100.77M,"236,586",1.57B,$1.56,"46,500",788.50,Buy,740.62,"Sep 24, 2024",CTAS,Cintas Corporation,79.46B,788.50,9.60B,4.58%,8.06%,22.38%,+4.43%,+18.42%,"QQQ ETF Update, 9/6/2024 ","QQQ ETF Update, 9/4/2024 ","QQQ ETF Update, 8/29/2024 ","QQQ ETF Update, 8/27/2024 ","QQQ ETF Update, 8/23/2024 ","QQQ ETF Update, 9/6/2024  QQQ ETF Update, 9/4/2024  QQQ ETF Update, 8/29/2024  QQQ ETF Update, 8/27/2024  QQQ ETF Update, 8/23/2024 ",1,0,0,0,0,0
94.94M,"283,971",1.04B,$17.04,"13,151",827.96,Buy,863.36,"Aug 7, 2024",EQIX,"Equinix, Inc.",78.61B,827.96,8.02B,0.79%,3.68%,2.45%,+2.97%,+3.73%,Turn to these dividend growers as the Fed cuts rates,"Equinix CFO Taylor sells 1,500 common shares","Equinix price target lowered to $900 from $1,000 at Argus",Equinix (EQIX) Receives a Hold from Morgan Stanley,Scotiabank Reaffirms Their Buy Rating on Equinix (EQIX),"Turn to these dividend growers as the Fed cuts rates Equinix CFO Taylor sells 1,500 common shares Equinix price target lowered to $900 from $1,000 at Argus Equinix (EQIX) Receives a Hold from Morgan Stanley Scotiabank Reaffirms Their Buy Rating on Equinix (EQIX)",1,0,1,0,0,1
273.82M,"1,944,545",1.06B,-1,"11,200",273.90,Strong Buy,334.56,"Jul 22, 2024",CDNS,"Cadence Design Systems, Inc.",75.00B,273.90,4.16B,0.28%,-6.87%,-6.74%,-1.71%,-14.59%,Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings,"Novartis upgrade, Intel downgrade part of Erste global equity changes",Cadence Design downgraded to Hold from Buy at Erste Group,Cadence Design Strengthens Financial Strategy with New Credit Facility,"CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?","Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings Novartis upgrade, Intel downgrade part of Erste global equity changes Cadence Design downgraded to Hold from Buy at Erste Group Cadence Design Strengthens Financial Strategy with New Credit Facility CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?",1,1,1,1,1,0
360.10M,"1,636,056",3.26B,$4.60,"3,565",207.05,Hold,213.69,"Oct 23, 2024",CME,CME Group Inc.,74.56B,207.05,5.79B,3.85%,6.23%,2.61%,+11.05%,+1.91%,"Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI","S&P 500, Nasdaq snap eight-day winning streak as rebound rally pauses",Buy/Sell: Wall Street’s top 10 stock calls this week,"CME Group to launch options on BCOM futures on September 23, pending review",Analysts Have Conflicting Sentiments on These Financial Companies: Voya Financial (VOYA) and CME Group (CME),"Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI S&P 500, Nasdaq snap eight-day winning streak as rebound rally pauses Buy/Sell: Wall Street’s top 10 stock calls this week CME Group to launch options on BCOM futures on September 23, pending review Analysts Have Conflicting Sentiments on These Financial Companies: Voya Financial (VOYA) and CME Group (CME)",0,0,1,0,0,0
632.42M,"4,924,459",4.84B,-1,"6,907",116.85,Hold,133.16,"Aug 6, 2024",ABNB,"Airbnb, Inc.",73.90B,116.85,10.51B,-3.70%,-15.19%,-19.66%,-15.79%,-27.35%,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions",Take a look inside my oceanfront dream home in Puerto Rico: ‘Slice of paradise’,‘Travel is too expensive right now’: Americans spend less or skip trips altogether,Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion,LVMH CEO Bernard Arnault’s family office goes shopping for AI startups,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions Take a look inside my oceanfront dream home in Puerto Rico: ‘Slice of paradise’ ‘Travel is too expensive right now’: Americans spend less or skip trips altogether Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion LVMH CEO Bernard Arnault’s family office goes shopping for AI startups",1,0,0,0,0,0
1.02B,"8,791,198",4.44B,-1,"27,200",71.70,Buy,75.88,"Jul 30, 2024",PYPL,"PayPal Holdings, Inc.",73.30B,71.70,31.03B,7.60%,14.96%,15.56%,+7.07%,+8.10%,"Earn 5% cash back with PayPal’s debit card, even if you have bad credit","88 corporate leaders endorse Harris, including CEOs of Yelp, Box","Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings","The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos","Buy now, pay later firm Klarna swings to first-half profit ahead of IPO","Earn 5% cash back with PayPal’s debit card, even if you have bad credit 88 corporate leaders endorse Harris, including CEOs of Yelp, Box Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos Buy now, pay later firm Klarna swings to first-half profit ahead of IPO",1,1,1,1,1,1
265.29M,"3,153,876",1.54B,-1,"18,800",259.95,Buy,288.79,"Aug 22, 2024",WDAY,"Workday, Inc.",68.96B,259.95,7.86B,17.44%,17.92%,4.13%,+14.61%,-2.99%,Dell and Palantir to join S&P 500; shares of both jump,"These five stocks are best positioned for growth, Goldman Sachs says","Final Trades: Workday, TransDigm and Louisiana Pacific",Workday stock gains as software provider widens 2027 margin target,"Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more","Dell and Palantir to join S&P 500; shares of both jump These five stocks are best positioned for growth, Goldman Sachs says Final Trades: Workday, TransDigm and Louisiana Pacific Workday stock gains as software provider widens 2027 margin target Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more",1,1,1,0,0,1
243.36M,"3,529,606",131.66M,-1,"7,925",271.54,Buy,334.56,"Aug 28, 2024",CRWD,"CrowdStrike Holdings, Inc.",66.08B,271.54,3.28B,8.98%,-13.25%,-9.57%,+13.90%,-16.26%,Dell and Palantir to join S&P 500; shares of both jump,A September trading strategy from Goldman that nets an 18% return on average,Cramer names No. 1 underappreciated megacap to buy in recent tech stock sell-off,"We like Apple for its sustained business model, not its AI story","These five stocks are best positioned for growth, Goldman Sachs says","Dell and Palantir to join S&P 500; shares of both jump A September trading strategy from Goldman that nets an 18% return on average Cramer names No. 1 underappreciated megacap to buy in recent tech stock sell-off We like Apple for its sustained business model, not its AI story These five stocks are best positioned for growth, Goldman Sachs says",0,1,0,0,1,1
1.94B,"5,615,481",3.60B,$0.48,"23,000",33.69,Buy,39.67,"Oct 17, 2024",CSX,CSX Corporation,65.32B,33.69,14.63B,-0.71%,-0.40%,-2.74%,-3.93%,-7.11%,Thursday’s stock stories: What’s likely to move the market in the next session,CSX President and Chief Executive Officer to Address Morgan Stanley Laguna Conference,North American rail traffic up 5.2% for the week ending August 31,CSX Expands Labor Agreements with Two More Partners,North American rail traffic up 1.3% for the week ending August 24,Thursday’s stock stories: What’s likely to move the market in the next session CSX President and Chief Executive Officer to Address Morgan Stanley Laguna Conference North American rail traffic up 5.2% for the week ending August 31 CSX Expands Labor Agreements with Two More Partners North American rail traffic up 1.3% for the week ending August 24,1,0,1,0,0,0
58.01M,"205,146",2.37B,-1,"90,302","1,116.57",Strong Buy,"1,144.06","Jul 24, 2024",ORLY,"O'Reilly Automotive, Inc.",64.77B,"1,116.57",16.28B,0.42%,4.51%,8.64%,+1.10%,+1.89%,"Ride out future market volatility with all-weather stocks, Bank of America says",O’Reilly Auto’s Resilient Model and Growth Potential Bolster Buy Rating,TD Cowen Reaffirms Their Buy Rating on O’Reilly Auto (ORLY),Analysts Offer Insights on Consumer Cyclical Companies: Toll Brothers (TOL) and O’Reilly Auto (ORLY),Morgan Stanley Sticks to Their Hold Rating for O’Reilly Auto (ORLY),"Ride out future market volatility with all-weather stocks, Bank of America says O’Reilly Auto’s Resilient Model and Growth Potential Bolster Buy Rating TD Cowen Reaffirms Their Buy Rating on O’Reilly Auto (ORLY) Analysts Offer Insights on Consumer Cyclical Companies: Toll Brothers (TOL) and O’Reilly Auto (ORLY) Morgan Stanley Sticks to Their Hold Rating for O’Reilly Auto (ORLY)",1,1,1,1,1,1
254.73M,"1,556,475",2.78B,$4.06,"34,200",252.63,Buy,293.22,"Jul 22, 2024",NXPI,NXP Semiconductors N.V.,64.35B,252.63,13.11B,2.34%,-3.20%,4.68%,-6.17%,+2.45%,"NXP Semiconductors, VIS establish VSMC joint venture",VIS and NXP Announce Establishment of VSMC Joint Venture,"NXP Semiconductors announces dividend of $1.014 p/s, $2B share repurchase",NXP Semiconductors Announces Quarterly Dividend and Additional Share Repurchase Authorization,Analog Devices price target lowered to $255 from $260 at BofA,"NXP Semiconductors, VIS establish VSMC joint venture VIS and NXP Announce Establishment of VSMC Joint Venture NXP Semiconductors announces dividend of $1.014 p/s, $2B share repurchase NXP Semiconductors Announces Quarterly Dividend and Additional Share Repurchase Authorization Analog Devices price target lowered to $255 from $260 at BofA",0,0,0,0,0,0
281.52M,"1,091,880",2.94B,$2.52,"411,000",225.26,Buy,242.79,"Jul 31, 2024",MAR,"Marriott International, Inc.",63.42B,225.26,6.47B,3.20%,-2.49%,-2.56%,+0.01%,-10.48%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike","Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick",Watch CNBC’s full interview with Hyatt CEO Mark Hoplamazian,‘Travel is too expensive right now’: Americans spend less or skip trips altogether,Travelers are finally cracking under the pressure of high costs,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick Watch CNBC’s full interview with Hyatt CEO Mark Hoplamazian ‘Travel is too expensive right now’: Americans spend less or skip trips altogether Travelers are finally cracking under the pressure of high costs",0,1,1,0,0,0
865.60M,"10,312,724",-980.10M,$0.24,"6,577",71.84,Strong Buy,88.78,"Aug 29, 2024",MRVL,"Marvell Technology, Inc.",62.18B,71.84,5.35B,7.75%,2.38%,4.74%,+2.18%,-5.79%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Why Broadcom stock is tumbling after an earnings beat — and how to play the dip,"S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022",Small-cap portfolio manager says these stocks will thrive in slow growth environment,S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Why Broadcom stock is tumbling after an earnings beat — and how to play the dip S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022 Small-cap portfolio manager says these stocks will thrive in slow growth environment S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September",0,1,1,0,0,0
312.69M,"1,881,490",2.39B,$1.41,"13,871",194.99,Buy,225.00,"Aug 6, 2024",CEG,Constellation Energy Corporation,60.97B,194.99,23.54B,5.48%,-0.26%,17.11%,+2.09%,+0.36%,Small nuclear reactors could power the future — the challenge is getting one built,Why the U.S. is pumping more oil than any country in history,Wednesday’s stock stories: What’s likely to move the market in the next session,Morgan Stanley Wealth Management adds this utilities play to dividend portfolio,AI demand could strain electrical grid in coming decade,Small nuclear reactors could power the future — the challenge is getting one built Why the U.S. is pumping more oil than any country in history Wednesday’s stock stories: What’s likely to move the market in the next session Morgan Stanley Wealth Management adds this utilities play to dividend portfolio AI demand could strain electrical grid in coming decade,1,0,0,0,1,0
107.20M,"330,219",1.46B,$3.00,"16,800",547.82,Buy,607.40,"Jul 24, 2024",ROP,"Roper Technologies, Inc.",58.73B,547.82,6.57B,2.76%,0.22%,1.75%,+1.02%,+1.35%,Roper Technologies to present at Goldman Sachs technology conference,"IntelliTrans expands office footprint in Conway, Arkansas",Truist Financial Sticks to Its Buy Rating for Roper Technologies (ROP),"Roper Technologies Prices Public Offering Of $500 Million Senior Unsecured Notes Due 2029, $500 Million Senior Unsecured Notes Due 2032, $1 Billion Senior Unsecured Notes Due 2034",Roper Technologies price target raised to $635 from $625 at Jefferies,"Roper Technologies to present at Goldman Sachs technology conference IntelliTrans expands office footprint in Conway, Arkansas Truist Financial Sticks to Its Buy Rating for Roper Technologies (ROP) Roper Technologies Prices Public Offering Of $500 Million Senior Unsecured Notes Due 2029, $500 Million Senior Unsecured Notes Due 2032, $1 Billion Senior Unsecured Notes Due 2034 Roper Technologies price target raised to $635 from $625 at Jefferies",0,0,0,0,0,0
764.91M,"2,714,484",1.31B,-1,"13,568",74.73,Hold,70.46,"Aug 6, 2024",FTNT,"Fortinet, Inc.",57.16B,74.73,5.54B,11.58%,21.16%,21.87%,+30.27%,+6.63%,"We like Apple for its sustained business model, not its AI story","Palo Alto Networks finally gets back on track — delivering solid earnings, outlook",Palo Alto Networks bet big on bundling. Investors want more proof it’s working,"Walmart, Starbucks among the most overbought stocks due for a pullback","QQQ ETF Update, 9/6/2024 ","We like Apple for its sustained business model, not its AI story Palo Alto Networks finally gets back on track — delivering solid earnings, outlook Palo Alto Networks bet big on bundling. Investors want more proof it’s working Walmart, Starbucks among the most overbought stocks due for a pullback QQQ ETF Update, 9/6/2024 ",1,1,0,0,1,0
215.51M,"964,674",997.00M,-1,"14,100",255.26,Buy,269.24,"Aug 29, 2024",ADSK,"Autodesk, Inc.",55.01B,255.26,5.65B,5.33%,5.15%,8.29%,+2.87%,+4.04%,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","Autodesk is ‘fully aligned with Starboard’ that there is more value to come, says CEO Anagnost",Dow Jones notches another record close,"Calls of the Day: Autodesk, Uber, D.R. Horton, Constellation Brands and Chipotle","Analyst calls: Oil giant to surge more than 35%, Planet Fitness a top pick","Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Autodesk is ‘fully aligned with Starboard’ that there is more value to come, says CEO Anagnost Dow Jones notches another record close Calls of the Day: Autodesk, Uber, D.R. Horton, Constellation Brands and Chipotle Analyst calls: Oil giant to surge more than 35%, Planet Fitness a top pick",0,1,1,0,1,0
411.54M,"2,235,625",-407.00M,-1,"19,300",128.81,Buy,136.46,"Aug 1, 2024",DASH,"DoorDash, Inc.",53.01B,128.81,9.61B,4.10%,12.69%,12.50%,+14.85%,-8.89%,"Ulta misses expectations, trims guidance after quarterly sales decline",Costco may have another winner after its gold bar success: gift cards,"Evercore ISI’s Mark Mahaney on his new top internet stock picks: Amazon, Doordash, Uber",Andreas Halvorsen’s Viking Global poured money into tech last quarter,Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness,"Ulta misses expectations, trims guidance after quarterly sales decline Costco may have another winner after its gold bar success: gift cards Evercore ISI’s Mark Mahaney on his new top internet stock picks: Amazon, Doordash, Uber Andreas Halvorsen’s Viking Global poured money into tech last quarter Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness",0,0,0,0,0,0
644.49M,"1,856,935",3.96B,$1.74,"29,128",82.08,Strong Buy,114.43,"Aug 22, 2024",NTES,"NetEase, Inc.",52.90B,82.08,14.69B,-5.93%,-8.57%,-15.29%,-12.75%,-16.97%,"Game On: Tencent, NetEase reconsidering Japan investments",Analysts Stay Bullish on NetEase After Q2 Results,"Dell, Marvell get AI boost to beat expectations: Morning Buzz","Tencent, NetEase reconsider Japan investment strategies, Bloomberg says",Jefferies Reaffirms Their Buy Rating on Netease Inc (9999),"Game On: Tencent, NetEase reconsidering Japan investments Analysts Stay Bullish on NetEase After Q2 Results Dell, Marvell get AI boost to beat expectations: Morning Buzz Tencent, NetEase reconsider Japan investment strategies, Bloomberg says Jefferies Reaffirms Their Buy Rating on Netease Inc (9999)",0,0,1,1,0,1
248.48M,"5,379,624",1.48B,-1,"3,416",211.40,Buy,248.00,"Aug 1, 2024",COIN,"Coinbase Global, Inc.",52.53B,211.40,4.50B,-1.51%,-10.04%,1.68%,-15.23%,-21.05%,Coinbase has worst week of the year as crypto stocks plummet,Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade",Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World,"Coinbase has worst week of the year as crypto stocks plummet Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World",0,0,0,1,0,0
532.12M,"1,689,962",2.63B,$3.52,"17,250",98.25,Hold,94.54,"Jul 30, 2024",AEP,"American Electric Power Company, Inc.",52.28B,98.25,19.52B,0.27%,5.45%,15.05%,+0.43%,+17.38%,AI demand could strain electrical grid in coming decade,This power provider has doubled as it charts a path for nuclear data centers,Tech companies hunt for nuclear power sparks backlash from some utilities,"QQQ ETF Update, 9/6/2024 ","QQQ ETF Update, 9/4/2024 ","AI demand could strain electrical grid in coming decade This power provider has doubled as it charts a path for nuclear data centers Tech companies hunt for nuclear power sparks backlash from some utilities QQQ ETF Update, 9/6/2024  QQQ ETF Update, 9/4/2024 ",0,0,1,1,0,0
333.57M,"2,225,763",2.07B,$1.47,"108,000",155.21,Strong Buy,167.89,"Aug 22, 2024",ROST,"Ross Stores, Inc.",51.77B,155.21,21.09B,6.21%,5.35%,9.60%,+4.66%,+7.43%,"Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20%",TJ Maxx’s owner is bringing its secret sauce to new countries — with a twist,These comeback kids have wiped out the August sell-off,One retailer is on a tear into earnings. How to trade it without chasing it,"Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more","Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20% TJ Maxx’s owner is bringing its secret sauce to new countries — with a twist These comeback kids have wiped out the August sell-off One retailer is on a tear into earnings. How to trade it without chasing it Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more",0,1,0,1,0,1
491.58M,"2,053,190",253.36M,-1,"3,115",105.00,Strong Buy,108.65,"Aug 8, 2024",TTD,"The Trade Desk, Inc.",51.62B,105.00,2.17B,8.91%,7.55%,24.33%,+13.68%,+19.05%,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos",Trade Tracker: Josh Brown buys Trade Desk and Sweetgreen,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more",Jim Cramer’s top 10 things to watch in the stock market Friday,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos Trade Tracker: Josh Brown buys Trade Desk and Sweetgreen Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Jim Cramer’s top 10 things to watch in the stock market Friday",0,1,1,1,1,0
962.30M,"2,441,986",1.39B,-1,"10,200",52.76,Hold,50.33,"Sep 12, 2024",CPRT,"Copart, Inc.",50.77B,52.76,4.17B,2.36%,-0.23%,0.78%,+1.68%,-5.91%,"Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more",Barrington Reaffirms Their Hold Rating on Copart (CPRT),Copart price target lowered to $56 from $58 at Baird,Closing Bell Movers: C3.ai falls 16% with guidance unchanged despite Q1 beat,"Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more Barrington Reaffirms Their Hold Rating on Copart (CPRT) Copart price target lowered to $56 from $58 at Baird Closing Bell Movers: C3.ai falls 16% with guidance unchanged despite Q1 beat",1,1,1,0,0,0
524.22M,"2,178,469",4.96B,$1.20,"32,400",96.46,Buy,111.27,"Oct 22, 2024",PCAR,PACCAR Inc,50.57B,96.46,35.29B,-0.27%,-5.80%,-9.02%,-4.19%,-22.65%,Paccar price target lowered to $100 from $106 at Citi,,,,,Paccar price target lowered to $100 from $106 at Citi,1,0,-1,-1,-1,-1
142.74M,"609,488",4.65B,-1,"101,100",348.73,Hold,374.27,"Oct 25, 2024",CHTR,"Charter Communications, Inc.",49.78B,348.73,54.66B,0.61%,10.17%,11.97%,-6.30%,+33.01%,"NFL’s next big media rights payday is years off, subject to shifting industry","YES Network, MSG Networks to launch combined New York regional sports app",DirecTV is pushing its pay TV bundle — without a satellite dish,MoffettNathanson says Frontier deal implications ‘mixed’ for Verizon competitors,Charter and AMC Networks to renew distribution agreement,"NFL’s next big media rights payday is years off, subject to shifting industry YES Network, MSG Networks to launch combined New York regional sports app DirecTV is pushing its pay TV bundle — without a satellite dish MoffettNathanson says Frontier deal implications ‘mixed’ for Verizon competitors Charter and AMC Networks to renew distribution agreement",1,1,1,1,0,0
1.36B,"3,425,913",2.18B,$0.86,"28,100",35.73,Buy,36.50,"Oct 24, 2024",KDP,Keurig Dr Pepper Inc.,48.45B,35.73,15.06B,3.79%,6.99%,12.17%,+5.66%,+17.71%,Evercore ISI Remains a Hold on Keurig Dr Pepper (KDP),BRC Inc. announces distribution pact with Keurig Dr Pepper for energy beverages,"Keurig Dr Pepper, SUM announce new multi-year partnership with FMF",,,"Evercore ISI Remains a Hold on Keurig Dr Pepper (KDP) BRC Inc. announces distribution pact with Keurig Dr Pepper for energy beverages Keurig Dr Pepper, SUM announce new multi-year partnership with FMF",1,1,1,1,-1,-1
360.13M,"1,782,652",1.69B,$3.92,"16,600",130.00,Hold,122.62,"Sep 25, 2024",PAYX,"Paychex, Inc.",46.82B,130.00,5.28B,3.15%,5.39%,6.61%,+1.53%,+6.21%,"Lightning Round: ARM is a great stock to buy, says Jim Cramer",Cramer’s Lightning Round: Paychex is a buy,"QQQ ETF Update, 9/6/2024 ","QQQ ETF Update, 9/4/2024 ","QQQ ETF Update, 8/29/2024 ","Lightning Round: ARM is a great stock to buy, says Jim Cramer Cramer’s Lightning Round: Paychex is a buy QQQ ETF Update, 9/6/2024  QQQ ETF Update, 9/4/2024  QQQ ETF Update, 8/29/2024 ",0,0,0,0,0,0
979.54M,"3,747,652",1.69B,-1,"6,003",46.65,Buy,55.24,"Aug 7, 2024",MNST,Monster Beverage Corporation,45.70B,46.65,7.39B,-1.06%,-3.30%,-11.92%,-8.55%,-15.83%,Monster Beverage Board Authorizes New $500.0 Million Share Repurchase Program,Monster Beverage announces new $500M share repurchase program,Monster Beverage call volume above normal and directionally bullish,"Analysts Offer Insights on Consumer Goods Companies: Monster Beverage (MNST), Bj’s Wholesale Club Holdings (BJ) and Target (TGT)",Monster Beverage price target lowered to $50 from $56 at Roth MKM,"Monster Beverage Board Authorizes New $500.0 Million Share Repurchase Program Monster Beverage announces new $500M share repurchase program Monster Beverage call volume above normal and directionally bullish Analysts Offer Insights on Consumer Goods Companies: Monster Beverage (MNST), Bj’s Wholesale Club Holdings (BJ) and Target (TGT) Monster Beverage price target lowered to $50 from $56 at Roth MKM",1,1,1,1,1,1
48.75M,"495,993",410.98M,$5.00,"3,564",936.29,Strong Buy,912.30,"Aug 1, 2024",MPWR,"Monolithic Power Systems, Inc.",45.65B,936.29,1.89B,10.41%,12.38%,34.43%,+7.67%,+42.03%,These stocks have the most riding on Nvidia’s results with highest correlation,"Monolithic Power price target raised to $1,100 from $925 at TD Cowen",Analysts’ Opinions Are Mixed on These Technology Stocks: Monolithic Power (MPWR) and Texas Instruments (TXN),,,"These stocks have the most riding on Nvidia’s results with highest correlation Monolithic Power price target raised to $1,100 from $925 at TD Cowen Analysts’ Opinions Are Mixed on These Technology Stocks: Monolithic Power (MPWR) and Texas Instruments (TXN)",1,1,0,0,-1,-1
536.51M,"5,537,490",1.37B,$1.82,"22,300",81.79,Strong Buy,99.20,"Aug 1, 2024",MCHP,Microchip Technology Incorporated,43.88B,81.79,6.59B,1.69%,-6.34%,-7.55%,-10.57%,-9.33%,"Stocks making the biggest moves after hours: Toll Brothers, Keysight and more","Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Stocks making the biggest moves premarket: H&R Block, Applied Materials, Microchip",Friday analyst calls: Media and entertainment companies take focus of upgrades,Microchip (MCHP) Receives a Buy from Citi,"Stocks making the biggest moves after hours: Toll Brothers, Keysight and more Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Stocks making the biggest moves premarket: H&R Block, Applied Materials, Microchip Friday analyst calls: Media and entertainment companies take focus of upgrades Microchip (MCHP) Receives a Buy from Citi",1,1,0,1,1,1
214.30M,"777,251",1.28B,$1.04,"22,902",203.77,Hold,202.97,"Jul 24, 2024",ODFL,"Old Dominion Freight Line, Inc.",43.67B,203.77,5.97B,-2.83%,1.04%,-2.41%,-7.60%,-13.52%,Friday’s stock stories: What’s likely to move the market in the next session,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",Old Dominion price target lowered to $189 from $193 at JPMorgan,Old Dominion price target lowered to $206 from $210 at BofA,Mixed Performance Indicators Inform Hold Rating for Old Dominion Freight,"Friday’s stock stories: What’s likely to move the market in the next session Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Old Dominion price target lowered to $189 from $193 at JPMorgan Old Dominion price target lowered to $206 from $210 at BofA Mixed Performance Indicators Inform Hold Rating for Old Dominion Freight",0,0,1,0,0,0
1.21B,"5,872,266",1.92B,$1.60,"36,000",35.91,Buy,37.75,"Jul 31, 2024",KHC,The Kraft Heinz Company,43.42B,35.91,26.32B,1.94%,6.34%,0.82%,+0.51%,-4.51%,Morningstar’s Dave Sekera shares his top value stock picks,Berkshire Hathaway’s new stock pick Ulta Beauty is a classic value buy,Cheap stocks to buy for the long term during the volatility,"These dividend payers will beat yields on cash as the Fed cuts rates, BofA says",Kraft Heinz: Hold Rating Amidst Challenging Market Conditions and Pursuit of Growth Strategies,"Morningstar’s Dave Sekera shares his top value stock picks Berkshire Hathaway’s new stock pick Ulta Beauty is a classic value buy Cheap stocks to buy for the long term during the volatility These dividend payers will beat yields on cash as the Fed cuts rates, BofA says Kraft Heinz: Hold Rating Amidst Challenging Market Conditions and Pursuit of Growth Strategies",0,1,1,0,0,0
260.03M,"1,959,200",-300.52M,-1,"12,157",160.00,Buy,217.69,"Aug 1, 2024",TEAM,Atlassian Corporation,41.60B,160.00,4.36B,7.72%,-0.59%,-14.59%,-8.29%,-17.64%,StockTok: DOJ vows to stop pressuring social media companies to censor content,Atlassian-unit Loom acquires AI-powered virtual meeting firm Rewatch,,,,StockTok: DOJ vows to stop pressuring social media companies to censor content Atlassian-unit Loom acquires AI-powered virtual meeting firm Rewatch,1,0,1,-1,-1,-1
374.53M,"1,217,180",5.41B,-1,"6,400",109.02,Buy,108.43,"Jul 30, 2024",ACGL,Arch Capital Group Ltd.,40.83B,109.02,15.47B,9.98%,11.39%,22.04%,+15.90%,+16.98%,Friday’s big stock stories: What’s likely to move the market in the next trading session,Arch Capital initiated with an Equal Weight at Barclays,Arch Capital Group Welcomes New Board Members,Arch Capital price target raised to $125 from $110 at Roth MKM,Roth MKM Reaffirms Their Buy Rating on Arch Capital Group (ACGL),Friday’s big stock stories: What’s likely to move the market in the next trading session Arch Capital initiated with an Equal Weight at Barclays Arch Capital Group Welcomes New Board Members Arch Capital price target raised to $125 from $110 at Roth MKM Roth MKM Reaffirms Their Buy Rating on Arch Capital Group (ACGL),1,0,1,1,1,1
575.94M,"1,214,105",947.00M,$0.96,"8,525",70.35,Buy,70.27,"Oct 16, 2024",NDAQ,"Nasdaq, Inc.",40.52B,70.35,6.57B,3.56%,10.27%,18.89%,+4.83%,+14.36%,"Final Trade: ET, META, JBLU & NDAQ",Cramer’s Stop Trading: Nasdaq,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Looking beyond the U.S.? One portfolio manager is bullish on India, names stocks",Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,"Final Trade: ET, META, JBLU & NDAQ Cramer’s Stop Trading: Nasdaq Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Looking beyond the U.S.? One portfolio manager is bullish on India, names stocks Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings",1,1,0,1,1,0
82.31M,"275,146",845.63M,-1,"11,000",488.13,Buy,579.43,"Aug 6, 2024",IDXX,"IDEXX Laboratories, Inc.",40.18B,488.13,3.78B,0.26%,-0.18%,-5.67%,+1.13%,-7.33%,Buy Rating for Idexx Laboratories Amid Innovative Cancer Detection Product and Strong Financial Projections,Buy Rating Affirmed for Idexx Laboratories on Strong Growth and Innovation Prospects,Idexx Laboratories (IDXX) Gets a Hold from Piper Sandler,Idexx Laboratories: Holding Steady Amidst Challenges in Veterinary Industry,Buy Rating Affirmed for Idexx Laboratories Amid Operational Excellence and Growth Potential,Buy Rating for Idexx Laboratories Amid Innovative Cancer Detection Product and Strong Financial Projections Buy Rating Affirmed for Idexx Laboratories on Strong Growth and Innovation Prospects Idexx Laboratories (IDXX) Gets a Hold from Piper Sandler Idexx Laboratories: Holding Steady Amidst Challenges in Veterinary Industry Buy Rating Affirmed for Idexx Laboratories Amid Operational Excellence and Growth Potential,0,0,0,0,0,0
337.15M,"1,379,587",163.08M,-1,"5,200",117.23,Buy,139.70,"Aug 8, 2024",DDOG,"Datadog, Inc.",39.52B,117.23,2.39B,2.27%,-2.98%,-4.15%,-2.59%,-8.83%,"Lightning Round: KKR is ‘one of the best run companies in the world’, says Jim Cramer",Cramer’s Lightning Round: KKR is a ‘really great company’,DA Davidson technology analysts hold an analyst/industry conference call,"New Buy Rating for Datadog (DDOG), the Technology Giant","CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?","Lightning Round: KKR is ‘one of the best run companies in the world’, says Jim Cramer Cramer’s Lightning Round: KKR is a ‘really great company’ DA Davidson technology analysts hold an analyst/industry conference call New Buy Rating for Datadog (DDOG), the Technology Giant CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?",0,0,0,1,0,0
1.46B,"26,763,178",4.28B,$0.74,"517,124",26.83,Strong Buy,37.33,"Aug 15, 2024",JD,"JD.com, Inc.",39.28B,26.83,152.09B,-0.29%,-1.75%,-1.99%,-1.71%,-0.31%,Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps,Chinese consumer brands look to crack the global market with Singapore as a testbed,"A China stock bull earlier, fund manager explains why he has turned bearish now",Vance grilled on high cost of Trump’s new IVF plan,CNBC Daily Open: Everyone’s waiting for Nvidia,"Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps Chinese consumer brands look to crack the global market with Singapore as a testbed A China stock bull earlier, fund manager explains why he has turned bearish now Vance grilled on high cost of Trump’s new IVF plan CNBC Daily Open: Everyone’s waiting for Nvidia",1,1,0,0,0,0
264.20M,"1,439,751",1.15B,$0.76,"13,700",147.62,Buy,159.58,"Jul 30, 2024",EA,Electronic Arts Inc.,39.00B,147.62,7.30B,1.05%,3.64%,8.92%,-1.07%,+14.61%,A September trading strategy from Goldman that nets an 18% return on average,China’s first global gaming hit sells millions. Its investor shares what’s next,Friday’s big stock stories: What’s likely to move the market in the next session,Stifel Nicolaus Sticks to Its Buy Rating for Electronic Arts (EA),"Game On: Tencent, NetEase reconsidering Japan investments","A September trading strategy from Goldman that nets an 18% return on average China’s first global gaming hit sells millions. Its investor shares what’s next Friday’s big stock stories: What’s likely to move the market in the next session Stifel Nicolaus Sticks to Its Buy Rating for Electronic Arts (EA) Game On: Tencent, NetEase reconsidering Japan investments",0,0,0,0,1,0
572.65M,"1,266,112",1.15B,$1.56,"23,201",68.10,Buy,69.29,"Oct 10, 2024",FAST,Fastenal Company,39.00B,68.10,7.42B,0.76%,2.18%,0.53%,-4.72%,-12.03%,"Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer",Fastenal reports August net sales down 2.3% to $652.66M,Fastenal initiated with an Equal Weight at Morgan Stanley,,,"Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer Fastenal reports August net sales down 2.3% to $652.66M Fastenal initiated with an Equal Weight at Morgan Stanley",1,1,0,1,-1,-1
456.66M,"1,410,953",1.58B,$0.12,"51,000",84.78,Buy,95.00,"Jul 31, 2024",GEHC,GE HealthCare Technologies Inc.,38.72B,84.78,19.52B,1.09%,4.37%,4.98%,-0.83%,-5.13%,Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,Buy Rating Affirmed for GE HealthCare Technologies on Innovation and Strong Financial Outlook,Brink’s announces Teteak as Brinks Business System leader,GE HealthCare collaborates with University of California’s CTIPM,"GE HealthCare exec Stacherski sells 19,008 common shares","Cramer updates his takes on all 32 portfolio stocks and grades earnings reports Buy Rating Affirmed for GE HealthCare Technologies on Innovation and Strong Financial Outlook Brink’s announces Teteak as Brinks Business System leader GE HealthCare collaborates with University of California’s CTIPM GE HealthCare exec Stacherski sells 19,008 common shares",0,0,0,1,0,0
142.42M,"403,416",889.10M,$1.56,"7,500",268.15,Buy,272.33,"Jul 31, 2024",VRSK,"Verisk Analytics, Inc.",38.19B,268.15,2.78B,0.90%,-0.84%,8.65%,+3.71%,+19.25%,"Update: U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Half Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization","U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Quarter Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization",Verisk Analytics: A Balanced Hold Rating Amidst Growth and Market Risks,Verisk Analytics initiated with an Overweight at Wells Fargo,,"Update: U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Half Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Quarter Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization Verisk Analytics: A Balanced Hold Rating Amidst Growth and Market Risks Verisk Analytics initiated with an Overweight at Wells Fargo",1,1,1,1,1,-1
495.66M,"1,785,723",2.20B,$1.20,"347,700",76.68,Hold,76.11,"Jul 31, 2024",CTSH,Cognizant Technology Solutions Corporation,38.01B,76.68,19.27B,2.97%,7.03%,6.93%,+1.57%,+8.07%,Cognizant price target raised to $89 from $82 at JPMorgan,Cognizant’s Solid Financials and Strategic Growth Initiatives Garner Buy Rating,Cognizant’s Hold Rating: A Balanced View Amidst Modest Growth and Acquisition Costs,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Cognizant price target raised to $82 from $81 at RBC Capital,"Cognizant price target raised to $89 from $82 at JPMorgan Cognizant’s Solid Financials and Strategic Growth Initiatives Garner Buy Rating Cognizant’s Hold Rating: A Balanced View Amidst Modest Growth and Acquisition Costs Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Cognizant price target raised to $82 from $81 at RBC Capital",1,1,1,1,1,1
1.00B,"2,859,800",2.42B,$1.52,"19,962",37.79,Buy,39.67,"Aug 1, 2024",EXC,Exelon Corporation,37.81B,37.79,22.75B,0.18%,3.96%,2.69%,+1.85%,+1.47%,This power provider has doubled as it charts a path for nuclear data centers,Tech companies hunt for nuclear power sparks backlash from some utilities,Exelon price target raised to $42 from $39 at Morgan Stanley,Exelon (EXC) Receives a Hold from Morgan Stanley,Exelon price target raised to $40 from $37 at Scotiabank,This power provider has doubled as it charts a path for nuclear data centers Tech companies hunt for nuclear power sparks backlash from some utilities Exelon price target raised to $42 from $39 at Morgan Stanley Exelon (EXC) Receives a Hold from Morgan Stanley Exelon price target raised to $40 from $37 at Scotiabank,1,1,1,0,0,1
460.37M,"1,002,372",1.73B,$2.03,"32,315",78.73,Strong Buy,78.11,"Aug 7, 2024",CCEP,Coca-Cola Europacific Partners PLC,36.12B,78.73,20.52B,6.04%,7.54%,14.57%,+8.62%,+15.64%,Coca-Cola CEO Sells Shares Worth Millions,Evercore ISI Reaffirms Their Buy Rating on Coca-Cola Europacific Partners (CCEP),Coca-Cola Europacific Partners Updates Share Count,Kepler Capital Keeps Their Hold Rating on Coca-Cola Europacific Partners (CCEP),Coca-Cola Europacific Exec Awarded Performance Shares,Coca-Cola CEO Sells Shares Worth Millions Evercore ISI Reaffirms Their Buy Rating on Coca-Cola Europacific Partners (CCEP) Coca-Cola Europacific Partners Updates Share Count Kepler Capital Keeps Their Hold Rating on Coca-Cola Europacific Partners (CCEP) Coca-Cola Europacific Exec Awarded Performance Shares,1,0,0,0,0,0
58.56M,"8,941,171",1.21B,-1,"5,126",613.24,Buy,953.42,"Aug 6, 2024",SMCI,"Super Micro Computer, Inc.",35.91B,613.24,14.94B,-8.59%,-26.16%,-20.12%,-36.79%,-53.22%,Super Micro Computer is among the most oversold names on the Street,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Stocks making the biggest moves premarket: Bowlero, UiPath, Broadcom and more","Super Micro Computer is among the most oversold names on the Street Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Stocks making the biggest moves premarket: Bowlero, UiPath, Broadcom and more",1,1,1,0,1,1
128.38M,"614,942",-72.94M,-1,"2,100",272.64,Buy,281.68,"Aug 1, 2024",ALNY,"Alnylam Pharmaceuticals, Inc.",35.00B,272.64,2.34B,5.27%,14.55%,52.99%,+18.21%,+82.80%,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more",RBC Capital Sticks to Their Buy Rating for Alnylam Pharma (ALNY),Alnylam Pharma’s Vutrisiran Garners Strong Buy Rating Amidst Positive ATTR-CM Treatment Prospects,"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Viridian Therapeutics (VRDN) and Impedimed Limited (OtherIPDQF)",Stifel Nicolaus Sticks to Their Buy Rating for Alnylam Pharma (ALNY),"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more RBC Capital Sticks to Their Buy Rating for Alnylam Pharma (ALNY) Alnylam Pharma’s Vutrisiran Garners Strong Buy Rating Amidst Positive ATTR-CM Treatment Prospects Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Viridian Therapeutics (VRDN) and Impedimed Limited (OtherIPDQF) Stifel Nicolaus Sticks to Their Buy Rating for Alnylam Pharma (ALNY)",0,1,0,0,0,0
993.42M,"3,085,909",1.99B,$0.84,"58,000",35.22,Strong Buy,43.31,"Jul 25, 2024",BKR,Baker Hughes Company,34.99B,35.22,27.03B,0.08%,1.23%,7.71%,-9.71%,+1.89%,Baker Hughes reports U.S. rig count down 1 to 582 rigs,Baker Hughes announces leadership changes to continue strategic growth,Baker Hughes Announces Leadership Changes to Continue Strategic Growth and Customer Success  ,Baker Hughes reports U.S. rig count down 2 to 583 rigs,Seaport Research oilfield services analyst has analyst/industry conference call,Baker Hughes reports U.S. rig count down 1 to 582 rigs Baker Hughes announces leadership changes to continue strategic growth Baker Hughes Announces Leadership Changes to Continue Strategic Growth and Customer Success   Baker Hughes reports U.S. rig count down 2 to 583 rigs Seaport Research oilfield services analyst has analyst/industry conference call,1,1,1,1,1,1
178.39M,"1,116,866",3.46B,$9.36,"1,032",195.22,Buy,216.21,"Aug 5, 2024",FANG,"Diamondback Energy, Inc.",34.83B,195.22,8.85B,0.36%,-1.26%,8.56%,-3.83%,-4.77%,Diamondback Energy price target lowered to $237 from $245 at Susquehanna,Morgan Stanley Remains a Buy on Diamondback (FANG),Piper Sandler Keeps Their Buy Rating on Diamondback (FANG),Diamondback Energy price target lowered to $240 from $249 at Piper Sandler,Diamondback Energy price target lowered to $230 from $231 at Wells Fargo,Diamondback Energy price target lowered to $237 from $245 at Susquehanna Morgan Stanley Remains a Buy on Diamondback (FANG) Piper Sandler Keeps Their Buy Rating on Diamondback (FANG) Diamondback Energy price target lowered to $240 from $249 at Piper Sandler Diamondback Energy price target lowered to $230 from $231 at Wells Fargo,1,1,1,1,1,1
125.00M,"2,486,838",1.58B,-1,"38,000",268.55,Buy,390.74,"Aug 29, 2024",LULU,Lululemon Athletica Inc.,33.57B,268.55,9.83B,8.26%,-1.63%,-29.23%,+0.07%,-27.47%,Cramer on Lululemon: The core business is struggling and there’s a lot of new competition in athleisure,Jim Cramer says Broadcom stock is a buy but cautions investors to keep it small,"Cannabis industry targets luxury consumers on Fifth Avenue, in the Hamptons","3-Stock Lunch: Intel, Lululemon & Walgreens Boots",Trade Alert: Rob Sechan sells Lululemon,"Cramer on Lululemon: The core business is struggling and there’s a lot of new competition in athleisure Jim Cramer says Broadcom stock is a buy but cautions investors to keep it small Cannabis industry targets luxury consumers on Fifth Avenue, in the Hamptons 3-Stock Lunch: Intel, Lululemon & Walgreens Boots Trade Alert: Rob Sechan sells Lululemon",1,0,0,1,1,0
557.50M,"3,282,303",1.86B,$2.19,"11,311",60.12,Buy,63.14,"Oct 25, 2024",XEL,Xcel Energy Inc.,33.52B,60.12,13.78B,2.92%,8.39%,7.02%,+4.12%,+13.36%,AI demand could strain electrical grid in coming decade,Bank of America Securities Remains a Buy on Xcel Energy (XEL),"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls","Xcel Energy upgraded to Buy at Argus on data center potential, dividend growth",Xcel Energy upgraded to Buy from Hold at Argus,"AI demand could strain electrical grid in coming decade Bank of America Securities Remains a Buy on Xcel Energy (XEL) Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Xcel Energy upgraded to Buy at Argus on data center potential, dividend growth Xcel Energy upgraded to Buy from Hold at Argus",1,0,1,1,1,1
428.36M,"5,128,320",1.94B,-1,"30,100",76.36,Buy,85.79,"Jul 29, 2024",ON,ON Semiconductor Corporation,32.71B,76.36,7.80B,4.17%,4.77%,3.18%,-4.63%,+7.66%,The Big Tech deterioration raises a major red flag for the market,ON Semiconductor (ON) Receives a Rating Update from a Top Analyst,ON Semiconductor: Balancing Growth Prospects with Industry Challenges – A Neutral Outlook,ON Semiconductor put volume heavy and directionally bearish,Analog Devices price target lowered to $255 from $260 at BofA,The Big Tech deterioration raises a major red flag for the market ON Semiconductor (ON) Receives a Rating Update from a Top Analyst ON Semiconductor: Balancing Growth Prospects with Industry Challenges – A Neutral Outlook ON Semiconductor put volume heavy and directionally bearish Analog Devices price target lowered to $255 from $260 at BofA,0,1,0,1,1,0
384.40M,"2,285,803",-5.87B,-1,"5,600",82.44,Buy,127.31,"Aug 1, 2024",MRNA,"Moderna, Inc.",31.69B,82.44,5.05B,-10.47%,-27.96%,-25.59%,-34.27%,-23.83%,A September trading strategy from Goldman that nets an 18% return on average,Cramer’s Lightning Round: KKR is a buy,FDA authorizes Novavax Covid vaccine targeting JN.1,"Lockheed Martin, Northrop Grumman among the most overbought stocks","Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more","A September trading strategy from Goldman that nets an 18% return on average Cramer’s Lightning Round: KKR is a buy FDA authorizes Novavax Covid vaccine targeting JN.1 Lockheed Martin, Northrop Grumman among the most overbought stocks Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more",0,0,0,0,1,1
409.82M,"1,491,257",212.90M,-1,"6,152",76.99,Strong Buy,96.14,"Jul 23, 2024",CSGP,"CoStar Group, Inc.",31.55B,76.99,2.60B,2.89%,3.20%,-7.18%,-1.92%,-19.23%,"Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings","Murdoch’s property group considers bid for Rightmove, sending shares 21% higher",KBW Reaffirms Their Buy Rating on CoStar Group (CSGP),CoStar Group management to meet with Stephens,Buy Rating Reaffirmed for CoStar Group Amid Rising Homes.com Traffic and Potential Revenue Growth,"Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings Murdoch’s property group considers bid for Rightmove, sending shares 21% higher KBW Reaffirms Their Buy Rating on CoStar Group (CSGP) CoStar Group management to meet with Stephens Buy Rating Reaffirmed for CoStar Group Amid Rising Homes.com Traffic and Potential Revenue Growth",1,1,1,1,1,1
59.80M,"109,396",-204.35M,-1,"1,148",516.69,Strong Buy,544.06,"Jul 25, 2024",ARGX,argenx SE,31.10B,516.69,1.66B,-0.06%,8.90%,23.66%,+0.60%,+34.10%,Argenx price target raised to EUR 510 from EUR 470 at UBS,Argenx price target raised to $510 from $470 at UBS,argenx to Present at Upcoming Investor Conferences,Argenx price target raised to $640 from $500 at JPMorgan,,Argenx price target raised to EUR 510 from EUR 470 at UBS Argenx price target raised to $510 from $470 at UBS argenx to Present at Upcoming Investor Conferences Argenx price target raised to $640 from $500 at JPMorgan,1,1,1,1,1,-1
133.58M,"1,502,535",1.11B,$2.48,"15,100",229.12,Strong Buy,254.63,"Jul 31, 2024",CDW,CDW Corporation,30.69B,229.74,20.94B,4.05%,1.63%,-0.92%,+2.93%,-12.03%,"Analysts Offer Insights on Technology Companies: Workday (WDAY), CDW (CDW) and Texas Instruments (TXN)",,,,,"Analysts Offer Insights on Technology Companies: Workday (WDAY), CDW (CDW) and Texas Instruments (TXN)",0,0,-1,-1,-1,-1
727.88M,"25,725",808.96M,$0.78,"24,799",41.75,,,,FER,Ferrovial SE,30.24B,41.75,9.47B,2.50%,1.76%,21.93%,+3.84%,+39.93%,Ferrovial Concludes Share Buyback Program,Ferrovial Initiates Multi-Million Euro Share Buyback,Ferrovial Advances Share Buyback Program,,,Ferrovial Concludes Share Buyback Program Ferrovial Initiates Multi-Million Euro Share Buyback Ferrovial Advances Share Buyback Program,0,0,1,1,-1,-1
334.25M,"2,040,837",823.80M,-1,"1,745",90.20,Buy,82.86,"Aug 7, 2024",APP,AppLovin Corporation,30.15B,90.20,3.96B,13.11%,11.42%,41.14%,+14.14%,+17.65%,AppLovin Stock Is a Cheap Hidden AI Gem,Benchmark Co. Keeps Their Sell Rating on AppLovin (APP),"With a 0.61x PEG Ratio, AppLovin Stock (NASDAQ:APP) Looks Deeply Undervalued","Lone Pine buys GE Vernova, exits Live Nation in Q2",,"AppLovin Stock Is a Cheap Hidden AI Gem Benchmark Co. Keeps Their Sell Rating on AppLovin (APP) With a 0.61x PEG Ratio, AppLovin Stock (NASDAQ:APP) Looks Deeply Undervalued Lone Pine buys GE Vernova, exits Live Nation in Q2",0,0,1,0,0,-1
151.15M,"1,172,414",-73.50M,-1,"5,962",199.43,Buy,224.58,"Sep 3, 2024",ZS,"Zscaler, Inc.",30.14B,199.43,2.03B,8.07%,5.39%,-0.51%,+8.15%,+5.80%,Traders ahead of session: What the Fed should do and looking for tech bargains,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Zscaler CEO on guidance, market reaction and CrowdStrike impact","Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more","Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde","Traders ahead of session: What the Fed should do and looking for tech bargains Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Zscaler CEO on guidance, market reaction and CrowdStrike impact Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde",1,1,1,0,1,1
350.65M,"3,381,407",2.68B,-1,"39,800",85.70,Strong Buy,140.43,"Aug 22, 2024",BIDU,"Baidu, Inc.",30.05B,85.70,18.56B,-1.57%,-4.59%,-17.18%,-7.01%,-22.66%,"A China stock bull earlier, fund manager explains why he has turned bearish now",China’s drivers fret over robotaxi push. Experts say there will be new jobs,Tesla’s Optimus faces stiff humanoid competition at Beijing robot conference,Baidu reports slower growth in robotaxi rides,"Retail earnings lift other boats — plus, stocks take negative jobs update in stride","A China stock bull earlier, fund manager explains why he has turned bearish now China’s drivers fret over robotaxi push. Experts say there will be new jobs Tesla’s Optimus faces stiff humanoid competition at Beijing robot conference Baidu reports slower growth in robotaxi rides Retail earnings lift other boats — plus, stocks take negative jobs update in stride",0,0,0,0,1,1
145.66M,"475,951",1.16B,-1,"7,570",205.00,Buy,278.96,"Aug 1, 2024",BIIB,Biogen Inc.,29.86B,205.00,9.67B,-0.49%,-6.54%,-10.08%,-4.22%,+0.16%,Optimistic Buy Rating for Biogen on Strategic Cost-Cutting and Growth Asset Prioritization,Biogen announces higher dose of nusinersen shows statistical improvement,"Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA",Biogen’s Upward Trajectory: A Buy Rating on Alzheimer’s and Pipeline Progress,Barclays Keeps Their Hold Rating on Biogen (BIIB),"Optimistic Buy Rating for Biogen on Strategic Cost-Cutting and Growth Asset Prioritization Biogen announces higher dose of nusinersen shows statistical improvement Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA Biogen’s Upward Trajectory: A Buy Rating on Alzheimer’s and Pipeline Progress Barclays Keeps Their Hold Rating on Biogen (BIIB)",0,0,0,0,0,0
400.73M,"2,520,394",666.90M,-1,"9,600",74.07,Buy,108.24,"Jul 25, 2024",DXCM,"DexCom, Inc.",29.68B,74.07,3.93B,0.23%,-23.72%,-38.07%,+3.92%,-49.27%,Cramer’s Lightning Round: Whirlpool is ‘too inconsistent’,"These stocks are contenders for selling — and can help cut taxes, Wolfe says","Healthy Returns: What to know about updated Pfizer, Moderna Covid vaccines",Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like,"Today we had a bit of a reckoning in the market, says Jim Cramer","Cramer’s Lightning Round: Whirlpool is ‘too inconsistent’ These stocks are contenders for selling — and can help cut taxes, Wolfe says Healthy Returns: What to know about updated Pfizer, Moderna Covid vaccines Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like Today we had a bit of a reckoning in the market, says Jim Cramer",1,0,1,1,1,0
194.32M,"10,311,074",-209.99M,-1,"1,934",150.01,Strong Buy,205.94,"Aug 1, 2024",MSTR,MicroStrategy Incorporated,29.15B,150.01,480.63M,0.54%,-3.92%,24.82%,-18.18%,-8.21%,Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade","Bitcoin turns positive after overnight sell-off briefly pulls it below $56,000","Stocks making biggest moves premarket: Super Micro, Abercrombie and more","Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade Bitcoin turns positive after overnight sell-off briefly pulls it below $56,000 Stocks making biggest moves premarket: Super Micro, Abercrombie and more",1,0,1,0,0,1
14.47M,"109,641",2.64B,$6.56,"16,021","2,015.05",Buy,"1,913.78","Oct 24, 2024",FCNCA,"First Citizens BancShares, Inc.",29.15B,"2,015.05",9.44B,-1.73%,5.60%,20.59%,-5.25%,+24.05%,First Citizens files automatic mixed securities shelf,,,,,First Citizens files automatic mixed securities shelf,0,1,-1,-1,-1,-1
107.87M,"794,911",1.13B,$4.40,"50,000",269.18,Buy,254.50,"Jul 25, 2024",TSCO,Tractor Supply Company,29.04B,269.18,14.71B,4.23%,2.34%,10.16%,+3.77%,+8.23%,Molson Coors pumps the brakes on DEI practices,Ford joins list of companies walking back DEI policies,Harley-Davidson drops diversity efforts after online pressure,Tractor Supply price target raised to $260 from $250 at Loop Capital,Loop Capital Markets Reaffirms Their Hold Rating on Tractor Supply (TSCO),Molson Coors pumps the brakes on DEI practices Ford joins list of companies walking back DEI policies Harley-Davidson drops diversity efforts after online pressure Tractor Supply price target raised to $260 from $250 at Loop Capital Loop Capital Markets Reaffirms Their Hold Rating on Tractor Supply (TSCO),1,0,0,0,1,1
14.47M,"14,194",2.64B,$1.41,"16,021",23.55,,,"Jul 25, 2024",FCNCO,"First Citizens BancShares, Inc.",28.94B,23.60,9.44B,,2.34%,10.16%,+5.22%,+2.52%,,,,,,,0,-1,-1,-1,-1,-1
489.00M,"3,196,385",2.69B,$1.08,"12,300",58.88,Buy,56.91,"Jul 31, 2024",EBAY,eBay Inc.,28.79B,58.88,10.19B,5.14%,8.41%,21.75%,+3.90%,+10.99%,Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,eBay initiated with a Neutral at Cantor Fitzgerald,US regulators want to probe Shein and Temu for consumer safety,"Ikea launches Ikea Preowned to compete with eBay, FT reports","Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call eBay initiated with a Neutral at Cantor Fitzgerald US regulators want to probe Shein and Temu for consumer safety Ikea launches Ikea Preowned to compete with eBay, FT reports",1,0,1,1,1,0
101.56M,"361,826",1.09B,$3.52,"48,000",281.46,Buy,302.00,"Jul 25, 2024",WTW,Willis Towers Watson Public Limited Company,28.58B,281.46,9.69B,2.81%,6.52%,10.96%,+2.55%,+6.84%,Roth MKM Remains a Buy on Willis Towers Watson (WTW),WTW initiated with an Underweight at Barclays,WTW launches new property facility with Canopius,WTW announces new leadership for Transactional Insurance Solutions,WTW announces new Property & Casualty leader for Private Equity and Transactional Solutions,Roth MKM Remains a Buy on Willis Towers Watson (WTW) WTW initiated with an Underweight at Barclays WTW launches new property facility with Canopius WTW announces new leadership for Transactional Insurance Solutions WTW announces new Property & Casualty leader for Private Equity and Transactional Solutions,1,0,0,1,1,1
676.08M,"3,059,998",2.16B,$1.40,"18,724",42.12,Buy,40.62,"Oct 17, 2024",FITB,Fifth Third Bancorp,28.48B,42.12,8.13B,3.25%,6.92%,17.40%,-0.33%,+19.55%,"These are the top stocks to own for rest of the year, per Wolfe Research","These banks could be primed to outperform when rates fall, Evercore ISI says","Analysts Offer Insights on Financial Companies: Sagicor Financial (OtherSGCFF), Equitable Holdings (EQH) and Fifth Third Bancorp (FITB)",Bank of America Securities Keeps Their Buy Rating on Fifth Third Bancorp (FITB),,"These are the top stocks to own for rest of the year, per Wolfe Research These banks could be primed to outperform when rates fall, Evercore ISI says Analysts Offer Insights on Financial Companies: Sagicor Financial (OtherSGCFF), Equitable Holdings (EQH) and Fifth Third Bancorp (FITB) Bank of America Securities Keeps Their Buy Rating on Fifth Third Bancorp (FITB)",0,0,0,0,0,-1
87.39M,"191,420",495.08M,-1,"6,200",323.45,Hold,318.33,"Jul 31, 2024",ANSS,"ANSYS, Inc.",28.27B,323.45,2.32B,1.06%,-0.36%,-1.96%,+0.63%,-7.68%,,,,,,,1,-1,-1,-1,-1,-1
75.57M,"567,985",290.68M,-1,"4,260",370.70,Strong Buy,358.08,"Aug 6, 2024",AXON,"Axon Enterprise, Inc.",28.02B,370.70,1.81B,4.73%,13.76%,26.77%,+20.81%,+16.96%,Disney and this AI stock are among the most oversold stocks this week,Axon and Skydio CEOs talk partnership developing first responder drones,"NFL stadium drone incursions present opportunity for Axon, says BofA",Axon management to meet with JMP Securities,Axon participates in a conference call with JPMorgan,"Disney and this AI stock are among the most oversold stocks this week Axon and Skydio CEOs talk partnership developing first responder drones NFL stadium drone incursions present opportunity for Axon, says BofA Axon management to meet with JMP Securities Axon participates in a conference call with JPMorgan",0,0,0,0,1,0
175.28M,"797,403",-3.80B,-1,"12,371",159.39,Strong Buy,184.76,"Aug 8, 2024",TTWO,"Take-Two Interactive Software, Inc.",27.94B,159.39,5.40B,8.40%,6.14%,4.87%,+5.63%,+5.27%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike","Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick",Andreas Halvorsen’s Viking Global poured money into tech last quarter,Take-Two CEO Strauss Zelnick sits down with Jim Cramer,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks","Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick Andreas Halvorsen’s Viking Global poured money into tech last quarter Take-Two CEO Strauss Zelnick sits down with Jim Cramer Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",1,1,1,0,0,1
651.11M,"3,410,064",1.50B,-1,"36,249",42.18,Strong Buy,63.38,"Aug 26, 2024",TCOM,Trip.com Group Limited,27.46B,42.18,6.54B,9.81%,1.19%,5.63%,+8.58%,-4.07%,PDD just gave markets the latest warning on China’s consumer,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more","Stocks making the biggest moves premarket: Paramount, Cava, JD.com and more","Is the market rotation back? Plus, the mob scene at Costco’s new store in Japan",Citi Keeps Their Buy Rating on Trip.com Group Ltd. Sponsored ADR (TCOM),"PDD just gave markets the latest warning on China’s consumer Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more Stocks making the biggest moves premarket: Paramount, Cava, JD.com and more Is the market rotation back? Plus, the mob scene at Costco’s new store in Japan Citi Keeps Their Buy Rating on Trip.com Group Ltd. Sponsored ADR (TCOM)",0,0,1,1,0,0
205.80M,"919,298",986.00M,$2.08,"11,800",133.12,Buy,125.13,"Aug 28, 2024",NTAP,"NetApp, Inc.",27.40B,133.12,6.27B,5.93%,4.50%,27.54%,+3.88%,+25.57%,Trade Tracker: Josh Brown Sells NetApp,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","Stocks making the biggest moves premarket: United States Steel, Boeing and more","Tuesday’s analyst calls: Ferrari to jump 20%, Boeing downgraded to sell","Committee Stocks on the Move: NetApp, Dell, Freeport-McMoRan, P&G and Bitcoin","Trade Tracker: Josh Brown Sells NetApp Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Stocks making the biggest moves premarket: United States Steel, Boeing and more Tuesday’s analyst calls: Ferrari to jump 20%, Boeing downgraded to sell Committee Stocks on the Move: NetApp, Dell, Freeport-McMoRan, P&G and Bitcoin",1,0,1,1,1,0
82.82M,"226,361",714.43M,-1,"41,100",324.16,Strong Buy,352.56,"Jul 24, 2024",ICLR,ICON Public Limited Company,26.85B,324.16,8.33B,2.01%,1.17%,7.81%,-2.34%,+0.60%,ICON plc CEO to Speak at Global Healthcare Event,Truist Financial Remains a Buy on Icon (ICLR),Evercore ISI Sticks to Its Buy Rating for Icon (ICLR),ICON plc Welcomes New CFO Nigel Clerkin,Icon names Nigel Clerkin as new CFO,ICON plc CEO to Speak at Global Healthcare Event Truist Financial Remains a Buy on Icon (ICLR) Evercore ISI Sticks to Its Buy Rating for Icon (ICLR) ICON plc Welcomes New CFO Nigel Clerkin Icon names Nigel Clerkin as new CFO,1,0,0,0,0,0
27.08B,"2,512,080",1.23B,$0.96,"96,282",9.72,Buy,7.70,"May 14, 2024",VOD,Vodafone Group Public Limited Company,25.83B,9.72,39.61B,4.50%,7.13%,10.45%,+4.81%,+13.81%,Goldman Sachs Reaffirms Their Buy Rating on Vodafone (VOD),,,,,Goldman Sachs Reaffirms Their Buy Rating on Vodafone (VOD),0,0,-1,-1,-1,-1
52.29M,"68,700",530.42M,$5.10,"6,556",489.24,,,"Jul 25, 2024",ERIE,Erie Indemnity Company,25.58B,489.24,3.55B,6.61%,20.24%,31.90%,+12.32%,+23.69%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance","Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500","Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23",,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23",1,1,1,1,-1,-1
551.78M,"821,536",814.00M,-1,"12,000",46.07,Buy,58.25,"Aug 6, 2024",GFS,GlobalFoundries Inc.,25.42B,46.07,6.89B,1.33%,-7.38%,-12.19%,-11.10%,-10.29%,10 things to watch in the stock market Friday including more bullishness on Lilly,"Lightning Round: I’m a buyer of Clorox, says Jim Cramer",Cramer’s Lightning Round: Clorox is a buy,Accelerating AI with Essential Chips at GlobalFoundries Technology Summit 2024,Buy Rating on GlobalFoundries Inc: Strong Market Position and Bullish Financial Outlook,"10 things to watch in the stock market Friday including more bullishness on Lilly Lightning Round: I’m a buyer of Clorox, says Jim Cramer Cramer’s Lightning Round: Clorox is a buy Accelerating AI with Essential Chips at GlobalFoundries Technology Summit 2024 Buy Rating on GlobalFoundries Inc: Strong Market Position and Bullish Financial Outlook",1,0,0,0,0,0
213.23M,"459,859",432.90M,$0.40,"1,179",117.45,Buy,118.00,"Jul 25, 2024",TW,Tradeweb Markets Inc.,25.04B,117.45,1.51B,2.91%,7.22%,14.19%,+4.28%,+13.73%,This small-cap fund is outperforming the Russell 2000. Here’s how it works,Tradeweb Markets reports total trading volume for August of $50.9T,Tradeweb Markets price target raised to $113 from $110 at Deutsche Bank,,,This small-cap fund is outperforming the Russell 2000. Here’s how it works Tradeweb Markets reports total trading volume for August of $50.9T Tradeweb Markets price target raised to $113 from $110 at Deutsche Bank,1,0,1,1,-1,-1
107.05M,"2,439,299",1.20B,-1,"6,700",231.07,Buy,277.74,"Jul 30, 2024",FSLR,"First Solar, Inc.",24.73B,231.07,3.76B,7.17%,3.33%,25.38%,+5.82%,+30.91%,Why the U.S. is pumping more oil than any country in history,How the Inflation Reduction Act sparked a manufacturing and clean energy boom,"The long-term winners as AI boosts U.S. power needs, according to Mizuho",Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness,First Solar (FSLR) Poised for Growth: Strong Buy Rating Amid Market Challenges and Policy Tailwinds,"Why the U.S. is pumping more oil than any country in history How the Inflation Reduction Act sparked a manufacturing and clean energy boom The long-term winners as AI boosts U.S. power needs, according to Mizuho Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness First Solar (FSLR) Poised for Growth: Strong Buy Rating Amid Market Challenges and Policy Tailwinds",0,0,1,0,0,0
3.33B,"15,511,757",-3.38B,$0.25,"99,952",7.40,Hold,5.90,"Oct 15, 2024",ERIC,Telefonaktiebolaget LM Ericsson (publ),24.64B,7.40,23.54B,7.18%,12.98%,28.14%,+7.55%,+45.87%,Telefonaktiebolaget LM Ericsson Class B (0O87): New Sell Recommendation for This Technology Giant,Cradlepoint Enhances Wyoming Highway Patrol Vehicle Connectivity with Cellular-to-Satellite Failover,Wyoming Highway Patrol leverages Cradlepoint routers for connectivity,Ericsson Sells Subsidiary iconectiv to Koch Equity,Koch Equity Development Signs Agreement to Acquire Telecommunications Solutions Leader iconectiv,Telefonaktiebolaget LM Ericsson Class B (0O87): New Sell Recommendation for This Technology Giant Cradlepoint Enhances Wyoming Highway Patrol Vehicle Connectivity with Cellular-to-Satellite Failover Wyoming Highway Patrol leverages Cradlepoint routers for connectivity Ericsson Sells Subsidiary iconectiv to Koch Equity Koch Equity Development Signs Agreement to Acquire Telecommunications Solutions Leader iconectiv,1,1,0,0,1,0
107.47M,"499,180",514.32M,$3.92,"1,787",227.28,Strong Buy,243.54,"Jul 29, 2024",SBAC,SBA Communications Corporation,24.43B,227.28,2.68B,3.95%,9.56%,5.73%,+3.70%,+6.69%,"Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC)",SBA Communications price target raised to $240 from $230 at Deutsche Bank,,,,"Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC) SBA Communications price target raised to $240 from $230 at Deutsche Bank",1,0,1,-1,-1,-1
222.60M,"883,760",1.90B,$4.96,"7,906",109.62,Hold,113.90,"Oct 25, 2024",TROW,"T. Rowe Price Group, Inc.",24.40B,109.62,6.80B,0.18%,-4.35%,-2.65%,-5.87%,-7.83%,OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing,Evercore ISI Keeps Their Hold Rating on T Rowe Price (TROW),"Hershey, Temu parent PDD downgraded: Wall Street’s top analyst calls",T. Rowe Price initiated with an Underweight at Barclays,T. Rowe Price price target raised to $113 from $112 at Deutsche Bank,"OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing Evercore ISI Keeps Their Hold Rating on T Rowe Price (TROW) Hershey, Temu parent PDD downgraded: Wall Street’s top analyst calls T. Rowe Price initiated with an Underweight at Barclays T. Rowe Price price target raised to $113 from $112 at Deutsche Bank",1,0,0,1,0,0
190.02M,"155,007",1.97B,$7.17,"8,772",127.58,Buy,147.67,"Jul 22, 2024",KSPI,Joint Stock Company Kaspi.kz,24.24B,127.58,4.70B,2.53%,-1.12%,19.49%,-5.75%,-7.62%,Kaspi.kz JSC Declares Q2 Dividends and Auditor,Announcement of Extraordinary General Meeting Results,Kaspi.kz price target raised to $183 from $159 at JPMorgan,,,Kaspi.kz JSC Declares Q2 Dividends and Auditor Announcement of Extraordinary General Meeting Results Kaspi.kz price target raised to $183 from $159 at JPMorgan,0,0,0,0,-1,-1
1.06B,"6,415,325",1.57B,-1,"31,591",21.22,Strong Buy,40.08,"Aug 28, 2024",LI,Li Auto Inc.,22.51B,21.22,18.10B,6.80%,7.96%,-25.21%,-9.83%,-40.33%,CNBC Daily Open: Soft landing in sight?,BYD sales hit a record in August despite broader China EV slowdown,Chinese EV company Xpeng sees shares pop 6% after it launches mass-market car,"Test driving BYD, Nio and other Chinese EV rivals of Tesla",Tuesday’s big stock stories: What’s likely to move the market in the next trading session,"CNBC Daily Open: Soft landing in sight? BYD sales hit a record in August despite broader China EV slowdown Chinese EV company Xpeng sees shares pop 6% after it launches mass-market car Test driving BYD, Nio and other Chinese EV rivals of Tesla Tuesday’s big stock stories: What’s likely to move the market in the next trading session",0,0,0,0,0,0
163.18M,"1,412,624",495.64M,$0.48,"6,500",135.94,Buy,138.73,"Oct 23, 2024",TER,"Teradyne, Inc.",22.18B,135.94,2.70B,6.88%,-3.28%,15.69%,+0.88%,+23.34%,An options trade that pays off if the S&P 500 fails to get back to new highs,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",Friday analyst calls: Media and entertainment companies take focus of upgrades,Early notable gainers among liquid option names on August 23rd,"Cisco, Nike upgrades among today’s top calls on Wall Street","An options trade that pays off if the S&P 500 fails to get back to new highs Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Friday analyst calls: Media and entertainment companies take focus of upgrades Early notable gainers among liquid option names on August 23rd Cisco, Nike upgrades among today’s top calls on Wall Street",0,0,0,1,1,1
343.45M,"3,170,452",-852.00M,-1,"53,000",64.35,Buy,85.60,"Jul 31, 2024",WDC,Western Digital Corporation,22.10B,64.35,13.00B,1.87%,-10.07%,-0.41%,-6.89%,-14.61%,"Don’t be scared by volatility, keep buying chip stocks in 2H, says Cantor",Buy Rating Justified by Western Digital’s Strategic Restructuring and Strong Market Position,Wells says Seagate comments suggest HAMR cloud qualification could be pushed out,Western Digital (WDC) Receives a Buy from Morgan Stanley,"SPY ETF Update, 8/28/2024 ","Don’t be scared by volatility, keep buying chip stocks in 2H, says Cantor Buy Rating Justified by Western Digital’s Strategic Restructuring and Strong Market Position Wells says Seagate comments suggest HAMR cloud qualification could be pushed out Western Digital (WDC) Receives a Buy from Morgan Stanley SPY ETF Update, 8/28/2024 ",0,1,0,0,0,0
210.20M,"1,346,494",335.00M,$2.80,"30,000",104.41,Buy,114.94,"Jul 23, 2024",STX,Seagate Technology Holdings plc,21.95B,104.41,6.55B,1.64%,-1.61%,10.73%,-2.86%,+10.29%,"Final Trades: Lennar, Oracle and Seagate",‘Near certainty’: Morgan Stanley shares how to position for global tech downturn,"These dividend payers will beat yields on cash as the Fed cuts rates, BofA says",Seagate Tech: Steady Growth Amidst HAMR Qualification Delays – Hold Rating Maintained,Wells says Seagate comments suggest HAMR cloud qualification could be pushed out,"Final Trades: Lennar, Oracle and Seagate ‘Near certainty’: Morgan Stanley shares how to position for global tech downturn These dividend payers will beat yields on cash as the Fed cuts rates, BofA says Seagate Tech: Steady Growth Amidst HAMR Qualification Delays – Hold Rating Maintained Wells says Seagate comments suggest HAMR cloud qualification could be pushed out",0,0,1,0,0,0
307.79M,"6,537,833",875.37M,-1,"7,420",70.14,Hold,75.10,"Aug 21, 2024",ZM,"Zoom Video Communications, Inc.",21.59B,70.14,4.59B,20.61%,22.24%,12.70%,+17.04%,+12.31%,"Zoom stock has best day in almost 2 years on quarterly results, increased guidance","Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more",Jim Cramer says market-share gains are fueling this cyber stock’s rally,"Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video",Zoom beats on revenue and earnings as stock climbs in after-hours,"Zoom stock has best day in almost 2 years on quarterly results, increased guidance Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Jim Cramer says market-share gains are fueling this cyber stock’s rally Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video Zoom beats on revenue and earnings as stock climbs in after-hours",0,1,1,0,1,1
112.91M,"356,576",835.50M,-1,"6,450",190.31,Buy,183.68,"Jul 24, 2024",CHKP,Check Point Software Technologies Ltd.,21.49B,190.31,2.49B,2.53%,8.05%,17.70%,+3.34%,+15.32%,Microsoft plans September event to discuss changes after CrowdStrike outage,Palo Alto Networks bet big on bundling. Investors want more proof it’s working,Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and Ease of Doing Business,Maintaining a Hold: Assessing Check Point’s Strategic Acquisition Amidst CEO Transition,Maintaining Hold on Check Point Software Amid Strategic Acquisitions and Market Challenges,Microsoft plans September event to discuss changes after CrowdStrike outage Palo Alto Networks bet big on bundling. Investors want more proof it’s working Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and Ease of Doing Business Maintaining a Hold: Assessing Check Point’s Strategic Acquisition Amidst CEO Transition Maintaining Hold on Check Point Software Amid Strategic Acquisitions and Market Challenges,0,0,0,0,0,0
120.14M,"371,785",295.41M,-1,"7,231",177.31,Buy,200.18,"Jul 31, 2024",PTC,PTC Inc.,21.30B,177.31,2.22B,1.47%,-0.30%,0.12%,-2.23%,-6.15%,PTC Inc. Welcomes New Board Member with Extensive VC Expertise,"Lone Pine buys GE Vernova, exits Live Nation in Q2",,,,"PTC Inc. Welcomes New Board Member with Extensive VC Expertise Lone Pine buys GE Vernova, exits Live Nation in Q2",1,1,0,-1,-1,-1
1.45B,"9,251,526",1.55B,$0.62,"19,995",14.63,Buy,15.59,"Oct 18, 2024",HBAN,Huntington Bancshares Incorporated,21.25B,14.63,6.71B,4.74%,6.42%,11.57%,-2.07%,+7.65%,"Beat Treasury yields with these dividend-paying bank stocks, Janney says",Cleveland Browns’ stadium to be called ‘Huntington Bank Field’ under new deal,"Analysts Are Bullish on These Financial Stocks: HCI Group (HCI), Credicorp (BAP)",,,"Beat Treasury yields with these dividend-paying bank stocks, Janney says Cleveland Browns’ stadium to be called ‘Huntington Bank Field’ under new deal Analysts Are Bullish on These Financial Stocks: HCI Group (HCI), Credicorp (BAP)",1,1,0,1,-1,-1
237.77M,"471,455",-540.45M,-1,"6,133",88.19,Buy,109.09,"Aug 5, 2024",BNTX,BioNTech SE,20.97B,88.19,2.88B,3.38%,3.52%,-6.34%,+2.32%,-2.56%,"Healthy Returns: The combination Covid, flu shot race is heating up",BioNTech Highlights Oncology Advances at ESMO 2024,"BioNTech to present data updates across mRNA, immunomodulatory portfolio",BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024,Tempus announces real world data collaboration with BioNTech,"Healthy Returns: The combination Covid, flu shot race is heating up BioNTech Highlights Oncology Advances at ESMO 2024 BioNTech to present data updates across mRNA, immunomodulatory portfolio BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 Tempus announces real world data collaboration with BioNTech",0,1,1,0,1,0
159.30M,"880,183",-3.04B,-1,"13,360",131.39,Buy,150.39,"Aug 6, 2024",ILMN,"Illumina, Inc.",20.93B,131.39,4.43B,4.46%,11.80%,8.91%,+7.42%,+3.09%,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,Morfit’s ValueAct bought more Disney and Salesforce in the second quarter,"Stocks making the biggest moves midday: Brinker International, Victoria’s Secret","Wednesday’s top analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Target","Stocks making the biggest moves premarket: Kellanova, Alphabet, Flutter and more","Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Morfit’s ValueAct bought more Disney and Salesforce in the second quarter Stocks making the biggest moves midday: Brinker International, Victoria’s Secret Wednesday’s top analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Target Stocks making the biggest moves premarket: Kellanova, Alphabet, Flutter and more",1,0,1,1,1,1
214.94M,"2,169,301",-997.30M,-1,"211,826",97.00,Buy,142.70,"Sep 4, 2024",DLTR,"Dollar Tree, Inc.",20.85B,97.00,30.91B,-2.30%,-6.97%,-21.80%,-9.47%,-27.73%,Super Micro Computer is among the most oversold names on the Street,"These stocks are contenders for selling — and can help cut taxes, Wolfe says",Jim Cramer’s top 10 things to watch in the stock market Thursday,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Super Micro Computer is among the most oversold names on the Street These stocks are contenders for selling — and can help cut taxes, Wolfe says Jim Cramer’s top 10 things to watch in the stock market Thursday Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more",0,1,1,0,1,1
156.24M,"220,324",2.15B,$3.24,"5,426",132.81,Buy,131.57,"Oct 24, 2024",CINF,Cincinnati Financial Corporation,20.75B,132.81,10.65B,3.08%,8.33%,16.38%,+3.22%,+10.94%,Cincinnati Financial Declares Regular Quarterly Dividend,Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend,Cincinnati Financial Releases New Investor Presentation,,,Cincinnati Financial Declares Regular Quarterly Dividend Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend Cincinnati Financial Releases New Investor Presentation,1,0,0,0,-1,-1
106.12M,"427,999",-523.70M,-1,"10,600",193.82,Buy,247.31,"Aug 7, 2024",BGNE,"BeiGene, Ltd.",20.57B,193.82,3.10B,10.74%,22.74%,22.96%,+18.96%,+32.08%,BeiGene announces FDA grants Fast Track Designation to BGB-16673,"3 Best Stocks to Buy Now, 8/21/2024, According to Top Analysts ",BeiGene price target raised to $200 from $194 at JPMorgan,TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE),Jefferies Sticks to Their Buy Rating for BeiGene (BGNE),"BeiGene announces FDA grants Fast Track Designation to BGB-16673 3 Best Stocks to Buy Now, 8/21/2024, According to Top Analysts  BeiGene price target raised to $200 from $194 at JPMorgan TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE) Jefferies Sticks to Their Buy Rating for BeiGene (BGNE)",0,0,1,0,0,0
2.45B,"33,707,131",-11.77B,-1,"35,300",8.05,Buy,11.59,"Aug 7, 2024",WBD,"Warner Bros. Discovery, Inc.",19.74B,8.05,39.93B,5.65%,6.07%,-9.90%,-7.86%,-4.21%,"Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’","NFL’s next big media rights payday is years off, subject to shifting industry",A look at the behind-the-scenes business of Hollywood studio lot tours,"YES Network, MSG Networks to launch combined New York regional sports app","Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more","Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’ NFL’s next big media rights payday is years off, subject to shifting industry A look at the behind-the-scenes business of Hollywood studio lot tours YES Network, MSG Networks to launch combined New York regional sports app Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more",0,0,1,0,1,1
227.69M,"644,221",-229.40M,-1,"26,127",85.82,Buy,94.07,"Sep 3, 2024",LINE,"Lineage, Inc.",19.54B,85.82,5.33B,0.10%,0.52%,0.52%,-4.14%,,Wall Street loves this under-the-radar stock that is key to our food supply,Jim Cramer’s top 10 things to watch in the stock market Monday,"Stocks making biggest moves premarket: AMD, Estée Lauder, Dutch Bros and more","Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen","RBC Capital Sticks to Their Buy Rating for Lineage, Inc. (LINE)","Wall Street loves this under-the-radar stock that is key to our food supply Jim Cramer’s top 10 things to watch in the stock market Monday Stocks making biggest moves premarket: AMD, Estée Lauder, Dutch Bros and more Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen RBC Capital Sticks to Their Buy Rating for Lineage, Inc. (LINE)",1,0,0,1,1,0
460.23M,"1,819,857",1.50B,$0.53,"10,200",41.01,Buy,36.71,"Aug 6, 2024",FOXA,Fox Corporation,18.87B,41.01,13.98B,4.83%,11.16%,26.44%,+8.39%,+32.91%,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry",82% of Americans say saving for retirement is harder now than it used to be,"YES Network, MSG Networks to launch combined New York regional sports app",5 things to know before the stock market opens Monday,"Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry 82% of Americans say saving for retirement is harder now than it used to be YES Network, MSG Networks to launch combined New York regional sports app 5 things to know before the stock market opens Monday",1,1,1,1,1,1
1.13B,"323,242",1.73B,$2.89,"22,261",105.74,Buy,158.50,"Jul 22, 2024",RYAAY,Ryanair Holdings plc,18.86B,105.74,14.38B,6.53%,-0.38%,-13.92%,+7.44%,-25.32%,Europe markets close higher as investors weigh global outlook,"Europe markets close slightly higher, led by travel stocks","Elliott will launch proxy fight at Southwest, nominate 10 directors",Ryanair Progresses With Share Buy-Back Program,Ryanair Holdings Sees Major Voting Rights Shift,"Europe markets close higher as investors weigh global outlook Europe markets close slightly higher, led by travel stocks Elliott will launch proxy fight at Southwest, nominate 10 directors Ryanair Progresses With Share Buy-Back Program Ryanair Holdings Sees Major Voting Rights Shift",0,0,0,0,0,0
199.12M,"1,157,296",339.90M,$0.02,"15,000",94.62,Strong Buy,111.78,"Aug 28, 2024",COO,"The Cooper Companies, Inc.",18.84B,94.62,3.73B,1.24%,3.64%,1.66%,+1.30%,-4.12%,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,Stifel Nicolaus Reaffirms Their Buy Rating on Cooper Co (COO),Early notable gainers among liquid option names on August 29th,Piper Sandler Keeps Their Buy Rating on Cooper Co (COO),Cooper Companies price target raised to $125 from $118 at Baird,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Stifel Nicolaus Reaffirms Their Buy Rating on Cooper Co (COO) Early notable gainers among liquid option names on August 29th Piper Sandler Keeps Their Buy Rating on Cooper Co (COO) Cooper Companies price target raised to $125 from $118 at Baird,1,0,1,1,1,1
884.68M,"8,868,141",290.00M,-1,"2,200",21.12,Buy,22.81,"Aug 7, 2024",HOOD,"Robinhood Markets, Inc.",18.68B,21.12,2.24B,11.58%,1.05%,29.62%,-1.22%,+10.43%,Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade",Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World,"Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more","Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more",0,0,1,0,0,1
154.30M,"973,172",2.01B,$1.84,"12,600",120.88,Hold,132.13,"Oct 16, 2024",STLD,"Steel Dynamics, Inc.",18.65B,120.88,18.15B,0.80%,-2.51%,-3.69%,-11.40%,-19.85%,Seaport Research steel analyst to hold analyst/industry conference call,Steel Dynamics upgraded to Buy from Neutral at UBS,Steel Dynamics Announces Third Quarter 2024 Cash Dividend,Morgan Stanley Sticks to Their Hold Rating for Steel Dynamics (STLD),Steel Dynamics price target raised to $138 from $134 at Morgan Stanley,Seaport Research steel analyst to hold analyst/industry conference call Steel Dynamics upgraded to Buy from Neutral at UBS Steel Dynamics Announces Third Quarter 2024 Cash Dividend Morgan Stanley Sticks to Their Hold Rating for Steel Dynamics (STLD) Steel Dynamics price target raised to $138 from $134 at Morgan Stanley,1,0,0,0,0,0
232.27M,"877,422",701.50M,-1,"6,990",80.25,Buy,87.60,"Jul 29, 2024",HOLX,"Hologic, Inc.",18.64B,80.25,3.99B,-2.40%,2.35%,6.44%,-1.51%,+3.08%,Citi Remains a Buy on Hologic (HOLX),Hologic participates in a conference call with JPMorgan,RBC Capital Sticks to Their Hold Rating for Hologic (HOLX),,,Citi Remains a Buy on Hologic (HOLX) Hologic participates in a conference call with JPMorgan RBC Capital Sticks to Their Hold Rating for Hologic (HOLX),0,1,0,0,-1,-1
231.58M,"672,384",1.26B,$2.88,"19,800",79.48,Hold,84.33,"Jul 25, 2024",PFG,"Principal Financial Group, Inc.",18.41B,79.48,15.65B,3.38%,-0.32%,-0.05%,-1.63%,-5.12%,Principal Financial initiated with an Underweight at Barclays,Principal Financial names Deanna Strable President and Chief Operating Officer,Principal Financial price target lowered to $83 from $85 at Morgan Stanley,Morgan Stanley Sticks to Its Hold Rating for Principal Financial (PFG),,Principal Financial initiated with an Underweight at Barclays Principal Financial names Deanna Strable President and Chief Operating Officer Principal Financial price target lowered to $83 from $85 at Morgan Stanley Morgan Stanley Sticks to Its Hold Rating for Principal Financial (PFG),0,0,0,0,0,-1
235.03M,"1,019,503",279.00M,-1,,77.50,Buy,84.00,"Aug 8, 2024",FWONK,Formula One Group,18.22B,77.50,3.69B,0.09%,1.72%,11.10%,-4.48%,+12.79%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
,,,-1,"10,400",,,,,FOX,Fox Corporation,18.20B,38.14,13.98B,4.53%,10.84%,26.72%,+8.02%,+34.52%,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry",82% of Americans say saving for retirement is harder now than it used to be,"YES Network, MSG Networks to launch combined New York regional sports app",5 things to know before the stock market opens Monday,"Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry 82% of Americans say saving for retirement is harder now than it used to be YES Network, MSG Networks to launch combined New York regional sports app 5 things to know before the stock market opens Monday",1,1,1,1,1,1
460.23M,"752,393",1.50B,$0.53,"26,600",38.14,,,"Aug 6, 2024",SSNC,"SS&C Technologies Holdings, Inc.",18.17B,74.03,5.66B,3.27%,10.02%,18.74%,+1.77%,+18.35%,SS&C Increases Common Stock Dividend to $0.25 Per Share,SS&C raises quarterly dividend to 25c from 24c per share,,,,SS&C Increases Common Stock Dividend to $0.25 Per Share SS&C raises quarterly dividend to 25c from 24c per share,1,0,1,-1,-1,-1
245.42M,"819,396",698.30M,$1.00,"5,037",74.03,Buy,70.75,"Jul 25, 2024",MDB,"MongoDB, Inc.",18.16B,247.61,1.77B,-1.30%,-2.53%,-31.05%,-6.73%,-35.13%,Jim Cramer’s top 10 things to watch in the stock market Tuesday,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more",MongoDB CEO on earnings: ‘We feel like we’re well positioned for the AI era’,"10 key things to watch in the stock market Friday, including two AI gainers","Stocks close higher Friday, S&P 500 posts fourth straight winning month","Jim Cramer’s top 10 things to watch in the stock market Tuesday Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more MongoDB CEO on earnings: ‘We feel like we’re well positioned for the AI era’ 10 key things to watch in the stock market Friday, including two AI gainers Stocks close higher Friday, S&P 500 posts fourth straight winning month",1,0,1,1,1,0
73.35M,"1,331,653",-202.95M,-1,"9,750",247.61,Buy,361.04,"Aug 29, 2024",ZBRA,Zebra Technologies Corporation,18.14B,351.62,4.36B,3.20%,6.91%,20.84%,-2.10%,+18.41%,These stocks typically have the best and worst Septembers,Zebra Tech (ZBRA) Gets a Buy from TD Cowen,,,,These stocks typically have the best and worst Septembers Zebra Tech (ZBRA) Gets a Buy from TD Cowen,0,0,0,-1,-1,-1
51.58M,"226,094",230.00M,-1,"56,000",351.62,Buy,347.10,"Jul 30, 2024",ULTA,"Ulta Beauty, Inc.",18.07B,378.65,11.30B,5.70%,-0.64%,-15.74%,+0.53%,-17.52%,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more","10 key things to watch in the stock market Friday, including two AI gainers","Stocks making the biggest moves premarket: CrowdStrike, Alibaba, Ulta and more",5 things to know before the stock market opens Friday,"Stocks close higher Friday, S&P 500 posts fourth straight winning month","Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more 10 key things to watch in the stock market Friday, including two AI gainers Stocks making the biggest moves premarket: CrowdStrike, Alibaba, Ulta and more 5 things to know before the stock market opens Friday Stocks close higher Friday, S&P 500 posts fourth straight winning month",0,1,1,1,1,0
47.72M,"845,569",1.26B,-1,"34,718",378.65,Buy,487.00,"Aug 29, 2024",JBHT,"J.B. Hunt Transport Services, Inc.",18.05B,176.97,12.34B,2.14%,4.69%,-5.18%,+0.59%,-10.83%,Friday’s stock stories: What’s likely to move the market in the next session,J.B. Hunt management to meet with Stephens,J.B. Hunt board authorizes repurchase of $1B of company’s common stock,Ken Hoexter Recommends Buy on JB Hunt Following $1 Billion Share Buyback and Solid Financial Performance,J.B. Hunt Trucking (NASDAQ:JBHT) Proves a Force in Autonomous Trucking,Friday’s stock stories: What’s likely to move the market in the next session J.B. Hunt management to meet with Stephens J.B. Hunt board authorizes repurchase of $1B of company’s common stock Ken Hoexter Recommends Buy on JB Hunt Following $1 Billion Share Buyback and Solid Financial Performance J.B. Hunt Trucking (NASDAQ:JBHT) Proves a Force in Autonomous Trucking,1,0,1,0,0,0
101.99M,"407,868",604.33M,$1.72,"6,486",176.97,Buy,181.25,"Oct 15, 2024",FWONA,Formula One Group,18.02B,70.44,3.69B,-0.62%,1.53%,11.28%,-5.66%,+14.69%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
234.91M,"37,751",279.00M,-1,"17,100",70.44,Strong Buy,75.00,"Aug 8, 2024",EXPE,"Expedia Group, Inc.",17.98B,138.13,13.26B,10.68%,10.07%,5.89%,+9.44%,+6.02%,These are the 10 U.S. states boasting America’s best workforces,Here are Wolfe’s favorite stocks as market approaches fresh record,‘Travel is too expensive right now’: Americans spend less or skip trips altogether,Travelers are finally cracking under the pressure of high costs,Benchmark’s Daniel Kurnos talks how to position in travel stocks,These are the 10 U.S. states boasting America’s best workforces Here are Wolfe’s favorite stocks as market approaches fresh record ‘Travel is too expensive right now’: Americans spend less or skip trips altogether Travelers are finally cracking under the pressure of high costs Benchmark’s Daniel Kurnos talks how to position in travel stocks,0,1,1,0,0,0
130.18M,"1,221,754",808.00M,-1,"23,100",138.13,Buy,148.00,"Aug 8, 2024",NTRS,Northern Trust Corporation,17.89B,88.70,7.61B,3.69%,4.10%,7.18%,unch,+2.15%,Northern (NTRS) Receives a Sell from Morgan Stanley,Northern Trust partners with Greenlight to expand financial literacy,Northern Trust price target lowered to $84 from $85 at Deutsche Bank,,,Northern (NTRS) Receives a Sell from Morgan Stanley Northern Trust partners with Greenlight to expand financial literacy Northern Trust price target lowered to $84 from $85 at Deutsche Bank,0,1,0,1,-1,-1
201.64M,"804,842",1.50B,$3.00,"4,200",88.70,Hold,89.54,"Oct 16, 2024",DKNG,DraftKings Inc.,17.66B,36.37,4.30B,5.78%,-2.58%,-9.76%,-7.04%,-27.22%,Wall Street is still bullish on sports betting stocks despite mixed results,How the Cowboys went from losing $1 million a month to topping the NFL in value,Wednesday’s stock stories: What’s likely to move the market in the next session,DraftKings fined in Conn. over online slot machines that paid zero wins for week,NFL season expected to spur record $35 billion in legal sports wagers,Wall Street is still bullish on sports betting stocks despite mixed results How the Cowboys went from losing $1 million a month to topping the NFL in value Wednesday’s stock stories: What’s likely to move the market in the next session DraftKings fined in Conn. over online slot machines that paid zero wins for week NFL season expected to spur record $35 billion in legal sports wagers,1,1,0,0,1,1
485.53M,"7,491,240",-406.47M,-1,"8,000",36.37,Strong Buy,49.50,"Aug 1, 2024",ENTG,"Entegris, Inc.",17.56B,116.32,3.28B,5.26%,-7.57%,-7.27%,-4.61%,-18.73%,Entegris Enhances Board with Semiconductor Expert Mary Puma,,,,,Entegris Enhances Board with Semiconductor Expert Mary Puma,0,1,-1,-1,-1,-1
150.98M,"1,407,815",184.15M,$0.40,908,116.32,Strong Buy,145.80,"Jul 31, 2024",VRSN,"VeriSign, Inc.",17.50B,179.32,1.53B,1.01%,1.65%,-4.19%,-3.11%,-3.53%,Buy Rating on Verisign: A Balance of Contract Renewal Confidence and Growth Potential,,,,,Buy Rating on Verisign: A Balance of Contract Renewal Confidence and Growth Potential,1,1,-1,-1,-1,-1
97.60M,"478,642",846.10M,-1,"21,610",179.32,Buy,218.00,"Jul 25, 2024",ALGN,"Align Technology, Inc.",17.48B,233.97,3.94B,5.39%,0.30%,-10.88%,-0.41%,-27.28%,Stifel Nicolaus Reaffirms Their Buy Rating on Align Tech (ALGN),Early notable gainers among liquid option names on August 15th,Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Arcutis Biotherapeutics (ARQT),,,Stifel Nicolaus Reaffirms Their Buy Rating on Align Tech (ALGN) Early notable gainers among liquid option names on August 15th Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Arcutis Biotherapeutics (ARQT),1,1,1,0,-1,-1
74.70M,"627,903",447.03M,-1,"9,750",233.97,Buy,322.78,"Jul 24, 2024",SWKS,"Skyworks Solutions, Inc.",17.44B,109.21,4.37B,1.69%,-0.80%,4.43%,-6.06%,+1.19%,,,,,,,0,-1,-1,-1,-1,-1
159.72M,"1,343,720",780.30M,$2.80,"2,204",109.21,Hold,113.59,"Jul 30, 2024",GMAB,Genmab A/S,17.36B,27.34,2.73B,2.58%,4.38%,-3.71%,-2.09%,-6.92%,Genmab resumed with an Equal Weight at Morgan Stanley,Genmab’s Hold Rating: Balancing Stability and Uncertainty,"Genmab price target lowered to DKK 2,500 from DKK 2,750 at Deutsche Bank",Strong Pipeline and Regulatory Approval Prospects Affirm Buy Rating for Genmab,Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference,"Genmab resumed with an Equal Weight at Morgan Stanley Genmab’s Hold Rating: Balancing Stability and Uncertainty Genmab price target lowered to DKK 2,500 from DKK 2,750 at Deutsche Bank Strong Pipeline and Regulatory Approval Prospects Affirm Buy Rating for Genmab Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference",1,1,1,1,1,1
63.47M,"305,559",795.95M,-1,"3,401",27.34,Buy,46.00,"Aug 8, 2024",BMRN,BioMarin Pharmaceutical Inc.,17.14B,90.02,2.59B,2.49%,5.62%,3.69%,+7.10%,+3.88%,"Tuesday’s biggest analyst calls: Nvidia, Amazon, AMD, Ulta, Eli Lilly and more",Buy Rating Affirmed for BioMarin Pharmaceutical Amid Strong Voxzogo Outlook and Strategic Growth Initiatives,BioMarin price target raised to $95 from $86 at Scotiabank,BioMarin price target raised to $120 from $111 at JPMorgan,Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT),"Tuesday’s biggest analyst calls: Nvidia, Amazon, AMD, Ulta, Eli Lilly and more Buy Rating Affirmed for BioMarin Pharmaceutical Amid Strong Voxzogo Outlook and Strategic Growth Initiatives BioMarin price target raised to $95 from $86 at Scotiabank BioMarin price target raised to $120 from $111 at JPMorgan Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT)",0,1,1,0,0,0
190.38M,"852,274",256.59M,-1,"8,400",90.02,Buy,106.78,"Aug 5, 2024",LPLA,LPL Financial Holdings Inc.,16.73B,223.82,10.93B,7.68%,-5.16%,-8.58%,-0.28%,-15.14%,"LPL Financial to acquire The Investment Center, terms not disclosed","LPL Financial to Acquire The Investment Center, Inc.",LPL Financial appoints Tom Gannon as chief advocacy officer,LPL Financial Appoints Tom Gannon as Chief Advocacy Officer,LPL Financial welcomes advisor Kelly Compton,"LPL Financial to acquire The Investment Center, terms not disclosed LPL Financial to Acquire The Investment Center, Inc. LPL Financial appoints Tom Gannon as chief advocacy officer LPL Financial Appoints Tom Gannon as Chief Advocacy Officer LPL Financial welcomes advisor Kelly Compton",0,0,0,0,0,0
74.76M,"511,698",974.41M,$1.20,"3,157",223.82,Buy,278.00,"Oct 24, 2024",ENPH,"Enphase Energy, Inc.",16.66B,123.00,1.42B,9.03%,11.22%,7.80%,+7.42%,+10.14%,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research",Enphase announces solution for expanding legacy NEM systems in California,Enphase Energy price target raised to $115 from $111 at Jefferies,Tesla or Enphase Energy: Top Analyst Chooses the Superior Clean Energy Stock to Buy,Enphase Energy initiated with a Market Perform at William Blair,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research Enphase announces solution for expanding legacy NEM systems in California Enphase Energy price target raised to $115 from $111 at Jefferies Tesla or Enphase Energy: Top Analyst Chooses the Superior Clean Energy Stock to Buy Enphase Energy initiated with a Market Perform at William Blair",0,0,0,1,1,1
135.42M,"3,047,199",129.61M,-1,"5,908",123.00,Buy,128.39,"Oct 24, 2024",OKTA,"Okta, Inc.",16.66B,99.01,2.36B,4.52%,4.31%,7.19%,+2.77%,-4.89%,"Stocks making the biggest moves midday: Dollar General, Affirm and more","Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more","Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike","Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick","Stocks making the biggest moves after hours: Nvidia, Salesforce and more","Stocks making the biggest moves midday: Dollar General, Affirm and more Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick Stocks making the biggest moves after hours: Nvidia, Salesforce and more",1,1,1,1,1,1
168.23M,"1,628,744",-276.00M,-1,"23,900",99.01,Buy,104.53,"Aug 28, 2024",NWS,News Corporation,16.19B,29.20,10.09B,2.96%,2.60%,10.35%,+2.35%,+10.20%,Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch,"Murdoch’s property group considers bid for Rightmove, sending shares 21% higher","Starboard raised Salesforce in Q2, cut stake in this online web services stock",Murdoch family battle highlights Nevada’s secret trust boom,"Starboard files proposal to end News Corp dual-class structure, Reuters says","Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch Murdoch’s property group considers bid for Rightmove, sending shares 21% higher Starboard raised Salesforce in Q2, cut stake in this online web services stock Murdoch family battle highlights Nevada’s secret trust boom Starboard files proposal to end News Corp dual-class structure, Reuters says",1,1,1,1,1,1
568.58M,"455,814",266.00M,$0.20,"4,580",29.20,Buy,33.00,"Aug 8, 2024",MANH,"Manhattan Associates, Inc.",16.08B,262.51,996.57M,3.82%,6.90%,12.32%,+1.42%,+6.36%,,,,,,,0,-1,-1,-1,-1,-1
61.25M,"199,701",204.72M,-1,"23,900",262.51,Strong Buy,257.43,"Oct 22, 2024",NWSA,News Corporation,15.99B,28.14,10.09B,2.79%,2.06%,10.20%,+1.81%,+9.43%,Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch,"Murdoch’s property group considers bid for Rightmove, sending shares 21% higher","Starboard raised Salesforce in Q2, cut stake in this online web services stock",Murdoch family battle highlights Nevada’s secret trust boom,"Starboard files proposal to end News Corp dual-class structure, Reuters says","Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch Murdoch’s property group considers bid for Rightmove, sending shares 21% higher Starboard raised Salesforce in Q2, cut stake in this online web services stock Murdoch family battle highlights Nevada’s secret trust boom Starboard files proposal to end News Corp dual-class structure, Reuters says",0,1,1,1,1,1
568.27M,"1,145,060",266.00M,$0.20,"5,200",28.14,Buy,33.00,"Aug 8, 2024",BSY,"Bentley Systems, Incorporated",15.92B,50.22,1.29B,6.47%,5.50%,2.23%,+3.78%,+2.14%,Bentley Systems Expands Board and Announces Dividend,"Bentley Systems acquires Cesium, names CEO Patrick Cozzi chief platform officer",Bentley Systems management to meet with KeyBanc,Bentley Systems: Strong ARR Growth and EBITDA Expansion Justify Buy Rating Amidst Economic Headwinds,,"Bentley Systems Expands Board and Announces Dividend Bentley Systems acquires Cesium, names CEO Patrick Cozzi chief platform officer Bentley Systems management to meet with KeyBanc Bentley Systems: Strong ARR Growth and EBITDA Expansion Justify Buy Rating Amidst Economic Headwinds",0,1,1,1,1,-1
317.09M,"682,256",374.96M,$0.24,"3,400",50.22,Buy,59.57,"Aug 6, 2024",GEN,Gen Digital Inc.,15.83B,25.72,3.83B,4.69%,5.47%,14.98%,+0.88%,+18.37%,"Starboard boosts stake in Salesforce, cuts stake in Humana",,,,,"Starboard boosts stake in Salesforce, cuts stake in Humana",0,1,-1,-1,-1,-1
615.53M,"3,384,228",610.00M,$0.50,"1,168",25.72,Buy,27.20,"Aug 1, 2024",UTHR,United Therapeutics Corporation,15.48B,348.03,2.62B,5.01%,7.18%,34.31%,+14.86%,+54.07%,MannKind price target raised to $12 from $10 at Oppenheimer,Buy Rating Affirmed for United Therapeutics on Strengthened Tyvaso Franchise Position,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR)",Liquidia price target lowered to $28 from $30 at Ladenburg,Liquidia price target lowered to $23 from $24 at BofA,"MannKind price target raised to $12 from $10 at Oppenheimer Buy Rating Affirmed for United Therapeutics on Strengthened Tyvaso Franchise Position Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR) Liquidia price target lowered to $28 from $30 at Ladenburg Liquidia price target lowered to $23 from $24 at BofA",1,0,0,1,0,0
44.49M,"224,785",1.07B,-1,"1,400",348.03,Buy,335.73,"Jul 31, 2024",NBIX,"Neurocrine Biosciences, Inc.",15.43B,152.81,2.12B,2.92%,5.99%,12.76%,-12.58%,-10.91%,Writing options on these stocks could create income for your portfolio,"Stocks making the biggest moves midday: Super Micro, Abercrombie and more",Election 2024: Where To Put Your Money Ahead of the Vote,Biotech Alert: Searches spiking for these stocks today,Buy Rating Affirmed for Neurocrine on Market Potential and Superior Safety Profile,"Writing options on these stocks could create income for your portfolio Stocks making the biggest moves midday: Super Micro, Abercrombie and more Election 2024: Where To Put Your Money Ahead of the Vote Biotech Alert: Searches spiking for these stocks today Buy Rating Affirmed for Neurocrine on Market Potential and Superior Safety Profile",1,0,1,1,1,1
100.98M,"479,197",339.20M,-1,"10,250",152.81,Buy,163.26,"Aug 1, 2024",AKAM,"Akamai Technologies, Inc.",15.43B,101.83,3.93B,3.01%,6.71%,-4.11%,+1.83%,-5.80%,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more","Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more","Akamai CEO Tom Leighton on Q2 earnings beat, AI adoption and growth outlook",Akamai Technologies: A Strong Buy on Strategic Security Shift and Solid Financials,Akamai (AKAM) Receives a Buy from Craig-Hallum,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more Akamai CEO Tom Leighton on Q2 earnings beat, AI adoption and growth outlook Akamai Technologies: A Strong Buy on Strategic Security Shift and Solid Financials Akamai (AKAM) Receives a Buy from Craig-Hallum",1,1,1,0,0,0
151.53M,"760,145",628.81M,-1,"3,293",101.83,Buy,115.39,"Aug 8, 2024",NTRA,"Natera, Inc.",15.18B,122.71,1.36B,6.87%,9.15%,38.03%,+16.04%,+22.80%,"The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos",Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,Natera price target raised to $145 from $130 at Canaccord,"Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)",J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA),"The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Natera price target raised to $145 from $130 at Canaccord Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON) J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA)",0,1,0,0,0,0
123.68M,"835,403",-292.12M,-1,"14,500",122.71,Strong Buy,122.57,"Aug 8, 2024",CPB,Campbell Soup Company,15.17B,50.80,9.41B,1.36%,5.97%,12.49%,+7.06%,+15.87%,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General",Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks,"Dow rises 200 points for fresh record close, Nasdaq falls as Nvidia shares tumble",Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,Nvidia will be in the spotlight next week as Street wraps up a tumultuous August,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks Dow rises 200 points for fresh record close, Nasdaq falls as Nvidia shares tumble Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings Nvidia will be in the spotlight next week as Street wraps up a tumultuous August",0,1,1,0,0,0
298.55M,"3,046,006",739.00M,$1.48,"5,900",50.80,Hold,46.25,"Aug 29, 2024",WMG,Warner Music Group Corp.,15.07B,29.10,6.38B,1.62%,-2.65%,-11.25%,-3.30%,-12.93%,"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies",Paramount-Skydance ‘go shop’ period extended to review Bronfman offer,Paramount (NASDAQ:PARA) Drama Not Over Yet as Edgar Bronfman Comes Back,Warner Music Group Corp. Announces Quarterly Cash Dividend,Evercore ISI Sticks to Their Buy Rating for Warner Music Group (WMG),"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies Paramount-Skydance ‘go shop’ period extended to review Bronfman offer Paramount (NASDAQ:PARA) Drama Not Over Yet as Edgar Bronfman Comes Back Warner Music Group Corp. Announces Quarterly Cash Dividend Evercore ISI Sticks to Their Buy Rating for Warner Music Group (WMG)",0,0,0,0,0,0
517.92M,"1,241,812",539.00M,$0.72,"5,442",29.10,Buy,37.07,"Aug 7, 2024",LNT,Alliant Energy Corporation,14.88B,58.03,3.96B,1.52%,6.14%,13.12%,+3.84%,+18.32%,These are the best teen checking accounts of September 2024,Best personal loans offered by credit unions,Best CD rates,Best credit unions,Alliant Energy (LNT) Gets a Buy from Bank of America Securities,These are the best teen checking accounts of September 2024 Best personal loans offered by credit unions Best CD rates Best credit unions Alliant Energy (LNT) Gets a Buy from Bank of America Securities,1,0,0,0,0,1
256.50M,"645,024",625.00M,$1.92,"7,900",58.03,Buy,58.36,"Aug 1, 2024",NDSN,Nordson Corporation,14.72B,257.40,2.66B,5.71%,7.86%,2.32%,+2.38%,-5.47%,"Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more","Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more",Seaport Global Reaffirms Their Hold Rating on Nordson (NDSN),Oppenheimer Reaffirms Their Hold Rating on Nordson (NDSN),Nordson (NDSN) Receives a Hold from Seaport Global,"Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more Seaport Global Reaffirms Their Hold Rating on Nordson (NDSN) Oppenheimer Reaffirms Their Hold Rating on Nordson (NDSN) Nordson (NDSN) Receives a Hold from Seaport Global",0,1,1,1,0,1
57.18M,"253,745",472.89M,$3.12,"2,200",257.40,Buy,290.40,"Aug 21, 2024",CG,The Carlyle Group Inc.,14.34B,40.25,2.78B,-3.27%,-4.42%,-3.60%,-19.32%,-14.89%,5 things to know before the stock market opens Wednesday,"Calls of the Day: Ferrari, Cleveland Cliffs, Carlyle Group and BlackRock",NFL owners vote in favor of private equity investment,"Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more",‘Private Markets Are the Hot Spot’: Analyst Suggests 2 Alternative Asset Stocks to Consider,"5 things to know before the stock market opens Wednesday Calls of the Day: Ferrari, Cleveland Cliffs, Carlyle Group and BlackRock NFL owners vote in favor of private equity investment Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more ‘Private Markets Are the Hot Spot’: Analyst Suggests 2 Alternative Asset Stocks to Consider",0,1,1,1,1,1
356.38M,"1,733,997",-396.90M,$1.40,"103,300",40.25,Buy,46.62,"Aug 5, 2024",UAL,"United Airlines Holdings, Inc.",14.25B,43.32,55.64B,1.22%,-6.83%,-6.51%,-9.00%,-4.31%,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree",Friday’s stock stories: What’s likely to move the market in the next session,Here’s where American Airlines is adding flights to Europe in summer 2025,Why airlines like American are scrambling to make engines last longer,Airlines are leaning into AI to improve flights,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree Friday’s stock stories: What’s likely to move the market in the next session Here’s where American Airlines is adding flights to Europe in summer 2025 Why airlines like American are scrambling to make engines last longer Airlines are leaning into AI to improve flights",0,0,0,0,1,0
328.83M,"3,308,035",2.94B,-1,"16,790",43.32,Strong Buy,72.78,"Oct 15, 2024",RIVN,"Rivian Automotive, Inc.",14.08B,13.96,5.01B,2.50%,-0.60%,2.14%,-15.72%,+36.93%,"Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here","These stocks are contenders for selling — and can help cut taxes, Wolfe says",Tesla Cybertruck is in a category of its own for better or worse,5 things to know before the stock market opens Wednesday,GMC expects to outsell electric truck competitors as it launches new Sierra pickup,"Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here These stocks are contenders for selling — and can help cut taxes, Wolfe says Tesla Cybertruck is in a category of its own for better or worse 5 things to know before the stock market opens Wednesday GMC expects to outsell electric truck competitors as it launches new Sierra pickup",0,1,1,0,1,0
1.01B,"33,005,416",-5.79B,-1,"7,300",13.96,Buy,17.90,"Aug 6, 2024",LOGI,Logitech International S.A.,14.05B,92.26,4.41B,2.62%,-0.79%,1.49%,-0.40%,+3.26%,Kepler Capital Sticks to Their Hold Rating for Logitech (LOGI),Logitech shareholders approve all proposals at AGM,Logitech price target raised to $88 from $87 at Loop Capital,Loop Capital Markets Remains a Hold on Logitech (LOGI),,Kepler Capital Sticks to Their Hold Rating for Logitech (LOGI) Logitech shareholders approve all proposals at AGM Logitech price target raised to $88 from $87 at Loop Capital Loop Capital Markets Remains a Hold on Logitech (LOGI),1,1,1,1,1,-1
152.81M,"233,533",691.25M,$1.29,"38,000",92.26,Hold,94.56,"Jul 22, 2024",VTRS,Viatris Inc.,14.04B,11.76,15.24B,-0.28%,3.87%,4.28%,-1.33%,+0.85%,Viatris Initiates Cash Tender Offers for Senior Notes,Viatris Announces Cash Tender Offers for Certain Outstanding Notes,Analyst Maintains Sell Rating on Viatris Citing Long-Term Revenue Concerns and Growth Challenges,,,Viatris Initiates Cash Tender Offers for Senior Notes Viatris Announces Cash Tender Offers for Certain Outstanding Notes Analyst Maintains Sell Rating on Viatris Citing Long-Term Revenue Concerns and Growth Challenges,1,0,0,1,-1,-1
1.19B,"5,847,074",-646.50M,$0.48,18,11.76,Hold,12.33,"Aug 8, 2024",GLPI,"Gaming and Leisure Properties, Inc.",13.92B,50.74,1.49B,2.94%,7.29%,10.84%,+1.75%,+13.11%,"Gaming and Leisure Properties, Inc. Declares Third Quarter 2024 Cash Dividend of $0.76 Per Share",Bet On It: Missouri sports betting certification process challenged with lawsuit,Gaming and Leisure Properties upgraded to Outperform from Peer Perform at Wolfe Research,Gaming and Leisure price target raised to $53 from $50 at Raymond James,Gaming and Leisure Properties price target raised to $55 from $53 at JMP Securities,"Gaming and Leisure Properties, Inc. Declares Third Quarter 2024 Cash Dividend of $0.76 Per Share Bet On It: Missouri sports betting certification process challenged with lawsuit Gaming and Leisure Properties upgraded to Outperform from Peer Perform at Wolfe Research Gaming and Leisure price target raised to $53 from $50 at Raymond James Gaming and Leisure Properties price target raised to $55 from $53 at JMP Securities",0,0,0,0,0,0
274.39M,"1,018,697",777.59M,$3.04,"12,700",50.74,Buy,51.57,"Jul 25, 2024",TRMB,Trimble Inc.,13.92B,56.99,3.71B,5.62%,2.75%,2.85%,+2.92%,-8.66%,"Trimble Struggles with Reporting Compliance, Receives Nasdaq Extension",Trimble receives listing deficiency notification from Nasdaq,"Analysts Are Bullish on These Technology Stocks: Onestream, Inc. Class A (OS), Trimble (TRMB)",Trimble called ‘highest conviction’ second half idea at Piper Sandler,"Jana added Rapid7 during Q2, sold out of Freshpet","Trimble Struggles with Reporting Compliance, Receives Nasdaq Extension Trimble receives listing deficiency notification from Nasdaq Analysts Are Bullish on These Technology Stocks: Onestream, Inc. Class A (OS), Trimble (TRMB) Trimble called ‘highest conviction’ second half idea at Piper Sandler Jana added Rapid7 during Q2, sold out of Freshpet",1,1,0,1,1,1
244.21M,"535,620",1.51B,-1,"6,000",56.99,Buy,66.29,"Aug 6, 2024",POOL,Pool Corporation,13.72B,358.52,5.37B,-0.21%,4.52%,-4.01%,-6.53%,-11.77%,Pool Corp. price target raised to $335 from $310 at Stifel,Pool Corporation Announces Upcoming Investor Conference Participation,,,,Pool Corp. price target raised to $335 from $310 at Stifel Pool Corporation Announces Upcoming Investor Conference Participation,0,0,1,-1,-1,-1
38.26M,"170,554",458.20M,$4.80,"45,359",358.52,Hold,344.63,"Oct 17, 2024",CASY,"Casey's General Stores, Inc.",13.71B,369.40,14.86B,-0.65%,-0.78%,16.90%,-5.09%,+16.23%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines",Proposed 7-Eleven buyout deal likely to face antitrust scrutiny: Retail analyst,Casey’s General Stores price target raised to $403 from $393 at RBC Capital,Evercore ISI Remains a Buy on Casey’s General (CASY),"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines Proposed 7-Eleven buyout deal likely to face antitrust scrutiny: Retail analyst Casey’s General Stores price target raised to $403 from $393 at RBC Capital Evercore ISI Remains a Buy on Casey’s General (CASY)",0,1,1,1,0,0
37.11M,"222,517",501.97M,$2.00,"1,187",369.40,Strong Buy,410.22,"Sep 4, 2024",AZPN,"Aspen Technology, Inc.",13.68B,216.23,1.13B,5.20%,8.11%,7.31%,+16.78%,+1.79%,"Software is a good small cap play because earnings are more recurring, says Julie Biel",,,,,"Software is a good small cap play because earnings are more recurring, says Julie Biel",0,0,-1,-1,-1,-1
63.25M,"112,896",-9.77M,$0.53,912,216.23,Strong Buy,224.50,"Aug 6, 2024",INSM,Insmed Incorporated,13.55B,78.84,328.61M,3.30%,6.41%,91.12%,+5.20%,+176.68%,Insmed added to Americas Conviction List at Goldman Sachs,Insmed’s Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition,Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities,Truist Financial Reaffirms Their Buy Rating on Insmed (INSM),Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition,Insmed added to Americas Conviction List at Goldman Sachs Insmed’s Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities Truist Financial Reaffirms Their Buy Rating on Insmed (INSM) Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition,0,0,0,0,0,0
171.85M,"2,353,397",-802.69M,-1,"4,658",78.84,Strong Buy,81.40,"Aug 8, 2024",EVRG,"Evergy, Inc.",13.46B,58.53,5.64B,-0.15%,4.89%,10.94%,+1.33%,+12.59%,Wednesday’s stock stories: What’s likely to move the market in the next session,Evergy appoints W. Bryan Buckler as CFO,Evergy files automatic mixed securities shelf,Evergy price target raised to $64 from $61 at Barclays,Barclays Keeps Their Buy Rating on Evergy (EVRG),Wednesday’s stock stories: What’s likely to move the market in the next session Evergy appoints W. Bryan Buckler as CFO Evergy files automatic mixed securities shelf Evergy price target raised to $64 from $61 at Barclays Barclays Keeps Their Buy Rating on Evergy (EVRG),1,0,1,1,1,1
229.96M,"1,708,126",739.30M,$2.57,"11,334",58.53,Buy,58.33,"Aug 9, 2024",MORN,"Morningstar, Inc.",13.44B,313.83,2.17B,0.08%,1.79%,6.19%,-2.35%,+0.13%,Only 11% of American workers don’t plan to work at all after they retire,"Utilities are getting expensive, but these 2 names are undervalued: Strategist",79% of Americans who make this one move won’t run out of money in retirement,‘Long-term opportunity’: Morningstar analyst names 2 luxury stocks to buy,The 3 biggest ways retirement savers ‘shoot themselves in the foot’,"Only 11% of American workers don’t plan to work at all after they retire Utilities are getting expensive, but these 2 names are undervalued: Strategist 79% of Americans who make this one move won’t run out of money in retirement ‘Long-term opportunity’: Morningstar analyst names 2 luxury stocks to buy The 3 biggest ways retirement savers ‘shoot themselves in the foot’",1,1,1,1,1,1
42.84M,"117,473",245.90M,$1.62,"2,932",313.83,Strong Buy,336.00,"Jul 24, 2024",IBKR,"Interactive Brokers Group, Inc.",13.43B,123.40,4.77B,7.44%,5.39%,19.25%,+5.91%,+12.12%,Barclays Sticks to Its Buy Rating for Interactive Brokers (IBKR),Interactive Brokers reports August average revenue trades up 40% vs. last year,Interactive Brokers expands overnight trading offering,,,Barclays Sticks to Its Buy Rating for Interactive Brokers (IBKR) Interactive Brokers reports August average revenue trades up 40% vs. last year Interactive Brokers expands overnight trading offering,1,0,1,0,-1,-1
108.84M,"499,270",681.00M,$1.00,"1,314",123.40,Strong Buy,127.10,"Oct 15, 2024",SRPT,"Sarepta Therapeutics, Inc.",13.40B,140.56,1.50B,1.77%,-2.15%,15.02%,-2.34%,+10.18%,Election 2024: Where To Put Your Money Ahead of the Vote,Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Danaher (DHR),Biotech Alert: Searches spiking for these stocks today,RBC Capital Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT),Evercore ISI Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT),Election 2024: Where To Put Your Money Ahead of the Vote Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Danaher (DHR) Biotech Alert: Searches spiking for these stocks today RBC Capital Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT) Evercore ISI Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT),0,1,0,1,0,0
95.37M,"544,472",47.30M,-1,"2,800",140.56,Buy,185.41,"Aug 7, 2024",ARCC,Ares Capital Corporation,13.19B,20.92,2.82B,2.02%,1.43%,2.90%,+0.14%,+1.94%,,,,,,,0,-1,-1,-1,-1,-1
630.39M,"3,749,942",1.68B,$1.92,"6,450",20.92,Buy,21.63,"Oct 22, 2024",NTNX,"Nutanix, Inc.",13.16B,53.35,2.10B,5.56%,1.48%,-3.51%,+3.52%,-20.75%,"Stocks making the biggest moves midday: Dollar General, Affirm and more","Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more","Stocks making the biggest moves after hours: Nvidia, Salesforce and more","Nutanix COO David Sangster Plans Retirement, Continues as Advisor",Analysts Have Conflicting Sentiments on These Technology Companies: Dave (DAVE) and Nutanix (NTNX),"Stocks making the biggest moves midday: Dollar General, Affirm and more Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Stocks making the biggest moves after hours: Nvidia, Salesforce and more Nutanix COO David Sangster Plans Retirement, Continues as Advisor Analysts Have Conflicting Sentiments on These Technology Companies: Dave (DAVE) and Nutanix (NTNX)",1,1,1,1,1,1
246.64M,"1,732,330",-11.96M,-1,"1,854",53.35,Buy,66.43,"Aug 28, 2024",MNDY,monday.com Ltd.,13.13B,263.42,844.78M,7.25%,9.69%,23.11%,+11.47%,+18.05%,Top Wall Street analysts are upbeat about the potential of these 3 stocks ,Jim Cramer’s top 10 things to watch in the stock market Tuesday,Op-ed: Small caps could be in for a revival. Here’s why,"Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more","After a busy week of stock trades, we’re looking ahead to some key inflation data","Top Wall Street analysts are upbeat about the potential of these 3 stocks  Jim Cramer’s top 10 things to watch in the stock market Tuesday Op-ed: Small caps could be in for a revival. Here’s why Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more After a busy week of stock trades, we’re looking ahead to some key inflation data",1,1,0,1,1,1
49.86M,"257,164",41.22M,-1,"172,000",263.42,Strong Buy,280.57,"Aug 12, 2024",FLEX,Flex Ltd.,13.08B,32.93,25.84B,5.32%,5.76%,19.02%,-0.62%,+9.94%,Flex Adjusts Executive Compensation to Reflect Roles and Performance,Flex files automatic mixed securities shelf,,,,Flex Adjusts Executive Compensation to Reflect Roles and Performance Flex files automatic mixed securities shelf,1,0,0,-1,-1,-1
397.07M,"1,433,066",959.00M,-1,"3,000",32.93,Strong Buy,38.80,"Jul 24, 2024",PODD,Insulet Corporation,12.96B,185.04,1.87B,0.84%,-1.51%,2.97%,+5.18%,+23.89%,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more",We’re trimming a health-care stock on concerns its business could be hurt by Lilly,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more","Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more",Strong Growth and Market Leadership Support Buy Rating for Insulet,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more We’re trimming a health-care stock on concerns its business could be hurt by Lilly Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more Strong Growth and Market Leadership Support Buy Rating for Insulet",1,1,0,1,1,0
70.04M,"404,074",395.30M,-1,"6,263",185.04,Buy,223.43,"Aug 8, 2024",Z,"Zillow Group, Inc.",12.93B,56.35,2.07B,13.10%,16.07%,17.37%,+15.73%,+19.36%,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Citi ‘incrementally positive’ on Zillow shares after meetings,Zillow Group initiated with a Neutral at Cantor Fitzgerald,Zillow Group management to meet with Stephens,Zillow Group price target raised to $66 from $60 at RBC Capital,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Citi ‘incrementally positive’ on Zillow shares after meetings Zillow Group initiated with a Neutral at Cantor Fitzgerald Zillow Group management to meet with Stephens Zillow Group price target raised to $66 from $60 at RBC Capital,1,1,1,1,1,1
231.44M,"3,760,083",-141.00M,-1,502,56.35,Buy,57.44,"Aug 7, 2024",REG,Regency Centers Corporation,12.93B,71.42,1.46B,1.99%,8.07%,13.75%,+6.42%,+21.87%,Regency Centers to Present at the BofA Securities 2024 Global Real Estate Conference,Regency Centers price target raised to $72 from $71 at Evercore ISI,Wells Fargo Sticks to Its Buy Rating for Regency Centers (REG),Regency Centers price target raised to $79 from $69 at Wells Fargo,Regency Centers Announces New Safeway-Anchored Ground-Up Shopping Center Development in Bay Area,Regency Centers to Present at the BofA Securities 2024 Global Real Estate Conference Regency Centers price target raised to $72 from $71 at Evercore ISI Wells Fargo Sticks to Its Buy Rating for Regency Centers (REG) Regency Centers price target raised to $79 from $69 at Wells Fargo Regency Centers Announces New Safeway-Anchored Ground-Up Shopping Center Development in Bay Area,0,1,0,0,0,0
181.03M,"707,869",381.05M,$2.68,"12,005",71.42,Strong Buy,73.45,"Aug 1, 2024",GRAB,Grab Holdings Limited,12.79B,3.23,2.58B,-0.06%,-4.57%,-2.68%,-2.73%,-0.93%,Grab Holdings management to meet with Benchmark,"Analysts Offer Insights on Technology Companies: Uber Technologies (UBER), Grab (GRAB) and Advanced Micro Devices (AMD)",Barclays Sticks to Its Buy Rating for Grab (GRAB),J.P. Morgan Sticks to Their Buy Rating for Grab (GRAB),Analysts Offer Insights on Technology Companies: Grab (GRAB) and Salesforce (CRM),"Grab Holdings management to meet with Benchmark Analysts Offer Insights on Technology Companies: Uber Technologies (UBER), Grab (GRAB) and Advanced Micro Devices (AMD) Barclays Sticks to Its Buy Rating for Grab (GRAB) J.P. Morgan Sticks to Their Buy Rating for Grab (GRAB) Analysts Offer Insights on Technology Companies: Grab (GRAB) and Salesforce (CRM)",1,1,1,1,1,1
3.96B,"21,204,882",-213.00M,-1,89,3.230,Strong Buy,5.09,"Aug 15, 2024",RPRX,Royalty Pharma plc,12.63B,28.19,2.24B,3.87%,4.77%,1.26%,+2.27%,-1.30%,"Lightning Round: I’ll pass on buying a flying car from China, says Jim Cramer on Xpeng",Cramer’s Lightning Round: Ally Financial is a buy,Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement,Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference,Royalty Pharma price target raised to $51 from $50 at Goldman Sachs,"Lightning Round: I’ll pass on buying a flying car from China, says Jim Cramer on Xpeng Cramer’s Lightning Round: Ally Financial is a buy Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference Royalty Pharma price target raised to $51 from $50 at Goldman Sachs",0,0,0,0,0,0
448.13M,"1,456,253",673.24M,$0.84,"6,263",28.19,Strong Buy,42.00,"Aug 8, 2024",ZG,"Zillow Group, Inc.",12.62B,54.53,2.07B,13.09%,15.77%,16.64%,+15.02%,+17.93%,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Citi ‘incrementally positive’ on Zillow shares after meetings,Zillow Group initiated with a Neutral at Cantor Fitzgerald,Zillow Group management to meet with Stephens,Zillow Group price target raised to $66 from $60 at RBC Capital,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Citi ‘incrementally positive’ on Zillow shares after meetings Zillow Group initiated with a Neutral at Cantor Fitzgerald Zillow Group management to meet with Stephens Zillow Group price target raised to $66 from $60 at RBC Capital,1,1,1,1,1,1
231.44M,"577,644",-141.00M,-1,"27,000",54.53,Buy,57.44,"Aug 7, 2024",TTEK,"Tetra Tech, Inc.",12.62B,235.71,4.23B,3.60%,9.98%,24.74%,+9.84%,+21.36%,Tetra Tech management to meet with KeyBanc,2 ‘Strong Buy’ Stocks to Watch Ahead of Stock Splits in September,,,,Tetra Tech management to meet with KeyBanc 2 ‘Strong Buy’ Stocks to Watch Ahead of Stock Splits in September,0,1,0,-1,-1,-1
53.53M,"136,775",290.88M,$1.16,"4,200",235.71,Buy,242.50,"Jul 31, 2024",PAA,"Plains All American Pipeline, L.P.",12.51B,17.85,49.70B,0.56%,-1.44%,5.20%,-4.95%,-6.84%,Plains All American files $1.1B mixed securities shelf,Plains All American files automatic mixed securities shelf,Plains All American (PAA) Receives a Rating Update from a Top Analyst,Plains All American (PAA) Gets a Buy from Morgan Stanley,Barclays Sticks to Their Sell Rating for Plains All American (PAA),Plains All American files $1.1B mixed securities shelf Plains All American files automatic mixed securities shelf Plains All American (PAA) Receives a Rating Update from a Top Analyst Plains All American (PAA) Gets a Buy from Morgan Stanley Barclays Sticks to Their Sell Rating for Plains All American (PAA),1,1,1,1,1,1
701.08M,"2,004,231",770.00M,$1.27,"3,550",17.85,Buy,19.80,"Aug 2, 2024",LAMR,Lamar Advertising Company,12.50B,122.19,2.16B,4.23%,4.01%,9.49%,+2.31%,+6.61%,Lamar Advertising Company Announces Cash Dividend on Common Stock,J.P. Morgan Keeps Their Hold Rating on Lamar Advertising (LAMR),"Analysts Offer Insights on Real Estate Companies: BRC (BRCC), Lamar Advertising (LAMR) and Douglas Elliman Inc. (DOUG)",Lamar Advertising price target raised to $140 from $135 at TD Cowen,Buy Rating for Lamar Advertising Backed by Strong Q2 Performance and Positive Growth Outlook,"Lamar Advertising Company Announces Cash Dividend on Common Stock J.P. Morgan Keeps Their Hold Rating on Lamar Advertising (LAMR) Analysts Offer Insights on Real Estate Companies: BRC (BRCC), Lamar Advertising (LAMR) and Douglas Elliman Inc. (DOUG) Lamar Advertising price target raised to $140 from $135 at TD Cowen Buy Rating for Lamar Advertising Backed by Strong Q2 Performance and Positive Growth Outlook",1,1,1,1,1,1
102.30M,"218,454",504.33M,$5.20,170,122.19,Buy,123.25,"Aug 8, 2024",FTAI,FTAI Aviation Ltd.,12.44B,121.74,1.37B,11.22%,16.16%,71.30%,+8.28%,+65.95%,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",FTAI Aviation assumed with a Buy at BTIG,FTA Aviation’s Strong EBITDA Growth and Expansion Strategy Merit a Buy Rating,FTAI Aviation Ltd. to Participate in the Jefferies Industrials Conference,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls FTAI Aviation assumed with a Buy at BTIG FTA Aviation’s Strong EBITDA Growth and Expansion Strategy Merit a Buy Rating FTAI Aviation Ltd. to Participate in the Jefferies Industrials Conference",1,0,1,0,1,0
102.21M,"606,531",-53.92M,$1.20,"2,524",121.74,Strong Buy,118.45,"Jul 23, 2024",INCY,Incyte Corporation,12.35B,64.14,3.86B,4.14%,4.12%,11.10%,+0.88%,+18.83%,These stocks typically have the best and worst Septembers,RBC says expectations ‘should remain grounded’ into Incyte data,"Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in Africa",Incyte to present data from Phase 3 Retifanlimab study at ESMO Congress 2024,Incyte Corporation: Market Successes Counterbalanced by Valuation and Patent Expiry Concerns,"These stocks typically have the best and worst Septembers RBC says expectations ‘should remain grounded’ into Incyte data Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in Africa Incyte to present data from Phase 3 Retifanlimab study at ESMO Congress 2024 Incyte Corporation: Market Successes Counterbalanced by Valuation and Patent Expiry Concerns",1,0,1,1,0,1
192.60M,"1,729,081",97.30M,-1,"5,680",64.14,Buy,71.13,"Jul 30, 2024",SIRI,Sirius XM Holdings Inc.,12.32B,3.20,8.90B,0.79%,-2.35%,-20.38%,-6.09%,-7.16%,"Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more",Walmart+ is only $49 for a limited-time,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Notable open interest changes for August 22nd,"Target reports Q2 beat, Walmart sells JD.com stake: Morning Buzz","Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more Walmart+ is only $49 for a limited-time Split-off of Liberty SiriusXM approved at Liberty Media special meeting Notable open interest changes for August 22nd Target reports Q2 beat, Walmart sells JD.com stake: Morning Buzz",0,1,0,1,1,1
3.85B,"17,196,254",1.30B,$0.11,163,3.200,Hold,3.78,"Aug 1, 2024",HST,"Host Hotels & Resorts, Inc.",12.23B,17.41,5.48B,4.11%,-0.46%,-7.41%,-1.54%,-14.99%,Turn to these dividend growers as the Fed cuts rates,Host Hotels price target lowered to $20 from $23 at Truist,Morgan Stanley Reaffirms Their Sell Rating on Host Hotels & Resorts (HST),Analysts Offer Insights on Real Estate Companies: Kennedy-Wilson (KW) and Host Hotels & Resorts (HST),Host Hotels & Resorts: A Detailed Look at Financial Strategy and Hold Rating Justification,Turn to these dividend growers as the Fed cuts rates Host Hotels price target lowered to $20 from $23 at Truist Morgan Stanley Reaffirms Their Sell Rating on Host Hotels & Resorts (HST) Analysts Offer Insights on Real Estate Companies: Kennedy-Wilson (KW) and Host Hotels & Resorts (HST) Host Hotels & Resorts: A Detailed Look at Financial Strategy and Hold Rating Justification,0,0,0,1,1,1
702.44M,"7,757,350",750.00M,$0.80,"5,900",17.41,Buy,21.06,"Jul 31, 2024",MEDP,"Medpace Holdings, Inc.",12.09B,390.91,2.03B,-0.08%,-4.00%,5.56%,-0.39%,-4.93%,Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Medpace Holdings (MEDP),,,,,Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Medpace Holdings (MEDP),1,0,-1,-1,-1,-1
30.93M,"138,310",339.65M,-1,"3,018",390.91,Strong Buy,426.50,"Oct 21, 2024",CYBR,CyberArk Software Ltd.,12.08B,279.88,860.60M,5.59%,6.10%,16.32%,+9.19%,+8.71%,Top Wall Street analysts are upbeat about the potential of these 3 stocks ,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more",Bank of America says buy this ‘diamond in the rough’ cybersecurity stock,"Identity theft is where bad actors are focusing their attention, says CyberArk CEO","Analysts Conflicted on These Technology Names: DigitalOcean Holdings (DOCN), WEBTOON Entertainment Inc (WBTN) and CyberArk Software (CYBR)","Top Wall Street analysts are upbeat about the potential of these 3 stocks  Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Bank of America says buy this ‘diamond in the rough’ cybersecurity stock Identity theft is where bad actors are focusing their attention, says CyberArk CEO Analysts Conflicted on These Technology Names: DigitalOcean Holdings (DOCN), WEBTOON Entertainment Inc (WBTN) and CyberArk Software (CYBR)",0,1,1,1,0,0
43.15M,"336,780",-13.15M,-1,"7,120",279.88,Strong Buy,288.85,"Aug 8, 2024",JKHY,"Jack Henry & Associates, Inc.",12.00B,164.63,2.19B,2.99%,3.15%,3.15%,+1.33%,+2.19%,Jack Henry & Associates (JKHY) Gets a Hold from RBC Capital,Jack Henry initiated with Neutral on weaker growth at Compass Point,Jack Henry initiated with a Neutral at Compass Point,Jack Henry announces collaboration with Moov,Jack Henry & Associates Announces Regular Quarterly Dividend,Jack Henry & Associates (JKHY) Gets a Hold from RBC Capital Jack Henry initiated with Neutral on weaker growth at Compass Point Jack Henry initiated with a Neutral at Compass Point Jack Henry announces collaboration with Moov Jack Henry & Associates Announces Regular Quarterly Dividend,0,0,1,1,1,1
72.90M,"510,437",378.52M,$2.20,"15,246",164.63,Buy,176.45,"Aug 20, 2024",CHRW,"C.H. Robinson Worldwide, Inc.",11.94B,101.79,17.46B,5.17%,12.60%,25.24%,+16.74%,+46.05%,"‘We’ll shut them down’: Ports union near strike, cites contract impasse","C.H. Robinson CHRO Freeman sells 8,387 common shares",CH Robinson Announces Election and Committee Appointments of New Directors,,,"‘We’ll shut them down’: Ports union near strike, cites contract impasse C.H. Robinson CHRO Freeman sells 8,387 common shares CH Robinson Announces Election and Committee Appointments of New Directors",0,1,1,0,-1,-1
117.28M,"595,572",332.08M,$2.48,"1,225",101.79,Hold,93.27,"Jul 31, 2024",WING,Wingstop Inc.,11.84B,403.89,545.65M,8.08%,4.78%,21.44%,+3.84%,+10.78%,How Wingstop is outpacing its fast-food competitors,The rise of Wingstop,"TikTok, fast-food rivalry fuel Chili’s as Brinker says turnaround is taking hold",McDonald’s Is Destined to Underperform Its Competitors and the Stock Market,Wingstop (NASDAQ:WING) Slips Despite Surprising Success,"How Wingstop is outpacing its fast-food competitors The rise of Wingstop TikTok, fast-food rivalry fuel Chili’s as Brinker says turnaround is taking hold McDonald’s Is Destined to Underperform Its Competitors and the Stock Market Wingstop (NASDAQ:WING) Slips Despite Surprising Success",0,0,0,1,0,0
29.30M,"391,691",94.56M,$1.08,"17,000",403.89,Buy,374.47,"Jul 31, 2024",COKE,"Coca-Cola Consolidated, Inc.",11.83B,"1,350.00",6.73B,5.66%,16.19%,43.82%,+15.87%,+59.95%,Coca-Cola Consolidated Announces Dividend Increase and Share Repurchase Program,Coca-Cola Consolidated announces $1B share repurchase program,Coca-Cola Consolidated increases quarterly dividend to $2.50 per share,,,Coca-Cola Consolidated Announces Dividend Increase and Share Repurchase Program Coca-Cola Consolidated announces $1B share repurchase program Coca-Cola Consolidated increases quarterly dividend to $2.50 per share,0,0,0,0,-1,-1
8.76M,"38,202",506.48M,$3.50,"6,840","1,350.00",,,"Jul 31, 2024",DOCU,"DocuSign, Inc.",11.76B,57.44,2.81B,7.23%,7.80%,6.49%,+3.93%,-3.04%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more","S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022","Stocks making the biggest moves after hours: Broadcom, DocuSign, UiPath and more","Procter & Gamble’s lingering China problem, plus Magnificent 7 stocks surprise",DocuSign price target raised to $68 from $60 at BofA,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022 Stocks making the biggest moves after hours: Broadcom, DocuSign, UiPath and more Procter & Gamble’s lingering China problem, plus Magnificent 7 stocks surprise DocuSign price target raised to $68 from $60 at BofA",0,1,0,1,0,0
204.69M,"2,305,057",107.20M,-1,"3,206",57.44,Hold,61.46,"Sep 5, 2024",EWBC,"East West Bancorp, Inc.",11.74B,84.69,2.36B,1.67%,5.18%,11.65%,-5.59%,+10.04%,East West Bancorp’s Investor Presentation Highlights Growth Strategy,East West Bancorp (EWBC) Gets a Buy from Truist Financial,Barclays Sticks to Its Buy Rating for East West Bancorp (EWBC),,,East West Bancorp’s Investor Presentation Highlights Growth Strategy East West Bancorp (EWBC) Gets a Buy from Truist Financial Barclays Sticks to Its Buy Rating for East West Bancorp (EWBC),0,1,0,1,-1,-1
138.61M,"775,772",1.10B,$2.20,"3,700",84.69,Strong Buy,88.73,"Jul 23, 2024",MBLY,Mobileye Global Inc.,11.68B,14.40,1.85B,-11.17%,-36.82%,-52.89%,-35.67%,-57.40%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",CNBC Daily Open: Nvidia’s ‘drop-the-mic moment’,"Intel has hired Morgan Stanley, other advisers for activist defense",Shareholders Revolt as Intel (NASDAQ:INTC) Fire Sale Continues,"Intel to explore sale of part of stake in Mobileye, Bloomberg reports","Stocks making the biggest moves midday: Intel, Nio, Broadcom and more CNBC Daily Open: Nvidia’s ‘drop-the-mic moment’ Intel has hired Morgan Stanley, other advisers for activist defense Shareholders Revolt as Intel (NASDAQ:INTC) Fire Sale Continues Intel to explore sale of part of stake in Mobileye, Bloomberg reports",1,1,0,0,1,1
811.05M,"4,337,954",-224.00M,-1,"6,524",14.40,Buy,32.00,"Aug 1, 2024",FFIV,"F5, Inc.",11.60B,199.01,2.78B,2.78%,10.01%,11.59%,-2.33%,+3.36%,Piper Sandler Sticks to Their Hold Rating for F5 Networks (FFIV),F5 Networks Announces Executive Team Reshuffle and Officer Resignation,F5 Networks announces new leadership roles,"F5 Networks, Intel collaborate to simplify security, delivery of AI services",,"Piper Sandler Sticks to Their Hold Rating for F5 Networks (FFIV) F5 Networks Announces Executive Team Reshuffle and Officer Resignation F5 Networks announces new leadership roles F5 Networks, Intel collaborate to simplify security, delivery of AI services",1,0,1,0,1,-1
58.28M,"300,100",553.62M,-1,"3,050",199.01,Hold,200.89,"Jul 29, 2024",TECH,Bio-Techne Corporation,11.47B,72.29,1.16B,-5.33%,-5.27%,-1.67%,-12.24%,+6.88%,Scotiabank Reaffirms Their Buy Rating on Bio-Techne (TECH),Benchmark Co. Remains a Buy on Bio-Techne (TECH),Bio-Techne: A Compelling Buy Amidst Market Uncertainty and Anticipated Growth Catalysts,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS)",Buy Rating Affirmed for Bio-Techne on Strong Consumables Foundation and Market Growth Potential,"Scotiabank Reaffirms Their Buy Rating on Bio-Techne (TECH) Benchmark Co. Remains a Buy on Bio-Techne (TECH) Bio-Techne: A Compelling Buy Amidst Market Uncertainty and Anticipated Growth Catalysts Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS) Buy Rating Affirmed for Bio-Techne on Strong Consumables Foundation and Market Growth Potential",1,1,1,1,0,1
158.60M,"499,175",168.07M,$0.32,"91,000",72.29,Buy,80.67,"Aug 7, 2024",TXRH,"Texas Roadhouse, Inc.",11.24B,168.59,4.95B,0.38%,-0.20%,14.61%,-2.87%,+13.07%,McDonald’s Is Destined to Underperform Its Competitors and the Stock Market,Texas Roadhouse: Growth at a Reasonable Price,"Texas Roadhouse, Inc. Announces Quarterly Dividend",,,"McDonald’s Is Destined to Underperform Its Competitors and the Stock Market Texas Roadhouse: Growth at a Reasonable Price Texas Roadhouse, Inc. Announces Quarterly Dividend",1,0,0,0,-1,-1
66.68M,"522,987",369.57M,$2.44,"8,384",168.59,Buy,168.86,"Jul 25, 2024",NICE,NICE Ltd.,11.24B,178.26,2.55B,5.13%,5.02%,-10.96%,-3.45%,-28.41%,NICE Actimize Clinches Top RegTech Award for Innovation,Nice announces new centralized gateway to Government Services,"Nice’s AI-powered digital evidence solution selected by Augusta, Georgia DA",JMP Securities Sticks to Their Buy Rating for NICE (NICE),"Nice’s Q2 bookings growth stable, says DA Davidson","NICE Actimize Clinches Top RegTech Award for Innovation Nice announces new centralized gateway to Government Services Nice’s AI-powered digital evidence solution selected by Augusta, Georgia DA JMP Securities Sticks to Their Buy Rating for NICE (NICE) Nice’s Q2 bookings growth stable, says DA Davidson",0,0,1,0,1,1
63.53M,"423,847",396.16M,-1,"49,000",178.26,Strong Buy,269.64,"Aug 15, 2024",LKQ,LKQ Corporation,11.22B,42.63,14.48B,5.06%,2.01%,-7.44%,+0.92%,-18.63%,,,,,,,0,-1,-1,-1,-1,-1
263.26M,"1,095,407",728.00M,$1.20,"12,000",42.63,Strong Buy,60.80,"Oct 24, 2024",LECO,"Lincoln Electric Holdings, Inc.",11.22B,197.98,4.09B,0.59%,0.74%,-9.60%,-5.36%,-21.60%,Buy Rating for Lincoln Electric Amidst Challenging Industrial Cycle and Strong Cost Management,Barclays cuts Lincoln Electric estimates after ‘broad-based’ cautious commentary,Lincoln Electric price target lowered to $210 from $240 at KeyBanc,Lincoln Electric price target lowered to $212 from $220 at Baird,Robert W. Baird Sticks to Their Buy Rating for Lincoln Electric Holdings (LECO),Buy Rating for Lincoln Electric Amidst Challenging Industrial Cycle and Strong Cost Management Barclays cuts Lincoln Electric estimates after ‘broad-based’ cautious commentary Lincoln Electric price target lowered to $210 from $240 at KeyBanc Lincoln Electric price target lowered to $212 from $220 at Baird Robert W. Baird Sticks to Their Buy Rating for Lincoln Electric Holdings (LECO),1,1,0,1,0,0
56.68M,"159,347",511.11M,$2.84,"6,600",197.98,Buy,218.25,"Jul 31, 2024",EXAS,Exact Sciences Corporation,11.03B,59.70,2.61B,5.49%,20.36%,1.72%,+33.87%,-12.93%,Buy Rating Affirmed for Exact Sciences Amid Promising Cancer Screening Innovations and Strategic Advantages,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Exact Sciences initiated with an Overweight at Wells Fargo,Exact Sciences: 1st patient enrolled in MCED Falcon Registry RWE study,"Buy Rating Affirmed for Exact Sciences Amid Promising Cancer Screening Innovations and Strategic Advantages Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Exact Sciences initiated with an Overweight at Wells Fargo Exact Sciences: 1st patient enrolled in MCED Falcon Registry RWE study",1,1,1,1,1,0
184.77M,"2,162,579",-175.01M,-1,"4,576",59.70,Strong Buy,77.64,"Jul 31, 2024",MMYT,MakeMyTrip Limited,10.98B,100.00,840.31M,4.78%,9.70%,46.09%,+2.85%,+26.71%,MakeMyTrip downgraded to Add from Buy at Axis Capital,MakeMyTrip price target raised to $112 from $100 at BofA,Makemytrip’s Growth and Profitability Outlook: A Buy Rating with Robust Potential,Makemytrip (MMYT) Receives ‘Buy’ Rating on Robust Volume Growth and Market Resilience,Makemytrip (MMYT): Outperforming the OTA Sector with Sustained Growth and Profitability,MakeMyTrip downgraded to Add from Buy at Axis Capital MakeMyTrip price target raised to $112 from $100 at BofA Makemytrip’s Growth and Profitability Outlook: A Buy Rating with Robust Potential Makemytrip (MMYT) Receives ‘Buy’ Rating on Robust Volume Growth and Market Resilience Makemytrip (MMYT): Outperforming the OTA Sector with Sustained Growth and Profitability,1,1,1,1,1,1
109.78M,"376,903",219.37M,-1,"8,700",100.00,Strong Buy,91.67,"Jul 23, 2024",QRVO,"Qorvo, Inc.",10.96B,115.52,4.01B,3.12%,-1.77%,4.70%,-6.29%,-2.46%,Qorvo® to Present at the Goldman Sachs Communacopia + Technology Conference,,,,,Qorvo® to Present at the Goldman Sachs Communacopia + Technology Conference,1,0,-1,-1,-1,-1
94.86M,"946,302",-26.33M,-1,"14,000",115.52,Hold,118.53,"Jul 30, 2024",SAIA,"Saia, Inc.",10.67B,402.33,3.10B,-3.51%,-13.50%,-19.66%,-11.13%,-37.38%,Friday’s stock stories: What’s likely to move the market in the next session,"Final Trade: GDX, NFLX, SAIA, SIG",Saia price target raised to $481 from $479 at JPMorgan,Saia (SAIA) Gets a Buy from Benchmark Co.,Saia price target raised to $418 from $416 at TD Cowen,"Friday’s stock stories: What’s likely to move the market in the next session Final Trade: GDX, NFLX, SAIA, SIG Saia price target raised to $481 from $479 at JPMorgan Saia (SAIA) Gets a Buy from Benchmark Co. Saia price target raised to $418 from $416 at TD Cowen",0,0,0,0,0,0
26.52M,"185,254",380.66M,-1,"61,200",402.33,Buy,493.93,"Oct 25, 2024",PPC,Pilgrim's Pride Corporation,10.59B,44.67,17.81B,2.48%,10.47%,33.48%,+10.82%,+30.25%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC","Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30%",Pilgrim’s Pride price target raised to $55 from $50 at Argus,"Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls",Pilgrim’s Pride (PPC): Downgrade to Neutral Amid Anticipated Market Challenges,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30% Pilgrim’s Pride price target raised to $55 from $50 at Argus Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls Pilgrim’s Pride (PPC): Downgrade to Neutral Amid Anticipated Market Challenges",1,1,1,0,1,1
237.12M,"592,120",756.66M,-1,"1,826",44.67,Buy,42.83,"Jul 31, 2024",LEGN,Legend Biotech Corporation,10.53B,57.50,455.99M,1.64%,9.23%,3.89%,+0.48%,+3.15%,Buy Rating for Legend Biotech: Strong Market Potential and Strategic Operations Amidst Approval of CARVYKTI in China,Legend Biotech announces cilta-cel approval in China for multiple myeloma,Legend Biotech’s New Cancer Drug Wins Approval,Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,Jefferies Remains a Buy on Legend Biotech (LEGN),Buy Rating for Legend Biotech: Strong Market Potential and Strategic Operations Amidst Approval of CARVYKTI in China Legend Biotech announces cilta-cel approval in China for multiple myeloma Legend Biotech’s New Cancer Drug Wins Approval Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Jefferies Remains a Buy on Legend Biotech (LEGN),1,1,1,1,1,1
183.17M,"309,376",-285.01M,-1,"2,271",57.50,Strong Buy,81.08,"Aug 9, 2024",APA,APA Corporation,10.53B,28.47,8.91B,-1.50%,-3.37%,-10.66%,-8.40%,-20.06%,Wednesday’s stock stories: What’s likely to move the market in the next session,APA (APA) Receives a Rating Update from a Top Analyst,APA Corp. price target lowered to $52 from $57 at Susquehanna,"AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz","APA Corp. exploring $1B sale of Permian assets, Reuters reports","Wednesday’s stock stories: What’s likely to move the market in the next session APA (APA) Receives a Rating Update from a Top Analyst APA Corp. price target lowered to $52 from $57 at Susquehanna AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz APA Corp. exploring $1B sale of Permian assets, Reuters reports",1,0,1,1,1,1
369.90M,"3,758,456",2.91B,$1.00,"6,669",28.47,Hold,38.27,"Jul 31, 2024",XP,XP Inc.,10.50B,19.60,2.84B,6.78%,8.68%,-11.69%,+11.81%,-22.46%,XP (XP) Is Making Impressive Strides While Beating Expectations,XP (XP) Receives a Buy from Citi,XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment,"Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz",Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.,"XP (XP) Is Making Impressive Strides While Beating Expectations XP (XP) Receives a Buy from Citi XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.",0,1,1,1,1,1
535.91M,"5,676,094",770.16M,$1.46,"7,970",19.60,Buy,25.43,"Aug 13, 2024",CHDN,Churchill Downs Incorporated,10.15B,138.24,2.62B,0.68%,-0.84%,7.25%,-3.23%,+14.69%,NFL season expected to spur record $35 billion in legal sports wagers,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks","Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30%",Bet On It: AGA estimates $35B to be wagered throughout NFL season,Bet On It: DraftKings leans into live betting opportunity with Simplebet deal,"NFL season expected to spur record $35 billion in legal sports wagers Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30% Bet On It: AGA estimates $35B to be wagered throughout NFL season Bet On It: DraftKings leans into live betting opportunity with Simplebet deal",0,1,1,1,0,0
73.42M,"195,592",407.50M,$0.38,"1,952",138.24,Strong Buy,157.30,"Oct 23, 2024",TEM,"Tempus AI, Inc",10.02B,64.95,595.57M,42.20%,68.61%,68.61%,+36.85%,,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions",Tempus announces real world data collaboration with BioNTech,tempus AI Inc Class A put volume heavy and directionally bearish,Largest borrow rate increases among liquid names,Cathie Wood’s ARK Investment bought 134K shares of Tempus AI today,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions Tempus announces real world data collaboration with BioNTech tempus AI Inc Class A put volume heavy and directionally bearish Largest borrow rate increases among liquid names Cathie Wood’s ARK Investment bought 134K shares of Tempus AI today",0,0,0,1,1,1
154.32M,"1,038,972",-790.20M,-1,"3,150",64.95,Strong Buy,45.25,"Aug 6, 2024",ROKU,"Roku, Inc.",10.00B,69.15,3.75B,19.85%,18.35%,-2.33%,+14.84%,+11.73%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Cord cutters hit with political ad blitz as campaigns flood Roku, Hulu before election",Roku: Guggenheim upgrades the stock to ‘buy’,"Friday’s analyst calls: Warby Parker to rally more than 40%, Peloton downgraded","Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Cord cutters hit with political ad blitz as campaigns flood Roku, Hulu before election Roku: Guggenheim upgrades the stock to ‘buy’ Friday’s analyst calls: Warby Parker to rally more than 40%, Peloton downgraded",1,1,1,0,0,1
144.69M,"3,611,635",-493.17M,-1,"31,000",69.15,Buy,76.57,"Aug 1, 2024",SFM,"Sprouts Farmers Market, Inc.",9.80B,97.87,7.19B,5.54%,16.52%,55.46%,+2.07%,+60.67%,Sprouts Farmers Market price target raised to $115 from $100 at BofA,Buy Rating Affirmed for Sprouts Farmers Market with Promising Sales Outlook and Margin Stability,,,,Sprouts Farmers Market price target raised to $115 from $100 at BofA Buy Rating Affirmed for Sprouts Farmers Market with Promising Sales Outlook and Margin Stability,0,0,0,-1,-1,-1
100.13M,"1,740,852",324.75M,-1,"30,695",97.87,Buy,95.00,"Jul 29, 2024",DOX,Amdocs Limited,9.76B,85.43,4.98B,1.18%,4.12%,-0.30%,-2.60%,-2.99%,"Analysts’ Opinions Are Mixed on These Technology Stocks: Amdocs (DOX), Bumble (BMBL) and Corpay Inc (CPAY)",Amdocs: Hold Rating Affirmed Amid Solid Q3 Performance and Market Uncertainties,,,,"Analysts’ Opinions Are Mixed on These Technology Stocks: Amdocs (DOX), Bumble (BMBL) and Corpay Inc (CPAY) Amdocs: Hold Rating Affirmed Amid Solid Q3 Performance and Market Uncertainties",0,0,0,-1,-1,-1
114.19M,"315,412",508.77M,$1.92,"6,500",85.43,Strong Buy,102.50,"Aug 7, 2024",LCID,"Lucid Group, Inc.",9.74B,4.20,668.29M,23.53%,28.75%,26.01%,+11.93%,+50.96%,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,CNBC Daily Open: Fed minutes signals September rate cut,Lucid Group Showcases Gravity SUV in Technology Day Event,Unusually active option classes on open September 3rd,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer Cramer’s Lightning Round: Dell is a buy CNBC Daily Open: Fed minutes signals September rate cut Lucid Group Showcases Gravity SUV in Technology Day Event Unusually active option classes on open September 3rd",1,0,0,0,0,0
2.32B,"63,866,215",-2.76B,-1,"2,171",4.200,Hold,3.55,"Aug 5, 2024",AFRM,"Affirm Holdings, Inc.",9.73B,31.46,2.11B,18.45%,12.49%,-5.77%,+11.63%,-3.92%,"3-Stock Lunch: Best Buy, Dollar General & Affirm","Affirm shares have best day in three years, surge 32% after earnings beat","Stocks making the biggest moves midday: Dollar General, Affirm and more","Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more",Affirm CEO Max Levchin sits down with Jim Cramer,"3-Stock Lunch: Best Buy, Dollar General & Affirm Affirm shares have best day in three years, surge 32% after earnings beat Stocks making the biggest moves midday: Dollar General, Affirm and more Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Affirm CEO Max Levchin sits down with Jim Cramer",1,1,1,1,1,1
309.12M,"9,175,021",-678.58M,-1,"9,707",31.46,Hold,35.17,"Aug 28, 2024",BRKR,Bruker Corporation,9.72B,64.20,3.12B,0.01%,0.01%,-12.47%,-5.98%,-28.77%,Jefferies Sticks to Its Buy Rating for Bruker (BRKR),"Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz","Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Bruker initiated with an Overweight at Wells Fargo,"Jefferies Sticks to Its Buy Rating for Bruker (BRKR) Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Bruker initiated with an Overweight at Wells Fargo",1,0,1,1,1,1
151.39M,"989,231",352.10M,$0.20,"8,800",64.20,Buy,80.38,"Aug 6, 2024",WWD,"Woodward, Inc.",9.70B,162.52,3.25B,6.50%,-2.03%,7.83%,+5.67%,+4.16%,Woodward (WWD) Financial Review: Strong Pricing Power and Growth Prospects Justify Buy Rating,Woodward Management Discusses Company Affairs in Webcast,Woodward names Karrie Bem as General Counsel,Woodward Poised for Growth and Margin Improvement: Buy Rating Affirmed,Woodward participates in a conference call with Goldman Sachs,Woodward (WWD) Financial Review: Strong Pricing Power and Growth Prospects Justify Buy Rating Woodward Management Discusses Company Affairs in Webcast Woodward names Karrie Bem as General Counsel Woodward Poised for Growth and Margin Improvement: Buy Rating Affirmed Woodward participates in a conference call with Goldman Sachs,1,0,0,1,0,0
59.66M,"245,646",372.33M,$1.00,"1,000",162.52,Buy,180.75,"Jul 29, 2024",CHK,Chesapeake Energy Corporation,9.64B,73.44,4.10B,-0.08%,-7.03%,-10.79%,-5.70%,-19.58%,Chesapeake price target lowered to $105 from $110 at Scotiabank,Chesapeake price target lowered to $89 from $102 at Barclays,Chesapeake Energy (CHK) Receives a Hold from Seaport Global,,,Chesapeake price target lowered to $105 from $110 at Scotiabank Chesapeake price target lowered to $89 from $102 at Barclays Chesapeake Energy (CHK) Receives a Hold from Seaport Global,1,1,0,1,-1,-1
131.28M,"1,753,246",438.00M,$2.30,"2,620",73.44,Buy,102.73,"Jul 29, 2024",MTCH,"Match Group, Inc.",9.62B,37.32,3.47B,3.49%,11.08%,10.05%,-3.67%,+8.99%,"These stocks are contenders for selling — and can help cut taxes, Wolfe says","Final Trade: TGT, MTCH, XLU & IBM",These stocks could have a good September after forming a ‘golden cross’,"Starboard raised Salesforce in Q2, cut stake in this online web services stock",A shopping list of quality stocks to buy during the pullback from Strategas,"These stocks are contenders for selling — and can help cut taxes, Wolfe says Final Trade: TGT, MTCH, XLU & IBM These stocks could have a good September after forming a ‘golden cross’ Starboard raised Salesforce in Q2, cut stake in this online web services stock A shopping list of quality stocks to buy during the pullback from Strategas",0,1,0,0,1,0
257.90M,"2,914,699",649.90M,-1,"6,500",37.32,Buy,43.22,"Jul 30, 2024",LNW,"Light & Wonder, Inc.",9.59B,108.14,3.08B,3.95%,4.55%,15.38%,unch,+8.34%,Bet On It: DraftKings leans into live betting opportunity with Simplebet deal,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",Light & Wonder initiated with a Buy at Maxim,Light & Wonder Updates on CHESS Depositary Interests,Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL,"Bet On It: DraftKings leans into live betting opportunity with Simplebet deal Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Light & Wonder initiated with a Buy at Maxim Light & Wonder Updates on CHESS Depositary Interests Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL",0,0,1,1,0,1
88.72M,"530,342",306.00M,-1,"5,502",108.14,Buy,106.36,"Aug 7, 2024",HAS,"Hasbro, Inc.",9.48B,68.02,4.54B,4.32%,9.90%,22.96%,+5.06%,+20.03%,Cheap stocks to buy for the long term during the volatility,management to meet with Roth MKM,"Analysts Offer Insights on Consumer Cyclical Companies: Mercedes-Benz Group (OtherMBGAF), Signet Jewelers (SIG) and Hasbro (HAS)","Citi, Goldman among stocks that look like buys for soft landing, Barron’s says",,"Cheap stocks to buy for the long term during the volatility management to meet with Roth MKM Analysts Offer Insights on Consumer Cyclical Companies: Mercedes-Benz Group (OtherMBGAF), Signet Jewelers (SIG) and Hasbro (HAS) Citi, Goldman among stocks that look like buys for soft landing, Barron’s says",1,0,1,1,1,-1
139.41M,"949,065",-1.04B,$2.80,105,68.02,Strong Buy,68.30,"Jul 25, 2024",SMMT,Summit Therapeutics Inc.,9.48B,13.08,-,18.62%,38.43%,151.92%,+21.48%,+238.14%,Summit Therapeutics’ Ivonescimab Poised to Outperform KEYTRUDA: A Strong Buy Rating,Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA),Wall Street Analysts Are Bullish on Top Healthcare Picks,Summit Therapeutics initiated with a Buy at H.C. Wainwright,,Summit Therapeutics’ Ivonescimab Poised to Outperform KEYTRUDA: A Strong Buy Rating Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA) Wall Street Analysts Are Bullish on Top Healthcare Picks Summit Therapeutics initiated with a Buy at H.C. Wainwright,0,0,0,1,0,-1
724.54M,"1,223,844",-161.69M,-1,"5,302",13.08,Strong Buy,14.33,"Aug 6, 2024",WIX,Wix.com Ltd.,9.40B,167.97,1.65B,3.97%,4.07%,22.28%,+5.17%,+21.20%,"Starboard raised Salesforce in Q2, cut stake in this online web services stock",Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Wix.com initiated with an Overweight at Cantor Fitzgerald,"Analysts Offer Insights on Technology Companies: Peraso, Inc. (PRSO), Wix (WIX) and Dell Technologies (DELL)",Wix (WIX) Gets a Buy from Barclays,"Starboard raised Salesforce in Q2, cut stake in this online web services stock Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Wix.com initiated with an Overweight at Cantor Fitzgerald Analysts Offer Insights on Technology Companies: Peraso, Inc. (PRSO), Wix (WIX) and Dell Technologies (DELL) Wix (WIX) Gets a Buy from Barclays",0,1,1,1,1,1
55.97M,"615,254",73.45M,-1,514,167.97,Strong Buy,179.17,"Aug 7, 2024",CHRD,Chord Energy Corporation,9.28B,150.00,4.15B,-4.10%,-9.51%,-10.07%,-14.42%,-20.45%,Buy Rating Affirmed for Chord Energy: Undervalued Market Position and Promising Future Prospects,Chord Energy: Balancing Operational Gains with Long-Term Asset Uncertainties,Chord Energy initiated with a Hold at Jefferies,Chord Energy (CHRD) Receives a Rating Update from a Top Analyst,Chord Energy price target raised to $208 from $201 at BofA,Buy Rating Affirmed for Chord Energy: Undervalued Market Position and Promising Future Prospects Chord Energy: Balancing Operational Gains with Long-Term Asset Uncertainties Chord Energy initiated with a Hold at Jefferies Chord Energy (CHRD) Receives a Rating Update from a Top Analyst Chord Energy price target raised to $208 from $201 at BofA,1,1,1,1,1,1
61.88M,"474,008",919.68M,$5.00,30,150.00,Strong Buy,201.78,"Aug 7, 2024",RGLD,"Royal Gold, Inc.",9.28B,141.15,607.22M,5.10%,6.96%,16.36%,+1.52%,+11.86%,Gold miners ‘ripe’ for a break out: Analysts name stocks to buy as gold soars,Royal Gold Secures Expertise by Extending COO’s Agreement,Royal Gold price target raised to $157 from $148 at Scotiabank,Royal Gold price target raised to $169 from $167 at TD Securities,Royal Gold price target raised to $170 from $167 at Raymond James,Gold miners ‘ripe’ for a break out: Analysts name stocks to buy as gold soars Royal Gold Secures Expertise by Extending COO’s Agreement Royal Gold price target raised to $157 from $148 at Scotiabank Royal Gold price target raised to $169 from $167 at TD Securities Royal Gold price target raised to $170 from $167 at Raymond James,1,1,1,1,1,0
65.74M,"171,301",240.49M,$1.60,720,141.15,Hold,157.33,"Aug 7, 2024",DUOL,"Duolingo, Inc.",9.26B,212.57,634.49M,10.70%,9.34%,1.93%,+17.96%,-5.67%,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly","Analysts’ Top Technology Picks: Marvell (MRVL), MongoDB (MDB)",Duolingo’s Strategic Partnerships and Innovations Underpin Buy Rating and $255 Price Target,Duolingo partners with Sony Music to add recordings to music course,Duolingo Partners with Sony Music to Add Hit Recordings From Major Artists to Music Course,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly Analysts’ Top Technology Picks: Marvell (MRVL), MongoDB (MDB) Duolingo’s Strategic Partnerships and Innovations Underpin Buy Rating and $255 Price Target Duolingo partners with Sony Music to add recordings to music course Duolingo Partners with Sony Music to Add Hit Recordings From Major Artists to Music Course",1,1,0,1,1,1
43.54M,"437,728",66.23M,-1,765,212.57,Buy,237.70,"Aug 7, 2024",CELH,"Celsius Holdings, Inc.",9.22B,39.54,1.49B,-2.94%,-19.37%,-37.34%,-18.66%,-54.62%,Trade Tracker: Brian Belski shares his latest portfolio moves,Celsius Holdings price target lowered to $30 from $45 at Truist,Celsius Holdings: A Strong Buy on Robust Growth and Market Share Expansion,Celsius Holdings: Persistent Demand Weakness and Inventory Issues Prompt Sell Rating and Lowered Price Objective,Celsius Holdings price target lowered to $26 from $32 at BofA,Trade Tracker: Brian Belski shares his latest portfolio moves Celsius Holdings price target lowered to $30 from $45 at Truist Celsius Holdings: A Strong Buy on Robust Growth and Market Share Expansion Celsius Holdings: Persistent Demand Weakness and Inventory Issues Prompt Sell Rating and Lowered Price Objective Celsius Holdings price target lowered to $26 from $32 at BofA,1,1,1,1,1,1
233.07M,"3,285,010",241.29M,-1,456,39.54,Strong Buy,66.93,"Aug 6, 2024",OLED,Universal Display Corporation,9.21B,194.12,623.16M,1.34%,-8.29%,3.99%,-15.65%,+15.26%,"Apple to use OLED displays in all iPhone models starting in 2025, Nikkei reports",,,,,"Apple to use OLED displays in all iPhone models starting in 2025, Nikkei reports",0,0,-1,-1,-1,-1
47.45M,"186,048",221.84M,$1.60,"3,380",194.12,Strong Buy,222.43,"Aug 1, 2024",CART,Maplebear Inc.,9.15B,35.60,3.21B,8.24%,6.71%,15.31%,+2.55%,-9.59%,"Why the fast-food value menu vanished, but now is making a comeback",Costco may have another winner after its gold bar success: gift cards,Instacart initiated with an Overweight at Cantor Fitzgerald,"Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI)",Maplebear Inc call volume above normal and directionally bullish,"Why the fast-food value menu vanished, but now is making a comeback Costco may have another winner after its gold bar success: gift cards Instacart initiated with an Overweight at Cantor Fitzgerald Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI) Maplebear Inc call volume above normal and directionally bullish",0,0,0,1,0,1
257.10M,"3,051,146",-1.46B,-1,"26,985",35.60,Buy,42.90,"Aug 6, 2024",HTHT,H World Group Limited,9.11B,29.08,3.21B,2.40%,-4.71%,-15.42%,-4.30%,-29.29%,"H World CFO Jun Zuo to resign, Hui Chen to succeed",H World Group Limited Announces Change of Chief Financial Officer,H World removed from Asia Conviction List at Goldman Sachs,Jefferies Keeps Their Buy Rating on Huazhu Group Ltd (CL4),H World Group price target lowered to $53 from $64 at Benchmark,"H World CFO Jun Zuo to resign, Hui Chen to succeed H World Group Limited Announces Change of Chief Financial Officer H World removed from Asia Conviction List at Goldman Sachs Jefferies Keeps Their Buy Rating on Huazhu Group Ltd (CL4) H World Group price target lowered to $53 from $64 at Benchmark",0,1,0,1,0,0
313.33M,"880,785",523.74M,$1.56,"18,984",29.08,Strong Buy,48.00,"Aug 20, 2024",ESLT,Elbit Systems Ltd.,9.07B,199.00,6.31B,4.97%,7.52%,0.48%,+11.68%,-0.13%,Elbit Systems management to meet with BTIG,Elbit Systems Announces Upcoming Shareholders Meeting,Morning Movers: Kellanova climbs following deal to be acquired by Mars,Elbit Systems Reports Robust Growth Amidst Defense Demands,"Elbit Systems reports Q2 EPS $2.08, consensus $1.77","Elbit Systems management to meet with BTIG Elbit Systems Announces Upcoming Shareholders Meeting Morning Movers: Kellanova climbs following deal to be acquired by Mars Elbit Systems Reports Robust Growth Amidst Defense Demands Elbit Systems reports Q2 EPS $2.08, consensus $1.77",1,0,0,1,0,0
44.48M,"18,086",242.75M,$2.00,"25,000",199.00,,,"Aug 14, 2024",HSIC,"Henry Schein, Inc.",8.97B,70.82,12.49B,3.81%,5.93%,0.94%,-2.03%,-2.81%,,,,,,,0,-1,-1,-1,-1,-1
126.71M,"1,827,445",352.00M,-1,881,70.82,Buy,77.10,"Aug 6, 2024",MKTX,MarketAxess Holdings Inc.,8.90B,235.82,777.51M,1.33%,8.09%,3.64%,+6.30%,+5.43%,Early notable gainers among liquid option names on September 5th,MarketAxess announces August volume statistics,Buy Rating on Marketaxess Holdings Amid Favorable Market Conditions and Strong Growth Prospects,Citi opens ‘positive catalyst watch’ on MarketAxess,MarketAxess price target raised to $223 from $218 at Deutsche Bank,Early notable gainers among liquid option names on September 5th MarketAxess announces August volume statistics Buy Rating on Marketaxess Holdings Amid Favorable Market Conditions and Strong Growth Prospects Citi opens ‘positive catalyst watch’ on MarketAxess MarketAxess price target raised to $223 from $218 at Deutsche Bank,1,1,1,1,1,1
37.75M,"198,498",262.12M,$2.96,"331,000",235.82,Hold,239.27,"Aug 6, 2024",WBA,"Walgreens Boots Alliance, Inc.",8.89B,10.30,145.53B,-12.86%,-20.59%,-48.70%,-20.98%,-50.97%,"These stocks are contenders for selling — and can help cut taxes, Wolfe says","3-Stock Lunch: Intel, Lululemon & Walgreens Boots",Thursday’s stock stories: What’s likely to move the market in the next session,"Bilt and Walgreens partner to simplify FSA, HSA purchases",Here are Wolfe’s favorite stocks as market approaches fresh record,"These stocks are contenders for selling — and can help cut taxes, Wolfe says 3-Stock Lunch: Intel, Lululemon & Walgreens Boots Thursday’s stock stories: What’s likely to move the market in the next session Bilt and Walgreens partner to simplify FSA, HSA purchases Here are Wolfe’s favorite stocks as market approaches fresh record",1,1,1,0,0,1
863.28M,"15,834,709",-5.81B,$1.23,"1,900",10.30,Hold,16.86,"Oct 10, 2024",LBRDK,Liberty Broadband Corporation,8.88B,62.13,981.00M,-0.09%,8.95%,1.25%,-5.39%,+24.26%,Liberty Broadband CEO to Present at Goldman Sachs Conference,Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank,"Elliott adds Southwest, exits Peabody in Q2",Liberty Broadband price target raised to $91 from $80 at Rosenblatt,"Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)","Liberty Broadband CEO to Present at Goldman Sachs Conference Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank Elliott adds Southwest, exits Peabody in Q2 Liberty Broadband price target raised to $91 from $80 at Rosenblatt Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)",0,1,1,0,1,1
142.85M,"506,167",803.00M,-1,254,62.13,Strong Buy,81.00,"Aug 8, 2024",PCVX,"Vaxcyte, Inc.",8.86B,79.35,-,1.90%,0.56%,15.31%,-0.58%,+22.57%,"Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more",Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares,Vaxcyte Announces Pricing of $1.3 Billion Public Offering,Vaxcyte price target raised to $130 from $101 at Guggenheim,Vaxcyte price target raised to $140 from $101 at BofA,"Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Vaxcyte Announces Pricing of $1.3 Billion Public Offering Vaxcyte price target raised to $130 from $101 at Guggenheim Vaxcyte price target raised to $140 from $101 at BofA",1,1,1,1,1,1
111.61M,"271,286",-497.19M,-1,"1,900",79.35,Strong Buy,96.00,"Aug 6, 2024",LBRDA,Liberty Broadband Corporation,8.85B,60.87,981.00M,-0.28%,8.11%,-0.40%,-5.44%,+21.59%,Liberty Broadband CEO to Present at Goldman Sachs Conference,Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank,"Elliott adds Southwest, exits Peabody in Q2",Liberty Broadband price target raised to $91 from $80 at Rosenblatt,"Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)","Liberty Broadband CEO to Present at Goldman Sachs Conference Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank Elliott adds Southwest, exits Peabody in Q2 Liberty Broadband price target raised to $91 from $80 at Rosenblatt Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)",0,1,1,0,1,1
142.85M,"71,909",803.00M,-1,908,60.87,Strong Buy,81.00,"Aug 8, 2024",ROIV,Roivant Sciences Ltd.,8.79B,11.88,158.30M,6.76%,7.99%,10.48%,+10.60%,+2.21%,"Final Trade: CRWD, ROIV, SPY, WMT","3 Best Stocks to Buy Now, 8/20/2024, According to Top Analysts ",Roivant Sciences (ROIV) Receives a Buy from H.C. Wainwright,Wall Street Analysts Are Bullish on Top Healthcare Picks,Buy Rating Affirmed on Roivant Sciences Ahead of Revealing High-Potential Phase 2 Asset and Promising Pipeline Milestones,"Final Trade: CRWD, ROIV, SPY, WMT 3 Best Stocks to Buy Now, 8/20/2024, According to Top Analysts  Roivant Sciences (ROIV) Receives a Buy from H.C. Wainwright Wall Street Analysts Are Bullish on Top Healthcare Picks Buy Rating Affirmed on Roivant Sciences Ahead of Revealing High-Potential Phase 2 Asset and Promising Pipeline Milestones",1,0,1,0,1,1
739.52M,"2,633,838",4.74B,-1,"5,089",11.88,Strong Buy,17.33,"Aug 8, 2024",SEIC,SEI Investments Company,8.75B,67.37,1.99B,1.31%,1.32%,2.18%,-0.80%,-4.73%,SEI’s Advisors’ Inner Circle Fund Reaches $100 Billion in Net Assets,SEI Investments Company (SEIC) Gets a Sell from Morgan Stanley,,,,SEI’s Advisors’ Inner Circle Fund Reaches $100 Billion in Net Assets SEI Investments Company (SEIC) Gets a Sell from Morgan Stanley,0,0,0,-1,-1,-1
129.89M,"379,534",506.91M,$0.92,"6,400",67.37,Hold,70.20,"Jul 24, 2024",PCTY,Paylocity Holding Corporation,8.69B,156.43,1.40B,5.52%,11.85%,3.21%,+7.30%,-2.45%,Jefferies has ‘constructive view’ of Paylocity plans to acquire Airbase,Paylocity (PCTY) Gets a Buy from TD Cowen,Truist Financial Remains a Buy on Paylocity (PCTY),Analysts Conflicted on These Technology Names: Paylocity (PCTY) and Sensata (ST),Strategic Acquisition Bolsters Paylocity’s Market Position and Product Suite,Jefferies has ‘constructive view’ of Paylocity plans to acquire Airbase Paylocity (PCTY) Gets a Buy from TD Cowen Truist Financial Remains a Buy on Paylocity (PCTY) Analysts Conflicted on These Technology Names: Paylocity (PCTY) and Sensata (ST) Strategic Acquisition Bolsters Paylocity’s Market Position and Product Suite,1,1,0,0,1,0
55.57M,"420,134",206.77M,-1,"3,213",156.43,Buy,177.47,"Aug 1, 2024",FUTU,Futu Holdings Limited,8.68B,62.92,1.22B,2.22%,-3.39%,3.33%,-6.78%,+4.44%,Futu Holdings call volume above normal and directionally bullish,Unusually active option classes on open August 30th,Futu Announces Investment Grade Rating Reaffirmed by S&P Global Ratings,Futu Holdings price target lowered to $79 from $100 at Citi,DBS Reaffirms Their Buy Rating on Futu Holdings (FUTU),Futu Holdings call volume above normal and directionally bullish Unusually active option classes on open August 30th Futu Announces Investment Grade Rating Reaffirmed by S&P Global Ratings Futu Holdings price target lowered to $79 from $100 at Citi DBS Reaffirms Their Buy Rating on Futu Holdings (FUTU),0,0,0,0,0,0
137.92M,"1,482,023",540.46M,-1,"22,900",62.92,Strong Buy,71.57,"Aug 20, 2024",OTEX,Open Text Corporation,8.64B,32.59,5.77B,5.69%,6.35%,-8.78%,+1.52%,-14.87%,OpenText selected by Nippon Gases Deutschland for e-invoicing compliance,,,,,OpenText selected by Nippon Gases Deutschland for e-invoicing compliance,1,0,-1,-1,-1,-1
265.05M,"443,024",465.09M,$0.94,"7,030",32.59,Hold,38.33,"Aug 1, 2024",CROX,"Crocs, Inc.",8.59B,144.69,4.06B,7.24%,2.97%,15.90%,+6.50%,+6.73%,10 things to watch in the stock market Friday including big earnings movers,"Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more","Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more","Thursday’s top analyst calls: Nvidia, Apple, Dell, Microsoft and more","Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more","10 things to watch in the stock market Friday including big earnings movers Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Thursday’s top analyst calls: Nvidia, Apple, Dell, Microsoft and more Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more",1,0,1,1,1,1
59.39M,"978,105",811.97M,-1,"13,953",144.69,Buy,158.40,"Aug 1, 2024",VFS,VinFast Auto Ltd.,8.56B,3.66,1.37B,-3.08%,-10.39%,-27.13%,-8.63%,-13.46%,VinFast Auto Set to Unveil Q2 2024 Financials,Largest borrow rate increases among liquid names,,,,VinFast Auto Set to Unveil Q2 2024 Financials Largest borrow rate increases among liquid names,1,1,1,-1,-1,-1
2.34B,"831,092",-2.33B,-1,"27,800",3.660,Strong Buy,9.60,"Oct 3, 2024",WYNN,"Wynn Resorts, Limited",8.51B,77.37,7.11B,0.50%,-6.30%,-16.57%,-9.08%,-29.93%,"Final Trades: Epam Systems, Salesforce, Charles Schwab and Wynn Resorts",Here are JPMorgan’s top stock picks for September,"Final Trades: Berkshire Hathaway, Vistra Corp, Wynn Resorts and Chipotle","Cramer: An old investing rule has let me down, but Starbucks shows it’s still alive",August Monthly Meeting: Cramer grades stocks in the portfolio,"Final Trades: Epam Systems, Salesforce, Charles Schwab and Wynn Resorts Here are JPMorgan’s top stock picks for September Final Trades: Berkshire Hathaway, Vistra Corp, Wynn Resorts and Chipotle Cramer: An old investing rule has let me down, but Starbucks shows it’s still alive August Monthly Meeting: Cramer grades stocks in the portfolio",0,1,0,1,1,0
110.01M,"1,228,495",868.64M,$1.00,"2,083",77.37,Strong Buy,118.14,"Aug 6, 2024",DSGX,The Descartes Systems Group Inc.,8.51B,99.50,587.67M,3.48%,3.28%,11.56%,-2.11%,+10.92%,The Descartes Systems Group (DSGX) Gets a Buy from Scotiabank,CIBC Reaffirms Their Buy Rating on The Descartes Systems Group (DSGX),Descartes Systems price target raised to $104 from $100 at BMO Capital,Hold Rating on Descartes Systems Group Amid Solid Performance and Market Uncertainties,RBC Capital Sticks to Their Buy Rating for The Descartes Systems Group (DSGX),The Descartes Systems Group (DSGX) Gets a Buy from Scotiabank CIBC Reaffirms Their Buy Rating on The Descartes Systems Group (DSGX) Descartes Systems price target raised to $104 from $100 at BMO Capital Hold Rating on Descartes Systems Group Amid Solid Performance and Market Uncertainties RBC Capital Sticks to Their Buy Rating for The Descartes Systems Group (DSGX),0,0,0,0,0,0
85.39M,"219,528",121.22M,-1,"35,300",99.50,Buy,101.36,"Sep 4, 2024",ENSG,"The Ensign Group, Inc.",8.40B,148.07,3.97B,4.32%,10.19%,22.20%,+5.62%,+24.17%,Ensign Group management to meet with Oppenheimer,Ensign Group acquires new operation in Kansas,Ensign Group acquires seven skilled nursing facilities in Colorado,The Ensign Group Acquires New Operation in Kansas,The Ensign Group Adds Seven New Operations in Colorado,Ensign Group management to meet with Oppenheimer Ensign Group acquires new operation in Kansas Ensign Group acquires seven skilled nursing facilities in Colorado The Ensign Group Acquires New Operation in Kansas The Ensign Group Adds Seven New Operations in Colorado,0,0,0,0,0,0
56.70M,"182,909",225.40M,$0.24,"1,504",148.07,Buy,139.40,"Jul 25, 2024",APPF,"AppFolio, Inc.",8.32B,229.46,722.08M,6.62%,-1.48%,5.70%,+3.49%,-1.34%,New AppFolio Survey Finds Property Managers Must Innovate to Meet Modern Renter Expectations,"Analysts Have Conflicting Sentiments on These Technology Companies: FiscalNote Holdings (NOTE), AppFolio (APPF) and I3 Verticals (IIIV)",AppFolio Names Marcy Campbell as Chief Revenue Officer,AppFolio appoints Marcy Campbell as CRO,AppFolio (APPF) Gets a Buy from D.A. Davidson,"New AppFolio Survey Finds Property Managers Must Innovate to Meet Modern Renter Expectations Analysts Have Conflicting Sentiments on These Technology Companies: FiscalNote Holdings (NOTE), AppFolio (APPF) and I3 Verticals (IIIV) AppFolio Names Marcy Campbell as Chief Revenue Officer AppFolio appoints Marcy Campbell as CRO AppFolio (APPF) Gets a Buy from D.A. Davidson",0,1,1,1,1,1
36.27M,"192,128",125.03M,-1,"51,000",229.46,Buy,284.50,"Jul 25, 2024",CZR,"Caesars Entertainment, Inc.",8.28B,38.29,11.39B,4.19%,2.16%,-6.88%,-7.18%,-13.59%,Here are JPMorgan’s top stock picks for September,Wednesday’s stock stories: What’s likely to move the market in the next session,NFL season expected to spur record $35 billion in legal sports wagers,Bet On It: AGA estimates $35B to be wagered throughout NFL season,Unusually active option classes on open September 5th,Here are JPMorgan’s top stock picks for September Wednesday’s stock stories: What’s likely to move the market in the next session NFL season expected to spur record $35 billion in legal sports wagers Bet On It: AGA estimates $35B to be wagered throughout NFL season Unusually active option classes on open September 5th,1,0,0,1,0,0
216.34M,"4,767,726",-278.00M,-1,"28,700",38.29,Buy,53.00,"Jul 30, 2024",AMKR,"Amkor Technology, Inc.",8.22B,33.37,6.40B,5.36%,-9.58%,1.43%,-0.09%,+5.87%,,,,,,,0,-1,-1,-1,-1,-1
246.39M,"957,567",375.97M,$0.32,"1,783",33.37,Buy,41.71,"Jul 29, 2024",RGEN,Repligen Corporation,8.22B,146.80,602.35M,-7.95%,4.88%,-11.85%,-13.10%,-16.33%,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Repligen initiated with an Overweight at Wells Fargo,Repligen to present at Wells Fargo Conferences,Repligen Corporation to Present at Wells Fargo Healthcare Conference,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Repligen initiated with an Overweight at Wells Fargo Repligen to present at Wells Fargo Conferences Repligen Corporation to Present at Wells Fargo Healthcare Conference",1,1,1,1,1,1
56.01M,"395,007",-1.90M,-1,"10,200",146.80,Buy,189.57,"Jul 30, 2024",MKSI,"MKS Instruments, Inc.",8.19B,121.68,3.58B,3.59%,-5.31%,2.97%,-7.66%,-9.58%,MKS Instruments initiated with a Neutral at Goldman Sachs,MKS Instruments to Participate in Citi’s 2024 Global TMT Conference,MKS Instruments Announces Executive Leadership Changes,"MKS Instruments appoints Mayampurathas EVP, CFO, treasurer",Ram Mayampurath to Join MKS Instruments as Chief Financial Officer,"MKS Instruments initiated with a Neutral at Goldman Sachs MKS Instruments to Participate in Citi’s 2024 Global TMT Conference MKS Instruments Announces Executive Leadership Changes MKS Instruments appoints Mayampurathas EVP, CFO, treasurer Ram Mayampurath to Join MKS Instruments as Chief Financial Officer",0,1,1,1,1,1
67.29M,"943,132",8.00M,$0.88,"4,592",121.46,Strong Buy,146.63,"Aug 7, 2024",CBSH,"Commerce Bancshares, Inc.",8.18B,63.48,1.58B,2.16%,5.83%,15.84%,-1.84%,+19.98%,,,,,,,1,-1,-1,-1,-1,-1
128.92M,"377,085",477.62M,$1.08,"21,900",63.48,Hold,60.00,"Oct 16, 2024",PARAA,Paramount Global,8.10B,24.20,29.27B,,5.83%,15.84%,-3.36%,-5.14%,Automakers are getting back into advertising’s biggest arena: NFL,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Rising NFL valuations mean massive returns for owners,"Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’","NFL’s next big media rights payday is years off, subject to shifting industry","Automakers are getting back into advertising’s biggest arena: NFL 88 corporate leaders endorse Harris, including CEOs of Yelp, Box Rising NFL valuations mean massive returns for owners Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’ NFL’s next big media rights payday is years off, subject to shifting industry",0,0,1,1,0,1
666.71M,"24,438",-5.20B,$0.20,"4,400",24.20,Sell,12.29,"Aug 8, 2024",SOFI,"SoFi Technologies, Inc.",8.02B,7.52,2.34B,11.41%,12.62%,3.46%,-0.66%,+1.22%,Why the LA Rams are worth $2 billion more than the LA Chargers,2. Los Angeles Rams,SoFi CEO: Consumer activity and sentiment are ‘trending okay’,Washington Commanders’ stadium naming goes to Northwest Federal Credit Union,Cramer’s Lightning Round: Dell is a buy,Why the LA Rams are worth $2 billion more than the LA Chargers 2. Los Angeles Rams SoFi CEO: Consumer activity and sentiment are ‘trending okay’ Washington Commanders’ stadium naming goes to Northwest Federal Credit Union Cramer’s Lightning Round: Dell is a buy,0,0,0,1,1,0
1.07B,"31,194,858",-153.23M,-1,879,7.52,Buy,9.07,"Jul 30, 2024",ASND,Ascendis Pharma A/S,8.01B,139.68,354.97M,3.56%,3.66%,4.72%,+4.05%,-7.32%,Biotech Alert: Searches spiking for these stocks today,"Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls",Ascendis Pharma upgraded to Outperform from Perform at Oppenheimer,Ascendis Pharma price target raised to $175 from $165 at BofA,Morning Movers: Nvidia dips after report of DOJ subpoena,"Biotech Alert: Searches spiking for these stocks today Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls Ascendis Pharma upgraded to Outperform from Perform at Oppenheimer Ascendis Pharma price target raised to $175 from $165 at BofA Morning Movers: Nvidia dips after report of DOJ subpoena",0,1,1,0,0,0
57.35M,"206,105",-541.12M,-1,53,139.68,Strong Buy,192.20,"Sep 3, 2024",AGNC,AGNC Investment Corp.,7.97B,10.19,514.00M,1.94%,2.73%,6.75%,+2.70%,+6.42%,AGNC Investment price target raised to $11 from $10 at RBC Capital,"Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC)",,,,"AGNC Investment price target raised to $11 from $10 at RBC Capital Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC)",1,0,0,-1,-1,-1
782.46M,"13,666,189",290.00M,$1.44,373,10.19,Buy,10.25,"Jul 22, 2024",HALO,"Halozyme Therapeutics, Inc.",7.95B,62.72,873.30M,10.17%,15.58%,45.73%,+16.58%,+56.85%,"Final Trade: LULU, VIK, HALO, CCJ",,,,,"Final Trade: LULU, VIK, HALO, CCJ",1,1,-1,-1,-1,-1
126.68M,"927,381",337.29M,-1,"2,693",62.72,Buy,59.44,"Aug 6, 2024",DBX,"Dropbox, Inc.",7.92B,24.33,2.53B,6.34%,7.63%,-3.97%,+1.92%,+4.77%,"Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more",Dropbox call volume above normal and directionally bullish,Dropbox put volume heavy and directionally bearish,RBC Capital Sticks to Their Buy Rating for Dropbox (DBX),Dropbox Financial Analysis: Hold Rating Amidst Modest Growth and Market Headwinds,"Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more Dropbox call volume above normal and directionally bullish Dropbox put volume heavy and directionally bearish RBC Capital Sticks to Their Buy Rating for Dropbox (DBX) Dropbox Financial Analysis: Hold Rating Amidst Modest Growth and Market Headwinds",1,1,1,1,1,1
325.42M,"2,210,485",584.20M,-1,"27,000",24.33,Hold,28.67,"Aug 8, 2024",FSV,FirstService Corporation,7.91B,175.72,4.65B,4.29%,9.42%,12.39%,+1.80%,+11.88%,FirstService Plans Share Buyback to Boost Value,,,,,FirstService Plans Share Buyback to Boost Value,0,1,-1,-1,-1,-1
45.02M,"54,623",80.28M,$1.00,"18,500",175.72,Buy,186.00,"Jul 25, 2024",WFRD,Weatherford International plc,7.90B,108.01,5.44B,0.38%,-7.70%,-0.82%,-11.70%,-15.85%,Analysts Offer Insights on Energy Companies: Talos Energy (TALO) and Weatherford International (WFRD),Weatherford International (WFRD) Gets a Buy from Goldman Sachs,Weatherford International to Speak at Barclays Energy Conference,"Weatherford announces acquisition of Datagration, terms not disclosed",Weatherford Announces Acquisition of Datagration,"Analysts Offer Insights on Energy Companies: Talos Energy (TALO) and Weatherford International (WFRD) Weatherford International (WFRD) Gets a Buy from Goldman Sachs Weatherford International to Speak at Barclays Energy Conference Weatherford announces acquisition of Datagration, terms not disclosed Weatherford Announces Acquisition of Datagration",0,0,0,0,0,0
73.16M,"383,915",500.00M,$0.25,610,108.01,Strong Buy,154.00,"Jul 23, 2024",ITCI,"Intra-Cellular Therapies, Inc.",7.87B,74.48,564.53M,-2.69%,-1.51%,6.92%,-7.56%,+6.33%,Broadcom AI results fail to enthuse the Street: Morning Buzz,Piper upgrades Intra-Cellular on potential in major depressive disorder,Intra-Cellular upgraded to Overweight from Neutral at Piper Sandler,Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences,Intra-Cellular price target raised to $81 from $79 at JPMorgan,Broadcom AI results fail to enthuse the Street: Morning Buzz Piper upgrades Intra-Cellular on potential in major depressive disorder Intra-Cellular upgraded to Overweight from Neutral at Piper Sandler Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences Intra-Cellular price target raised to $81 from $79 at JPMorgan,0,1,0,0,0,0
105.67M,"203,691",-84.30M,-1,"1,500",74.48,Strong Buy,97.00,"Aug 7, 2024",MTSI,"MACOM Technology Solutions Holdings, Inc.",7.72B,107.00,679.24M,2.54%,-1.29%,9.19%,+4.52%,+4.78%,,,,,,,0,-1,-1,-1,-1,-1
72.19M,"266,397",71.90M,-1,"1,625",107.00,Strong Buy,118.33,"Aug 1, 2024",CRUS,"Cirrus Logic, Inc.",7.72B,144.52,1.85B,8.14%,8.83%,43.09%,+8.45%,+54.20%,,,,,,,0,-1,-1,-1,-1,-1
53.41M,"320,815",301.07M,-1,"3,400",144.52,Strong Buy,143.33,"Aug 6, 2024",ALTR,Altair Engineering Inc.,7.67B,90.41,627.21M,2.69%,-2.31%,5.96%,+0.57%,+5.07%,"Altair Engineering, Oasys announce joint development agreement",Closing Bell Movers: Bigbear.ai surges after announcing FAA contract,Altair Engineering rallies after Matrix Capital clarifies position,Altair Responds to Matrix Capital Management Statement on Altair Holdings,Altair says it appreciates Matrix Capital’s decision to maintain full position,"Altair Engineering, Oasys announce joint development agreement Closing Bell Movers: Bigbear.ai surges after announcing FAA contract Altair Engineering rallies after Matrix Capital clarifies position Altair Responds to Matrix Capital Management Statement on Altair Holdings Altair says it appreciates Matrix Capital’s decision to maintain full position",0,0,0,0,0,0
84.89M,"273,827",26.71M,-1,"3,856",90.41,Hold,90.67,"Aug 1, 2024",AAON,"AAON, Inc.",7.66B,94.55,1.19B,5.12%,7.34%,17.84%,+4.79%,+3.17%,AAON Announces Quarterly Cash Dividend,,,,,AAON Announces Quarterly Cash Dividend,1,1,-1,-1,-1,-1
81.01M,"265,144",186.37M,$0.32,"10,722",94.55,Buy,102.00,"Aug 1, 2024",MIDD,The Middleby Corporation,7.64B,142.05,3.91B,1.55%,7.50%,1.88%,+2.73%,-7.60%,The Middleby (MIDD) Gets a Buy from KeyBanc,"McNamara’s Buy Rating for Middleby: Growth, Efficiency, and New Market Opportunities",,,,"The Middleby (MIDD) Gets a Buy from KeyBanc McNamara’s Buy Rating for Middleby: Growth, Efficiency, and New Market Opportunities",1,0,1,-1,-1,-1
53.77M,"236,901",386.91M,-1,"2,402",142.05,Buy,158.38,"Aug 1, 2024",LSXMK,The Liberty SiriusXM Group,7.60B,23.26,8.90B,4.90%,4.07%,-11.01%,+3.73%,-14.41%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
326.69M,"928,475",978.00M,-1,"2,402",23.26,Strong Buy,28.00,"Aug 8, 2024",LSXMB,The Liberty SiriusXM Group,7.59B,23.15,8.90B,,4.07%,-11.01%,+15.29%,-6.53%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
326.69M,704,978.00M,-1,"2,402",23.69,,,"Aug 8, 2024",LSXMA,The Liberty SiriusXM Group,7.59B,23.24,8.90B,4.82%,4.03%,-11.11%,+3.40%,-14.35%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
326.69M,"472,937",978.00M,-1,"15,800",23.24,Strong Buy,35.30,"Aug 8, 2024",UFPI,"UFP Industries, Inc.",7.59B,125.02,6.89B,0.18%,2.69%,4.13%,-8.27%,+1.86%,UFP Industries Announces Leadership Changes and Salary Details,"UFP Industries CEO Missad to move to exec chairman, Schwartz named CEO",,,,"UFP Industries Announces Leadership Changes and Salary Details UFP Industries CEO Missad to move to exec chairman, Schwartz named CEO",0,0,0,-1,-1,-1
60.72M,"166,162",462.48M,$1.32,"4,981",125.02,Buy,129.00,"Jul 30, 2024",TLN,Talen Energy Corporation,7.59B,148.80,2.11B,18.87%,23.33%,66.92%,+18.85%,+57.29%,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",AI demand could strain electrical grid in coming decade,The charts are bullish on the utilities sector and this member breaking out,This power provider has doubled as it charts a path for nuclear data centers,Crypto investors weigh new inflation data that clears way for potential rate cuts: CNBC Crypto World,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more AI demand could strain electrical grid in coming decade The charts are bullish on the utilities sector and this member breaking out This power provider has doubled as it charts a path for nuclear data centers Crypto investors weigh new inflation data that clears way for potential rate cuts: CNBC Crypto World",1,1,0,1,1,0
51.00M,"823,297",853.00M,-1,"21,900",148.80,Strong Buy,145.00,"Aug 13, 2024",PARA,Paramount Global,7.57B,11.36,29.27B,-2.81%,-3.72%,-14.99%,-6.30%,-10.61%,Automakers are getting back into advertising’s biggest arena: NFL,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Rising NFL valuations mean massive returns for owners,"Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’","NFL’s next big media rights payday is years off, subject to shifting industry","Automakers are getting back into advertising’s biggest arena: NFL 88 corporate leaders endorse Harris, including CEOs of Yelp, Box Rising NFL valuations mean massive returns for owners Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’ NFL’s next big media rights payday is years off, subject to shifting industry",1,0,1,1,0,1
666.71M,"9,363,288",-5.20B,$0.20,"15,038",11.36,Sell,12.29,"Aug 8, 2024",IEP,Icahn Enterprises L.P.,7.56B,15.89,10.28B,-15.53%,-16.72%,-20.30%,-24.59%,-22.44%,"Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more",5 things to know before the stock market opens Tuesday,CNBC Daily Open: Wall Street extends winning run,SEC charges Carl Icahn with hiding billions in loans backed by IEP stock,Icahn Enterprises put volume heavy and directionally bearish,"Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more 5 things to know before the stock market opens Tuesday CNBC Daily Open: Wall Street extends winning run SEC charges Carl Icahn with hiding billions in loans backed by IEP stock Icahn Enterprises put volume heavy and directionally bearish",1,1,1,0,0,1
475.46M,"6,797,837",-504.00M,$4.00,"3,357",15.89,,,"Aug 7, 2024",PNFP,"Pinnacle Financial Partners, Inc.",7.53B,98.39,1.49B,7.75%,12.63%,18.29%,+1.94%,+19.34%,Barclays Sticks to Their Hold Rating for Pinnacle Financial Partners (PNFP),,,,,Barclays Sticks to Their Hold Rating for Pinnacle Financial Partners (PNFP),1,0,-1,-1,-1,-1
76.52M,"398,955",389.50M,$0.88,"6,600",98.39,Buy,99.36,"Oct 15, 2024",DRS,"Leonardo DRS, Inc.",7.49B,28.42,3.07B,0.12%,2.24%,22.78%,-0.32%,+34.50%,Leonardo DRS management to meet with BTIG,Leonardo DRS management to meet with Truist,Leonardo DRS awarded $117M production order for family of weapon sights,Leonardo DRS awarded $49M contract for additional joint assault bridge systems,Leonardo DRS awarded $52M follow-on production order,Leonardo DRS management to meet with BTIG Leonardo DRS management to meet with Truist Leonardo DRS awarded $117M production order for family of weapon sights Leonardo DRS awarded $49M contract for additional joint assault bridge systems Leonardo DRS awarded $52M follow-on production order,0,0,0,0,0,0
263.70M,"338,324",188.00M,-1,"2,130",28.42,Buy,28.50,"Jul 30, 2024",GTLB,GitLab Inc.,7.47B,46.98,622.22M,3.46%,-2.43%,-16.08%,-10.01%,-18.23%,"Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more","Stocks making the biggest moves premarket: Nvidia, GitLab, Sweetgreen and more","Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more",GitLab Recognized as a Leader in the Gartner® Magic Quadrant™ for DevOps Platforms for the Second Consecutive Year,GitLab price target raised to $55 from $50 at Barclays,"Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more Stocks making the biggest moves premarket: Nvidia, GitLab, Sweetgreen and more Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more GitLab Recognized as a Leader in the Gartner® Magic Quadrant™ for DevOps Platforms for the Second Consecutive Year GitLab price target raised to $55 from $50 at Barclays",1,1,1,1,1,1
158.90M,"877,279",-426.35M,-1,"2,489",46.98,Buy,66.56,"Sep 3, 2024",SPSC,"SPS Commerce, Inc.",7.45B,198.36,583.80M,-0.54%,0.49%,5.72%,-8.86%,+9.48%,SPS Commerce to Present at Citi’s 2024 Global TMT Conference,Buy Rating Affirmed for SPS Commerce on Consistent ARR Growth and Successful M&A Strategy,"SPS Commerce files to sell 404,587 shares of common stock for holders",,,"SPS Commerce to Present at Citi’s 2024 Global TMT Conference Buy Rating Affirmed for SPS Commerce on Consistent ARR Growth and Successful M&A Strategy SPS Commerce files to sell 404,587 shares of common stock for holders",0,1,0,1,-1,-1
37.55M,"83,275",71.89M,-1,834,198.36,Strong Buy,220.25,"Jul 25, 2024",LNTH,"Lantheus Holdings, Inc.",7.44B,107.16,1.44B,9.59%,11.38%,48.05%,+4.66%,+80.36%,Lantheus Bolsters Board with Expert Finance Executive,Lantheus appoints Eastland as new board member,Lantheus Appoints Julie Eastland as New Board Member,Lantheus initiated with a Buy at Redburn Atlantic,Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,Lantheus Bolsters Board with Expert Finance Executive Lantheus appoints Eastland as new board member Lantheus Appoints Julie Eastland as New Board Member Lantheus initiated with a Buy at Redburn Atlantic Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,1,1,1,1,1,1
69.43M,"611,269",428.48M,-1,"23,500",107.16,Strong Buy,117.67,"Jul 31, 2024",ACHC,"Acadia Healthcare Company, Inc.",7.42B,79.91,3.06B,6.95%,12.98%,5.19%,+21.91%,+4.07%,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer",New York Times investigation finds Acadia breaks law by holding patients,,,,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer New York Times investigation finds Acadia breaks law by holding patients",0,0,0,-1,-1,-1
92.87M,"634,133",-5.12M,-1,"1,800",79.91,Buy,85.56,"Jul 31, 2024",AUR,"Aurora Innovation, Inc.",7.40B,4.30,-,12.45%,20.54%,39.81%,+3.50%,+38.00%,Cathie Wood’s ARK Investment bought 564K shares of Aurora Innovation today,Cathie Wood’s ARK Investment bought 558K shares of Aurora Innovation today,,,,Cathie Wood’s ARK Investment bought 564K shares of Aurora Innovation today Cathie Wood’s ARK Investment bought 558K shares of Aurora Innovation today,1,1,1,-1,-1,-1
1.72B,"9,331,395",-729.00M,-1,"1,310",4.300,Hold,3.75,"Jul 31, 2024",EXEL,"Exelixis, Inc.",7.38B,25.88,2.01B,0.48%,8.78%,13.95%,+10.11%,+11.58%,Bank of America Securities Sticks to Its Buy Rating for Exelixis (EXEL),Exelixis put volume heavy and directionally bearish,Biotech Alert: Searches spiking for these stocks today,,,Bank of America Securities Sticks to Its Buy Rating for Exelixis (EXEL) Exelixis put volume heavy and directionally bearish Biotech Alert: Searches spiking for these stocks today,1,1,1,1,-1,-1
285.25M,"1,295,756",349.99M,-1,"9,679",25.88,Buy,27.46,"Aug 6, 2024",ZION,"Zions Bancorporation, National Association",7.37B,49.91,2.96B,3.16%,5.13%,15.23%,-4.63%,+17.11%,Analysts Conflicted on These Financial Names: Zions Bancorporation National Association (ZION) and Standard Chartered (OtherSCBFF),Zions Bancorp price target lowered to $50 from $52 at Wells Fargo,Unusually active option classes on open August 12th,,,Analysts Conflicted on These Financial Names: Zions Bancorporation National Association (ZION) and Standard Chartered (OtherSCBFF) Zions Bancorp price target lowered to $50 from $52 at Wells Fargo Unusually active option classes on open August 12th,1,1,0,0,-1,-1
147.70M,"959,481",612.00M,$1.64,"5,000",49.91,Hold,48.74,"Oct 21, 2024",WSC,WillScot Holdings Corporation,7.34B,38.93,2.41B,6.08%,2.09%,-6.69%,-6.71%,-13.09%,Constellium appoints Bradley Soultz as special advisor to board,WillScot Announces Investor Conference Schedule for September 2024,,,,Constellium appoints Bradley Soultz as special advisor to board WillScot Announces Investor Conference Schedule for September 2024,1,1,0,-1,-1,-1
188.49M,"1,527,204",187.23M,-1,"18,450",38.93,Strong Buy,48.50,"Aug 1, 2024",CIGI,Colliers International Group Inc.,7.31B,145.40,4.43B,5.79%,14.69%,23.67%,+6.10%,+20.71%,"Colliers buys Western Australian engineering firm Pritchard Francis, no terms",Colliers to acquire leading Western Australian engineering firm,,,,"Colliers buys Western Australian engineering firm Pritchard Francis, no terms Colliers to acquire leading Western Australian engineering firm",0,0,0,-1,-1,-1
50.28M,"90,102",141.93M,$0.30,378,145.40,Buy,153.75,"Aug 1, 2024",RVMD,"Revolution Medicines, Inc.",7.29B,43.64,742.00K,0.07%,2.37%,28.76%,-6.55%,+36.39%,Wall Street Analysts Are Bullish on Top Healthcare Picks,Revolution Medicines: A Strong Buy on Robust Financials and Promising Clinical Pipeline,Revolution Medicines Maintains Buy Rating Amid Promising Clinical Progress and Strong Financial Standing,,,Wall Street Analysts Are Bullish on Top Healthcare Picks Revolution Medicines: A Strong Buy on Robust Financials and Promising Clinical Pipeline Revolution Medicines Maintains Buy Rating Amid Promising Clinical Progress and Strong Financial Standing,1,1,1,1,-1,-1
167.04M,"516,192",-519.21M,-1,"9,237",43.64,Strong Buy,49.54,"Aug 7, 2024",BPOP,"Popular, Inc.",7.20B,99.50,2.60B,2.70%,6.06%,16.41%,-0.78%,+19.39%,Popular assumed with an Overweight at Piper Sandler,Barclays Sticks to Its Buy Rating for Popular (BPOP),,,,Popular assumed with an Overweight at Piper Sandler Barclays Sticks to Its Buy Rating for Popular (BPOP),0,0,0,-1,-1,-1
72.37M,"407,794",510.86M,$2.48,"6,245",99.50,Buy,104.00,"Jul 24, 2024",GNTX,Gentex Corporation,7.19B,31.21,2.33B,3.73%,-3.69%,-7.39%,-0.87%,-14.26%,Gentex initiated with a Neutral at UBS,Gentex Announces Third Quarter 2024 Cash Dividend,Gentex announces Q3 cash dividend 12c,"Voxx jumps after Gentex buys shares at $5, offers buyout","Gentex raises stake in Voxx, submitted proposal to acquire all shares","Gentex initiated with a Neutral at UBS Gentex Announces Third Quarter 2024 Cash Dividend Gentex announces Q3 cash dividend 12c Voxx jumps after Gentex buys shares at $5, offers buyout Gentex raises stake in Voxx, submitted proposal to acquire all shares",1,1,1,1,1,1
230.22M,"1,281,790",409.90M,$0.48,27,31.21,Buy,38.00,"Jul 26, 2024",VKTX,"Viking Therapeutics, Inc.",7.16B,64.63,-,5.08%,10.52%,27.23%,+7.30%,-20.00%,"Lightning Round: Chipotle is likely done going down, says Jim Cramer",Cramer’s Lightning Round: Builders FirstSource ‘can go higher’,Buy Rating on Viking Therapeutics: A Strategic Opportunity Amid Market Overreaction,"Viking Therapeutics selloff on Zepbound news an opportunity, says Truist",Biotech Alert: Searches spiking for these stocks today,"Lightning Round: Chipotle is likely done going down, says Jim Cramer Cramer’s Lightning Round: Builders FirstSource ‘can go higher’ Buy Rating on Viking Therapeutics: A Strategic Opportunity Amid Market Overreaction Viking Therapeutics selloff on Zepbound news an opportunity, says Truist Biotech Alert: Searches spiking for these stocks today",0,0,0,0,0,1
110.80M,"2,320,864",-96.75M,-1,"5,521",64.63,Strong Buy,111.78,"Jul 24, 2024",WTFC,Wintrust Financial Corporation,7.16B,107.65,2.22B,4.14%,4.11%,9.06%,-0.91%,+6.45%,"Wintrust Appoints New Head of Diversity, Equity, and Inclusion","Wintrust Expands Workplace Solutions Offering for HSAs, FSAs, and More, Powered by First Dollar",Barclays Sticks to Its Buy Rating for Wintrust Financial (WTFC),,,"Wintrust Appoints New Head of Diversity, Equity, and Inclusion Wintrust Expands Workplace Solutions Offering for HSAs, FSAs, and More, Powered by First Dollar Barclays Sticks to Its Buy Rating for Wintrust Financial (WTFC)",0,1,0,0,-1,-1
66.50M,"271,520",599.40M,$1.80,"13,300",107.65,Strong Buy,117.85,"Oct 15, 2024",FYBR,"Frontier Communications Parent, Inc.",7.13B,28.62,5.80B,2.82%,6.87%,17.68%,-2.94%,+25.07%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",Jim Cramer’s top 10 things to watch in the stock market Thursday,"Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more",Verizon CEO Hans Vestberg on $20B Frontier deal: Enhances and accelerates our broadband efforts,"Dow falls 200 points, S&P 500 posts third straight loss as growth fears plague investors","Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Jim Cramer’s top 10 things to watch in the stock market Thursday Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Verizon CEO Hans Vestberg on $20B Frontier deal: Enhances and accelerates our broadband efforts Dow falls 200 points, S&P 500 posts third straight loss as growth fears plague investors",1,1,0,1,0,0
248.98M,"1,797,584",-94.00M,-1,"2,800",28.62,Strong Buy,30.90,"Aug 2, 2024",JAZZ,Jazz Pharmaceuticals plc,7.03B,113.87,3.91B,2.24%,5.03%,-0.71%,+5.55%,-0.04%,Truist healthcare analyst holds an analyst/industry conference call,Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations,Analyzing Jazz Pharmaceuticals: A Hold Rating Amidst Oncology and Sleep Disorder Market Dynamics,"H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’",Jazz Pharmaceuticals (JAZZ) Gets a Buy from Stifel Nicolaus,"Truist healthcare analyst holds an analyst/industry conference call Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations Analyzing Jazz Pharmaceuticals: A Hold Rating Amidst Oncology and Sleep Disorder Market Dynamics H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’ Jazz Pharmaceuticals (JAZZ) Gets a Buy from Stifel Nicolaus",1,1,1,0,1,1
61.75M,"321,569",394.92M,-1,"9,860",113.87,Buy,172.73,"Jul 31, 2024",LBTYB,Liberty Global Ltd.,7.01B,19.79,7.59B,,5.03%,-0.71%,+10.11%,+17.50%,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",Liberty Global A Subsidiaries’ Latest Financial Overview Released,Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report,Liberty Global upgraded to Neutral from Underperform at BofA,Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Liberty Global A Subsidiaries’ Latest Financial Overview Released Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report Liberty Global upgraded to Neutral from Underperform at BofA Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties",0,1,1,1,1,1
365.44M,305,-2.05B,-1,"9,860",19.14,,,,LBTYK,Liberty Global Ltd.,7.01B,19.46,7.59B,3.23%,6.26%,9.87%,-1.79%,+12.60%,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",Liberty Global A Subsidiaries’ Latest Financial Overview Released,Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report,Liberty Global upgraded to Neutral from Underperform at BofA,Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Liberty Global A Subsidiaries’ Latest Financial Overview Released Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report Liberty Global upgraded to Neutral from Underperform at BofA Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties",0,1,1,1,1,1
365.44M,"984,816",-2.05B,-1,"9,489",19.46,,,,GGAL,Grupo Financiero Galicia S.A.,6.96B,34.68,6.47B,10.58%,17.59%,46.71%,+21.47%,+28.59%,Grupo Financiero Galicia upgraded to Buy from Neutral at Citi,Grupo Financiero Galicia upgraded to Overweight from Underweight at JPMorgan,Grupo Financiero Galicia Names New CRO,Grupo Financiero Announces Capital Growth Plan,Grupo Galicia Reports Strong Growth in Q2 2024,Grupo Financiero Galicia upgraded to Buy from Neutral at Citi Grupo Financiero Galicia upgraded to Overweight from Underweight at JPMorgan Grupo Financiero Galicia Names New CRO Grupo Financiero Announces Capital Growth Plan Grupo Galicia Reports Strong Growth in Q2 2024,1,1,0,1,0,1
1.47B,"697,814",978.39M,$2.49,"14,437",34.68,Strong Buy,36.00,"Sep 26, 2024",NSIT,"Insight Enterprises, Inc.",6.95B,213.39,9.04B,8.01%,5.59%,14.33%,-4.52%,+15.35%,Insight Enterprises Enhances Leadership and Financial Strategy,Insight Enterprises appoints James Morgado as chief financial officer,,,,Insight Enterprises Enhances Leadership and Financial Strategy Insight Enterprises appoints James Morgado as chief financial officer,1,1,1,-1,-1,-1
32.59M,"160,151",305.33M,-1,"23,737",213.39,Hold,216.67,"Aug 1, 2024",GRFS,"Grifols, S.A.",6.90B,8.58,7.30B,16.76%,16.69%,11.03%,+20.48%,+26.94%,Grifols postpones Capital Markets Day until further notice,"Brookfield in talks to join buyout of Grifols, Bloomberg reports","Brookfield in talks to join sovereign funds in Grifols bid, Bloomberg says",,,"Grifols postpones Capital Markets Day until further notice Brookfield in talks to join buyout of Grifols, Bloomberg reports Brookfield in talks to join sovereign funds in Grifols bid, Bloomberg says",1,0,1,1,-1,-1
679.63M,"808,432",177.51M,-1,"2,744",8.58,Sell,10.50,,CFLT,"Confluent, Inc.",6.89B,21.36,865.59M,-0.23%,-14.18%,-19.94%,-18.39%,-30.35%,Confluent CEO Jay Kreps goes one-on-one with Jim Cramer,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Balancing Growth and Challenges: A Hold Rating for Confluent’s Market Position and Financial Health,Confluent (CFLT) Receives a Buy from Stifel Nicolaus,DA Davidson technology analysts hold an analyst/industry conference call,"Confluent CEO Jay Kreps goes one-on-one with Jim Cramer Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Balancing Growth and Challenges: A Hold Rating for Confluent’s Market Position and Financial Health Confluent (CFLT) Receives a Buy from Stifel Nicolaus DA Davidson technology analysts hold an analyst/industry conference call",1,1,1,1,1,1
322.72M,"1,619,323",-369.63M,-1,"9,860",21.36,Buy,30.64,"Jul 31, 2024",LBTYA,Liberty Global Ltd.,6.88B,18.84,7.59B,3.32%,5.91%,11.24%,-0.87%,+13.98%,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",Liberty Global A Subsidiaries’ Latest Financial Overview Released,Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report,Liberty Global upgraded to Neutral from Underperform at BofA,Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Liberty Global A Subsidiaries’ Latest Financial Overview Released Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report Liberty Global upgraded to Neutral from Underperform at BofA Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties",1,1,1,1,1,1
365.44M,"1,051,104",-2.05B,-1,927,18.84,Buy,25.50,"Jul 25, 2024",IONS,"Ionis Pharmaceuticals, Inc.",6.86B,46.92,813.46M,1.47%,2.47%,5.20%,-0.42%,+13.95%,Ionis Pharmaceuticals management to meet with Oppenheimer,Ionis Pharmaceuticals’ Strong Position in the Market Post-Competitor Trial Analysis,Ionis Pharmaceuticals: A Strong Buy Amidst Burgeoning Cardiomyopathy Market,JPMorgan healthcare analysts hold an analyst/industry conference call,Truist biotech analysts hold an analyst/industry conference call,Ionis Pharmaceuticals management to meet with Oppenheimer Ionis Pharmaceuticals’ Strong Position in the Market Post-Competitor Trial Analysis Ionis Pharmaceuticals: A Strong Buy Amidst Burgeoning Cardiomyopathy Market JPMorgan healthcare analysts hold an analyst/industry conference call Truist biotech analysts hold an analyst/industry conference call,1,0,0,0,1,1
146.21M,"566,618",-365.74M,-1,"132,100",46.92,Buy,61.75,"Aug 1, 2024",AAL,American Airlines Group Inc.,6.82B,10.39,53.45B,1.80%,-3.70%,-21.82%,-4.61%,-26.24%,Dell and Palantir to join S&P 500; shares of both jump,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree",Friday’s stock stories: What’s likely to move the market in the next session,Here’s where American Airlines is adding flights to Europe in summer 2025,Why airlines like American are scrambling to make engines last longer,"Dell and Palantir to join S&P 500; shares of both jump U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree Friday’s stock stories: What’s likely to move the market in the next session Here’s where American Airlines is adding flights to Europe in summer 2025 Why airlines like American are scrambling to make engines last longer",1,1,0,0,0,1
656.70M,"20,531,865",-121.00M,-1,"2,325",10.39,Buy,15.67,"Oct 17, 2024",CCCS,CCC Intelligent Solutions Holdings Inc.,6.82B,10.94,909.60M,3.67%,-0.91%,-4.14%,+4.68%,-7.89%,CCC Intelligent Solutions resumed with a Buy at BofA,Wall Street Analysts Are Bullish on Top Technology Picks,CCC Intelligent Solutions: A Strong Buy on Robust Growth and Profitability Outlook,,,CCC Intelligent Solutions resumed with a Buy at BofA Wall Street Analysts Are Bullish on Top Technology Picks CCC Intelligent Solutions: A Strong Buy on Robust Growth and Profitability Outlook,1,1,1,1,-1,-1
623.40M,"1,407,336",21.48M,-1,"2,200",10.94,Strong Buy,13.88,"Jul 30, 2024",HCP,"HashiCorp, Inc.",6.82B,33.90,605.73M,0.33%,0.66%,21.30%,+0.15%,+30.96%,HashiCorp resumed with a Neutral at CitiI,Maintaining Hold on HashiCorp Amid IBM Acquisition and Transition Risks,Truist Financial Keeps Their Hold Rating on HashiCorp (HCP),"HashiCorp reports Q2 EPS 8, consensus 0c","Hashicorp, Inc. Class A (HCP) Q2 Earnings Cheat Sheet","HashiCorp resumed with a Neutral at CitiI Maintaining Hold on HashiCorp Amid IBM Acquisition and Transition Risks Truist Financial Keeps Their Hold Rating on HashiCorp (HCP) HashiCorp reports Q2 EPS 8, consensus 0c Hashicorp, Inc. Class A (HCP) Q2 Earnings Cheat Sheet",1,1,0,0,1,1
201.06M,"2,634,020",-188.54M,-1,"2,992",33.90,Hold,31.70,"Aug 29, 2024",CGNX,Cognex Corporation,6.81B,39.69,844.00M,-1.51%,-12.97%,-5.71%,-21.83%,-4.03%,,,,,,,1,-1,-1,-1,-1,-1
171.50M,"1,124,986",78.38M,$0.30,"17,000",39.69,Buy,48.58,"Jul 31, 2024",LFUS,"Littelfuse, Inc.",6.77B,273.15,2.23B,5.31%,4.20%,8.71%,+0.42%,+13.41%,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly",Littelfuse price target raised to $315 from $300 at Baird,"Analysts Conflicted on These Technology Names: TTEC Holdings (TTEC), Littelfuse (LFUS) and NEXTracker, Inc. Class A (NXT)",Analysts Offer Insights on Technology Companies: Salesforce (CRM) and Littelfuse (LFUS),Littelfuse upgraded to Buy from Hold at Stifel,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly Littelfuse price target raised to $315 from $300 at Baird Analysts Conflicted on These Technology Names: TTEC Holdings (TTEC), Littelfuse (LFUS) and NEXTracker, Inc. Class A (NXT) Analysts Offer Insights on Technology Companies: Salesforce (CRM) and Littelfuse (LFUS) Littelfuse upgraded to Buy from Hold at Stifel",0,1,0,1,0,0
24.79M,"102,835",194.59M,$2.80,423,273.15,Buy,275.00,"Jul 30, 2024",CYTK,"Cytokinetics, Incorporated",6.74B,57.32,3.13M,-0.66%,0.26%,-8.24%,-5.90%,-23.63%,Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting,Cytokinetics price target raised to $71 from $65 at JPMorgan,Truist Financial Issues a Buy Rating on Cytokinetics (CYTK),Hold Rating on Cytokinetics’ Aficamten Amid Positive Safety and Efficacy Profiles,Cytokinetics Hold Rating Affirmed Amid Incremental Drug Updates and Competitive Uncertainties,Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting Cytokinetics price target raised to $71 from $65 at JPMorgan Truist Financial Issues a Buy Rating on Cytokinetics (CYTK) Hold Rating on Cytokinetics’ Aficamten Amid Positive Safety and Efficacy Profiles Cytokinetics Hold Rating Affirmed Amid Incremental Drug Updates and Competitive Uncertainties,1,1,1,0,1,1
117.66M,"570,858",-545.28M,-1,"1,083",57.32,Buy,78.88,"Aug 8, 2024",FRPT,"Freshpet, Inc.",6.73B,138.84,875.14M,5.21%,6.71%,27.66%,+11.08%,+16.51%,"Freshpet, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)",Freshpet’s Strategic Hiring and Strong Growth Prospects Justify a Buy Rating and Higher Price Target,Freshpet price target raised to $160 from $143 at TD Cowen,Freshpet’s Bullish Outlook: Strategic Leadership and Enhanced Performance Drive Outperform Rating,"Baird ups Freshpet target, says hiring of Baty ‘big win’","Freshpet, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Freshpet’s Strategic Hiring and Strong Growth Prospects Justify a Buy Rating and Higher Price Target Freshpet price target raised to $160 from $143 at TD Cowen Freshpet’s Bullish Outlook: Strategic Leadership and Enhanced Performance Drive Outperform Rating Baird ups Freshpet target, says hiring of Baty ‘big win’",1,1,1,1,1,1
48.49M,"562,306",25.03M,-1,"4,966",138.84,Strong Buy,140.60,"Aug 5, 2024",BOKF,BOK Financial Corporation,6.73B,104.89,1.98B,3.65%,6.30%,16.97%,+1.38%,+16.04%,BOK Financial Releases Investor Presentation Online,,,,,BOK Financial Releases Investor Presentation Online,0,1,-1,-1,-1,-1
64.13M,"99,072",460.41M,$2.20,"1,468",104.89,Hold,101.00,"Jul 22, 2024",LSTR,"Landstar System, Inc.",6.69B,188.61,4.90B,-3.51%,-2.16%,-1.77%,-4.20%,-3.04%,Friday’s stock stories: What’s likely to move the market in the next session,"Analysts Are Neutral on These Industrial Goods Stocks: Landstar System (LSTR), Fortune Brands Innovations (FBIN)",,,,"Friday’s stock stories: What’s likely to move the market in the next session Analysts Are Neutral on These Industrial Goods Stocks: Landstar System (LSTR), Fortune Brands Innovations (FBIN)",1,0,1,-1,-1,-1
35.45M,"154,503",219.36M,$1.44,"2,882",188.61,Hold,177.20,"Oct 23, 2024",CVLT,"Commvault Systems, Inc.",6.67B,152.62,865.77M,2.35%,14.56%,48.53%,-1.60%,+50.11%,D.A. Davidson Sticks to Its Buy Rating for CommVault Systems (CVLT),Commvault price target raised to $175 from $170 at DA Davidson,Commvault exec sells $2.6M in common stock,,,D.A. Davidson Sticks to Its Buy Rating for CommVault Systems (CVLT) Commvault price target raised to $175 from $170 at DA Davidson Commvault exec sells $2.6M in common stock,0,0,0,0,-1,-1
43.71M,"245,394",174.80M,-1,"3,150",152.62,Buy,134.29,"Jul 30, 2024",HQY,"HealthEquity, Inc.",6.67B,76.62,1.04B,3.93%,-2.13%,-0.46%,-3.75%,-4.85%,HealthEquity files automatic mixed securities shelf,HealthEquity price target raised to $103 from $102 at Deutsche Bank,HealthEquity Outperforms with Strong Financials and Positive Outlook: A Buy Rating Justified,HealthEquity price target lowered to $100 from $105 at BofA,RBC Capital Remains a Buy on Healthequity (HQY),HealthEquity files automatic mixed securities shelf HealthEquity price target raised to $103 from $102 at Deutsche Bank HealthEquity Outperforms with Strong Financials and Positive Outlook: A Buy Rating Justified HealthEquity price target lowered to $100 from $105 at BofA RBC Capital Remains a Buy on Healthequity (HQY),0,0,0,0,0,0
87.01M,"314,404",80.43M,-1,"33,000",76.62,Strong Buy,101.45,"Sep 3, 2024",MAT,"Mattel, Inc.",6.65B,19.55,5.43B,2.40%,9.32%,5.45%,-0.10%,-0.21%,"Gap beats earnings and revenue estimates, hikes profit margin outlook",Nokia phone maker launches Barbie handset for $130 — with no internet,"Mattel’s Fisher-Price, John Legend partner to release covers of three songs",Mattel announces multi-brand collaboration celebrating Barbie fashion,"Mattel, BMW announce Uno for in-car gaming","Gap beats earnings and revenue estimates, hikes profit margin outlook Nokia phone maker launches Barbie handset for $130 — with no internet Mattel’s Fisher-Price, John Legend partner to release covers of three songs Mattel announces multi-brand collaboration celebrating Barbie fashion Mattel, BMW announce Uno for in-car gaming",0,0,0,0,0,0
339.90M,"1,125,331",322.22M,-1,"24,000",19.55,Buy,22.75,"Jul 23, 2024",SAIC,Science Applications International Corporation,6.64B,129.56,7.26B,3.72%,6.69%,1.73%,+3.25%,-0.94%,SAIC price target raised to $135 from $125 at Truist,SAIC price target raised to $150 from $132 at JPMorgan,Citi Reaffirms Their Buy Rating on Science Applications (SAIC),SAIC price target raised to $155 from $145 at TD Cowen,Science Applications (SAIC) Receives a Rating Update from a Top Analyst,SAIC price target raised to $135 from $125 at Truist SAIC price target raised to $150 from $132 at JPMorgan Citi Reaffirms Their Buy Rating on Science Applications (SAIC) SAIC price target raised to $155 from $145 at TD Cowen Science Applications (SAIC) Receives a Rating Update from a Top Analyst,0,0,0,0,0,0
51.23M,"219,282",456.00M,$1.48,"2,900",129.56,Hold,127.67,"Sep 5, 2024",NOVT,Novanta Inc.,6.59B,183.54,899.85M,3.88%,6.04%,11.67%,-0.45%,+7.10%,Novanta Promotes John Burke to Chief Accounting Officer,,,,,Novanta Promotes John Burke to Chief Accounting Officer,1,0,-1,-1,-1,-1
35.90M,"109,782",62.17M,-1,"1,156",183.54,Hold,175.00,"Aug 6, 2024",LSCC,Lattice Semiconductor Corporation,6.58B,47.78,627.66M,-0.96%,-13.37%,-28.36%,-12.60%,-38.22%,"Lattice Semiconductor CFO Luther sells over 20,000 common shares",,,,,"Lattice Semiconductor CFO Luther sells over 20,000 common shares",0,1,-1,-1,-1,-1
137.77M,"2,417,093",189.92M,-1,267,47.78,Strong Buy,65.17,"Jul 29, 2024",ALAB,"Astera Labs, Inc.",6.54B,41.77,229.55M,8.77%,-11.24%,-27.65%,-0.73%,-39.00%,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",Astera Labs upgraded to Overweight from Equal Weight at Morgan Stanley,"Astera Labs, Inc.: A Buy Rating With Potential for Significant Growth Amidst Undervaluation","Analysts’ Top NA Picks: SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR (HDL), Astera Labs, Inc. (ALAB)","AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Astera Labs upgraded to Overweight from Equal Weight at Morgan Stanley Astera Labs, Inc.: A Buy Rating With Potential for Significant Growth Amidst Undervaluation Analysts’ Top NA Picks: SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR (HDL), Astera Labs, Inc. (ALAB)",0,0,1,0,0,0
156.66M,"3,355,461",-89.34M,-1,"1,202",41.77,Strong Buy,71.36,"Aug 6, 2024",NVMI,Nova Ltd.,6.48B,223.01,561.68M,5.71%,1.59%,27.16%,+6.50%,+22.77%,Nova Ltd. Engages Investors at Upcoming Conferences,Nova (NVMI) Receives a Buy from Evercore ISI,Nova price target raised to $240 from $215 at Benchmark,Strong Performance and Positive Market Positioning Merit a Buy Rating for Nova (NVMI),,Nova Ltd. Engages Investors at Upcoming Conferences Nova (NVMI) Receives a Buy from Evercore ISI Nova price target raised to $240 from $215 at Benchmark Strong Performance and Positive Market Positioning Merit a Buy Rating for Nova (NVMI),1,0,0,0,0,-1
29.05M,"108,524",153.76M,-1,"6,000",223.01,Strong Buy,236.60,"Aug 8, 2024",REYN,Reynolds Consumer Products Inc.,6.45B,30.70,3.71B,4.73%,9.35%,10.85%,+11.72%,+10.45%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike",,,,,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike",1,1,-1,-1,-1,-1
210.14M,"280,200",360.00M,$0.92,"2,233",30.70,Hold,31.00,"Aug 7, 2024",VRNS,"Varonis Systems, Inc.",6.42B,57.27,520.78M,5.17%,15.22%,24.17%,+2.68%,+18.41%,Varonis prices upsized offering of $400M in convertible senior notes,Varonis announces proposed offering of $350M of convertible senior notes,Varonis to Present at Upcoming Investor Conference,"Analysts’ Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)",,"Varonis prices upsized offering of $400M in convertible senior notes Varonis announces proposed offering of $350M of convertible senior notes Varonis to Present at Upcoming Investor Conference Analysts’ Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)",0,0,0,0,0,-1
112.18M,"704,377",-88.35M,-1,"3,800",57.27,Buy,56.33,"Jul 29, 2024",MASI,Masimo Corporation,6.38B,119.94,2.02B,-1.76%,-1.16%,-4.56%,+8.79%,-18.33%,"Masimo CEO shared confidential documents with investor before release, documents show","Masimo, under activist pressure, subpoenaed proxy advisors for investor messages",Masimo urges stockholder to vote ‘FOR’ only the company’s director nominees,Buy Rating Affirmed for Masimo Amidst Favorable Legal Developments and Strong Financials,Masimo Explores Strategic Options for Consumer Business Division,"Masimo CEO shared confidential documents with investor before release, documents show Masimo, under activist pressure, subpoenaed proxy advisors for investor messages Masimo urges stockholder to vote ‘FOR’ only the company’s director nominees Buy Rating Affirmed for Masimo Amidst Favorable Legal Developments and Strong Financials Masimo Explores Strategic Options for Consumer Business Division",0,1,1,0,1,0
53.20M,"415,027",79.40M,-1,"2,420",119.94,Buy,156.40,"Aug 6, 2024",ETSY,"Etsy, Inc.",6.36B,55.40,2.77B,-0.71%,-4.99%,-18.01%,-15.21%,-15.00%,Dell and Palantir to join S&P 500; shares of both jump,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance","Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23",Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Etsy initiated with a Neutral at Cantor Fitzgerald,"Dell and Palantir to join S&P 500; shares of both jump S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23 Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Etsy initiated with a Neutral at Cantor Fitzgerald",0,1,1,1,1,1
114.75M,"2,220,066",287.13M,-1,"5,346",55.40,Hold,70.80,"Jul 31, 2024",BZ,Kanzhun Limited,6.26B,14.18,883.35M,0.08%,-14.49%,-18.44%,-19.37%,-42.73%,Kanzhun Limited Executes Post-IPO Share Purchase,Kanzhun Ltd Maintains Share Capital Stability,Kanzhun Limited Executes Post-IPO Share Scheme Purchase,Kanzhun price target lowered to $14 from $27 at Barclays,Barclays Sticks to Its Buy Rating for Kanzhun Ltd Sponsored (BZ),Kanzhun Limited Executes Post-IPO Share Purchase Kanzhun Ltd Maintains Share Capital Stability Kanzhun Limited Executes Post-IPO Share Scheme Purchase Kanzhun price target lowered to $14 from $27 at Barclays Barclays Sticks to Its Buy Rating for Kanzhun Ltd Sponsored (BZ),1,1,1,1,1,1
441.23M,"1,631,616",181.64M,-1,"3,940",14.18,Buy,24.00,"Aug 28, 2024",ONB,Old National Bancorp,6.25B,19.58,1.73B,4.29%,6.70%,15.23%,-2.25%,+17.96%,Old National to Present at the 2024 Barclays Global Financial Services Conference,Old National Bancorp Announces Quarterly Dividends,Barclays Reaffirms Their Buy Rating on Old National Bancorp Capital (ONB),Old National Bancorp Unveils New Investor Presentation Materials,,Old National to Present at the 2024 Barclays Global Financial Services Conference Old National Bancorp Announces Quarterly Dividends Barclays Reaffirms Their Buy Rating on Old National Bancorp Capital (ONB) Old National Bancorp Unveils New Investor Presentation Materials,1,1,1,1,1,-1
318.97M,"1,448,941",505.73M,$0.56,"4,200",19.58,Buy,19.57,"Oct 22, 2024",CWST,"Casella Waste Systems, Inc.",6.23B,107.10,1.43B,1.56%,3.32%,13.45%,+3.16%,+13.06%,Casella Waste sees $9M charge in September quarter due to landfill closure,Casella Recognizes 2024 Sustainability Leaders,,,,Casella Waste sees $9M charge in September quarter due to landfill closure Casella Recognizes 2024 Sustainability Leaders,1,0,1,-1,-1,-1
58.13M,"216,470",19.25M,-1,"8,801",107.10,Strong Buy,103.80,"Aug 1, 2024",BILI,Bilibili Inc.,6.19B,14.94,3.30B,0.44%,-5.81%,12.29%,-9.83%,+25.67%,China’s first global gaming hit sells millions. Its investor shares what’s next,Bilibili Inc. Reports Stable Share Capital,Bilibili price target raised to $19 from $18 at BofA,Bilibili’s Robust Gaming and Ad Revenue Growth Spurs Buy Rating,Bilibili’s Strong Financial Performance and Growth Prospects Merit a Buy Rating,China’s first global gaming hit sells millions. Its investor shares what’s next Bilibili Inc. Reports Stable Share Capital Bilibili price target raised to $19 from $18 at BofA Bilibili’s Robust Gaming and Ad Revenue Growth Spurs Buy Rating Bilibili’s Strong Financial Performance and Growth Prospects Merit a Buy Rating,1,0,0,0,1,0
414.14M,"7,631,956",-551.15M,-1,700,14.94,Strong Buy,16.54,"Aug 22, 2024",HLNE,Hamilton Lane Incorporated,6.14B,151.45,625.54M,9.30%,14.57%,31.15%,+3.86%,+32.96%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",Hamilton Lane Shareholders Approve Key Corporate Changes,Analysts Offer Insights on Financial Companies: REVO S.p.A. (H0O) and Hamilton Lane (HLNE),Hold Rating Maintained for Hamilton Lane with Mixed Earnings Outlook and Raised Price Target,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Hamilton Lane Shareholders Approve Key Corporate Changes Analysts Offer Insights on Financial Companies: REVO S.p.A. (H0O) and Hamilton Lane (HLNE) Hold Rating Maintained for Hamilton Lane with Mixed Earnings Outlook and Raised Price Target",1,1,1,0,0,-1
40.53M,"207,158",168.82M,$1.96,"7,100",151.45,Hold,130.86,"Aug 6, 2024",CHX,ChampionX Corporation,6.08B,31.94,3.70B,0.75%,-1.99%,0.48%,-9.81%,-21.45%,ChampionX Declares Quarterly Dividend,,,,,ChampionX Declares Quarterly Dividend,1,0,-1,-1,-1,-1
190.46M,"1,243,950",320.40M,$0.38,"11,500",31.94,Buy,37.83,"Jul 24, 2024",OLLI,"Ollie's Bargain Outlet Holdings, Inc.",6.05B,98.89,2.15B,0.34%,-2.07%,17.21%,-3.64%,+28.14%,Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,"Monday’s biggest analyst calls: Nvidia, Amazon, Microsoft, BJ’s and more",Craig-Hallum Sticks to Their Buy Rating for Ollie’s Bargain Outlet Holding (OLLI),"Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI)","Analysts Conflicted on These Consumer Cyclical Names: Best Buy Co (BBY), Lululemon Athletica (LULU) and Ollie’s Bargain Outlet Holding (OLLI)","Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings Monday’s biggest analyst calls: Nvidia, Amazon, Microsoft, BJ’s and more Craig-Hallum Sticks to Their Buy Rating for Ollie’s Bargain Outlet Holding (OLLI) Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI) Analysts Conflicted on These Consumer Cyclical Names: Best Buy Co (BBY), Lululemon Athletica (LULU) and Ollie’s Bargain Outlet Holding (OLLI)",1,0,1,0,0,1
61.21M,"943,487",196.80M,-1,"1,050",98.89,Strong Buy,102.25,"Aug 29, 2024",NXT,Nextracker Inc.,6.04B,42.11,2.74B,0.03%,-10.82%,-14.82%,-18.11%,-19.60%,"We’re adding to a stock that should see relief from rate cuts, election clarity",Cramer sees a ‘potential tailwind’ for Amazon from a big Chinese online retailer,"Fed Chair Powell checks the box, and our rate sensitive stocks react accordingly","The long-term winners as AI boosts U.S. power needs, according to Mizuho",Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,"We’re adding to a stock that should see relief from rate cuts, election clarity Cramer sees a ‘potential tailwind’ for Amazon from a big Chinese online retailer Fed Chair Powell checks the box, and our rate sensitive stocks react accordingly The long-term winners as AI boosts U.S. power needs, according to Mizuho Cramer updates his takes on all 32 portfolio stocks and grades earnings reports",0,0,0,1,0,0
143.44M,"2,464,935",407.51M,-1,500,42.11,Strong Buy,58.22,"Aug 1, 2024",CRDO,Credo Technology Group Holding Ltd,6.02B,36.45,192.97M,20.55%,18.61%,56.16%,+22.88%,+59.64%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","Analysts Offer Insights on Technology Companies: Oracle (ORCL), Credo Technology Group Holding Ltd (CRDO) and Samsara (IOT)",Credo Technology price target raised to $38 from $30 at Craig-Hallum,Credo Technology price target raised to $27 from $25 at BofA,Credo Technology price target raised to $35 from $30 at Roth MKM,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Analysts Offer Insights on Technology Companies: Oracle (ORCL), Credo Technology Group Holding Ltd (CRDO) and Samsara (IOT) Credo Technology price target raised to $38 from $30 at Craig-Hallum Credo Technology price target raised to $27 from $25 at BofA Credo Technology price target raised to $35 from $30 at Roth MKM",0,1,0,0,0,0
165.19M,"2,247,770",-28.37M,-1,"5,406",36.45,Strong Buy,30.38,"Sep 4, 2024",PEGA,Pegasystems Inc.,6.00B,70.22,1.49B,3.06%,10.44%,20.16%,-1.53%,+10.55%,Pegasystems (PEGA) Receives a Buy from William Blair,,,,,Pegasystems (PEGA) Receives a Buy from William Blair,1,1,-1,-1,-1,-1
85.41M,"912,576",129.88M,$0.12,655,70.22,Buy,82.60,"Jul 24, 2024",BPMC,Blueprint Medicines Corporation,5.99B,94.55,362.80M,-2.47%,-11.46%,1.05%,-14.36%,+1.20%,,,,,,,0,-1,-1,-1,-1,-1
63.35M,"279,075",-205.49M,-1,"6,800",94.55,Buy,120.18,"Aug 1, 2024",COOP,Mr. Cooper Group Inc.,5.98B,92.76,2.13B,4.27%,7.13%,22.44%,+2.34%,+19.25%,"Leon Cooperman slashes Microsoft holding, says he’s conservative on markets",Mr. Cooper management to meet with Compass Point,Analysts Have Conflicting Sentiments on These Financial Companies: P10 Holdings (PX) and Mr Cooper Group (COOP),,,"Leon Cooperman slashes Microsoft holding, says he’s conservative on markets Mr. Cooper management to meet with Compass Point Analysts Have Conflicting Sentiments on These Financial Companies: P10 Holdings (PX) and Mr Cooper Group (COOP)",1,0,1,1,-1,-1
64.48M,"364,173",706.00M,-1,"30,000",92.76,Buy,89.10,"Jul 25, 2024",RCM,R1 RCM Inc.,5.93B,14.04,2.38B,1.18%,7.17%,16.93%,+9.16%,+12.75%,Truist Financial Releases a Hold Rating on R1 RCM (RCM),,,,,Truist Financial Releases a Hold Rating on R1 RCM (RCM),0,0,-1,-1,-1,-1
422.11M,"2,956,613",-40.00M,-1,584,14.04,Buy,15.30,"Aug 7, 2024",TMDX,"TransMedics Group, Inc.",5.86B,175.66,358.76M,9.69%,15.96%,65.08%,+18.80%,+98.73%,TransMedics Group: A Strong Buy on Steady Transplant Volume Growth and Market Potential,TransMedics Group (TMDX) Receives a Buy from Piper Sandler,Oppenheimer Sticks to Its Buy Rating for TransMedics Group (TMDX),TransMedics Group: A Strong Buy on Unique Positioning and Growth in the Organ Transplant Market,Oppenheimer Reaffirms Their Buy Rating on TransMedics Group (TMDX),TransMedics Group: A Strong Buy on Steady Transplant Volume Growth and Market Potential TransMedics Group (TMDX) Receives a Buy from Piper Sandler Oppenheimer Sticks to Its Buy Rating for TransMedics Group (TMDX) TransMedics Group: A Strong Buy on Unique Positioning and Growth in the Organ Transplant Market Oppenheimer Reaffirms Their Buy Rating on TransMedics Group (TMDX),1,1,1,1,1,1
33.36M,"642,623",3.00M,-1,"54,000",175.66,Buy,154.70,"Jul 31, 2024",EXLS,"ExlService Holdings, Inc.",5.85B,36.27,1.71B,4.28%,9.44%,17.40%,+2.75%,+22.52%,ExlService price target raised to $41 from $38 at JPMorgan,EXL to participate in Citi Global TMT Conference in New York,Analysts Offer Insights on Technology Companies: MarketWise (MKTW) and Exlservice Holdings (EXLS),ExlService management to meet virtually with Barrington,,ExlService price target raised to $41 from $38 at JPMorgan EXL to participate in Citi Global TMT Conference in New York Analysts Offer Insights on Technology Companies: MarketWise (MKTW) and Exlservice Holdings (EXLS) ExlService management to meet virtually with Barrington,0,0,1,0,0,-1
161.40M,"413,371",178.75M,-1,923,36.27,Buy,37.33,"Oct 24, 2024",GLBE,Global-E Online Ltd.,5.83B,34.91,632.89M,3.64%,1.39%,-0.38%,-1.63%,-0.21%,Global-e Online (GLBE) Receives a Buy from Jefferies,Global-e Online: A Strong Buy on Resilient EBITDA and Strategic Expansion Potential,Global-e Online price target lowered to $38 from $40 at KeyBanc,Global-e Online price target lowered to $45 from $47 at BofA,Buy Rating Affirmed for Global-e Online with Promising Growth and Resilience Amidst Challenges,Global-e Online (GLBE) Receives a Buy from Jefferies Global-e Online: A Strong Buy on Resilient EBITDA and Strategic Expansion Potential Global-e Online price target lowered to $38 from $40 at KeyBanc Global-e Online price target lowered to $45 from $47 at BofA Buy Rating Affirmed for Global-e Online with Promising Growth and Resilience Amidst Challenges,1,1,1,1,1,1
166.99M,"745,574",-109.68M,-1,"2,232",34.91,Strong Buy,43.00,"Aug 14, 2024",CACC,Credit Acceptance Corporation,5.83B,480.97,815.20M,-0.66%,-7.53%,-8.19%,-17.60%,-12.60%,Capital One Spark Cash Plus review: 2% cash back on all eligible purchases,Credit Acceptance Named One of PEOPLE Magazine’s 100 Companies that Care for Third Consecutive Year,,,,Capital One Spark Cash Plus review: 2% cash back on all eligible purchases Credit Acceptance Named One of PEOPLE Magazine’s 100 Companies that Care for Third Consecutive Year,0,0,0,-1,-1,-1
12.11M,"27,459",181.60M,-1,229,480.97,Sell,395.67,"Jul 31, 2024",KRYS,"Krystal Biotech, Inc.",5.79B,201.58,166.23M,3.13%,3.17%,28.80%,-2.18%,+13.27%,Krystal Biotech price target raised to $205 from $195 at BofA,Krystal Biotech (KRYS) Receives a Buy from TD Cowen,Krystal Biotech Reports Promising KB301 Phase 1 Results,Buy Rating Affirmed for Krystal Biotech Following Promising KB301 Study Results,Krystal Biotech price target raised to $221 from $200 at H.C. Wainwright,Krystal Biotech price target raised to $205 from $195 at BofA Krystal Biotech (KRYS) Receives a Buy from TD Cowen Krystal Biotech Reports Promising KB301 Phase 1 Results Buy Rating Affirmed for Krystal Biotech Following Promising KB301 Study Results Krystal Biotech price target raised to $221 from $200 at H.C. Wainwright,0,0,0,0,0,0
28.73M,"124,445",105.94M,-1,"1,500",201.58,Strong Buy,185.10,"Aug 5, 2024",VERX,"Vertex, Inc.",5.76B,37.06,617.83M,4.19%,4.27%,24.22%,-5.15%,+18.46%,Vertex to Present at Goldman Sachs Conference,Vertex completes acquisition of ecosio,Vertex Completes Acquisition of ecosio,"Buy Rating for Vertex Inc.: Strong Demand, Strategic Acquisitions, and ERP Opportunities Fuel Growth Outlook",JMP Securities Reaffirms Their Buy Rating on Vertex (VERX),"Vertex to Present at Goldman Sachs Conference Vertex completes acquisition of ecosio Vertex Completes Acquisition of ecosio Buy Rating for Vertex Inc.: Strong Demand, Strategic Acquisitions, and ERP Opportunities Fuel Growth Outlook JMP Securities Reaffirms Their Buy Rating on Vertex (VERX)",0,0,0,0,0,0
155.52M,"1,000,031",19.78M,-1,"6,197",37.06,Buy,37.73,"Aug 7, 2024",FRHC,Freedom Holding Corp.,5.69B,93.75,1.16B,7.25%,12.56%,18.87%,+8.15%,+30.97%,Freedom Holding reports Q1 EPS 57c vs. $1.15 last year,,,,,Freedom Holding reports Q1 EPS 57c vs. $1.15 last year,1,1,-1,-1,-1,-1
60.75M,"73,093",341.84M,-1,195,93.75,,,"Aug 9, 2024",QXO,"QXO, Inc.",5.69B,13.90,57.11M,22.68%,-69.26%,-81.52%,+12.56%,-86.30%,Trade Tracker: Steve Weiss buys more QXO,Largest borrow rate increases among liquid names,"QXO, Inc. reports Q2 EPS ($9.93) vs 52c last year",Two new option listings on August 9th,,"Trade Tracker: Steve Weiss buys more QXO Largest borrow rate increases among liquid names QXO, Inc. reports Q2 EPS ($9.93) vs 52c last year Two new option listings on August 9th",1,1,1,1,0,-1
409.43M,"6,003,505",-8.14M,-1,"8,063",13.90,,,"Aug 14, 2024",BECN,"Beacon Roofing Supply, Inc.",5.61B,90.60,9.47B,1.65%,-2.79%,-0.79%,-13.59%,-12.95%,Beacon announces PaYS partnership with U.S. Army,"Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: ALD SA (Frankfurt: DE:3AL), Sixt SE (GB:0NW7) and Beacon Roofing Supply (BECN)",,,,"Beacon announces PaYS partnership with U.S. Army Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: ALD SA (Frankfurt: DE:3AL), Sixt SE (GB:0NW7) and Beacon Roofing Supply (BECN)",0,0,1,-1,-1,-1
61.87M,"637,328",-39.50M,-1,"1,302",90.60,Buy,113.78,"Aug 1, 2024",BCPC,Balchem Corporation,5.60B,172.74,932.39M,2.25%,4.18%,14.81%,-3.25%,+14.28%,"Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024",,,,,"Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024",0,0,-1,-1,-1,-1
32.44M,"66,218",116.78M,$1.19,"13,294",172.74,Strong Buy,185.00,"Jul 26, 2024",NXST,"Nexstar Media Group, Inc.",5.53B,171.55,4.99B,0.48%,0.57%,3.38%,-8.37%,+1.12%,"Frequent media bidder Byron Allen draws ire with late payments to ABC, CBS, NBC",Nexstar announces select television stations to become affiliates of CW Network,Nexstar Media Group: Strong Positioning and Financials Warrant a Buy Rating,Gray Television to renew affiliation agreements with CW Network,Election 2024: Where To Put Your Money Ahead of the Vote,"Frequent media bidder Byron Allen draws ire with late payments to ABC, CBS, NBC Nexstar announces select television stations to become affiliates of CW Network Nexstar Media Group: Strong Positioning and Financials Warrant a Buy Rating Gray Television to renew affiliation agreements with CW Network Election 2024: Where To Put Your Money Ahead of the Vote",0,0,1,1,1,1
32.26M,"205,449",432.00M,$6.76,92,171.55,Strong Buy,201.67,"Aug 8, 2024",NUVL,"Nuvalent, Inc.",5.53B,85.32,-,12.29%,9.61%,13.79%,+5.92%,+20.61%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike",Nuvalent price target raised to $100 from $90 at JPMorgan,Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX),Nuvalent (NUVL) Gets a Buy from Piper Sandler,"3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts ","Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Nuvalent price target raised to $100 from $90 at JPMorgan Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX) Nuvalent (NUVL) Gets a Buy from Piper Sandler 3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts ",1,1,0,1,0,0
64.80M,"216,721",-173.59M,-1,60,85.32,Strong Buy,103.13,"Aug 8, 2024",MARA,"Marathon Digital Holdings, Inc.",5.50B,18.69,564.95M,4.04%,-8.93%,-8.34%,-12.91%,-7.05%,Coinbase has worst week of the year as crypto stocks plummet,"Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World","Ether climbs to start the week after crossing $2,600 over the weekend: CNBC Crypto World","Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more",Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said,"Coinbase has worst week of the year as crypto stocks plummet Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World Ether climbs to start the week after crossing $2,600 over the weekend: CNBC Crypto World Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said",0,0,0,0,1,1
294.47M,"29,534,202",288.95M,-1,376,18.69,Buy,19.22,"Aug 1, 2024",MDGL,"Madrigal Pharmaceuticals, Inc.",5.49B,252.74,14.64M,-0.33%,-5.76%,7.41%,-11.90%,+3.19%,Short Report: Bearish positioning in Madrigal Pharmaceuticals at 3-month high,"Paulson buys Everbridge, cuts Anglogold in Q2",,,,"Short Report: Bearish positioning in Madrigal Pharmaceuticals at 3-month high Paulson buys Everbridge, cuts Anglogold in Q2",0,0,0,-1,-1,-1
21.71M,"119,316",-510.45M,-1,465,252.74,Buy,343.83,"Aug 7, 2024",ACT,"Enact Holdings, Inc.",5.48B,35.20,1.19B,4.37%,8.39%,17.86%,+3.00%,+14.10%,Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines,"Enact Re, Ltd. Receives A- Rating from S&P Global Ratings",,,,"Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines Enact Re, Ltd. Receives A- Rating from S&P Global Ratings",0,0,0,-1,-1,-1
155.70M,"226,770",666.16M,$0.74,"4,593",35.20,Buy,33.60,"Jul 31, 2024",ALGM,"Allegro MicroSystems, Inc.",5.47B,24.99,937.99M,4.31%,-8.06%,-12.72%,unch,-8.80%,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","3 Best Stocks to Buy Now, 9/3/2024, According to Top Analysts ",Allegro MicroSystems initiated with a Buy at UBS,"Analysts Offer Insights on Technology Companies: Datadog (DDOG), Fidelity National Info (FIS) and Allegro MicroSystems (ALGM)",,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber 3 Best Stocks to Buy Now, 9/3/2024, According to Top Analysts  Allegro MicroSystems initiated with a Buy at UBS Analysts Offer Insights on Technology Companies: Datadog (DDOG), Fidelity National Info (FIS) and Allegro MicroSystems (ALGM)",1,1,0,1,1,-1
218.92M,"1,027,751",74.17M,-1,"13,500",24.99,Strong Buy,35.29,"Aug 1, 2024",SRCL,"Stericycle, Inc.",5.46B,58.86,2.63B,0.02%,0.48%,13.43%,+0.61%,+13.73%,"Soros buys JD.com, cuts AerCap in Q2",,,,,"Soros buys JD.com, cuts AerCap in Q2",0,0,-1,-1,-1,-1
92.84M,"787,572",36.00M,-1,"2,650",58.86,Hold,74.00,"Jul 25, 2024",SIGI,"Selective Insurance Group, Inc.",5.46B,89.80,4.55B,1.10%,-2.03%,-10.07%,-0.16%,-13.70%,Insurance stocks are racing ahead of the market in the third quarter,Best homeowners insurance in New Jersey,,,,Insurance stocks are racing ahead of the market in the third quarter Best homeowners insurance in New Jersey,0,0,1,-1,-1,-1
60.83M,"266,990",224.06M,$1.40,"7,802",89.80,Hold,98.67,"Jul 18, 2024",OPCH,"Option Care Health, Inc.",5.44B,31.83,4.59B,1.39%,5.09%,1.16%,+5.86%,-1.84%,Option Care Health Board Reshuffles and By-law Amendments,,,,,Option Care Health Board Reshuffles and By-law Amendments,0,0,-1,-1,-1,-1
171.02M,"1,433,626",211.31M,-1,"6,950",31.83,Strong Buy,39.50,"Jul 31, 2024",MMSI,"Merit Medical Systems, Inc.",5.43B,93.29,1.30B,4.51%,8.05%,19.03%,+12.33%,+32.43%,Buy Rating Affirmed: Merit Medical’s WRAPSODY Stent Projected to Drive Strong Growth and Increase Stock Value,,,,,Buy Rating Affirmed: Merit Medical’s WRAPSODY Stent Projected to Drive Strong Growth and Increase Stock Value,0,0,-1,-1,-1,-1
58.21M,"177,305",117.43M,-1,"1,320",93.29,Buy,94.10,"Aug 1, 2024",EXPO,"Exponent, Inc.",5.39B,106.26,508.47M,2.45%,5.72%,20.39%,-0.31%,+34.05%,Exponent management to meet with Truist,,,,,Exponent management to meet with Truist,1,0,-1,-1,-1,-1
50.73M,"132,154",104.84M,$1.12,"4,870",106.26,Strong Buy,120.00,"Oct 24, 2024",CRVL,CorVel Corporation,5.39B,314.57,816.78M,1.16%,9.68%,24.07%,+2.57%,+30.67%,"CERIS Announces Enhanced Offering to Fraud, Waste, and Abuse Solutions",CERIS announces advancements to FWA solutions,,,,"CERIS Announces Enhanced Offering to Fraud, Waste, and Abuse Solutions CERIS announces advancements to FWA solutions",1,1,0,-1,-1,-1
17.13M,"19,531",78.02M,-1,"19,000",314.57,,,"Jul 30, 2024",FCFS,"FirstCash Holdings, Inc.",5.30B,118.52,3.31B,1.03%,5.55%,1.30%,+3.77%,-7.18%,FirstCash Bolsters Financial Flexibility and Growth Potential,,,,,FirstCash Bolsters Financial Flexibility and Growth Potential,1,1,-1,-1,-1,-1
44.75M,"144,075",237.17M,$1.52,"15,300",118.52,Strong Buy,142.50,"Oct 24, 2024",SATS,EchoStar Corporation,5.30B,19.52,16.24B,5.58%,5.38%,27.04%,-4.73%,+43.83%,Judge temporarily blocks sports streaming service Venu over antitrust concerns,DirecTV is pushing its pay TV bundle — without a satellite dish,"Dish Network in talks with creditors to resolve lawsuit, Bloomberg says",Deutsche Bank Keeps Their Buy Rating on Echostar (SATS),"Soros buys JD.com, cuts AerCap in Q2","Judge temporarily blocks sports streaming service Venu over antitrust concerns DirecTV is pushing its pay TV bundle — without a satellite dish Dish Network in talks with creditors to resolve lawsuit, Bloomberg says Deutsche Bank Keeps Their Buy Rating on Echostar (SATS) Soros buys JD.com, cuts AerCap in Q2",1,1,1,0,1,0
271.68M,"736,652",-2.48B,-1,"23,000",19.52,Buy,22.00,"Aug 9, 2024",DOOO,BRP Inc.,5.25B,71.58,7.25B,3.01%,5.53%,5.30%,-2.24%,-2.63%,"BRP Q2 FY2025: Revenue Falls, Guidance Revised",BRP Inc. Faces Earnings Plunge in 2024,Morning Movers: Broadcom sinks after earnings,BRP Inc. cuts FY25 normalized EPS view to C$2.75-C$3.25 from C$6.00-C$7.00,BRP Inc. sees Q3 EPS up between high-single digit to low-teen percentage vs. Q2,"BRP Q2 FY2025: Revenue Falls, Guidance Revised BRP Inc. Faces Earnings Plunge in 2024 Morning Movers: Broadcom sinks after earnings BRP Inc. cuts FY25 normalized EPS view to C$2.75-C$3.25 from C$6.00-C$7.00 BRP Inc. sees Q3 EPS up between high-single digit to low-teen percentage vs. Q2",0,0,0,0,0,0
74.14M,"78,901",423.17M,$0.61,"5,114",71.58,Strong Buy,106.00,"Sep 6, 2024",COLB,"Columbia Banking System, Inc.",5.23B,24.97,1.85B,3.11%,10.97%,16.52%,-5.05%,+35.29%,Barclays Remains a Hold on Columbia Banking System (COLB),Columbia Banking System Announces $0.36 Per Common Share Dividend,,,,Barclays Remains a Hold on Columbia Banking System (COLB) Columbia Banking System Announces $0.36 Per Common Share Dividend,1,1,1,-1,-1,-1
209.48M,"1,697,973",473.60M,$1.44,"1,276",24.97,Hold,25.04,"Oct 16, 2024",RARE,Ultragenyx Pharmaceutical Inc.,5.23B,56.75,481.30M,12.35%,25.85%,28.60%,+28.37%,+15.03%,Stifel Nicolaus Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE),Truist biotech analysts hold an analyst/industry conference call,Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),"Abeona Therapeutics appoints Zeiher, Crombez to board of directors",,"Stifel Nicolaus Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE) Truist biotech analysts hold an analyst/industry conference call Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Abeona Therapeutics appoints Zeiher, Crombez to board of directors",1,1,1,1,1,-1
92.10M,"425,734",-585.12M,-1,"2,635",56.75,Strong Buy,87.47,"Aug 1, 2024",UBSI,"United Bankshares, Inc.",5.22B,38.69,1.01B,4.03%,8.65%,9.99%,-0.74%,+13.45%,"United Bankshares Expands Board, Appoints Dr. DuMond",,,,,"United Bankshares Expands Board, Appoints Dr. DuMond",0,1,-1,-1,-1,-1
134.90M,"503,335",358.04M,$1.48,"1,428",38.69,Hold,40.25,"Jul 25, 2024",AVAV,"AeroVironment, Inc.",5.20B,185.62,716.72M,-0.67%,-0.97%,14.30%,+8.58%,+30.52%,AeroVironment CEO calls drones ‘incredibly affordable’,"Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more","GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines","Stocks making the biggest moves midday: Super Micro, Abercrombie and more","Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more","AeroVironment CEO calls drones ‘incredibly affordable’ Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines Stocks making the biggest moves midday: Super Micro, Abercrombie and more Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more",1,0,1,1,1,1
28.00M,"295,218",59.67M,-1,"1,500",185.62,Buy,187.75,"Sep 4, 2024",FFIN,"First Financial Bankshares, Inc.",5.20B,36.61,496.90M,0.96%,8.06%,16.71%,-5.77%,+15.27%,,,,,,,1,-1,-1,-1,-1,-1
141.92M,"540,296",201.42M,$0.72,"3,212",36.61,Hold,35.25,"Oct 17, 2024",ACIW,"ACI Worldwide, Inc.",5.18B,49.48,1.53B,5.79%,15.85%,43.95%,+13.09%,+51.08%,ACI Worldwide price target raised to $61 from $56 at Seaport Research,Analysts’ Opinions Are Mixed on These Technology Stocks: Keysight Technologies (KEYS) and ACI Worldwide (ACIW),,,,ACI Worldwide price target raised to $61 from $56 at Seaport Research Analysts’ Opinions Are Mixed on These Technology Stocks: Keysight Technologies (KEYS) and ACI Worldwide (ACIW),0,0,0,-1,-1,-1
104.66M,"433,205",183.66M,-1,"1,850",49.48,Strong Buy,44.20,"Aug 1, 2024",TPG,TPG Inc.,5.17B,50.21,2.71B,6.20%,11.48%,18.90%,-2.22%,+12.15%,"ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz","TPG sold stake in Sixth Street back to former credit arm, Semafor reports","ESPN, ABC go dark on DirectTV in feud with Disney, NY Times reports","TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says","Evolent working with adviser on sale after interest, Reuters says","ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz TPG sold stake in Sixth Street back to former credit arm, Semafor reports ESPN, ABC go dark on DirectTV in feud with Disney, NY Times reports TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says Evolent working with adviser on sale after interest, Reuters says",1,0,1,1,0,1
102.87M,"498,002",16.73M,$1.68,"15,000",50.21,Buy,45.90,"Aug 6, 2024",XRAY,DENTSPLY SIRONA Inc.,5.13B,25.31,3.90B,1.45%,0.09%,-16.19%,-8.88%,-23.46%,DENTSPLY SIRONA: A Buy Rating Amid CFO Transition and Robust Growth Targets,Buy Rating Affirmed Despite CFO Departure: Confidence in DENTSPLY SIRONA’s Strategic Initiatives and Growth Prospects,DENTSPLY SIRONA Announces CFO Glenn Coleman’s Departure,Premier names Glenn Coleman as Chief Administrative and Financial Officer,Dentsply Sirona Initiates Search for New CFO,DENTSPLY SIRONA: A Buy Rating Amid CFO Transition and Robust Growth Targets Buy Rating Affirmed Despite CFO Departure: Confidence in DENTSPLY SIRONA’s Strategic Initiatives and Growth Prospects DENTSPLY SIRONA Announces CFO Glenn Coleman’s Departure Premier names Glenn Coleman as Chief Administrative and Financial Officer Dentsply Sirona Initiates Search for New CFO,0,1,1,1,1,0
202.71M,"1,798,231",-185.00M,$0.64,253,25.31,Buy,33.44,"Jul 31, 2024",RNA,"Avidity Biosciences, Inc.",5.10B,43.52,10.60M,-0.78%,1.87%,82.81%,-4.28%,+77.14%,"3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts ","Analysts’ Top Healthcare Picks: Addex Therapeutics (ADXN), Avidity Biosciences (RNA)",Avidity Biosciences initiated with an Overweight at Barclays,Avidity Biosciences price target lowered to $53 from $54 at Evercore ISI,Promising Phase 1/2 Results for Avidity Biosciences Reinforce Buy Rating with New Price Objective,"3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts  Analysts’ Top Healthcare Picks: Addex Therapeutics (ADXN), Avidity Biosciences (RNA) Avidity Biosciences initiated with an Overweight at Barclays Avidity Biosciences price target lowered to $53 from $54 at Evercore ISI Promising Phase 1/2 Results for Avidity Biosciences Reinforce Buy Rating with New Price Objective",1,0,1,1,1,1
117.12M,"606,041",-252.45M,-1,"3,599",43.52,Strong Buy,54.67,"Aug 9, 2024",UMBF,UMB Financial Corporation,5.07B,104.08,1.49B,6.29%,12.41%,23.49%,+0.39%,+23.00%,Barclays Sticks to Its Buy Rating for UMB Financial (UMBF),,,,,Barclays Sticks to Its Buy Rating for UMB Financial (UMBF),0,0,-1,-1,-1,-1
48.75M,"634,379",379.08M,$1.56,"2,600",104.08,Buy,101.00,"Jul 30, 2024",CSWI,"CSW Industrials, Inc.",5.05B,325.18,815.66M,5.55%,12.61%,36.94%,+0.25%,+37.65%,CSW Industrials Announces Upsize and Pricing of Public Offering of Common Stock,CSW Industrials prices 1.1M shares at $285 in upsized public offering,CSW Industrials 1M share Spot Secondary; price range $280.00-$290.00,CSW Industrials files automatic mixed securities shelf,CSW Industrials announces offering of 1M shares of common stock,CSW Industrials Announces Upsize and Pricing of Public Offering of Common Stock CSW Industrials prices 1.1M shares at $285 in upsized public offering CSW Industrials 1M share Spot Secondary; price range $280.00-$290.00 CSW Industrials files automatic mixed securities shelf CSW Industrials announces offering of 1M shares of common stock,0,0,0,0,0,1
15.53M,"49,445",109.63M,$0.84,623,325.18,Strong Buy,,"Jul 31, 2024",RMBS,Rambus Inc.,5.02B,46.65,477.53M,0.44%,-16.11%,-24.85%,-14.60%,-26.86%,,,,,,,1,-1,-1,-1,-1,-1
107.68M,"1,156,387",230.70M,-1,489,46.65,Strong Buy,77.75,"Jul 29, 2024",ASTS,"AST SpaceMobile, Inc.",4.98B,32.86,1.40M,21.41%,74.92%,316.25%,+34.77%,"+1,163.95%","Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more","Buy this satellite stock primed to rally more than 100%, Deutsche Bank says","Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer",Cramer’s Lightning Round: Flutter is a buy,AST SpaceMobile files automatic mixed securities shelf,"Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more Buy this satellite stock primed to rally more than 100%, Deutsche Bank says Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer Cramer’s Lightning Round: Flutter is a buy AST SpaceMobile files automatic mixed securities shelf",1,1,1,1,0,1
151.48M,"17,531,419",-145.12M,-1,"2,744",32.86,Strong Buy,30.23,"Aug 14, 2024",OZK,Bank OZK,4.94B,43.51,1.42B,1.23%,1.16%,-2.88%,-7.66%,-1.99%,Analysts Offer Insights on Financial Companies: Bank OZK (OZK) and CME Group (CME),,,,,Analysts Offer Insights on Financial Companies: Bank OZK (OZK) and CME Group (CME),0,0,-1,-1,-1,-1
113.46M,"1,023,843",685.81M,$1.60,"1,999",43.51,Hold,48.78,"Oct 17, 2024",TENB,"Tenable Holdings, Inc.",4.93B,41.35,852.04M,-2.75%,-3.57%,-8.17%,-10.63%,-15.05%,"Tenable announces risk prioritization, compliance features for Tenable Nessus",Tenable Enhances Nessus Risk Prioritization to Help Customers Expose and Close Exposures,"Tenable, Deckers removed from Best Ideas List at Wedbush",Tenable files to sell 1.45M shares of common stock for holders,Stifel Nicolaus Remains a Buy on Tenable Holdings (TENB),"Tenable announces risk prioritization, compliance features for Tenable Nessus Tenable Enhances Nessus Risk Prioritization to Help Customers Expose and Close Exposures Tenable, Deckers removed from Best Ideas List at Wedbush Tenable files to sell 1.45M shares of common stock for holders Stifel Nicolaus Remains a Buy on Tenable Holdings (TENB)",1,1,1,1,1,1
119.11M,"751,900",-66.17M,-1,"10,070",41.35,Buy,52.94,"Jul 31, 2024",COLM,Columbia Sportswear Company,4.90B,83.74,3.39B,2.35%,3.49%,3.50%,-1.33%,+6.81%,,,,,,,0,-1,-1,-1,-1,-1
58.55M,"217,015",227.41M,$1.20,706,83.74,Hold,77.00,"Jul 25, 2024",APLS,"Apellis Pharmaceuticals, Inc.",4.88B,40.11,628.79M,5.90%,3.86%,-22.50%,-3.59%,-31.71%,Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Apellis Pharmaceuticals to Present at Upcoming Investor Conferences,Apellis price target lowered to $64 from $72 at JPMorgan,Apellis price target raised to $41 from $38 at Wedbush,Wedbush Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS),Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apellis Pharmaceuticals to Present at Upcoming Investor Conferences Apellis price target lowered to $64 from $72 at JPMorgan Apellis price target raised to $41 from $38 at Wedbush Wedbush Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS),0,0,0,0,0,0
121.77M,"551,184",-332.89M,-1,"15,800",40.11,Strong Buy,70.18,"Aug 1, 2024",AVT,"Avnet, Inc.",4.87B,55.30,23.76B,3.19%,4.33%,10.68%,+1.32%,+12.24%,Avnet’s Financial Maneuvers Lead to Sell Rating Amidst Underwhelming Shareholder Value Strategies,"Avnet boosts repurchase pact to $600M, hikes dividend 6% to 33c per share",Avnet Announces New Board Members and Audit Committee Appointments,"Analysts Offer Insights on Technology Companies: MeridianLink (MLNK), Avnet (AVT) and International Business Machines (IBM)",Avnet price target raised to $52 from $48 at Truist,"Avnet’s Financial Maneuvers Lead to Sell Rating Amidst Underwhelming Shareholder Value Strategies Avnet boosts repurchase pact to $600M, hikes dividend 6% to 33c per share Avnet Announces New Board Members and Audit Committee Appointments Analysts Offer Insights on Technology Companies: MeridianLink (MLNK), Avnet (AVT) and International Business Machines (IBM) Avnet price target raised to $52 from $48 at Truist",0,0,0,0,0,0
88.11M,"332,631",498.70M,$1.32,"8,441",55.30,Sell,48.50,"Aug 8, 2024",RDNT,"RadNet, Inc.",4.81B,65.00,1.71B,4.76%,6.13%,34.75%,+9.77%,+33.75%,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more",Broadcom AI results fail to enthuse the Street: Morning Buzz,Coinbase and Robinhood upgraded: Wall Street’s top analyst calls,RadNet’s DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare,"RadNet, Inc. to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024","Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Broadcom AI results fail to enthuse the Street: Morning Buzz Coinbase and Robinhood upgraded: Wall Street’s top analyst calls RadNet’s DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare RadNet, Inc. to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024",1,1,1,1,0,1
73.96M,"307,188",9.92M,-1,"10,833",65.00,Strong Buy,65.50,"Aug 7, 2024",RUN,Sunrun Inc.,4.81B,21.50,2.06B,11.86%,28.95%,48.52%,+17.51%,+74.13%,Oppenheimer’s picks for a Republican or Democratic election sweep,"Wednesday’s top analyst calls: Nvidia, Apple, Netflix, Sunrun, Amazon and more","‘Massive risk’ to number of solar players flying under radar, says GLJ Research","Jefferies power, utilities/energy analyst holds analyst/industry conference call",Sunrun price target raised to $31 from $26 at Jefferies,"Oppenheimer’s picks for a Republican or Democratic election sweep Wednesday’s top analyst calls: Nvidia, Apple, Netflix, Sunrun, Amazon and more ‘Massive risk’ to number of solar players flying under radar, says GLJ Research Jefferies power, utilities/energy analyst holds analyst/industry conference call Sunrun price target raised to $31 from $26 at Jefferies",1,0,1,0,1,0
223.54M,"8,188,510",-1.37B,-1,"2,945",21.50,Buy,23.08,"Aug 6, 2024",LYFT,"Lyft, Inc.",4.79B,11.68,5.10B,6.53%,-5.34%,-19.64%,-4.90%,-35.76%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion,"David Tepper’s Appaloosa slashes Nvidia stake, trims megacap tech positions","Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly",Best commercial auto insurance companies,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion David Tepper’s Appaloosa slashes Nvidia stake, trims megacap tech positions Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly Best commercial auto insurance companies",0,1,0,1,1,1
410.16M,"11,263,145",-64.93M,-1,805,11.68,Buy,16.17,"Aug 7, 2024",ESGR,Enstar Group Limited,4.79B,326.60,1.13B,1.16%,1.37%,9.92%,+0.35%,+10.69%,Enstar Group announces expiration of ‘go-shop’ period,Enstar Announces Expiration of “Go-Shop” Period,Enstar Group completes transaction with Insurance Australia Group,Enstar Completes Previously Announced Transaction with IAG,,Enstar Group announces expiration of ‘go-shop’ period Enstar Announces Expiration of “Go-Shop” Period Enstar Group completes transaction with Insurance Australia Group Enstar Completes Previously Announced Transaction with IAG,1,1,1,1,1,-1
14.67M,"47,701",882.00M,-1,"3,400",326.60,,,"Jul 29, 2024",LANC,Lancaster Colony Corporation,4.78B,173.51,1.87B,-11.83%,-10.99%,-9.84%,-12.53%,-17.29%,Benchmark Co. Keeps Their Hold Rating on Lancaster Colony (LANC),Lancaster Colony price target lowered to $232 from $236 at Loop Capital,Loop Capital Markets Sticks to Their Buy Rating for Lancaster Colony (LANC),Benchmark Co. Sticks to Their Hold Rating for Lancaster Colony (LANC),Lancaster Colony expects Retail segment sales benefit in 2025,Benchmark Co. Keeps Their Hold Rating on Lancaster Colony (LANC) Lancaster Colony price target lowered to $232 from $236 at Loop Capital Loop Capital Markets Sticks to Their Buy Rating for Lancaster Colony (LANC) Benchmark Co. Sticks to Their Hold Rating for Lancaster Colony (LANC) Lancaster Colony expects Retail segment sales benefit in 2025,0,1,1,1,1,0
27.53M,"201,649",158.20M,$3.60,556,173.51,Buy,205.00,"Aug 22, 2024",BBIO,"BridgeBio Pharma, Inc.",4.76B,25.31,219.12M,-0.38%,-3.19%,-17.08%,-4.05%,-11.39%,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more",A Promising Pipeline Ready to Breakout at BridgeBio Pharma (BBIO),BridgeBio reports inducement grants under Nasdaq listing rule,Biotech Alert: Searches spiking for these stocks today,Piper starts BridgeBio with Overweight into expected acoramidis approval,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more A Promising Pipeline Ready to Breakout at BridgeBio Pharma (BBIO) BridgeBio reports inducement grants under Nasdaq listing rule Biotech Alert: Searches spiking for these stocks today Piper starts BridgeBio with Overweight into expected acoramidis approval",0,1,0,0,1,0
188.03M,"784,020",-453.82M,-1,"10,000",25.31,Strong Buy,47.33,"Aug 1, 2024",EEFT,"Euronet Worldwide, Inc.",4.75B,105.72,3.80B,5.88%,3.46%,2.88%,+3.32%,-2.53%,Euronet Worldwide: Strategic Partnerships and Growth Potential Underscore a Buy Rating,,,,,Euronet Worldwide: Strategic Partnerships and Growth Potential Underscore a Buy Rating,0,0,-1,-1,-1,-1
44.91M,"207,255",282.80M,-1,207,105.72,Strong Buy,124.63,"Oct 18, 2024",IMVT,"Immunovant, Inc.",4.75B,32.42,-,6.62%,10.51%,-3.24%,+7.84%,-0.41%,Immunovant’s IMVT-1401: A High Potential Buy Rating for Unmet Graves’ Disease Needs,"Immunovant to Host Graves’ Disease Program Update on September 9, 2024","Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)",Buy Rating Affirmed for Immunovant Amidst Positive Clinical Advancements and Strong Market Prospects,,"Immunovant’s IMVT-1401: A High Potential Buy Rating for Unmet Graves’ Disease Needs Immunovant to Host Graves’ Disease Program Update on September 9, 2024 Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB) Buy Rating Affirmed for Immunovant Amidst Positive Clinical Advancements and Strong Market Prospects",1,0,0,0,0,-1
146.37M,"541,646",-272.55M,-1,"2,202",32.42,Strong Buy,47.50,"Aug 6, 2024",NVEI,Nuvei Corporation,4.72B,33.22,1.31B,0.44%,1.58%,16.92%,+0.48%,+3.39%,Nuvei Corp (NVEI) Announces Q3 Dividend: Read On for Important Dates,,,,,Nuvei Corp (NVEI) Announces Q3 Dividend: Read On for Important Dates,1,0,-1,-1,-1,-1
141.78M,"369,658",-11.38M,$0.40,"3,895",33.22,Hold,32.00,"Aug 6, 2024",BGC,"BGC Group, Inc.",4.72B,9.70,2.05B,8.13%,10.63%,26.28%,+6.30%,+20.42%,Buy/Sell: Wall Street’s top 10 stock calls this week,CME Group downgraded to Underperform at BofA amid intensifying competition,,,,Buy/Sell: Wall Street’s top 10 stock calls this week CME Group downgraded to Underperform at BofA amid intensifying competition,1,0,0,-1,-1,-1
486.60M,"1,723,704",117.30M,$0.08,"1,740",9.70,Buy,11.50,"Jul 30, 2024",SLM,SLM Corporation,4.71B,21.65,1.68B,0.55%,-1.20%,5.86%,-4.98%,+1.60%,"Beat Treasury yields with these dividend-paying bank stocks, Janney says",These banks are cutting CD and savings rates. Where to park cash to get yield,SLM Corporation Announces Board Membership Reduction,"Analysts’ Opinions Are Mixed on These Financial Stocks: Moody’s (MCO), UOB (OtherUOVEF) and SLM (SLM)",Buy Rating for SLM Amid Seasonal Delinquency Trends and Strong Fundamentals,"Beat Treasury yields with these dividend-paying bank stocks, Janney says These banks are cutting CD and savings rates. Where to park cash to get yield SLM Corporation Announces Board Membership Reduction Analysts’ Opinions Are Mixed on These Financial Stocks: Moody’s (MCO), UOB (OtherUOVEF) and SLM (SLM) Buy Rating for SLM Amid Seasonal Delinquency Trends and Strong Fundamentals",0,1,0,0,0,0
217.46M,"693,662",721.08M,$0.44,"6,400",21.65,Buy,23.82,"Jul 24, 2024",FELE,"Franklin Electric Co., Inc.",4.69B,102.74,2.02B,2.28%,3.04%,4.37%,-4.10%,-0.75%,,,,,,,0,-1,-1,-1,-1,-1
45.67M,"82,706",187.71M,$1.00,141,102.74,Buy,95.00,"Jul 23, 2024",DYN,"Dyne Therapeutics, Inc.",4.67B,46.53,-,-0.01%,8.68%,66.16%,+4.89%,+70.23%,Dyne Therapeutics’ Promising DYNE-251 Program Garners Buy Rating Amid Efficacy and Safety Optimism,Buy Rating Reaffirmed for Dyne Therapeutics Amid Promising Clinical Data and Strategic Management Shifts,Buy Rating Affirmed Amidst Dose Adjustments and Promising Trial Results for Dyne Therapeutics,Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’,Stifel views pullback in Dyne Therapeutics shares as buying opportunity,Dyne Therapeutics’ Promising DYNE-251 Program Garners Buy Rating Amid Efficacy and Safety Optimism Buy Rating Reaffirmed for Dyne Therapeutics Amid Promising Clinical Data and Strategic Management Shifts Buy Rating Affirmed Amidst Dose Adjustments and Promising Trial Results for Dyne Therapeutics Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’ Stifel views pullback in Dyne Therapeutics shares as buying opportunity,1,1,1,1,1,1
100.40M,"970,148",-257.60M,-1,"1,300",46.53,Strong Buy,47.33,"Aug 12, 2024",OS,"OneStream, Inc.",4.63B,29.60,406.39M,4.16%,4.67%,4.67%,+6.10%,,"Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen",OneStream price target raised to $35 from $33 at Needham,OneStream price target raised to $37 from $35 at Truist,OneStream price target raised to $34 from $32 at Raymond James,OneStream price target raised to $35 from $34 at Guggenheim,"Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen OneStream price target raised to $35 from $33 at Needham OneStream price target raised to $37 from $35 at Truist OneStream price target raised to $34 from $32 at Raymond James OneStream price target raised to $35 from $34 at Guggenheim",0,1,0,0,0,0
156.58M,"161,798",-10.82M,-1,"2,188",29.60,Strong Buy,33.07,"Sep 3, 2024",QLYS,"Qualys, Inc.",4.60B,125.06,581.08M,-2.60%,-8.03%,-22.75%,-16.55%,-24.50%,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,Qualys’s VMDR Strategy Fuels Growth and Customer Expansion Amidst Economic Challenges,Qualys management to meet with William Blair,,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer Cramer’s Lightning Round: Dell is a buy Qualys’s VMDR Strategy Fuels Growth and Customer Expansion Amidst Economic Challenges Qualys management to meet with William Blair",0,0,0,1,1,-1
36.81M,"196,012",170.61M,-1,"2,100",125.06,Hold,151.71,"Aug 6, 2024",ALKS,Alkermes plc,4.60B,27.95,1.51B,3.23%,9.31%,7.69%,+2.75%,+7.47%,Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680,Fulcrum appoints Isabel Kalofonos as CCO,,,,Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680 Fulcrum appoints Isabel Kalofonos as CCO,0,0,1,-1,-1,-1
164.67M,"870,784",288.72M,-1,475,27.95,Buy,36.70,"Jul 24, 2024",PI,"Impinj, Inc.",4.60B,163.67,314.98M,7.30%,4.37%,30.99%,+2.57%,+34.38%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",,,,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",1,1,-1,-1,-1,-1
28.12M,"171,234",12.37M,-1,"5,613",163.67,Strong Buy,186.78,"Jul 24, 2024",TSEM,Tower Semiconductor Ltd.,4.60B,41.43,1.39B,8.78%,7.11%,26.52%,+5.12%,+31.40%,Tower Semiconductor participates in a conference call with Benchmark,Myriad Uranium Corp. Advances Financing Efforts,,,,Tower Semiconductor participates in a conference call with Benchmark Myriad Uranium Corp. Advances Financing Efforts,0,0,0,-1,-1,-1
111.07M,"339,976",493.98M,-1,"1,788",41.43,Strong Buy,46.33,"Sep 6, 2024",VRRM,Verra Mobility Corporation,4.59B,27.85,853.10M,-1.74%,-2.58%,11.89%,-7.87%,+13.54%,Verra Mobility announces partnership with Xtract,"Verra Mobility CFO Conti sells 25,000 class A shares",Morgan Stanley Remains a Hold on Verra Mobility (VRRM),Analysts Offer Insights on Industrial Goods Companies: Boeing (BA) and Verra Mobility (VRRM),Verra Mobility price target raised to $31 from $28 at Deutsche Bank,"Verra Mobility announces partnership with Xtract Verra Mobility CFO Conti sells 25,000 class A shares Morgan Stanley Remains a Hold on Verra Mobility (VRRM) Analysts Offer Insights on Industrial Goods Companies: Boeing (BA) and Verra Mobility (VRRM) Verra Mobility price target raised to $31 from $28 at Deutsche Bank",1,1,1,1,1,1
164.66M,"699,994",96.70M,-1,"5,081",27.85,Buy,29.00,"Aug 8, 2024",ITRI,"Itron, Inc.",4.58B,101.96,2.35B,2.61%,1.18%,14.39%,-3.03%,+9.63%,Itron initiated with an Outperform at Exane BNP Paribas,Roth MKM Remains a Buy on Itron (ITRI),Itron Poised for Growth Amidst Rising AI-Driven Energy Demand: A Strong Buy Recommendation,Roth MKM Keeps Their Buy Rating on Itron (ITRI),Itron (ITRI) Receives a Buy from Roth MKM,Itron initiated with an Outperform at Exane BNP Paribas Roth MKM Remains a Buy on Itron (ITRI) Itron Poised for Growth Amidst Rising AI-Driven Energy Demand: A Strong Buy Recommendation Roth MKM Keeps Their Buy Rating on Itron (ITRI) Itron (ITRI) Receives a Buy from Roth MKM,0,1,0,1,0,0
44.96M,"351,598",187.60M,-1,"16,500",101.96,Buy,109.55,"Aug 1, 2024",TIGO,Millicom International Cellular S.A.,4.57B,26.68,5.84B,4.46%,7.73%,29.85%,+6.34%,+30.85%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC",Millicom (Tigo) files standard form for notification of major holdings,Buy Rating on Millicom International: Strong Financials and Attractive Valuation,Millicom resumed with an Overweight at JPMorgan,Millicom initiated with a Market Perform at Handelsbanken,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Millicom (Tigo) files standard form for notification of major holdings Buy Rating on Millicom International: Strong Financials and Attractive Valuation Millicom resumed with an Overweight at JPMorgan Millicom initiated with a Market Perform at Handelsbanken",1,1,0,1,1,1
171.31M,"59,659",107.00M,-1,"440,000",26.68,Buy,26.67,"Aug 2, 2024",CNXC,Concentrix Corporation,4.57B,69.95,8.65B,8.31%,10.29%,-2.10%,+5.86%,+26.60%,Concentrix Schedules Release of Third Quarter 2024 Financial Results and Webcast of Investor Conference Call,BofA upgrades Concentrix to Neutral on limited near-term downside,Concentrix upgraded to Neutral from Underperform at BofA,,,Concentrix Schedules Release of Third Quarter 2024 Financial Results and Webcast of Investor Conference Call BofA upgrades Concentrix to Neutral on limited near-term downside Concentrix upgraded to Neutral from Underperform at BofA,1,0,1,0,-1,-1
65.33M,"222,645",258.40M,$1.21,"1,548",69.95,Buy,98.00,"Sep 25, 2024",BRZE,"Braze, Inc.",4.56B,44.86,505.48M,10.16%,15.08%,-1.91%,+1.11%,+3.24%,Broadcom AI results fail to enthuse the Street: Morning Buzz,Scotiabank Sticks to Their Buy Rating for Braze (BRZE),Braze (BRZE) Gets a Buy from Piper Sandler,Braze Inc. (BRZE) Buy Rating Affirmed on Strong Q2 Performance and Growth Prospects,"Braze: A Strong Buy on Early Profitability, Margin Improvement, and Solid Growth Prospects","Broadcom AI results fail to enthuse the Street: Morning Buzz Scotiabank Sticks to Their Buy Rating for Braze (BRZE) Braze (BRZE) Gets a Buy from Piper Sandler Braze Inc. (BRZE) Buy Rating Affirmed on Strong Q2 Performance and Growth Prospects Braze: A Strong Buy on Early Profitability, Margin Improvement, and Solid Growth Prospects",0,1,0,0,0,0
101.63M,"941,779",-126.35M,-1,"22,000",44.86,Strong Buy,60.18,"Sep 5, 2024",FIVE,"Five Below, Inc.",4.54B,82.46,3.64B,13.57%,-6.16%,-46.26%,+8.52%,-51.50%,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General",Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks,"Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more","Stocks making the biggest moves after hours: Nvidia, Salesforce and more",Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Stocks making the biggest moves after hours: Nvidia, Salesforce and more Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings",1,1,1,1,1,0
55.07M,"1,570,539",295.10M,-1,"3,591",82.46,Buy,126.95,"Aug 28, 2024",HWC,Hancock Whitney Corporation,4.53B,52.46,1.30B,4.02%,4.82%,13.38%,-3.00%,+20.96%,Hancock Whitney chief legal officer Phillips to retire,,,,,Hancock Whitney chief legal officer Phillips to retire,1,1,-1,-1,-1,-1
86.35M,"363,991",368.48M,$1.60,"3,749",52.46,Buy,53.92,"Oct 15, 2024",VLY,Valley National Bancorp,4.53B,8.89,1.65B,5.22%,12.72%,2.91%,+2.62%,+14.78%,"Valley Bank CEO on the health of banks, rate cut optimism and bank lending",Valley National Bancorp Announces Board Member Transition,Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends,Valley National Bancorp (VLY) Gets a Sell from Barclays,,"Valley Bank CEO on the health of banks, rate cut optimism and bank lending Valley National Bancorp Announces Board Member Transition Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends Valley National Bancorp (VLY) Gets a Sell from Barclays",1,1,1,0,1,-1
509.22M,"5,554,975",363.15M,$0.44,"9,500",8.89,Hold,8.25,"Jul 25, 2024",IAC,IAC Inc.,4.47B,51.96,4.05B,3.80%,5.87%,2.59%,-2.88%,-1.59%,Benchmark Co. Sticks to Its Buy Rating for IAC/InteractiveCorp. (IAC),FTC agrees to $8.5M settlement with IAC’s Care.com,IAC price target lowered to $66 from $67 at KeyBanc,,,Benchmark Co. Sticks to Its Buy Rating for IAC/InteractiveCorp. (IAC) FTC agrees to $8.5M settlement with IAC’s Care.com IAC price target lowered to $66 from $67 at KeyBanc,1,1,0,1,-1,-1
86.12M,"399,871",-157.91M,-1,290,51.96,Strong Buy,76.40,"Aug 6, 2024",PECO,"Phillips Edison & Company, Inc.",4.47B,36.45,629.74M,4.76%,8.21%,7.12%,+5.07%,+7.84%,Phillips Edison increases monthly dividend distribution by 5.1% to 10.25c p/s,Phillips Edison Announces Upcoming Monthly Share Distributions,Phillips Edison & Company Increases Monthly Dividend Distribution by 5.1% to $0.1025 Per Common Share,Phillips Edison & Company to Present at BofA Securities 2024 Global Real Estate Conference,Phillips Edison upgraded to Equal Weight on better FFO growth at Wells,Phillips Edison increases monthly dividend distribution by 5.1% to 10.25c p/s Phillips Edison Announces Upcoming Monthly Share Distributions Phillips Edison & Company Increases Monthly Dividend Distribution by 5.1% to $0.1025 Per Common Share Phillips Edison & Company to Present at BofA Securities 2024 Global Real Estate Conference Phillips Edison upgraded to Equal Weight on better FFO growth at Wells,1,0,0,0,1,0
122.50M,"482,126",58.72M,$1.17,565,36.45,Hold,36.83,"Jul 25, 2024",CAMT,Camtek Ltd.,4.44B,97.97,368.76M,0.72%,-13.72%,9.26%,-12.20%,+17.60%,Camtek Ltd. Announces Upcoming Shareholder Meeting,,,,,Camtek Ltd. Announces Upcoming Shareholder Meeting,0,0,-1,-1,-1,-1
45.37M,"495,199",95.61M,$1.33,36,97.97,Strong Buy,109.43,"Aug 1, 2024",DJT,Trump Media & Technology Group Corp.,4.44B,22.81,3.43M,-16.18%,-29.51%,-38.10%,-30.06%,-50.48%,Trump Media shares erase 2024 gains as key DJT sale date nears,The latest hiccup in Trump’s crypto launch: Deleted posts and a hacking claim,"Trump Media stock slides under $18, a new low since it began publicly trading","Trump Media stock falls below $20 per share, a first since company went public",Trump says Elon Musk wouldn’t have time to be in his White House cabinet,"Trump Media shares erase 2024 gains as key DJT sale date nears The latest hiccup in Trump’s crypto launch: Deleted posts and a hacking claim Trump Media stock slides under $18, a new low since it began publicly trading Trump Media stock falls below $20 per share, a first since company went public Trump says Elon Musk wouldn’t have time to be in his White House cabinet",0,0,0,0,0,0
194.72M,"4,541,887",-379.18M,-1,"1,400",22.81,,,"Aug 9, 2024",WAY,Waystar Holding Corp.,4.40B,26.39,863.29M,8.11%,15.23%,15.71%,+15.96%,,Jim Cramer revisits 2024′s largest IPOs,Waystar price target raised to $31 from $27 at RBC Capital,RBC Capital Remains a Buy on Waystar Holding Corp. (WAY),Waystar price target raised to $27 from $24 at JPMorgan,Waystar price target raised to $31 from $27 at Deutsche Bank,Jim Cramer revisits 2024′s largest IPOs Waystar price target raised to $31 from $27 at RBC Capital RBC Capital Remains a Buy on Waystar Holding Corp. (WAY) Waystar price target raised to $27 from $24 at JPMorgan Waystar price target raised to $31 from $27 at Deutsche Bank,0,0,0,0,0,0
166.66M,"567,086",-73.52M,-1,"3,000",26.39,Strong Buy,28.50,"Aug 7, 2024",SHC,Sotera Health Company,4.37B,15.42,1.10B,7.15%,18.21%,15.91%,+9.52%,+33.95%,Sotera Health Board Changes and Shareholder Stock Sale,Sotera Health Announces Secondary Offering of Common Stock,,,,Sotera Health Board Changes and Shareholder Stock Sale Sotera Health Announces Secondary Offering of Common Stock,1,1,0,-1,-1,-1
283.21M,"1,747,017",39.94M,-1,,15.42,Buy,15.70,"Aug 5, 2024",VNOM,"Viper Energy, Inc.",4.34B,47.41,878.51M,6.76%,15.63%,33.69%,+12.37%,+22.20%,Viper Energy price target raised to $52 from $47 at Barclays,Piper Sandler Sticks to Their Buy Rating for Viper Energy (VNOM),Viper Energy price target raised to $57 from $44 at Piper Sandler,,,Viper Energy price target raised to $52 from $47 at Barclays Piper Sandler Sticks to Their Buy Rating for Viper Energy (VNOM) Viper Energy price target raised to $57 from $44 at Piper Sandler,0,0,0,0,-1,-1
91.45M,"628,695",235.48M,$2.56,407,47.41,Strong Buy,45.14,"Aug 5, 2024",CRSP,CRISPR Therapeutics AG,4.31B,48.69,202.23M,-2.87%,-10.73%,-22.39%,-17.12%,-24.52%,Oruka announces closing of merger with ARCA Biopharma,Crispr Therapeutics call volume above normal and directionally bullish,Crispr Therapeutics price target lowered to $100 from $120 at Truist,Crispr Therapeutics AG (CRSP) Receives a Buy from Truist Financial,,Oruka announces closing of merger with ARCA Biopharma Crispr Therapeutics call volume above normal and directionally bullish Crispr Therapeutics price target lowered to $100 from $120 at Truist Crispr Therapeutics AG (CRSP) Receives a Buy from Truist Financial,0,0,1,0,0,-1
,,,-1,"1,559",,,,,FIZZ,National Beverage Corp.,4.29B,45.84,1.19B,-3.01%,-6.33%,-1.28%,-6.89%,-8.43%,National Beverage reports Q1 EPS 61c vs. 53c last year,FIZZ Upcoming Earnings Report: What to Expect?,LaCroix enters multi-year partnership with Kansas City Current,,,National Beverage reports Q1 EPS 61c vs. 53c last year FIZZ Upcoming Earnings Report: What to Expect? LaCroix enters multi-year partnership with Kansas City Current,0,1,1,1,-1,-1
88.52M,"705,053",-265.80M,-1,624,48.69,Buy,74.38,"Aug 5, 2024",ADMA,"ADMA Biologics, Inc.",4.29B,18.40,330.24M,13.79%,30.22%,122.11%,+40.39%,+169.80%,Cramer’s Lightning Round: ADMA Biologics is ‘a very speculative situation’,"Lightning Round: MP Materials needs to pull out of the ‘tailspin of losses’, says Jim Cramer",Largest borrow rate increases among liquid names,ADMA Biologics Announces Partial Paydown of Revolving Credit Facility,Adma Biologics announces partial paydown of revolving credit facility,"Cramer’s Lightning Round: ADMA Biologics is ‘a very speculative situation’ Lightning Round: MP Materials needs to pull out of the ‘tailspin of losses’, says Jim Cramer Largest borrow rate increases among liquid names ADMA Biologics Announces Partial Paydown of Revolving Credit Facility Adma Biologics announces partial paydown of revolving credit facility",0,0,0,1,0,0
93.58M,"134,595",176.73M,$3.25,"7,239",45.84,Strong Sell,48.00,"Sep 5, 2024",STNE,StoneCo Ltd.,4.27B,13.94,2.18B,0.95%,4.10%,-11.86%,-0.76%,-22.64%,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded","These high-quality small-cap stocks are a buy, Bank of America says","Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz","Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded These high-quality small-cap stocks are a buy, Bank of America says Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz",1,1,1,1,1,1
233.08M,"4,020,663",34.79M,-1,"13,500",18.40,Strong Buy,15.50,"Aug 8, 2024",SGRY,"Surgery Partners, Inc.",4.26B,33.69,2.89B,9.38%,18.20%,11.92%,+5.43%,+16.65%,Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY),"TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says",Surgery Partners up 14% to $32.62 after Bloomberg says UNH among bidders,"UnitedHealth, TPG among suitors for Surgery Partners, Bloomberg says",Surgery Partners’ Strong Q2 Performance and Upward 2024 Guidance Fuel Buy Rating,"Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY) TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says Surgery Partners up 14% to $32.62 after Bloomberg says UNH among bidders UnitedHealth, TPG among suitors for Surgery Partners, Bloomberg says Surgery Partners’ Strong Q2 Performance and Upward 2024 Guidance Fuel Buy Rating",0,0,0,0,0,0
306.34M,"3,325,349",347.49M,-1,290,13.94,Buy,18.54,"Aug 14, 2024",CRNX,"Crinetics Pharmaceuticals, Inc.",4.25B,53.15,1.39M,5.83%,9.08%,27.95%,+2.41%,+14.45%,Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE)",Buy Rating Affirmed for Crinetics Pharmaceuticals on Strong Pipeline and Regulatory Progress,Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Morgan Stanley Sticks to Its Buy Rating for Crinetics Pharmaceuticals (CRNX),"Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE) Buy Rating Affirmed for Crinetics Pharmaceuticals on Strong Pipeline and Regulatory Progress Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Morgan Stanley Sticks to Its Buy Rating for Crinetics Pharmaceuticals (CRNX)",0,0,0,0,0,0
126.39M,"1,663,026",-33.80M,-1,"8,509",33.69,Buy,39.86,"Aug 6, 2024",RUSHA,"Rush Enterprises, Inc.",4.22B,53.64,7.91B,1.49%,10.63%,13.94%,+2.25%,+0.12%,Rush Enterprises A Enhances Investor Engagement with New Presentation,,,,,Rush Enterprises A Enhances Investor Engagement with New Presentation,1,1,-1,-1,-1,-1
80.04M,"455,658",-258.54M,-1,545,53.15,Strong Buy,66.00,"Aug 8, 2024",AXSM,"Axsome Therapeutics, Inc.",4.22B,87.99,291.49M,3.42%,6.86%,13.83%,+1.28%,+22.39%,Biotech Alert: Searches spiking for these stocks today,Axsome Therapeutics (AXSM) Gets a Buy from Cantor Fitzgerald,Buy Rating Affirmed for Axsome Therapeutics on Robust Pipeline and Promising Regulatory Prospects,Buy Rating Affirmed for Axsome Therapeutics on Strong Pipeline and Promising Drug Trials,Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine,Biotech Alert: Searches spiking for these stocks today Axsome Therapeutics (AXSM) Gets a Buy from Cantor Fitzgerald Buy Rating Affirmed for Axsome Therapeutics on Robust Pipeline and Promising Regulatory Prospects Buy Rating Affirmed for Axsome Therapeutics on Strong Pipeline and Promising Drug Trials Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine,1,1,1,1,1,0
78.76M,"271,256",308.59M,$0.72,"10,000",53.64,Buy,60.00,"Oct 22, 2024",AEIS,"Advanced Energy Industries, Inc.",4.17B,110.70,1.51B,3.67%,0.69%,5.60%,-8.43%,+8.78%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC","Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls",Advanced Energy initiated with a Buy at Stifel,,,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls Advanced Energy initiated with a Buy at Stifel",0,1,1,1,-1,-1
48.00M,"266,874",-308.55M,-1,"5,800",87.99,Strong Buy,124.83,"Aug 5, 2024",LOPE,"Grand Canyon Education, Inc.",4.13B,142.29,1.00B,-1.95%,-1.36%,3.39%,-7.98%,+8.34%,Buy Rating Affirmed for Grand Canyon Education Amid Strong Financial Performance and Positive Outlook,,,,,Buy Rating Affirmed for Grand Canyon Education Amid Strong Financial Performance and Positive Outlook,1,0,-1,-1,-1,-1
37.67M,"162,966",90.47M,$0.40,"3,000",110.60,Buy,113.25,"Jul 30, 2024",BLKB,"Blackbaud, Inc.",4.13B,81.77,1.14B,5.90%,6.72%,6.22%,+3.20%,+13.76%,,,,,,,1,-1,-1,-1,-1,-1
29.05M,"82,055",219.34M,-1,"8,509",142.29,Buy,165.67,"Aug 6, 2024",RUSHB,"Rush Enterprises, Inc.",4.13B,47.80,7.91B,,6.72%,6.22%,-0.51%,-7.75%,Rush Enterprises A Enhances Investor Engagement with New Presentation,,,,,Rush Enterprises A Enhances Investor Engagement with New Presentation,0,1,-1,-1,-1,-1
50.52M,"148,378",41.47M,-1,626,81.77,Buy,92.00,"Jul 30, 2024",PRCT,PROCEPT BioRobotics Corporation,4.12B,79.34,176.58M,23.69%,25.58%,53.04%,+26.36%,+70.09%,Cramer’s Lightning Round: ‘I like Zoetis very much’,BTIG medical technology analyst holds an analyst/industry conference call,"PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024",Procept BioRobotics management to meet with Truist,PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial,"Cramer’s Lightning Round: ‘I like Zoetis very much’ BTIG medical technology analyst holds an analyst/industry conference call PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 Procept BioRobotics management to meet with Truist PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial",0,0,0,0,0,0
78.76M,"27,926",308.59M,$0.72,"1,653",47.80,,,"Oct 22, 2024",NCNO,"nCino, Inc.",4.03B,35.00,490.96M,4.77%,6.95%,9.93%,-9.22%,-13.07%,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","Stocks making the biggest moves midday: Super Micro, Abercrombie and more","Stocks making biggest moves premarket: Super Micro, Abercrombie and more","Stocks making the biggest moves after hours: Nordstrom, SentinelOne and more",Goldman believes this maker of software for banks offers 30% upside,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Stocks making the biggest moves midday: Super Micro, Abercrombie and more Stocks making biggest moves premarket: Super Micro, Abercrombie and more Stocks making the biggest moves after hours: Nordstrom, SentinelOne and more Goldman believes this maker of software for banks offers 30% upside",0,1,1,1,1,1
51.93M,"509,002",-103.71M,-1,607,79.34,Strong Buy,70.67,"Aug 1, 2024",IPAR,"Inter Parfums, Inc.",4.02B,125.66,1.36B,-4.19%,-0.33%,-5.06%,-11.45%,-5.06%,,,,,,,1,-1,-1,-1,-1,-1
115.08M,"905,745",-34.08M,-1,"7,500",35.00,Buy,37.31,"Aug 27, 2024",LITE,Lumentum Holdings Inc.,4.02B,59.17,1.36B,17.24%,11.75%,18.69%,+9.25%,+23.25%,"Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more","Stocks making the biggest moves premarket: Ulta Beauty, Walmart, Cisco Systems and more","Stocks making the biggest moves after hours: Cisco, Ulta, Nike and more",Lumentum management to meet with B. Riley,"Top Stock Gainers Today – PANW, SIRI, and More","Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more Stocks making the biggest moves premarket: Ulta Beauty, Walmart, Cisco Systems and more Stocks making the biggest moves after hours: Cisco, Ulta, Nike and more Lumentum management to meet with B. Riley Top Stock Gainers Today – PANW, SIRI, and More",1,1,1,1,0,1
32.02M,"84,424",141.51M,$3.00,"14,000",125.66,Strong Buy,163.75,"Aug 6, 2024",ICUI,"ICU Medical, Inc.",3.99B,163.55,2.30B,13.36%,25.29%,53.84%,+28.45%,+60.39%,ICU Medical to Participate in Upcoming Investor Conferences,,,,,ICU Medical to Participate in Upcoming Investor Conferences,1,0,-1,-1,-1,-1
67.90M,"1,647,651",-546.50M,-1,"2,115",59.17,Buy,58.36,"Aug 14, 2024",FORM,"FormFactor, Inc.",3.98B,51.41,705.94M,7.26%,-6.49%,8.45%,-8.53%,+5.83%,FormFactor Announces Participation at Upcoming Conferences,,,,,FormFactor Announces Participation at Upcoming Conferences,0,1,-1,-1,-1,-1
24.43M,"178,053",-70.79M,-1,875,163.55,Buy,138.33,"Aug 7, 2024",GBDC,"Golub Capital BDC, Inc.",3.97B,14.99,664.81M,2.87%,-0.67%,-2.36%,-1.90%,-9.81%,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,Bank of America Securities Sticks to Its Buy Rating for Golub Capital Bdc (GBDC),,,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer Cramer’s Lightning Round: Dell is a buy Bank of America Securities Sticks to Its Buy Rating for Golub Capital Bdc (GBDC)",0,0,0,0,-1,-1
77.39M,"368,875",121.39M,-1,"22,012",51.41,Buy,59.63,"Jul 31, 2024",ASO,"Academy Sports and Outdoors, Inc.",3.93B,54.49,6.14B,7.18%,5.48%,-5.10%,+1.31%,-13.66%,Tuesday’s stock stories: What’s likely to move the market in the next session,"Analyst calls: Warner Bros. Discovery gets downgraded, cybersecurity stock a buy",ASO Earnings this Week: How Will it Perform?,Academy Sports + Outdoors Announces Quarterly Cash Dividend,Telsey Advisory Remains a Buy on Academy Sports and Outdoors (ASO),"Tuesday’s stock stories: What’s likely to move the market in the next session Analyst calls: Warner Bros. Discovery gets downgraded, cybersecurity stock a buy ASO Earnings this Week: How Will it Perform? Academy Sports + Outdoors Announces Quarterly Cash Dividend Telsey Advisory Remains a Buy on Academy Sports and Outdoors (ASO)",1,0,0,0,1,1
264.61M,"1,640,393",280.15M,$1.16,48,14.99,Buy,16.36,"Aug 5, 2024",SBRA,"Sabra Health Care REIT, Inc.",3.90B,16.63,665.99M,2.70%,5.67%,15.45%,+3.45%,+15.95%,Sabra Health Care price target raised to $18 from $16 at Truist,Sabra Health Care price target raised to $17 from $15 at Scotiabank,Sabra Healthcare REIT (SBRA) Gets a Hold from Wells Fargo,Sabra Health Care price target raised to $16 from $14 at Wells Fargo,Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects,Sabra Health Care price target raised to $18 from $16 at Truist Sabra Health Care price target raised to $17 from $15 at Scotiabank Sabra Healthcare REIT (SBRA) Gets a Hold from Wells Fargo Sabra Health Care price target raised to $16 from $14 at Wells Fargo Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects,0,0,0,0,0,0
72.13M,"1,132,561",501.69M,$0.44,"3,121",54.49,Buy,65.56,"Sep 6, 2024",QFIN,"Qifu Technology, Inc.",3.88B,25.02,2.35B,16.57%,24.54%,43.76%,+26.05%,+32.78%,Qifu Technology (QFIN) Discloses Q4 Dividend: What Shareholders Should Know,Qifu Technology price target raised to $28.40 from $25 at BofA,Qifu Technology (QFIN) Gets a Buy from Bank of America Securities,"Is QFIN a Buy, Before Earnings?",,"Qifu Technology (QFIN) Discloses Q4 Dividend: What Shareholders Should Know Qifu Technology price target raised to $28.40 from $25 at BofA Qifu Technology (QFIN) Gets a Buy from Bank of America Securities Is QFIN a Buy, Before Earnings?",1,1,0,1,1,-1
234.26M,"1,827,975",52.28M,$1.20,"2,292",16.63,Strong Buy,16.56,"Aug 7, 2024",IBOC,International Bancshares Corporation,3.88B,62.45,798.42M,2.31%,2.59%,12.57%,-7.15%,+13.01%,,,,,,,1,-1,-1,-1,-1,-1
155.25M,"2,071,398",660.34M,$1.18,"34,000",25.02,Strong Buy,23.80,"Aug 13, 2024",SANM,Sanmina Corporation,3.87B,70.76,7.60B,-0.95%,-0.38%,13.23%,-9.20%,+14.00%,,,,,,,0,-1,-1,-1,-1,-1
62.19M,"322,559",403.95M,$1.32,819,62.45,,,"Aug 1, 2024",POWI,"Power Integrations, Inc.",3.86B,67.90,412.90M,0.39%,-6.24%,-11.23%,-12.62%,-7.32%,Power Integrations Announces VP of Worldwide Sales Transition,Power Integrations participates in a conference call with Benchmark,Power Integrations upgraded to Outperform from Market Perform at Northland,,,Power Integrations Announces VP of Worldwide Sales Transition Power Integrations participates in a conference call with Benchmark Power Integrations upgraded to Outperform from Market Perform at Northland,0,0,0,0,-1,-1
54.65M,"367,415",223.00M,-1,"8,427",70.76,Sell,53.50,"Jul 29, 2024",IESC,"IES Holdings, Inc.",3.84B,192.43,2.76B,9.48%,19.48%,53.66%,+14.51%,+31.94%,IES Holdings Announces Board Member Elizabeth Leykum’s Resignation,,,,,IES Holdings Announces Board Member Elizabeth Leykum’s Resignation,1,1,-1,-1,-1,-1
56.83M,"268,832",42.87M,$0.80,"1,846",67.90,Buy,78.50,"Aug 6, 2024",SLAB,Silicon Laboratories Inc.,3.82B,118.32,542.35M,10.83%,5.70%,-3.17%,-5.01%,-13.04%,Op-ed: Small caps could be in for a revival. Here’s why,,,,,Op-ed: Small caps could be in for a revival. Here’s why,1,1,-1,-1,-1,-1
19.98M,"178,824",173.74M,-1,"2,655",192.43,,,"Aug 2, 2024",OTTR,Otter Tail Corporation,3.80B,90.89,1.36B,-4.06%,-3.42%,0.42%,-12.60%,-1.67%,"Analysts Offer Insights on Utilities Companies: Montauk Renewables (MNTK), Otter Tail (OTTR) and Enel Chile SA (ENIC)",,,,,"Analysts Offer Insights on Utilities Companies: Montauk Renewables (MNTK), Otter Tail (OTTR) and Enel Chile SA (ENIC)",0,1,-1,-1,-1,-1
32.29M,"344,788",-198.12M,-1,"1,388",118.32,Buy,130.14,"Jul 24, 2024",UPST,"Upstart Holdings, Inc.",3.76B,42.00,575.96M,29.66%,53.95%,53.99%,+50.66%,+70.64%,5 best installment loans for bad credit of September 2024,Hedge fund manager Eric Jackson reveals his next ‘back-from-the-dead’ AI pick,Easiest personal loans to get,Best home improvement loans,Best hardship loans,5 best installment loans for bad credit of September 2024 Hedge fund manager Eric Jackson reveals his next ‘back-from-the-dead’ AI pick Easiest personal loans to get Best home improvement loans Best hardship loans,1,0,0,0,0,0
41.83M,"152,093",311.07M,$1.87,"5,000",90.89,,,"Aug 5, 2024",PAGP,"Plains GP Holdings, L.P.",3.76B,19.05,49.70B,1.21%,-0.04%,7.49%,-2.77%,-3.78%,Plains GP Holdings (PAGP) Gets a Buy from Morgan Stanley,Barclays Keeps Their Sell Rating on Plains GP Holdings (PAGP),,,,Plains GP Holdings (PAGP) Gets a Buy from Morgan Stanley Barclays Keeps Their Sell Rating on Plains GP Holdings (PAGP),1,1,1,-1,-1,-1
89.51M,"6,605,845",-201.78M,-1,995,42.00,Sell,25.14,"Aug 6, 2024",TFSL,TFS Financial Corporation,3.75B,13.46,305.49M,2.89%,3.69%,2.92%,-0.59%,+10.22%,,,,,,,1,-1,-1,-1,-1,-1
197.26M,"875,032",162.00M,$1.22,130,19.05,Buy,20.11,"Aug 2, 2024",ACLX,"Arcellx, Inc.",3.73B,69.38,144.75M,17.22%,20.34%,23.26%,+12.12%,+11.38%,Arcellx initiated with an Overweight at Cantor Fitzgerald,Buy Rating for Arcellx Inc. on Strong Oncology Program Progress and Promising CAR-T Therapy Developments,Buy Rating Affirmed for Arcellx Inc. on Strong CAR-T Therapy Prospects and Financial Stability,ACLX Upcoming Earnings Report: What to Expect?,"Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)","Arcellx initiated with an Overweight at Cantor Fitzgerald Buy Rating for Arcellx Inc. on Strong Oncology Program Progress and Promising CAR-T Therapy Developments Buy Rating Affirmed for Arcellx Inc. on Strong CAR-T Therapy Prospects and Financial Stability ACLX Upcoming Earnings Report: What to Expect? Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)",1,1,1,1,1,1
278.33M,"176,543",79.42M,$1.13,"1,620",13.46,Hold,14.00,"Jul 30, 2024",ACLS,"Axcelis Technologies, Inc.",3.73B,114.22,1.11B,-1.60%,-13.49%,-8.48%,-13.72%,+3.59%,,,,,,,1,-1,-1,-1,-1,-1
53.76M,"537,803",-53.89M,-1,"1,716",69.38,Strong Buy,76.67,"Aug 8, 2024",FTDR,"Frontdoor, Inc.",3.71B,48.52,1.81B,7.28%,23.24%,39.11%,+20.48%,+54.60%,,,,,,,0,-1,-1,-1,-1,-1
32.62M,"488,009",239.45M,-1,"10,600",114.22,Strong Buy,169.80,"Jul 31, 2024",PTEN,"Patterson-UTI Energy, Inc.",3.66B,9.31,5.45B,-0.65%,-6.18%,-15.08%,-17.47%,-27.56%,Patterson-UTI Engages Investors with Informative Presentation,"Ex-Dividend Date Nearing for These 9 Stocks – Week of September 2, 2024",Patterson-UTI price target lowered to $14 from $15 at Barclays,"Analysts Offer Insights on Energy Companies: Patterson-UTI (PTEN), Phillips 66 (PSX) and Magnolia Oil & Gas (MGY)",,"Patterson-UTI Engages Investors with Informative Presentation Ex-Dividend Date Nearing for These 9 Stocks – Week of September 2, 2024 Patterson-UTI price target lowered to $14 from $15 at Barclays Analysts Offer Insights on Energy Companies: Patterson-UTI (PTEN), Phillips 66 (PSX) and Magnolia Oil & Gas (MGY)",0,0,0,0,0,-1
76.52M,"687,090",206.00M,-1,229,48.52,Buy,44.83,"Aug 1, 2024",MRUS,Merus N.V.,3.66B,53.59,35.19M,2.12%,-2.23%,23.84%,-2.39%,+15.82%,"Merus, Foundation Medicine collaborate to advance treatments for NRG1+","Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)","Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Brookdale Senior Living (BKD) and Arrowhead Pharmaceuticals (ARWR)",,,"Merus, Foundation Medicine collaborate to advance treatments for NRG1+ Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI) Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Brookdale Senior Living (BKD) and Arrowhead Pharmaceuticals (ARWR)",1,1,0,0,-1,-1
393.05M,"4,441,018",124.31M,$0.32,990,9.31,Buy,14.59,"Jul 24, 2024",STEP,StepStone Group Inc.,3.65B,53.68,720.02M,7.60%,13.04%,45.09%,+6.29%,+49.09%,StepStone Group to Present at the Barclays Global Financial Services Conference,Stepstone Group price target raised to $55 from $44 at UBS,Stepstone Group price target raised to $52 from $43 at Morgan Stanley,Maintaining Hold on StepStone Group Amid Balanced Risk/Reward and Revised Earnings Estimates,J.P. Morgan Reaffirms Their Buy Rating on StepStone Group (STEP),StepStone Group to Present at the Barclays Global Financial Services Conference Stepstone Group price target raised to $55 from $44 at UBS Stepstone Group price target raised to $52 from $43 at Morgan Stanley Maintaining Hold on StepStone Group Amid Balanced Risk/Reward and Revised Earnings Estimates J.P. Morgan Reaffirms Their Buy Rating on StepStone Group (STEP),1,1,1,0,1,1
68.21M,"159,215",-167.66M,-1,"2,917",53.59,Strong Buy,82.20,"Aug 1, 2024",NEOG,Neogen Corporation,3.64B,16.78,924.22M,3.58%,4.66%,7.58%,-1.23%,+17.21%,Neogen Showcases Food Safety Innovations at Healthcare Conference,,,,,Neogen Showcases Food Safety Innovations at Healthcare Conference,0,0,-1,-1,-1,-1
67.93M,"517,089",50.15M,$0.45,352,53.68,Hold,49.81,"Aug 8, 2024",CORT,Corcept Therapeutics Incorporated,3.64B,34.79,569.61M,-0.59%,4.79%,25.67%,-10.94%,+36.67%,Buy Rating Affirmed for Corcept Therapeutics on Strong Financials and Promising Drug Pipeline,,,,,Buy Rating Affirmed for Corcept Therapeutics on Strong Financials and Promising Drug Pipeline,0,1,-1,-1,-1,-1
216.69M,"1,890,720",-9.42M,-1,,16.78,Hold,17.50,"Oct 8, 2024",LLYVK,Liberty Live Group,3.63B,39.61,-,4.23%,5.82%,5.91%,+3.69%,-6.92%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
104.49M,"619,862",124.96M,-1,"3,000",34.79,Strong Buy,56.50,"Jul 29, 2024",STRL,"Sterling Infrastructure, Inc.",3.63B,118.10,2.07B,6.35%,2.52%,18.32%,+0.14%,+8.34%,Veteran Board Member Retires from Sterling Construction,,,,,Veteran Board Member Retires from Sterling Construction,1,1,-1,-1,-1,-1
91.72M,"113,867",,-1,579,39.61,,,,TRMD,TORM plc,3.61B,38.32,1.63B,3.16%,2.76%,11.62%,-4.03%,+4.95%,TORM Expands Capital with New Share Issuance,TORM plc Announces Share Capital Increase,Torm (TRMD) Receives a Buy from Evercore ISI,TORM Reports Strong Q2 Growth and Fleet Expansion,TORM plc Announces Strong Q2 Results and Dividends,TORM Expands Capital with New Share Issuance TORM plc Announces Share Capital Increase Torm (TRMD) Receives a Buy from Evercore ISI TORM Reports Strong Q2 Growth and Fleet Expansion TORM plc Announces Strong Q2 Results and Dividends,1,0,0,0,1,0
,,,-1,,,,,,LLYVA,Liberty Live Group,3.61B,38.83,-,4.69%,6.59%,7.02%,+4.90%,-6.67%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
30.73M,"149,796",162.45M,-1,"4,900",118.10,Hold,115.00,"Aug 5, 2024",FRSH,Freshworks Inc.,3.61B,11.95,652.94M,4.07%,-1.69%,-29.54%,-6.96%,-35.99%,"Tiger Global buys Qualcomm, exits Instacart in Q2",Freshworks CPO Resigns for New Opportunities,,,,"Tiger Global buys Qualcomm, exits Instacart in Q2 Freshworks CPO Resigns for New Opportunities",1,1,1,-1,-1,-1
94.00M,"734,373",713.17M,$7.20,557,38.32,Buy,48.00,"Aug 15, 2024",IOVA,"Iovance Biotherapeutics, Inc.",3.60B,11.87,32.77M,16.45%,28.32%,15.49%,+29.78%,-16.26%,Iovance Biotherapeutics to Present at Upcoming Conferences,Iovance Biotherapeutics put volume heavy and directionally bearish,Iovance Biotherapeutics call volume above normal and directionally bullish,"Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli",Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),"Iovance Biotherapeutics to Present at Upcoming Conferences Iovance Biotherapeutics put volume heavy and directionally bearish Iovance Biotherapeutics call volume above normal and directionally bullish Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",0,1,1,1,1,1
,"72,820",,-1,999,38.83,Strong Buy,56.00,,ALVO,Alvotech,3.59B,11.89,308.73M,0.74%,-2.74%,-8.36%,-0.43%,-3.08%,Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,Alvotech files to sell 1.79M ordinary shares for holders,Alvotech’s Strong Q2 Performance and Positive Outlook Justify Buy Rating,Alvotech Reports Revenue Surge Amidst Expansion,Alvotech’s Biosimilar AVT06 Eyes European Market,Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Alvotech files to sell 1.79M ordinary shares for holders Alvotech’s Strong Q2 Performance and Positive Outlook Justify Buy Rating Alvotech Reports Revenue Surge Amidst Expansion Alvotech’s Biosimilar AVT06 Eyes European Market,0,0,0,0,0,0
,,,-1,"1,779",,,,,GH,"Guardant Health, Inc.",3.57B,29.02,643.81M,-13.72%,-13.78%,6.30%,-25.42%,+44.35%,Guardant Health management to meet with Craig-Hallum,Buy Rating Affirmed for Guardant Health Amidst Expanding MRD Market and AI Integration,Boeing’s Starliner to return without astronauts: Morning Buzz,Scotiabank Keeps Their Buy Rating on Guardant Health (GH),"Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)","Guardant Health management to meet with Craig-Hallum Buy Rating Affirmed for Guardant Health Amidst Expanding MRD Market and AI Integration Boeing’s Starliner to return without astronauts: Morning Buzz Scotiabank Keeps Their Buy Rating on Guardant Health (GH) Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)",0,0,0,1,1,1
302.09M,"1,127,432",-102.62M,-1,"1,008",11.95,Buy,19.47,"Jul 30, 2024",CLBT,Cellebrite DI Ltd.,3.57B,17.15,346.76M,19.60%,31.67%,60.73%,+24.16%,+49.21%,Cellebrite DI Ltd. Sets Terms for Warrant Redemption,Cellebrite announces ‘Redemption Fair Market Value’,Cellebrite DI Announces Warrant Redemption Plan,"Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS)",Cellebrite price target raised to $17 from $13.50 at Lake Street,"Cellebrite DI Ltd. Sets Terms for Warrant Redemption Cellebrite announces ‘Redemption Fair Market Value’ Cellebrite DI Announces Warrant Redemption Plan Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS) Cellebrite price target raised to $17 from $13.50 at Lake Street",0,0,0,0,0,0
303.51M,"5,124,738",-440.22M,-1,"28,000",11.87,Strong Buy,24.80,"Aug 8, 2024",URBN,"Urban Outfitters, Inc.",3.56B,38.59,5.32B,-9.27%,-14.30%,-8.66%,-20.39%,-7.77%,"2 stocks that are winning the back-to-school shopping season, per Morgan Stanley","Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more","Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more",Jim Cramer says market-share gains are fueling this cyber stock’s rally,"Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video","2 stocks that are winning the back-to-school shopping season, per Morgan Stanley Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Jim Cramer says market-share gains are fueling this cyber stock’s rally Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video",0,0,1,1,0,1
301.64M,"33,528",-618.38M,-1,"3,516",11.89,Buy,14.00,"Aug 15, 2024",ZI,ZoomInfo Technologies Inc.,3.55B,9.72,1.23B,1.81%,-11.21%,-31.76%,-14.44%,-36.55%,"These stocks are contenders for selling — and can help cut taxes, Wolfe says",ZoomInfo Technologies Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – ZI,Stifel Nicolaus Keeps Their Buy Rating on ZoomInfo Technologies (ZI),ZoomInfo downgraded to Neutral from Outperform at Daiwa,ZoomInfo Technologies put volume heavy and directionally bearish,"These stocks are contenders for selling — and can help cut taxes, Wolfe says ZoomInfo Technologies Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – ZI Stifel Nicolaus Keeps Their Buy Rating on ZoomInfo Technologies (ZI) ZoomInfo downgraded to Neutral from Outperform at Daiwa ZoomInfo Technologies put volume heavy and directionally bearish",1,1,1,1,1,1
123.02M,"4,298,662",-490.76M,-1,481,29.02,Strong Buy,39.31,"Aug 7, 2024",VCTR,"Victory Capital Holdings, Inc.",3.55B,54.69,850.96M,8.79%,9.21%,28.07%,+1.03%,+22.95%,Victory Capital initiated with an Equal Weight at Barclays,Victory Capital Holdings: Strategic Acquisitions and Positive Net Flows Signal Growth and Diversification,Victory Capital price target raised to $49 from $45 at JPMorgan,Victory Capital price target lowered to $55 from $56 at RBC Capital,Victory Capital price target raised to $40 from $39 at Morgan Stanley,Victory Capital initiated with an Equal Weight at Barclays Victory Capital Holdings: Strategic Acquisitions and Positive Net Flows Signal Growth and Diversification Victory Capital price target raised to $49 from $45 at JPMorgan Victory Capital price target lowered to $55 from $56 at RBC Capital Victory Capital price target raised to $40 from $39 at Morgan Stanley,0,0,0,0,0,0
208.04M,"1,706,481",-103.33M,-1,445,17.15,Strong Buy,16.86,"Aug 15, 2024",DNLI,Denali Therapeutics Inc.,3.55B,24.77,1.27M,7.32%,9.74%,25.46%,+0.57%,+26.41%,Denali Therapeutics price target raised to $29 from $25 at BofA,Buy Rating Affirmed: FDA’s Endorsement and Promising Data Bolster Denali Therapeutics’s Drug Pipeline,Denali Therapeutics: Strong Buy on Regulatory Wins and ETV Franchise Progress,Denali Therapeutics’ DNL310 Shows Promise for Early Approval and Market Success,Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome),Denali Therapeutics price target raised to $29 from $25 at BofA Buy Rating Affirmed: FDA’s Endorsement and Promising Data Bolster Denali Therapeutics’s Drug Pipeline Denali Therapeutics: Strong Buy on Regulatory Wins and ETV Franchise Progress Denali Therapeutics’ DNL310 Shows Promise for Early Approval and Market Success Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome),0,0,0,0,0,0
92.26M,"2,972,324",310.02M,-1,"2,109",38.59,Hold,41.27,"Aug 21, 2024",BANF,BancFirst Corporation,3.54B,107.06,594.14M,4.20%,10.06%,16.90%,-0.78%,+25.67%,"BancFirst director Rainbolt sells over 18,000 common shares",BancFirst Announces Dividends and Subsidiary Interest Payments,BancFirst raises quarterly dividend to 46c from 43c per share,,,"BancFirst director Rainbolt sells over 18,000 common shares BancFirst Announces Dividends and Subsidiary Interest Payments BancFirst raises quarterly dividend to 46c from 43c per share",1,1,1,0,-1,-1
365.28M,"4,225,204",15.40M,-1,797,9.72,Hold,13.71,"Aug 5, 2024",AXNX,"Axonics, Inc.",3.52B,68.95,408.81M,0.58%,1.46%,4.97%,+0.91%,+1.84%,"Soros buys JD.com, cuts AerCap in Q2",,,,,"Soros buys JD.com, cuts AerCap in Q2",1,0,-1,-1,-1,-1
64.88M,"189,674",237.16M,$1.64,264,54.69,Buy,51.86,"Aug 8, 2024",TGTX,"TG Therapeutics, Inc.",3.51B,24.46,346.72M,8.07%,14.54%,38.78%,+18.17%,+60.81%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting,Biotech Alert: Searches spiking for these stocks today,TG Therapeutics call volume above normal and directionally bullish,TG Therapeutics put volume heavy and directionally bearish,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting Biotech Alert: Searches spiking for these stocks today TG Therapeutics call volume above normal and directionally bullish TG Therapeutics put volume heavy and directionally bearish",0,1,0,1,1,1
143.17M,"885,838",-419.65M,-1,"3,400",24.77,Strong Buy,39.33,"Aug 1, 2024",FULT,Fulton Financial Corporation,3.51B,19.28,1.08B,5.30%,6.65%,16.99%,-1.14%,+25.00%,Fulton Financial Unveils Strategic Outlook and Performance Data,,,,,Fulton Financial Unveils Strategic Outlook and Performance Data,0,0,-1,-1,-1,-1
33.02M,"74,039",200.90M,$1.72,"3,067",107.06,Sell,93.50,"Oct 17, 2024",CALM,"Cal-Maine Foods, Inc.",3.50B,71.45,2.33B,0.69%,7.74%,21.13%,-0.18%,+13.58%,Egg prices are rising once again as bird flu limits supply,,,,,Egg prices are rising once again as bird flu limits supply,1,1,-1,-1,-1,-1
51.12M,"209,520",-1.71M,-1,"3,180",68.95,Hold,70.67,"Aug 1, 2024",LOT,Lotus Technology Inc.,3.50B,5.17,832.97M,1.11%,-9.44%,-32.99%,-0.71%,-17.01%,Lotus Technology wins 2024 EUCCC Sustainable Business Award for Decarbonization Leadership,Lotus Enters the GCC Region with Two Award Winning Models,"Lotus obtains local homologation certification for Eletre, Emeya in GCC region",Lotus Tech Achieves Record Growth Amidst Adjustments,"Lotus Technology aims to achieve positive operating cashflow, EBITDA in 2026","Lotus Technology wins 2024 EUCCC Sustainable Business Award for Decarbonization Leadership Lotus Enters the GCC Region with Two Award Winning Models Lotus obtains local homologation certification for Eletre, Emeya in GCC region Lotus Tech Achieves Record Growth Amidst Adjustments Lotus Technology aims to achieve positive operating cashflow, EBITDA in 2026",0,0,0,0,0,0
143.45M,"2,507,387",95.69M,-1,"161,000",24.46,Strong Buy,33.60,"Aug 6, 2024",AAPL,Apple Inc.,"3,448.91B",226.84,385.60B,3.57%,3.46%,18.01%,+1.99%,+33.56%,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings","Masimo CEO shared confidential documents with investor before release, documents show","Keep an eye on Meta, says KKM’s Jeff Kilburg",What to expect from Apple’s ‘It’s Glowtime’ event,"Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings Masimo CEO shared confidential documents with investor before release, documents show Keep an eye on Meta, says KKM’s Jeff Kilburg What to expect from Apple’s ‘It’s Glowtime’ event",1,1,0,1,1,1
181.91M,"1,195,793",283.03M,$0.68,"29,600",19.28,Hold,18.40,"Oct 15, 2024",NVDA,NVIDIA Corporation,"3,179.31B",129.37,79.77B,11.25%,6.18%,48.36%,+7.34%,+42.73%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,"Cramer: There isn’t an AI bubble, just intense demand and very little supply",Jim Cramer deep dives into the weakness in chipmakers,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability This semiconductor ETF just had its worst week since 2020. Here’s what’s next Cramer: There isn’t an AI bubble, just intense demand and very little supply Jim Cramer deep dives into the weakness in chipmakers Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street",0,1,0,0,0,1
49.04M,"242,376",277.89M,$3.08,"228,000",71.45,Sell,58.50,"Oct 1, 2024",MSFT,Microsoft Corporation,"3,098.02B",416.79,245.12B,0.18%,-4.65%,1.01%,-1.85%,-3.51%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,"Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett",Wells Fargo’s top picks in September include this tech giant and pharma leader,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett Wells Fargo’s top picks in September include this tech giant and pharma leader Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit",1,1,1,1,1,1
676.74M,"100,977",-853.07M,-1,"182,381",5.17,,,"Aug 28, 2024",GOOG,Alphabet Inc.,"2,048.89B",167.43,328.28B,0.15%,-5.46%,5.88%,-5.00%,+6.86%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,YouTube group The Try Guys quickly found success in launching subscription model,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings",Top 10 people most likely to reach trillionaire status,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability YouTube group The Try Guys quickly found success in launching subscription model Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings Top 10 people most likely to reach trillionaire status",0,1,0,1,0,0
15.20B,"29,834,257",101.96B,$1.00,"182,502",226.84,Buy,236.31,"Aug 1, 2024",GOOGL,Alphabet Inc.,"2,038.78B",165.62,328.28B,0.18%,-5.56%,5.79%,-5.07%,+6.79%,3 ways Wall Street’s largest banks are leveraging AI to increase profitability,YouTube group The Try Guys quickly found success in launching subscription model,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings",Top 10 people most likely to reach trillionaire status,"3 ways Wall Street’s largest banks are leveraging AI to increase profitability YouTube group The Try Guys quickly found success in launching subscription model Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings Top 10 people most likely to reach trillionaire status",1,1,0,1,0,0
24.58B,"310,565,961",42.60B,$0.04,"1,525,000",129.37,Strong Buy,136.74,"Aug 28, 2024",AMZN,"Amazon.com, Inc.","1,858.14B",177.04,604.33B,-0.13%,-5.58%,0.79%,-8.65%,-7.71%,Wells Fargo report: Amazon was 2023′s top apparel and footwear seller,OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit,Google’s second antitrust trial could help shape the future of online ads,Buy levels for 3 industrial stocks that benefit from AI boom and sector megatrends,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions","Wells Fargo report: Amazon was 2023′s top apparel and footwear seller OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit Google’s second antitrust trial could help shape the future of online ads Buy levels for 3 industrial stocks that benefit from AI boom and sector megatrends AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions",1,1,1,1,1,0
7.43B,"12,917,138",88.14B,$3.00,"67,317",416.79,Strong Buy,493.97,"Jul 30, 2024",META,"Meta Platforms, Inc.","1,335.74B",528.00,149.78B,1.60%,3.14%,15.29%,+8.83%,-2.00%,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Keep an eye on Meta, says KKM’s Jeff Kilburg",Top 10 people most likely to reach trillionaire status,OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit,Google’s second antitrust trial could help shape the future of online ads,"Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Keep an eye on Meta, says KKM’s Jeff Kilburg Top 10 people most likely to reach trillionaire status OpenAI gives artists access to unreleased tools like Sora for New York gallery exhibit Google’s second antitrust trial could help shape the future of online ads",1,1,1,0,1,1
12.31B,"11,634,952",87.66B,$0.80,"20,000",167.43,Buy,200.36,"Jul 23, 2024",AVGO,Broadcom Inc.,774.39B,166.36,42.62B,4.35%,0.33%,22.27%,-1.56%,+18.09%,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,"Cramer: There isn’t an AI bubble, just intense demand and very little supply",Jim Cramer deep dives into the weakness in chipmakers,Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street,"Three-Stock Lunch: Broadcom, 3M, & Bowlero","This semiconductor ETF just had its worst week since 2020. Here’s what’s next Cramer: There isn’t an AI bubble, just intense demand and very little supply Jim Cramer deep dives into the weakness in chipmakers Cramer pushes back against a ‘new and negative AI narrative’ on Wall Street Three-Stock Lunch: Broadcom, 3M, & Bowlero",1,0,0,0,1,1
12.31B,"10,831,461",87.66B,$0.80,"140,473",165.62,Buy,199.27,"Jul 23, 2024",TSLA,"Tesla, Inc.",703.84B,220.32,95.32B,-0.79%,-4.32%,2.91%,-11.34%,+24.77%,"Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here",Oppenheimer’s picks for a Republican or Democratic election sweep,Top 10 people most likely to reach trillionaire status,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","U.S. markets, public companies are a growing target for Russian hackers","Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here Oppenheimer’s picks for a Republican or Democratic election sweep Top 10 people most likely to reach trillionaire status Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more U.S. markets, public companies are a growing target for Russian hackers",1,1,0,0,1,0
10.50B,"21,904,019",44.42B,-1,"316,000",177.04,Strong Buy,218.51,"Oct 24, 2024",COST,Costco Wholesale Corporation,389.78B,879.21,253.70B,6.85%,6.74%,22.45%,+8.04%,+24.43%,"Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell",Jim Cramer recommends buying Costco stock as a port in September’s market storm,"Friday, September 6, 2024: Cramer says this chipmaker is a buy despite its post-earnings drawdown",Cramer’s Mad Dash: Costco,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell Jim Cramer recommends buying Costco stock as a port in September’s market storm Friday, September 6, 2024: Cramer says this chipmaker is a buy despite its post-earnings drawdown Cramer’s Mad Dash: Costco Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more",1,1,1,0,1,1
2.53B,"9,547,234",51.43B,$2.00,"42,416",528.00,Strong Buy,557.90,"Jul 31, 2024",ASML,ASML Holding N.V.,360.37B,907.26,27.26B,0.68%,-7.04%,0.20%,-5.19%,-9.33%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more","Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Dutch take on U.S. export controls, controlling shipments of some ASML machines","European stocks end week down 2.5%, worst since early August slump",U.S. rolls out new chip-related export controls as China makes industry advances,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Dutch take on U.S. export controls, controlling shipments of some ASML machines European stocks end week down 2.5%, worst since early August slump U.S. rolls out new chip-related export controls as China makes industry advances",1,1,1,1,1,1
4.65B,"18,441,771",10.27B,$2.10,"13,000",166.36,Strong Buy,178.79,"Sep 5, 2024",NFLX,"Netflix, Inc.",294.72B,686.73,36.30B,7.02%,5.71%,19.15%,+8.83%,+7.49%,"Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett",Bill Gates says this is the No. 1 unsolvable problem facing today’s young people,NFL team sales are likely to stall as valuations soar,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry","Bill Gates wants to work another 20 to 30 years, like his friend Warren Buffett Bill Gates says this is the No. 1 unsolvable problem facing today’s young people NFL team sales are likely to stall as valuations soar Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry",1,1,1,1,1,1
3.19B,"58,984,295",12.39B,-1,"89,900",220.32,Hold,202.12,"Oct 16, 2024",AZN,AstraZeneca PLC,268.01B,86.66,49.13B,5.33%,8.76%,21.74%,+10.37%,+29.52%,AstraZeneca says staff detained in China amid reports of drug-import investigation,India and Singapore agree to cooperate on chips as countries seek to strengthen partnership,India’s Modi expected to usher in new era of bilateral agreements in Singapore visit,Biden administration releases prices of 10 drugs in Medicare talks,These low-volatility stocks have a winning record and are attractively valued,AstraZeneca says staff detained in China amid reports of drug-import investigation India and Singapore agree to cooperate on chips as countries seek to strengthen partnership India’s Modi expected to usher in new era of bilateral agreements in Singapore visit Biden administration releases prices of 10 drugs in Medicare talks These low-volatility stocks have a winning record and are attractively valued,0,0,0,0,0,0
443.34M,"1,274,188",7.17B,$4.64,"26,000",879.21,Buy,819.89,"Sep 26, 2024",AMD,"Advanced Micro Devices, Inc.",250.83B,154.98,23.28B,5.50%,-2.35%,-4.52%,+1.30%,-14.12%,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,Why Broadcom stock is tumbling after an earnings beat — and how to play the dip,"S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022","These are the top stocks to own for rest of the year, per Wolfe Research",CNBC Daily Open: Rate cuts need to start before inflation’s 2%,"This semiconductor ETF just had its worst week since 2020. Here’s what’s next Why Broadcom stock is tumbling after an earnings beat — and how to play the dip S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022 These are the top stocks to own for rest of the year, per Wolfe Research CNBC Daily Open: Rate cuts need to start before inflation’s 2%",0,0,1,0,0,0
393.20M,"1,239,512",7.23B,$6.57,"29,945",907.26,Buy,"1,147.80","Oct 16, 2024",ADBE,Adobe Inc.,247.55B,558.30,20.43B,4.70%,4.01%,3.97%,+1.61%,+15.55%,"Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings",The latest jobs report leaves stocks in a tough spot heading into the new week,"Chips get crushed, and clues in the jobs report for Modelo brewer Constellation","These are the top stocks to own for rest of the year, per Wolfe Research","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Cramer’s week ahead: iPhone 16 launch, consumer price index and Oracle earnings The latest jobs report leaves stocks in a tough spot heading into the new week Chips get crushed, and clues in the jobs report for Modelo brewer Constellation These are the top stocks to own for rest of the year, per Wolfe Research Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",0,0,0,0,0,1
429.16M,"1,347,866",7.09B,-1,"318,000",686.73,Buy,687.67,"Oct 16, 2024",PEP,"PepsiCo, Inc.",241.57B,175.87,92.05B,0.83%,3.49%,3.13%,+0.72%,+2.83%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",How the Cowboys went from losing $1 million a month to topping the NFL in value,Beyond Meat to launch new steak alternative as it focuses on health,Jim Cramer expresses regret over BlackRock and gives his views on 3 other stocks,Delta chief operations officer departing for another company,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box How the Cowboys went from losing $1 million a month to topping the NFL in value Beyond Meat to launch new steak alternative as it focuses on health Jim Cramer expresses regret over BlackRock and gives his views on 3 other stocks Delta chief operations officer departing for another company",1,1,0,1,1,0
1.55B,"2,350,366",6.44B,$1.48,"67,000",86.66,Buy,88.80,"Jul 25, 2024",TMUS,"T-Mobile US, Inc.",231.70B,198.58,79.10B,5.95%,10.82%,22.06%,+10.49%,+25.01%,This ETF’s 2024 gains nearly match the Nasdaq Composite — with less volatility,Cramer says a carrier war could boost demand for the expected AI-enabled iPhone,These stocks outperformed in August. Here’s where they’re expected to go,Top Wall Street analysts are upbeat about the potential of these 3 stocks ,These low-volatility stocks have a winning record and are attractively valued,This ETF’s 2024 gains nearly match the Nasdaq Composite — with less volatility Cramer says a carrier war could boost demand for the expected AI-enabled iPhone These stocks outperformed in August. Here’s where they’re expected to go Top Wall Street analysts are upbeat about the potential of these 3 stocks  These low-volatility stocks have a winning record and are attractively valued,1,0,1,1,1,0
1.62B,"49,697,991",1.35B,-1,"66,323",154.98,Strong Buy,195.93,"Jul 30, 2024",LIN,Linde plc,222.39B,465.74,32.82B,4.13%,5.96%,8.97%,+4.26%,+1.75%,"Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde","Wednesday, August 28, 2024: Cramer says this industrial stock could be a ‘Harris trade’",Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,Linde price target raised to $550 from $523 at Jefferies,Linde (LIN): New Sell Recommendation for This Basic Materials Giant,"Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde Wednesday, August 28, 2024: Cramer says this industrial stock could be a ‘Harris trade’ Cramer updates his takes on all 32 portfolio stocks and grades earnings reports Linde price target raised to $550 from $523 at Jefferies Linde (LIN): New Sell Recommendation for This Basic Materials Giant",1,1,1,0,1,1
443.40M,"1,385,944",5.08B,-1,"84,900",558.30,Buy,599.31,"Sep 12, 2024",CSCO,"Cisco Systems, Inc.",204.42B,50.74,53.80B,6.42%,7.28%,4.39%,+2.89%,+2.68%,"Final Trades: Apple, Cisco, Kinetik Holdings and the 2-Year Treasury","Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier","Palo Alto Networks finally gets back on track — delivering solid earnings, outlook",Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Final Trades: Apple, Cisco, Kinetik Holdings and the 2-Year Treasury Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier Palo Alto Networks finally gets back on track — delivering solid earnings, outlook Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",0,1,0,0,0,0
1.37B,"4,144,019",9.52B,$5.42,"17,403",175.87,Buy,186.00,"Oct 8, 2024",PDD,PDD Holdings Inc.,194.25B,139.87,41.11B,-29.65%,-29.80%,-28.29%,-30.82%,-24.35%,Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps,There is ‘lack of confidence’ in market on Chinese banks’ balance sheets,PDD just gave markets the latest warning on China’s consumer,Investors ‘left waiting’ for China’s market recovery: KraneShares CIO,CNBC Daily Open: Nvidia beating expectations isn’t enough,Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps There is ‘lack of confidence’ in market on Chinese banks’ balance sheets PDD just gave markets the latest warning on China’s consumer Investors ‘left waiting’ for China’s market recovery: KraneShares CIO CNBC Daily Open: Nvidia beating expectations isn’t enough,1,1,0,0,0,0
1.17B,"2,536,262",9.46B,$2.60,"50,000",198.58,Strong Buy,196.11,"Jul 31, 2024",QCOM,QUALCOMM Incorporated,193.28B,173.50,37.35B,3.81%,-7.14%,4.13%,-5.03%,+0.19%,AI gadgets have been a bust so far. Apple aims to change that,Qualcomm says it’s working on mixed reality smart glasses with Samsung and Google,Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip,"CNBC Daily Open: Nvidia sinks and data’s weak, but stay strong",S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September,"AI gadgets have been a bust so far. Apple aims to change that Qualcomm says it’s working on mixed reality smart glasses with Samsung and Google Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip CNBC Daily Open: Nvidia sinks and data’s weak, but stay strong S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September",0,0,0,1,0,0
477.50M,"1,106,510",6.40B,$5.56,"34,000",465.74,Buy,487.10,"Oct 24, 2024",TXN,Texas Instruments Incorporated,191.63B,209.88,16.09B,6.84%,6.35%,18.80%,+1.93%,+24.02%,Dividend stocks are expected to pop as the Fed lowers rates. How to choose them,"Intel has hired Morgan Stanley, other advisers for activist defense","Stocks making the biggest moves midday: Target, JD.com, Macy’s and more","Wednesday’s rapid-fire: Toll Brothers, Target, Macy’s, American Express, Texas Instruments",Jim Cramer says Toll Brothers can benefit from shortage of $1 million new homes,"Dividend stocks are expected to pop as the Fed lowers rates. How to choose them Intel has hired Morgan Stanley, other advisers for activist defense Stocks making the biggest moves midday: Target, JD.com, Macy’s and more Wednesday’s rapid-fire: Toll Brothers, Target, Macy’s, American Express, Texas Instruments Jim Cramer says Toll Brothers can benefit from shortage of $1 million new homes",1,0,0,1,1,0
4.03B,"9,792,080",10.32B,$1.60,"26,700",50.74,Buy,56.06,"Aug 14, 2024",AMGN,Amgen Inc.,176.67B,328.80,30.93B,0.16%,1.25%,10.42%,-0.90%,+22.06%,"Final Trades: Intuit, Amgen, the INDY and URNM",Eli Lilly CEO: People on GLP-1 weight loss drugs eat 800 calories less per day,Biden administration releases prices of 10 drugs in Medicare talks,These low-volatility stocks have a winning record and are attractively valued,Piper Sandler Sticks to Their Buy Rating for Amgen (AMGN),"Final Trades: Intuit, Amgen, the INDY and URNM Eli Lilly CEO: People on GLP-1 weight loss drugs eat 800 calories less per day Biden administration releases prices of 10 drugs in Medicare talks These low-volatility stocks have a winning record and are attractively valued Piper Sandler Sticks to Their Buy Rating for Amgen (AMGN)",0,1,0,0,0,0
1.39B,"102,367,839",13.60B,-1,"18,200",139.87,Strong Buy,211.11,"Aug 26, 2024",INTU,Intuit Inc.,173.28B,619.85,16.29B,-1.71%,-1.85%,0.57%,-4.68%,-2.94%,A September trading strategy from Goldman that nets an 18% return on average,"Final Trades: Intuit, Amgen, the INDY and URNM","3-Stock Lunch: Uber, Intuit & Cava","Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more",Intuit CEO Sasan Goodarzi goes one-on-one with Jim Cramer,"A September trading strategy from Goldman that nets an 18% return on average Final Trades: Intuit, Amgen, the INDY and URNM 3-Stock Lunch: Uber, Intuit & Cava Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more Intuit CEO Sasan Goodarzi goes one-on-one with Jim Cramer",1,0,1,1,1,1
1.11B,"7,080,413",8.71B,$3.40,"13,676",173.50,Buy,205.21,"Jul 31, 2024",ISRG,"Intuitive Surgical, Inc.",172.90B,486.55,7.57B,3.58%,7.14%,24.32%,+8.46%,+24.16%,Friday’s big stock stories: What’s likely to move the market in the next trading session,Intuitive Surgical (ISRG) Receives a Buy from BTIG,Intuitive Surgical price target raised to $494 from $469 at BTIG,Intuitive Surgical price target raised to $560 from $512 at Citi,Intuitive Surgical price target raised to $515 from $475 at RBC Capital,Friday’s big stock stories: What’s likely to move the market in the next trading session Intuitive Surgical (ISRG) Receives a Buy from BTIG Intuitive Surgical price target raised to $494 from $469 at BTIG Intuitive Surgical price target raised to $560 from $512 at Citi Intuitive Surgical price target raised to $515 from $475 at RBC Capital,0,0,0,0,0,0
913.05M,"5,804,012",5.28B,$5.20,"34,000",209.88,Hold,199.48,"Oct 22, 2024",AMAT,"Applied Materials, Inc.",167.08B,202.67,26.85B,-0.95%,-10.41%,0.88%,-9.10%,-7.20%,These stocks have the most riding on Nvidia’s results with highest correlation,"Final Trades: Amazon, Applied Materials and Home Depot","Stocks making biggest moves midday: Rocket Lab, H&R Block and more",10 things to watch in the stock market Friday including more bullishness on Lilly,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","These stocks have the most riding on Nvidia’s results with highest correlation Final Trades: Amazon, Applied Materials and Home Depot Stocks making biggest moves midday: Rocket Lab, H&R Block and more 10 things to watch in the stock market Friday including more bullishness on Lilly Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",0,1,0,1,0,0
537.33M,"1,716,778",3.13B,$9.00,"186,000",328.80,Buy,323.21,"Aug 6, 2024",CMCSA,Comcast Corporation,154.20B,39.82,121.11B,1.51%,3.29%,-1.93%,-3.25%,-2.37%,Automakers are getting back into advertising’s biggest arena: NFL,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry","NBC ripped up its Olympics playbook for 2024 — so far, it paid off",A look at the behind-the-scenes business of Hollywood studio lot tours,"Automakers are getting back into advertising’s biggest arena: NFL Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry NBC ripped up its Olympics playbook for 2024 — so far, it paid off A look at the behind-the-scenes business of Hollywood studio lot tours",0,0,1,1,0,0
279.55M,"1,907,131",2.96B,$4.16,"7,096",619.85,Buy,696.96,"Aug 22, 2024",ARM,Arm Holdings plc,142.14B,135.63,3.50B,5.22%,-12.13%,17.00%,-13.07%,+0.40%,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded",Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip,Nvidia $279 billion wipeout — the biggest in U.S. history — drags down global chip stocks,Slowdown in Nvidia’s sales growth spooks chip stocks in U.S. and Asia,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded Qualcomm ramps up challenge to Intel and AMD with latest AI PC chip Nvidia $279 billion wipeout — the biggest in U.S. history — drags down global chip stocks Slowdown in Nvidia’s sales growth spooks chip stocks in U.S. and Asia",0,1,1,1,1,1
355.35M,"1,165,092",2.09B,-1,"86,088",486.55,Buy,444.14,"Oct 17, 2024",SNY,Sanofi,140.76B,56.21,50.44B,5.61%,10.10%,14.98%,+8.30%,+18.75%,"Healthy Returns: The combination Covid, flu shot race is heating up",Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer,Buy Rating Affirmed for Sanofi on Strong Clinical Trial Outcomes and Promising MS Drug Pipeline,Sanofi (SNY) Gets a Hold from TD Cowen,Deutsche Bank Sticks to Its Sell Rating for Sanofi (SNYNF),"Healthy Returns: The combination Covid, flu shot race is heating up Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer Buy Rating Affirmed for Sanofi on Strong Clinical Trial Outcomes and Promising MS Drug Pipeline Sanofi (SNY) Gets a Hold from TD Cowen Deutsche Bank Sticks to Its Sell Rating for Sanofi (SNYNF)",0,1,1,1,1,1
824.40M,"6,696,957",7.45B,$1.60,"95,000",202.67,Buy,225.15,"Aug 15, 2024",HON,Honeywell International Inc.,131.55B,202.48,37.33B,2.92%,-0.87%,2.36%,+0.12%,+3.98%,"Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell",Jim Cramer’s top 10 things to watch in the stock market Friday,"Monday, August 26, 2024: Cramer explains why he’s ‘concerned’ ahead of this chipmaker’s earnings",Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,Honeywell initiated with an Equal Weight at Morgan Stanley,"Calls of the Day: Oracle, Costco, Energy Transfer, Spotify and Honeywell Jim Cramer’s top 10 things to watch in the stock market Friday Monday, August 26, 2024: Cramer explains why he’s ‘concerned’ ahead of this chipmaker’s earnings Cramer updates his takes on all 32 portfolio stocks and grades earnings reports Honeywell initiated with an Equal Weight at Morgan Stanley",1,1,0,0,0,1
3.87B,"11,120,225",15.09B,$1.24,"13,450",39.82,Buy,47.02,"Oct 24, 2024",REGN,"Regeneron Pharmaceuticals, Inc.",129.43B,"1,199.12",13.49B,5.72%,10.10%,24.55%,+11.13%,+27.22%,Election 2024: Where To Put Your Money Ahead of the Vote,RBC Capital Keeps Their Buy Rating on Regeneron (REGN),"QQQ ETF Update, 8/29/2024 ",Regeneron announces EC approved Ordspono for adults,Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma,"Election 2024: Where To Put Your Money Ahead of the Vote RBC Capital Keeps Their Buy Rating on Regeneron (REGN) QQQ ETF Update, 8/29/2024  Regeneron announces EC approved Ordspono for adults Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma",1,1,0,0,0,1
1.05B,"5,991,731",424.00M,-1,"23,600",135.63,Buy,130.00,"Jul 31, 2024",BKNG,Booking Holdings Inc.,128.42B,"3,830.58",22.40B,8.20%,2.23%,8.03%,+4.93%,+8.23%,"Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier","Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20%",Travelers are finally cracking under the pressure of high costs,"Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20% Travelers are finally cracking under the pressure of high costs",1,0,1,1,1,0
1.25B,"978,653",4.52B,$2.04,"5,400",56.21,Buy,57.50,"Jul 25, 2024",VRTX,Vertex Pharmaceuticals Incorporated,124.21B,481.24,10.34B,-0.02%,-0.25%,11.82%,-1.21%,+20.42%,"Lightning Round: Chipotle is likely done going down, says Jim Cramer",Cramer’s Lightning Round: Builders FirstSource ‘can go higher’,"Ride out future market volatility with all-weather stocks, Bank of America says",Evercore ISI Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),Vertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline Uncertainty,"Lightning Round: Chipotle is likely done going down, says Jim Cramer Cramer’s Lightning Round: Builders FirstSource ‘can go higher’ Ride out future market volatility with all-weather stocks, Bank of America says Evercore ISI Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX) Vertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline Uncertainty",1,0,0,1,0,0
649.67M,"1,717,257",5.78B,$4.32,"43,000",202.48,Buy,225.00,"Jul 25, 2024",MU,"Micron Technology, Inc.",114.04B,102.85,21.37B,-1.96%,-16.75%,-5.68%,-13.62%,-23.24%,Wednesday’s stock stories: What’s likely to move the market in the next session,"Three-Stock Lunch: Boeing, Micron, Redfin","Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more","Dow closes 600 points lower to begin September, S&P 500 drops 2%",Morgan Stanley is bullish on 3 stocks from a corner of the semiconductor sector,"Wednesday’s stock stories: What’s likely to move the market in the next session Three-Stock Lunch: Boeing, Micron, Redfin Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Dow closes 600 points lower to begin September, S&P 500 drops 2% Morgan Stanley is bullish on 3 stocks from a corner of the semiconductor sector",1,0,1,1,1,1
107.93M,"238,223",4.32B,-1,"13,948","1,199.12",Buy,"1,091.83","Aug 1, 2024",PANW,"Palo Alto Networks, Inc.",113.57B,350.75,8.03B,5.91%,6.03%,13.80%,+7.92%,+30.27%,"Palo Alto CEO on CrowdStrike fallout, IBM deal and cybersecurity issues",These stocks typically have the best and worst Septembers,Jim Cramer’s top 10 things to watch in the stock market Wednesday,Can tech stocks go up with rates coming down? Here’s why we think so,It’s been nearly a year since we took profits in Lilly. We’re due for another trim,"Palo Alto CEO on CrowdStrike fallout, IBM deal and cybersecurity issues These stocks typically have the best and worst Septembers Jim Cramer’s top 10 things to watch in the stock market Wednesday Can tech stocks go up with rates coming down? Here’s why we think so It’s been nearly a year since we took profits in Lilly. We’re due for another trim",0,0,0,0,0,0
33.52M,"217,547",5.03B,$35.00,"26,000","3,830.58",Buy,"4,063.00","Aug 1, 2024",ADI,"Analog Devices, Inc.",113.39B,228.39,9.70B,6.36%,2.51%,13.40%,-1.82%,+16.64%,These stocks have the most riding on Nvidia’s results with highest correlation,"Retail earnings lift other boats — plus, stocks take negative jobs update in stride","Stocks making the biggest moves midday: Target, JD.com, Macy’s and more","S&P 500, Nasdaq close higher as Fed minutes lift investors’ hopes for a September rate cut","Why we’ve raised cash into the rally — plus, earnings insights on 2 of our stocks","These stocks have the most riding on Nvidia’s results with highest correlation Retail earnings lift other boats — plus, stocks take negative jobs update in stride Stocks making the biggest moves midday: Target, JD.com, Macy’s and more S&P 500, Nasdaq close higher as Fed minutes lift investors’ hopes for a September rate cut Why we’ve raised cash into the rally — plus, earnings insights on 2 of our stocks",1,1,1,1,1,0
258.10M,"877,494",-489.90M,-1,"17,200",481.24,Buy,495.82,"Aug 1, 2024",LRCX,Lam Research Corporation,110.48B,847.37,14.91B,-1.41%,-13.60%,-7.39%,-12.61%,-16.88%,"Lightning Round: Buy Lam Research slowly, not all at once",Cramer’s Lightning Round: ‘I like’ GE Vernova,Trade Tracker: Stephanie Link trims Lam Research,Lam Research Appoints New Board Members with Diverse Expertise,Unusually active option classes on open August 30th,"Lightning Round: Buy Lam Research slowly, not all at once Cramer’s Lightning Round: ‘I like’ GE Vernova Trade Tracker: Stephanie Link trims Lam Research Lam Research Appoints New Board Members with Diverse Expertise Unusually active option classes on open August 30th",0,0,0,0,0,0
1.11B,"24,264,183",-1.54B,$0.46,"64,000",102.85,Strong Buy,157.42,"Sep 25, 2024",ADP,"Automatic Data Processing, Inc.",109.94B,269.60,19.20B,4.33%,9.37%,12.53%,+3.83%,+11.37%,Salesforce CEO explains how customers use new platform ‘Agentforce’,Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech,ADP price target raised to $285 from $250 at JPMorgan,,,Salesforce CEO explains how customers use new platform ‘Agentforce’ Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech ADP price target raised to $285 from $250 at JPMorgan,0,0,0,0,-1,-1
323.80M,"3,144,385",2.58B,-1,"15,230",350.75,Buy,371.26,"Aug 19, 2024",KLAC,KLA Corporation,109.94B,817.84,9.81B,4.70%,0.96%,18.04%,-2.28%,+17.78%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Wednesday’s stock stories: What’s likely to move the market in the next session,"Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more","Dow closes 600 points lower to begin September, S&P 500 drops 2%",KLA Corp. raises quarterly dividend 17% to $1.70 from $1.45 per share,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Wednesday’s stock stories: What’s likely to move the market in the next session Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Dow closes 600 points lower to begin September, S&P 500 drops 2% KLA Corp. raises quarterly dividend 17% to $1.70 from $1.45 per share",1,1,0,1,1,0
496.49M,"2,528,087",1.66B,$3.68,"381,000",228.39,Buy,243.52,"Aug 21, 2024",SBUX,Starbucks Corporation,106.54B,94.02,36.48B,16.21%,23.43%,12.10%,+22.26%,+9.73%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box","4 simple steps to ‘make yourself indispensable’ at work, says bestselling author",Best Buy is the stock of the summer — plus 2 more encouraging economic updates,These stocks outperformed in August. Here’s where they’re expected to go,Jim Cramer: Starbucks’ stock will shoot higher under incoming CEO Brian Niccol,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box 4 simple steps to ‘make yourself indispensable’ at work, says bestselling author Best Buy is the stock of the summer — plus 2 more encouraging economic updates These stocks outperformed in August. Here’s where they’re expected to go Jim Cramer: Starbucks’ stock will shoot higher under incoming CEO Brian Niccol",0,1,1,0,1,0
130.38M,"1,109,642",3.83B,$8.00,"58,313",847.37,Strong Buy,983.19,"Oct 16, 2024",MELI,"MercadoLibre, Inc.",101.41B,"2,000.31",17.11B,8.30%,16.94%,24.94%,+19.55%,+32.86%,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,"MercadoLibre initiated with an Overweight, called a ‘Top Pick’ at Cantor","MercadoLibre price target raised to $2,350 from $2,300 at Susquehanna","MercadoLibre price target raised to $2,250 from $2,100 at Jefferies",StockTok: Meta revises limits on ad data to assuage CMA scrutiny,"Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call MercadoLibre initiated with an Overweight, called a ‘Top Pick’ at Cantor MercadoLibre price target raised to $2,350 from $2,300 at Susquehanna MercadoLibre price target raised to $2,250 from $2,100 at Jefferies StockTok: Meta revises limits on ad data to assuage CMA scrutiny",0,1,1,1,0,1
407.80M,"776,708",3.75B,$5.60,"18,000",269.60,Hold,262.82,"Jul 31, 2024",GILD,"Gilead Sciences, Inc.",95.52B,76.72,27.81B,2.48%,6.77%,5.30%,+3.29%,+12.91%,Gilead alleges it uncovered a drug-counterfeiting operation at 2 NYC pharmacies,Gilead Sciences: A Balanced Hold Rating Amidst Growth Potential and Market Challenges,Gilead price target raised to $74 from $72 at RBC Capital,Gilead Sciences (GILD) Gets a Hold from RBC Capital,Gilead put volume heavy and directionally bearish,Gilead alleges it uncovered a drug-counterfeiting operation at 2 NYC pharmacies Gilead Sciences: A Balanced Hold Rating Amidst Growth Potential and Market Challenges Gilead price target raised to $74 from $72 at RBC Capital Gilead Sciences (GILD) Gets a Hold from RBC Capital Gilead put volume heavy and directionally bearish,1,0,1,0,0,1
134.43M,"776,009",2.76B,$5.80,"91,000",817.84,Buy,805.55,"Jul 24, 2024",MDLZ,"Mondelez International, Inc.",95.15B,71.23,35.98B,1.86%,5.19%,1.42%,+4.24%,+4.79%,"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies",Cheap stocks to buy for the long term during the volatility,Turn to these dividend growers as the Fed cuts rates,"Jim Cramer prefers Mondelez over this food peer — plus, his take on 4 more stocks",Jim Cramer’s top 10 things to watch in the stock market Monday,"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies Cheap stocks to buy for the long term during the volatility Turn to these dividend growers as the Fed cuts rates Jim Cramer prefers Mondelez over this food peer — plus, his take on 4 more stocks Jim Cramer’s top 10 things to watch in the stock market Monday",0,0,0,0,0,0
1.13B,"10,812,035",4.07B,$2.28,"124,800",94.02,Buy,99.18,"Jul 30, 2024",INTC,Intel Corporation,87.83B,20.54,55.12B,-8.05%,-28.46%,-46.23%,-36.21%,-49.34%,This semiconductor ETF just had its worst week since 2020. Here’s what’s next,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Jim Cramer’s top 10 things to watch in the stock market Friday,Nvidia says it didn’t receive antitrust subpoena from DOJ,"Cramer says ‘don’t be a hero’ on Nvidia, downplays AI spending concerns and DOJ probe","This semiconductor ETF just had its worst week since 2020. Here’s what’s next Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Jim Cramer’s top 10 things to watch in the stock market Friday Nvidia says it didn’t receive antitrust subpoena from DOJ Cramer says ‘don’t be a hero’ on Nvidia, downplays AI spending concerns and DOJ probe",0,0,1,0,0,0
50.70M,"181,637",1.40B,-1,"20,300","2,000.31",Strong Buy,"2,089.09","Aug 1, 2024",SNPS,"Synopsys, Inc.",82.86B,539.39,6.48B,-1.72%,-8.24%,-5.97%,-8.66%,-11.38%,Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings,Cramer’s Stop Trading: Synopsys,Cramer looks at reasons for the market decline and provides new views on 3 stocks,Synopsys CEO on Q3 earnings,"This little-known chip design stock benefits from AI, Bank of America says","Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings Cramer’s Stop Trading: Synopsys Cramer looks at reasons for the market decline and provides new views on 3 stocks Synopsys CEO on Q3 earnings This little-known chip design stock benefits from AI, Bank of America says",0,1,0,0,0,1
1.24B,"2,897,238",1.05B,$3.08,"46,500",76.72,Buy,81.81,"Aug 8, 2024",CTAS,Cintas Corporation,79.46B,788.50,9.60B,4.58%,8.06%,22.38%,+4.43%,+18.42%,"QQQ ETF Update, 9/6/2024 ","QQQ ETF Update, 9/4/2024 ","QQQ ETF Update, 8/29/2024 ","QQQ ETF Update, 8/27/2024 ","QQQ ETF Update, 8/23/2024 ","QQQ ETF Update, 9/6/2024  QQQ ETF Update, 9/4/2024  QQQ ETF Update, 8/29/2024  QQQ ETF Update, 8/27/2024  QQQ ETF Update, 8/23/2024 ",0,0,0,0,0,0
1.34B,"3,498,847",3.95B,$1.88,"13,151",71.23,Strong Buy,79.59,"Jul 30, 2024",EQIX,"Equinix, Inc.",78.61B,827.96,8.02B,0.79%,3.68%,2.45%,+2.97%,+3.73%,Turn to these dividend growers as the Fed cuts rates,"Equinix CFO Taylor sells 1,500 common shares","Equinix price target lowered to $900 from $1,000 at Argus",Equinix (EQIX) Receives a Hold from Morgan Stanley,Scotiabank Reaffirms Their Buy Rating on Equinix (EQIX),"Turn to these dividend growers as the Fed cuts rates Equinix CFO Taylor sells 1,500 common shares Equinix price target lowered to $900 from $1,000 at Argus Equinix (EQIX) Receives a Hold from Morgan Stanley Scotiabank Reaffirms Their Buy Rating on Equinix (EQIX)",0,0,1,0,0,1
4.28B,"57,358,323",975.00M,$0.50,"11,200",20.54,Hold,32.96,"Aug 1, 2024",CDNS,"Cadence Design Systems, Inc.",75.00B,273.90,4.16B,0.28%,-6.87%,-6.74%,-1.71%,-14.59%,Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings,"Novartis upgrade, Intel downgrade part of Erste global equity changes",Cadence Design downgraded to Hold from Buy at Erste Group,Cadence Design Strengthens Financial Strategy with New Credit Facility,"CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?","Jim Cramer says these 2 stocks show investors are nervous about Nvidia’s earnings Novartis upgrade, Intel downgrade part of Erste global equity changes Cadence Design downgraded to Hold from Buy at Erste Group Cadence Design Strengthens Financial Strategy with New Credit Facility CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?",1,1,1,1,1,0
153.61M,"916,354",1.50B,-1,"3,565",539.39,Strong Buy,641.00,"Aug 21, 2024",CME,CME Group Inc.,74.56B,207.05,5.79B,3.85%,6.23%,2.61%,+11.05%,+1.91%,"Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI","S&P 500, Nasdaq snap eight-day winning streak as rebound rally pauses",Buy/Sell: Wall Street’s top 10 stock calls this week,"CME Group to launch options on BCOM futures on September 23, pending review",Analysts Have Conflicting Sentiments on These Financial Companies: Voya Financial (VOYA) and CME Group (CME),"Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI S&P 500, Nasdaq snap eight-day winning streak as rebound rally pauses Buy/Sell: Wall Street’s top 10 stock calls this week CME Group to launch options on BCOM futures on September 23, pending review Analysts Have Conflicting Sentiments on These Financial Companies: Voya Financial (VOYA) and CME Group (CME)",0,0,1,0,0,0
100.77M,"236,586",1.57B,$1.56,"6,907",788.50,Buy,740.62,"Sep 24, 2024",ABNB,"Airbnb, Inc.",73.90B,116.85,10.51B,-3.70%,-15.19%,-19.66%,-15.79%,-27.35%,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions",Take a look inside my oceanfront dream home in Puerto Rico: ‘Slice of paradise’,‘Travel is too expensive right now’: Americans spend less or skip trips altogether,Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion,LVMH CEO Bernard Arnault’s family office goes shopping for AI startups,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions Take a look inside my oceanfront dream home in Puerto Rico: ‘Slice of paradise’ ‘Travel is too expensive right now’: Americans spend less or skip trips altogether Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion LVMH CEO Bernard Arnault’s family office goes shopping for AI startups",0,0,0,0,0,0
94.94M,"283,971",1.04B,$17.04,"27,200",827.96,Buy,863.36,"Aug 7, 2024",PYPL,"PayPal Holdings, Inc.",73.30B,71.70,31.03B,7.60%,14.96%,15.56%,+7.07%,+8.10%,"Earn 5% cash back with PayPal’s debit card, even if you have bad credit","88 corporate leaders endorse Harris, including CEOs of Yelp, Box","Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings","The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos","Buy now, pay later firm Klarna swings to first-half profit ahead of IPO","Earn 5% cash back with PayPal’s debit card, even if you have bad credit 88 corporate leaders endorse Harris, including CEOs of Yelp, Box Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos Buy now, pay later firm Klarna swings to first-half profit ahead of IPO",1,1,1,1,1,1
273.82M,"1,944,545",1.06B,-1,"18,800",273.90,Strong Buy,334.56,"Jul 22, 2024",WDAY,"Workday, Inc.",68.96B,259.95,7.86B,17.44%,17.92%,4.13%,+14.61%,-2.99%,Dell and Palantir to join S&P 500; shares of both jump,"These five stocks are best positioned for growth, Goldman Sachs says","Final Trades: Workday, TransDigm and Louisiana Pacific",Workday stock gains as software provider widens 2027 margin target,"Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more","Dell and Palantir to join S&P 500; shares of both jump These five stocks are best positioned for growth, Goldman Sachs says Final Trades: Workday, TransDigm and Louisiana Pacific Workday stock gains as software provider widens 2027 margin target Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more",1,1,1,0,0,1
360.10M,"1,636,056",3.26B,$4.60,"7,925",207.05,Hold,213.69,"Oct 23, 2024",CRWD,"CrowdStrike Holdings, Inc.",66.08B,271.54,3.28B,8.98%,-13.25%,-9.57%,+13.90%,-16.26%,Dell and Palantir to join S&P 500; shares of both jump,A September trading strategy from Goldman that nets an 18% return on average,Cramer names No. 1 underappreciated megacap to buy in recent tech stock sell-off,"We like Apple for its sustained business model, not its AI story","These five stocks are best positioned for growth, Goldman Sachs says","Dell and Palantir to join S&P 500; shares of both jump A September trading strategy from Goldman that nets an 18% return on average Cramer names No. 1 underappreciated megacap to buy in recent tech stock sell-off We like Apple for its sustained business model, not its AI story These five stocks are best positioned for growth, Goldman Sachs says",1,1,0,0,1,1
632.42M,"4,924,459",4.84B,-1,"23,000",116.85,Hold,133.16,"Aug 6, 2024",CSX,CSX Corporation,65.32B,33.69,14.63B,-0.71%,-0.40%,-2.74%,-3.93%,-7.11%,Thursday’s stock stories: What’s likely to move the market in the next session,CSX President and Chief Executive Officer to Address Morgan Stanley Laguna Conference,North American rail traffic up 5.2% for the week ending August 31,CSX Expands Labor Agreements with Two More Partners,North American rail traffic up 1.3% for the week ending August 24,Thursday’s stock stories: What’s likely to move the market in the next session CSX President and Chief Executive Officer to Address Morgan Stanley Laguna Conference North American rail traffic up 5.2% for the week ending August 31 CSX Expands Labor Agreements with Two More Partners North American rail traffic up 1.3% for the week ending August 24,1,0,1,0,0,0
1.02B,"8,791,198",4.44B,-1,"90,302",71.70,Buy,75.88,"Jul 30, 2024",ORLY,"O'Reilly Automotive, Inc.",64.77B,"1,116.57",16.28B,0.42%,4.51%,8.64%,+1.10%,+1.89%,"Ride out future market volatility with all-weather stocks, Bank of America says",O’Reilly Auto’s Resilient Model and Growth Potential Bolster Buy Rating,TD Cowen Reaffirms Their Buy Rating on O’Reilly Auto (ORLY),Analysts Offer Insights on Consumer Cyclical Companies: Toll Brothers (TOL) and O’Reilly Auto (ORLY),Morgan Stanley Sticks to Their Hold Rating for O’Reilly Auto (ORLY),"Ride out future market volatility with all-weather stocks, Bank of America says O’Reilly Auto’s Resilient Model and Growth Potential Bolster Buy Rating TD Cowen Reaffirms Their Buy Rating on O’Reilly Auto (ORLY) Analysts Offer Insights on Consumer Cyclical Companies: Toll Brothers (TOL) and O’Reilly Auto (ORLY) Morgan Stanley Sticks to Their Hold Rating for O’Reilly Auto (ORLY)",1,1,1,1,1,1
265.29M,"3,188,587",1.54B,-1,"34,200",259.95,Buy,288.79,"Aug 22, 2024",NXPI,NXP Semiconductors N.V.,64.35B,252.63,13.11B,2.34%,-3.20%,4.68%,-6.17%,+2.45%,"NXP Semiconductors, VIS establish VSMC joint venture",VIS and NXP Announce Establishment of VSMC Joint Venture,"NXP Semiconductors announces dividend of $1.014 p/s, $2B share repurchase",NXP Semiconductors Announces Quarterly Dividend and Additional Share Repurchase Authorization,Analog Devices price target lowered to $255 from $260 at BofA,"NXP Semiconductors, VIS establish VSMC joint venture VIS and NXP Announce Establishment of VSMC Joint Venture NXP Semiconductors announces dividend of $1.014 p/s, $2B share repurchase NXP Semiconductors Announces Quarterly Dividend and Additional Share Repurchase Authorization Analog Devices price target lowered to $255 from $260 at BofA",1,0,0,0,0,0
243.36M,"3,529,606",131.66M,-1,"411,000",271.54,Buy,334.56,"Aug 28, 2024",MAR,"Marriott International, Inc.",63.42B,225.26,6.47B,3.20%,-2.49%,-2.56%,+0.01%,-10.48%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike","Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick",Watch CNBC’s full interview with Hyatt CEO Mark Hoplamazian,‘Travel is too expensive right now’: Americans spend less or skip trips altogether,Travelers are finally cracking under the pressure of high costs,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick Watch CNBC’s full interview with Hyatt CEO Mark Hoplamazian ‘Travel is too expensive right now’: Americans spend less or skip trips altogether Travelers are finally cracking under the pressure of high costs",0,1,1,0,0,0
1.94B,"5,813,628",3.60B,$0.48,"6,577",33.69,Buy,39.67,"Oct 17, 2024",MRVL,"Marvell Technology, Inc.",62.18B,71.84,5.35B,7.75%,2.38%,4.74%,+2.18%,-5.79%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Why Broadcom stock is tumbling after an earnings beat — and how to play the dip,"S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022",Small-cap portfolio manager says these stocks will thrive in slow growth environment,S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Why Broadcom stock is tumbling after an earnings beat — and how to play the dip S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022 Small-cap portfolio manager says these stocks will thrive in slow growth environment S&P 500 books back-to-back losses as Wall Street grapples with a rocky start to September",1,1,1,0,0,0
58.01M,"212,972",2.37B,-1,"13,871","1,116.57",Strong Buy,"1,144.06","Jul 24, 2024",CEG,Constellation Energy Corporation,60.97B,194.99,23.54B,5.48%,-0.26%,17.11%,+2.09%,+0.36%,Small nuclear reactors could power the future — the challenge is getting one built,Why the U.S. is pumping more oil than any country in history,Wednesday’s stock stories: What’s likely to move the market in the next session,Morgan Stanley Wealth Management adds this utilities play to dividend portfolio,AI demand could strain electrical grid in coming decade,Small nuclear reactors could power the future — the challenge is getting one built Why the U.S. is pumping more oil than any country in history Wednesday’s stock stories: What’s likely to move the market in the next session Morgan Stanley Wealth Management adds this utilities play to dividend portfolio AI demand could strain electrical grid in coming decade,0,0,0,0,1,0
254.73M,"2,037,629",2.78B,$4.06,"16,800",252.63,Buy,293.22,"Jul 22, 2024",ROP,"Roper Technologies, Inc.",58.73B,547.82,6.57B,2.76%,0.22%,1.75%,+1.02%,+1.35%,Roper Technologies to present at Goldman Sachs technology conference,"IntelliTrans expands office footprint in Conway, Arkansas",Truist Financial Sticks to Its Buy Rating for Roper Technologies (ROP),"Roper Technologies Prices Public Offering Of $500 Million Senior Unsecured Notes Due 2029, $500 Million Senior Unsecured Notes Due 2032, $1 Billion Senior Unsecured Notes Due 2034",Roper Technologies price target raised to $635 from $625 at Jefferies,"Roper Technologies to present at Goldman Sachs technology conference IntelliTrans expands office footprint in Conway, Arkansas Truist Financial Sticks to Its Buy Rating for Roper Technologies (ROP) Roper Technologies Prices Public Offering Of $500 Million Senior Unsecured Notes Due 2029, $500 Million Senior Unsecured Notes Due 2032, $1 Billion Senior Unsecured Notes Due 2034 Roper Technologies price target raised to $635 from $625 at Jefferies",0,0,0,0,0,0
281.52M,"1,091,880",2.94B,$2.52,"13,568",225.26,Buy,242.79,"Jul 31, 2024",FTNT,"Fortinet, Inc.",57.16B,74.73,5.54B,11.58%,21.16%,21.87%,+30.27%,+6.63%,"We like Apple for its sustained business model, not its AI story","Palo Alto Networks finally gets back on track — delivering solid earnings, outlook",Palo Alto Networks bet big on bundling. Investors want more proof it’s working,"Walmart, Starbucks among the most overbought stocks due for a pullback","QQQ ETF Update, 9/6/2024 ","We like Apple for its sustained business model, not its AI story Palo Alto Networks finally gets back on track — delivering solid earnings, outlook Palo Alto Networks bet big on bundling. Investors want more proof it’s working Walmart, Starbucks among the most overbought stocks due for a pullback QQQ ETF Update, 9/6/2024 ",1,1,0,0,1,0
865.60M,"10,312,724",-980.10M,$0.24,"14,100",71.84,Strong Buy,88.78,"Aug 29, 2024",ADSK,"Autodesk, Inc.",55.01B,255.26,5.65B,5.33%,5.15%,8.29%,+2.87%,+4.04%,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","Autodesk is ‘fully aligned with Starboard’ that there is more value to come, says CEO Anagnost",Dow Jones notches another record close,"Calls of the Day: Autodesk, Uber, D.R. Horton, Constellation Brands and Chipotle","Analyst calls: Oil giant to surge more than 35%, Planet Fitness a top pick","Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Autodesk is ‘fully aligned with Starboard’ that there is more value to come, says CEO Anagnost Dow Jones notches another record close Calls of the Day: Autodesk, Uber, D.R. Horton, Constellation Brands and Chipotle Analyst calls: Oil giant to surge more than 35%, Planet Fitness a top pick",0,1,1,0,1,0
312.69M,"1,881,490",2.39B,$1.41,"19,300",194.99,Buy,225.00,"Aug 6, 2024",DASH,"DoorDash, Inc.",53.01B,128.81,9.61B,4.10%,12.69%,12.50%,+14.85%,-8.89%,"Ulta misses expectations, trims guidance after quarterly sales decline",Costco may have another winner after its gold bar success: gift cards,"Evercore ISI’s Mark Mahaney on his new top internet stock picks: Amazon, Doordash, Uber",Andreas Halvorsen’s Viking Global poured money into tech last quarter,Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness,"Ulta misses expectations, trims guidance after quarterly sales decline Costco may have another winner after its gold bar success: gift cards Evercore ISI’s Mark Mahaney on his new top internet stock picks: Amazon, Doordash, Uber Andreas Halvorsen’s Viking Global poured money into tech last quarter Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness",0,0,0,0,0,0
107.20M,"330,219",1.46B,$3.00,"29,128",547.82,Buy,607.40,"Jul 24, 2024",NTES,"NetEase, Inc.",52.90B,82.08,14.69B,-5.93%,-8.57%,-15.29%,-12.75%,-16.97%,"Game On: Tencent, NetEase reconsidering Japan investments",Analysts Stay Bullish on NetEase After Q2 Results,"Dell, Marvell get AI boost to beat expectations: Morning Buzz","Tencent, NetEase reconsider Japan investment strategies, Bloomberg says",Jefferies Reaffirms Their Buy Rating on Netease Inc (9999),"Game On: Tencent, NetEase reconsidering Japan investments Analysts Stay Bullish on NetEase After Q2 Results Dell, Marvell get AI boost to beat expectations: Morning Buzz Tencent, NetEase reconsider Japan investment strategies, Bloomberg says Jefferies Reaffirms Their Buy Rating on Netease Inc (9999)",1,0,1,1,0,1
764.91M,"2,714,484",1.31B,-1,"3,416",74.73,Hold,70.46,"Aug 6, 2024",COIN,"Coinbase Global, Inc.",52.53B,211.40,4.50B,-1.51%,-10.04%,1.68%,-15.23%,-21.05%,Coinbase has worst week of the year as crypto stocks plummet,Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade",Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World,"Coinbase has worst week of the year as crypto stocks plummet Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World",0,0,0,1,0,0
215.51M,"964,674",997.00M,-1,"17,250",255.26,Buy,269.24,"Aug 29, 2024",AEP,"American Electric Power Company, Inc.",52.28B,98.25,19.52B,0.27%,5.45%,15.05%,+0.43%,+17.38%,AI demand could strain electrical grid in coming decade,This power provider has doubled as it charts a path for nuclear data centers,Tech companies hunt for nuclear power sparks backlash from some utilities,"QQQ ETF Update, 9/6/2024 ","QQQ ETF Update, 9/4/2024 ","AI demand could strain electrical grid in coming decade This power provider has doubled as it charts a path for nuclear data centers Tech companies hunt for nuclear power sparks backlash from some utilities QQQ ETF Update, 9/6/2024  QQQ ETF Update, 9/4/2024 ",0,0,1,1,0,0
411.54M,"2,235,625",-407.00M,-1,"108,000",128.81,Buy,136.46,"Aug 1, 2024",ROST,"Ross Stores, Inc.",51.77B,155.21,21.09B,6.21%,5.35%,9.60%,+4.66%,+7.43%,"Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20%",TJ Maxx’s owner is bringing its secret sauce to new countries — with a twist,These comeback kids have wiped out the August sell-off,One retailer is on a tear into earnings. How to trade it without chasing it,"Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more","Analyst calls: Super Micro gets a downgrade, aluminum products stock to pop 20% TJ Maxx’s owner is bringing its secret sauce to new countries — with a twist These comeback kids have wiped out the August sell-off One retailer is on a tear into earnings. How to trade it without chasing it Stocks making the biggest moves midday: Cava, Intuit, Ross Stores and more",1,1,0,1,0,1
644.49M,"1,856,935",3.96B,$1.74,"3,115",82.08,Strong Buy,114.43,"Aug 22, 2024",TTD,"The Trade Desk, Inc.",51.62B,105.00,2.17B,8.91%,7.55%,24.33%,+13.68%,+19.05%,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos",Trade Tracker: Josh Brown buys Trade Desk and Sweetgreen,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more",Jim Cramer’s top 10 things to watch in the stock market Friday,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos Trade Tracker: Josh Brown buys Trade Desk and Sweetgreen Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Jim Cramer’s top 10 things to watch in the stock market Friday",0,1,1,1,1,0
248.48M,"5,379,624",1.48B,-1,"10,200",211.40,Buy,248.00,"Aug 1, 2024",CPRT,"Copart, Inc.",50.77B,52.76,4.17B,2.36%,-0.23%,0.78%,+1.68%,-5.91%,"Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more",Barrington Reaffirms Their Hold Rating on Copart (CPRT),Copart price target lowered to $56 from $58 at Baird,Closing Bell Movers: C3.ai falls 16% with guidance unchanged despite Q1 beat,"Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more Barrington Reaffirms Their Hold Rating on Copart (CPRT) Copart price target lowered to $56 from $58 at Baird Closing Bell Movers: C3.ai falls 16% with guidance unchanged despite Q1 beat",0,1,1,0,0,0
532.12M,"1,689,962",2.63B,$3.52,"32,400",98.25,Hold,94.54,"Jul 30, 2024",PCAR,PACCAR Inc,50.57B,96.46,35.29B,-0.27%,-5.80%,-9.02%,-4.19%,-22.65%,Paccar price target lowered to $100 from $106 at Citi,,,,,Paccar price target lowered to $100 from $106 at Citi,0,0,-1,-1,-1,-1
333.57M,"2,225,763",2.07B,$1.47,"101,100",155.21,Strong Buy,167.89,"Aug 22, 2024",CHTR,"Charter Communications, Inc.",49.78B,348.73,54.66B,0.61%,10.17%,11.97%,-6.30%,+33.01%,"NFL’s next big media rights payday is years off, subject to shifting industry","YES Network, MSG Networks to launch combined New York regional sports app",DirecTV is pushing its pay TV bundle — without a satellite dish,MoffettNathanson says Frontier deal implications ‘mixed’ for Verizon competitors,Charter and AMC Networks to renew distribution agreement,"NFL’s next big media rights payday is years off, subject to shifting industry YES Network, MSG Networks to launch combined New York regional sports app DirecTV is pushing its pay TV bundle — without a satellite dish MoffettNathanson says Frontier deal implications ‘mixed’ for Verizon competitors Charter and AMC Networks to renew distribution agreement",0,1,1,1,0,0
491.58M,"2,097,441",253.36M,-1,"28,100",105.00,Strong Buy,108.65,"Aug 8, 2024",KDP,Keurig Dr Pepper Inc.,48.45B,35.73,15.06B,3.79%,6.99%,12.17%,+5.66%,+17.71%,Evercore ISI Remains a Hold on Keurig Dr Pepper (KDP),BRC Inc. announces distribution pact with Keurig Dr Pepper for energy beverages,"Keurig Dr Pepper, SUM announce new multi-year partnership with FMF",,,"Evercore ISI Remains a Hold on Keurig Dr Pepper (KDP) BRC Inc. announces distribution pact with Keurig Dr Pepper for energy beverages Keurig Dr Pepper, SUM announce new multi-year partnership with FMF",1,1,1,1,-1,-1
962.30M,"2,441,986",1.39B,-1,"16,600",52.76,Hold,50.33,"Sep 12, 2024",PAYX,"Paychex, Inc.",46.82B,130.00,5.28B,3.15%,5.39%,6.61%,+1.53%,+6.21%,"Lightning Round: ARM is a great stock to buy, says Jim Cramer",Cramer’s Lightning Round: Paychex is a buy,"QQQ ETF Update, 9/6/2024 ","QQQ ETF Update, 9/4/2024 ","QQQ ETF Update, 8/29/2024 ","Lightning Round: ARM is a great stock to buy, says Jim Cramer Cramer’s Lightning Round: Paychex is a buy QQQ ETF Update, 9/6/2024  QQQ ETF Update, 9/4/2024  QQQ ETF Update, 8/29/2024 ",0,0,0,0,0,0
524.22M,"2,178,469",4.96B,$1.20,"6,003",96.46,Buy,111.27,"Oct 22, 2024",MNST,Monster Beverage Corporation,45.70B,46.65,7.39B,-1.06%,-3.30%,-11.92%,-8.55%,-15.83%,Monster Beverage Board Authorizes New $500.0 Million Share Repurchase Program,Monster Beverage announces new $500M share repurchase program,Monster Beverage call volume above normal and directionally bullish,"Analysts Offer Insights on Consumer Goods Companies: Monster Beverage (MNST), Bj’s Wholesale Club Holdings (BJ) and Target (TGT)",Monster Beverage price target lowered to $50 from $56 at Roth MKM,"Monster Beverage Board Authorizes New $500.0 Million Share Repurchase Program Monster Beverage announces new $500M share repurchase program Monster Beverage call volume above normal and directionally bullish Analysts Offer Insights on Consumer Goods Companies: Monster Beverage (MNST), Bj’s Wholesale Club Holdings (BJ) and Target (TGT) Monster Beverage price target lowered to $50 from $56 at Roth MKM",1,1,1,1,1,1
142.74M,"609,488",4.65B,-1,"3,564",348.73,Hold,374.27,"Oct 25, 2024",MPWR,"Monolithic Power Systems, Inc.",45.65B,936.29,1.89B,10.41%,12.38%,34.43%,+7.67%,+42.03%,These stocks have the most riding on Nvidia’s results with highest correlation,"Monolithic Power price target raised to $1,100 from $925 at TD Cowen",Analysts’ Opinions Are Mixed on These Technology Stocks: Monolithic Power (MPWR) and Texas Instruments (TXN),,,"These stocks have the most riding on Nvidia’s results with highest correlation Monolithic Power price target raised to $1,100 from $925 at TD Cowen Analysts’ Opinions Are Mixed on These Technology Stocks: Monolithic Power (MPWR) and Texas Instruments (TXN)",0,1,0,0,-1,-1
1.36B,"3,425,913",2.18B,$0.86,"22,300",35.73,Buy,36.50,"Oct 24, 2024",MCHP,Microchip Technology Incorporated,43.88B,81.79,6.59B,1.69%,-6.34%,-7.55%,-10.57%,-9.33%,"Stocks making the biggest moves after hours: Toll Brothers, Keysight and more","Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Stocks making the biggest moves premarket: H&R Block, Applied Materials, Microchip",Friday analyst calls: Media and entertainment companies take focus of upgrades,Microchip (MCHP) Receives a Buy from Citi,"Stocks making the biggest moves after hours: Toll Brothers, Keysight and more Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Stocks making the biggest moves premarket: H&R Block, Applied Materials, Microchip Friday analyst calls: Media and entertainment companies take focus of upgrades Microchip (MCHP) Receives a Buy from Citi",1,1,0,1,1,1
360.13M,"1,782,652",1.69B,$3.92,"22,902",130.00,Hold,122.62,"Sep 25, 2024",ODFL,"Old Dominion Freight Line, Inc.",43.67B,203.77,5.97B,-2.83%,1.04%,-2.41%,-7.60%,-13.52%,Friday’s stock stories: What’s likely to move the market in the next session,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",Old Dominion price target lowered to $189 from $193 at JPMorgan,Old Dominion price target lowered to $206 from $210 at BofA,Mixed Performance Indicators Inform Hold Rating for Old Dominion Freight,"Friday’s stock stories: What’s likely to move the market in the next session Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Old Dominion price target lowered to $189 from $193 at JPMorgan Old Dominion price target lowered to $206 from $210 at BofA Mixed Performance Indicators Inform Hold Rating for Old Dominion Freight",1,0,1,0,0,0
979.54M,"3,747,652",1.69B,-1,"36,000",46.65,Buy,55.24,"Aug 7, 2024",KHC,The Kraft Heinz Company,43.42B,35.91,26.32B,1.94%,6.34%,0.82%,+0.51%,-4.51%,Morningstar’s Dave Sekera shares his top value stock picks,Berkshire Hathaway’s new stock pick Ulta Beauty is a classic value buy,Cheap stocks to buy for the long term during the volatility,"These dividend payers will beat yields on cash as the Fed cuts rates, BofA says",Kraft Heinz: Hold Rating Amidst Challenging Market Conditions and Pursuit of Growth Strategies,"Morningstar’s Dave Sekera shares his top value stock picks Berkshire Hathaway’s new stock pick Ulta Beauty is a classic value buy Cheap stocks to buy for the long term during the volatility These dividend payers will beat yields on cash as the Fed cuts rates, BofA says Kraft Heinz: Hold Rating Amidst Challenging Market Conditions and Pursuit of Growth Strategies",1,1,1,0,0,0
48.75M,"495,993",410.98M,$5.00,"12,157",936.29,Strong Buy,912.30,"Aug 1, 2024",TEAM,Atlassian Corporation,41.60B,160.00,4.36B,7.72%,-0.59%,-14.59%,-8.29%,-17.64%,StockTok: DOJ vows to stop pressuring social media companies to censor content,Atlassian-unit Loom acquires AI-powered virtual meeting firm Rewatch,,,,StockTok: DOJ vows to stop pressuring social media companies to censor content Atlassian-unit Loom acquires AI-powered virtual meeting firm Rewatch,1,0,1,-1,-1,-1
536.51M,"5,537,490",1.37B,$1.82,"6,400",81.79,Strong Buy,99.20,"Aug 1, 2024",ACGL,Arch Capital Group Ltd.,40.83B,109.02,15.47B,9.98%,11.39%,22.04%,+15.90%,+16.98%,Friday’s big stock stories: What’s likely to move the market in the next trading session,Arch Capital initiated with an Equal Weight at Barclays,Arch Capital Group Welcomes New Board Members,Arch Capital price target raised to $125 from $110 at Roth MKM,Roth MKM Reaffirms Their Buy Rating on Arch Capital Group (ACGL),Friday’s big stock stories: What’s likely to move the market in the next trading session Arch Capital initiated with an Equal Weight at Barclays Arch Capital Group Welcomes New Board Members Arch Capital price target raised to $125 from $110 at Roth MKM Roth MKM Reaffirms Their Buy Rating on Arch Capital Group (ACGL),1,0,1,1,1,1
214.30M,"836,834",1.28B,$1.04,"8,525",203.77,Hold,202.97,"Jul 24, 2024",NDAQ,"Nasdaq, Inc.",40.52B,70.35,6.57B,3.56%,10.27%,18.89%,+4.83%,+14.36%,"Final Trade: ET, META, JBLU & NDAQ",Cramer’s Stop Trading: Nasdaq,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Looking beyond the U.S.? One portfolio manager is bullish on India, names stocks",Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,"Final Trade: ET, META, JBLU & NDAQ Cramer’s Stop Trading: Nasdaq Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Looking beyond the U.S.? One portfolio manager is bullish on India, names stocks Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings",1,1,0,1,1,0
1.21B,"5,872,266",1.92B,$1.60,"11,000",35.91,Buy,37.75,"Jul 31, 2024",IDXX,"IDEXX Laboratories, Inc.",40.18B,488.13,3.78B,0.26%,-0.18%,-5.67%,+1.13%,-7.33%,Buy Rating for Idexx Laboratories Amid Innovative Cancer Detection Product and Strong Financial Projections,Buy Rating Affirmed for Idexx Laboratories on Strong Growth and Innovation Prospects,Idexx Laboratories (IDXX) Gets a Hold from Piper Sandler,Idexx Laboratories: Holding Steady Amidst Challenges in Veterinary Industry,Buy Rating Affirmed for Idexx Laboratories Amid Operational Excellence and Growth Potential,Buy Rating for Idexx Laboratories Amid Innovative Cancer Detection Product and Strong Financial Projections Buy Rating Affirmed for Idexx Laboratories on Strong Growth and Innovation Prospects Idexx Laboratories (IDXX) Gets a Hold from Piper Sandler Idexx Laboratories: Holding Steady Amidst Challenges in Veterinary Industry Buy Rating Affirmed for Idexx Laboratories Amid Operational Excellence and Growth Potential,0,0,0,0,0,0
260.03M,"1,973,443",-300.52M,-1,"5,200",160.00,Buy,217.69,"Aug 1, 2024",DDOG,"Datadog, Inc.",39.52B,117.23,2.39B,2.27%,-2.98%,-4.15%,-2.59%,-8.83%,"Lightning Round: KKR is ‘one of the best run companies in the world’, says Jim Cramer",Cramer’s Lightning Round: KKR is a ‘really great company’,DA Davidson technology analysts hold an analyst/industry conference call,"New Buy Rating for Datadog (DDOG), the Technology Giant","CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?","Lightning Round: KKR is ‘one of the best run companies in the world’, says Jim Cramer Cramer’s Lightning Round: KKR is a ‘really great company’ DA Davidson technology analysts hold an analyst/industry conference call New Buy Rating for Datadog (DDOG), the Technology Giant CDNS, DDOG, FSLR: Which Strong Buy-Rated Tech Stock’s a Better Buy?",0,0,0,1,0,0
374.53M,"1,217,180",5.41B,-1,"517,124",109.02,Buy,108.43,"Jul 30, 2024",JD,"JD.com, Inc.",39.28B,26.83,152.09B,-0.29%,-1.75%,-1.99%,-1.71%,-0.31%,Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps,Chinese consumer brands look to crack the global market with Singapore as a testbed,"A China stock bull earlier, fund manager explains why he has turned bearish now",Vance grilled on high cost of Trump’s new IVF plan,CNBC Daily Open: Everyone’s waiting for Nvidia,"Alibaba to allow payment through Tencent’s WeChat Pay on e-commerce apps Chinese consumer brands look to crack the global market with Singapore as a testbed A China stock bull earlier, fund manager explains why he has turned bearish now Vance grilled on high cost of Trump’s new IVF plan CNBC Daily Open: Everyone’s waiting for Nvidia",0,1,0,0,0,0
575.94M,"1,301,209",947.00M,$0.96,"13,700",70.35,Buy,70.27,"Oct 16, 2024",EA,Electronic Arts Inc.,39.00B,147.62,7.30B,1.05%,3.64%,8.92%,-1.07%,+14.61%,A September trading strategy from Goldman that nets an 18% return on average,China’s first global gaming hit sells millions. Its investor shares what’s next,Friday’s big stock stories: What’s likely to move the market in the next session,Stifel Nicolaus Sticks to Its Buy Rating for Electronic Arts (EA),"Game On: Tencent, NetEase reconsidering Japan investments","A September trading strategy from Goldman that nets an 18% return on average China’s first global gaming hit sells millions. Its investor shares what’s next Friday’s big stock stories: What’s likely to move the market in the next session Stifel Nicolaus Sticks to Its Buy Rating for Electronic Arts (EA) Game On: Tencent, NetEase reconsidering Japan investments",0,0,0,0,1,0
82.31M,"275,146",845.63M,-1,"23,201",488.13,Buy,579.43,"Aug 6, 2024",FAST,Fastenal Company,39.00B,68.10,7.42B,0.76%,2.18%,0.53%,-4.72%,-12.03%,"Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer",Fastenal reports August net sales down 2.3% to $652.66M,Fastenal initiated with an Equal Weight at Morgan Stanley,,,"Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer Fastenal reports August net sales down 2.3% to $652.66M Fastenal initiated with an Equal Weight at Morgan Stanley",1,1,0,1,-1,-1
337.15M,"1,379,587",163.08M,-1,"51,000",117.23,Buy,139.70,"Aug 8, 2024",GEHC,GE HealthCare Technologies Inc.,38.72B,84.78,19.52B,1.09%,4.37%,4.98%,-0.83%,-5.13%,Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,Buy Rating Affirmed for GE HealthCare Technologies on Innovation and Strong Financial Outlook,Brink’s announces Teteak as Brinks Business System leader,GE HealthCare collaborates with University of California’s CTIPM,"GE HealthCare exec Stacherski sells 19,008 common shares","Cramer updates his takes on all 32 portfolio stocks and grades earnings reports Buy Rating Affirmed for GE HealthCare Technologies on Innovation and Strong Financial Outlook Brink’s announces Teteak as Brinks Business System leader GE HealthCare collaborates with University of California’s CTIPM GE HealthCare exec Stacherski sells 19,008 common shares",1,0,0,1,0,0
1.46B,"26,763,178",4.28B,$0.74,"7,500",26.83,Strong Buy,37.33,"Aug 15, 2024",VRSK,"Verisk Analytics, Inc.",38.19B,268.15,2.78B,0.90%,-0.84%,8.65%,+3.71%,+19.25%,"Update: U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Half Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization","U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Quarter Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization",Verisk Analytics: A Balanced Hold Rating Amidst Growth and Market Risks,Verisk Analytics initiated with an Overweight at Wells Fargo,,"Update: U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Half Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization U.S. Insurance Industry Begins to See Surplus Recovery, Boosted by First Quarter Capital Gains and Signs of U.S. Property and Casualty Firms Inching Towards Stabilization Verisk Analytics: A Balanced Hold Rating Amidst Growth and Market Risks Verisk Analytics initiated with an Overweight at Wells Fargo",0,1,1,1,1,-1
264.20M,"1,439,751",1.15B,$0.76,"347,700",147.62,Buy,159.58,"Jul 30, 2024",CTSH,Cognizant Technology Solutions Corporation,38.01B,76.68,19.27B,2.97%,7.03%,6.93%,+1.57%,+8.07%,Cognizant price target raised to $89 from $82 at JPMorgan,Cognizant’s Solid Financials and Strategic Growth Initiatives Garner Buy Rating,Cognizant’s Hold Rating: A Balanced View Amidst Modest Growth and Acquisition Costs,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Cognizant price target raised to $82 from $81 at RBC Capital,"Cognizant price target raised to $89 from $82 at JPMorgan Cognizant’s Solid Financials and Strategic Growth Initiatives Garner Buy Rating Cognizant’s Hold Rating: A Balanced View Amidst Modest Growth and Acquisition Costs Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Cognizant price target raised to $82 from $81 at RBC Capital",1,1,1,1,1,1
572.65M,"1,266,112",1.15B,$1.56,"19,962",68.10,Buy,69.29,"Oct 10, 2024",EXC,Exelon Corporation,37.81B,37.79,22.75B,0.18%,3.96%,2.69%,+1.85%,+1.47%,This power provider has doubled as it charts a path for nuclear data centers,Tech companies hunt for nuclear power sparks backlash from some utilities,Exelon price target raised to $42 from $39 at Morgan Stanley,Exelon (EXC) Receives a Hold from Morgan Stanley,Exelon price target raised to $40 from $37 at Scotiabank,This power provider has doubled as it charts a path for nuclear data centers Tech companies hunt for nuclear power sparks backlash from some utilities Exelon price target raised to $42 from $39 at Morgan Stanley Exelon (EXC) Receives a Hold from Morgan Stanley Exelon price target raised to $40 from $37 at Scotiabank,1,1,1,0,0,1
456.66M,"1,410,953",1.58B,$0.12,"32,315",84.78,Buy,95.00,"Jul 31, 2024",CCEP,Coca-Cola Europacific Partners PLC,36.12B,78.73,20.52B,6.04%,7.54%,14.57%,+8.62%,+15.64%,Coca-Cola CEO Sells Shares Worth Millions,Evercore ISI Reaffirms Their Buy Rating on Coca-Cola Europacific Partners (CCEP),Coca-Cola Europacific Partners Updates Share Count,Kepler Capital Keeps Their Hold Rating on Coca-Cola Europacific Partners (CCEP),Coca-Cola Europacific Exec Awarded Performance Shares,Coca-Cola CEO Sells Shares Worth Millions Evercore ISI Reaffirms Their Buy Rating on Coca-Cola Europacific Partners (CCEP) Coca-Cola Europacific Partners Updates Share Count Kepler Capital Keeps Their Hold Rating on Coca-Cola Europacific Partners (CCEP) Coca-Cola Europacific Exec Awarded Performance Shares,0,0,0,0,0,0
142.42M,"533,819",889.10M,$1.56,"5,126",268.15,Buy,272.33,"Jul 31, 2024",SMCI,"Super Micro Computer, Inc.",35.91B,613.24,14.94B,-8.59%,-26.16%,-20.12%,-36.79%,-53.22%,Super Micro Computer is among the most oversold names on the Street,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Stocks making the biggest moves premarket: Bowlero, UiPath, Broadcom and more","Super Micro Computer is among the most oversold names on the Street Stocks making the biggest moves midday: Intel, Nio, Broadcom and more Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Stocks making the biggest moves premarket: Bowlero, UiPath, Broadcom and more",1,1,1,0,1,1
495.66M,"1,785,723",2.20B,$1.20,"2,100",76.68,Hold,76.11,"Jul 31, 2024",ALNY,"Alnylam Pharmaceuticals, Inc.",35.00B,272.64,2.34B,5.27%,14.55%,52.99%,+18.21%,+82.80%,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more",RBC Capital Sticks to Their Buy Rating for Alnylam Pharma (ALNY),Alnylam Pharma’s Vutrisiran Garners Strong Buy Rating Amidst Positive ATTR-CM Treatment Prospects,"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Viridian Therapeutics (VRDN) and Impedimed Limited (OtherIPDQF)",Stifel Nicolaus Sticks to Their Buy Rating for Alnylam Pharma (ALNY),"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more RBC Capital Sticks to Their Buy Rating for Alnylam Pharma (ALNY) Alnylam Pharma’s Vutrisiran Garners Strong Buy Rating Amidst Positive ATTR-CM Treatment Prospects Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Viridian Therapeutics (VRDN) and Impedimed Limited (OtherIPDQF) Stifel Nicolaus Sticks to Their Buy Rating for Alnylam Pharma (ALNY)",0,1,0,0,0,0
1.00B,"2,859,800",2.42B,$1.52,"58,000",37.79,Buy,39.67,"Aug 1, 2024",BKR,Baker Hughes Company,34.99B,35.22,27.03B,0.08%,1.23%,7.71%,-9.71%,+1.89%,Baker Hughes reports U.S. rig count down 1 to 582 rigs,Baker Hughes announces leadership changes to continue strategic growth,Baker Hughes Announces Leadership Changes to Continue Strategic Growth and Customer Success  ,Baker Hughes reports U.S. rig count down 2 to 583 rigs,Seaport Research oilfield services analyst has analyst/industry conference call,Baker Hughes reports U.S. rig count down 1 to 582 rigs Baker Hughes announces leadership changes to continue strategic growth Baker Hughes Announces Leadership Changes to Continue Strategic Growth and Customer Success   Baker Hughes reports U.S. rig count down 2 to 583 rigs Seaport Research oilfield services analyst has analyst/industry conference call,1,1,1,1,1,1
460.37M,"1,002,372",1.73B,$2.03,"1,032",78.73,Strong Buy,78.11,"Aug 7, 2024",FANG,"Diamondback Energy, Inc.",34.83B,195.22,8.85B,0.36%,-1.26%,8.56%,-3.83%,-4.77%,Diamondback Energy price target lowered to $237 from $245 at Susquehanna,Morgan Stanley Remains a Buy on Diamondback (FANG),Piper Sandler Keeps Their Buy Rating on Diamondback (FANG),Diamondback Energy price target lowered to $240 from $249 at Piper Sandler,Diamondback Energy price target lowered to $230 from $231 at Wells Fargo,Diamondback Energy price target lowered to $237 from $245 at Susquehanna Morgan Stanley Remains a Buy on Diamondback (FANG) Piper Sandler Keeps Their Buy Rating on Diamondback (FANG) Diamondback Energy price target lowered to $240 from $249 at Piper Sandler Diamondback Energy price target lowered to $230 from $231 at Wells Fargo,1,1,1,1,1,1
58.56M,"8,941,171",1.21B,-1,"38,000",613.24,Buy,953.42,"Aug 6, 2024",LULU,Lululemon Athletica Inc.,33.57B,268.55,9.83B,8.26%,-1.63%,-29.23%,+0.07%,-27.47%,Cramer on Lululemon: The core business is struggling and there’s a lot of new competition in athleisure,Jim Cramer says Broadcom stock is a buy but cautions investors to keep it small,"Cannabis industry targets luxury consumers on Fifth Avenue, in the Hamptons","3-Stock Lunch: Intel, Lululemon & Walgreens Boots",Trade Alert: Rob Sechan sells Lululemon,"Cramer on Lululemon: The core business is struggling and there’s a lot of new competition in athleisure Jim Cramer says Broadcom stock is a buy but cautions investors to keep it small Cannabis industry targets luxury consumers on Fifth Avenue, in the Hamptons 3-Stock Lunch: Intel, Lululemon & Walgreens Boots Trade Alert: Rob Sechan sells Lululemon",0,0,0,1,1,0
128.38M,"614,942",-72.94M,-1,"11,311",272.64,Buy,281.68,"Aug 1, 2024",XEL,Xcel Energy Inc.,33.52B,60.12,13.78B,2.92%,8.39%,7.02%,+4.12%,+13.36%,AI demand could strain electrical grid in coming decade,Bank of America Securities Remains a Buy on Xcel Energy (XEL),"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls","Xcel Energy upgraded to Buy at Argus on data center potential, dividend growth",Xcel Energy upgraded to Buy from Hold at Argus,"AI demand could strain electrical grid in coming decade Bank of America Securities Remains a Buy on Xcel Energy (XEL) Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Xcel Energy upgraded to Buy at Argus on data center potential, dividend growth Xcel Energy upgraded to Buy from Hold at Argus",1,0,1,1,1,1
993.42M,"3,085,909",1.99B,$0.84,"30,100",35.22,Strong Buy,43.31,"Jul 25, 2024",ON,ON Semiconductor Corporation,32.71B,76.36,7.80B,4.17%,4.77%,3.18%,-4.63%,+7.66%,The Big Tech deterioration raises a major red flag for the market,ON Semiconductor (ON) Receives a Rating Update from a Top Analyst,ON Semiconductor: Balancing Growth Prospects with Industry Challenges – A Neutral Outlook,ON Semiconductor put volume heavy and directionally bearish,Analog Devices price target lowered to $255 from $260 at BofA,The Big Tech deterioration raises a major red flag for the market ON Semiconductor (ON) Receives a Rating Update from a Top Analyst ON Semiconductor: Balancing Growth Prospects with Industry Challenges – A Neutral Outlook ON Semiconductor put volume heavy and directionally bearish Analog Devices price target lowered to $255 from $260 at BofA,1,1,0,1,1,0
178.39M,"1,116,866",3.46B,$9.36,"5,600",195.22,Buy,216.21,"Aug 5, 2024",MRNA,"Moderna, Inc.",31.69B,82.44,5.05B,-10.47%,-27.96%,-25.59%,-34.27%,-23.83%,A September trading strategy from Goldman that nets an 18% return on average,Cramer’s Lightning Round: KKR is a buy,FDA authorizes Novavax Covid vaccine targeting JN.1,"Lockheed Martin, Northrop Grumman among the most overbought stocks","Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more","A September trading strategy from Goldman that nets an 18% return on average Cramer’s Lightning Round: KKR is a buy FDA authorizes Novavax Covid vaccine targeting JN.1 Lockheed Martin, Northrop Grumman among the most overbought stocks Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more",1,0,0,0,1,1
125.00M,"2,486,838",1.58B,-1,"6,152",268.55,Buy,390.74,"Aug 29, 2024",CSGP,"CoStar Group, Inc.",31.55B,76.99,2.60B,2.89%,3.20%,-7.18%,-1.92%,-19.23%,"Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings","Murdoch’s property group considers bid for Rightmove, sending shares 21% higher",KBW Reaffirms Their Buy Rating on CoStar Group (CSGP),CoStar Group management to meet with Stephens,Buy Rating Reaffirmed for CoStar Group Amid Rising Homes.com Traffic and Potential Revenue Growth,"Final Trades: Dell Technologies, CoStar Group, Johnson & Johnson and PayPal Holdings Murdoch’s property group considers bid for Rightmove, sending shares 21% higher KBW Reaffirms Their Buy Rating on CoStar Group (CSGP) CoStar Group management to meet with Stephens Buy Rating Reaffirmed for CoStar Group Amid Rising Homes.com Traffic and Potential Revenue Growth",1,1,1,1,1,1
557.50M,"3,677,933",1.86B,$2.19,"1,148",60.12,Buy,63.14,"Oct 25, 2024",ARGX,argenx SE,31.10B,516.69,1.66B,-0.06%,8.90%,23.66%,+0.60%,+34.10%,Argenx price target raised to EUR 510 from EUR 470 at UBS,Argenx price target raised to $510 from $470 at UBS,argenx to Present at Upcoming Investor Conferences,Argenx price target raised to $640 from $500 at JPMorgan,,Argenx price target raised to EUR 510 from EUR 470 at UBS Argenx price target raised to $510 from $470 at UBS argenx to Present at Upcoming Investor Conferences Argenx price target raised to $640 from $500 at JPMorgan,1,1,1,1,1,-1
428.36M,"5,170,265",1.94B,-1,"15,100",76.36,Buy,85.79,"Jul 29, 2024",CDW,CDW Corporation,30.69B,229.74,20.94B,4.05%,1.63%,-0.92%,+2.93%,-12.03%,"Analysts Offer Insights on Technology Companies: Workday (WDAY), CDW (CDW) and Texas Instruments (TXN)",,,,,"Analysts Offer Insights on Technology Companies: Workday (WDAY), CDW (CDW) and Texas Instruments (TXN)",0,0,-1,-1,-1,-1
384.40M,"2,285,803",-5.87B,-1,"24,799",82.44,Buy,127.31,"Aug 1, 2024",FER,Ferrovial SE,30.24B,41.75,9.47B,2.50%,1.76%,21.93%,+3.84%,+39.93%,Ferrovial Concludes Share Buyback Program,Ferrovial Initiates Multi-Million Euro Share Buyback,Ferrovial Advances Share Buyback Program,,,Ferrovial Concludes Share Buyback Program Ferrovial Initiates Multi-Million Euro Share Buyback Ferrovial Advances Share Buyback Program,1,0,1,1,-1,-1
409.82M,"1,491,257",212.90M,-1,"1,745",76.99,Strong Buy,96.14,"Jul 23, 2024",APP,AppLovin Corporation,30.15B,90.20,3.96B,13.11%,11.42%,41.14%,+14.14%,+17.65%,AppLovin Stock Is a Cheap Hidden AI Gem,Benchmark Co. Keeps Their Sell Rating on AppLovin (APP),"With a 0.61x PEG Ratio, AppLovin Stock (NASDAQ:APP) Looks Deeply Undervalued","Lone Pine buys GE Vernova, exits Live Nation in Q2",,"AppLovin Stock Is a Cheap Hidden AI Gem Benchmark Co. Keeps Their Sell Rating on AppLovin (APP) With a 0.61x PEG Ratio, AppLovin Stock (NASDAQ:APP) Looks Deeply Undervalued Lone Pine buys GE Vernova, exits Live Nation in Q2",0,0,1,0,0,-1
59.80M,"109,396",-204.35M,-1,"5,962",516.69,Strong Buy,544.06,"Jul 25, 2024",ZS,"Zscaler, Inc.",30.14B,199.43,2.03B,8.07%,5.39%,-0.51%,+8.15%,+5.80%,Traders ahead of session: What the Fed should do and looking for tech bargains,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Zscaler CEO on guidance, market reaction and CrowdStrike impact","Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more","Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde","Traders ahead of session: What the Fed should do and looking for tech bargains Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Zscaler CEO on guidance, market reaction and CrowdStrike impact Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more Wednesday’s rapid fire: Dollar Tree, Zscaler, Hormel Foods, Booking Holdings, Linde",0,1,1,0,1,1
133.58M,"1,502,535",1.11B,$2.48,"39,800",229.12,Strong Buy,254.63,"Jul 31, 2024",BIDU,"Baidu, Inc.",30.05B,85.70,18.56B,-1.57%,-4.59%,-17.18%,-7.01%,-22.66%,"A China stock bull earlier, fund manager explains why he has turned bearish now",China’s drivers fret over robotaxi push. Experts say there will be new jobs,Tesla’s Optimus faces stiff humanoid competition at Beijing robot conference,Baidu reports slower growth in robotaxi rides,"Retail earnings lift other boats — plus, stocks take negative jobs update in stride","A China stock bull earlier, fund manager explains why he has turned bearish now China’s drivers fret over robotaxi push. Experts say there will be new jobs Tesla’s Optimus faces stiff humanoid competition at Beijing robot conference Baidu reports slower growth in robotaxi rides Retail earnings lift other boats — plus, stocks take negative jobs update in stride",0,0,0,0,1,1
727.88M,"25,725",808.96M,$0.78,"7,570",41.75,,,,BIIB,Biogen Inc.,29.86B,205.00,9.67B,-0.49%,-6.54%,-10.08%,-4.22%,+0.16%,Optimistic Buy Rating for Biogen on Strategic Cost-Cutting and Growth Asset Prioritization,Biogen announces higher dose of nusinersen shows statistical improvement,"Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA",Biogen’s Upward Trajectory: A Buy Rating on Alzheimer’s and Pipeline Progress,Barclays Keeps Their Hold Rating on Biogen (BIIB),"Optimistic Buy Rating for Biogen on Strategic Cost-Cutting and Growth Asset Prioritization Biogen announces higher dose of nusinersen shows statistical improvement Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA Biogen’s Upward Trajectory: A Buy Rating on Alzheimer’s and Pipeline Progress Barclays Keeps Their Hold Rating on Biogen (BIIB)",0,0,0,0,0,0
334.25M,"2,040,837",823.80M,-1,"9,600",90.20,Buy,82.86,"Aug 7, 2024",DXCM,"DexCom, Inc.",29.68B,74.07,3.93B,0.23%,-23.72%,-38.07%,+3.92%,-49.27%,Cramer’s Lightning Round: Whirlpool is ‘too inconsistent’,"These stocks are contenders for selling — and can help cut taxes, Wolfe says","Healthy Returns: What to know about updated Pfizer, Moderna Covid vaccines",Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like,"Today we had a bit of a reckoning in the market, says Jim Cramer","Cramer’s Lightning Round: Whirlpool is ‘too inconsistent’ These stocks are contenders for selling — and can help cut taxes, Wolfe says Healthy Returns: What to know about updated Pfizer, Moderna Covid vaccines Dexcom launches first over-the-counter continuous glucose monitor. Here’s what it’s like Today we had a bit of a reckoning in the market, says Jim Cramer",0,0,1,1,1,0
151.15M,"1,172,414",-73.50M,-1,"1,934",199.43,Buy,224.58,"Sep 3, 2024",MSTR,MicroStrategy Incorporated,29.15B,150.01,480.63M,0.54%,-3.92%,24.82%,-18.18%,-8.21%,Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade","Bitcoin turns positive after overnight sell-off briefly pulls it below $56,000","Stocks making biggest moves premarket: Super Micro, Abercrombie and more","Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade Bitcoin turns positive after overnight sell-off briefly pulls it below $56,000 Stocks making biggest moves premarket: Super Micro, Abercrombie and more",0,0,1,0,0,1
350.65M,"3,381,407",2.68B,-1,"16,021",85.70,Strong Buy,140.43,"Aug 22, 2024",FCNCA,"First Citizens BancShares, Inc.",29.15B,"2,015.05",9.44B,-1.73%,5.60%,20.59%,-5.25%,+24.05%,First Citizens files automatic mixed securities shelf,,,,,First Citizens files automatic mixed securities shelf,0,1,-1,-1,-1,-1
145.66M,"475,951",1.16B,-1,"50,000",205.00,Buy,278.96,"Aug 1, 2024",TSCO,Tractor Supply Company,29.04B,269.18,14.71B,4.23%,2.34%,10.16%,+3.77%,+8.23%,Molson Coors pumps the brakes on DEI practices,Ford joins list of companies walking back DEI policies,Harley-Davidson drops diversity efforts after online pressure,Tractor Supply price target raised to $260 from $250 at Loop Capital,Loop Capital Markets Reaffirms Their Hold Rating on Tractor Supply (TSCO),Molson Coors pumps the brakes on DEI practices Ford joins list of companies walking back DEI policies Harley-Davidson drops diversity efforts after online pressure Tractor Supply price target raised to $260 from $250 at Loop Capital Loop Capital Markets Reaffirms Their Hold Rating on Tractor Supply (TSCO),1,0,0,0,1,1
400.73M,"2,520,394",666.90M,-1,"16,021",74.07,Buy,108.24,"Jul 25, 2024",FCNCO,"First Citizens BancShares, Inc.",28.94B,23.60,9.44B,,2.34%,10.16%,+5.22%,+2.52%,,,,,,,0,-1,-1,-1,-1,-1
194.32M,"10,311,074",-209.99M,-1,"12,300",150.01,Strong Buy,205.94,"Aug 1, 2024",EBAY,eBay Inc.,28.79B,58.88,10.19B,5.14%,8.41%,21.75%,+3.90%,+10.99%,Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,eBay initiated with a Neutral at Cantor Fitzgerald,US regulators want to probe Shein and Temu for consumer safety,"Ikea launches Ikea Preowned to compete with eBay, FT reports","Jackson Hole technical trade: BTIG says these stocks are buys ahead of Powell speech Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call eBay initiated with a Neutral at Cantor Fitzgerald US regulators want to probe Shein and Temu for consumer safety Ikea launches Ikea Preowned to compete with eBay, FT reports",0,0,1,1,1,0
14.47M,"109,641",2.64B,$6.56,"48,000","2,015.05",Buy,"1,913.78","Oct 24, 2024",WTW,Willis Towers Watson Public Limited Company,28.58B,281.46,9.69B,2.81%,6.52%,10.96%,+2.55%,+6.84%,Roth MKM Remains a Buy on Willis Towers Watson (WTW),WTW initiated with an Underweight at Barclays,WTW launches new property facility with Canopius,WTW announces new leadership for Transactional Insurance Solutions,WTW announces new Property & Casualty leader for Private Equity and Transactional Solutions,Roth MKM Remains a Buy on Willis Towers Watson (WTW) WTW initiated with an Underweight at Barclays WTW launches new property facility with Canopius WTW announces new leadership for Transactional Insurance Solutions WTW announces new Property & Casualty leader for Private Equity and Transactional Solutions,0,0,0,1,1,1
107.87M,"816,419",1.13B,$4.40,"18,724",269.18,Buy,254.50,"Jul 25, 2024",FITB,Fifth Third Bancorp,28.48B,42.12,8.13B,3.25%,6.92%,17.40%,-0.33%,+19.55%,"These are the top stocks to own for rest of the year, per Wolfe Research","These banks could be primed to outperform when rates fall, Evercore ISI says","Analysts Offer Insights on Financial Companies: Sagicor Financial (OtherSGCFF), Equitable Holdings (EQH) and Fifth Third Bancorp (FITB)",Bank of America Securities Keeps Their Buy Rating on Fifth Third Bancorp (FITB),,"These are the top stocks to own for rest of the year, per Wolfe Research These banks could be primed to outperform when rates fall, Evercore ISI says Analysts Offer Insights on Financial Companies: Sagicor Financial (OtherSGCFF), Equitable Holdings (EQH) and Fifth Third Bancorp (FITB) Bank of America Securities Keeps Their Buy Rating on Fifth Third Bancorp (FITB)",0,0,0,0,0,-1
14.47M,"14,194",2.64B,$1.41,"6,200",23.55,,,"Jul 25, 2024",ANSS,"ANSYS, Inc.",28.27B,323.45,2.32B,1.06%,-0.36%,-1.96%,+0.63%,-7.68%,,,,,,,1,-1,-1,-1,-1,-1
489.00M,"3,196,385",2.69B,$1.08,"4,260",58.88,Buy,56.91,"Jul 31, 2024",AXON,"Axon Enterprise, Inc.",28.02B,370.70,1.81B,4.73%,13.76%,26.77%,+20.81%,+16.96%,Disney and this AI stock are among the most oversold stocks this week,Axon and Skydio CEOs talk partnership developing first responder drones,"NFL stadium drone incursions present opportunity for Axon, says BofA",Axon management to meet with JMP Securities,Axon participates in a conference call with JPMorgan,"Disney and this AI stock are among the most oversold stocks this week Axon and Skydio CEOs talk partnership developing first responder drones NFL stadium drone incursions present opportunity for Axon, says BofA Axon management to meet with JMP Securities Axon participates in a conference call with JPMorgan",1,0,0,0,1,0
101.56M,"361,826",1.09B,$3.52,"12,371",281.46,Buy,302.00,"Jul 25, 2024",TTWO,"Take-Two Interactive Software, Inc.",27.94B,159.39,5.40B,8.40%,6.14%,4.87%,+5.63%,+5.27%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike","Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick",Andreas Halvorsen’s Viking Global poured money into tech last quarter,Take-Two CEO Strauss Zelnick sits down with Jim Cramer,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks","Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick Andreas Halvorsen’s Viking Global poured money into tech last quarter Take-Two CEO Strauss Zelnick sits down with Jim Cramer Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",0,1,1,0,0,1
676.08M,"3,059,998",2.16B,$1.40,"36,249",42.12,Buy,40.62,"Oct 17, 2024",TCOM,Trip.com Group Limited,27.46B,42.18,6.54B,9.81%,1.19%,5.63%,+8.58%,-4.07%,PDD just gave markets the latest warning on China’s consumer,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more","Stocks making the biggest moves premarket: Paramount, Cava, JD.com and more","Is the market rotation back? Plus, the mob scene at Costco’s new store in Japan",Citi Keeps Their Buy Rating on Trip.com Group Ltd. Sponsored ADR (TCOM),"PDD just gave markets the latest warning on China’s consumer Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more Stocks making the biggest moves premarket: Paramount, Cava, JD.com and more Is the market rotation back? Plus, the mob scene at Costco’s new store in Japan Citi Keeps Their Buy Rating on Trip.com Group Ltd. Sponsored ADR (TCOM)",0,0,1,1,0,0
87.39M,"191,420",495.08M,-1,"11,800",323.45,Hold,318.33,"Jul 31, 2024",NTAP,"NetApp, Inc.",27.40B,133.12,6.27B,5.93%,4.50%,27.54%,+3.88%,+25.57%,Trade Tracker: Josh Brown Sells NetApp,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","Stocks making the biggest moves premarket: United States Steel, Boeing and more","Tuesday’s analyst calls: Ferrari to jump 20%, Boeing downgraded to sell","Committee Stocks on the Move: NetApp, Dell, Freeport-McMoRan, P&G and Bitcoin","Trade Tracker: Josh Brown Sells NetApp Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Stocks making the biggest moves premarket: United States Steel, Boeing and more Tuesday’s analyst calls: Ferrari to jump 20%, Boeing downgraded to sell Committee Stocks on the Move: NetApp, Dell, Freeport-McMoRan, P&G and Bitcoin",0,0,1,1,1,0
75.57M,"567,985",290.68M,-1,"41,100",370.70,Strong Buy,358.08,"Aug 6, 2024",ICLR,ICON Public Limited Company,26.85B,324.16,8.33B,2.01%,1.17%,7.81%,-2.34%,+0.60%,ICON plc CEO to Speak at Global Healthcare Event,Truist Financial Remains a Buy on Icon (ICLR),Evercore ISI Sticks to Its Buy Rating for Icon (ICLR),ICON plc Welcomes New CFO Nigel Clerkin,Icon names Nigel Clerkin as new CFO,ICON plc CEO to Speak at Global Healthcare Event Truist Financial Remains a Buy on Icon (ICLR) Evercore ISI Sticks to Its Buy Rating for Icon (ICLR) ICON plc Welcomes New CFO Nigel Clerkin Icon names Nigel Clerkin as new CFO,0,0,0,0,0,0
175.28M,"797,403",-3.80B,-1,"96,282",159.39,Strong Buy,184.76,"Aug 8, 2024",VOD,Vodafone Group Public Limited Company,25.83B,9.72,39.61B,4.50%,7.13%,10.45%,+4.81%,+13.81%,Goldman Sachs Reaffirms Their Buy Rating on Vodafone (VOD),,,,,Goldman Sachs Reaffirms Their Buy Rating on Vodafone (VOD),1,0,-1,-1,-1,-1
651.11M,"3,448,571",1.50B,-1,"6,556",42.18,Strong Buy,63.38,"Aug 26, 2024",ERIE,Erie Indemnity Company,25.58B,489.24,3.55B,6.61%,20.24%,31.90%,+12.32%,+23.69%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance","Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500","Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23",,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23",1,1,1,1,-1,-1
205.80M,"919,298",986.00M,$2.08,"12,000",133.12,Buy,125.13,"Aug 28, 2024",GFS,GlobalFoundries Inc.,25.42B,46.07,6.89B,1.33%,-7.38%,-12.19%,-11.10%,-10.29%,10 things to watch in the stock market Friday including more bullishness on Lilly,"Lightning Round: I’m a buyer of Clorox, says Jim Cramer",Cramer’s Lightning Round: Clorox is a buy,Accelerating AI with Essential Chips at GlobalFoundries Technology Summit 2024,Buy Rating on GlobalFoundries Inc: Strong Market Position and Bullish Financial Outlook,"10 things to watch in the stock market Friday including more bullishness on Lilly Lightning Round: I’m a buyer of Clorox, says Jim Cramer Cramer’s Lightning Round: Clorox is a buy Accelerating AI with Essential Chips at GlobalFoundries Technology Summit 2024 Buy Rating on GlobalFoundries Inc: Strong Market Position and Bullish Financial Outlook",0,0,0,0,0,0
82.82M,"226,361",714.43M,-1,"1,179",324.16,Strong Buy,352.56,"Jul 24, 2024",TW,Tradeweb Markets Inc.,25.04B,117.45,1.51B,2.91%,7.22%,14.19%,+4.28%,+13.73%,This small-cap fund is outperforming the Russell 2000. Here’s how it works,Tradeweb Markets reports total trading volume for August of $50.9T,Tradeweb Markets price target raised to $113 from $110 at Deutsche Bank,,,This small-cap fund is outperforming the Russell 2000. Here’s how it works Tradeweb Markets reports total trading volume for August of $50.9T Tradeweb Markets price target raised to $113 from $110 at Deutsche Bank,0,0,1,1,-1,-1
27.08B,"2,512,080",1.23B,$0.96,"6,700",9.72,Buy,7.70,"May 14, 2024",FSLR,"First Solar, Inc.",24.73B,231.07,3.76B,7.17%,3.33%,25.38%,+5.82%,+30.91%,Why the U.S. is pumping more oil than any country in history,How the Inflation Reduction Act sparked a manufacturing and clean energy boom,"The long-term winners as AI boosts U.S. power needs, according to Mizuho",Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness,First Solar (FSLR) Poised for Growth: Strong Buy Rating Amid Market Challenges and Policy Tailwinds,"Why the U.S. is pumping more oil than any country in history How the Inflation Reduction Act sparked a manufacturing and clean energy boom The long-term winners as AI boosts U.S. power needs, according to Mizuho Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness First Solar (FSLR) Poised for Growth: Strong Buy Rating Amid Market Challenges and Policy Tailwinds",0,0,1,0,0,0
52.29M,"68,700",530.42M,$5.10,"99,952",489.24,,,"Jul 25, 2024",ERIC,Telefonaktiebolaget LM Ericsson (publ),24.64B,7.40,23.54B,7.18%,12.98%,28.14%,+7.55%,+45.87%,Telefonaktiebolaget LM Ericsson Class B (0O87): New Sell Recommendation for This Technology Giant,Cradlepoint Enhances Wyoming Highway Patrol Vehicle Connectivity with Cellular-to-Satellite Failover,Wyoming Highway Patrol leverages Cradlepoint routers for connectivity,Ericsson Sells Subsidiary iconectiv to Koch Equity,Koch Equity Development Signs Agreement to Acquire Telecommunications Solutions Leader iconectiv,Telefonaktiebolaget LM Ericsson Class B (0O87): New Sell Recommendation for This Technology Giant Cradlepoint Enhances Wyoming Highway Patrol Vehicle Connectivity with Cellular-to-Satellite Failover Wyoming Highway Patrol leverages Cradlepoint routers for connectivity Ericsson Sells Subsidiary iconectiv to Koch Equity Koch Equity Development Signs Agreement to Acquire Telecommunications Solutions Leader iconectiv,1,1,0,0,1,0
551.78M,"821,536",814.00M,-1,"1,787",46.07,Buy,58.25,"Aug 6, 2024",SBAC,SBA Communications Corporation,24.43B,227.28,2.68B,3.95%,9.56%,5.73%,+3.70%,+6.69%,"Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC)",SBA Communications price target raised to $240 from $230 at Deutsche Bank,,,,"Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC) SBA Communications price target raised to $240 from $230 at Deutsche Bank",0,0,1,-1,-1,-1
213.23M,"459,859",432.90M,$0.40,"7,906",117.45,Buy,118.00,"Jul 25, 2024",TROW,"T. Rowe Price Group, Inc.",24.40B,109.62,6.80B,0.18%,-4.35%,-2.65%,-5.87%,-7.83%,OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing,Evercore ISI Keeps Their Hold Rating on T Rowe Price (TROW),"Hershey, Temu parent PDD downgraded: Wall Street’s top analyst calls",T. Rowe Price initiated with an Underweight at Barclays,T. Rowe Price price target raised to $113 from $112 at Deutsche Bank,"OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing Evercore ISI Keeps Their Hold Rating on T Rowe Price (TROW) Hershey, Temu parent PDD downgraded: Wall Street’s top analyst calls T. Rowe Price initiated with an Underweight at Barclays T. Rowe Price price target raised to $113 from $112 at Deutsche Bank",0,0,0,1,0,0
107.05M,"2,439,299",1.20B,-1,"8,772",231.07,Buy,277.74,"Jul 30, 2024",KSPI,Joint Stock Company Kaspi.kz,24.24B,127.58,4.70B,2.53%,-1.12%,19.49%,-5.75%,-7.62%,Kaspi.kz JSC Declares Q2 Dividends and Auditor,Announcement of Extraordinary General Meeting Results,Kaspi.kz price target raised to $183 from $159 at JPMorgan,,,Kaspi.kz JSC Declares Q2 Dividends and Auditor Announcement of Extraordinary General Meeting Results Kaspi.kz price target raised to $183 from $159 at JPMorgan,0,0,0,0,-1,-1
3.33B,"15,511,757",-3.38B,$0.25,"31,591",7.40,Hold,5.90,"Oct 15, 2024",LI,Li Auto Inc.,22.51B,21.22,18.10B,6.80%,7.96%,-25.21%,-9.83%,-40.33%,CNBC Daily Open: Soft landing in sight?,BYD sales hit a record in August despite broader China EV slowdown,Chinese EV company Xpeng sees shares pop 6% after it launches mass-market car,"Test driving BYD, Nio and other Chinese EV rivals of Tesla",Tuesday’s big stock stories: What’s likely to move the market in the next trading session,"CNBC Daily Open: Soft landing in sight? BYD sales hit a record in August despite broader China EV slowdown Chinese EV company Xpeng sees shares pop 6% after it launches mass-market car Test driving BYD, Nio and other Chinese EV rivals of Tesla Tuesday’s big stock stories: What’s likely to move the market in the next trading session",0,0,0,0,0,0
107.47M,"509,429",514.32M,$3.92,"6,500",227.28,Strong Buy,243.54,"Jul 29, 2024",TER,"Teradyne, Inc.",22.18B,135.94,2.70B,6.88%,-3.28%,15.69%,+0.88%,+23.34%,An options trade that pays off if the S&P 500 fails to get back to new highs,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",Friday analyst calls: Media and entertainment companies take focus of upgrades,Early notable gainers among liquid option names on August 23rd,"Cisco, Nike upgrades among today’s top calls on Wall Street","An options trade that pays off if the S&P 500 fails to get back to new highs Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Friday analyst calls: Media and entertainment companies take focus of upgrades Early notable gainers among liquid option names on August 23rd Cisco, Nike upgrades among today’s top calls on Wall Street",0,0,0,1,1,1
222.60M,"883,760",1.90B,$4.96,"53,000",109.62,Hold,113.90,"Oct 25, 2024",WDC,Western Digital Corporation,22.10B,64.35,13.00B,1.87%,-10.07%,-0.41%,-6.89%,-14.61%,"Don’t be scared by volatility, keep buying chip stocks in 2H, says Cantor",Buy Rating Justified by Western Digital’s Strategic Restructuring and Strong Market Position,Wells says Seagate comments suggest HAMR cloud qualification could be pushed out,Western Digital (WDC) Receives a Buy from Morgan Stanley,"SPY ETF Update, 8/28/2024 ","Don’t be scared by volatility, keep buying chip stocks in 2H, says Cantor Buy Rating Justified by Western Digital’s Strategic Restructuring and Strong Market Position Wells says Seagate comments suggest HAMR cloud qualification could be pushed out Western Digital (WDC) Receives a Buy from Morgan Stanley SPY ETF Update, 8/28/2024 ",0,1,0,0,0,0
190.02M,"155,007",1.97B,$7.17,"30,000",127.58,Buy,147.67,"Jul 22, 2024",STX,Seagate Technology Holdings plc,21.95B,104.41,6.55B,1.64%,-1.61%,10.73%,-2.86%,+10.29%,"Final Trades: Lennar, Oracle and Seagate",‘Near certainty’: Morgan Stanley shares how to position for global tech downturn,"These dividend payers will beat yields on cash as the Fed cuts rates, BofA says",Seagate Tech: Steady Growth Amidst HAMR Qualification Delays – Hold Rating Maintained,Wells says Seagate comments suggest HAMR cloud qualification could be pushed out,"Final Trades: Lennar, Oracle and Seagate ‘Near certainty’: Morgan Stanley shares how to position for global tech downturn These dividend payers will beat yields on cash as the Fed cuts rates, BofA says Seagate Tech: Steady Growth Amidst HAMR Qualification Delays – Hold Rating Maintained Wells says Seagate comments suggest HAMR cloud qualification could be pushed out",1,0,1,0,0,0
1.06B,"6,415,325",1.57B,-1,"7,420",21.22,Strong Buy,40.08,"Aug 28, 2024",ZM,"Zoom Video Communications, Inc.",21.59B,70.14,4.59B,20.61%,22.24%,12.70%,+17.04%,+12.31%,"Zoom stock has best day in almost 2 years on quarterly results, increased guidance","Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more",Jim Cramer says market-share gains are fueling this cyber stock’s rally,"Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video",Zoom beats on revenue and earnings as stock climbs in after-hours,"Zoom stock has best day in almost 2 years on quarterly results, increased guidance Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Jim Cramer says market-share gains are fueling this cyber stock’s rally Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video Zoom beats on revenue and earnings as stock climbs in after-hours",1,1,1,0,1,1
163.18M,"1,648,579",495.64M,$0.48,"6,450",135.94,Buy,138.73,"Oct 23, 2024",CHKP,Check Point Software Technologies Ltd.,21.49B,190.31,2.49B,2.53%,8.05%,17.70%,+3.34%,+15.32%,Microsoft plans September event to discuss changes after CrowdStrike outage,Palo Alto Networks bet big on bundling. Investors want more proof it’s working,Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and Ease of Doing Business,Maintaining a Hold: Assessing Check Point’s Strategic Acquisition Amidst CEO Transition,Maintaining Hold on Check Point Software Amid Strategic Acquisitions and Market Challenges,Microsoft plans September event to discuss changes after CrowdStrike outage Palo Alto Networks bet big on bundling. Investors want more proof it’s working Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and Ease of Doing Business Maintaining a Hold: Assessing Check Point’s Strategic Acquisition Amidst CEO Transition Maintaining Hold on Check Point Software Amid Strategic Acquisitions and Market Challenges,0,0,0,0,0,0
343.45M,"3,222,352",-852.00M,-1,"7,231",64.35,Buy,85.60,"Jul 31, 2024",PTC,PTC Inc.,21.30B,177.31,2.22B,1.47%,-0.30%,0.12%,-2.23%,-6.15%,PTC Inc. Welcomes New Board Member with Extensive VC Expertise,"Lone Pine buys GE Vernova, exits Live Nation in Q2",,,,"PTC Inc. Welcomes New Board Member with Extensive VC Expertise Lone Pine buys GE Vernova, exits Live Nation in Q2",1,1,0,-1,-1,-1
210.20M,"1,346,494",335.00M,$2.80,"19,995",104.41,Buy,114.94,"Jul 23, 2024",HBAN,Huntington Bancshares Incorporated,21.25B,14.63,6.71B,4.74%,6.42%,11.57%,-2.07%,+7.65%,"Beat Treasury yields with these dividend-paying bank stocks, Janney says",Cleveland Browns’ stadium to be called ‘Huntington Bank Field’ under new deal,"Analysts Are Bullish on These Financial Stocks: HCI Group (HCI), Credicorp (BAP)",,,"Beat Treasury yields with these dividend-paying bank stocks, Janney says Cleveland Browns’ stadium to be called ‘Huntington Bank Field’ under new deal Analysts Are Bullish on These Financial Stocks: HCI Group (HCI), Credicorp (BAP)",1,1,0,1,-1,-1
307.79M,"6,537,833",875.37M,-1,"6,133",70.14,Hold,75.10,"Aug 21, 2024",BNTX,BioNTech SE,20.97B,88.19,2.88B,3.38%,3.52%,-6.34%,+2.32%,-2.56%,"Healthy Returns: The combination Covid, flu shot race is heating up",BioNTech Highlights Oncology Advances at ESMO 2024,"BioNTech to present data updates across mRNA, immunomodulatory portfolio",BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024,Tempus announces real world data collaboration with BioNTech,"Healthy Returns: The combination Covid, flu shot race is heating up BioNTech Highlights Oncology Advances at ESMO 2024 BioNTech to present data updates across mRNA, immunomodulatory portfolio BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 Tempus announces real world data collaboration with BioNTech",1,1,1,0,1,0
112.91M,"356,576",835.50M,-1,"13,360",190.31,Buy,183.68,"Jul 24, 2024",ILMN,"Illumina, Inc.",20.93B,131.39,4.43B,4.46%,11.80%,8.91%,+7.42%,+3.09%,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,Morfit’s ValueAct bought more Disney and Salesforce in the second quarter,"Stocks making the biggest moves midday: Brinker International, Victoria’s Secret","Wednesday’s top analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Target","Stocks making the biggest moves premarket: Kellanova, Alphabet, Flutter and more","Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Morfit’s ValueAct bought more Disney and Salesforce in the second quarter Stocks making the biggest moves midday: Brinker International, Victoria’s Secret Wednesday’s top analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Target Stocks making the biggest moves premarket: Kellanova, Alphabet, Flutter and more",0,0,1,1,1,1
120.14M,"371,785",295.41M,-1,"211,826",177.31,Buy,200.18,"Jul 31, 2024",DLTR,"Dollar Tree, Inc.",20.85B,97.00,30.91B,-2.30%,-6.97%,-21.80%,-9.47%,-27.73%,Super Micro Computer is among the most oversold names on the Street,"These stocks are contenders for selling — and can help cut taxes, Wolfe says",Jim Cramer’s top 10 things to watch in the stock market Thursday,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Super Micro Computer is among the most oversold names on the Street These stocks are contenders for selling — and can help cut taxes, Wolfe says Jim Cramer’s top 10 things to watch in the stock market Thursday Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more",1,1,1,0,1,1
1.45B,"9,251,526",1.55B,$0.62,"5,426",14.63,Buy,15.59,"Oct 18, 2024",CINF,Cincinnati Financial Corporation,20.75B,132.81,10.65B,3.08%,8.33%,16.38%,+3.22%,+10.94%,Cincinnati Financial Declares Regular Quarterly Dividend,Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend,Cincinnati Financial Releases New Investor Presentation,,,Cincinnati Financial Declares Regular Quarterly Dividend Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend Cincinnati Financial Releases New Investor Presentation,0,0,0,0,-1,-1
237.77M,"471,455",-540.45M,-1,"10,600",88.19,Buy,109.09,"Aug 5, 2024",BGNE,"BeiGene, Ltd.",20.57B,193.82,3.10B,10.74%,22.74%,22.96%,+18.96%,+32.08%,BeiGene announces FDA grants Fast Track Designation to BGB-16673,"3 Best Stocks to Buy Now, 8/21/2024, According to Top Analysts ",BeiGene price target raised to $200 from $194 at JPMorgan,TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE),Jefferies Sticks to Their Buy Rating for BeiGene (BGNE),"BeiGene announces FDA grants Fast Track Designation to BGB-16673 3 Best Stocks to Buy Now, 8/21/2024, According to Top Analysts  BeiGene price target raised to $200 from $194 at JPMorgan TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE) Jefferies Sticks to Their Buy Rating for BeiGene (BGNE)",0,0,1,0,0,0
159.30M,"880,183",-3.04B,-1,"35,300",131.39,Buy,150.39,"Aug 6, 2024",WBD,"Warner Bros. Discovery, Inc.",19.74B,8.05,39.93B,5.65%,6.07%,-9.90%,-7.86%,-4.21%,"Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’","NFL’s next big media rights payday is years off, subject to shifting industry",A look at the behind-the-scenes business of Hollywood studio lot tours,"YES Network, MSG Networks to launch combined New York regional sports app","Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more","Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’ NFL’s next big media rights payday is years off, subject to shifting industry A look at the behind-the-scenes business of Hollywood studio lot tours YES Network, MSG Networks to launch combined New York regional sports app Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more",1,0,1,0,1,1
214.94M,"2,169,301",-997.30M,-1,"26,127",97.00,Buy,142.70,"Sep 4, 2024",LINE,"Lineage, Inc.",19.54B,85.82,5.33B,0.10%,0.52%,0.52%,-4.14%,,Wall Street loves this under-the-radar stock that is key to our food supply,Jim Cramer’s top 10 things to watch in the stock market Monday,"Stocks making biggest moves premarket: AMD, Estée Lauder, Dutch Bros and more","Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen","RBC Capital Sticks to Their Buy Rating for Lineage, Inc. (LINE)","Wall Street loves this under-the-radar stock that is key to our food supply Jim Cramer’s top 10 things to watch in the stock market Monday Stocks making biggest moves premarket: AMD, Estée Lauder, Dutch Bros and more Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen RBC Capital Sticks to Their Buy Rating for Lineage, Inc. (LINE)",1,0,0,1,1,0
156.24M,"220,324",2.15B,$3.24,"10,200",132.81,Buy,131.57,"Oct 24, 2024",FOXA,Fox Corporation,18.87B,41.01,13.98B,4.83%,11.16%,26.44%,+8.39%,+32.91%,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry",82% of Americans say saving for retirement is harder now than it used to be,"YES Network, MSG Networks to launch combined New York regional sports app",5 things to know before the stock market opens Monday,"Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry 82% of Americans say saving for retirement is harder now than it used to be YES Network, MSG Networks to launch combined New York regional sports app 5 things to know before the stock market opens Monday",1,1,1,1,1,1
106.12M,"427,999",-523.70M,-1,"22,261",193.82,Buy,247.31,"Aug 7, 2024",RYAAY,Ryanair Holdings plc,18.86B,105.74,14.38B,6.53%,-0.38%,-13.92%,+7.44%,-25.32%,Europe markets close higher as investors weigh global outlook,"Europe markets close slightly higher, led by travel stocks","Elliott will launch proxy fight at Southwest, nominate 10 directors",Ryanair Progresses With Share Buy-Back Program,Ryanair Holdings Sees Major Voting Rights Shift,"Europe markets close higher as investors weigh global outlook Europe markets close slightly higher, led by travel stocks Elliott will launch proxy fight at Southwest, nominate 10 directors Ryanair Progresses With Share Buy-Back Program Ryanair Holdings Sees Major Voting Rights Shift",0,0,0,0,0,0
2.45B,"36,011,277",-11.77B,-1,"15,000",8.05,Buy,11.59,"Aug 7, 2024",COO,"The Cooper Companies, Inc.",18.84B,94.62,3.73B,1.24%,3.64%,1.66%,+1.30%,-4.12%,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,Stifel Nicolaus Reaffirms Their Buy Rating on Cooper Co (COO),Early notable gainers among liquid option names on August 29th,Piper Sandler Keeps Their Buy Rating on Cooper Co (COO),Cooper Companies price target raised to $125 from $118 at Baird,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Stifel Nicolaus Reaffirms Their Buy Rating on Cooper Co (COO) Early notable gainers among liquid option names on August 29th Piper Sandler Keeps Their Buy Rating on Cooper Co (COO) Cooper Companies price target raised to $125 from $118 at Baird,1,0,1,1,1,1
227.69M,"644,221",-229.40M,-1,"2,200",85.82,Buy,94.07,"Sep 3, 2024",HOOD,"Robinhood Markets, Inc.",18.68B,21.12,2.24B,11.58%,1.05%,29.62%,-1.22%,+10.43%,Jim Cramer’s top 10 things to watch in the stock market Friday,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more","Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade",Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World,"Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more","Jim Cramer’s top 10 things to watch in the stock market Friday Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Analyst calls: Broadcom earnings reaction, Chinese EV stock gets an upgrade Super PAC backing Kamala Harris to accept crypto donations: CNBC Crypto World Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more",0,0,1,0,0,1
460.23M,"1,819,857",1.50B,$0.53,"12,600",41.01,Buy,36.71,"Aug 6, 2024",STLD,"Steel Dynamics, Inc.",18.65B,120.88,18.15B,0.80%,-2.51%,-3.69%,-11.40%,-19.85%,Seaport Research steel analyst to hold analyst/industry conference call,Steel Dynamics upgraded to Buy from Neutral at UBS,Steel Dynamics Announces Third Quarter 2024 Cash Dividend,Morgan Stanley Sticks to Their Hold Rating for Steel Dynamics (STLD),Steel Dynamics price target raised to $138 from $134 at Morgan Stanley,Seaport Research steel analyst to hold analyst/industry conference call Steel Dynamics upgraded to Buy from Neutral at UBS Steel Dynamics Announces Third Quarter 2024 Cash Dividend Morgan Stanley Sticks to Their Hold Rating for Steel Dynamics (STLD) Steel Dynamics price target raised to $138 from $134 at Morgan Stanley,0,0,0,0,0,0
1.13B,"323,242",1.73B,$2.89,"6,990",105.74,Buy,158.50,"Jul 22, 2024",HOLX,"Hologic, Inc.",18.64B,80.25,3.99B,-2.40%,2.35%,6.44%,-1.51%,+3.08%,Citi Remains a Buy on Hologic (HOLX),Hologic participates in a conference call with JPMorgan,RBC Capital Sticks to Their Hold Rating for Hologic (HOLX),,,Citi Remains a Buy on Hologic (HOLX) Hologic participates in a conference call with JPMorgan RBC Capital Sticks to Their Hold Rating for Hologic (HOLX),0,1,0,0,-1,-1
199.12M,"1,157,296",339.90M,$0.02,"19,800",94.62,Strong Buy,111.78,"Aug 28, 2024",PFG,"Principal Financial Group, Inc.",18.41B,79.48,15.65B,3.38%,-0.32%,-0.05%,-1.63%,-5.12%,Principal Financial initiated with an Underweight at Barclays,Principal Financial names Deanna Strable President and Chief Operating Officer,Principal Financial price target lowered to $83 from $85 at Morgan Stanley,Morgan Stanley Sticks to Its Hold Rating for Principal Financial (PFG),,Principal Financial initiated with an Underweight at Barclays Principal Financial names Deanna Strable President and Chief Operating Officer Principal Financial price target lowered to $83 from $85 at Morgan Stanley Morgan Stanley Sticks to Its Hold Rating for Principal Financial (PFG),0,0,0,0,0,-1
884.68M,"8,868,141",290.00M,-1,,21.12,Buy,22.81,"Aug 7, 2024",FWONK,Formula One Group,18.22B,77.50,3.69B,0.09%,1.72%,11.10%,-4.48%,+12.79%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
154.30M,"973,172",2.01B,$1.84,"10,400",120.88,Hold,132.13,"Oct 16, 2024",FOX,Fox Corporation,18.20B,38.14,13.98B,4.53%,10.84%,26.72%,+8.02%,+34.52%,Rising NFL valuations mean massive returns for owners,"NFL’s next big media rights payday is years off, subject to shifting industry",82% of Americans say saving for retirement is harder now than it used to be,"YES Network, MSG Networks to launch combined New York regional sports app",5 things to know before the stock market opens Monday,"Rising NFL valuations mean massive returns for owners NFL’s next big media rights payday is years off, subject to shifting industry 82% of Americans say saving for retirement is harder now than it used to be YES Network, MSG Networks to launch combined New York regional sports app 5 things to know before the stock market opens Monday",0,1,1,1,1,1
232.27M,"877,422",701.50M,-1,"26,600",80.25,Buy,87.60,"Jul 29, 2024",SSNC,"SS&C Technologies Holdings, Inc.",18.17B,74.03,5.66B,3.27%,10.02%,18.74%,+1.77%,+18.35%,SS&C Increases Common Stock Dividend to $0.25 Per Share,SS&C raises quarterly dividend to 25c from 24c per share,,,,SS&C Increases Common Stock Dividend to $0.25 Per Share SS&C raises quarterly dividend to 25c from 24c per share,0,0,1,-1,-1,-1
231.58M,"672,384",1.26B,$2.88,"5,037",79.48,Hold,84.33,"Jul 25, 2024",MDB,"MongoDB, Inc.",18.16B,247.61,1.77B,-1.30%,-2.53%,-31.05%,-6.73%,-35.13%,Jim Cramer’s top 10 things to watch in the stock market Tuesday,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more",MongoDB CEO on earnings: ‘We feel like we’re well positioned for the AI era’,"10 key things to watch in the stock market Friday, including two AI gainers","Stocks close higher Friday, S&P 500 posts fourth straight winning month","Jim Cramer’s top 10 things to watch in the stock market Tuesday Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more MongoDB CEO on earnings: ‘We feel like we’re well positioned for the AI era’ 10 key things to watch in the stock market Friday, including two AI gainers Stocks close higher Friday, S&P 500 posts fourth straight winning month",0,0,1,1,1,0
235.03M,"1,019,503",279.00M,-1,"9,750",77.50,Buy,84.00,"Aug 8, 2024",ZBRA,Zebra Technologies Corporation,18.14B,351.62,4.36B,3.20%,6.91%,20.84%,-2.10%,+18.41%,These stocks typically have the best and worst Septembers,Zebra Tech (ZBRA) Gets a Buy from TD Cowen,,,,These stocks typically have the best and worst Septembers Zebra Tech (ZBRA) Gets a Buy from TD Cowen,1,0,0,-1,-1,-1
,,,-1,"56,000",,,,,ULTA,"Ulta Beauty, Inc.",18.07B,378.65,11.30B,5.70%,-0.64%,-15.74%,+0.53%,-17.52%,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more","10 key things to watch in the stock market Friday, including two AI gainers","Stocks making the biggest moves premarket: CrowdStrike, Alibaba, Ulta and more",5 things to know before the stock market opens Friday,"Stocks close higher Friday, S&P 500 posts fourth straight winning month","Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more 10 key things to watch in the stock market Friday, including two AI gainers Stocks making the biggest moves premarket: CrowdStrike, Alibaba, Ulta and more 5 things to know before the stock market opens Friday Stocks close higher Friday, S&P 500 posts fourth straight winning month",0,1,1,1,1,0
460.23M,"752,393",1.50B,$0.53,"34,718",38.14,,,"Aug 6, 2024",JBHT,"J.B. Hunt Transport Services, Inc.",18.05B,176.97,12.34B,2.14%,4.69%,-5.18%,+0.59%,-10.83%,Friday’s stock stories: What’s likely to move the market in the next session,J.B. Hunt management to meet with Stephens,J.B. Hunt board authorizes repurchase of $1B of company’s common stock,Ken Hoexter Recommends Buy on JB Hunt Following $1 Billion Share Buyback and Solid Financial Performance,J.B. Hunt Trucking (NASDAQ:JBHT) Proves a Force in Autonomous Trucking,Friday’s stock stories: What’s likely to move the market in the next session J.B. Hunt management to meet with Stephens J.B. Hunt board authorizes repurchase of $1B of company’s common stock Ken Hoexter Recommends Buy on JB Hunt Following $1 Billion Share Buyback and Solid Financial Performance J.B. Hunt Trucking (NASDAQ:JBHT) Proves a Force in Autonomous Trucking,0,0,1,0,0,0
245.42M,"819,396",698.30M,$1.00,"6,486",74.03,Buy,70.75,"Jul 25, 2024",FWONA,Formula One Group,18.02B,70.44,3.69B,-0.62%,1.53%,11.28%,-5.66%,+14.69%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
73.35M,"1,331,653",-202.95M,-1,"17,100",247.61,Buy,361.04,"Aug 29, 2024",EXPE,"Expedia Group, Inc.",17.98B,138.13,13.26B,10.68%,10.07%,5.89%,+9.44%,+6.02%,These are the 10 U.S. states boasting America’s best workforces,Here are Wolfe’s favorite stocks as market approaches fresh record,‘Travel is too expensive right now’: Americans spend less or skip trips altogether,Travelers are finally cracking under the pressure of high costs,Benchmark’s Daniel Kurnos talks how to position in travel stocks,These are the 10 U.S. states boasting America’s best workforces Here are Wolfe’s favorite stocks as market approaches fresh record ‘Travel is too expensive right now’: Americans spend less or skip trips altogether Travelers are finally cracking under the pressure of high costs Benchmark’s Daniel Kurnos talks how to position in travel stocks,1,1,1,0,0,0
51.58M,"226,094",230.00M,-1,"23,100",351.62,Buy,347.10,"Jul 30, 2024",NTRS,Northern Trust Corporation,17.89B,88.70,7.61B,3.69%,4.10%,7.18%,unch,+2.15%,Northern (NTRS) Receives a Sell from Morgan Stanley,Northern Trust partners with Greenlight to expand financial literacy,Northern Trust price target lowered to $84 from $85 at Deutsche Bank,,,Northern (NTRS) Receives a Sell from Morgan Stanley Northern Trust partners with Greenlight to expand financial literacy Northern Trust price target lowered to $84 from $85 at Deutsche Bank,1,1,0,1,-1,-1
47.72M,"845,569",1.26B,-1,"4,200",378.65,Buy,487.00,"Aug 29, 2024",DKNG,DraftKings Inc.,17.66B,36.37,4.30B,5.78%,-2.58%,-9.76%,-7.04%,-27.22%,Wall Street is still bullish on sports betting stocks despite mixed results,How the Cowboys went from losing $1 million a month to topping the NFL in value,Wednesday’s stock stories: What’s likely to move the market in the next session,DraftKings fined in Conn. over online slot machines that paid zero wins for week,NFL season expected to spur record $35 billion in legal sports wagers,Wall Street is still bullish on sports betting stocks despite mixed results How the Cowboys went from losing $1 million a month to topping the NFL in value Wednesday’s stock stories: What’s likely to move the market in the next session DraftKings fined in Conn. over online slot machines that paid zero wins for week NFL season expected to spur record $35 billion in legal sports wagers,1,1,0,0,1,1
101.99M,"407,868",604.33M,$1.72,"8,000",176.97,Buy,181.25,"Oct 15, 2024",ENTG,"Entegris, Inc.",17.56B,116.32,3.28B,5.26%,-7.57%,-7.27%,-4.61%,-18.73%,Entegris Enhances Board with Semiconductor Expert Mary Puma,,,,,Entegris Enhances Board with Semiconductor Expert Mary Puma,0,1,-1,-1,-1,-1
234.91M,"37,751",279.00M,-1,908,70.44,Strong Buy,75.00,"Aug 8, 2024",VRSN,"VeriSign, Inc.",17.50B,179.32,1.53B,1.01%,1.65%,-4.19%,-3.11%,-3.53%,Buy Rating on Verisign: A Balance of Contract Renewal Confidence and Growth Potential,,,,,Buy Rating on Verisign: A Balance of Contract Renewal Confidence and Growth Potential,0,1,-1,-1,-1,-1
130.18M,"1,221,754",808.00M,-1,"21,610",138.13,Buy,148.00,"Aug 8, 2024",ALGN,"Align Technology, Inc.",17.48B,233.97,3.94B,5.39%,0.30%,-10.88%,-0.41%,-27.28%,Stifel Nicolaus Reaffirms Their Buy Rating on Align Tech (ALGN),Early notable gainers among liquid option names on August 15th,Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Arcutis Biotherapeutics (ARQT),,,Stifel Nicolaus Reaffirms Their Buy Rating on Align Tech (ALGN) Early notable gainers among liquid option names on August 15th Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN) and Arcutis Biotherapeutics (ARQT),0,1,1,0,-1,-1
201.64M,"804,842",1.50B,$3.00,"9,750",88.70,Hold,89.54,"Oct 16, 2024",SWKS,"Skyworks Solutions, Inc.",17.44B,109.21,4.37B,1.69%,-0.80%,4.43%,-6.06%,+1.19%,,,,,,,0,-1,-1,-1,-1,-1
485.53M,"7,491,240",-406.47M,-1,"2,204",36.37,Strong Buy,49.50,"Aug 1, 2024",GMAB,Genmab A/S,17.36B,27.34,2.73B,2.58%,4.38%,-3.71%,-2.09%,-6.92%,Genmab resumed with an Equal Weight at Morgan Stanley,Genmab’s Hold Rating: Balancing Stability and Uncertainty,"Genmab price target lowered to DKK 2,500 from DKK 2,750 at Deutsche Bank",Strong Pipeline and Regulatory Approval Prospects Affirm Buy Rating for Genmab,Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference,"Genmab resumed with an Equal Weight at Morgan Stanley Genmab’s Hold Rating: Balancing Stability and Uncertainty Genmab price target lowered to DKK 2,500 from DKK 2,750 at Deutsche Bank Strong Pipeline and Regulatory Approval Prospects Affirm Buy Rating for Genmab Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference",1,1,1,1,1,1
150.98M,"1,407,815",184.15M,$0.40,"3,401",116.32,Strong Buy,145.80,"Jul 31, 2024",BMRN,BioMarin Pharmaceutical Inc.,17.14B,90.02,2.59B,2.49%,5.62%,3.69%,+7.10%,+3.88%,"Tuesday’s biggest analyst calls: Nvidia, Amazon, AMD, Ulta, Eli Lilly and more",Buy Rating Affirmed for BioMarin Pharmaceutical Amid Strong Voxzogo Outlook and Strategic Growth Initiatives,BioMarin price target raised to $95 from $86 at Scotiabank,BioMarin price target raised to $120 from $111 at JPMorgan,Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT),"Tuesday’s biggest analyst calls: Nvidia, Amazon, AMD, Ulta, Eli Lilly and more Buy Rating Affirmed for BioMarin Pharmaceutical Amid Strong Voxzogo Outlook and Strategic Growth Initiatives BioMarin price target raised to $95 from $86 at Scotiabank BioMarin price target raised to $120 from $111 at JPMorgan Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT)",1,1,1,0,0,0
97.60M,"555,911",846.10M,-1,"8,400",179.32,Buy,218.00,"Jul 25, 2024",LPLA,LPL Financial Holdings Inc.,16.73B,223.82,10.93B,7.68%,-5.16%,-8.58%,-0.28%,-15.14%,"LPL Financial to acquire The Investment Center, terms not disclosed","LPL Financial to Acquire The Investment Center, Inc.",LPL Financial appoints Tom Gannon as chief advocacy officer,LPL Financial Appoints Tom Gannon as Chief Advocacy Officer,LPL Financial welcomes advisor Kelly Compton,"LPL Financial to acquire The Investment Center, terms not disclosed LPL Financial to Acquire The Investment Center, Inc. LPL Financial appoints Tom Gannon as chief advocacy officer LPL Financial Appoints Tom Gannon as Chief Advocacy Officer LPL Financial welcomes advisor Kelly Compton",0,0,0,0,0,0
74.70M,"627,903",447.03M,-1,"3,157",233.97,Buy,322.78,"Jul 24, 2024",ENPH,"Enphase Energy, Inc.",16.66B,123.00,1.42B,9.03%,11.22%,7.80%,+7.42%,+10.14%,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research",Enphase announces solution for expanding legacy NEM systems in California,Enphase Energy price target raised to $115 from $111 at Jefferies,Tesla or Enphase Energy: Top Analyst Chooses the Superior Clean Energy Stock to Buy,Enphase Energy initiated with a Market Perform at William Blair,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research Enphase announces solution for expanding legacy NEM systems in California Enphase Energy price target raised to $115 from $111 at Jefferies Tesla or Enphase Energy: Top Analyst Chooses the Superior Clean Energy Stock to Buy Enphase Energy initiated with a Market Perform at William Blair",1,0,0,1,1,1
159.72M,"1,413,400",780.30M,$2.80,"5,908",109.21,Hold,113.59,"Jul 30, 2024",OKTA,"Okta, Inc.",16.66B,99.01,2.36B,4.52%,4.31%,7.19%,+2.77%,-4.89%,"Stocks making the biggest moves midday: Dollar General, Affirm and more","Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more","Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike","Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick","Stocks making the biggest moves after hours: Nvidia, Salesforce and more","Stocks making the biggest moves midday: Dollar General, Affirm and more Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Thursday’s analyst calls: Cava gets a downgrade, Apple a top AI pick Stocks making the biggest moves after hours: Nvidia, Salesforce and more",1,1,1,1,1,1
63.47M,"305,559",795.95M,-1,"23,900",27.34,Buy,46.00,"Aug 8, 2024",NWS,News Corporation,16.19B,29.20,10.09B,2.96%,2.60%,10.35%,+2.35%,+10.20%,Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch,"Murdoch’s property group considers bid for Rightmove, sending shares 21% higher","Starboard raised Salesforce in Q2, cut stake in this online web services stock",Murdoch family battle highlights Nevada’s secret trust boom,"Starboard files proposal to end News Corp dual-class structure, Reuters says","Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch Murdoch’s property group considers bid for Rightmove, sending shares 21% higher Starboard raised Salesforce in Q2, cut stake in this online web services stock Murdoch family battle highlights Nevada’s secret trust boom Starboard files proposal to end News Corp dual-class structure, Reuters says",0,1,1,1,1,1
190.38M,"852,274",256.59M,-1,"4,580",90.02,Buy,106.78,"Aug 5, 2024",MANH,"Manhattan Associates, Inc.",16.08B,262.51,996.57M,3.82%,6.90%,12.32%,+1.42%,+6.36%,,,,,,,0,-1,-1,-1,-1,-1
74.76M,"511,698",974.41M,$1.20,"23,900",223.82,Buy,278.00,"Oct 24, 2024",NWSA,News Corporation,15.99B,28.14,10.09B,2.79%,2.06%,10.20%,+1.81%,+9.43%,Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch,"Murdoch’s property group considers bid for Rightmove, sending shares 21% higher","Starboard raised Salesforce in Q2, cut stake in this online web services stock",Murdoch family battle highlights Nevada’s secret trust boom,"Starboard files proposal to end News Corp dual-class structure, Reuters says","Starboard moves to collapse News Corp’s dual class stock in challenge to Rupert Murdoch Murdoch’s property group considers bid for Rightmove, sending shares 21% higher Starboard raised Salesforce in Q2, cut stake in this online web services stock Murdoch family battle highlights Nevada’s secret trust boom Starboard files proposal to end News Corp dual-class structure, Reuters says",1,1,1,1,1,1
135.42M,"3,047,199",129.61M,-1,"5,200",123.00,Buy,128.39,"Oct 24, 2024",BSY,"Bentley Systems, Incorporated",15.92B,50.22,1.29B,6.47%,5.50%,2.23%,+3.78%,+2.14%,Bentley Systems Expands Board and Announces Dividend,"Bentley Systems acquires Cesium, names CEO Patrick Cozzi chief platform officer",Bentley Systems management to meet with KeyBanc,Bentley Systems: Strong ARR Growth and EBITDA Expansion Justify Buy Rating Amidst Economic Headwinds,,"Bentley Systems Expands Board and Announces Dividend Bentley Systems acquires Cesium, names CEO Patrick Cozzi chief platform officer Bentley Systems management to meet with KeyBanc Bentley Systems: Strong ARR Growth and EBITDA Expansion Justify Buy Rating Amidst Economic Headwinds",1,1,1,1,1,-1
168.23M,"1,649,468",-276.00M,-1,"3,400",99.01,Buy,104.53,"Aug 28, 2024",GEN,Gen Digital Inc.,15.83B,25.72,3.83B,4.69%,5.47%,14.98%,+0.88%,+18.37%,"Starboard boosts stake in Salesforce, cuts stake in Humana",,,,,"Starboard boosts stake in Salesforce, cuts stake in Humana",0,1,-1,-1,-1,-1
568.58M,"455,814",266.00M,$0.20,"1,168",29.20,Buy,33.00,"Aug 8, 2024",UTHR,United Therapeutics Corporation,15.48B,348.03,2.62B,5.01%,7.18%,34.31%,+14.86%,+54.07%,MannKind price target raised to $12 from $10 at Oppenheimer,Buy Rating Affirmed for United Therapeutics on Strengthened Tyvaso Franchise Position,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR)",Liquidia price target lowered to $28 from $30 at Ladenburg,Liquidia price target lowered to $23 from $24 at BofA,"MannKind price target raised to $12 from $10 at Oppenheimer Buy Rating Affirmed for United Therapeutics on Strengthened Tyvaso Franchise Position Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR) Liquidia price target lowered to $28 from $30 at Ladenburg Liquidia price target lowered to $23 from $24 at BofA",0,0,0,1,0,0
61.25M,"199,701",204.72M,-1,"1,400",262.51,Strong Buy,257.43,"Oct 22, 2024",NBIX,"Neurocrine Biosciences, Inc.",15.43B,152.81,2.12B,2.92%,5.99%,12.76%,-12.58%,-10.91%,Writing options on these stocks could create income for your portfolio,"Stocks making the biggest moves midday: Super Micro, Abercrombie and more",Election 2024: Where To Put Your Money Ahead of the Vote,Biotech Alert: Searches spiking for these stocks today,Buy Rating Affirmed for Neurocrine on Market Potential and Superior Safety Profile,"Writing options on these stocks could create income for your portfolio Stocks making the biggest moves midday: Super Micro, Abercrombie and more Election 2024: Where To Put Your Money Ahead of the Vote Biotech Alert: Searches spiking for these stocks today Buy Rating Affirmed for Neurocrine on Market Potential and Superior Safety Profile",1,0,1,1,1,1
568.27M,"1,145,060",266.00M,$0.20,"10,250",28.14,Buy,33.00,"Aug 8, 2024",AKAM,"Akamai Technologies, Inc.",15.43B,101.83,3.93B,3.01%,6.71%,-4.11%,+1.83%,-5.80%,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more","Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more","Akamai CEO Tom Leighton on Q2 earnings beat, AI adoption and growth outlook",Akamai Technologies: A Strong Buy on Strategic Security Shift and Solid Financials,Akamai (AKAM) Receives a Buy from Craig-Hallum,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more Akamai CEO Tom Leighton on Q2 earnings beat, AI adoption and growth outlook Akamai Technologies: A Strong Buy on Strategic Security Shift and Solid Financials Akamai (AKAM) Receives a Buy from Craig-Hallum",1,1,1,0,0,0
317.09M,"682,256",374.96M,$0.24,"3,293",50.22,Buy,59.57,"Aug 6, 2024",NTRA,"Natera, Inc.",15.18B,122.71,1.36B,6.87%,9.15%,38.03%,+16.04%,+22.80%,"The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos",Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,Natera price target raised to $145 from $130 at Canaccord,"Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)",J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA),"The Committee’s Comeback Kids: Trade Desk, Sweetgreen, Natera, Samsara, PayPal and Leidos Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Natera price target raised to $145 from $130 at Canaccord Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON) J.P. Morgan Sticks to Their Buy Rating for Natera (NTRA)",0,1,0,0,0,0
615.53M,"3,384,228",610.00M,$0.50,"14,500",25.72,Buy,27.20,"Aug 1, 2024",CPB,Campbell Soup Company,15.17B,50.80,9.41B,1.36%,5.97%,12.49%,+7.06%,+15.87%,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General",Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks,"Dow rises 200 points for fresh record close, Nasdaq falls as Nvidia shares tumble",Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,Nvidia will be in the spotlight next week as Street wraps up a tumultuous August,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks Dow rises 200 points for fresh record close, Nasdaq falls as Nvidia shares tumble Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings Nvidia will be in the spotlight next week as Street wraps up a tumultuous August",0,1,1,0,0,0
44.49M,"224,785",1.07B,-1,"5,900",348.03,Buy,335.73,"Jul 31, 2024",WMG,Warner Music Group Corp.,15.07B,29.10,6.38B,1.62%,-2.65%,-11.25%,-3.30%,-12.93%,"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies",Paramount-Skydance ‘go shop’ period extended to review Bronfman offer,Paramount (NASDAQ:PARA) Drama Not Over Yet as Edgar Bronfman Comes Back,Warner Music Group Corp. Announces Quarterly Cash Dividend,Evercore ISI Sticks to Their Buy Rating for Warner Music Group (WMG),"Likely policies under a Harris presidency and the stocks impacted, according to Jefferies Paramount-Skydance ‘go shop’ period extended to review Bronfman offer Paramount (NASDAQ:PARA) Drama Not Over Yet as Edgar Bronfman Comes Back Warner Music Group Corp. Announces Quarterly Cash Dividend Evercore ISI Sticks to Their Buy Rating for Warner Music Group (WMG)",0,0,0,0,0,0
100.98M,"487,519",339.20M,-1,"5,442",152.81,Buy,163.26,"Aug 1, 2024",LNT,Alliant Energy Corporation,14.88B,58.03,3.96B,1.52%,6.14%,13.12%,+3.84%,+18.32%,These are the best teen checking accounts of September 2024,Best personal loans offered by credit unions,Best CD rates,Best credit unions,Alliant Energy (LNT) Gets a Buy from Bank of America Securities,These are the best teen checking accounts of September 2024 Best personal loans offered by credit unions Best CD rates Best credit unions Alliant Energy (LNT) Gets a Buy from Bank of America Securities,1,0,0,0,0,1
151.53M,"760,145",628.81M,-1,"7,900",101.83,Buy,115.39,"Aug 8, 2024",NDSN,Nordson Corporation,14.72B,257.40,2.66B,5.71%,7.86%,2.32%,+2.38%,-5.47%,"Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more","Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more",Seaport Global Reaffirms Their Hold Rating on Nordson (NDSN),Oppenheimer Reaffirms Their Hold Rating on Nordson (NDSN),Nordson (NDSN) Receives a Hold from Seaport Global,"Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more Seaport Global Reaffirms Their Hold Rating on Nordson (NDSN) Oppenheimer Reaffirms Their Hold Rating on Nordson (NDSN) Nordson (NDSN) Receives a Hold from Seaport Global",1,1,1,1,0,1
123.68M,"835,403",-292.12M,-1,"2,200",122.71,Strong Buy,122.57,"Aug 8, 2024",CG,The Carlyle Group Inc.,14.34B,40.25,2.78B,-3.27%,-4.42%,-3.60%,-19.32%,-14.89%,5 things to know before the stock market opens Wednesday,"Calls of the Day: Ferrari, Cleveland Cliffs, Carlyle Group and BlackRock",NFL owners vote in favor of private equity investment,"Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more",‘Private Markets Are the Hot Spot’: Analyst Suggests 2 Alternative Asset Stocks to Consider,"5 things to know before the stock market opens Wednesday Calls of the Day: Ferrari, Cleveland Cliffs, Carlyle Group and BlackRock NFL owners vote in favor of private equity investment Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more ‘Private Markets Are the Hot Spot’: Analyst Suggests 2 Alternative Asset Stocks to Consider",1,1,1,1,1,1
298.55M,"3,046,006",739.00M,$1.48,"103,300",50.80,Hold,46.25,"Aug 29, 2024",UAL,"United Airlines Holdings, Inc.",14.25B,43.32,55.64B,1.22%,-6.83%,-6.51%,-9.00%,-4.31%,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree",Friday’s stock stories: What’s likely to move the market in the next session,Here’s where American Airlines is adding flights to Europe in summer 2025,Why airlines like American are scrambling to make engines last longer,Airlines are leaning into AI to improve flights,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree Friday’s stock stories: What’s likely to move the market in the next session Here’s where American Airlines is adding flights to Europe in summer 2025 Why airlines like American are scrambling to make engines last longer Airlines are leaning into AI to improve flights",0,0,0,0,1,0
517.92M,"1,241,812",539.00M,$0.72,"16,790",29.10,Buy,37.07,"Aug 7, 2024",RIVN,"Rivian Automotive, Inc.",14.08B,13.96,5.01B,2.50%,-0.60%,2.14%,-15.72%,+36.93%,"Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here","These stocks are contenders for selling — and can help cut taxes, Wolfe says",Tesla Cybertruck is in a category of its own for better or worse,5 things to know before the stock market opens Wednesday,GMC expects to outsell electric truck competitors as it launches new Sierra pickup,"Tesla, GM, Rivian and Ford: The $100,000 electric truck market is here These stocks are contenders for selling — and can help cut taxes, Wolfe says Tesla Cybertruck is in a category of its own for better or worse 5 things to know before the stock market opens Wednesday GMC expects to outsell electric truck competitors as it launches new Sierra pickup",1,1,1,0,1,0
256.50M,"645,024",625.00M,$1.92,"7,300",58.03,Buy,58.36,"Aug 1, 2024",LOGI,Logitech International S.A.,14.05B,92.26,4.41B,2.62%,-0.79%,1.49%,-0.40%,+3.26%,Kepler Capital Sticks to Their Hold Rating for Logitech (LOGI),Logitech shareholders approve all proposals at AGM,Logitech price target raised to $88 from $87 at Loop Capital,Loop Capital Markets Remains a Hold on Logitech (LOGI),,Kepler Capital Sticks to Their Hold Rating for Logitech (LOGI) Logitech shareholders approve all proposals at AGM Logitech price target raised to $88 from $87 at Loop Capital Loop Capital Markets Remains a Hold on Logitech (LOGI),1,1,1,1,1,-1
57.18M,"253,745",472.89M,$3.12,"38,000",257.40,Buy,290.40,"Aug 21, 2024",VTRS,Viatris Inc.,14.04B,11.76,15.24B,-0.28%,3.87%,4.28%,-1.33%,+0.85%,Viatris Initiates Cash Tender Offers for Senior Notes,Viatris Announces Cash Tender Offers for Certain Outstanding Notes,Analyst Maintains Sell Rating on Viatris Citing Long-Term Revenue Concerns and Growth Challenges,,,Viatris Initiates Cash Tender Offers for Senior Notes Viatris Announces Cash Tender Offers for Certain Outstanding Notes Analyst Maintains Sell Rating on Viatris Citing Long-Term Revenue Concerns and Growth Challenges,1,0,0,1,-1,-1
356.38M,"1,733,997",-396.90M,$1.40,18,40.25,Buy,46.62,"Aug 5, 2024",GLPI,"Gaming and Leisure Properties, Inc.",13.92B,50.74,1.49B,2.94%,7.29%,10.84%,+1.75%,+13.11%,"Gaming and Leisure Properties, Inc. Declares Third Quarter 2024 Cash Dividend of $0.76 Per Share",Bet On It: Missouri sports betting certification process challenged with lawsuit,Gaming and Leisure Properties upgraded to Outperform from Peer Perform at Wolfe Research,Gaming and Leisure price target raised to $53 from $50 at Raymond James,Gaming and Leisure Properties price target raised to $55 from $53 at JMP Securities,"Gaming and Leisure Properties, Inc. Declares Third Quarter 2024 Cash Dividend of $0.76 Per Share Bet On It: Missouri sports betting certification process challenged with lawsuit Gaming and Leisure Properties upgraded to Outperform from Peer Perform at Wolfe Research Gaming and Leisure price target raised to $53 from $50 at Raymond James Gaming and Leisure Properties price target raised to $55 from $53 at JMP Securities",0,0,0,0,0,0
328.83M,"3,308,035",2.94B,-1,"12,700",43.32,Strong Buy,72.78,"Oct 15, 2024",TRMB,Trimble Inc.,13.92B,56.99,3.71B,5.62%,2.75%,2.85%,+2.92%,-8.66%,"Trimble Struggles with Reporting Compliance, Receives Nasdaq Extension",Trimble receives listing deficiency notification from Nasdaq,"Analysts Are Bullish on These Technology Stocks: Onestream, Inc. Class A (OS), Trimble (TRMB)",Trimble called ‘highest conviction’ second half idea at Piper Sandler,"Jana added Rapid7 during Q2, sold out of Freshpet","Trimble Struggles with Reporting Compliance, Receives Nasdaq Extension Trimble receives listing deficiency notification from Nasdaq Analysts Are Bullish on These Technology Stocks: Onestream, Inc. Class A (OS), Trimble (TRMB) Trimble called ‘highest conviction’ second half idea at Piper Sandler Jana added Rapid7 during Q2, sold out of Freshpet",0,1,0,1,1,1
1.01B,"33,005,416",-5.79B,-1,"6,000",13.96,Buy,17.90,"Aug 6, 2024",POOL,Pool Corporation,13.72B,358.52,5.37B,-0.21%,4.52%,-4.01%,-6.53%,-11.77%,Pool Corp. price target raised to $335 from $310 at Stifel,Pool Corporation Announces Upcoming Investor Conference Participation,,,,Pool Corp. price target raised to $335 from $310 at Stifel Pool Corporation Announces Upcoming Investor Conference Participation,1,0,1,-1,-1,-1
152.81M,"233,533",691.25M,$1.29,"45,359",92.26,Hold,94.56,"Jul 22, 2024",CASY,"Casey's General Stores, Inc.",13.71B,369.40,14.86B,-0.65%,-0.78%,16.90%,-5.09%,+16.23%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines",Proposed 7-Eleven buyout deal likely to face antitrust scrutiny: Retail analyst,"Casey’s beats estimates amid golden age for convenience stores, Barron’s says",Casey’s General Stores price target raised to $403 from $393 at RBC Capital,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines Proposed 7-Eleven buyout deal likely to face antitrust scrutiny: Retail analyst Casey’s beats estimates amid golden age for convenience stores, Barron’s says Casey’s General Stores price target raised to $403 from $393 at RBC Capital",1,1,1,1,1,0
1.19B,"5,847,074",-646.50M,$0.48,"1,187",11.76,Hold,12.33,"Aug 8, 2024",AZPN,"Aspen Technology, Inc.",13.68B,216.23,1.13B,5.20%,8.11%,7.31%,+16.78%,+1.79%,"Software is a good small cap play because earnings are more recurring, says Julie Biel",,,,,"Software is a good small cap play because earnings are more recurring, says Julie Biel",0,0,-1,-1,-1,-1
274.39M,"1,018,697",777.59M,$3.04,912,50.74,Buy,51.57,"Jul 25, 2024",INSM,Insmed Incorporated,13.55B,78.84,328.61M,3.30%,6.41%,91.12%,+5.20%,+176.68%,Insmed added to Americas Conviction List at Goldman Sachs,Insmed’s Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition,Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities,Truist Financial Reaffirms Their Buy Rating on Insmed (INSM),Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition,Insmed added to Americas Conviction List at Goldman Sachs Insmed’s Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities Truist Financial Reaffirms Their Buy Rating on Insmed (INSM) Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition,0,0,0,0,0,0
244.21M,"535,620",1.51B,-1,"4,658",56.99,Buy,66.29,"Aug 6, 2024",EVRG,"Evergy, Inc.",13.46B,58.53,5.64B,-0.15%,4.89%,10.94%,+1.33%,+12.59%,Wednesday’s stock stories: What’s likely to move the market in the next session,Evergy appoints W. Bryan Buckler as CFO,Evergy files automatic mixed securities shelf,Evergy price target raised to $64 from $61 at Barclays,Barclays Keeps Their Buy Rating on Evergy (EVRG),Wednesday’s stock stories: What’s likely to move the market in the next session Evergy appoints W. Bryan Buckler as CFO Evergy files automatic mixed securities shelf Evergy price target raised to $64 from $61 at Barclays Barclays Keeps Their Buy Rating on Evergy (EVRG),1,0,1,1,1,1
38.26M,"170,554",458.20M,$4.80,"11,334",358.52,Hold,344.63,"Oct 17, 2024",MORN,"Morningstar, Inc.",13.44B,313.83,2.17B,0.08%,1.79%,6.19%,-2.35%,+0.13%,Only 11% of American workers don’t plan to work at all after they retire,"Utilities are getting expensive, but these 2 names are undervalued: Strategist",79% of Americans who make this one move won’t run out of money in retirement,‘Long-term opportunity’: Morningstar analyst names 2 luxury stocks to buy,The 3 biggest ways retirement savers ‘shoot themselves in the foot’,"Only 11% of American workers don’t plan to work at all after they retire Utilities are getting expensive, but these 2 names are undervalued: Strategist 79% of Americans who make this one move won’t run out of money in retirement ‘Long-term opportunity’: Morningstar analyst names 2 luxury stocks to buy The 3 biggest ways retirement savers ‘shoot themselves in the foot’",1,1,1,1,1,1
37.11M,"222,517",501.97M,$2.00,"2,932",369.40,Strong Buy,410.22,"Sep 4, 2024",IBKR,"Interactive Brokers Group, Inc.",13.43B,123.40,4.77B,7.44%,5.39%,19.25%,+5.91%,+12.12%,Barclays Sticks to Its Buy Rating for Interactive Brokers (IBKR),Interactive Brokers reports August average revenue trades up 40% vs. last year,Interactive Brokers expands overnight trading offering,,,Barclays Sticks to Its Buy Rating for Interactive Brokers (IBKR) Interactive Brokers reports August average revenue trades up 40% vs. last year Interactive Brokers expands overnight trading offering,0,0,1,0,-1,-1
63.25M,"112,896",-9.77M,$0.53,"1,314",216.23,Strong Buy,224.50,"Aug 6, 2024",SRPT,"Sarepta Therapeutics, Inc.",13.40B,140.56,1.50B,1.77%,-2.15%,15.02%,-2.34%,+10.18%,Election 2024: Where To Put Your Money Ahead of the Vote,Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Danaher (DHR),Biotech Alert: Searches spiking for these stocks today,RBC Capital Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT),Evercore ISI Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT),Election 2024: Where To Put Your Money Ahead of the Vote Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Danaher (DHR) Biotech Alert: Searches spiking for these stocks today RBC Capital Sticks to Their Buy Rating for Sarepta Therapeutics (SRPT) Evercore ISI Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT),0,1,0,1,0,0
171.85M,"2,353,397",-802.69M,-1,"2,800",78.84,Strong Buy,81.40,"Aug 8, 2024",ARCC,Ares Capital Corporation,13.19B,20.92,2.82B,2.02%,1.43%,2.90%,+0.14%,+1.94%,,,,,,,0,-1,-1,-1,-1,-1
229.96M,"1,708,126",739.30M,$2.57,"6,450",58.53,Buy,58.33,"Aug 9, 2024",NTNX,"Nutanix, Inc.",13.16B,53.35,2.10B,5.56%,1.48%,-3.51%,+3.52%,-20.75%,"Stocks making the biggest moves midday: Dollar General, Affirm and more","Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more","Stocks making the biggest moves after hours: Nvidia, Salesforce and more","Nutanix COO David Sangster Plans Retirement, Continues as Advisor",Analysts Have Conflicting Sentiments on These Technology Companies: Dave (DAVE) and Nutanix (NTNX),"Stocks making the biggest moves midday: Dollar General, Affirm and more Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Stocks making the biggest moves after hours: Nvidia, Salesforce and more Nutanix COO David Sangster Plans Retirement, Continues as Advisor Analysts Have Conflicting Sentiments on These Technology Companies: Dave (DAVE) and Nutanix (NTNX)",1,1,1,1,1,1
42.84M,"117,473",245.90M,$1.62,"1,854",313.83,Strong Buy,336.00,"Jul 24, 2024",MNDY,monday.com Ltd.,13.13B,263.42,844.78M,7.25%,9.69%,23.11%,+11.47%,+18.05%,Top Wall Street analysts are upbeat about the potential of these 3 stocks ,Jim Cramer’s top 10 things to watch in the stock market Tuesday,Op-ed: Small caps could be in for a revival. Here’s why,"Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more","After a busy week of stock trades, we’re looking ahead to some key inflation data","Top Wall Street analysts are upbeat about the potential of these 3 stocks  Jim Cramer’s top 10 things to watch in the stock market Tuesday Op-ed: Small caps could be in for a revival. Here’s why Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more After a busy week of stock trades, we’re looking ahead to some key inflation data",1,1,0,1,1,1
108.84M,"499,270",681.00M,$1.00,"172,000",123.40,Strong Buy,127.10,"Oct 15, 2024",FLEX,Flex Ltd.,13.08B,32.93,25.84B,5.32%,5.76%,19.02%,-0.62%,+9.94%,Flex Adjusts Executive Compensation to Reflect Roles and Performance,Flex files automatic mixed securities shelf,,,,Flex Adjusts Executive Compensation to Reflect Roles and Performance Flex files automatic mixed securities shelf,0,0,0,-1,-1,-1
95.37M,"544,472",47.30M,-1,"3,000",140.56,Buy,185.41,"Aug 7, 2024",PODD,Insulet Corporation,12.96B,185.04,1.87B,0.84%,-1.51%,2.97%,+5.18%,+23.89%,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more",We’re trimming a health-care stock on concerns its business could be hurt by Lilly,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more","Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more",Strong Growth and Market Leadership Support Buy Rating for Insulet,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more We’re trimming a health-care stock on concerns its business could be hurt by Lilly Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more Strong Growth and Market Leadership Support Buy Rating for Insulet",0,1,0,1,1,0
630.39M,"3,749,942",1.68B,$1.92,"6,263",20.92,Buy,21.63,"Oct 22, 2024",Z,"Zillow Group, Inc.",12.93B,56.35,2.07B,13.10%,16.07%,17.37%,+15.73%,+19.36%,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Citi ‘incrementally positive’ on Zillow shares after meetings,Zillow Group initiated with a Neutral at Cantor Fitzgerald,Zillow Group management to meet with Stephens,Zillow Group price target raised to $66 from $60 at RBC Capital,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Citi ‘incrementally positive’ on Zillow shares after meetings Zillow Group initiated with a Neutral at Cantor Fitzgerald Zillow Group management to meet with Stephens Zillow Group price target raised to $66 from $60 at RBC Capital,1,1,1,1,1,1
246.64M,"1,732,330",-11.96M,-1,502,53.35,Buy,66.43,"Aug 28, 2024",REG,Regency Centers Corporation,12.93B,71.42,1.46B,1.99%,8.07%,13.75%,+6.42%,+21.87%,Regency Centers to Present at the BofA Securities 2024 Global Real Estate Conference,Regency Centers price target raised to $72 from $71 at Evercore ISI,Wells Fargo Sticks to Its Buy Rating for Regency Centers (REG),Regency Centers price target raised to $79 from $69 at Wells Fargo,Regency Centers Announces New Safeway-Anchored Ground-Up Shopping Center Development in Bay Area,Regency Centers to Present at the BofA Securities 2024 Global Real Estate Conference Regency Centers price target raised to $72 from $71 at Evercore ISI Wells Fargo Sticks to Its Buy Rating for Regency Centers (REG) Regency Centers price target raised to $79 from $69 at Wells Fargo Regency Centers Announces New Safeway-Anchored Ground-Up Shopping Center Development in Bay Area,1,1,0,0,0,0
49.86M,"257,164",41.22M,-1,"12,005",263.42,Strong Buy,280.57,"Aug 12, 2024",GRAB,Grab Holdings Limited,12.79B,3.23,2.58B,-0.06%,-4.57%,-2.68%,-2.73%,-0.93%,Grab Holdings management to meet with Benchmark,"Analysts Offer Insights on Technology Companies: Uber Technologies (UBER), Grab (GRAB) and Advanced Micro Devices (AMD)",Barclays Sticks to Its Buy Rating for Grab (GRAB),J.P. Morgan Sticks to Their Buy Rating for Grab (GRAB),Analysts Offer Insights on Technology Companies: Grab (GRAB) and Salesforce (CRM),"Grab Holdings management to meet with Benchmark Analysts Offer Insights on Technology Companies: Uber Technologies (UBER), Grab (GRAB) and Advanced Micro Devices (AMD) Barclays Sticks to Its Buy Rating for Grab (GRAB) J.P. Morgan Sticks to Their Buy Rating for Grab (GRAB) Analysts Offer Insights on Technology Companies: Grab (GRAB) and Salesforce (CRM)",1,1,1,1,1,1
397.07M,"1,433,066",959.00M,-1,89,32.93,Strong Buy,38.80,"Jul 24, 2024",RPRX,Royalty Pharma plc,12.63B,28.19,2.24B,3.87%,4.77%,1.26%,+2.27%,-1.30%,"Lightning Round: I’ll pass on buying a flying car from China, says Jim Cramer on Xpeng",Cramer’s Lightning Round: Ally Financial is a buy,Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement,Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference,Royalty Pharma price target raised to $51 from $50 at Goldman Sachs,"Lightning Round: I’ll pass on buying a flying car from China, says Jim Cramer on Xpeng Cramer’s Lightning Round: Ally Financial is a buy Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference Royalty Pharma price target raised to $51 from $50 at Goldman Sachs",1,0,0,0,0,0
70.04M,"404,074",395.30M,-1,"6,263",185.04,Buy,223.43,"Aug 8, 2024",ZG,"Zillow Group, Inc.",12.62B,54.53,2.07B,13.09%,15.77%,16.64%,+15.02%,+17.93%,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Citi ‘incrementally positive’ on Zillow shares after meetings,Zillow Group initiated with a Neutral at Cantor Fitzgerald,Zillow Group management to meet with Stephens,Zillow Group price target raised to $66 from $60 at RBC Capital,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Citi ‘incrementally positive’ on Zillow shares after meetings Zillow Group initiated with a Neutral at Cantor Fitzgerald Zillow Group management to meet with Stephens Zillow Group price target raised to $66 from $60 at RBC Capital,0,1,1,1,1,1
231.44M,"3,760,083",-141.00M,-1,"27,000",56.35,Buy,57.44,"Aug 7, 2024",TTEK,"Tetra Tech, Inc.",12.62B,235.71,4.23B,3.60%,9.98%,24.74%,+9.84%,+21.36%,Tetra Tech management to meet with KeyBanc,2 ‘Strong Buy’ Stocks to Watch Ahead of Stock Splits in September,,,,Tetra Tech management to meet with KeyBanc 2 ‘Strong Buy’ Stocks to Watch Ahead of Stock Splits in September,0,1,0,-1,-1,-1
181.03M,"707,869",381.05M,$2.68,"4,200",71.42,Strong Buy,73.45,"Aug 1, 2024",PAA,"Plains All American Pipeline, L.P.",12.51B,17.85,49.70B,0.56%,-1.44%,5.20%,-4.95%,-6.84%,Plains All American files $1.1B mixed securities shelf,Plains All American files automatic mixed securities shelf,Plains All American (PAA) Receives a Rating Update from a Top Analyst,Plains All American (PAA) Gets a Buy from Morgan Stanley,Barclays Sticks to Their Sell Rating for Plains All American (PAA),Plains All American files $1.1B mixed securities shelf Plains All American files automatic mixed securities shelf Plains All American (PAA) Receives a Rating Update from a Top Analyst Plains All American (PAA) Gets a Buy from Morgan Stanley Barclays Sticks to Their Sell Rating for Plains All American (PAA),1,1,1,1,1,1
3.96B,"21,204,882",-213.00M,-1,"3,550",3.230,Strong Buy,5.09,"Aug 15, 2024",LAMR,Lamar Advertising Company,12.50B,122.19,2.16B,4.23%,4.01%,9.49%,+2.31%,+6.61%,Lamar Advertising Company Announces Cash Dividend on Common Stock,J.P. Morgan Keeps Their Hold Rating on Lamar Advertising (LAMR),"Analysts Offer Insights on Real Estate Companies: BRC (BRCC), Lamar Advertising (LAMR) and Douglas Elliman Inc. (DOUG)",Lamar Advertising price target raised to $140 from $135 at TD Cowen,Buy Rating for Lamar Advertising Backed by Strong Q2 Performance and Positive Growth Outlook,"Lamar Advertising Company Announces Cash Dividend on Common Stock J.P. Morgan Keeps Their Hold Rating on Lamar Advertising (LAMR) Analysts Offer Insights on Real Estate Companies: BRC (BRCC), Lamar Advertising (LAMR) and Douglas Elliman Inc. (DOUG) Lamar Advertising price target raised to $140 from $135 at TD Cowen Buy Rating for Lamar Advertising Backed by Strong Q2 Performance and Positive Growth Outlook",0,1,1,1,1,1
448.13M,"1,456,253",673.24M,$0.84,170,28.19,Strong Buy,42.00,"Aug 8, 2024",FTAI,FTAI Aviation Ltd.,12.44B,121.74,1.37B,11.22%,16.16%,71.30%,+8.28%,+65.95%,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",FTAI Aviation assumed with a Buy at BTIG,FTA Aviation’s Strong EBITDA Growth and Expansion Strategy Merit a Buy Rating,FTAI Aviation Ltd. to Participate in the Jefferies Industrials Conference,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls FTAI Aviation assumed with a Buy at BTIG FTA Aviation’s Strong EBITDA Growth and Expansion Strategy Merit a Buy Rating FTAI Aviation Ltd. to Participate in the Jefferies Industrials Conference",0,0,1,0,1,0
231.44M,"577,644",-141.00M,-1,"2,524",54.53,Buy,57.44,"Aug 7, 2024",INCY,Incyte Corporation,12.35B,64.14,3.86B,4.14%,4.12%,11.10%,+0.88%,+18.83%,These stocks typically have the best and worst Septembers,RBC says expectations ‘should remain grounded’ into Incyte data,"Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in Africa",Incyte to present data from Phase 3 Retifanlimab study at ESMO Congress 2024,Incyte Corporation: Market Successes Counterbalanced by Valuation and Patent Expiry Concerns,"These stocks typically have the best and worst Septembers RBC says expectations ‘should remain grounded’ into Incyte data Eli Lilly, EVA Pharma collaborate to expand access to baricitinib in Africa Incyte to present data from Phase 3 Retifanlimab study at ESMO Congress 2024 Incyte Corporation: Market Successes Counterbalanced by Valuation and Patent Expiry Concerns",1,0,1,1,0,1
53.53M,"136,775",290.88M,$1.16,"5,680",235.71,Buy,242.50,"Jul 31, 2024",SIRI,Sirius XM Holdings Inc.,12.32B,3.20,8.90B,0.79%,-2.35%,-20.38%,-6.09%,-7.16%,"Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more",Walmart+ is only $49 for a limited-time,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Notable open interest changes for August 22nd,"Target reports Q2 beat, Walmart sells JD.com stake: Morning Buzz","Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more Walmart+ is only $49 for a limited-time Split-off of Liberty SiriusXM approved at Liberty Media special meeting Notable open interest changes for August 22nd Target reports Q2 beat, Walmart sells JD.com stake: Morning Buzz",1,1,0,1,1,1
701.08M,"2,004,231",770.00M,$1.27,163,17.85,Buy,19.80,"Aug 2, 2024",HST,"Host Hotels & Resorts, Inc.",12.23B,17.41,5.48B,4.11%,-0.46%,-7.41%,-1.54%,-14.99%,Turn to these dividend growers as the Fed cuts rates,Host Hotels price target lowered to $20 from $23 at Truist,Morgan Stanley Reaffirms Their Sell Rating on Host Hotels & Resorts (HST),Analysts Offer Insights on Real Estate Companies: Kennedy-Wilson (KW) and Host Hotels & Resorts (HST),Host Hotels & Resorts: A Detailed Look at Financial Strategy and Hold Rating Justification,Turn to these dividend growers as the Fed cuts rates Host Hotels price target lowered to $20 from $23 at Truist Morgan Stanley Reaffirms Their Sell Rating on Host Hotels & Resorts (HST) Analysts Offer Insights on Real Estate Companies: Kennedy-Wilson (KW) and Host Hotels & Resorts (HST) Host Hotels & Resorts: A Detailed Look at Financial Strategy and Hold Rating Justification,1,0,0,1,1,1
102.30M,"218,454",504.33M,$5.20,"5,900",122.19,Buy,123.25,"Aug 8, 2024",MEDP,"Medpace Holdings, Inc.",12.09B,390.91,2.03B,-0.08%,-4.00%,5.56%,-0.39%,-4.93%,Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Medpace Holdings (MEDP),,,,,Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Medpace Holdings (MEDP),0,0,-1,-1,-1,-1
102.21M,"606,531",-53.92M,$1.20,"3,018",121.74,Strong Buy,118.45,"Jul 23, 2024",CYBR,CyberArk Software Ltd.,12.08B,279.88,860.60M,5.59%,6.10%,16.32%,+9.19%,+8.71%,Top Wall Street analysts are upbeat about the potential of these 3 stocks ,"Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more",Bank of America says buy this ‘diamond in the rough’ cybersecurity stock,"Identity theft is where bad actors are focusing their attention, says CyberArk CEO","Analysts Conflicted on These Technology Names: DigitalOcean Holdings (DOCN), WEBTOON Entertainment Inc (WBTN) and CyberArk Software (CYBR)","Top Wall Street analysts are upbeat about the potential of these 3 stocks  Stocks making the biggest moves midday: Sweetgreen, E.l.f. Beauty and more Bank of America says buy this ‘diamond in the rough’ cybersecurity stock Identity theft is where bad actors are focusing their attention, says CyberArk CEO Analysts Conflicted on These Technology Names: DigitalOcean Holdings (DOCN), WEBTOON Entertainment Inc (WBTN) and CyberArk Software (CYBR)",0,1,1,1,0,0
192.60M,"1,729,081",97.30M,-1,"7,120",64.14,Buy,71.13,"Jul 30, 2024",JKHY,"Jack Henry & Associates, Inc.",12.00B,164.63,2.19B,2.99%,3.15%,3.15%,+1.33%,+2.19%,Jack Henry & Associates (JKHY) Gets a Hold from RBC Capital,Jack Henry initiated with Neutral on weaker growth at Compass Point,Jack Henry initiated with a Neutral at Compass Point,Jack Henry announces collaboration with Moov,Jack Henry & Associates Announces Regular Quarterly Dividend,Jack Henry & Associates (JKHY) Gets a Hold from RBC Capital Jack Henry initiated with Neutral on weaker growth at Compass Point Jack Henry initiated with a Neutral at Compass Point Jack Henry announces collaboration with Moov Jack Henry & Associates Announces Regular Quarterly Dividend,1,0,1,1,1,1
3.85B,"17,196,254",1.30B,$0.11,"15,246",3.200,Hold,3.78,"Aug 1, 2024",CHRW,"C.H. Robinson Worldwide, Inc.",11.94B,101.79,17.46B,5.17%,12.60%,25.24%,+16.74%,+46.05%,"‘We’ll shut them down’: Ports union near strike, cites contract impasse","C.H. Robinson CHRO Freeman sells 8,387 common shares",CH Robinson Announces Election and Committee Appointments of New Directors,,,"‘We’ll shut them down’: Ports union near strike, cites contract impasse C.H. Robinson CHRO Freeman sells 8,387 common shares CH Robinson Announces Election and Committee Appointments of New Directors",0,1,1,0,-1,-1
702.44M,"7,757,350",750.00M,$0.80,"1,225",17.41,Buy,21.06,"Jul 31, 2024",WING,Wingstop Inc.,11.84B,403.89,545.65M,8.08%,4.78%,21.44%,+3.84%,+10.78%,How Wingstop is outpacing its fast-food competitors,The rise of Wingstop,"TikTok, fast-food rivalry fuel Chili’s as Brinker says turnaround is taking hold",McDonald’s Is Destined to Underperform Its Competitors and the Stock Market,Wingstop (NASDAQ:WING) Slips Despite Surprising Success,"How Wingstop is outpacing its fast-food competitors The rise of Wingstop TikTok, fast-food rivalry fuel Chili’s as Brinker says turnaround is taking hold McDonald’s Is Destined to Underperform Its Competitors and the Stock Market Wingstop (NASDAQ:WING) Slips Despite Surprising Success",1,0,0,1,0,0
30.93M,"138,310",339.65M,-1,"17,000",390.91,Strong Buy,426.50,"Oct 21, 2024",COKE,"Coca-Cola Consolidated, Inc.",11.83B,"1,350.00",6.73B,5.66%,16.19%,43.82%,+15.87%,+59.95%,Coca-Cola Consolidated Announces Dividend Increase and Share Repurchase Program,Coca-Cola Consolidated announces $1B share repurchase program,Coca-Cola Consolidated increases quarterly dividend to $2.50 per share,,,Coca-Cola Consolidated Announces Dividend Increase and Share Repurchase Program Coca-Cola Consolidated announces $1B share repurchase program Coca-Cola Consolidated increases quarterly dividend to $2.50 per share,0,0,0,0,-1,-1
43.15M,"336,780",-13.15M,-1,"6,840",279.88,Strong Buy,288.85,"Aug 8, 2024",DOCU,"DocuSign, Inc.",11.76B,57.44,2.81B,7.23%,7.80%,6.49%,+3.93%,-3.04%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more","S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022","Stocks making the biggest moves after hours: Broadcom, DocuSign, UiPath and more","Procter & Gamble’s lingering China problem, plus Magnificent 7 stocks surprise",DocuSign price target raised to $68 from $60 at BofA,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more S&P 500 tumbles Friday to post worst week since 2023, Nasdaq drops 2% for worst week since 2022 Stocks making the biggest moves after hours: Broadcom, DocuSign, UiPath and more Procter & Gamble’s lingering China problem, plus Magnificent 7 stocks surprise DocuSign price target raised to $68 from $60 at BofA",1,1,0,1,0,0
72.90M,"510,437",378.52M,$2.20,"3,206",164.63,Buy,176.45,"Aug 20, 2024",EWBC,"East West Bancorp, Inc.",11.74B,84.69,2.36B,1.67%,5.18%,11.65%,-5.59%,+10.04%,East West Bancorp’s Investor Presentation Highlights Growth Strategy,East West Bancorp (EWBC) Gets a Buy from Truist Financial,Barclays Sticks to Its Buy Rating for East West Bancorp (EWBC),,,East West Bancorp’s Investor Presentation Highlights Growth Strategy East West Bancorp (EWBC) Gets a Buy from Truist Financial Barclays Sticks to Its Buy Rating for East West Bancorp (EWBC),1,1,0,1,-1,-1
117.28M,"595,572",332.08M,$2.48,"3,700",101.79,Hold,93.27,"Jul 31, 2024",MBLY,Mobileye Global Inc.,11.68B,14.40,1.85B,-11.17%,-36.82%,-52.89%,-35.67%,-57.40%,"Stocks making the biggest moves midday: Intel, Nio, Broadcom and more",CNBC Daily Open: Nvidia’s ‘drop-the-mic moment’,"Intel has hired Morgan Stanley, other advisers for activist defense",Shareholders Revolt as Intel (NASDAQ:INTC) Fire Sale Continues,"Intel to explore sale of part of stake in Mobileye, Bloomberg reports","Stocks making the biggest moves midday: Intel, Nio, Broadcom and more CNBC Daily Open: Nvidia’s ‘drop-the-mic moment’ Intel has hired Morgan Stanley, other advisers for activist defense Shareholders Revolt as Intel (NASDAQ:INTC) Fire Sale Continues Intel to explore sale of part of stake in Mobileye, Bloomberg reports",0,1,0,0,1,1
29.30M,"391,691",94.56M,$1.08,"6,524",403.89,Buy,374.47,"Jul 31, 2024",FFIV,"F5, Inc.",11.60B,199.01,2.78B,2.78%,10.01%,11.59%,-2.33%,+3.36%,Piper Sandler Sticks to Their Hold Rating for F5 Networks (FFIV),F5 Networks Announces Executive Team Reshuffle and Officer Resignation,F5 Networks announces new leadership roles,"F5 Networks, Intel collaborate to simplify security, delivery of AI services",,"Piper Sandler Sticks to Their Hold Rating for F5 Networks (FFIV) F5 Networks Announces Executive Team Reshuffle and Officer Resignation F5 Networks announces new leadership roles F5 Networks, Intel collaborate to simplify security, delivery of AI services",0,0,1,0,1,-1
8.76M,"38,202",506.48M,$3.50,"3,050","1,350.00",,,"Jul 31, 2024",TECH,Bio-Techne Corporation,11.47B,72.29,1.16B,-5.33%,-5.27%,-1.67%,-12.24%,+6.88%,Scotiabank Reaffirms Their Buy Rating on Bio-Techne (TECH),Benchmark Co. Remains a Buy on Bio-Techne (TECH),Bio-Techne: A Compelling Buy Amidst Market Uncertainty and Anticipated Growth Catalysts,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS)",,"Scotiabank Reaffirms Their Buy Rating on Bio-Techne (TECH) Benchmark Co. Remains a Buy on Bio-Techne (TECH) Bio-Techne: A Compelling Buy Amidst Market Uncertainty and Anticipated Growth Catalysts Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS)",0,1,1,1,0,-1
204.69M,"2,305,057",107.20M,-1,"91,000",57.44,Hold,61.46,"Sep 5, 2024",TXRH,"Texas Roadhouse, Inc.",11.24B,168.59,4.95B,0.38%,-0.20%,14.61%,-2.87%,+13.07%,McDonald’s Is Destined to Underperform Its Competitors and the Stock Market,Texas Roadhouse: Growth at a Reasonable Price,"Texas Roadhouse, Inc. Announces Quarterly Dividend",,,"McDonald’s Is Destined to Underperform Its Competitors and the Stock Market Texas Roadhouse: Growth at a Reasonable Price Texas Roadhouse, Inc. Announces Quarterly Dividend",0,0,0,0,-1,-1
138.61M,"775,772",1.10B,$2.20,"8,384",84.69,Strong Buy,88.73,"Jul 23, 2024",NICE,NICE Ltd.,11.24B,178.26,2.55B,5.13%,5.02%,-10.96%,-3.45%,-28.41%,NICE Actimize Clinches Top RegTech Award for Innovation,Nice announces new centralized gateway to Government Services,"Nice’s AI-powered digital evidence solution selected by Augusta, Georgia DA",JMP Securities Sticks to Their Buy Rating for NICE (NICE),"Nice’s Q2 bookings growth stable, says DA Davidson","NICE Actimize Clinches Top RegTech Award for Innovation Nice announces new centralized gateway to Government Services Nice’s AI-powered digital evidence solution selected by Augusta, Georgia DA JMP Securities Sticks to Their Buy Rating for NICE (NICE) Nice’s Q2 bookings growth stable, says DA Davidson",1,0,1,0,1,1
811.05M,"4,337,954",-224.00M,-1,"49,000",14.40,Buy,32.00,"Aug 1, 2024",LKQ,LKQ Corporation,11.22B,42.63,14.48B,5.06%,2.01%,-7.44%,+0.92%,-18.63%,,,,,,,1,-1,-1,-1,-1,-1
58.28M,"300,100",553.62M,-1,"12,000",199.01,Hold,200.89,"Jul 29, 2024",LECO,"Lincoln Electric Holdings, Inc.",11.22B,197.98,4.09B,0.59%,0.74%,-9.60%,-5.36%,-21.60%,Buy Rating for Lincoln Electric Amidst Challenging Industrial Cycle and Strong Cost Management,Barclays cuts Lincoln Electric estimates after ‘broad-based’ cautious commentary,Lincoln Electric price target lowered to $210 from $240 at KeyBanc,Lincoln Electric price target lowered to $212 from $220 at Baird,Robert W. Baird Sticks to Their Buy Rating for Lincoln Electric Holdings (LECO),Buy Rating for Lincoln Electric Amidst Challenging Industrial Cycle and Strong Cost Management Barclays cuts Lincoln Electric estimates after ‘broad-based’ cautious commentary Lincoln Electric price target lowered to $210 from $240 at KeyBanc Lincoln Electric price target lowered to $212 from $220 at Baird Robert W. Baird Sticks to Their Buy Rating for Lincoln Electric Holdings (LECO),0,1,0,1,0,0
158.60M,"499,175",168.07M,$0.32,"6,600",72.29,Buy,80.67,"Aug 7, 2024",EXAS,Exact Sciences Corporation,11.03B,59.70,2.61B,5.49%,20.36%,1.72%,+33.87%,-12.93%,Buy Rating Affirmed for Exact Sciences Amid Promising Cancer Screening Innovations and Strategic Advantages,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Exact Sciences initiated with an Overweight at Wells Fargo,Exact Sciences: 1st patient enrolled in MCED Falcon Registry RWE study,"Buy Rating Affirmed for Exact Sciences Amid Promising Cancer Screening Innovations and Strategic Advantages Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Exact Sciences initiated with an Overweight at Wells Fargo Exact Sciences: 1st patient enrolled in MCED Falcon Registry RWE study",1,1,1,1,1,0
66.68M,"522,987",369.57M,$2.44,"4,576",168.59,Buy,168.86,"Jul 25, 2024",MMYT,MakeMyTrip Limited,10.98B,100.00,840.31M,4.78%,9.70%,46.09%,+2.85%,+26.71%,MakeMyTrip downgraded to Add from Buy at Axis Capital,MakeMyTrip price target raised to $112 from $100 at BofA,Makemytrip’s Growth and Profitability Outlook: A Buy Rating with Robust Potential,Makemytrip (MMYT) Receives ‘Buy’ Rating on Robust Volume Growth and Market Resilience,Makemytrip (MMYT): Outperforming the OTA Sector with Sustained Growth and Profitability,MakeMyTrip downgraded to Add from Buy at Axis Capital MakeMyTrip price target raised to $112 from $100 at BofA Makemytrip’s Growth and Profitability Outlook: A Buy Rating with Robust Potential Makemytrip (MMYT) Receives ‘Buy’ Rating on Robust Volume Growth and Market Resilience Makemytrip (MMYT): Outperforming the OTA Sector with Sustained Growth and Profitability,1,1,1,1,1,1
63.53M,"423,847",396.16M,-1,"8,700",178.26,Strong Buy,269.64,"Aug 15, 2024",QRVO,"Qorvo, Inc.",10.96B,115.52,4.01B,3.12%,-1.77%,4.70%,-6.29%,-2.46%,Qorvo® to Present at the Goldman Sachs Communacopia + Technology Conference,,,,,Qorvo® to Present at the Goldman Sachs Communacopia + Technology Conference,0,0,-1,-1,-1,-1
263.26M,"1,095,407",728.00M,$1.20,"14,000",42.63,Strong Buy,60.80,"Oct 24, 2024",SAIA,"Saia, Inc.",10.67B,402.33,3.10B,-3.51%,-13.50%,-19.66%,-11.13%,-37.38%,Friday’s stock stories: What’s likely to move the market in the next session,"Final Trade: GDX, NFLX, SAIA, SIG",Saia price target raised to $481 from $479 at JPMorgan,Saia (SAIA) Gets a Buy from Benchmark Co.,Saia price target raised to $418 from $416 at TD Cowen,"Friday’s stock stories: What’s likely to move the market in the next session Final Trade: GDX, NFLX, SAIA, SIG Saia price target raised to $481 from $479 at JPMorgan Saia (SAIA) Gets a Buy from Benchmark Co. Saia price target raised to $418 from $416 at TD Cowen",0,0,0,0,0,0
56.68M,"159,347",511.11M,$2.84,"61,200",197.98,Buy,218.25,"Jul 31, 2024",PPC,Pilgrim's Pride Corporation,10.59B,44.67,17.81B,2.48%,10.47%,33.48%,+10.82%,+30.25%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC","Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30%",Pilgrim’s Pride price target raised to $55 from $50 at Argus,"Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls",Pilgrim’s Pride (PPC): Downgrade to Neutral Amid Anticipated Market Challenges,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30% Pilgrim’s Pride price target raised to $55 from $50 at Argus Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls Pilgrim’s Pride (PPC): Downgrade to Neutral Amid Anticipated Market Challenges",0,1,1,0,1,1
184.77M,"2,162,579",-175.01M,-1,"1,826",59.70,Strong Buy,77.64,"Jul 31, 2024",LEGN,Legend Biotech Corporation,10.53B,57.50,455.99M,1.64%,9.23%,3.89%,+0.48%,+3.15%,Buy Rating for Legend Biotech: Strong Market Potential and Strategic Operations Amidst Approval of CARVYKTI in China,Legend Biotech announces cilta-cel approval in China for multiple myeloma,Legend Biotech’s New Cancer Drug Wins Approval,Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,Jefferies Remains a Buy on Legend Biotech (LEGN),Buy Rating for Legend Biotech: Strong Market Potential and Strategic Operations Amidst Approval of CARVYKTI in China Legend Biotech announces cilta-cel approval in China for multiple myeloma Legend Biotech’s New Cancer Drug Wins Approval Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Jefferies Remains a Buy on Legend Biotech (LEGN),1,1,1,1,1,1
109.78M,"376,903",219.37M,-1,"2,271",100.00,Strong Buy,91.67,"Jul 23, 2024",APA,APA Corporation,10.53B,28.47,8.91B,-1.50%,-3.37%,-10.66%,-8.40%,-20.06%,Wednesday’s stock stories: What’s likely to move the market in the next session,APA (APA) Receives a Rating Update from a Top Analyst,APA Corp. price target lowered to $52 from $57 at Susquehanna,"AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz","APA Corp. exploring $1B sale of Permian assets, Reuters reports","Wednesday’s stock stories: What’s likely to move the market in the next session APA (APA) Receives a Rating Update from a Top Analyst APA Corp. price target lowered to $52 from $57 at Susquehanna AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz APA Corp. exploring $1B sale of Permian assets, Reuters reports",1,0,1,1,1,1
94.86M,"946,302",-26.33M,-1,"6,669",115.52,Hold,118.53,"Jul 30, 2024",XP,XP Inc.,10.50B,19.60,2.84B,6.78%,8.68%,-11.69%,+11.81%,-22.46%,XP (XP) Is Making Impressive Strides While Beating Expectations,XP (XP) Receives a Buy from Citi,XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment,"Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz",Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.,"XP (XP) Is Making Impressive Strides While Beating Expectations XP (XP) Receives a Buy from Citi XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.",1,1,1,1,1,1
26.52M,"185,254",380.66M,-1,"7,970",402.33,Buy,493.93,"Oct 25, 2024",CHDN,Churchill Downs Incorporated,10.15B,138.24,2.62B,0.68%,-0.84%,7.25%,-3.23%,+14.69%,NFL season expected to spur record $35 billion in legal sports wagers,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks","Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30%",Bet On It: AGA estimates $35B to be wagered throughout NFL season,Bet On It: DraftKings leans into live betting opportunity with Simplebet deal,"NFL season expected to spur record $35 billion in legal sports wagers Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Monday’s analyst calls: Nvidia earnings preview, Robinhood to rally nearly 30% Bet On It: AGA estimates $35B to be wagered throughout NFL season Bet On It: DraftKings leans into live betting opportunity with Simplebet deal",1,1,1,1,0,0
237.12M,"592,120",756.66M,-1,"1,952",44.67,Buy,42.83,"Jul 31, 2024",TEM,"Tempus AI, Inc",10.02B,64.95,595.57M,42.20%,68.61%,68.61%,+36.85%,,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions",Tempus announces real world data collaboration with BioNTech,tempus AI Inc Class A put volume heavy and directionally bearish,Largest borrow rate increases among liquid names,Cathie Wood’s ARK Investment bought 134K shares of Tempus AI today,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions Tempus announces real world data collaboration with BioNTech tempus AI Inc Class A put volume heavy and directionally bearish Largest borrow rate increases among liquid names Cathie Wood’s ARK Investment bought 134K shares of Tempus AI today",1,0,0,1,1,1
183.17M,"309,376",-285.01M,-1,"3,150",57.50,Strong Buy,81.08,"Aug 9, 2024",ROKU,"Roku, Inc.",10.00B,69.15,3.75B,19.85%,18.35%,-2.33%,+14.84%,+11.73%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Cord cutters hit with political ad blitz as campaigns flood Roku, Hulu before election",Roku: Guggenheim upgrades the stock to ‘buy’,"Friday’s analyst calls: Warby Parker to rally more than 40%, Peloton downgraded","Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Cord cutters hit with political ad blitz as campaigns flood Roku, Hulu before election Roku: Guggenheim upgrades the stock to ‘buy’ Friday’s analyst calls: Warby Parker to rally more than 40%, Peloton downgraded",1,1,1,0,0,1
369.90M,"3,758,456",2.91B,$1.00,"31,000",28.47,Hold,38.27,"Jul 31, 2024",SFM,"Sprouts Farmers Market, Inc.",9.80B,97.87,7.19B,5.54%,16.52%,55.46%,+2.07%,+60.67%,Sprouts Farmers Market price target raised to $115 from $100 at BofA,Buy Rating Affirmed for Sprouts Farmers Market with Promising Sales Outlook and Margin Stability,,,,Sprouts Farmers Market price target raised to $115 from $100 at BofA Buy Rating Affirmed for Sprouts Farmers Market with Promising Sales Outlook and Margin Stability,0,0,0,-1,-1,-1
535.91M,"5,751,790",770.16M,$1.46,"30,695",19.60,Buy,25.43,"Aug 13, 2024",DOX,Amdocs Limited,9.76B,85.43,4.98B,1.18%,4.12%,-0.30%,-2.60%,-2.99%,"Analysts’ Opinions Are Mixed on These Technology Stocks: Amdocs (DOX), Bumble (BMBL) and Corpay Inc (CPAY)",Amdocs: Hold Rating Affirmed Amid Solid Q3 Performance and Market Uncertainties,,,,"Analysts’ Opinions Are Mixed on These Technology Stocks: Amdocs (DOX), Bumble (BMBL) and Corpay Inc (CPAY) Amdocs: Hold Rating Affirmed Amid Solid Q3 Performance and Market Uncertainties",0,0,0,-1,-1,-1
73.42M,"195,592",407.50M,$0.38,"6,500",138.24,Strong Buy,157.30,"Oct 23, 2024",LCID,"Lucid Group, Inc.",9.74B,4.20,668.29M,23.53%,28.75%,26.01%,+11.93%,+50.96%,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,CNBC Daily Open: Fed minutes signals September rate cut,Lucid Group Showcases Gravity SUV in Technology Day Event,Unusually active option classes on open September 3rd,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer Cramer’s Lightning Round: Dell is a buy CNBC Daily Open: Fed minutes signals September rate cut Lucid Group Showcases Gravity SUV in Technology Day Event Unusually active option classes on open September 3rd",0,0,0,0,0,0
154.32M,"1,038,972",-790.20M,-1,"2,171",64.95,Strong Buy,45.25,"Aug 6, 2024",AFRM,"Affirm Holdings, Inc.",9.73B,31.46,2.11B,18.45%,12.49%,-5.77%,+11.63%,-3.92%,"3-Stock Lunch: Best Buy, Dollar General & Affirm","Affirm shares have best day in three years, surge 32% after earnings beat","Stocks making the biggest moves midday: Dollar General, Affirm and more","Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more",Affirm CEO Max Levchin sits down with Jim Cramer,"3-Stock Lunch: Best Buy, Dollar General & Affirm Affirm shares have best day in three years, surge 32% after earnings beat Stocks making the biggest moves midday: Dollar General, Affirm and more Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Affirm CEO Max Levchin sits down with Jim Cramer",0,1,1,1,1,1
144.69M,"3,611,635",-493.17M,-1,"9,707",69.15,Buy,76.57,"Aug 1, 2024",BRKR,Bruker Corporation,9.72B,64.20,3.12B,0.01%,0.01%,-12.47%,-5.98%,-28.77%,Jefferies Sticks to Its Buy Rating for Bruker (BRKR),"Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz","Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Bruker initiated with an Overweight at Wells Fargo,"Jefferies Sticks to Its Buy Rating for Bruker (BRKR) Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Bruker initiated with an Overweight at Wells Fargo",0,0,1,1,1,1
100.13M,"1,740,852",324.75M,-1,"8,800",97.87,Buy,95.00,"Jul 29, 2024",WWD,"Woodward, Inc.",9.70B,162.52,3.25B,6.50%,-2.03%,7.83%,+5.67%,+4.16%,Woodward (WWD) Financial Review: Strong Pricing Power and Growth Prospects Justify Buy Rating,Woodward Management Discusses Company Affairs in Webcast,Woodward names Karrie Bem as General Counsel,Woodward Poised for Growth and Margin Improvement: Buy Rating Affirmed,Woodward participates in a conference call with Goldman Sachs,Woodward (WWD) Financial Review: Strong Pricing Power and Growth Prospects Justify Buy Rating Woodward Management Discusses Company Affairs in Webcast Woodward names Karrie Bem as General Counsel Woodward Poised for Growth and Margin Improvement: Buy Rating Affirmed Woodward participates in a conference call with Goldman Sachs,0,0,0,1,0,0
114.19M,"315,412",508.77M,$1.92,"1,000",85.43,Strong Buy,102.50,"Aug 7, 2024",CHK,Chesapeake Energy Corporation,9.64B,73.44,4.10B,-0.08%,-7.03%,-10.79%,-5.70%,-19.58%,Chesapeake price target lowered to $105 from $110 at Scotiabank,Chesapeake price target lowered to $89 from $102 at Barclays,Chesapeake Energy (CHK) Receives a Hold from Seaport Global,,,Chesapeake price target lowered to $105 from $110 at Scotiabank Chesapeake price target lowered to $89 from $102 at Barclays Chesapeake Energy (CHK) Receives a Hold from Seaport Global,1,1,0,1,-1,-1
2.32B,"63,866,215",-2.76B,-1,"2,620",4.200,Hold,3.55,"Aug 5, 2024",MTCH,"Match Group, Inc.",9.62B,37.32,3.47B,3.49%,11.08%,10.05%,-3.67%,+8.99%,"These stocks are contenders for selling — and can help cut taxes, Wolfe says","Final Trade: TGT, MTCH, XLU & IBM",These stocks could have a good September after forming a ‘golden cross’,"Starboard raised Salesforce in Q2, cut stake in this online web services stock",A shopping list of quality stocks to buy during the pullback from Strategas,"These stocks are contenders for selling — and can help cut taxes, Wolfe says Final Trade: TGT, MTCH, XLU & IBM These stocks could have a good September after forming a ‘golden cross’ Starboard raised Salesforce in Q2, cut stake in this online web services stock A shopping list of quality stocks to buy during the pullback from Strategas",0,1,0,0,1,0
309.12M,"9,175,021",-678.58M,-1,"6,500",31.46,Hold,35.17,"Aug 28, 2024",LNW,"Light & Wonder, Inc.",9.59B,108.14,3.08B,3.95%,4.55%,15.38%,unch,+8.34%,Bet On It: DraftKings leans into live betting opportunity with Simplebet deal,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",Light & Wonder initiated with a Buy at Maxim,Light & Wonder Updates on CHESS Depositary Interests,Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL,"Bet On It: DraftKings leans into live betting opportunity with Simplebet deal Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Light & Wonder initiated with a Buy at Maxim Light & Wonder Updates on CHESS Depositary Interests Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL",0,0,1,1,0,1
151.39M,"989,231",352.10M,$0.20,"5,502",64.20,Buy,80.38,"Aug 6, 2024",HAS,"Hasbro, Inc.",9.48B,68.02,4.54B,4.32%,9.90%,22.96%,+5.06%,+20.03%,Cheap stocks to buy for the long term during the volatility,management to meet with Roth MKM,"Analysts Offer Insights on Consumer Cyclical Companies: Mercedes-Benz Group (OtherMBGAF), Signet Jewelers (SIG) and Hasbro (HAS)","Citi, Goldman among stocks that look like buys for soft landing, Barron’s says",,"Cheap stocks to buy for the long term during the volatility management to meet with Roth MKM Analysts Offer Insights on Consumer Cyclical Companies: Mercedes-Benz Group (OtherMBGAF), Signet Jewelers (SIG) and Hasbro (HAS) Citi, Goldman among stocks that look like buys for soft landing, Barron’s says",1,0,1,1,1,-1
59.66M,"245,646",372.33M,$1.00,105,162.52,Buy,180.75,"Jul 29, 2024",SMMT,Summit Therapeutics Inc.,9.48B,13.08,-,18.62%,38.43%,151.92%,+21.48%,+238.14%,Summit Therapeutics’ Ivonescimab Poised to Outperform KEYTRUDA: A Strong Buy Rating,Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA),Wall Street Analysts Are Bullish on Top Healthcare Picks,Summit Therapeutics initiated with a Buy at H.C. Wainwright,,Summit Therapeutics’ Ivonescimab Poised to Outperform KEYTRUDA: A Strong Buy Rating Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA) Wall Street Analysts Are Bullish on Top Healthcare Picks Summit Therapeutics initiated with a Buy at H.C. Wainwright,0,0,0,1,0,-1
131.28M,"1,753,246",438.00M,$2.30,"5,302",73.44,Buy,102.73,"Jul 29, 2024",WIX,Wix.com Ltd.,9.40B,167.97,1.65B,3.97%,4.07%,22.28%,+5.17%,+21.20%,"Starboard raised Salesforce in Q2, cut stake in this online web services stock",Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Wix.com initiated with an Overweight at Cantor Fitzgerald,"Analysts Offer Insights on Technology Companies: Peraso, Inc. (PRSO), Wix (WIX) and Dell Technologies (DELL)",Wix (WIX) Gets a Buy from Barclays,"Starboard raised Salesforce in Q2, cut stake in this online web services stock Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Wix.com initiated with an Overweight at Cantor Fitzgerald Analysts Offer Insights on Technology Companies: Peraso, Inc. (PRSO), Wix (WIX) and Dell Technologies (DELL) Wix (WIX) Gets a Buy from Barclays",1,1,1,1,1,1
257.90M,"2,914,699",649.90M,-1,514,37.32,Buy,43.22,"Jul 30, 2024",CHRD,Chord Energy Corporation,9.28B,150.00,4.15B,-4.10%,-9.51%,-10.07%,-14.42%,-20.45%,Buy Rating Affirmed for Chord Energy: Undervalued Market Position and Promising Future Prospects,Chord Energy: Balancing Operational Gains with Long-Term Asset Uncertainties,Chord Energy initiated with a Hold at Jefferies,Chord Energy (CHRD) Receives a Rating Update from a Top Analyst,Chord Energy price target raised to $208 from $201 at BofA,Buy Rating Affirmed for Chord Energy: Undervalued Market Position and Promising Future Prospects Chord Energy: Balancing Operational Gains with Long-Term Asset Uncertainties Chord Energy initiated with a Hold at Jefferies Chord Energy (CHRD) Receives a Rating Update from a Top Analyst Chord Energy price target raised to $208 from $201 at BofA,0,1,1,1,1,1
88.72M,"530,342",306.00M,-1,30,108.14,Buy,106.36,"Aug 7, 2024",RGLD,"Royal Gold, Inc.",9.28B,141.15,607.22M,5.10%,6.96%,16.36%,+1.52%,+11.86%,Gold miners ‘ripe’ for a break out: Analysts name stocks to buy as gold soars,Royal Gold Secures Expertise by Extending COO’s Agreement,Royal Gold price target raised to $157 from $148 at Scotiabank,Royal Gold price target raised to $169 from $167 at TD Securities,Royal Gold price target raised to $170 from $167 at Raymond James,Gold miners ‘ripe’ for a break out: Analysts name stocks to buy as gold soars Royal Gold Secures Expertise by Extending COO’s Agreement Royal Gold price target raised to $157 from $148 at Scotiabank Royal Gold price target raised to $169 from $167 at TD Securities Royal Gold price target raised to $170 from $167 at Raymond James,1,1,1,1,1,0
139.41M,"949,065",-1.04B,$2.80,720,68.02,Strong Buy,68.30,"Jul 25, 2024",DUOL,"Duolingo, Inc.",9.26B,212.57,634.49M,10.70%,9.34%,1.93%,+17.96%,-5.67%,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly","Analysts’ Top Technology Picks: Marvell (MRVL), MongoDB (MDB)",Duolingo’s Strategic Partnerships and Innovations Underpin Buy Rating and $255 Price Target,Duolingo partners with Sony Music to add recordings to music course,Duolingo Partners with Sony Music to Add Hit Recordings From Major Artists to Music Course,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly Analysts’ Top Technology Picks: Marvell (MRVL), MongoDB (MDB) Duolingo’s Strategic Partnerships and Innovations Underpin Buy Rating and $255 Price Target Duolingo partners with Sony Music to add recordings to music course Duolingo Partners with Sony Music to Add Hit Recordings From Major Artists to Music Course",1,1,0,1,1,1
724.54M,"1,223,844",-161.69M,-1,765,13.08,Strong Buy,14.33,"Aug 6, 2024",CELH,"Celsius Holdings, Inc.",9.22B,39.54,1.49B,-2.94%,-19.37%,-37.34%,-18.66%,-54.62%,Trade Tracker: Brian Belski shares his latest portfolio moves,"Celsius is everywhere, stock can still provide a jolt, Barron’s says",Celsius Holdings price target lowered to $30 from $45 at Truist,Celsius Holdings: A Strong Buy on Robust Growth and Market Share Expansion,Celsius Holdings: Persistent Demand Weakness and Inventory Issues Prompt Sell Rating and Lowered Price Objective,"Trade Tracker: Brian Belski shares his latest portfolio moves Celsius is everywhere, stock can still provide a jolt, Barron’s says Celsius Holdings price target lowered to $30 from $45 at Truist Celsius Holdings: A Strong Buy on Robust Growth and Market Share Expansion Celsius Holdings: Persistent Demand Weakness and Inventory Issues Prompt Sell Rating and Lowered Price Objective",1,1,1,1,1,1
55.97M,"615,254",73.45M,-1,456,167.97,Strong Buy,179.17,"Aug 7, 2024",OLED,Universal Display Corporation,9.21B,194.12,623.16M,1.34%,-8.29%,3.99%,-15.65%,+15.26%,"Apple to use OLED displays in all iPhone models starting in 2025, Nikkei reports",,,,,"Apple to use OLED displays in all iPhone models starting in 2025, Nikkei reports",0,0,-1,-1,-1,-1
61.88M,"474,008",919.68M,$5.00,"3,380",150.00,Strong Buy,201.78,"Aug 7, 2024",CART,Maplebear Inc.,9.15B,35.60,3.21B,8.24%,6.71%,15.31%,+2.55%,-9.59%,"Why the fast-food value menu vanished, but now is making a comeback",Costco may have another winner after its gold bar success: gift cards,Instacart initiated with an Overweight at Cantor Fitzgerald,"Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI)",Maplebear Inc call volume above normal and directionally bullish,"Why the fast-food value menu vanished, but now is making a comeback Costco may have another winner after its gold bar success: gift cards Instacart initiated with an Overweight at Cantor Fitzgerald Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI) Maplebear Inc call volume above normal and directionally bullish",1,0,0,1,0,1
65.74M,"171,301",240.49M,$1.60,"26,985",141.15,Hold,157.33,"Aug 7, 2024",HTHT,H World Group Limited,9.11B,29.08,3.21B,2.40%,-4.71%,-15.42%,-4.30%,-29.29%,"H World CFO Jun Zuo to resign, Hui Chen to succeed",H World Group Limited Announces Change of Chief Financial Officer,H World removed from Asia Conviction List at Goldman Sachs,Jefferies Keeps Their Buy Rating on Huazhu Group Ltd (CL4),H World Group price target lowered to $53 from $64 at Benchmark,"H World CFO Jun Zuo to resign, Hui Chen to succeed H World Group Limited Announces Change of Chief Financial Officer H World removed from Asia Conviction List at Goldman Sachs Jefferies Keeps Their Buy Rating on Huazhu Group Ltd (CL4) H World Group price target lowered to $53 from $64 at Benchmark",1,1,0,1,0,0
43.54M,"437,728",66.23M,-1,"18,984",212.57,Buy,237.70,"Aug 7, 2024",ESLT,Elbit Systems Ltd.,9.07B,199.00,6.31B,4.97%,7.52%,0.48%,+11.68%,-0.13%,Elbit Systems management to meet with BTIG,Elbit Systems Announces Upcoming Shareholders Meeting,Morning Movers: Kellanova climbs following deal to be acquired by Mars,Elbit Systems Reports Robust Growth Amidst Defense Demands,"Elbit Systems reports Q2 EPS $2.08, consensus $1.77","Elbit Systems management to meet with BTIG Elbit Systems Announces Upcoming Shareholders Meeting Morning Movers: Kellanova climbs following deal to be acquired by Mars Elbit Systems Reports Robust Growth Amidst Defense Demands Elbit Systems reports Q2 EPS $2.08, consensus $1.77",0,0,0,1,0,0
233.07M,"3,285,010",241.29M,-1,"25,000",39.54,Strong Buy,66.93,"Aug 6, 2024",HSIC,"Henry Schein, Inc.",8.97B,70.82,12.49B,3.81%,5.93%,0.94%,-2.03%,-2.81%,,,,,,,1,-1,-1,-1,-1,-1
47.45M,"186,048",221.84M,$1.60,881,194.12,Strong Buy,222.43,"Aug 1, 2024",MKTX,MarketAxess Holdings Inc.,8.90B,235.82,777.51M,1.33%,8.09%,3.64%,+6.30%,+5.43%,Early notable gainers among liquid option names on September 5th,MarketAxess announces August volume statistics,Buy Rating on Marketaxess Holdings Amid Favorable Market Conditions and Strong Growth Prospects,Citi opens ‘positive catalyst watch’ on MarketAxess,MarketAxess price target raised to $223 from $218 at Deutsche Bank,Early notable gainers among liquid option names on September 5th MarketAxess announces August volume statistics Buy Rating on Marketaxess Holdings Amid Favorable Market Conditions and Strong Growth Prospects Citi opens ‘positive catalyst watch’ on MarketAxess MarketAxess price target raised to $223 from $218 at Deutsche Bank,1,1,1,1,1,1
257.10M,"3,051,146",-1.46B,-1,"331,000",35.60,Buy,42.90,"Aug 6, 2024",WBA,"Walgreens Boots Alliance, Inc.",8.89B,10.30,145.53B,-12.86%,-20.59%,-48.70%,-20.98%,-50.97%,"These stocks are contenders for selling — and can help cut taxes, Wolfe says","3-Stock Lunch: Intel, Lululemon & Walgreens Boots",Thursday’s stock stories: What’s likely to move the market in the next session,"Bilt and Walgreens partner to simplify FSA, HSA purchases",Here are Wolfe’s favorite stocks as market approaches fresh record,"These stocks are contenders for selling — and can help cut taxes, Wolfe says 3-Stock Lunch: Intel, Lululemon & Walgreens Boots Thursday’s stock stories: What’s likely to move the market in the next session Bilt and Walgreens partner to simplify FSA, HSA purchases Here are Wolfe’s favorite stocks as market approaches fresh record",0,1,1,0,0,1
313.33M,"880,785",523.74M,$1.56,"1,900",29.08,Strong Buy,48.00,"Aug 20, 2024",LBRDK,Liberty Broadband Corporation,8.88B,62.13,981.00M,-0.09%,8.95%,1.25%,-5.39%,+24.26%,Liberty Broadband CEO to Present at Goldman Sachs Conference,Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank,"Elliott adds Southwest, exits Peabody in Q2",Liberty Broadband price target raised to $91 from $80 at Rosenblatt,"Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)","Liberty Broadband CEO to Present at Goldman Sachs Conference Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank Elliott adds Southwest, exits Peabody in Q2 Liberty Broadband price target raised to $91 from $80 at Rosenblatt Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)",1,1,1,0,1,1
44.48M,"18,086",242.75M,$2.00,254,199.00,,,"Aug 14, 2024",PCVX,"Vaxcyte, Inc.",8.86B,79.35,-,1.90%,0.56%,15.31%,-0.58%,+22.57%,"Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more",Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares,Vaxcyte Announces Pricing of $1.3 Billion Public Offering,Vaxcyte price target raised to $130 from $101 at Guggenheim,Vaxcyte price target raised to $140 from $101 at BofA,"Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Vaxcyte Announces Pricing of $1.3 Billion Public Offering Vaxcyte price target raised to $130 from $101 at Guggenheim Vaxcyte price target raised to $140 from $101 at BofA",1,1,1,1,1,1
126.71M,"1,827,445",352.00M,-1,"1,900",70.82,Buy,77.10,"Aug 6, 2024",LBRDA,Liberty Broadband Corporation,8.85B,60.87,981.00M,-0.28%,8.11%,-0.40%,-5.44%,+21.59%,Liberty Broadband CEO to Present at Goldman Sachs Conference,Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank,"Elliott adds Southwest, exits Peabody in Q2",Liberty Broadband price target raised to $91 from $80 at Rosenblatt,"Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)","Liberty Broadband CEO to Present at Goldman Sachs Conference Liberty Broadband price target lowered to $90 from $104 at Deutsche Bank Elliott adds Southwest, exits Peabody in Q2 Liberty Broadband price target raised to $91 from $80 at Rosenblatt Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)",1,1,1,0,1,1
37.75M,"198,498",262.12M,$2.96,908,235.82,Hold,239.27,"Aug 6, 2024",ROIV,Roivant Sciences Ltd.,8.79B,11.88,158.30M,6.76%,7.99%,10.48%,+10.60%,+2.21%,"Final Trade: CRWD, ROIV, SPY, WMT","3 Best Stocks to Buy Now, 8/20/2024, According to Top Analysts ",Roivant Sciences (ROIV) Receives a Buy from H.C. Wainwright,Wall Street Analysts Are Bullish on Top Healthcare Picks,Buy Rating Affirmed on Roivant Sciences Ahead of Revealing High-Potential Phase 2 Asset and Promising Pipeline Milestones,"Final Trade: CRWD, ROIV, SPY, WMT 3 Best Stocks to Buy Now, 8/20/2024, According to Top Analysts  Roivant Sciences (ROIV) Receives a Buy from H.C. Wainwright Wall Street Analysts Are Bullish on Top Healthcare Picks Buy Rating Affirmed on Roivant Sciences Ahead of Revealing High-Potential Phase 2 Asset and Promising Pipeline Milestones",1,0,1,0,1,1
863.28M,"15,834,709",-5.81B,$1.23,"5,089",10.30,Hold,16.86,"Oct 10, 2024",SEIC,SEI Investments Company,8.75B,67.37,1.99B,1.31%,1.32%,2.18%,-0.80%,-4.73%,SEI’s Advisors’ Inner Circle Fund Reaches $100 Billion in Net Assets,SEI Investments Company (SEIC) Gets a Sell from Morgan Stanley,,,,SEI’s Advisors’ Inner Circle Fund Reaches $100 Billion in Net Assets SEI Investments Company (SEIC) Gets a Sell from Morgan Stanley,0,0,0,-1,-1,-1
142.85M,"506,167",803.00M,-1,"6,400",62.13,Strong Buy,81.00,"Aug 8, 2024",PCTY,Paylocity Holding Corporation,8.69B,156.43,1.40B,5.52%,11.85%,3.21%,+7.30%,-2.45%,Jefferies has ‘constructive view’ of Paylocity plans to acquire Airbase,Paylocity (PCTY) Gets a Buy from TD Cowen,Truist Financial Remains a Buy on Paylocity (PCTY),Analysts Conflicted on These Technology Names: Paylocity (PCTY) and Sensata (ST),Strategic Acquisition Bolsters Paylocity’s Market Position and Product Suite,Jefferies has ‘constructive view’ of Paylocity plans to acquire Airbase Paylocity (PCTY) Gets a Buy from TD Cowen Truist Financial Remains a Buy on Paylocity (PCTY) Analysts Conflicted on These Technology Names: Paylocity (PCTY) and Sensata (ST) Strategic Acquisition Bolsters Paylocity’s Market Position and Product Suite,0,1,0,0,1,0
111.61M,"271,286",-497.19M,-1,"3,213",79.35,Strong Buy,96.00,"Aug 6, 2024",FUTU,Futu Holdings Limited,8.68B,62.92,1.22B,2.22%,-3.39%,3.33%,-6.78%,+4.44%,Futu Holdings call volume above normal and directionally bullish,Unusually active option classes on open August 30th,Futu Announces Investment Grade Rating Reaffirmed by S&P Global Ratings,Futu Holdings price target lowered to $79 from $100 at Citi,DBS Reaffirms Their Buy Rating on Futu Holdings (FUTU),Futu Holdings call volume above normal and directionally bullish Unusually active option classes on open August 30th Futu Announces Investment Grade Rating Reaffirmed by S&P Global Ratings Futu Holdings price target lowered to $79 from $100 at Citi DBS Reaffirms Their Buy Rating on Futu Holdings (FUTU),0,0,0,0,0,0
142.85M,"71,909",803.00M,-1,"22,900",60.87,Strong Buy,81.00,"Aug 8, 2024",OTEX,Open Text Corporation,8.64B,32.59,5.77B,5.69%,6.35%,-8.78%,+1.52%,-14.87%,OpenText selected by Nippon Gases Deutschland for e-invoicing compliance,,,,,OpenText selected by Nippon Gases Deutschland for e-invoicing compliance,0,0,-1,-1,-1,-1
739.52M,"2,633,838",4.74B,-1,"7,030",11.88,Strong Buy,17.33,"Aug 8, 2024",CROX,"Crocs, Inc.",8.59B,144.69,4.06B,7.24%,2.97%,15.90%,+6.50%,+6.73%,10 things to watch in the stock market Friday including big earnings movers,"Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more","Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more","Thursday’s top analyst calls: Nvidia, Apple, Dell, Microsoft and more","Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more","10 things to watch in the stock market Friday including big earnings movers Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Thursday’s top analyst calls: Nvidia, Apple, Dell, Microsoft and more Stocks making the biggest moves premarket: Crocs, Paramount, Snowflake and more",1,0,1,1,1,1
129.89M,"379,534",506.91M,$0.92,"13,953",67.37,Hold,70.20,"Jul 24, 2024",VFS,VinFast Auto Ltd.,8.56B,3.66,1.37B,-3.08%,-10.39%,-27.13%,-8.63%,-13.46%,VinFast Auto Set to Unveil Q2 2024 Financials,Largest borrow rate increases among liquid names,,,,VinFast Auto Set to Unveil Q2 2024 Financials Largest borrow rate increases among liquid names,1,1,1,-1,-1,-1
55.57M,"420,134",206.77M,-1,"27,800",156.43,Buy,177.47,"Aug 1, 2024",WYNN,"Wynn Resorts, Limited",8.51B,77.37,7.11B,0.50%,-6.30%,-16.57%,-9.08%,-29.93%,"Final Trades: Epam Systems, Salesforce, Charles Schwab and Wynn Resorts",Here are JPMorgan’s top stock picks for September,"Final Trades: Berkshire Hathaway, Vistra Corp, Wynn Resorts and Chipotle","Cramer: An old investing rule has let me down, but Starbucks shows it’s still alive",August Monthly Meeting: Cramer grades stocks in the portfolio,"Final Trades: Epam Systems, Salesforce, Charles Schwab and Wynn Resorts Here are JPMorgan’s top stock picks for September Final Trades: Berkshire Hathaway, Vistra Corp, Wynn Resorts and Chipotle Cramer: An old investing rule has let me down, but Starbucks shows it’s still alive August Monthly Meeting: Cramer grades stocks in the portfolio",1,1,0,1,1,0
137.92M,"1,482,023",540.46M,-1,"2,083",62.92,Strong Buy,71.57,"Aug 20, 2024",DSGX,The Descartes Systems Group Inc.,8.51B,99.50,587.67M,3.48%,3.28%,11.56%,-2.11%,+10.92%,The Descartes Systems Group (DSGX) Gets a Buy from Scotiabank,CIBC Reaffirms Their Buy Rating on The Descartes Systems Group (DSGX),Descartes Systems price target raised to $104 from $100 at BMO Capital,Hold Rating on Descartes Systems Group Amid Solid Performance and Market Uncertainties,RBC Capital Sticks to Their Buy Rating for The Descartes Systems Group (DSGX),The Descartes Systems Group (DSGX) Gets a Buy from Scotiabank CIBC Reaffirms Their Buy Rating on The Descartes Systems Group (DSGX) Descartes Systems price target raised to $104 from $100 at BMO Capital Hold Rating on Descartes Systems Group Amid Solid Performance and Market Uncertainties RBC Capital Sticks to Their Buy Rating for The Descartes Systems Group (DSGX),0,0,0,0,0,0
265.05M,"443,024",465.09M,$0.94,"35,300",32.59,Hold,38.33,"Aug 1, 2024",ENSG,"The Ensign Group, Inc.",8.40B,148.07,3.97B,4.32%,10.19%,22.20%,+5.62%,+24.17%,Ensign Group management to meet with Oppenheimer,Ensign Group acquires new operation in Kansas,Ensign Group acquires seven skilled nursing facilities in Colorado,The Ensign Group Acquires New Operation in Kansas,The Ensign Group Adds Seven New Operations in Colorado,Ensign Group management to meet with Oppenheimer Ensign Group acquires new operation in Kansas Ensign Group acquires seven skilled nursing facilities in Colorado The Ensign Group Acquires New Operation in Kansas The Ensign Group Adds Seven New Operations in Colorado,0,0,0,0,0,0
59.39M,"978,105",811.97M,-1,"1,504",144.69,Buy,158.40,"Aug 1, 2024",APPF,"AppFolio, Inc.",8.32B,229.46,722.08M,6.62%,-1.48%,5.70%,+3.49%,-1.34%,New AppFolio Survey Finds Property Managers Must Innovate to Meet Modern Renter Expectations,"Analysts Have Conflicting Sentiments on These Technology Companies: FiscalNote Holdings (NOTE), AppFolio (APPF) and I3 Verticals (IIIV)",AppFolio Names Marcy Campbell as Chief Revenue Officer,AppFolio appoints Marcy Campbell as CRO,AppFolio (APPF) Gets a Buy from D.A. Davidson,"New AppFolio Survey Finds Property Managers Must Innovate to Meet Modern Renter Expectations Analysts Have Conflicting Sentiments on These Technology Companies: FiscalNote Holdings (NOTE), AppFolio (APPF) and I3 Verticals (IIIV) AppFolio Names Marcy Campbell as Chief Revenue Officer AppFolio appoints Marcy Campbell as CRO AppFolio (APPF) Gets a Buy from D.A. Davidson",1,1,1,1,1,1
2.34B,"831,092",-2.33B,-1,"51,000",3.660,Strong Buy,9.60,"Oct 3, 2024",CZR,"Caesars Entertainment, Inc.",8.28B,38.29,11.39B,4.19%,2.16%,-6.88%,-7.18%,-13.59%,Here are JPMorgan’s top stock picks for September,Wednesday’s stock stories: What’s likely to move the market in the next session,NFL season expected to spur record $35 billion in legal sports wagers,Bet On It: AGA estimates $35B to be wagered throughout NFL season,Unusually active option classes on open September 5th,Here are JPMorgan’s top stock picks for September Wednesday’s stock stories: What’s likely to move the market in the next session NFL season expected to spur record $35 billion in legal sports wagers Bet On It: AGA estimates $35B to be wagered throughout NFL season Unusually active option classes on open September 5th,0,0,0,1,0,0
110.01M,"1,228,495",868.64M,$1.00,"28,700",77.37,Strong Buy,118.14,"Aug 6, 2024",AMKR,"Amkor Technology, Inc.",8.22B,33.37,6.40B,5.36%,-9.58%,1.43%,-0.09%,+5.87%,,,,,,,1,-1,-1,-1,-1,-1
85.39M,"219,528",121.22M,-1,"1,783",99.50,Buy,101.36,"Sep 4, 2024",RGEN,Repligen Corporation,8.22B,146.80,602.35M,-7.95%,4.88%,-11.85%,-13.10%,-16.33%,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Repligen initiated with an Overweight at Wells Fargo,Repligen to present at Wells Fargo Conferences,Repligen Corporation to Present at Wells Fargo Healthcare Conference,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Repligen initiated with an Overweight at Wells Fargo Repligen to present at Wells Fargo Conferences Repligen Corporation to Present at Wells Fargo Healthcare Conference",1,1,1,1,1,1
56.70M,"182,909",225.40M,$0.24,"10,200",148.07,Buy,139.40,"Jul 25, 2024",MKSI,"MKS Instruments, Inc.",8.19B,121.68,3.58B,3.59%,-5.31%,2.97%,-7.66%,-9.58%,MKS Instruments initiated with a Neutral at Goldman Sachs,MKS Instruments to Participate in Citi’s 2024 Global TMT Conference,MKS Instruments Announces Executive Leadership Changes,"MKS Instruments appoints Mayampurathas EVP, CFO, treasurer",Ram Mayampurath to Join MKS Instruments as Chief Financial Officer,"MKS Instruments initiated with a Neutral at Goldman Sachs MKS Instruments to Participate in Citi’s 2024 Global TMT Conference MKS Instruments Announces Executive Leadership Changes MKS Instruments appoints Mayampurathas EVP, CFO, treasurer Ram Mayampurath to Join MKS Instruments as Chief Financial Officer",1,1,1,1,1,1
36.27M,"192,128",125.03M,-1,"4,592",229.46,Buy,284.50,"Jul 25, 2024",CBSH,"Commerce Bancshares, Inc.",8.18B,63.48,1.58B,2.16%,5.83%,15.84%,-1.84%,+19.98%,,,,,,,0,-1,-1,-1,-1,-1
216.34M,"4,767,726",-278.00M,-1,"21,900",38.29,Buy,53.00,"Jul 30, 2024",PARAA,Paramount Global,8.10B,24.20,29.27B,,5.83%,15.84%,-3.36%,-5.14%,Automakers are getting back into advertising’s biggest arena: NFL,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Rising NFL valuations mean massive returns for owners,"Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’","NFL’s next big media rights payday is years off, subject to shifting industry","Automakers are getting back into advertising’s biggest arena: NFL 88 corporate leaders endorse Harris, including CEOs of Yelp, Box Rising NFL valuations mean massive returns for owners Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’ NFL’s next big media rights payday is years off, subject to shifting industry",0,0,1,1,0,1
246.39M,"957,567",375.97M,$0.32,"4,400",33.37,Buy,41.71,"Jul 29, 2024",SOFI,"SoFi Technologies, Inc.",8.02B,7.52,2.34B,11.41%,12.62%,3.46%,-0.66%,+1.22%,Why the LA Rams are worth $2 billion more than the LA Chargers,2. Los Angeles Rams,SoFi CEO: Consumer activity and sentiment are ‘trending okay’,Washington Commanders’ stadium naming goes to Northwest Federal Credit Union,Cramer’s Lightning Round: Dell is a buy,Why the LA Rams are worth $2 billion more than the LA Chargers 2. Los Angeles Rams SoFi CEO: Consumer activity and sentiment are ‘trending okay’ Washington Commanders’ stadium naming goes to Northwest Federal Credit Union Cramer’s Lightning Round: Dell is a buy,0,0,0,1,1,0
56.01M,"395,007",-1.90M,-1,879,146.80,Buy,189.57,"Jul 30, 2024",ASND,Ascendis Pharma A/S,8.01B,139.68,354.97M,3.56%,3.66%,4.72%,+4.05%,-7.32%,Biotech Alert: Searches spiking for these stocks today,"Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls",Ascendis Pharma upgraded to Outperform from Perform at Oppenheimer,Ascendis Pharma price target raised to $175 from $165 at BofA,Morning Movers: Nvidia dips after report of DOJ subpoena,"Biotech Alert: Searches spiking for these stocks today Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls Ascendis Pharma upgraded to Outperform from Perform at Oppenheimer Ascendis Pharma price target raised to $175 from $165 at BofA Morning Movers: Nvidia dips after report of DOJ subpoena",0,1,1,0,0,0
67.29M,"943,132",8.00M,$0.88,53,121.46,Strong Buy,146.63,"Aug 7, 2024",AGNC,AGNC Investment Corp.,7.97B,10.19,514.00M,1.94%,2.73%,6.75%,+2.70%,+6.42%,AGNC Investment price target raised to $11 from $10 at RBC Capital,"Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC)",,,,"AGNC Investment price target raised to $11 from $10 at RBC Capital Analysts’ Opinions Are Mixed on These Real Estate Stocks: SBA Communications (SBAC), Dream Office Real Estate Investment (OtherDRETF) and AGNC Investment (AGNC)",0,0,0,-1,-1,-1
128.92M,"377,085",477.62M,$1.08,373,63.48,Hold,60.00,"Oct 16, 2024",HALO,"Halozyme Therapeutics, Inc.",7.95B,62.72,873.30M,10.17%,15.58%,45.73%,+16.58%,+56.85%,"Final Trade: LULU, VIK, HALO, CCJ",,,,,"Final Trade: LULU, VIK, HALO, CCJ",1,1,-1,-1,-1,-1
666.71M,"24,438",-5.20B,$0.20,"2,693",24.20,Sell,12.29,"Aug 8, 2024",DBX,"Dropbox, Inc.",7.92B,24.33,2.53B,6.34%,7.63%,-3.97%,+1.92%,+4.77%,"Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more",Dropbox call volume above normal and directionally bullish,Dropbox put volume heavy and directionally bearish,RBC Capital Sticks to Their Buy Rating for Dropbox (DBX),Dropbox Financial Analysis: Hold Rating Amidst Modest Growth and Market Headwinds,"Stocks making the biggest moves premarket: Taiwan Semiconductor, Insulet, Expedia and more Dropbox call volume above normal and directionally bullish Dropbox put volume heavy and directionally bearish RBC Capital Sticks to Their Buy Rating for Dropbox (DBX) Dropbox Financial Analysis: Hold Rating Amidst Modest Growth and Market Headwinds",0,1,1,1,1,1
1.07B,"31,194,858",-153.23M,-1,"27,000",7.52,Buy,9.07,"Jul 30, 2024",FSV,FirstService Corporation,7.91B,175.72,4.65B,4.29%,9.42%,12.39%,+1.80%,+11.88%,FirstService Plans Share Buyback to Boost Value,,,,,FirstService Plans Share Buyback to Boost Value,1,1,-1,-1,-1,-1
57.35M,"206,105",-541.12M,-1,"18,500",139.68,Strong Buy,192.20,"Sep 3, 2024",WFRD,Weatherford International plc,7.90B,108.01,5.44B,0.38%,-7.70%,-0.82%,-11.70%,-15.85%,Analysts Offer Insights on Energy Companies: Talos Energy (TALO) and Weatherford International (WFRD),Weatherford International (WFRD) Gets a Buy from Goldman Sachs,Weatherford International to Speak at Barclays Energy Conference,"Weatherford announces acquisition of Datagration, terms not disclosed",Weatherford Announces Acquisition of Datagration,"Analysts Offer Insights on Energy Companies: Talos Energy (TALO) and Weatherford International (WFRD) Weatherford International (WFRD) Gets a Buy from Goldman Sachs Weatherford International to Speak at Barclays Energy Conference Weatherford announces acquisition of Datagration, terms not disclosed Weatherford Announces Acquisition of Datagration",0,0,0,0,0,0
782.46M,"13,666,189",290.00M,$1.44,610,10.19,Buy,10.25,"Jul 22, 2024",ITCI,"Intra-Cellular Therapies, Inc.",7.87B,74.48,564.53M,-2.69%,-1.51%,6.92%,-7.56%,+6.33%,Broadcom AI results fail to enthuse the Street: Morning Buzz,Piper upgrades Intra-Cellular on potential in major depressive disorder,Intra-Cellular upgraded to Overweight from Neutral at Piper Sandler,Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences,Intra-Cellular price target raised to $81 from $79 at JPMorgan,Broadcom AI results fail to enthuse the Street: Morning Buzz Piper upgrades Intra-Cellular on potential in major depressive disorder Intra-Cellular upgraded to Overweight from Neutral at Piper Sandler Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences Intra-Cellular price target raised to $81 from $79 at JPMorgan,0,1,0,0,0,0
126.68M,"927,381",337.29M,-1,"1,500",62.72,Buy,59.44,"Aug 6, 2024",MTSI,"MACOM Technology Solutions Holdings, Inc.",7.72B,107.00,679.24M,2.54%,-1.29%,9.19%,+4.52%,+4.78%,,,,,,,0,-1,-1,-1,-1,-1
325.42M,"2,210,485",584.20M,-1,"1,625",24.33,Hold,28.67,"Aug 8, 2024",CRUS,"Cirrus Logic, Inc.",7.72B,144.52,1.85B,8.14%,8.83%,43.09%,+8.45%,+54.20%,,,,,,,1,-1,-1,-1,-1,-1
45.02M,"54,623",80.28M,$1.00,"3,400",175.72,Buy,186.00,"Jul 25, 2024",ALTR,Altair Engineering Inc.,7.67B,90.41,627.21M,2.69%,-2.31%,5.96%,+0.57%,+5.07%,"Altair Engineering, Oasys announce joint development agreement",Closing Bell Movers: Bigbear.ai surges after announcing FAA contract,Altair Engineering rallies after Matrix Capital clarifies position,Altair Responds to Matrix Capital Management Statement on Altair Holdings,Altair says it appreciates Matrix Capital’s decision to maintain full position,"Altair Engineering, Oasys announce joint development agreement Closing Bell Movers: Bigbear.ai surges after announcing FAA contract Altair Engineering rallies after Matrix Capital clarifies position Altair Responds to Matrix Capital Management Statement on Altair Holdings Altair says it appreciates Matrix Capital’s decision to maintain full position",0,0,0,0,0,0
73.16M,"383,915",500.00M,$0.25,"3,856",108.01,Strong Buy,154.00,"Jul 23, 2024",AAON,"AAON, Inc.",7.66B,94.55,1.19B,5.12%,7.34%,17.84%,+4.79%,+3.17%,AAON Announces Quarterly Cash Dividend,,,,,AAON Announces Quarterly Cash Dividend,0,1,-1,-1,-1,-1
105.67M,"203,691",-84.30M,-1,"10,722",74.48,Strong Buy,97.00,"Aug 7, 2024",MIDD,The Middleby Corporation,7.64B,142.05,3.91B,1.55%,7.50%,1.88%,+2.73%,-7.60%,The Middleby (MIDD) Gets a Buy from KeyBanc,"McNamara’s Buy Rating for Middleby: Growth, Efficiency, and New Market Opportunities",,,,"The Middleby (MIDD) Gets a Buy from KeyBanc McNamara’s Buy Rating for Middleby: Growth, Efficiency, and New Market Opportunities",1,0,1,-1,-1,-1
72.19M,"266,397",71.90M,-1,"2,402",107.00,Strong Buy,118.33,"Aug 1, 2024",LSXMK,The Liberty SiriusXM Group,7.60B,23.26,8.90B,4.90%,4.07%,-11.01%,+3.73%,-14.41%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
53.41M,"320,815",301.07M,-1,"2,402",144.52,Strong Buy,143.33,"Aug 6, 2024",LSXMB,The Liberty SiriusXM Group,7.59B,23.15,8.90B,,4.07%,-11.01%,+15.29%,-6.53%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
84.89M,"273,827",26.71M,-1,"2,402",90.41,Hold,90.67,"Aug 1, 2024",LSXMA,The Liberty SiriusXM Group,7.59B,23.24,8.90B,4.82%,4.03%,-11.11%,+3.40%,-14.35%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
81.01M,"265,144",186.37M,$0.32,"15,800",94.55,Buy,102.00,"Aug 1, 2024",UFPI,"UFP Industries, Inc.",7.59B,125.02,6.89B,0.18%,2.69%,4.13%,-8.27%,+1.86%,UFP Industries Announces Leadership Changes and Salary Details,"UFP Industries CEO Missad to move to exec chairman, Schwartz named CEO",,,,"UFP Industries Announces Leadership Changes and Salary Details UFP Industries CEO Missad to move to exec chairman, Schwartz named CEO",1,0,0,-1,-1,-1
53.77M,"236,901",386.91M,-1,"4,981",142.05,Buy,158.38,"Aug 1, 2024",TLN,Talen Energy Corporation,7.59B,148.80,2.11B,18.87%,23.33%,66.92%,+18.85%,+57.29%,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",AI demand could strain electrical grid in coming decade,The charts are bullish on the utilities sector and this member breaking out,This power provider has doubled as it charts a path for nuclear data centers,Crypto investors weigh new inflation data that clears way for potential rate cuts: CNBC Crypto World,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more AI demand could strain electrical grid in coming decade The charts are bullish on the utilities sector and this member breaking out This power provider has doubled as it charts a path for nuclear data centers Crypto investors weigh new inflation data that clears way for potential rate cuts: CNBC Crypto World",0,1,0,1,1,0
326.69M,"928,475",978.00M,-1,"21,900",23.26,Strong Buy,28.00,"Aug 8, 2024",PARA,Paramount Global,7.57B,11.36,29.27B,-2.81%,-3.72%,-14.99%,-6.30%,-10.61%,Automakers are getting back into advertising’s biggest arena: NFL,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Rising NFL valuations mean massive returns for owners,"Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’","NFL’s next big media rights payday is years off, subject to shifting industry","Automakers are getting back into advertising’s biggest arena: NFL 88 corporate leaders endorse Harris, including CEOs of Yelp, Box Rising NFL valuations mean massive returns for owners Summer box office bounced back thanks to ‘Inside Out 2,’ ‘Deadpool & Wolverine’ NFL’s next big media rights payday is years off, subject to shifting industry",0,0,1,1,0,1
326.69M,704,978.00M,-1,"15,038",23.69,,,"Aug 8, 2024",IEP,Icahn Enterprises L.P.,7.56B,15.89,10.28B,-15.53%,-16.72%,-20.30%,-24.59%,-22.44%,"Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more",5 things to know before the stock market opens Tuesday,CNBC Daily Open: Wall Street extends winning run,SEC charges Carl Icahn with hiding billions in loans backed by IEP stock,Icahn Enterprises put volume heavy and directionally bearish,"Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more 5 things to know before the stock market opens Tuesday CNBC Daily Open: Wall Street extends winning run SEC charges Carl Icahn with hiding billions in loans backed by IEP stock Icahn Enterprises put volume heavy and directionally bearish",1,1,1,0,0,1
326.69M,"472,937",978.00M,-1,"3,357",23.24,Strong Buy,35.30,"Aug 8, 2024",PNFP,"Pinnacle Financial Partners, Inc.",7.53B,98.39,1.49B,7.75%,12.63%,18.29%,+1.94%,+19.34%,Barclays Sticks to Their Hold Rating for Pinnacle Financial Partners (PNFP),,,,,Barclays Sticks to Their Hold Rating for Pinnacle Financial Partners (PNFP),0,0,-1,-1,-1,-1
60.72M,"166,162",462.48M,$1.32,"6,600",125.02,Buy,129.00,"Jul 30, 2024",DRS,"Leonardo DRS, Inc.",7.49B,28.42,3.07B,0.12%,2.24%,22.78%,-0.32%,+34.50%,Leonardo DRS management to meet with BTIG,Leonardo DRS management to meet with Truist,Leonardo DRS awarded $117M production order for family of weapon sights,Leonardo DRS awarded $49M contract for additional joint assault bridge systems,Leonardo DRS awarded $52M follow-on production order,Leonardo DRS management to meet with BTIG Leonardo DRS management to meet with Truist Leonardo DRS awarded $117M production order for family of weapon sights Leonardo DRS awarded $49M contract for additional joint assault bridge systems Leonardo DRS awarded $52M follow-on production order,0,0,0,0,0,0
51.00M,"823,297",853.00M,-1,"2,130",148.80,Strong Buy,145.00,"Aug 13, 2024",GTLB,GitLab Inc.,7.47B,46.98,622.22M,3.46%,-2.43%,-16.08%,-10.01%,-18.23%,"Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more","Stocks making the biggest moves premarket: Nvidia, GitLab, Sweetgreen and more","Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more",GitLab Recognized as a Leader in the Gartner® Magic Quadrant™ for DevOps Platforms for the Second Consecutive Year,GitLab price target raised to $55 from $50 at Barclays,"Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more Stocks making the biggest moves premarket: Nvidia, GitLab, Sweetgreen and more Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more GitLab Recognized as a Leader in the Gartner® Magic Quadrant™ for DevOps Platforms for the Second Consecutive Year GitLab price target raised to $55 from $50 at Barclays",1,1,1,1,1,1
666.71M,"9,363,288",-5.20B,$0.20,"2,489",11.36,Sell,12.29,"Aug 8, 2024",SPSC,"SPS Commerce, Inc.",7.45B,198.36,583.80M,-0.54%,0.49%,5.72%,-8.86%,+9.48%,SPS Commerce to Present at Citi’s 2024 Global TMT Conference,Buy Rating Affirmed for SPS Commerce on Consistent ARR Growth and Successful M&A Strategy,"SPS Commerce files to sell 404,587 shares of common stock for holders",,,"SPS Commerce to Present at Citi’s 2024 Global TMT Conference Buy Rating Affirmed for SPS Commerce on Consistent ARR Growth and Successful M&A Strategy SPS Commerce files to sell 404,587 shares of common stock for holders",0,1,0,1,-1,-1
475.46M,"6,797,837",-504.00M,$4.00,834,15.89,,,"Aug 7, 2024",LNTH,"Lantheus Holdings, Inc.",7.44B,107.16,1.44B,9.59%,11.38%,48.05%,+4.66%,+80.36%,Lantheus Bolsters Board with Expert Finance Executive,Lantheus appoints Eastland as new board member,Lantheus Appoints Julie Eastland as New Board Member,Lantheus initiated with a Buy at Redburn Atlantic,Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,Lantheus Bolsters Board with Expert Finance Executive Lantheus appoints Eastland as new board member Lantheus Appoints Julie Eastland as New Board Member Lantheus initiated with a Buy at Redburn Atlantic Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,1,1,1,1,1,1
76.52M,"398,955",389.50M,$0.88,"23,500",98.39,Buy,99.36,"Oct 15, 2024",ACHC,"Acadia Healthcare Company, Inc.",7.42B,79.91,3.06B,6.95%,12.98%,5.19%,+21.91%,+4.07%,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer",New York Times investigation finds Acadia breaks law by holding patients,,,,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer New York Times investigation finds Acadia breaks law by holding patients",0,0,0,-1,-1,-1
263.70M,"338,324",188.00M,-1,"1,800",28.42,Buy,28.50,"Jul 30, 2024",AUR,"Aurora Innovation, Inc.",7.40B,4.30,-,12.45%,20.54%,39.81%,+3.50%,+38.00%,Cathie Wood’s ARK Investment bought 564K shares of Aurora Innovation today,Cathie Wood’s ARK Investment bought 558K shares of Aurora Innovation today,,,,Cathie Wood’s ARK Investment bought 564K shares of Aurora Innovation today Cathie Wood’s ARK Investment bought 558K shares of Aurora Innovation today,1,1,1,-1,-1,-1
158.90M,"877,279",-426.35M,-1,"1,310",46.98,Buy,66.56,"Sep 3, 2024",EXEL,"Exelixis, Inc.",7.38B,25.88,2.01B,0.48%,8.78%,13.95%,+10.11%,+11.58%,Bank of America Securities Sticks to Its Buy Rating for Exelixis (EXEL),Exelixis put volume heavy and directionally bearish,Biotech Alert: Searches spiking for these stocks today,,,Bank of America Securities Sticks to Its Buy Rating for Exelixis (EXEL) Exelixis put volume heavy and directionally bearish Biotech Alert: Searches spiking for these stocks today,1,1,1,1,-1,-1
37.55M,"83,275",71.89M,-1,"9,679",198.36,Strong Buy,220.25,"Jul 25, 2024",ZION,"Zions Bancorporation, National Association",7.37B,49.91,2.96B,3.16%,5.13%,15.23%,-4.63%,+17.11%,Analysts Conflicted on These Financial Names: Zions Bancorporation National Association (ZION) and Standard Chartered (OtherSCBFF),Zions Bancorp price target lowered to $50 from $52 at Wells Fargo,Unusually active option classes on open August 12th,,,Analysts Conflicted on These Financial Names: Zions Bancorporation National Association (ZION) and Standard Chartered (OtherSCBFF) Zions Bancorp price target lowered to $50 from $52 at Wells Fargo Unusually active option classes on open August 12th,0,1,0,0,-1,-1
69.43M,"611,269",428.48M,-1,"5,000",107.16,Strong Buy,117.67,"Jul 31, 2024",WSC,WillScot Holdings Corporation,7.34B,38.93,2.41B,6.08%,2.09%,-6.69%,-6.71%,-13.09%,Constellium appoints Bradley Soultz as special advisor to board,WillScot Announces Investor Conference Schedule for September 2024,,,,Constellium appoints Bradley Soultz as special advisor to board WillScot Announces Investor Conference Schedule for September 2024,1,1,0,-1,-1,-1
92.87M,"634,133",-5.12M,-1,"18,450",79.91,Buy,85.56,"Jul 31, 2024",CIGI,Colliers International Group Inc.,7.31B,145.40,4.43B,5.79%,14.69%,23.67%,+6.10%,+20.71%,"Colliers buys Western Australian engineering firm Pritchard Francis, no terms",Colliers to acquire leading Western Australian engineering firm,,,,"Colliers buys Western Australian engineering firm Pritchard Francis, no terms Colliers to acquire leading Western Australian engineering firm",1,0,0,-1,-1,-1
1.72B,"9,331,395",-729.00M,-1,378,4.300,Hold,3.75,"Jul 31, 2024",RVMD,"Revolution Medicines, Inc.",7.29B,43.64,742.00K,0.07%,2.37%,28.76%,-6.55%,+36.39%,Wall Street Analysts Are Bullish on Top Healthcare Picks,Revolution Medicines: A Strong Buy on Robust Financials and Promising Clinical Pipeline,Revolution Medicines Maintains Buy Rating Amid Promising Clinical Progress and Strong Financial Standing,,,Wall Street Analysts Are Bullish on Top Healthcare Picks Revolution Medicines: A Strong Buy on Robust Financials and Promising Clinical Pipeline Revolution Medicines Maintains Buy Rating Amid Promising Clinical Progress and Strong Financial Standing,0,1,1,1,-1,-1
285.25M,"1,295,756",349.99M,-1,"9,237",25.88,Buy,27.46,"Aug 6, 2024",BPOP,"Popular, Inc.",7.20B,99.50,2.60B,2.70%,6.06%,16.41%,-0.78%,+19.39%,Popular assumed with an Overweight at Piper Sandler,Barclays Sticks to Its Buy Rating for Popular (BPOP),,,,Popular assumed with an Overweight at Piper Sandler Barclays Sticks to Its Buy Rating for Popular (BPOP),1,0,0,-1,-1,-1
147.70M,"959,481",612.00M,$1.64,"6,245",49.91,Hold,48.74,"Oct 21, 2024",GNTX,Gentex Corporation,7.19B,31.21,2.33B,3.73%,-3.69%,-7.39%,-0.87%,-14.26%,Gentex initiated with a Neutral at UBS,Gentex Announces Third Quarter 2024 Cash Dividend,Gentex announces Q3 cash dividend 12c,"Voxx jumps after Gentex buys shares at $5, offers buyout","Gentex raises stake in Voxx, submitted proposal to acquire all shares","Gentex initiated with a Neutral at UBS Gentex Announces Third Quarter 2024 Cash Dividend Gentex announces Q3 cash dividend 12c Voxx jumps after Gentex buys shares at $5, offers buyout Gentex raises stake in Voxx, submitted proposal to acquire all shares",1,1,1,1,1,1
188.49M,"1,527,204",187.23M,-1,27,38.93,Strong Buy,48.50,"Aug 1, 2024",VKTX,"Viking Therapeutics, Inc.",7.16B,64.63,-,5.08%,10.52%,27.23%,+7.30%,-20.00%,"Lightning Round: Chipotle is likely done going down, says Jim Cramer",Cramer’s Lightning Round: Builders FirstSource ‘can go higher’,Buy Rating on Viking Therapeutics: A Strategic Opportunity Amid Market Overreaction,"Viking Therapeutics selloff on Zepbound news an opportunity, says Truist",Biotech Alert: Searches spiking for these stocks today,"Lightning Round: Chipotle is likely done going down, says Jim Cramer Cramer’s Lightning Round: Builders FirstSource ‘can go higher’ Buy Rating on Viking Therapeutics: A Strategic Opportunity Amid Market Overreaction Viking Therapeutics selloff on Zepbound news an opportunity, says Truist Biotech Alert: Searches spiking for these stocks today",1,0,0,0,0,1
50.28M,"90,102",141.93M,$0.30,"5,521",145.40,Buy,153.75,"Aug 1, 2024",WTFC,Wintrust Financial Corporation,7.16B,107.65,2.22B,4.14%,4.11%,9.06%,-0.91%,+6.45%,"Wintrust Appoints New Head of Diversity, Equity, and Inclusion","Wintrust Expands Workplace Solutions Offering for HSAs, FSAs, and More, Powered by First Dollar",Barclays Sticks to Its Buy Rating for Wintrust Financial (WTFC),,,"Wintrust Appoints New Head of Diversity, Equity, and Inclusion Wintrust Expands Workplace Solutions Offering for HSAs, FSAs, and More, Powered by First Dollar Barclays Sticks to Its Buy Rating for Wintrust Financial (WTFC)",0,1,0,0,-1,-1
167.04M,"516,192",-519.21M,-1,"13,300",43.64,Strong Buy,49.54,"Aug 7, 2024",FYBR,"Frontier Communications Parent, Inc.",7.13B,28.62,5.80B,2.82%,6.87%,17.68%,-2.94%,+25.07%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",Jim Cramer’s top 10 things to watch in the stock market Thursday,"Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more",Verizon CEO Hans Vestberg on $20B Frontier deal: Enhances and accelerates our broadband efforts,"Dow falls 200 points, S&P 500 posts third straight loss as growth fears plague investors","Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Jim Cramer’s top 10 things to watch in the stock market Thursday Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Verizon CEO Hans Vestberg on $20B Frontier deal: Enhances and accelerates our broadband efforts Dow falls 200 points, S&P 500 posts third straight loss as growth fears plague investors",0,1,0,1,0,0
72.37M,"407,794",510.86M,$2.48,"2,800",99.50,Buy,104.00,"Jul 24, 2024",JAZZ,Jazz Pharmaceuticals plc,7.03B,113.87,3.91B,2.24%,5.03%,-0.71%,+5.55%,-0.04%,Truist healthcare analyst holds an analyst/industry conference call,Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations,Analyzing Jazz Pharmaceuticals: A Hold Rating Amidst Oncology and Sleep Disorder Market Dynamics,"H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’",Jazz Pharmaceuticals (JAZZ) Gets a Buy from Stifel Nicolaus,"Truist healthcare analyst holds an analyst/industry conference call Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations Analyzing Jazz Pharmaceuticals: A Hold Rating Amidst Oncology and Sleep Disorder Market Dynamics H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’ Jazz Pharmaceuticals (JAZZ) Gets a Buy from Stifel Nicolaus",0,1,1,0,1,1
230.22M,"1,281,790",409.90M,$0.48,"9,860",31.21,Buy,38.00,"Jul 26, 2024",LBTYB,Liberty Global Ltd.,7.01B,19.79,7.59B,,5.03%,-0.71%,+10.11%,+17.50%,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",Liberty Global A Subsidiaries’ Latest Financial Overview Released,Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report,Liberty Global upgraded to Neutral from Underperform at BofA,Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Liberty Global A Subsidiaries’ Latest Financial Overview Released Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report Liberty Global upgraded to Neutral from Underperform at BofA Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties",0,1,1,1,1,1
110.80M,"2,320,864",-96.75M,-1,"9,860",64.63,Strong Buy,111.78,"Jul 24, 2024",LBTYK,Liberty Global Ltd.,7.01B,19.46,7.59B,3.23%,6.26%,9.87%,-1.79%,+12.60%,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",Liberty Global A Subsidiaries’ Latest Financial Overview Released,Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report,Liberty Global upgraded to Neutral from Underperform at BofA,Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Liberty Global A Subsidiaries’ Latest Financial Overview Released Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report Liberty Global upgraded to Neutral from Underperform at BofA Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties",1,1,1,1,1,1
66.50M,"271,520",599.40M,$1.80,"9,489",107.65,Strong Buy,117.85,"Oct 15, 2024",GGAL,Grupo Financiero Galicia S.A.,6.96B,34.68,6.47B,10.58%,17.59%,46.71%,+21.47%,+28.59%,Grupo Financiero Galicia upgraded to Buy from Neutral at Citi,Grupo Financiero Galicia upgraded to Overweight from Underweight at JPMorgan,Grupo Financiero Galicia Names New CRO,Grupo Financiero Announces Capital Growth Plan,Grupo Galicia Reports Strong Growth in Q2 2024,Grupo Financiero Galicia upgraded to Buy from Neutral at Citi Grupo Financiero Galicia upgraded to Overweight from Underweight at JPMorgan Grupo Financiero Galicia Names New CRO Grupo Financiero Announces Capital Growth Plan Grupo Galicia Reports Strong Growth in Q2 2024,0,1,0,1,0,1
248.98M,"1,797,584",-94.00M,-1,"14,437",28.62,Strong Buy,30.90,"Aug 2, 2024",NSIT,"Insight Enterprises, Inc.",6.95B,213.39,9.04B,8.01%,5.59%,14.33%,-4.52%,+15.35%,Insight Enterprises Enhances Leadership and Financial Strategy,Insight Enterprises appoints James Morgado as chief financial officer,,,,Insight Enterprises Enhances Leadership and Financial Strategy Insight Enterprises appoints James Morgado as chief financial officer,0,1,1,-1,-1,-1
61.75M,"321,569",394.92M,-1,"23,737",113.87,Buy,172.73,"Jul 31, 2024",GRFS,"Grifols, S.A.",6.90B,8.58,7.30B,16.76%,16.69%,11.03%,+20.48%,+26.94%,Grifols postpones Capital Markets Day until further notice,"Brookfield in talks to join buyout of Grifols, Bloomberg reports","Brookfield in talks to join sovereign funds in Grifols bid, Bloomberg says",,,"Grifols postpones Capital Markets Day until further notice Brookfield in talks to join buyout of Grifols, Bloomberg reports Brookfield in talks to join sovereign funds in Grifols bid, Bloomberg says",1,0,1,1,-1,-1
365.44M,305,-2.05B,-1,"2,744",19.14,,,,CFLT,"Confluent, Inc.",6.89B,21.36,865.59M,-0.23%,-14.18%,-19.94%,-18.39%,-30.35%,Confluent CEO Jay Kreps goes one-on-one with Jim Cramer,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Balancing Growth and Challenges: A Hold Rating for Confluent’s Market Position and Financial Health,Confluent (CFLT) Receives a Buy from Stifel Nicolaus,DA Davidson technology analysts hold an analyst/industry conference call,"Confluent CEO Jay Kreps goes one-on-one with Jim Cramer Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Balancing Growth and Challenges: A Hold Rating for Confluent’s Market Position and Financial Health Confluent (CFLT) Receives a Buy from Stifel Nicolaus DA Davidson technology analysts hold an analyst/industry conference call",1,1,1,1,1,1
365.44M,"984,816",-2.05B,-1,"9,860",19.46,,,,LBTYA,Liberty Global Ltd.,6.88B,18.84,7.59B,3.32%,5.91%,11.24%,-0.87%,+13.98%,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks",Liberty Global A Subsidiaries’ Latest Financial Overview Released,Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report,Liberty Global upgraded to Neutral from Underperform at BofA,Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks Liberty Global A Subsidiaries’ Latest Financial Overview Released Liberty Global A Publishes VodafoneZiggo’s Quarterly Financial Report Liberty Global upgraded to Neutral from Underperform at BofA Liberty Global A: Hold Rating Amid Spin-Off Potential and Strategic Uncertainties",1,1,1,1,1,1
1.47B,"697,814",978.39M,$2.49,927,34.68,Strong Buy,36.00,"Sep 26, 2024",IONS,"Ionis Pharmaceuticals, Inc.",6.86B,46.92,813.46M,1.47%,2.47%,5.20%,-0.42%,+13.95%,Ionis Pharmaceuticals management to meet with Oppenheimer,Ionis Pharmaceuticals’ Strong Position in the Market Post-Competitor Trial Analysis,Ionis Pharmaceuticals: A Strong Buy Amidst Burgeoning Cardiomyopathy Market,JPMorgan healthcare analysts hold an analyst/industry conference call,Truist biotech analysts hold an analyst/industry conference call,Ionis Pharmaceuticals management to meet with Oppenheimer Ionis Pharmaceuticals’ Strong Position in the Market Post-Competitor Trial Analysis Ionis Pharmaceuticals: A Strong Buy Amidst Burgeoning Cardiomyopathy Market JPMorgan healthcare analysts hold an analyst/industry conference call Truist biotech analysts hold an analyst/industry conference call,1,0,0,0,1,1
32.59M,"160,151",305.33M,-1,"132,100",213.39,Hold,216.67,"Aug 1, 2024",AAL,American Airlines Group Inc.,6.82B,10.39,53.45B,1.80%,-3.70%,-21.82%,-4.61%,-26.24%,Dell and Palantir to join S&P 500; shares of both jump,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree",Friday’s stock stories: What’s likely to move the market in the next session,Here’s where American Airlines is adding flights to Europe in summer 2025,Why airlines like American are scrambling to make engines last longer,"Dell and Palantir to join S&P 500; shares of both jump U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree Friday’s stock stories: What’s likely to move the market in the next session Here’s where American Airlines is adding flights to Europe in summer 2025 Why airlines like American are scrambling to make engines last longer",1,1,0,0,0,1
679.63M,"808,432",177.51M,-1,"2,325",8.58,Sell,10.50,,CCCS,CCC Intelligent Solutions Holdings Inc.,6.82B,10.94,909.60M,3.67%,-0.91%,-4.14%,+4.68%,-7.89%,CCC Intelligent Solutions resumed with a Buy at BofA,Wall Street Analysts Are Bullish on Top Technology Picks,CCC Intelligent Solutions: A Strong Buy on Robust Growth and Profitability Outlook,,,CCC Intelligent Solutions resumed with a Buy at BofA Wall Street Analysts Are Bullish on Top Technology Picks CCC Intelligent Solutions: A Strong Buy on Robust Growth and Profitability Outlook,1,1,1,1,-1,-1
322.72M,"1,619,323",-369.63M,-1,"2,200",21.36,Buy,30.64,"Jul 31, 2024",HCP,"HashiCorp, Inc.",6.82B,33.90,605.73M,0.33%,0.66%,21.30%,+0.15%,+30.96%,HashiCorp resumed with a Neutral at CitiI,Maintaining Hold on HashiCorp Amid IBM Acquisition and Transition Risks,Truist Financial Keeps Their Hold Rating on HashiCorp (HCP),"HashiCorp reports Q2 EPS 8, consensus 0c","Hashicorp, Inc. Class A (HCP) Q2 Earnings Cheat Sheet","HashiCorp resumed with a Neutral at CitiI Maintaining Hold on HashiCorp Amid IBM Acquisition and Transition Risks Truist Financial Keeps Their Hold Rating on HashiCorp (HCP) HashiCorp reports Q2 EPS 8, consensus 0c Hashicorp, Inc. Class A (HCP) Q2 Earnings Cheat Sheet",0,1,0,0,1,1
365.44M,"1,051,104",-2.05B,-1,"2,992",18.84,Buy,25.50,"Jul 25, 2024",CGNX,Cognex Corporation,6.81B,39.69,844.00M,-1.51%,-12.97%,-5.71%,-21.83%,-4.03%,,,,,,,1,-1,-1,-1,-1,-1
146.21M,"566,618",-365.74M,-1,"17,000",46.92,Buy,61.75,"Aug 1, 2024",LFUS,"Littelfuse, Inc.",6.77B,273.15,2.23B,5.31%,4.20%,8.71%,+0.42%,+13.41%,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly",Littelfuse price target raised to $315 from $300 at Baird,"Analysts Conflicted on These Technology Names: TTEC Holdings (TTEC), Littelfuse (LFUS) and NEXTracker, Inc. Class A (NXT)",Analysts Offer Insights on Technology Companies: Salesforce (CRM) and Littelfuse (LFUS),Littelfuse upgraded to Buy from Hold at Stifel,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly Littelfuse price target raised to $315 from $300 at Baird Analysts Conflicted on These Technology Names: TTEC Holdings (TTEC), Littelfuse (LFUS) and NEXTracker, Inc. Class A (NXT) Analysts Offer Insights on Technology Companies: Salesforce (CRM) and Littelfuse (LFUS) Littelfuse upgraded to Buy from Hold at Stifel",0,1,0,1,0,0
656.70M,"20,531,865",-121.00M,-1,423,10.39,Buy,15.67,"Oct 17, 2024",CYTK,"Cytokinetics, Incorporated",6.74B,57.32,3.13M,-0.66%,0.26%,-8.24%,-5.90%,-23.63%,Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting,Cytokinetics price target raised to $71 from $65 at JPMorgan,Truist Financial Issues a Buy Rating on Cytokinetics (CYTK),Hold Rating on Cytokinetics’ Aficamten Amid Positive Safety and Efficacy Profiles,Cytokinetics Hold Rating Affirmed Amid Incremental Drug Updates and Competitive Uncertainties,Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting Cytokinetics price target raised to $71 from $65 at JPMorgan Truist Financial Issues a Buy Rating on Cytokinetics (CYTK) Hold Rating on Cytokinetics’ Aficamten Amid Positive Safety and Efficacy Profiles Cytokinetics Hold Rating Affirmed Amid Incremental Drug Updates and Competitive Uncertainties,0,1,1,0,1,1
623.40M,"1,407,336",21.48M,-1,"1,083",10.94,Strong Buy,13.88,"Jul 30, 2024",FRPT,"Freshpet, Inc.",6.73B,138.84,875.14M,5.21%,6.71%,27.66%,+11.08%,+16.51%,"Freshpet, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)",Freshpet’s Strategic Hiring and Strong Growth Prospects Justify a Buy Rating and Higher Price Target,Freshpet price target raised to $160 from $143 at TD Cowen,Freshpet’s Bullish Outlook: Strategic Leadership and Enhanced Performance Drive Outperform Rating,"Baird ups Freshpet target, says hiring of Baty ‘big win’","Freshpet, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Freshpet’s Strategic Hiring and Strong Growth Prospects Justify a Buy Rating and Higher Price Target Freshpet price target raised to $160 from $143 at TD Cowen Freshpet’s Bullish Outlook: Strategic Leadership and Enhanced Performance Drive Outperform Rating Baird ups Freshpet target, says hiring of Baty ‘big win’",1,1,1,1,1,1
201.06M,"2,634,020",-188.54M,-1,"4,966",33.90,Hold,31.70,"Aug 29, 2024",BOKF,BOK Financial Corporation,6.73B,104.89,1.98B,3.65%,6.30%,16.97%,+1.38%,+16.04%,BOK Financial Releases Investor Presentation Online,,,,,BOK Financial Releases Investor Presentation Online,0,1,-1,-1,-1,-1
171.50M,"1,124,986",78.38M,$0.30,"1,468",39.69,Buy,48.58,"Jul 31, 2024",LSTR,"Landstar System, Inc.",6.69B,188.61,4.90B,-3.51%,-2.16%,-1.77%,-4.20%,-3.04%,Friday’s stock stories: What’s likely to move the market in the next session,"Analysts Are Neutral on These Industrial Goods Stocks: Landstar System (LSTR), Fortune Brands Innovations (FBIN)",,,,"Friday’s stock stories: What’s likely to move the market in the next session Analysts Are Neutral on These Industrial Goods Stocks: Landstar System (LSTR), Fortune Brands Innovations (FBIN)",1,0,1,-1,-1,-1
24.79M,"102,835",194.59M,$2.80,"2,882",273.15,Buy,275.00,"Jul 30, 2024",CVLT,"Commvault Systems, Inc.",6.67B,152.62,865.77M,2.35%,14.56%,48.53%,-1.60%,+50.11%,D.A. Davidson Sticks to Its Buy Rating for CommVault Systems (CVLT),Commvault price target raised to $175 from $170 at DA Davidson,Commvault exec sells $2.6M in common stock,,,D.A. Davidson Sticks to Its Buy Rating for CommVault Systems (CVLT) Commvault price target raised to $175 from $170 at DA Davidson Commvault exec sells $2.6M in common stock,0,0,0,0,-1,-1
117.66M,"570,858",-545.28M,-1,"3,150",57.32,Buy,78.88,"Aug 8, 2024",HQY,"HealthEquity, Inc.",6.67B,76.62,1.04B,3.93%,-2.13%,-0.46%,-3.75%,-4.85%,HealthEquity files automatic mixed securities shelf,HealthEquity price target raised to $103 from $102 at Deutsche Bank,HealthEquity Outperforms with Strong Financials and Positive Outlook: A Buy Rating Justified,HealthEquity price target lowered to $100 from $105 at BofA,RBC Capital Remains a Buy on Healthequity (HQY),HealthEquity files automatic mixed securities shelf HealthEquity price target raised to $103 from $102 at Deutsche Bank HealthEquity Outperforms with Strong Financials and Positive Outlook: A Buy Rating Justified HealthEquity price target lowered to $100 from $105 at BofA RBC Capital Remains a Buy on Healthequity (HQY),0,0,0,0,0,0
48.49M,"562,306",25.03M,-1,"33,000",138.84,Strong Buy,140.60,"Aug 5, 2024",MAT,"Mattel, Inc.",6.65B,19.55,5.43B,2.40%,9.32%,5.45%,-0.10%,-0.21%,"Gap beats earnings and revenue estimates, hikes profit margin outlook",Nokia phone maker launches Barbie handset for $130 — with no internet,"Mattel’s Fisher-Price, John Legend partner to release covers of three songs",Mattel announces multi-brand collaboration celebrating Barbie fashion,"Mattel, BMW announce Uno for in-car gaming","Gap beats earnings and revenue estimates, hikes profit margin outlook Nokia phone maker launches Barbie handset for $130 — with no internet Mattel’s Fisher-Price, John Legend partner to release covers of three songs Mattel announces multi-brand collaboration celebrating Barbie fashion Mattel, BMW announce Uno for in-car gaming",0,0,0,0,0,0
64.13M,"99,072",460.41M,$2.20,"24,000",104.89,Hold,101.00,"Jul 22, 2024",SAIC,Science Applications International Corporation,6.64B,129.56,7.26B,3.72%,6.69%,1.73%,+3.25%,-0.94%,SAIC price target raised to $135 from $125 at Truist,SAIC price target raised to $150 from $132 at JPMorgan,Citi Reaffirms Their Buy Rating on Science Applications (SAIC),SAIC price target raised to $155 from $145 at TD Cowen,Science Applications (SAIC) Receives a Rating Update from a Top Analyst,SAIC price target raised to $135 from $125 at Truist SAIC price target raised to $150 from $132 at JPMorgan Citi Reaffirms Their Buy Rating on Science Applications (SAIC) SAIC price target raised to $155 from $145 at TD Cowen Science Applications (SAIC) Receives a Rating Update from a Top Analyst,0,0,0,0,0,0
35.45M,"154,503",219.36M,$1.44,"2,900",188.61,Hold,177.20,"Oct 23, 2024",NOVT,Novanta Inc.,6.59B,183.54,899.85M,3.88%,6.04%,11.67%,-0.45%,+7.10%,Novanta Promotes John Burke to Chief Accounting Officer,,,,,Novanta Promotes John Burke to Chief Accounting Officer,0,0,-1,-1,-1,-1
43.71M,"245,394",174.80M,-1,"1,156",152.62,Buy,134.29,"Jul 30, 2024",LSCC,Lattice Semiconductor Corporation,6.58B,47.78,627.66M,-0.96%,-13.37%,-28.36%,-12.60%,-38.22%,"Lattice Semiconductor CFO Luther sells over 20,000 common shares",,,,,"Lattice Semiconductor CFO Luther sells over 20,000 common shares",1,1,-1,-1,-1,-1
87.01M,"314,404",80.43M,-1,267,76.62,Strong Buy,101.45,"Sep 3, 2024",ALAB,"Astera Labs, Inc.",6.54B,41.77,229.55M,8.77%,-11.24%,-27.65%,-0.73%,-39.00%,"AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",Astera Labs upgraded to Overweight from Equal Weight at Morgan Stanley,"Astera Labs, Inc.: A Buy Rating With Potential for Significant Growth Amidst Undervaluation","Analysts’ Top NA Picks: SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR (HDL), Astera Labs, Inc. (ALAB)","AI craze distorts VC market, as tech giants Microsoft and Amazon pour in billions Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Astera Labs upgraded to Overweight from Equal Weight at Morgan Stanley Astera Labs, Inc.: A Buy Rating With Potential for Significant Growth Amidst Undervaluation Analysts’ Top NA Picks: SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR (HDL), Astera Labs, Inc. (ALAB)",0,0,1,0,0,0
339.90M,"1,125,331",322.22M,-1,"1,202",19.55,Buy,22.75,"Jul 23, 2024",NVMI,Nova Ltd.,6.48B,223.01,561.68M,5.71%,1.59%,27.16%,+6.50%,+22.77%,Nova Ltd. Engages Investors at Upcoming Conferences,Nova (NVMI) Receives a Buy from Evercore ISI,Nova price target raised to $240 from $215 at Benchmark,,,Nova Ltd. Engages Investors at Upcoming Conferences Nova (NVMI) Receives a Buy from Evercore ISI Nova price target raised to $240 from $215 at Benchmark,0,0,0,0,-1,-1
51.23M,"219,282",456.00M,$1.48,"6,000",129.56,Hold,127.67,"Sep 5, 2024",REYN,Reynolds Consumer Products Inc.,6.45B,30.70,3.71B,4.73%,9.35%,10.85%,+11.72%,+10.45%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike",,,,,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike",1,1,-1,-1,-1,-1
35.90M,"109,782",62.17M,-1,"2,233",183.54,Hold,175.00,"Aug 6, 2024",VRNS,"Varonis Systems, Inc.",6.42B,57.27,520.78M,5.17%,15.22%,24.17%,+2.68%,+18.41%,Varonis prices upsized offering of $400M in convertible senior notes,Varonis announces proposed offering of $350M of convertible senior notes,Varonis to Present at Upcoming Investor Conference,"Analysts’ Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)",,"Varonis prices upsized offering of $400M in convertible senior notes Varonis announces proposed offering of $350M of convertible senior notes Varonis to Present at Upcoming Investor Conference Analysts’ Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)",0,0,0,0,0,-1
137.77M,"2,417,093",189.92M,-1,"3,800",47.78,Strong Buy,65.17,"Jul 29, 2024",MASI,Masimo Corporation,6.38B,119.94,2.02B,-1.76%,-1.16%,-4.56%,+8.79%,-18.33%,"Masimo CEO shared confidential documents with investor before release, documents show","Masimo, under activist pressure, subpoenaed proxy advisors for investor messages",Masimo urges stockholder to vote ‘FOR’ only the company’s director nominees,Buy Rating Affirmed for Masimo Amidst Favorable Legal Developments and Strong Financials,Masimo Explores Strategic Options for Consumer Business Division,"Masimo CEO shared confidential documents with investor before release, documents show Masimo, under activist pressure, subpoenaed proxy advisors for investor messages Masimo urges stockholder to vote ‘FOR’ only the company’s director nominees Buy Rating Affirmed for Masimo Amidst Favorable Legal Developments and Strong Financials Masimo Explores Strategic Options for Consumer Business Division",1,1,1,0,1,0
156.66M,"3,355,461",-89.34M,-1,"2,420",41.77,Strong Buy,71.36,"Aug 6, 2024",ETSY,"Etsy, Inc.",6.36B,55.40,2.77B,-0.71%,-4.99%,-18.01%,-15.21%,-15.00%,Dell and Palantir to join S&P 500; shares of both jump,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance","Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23",Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,Etsy initiated with a Neutral at Cantor Fitzgerald,"Dell and Palantir to join S&P 500; shares of both jump S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23 Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call Etsy initiated with a Neutral at Cantor Fitzgerald",1,1,1,1,1,1
29.05M,"108,524",153.76M,-1,"5,346",223.01,Strong Buy,236.60,"Aug 8, 2024",BZ,Kanzhun Limited,6.26B,14.18,883.35M,0.08%,-14.49%,-18.44%,-19.37%,-42.73%,Kanzhun Limited Executes Post-IPO Share Purchase,Kanzhun Ltd Maintains Share Capital Stability,Kanzhun Limited Executes Post-IPO Share Scheme Purchase,Kanzhun price target lowered to $14 from $27 at Barclays,Barclays Sticks to Its Buy Rating for Kanzhun Ltd Sponsored (BZ),Kanzhun Limited Executes Post-IPO Share Purchase Kanzhun Ltd Maintains Share Capital Stability Kanzhun Limited Executes Post-IPO Share Scheme Purchase Kanzhun price target lowered to $14 from $27 at Barclays Barclays Sticks to Its Buy Rating for Kanzhun Ltd Sponsored (BZ),1,1,1,1,1,1
210.14M,"280,200",360.00M,$0.92,"3,940",30.70,Hold,31.00,"Aug 7, 2024",ONB,Old National Bancorp,6.25B,19.58,1.73B,4.29%,6.70%,15.23%,-2.25%,+17.96%,Old National to Present at the 2024 Barclays Global Financial Services Conference,Old National Bancorp Announces Quarterly Dividends,Barclays Reaffirms Their Buy Rating on Old National Bancorp Capital (ONB),Old National Bancorp Unveils New Investor Presentation Materials,,Old National to Present at the 2024 Barclays Global Financial Services Conference Old National Bancorp Announces Quarterly Dividends Barclays Reaffirms Their Buy Rating on Old National Bancorp Capital (ONB) Old National Bancorp Unveils New Investor Presentation Materials,1,1,1,1,1,-1
112.18M,"704,377",-88.35M,-1,"4,200",57.27,Buy,56.33,"Jul 29, 2024",CWST,"Casella Waste Systems, Inc.",6.23B,107.10,1.43B,1.56%,3.32%,13.45%,+3.16%,+13.06%,Casella Waste sees $9M charge in September quarter due to landfill closure,Casella Recognizes 2024 Sustainability Leaders,,,,Casella Waste sees $9M charge in September quarter due to landfill closure Casella Recognizes 2024 Sustainability Leaders,0,0,1,-1,-1,-1
53.20M,"415,027",79.40M,-1,"8,801",119.94,Buy,156.40,"Aug 6, 2024",BILI,Bilibili Inc.,6.19B,14.94,3.30B,0.44%,-5.81%,12.29%,-9.83%,+25.67%,China’s first global gaming hit sells millions. Its investor shares what’s next,Bilibili Inc. Reports Stable Share Capital,Bilibili price target raised to $19 from $18 at BofA,Bilibili’s Robust Gaming and Ad Revenue Growth Spurs Buy Rating,Bilibili’s Strong Financial Performance and Growth Prospects Merit a Buy Rating,China’s first global gaming hit sells millions. Its investor shares what’s next Bilibili Inc. Reports Stable Share Capital Bilibili price target raised to $19 from $18 at BofA Bilibili’s Robust Gaming and Ad Revenue Growth Spurs Buy Rating Bilibili’s Strong Financial Performance and Growth Prospects Merit a Buy Rating,0,0,0,0,1,0
114.75M,"2,220,066",287.13M,-1,700,55.40,Hold,70.80,"Jul 31, 2024",HLNE,Hamilton Lane Incorporated,6.14B,151.45,625.54M,9.30%,14.57%,31.15%,+3.86%,+32.96%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",Hamilton Lane Shareholders Approve Key Corporate Changes,Analysts Offer Insights on Financial Companies: REVO S.p.A. (H0O) and Hamilton Lane (HLNE),Hold Rating Maintained for Hamilton Lane with Mixed Earnings Outlook and Raised Price Target,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Hamilton Lane Shareholders Approve Key Corporate Changes Analysts Offer Insights on Financial Companies: REVO S.p.A. (H0O) and Hamilton Lane (HLNE) Hold Rating Maintained for Hamilton Lane with Mixed Earnings Outlook and Raised Price Target",1,1,1,0,0,-1
441.23M,"1,631,616",181.64M,-1,"7,100",14.18,Buy,24.00,"Aug 28, 2024",CHX,ChampionX Corporation,6.08B,31.94,3.70B,0.75%,-1.99%,0.48%,-9.81%,-21.45%,ChampionX Declares Quarterly Dividend,,,,,ChampionX Declares Quarterly Dividend,1,0,-1,-1,-1,-1
318.97M,"1,448,941",505.73M,$0.56,"11,500",19.58,Buy,19.57,"Oct 22, 2024",OLLI,"Ollie's Bargain Outlet Holdings, Inc.",6.05B,98.89,2.15B,0.34%,-2.07%,17.21%,-3.64%,+28.14%,Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,"Monday’s biggest analyst calls: Nvidia, Amazon, Microsoft, BJ’s and more",Craig-Hallum Sticks to Their Buy Rating for Ollie’s Bargain Outlet Holding (OLLI),"Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI)","Analysts Conflicted on These Consumer Cyclical Names: Best Buy Co (BBY), Lululemon Athletica (LULU) and Ollie’s Bargain Outlet Holding (OLLI)","Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings Monday’s biggest analyst calls: Nvidia, Amazon, Microsoft, BJ’s and more Craig-Hallum Sticks to Their Buy Rating for Ollie’s Bargain Outlet Holding (OLLI) Analysts’ Top Consumer Cyclical Picks: Amazon (AMZN), Ollie’s Bargain Outlet Holding (OLLI) Analysts Conflicted on These Consumer Cyclical Names: Best Buy Co (BBY), Lululemon Athletica (LULU) and Ollie’s Bargain Outlet Holding (OLLI)",0,0,1,0,0,1
58.13M,"216,470",19.25M,-1,"1,050",107.10,Strong Buy,103.80,"Aug 1, 2024",NXT,Nextracker Inc.,6.04B,42.11,2.74B,0.03%,-10.82%,-14.82%,-18.11%,-19.60%,"We’re adding to a stock that should see relief from rate cuts, election clarity",Cramer sees a ‘potential tailwind’ for Amazon from a big Chinese online retailer,"Fed Chair Powell checks the box, and our rate sensitive stocks react accordingly","The long-term winners as AI boosts U.S. power needs, according to Mizuho",Cramer updates his takes on all 32 portfolio stocks and grades earnings reports,"We’re adding to a stock that should see relief from rate cuts, election clarity Cramer sees a ‘potential tailwind’ for Amazon from a big Chinese online retailer Fed Chair Powell checks the box, and our rate sensitive stocks react accordingly The long-term winners as AI boosts U.S. power needs, according to Mizuho Cramer updates his takes on all 32 portfolio stocks and grades earnings reports",0,0,0,1,0,0
414.14M,"7,631,956",-551.15M,-1,500,14.94,Strong Buy,16.54,"Aug 22, 2024",CRDO,Credo Technology Group Holding Ltd,6.02B,36.45,192.97M,20.55%,18.61%,56.16%,+22.88%,+59.64%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","Analysts Offer Insights on Technology Companies: Oracle (ORCL), Credo Technology Group Holding Ltd (CRDO) and Samsara (IOT)",Credo Technology price target raised to $38 from $30 at Craig-Hallum,Credo Technology price target raised to $27 from $25 at BofA,Credo Technology price target raised to $35 from $30 at Roth MKM,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Analysts Offer Insights on Technology Companies: Oracle (ORCL), Credo Technology Group Holding Ltd (CRDO) and Samsara (IOT) Credo Technology price target raised to $38 from $30 at Craig-Hallum Credo Technology price target raised to $27 from $25 at BofA Credo Technology price target raised to $35 from $30 at Roth MKM",0,1,0,0,0,0
40.53M,"207,158",168.82M,$1.96,"5,406",151.45,Hold,130.86,"Aug 6, 2024",PEGA,Pegasystems Inc.,6.00B,70.22,1.49B,3.06%,10.44%,20.16%,-1.53%,+10.55%,Pegasystems (PEGA) Receives a Buy from William Blair,,,,,Pegasystems (PEGA) Receives a Buy from William Blair,1,1,-1,-1,-1,-1
190.46M,"1,243,950",320.40M,$0.38,655,31.94,Buy,37.83,"Jul 24, 2024",BPMC,Blueprint Medicines Corporation,5.99B,94.55,362.80M,-2.47%,-11.46%,1.05%,-14.36%,+1.20%,,,,,,,0,-1,-1,-1,-1,-1
61.21M,"943,487",196.80M,-1,"6,800",98.89,Strong Buy,102.25,"Aug 29, 2024",COOP,Mr. Cooper Group Inc.,5.98B,92.76,2.13B,4.27%,7.13%,22.44%,+2.34%,+19.25%,"Leon Cooperman slashes Microsoft holding, says he’s conservative on markets",Mr. Cooper management to meet with Compass Point,Analysts Have Conflicting Sentiments on These Financial Companies: P10 Holdings (PX) and Mr Cooper Group (COOP),,,"Leon Cooperman slashes Microsoft holding, says he’s conservative on markets Mr. Cooper management to meet with Compass Point Analysts Have Conflicting Sentiments on These Financial Companies: P10 Holdings (PX) and Mr Cooper Group (COOP)",1,0,1,1,-1,-1
143.44M,"2,464,935",407.51M,-1,"30,000",42.11,Strong Buy,58.22,"Aug 1, 2024",RCM,R1 RCM Inc.,5.93B,14.04,2.38B,1.18%,7.17%,16.93%,+9.16%,+12.75%,Truist Financial Releases a Hold Rating on R1 RCM (RCM),,,,,Truist Financial Releases a Hold Rating on R1 RCM (RCM),0,0,-1,-1,-1,-1
165.19M,"2,247,770",-28.37M,-1,584,36.45,Strong Buy,30.38,"Sep 4, 2024",TMDX,"TransMedics Group, Inc.",5.86B,175.66,358.76M,9.69%,15.96%,65.08%,+18.80%,+98.73%,TransMedics Group: A Strong Buy on Steady Transplant Volume Growth and Market Potential,TransMedics Group (TMDX) Receives a Buy from Piper Sandler,Oppenheimer Sticks to Its Buy Rating for TransMedics Group (TMDX),TransMedics Group: A Strong Buy on Unique Positioning and Growth in the Organ Transplant Market,Oppenheimer Reaffirms Their Buy Rating on TransMedics Group (TMDX),TransMedics Group: A Strong Buy on Steady Transplant Volume Growth and Market Potential TransMedics Group (TMDX) Receives a Buy from Piper Sandler Oppenheimer Sticks to Its Buy Rating for TransMedics Group (TMDX) TransMedics Group: A Strong Buy on Unique Positioning and Growth in the Organ Transplant Market Oppenheimer Reaffirms Their Buy Rating on TransMedics Group (TMDX),1,1,1,1,1,1
85.41M,"912,576",129.88M,$0.12,"54,000",70.22,Buy,82.60,"Jul 24, 2024",EXLS,"ExlService Holdings, Inc.",5.85B,36.27,1.71B,4.28%,9.44%,17.40%,+2.75%,+22.52%,ExlService price target raised to $41 from $38 at JPMorgan,EXL to participate in Citi Global TMT Conference in New York,Analysts Offer Insights on Technology Companies: MarketWise (MKTW) and Exlservice Holdings (EXLS),ExlService management to meet virtually with Barrington,,ExlService price target raised to $41 from $38 at JPMorgan EXL to participate in Citi Global TMT Conference in New York Analysts Offer Insights on Technology Companies: MarketWise (MKTW) and Exlservice Holdings (EXLS) ExlService management to meet virtually with Barrington,1,0,1,0,0,-1
63.35M,"279,075",-205.49M,-1,923,94.55,Buy,120.18,"Aug 1, 2024",GLBE,Global-E Online Ltd.,5.83B,34.91,632.89M,3.64%,1.39%,-0.38%,-1.63%,-0.21%,Global-e Online (GLBE) Receives a Buy from Jefferies,Global-e Online: A Strong Buy on Resilient EBITDA and Strategic Expansion Potential,Global-e Online price target lowered to $38 from $40 at KeyBanc,Global-e Online price target lowered to $45 from $47 at BofA,Buy Rating Affirmed for Global-e Online with Promising Growth and Resilience Amidst Challenges,Global-e Online (GLBE) Receives a Buy from Jefferies Global-e Online: A Strong Buy on Resilient EBITDA and Strategic Expansion Potential Global-e Online price target lowered to $38 from $40 at KeyBanc Global-e Online price target lowered to $45 from $47 at BofA Buy Rating Affirmed for Global-e Online with Promising Growth and Resilience Amidst Challenges,1,1,1,1,1,1
64.48M,"364,173",706.00M,-1,"2,232",92.76,Buy,89.10,"Jul 25, 2024",CACC,Credit Acceptance Corporation,5.83B,480.97,815.20M,-0.66%,-7.53%,-8.19%,-17.60%,-12.60%,Capital One Spark Cash Plus review: 2% cash back on all eligible purchases,Credit Acceptance Named One of PEOPLE Magazine’s 100 Companies that Care for Third Consecutive Year,,,,Capital One Spark Cash Plus review: 2% cash back on all eligible purchases Credit Acceptance Named One of PEOPLE Magazine’s 100 Companies that Care for Third Consecutive Year,1,0,0,-1,-1,-1
422.11M,"2,956,613",-40.00M,-1,229,14.04,Buy,15.30,"Aug 7, 2024",KRYS,"Krystal Biotech, Inc.",5.79B,201.58,166.23M,3.13%,3.17%,28.80%,-2.18%,+13.27%,Krystal Biotech price target raised to $205 from $195 at BofA,Krystal Biotech (KRYS) Receives a Buy from TD Cowen,Krystal Biotech Reports Promising KB301 Phase 1 Results,Buy Rating Affirmed for Krystal Biotech Following Promising KB301 Study Results,Krystal Biotech price target raised to $221 from $200 at H.C. Wainwright,Krystal Biotech price target raised to $205 from $195 at BofA Krystal Biotech (KRYS) Receives a Buy from TD Cowen Krystal Biotech Reports Promising KB301 Phase 1 Results Buy Rating Affirmed for Krystal Biotech Following Promising KB301 Study Results Krystal Biotech price target raised to $221 from $200 at H.C. Wainwright,0,0,0,0,0,0
33.36M,"642,623",3.00M,-1,"1,500",175.66,Buy,154.70,"Jul 31, 2024",VERX,"Vertex, Inc.",5.76B,37.06,617.83M,4.19%,4.27%,24.22%,-5.15%,+18.46%,Vertex to Present at Goldman Sachs Conference,Vertex completes acquisition of ecosio,Vertex Completes Acquisition of ecosio,"Buy Rating for Vertex Inc.: Strong Demand, Strategic Acquisitions, and ERP Opportunities Fuel Growth Outlook",JMP Securities Reaffirms Their Buy Rating on Vertex (VERX),"Vertex to Present at Goldman Sachs Conference Vertex completes acquisition of ecosio Vertex Completes Acquisition of ecosio Buy Rating for Vertex Inc.: Strong Demand, Strategic Acquisitions, and ERP Opportunities Fuel Growth Outlook JMP Securities Reaffirms Their Buy Rating on Vertex (VERX)",1,0,0,0,0,0
161.40M,"413,371",178.75M,-1,"6,197",36.27,Buy,37.33,"Oct 24, 2024",FRHC,Freedom Holding Corp.,5.69B,93.75,1.16B,7.25%,12.56%,18.87%,+8.15%,+30.97%,Freedom Holding reports Q1 EPS 57c vs. $1.15 last year,,,,,Freedom Holding reports Q1 EPS 57c vs. $1.15 last year,0,1,-1,-1,-1,-1
166.99M,"745,574",-109.68M,-1,195,34.91,Strong Buy,43.00,"Aug 14, 2024",QXO,"QXO, Inc.",5.69B,13.90,57.11M,22.68%,-69.26%,-81.52%,+12.56%,-86.30%,Trade Tracker: Steve Weiss buys more QXO,Largest borrow rate increases among liquid names,"QXO, Inc. reports Q2 EPS ($9.93) vs 52c last year",Two new option listings on August 9th,,"Trade Tracker: Steve Weiss buys more QXO Largest borrow rate increases among liquid names QXO, Inc. reports Q2 EPS ($9.93) vs 52c last year Two new option listings on August 9th",0,1,1,1,0,-1
12.11M,"27,459",181.60M,-1,"8,063",480.97,Sell,395.67,"Jul 31, 2024",BECN,"Beacon Roofing Supply, Inc.",5.61B,90.60,9.47B,1.65%,-2.79%,-0.79%,-13.59%,-12.95%,Beacon announces PaYS partnership with U.S. Army,"Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: ALD SA (Frankfurt: DE:3AL), Sixt SE (GB:0NW7) and Beacon Roofing Supply (BECN)",,,,"Beacon announces PaYS partnership with U.S. Army Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: ALD SA (Frankfurt: DE:3AL), Sixt SE (GB:0NW7) and Beacon Roofing Supply (BECN)",0,0,1,-1,-1,-1
28.73M,"124,445",105.94M,-1,"1,302",201.58,Strong Buy,185.10,"Aug 5, 2024",BCPC,Balchem Corporation,5.60B,172.74,932.39M,2.25%,4.18%,14.81%,-3.25%,+14.28%,"Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024",,,,,"Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024",1,0,-1,-1,-1,-1
155.52M,"1,000,031",19.78M,-1,"13,294",37.06,Buy,37.73,"Aug 7, 2024",NXST,"Nexstar Media Group, Inc.",5.53B,171.55,4.99B,0.48%,0.57%,3.38%,-8.37%,+1.12%,"Frequent media bidder Byron Allen draws ire with late payments to ABC, CBS, NBC",Nexstar announces select television stations to become affiliates of CW Network,Nexstar Media Group: Strong Positioning and Financials Warrant a Buy Rating,Gray Television to renew affiliation agreements with CW Network,Election 2024: Where To Put Your Money Ahead of the Vote,"Frequent media bidder Byron Allen draws ire with late payments to ABC, CBS, NBC Nexstar announces select television stations to become affiliates of CW Network Nexstar Media Group: Strong Positioning and Financials Warrant a Buy Rating Gray Television to renew affiliation agreements with CW Network Election 2024: Where To Put Your Money Ahead of the Vote",1,0,1,1,1,1
60.75M,"73,093",341.84M,-1,92,93.75,,,"Aug 9, 2024",NUVL,"Nuvalent, Inc.",5.53B,85.32,-,12.29%,9.61%,13.79%,+5.92%,+20.61%,"Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike",Nuvalent price target raised to $100 from $90 at JPMorgan,Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX),Nuvalent (NUVL) Gets a Buy from Piper Sandler,"3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts ","Thursday’s top analyst calls: Nvidia, Apple, Tesla, Marriott, CrowdStrike Nuvalent price target raised to $100 from $90 at JPMorgan Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX) Nuvalent (NUVL) Gets a Buy from Piper Sandler 3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts ",0,1,0,1,0,0
409.43M,"6,003,505",-8.14M,-1,60,13.90,,,"Aug 14, 2024",MARA,"Marathon Digital Holdings, Inc.",5.50B,18.69,564.95M,4.04%,-8.93%,-8.34%,-12.91%,-7.05%,Coinbase has worst week of the year as crypto stocks plummet,"Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World","Ether climbs to start the week after crossing $2,600 over the weekend: CNBC Crypto World","Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more",Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said,"Coinbase has worst week of the year as crypto stocks plummet Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World Ether climbs to start the week after crossing $2,600 over the weekend: CNBC Crypto World Stocks making big midday moves: JetBlue, Hawaiian Electric, KeyCorp and more Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said",1,0,0,0,1,1
61.87M,"637,328",-39.50M,-1,376,90.60,Buy,113.78,"Aug 1, 2024",MDGL,"Madrigal Pharmaceuticals, Inc.",5.49B,252.74,14.64M,-0.33%,-5.76%,7.41%,-11.90%,+3.19%,Short Report: Bearish positioning in Madrigal Pharmaceuticals at 3-month high,"Paulson buys Everbridge, cuts Anglogold in Q2",,,,"Short Report: Bearish positioning in Madrigal Pharmaceuticals at 3-month high Paulson buys Everbridge, cuts Anglogold in Q2",1,0,0,-1,-1,-1
32.44M,"66,218",116.78M,$1.19,465,172.74,Strong Buy,185.00,"Jul 26, 2024",ACT,"Enact Holdings, Inc.",5.48B,35.20,1.19B,4.37%,8.39%,17.86%,+3.00%,+14.10%,Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines,"Enact Re, Ltd. Receives A- Rating from S&P Global Ratings",,,,"Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines Enact Re, Ltd. Receives A- Rating from S&P Global Ratings",1,0,0,-1,-1,-1
32.26M,"205,449",432.00M,$6.76,"4,593",171.55,Strong Buy,201.67,"Aug 8, 2024",ALGM,"Allegro MicroSystems, Inc.",5.47B,24.99,937.99M,4.31%,-8.06%,-12.72%,unch,-8.80%,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","3 Best Stocks to Buy Now, 9/3/2024, According to Top Analysts ",Allegro MicroSystems initiated with a Buy at UBS,"Analysts Offer Insights on Technology Companies: Datadog (DDOG), Fidelity National Info (FIS) and Allegro MicroSystems (ALGM)",,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber 3 Best Stocks to Buy Now, 9/3/2024, According to Top Analysts  Allegro MicroSystems initiated with a Buy at UBS Analysts Offer Insights on Technology Companies: Datadog (DDOG), Fidelity National Info (FIS) and Allegro MicroSystems (ALGM)",0,1,0,1,1,-1
64.80M,"216,721",-173.59M,-1,"13,500",85.32,Strong Buy,103.13,"Aug 8, 2024",SRCL,"Stericycle, Inc.",5.46B,58.86,2.63B,0.02%,0.48%,13.43%,+0.61%,+13.73%,"Soros buys JD.com, cuts AerCap in Q2",,,,,"Soros buys JD.com, cuts AerCap in Q2",0,0,-1,-1,-1,-1
294.47M,"29,534,202",288.95M,-1,"2,650",18.69,Buy,19.22,"Aug 1, 2024",SIGI,"Selective Insurance Group, Inc.",5.46B,89.80,4.55B,1.10%,-2.03%,-10.07%,-0.16%,-13.70%,Insurance stocks are racing ahead of the market in the third quarter,Best homeowners insurance in New Jersey,,,,Insurance stocks are racing ahead of the market in the third quarter Best homeowners insurance in New Jersey,0,0,1,-1,-1,-1
21.71M,"119,316",-510.45M,-1,"7,802",252.74,Buy,343.83,"Aug 7, 2024",OPCH,"Option Care Health, Inc.",5.44B,31.83,4.59B,1.39%,5.09%,1.16%,+5.86%,-1.84%,Option Care Health Board Reshuffles and By-law Amendments,,,,,Option Care Health Board Reshuffles and By-law Amendments,1,0,-1,-1,-1,-1
155.70M,"226,770",666.16M,$0.74,"6,950",35.20,Buy,33.60,"Jul 31, 2024",MMSI,"Merit Medical Systems, Inc.",5.43B,93.29,1.30B,4.51%,8.05%,19.03%,+12.33%,+32.43%,Buy Rating Affirmed: Merit Medical’s WRAPSODY Stent Projected to Drive Strong Growth and Increase Stock Value,,,,,Buy Rating Affirmed: Merit Medical’s WRAPSODY Stent Projected to Drive Strong Growth and Increase Stock Value,0,0,-1,-1,-1,-1
218.92M,"1,027,751",74.17M,-1,"1,320",24.99,Strong Buy,35.29,"Aug 1, 2024",EXPO,"Exponent, Inc.",5.39B,106.26,508.47M,2.45%,5.72%,20.39%,-0.31%,+34.05%,Exponent management to meet with Truist,,,,,Exponent management to meet with Truist,1,0,-1,-1,-1,-1
92.84M,"787,572",36.00M,-1,"4,870",58.86,Hold,74.00,"Jul 25, 2024",CRVL,CorVel Corporation,5.39B,314.57,816.78M,1.16%,9.68%,24.07%,+2.57%,+30.67%,"CERIS Announces Enhanced Offering to Fraud, Waste, and Abuse Solutions",CERIS announces advancements to FWA solutions,,,,"CERIS Announces Enhanced Offering to Fraud, Waste, and Abuse Solutions CERIS announces advancements to FWA solutions",1,1,0,-1,-1,-1
60.83M,"266,990",224.06M,$1.40,"19,000",89.80,Hold,98.67,"Jul 18, 2024",FCFS,"FirstCash Holdings, Inc.",5.30B,118.52,3.31B,1.03%,5.55%,1.30%,+3.77%,-7.18%,FirstCash Bolsters Financial Flexibility and Growth Potential,,,,,FirstCash Bolsters Financial Flexibility and Growth Potential,0,1,-1,-1,-1,-1
171.02M,"1,433,626",211.31M,-1,"15,300",31.83,Strong Buy,39.50,"Jul 31, 2024",SATS,EchoStar Corporation,5.30B,19.52,16.24B,5.58%,5.38%,27.04%,-4.73%,+43.83%,Judge temporarily blocks sports streaming service Venu over antitrust concerns,DirecTV is pushing its pay TV bundle — without a satellite dish,"Dish Network in talks with creditors to resolve lawsuit, Bloomberg says",Deutsche Bank Keeps Their Buy Rating on Echostar (SATS),"Soros buys JD.com, cuts AerCap in Q2","Judge temporarily blocks sports streaming service Venu over antitrust concerns DirecTV is pushing its pay TV bundle — without a satellite dish Dish Network in talks with creditors to resolve lawsuit, Bloomberg says Deutsche Bank Keeps Their Buy Rating on Echostar (SATS) Soros buys JD.com, cuts AerCap in Q2",0,1,1,0,1,0
58.21M,"177,305",117.43M,-1,"23,000",93.29,Buy,94.10,"Aug 1, 2024",DOOO,BRP Inc.,5.25B,71.58,7.25B,3.01%,5.53%,5.30%,-2.24%,-2.63%,"BRP Q2 FY2025: Revenue Falls, Guidance Revised",BRP Inc. Faces Earnings Plunge in 2024,Morning Movers: Broadcom sinks after earnings,BRP Inc. cuts FY25 normalized EPS view to C$2.75-C$3.25 from C$6.00-C$7.00,BRP Inc. sees Q3 EPS up between high-single digit to low-teen percentage vs. Q2,"BRP Q2 FY2025: Revenue Falls, Guidance Revised BRP Inc. Faces Earnings Plunge in 2024 Morning Movers: Broadcom sinks after earnings BRP Inc. cuts FY25 normalized EPS view to C$2.75-C$3.25 from C$6.00-C$7.00 BRP Inc. sees Q3 EPS up between high-single digit to low-teen percentage vs. Q2",0,0,0,0,0,0
50.73M,"132,154",104.84M,$1.12,"5,114",106.26,Strong Buy,120.00,"Oct 24, 2024",COLB,"Columbia Banking System, Inc.",5.23B,24.97,1.85B,3.11%,10.97%,16.52%,-5.05%,+35.29%,Barclays Remains a Hold on Columbia Banking System (COLB),Columbia Banking System Announces $0.36 Per Common Share Dividend,,,,Barclays Remains a Hold on Columbia Banking System (COLB) Columbia Banking System Announces $0.36 Per Common Share Dividend,1,1,1,-1,-1,-1
17.13M,"19,531",78.02M,-1,"1,276",314.57,,,"Jul 30, 2024",RARE,Ultragenyx Pharmaceutical Inc.,5.23B,56.75,481.30M,12.35%,25.85%,28.60%,+28.37%,+15.03%,Stifel Nicolaus Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE),Truist biotech analysts hold an analyst/industry conference call,Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),"Abeona Therapeutics appoints Zeiher, Crombez to board of directors",,"Stifel Nicolaus Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE) Truist biotech analysts hold an analyst/industry conference call Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Abeona Therapeutics appoints Zeiher, Crombez to board of directors",0,1,1,1,1,-1
44.75M,"144,075",237.17M,$1.52,"2,635",118.52,Strong Buy,142.50,"Oct 24, 2024",UBSI,"United Bankshares, Inc.",5.22B,38.69,1.01B,4.03%,8.65%,9.99%,-0.74%,+13.45%,"United Bankshares Expands Board, Appoints Dr. DuMond",,,,,"United Bankshares Expands Board, Appoints Dr. DuMond",0,1,-1,-1,-1,-1
271.68M,"736,652",-2.48B,-1,"1,428",19.52,Buy,22.00,"Aug 9, 2024",AVAV,"AeroVironment, Inc.",5.20B,185.62,716.72M,-0.67%,-0.97%,14.30%,+8.58%,+30.52%,AeroVironment CEO calls drones ‘incredibly affordable’,"Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more","GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines","Stocks making the biggest moves midday: Super Micro, Abercrombie and more","Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more","AeroVironment CEO calls drones ‘incredibly affordable’ Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more GE Healthcare shows signs of life, but a key uncertainty keeps us on the sidelines Stocks making the biggest moves midday: Super Micro, Abercrombie and more Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more",0,0,1,1,1,1
74.14M,"78,901",423.17M,$0.61,"1,500",71.58,Strong Buy,106.00,"Sep 6, 2024",FFIN,"First Financial Bankshares, Inc.",5.20B,36.61,496.90M,0.96%,8.06%,16.71%,-5.77%,+15.27%,,,,,,,1,-1,-1,-1,-1,-1
209.48M,"1,697,973",473.60M,$1.44,"3,212",24.97,Hold,25.04,"Oct 16, 2024",ACIW,"ACI Worldwide, Inc.",5.18B,49.48,1.53B,5.79%,15.85%,43.95%,+13.09%,+51.08%,ACI Worldwide price target raised to $61 from $56 at Seaport Research,Analysts’ Opinions Are Mixed on These Technology Stocks: Keysight Technologies (KEYS) and ACI Worldwide (ACIW),,,,ACI Worldwide price target raised to $61 from $56 at Seaport Research Analysts’ Opinions Are Mixed on These Technology Stocks: Keysight Technologies (KEYS) and ACI Worldwide (ACIW),0,0,0,-1,-1,-1
92.10M,"425,734",-585.12M,-1,"1,850",56.75,Strong Buy,87.47,"Aug 1, 2024",TPG,TPG Inc.,5.17B,50.21,2.71B,6.20%,11.48%,18.90%,-2.22%,+12.15%,"ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz","TPG sold stake in Sixth Street back to former credit arm, Semafor reports","ESPN, ABC go dark on DirectTV in feud with Disney, NY Times reports","TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says","Evolent working with adviser on sale after interest, Reuters says","ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz TPG sold stake in Sixth Street back to former credit arm, Semafor reports ESPN, ABC go dark on DirectTV in feud with Disney, NY Times reports TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says Evolent working with adviser on sale after interest, Reuters says",0,0,1,1,0,1
134.90M,"503,335",358.04M,$1.48,"15,000",38.69,Hold,40.25,"Jul 25, 2024",XRAY,DENTSPLY SIRONA Inc.,5.13B,25.31,3.90B,1.45%,0.09%,-16.19%,-8.88%,-23.46%,DENTSPLY SIRONA: A Buy Rating Amid CFO Transition and Robust Growth Targets,Buy Rating Affirmed Despite CFO Departure: Confidence in DENTSPLY SIRONA’s Strategic Initiatives and Growth Prospects,DENTSPLY SIRONA Announces CFO Glenn Coleman’s Departure,Premier names Glenn Coleman as Chief Administrative and Financial Officer,Dentsply Sirona Initiates Search for New CFO,DENTSPLY SIRONA: A Buy Rating Amid CFO Transition and Robust Growth Targets Buy Rating Affirmed Despite CFO Departure: Confidence in DENTSPLY SIRONA’s Strategic Initiatives and Growth Prospects DENTSPLY SIRONA Announces CFO Glenn Coleman’s Departure Premier names Glenn Coleman as Chief Administrative and Financial Officer Dentsply Sirona Initiates Search for New CFO,1,1,1,1,1,0
28.00M,"295,218",59.67M,-1,253,185.62,Buy,187.75,"Sep 4, 2024",RNA,"Avidity Biosciences, Inc.",5.10B,43.52,10.60M,-0.78%,1.87%,82.81%,-4.28%,+77.14%,"3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts ","Analysts’ Top Healthcare Picks: Addex Therapeutics (ADXN), Avidity Biosciences (RNA)",Avidity Biosciences initiated with an Overweight at Barclays,Avidity Biosciences price target lowered to $53 from $54 at Evercore ISI,Promising Phase 1/2 Results for Avidity Biosciences Reinforce Buy Rating with New Price Objective,"3 Best Stocks to Buy Now, 8/29/2024, According to Top Analysts  Analysts’ Top Healthcare Picks: Addex Therapeutics (ADXN), Avidity Biosciences (RNA) Avidity Biosciences initiated with an Overweight at Barclays Avidity Biosciences price target lowered to $53 from $54 at Evercore ISI Promising Phase 1/2 Results for Avidity Biosciences Reinforce Buy Rating with New Price Objective",1,0,1,1,1,1
141.92M,"540,296",201.42M,$0.72,"3,599",36.61,Hold,35.25,"Oct 17, 2024",UMBF,UMB Financial Corporation,5.07B,104.08,1.49B,6.29%,12.41%,23.49%,+0.39%,+23.00%,Barclays Sticks to Its Buy Rating for UMB Financial (UMBF),,,,,Barclays Sticks to Its Buy Rating for UMB Financial (UMBF),0,0,-1,-1,-1,-1
104.66M,"433,205",183.66M,-1,"2,600",49.48,Strong Buy,44.20,"Aug 1, 2024",CSWI,"CSW Industrials, Inc.",5.05B,325.18,815.66M,5.55%,12.61%,36.94%,+0.25%,+37.65%,CSW Industrials Announces Upsize and Pricing of Public Offering of Common Stock,CSW Industrials prices 1.1M shares at $285 in upsized public offering,CSW Industrials 1M share Spot Secondary; price range $280.00-$290.00,CSW Industrials files automatic mixed securities shelf,CSW Industrials announces offering of 1M shares of common stock,CSW Industrials Announces Upsize and Pricing of Public Offering of Common Stock CSW Industrials prices 1.1M shares at $285 in upsized public offering CSW Industrials 1M share Spot Secondary; price range $280.00-$290.00 CSW Industrials files automatic mixed securities shelf CSW Industrials announces offering of 1M shares of common stock,1,0,0,0,0,1
102.87M,"498,002",16.73M,$1.68,623,50.21,Buy,45.90,"Aug 6, 2024",RMBS,Rambus Inc.,5.02B,46.65,477.53M,0.44%,-16.11%,-24.85%,-14.60%,-26.86%,,,,,,,0,-1,-1,-1,-1,-1
202.71M,"1,798,231",-185.00M,$0.64,489,25.31,Buy,33.44,"Jul 31, 2024",ASTS,"AST SpaceMobile, Inc.",4.98B,32.86,1.40M,21.41%,74.92%,316.25%,+34.77%,"+1,163.95%","Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more","Buy this satellite stock primed to rally more than 100%, Deutsche Bank says","Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer",Cramer’s Lightning Round: Flutter is a buy,AST SpaceMobile files automatic mixed securities shelf,"Stocks making the biggest moves midday: Dollar Tree, GitLab, Zscaler and more Buy this satellite stock primed to rally more than 100%, Deutsche Bank says Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer Cramer’s Lightning Round: Flutter is a buy AST SpaceMobile files automatic mixed securities shelf",1,1,1,1,0,1
117.12M,"606,041",-252.45M,-1,"2,744",43.52,Strong Buy,54.67,"Aug 9, 2024",OZK,Bank OZK,4.94B,43.51,1.42B,1.23%,1.16%,-2.88%,-7.66%,-1.99%,Analysts Offer Insights on Financial Companies: Bank OZK (OZK) and CME Group (CME),,,,,Analysts Offer Insights on Financial Companies: Bank OZK (OZK) and CME Group (CME),1,0,-1,-1,-1,-1
48.75M,"634,379",379.08M,$1.56,"1,999",104.08,Buy,101.00,"Jul 30, 2024",TENB,"Tenable Holdings, Inc.",4.93B,41.35,852.04M,-2.75%,-3.57%,-8.17%,-10.63%,-15.05%,"Tenable announces risk prioritization, compliance features for Tenable Nessus",Tenable Enhances Nessus Risk Prioritization to Help Customers Expose and Close Exposures,"Tenable, Deckers removed from Best Ideas List at Wedbush",Tenable files to sell 1.45M shares of common stock for holders,Stifel Nicolaus Remains a Buy on Tenable Holdings (TENB),"Tenable announces risk prioritization, compliance features for Tenable Nessus Tenable Enhances Nessus Risk Prioritization to Help Customers Expose and Close Exposures Tenable, Deckers removed from Best Ideas List at Wedbush Tenable files to sell 1.45M shares of common stock for holders Stifel Nicolaus Remains a Buy on Tenable Holdings (TENB)",1,1,1,1,1,1
15.53M,"49,445",109.63M,$0.84,"10,070",325.18,Strong Buy,,"Jul 31, 2024",COLM,Columbia Sportswear Company,4.90B,83.74,3.39B,2.35%,3.49%,3.50%,-1.33%,+6.81%,,,,,,,0,-1,-1,-1,-1,-1
107.68M,"1,156,387",230.70M,-1,706,46.65,Strong Buy,77.75,"Jul 29, 2024",APLS,"Apellis Pharmaceuticals, Inc.",4.88B,40.11,628.79M,5.90%,3.86%,-22.50%,-3.59%,-31.71%,Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Apellis Pharmaceuticals to Present at Upcoming Investor Conferences,Apellis price target lowered to $64 from $72 at JPMorgan,Apellis price target raised to $41 from $38 at Wedbush,Wedbush Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS),Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apellis Pharmaceuticals to Present at Upcoming Investor Conferences Apellis price target lowered to $64 from $72 at JPMorgan Apellis price target raised to $41 from $38 at Wedbush Wedbush Reaffirms Their Hold Rating on Apellis Pharmaceuticals (APLS),0,0,0,0,0,0
151.48M,"17,531,419",-145.12M,-1,"15,800",32.86,Strong Buy,30.23,"Aug 14, 2024",AVT,"Avnet, Inc.",4.87B,55.30,23.76B,3.19%,4.33%,10.68%,+1.32%,+12.24%,Avnet’s Financial Maneuvers Lead to Sell Rating Amidst Underwhelming Shareholder Value Strategies,"Avnet boosts repurchase pact to $600M, hikes dividend 6% to 33c per share",Avnet Announces New Board Members and Audit Committee Appointments,"Analysts Offer Insights on Technology Companies: MeridianLink (MLNK), Avnet (AVT) and International Business Machines (IBM)",Avnet price target raised to $52 from $48 at Truist,"Avnet’s Financial Maneuvers Lead to Sell Rating Amidst Underwhelming Shareholder Value Strategies Avnet boosts repurchase pact to $600M, hikes dividend 6% to 33c per share Avnet Announces New Board Members and Audit Committee Appointments Analysts Offer Insights on Technology Companies: MeridianLink (MLNK), Avnet (AVT) and International Business Machines (IBM) Avnet price target raised to $52 from $48 at Truist",0,0,0,0,0,0
113.46M,"1,023,843",685.81M,$1.60,"8,441",43.51,Hold,48.78,"Oct 17, 2024",RDNT,"RadNet, Inc.",4.81B,65.00,1.71B,4.76%,6.13%,34.75%,+9.77%,+33.75%,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more",Broadcom AI results fail to enthuse the Street: Morning Buzz,Coinbase and Robinhood upgraded: Wall Street’s top analyst calls,RadNet’s DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare,"RadNet, Inc. to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024","Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more Broadcom AI results fail to enthuse the Street: Morning Buzz Coinbase and Robinhood upgraded: Wall Street’s top analyst calls RadNet’s DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare RadNet, Inc. to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024",1,1,1,1,0,1
119.11M,"751,900",-66.17M,-1,"10,833",41.35,Buy,52.94,"Jul 31, 2024",RUN,Sunrun Inc.,4.81B,21.50,2.06B,11.86%,28.95%,48.52%,+17.51%,+74.13%,Oppenheimer’s picks for a Republican or Democratic election sweep,"Wednesday’s top analyst calls: Nvidia, Apple, Netflix, Sunrun, Amazon and more","‘Massive risk’ to number of solar players flying under radar, says GLJ Research","Jefferies power, utilities/energy analyst holds analyst/industry conference call",Sunrun price target raised to $31 from $26 at Jefferies,"Oppenheimer’s picks for a Republican or Democratic election sweep Wednesday’s top analyst calls: Nvidia, Apple, Netflix, Sunrun, Amazon and more ‘Massive risk’ to number of solar players flying under radar, says GLJ Research Jefferies power, utilities/energy analyst holds analyst/industry conference call Sunrun price target raised to $31 from $26 at Jefferies",1,0,1,0,1,0
58.55M,"217,015",227.41M,$1.20,"2,945",83.74,Hold,77.00,"Jul 25, 2024",LYFT,"Lyft, Inc.",4.79B,11.68,5.10B,6.53%,-5.34%,-19.64%,-4.90%,-35.76%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion,"David Tepper’s Appaloosa slashes Nvidia stake, trims megacap tech positions","Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly",Best commercial auto insurance companies,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box Google IPO banker tracks two-decade journey from Silicon Valley upstart to $2 trillion David Tepper’s Appaloosa slashes Nvidia stake, trims megacap tech positions Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly Best commercial auto insurance companies",1,1,0,1,1,1
121.77M,"551,184",-332.89M,-1,805,40.11,Strong Buy,70.18,"Aug 1, 2024",ESGR,Enstar Group Limited,4.79B,326.60,1.13B,1.16%,1.37%,9.92%,+0.35%,+10.69%,Enstar Group announces expiration of ‘go-shop’ period,Enstar Announces Expiration of “Go-Shop” Period,Enstar Group completes transaction with Insurance Australia Group,Enstar Completes Previously Announced Transaction with IAG,,Enstar Group announces expiration of ‘go-shop’ period Enstar Announces Expiration of “Go-Shop” Period Enstar Group completes transaction with Insurance Australia Group Enstar Completes Previously Announced Transaction with IAG,0,1,1,1,1,-1
88.11M,"332,631",498.70M,$1.32,"3,400",55.30,Sell,48.50,"Aug 8, 2024",LANC,Lancaster Colony Corporation,4.78B,173.51,1.87B,-11.83%,-10.99%,-9.84%,-12.53%,-17.29%,Benchmark Co. Keeps Their Hold Rating on Lancaster Colony (LANC),Lancaster Colony price target lowered to $232 from $236 at Loop Capital,Loop Capital Markets Sticks to Their Buy Rating for Lancaster Colony (LANC),Benchmark Co. Sticks to Their Hold Rating for Lancaster Colony (LANC),Lancaster Colony expects Retail segment sales benefit in 2025,Benchmark Co. Keeps Their Hold Rating on Lancaster Colony (LANC) Lancaster Colony price target lowered to $232 from $236 at Loop Capital Loop Capital Markets Sticks to Their Buy Rating for Lancaster Colony (LANC) Benchmark Co. Sticks to Their Hold Rating for Lancaster Colony (LANC) Lancaster Colony expects Retail segment sales benefit in 2025,1,1,1,1,1,0
73.96M,"307,188",9.92M,-1,556,65.00,Strong Buy,65.50,"Aug 7, 2024",BBIO,"BridgeBio Pharma, Inc.",4.76B,25.31,219.12M,-0.38%,-3.19%,-17.08%,-4.05%,-11.39%,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more",A Promising Pipeline Ready to Breakout at BridgeBio Pharma (BBIO),BridgeBio reports inducement grants under Nasdaq listing rule,Biotech Alert: Searches spiking for these stocks today,Piper starts BridgeBio with Overweight into expected acoramidis approval,"Stocks making the biggest moves midday: Intel, Elastic NV, MongoDB and more A Promising Pipeline Ready to Breakout at BridgeBio Pharma (BBIO) BridgeBio reports inducement grants under Nasdaq listing rule Biotech Alert: Searches spiking for these stocks today Piper starts BridgeBio with Overweight into expected acoramidis approval",1,1,0,0,1,0
223.54M,"8,188,510",-1.37B,-1,"10,000",21.50,Buy,23.08,"Aug 6, 2024",EEFT,"Euronet Worldwide, Inc.",4.75B,105.72,3.80B,5.88%,3.46%,2.88%,+3.32%,-2.53%,Euronet Worldwide: Strategic Partnerships and Growth Potential Underscore a Buy Rating,,,,,Euronet Worldwide: Strategic Partnerships and Growth Potential Underscore a Buy Rating,0,0,-1,-1,-1,-1
410.16M,"11,263,145",-64.93M,-1,207,11.68,Buy,16.17,"Aug 7, 2024",IMVT,"Immunovant, Inc.",4.75B,32.42,-,6.62%,10.51%,-3.24%,+7.84%,-0.41%,Immunovant’s IMVT-1401: A High Potential Buy Rating for Unmet Graves’ Disease Needs,"Immunovant to Host Graves’ Disease Program Update on September 9, 2024","Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)",Buy Rating Affirmed for Immunovant Amidst Positive Clinical Advancements and Strong Market Prospects,,"Immunovant’s IMVT-1401: A High Potential Buy Rating for Unmet Graves’ Disease Needs Immunovant to Host Graves’ Disease Program Update on September 9, 2024 Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB) Buy Rating Affirmed for Immunovant Amidst Positive Clinical Advancements and Strong Market Prospects",0,0,0,0,0,-1
14.67M,"47,701",882.00M,-1,"2,202",326.60,,,"Jul 29, 2024",NVEI,Nuvei Corporation,4.72B,33.22,1.31B,0.44%,1.58%,16.92%,+0.48%,+3.39%,Nuvei Corp (NVEI) Announces Q3 Dividend: Read On for Important Dates,,,,,Nuvei Corp (NVEI) Announces Q3 Dividend: Read On for Important Dates,0,0,-1,-1,-1,-1
27.53M,"201,649",158.20M,$3.60,"3,895",173.51,Buy,205.00,"Aug 22, 2024",BGC,"BGC Group, Inc.",4.72B,9.70,2.05B,8.13%,10.63%,26.28%,+6.30%,+20.42%,Buy/Sell: Wall Street’s top 10 stock calls this week,CME Group downgraded to Underperform at BofA amid intensifying competition,,,,Buy/Sell: Wall Street’s top 10 stock calls this week CME Group downgraded to Underperform at BofA amid intensifying competition,0,0,0,-1,-1,-1
188.03M,"784,020",-453.82M,-1,"1,740",25.31,Strong Buy,47.33,"Aug 1, 2024",SLM,SLM Corporation,4.71B,21.65,1.68B,0.55%,-1.20%,5.86%,-4.98%,+1.60%,"Beat Treasury yields with these dividend-paying bank stocks, Janney says",These banks are cutting CD and savings rates. Where to park cash to get yield,SLM Corporation Announces Board Membership Reduction,"Analysts’ Opinions Are Mixed on These Financial Stocks: Moody’s (MCO), UOB (OtherUOVEF) and SLM (SLM)",Buy Rating for SLM Amid Seasonal Delinquency Trends and Strong Fundamentals,"Beat Treasury yields with these dividend-paying bank stocks, Janney says These banks are cutting CD and savings rates. Where to park cash to get yield SLM Corporation Announces Board Membership Reduction Analysts’ Opinions Are Mixed on These Financial Stocks: Moody’s (MCO), UOB (OtherUOVEF) and SLM (SLM) Buy Rating for SLM Amid Seasonal Delinquency Trends and Strong Fundamentals",0,1,0,0,0,0
44.91M,"207,255",282.80M,-1,"6,400",105.72,Strong Buy,124.63,"Oct 18, 2024",FELE,"Franklin Electric Co., Inc.",4.69B,102.74,2.02B,2.28%,3.04%,4.37%,-4.10%,-0.75%,,,,,,,1,-1,-1,-1,-1,-1
146.37M,"541,646",-272.55M,-1,141,32.42,Strong Buy,47.50,"Aug 6, 2024",DYN,"Dyne Therapeutics, Inc.",4.67B,46.53,-,-0.01%,8.68%,66.16%,+4.89%,+70.23%,Dyne Therapeutics’ Promising DYNE-251 Program Garners Buy Rating Amid Efficacy and Safety Optimism,Buy Rating Reaffirmed for Dyne Therapeutics Amid Promising Clinical Data and Strategic Management Shifts,Buy Rating Affirmed Amidst Dose Adjustments and Promising Trial Results for Dyne Therapeutics,Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’,Stifel views pullback in Dyne Therapeutics shares as buying opportunity,Dyne Therapeutics’ Promising DYNE-251 Program Garners Buy Rating Amid Efficacy and Safety Optimism Buy Rating Reaffirmed for Dyne Therapeutics Amid Promising Clinical Data and Strategic Management Shifts Buy Rating Affirmed Amidst Dose Adjustments and Promising Trial Results for Dyne Therapeutics Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’ Stifel views pullback in Dyne Therapeutics shares as buying opportunity,0,1,1,1,1,1
141.78M,"369,658",-11.38M,$0.40,"1,300",33.22,Hold,32.00,"Aug 6, 2024",OS,"OneStream, Inc.",4.63B,29.60,406.39M,4.16%,4.67%,4.67%,+6.10%,,"Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen",OneStream price target raised to $35 from $33 at Needham,OneStream price target raised to $37 from $35 at Truist,OneStream price target raised to $34 from $32 at Raymond James,OneStream price target raised to $35 from $34 at Guggenheim,"Monday’s top analyst calls: Nvidia, Apple, Amazon, McDonald’s, Walmart, Dell, Sweetgreen OneStream price target raised to $35 from $33 at Needham OneStream price target raised to $37 from $35 at Truist OneStream price target raised to $34 from $32 at Raymond James OneStream price target raised to $35 from $34 at Guggenheim",0,1,0,0,0,0
486.60M,"1,723,704",117.30M,$0.08,"2,188",9.70,Buy,11.50,"Jul 30, 2024",QLYS,"Qualys, Inc.",4.60B,125.06,581.08M,-2.60%,-8.03%,-22.75%,-16.55%,-24.50%,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,Qualys’s VMDR Strategy Fuels Growth and Customer Expansion Amidst Economic Challenges,Qualys management to meet with William Blair,,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer Cramer’s Lightning Round: Dell is a buy Qualys’s VMDR Strategy Fuels Growth and Customer Expansion Amidst Economic Challenges Qualys management to meet with William Blair",1,0,0,1,1,-1
217.46M,"693,662",721.08M,$0.44,"2,100",21.65,Buy,23.82,"Jul 24, 2024",ALKS,Alkermes plc,4.60B,27.95,1.51B,3.23%,9.31%,7.69%,+2.75%,+7.47%,Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680,Fulcrum appoints Isabel Kalofonos as CCO,,,,Alkermes initiates Vibrance-2 Phase 2 study evaluating ALKS 2680 Fulcrum appoints Isabel Kalofonos as CCO,0,0,1,-1,-1,-1
45.67M,"82,706",187.71M,$1.00,475,102.74,Buy,95.00,"Jul 23, 2024",PI,"Impinj, Inc.",4.60B,163.67,314.98M,7.30%,4.37%,30.99%,+2.57%,+34.38%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",,,,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",0,1,-1,-1,-1,-1
100.40M,"970,148",-257.60M,-1,"5,613",46.53,Strong Buy,47.33,"Aug 12, 2024",TSEM,Tower Semiconductor Ltd.,4.60B,41.43,1.39B,8.78%,7.11%,26.52%,+5.12%,+31.40%,Tower Semiconductor participates in a conference call with Benchmark,Myriad Uranium Corp. Advances Financing Efforts,,,,Tower Semiconductor participates in a conference call with Benchmark Myriad Uranium Corp. Advances Financing Efforts,0,0,0,-1,-1,-1
156.58M,"161,798",-10.82M,-1,"1,788",29.60,Strong Buy,33.07,"Sep 3, 2024",VRRM,Verra Mobility Corporation,4.59B,27.85,853.10M,-1.74%,-2.58%,11.89%,-7.87%,+13.54%,Verra Mobility announces partnership with Xtract,"Verra Mobility CFO Conti sells 25,000 class A shares",Morgan Stanley Remains a Hold on Verra Mobility (VRRM),Analysts Offer Insights on Industrial Goods Companies: Boeing (BA) and Verra Mobility (VRRM),Verra Mobility price target raised to $31 from $28 at Deutsche Bank,"Verra Mobility announces partnership with Xtract Verra Mobility CFO Conti sells 25,000 class A shares Morgan Stanley Remains a Hold on Verra Mobility (VRRM) Analysts Offer Insights on Industrial Goods Companies: Boeing (BA) and Verra Mobility (VRRM) Verra Mobility price target raised to $31 from $28 at Deutsche Bank",1,1,1,1,1,1
36.81M,"196,012",170.61M,-1,"5,081",125.06,Hold,151.71,"Aug 6, 2024",ITRI,"Itron, Inc.",4.58B,101.96,2.35B,2.61%,1.18%,14.39%,-3.03%,+9.63%,Itron initiated with an Outperform at Exane BNP Paribas,Roth MKM Remains a Buy on Itron (ITRI),Itron Poised for Growth Amidst Rising AI-Driven Energy Demand: A Strong Buy Recommendation,Roth MKM Keeps Their Buy Rating on Itron (ITRI),Itron (ITRI) Receives a Buy from Roth MKM,Itron initiated with an Outperform at Exane BNP Paribas Roth MKM Remains a Buy on Itron (ITRI) Itron Poised for Growth Amidst Rising AI-Driven Energy Demand: A Strong Buy Recommendation Roth MKM Keeps Their Buy Rating on Itron (ITRI) Itron (ITRI) Receives a Buy from Roth MKM,1,1,0,1,0,0
164.67M,"870,784",288.72M,-1,"16,500",27.95,Buy,36.70,"Jul 24, 2024",TIGO,Millicom International Cellular S.A.,4.57B,26.68,5.84B,4.46%,7.73%,29.85%,+6.34%,+30.85%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC",Millicom (Tigo) files standard form for notification of major holdings,Buy Rating on Millicom International: Strong Financials and Attractive Valuation,Millicom resumed with an Overweight at JPMorgan,Millicom initiated with a Market Perform at Handelsbanken,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Millicom (Tigo) files standard form for notification of major holdings Buy Rating on Millicom International: Strong Financials and Attractive Valuation Millicom resumed with an Overweight at JPMorgan Millicom initiated with a Market Perform at Handelsbanken",0,1,0,1,1,1
28.12M,"171,234",12.37M,-1,"440,000",163.67,Strong Buy,186.78,"Jul 24, 2024",CNXC,Concentrix Corporation,4.57B,69.95,8.65B,8.31%,10.29%,-2.10%,+5.86%,+26.60%,Concentrix Schedules Release of Third Quarter 2024 Financial Results and Webcast of Investor Conference Call,BofA upgrades Concentrix to Neutral on limited near-term downside,Concentrix upgraded to Neutral from Underperform at BofA,,,Concentrix Schedules Release of Third Quarter 2024 Financial Results and Webcast of Investor Conference Call BofA upgrades Concentrix to Neutral on limited near-term downside Concentrix upgraded to Neutral from Underperform at BofA,0,0,1,0,-1,-1
111.07M,"339,976",493.98M,-1,"1,548",41.43,Strong Buy,46.33,"Sep 6, 2024",BRZE,"Braze, Inc.",4.56B,44.86,505.48M,10.16%,15.08%,-1.91%,+1.11%,+3.24%,Broadcom AI results fail to enthuse the Street: Morning Buzz,Scotiabank Sticks to Their Buy Rating for Braze (BRZE),Braze (BRZE) Gets a Buy from Piper Sandler,Braze Inc. (BRZE) Buy Rating Affirmed on Strong Q2 Performance and Growth Prospects,"Braze: A Strong Buy on Early Profitability, Margin Improvement, and Solid Growth Prospects","Broadcom AI results fail to enthuse the Street: Morning Buzz Scotiabank Sticks to Their Buy Rating for Braze (BRZE) Braze (BRZE) Gets a Buy from Piper Sandler Braze Inc. (BRZE) Buy Rating Affirmed on Strong Q2 Performance and Growth Prospects Braze: A Strong Buy on Early Profitability, Margin Improvement, and Solid Growth Prospects",0,1,0,0,0,0
164.66M,"699,994",96.70M,-1,"22,000",27.85,Buy,29.00,"Aug 8, 2024",FIVE,"Five Below, Inc.",4.54B,82.46,3.64B,13.57%,-6.16%,-46.26%,+8.52%,-51.50%,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General",Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks,"Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more","Stocks making the biggest moves after hours: Nvidia, Salesforce and more",Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings,"Thursday’s rapid fire: CrowdStrike, Campbell, Five Below, Burlington, Dollar General Jim Cramer thinks CrowdStrike has bottomed and offers views on 4 other stocks Stocks making big moves premarket: Nvidia, Salesforce, CrowdStrike and more Stocks making the biggest moves after hours: Nvidia, Salesforce and more Wall Street wants to see Nvidia pull off a ‘Triple Lindy’ when it reports earnings",0,1,1,1,1,0
44.96M,"351,598",187.60M,-1,"3,591",101.96,Buy,109.55,"Aug 1, 2024",HWC,Hancock Whitney Corporation,4.53B,52.46,1.30B,4.02%,4.82%,13.38%,-3.00%,+20.96%,Hancock Whitney chief legal officer Phillips to retire,,,,,Hancock Whitney chief legal officer Phillips to retire,0,1,-1,-1,-1,-1
171.31M,"59,659",107.00M,-1,"3,749",26.68,Buy,26.67,"Aug 2, 2024",VLY,Valley National Bancorp,4.53B,8.89,1.65B,5.22%,12.72%,2.91%,+2.62%,+14.78%,"Valley Bank CEO on the health of banks, rate cut optimism and bank lending",Valley National Bancorp Announces Board Member Transition,Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends,Valley National Bancorp (VLY) Gets a Sell from Barclays,,"Valley Bank CEO on the health of banks, rate cut optimism and bank lending Valley National Bancorp Announces Board Member Transition Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends Valley National Bancorp (VLY) Gets a Sell from Barclays",0,1,1,0,1,-1
65.33M,"222,645",258.40M,$1.21,"9,500",69.95,Buy,98.00,"Sep 25, 2024",IAC,IAC Inc.,4.47B,51.96,4.05B,3.80%,5.87%,2.59%,-2.88%,-1.59%,Benchmark Co. Sticks to Its Buy Rating for IAC/InteractiveCorp. (IAC),FTC agrees to $8.5M settlement with IAC’s Care.com,IAC price target lowered to $66 from $67 at KeyBanc,,,Benchmark Co. Sticks to Its Buy Rating for IAC/InteractiveCorp. (IAC) FTC agrees to $8.5M settlement with IAC’s Care.com IAC price target lowered to $66 from $67 at KeyBanc,0,1,0,1,-1,-1
101.63M,"941,779",-126.35M,-1,290,44.86,Strong Buy,60.18,"Sep 5, 2024",PECO,"Phillips Edison & Company, Inc.",4.47B,36.45,629.74M,4.76%,8.21%,7.12%,+5.07%,+7.84%,Phillips Edison increases monthly dividend distribution by 5.1% to 10.25c p/s,Phillips Edison Announces Upcoming Monthly Share Distributions,Phillips Edison & Company Increases Monthly Dividend Distribution by 5.1% to $0.1025 Per Common Share,Phillips Edison & Company to Present at BofA Securities 2024 Global Real Estate Conference,Phillips Edison upgraded to Equal Weight on better FFO growth at Wells,Phillips Edison increases monthly dividend distribution by 5.1% to 10.25c p/s Phillips Edison Announces Upcoming Monthly Share Distributions Phillips Edison & Company Increases Monthly Dividend Distribution by 5.1% to $0.1025 Per Common Share Phillips Edison & Company to Present at BofA Securities 2024 Global Real Estate Conference Phillips Edison upgraded to Equal Weight on better FFO growth at Wells,0,0,0,0,1,0
55.07M,"1,570,539",295.10M,-1,565,82.46,Buy,126.95,"Aug 28, 2024",CAMT,Camtek Ltd.,4.44B,97.97,368.76M,0.72%,-13.72%,9.26%,-12.20%,+17.60%,Camtek Ltd. Announces Upcoming Shareholder Meeting,,,,,Camtek Ltd. Announces Upcoming Shareholder Meeting,0,0,-1,-1,-1,-1
86.35M,"363,991",368.48M,$1.60,36,52.46,Buy,53.92,"Oct 15, 2024",DJT,Trump Media & Technology Group Corp.,4.44B,22.81,3.43M,-16.18%,-29.51%,-38.10%,-30.06%,-50.48%,Trump Media shares erase 2024 gains as key DJT sale date nears,The latest hiccup in Trump’s crypto launch: Deleted posts and a hacking claim,"Trump Media stock slides under $18, a new low since it began publicly trading","Trump Media stock falls below $20 per share, a first since company went public",Trump says Elon Musk wouldn’t have time to be in his White House cabinet,"Trump Media shares erase 2024 gains as key DJT sale date nears The latest hiccup in Trump’s crypto launch: Deleted posts and a hacking claim Trump Media stock slides under $18, a new low since it began publicly trading Trump Media stock falls below $20 per share, a first since company went public Trump says Elon Musk wouldn’t have time to be in his White House cabinet",0,0,0,0,0,0
509.22M,"5,554,975",363.15M,$0.44,"1,400",8.89,Hold,8.25,"Jul 25, 2024",WAY,Waystar Holding Corp.,4.40B,26.39,863.29M,8.11%,15.23%,15.71%,+15.96%,,Jim Cramer revisits 2024′s largest IPOs,Waystar price target raised to $31 from $27 at RBC Capital,RBC Capital Remains a Buy on Waystar Holding Corp. (WAY),Waystar price target raised to $27 from $24 at JPMorgan,Waystar price target raised to $31 from $27 at Deutsche Bank,Jim Cramer revisits 2024′s largest IPOs Waystar price target raised to $31 from $27 at RBC Capital RBC Capital Remains a Buy on Waystar Holding Corp. (WAY) Waystar price target raised to $27 from $24 at JPMorgan Waystar price target raised to $31 from $27 at Deutsche Bank,0,0,0,0,0,0
86.12M,"399,871",-157.91M,-1,"3,000",51.96,Strong Buy,76.40,"Aug 6, 2024",SHC,Sotera Health Company,4.37B,15.42,1.10B,7.15%,18.21%,15.91%,+9.52%,+33.95%,Sotera Health Board Changes and Shareholder Stock Sale,Sotera Health Announces Secondary Offering of Common Stock,,,,Sotera Health Board Changes and Shareholder Stock Sale Sotera Health Announces Secondary Offering of Common Stock,0,1,0,-1,-1,-1
122.50M,"482,126",58.72M,$1.17,,36.45,Hold,36.83,"Jul 25, 2024",VNOM,"Viper Energy, Inc.",4.34B,47.41,878.51M,6.76%,15.63%,33.69%,+12.37%,+22.20%,Viper Energy price target raised to $52 from $47 at Barclays,Piper Sandler Sticks to Their Buy Rating for Viper Energy (VNOM),Viper Energy price target raised to $57 from $44 at Piper Sandler,,,Viper Energy price target raised to $52 from $47 at Barclays Piper Sandler Sticks to Their Buy Rating for Viper Energy (VNOM) Viper Energy price target raised to $57 from $44 at Piper Sandler,0,0,0,0,-1,-1
45.37M,"495,199",95.61M,$1.33,407,97.97,Strong Buy,109.43,"Aug 1, 2024",CRSP,CRISPR Therapeutics AG,4.31B,48.69,202.23M,-2.87%,-10.73%,-22.39%,-17.12%,-24.52%,Oruka announces closing of merger with ARCA Biopharma,Crispr Therapeutics call volume above normal and directionally bullish,Crispr Therapeutics price target lowered to $100 from $120 at Truist,Crispr Therapeutics AG (CRSP) Receives a Buy from Truist Financial,,Oruka announces closing of merger with ARCA Biopharma Crispr Therapeutics call volume above normal and directionally bullish Crispr Therapeutics price target lowered to $100 from $120 at Truist Crispr Therapeutics AG (CRSP) Receives a Buy from Truist Financial,0,0,1,0,0,-1
194.72M,"4,541,887",-379.18M,-1,"1,559",22.81,,,"Aug 9, 2024",FIZZ,National Beverage Corp.,4.29B,45.84,1.19B,-3.01%,-6.33%,-1.28%,-6.89%,-8.43%,National Beverage reports Q1 EPS 61c vs. 53c last year,FIZZ Upcoming Earnings Report: What to Expect?,LaCroix enters multi-year partnership with Kansas City Current,,,National Beverage reports Q1 EPS 61c vs. 53c last year FIZZ Upcoming Earnings Report: What to Expect? LaCroix enters multi-year partnership with Kansas City Current,1,1,1,1,-1,-1
166.66M,"567,086",-73.52M,-1,624,26.39,Strong Buy,28.50,"Aug 7, 2024",ADMA,"ADMA Biologics, Inc.",4.29B,18.40,330.24M,13.79%,30.22%,122.11%,+40.39%,+169.80%,Cramer’s Lightning Round: ADMA Biologics is ‘a very speculative situation’,"Lightning Round: MP Materials needs to pull out of the ‘tailspin of losses’, says Jim Cramer",Largest borrow rate increases among liquid names,ADMA Biologics Announces Partial Paydown of Revolving Credit Facility,Adma Biologics announces partial paydown of revolving credit facility,"Cramer’s Lightning Round: ADMA Biologics is ‘a very speculative situation’ Lightning Round: MP Materials needs to pull out of the ‘tailspin of losses’, says Jim Cramer Largest borrow rate increases among liquid names ADMA Biologics Announces Partial Paydown of Revolving Credit Facility Adma Biologics announces partial paydown of revolving credit facility",1,0,0,1,0,0
283.21M,"1,747,017",39.94M,-1,"7,239",15.42,Buy,15.70,"Aug 5, 2024",STNE,StoneCo Ltd.,4.27B,13.94,2.18B,0.95%,4.10%,-11.86%,-0.76%,-22.64%,"Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more","Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded","These high-quality small-cap stocks are a buy, Bank of America says","Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz","Thursday’s top analyst calls: Nvidia, Apple, Meta, Amazon, Arm and more Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Thursday’s analyst calls: Buy the Nvidia dip, General Motors gets downgraded These high-quality small-cap stocks are a buy, Bank of America says Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz",1,1,1,1,1,1
91.45M,"628,695",235.48M,$2.56,"13,500",47.41,Strong Buy,45.14,"Aug 5, 2024",SGRY,"Surgery Partners, Inc.",4.26B,33.69,2.89B,9.38%,18.20%,11.92%,+5.43%,+16.65%,Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY),"TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says",Surgery Partners up 14% to $32.62 after Bloomberg says UNH among bidders,"UnitedHealth, TPG among suitors for Surgery Partners, Bloomberg says",Surgery Partners’ Strong Q2 Performance and Upward 2024 Guidance Fuel Buy Rating,"Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY) TPG, UNH expressed interest in buying Surgery Partners, Bloomberg says Surgery Partners up 14% to $32.62 after Bloomberg says UNH among bidders UnitedHealth, TPG among suitors for Surgery Partners, Bloomberg says Surgery Partners’ Strong Q2 Performance and Upward 2024 Guidance Fuel Buy Rating",0,0,0,0,0,0
,,,-1,290,,,,,CRNX,"Crinetics Pharmaceuticals, Inc.",4.25B,53.15,1.39M,5.83%,9.08%,27.95%,+2.41%,+14.45%,Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE)",Buy Rating Affirmed for Crinetics Pharmaceuticals on Strong Pipeline and Regulatory Progress,Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Morgan Stanley Sticks to Its Buy Rating for Crinetics Pharmaceuticals (CRNX),"Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE) Buy Rating Affirmed for Crinetics Pharmaceuticals on Strong Pipeline and Regulatory Progress Crinetics Pharmaceuticals Announces August 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Morgan Stanley Sticks to Its Buy Rating for Crinetics Pharmaceuticals (CRNX)",0,0,0,0,0,0
88.52M,"705,053",-265.80M,-1,"8,509",48.69,Buy,74.38,"Aug 5, 2024",RUSHA,"Rush Enterprises, Inc.",4.22B,53.64,7.91B,1.49%,10.63%,13.94%,+2.25%,+0.12%,Rush Enterprises A Enhances Investor Engagement with New Presentation,,,,,Rush Enterprises A Enhances Investor Engagement with New Presentation,1,1,-1,-1,-1,-1
93.58M,"134,595",176.73M,$3.25,545,45.84,Strong Sell,48.00,"Sep 5, 2024",AXSM,"Axsome Therapeutics, Inc.",4.22B,87.99,291.49M,3.42%,6.86%,13.83%,+1.28%,+22.39%,Biotech Alert: Searches spiking for these stocks today,Axsome Therapeutics (AXSM) Gets a Buy from Cantor Fitzgerald,Buy Rating Affirmed for Axsome Therapeutics on Robust Pipeline and Promising Regulatory Prospects,Buy Rating Affirmed for Axsome Therapeutics on Strong Pipeline and Promising Drug Trials,Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine,Biotech Alert: Searches spiking for these stocks today Axsome Therapeutics (AXSM) Gets a Buy from Cantor Fitzgerald Buy Rating Affirmed for Axsome Therapeutics on Robust Pipeline and Promising Regulatory Prospects Buy Rating Affirmed for Axsome Therapeutics on Strong Pipeline and Promising Drug Trials Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine,1,1,1,1,1,0
233.08M,"4,020,663",34.79M,-1,"10,000",18.40,Strong Buy,15.50,"Aug 8, 2024",AEIS,"Advanced Energy Industries, Inc.",4.17B,110.70,1.51B,3.67%,0.69%,5.60%,-8.43%,+8.78%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC","Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls",Advanced Energy initiated with a Buy at Stifel,,,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls Advanced Energy initiated with a Buy at Stifel",1,1,1,1,-1,-1
306.34M,"3,325,349",347.49M,-1,"5,800",13.94,Buy,18.54,"Aug 14, 2024",LOPE,"Grand Canyon Education, Inc.",4.13B,142.29,1.00B,-1.95%,-1.36%,3.39%,-7.98%,+8.34%,,,,,,,1,-1,-1,-1,-1,-1
126.39M,"1,663,026",-33.80M,-1,"3,000",33.69,Buy,39.86,"Aug 6, 2024",BLKB,"Blackbaud, Inc.",4.13B,81.77,1.14B,5.90%,6.72%,6.22%,+3.20%,+13.76%,,,,,,,0,-1,-1,-1,-1,-1
80.04M,"455,658",-258.54M,-1,"8,509",53.15,Strong Buy,66.00,"Aug 8, 2024",RUSHB,"Rush Enterprises, Inc.",4.13B,47.80,7.91B,,6.72%,6.22%,-0.51%,-7.75%,Rush Enterprises A Enhances Investor Engagement with New Presentation,,,,,Rush Enterprises A Enhances Investor Engagement with New Presentation,1,1,-1,-1,-1,-1
78.76M,"271,256",308.59M,$0.72,626,53.64,Buy,60.00,"Oct 22, 2024",PRCT,PROCEPT BioRobotics Corporation,4.12B,79.34,176.58M,23.69%,25.58%,53.04%,+26.36%,+70.09%,Cramer’s Lightning Round: ‘I like Zoetis very much’,BTIG medical technology analyst holds an analyst/industry conference call,"PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024",Procept BioRobotics management to meet with Truist,PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial,"Cramer’s Lightning Round: ‘I like Zoetis very much’ BTIG medical technology analyst holds an analyst/industry conference call PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 Procept BioRobotics management to meet with Truist PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial",0,0,0,0,0,0
48.00M,"266,874",-308.55M,-1,"1,653",87.99,Strong Buy,124.83,"Aug 5, 2024",NCNO,"nCino, Inc.",4.03B,35.00,490.96M,4.77%,6.95%,9.93%,-9.22%,-13.07%,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber","Stocks making the biggest moves midday: Super Micro, Abercrombie and more","Stocks making biggest moves premarket: Super Micro, Abercrombie and more","Stocks making the biggest moves after hours: Nordstrom, SentinelOne and more",Goldman believes this maker of software for banks offers 30% upside,"Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Stocks making the biggest moves midday: Super Micro, Abercrombie and more Stocks making biggest moves premarket: Super Micro, Abercrombie and more Stocks making the biggest moves after hours: Nordstrom, SentinelOne and more Goldman believes this maker of software for banks offers 30% upside",0,1,1,1,1,1
37.67M,"162,966",90.47M,$0.40,607,110.60,Buy,113.25,"Jul 30, 2024",IPAR,"Inter Parfums, Inc.",4.02B,125.66,1.36B,-4.19%,-0.33%,-5.06%,-11.45%,-5.06%,,,,,,,1,-1,-1,-1,-1,-1
29.05M,"82,055",219.34M,-1,"7,500",142.29,Buy,165.67,"Aug 6, 2024",LITE,Lumentum Holdings Inc.,4.02B,59.17,1.36B,17.24%,11.75%,18.69%,+9.25%,+23.25%,"Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more","Stocks making the biggest moves premarket: Ulta Beauty, Walmart, Cisco Systems and more","Stocks making the biggest moves after hours: Cisco, Ulta, Nike and more",Lumentum management to meet with B. Riley,"Top Stock Gainers Today – PANW, SIRI, and More","Stocks making the biggest moves midday: Walmart, Nike, Dell, Tapestry and more Stocks making the biggest moves premarket: Ulta Beauty, Walmart, Cisco Systems and more Stocks making the biggest moves after hours: Cisco, Ulta, Nike and more Lumentum management to meet with B. Riley Top Stock Gainers Today – PANW, SIRI, and More",1,1,1,1,0,1
50.52M,"148,378",41.47M,-1,"14,000",81.77,Buy,92.00,"Jul 30, 2024",ICUI,"ICU Medical, Inc.",3.99B,163.55,2.30B,13.36%,25.29%,53.84%,+28.45%,+60.39%,ICU Medical to Participate in Upcoming Investor Conferences,,,,,ICU Medical to Participate in Upcoming Investor Conferences,0,0,-1,-1,-1,-1
78.76M,"27,926",308.59M,$0.72,"2,115",47.80,,,"Oct 22, 2024",FORM,"FormFactor, Inc.",3.98B,51.41,705.94M,7.26%,-6.49%,8.45%,-8.53%,+5.83%,FormFactor Announces Participation at Upcoming Conferences,,,,,FormFactor Announces Participation at Upcoming Conferences,0,1,-1,-1,-1,-1
51.93M,"509,002",-103.71M,-1,875,79.34,Strong Buy,70.67,"Aug 1, 2024",GBDC,"Golub Capital BDC, Inc.",3.97B,14.99,664.81M,2.87%,-0.67%,-2.36%,-1.90%,-9.81%,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,Bank of America Securities Sticks to Its Buy Rating for Golub Capital Bdc (GBDC),,,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer Cramer’s Lightning Round: Dell is a buy Bank of America Securities Sticks to Its Buy Rating for Golub Capital Bdc (GBDC)",0,0,0,0,-1,-1
115.08M,"905,745",-34.08M,-1,"22,012",35.00,Buy,37.31,"Aug 27, 2024",ASO,"Academy Sports and Outdoors, Inc.",3.93B,54.49,6.14B,7.18%,5.48%,-5.10%,+1.31%,-13.66%,Tuesday’s stock stories: What’s likely to move the market in the next session,"Analyst calls: Warner Bros. Discovery gets downgraded, cybersecurity stock a buy",ASO Earnings this Week: How Will it Perform?,Academy Sports + Outdoors Announces Quarterly Cash Dividend,Telsey Advisory Remains a Buy on Academy Sports and Outdoors (ASO),"Tuesday’s stock stories: What’s likely to move the market in the next session Analyst calls: Warner Bros. Discovery gets downgraded, cybersecurity stock a buy ASO Earnings this Week: How Will it Perform? Academy Sports + Outdoors Announces Quarterly Cash Dividend Telsey Advisory Remains a Buy on Academy Sports and Outdoors (ASO)",0,0,0,0,1,1
32.02M,"84,424",141.51M,$3.00,48,125.66,Strong Buy,163.75,"Aug 6, 2024",SBRA,"Sabra Health Care REIT, Inc.",3.90B,16.63,665.99M,2.70%,5.67%,15.45%,+3.45%,+15.95%,Sabra Health Care price target raised to $18 from $16 at Truist,Sabra Health Care price target raised to $17 from $15 at Scotiabank,Sabra Healthcare REIT (SBRA) Gets a Hold from Wells Fargo,Sabra Health Care price target raised to $16 from $14 at Wells Fargo,Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects,Sabra Health Care price target raised to $18 from $16 at Truist Sabra Health Care price target raised to $17 from $15 at Scotiabank Sabra Healthcare REIT (SBRA) Gets a Hold from Wells Fargo Sabra Health Care price target raised to $16 from $14 at Wells Fargo Sabra Healthcare REIT: A Strong Buy on Robust Financial Performance and Growth Prospects,0,0,0,0,0,0
67.90M,"1,647,651",-546.50M,-1,"3,121",59.17,Buy,58.36,"Aug 14, 2024",QFIN,"Qifu Technology, Inc.",3.88B,25.02,2.35B,16.57%,24.54%,43.76%,+26.05%,+32.78%,Qifu Technology (QFIN) Discloses Q4 Dividend: What Shareholders Should Know,Qifu Technology price target raised to $28.40 from $25 at BofA,Qifu Technology (QFIN) Gets a Buy from Bank of America Securities,"Is QFIN a Buy, Before Earnings?",,"Qifu Technology (QFIN) Discloses Q4 Dividend: What Shareholders Should Know Qifu Technology price target raised to $28.40 from $25 at BofA Qifu Technology (QFIN) Gets a Buy from Bank of America Securities Is QFIN a Buy, Before Earnings?",1,1,0,1,1,-1
24.43M,"178,053",-70.79M,-1,"2,292",163.55,Buy,138.33,"Aug 7, 2024",IBOC,International Bancshares Corporation,3.88B,62.45,798.42M,2.31%,2.59%,12.57%,-7.15%,+13.01%,,,,,,,1,-1,-1,-1,-1,-1
77.39M,"368,875",121.39M,-1,"34,000",51.41,Buy,59.63,"Jul 31, 2024",SANM,Sanmina Corporation,3.87B,70.76,7.60B,-0.95%,-0.38%,13.23%,-9.20%,+14.00%,,,,,,,1,-1,-1,-1,-1,-1
264.61M,"1,640,393",280.15M,$1.16,819,14.99,Buy,16.36,"Aug 5, 2024",POWI,"Power Integrations, Inc.",3.86B,67.90,412.90M,0.39%,-6.24%,-11.23%,-12.62%,-7.32%,Power Integrations Announces VP of Worldwide Sales Transition,Power Integrations participates in a conference call with Benchmark,Power Integrations upgraded to Outperform from Market Perform at Northland,,,Power Integrations Announces VP of Worldwide Sales Transition Power Integrations participates in a conference call with Benchmark Power Integrations upgraded to Outperform from Market Perform at Northland,0,0,0,0,-1,-1
72.13M,"1,132,561",501.69M,$0.44,"8,427",54.49,Buy,65.56,"Sep 6, 2024",IESC,"IES Holdings, Inc.",3.84B,192.43,2.76B,9.48%,19.48%,53.66%,+14.51%,+31.94%,IES Holdings Announces Board Member Elizabeth Leykum’s Resignation,,,,,IES Holdings Announces Board Member Elizabeth Leykum’s Resignation,1,1,-1,-1,-1,-1
234.26M,"1,827,975",52.28M,$1.20,"1,846",16.63,Strong Buy,16.56,"Aug 7, 2024",SLAB,Silicon Laboratories Inc.,3.82B,118.32,542.35M,10.83%,5.70%,-3.17%,-5.01%,-13.04%,Op-ed: Small caps could be in for a revival. Here’s why,,,,,Op-ed: Small caps could be in for a revival. Here’s why,0,1,-1,-1,-1,-1
155.25M,"2,071,398",660.34M,$1.18,"2,655",25.02,Strong Buy,23.80,"Aug 13, 2024",OTTR,Otter Tail Corporation,3.80B,90.89,1.36B,-4.06%,-3.42%,0.42%,-12.60%,-1.67%,"Analysts Offer Insights on Utilities Companies: Montauk Renewables (MNTK), Otter Tail (OTTR) and Enel Chile SA (ENIC)",,,,,"Analysts Offer Insights on Utilities Companies: Montauk Renewables (MNTK), Otter Tail (OTTR) and Enel Chile SA (ENIC)",0,1,-1,-1,-1,-1
62.19M,"322,559",403.95M,$1.32,"1,388",62.45,,,"Aug 1, 2024",UPST,"Upstart Holdings, Inc.",3.76B,42.00,575.96M,29.66%,53.95%,53.99%,+50.66%,+70.64%,5 best installment loans for bad credit of September 2024,Hedge fund manager Eric Jackson reveals his next ‘back-from-the-dead’ AI pick,Easiest personal loans to get,Best home improvement loans,Best hardship loans,5 best installment loans for bad credit of September 2024 Hedge fund manager Eric Jackson reveals his next ‘back-from-the-dead’ AI pick Easiest personal loans to get Best home improvement loans Best hardship loans,0,0,0,0,0,0
54.65M,"367,415",223.00M,-1,"5,000",70.76,Sell,53.50,"Jul 29, 2024",PAGP,"Plains GP Holdings, L.P.",3.76B,19.05,49.70B,1.21%,-0.04%,7.49%,-2.77%,-3.78%,Plains GP Holdings (PAGP) Gets a Buy from Morgan Stanley,Barclays Keeps Their Sell Rating on Plains GP Holdings (PAGP),,,,Plains GP Holdings (PAGP) Gets a Buy from Morgan Stanley Barclays Keeps Their Sell Rating on Plains GP Holdings (PAGP),1,1,1,-1,-1,-1
56.83M,"268,832",42.87M,$0.80,995,67.90,Buy,78.50,"Aug 6, 2024",TFSL,TFS Financial Corporation,3.75B,13.46,305.49M,2.89%,3.69%,2.92%,-0.59%,+10.22%,,,,,,,1,-1,-1,-1,-1,-1
19.98M,"178,824",173.74M,-1,130,192.43,,,"Aug 2, 2024",ACLX,"Arcellx, Inc.",3.73B,69.38,144.75M,17.22%,20.34%,23.26%,+12.12%,+11.38%,Arcellx initiated with an Overweight at Cantor Fitzgerald,Buy Rating for Arcellx Inc. on Strong Oncology Program Progress and Promising CAR-T Therapy Developments,Buy Rating Affirmed for Arcellx Inc. on Strong CAR-T Therapy Prospects and Financial Stability,ACLX Upcoming Earnings Report: What to Expect?,"Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)","Arcellx initiated with an Overweight at Cantor Fitzgerald Buy Rating for Arcellx Inc. on Strong Oncology Program Progress and Promising CAR-T Therapy Developments Buy Rating Affirmed for Arcellx Inc. on Strong CAR-T Therapy Prospects and Financial Stability ACLX Upcoming Earnings Report: What to Expect? Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)",1,1,1,1,1,1
32.29M,"344,788",-198.12M,-1,"1,620",118.32,Buy,130.14,"Jul 24, 2024",ACLS,"Axcelis Technologies, Inc.",3.73B,114.22,1.11B,-1.60%,-13.49%,-8.48%,-13.72%,+3.59%,,,,,,,0,-1,-1,-1,-1,-1
41.83M,"152,093",311.07M,$1.87,"1,716",90.89,,,"Aug 5, 2024",FTDR,"Frontdoor, Inc.",3.71B,48.52,1.81B,7.28%,23.24%,39.11%,+20.48%,+54.60%,,,,,,,0,-1,-1,-1,-1,-1
89.51M,"6,605,845",-201.78M,-1,"10,600",42.00,Sell,25.14,"Aug 6, 2024",PTEN,"Patterson-UTI Energy, Inc.",3.66B,9.31,5.45B,-0.65%,-6.18%,-15.08%,-17.47%,-27.56%,Patterson-UTI Engages Investors with Informative Presentation,"Ex-Dividend Date Nearing for These 9 Stocks – Week of September 2, 2024",Patterson-UTI price target lowered to $14 from $15 at Barclays,"Analysts Offer Insights on Energy Companies: Patterson-UTI (PTEN), Phillips 66 (PSX) and Magnolia Oil & Gas (MGY)",,"Patterson-UTI Engages Investors with Informative Presentation Ex-Dividend Date Nearing for These 9 Stocks – Week of September 2, 2024 Patterson-UTI price target lowered to $14 from $15 at Barclays Analysts Offer Insights on Energy Companies: Patterson-UTI (PTEN), Phillips 66 (PSX) and Magnolia Oil & Gas (MGY)",0,0,0,0,0,-1
197.26M,"875,032",162.00M,$1.22,229,19.05,Buy,20.11,"Aug 2, 2024",MRUS,Merus N.V.,3.66B,53.59,35.19M,2.12%,-2.23%,23.84%,-2.39%,+15.82%,"Merus, Foundation Medicine collaborate to advance treatments for NRG1+","Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)","Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Brookdale Senior Living (BKD) and Arrowhead Pharmaceuticals (ARWR)",,,"Merus, Foundation Medicine collaborate to advance treatments for NRG1+ Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI) Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Brookdale Senior Living (BKD) and Arrowhead Pharmaceuticals (ARWR)",1,1,0,0,-1,-1
278.33M,"176,543",79.42M,$1.13,990,13.46,Hold,14.00,"Jul 30, 2024",STEP,StepStone Group Inc.,3.65B,53.68,720.02M,7.60%,13.04%,45.09%,+6.29%,+49.09%,StepStone Group to Present at the Barclays Global Financial Services Conference,Stepstone Group price target raised to $55 from $44 at UBS,Stepstone Group price target raised to $52 from $43 at Morgan Stanley,Maintaining Hold on StepStone Group Amid Balanced Risk/Reward and Revised Earnings Estimates,J.P. Morgan Reaffirms Their Buy Rating on StepStone Group (STEP),StepStone Group to Present at the Barclays Global Financial Services Conference Stepstone Group price target raised to $55 from $44 at UBS Stepstone Group price target raised to $52 from $43 at Morgan Stanley Maintaining Hold on StepStone Group Amid Balanced Risk/Reward and Revised Earnings Estimates J.P. Morgan Reaffirms Their Buy Rating on StepStone Group (STEP),0,1,1,0,1,1
53.76M,"537,803",-53.89M,-1,"2,917",69.38,Strong Buy,76.67,"Aug 8, 2024",NEOG,Neogen Corporation,3.64B,16.78,924.22M,3.58%,4.66%,7.58%,-1.23%,+17.21%,Neogen Showcases Food Safety Innovations at Healthcare Conference,,,,,Neogen Showcases Food Safety Innovations at Healthcare Conference,1,0,-1,-1,-1,-1
32.62M,"488,009",239.45M,-1,352,114.22,Strong Buy,169.80,"Jul 31, 2024",CORT,Corcept Therapeutics Incorporated,3.64B,34.79,569.61M,-0.59%,4.79%,25.67%,-10.94%,+36.67%,Buy Rating Affirmed for Corcept Therapeutics on Strong Financials and Promising Drug Pipeline,,,,,Buy Rating Affirmed for Corcept Therapeutics on Strong Financials and Promising Drug Pipeline,0,1,-1,-1,-1,-1
76.52M,"687,090",206.00M,-1,,48.52,Buy,44.83,"Aug 1, 2024",LLYVK,Liberty Live Group,3.63B,39.61,-,4.23%,5.82%,5.91%,+3.69%,-6.92%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
393.05M,"4,441,018",124.31M,$0.32,"3,000",9.31,Buy,14.59,"Jul 24, 2024",STRL,"Sterling Infrastructure, Inc.",3.63B,118.10,2.07B,6.35%,2.52%,18.32%,+0.14%,+8.34%,Veteran Board Member Retires from Sterling Construction,,,,,Veteran Board Member Retires from Sterling Construction,0,1,-1,-1,-1,-1
68.21M,"159,215",-167.66M,-1,579,53.59,Strong Buy,82.20,"Aug 1, 2024",TRMD,TORM plc,3.61B,38.32,1.63B,3.16%,2.76%,11.62%,-4.03%,+4.95%,TORM Expands Capital with New Share Issuance,TORM plc Announces Share Capital Increase,Torm (TRMD) Receives a Buy from Evercore ISI,TORM Reports Strong Q2 Growth and Fleet Expansion,TORM plc Announces Strong Q2 Results and Dividends,TORM Expands Capital with New Share Issuance TORM plc Announces Share Capital Increase Torm (TRMD) Receives a Buy from Evercore ISI TORM Reports Strong Q2 Growth and Fleet Expansion TORM plc Announces Strong Q2 Results and Dividends,0,0,0,0,1,0
67.93M,"517,089",50.15M,$0.45,,53.68,Hold,49.81,"Aug 8, 2024",LLYVA,Liberty Live Group,3.61B,38.83,-,4.69%,6.59%,7.02%,+4.90%,-6.67%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
216.69M,"1,890,720",-9.42M,-1,"4,900",16.78,Hold,17.50,"Oct 8, 2024",FRSH,Freshworks Inc.,3.61B,11.95,652.94M,4.07%,-1.69%,-29.54%,-6.96%,-35.99%,"Tiger Global buys Qualcomm, exits Instacart in Q2",Freshworks CPO Resigns for New Opportunities,,,,"Tiger Global buys Qualcomm, exits Instacart in Q2 Freshworks CPO Resigns for New Opportunities",1,1,1,-1,-1,-1
104.49M,"619,862",124.96M,-1,557,34.79,Strong Buy,56.50,"Jul 29, 2024",IOVA,"Iovance Biotherapeutics, Inc.",3.60B,11.87,32.77M,16.45%,28.32%,15.49%,+29.78%,-16.26%,Iovance Biotherapeutics to Present at Upcoming Conferences,Iovance Biotherapeutics put volume heavy and directionally bearish,Iovance Biotherapeutics call volume above normal and directionally bullish,"Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli",Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4),"Iovance Biotherapeutics to Present at Upcoming Conferences Iovance Biotherapeutics put volume heavy and directionally bearish Iovance Biotherapeutics call volume above normal and directionally bullish Iovance Biotherapeutics ‘pretty attractive long idea,’ says Martin Shkreli Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",1,1,1,1,1,1
91.72M,"113,867",,-1,999,39.61,,,,ALVO,Alvotech,3.59B,11.89,308.73M,0.74%,-2.74%,-8.36%,-0.43%,-3.08%,Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,Alvotech files to sell 1.79M ordinary shares for holders,Alvotech’s Strong Q2 Performance and Positive Outlook Justify Buy Rating,Alvotech Reports Revenue Surge Amidst Expansion,Alvotech’s Biosimilar AVT06 Eyes European Market,Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Alvotech files to sell 1.79M ordinary shares for holders Alvotech’s Strong Q2 Performance and Positive Outlook Justify Buy Rating Alvotech Reports Revenue Surge Amidst Expansion Alvotech’s Biosimilar AVT06 Eyes European Market,0,0,0,0,0,0
,,,-1,"1,779",,,,,GH,"Guardant Health, Inc.",3.57B,29.02,643.81M,-13.72%,-13.78%,6.30%,-25.42%,+44.35%,Guardant Health management to meet with Craig-Hallum,Buy Rating Affirmed for Guardant Health Amidst Expanding MRD Market and AI Integration,Boeing’s Starliner to return without astronauts: Morning Buzz,Scotiabank Keeps Their Buy Rating on Guardant Health (GH),"Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)","Guardant Health management to meet with Craig-Hallum Buy Rating Affirmed for Guardant Health Amidst Expanding MRD Market and AI Integration Boeing’s Starliner to return without astronauts: Morning Buzz Scotiabank Keeps Their Buy Rating on Guardant Health (GH) Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)",1,0,0,1,1,1
30.73M,"149,796",162.45M,-1,"1,008",118.10,Hold,115.00,"Aug 5, 2024",CLBT,Cellebrite DI Ltd.,3.57B,17.15,346.76M,19.60%,31.67%,60.73%,+24.16%,+49.21%,Cellebrite DI Ltd. Sets Terms for Warrant Redemption,Cellebrite announces ‘Redemption Fair Market Value’,Cellebrite DI Announces Warrant Redemption Plan,"Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS)",Cellebrite price target raised to $17 from $13.50 at Lake Street,"Cellebrite DI Ltd. Sets Terms for Warrant Redemption Cellebrite announces ‘Redemption Fair Market Value’ Cellebrite DI Announces Warrant Redemption Plan Analysts Are Bullish on These Technology Stocks: Cellebrite DI (CLBT), D-Wave Quantum (QBTS) Cellebrite price target raised to $17 from $13.50 at Lake Street",0,0,0,0,0,0
94.00M,"734,373",713.17M,$7.20,"28,000",38.32,Buy,48.00,"Aug 15, 2024",URBN,"Urban Outfitters, Inc.",3.56B,38.59,5.32B,-9.27%,-14.30%,-8.66%,-20.39%,-7.77%,"2 stocks that are winning the back-to-school shopping season, per Morgan Stanley","Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more","Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more",Jim Cramer says market-share gains are fueling this cyber stock’s rally,"Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video","2 stocks that are winning the back-to-school shopping season, per Morgan Stanley Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more Stocks making the biggest moves midday: Urban Outfitters, Peloton, Zoom and more Jim Cramer says market-share gains are fueling this cyber stock’s rally Thursday’s rapid fire: Williams-Sonoma, Urban Outfitters, SentinelOne and Zoom Video",1,0,1,1,0,1
,"72,820",,-1,"3,516",38.83,Strong Buy,56.00,,ZI,ZoomInfo Technologies Inc.,3.55B,9.72,1.23B,1.81%,-11.21%,-31.76%,-14.44%,-36.55%,"These stocks are contenders for selling — and can help cut taxes, Wolfe says",ZoomInfo Technologies Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – ZI,Stifel Nicolaus Keeps Their Buy Rating on ZoomInfo Technologies (ZI),ZoomInfo downgraded to Neutral from Outperform at Daiwa,ZoomInfo Technologies put volume heavy and directionally bearish,"These stocks are contenders for selling — and can help cut taxes, Wolfe says ZoomInfo Technologies Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – ZI Stifel Nicolaus Keeps Their Buy Rating on ZoomInfo Technologies (ZI) ZoomInfo downgraded to Neutral from Outperform at Daiwa ZoomInfo Technologies put volume heavy and directionally bearish",1,1,1,1,1,1
,,,-1,481,,,,,VCTR,"Victory Capital Holdings, Inc.",3.55B,54.69,850.96M,8.79%,9.21%,28.07%,+1.03%,+22.95%,Victory Capital initiated with an Equal Weight at Barclays,Victory Capital Holdings: Strategic Acquisitions and Positive Net Flows Signal Growth and Diversification,Victory Capital price target raised to $49 from $45 at JPMorgan,Victory Capital price target lowered to $55 from $56 at RBC Capital,Victory Capital price target raised to $40 from $39 at Morgan Stanley,Victory Capital initiated with an Equal Weight at Barclays Victory Capital Holdings: Strategic Acquisitions and Positive Net Flows Signal Growth and Diversification Victory Capital price target raised to $49 from $45 at JPMorgan Victory Capital price target lowered to $55 from $56 at RBC Capital Victory Capital price target raised to $40 from $39 at Morgan Stanley,0,0,0,0,0,0
302.09M,"1,127,432",-102.62M,-1,445,11.95,Buy,19.47,"Jul 30, 2024",DNLI,Denali Therapeutics Inc.,3.55B,24.77,1.27M,7.32%,9.74%,25.46%,+0.57%,+26.41%,Denali Therapeutics price target raised to $29 from $25 at BofA,Buy Rating Affirmed: FDA’s Endorsement and Promising Data Bolster Denali Therapeutics’s Drug Pipeline,Denali Therapeutics: Strong Buy on Regulatory Wins and ETV Franchise Progress,Denali Therapeutics’ DNL310 Shows Promise for Early Approval and Market Success,Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome),Denali Therapeutics price target raised to $29 from $25 at BofA Buy Rating Affirmed: FDA’s Endorsement and Promising Data Bolster Denali Therapeutics’s Drug Pipeline Denali Therapeutics: Strong Buy on Regulatory Wins and ETV Franchise Progress Denali Therapeutics’ DNL310 Shows Promise for Early Approval and Market Success Denali Therapeutics Announces Successful Meeting with the FDA and Plans to File for Accelerated Approval of Tividenofusp Alfa (DNL310) for the Treatment of MPS II (Hunter Syndrome),0,0,0,0,0,0
303.51M,"5,124,738",-440.22M,-1,"2,109",11.87,Strong Buy,24.80,"Aug 8, 2024",BANF,BancFirst Corporation,3.54B,107.06,594.14M,4.20%,10.06%,16.90%,-0.78%,+25.67%,"BancFirst director Rainbolt sells over 18,000 common shares",BancFirst Announces Dividends and Subsidiary Interest Payments,BancFirst raises quarterly dividend to 46c from 43c per share,,,"BancFirst director Rainbolt sells over 18,000 common shares BancFirst Announces Dividends and Subsidiary Interest Payments BancFirst raises quarterly dividend to 46c from 43c per share",0,1,1,0,-1,-1
301.64M,"33,528",-618.38M,-1,797,11.89,Buy,14.00,"Aug 15, 2024",AXNX,"Axonics, Inc.",3.52B,68.95,408.81M,0.58%,1.46%,4.97%,+0.91%,+1.84%,"Soros buys JD.com, cuts AerCap in Q2",,,,,"Soros buys JD.com, cuts AerCap in Q2",0,0,-1,-1,-1,-1
123.02M,"4,311,586",-490.76M,-1,264,29.02,Strong Buy,39.31,"Aug 7, 2024",TGTX,"TG Therapeutics, Inc.",3.51B,24.46,346.72M,8.07%,14.54%,38.78%,+18.17%,+60.81%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting,Biotech Alert: Searches spiking for these stocks today,TG Therapeutics call volume above normal and directionally bullish,TG Therapeutics put volume heavy and directionally bearish,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting Biotech Alert: Searches spiking for these stocks today TG Therapeutics call volume above normal and directionally bullish TG Therapeutics put volume heavy and directionally bearish",0,1,0,1,1,1
208.04M,"1,706,481",-103.33M,-1,"3,400",17.15,Strong Buy,16.86,"Aug 15, 2024",FULT,Fulton Financial Corporation,3.51B,19.28,1.08B,5.30%,6.65%,16.99%,-1.14%,+25.00%,Fulton Financial Unveils Strategic Outlook and Performance Data,,,,,Fulton Financial Unveils Strategic Outlook and Performance Data,0,0,-1,-1,-1,-1
92.26M,"2,972,324",310.02M,-1,"3,067",38.59,Hold,41.27,"Aug 21, 2024",CALM,"Cal-Maine Foods, Inc.",3.50B,71.45,2.33B,0.69%,7.74%,21.13%,-0.18%,+13.58%,Egg prices are rising once again as bird flu limits supply,,,,,Egg prices are rising once again as bird flu limits supply,0,1,-1,-1,-1,-1
365.28M,"4,225,204",15.40M,-1,"3,180",9.72,Hold,13.71,"Aug 5, 2024",LOT,Lotus Technology Inc.,3.50B,5.17,832.97M,1.11%,-9.44%,-32.99%,-0.71%,-17.01%,Lotus Technology wins 2024 EUCCC Sustainable Business Award for Decarbonization Leadership,Lotus Enters the GCC Region with Two Award Winning Models,"Lotus obtains local homologation certification for Eletre, Emeya in GCC region",Lotus Tech Achieves Record Growth Amidst Adjustments,"Lotus Technology aims to achieve positive operating cashflow, EBITDA in 2026","Lotus Technology wins 2024 EUCCC Sustainable Business Award for Decarbonization Leadership Lotus Enters the GCC Region with Two Award Winning Models Lotus obtains local homologation certification for Eletre, Emeya in GCC region Lotus Tech Achieves Record Growth Amidst Adjustments Lotus Technology aims to achieve positive operating cashflow, EBITDA in 2026",0,0,0,0,0,0
64.88M,"189,674",237.16M,$1.64,"4,383",54.69,Buy,51.86,"Aug 8, 2024",SRAD,Sportradar Group AG,3.49B,11.71,1.07B,5.38%,5.47%,10.69%,+8.75%,+1.90%,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Wednesday’s top analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Target",Bet On It: AGA estimates $35B to be wagered throughout NFL season,"Airbnb, Booking Holdings downgraded: Wall Street’s top analyst calls",Sportradar upgraded to Outperform from Market Perform at JMP Securities,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Wednesday’s top analyst calls: Nvidia, Tesla, Starbucks, Chipotle, Target Bet On It: AGA estimates $35B to be wagered throughout NFL season Airbnb, Booking Holdings downgraded: Wall Street’s top analyst calls Sportradar upgraded to Outperform from Market Perform at JMP Securities",1,1,1,0,1,1
143.17M,"885,838",-419.65M,-1,517,24.77,Strong Buy,39.33,"Aug 1, 2024",FOLD,"Amicus Therapeutics, Inc.",3.49B,11.76,455.66M,3.21%,8.60%,0.54%,+8.73%,-4.35%,Amicus initiated with a Buy at Jefferies,UPDATE — Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024,Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024,Amicus price target lowered to $16 from $17 at JPMorgan,"Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)","Amicus initiated with a Buy at Jefferies UPDATE — Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 Amicus price target lowered to $16 from $17 at JPMorgan Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)",1,1,1,1,0,0
33.02M,"74,039",200.90M,$1.72,"25,000",107.06,Sell,93.50,"Oct 17, 2024",PLXS,Plexus Corp.,3.49B,128.04,3.93B,3.78%,10.46%,21.56%,-0.72%,+32.57%,Plexus Corp. Approves New $50 Million Share Buyback Plan,,,,,Plexus Corp. Approves New $50 Million Share Buyback Plan,1,1,-1,-1,-1,-1
51.12M,"209,520",-1.71M,-1,"1,384",68.95,Hold,70.67,"Aug 1, 2024",PCH,PotlatchDeltic Corporation,3.48B,44.16,1.07B,1.59%,4.86%,-2.38%,-3.36%,-5.26%,PotlatchDeltic Updates Investor Relations Materials with GAAP Comparisons,,,,,PotlatchDeltic Updates Investor Relations Materials with GAAP Comparisons,1,1,-1,-1,-1,-1
143.45M,"2,507,387",95.69M,-1,"1,650",24.46,Strong Buy,33.60,"Aug 6, 2024",RKLB,"Rocket Lab USA, Inc.",3.46B,6.96,326.67M,7.43%,15.31%,31.80%,+16.22%,+60.26%,"Stocks making biggest moves midday: Rocket Lab, H&R Block and more",Rocket Lab sets launch date for second dedicated Kineis Mission,Rocket Lab USA Appoints New Board Member and Audit Committee,Rocket Lab names former Lockheed CFO Possenriede to board,Rocket Lab USA call volume above normal and directionally bullish,"Stocks making biggest moves midday: Rocket Lab, H&R Block and more Rocket Lab sets launch date for second dedicated Kineis Mission Rocket Lab USA Appoints New Board Member and Audit Committee Rocket Lab names former Lockheed CFO Possenriede to board Rocket Lab USA call volume above normal and directionally bullish",1,1,1,1,1,1
181.91M,"1,195,793",283.03M,$0.68,"1,947",19.28,Hold,18.40,"Oct 15, 2024",CCOI,"Cogent Communications Holdings, Inc.",3.46B,72.93,999.44M,2.61%,13.65%,9.02%,+0.98%,+12.55%,RBC Capital Keeps Their Buy Rating on Cogent Comms (CCOI),Buy/Sell: Wall Street’s top 10 stock calls this week,"AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls","Cogent cut to Underperform at BofA on elevated valuation, diminished outlook",Cogent downgraded to Underperform from Neutral at BofA,"RBC Capital Keeps Their Buy Rating on Cogent Comms (CCOI) Buy/Sell: Wall Street’s top 10 stock calls this week AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls Cogent cut to Underperform at BofA on elevated valuation, diminished outlook Cogent downgraded to Underperform from Neutral at BofA",0,0,0,1,0,0
49.04M,"242,376",277.89M,$3.08,"3,872",71.45,Sell,58.50,"Oct 1, 2024",DORM,"Dorman Products, Inc.",3.44B,111.89,1.95B,6.43%,13.62%,26.42%,+9.67%,+15.36%,Dorman Products management to meet with Barrington,,,,,Dorman Products management to meet with Barrington,1,1,-1,-1,-1,-1
676.74M,"100,977",-853.07M,-1,"3,900",5.17,,,"Aug 28, 2024",KTOS,"Kratos Defense & Security Solutions, Inc.",3.44B,22.77,1.13B,6.47%,6.62%,14.60%,-0.09%,+26.52%,"AI is unlocking new uses for military drones, boosting demand for these companies",Kratos Turbine Technologies Division Welcomes Congressman Brian Mast to the KTT Facility in Jupiter,Kratos Defense (KTOS) Receives a Buy from Noble Financial,"Analysts Conflicted on These Industrial Goods Names: Kratos Defense (KTOS), Embraer SA (ERJ) and TPI Composites (TPIC)",Kratos Defense: A Hold Rating Amidst Growth and Diversification Concerns,"AI is unlocking new uses for military drones, boosting demand for these companies Kratos Turbine Technologies Division Welcomes Congressman Brian Mast to the KTT Facility in Jupiter Kratos Defense (KTOS) Receives a Buy from Noble Financial Analysts Conflicted on These Industrial Goods Names: Kratos Defense (KTOS), Embraer SA (ERJ) and TPI Composites (TPIC) Kratos Defense: A Hold Rating Amidst Growth and Diversification Concerns",0,0,1,0,0,0
298.16M,"239,938",27.56M,-1,"15,300",11.71,Strong Buy,14.43,"Aug 13, 2024",WEN,The Wendy's Company,3.43B,16.90,2.20B,-0.15%,0.44%,-7.54%,-0.95%,-9.06%,Why chains like McDonalds are going all in on the value meal wars,Star investors bought the dip in retail stocks amid concerns about consumer,Thursday’s big stock stories: What’s likely to move the market in the next trading session,"Nelson Peltz Exits Wendy’s Board, Arthur Winkleblack Appointed Chairman","Tigress Financial reiterates Buy on Wendy’s, citing breakfast success","Why chains like McDonalds are going all in on the value meal wars Star investors bought the dip in retail stocks amid concerns about consumer Thursday’s big stock stories: What’s likely to move the market in the next trading session Nelson Peltz Exits Wendy’s Board, Arthur Winkleblack Appointed Chairman Tigress Financial reiterates Buy on Wendy’s, citing breakfast success",1,1,1,0,1,0
296.59M,"1,073,663",-119.54M,-1,613,11.76,Buy,16.71,"Aug 8, 2024",WDFC,WD-40 Company,3.42B,252.40,575.02M,1.79%,6.57%,5.77%,-1.77%,+2.36%,,,,,,,0,-1,-1,-1,-1,-1
27.23M,"107,289",110.86M,-1,470,128.04,Buy,124.00,"Jul 24, 2024",GLNG,Golar LNG Limited,3.42B,32.84,276.58M,-0.44%,0.32%,27.60%,-6.22%,+28.71%,LNG is booming as Asia looks for coal substitutes. These stocks could surge,"Golar LNG Prices $300M Bond, Targets Expansion",Golar announces pricing of USD 300 million unsecured bond issue,Golar LNG Prepares for Potential Bond Issue,Analysts Have Conflicting Sentiments on These Energy Companies: Golar LNG (GLNG) and SM Energy (SM),"LNG is booming as Asia looks for coal substitutes. These stocks could surge Golar LNG Prices $300M Bond, Targets Expansion Golar announces pricing of USD 300 million unsecured bond issue Golar LNG Prepares for Potential Bond Issue Analysts Have Conflicting Sentiments on These Energy Companies: Golar LNG (GLNG) and SM Energy (SM)",1,1,0,0,0,1
78.91M,"513,109",36.91M,$1.80,"1,146",44.16,Hold,46.67,"Jul 29, 2024",ROAD,"Construction Partners, Inc.",3.41B,64.67,1.76B,7.81%,11.57%,27.20%,-0.71%,+11.69%,Analysts Conflicted on These Industrial Goods Names: Bloom Energy (BE) and Construction Partners (ROAD),Construction Partners: A Cautious Hold Amid Strong Performance and Conservative Guidance,Construction Partners price target raised to $55 from $50 at DA Davidson,Construction Partners (ROAD) Receives a Rating Update from a Top Analyst,Bank of America Securities Remains a Buy on Construction Partners (ROAD),Analysts Conflicted on These Industrial Goods Names: Bloom Energy (BE) and Construction Partners (ROAD) Construction Partners: A Cautious Hold Amid Strong Performance and Conservative Guidance Construction Partners price target raised to $55 from $50 at DA Davidson Construction Partners (ROAD) Receives a Rating Update from a Top Analyst Bank of America Securities Remains a Buy on Construction Partners (ROAD),0,1,0,0,0,1
496.64M,"13,236,191",-176.96M,-1,450,6.96,Buy,6.58,"Aug 8, 2024",IDCC,"InterDigital, Inc.",3.39B,135.08,732.66M,-0.21%,7.11%,22.62%,+10.00%,+40.86%,InterDigital to Showcase Excellence in Broadcast and Immersive Video Solutions at IBC 2024,"More than half of connected devices will be haptic enabled by 2028, revealing exciting opportunity for immersive video",,,,"InterDigital to Showcase Excellence in Broadcast and Immersive Video Solutions at IBC 2024 More than half of connected devices will be haptic enabled by 2028, revealing exciting opportunity for immersive video",1,0,1,-1,-1,-1
47.38M,"244,465",45.79M,$3.94,"6,500",72.93,Buy,76.60,"Aug 8, 2024",CVCO,"Cavco Industries, Inc.",3.38B,409.16,1.80B,4.54%,7.36%,13.98%,-2.85%,+5.89%,Housing stocks to watch as mortgage rates fall,,,,,Housing stocks to watch as mortgage rates fall,0,0,-1,-1,-1,-1
30.77M,"134,773",171.04M,-1,"1,744",111.89,Strong Buy,103.00,"Aug 1, 2024",EBC,"Eastern Bankshares, Inc.",3.37B,16.64,601.89M,6.85%,10.58%,20.55%,+0.66%,+28.16%,Eastern Bank appoints Sujata Yadav as CPO,,,,,Eastern Bank appoints Sujata Yadav as CPO,1,1,-1,-1,-1,-1
151.00M,"956,490",10.00M,-1,"4,030",22.77,Buy,23.50,"Aug 7, 2024",INTR,"Inter & Co, Inc.",3.36B,7.65,690.49M,10.16%,16.85%,33.24%,+17.65%,+30.36%,,,,,,,1,-1,-1,-1,-1,-1
203.24M,"2,499,273",201.62M,$1.00,382,16.90,Hold,20.30,"Aug 1, 2024",SITM,SiTime Corporation,3.35B,144.75,154.81M,9.15%,5.73%,25.15%,-2.44%,+65.82%,Buy/Sell: Wall Street’s top 10 stock calls this week,SiTime Corporation (SITM) was downgraded to a Sell Rating at Barclays,,,,Buy/Sell: Wall Street’s top 10 stock calls this week SiTime Corporation (SITM) was downgraded to a Sell Rating at Barclays,1,0,1,-1,-1,-1
13.55M,"70,594",69.18M,$3.52,124,252.40,Strong Buy,303.00,"Oct 17, 2024",IDYA,"IDEAYA Biosciences, Inc.",3.34B,39.49,11.96M,1.35%,1.74%,0.32%,-8.04%,-6.87%,Ideaya Biosciences price target lowered to $58 from $60 at Citi,Buy Rating Affirmed for IDEAYA Biosciences Amid Promising Developments and Pipeline Expansion,Ideaya Biosciences removed from Analyst Focus List at JPMorgan,,,Ideaya Biosciences price target lowered to $58 from $60 at Citi Buy Rating Affirmed for IDEAYA Biosciences Amid Promising Developments and Pipeline Expansion Ideaya Biosciences removed from Analyst Focus List at JPMorgan,1,0,1,0,-1,-1
104.00M,"708,061",140.74M,$1.00,917,32.59,Strong Buy,44.25,"Aug 15, 2024",ALKT,"Alkami Technology, Inc.",3.34B,33.70,297.36M,4.00%,8.33%,27.54%,-0.37%,+37.36%,"Analysts’ Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)",,,,,"Analysts’ Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)",1,0,-1,-1,-1,-1
52.76M,"243,384",70.54M,-1,"9,385",64.67,Buy,63.50,"Aug 9, 2024",RRR,"Red Rock Resorts, Inc.",3.32B,56.25,1.85B,2.56%,1.21%,5.13%,-0.09%,-7.47%,Bet On It: AGA estimates $35B to be wagered throughout NFL season,Red Rock Resorts price target raised to $56 from $54 at Morgan Stanley,,,,Bet On It: AGA estimates $35B to be wagered throughout NFL season Red Rock Resorts price target raised to $56 from $54 at Morgan Stanley,0,0,0,-1,-1,-1
25.13M,"227,358",278.34M,$1.60,"1,573",135.08,Hold,100.00,"Aug 1, 2024",NWE,"NorthWestern Energy Group, Inc.",3.31B,54.04,1.47B,1.38%,3.97%,6.47%,-0.04%,+7.76%,NorthWestern Energy Executives Engage Investors at Conference,"Northwestern Board Member Resigns, Board Size Reduced",,,,"NorthWestern Energy Executives Engage Investors at Conference Northwestern Board Member Resigns, Board Size Reduced",1,1,1,-1,-1,-1
8.25M,"45,786",145.89M,-1,"7,980",409.16,Strong Buy,423.50,"Aug 1, 2024",DIOD,Diodes Incorporated,3.30B,71.28,1.35B,0.81%,-7.22%,-5.11%,-14.35%,-1.34%,Strong Buy Rating for Diodes Incorporated on Diverse Portfolio and Market Penetration,David Williams Reiterates Buy Rating on Diodes Inc. Citing Strong Quarterly Performance and Positive Financial Outlook,Diodes Earnings Call Offers Future Outlook Insights,Diodes participates in a conference call with Benchmark,Diodes price target lowered to $69 from $74 at Truist,Strong Buy Rating for Diodes Incorporated on Diverse Portfolio and Market Penetration David Williams Reiterates Buy Rating on Diodes Inc. Citing Strong Quarterly Performance and Positive Financial Outlook Diodes Earnings Call Offers Future Outlook Insights Diodes participates in a conference call with Benchmark Diodes price target lowered to $69 from $74 at Truist,1,0,1,1,0,0
202.62M,"1,286,714",442.59M,$0.44,"2,229",16.64,Buy,17.83,"Jul 25, 2024",WSFS,WSFS Financial Corporation,3.28B,55.37,959.60M,2.77%,5.56%,18.08%,-4.57%,+24.65%,,,,,,,0,-1,-1,-1,-1,-1
438.84M,"1,705,848",113.74M,$0.12,"4,200",7.65,Strong Buy,7.10,"Aug 7, 2024",SHOO,"Steven Madden, Ltd.",3.28B,45.16,2.15B,2.18%,2.28%,6.49%,-2.67%,+7.74%,Steven Madden assumed with a Neutral at Piper Sandler,Unified Commerce Group announces acquisition of GREATS from Steve Madden,UNIFIED COMMERCE GROUP ANNOUNCES ACQUISITION OF GREATS FROM STEVE MADDEN AND NEW INVESTMENTS,,,Steven Madden assumed with a Neutral at Piper Sandler Unified Commerce Group announces acquisition of GREATS from Steve Madden UNIFIED COMMERCE GROUP ANNOUNCES ACQUISITION OF GREATS FROM STEVE MADDEN AND NEW INVESTMENTS,1,0,0,0,-1,-1
23.13M,"187,919",-93.60M,-1,"5,000",144.75,Strong Buy,130.00,"Aug 7, 2024",JJSF,J&J Snack Foods Corp.,3.26B,167.99,1.59B,0.74%,1.73%,7.76%,-1.04%,+19.04%,,,,,,,1,-1,-1,-1,-1,-1
84.48M,"336,667",-153.74M,-1,"2,345",39.49,Strong Buy,55.90,"Aug 6, 2024",GDS,GDS Holdings Limited,3.24B,16.69,1.45B,33.99%,47.49%,89.72%,+46.04%,+126.68%,"Stocks to play the Asia-Pacific region’s data center capacity boom, per BofA",China’s earnings season is wrapping up. How to play what’s next,Buy Rating for GDS Holdings Amidst Strong Growth and Expansion Prospects,GDS Holdings Advances on Sustainability Goals,GDS Holdings price target raised to $22.40 from $12.40 at BofA,"Stocks to play the Asia-Pacific region’s data center capacity boom, per BofA China’s earnings season is wrapping up. How to play what’s next Buy Rating for GDS Holdings Amidst Strong Growth and Expansion Prospects GDS Holdings Advances on Sustainability Goals GDS Holdings price target raised to $22.40 from $12.40 at BofA",0,1,1,1,1,0
98.99M,"377,292",-51.94M,-1,"1,246",33.70,Buy,33.89,"Jul 31, 2024",CATY,Cathay General Bancorp,3.24B,44.84,735.21M,3.93%,8.04%,11.23%,-0.61%,+20.29%,,,,,,,1,-1,-1,-1,-1,-1
59.08M,"201,685",170.33M,$1.00,"3,585",56.25,Buy,63.33,"Jul 23, 2024",FIBK,"First Interstate BancSystem, Inc.",3.21B,30.73,974.90M,5.70%,6.54%,11.65%,-1.43%,+20.43%,First Interstate Bancsystem (FIBK) Gets a Hold from Barclays,,,,,First Interstate Bancsystem (FIBK) Gets a Hold from Barclays,1,1,-1,-1,-1,-1
61.30M,"153,818",209.22M,$2.60,"1,150",54.04,Hold,52.86,"Jul 30, 2024",INTA,"Intapp, Inc.",3.21B,43.75,430.52M,20.57%,24.18%,21.93%,+27.83%,+44.66%,Intapp announces Alpaca Real Estate is live on Intapp DealCloud,Alpaca Real Estate using Intapp DealCloud for AI-driven proprietary data management,"Intapp chosen by private equity asset manager NORD for IR, fundraising functions",NORD Holding chooses Intapp DealCloud to modernize investor relations and fundraising functions,Intapp (INTA) Receives a Rating Update from a Top Analyst,"Intapp announces Alpaca Real Estate is live on Intapp DealCloud Alpaca Real Estate using Intapp DealCloud for AI-driven proprietary data management Intapp chosen by private equity asset manager NORD for IR, fundraising functions NORD Holding chooses Intapp DealCloud to modernize investor relations and fundraising functions Intapp (INTA) Receives a Rating Update from a Top Analyst",1,1,1,1,1,1
46.33M,"414,520",96.05M,-1,271,71.28,Buy,70.25,"Aug 8, 2024",SMPL,The Simply Good Foods Company,3.20B,31.96,1.28B,-1.78%,-7.09%,-11.65%,-6.31%,-1.30%,,,,,,,1,-1,-1,-1,-1,-1
59.27M,"246,458",273.11M,$0.60,"19,000",55.37,Buy,61.33,"Oct 21, 2024",AMED,"Amedisys, Inc.",3.19B,97.56,2.29B,-0.02%,1.35%,3.81%,-0.15%,+5.61%,Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model,,,,,Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model,0,0,-1,-1,-1,-1
72.62M,"436,673",179.61M,$0.84,"1,891",45.16,Buy,44.56,"Jul 31, 2024",SYNA,Synaptics Incorporated,3.19B,80.54,959.40M,5.52%,-4.14%,-16.21%,-10.68%,-16.43%,Op-ed: Small caps could be in for a revival. Here’s why,"Synaptics to Participate at Upcoming Investor Conference on Thursday, September 5, 2024","Synaptics to Participate at Upcoming Investor Conferences on Thursday, August 22, 2024 and Wednesday, August 28, 2024",Synaptics management to meet with KeyBanc,Synaptics Set to Outperform: A Comprehensive Buy Recommendation Amidst IoT Growth and Sector Rebound,"Op-ed: Small caps could be in for a revival. Here’s why Synaptics to Participate at Upcoming Investor Conference on Thursday, September 5, 2024 Synaptics to Participate at Upcoming Investor Conferences on Thursday, August 22, 2024 and Wednesday, August 28, 2024 Synaptics management to meet with KeyBanc Synaptics Set to Outperform: A Comprehensive Buy Recommendation Amidst IoT Growth and Sector Rebound",1,1,1,1,1,1
19.42M,"125,205",87.33M,$3.12,238,167.99,Strong Buy,200.00,"Aug 5, 2024",NMIH,"NMI Holdings, Inc.",3.17B,39.80,617.91M,5.41%,10.04%,25.54%,+2.44%,+29.91%,"NMI Holdings, Inc. To Host Investor Day On November 21, 2024","NMI Holdings, Inc. Provides Guidance on Capital Position Under Revised Private Mortgage Insurer Eligibility Requirements","Analysts Are Bullish on These Financial Stocks: Amalgamated Bank (AMAL), NMI Holdings (NMIH)",,,"NMI Holdings, Inc. To Host Investor Day On November 21, 2024 NMI Holdings, Inc. Provides Guidance on Capital Position Under Revised Private Mortgage Insurer Eligibility Requirements Analysts Are Bullish on These Financial Stocks: Amalgamated Bank (AMAL), NMI Holdings (NMIH)",1,1,1,1,-1,-1
194.40M,"2,508,732",-579.76M,-1,"1,750",16.69,Buy,12.92,"Aug 21, 2024",BL,"BlackLine, Inc.",3.16B,50.83,624.41M,0.82%,3.69%,-11.13%,+3.66%,-20.80%,BlackLine Announces Participation in Upcoming Investor Conference,"Jana added Rapid7 during Q2, sold out of Freshpet",,,,"BlackLine Announces Participation in Upcoming Investor Conference Jana added Rapid7 during Q2, sold out of Freshpet",1,1,1,-1,-1,-1
72.17M,"292,753",303.16M,$1.36,"2,170",44.84,Hold,43.00,"Oct 21, 2024",ACVA,ACV Auctions Inc.,3.16B,18.96,543.70M,5.63%,4.50%,11.30%,+8.02%,+0.22%,ACV Auctions Surpasses Expectations with Strong Q2 Performance and Market Share Growth,,,,,ACV Auctions Surpasses Expectations with Strong Q2 Performance and Market Share Growth,1,1,-1,-1,-1,-1
104.55M,"352,847",252.60M,$1.88,"1,987",30.73,Hold,33.33,"Jul 25, 2024",TCBI,"Texas Capital Bancshares, Inc.",3.16B,68.35,972.13M,6.70%,5.89%,9.64%,+0.74%,+13.54%,Texas Capital Bancshares Unveils Strategic Growth Initiatives,Texas Capital shares strategic business update,"Texas Capital Bancshares, Inc. Shares Strategic Business Update",Barclays Sticks to Their Sell Rating for Texas Capital Bancshares (TCBI),,"Texas Capital Bancshares Unveils Strategic Growth Initiatives Texas Capital shares strategic business update Texas Capital Bancshares, Inc. Shares Strategic Business Update Barclays Sticks to Their Sell Rating for Texas Capital Bancshares (TCBI)",0,0,0,0,0,-1
73.43M,"536,560",-32.02M,-1,731,43.75,Strong Buy,47.75,"Aug 13, 2024",MGEE,"MGE Energy, Inc.",3.16B,87.24,645.73M,-0.48%,4.86%,13.24%,-2.15%,+10.05%,MGE Energy price target raised to $71 from $66 at Morgan Stanley,Morgan Stanley Remains a Sell on MGE Energy (MGEE),MGE Energy raises quarterly dividend 5.3% to 45c per share,,,MGE Energy price target raised to $71 from $66 at Morgan Stanley Morgan Stanley Remains a Sell on MGE Energy (MGEE) MGE Energy raises quarterly dividend 5.3% to 45c per share,1,1,1,0,-1,-1
100.14M,"742,607",146.66M,-1,"6,180",31.96,Buy,38.86,"Oct 22, 2024",IPGP,IPG Photonics Corporation,3.14B,71.05,1.11B,-1.26%,-13.12%,-22.86%,-13.76%,-19.62%,IPG Photonics Divests Russian Subsidiary Amid Sanctions,IPG Photonics Announces Sale of its Russian Operations,IPG Photonics sells Russian operations for $51M,IPG Photonics Senior VP CTO Ovtchinnikov Set to Retire,,IPG Photonics Divests Russian Subsidiary Amid Sanctions IPG Photonics Announces Sale of its Russian Operations IPG Photonics sells Russian operations for $51M IPG Photonics Senior VP CTO Ovtchinnikov Set to Retire,1,1,1,1,1,-1
32.74M,"308,340",91.98M,-1,766,97.56,Hold,100.67,"Jul 24, 2024",IRDM,Iridium Communications Inc.,3.14B,26.53,797.26M,-4.15%,-2.33%,-16.28%,-12.30%,-0.12%,Iridium unveils Iridium Certus GMDSS,Iridium Communications Announces Executive Shifts and Dividend,Iridium appoints Vincent O’Neill as CFO,,,Iridium unveils Iridium Certus GMDSS Iridium Communications Announces Executive Shifts and Dividend Iridium appoints Vincent O’Neill as CFO,1,0,1,1,-1,-1
39.58M,"287,104",125.60M,-1,"24,500",80.54,Strong Buy,107.18,"Aug 8, 2024",CAR,"Avis Budget Group, Inc.",3.14B,87.92,11.93B,-2.57%,-12.73%,-33.28%,-19.48%,-33.02%,Writing options on these stocks could create income for your portfolio,,,,,Writing options on these stocks could create income for your portfolio,1,0,-1,-1,-1,-1
79.67M,"351,302",348.50M,-1,50,39.80,Buy,39.56,"Jul 30, 2024",MLTX,MoonLake Immunotherapeutics,3.13B,49.77,-,2.73%,5.98%,-2.10%,+12.39%,-0.76%,Boeing’s Starliner to return without astronauts: Morning Buzz,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",MoonLake Immunotherapeutics downgraded to at Wolfe on lower M&A odds,MoonLake downgraded to Peer Perform from Outperform at Wolfe Research,,"Boeing’s Starliner to return without astronauts: Morning Buzz Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls MoonLake Immunotherapeutics downgraded to at Wolfe on lower M&A odds MoonLake downgraded to Peer Perform from Outperform at Wolfe Research",1,1,1,1,0,-1
62.18M,"836,626",121.51M,-1,131,50.83,Hold,58.90,"Aug 6, 2024",CLSK,"CleanSpark, Inc.",3.13B,12.61,342.21M,-7.73%,-24.56%,-17.39%,-33.25%,-31.54%,Coinbase has worst week of the year as crypto stocks plummet,"Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World","Bitcoin dips to $57,000 level and crypto stocks tumble to begin September trading: CNBC Crypto World","Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more",Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said,"Coinbase has worst week of the year as crypto stocks plummet Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World Bitcoin dips to $57,000 level and crypto stocks tumble to begin September trading: CNBC Crypto World Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said",0,0,0,0,1,1
166.59M,"1,768,009",-79.01M,-1,694,18.96,Strong Buy,21.00,"Aug 7, 2024",GDRX,"GoodRx Holdings, Inc.",3.12B,8.23,775.09M,9.98%,7.00%,22.35%,-8.51%,+20.00%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Friday’s analyst calls: Morgan Stanley names a top drug stock pick,RBC Capital Keeps Their Buy Rating on GoodRx Holdings (GDRX),GoodRx Holdings: A Hold Rating Amid Mixed Performance and Market Challenges,"Charter names Simon Cassels as SVP, chief creative officer","Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Friday’s analyst calls: Morgan Stanley names a top drug stock pick RBC Capital Keeps Their Buy Rating on GoodRx Holdings (GDRX) GoodRx Holdings: A Hold Rating Amid Mixed Performance and Market Challenges Charter names Simon Cassels as SVP, chief creative officer",1,1,1,0,0,1
46.20M,"520,081",132.38M,-1,"1,451",68.35,Hold,65.27,"Oct 17, 2024",MEOH,Methanex Corporation,3.11B,46.05,3.58B,4.41%,-1.78%,-0.82%,-7.00%,-11.79%,RBC Capital Keeps Their Hold Rating on Methanex (MEOH),Methanex’s Strong Market Outlook and Upside Potential Justify Buy Rating,Methanex Corporation Secures Amended Credit Agreement,Methanex Halts New Zealand Operations for Energy Support,Methanex Corporation to Temporarily Idle New Zealand Operations to Assist in Improving Energy Balances,RBC Capital Keeps Their Hold Rating on Methanex (MEOH) Methanex’s Strong Market Outlook and Upside Potential Justify Buy Rating Methanex Corporation Secures Amended Credit Agreement Methanex Halts New Zealand Operations for Energy Support Methanex Corporation to Temporarily Idle New Zealand Operations to Assist in Improving Energy Balances,1,0,1,0,1,1
36.18M,"92,934",115.55M,$1.80,"2,000",87.24,Sell,71.00,"Aug 7, 2024",FHB,"First Hawaiian, Inc.",3.10B,24.26,802.87M,1.49%,5.37%,10.99%,-3.91%,+13.49%,Barclays Sticks to Its Hold Rating for First Hawaiian (FHB),Analysts Offer Insights on Financial Companies: First Hawaiian (FHB) and TCG BDC (CGBD),,,,Barclays Sticks to Its Hold Rating for First Hawaiian (FHB) Analysts Offer Insights on Financial Companies: First Hawaiian (FHB) and TCG BDC (CGBD),0,1,0,-1,-1,-1
44.23M,"141,041",140.68M,-1,259,71.05,Hold,89.33,"Jul 30, 2024",XENE,Xenon Pharmaceuticals Inc.,3.09B,40.76,-,1.27%,2.26%,-1.05%,-7.07%,-5.14%,RBC Capital Sticks to Its Buy Rating for Xenon (XENE),"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE)","Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH)",Xenon Pharmaceuticals Appoints New COO,Xenon Pharmaceuticals appoints Ronsheim as COO,"RBC Capital Sticks to Its Buy Rating for Xenon (XENE) Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE) Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH) Xenon Pharmaceuticals Appoints New COO Xenon Pharmaceuticals appoints Ronsheim as COO",1,0,0,1,1,1
118.38M,"522,845",88.37M,$0.56,525,26.53,Buy,45.00,"Oct 17, 2024",ARWR,"Arrowhead Pharmaceuticals, Inc.",3.08B,24.78,19.65M,-3.45%,-8.09%,-13.41%,-16.21%,-7.18%,Arrowhead Pharmaceuticals (ARWR) Receives a Buy from TD Cowen,Hold Rating on Arrowhead Pharmaceuticals Amid Promising Clinical Data and Upcoming Regulatory Hurdles,Arrowhead’s Plozasiran Shows Promise Amidst Competition and Operational Concerns: Maintaining Hold Rating,Arrowhead Pharmaceuticals’ Plozasiran: A Promising Treatment for FCS with Strong Market Potential,Strong Buy Rating for Arrowhead Pharmaceuticals’ Plozasiran Based on Positive Clinical Trial Outcomes and Market Potential,Arrowhead Pharmaceuticals (ARWR) Receives a Buy from TD Cowen Hold Rating on Arrowhead Pharmaceuticals Amid Promising Clinical Data and Upcoming Regulatory Hurdles Arrowhead’s Plozasiran Shows Promise Amidst Competition and Operational Concerns: Maintaining Hold Rating Arrowhead Pharmaceuticals’ Plozasiran: A Promising Treatment for FCS with Strong Market Potential Strong Buy Rating for Arrowhead Pharmaceuticals’ Plozasiran Based on Positive Clinical Trial Outcomes and Market Potential,0,0,0,0,0,0
35.66M,"308,788",785.00M,-1,"3,595",87.92,Buy,148.57,"Aug 5, 2024",ARLP,"Alliance Resource Partners, L.P.",3.08B,24.05,2.51B,2.04%,-0.98%,9.69%,-3.55%,+14.40%,,,,,,,0,-1,-1,-1,-1,-1
62.89M,"120,821",-54.80M,-1,"24,600",49.77,Strong Buy,75.89,"Aug 7, 2024",NWL,Newell Brands Inc.,3.08B,7.40,7.81B,-5.36%,2.83%,-6.26%,-17.00%,-1.38%,,,,,,,0,-1,-1,-1,-1,-1
248.12M,"16,980,586",-161.90M,-1,"13,121",12.61,Strong Buy,19.11,"Aug 9, 2024",SKYW,"SkyWest, Inc.",3.06B,76.29,3.19B,2.33%,-4.20%,14.43%,-6.96%,+7.45%,Tuesday’s stock stories: What’s likely to move the market in the next session,TD Cowen Keeps Their Buy Rating on SkyWest (SKYW),,,,Tuesday’s stock stories: What’s likely to move the market in the next session TD Cowen Keeps Their Buy Rating on SkyWest (SKYW),0,0,0,-1,-1,-1
379.45M,"1,197,743",-58.68M,-1,"9,000",8.23,Buy,9.34,"Aug 8, 2024",ICFI,"ICF International, Inc.",3.06B,163.09,1.99B,4.18%,11.34%,13.72%,+11.02%,+11.38%,Buy Rating for ICF International Amid Strong Growth and Financial Performance,ICF International price target raised to $174 from $173 at Barrington,,,,Buy Rating for ICF International Amid Strong Growth and Financial Performance ICF International price target raised to $174 from $173 at Barrington,1,1,0,-1,-1,-1
67.39M,"259,312",145.52M,$0.74,305,46.05,Buy,56.50,"Jul 30, 2024",SWTX,"SpringWorks Therapeutics, Inc.",3.05B,41.15,86.19M,11.46%,9.64%,2.71%,+14.73%,-7.39%,SpringWorks Therapeutics price target raised to $68 from $64 at JPMorgan,Springworks Therapeutics: Promising Outlook for Ogsiveo Drives Overweight Rating and Elevated Price Target,Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib,FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN,SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib,SpringWorks Therapeutics price target raised to $68 from $64 at JPMorgan Springworks Therapeutics: Promising Outlook for Ogsiveo Drives Overweight Rating and Elevated Price Target Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib,0,0,0,0,0,0
127.89M,"353,261",221.86M,$1.04,187,24.26,Sell,23.57,"Jul 26, 2024",KYMR,"Kymera Therapeutics, Inc.",3.05B,47.78,88.55M,11.31%,22.95%,43.58%,+5.02%,+33.30%,Kymera Therapeutics to Participate in Upcoming September Investor Conferences,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls","Wolfe upgrades Kymera Therapeutics, calls ‘great long-term trade’",Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares,Kymera Therapeutics TBA Spot Secondary priced at $44.75,"Kymera Therapeutics to Participate in Upcoming September Investor Conferences Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Wolfe upgrades Kymera Therapeutics, calls ‘great long-term trade’ Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Kymera Therapeutics TBA Spot Secondary priced at $44.75",0,1,1,0,1,0
75.76M,"167,014",-199.06M,-1,"1,900",40.76,Strong Buy,58.67,"Aug 8, 2024",AGYS,"Agilysys, Inc.",3.04B,110.40,244.92M,2.11%,4.93%,23.24%,-2.58%,+33.92%,Agilysys management to meet with Needham,Agilysys participates in a conference call with Northland,Buy Rating Affirmed on Agilysys Following Strategic Acquisition of Book4Time,Agilysys announces acquisition of Book4Time for $150M cash,Agilysys appoints Joe Youssef as chief commercial officer,Agilysys management to meet with Needham Agilysys participates in a conference call with Northland Buy Rating Affirmed on Agilysys Following Strategic Acquisition of Book4Time Agilysys announces acquisition of Book4Time for $150M cash Agilysys appoints Joe Youssef as chief commercial officer,1,0,0,0,1,1
124.32M,"588,440",-538.64M,-1,"1,989",24.78,Buy,44.25,"Aug 8, 2024",ALRM,"Alarm.com Holdings, Inc.",3.04B,61.67,905.18M,-5.40%,-7.48%,-8.65%,-17.04%,-15.42%,Alarm.com initiated with a Neutral at Goldman Sachs,Neutral Outlook for Alarm.com Amid Market Challenges and Growth Efforts,Alarm.com management to meet with Roth MKM,Bank of America Securities Sticks to Its Buy Rating for Alarm (ALRM),Alarm.com’s Strong Financials and Market Position Warrant a Buy Rating,Alarm.com initiated with a Neutral at Goldman Sachs Neutral Outlook for Alarm.com Amid Market Challenges and Growth Efforts Alarm.com management to meet with Roth MKM Bank of America Securities Sticks to Its Buy Rating for Alarm (ALRM) Alarm.com’s Strong Financials and Market Position Warrant a Buy Rating,0,0,0,0,1,0
128.06M,"208,026",514.04M,$2.80,"7,100",24.05,Strong Buy,26.00,"Jul 29, 2024",QDEL,QuidelOrtho Corporation,3.03B,45.01,2.83B,4.55%,18.61%,-12.34%,+11.45%,+2.55%,"Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz",Craig-Hallum ups QuidelOrtho to Buy on untapped earnings power,QuidelOrtho upgraded to Buy from Hold at Craig-Hallum,RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL),"Jana added Rapid7 during Q2, sold out of Freshpet","Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz Craig-Hallum ups QuidelOrtho to Buy on untapped earnings power QuidelOrtho upgraded to Buy from Hold at Craig-Hallum RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL) Jana added Rapid7 during Q2, sold out of Freshpet",0,1,0,0,0,1
416.00M,"4,491,180",-268.00M,$0.28,"1,270",7.40,Hold,8.70,"Oct 25, 2024",OMAB,"Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.",3.00B,62.23,814.04M,-7.89%,-12.18%,-19.68%,-10.77%,-27.83%,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more",OMA upgraded to Overweight from Equal Weight at Morgan Stanley,OMA upgraded to Neutral from Underperform at Bradesco BBI,OMA Responds to Unusual Trading Activity Queries,OMA Reports Dip in July Passenger Traffic,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more OMA upgraded to Overweight from Equal Weight at Morgan Stanley OMA upgraded to Neutral from Underperform at Bradesco BBI OMA Responds to Unusual Trading Activity Queries OMA Reports Dip in July Passenger Traffic",1,1,1,1,0,1
40.10M,"276,075",176.87M,-1,"2,120",76.29,Buy,76.67,"Jul 25, 2024",WAFD,"WaFd, Inc.",3.00B,36.89,666.87M,6.20%,14.37%,23.80%,+2.25%,+31.47%,Washington Federal Presents Future Financial Projections,,,,,Washington Federal Presents Future Financial Projections,0,0,-1,-1,-1,-1
18.76M,"73,312",98.83M,$0.56,"10,000",163.09,Buy,159.75,"Aug 1, 2024",PATK,"Patrick Industries, Inc.",2.98B,132.98,3.60B,5.06%,11.26%,22.07%,+0.94%,+12.00%,Benchmark starts Patrick Industries with a Buy on continued content growth,Patrick Industries initiated with a Buy at Benchmark,,,,Benchmark starts Patrick Industries with a Buy on continued content growth Patrick Industries initiated with a Buy at Benchmark,0,0,0,-1,-1,-1
74.24M,"799,880",-301.06M,-1,"1,988",41.15,Strong Buy,66.60,"Aug 7, 2024",HCM,HUTCHMED (China) Limited,2.97B,17.26,610.81M,-7.97%,-5.77%,-0.81%,-11.01%,+5.75%,HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia,,,,,HUTCHMED to Host Expert Call to discuss Immune Thrombocytopenia,0,0,-1,-1,-1,-1
63.76M,"449,101",-157.85M,-1,"1,343",47.78,Buy,47.64,"Aug 7, 2024",CARG,"CarGurus, Inc.",2.97B,28.72,877.03M,9.40%,11.26%,21.01%,+13.90%,+21.07%,CarGurus names Mike O’Hanlon as Chief Revenue Officer,CarGurus to Present at Citi’s 2024 Global TMT Conference,CarGurus Presents its 10th Annual Top Dealer Awards,CarGurus price target raised to $32 from $30 at JMP Securities,CarGurus price target raised to $32 from $29 at JPMorgan,CarGurus names Mike O’Hanlon as Chief Revenue Officer CarGurus to Present at Citi’s 2024 Global TMT Conference CarGurus Presents its 10th Annual Top Dealer Awards CarGurus price target raised to $32 from $30 at JMP Securities CarGurus price target raised to $32 from $29 at JPMorgan,0,1,1,0,0,0
27.51M,"165,058",98.01M,-1,"3,927",110.40,Strong Buy,122.00,"Jul 22, 2024",BWIN,"The Baldwin Insurance Group, Inc.",2.97B,44.46,1.31B,7.05%,15.20%,53.53%,+6.08%,+65.95%,"Analysts Offer Insights on Financial Companies: ANZ Group Holdings (OtherANZGF), Baldwin Insurance Group (BWIN) and Bridge Investment Group (BRDG)",,,,,"Analysts Offer Insights on Financial Companies: ANZ Group Holdings (OtherANZGF), Baldwin Insurance Group (BWIN) and Bridge Investment Group (BRDG)",1,1,-1,-1,-1,-1
49.25M,"262,820",107.93M,-1,628,61.67,Buy,70.67,"Aug 8, 2024",IBRX,"ImmunityBio, Inc.",2.96B,4.25,1.31M,-3.33%,-23.74%,-19.70%,-21.17%,-28.90%,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), ImmunityBio (IBRX) and Neurocrine (NBIX)",Piper Sandler Keeps Their Hold Rating on ImmunityBio (IBRX),ImmunityBio price target lowered to $4.75 from $6 at Piper Sandler,ImmunityBio: ANKTIVA now covered by more than ‘dozen’ insurance plans,,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), ImmunityBio (IBRX) and Neurocrine (NBIX) Piper Sandler Keeps Their Hold Rating on ImmunityBio (IBRX) ImmunityBio price target lowered to $4.75 from $6 at Piper Sandler ImmunityBio: ANKTIVA now covered by more than ‘dozen’ insurance plans",0,1,0,0,1,-1
67.24M,"560,413",-1.86B,-1,383,45.01,Hold,57.60,"Jul 31, 2024",LIF,"Life360, Inc.",2.94B,40.24,328.68M,12.58%,17.98%,20.29%,+14.07%,,Life360 Inc. Reports Increased CDI Issuance,Life360 CFO Expands Stake with Stock Acquisition,Life360 price target raised to $43 from $36 at Loop Capital,"Life360, Inc. (LIF) Receives a Buy from Loop Capital Markets",Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX) Gets a Buy from Canaccord Genuity,"Life360 Inc. Reports Increased CDI Issuance Life360 CFO Expands Stake with Stock Acquisition Life360 price target raised to $43 from $36 at Loop Capital Life360, Inc. (LIF) Receives a Buy from Loop Capital Markets Life360 Shs Chess Depository Interests Repr 3 Sh (LIFX) Gets a Buy from Canaccord Genuity",1,1,1,1,1,1
386.17M,"54,317",275.09M,$3.21,"23,333",62.23,Buy,94.00,"Jul 26, 2024",PENN,"PENN Entertainment, Inc.",2.93B,19.57,6.28B,2.07%,1.11%,-3.47%,-6.36%,+7.72%,NFL season expected to spur record $35 billion in legal sports wagers,DraftKings reverses plans for a tax on customers as FanDuel wows Wall Street,Bet On It: AGA estimates $35B to be wagered throughout NFL season,Penn National call volume above normal and directionally bullish,Craig-Hallum Sticks to Its Buy Rating for Penn National Gaming (PENN),NFL season expected to spur record $35 billion in legal sports wagers DraftKings reverses plans for a tax on customers as FanDuel wows Wall Street Bet On It: AGA estimates $35B to be wagered throughout NFL season Penn National call volume above normal and directionally bullish Craig-Hallum Sticks to Its Buy Rating for Penn National Gaming (PENN),0,1,0,0,1,0
81.22M,"362,746",174.48M,$1.04,"1,400",36.89,Buy,34.25,"Oct 15, 2024",FROG,JFrog Ltd.,2.93B,26.51,389.25M,-8.89%,-19.51%,-23.41%,-29.10%,-36.55%,"Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more",JFrog: Strengthened Buy Rating with Revised Cloud Guidance and Raised Price Target,Top Analyst Pounds the Table on 2 Software Stocks — Here’s Why You Should Follow,JFrog (FROG) Receives a Buy from Stifel Nicolaus,Closing Bell Movers: Apple down slightly on CFO change; Trip.com up on earnings,"Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more JFrog: Strengthened Buy Rating with Revised Cloud Guidance and Raised Price Target Top Analyst Pounds the Table on 2 Software Stocks — Here’s Why You Should Follow JFrog (FROG) Receives a Buy from Stifel Nicolaus Closing Bell Movers: Apple down slightly on CFO change; Trip.com up on earnings",1,1,1,1,1,1
22.40M,"102,488",153.34M,$2.20,"2,400",132.43,Buy,131.33,"Aug 1, 2024",TNDM,"Tandem Diabetes Care, Inc.",2.92B,44.60,796.00M,11.31%,9.00%,35.06%,+20.01%,+31.85%,Stifel Nicolaus Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM),"TJX downgraded, Crocs upgraded: Wall Street’s top analyst calls",Street analysts say diabetes stocks âoverreactingâ to Lilly GLP-1 study results,"Diabetes stock selloff on Lilly Surmount-1 results overdone, says Citi",Lake Street Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM),"Stifel Nicolaus Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM) TJX downgraded, Crocs upgraded: Wall Street’s top analyst calls Street analysts say diabetes stocks âoverreactingâ to Lilly GLP-1 study results Diabetes stock selloff on Lilly Surmount-1 results overdone, says Citi Lake Street Sticks to Its Buy Rating for Tandem Diabetes Care (TNDM)",1,1,1,1,1,0
854.44M,"55,838",-41.97M,-1,"3,600",17.26,Buy,30.37,"Jul 31, 2024",PLTK,Playtika Holding Corp.,2.91B,7.83,2.55B,6.56%,1.40%,-1.28%,-0.52%,+10.16%,Buy Rating Affirmed for Playtika Holding Amid Solid Management and Strategic Growth Prospects,,,,,Buy Rating Affirmed for Playtika Holding Amid Solid Management and Strategic Growth Prospects,0,0,-1,-1,-1,-1
103.37M,"428,482",-48.86M,-1,"2,400",28.72,Buy,29.25,"Aug 8, 2024",IOSP,Innospec Inc.,2.84B,113.69,1.89B,0.26%,-5.42%,-5.51%,-13.93%,-9.54%,Innospec Publishes 2023 Sustainability Report,Seaport Research chemicals analyst holds an analyst/industry conference call,Seaport Global Keeps Their Hold Rating on Innospec (IOSP),,,Innospec Publishes 2023 Sustainability Report Seaport Research chemicals analyst holds an analyst/industry conference call Seaport Global Keeps Their Hold Rating on Innospec (IOSP),1,1,1,1,-1,-1
66.74M,"324,667",-48.09M,-1,"1,259",44.46,Buy,42.25,"Aug 6, 2024",TXG,"10x Genomics, Inc.",2.83B,23.49,631.73M,8.21%,14.71%,-33.73%,+7.84%,-38.51%,Buy Rating Justified for 10x Genomics Amid Strategic Launch and Growth Potential,Buy Rating Affirmed for 10x Genomics on Strong Spatial Business Growth and Market Leadership,10x Genomics initiated with an Outperform at Leerink,10x Genomics price target lowered to $46 from $50 at Morgan Stanley,10x Genomics: A Cautious Hold Amidst Revised Forecasts and Organizational Changes,Buy Rating Justified for 10x Genomics Amid Strategic Launch and Growth Potential Buy Rating Affirmed for 10x Genomics on Strong Spatial Business Growth and Market Leadership 10x Genomics initiated with an Outperform at Leerink 10x Genomics price target lowered to $46 from $50 at Morgan Stanley 10x Genomics: A Cautious Hold Amidst Revised Forecasts and Organizational Changes,1,1,1,1,1,1
696.53M,"2,198,533",-597.65M,-1,91,4.250,Hold,4.75,"Aug 12, 2024",APGE,"Apogee Therapeutics, Inc.",2.83B,48.36,-,4.99%,8.00%,14.67%,-0.55%,-14.75%,"Wedbush bullish on Spyre Therapeutics, initiates with an Outperform",Apogee Therapeutics Begins Landmark Atopic Dermatitis Trial,Apogee announces first participants dosed in Phase 1 trial of APG990,Apogee Therapeutics: Advancing with Novel Combo Therapies in Inflammation and Immunology Markets,Apogee Therapeutics files automatic mixed securities shelf,"Wedbush bullish on Spyre Therapeutics, initiates with an Outperform Apogee Therapeutics Begins Landmark Atopic Dermatitis Trial Apogee announces first participants dosed in Phase 1 trial of APG990 Apogee Therapeutics: Advancing with Novel Combo Therapies in Inflammation and Immunology Markets Apogee Therapeutics files automatic mixed securities shelf",0,0,0,0,0,1
222.41M,"356,486",-30.43M,-1,226,40.24,Strong Buy,39.71,,RYTM,"Rhythm Pharmaceuticals, Inc.",2.82B,46.12,101.78M,3.43%,3.91%,12.84%,-3.78%,+14.43%,Rhythm announces FDA acceptance for priority review of sNDA for IMCIVREE,Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September,Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old,Rhythm Pharmaceuticals Announces New Employment Inducement Grants,Wells Fargo Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM),Rhythm announces FDA acceptance for priority review of sNDA for IMCIVREE Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old Rhythm Pharmaceuticals Announces New Employment Inducement Grants Wells Fargo Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM),0,0,0,0,0,0
149.59M,"2,465,469",-1.22B,-1,"10,000",19.57,Buy,24.23,"Aug 8, 2024",VC,Visteon Corporation,2.79B,100.90,3.95B,-0.33%,-4.14%,-10.99%,-13.51%,-9.08%,Visteon price target lowered to $129 from $144 at RBC Capital,Visteon (VC) Receives a Buy from RBC Capital,Visteon (VC) Receives a Hold from Wells Fargo,"Analysts Offer Insights on Consumer Cyclical Companies: TJX Companies (TJX), Visteon (VC) and Sea (SE)",,"Visteon price target lowered to $129 from $144 at RBC Capital Visteon (VC) Receives a Buy from RBC Capital Visteon (VC) Receives a Hold from Wells Fargo Analysts Offer Insights on Consumer Cyclical Companies: TJX Companies (TJX), Visteon (VC) and Sea (SE)",1,0,0,1,1,-1
110.42M,"1,267,106",-48.07M,-1,286,26.51,Strong Buy,36.19,"Aug 7, 2024",CORZ,"Core Scientific, Inc.",2.78B,10.76,575.23M,7.67%,5.66%,76.31%,+3.90%,+193.62%,"Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more","Lightning Round: I’ll pass on buying a flying car from China, says Jim Cramer on Xpeng",Cramer’s Lightning Round: Ally Financial is a buy,Crypto Currents: Riot urges change for Bitfarms board,"Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Lightning Round: I’ll pass on buying a flying car from China, says Jim Cramer on Xpeng Cramer’s Lightning Round: Ally Financial is a buy Crypto Currents: Riot urges change for Bitfarms board",0,0,1,0,0,0
65.46M,"799,305",-136.49M,-1,"1,917",44.60,Strong Buy,52.15,"Aug 1, 2024",SMTC,Semtech Corporation,2.77B,36.91,838.32M,16.66%,18.08%,39.09%,+33.76%,+30.39%,Semtech expands distribution footprint in Canada with GetWireless,Semtech Positioned for Growth: A Comprehensive Buy Rating Rationale,Semtech (SMTC) Is Leading the Charge Into the IoT Sphere,Strong Performance and Future Growth Prospects Affirm Semtech’s Buy Rating,Northland Securities Sticks to Its Buy Rating for Semtech (SMTC),Semtech expands distribution footprint in Canada with GetWireless Semtech Positioned for Growth: A Comprehensive Buy Rating Rationale Semtech (SMTC) Is Leading the Charge Into the IoT Sphere Strong Performance and Future Growth Prospects Affirm Semtech’s Buy Rating Northland Securities Sticks to Its Buy Rating for Semtech (SMTC),1,0,1,0,1,0
371.98M,"741,254",214.80M,$0.40,"5,000",7.83,Buy,9.13,"Aug 7, 2024",FA,First Advantage Corporation,2.76B,18.99,756.89M,8.91%,13.98%,17.77%,+10.28%,+21.65%,First Advantage President Retires with Continued Benefits,"Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: First Advantage (FA), Manitowoc Company (MTW) and Owens Corning (OC)",,,,"First Advantage President Retires with Continued Benefits Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: First Advantage (FA), Manitowoc Company (MTW) and Owens Corning (OC)",1,1,1,-1,-1,-1
24.94M,"116,102",149.60M,$1.48,"3,563",113.69,,,"Aug 6, 2024",CRTO,Criteo S.A.,2.76B,49.30,1.96B,0.50%,11.39%,39.94%,+4.94%,+33.28%,Macquarie sees upside for ad tech companies if Alphabet loses court battle,"Analysts Conflicted on These Communication Services Names: Criteo SA (CRTO), Warner Music Group (WMG) and Twilio (TWLO)",,,,"Macquarie sees upside for ad tech companies if Alphabet loses court battle Analysts Conflicted on These Communication Services Names: Criteo SA (CRTO), Warner Music Group (WMG) and Twilio (TWLO)",1,1,0,-1,-1,-1
120.49M,"1,164,599",-239.78M,-1,"1,500",23.49,Buy,27.18,"Aug 8, 2024",BHF,"Brighthouse Financial, Inc.",2.76B,45.37,4.01B,2.34%,0.71%,-5.68%,-8.64%,-11.19%,Brighthouse Financial initiated with an Equal Weight at Barclays,Brighthouse Financial price target lowered to $43 from $47 at Keefe Bruyette,Analysts Offer Insights on Financial Companies: goeasy (OtherEHMEF) and Brighthouse Financial (BHF),Brighthouse Financial (BHF) Gets a Buy from Jefferies,"Wells Fargo downgrades Brighthouse Financial to Underweight, cuts target to $40","Brighthouse Financial initiated with an Equal Weight at Barclays Brighthouse Financial price target lowered to $43 from $47 at Keefe Bruyette Analysts Offer Insights on Financial Companies: goeasy (OtherEHMEF) and Brighthouse Financial (BHF) Brighthouse Financial (BHF) Gets a Buy from Jefferies Wells Fargo downgrades Brighthouse Financial to Underweight, cuts target to $40",0,1,0,0,0,0
58.49M,"130,346",-118.49M,-1,"1,240",48.36,Strong Buy,72.25,"Aug 12, 2024",BATRA,"Atlanta Braves Holdings, Inc.",2.74B,46.24,659.53M,1.62%,4.39%,8.40%,+0.59%,+8.38%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,1,0,1,0,1,1
61.13M,"535,353",-260.73M,-1,141,46.12,Strong Buy,55.83,"Aug 6, 2024",GERN,Geron Corporation,2.74B,4.54,1.37M,1.69%,1.85%,46.08%,-4.85%,+35.84%,Geron price target raised to $5.50 from $5 at B. Riley,,,,,Geron price target raised to $5.50 from $5 at B. Riley,0,0,-1,-1,-1,-1
27.61M,"172,470",545.00M,-1,"5,950",100.90,Buy,134.27,"Jul 25, 2024",HUBG,"Hub Group, Inc.",2.72B,43.69,4.00B,0.25%,-0.17%,2.03%,-2.97%,+7.03%,Hub Group Declares Quarterly Dividend,,,,,Hub Group Declares Quarterly Dividend,1,1,-1,-1,-1,-1
258.22M,"8,438,207",-831.04M,-1,771,10.76,Strong Buy,14.71,"Aug 7, 2024",MQ,"Marqeta, Inc.",2.71B,5.34,470.95M,1.30%,0.00%,-8.98%,-3.34%,-11.54%,Marqeta’s Stock on the Rise: Robust Growth and Expanding Market Opportunities Justify Buy Rating,Barclays Remains a Buy on Marqeta (MQ),Marqeta’s Strong Growth Trajectory and Positive Outlook Affirmed with Buy Rating,,,Marqeta’s Stock on the Rise: Robust Growth and Expanding Market Opportunities Justify Buy Rating Barclays Remains a Buy on Marqeta (MQ) Marqeta’s Strong Growth Trajectory and Positive Outlook Affirmed with Buy Rating,1,1,1,1,-1,-1
75.03M,"1,081,673",-1.09B,-1,"1,240",36.91,Strong Buy,48.90,"Aug 27, 2024",BATRK,"Atlanta Braves Holdings, Inc.",2.71B,43.74,659.53M,1.48%,3.89%,9.63%,+1.24%,+11.46%,Liberty Media CEO to Discuss Financial Outlook at Tech Conference,Atlanta Braves Holdings Announces Strategic Leadership Overhaul,Liberty Media Announces Completion of Formula One Stock Offering,Liberty Media Announces SiriusXM Holdings Split-Off,Split-off of Liberty SiriusXM approved at Liberty Media special meeting,Liberty Media CEO to Discuss Financial Outlook at Tech Conference Atlanta Braves Holdings Announces Strategic Leadership Overhaul Liberty Media Announces Completion of Formula One Stock Offering Liberty Media Announces SiriusXM Holdings Split-Off Split-off of Liberty SiriusXM approved at Liberty Media special meeting,0,0,1,0,1,1
145.41M,"267,110",24.54M,-1,"11,000",18.99,Buy,76.25,"Aug 8, 2024",PSMT,"PriceSmart, Inc.",2.71B,89.30,4.81B,5.93%,7.95%,14.21%,-2.59%,+7.26%,,,,,,,0,-1,-1,-1,-1,-1
55.99M,"236,190",102.18M,-1,"2,700",49.30,Buy,51.22,"Aug 1, 2024",RELY,"Remitly Global, Inc.",2.69B,13.78,1.08B,-1.86%,2.55%,-20.83%,+1.51%,-35.06%,Remitly to Present at the 2024 Goldman Sachs Communacopia + Technology Conference,Remitly Global price target raised to $21 from $19 at JPMorgan,,,,Remitly to Present at the 2024 Goldman Sachs Communacopia + Technology Conference Remitly Global price target raised to $21 from $19 at JPMorgan,1,0,1,-1,-1,-1
60.76M,"312,022",-999.00M,-1,"2,167",45.37,Hold,49.78,"Aug 7, 2024",PAYO,Payoneer Global Inc.,2.68B,7.03,900.06M,11.36%,22.98%,35.56%,+28.39%,+47.61%,Buy Rating Justified by Payoneer’s Robust SMB Growth and Strategic Expansion,Payoneer Global price target raised to $8.50 from $7 at Citi,Goldman Sachs Sticks to Its Buy Rating for Payoneer (PAYO),,,Buy Rating Justified by Payoneer’s Robust SMB Growth and Strategic Expansion Payoneer Global price target raised to $8.50 from $7 at Citi Goldman Sachs Sticks to Its Buy Rating for Payoneer (PAYO),1,1,0,0,-1,-1
61.97M,"21,080",-60.57M,-1,"1,204",46.24,Strong Buy,53.50,"Aug 8, 2024",MGRC,McGrath RentCorp,2.68B,109.13,865.53M,2.34%,0.22%,-4.52%,-2.28%,-10.90%,,,,,,,1,-1,-1,-1,-1,-1
602.80M,"4,624,280",-219.55M,-1,"1,787",4.540,Strong Buy,6.93,"Aug 8, 2024",INDB,Independent Bank Corp.,2.68B,62.99,677.67M,4.06%,12.18%,13.38%,-1.86%,+27.99%,Independent Bank’s Insightful Presentation at Upcoming Conferences,,,,,Independent Bank’s Insightful Presentation at Upcoming Conferences,0,1,-1,-1,-1,-1
62.17M,"353,197",115.31M,$0.50,"3,007",43.69,Buy,45.04,"Aug 1, 2024",SFNC,Simmons First National Corporation,2.67B,21.30,727.05M,3.79%,8.46%,12.83%,-1.90%,+11.45%,,,,,,,0,-1,-1,-1,-1,-1
508.37M,"2,268,586",-12.32M,-1,"6,300",5.34,Buy,7.07,"Aug 7, 2024",CENT,Central Garden & Pet Company,2.67B,39.63,3.28B,1.74%,2.50%,0.34%,-1.13%,-4.42%,Central Garden Pet: Poised for Growth Amid Rising Pet Premiumization and Strategic Resilience,"Analysts Offer Insights on Consumer Goods Companies: Thai Beverage Public Co (OtherTBVPF), Central Garden Pet (CENT) and Kraft Heinz (KHC)",,,,"Central Garden Pet: Poised for Growth Amid Rising Pet Premiumization and Strategic Resilience Analysts Offer Insights on Consumer Goods Companies: Thai Beverage Public Co (OtherTBVPF), Central Garden Pet (CENT) and Kraft Heinz (KHC)",1,1,1,-1,-1,-1
61.97M,"171,081",-60.57M,-1,"1,089",43.74,Strong Buy,53.50,"Aug 8, 2024",LGIH,"LGI Homes, Inc.",2.65B,112.85,2.22B,5.74%,11.89%,2.25%,-6.58%,+8.81%,LGI Homes closed 610 homes in August 2024,"LGI Homes, Inc. Reports August 2024 Home Closings",LGI Homes Opens Two New Communities in the Albuquerque Market,,,"LGI Homes closed 610 homes in August 2024 LGI Homes, Inc. Reports August 2024 Home Closings LGI Homes Opens Two New Communities in the Albuquerque Market",0,0,0,0,-1,-1
30.30M,"174,956",123.94M,$1.15,677,89.30,Strong Buy,90.00,"Jul 10, 2024",NFE,New Fortress Energy Inc.,2.65B,12.90,2.36B,-13.95%,-31.48%,-54.63%,-38.70%,-59.22%,New Fortress Energy Releases Latest Financial Update,New Fortress receives DOE authorization for LNG export to non-FTA countries,New Fortress Energy: Fast LNG asset resumes production after maintenance,New Fortress Energy put buyer realizes 16% same-day gains,New Fortress Energy put volume heavy and directionally bearish,New Fortress Energy Releases Latest Financial Update New Fortress receives DOE authorization for LNG export to non-FTA countries New Fortress Energy: Fast LNG asset resumes production after maintenance New Fortress Energy put buyer realizes 16% same-day gains New Fortress Energy put volume heavy and directionally bearish,0,1,1,1,1,1
195.14M,"1,106,108",-103.85M,-1,598,13.78,Buy,22.78,"Jul 31, 2024",ACAD,ACADIA Pharmaceuticals Inc.,2.64B,15.94,890.53M,-4.86%,-5.91%,-23.24%,-17.46%,-12.83%,Cramer’s Lightning Round: Dell is a buy,NY Times says Acadia holding people against will to maximize insurance payouts,Analysts Offer Insights on Healthcare Companies: Veru (VERU) and ACADIA Pharmaceuticals (ACAD),Biotech Alert: Searches spiking for these stocks today,Oppenheimer Reaffirms Their Hold Rating on ACADIA Pharmaceuticals (ACAD),Cramer’s Lightning Round: Dell is a buy NY Times says Acadia holding people against will to maximize insurance payouts Analysts Offer Insights on Healthcare Companies: Veru (VERU) and ACADIA Pharmaceuticals (ACAD) Biotech Alert: Searches spiking for these stocks today Oppenheimer Reaffirms Their Hold Rating on ACADIA Pharmaceuticals (ACAD),0,0,0,0,1,0
381.82M,"2,236,332",101.25M,-1,"6,547",7.03,Strong Buy,8.25,"Aug 7, 2024",PRFT,"Perficient, Inc.",2.64B,75.14,882.15M,-0.08%,0.18%,12.58%,-0.44%,+45.84%,Perficient announces multi-year partnership with NFL’s Atlanta Falcons,Perficient (PRFT) Gets a Hold from Scotiabank,,,,Perficient announces multi-year partnership with NFL’s Atlanta Falcons Perficient (PRFT) Gets a Hold from Scotiabank,1,1,1,-1,-1,-1
24.55M,"63,723",115.85M,$1.90,386,109.13,Buy,116.00,"Jul 25, 2024",AGIO,"Agios Pharmaceuticals, Inc.",2.63B,46.22,31.31M,4.96%,4.73%,44.29%,-2.24%,+64.65%,"Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024",,,,,"Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024",1,1,-1,-1,-1,-1
42.48M,"230,846",214.71M,$2.28,"1,055",62.99,Hold,56.67,"Oct 17, 2024",PTCT,"PTC Therapeutics, Inc.",2.63B,34.15,900.45M,7.50%,6.54%,19.05%,+3.96%,+30.24%,"Monday’s biggest analyst calls: Nvidia, Amazon, Microsoft, BJ’s and more","PTC Therapeutics selloff ‘not warranted,’ says Morgan Stanley",PTC Therapeutics initiated with an Outperform at Baird,ClearPoint Neuro price target raised to $15 from $11 at Lake Street,Boeing’s Starliner to return without astronauts: Morning Buzz,"Monday’s biggest analyst calls: Nvidia, Amazon, Microsoft, BJ’s and more PTC Therapeutics selloff ‘not warranted,’ says Morgan Stanley PTC Therapeutics initiated with an Outperform at Baird ClearPoint Neuro price target raised to $15 from $11 at Lake Street Boeing’s Starliner to return without astronauts: Morning Buzz",0,1,1,0,0,1
125.55M,"405,521",150.79M,$0.84,"15,000",21.30,Hold,21.75,"Jul 24, 2024",ARCB,ArcBest Corporation,2.63B,111.06,4.33B,-3.11%,-4.56%,-12.80%,-16.44%,-29.72%,ArcBest price target lowered to $131 from $136 at TD Cowen,Buy Rating Affirmed for ArcBest with Positive Revenue Trends and Strong Future Growth Prospects,ArcBest price target lowered to $99 from $102 at BofA,Wells Fargo downgrades ArcBest to Equal Weight on softer demand outlook,Wells Fargo downgrades ArcBest (ARCB) to a Hold,ArcBest price target lowered to $131 from $136 at TD Cowen Buy Rating Affirmed for ArcBest with Positive Revenue Trends and Strong Future Growth Prospects ArcBest price target lowered to $99 from $102 at BofA Wells Fargo downgrades ArcBest to Equal Weight on softer demand outlook Wells Fargo downgrades ArcBest (ARCB) to a Hold,0,0,1,0,0,0
67.42M,"149,169",144.98M,-1,975,39.63,Strong Buy,53.00,"Aug 7, 2024",VIRT,"Virtu Financial, Inc.",2.62B,30.09,1.83B,7.04%,18.26%,44.29%,+10.47%,+45.38%,,,,,,,1,-1,-1,-1,-1,-1
23.50M,"149,792",194.76M,-1,934,112.85,Hold,114.40,"Jul 30, 2024",HWKN,"Hawkins, Inc.",2.62B,125.18,923.92M,5.79%,19.23%,55.62%,+18.19%,+57.11%,,,,,,,0,-1,-1,-1,-1,-1
205.07M,"3,507,134",242.32M,$0.40,213,12.90,Buy,29.00,"Aug 9, 2024",PLMR,"Palomar Holdings, Inc.",2.60B,99.04,445.93M,5.20%,11.17%,29.86%,+5.78%,+19.47%,"Palomar Holdings, Inc. Announces Participation in the 2024 KBW Insurance Conference",Palomar management to meet virtually with Piper Sandler,KBW Reaffirms Their Buy Rating on Palomar Holdings (PLMR),Palomar price target raised to $113 from $96 at Keefe Bruyette,,"Palomar Holdings, Inc. Announces Participation in the 2024 KBW Insurance Conference Palomar management to meet virtually with Piper Sandler KBW Reaffirms Their Buy Rating on Palomar Holdings (PLMR) Palomar price target raised to $113 from $96 at Keefe Bruyette",0,1,0,0,0,-1
165.88M,"1,665,968",30.57M,-1,"7,850",15.94,Buy,26.44,"Aug 6, 2024",AMRX,"Amneal Pharmaceuticals, Inc.",2.59B,8.38,2.60B,10.86%,17.13%,39.71%,+17.46%,+40.69%,Amneal Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan,Amneal Pharmaceuticals announces FDA approval of BORUZU,Amneal Pharmaceuticals receives FDA approval for Propofol Injectable Emulsion,Amneal Pharmaceuticals price target raised to $10 from $8 at Barclays,Amneal Pharmaceuticals (AMRX) Gets a Buy from Barclays,Amneal Pharmaceuticals upgraded to Neutral from Underweight at JPMorgan Amneal Pharmaceuticals announces FDA approval of BORUZU Amneal Pharmaceuticals receives FDA approval for Propofol Injectable Emulsion Amneal Pharmaceuticals price target raised to $10 from $8 at Barclays Amneal Pharmaceuticals (AMRX) Gets a Buy from Barclays,0,0,0,0,0,0
35.16M,"215,303",74.76M,-1,"4,137",75.14,Hold,69.40,"Aug 8, 2024",SNEX,StoneX Group Inc.,2.59B,81.50,84.27B,3.93%,5.71%,15.75%,-2.47%,+21.71%,StoneX Group Announces Multi-Million Share Buyback Plan,,,,,StoneX Group Announces Multi-Million Share Buyback Plan,0,1,-1,-1,-1,-1
56.89M,"253,693",-364.93M,-1,"3,093",46.22,Buy,51.33,"Aug 1, 2024",UFPT,"UFP Technologies, Inc.",2.58B,336.70,417.47M,6.15%,11.79%,47.73%,+2.31%,+30.90%,UFP Technologies Expands with AQF Medical Acquisition,UFP Technologies Acquires AQF Medical,"UFP Technologies announces acquisition of AQF Medical, terms not disclosed","UFP Technologies to Present and Host 1×1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th & 29th in Chicago, IL",,"UFP Technologies Expands with AQF Medical Acquisition UFP Technologies Acquires AQF Medical UFP Technologies announces acquisition of AQF Medical, terms not disclosed UFP Technologies to Present and Host 1×1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th & 29th in Chicago, IL",1,1,1,0,1,-1
76.92M,"426,460",-479.52M,-1,534,34.15,Hold,36.29,"Aug 8, 2024",RIOT,"Riot Platforms, Inc.",2.58B,8.50,280.02M,-5.55%,-17.37%,-31.48%,-25.02%,-25.10%,Coinbase has worst week of the year as crypto stocks plummet,"Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World",Bitcoin plunged 28%. Institutional investors bought the dip,Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said,Crypto Currents: Riot urges change for Bitfarms board,"Coinbase has worst week of the year as crypto stocks plummet Bitcoin recovers from overnight sell-off that pushed it below $56,000: CNBC Crypto World Bitcoin plunged 28%. Institutional investors bought the dip Trump’s bitcoin strategy shared behind closed doors with CEOs: Here’s what he said Crypto Currents: Riot urges change for Bitfarms board",1,0,0,1,1,0
23.65M,"150,343",128.32M,$0.48,"1,366",111.06,Buy,145.70,"Aug 2, 2024",AY,Atlantica Sustainable Infrastructure plc,2.58B,22.20,1.13B,0.56%,0.92%,9.42%,+0.86%,+21.60%,Atlantica Shareholders Approve Scheme of Arrangement,,,,,Atlantica Shareholders Approve Scheme of Arrangement,1,1,-1,-1,-1,-1
87.19M,"971,737",178.73M,$0.96,757,30.09,Buy,26.94,"Jul 18, 2024",TBBK,"The Bancorp, Inc.",2.56B,52.26,463.58M,4.29%,13.80%,29.55%,-3.30%,+56.80%,Bancorp Appoints FinTech Expert Todd Brockman to Board,,,,,Bancorp Appoints FinTech Expert Todd Brockman to Board,0,1,-1,-1,-1,-1
20.90M,"93,378",80.81M,$0.72,919,125.18,Strong Buy,96.00,"Jul 31, 2024",TWST,Twist Bioscience Corporation,2.56B,43.66,295.21M,-1.18%,-8.82%,16.52%,-20.86%,+35.45%,"Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)",,,,,"Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)",1,0,-1,-1,-1,-1
26.21M,"102,735",96.44M,-1,"6,423",99.04,Buy,101.33,"Aug 5, 2024",OSIS,"OSI Systems, Inc.",2.56B,150.00,1.54B,2.81%,3.39%,9.43%,-1.24%,+2.65%,OSI Systems gets $5M order to deliver advanced optical sensors,OSI Systems Appoints Cary Okawa as Chief Accounting Officer,OSI Systems price target raised to $180 from $165 at B. Riley,OSI Systems price target raised to $178 from $172 at Roth MKM,"OSI Systems sees FY25 adjusted EPS $8.80-$9.15, consensus $8.68","OSI Systems gets $5M order to deliver advanced optical sensors OSI Systems Appoints Cary Okawa as Chief Accounting Officer OSI Systems price target raised to $180 from $165 at B. Riley OSI Systems price target raised to $178 from $172 at Roth MKM OSI Systems sees FY25 adjusted EPS $8.80-$9.15, consensus $8.68",0,0,1,0,0,0
309.54M,"1,018,792",-174.62M,-1,"2,165",8.38,Strong Buy,8.60,"Aug 9, 2024",FFBC,First Financial Bancorp.,2.56B,26.77,772.98M,3.92%,8.32%,15.62%,-2.85%,+22.88%,"First Financial Bancorp board chair Davis sells 29,000 common shares",First Financial Bancorp Executives to Engage with Investors,,,,"First Financial Bancorp board chair Davis sells 29,000 common shares First Financial Bancorp Executives to Engage with Investors",1,1,1,-1,-1,-1
31.79M,"62,778",226.50M,-1,"2,700",81.50,,,"Aug 6, 2024",MYGN,"Myriad Genetics, Inc.",2.55B,28.12,802.20M,-0.20%,4.19%,23.65%,-0.11%,+37.91%,Maintained Buy Rating on Myriad Genetics Amid GeneSight Study Discontinuation,"Myriad Genetics study setback unlikely to impact GeneSight, says Leerink",Myriad Genetics Reports GeneSight Testing Study Progress,"Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz","Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls","Maintained Buy Rating on Myriad Genetics Amid GeneSight Study Discontinuation Myriad Genetics study setback unlikely to impact GeneSight, says Leerink Myriad Genetics Reports GeneSight Testing Study Progress Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",0,0,0,0,1,1
7.67M,"48,352",49.55M,-1,"2,800",336.70,Buy,323.50,"Jul 30, 2024",PYCR,"Paycor HCM, Inc.",2.55B,14.26,654.95M,12.43%,14.67%,-15.20%,+14.99%,-21.03%,Paycor to Host Inaugural Investor Day in New York City,Stifel Nicolaus Reaffirms Their Buy Rating on Paycor HCM (PYCR),Paycor Appoints Tiffany Sieve as Chief Marketing Officer,Paycor HCM appoints Sieve as CMO,Paycor to Present at Upcoming Investor Conferences,Paycor to Host Inaugural Investor Day in New York City Stifel Nicolaus Reaffirms Their Buy Rating on Paycor HCM (PYCR) Paycor Appoints Tiffany Sieve as Chief Marketing Officer Paycor HCM appoints Sieve as CMO Paycor to Present at Upcoming Investor Conferences,0,1,1,1,1,1
303.52M,"13,750,404",86.73M,-1,"1,107",8.50,Strong Buy,17.05,"Jul 31, 2024",CVBF,CVB Financial Corp.,2.54B,18.19,527.11M,5.55%,4.11%,3.83%,-3.52%,+9.73%,,,,,,,0,-1,-1,-1,-1,-1
116.16M,"765,594",34.75M,$1.78,"1,900",22.20,Hold,21.71,"Aug 1, 2024",PLUS,ePlus inc.,2.54B,95.51,2.20B,6.09%,14.72%,22.32%,+2.52%,+23.64%,"ePlus Acquires Bailiwick Services, LLC","ePlus unit acquires Bailiwick Services, terms not disclosed",,,,"ePlus Acquires Bailiwick Services, LLC ePlus unit acquires Bailiwick Services, terms not disclosed",0,1,0,-1,-1,-1
48.96M,"495,507",204.28M,-1,"2,784",52.26,Buy,55.00,"Jul 25, 2024",TOWN,TowneBank,2.54B,34.31,668.08M,4.55%,11.65%,19.74%,+3.25%,+26.08%,TowneBank Announces Quarterly Cash Dividend,,,,,TowneBank Announces Quarterly Cash Dividend,1,1,-1,-1,-1,-1
58.59M,"510,754",-220.31M,-1,"71,000",43.66,Strong Buy,48.22,"Aug 2, 2024",GT,The Goodyear Tire & Rubber Company,2.53B,8.89,19.37B,-1.21%,-16.42%,-30.02%,-25.30%,-32.51%,Goodyear Tire put volume heavy and directionally bearish,Goodyear Tire downgraded to Peer Perform from Outperform at Wolfe Research,Goodyear Tire assumed at Peer Perform from Outperform at Wolfe Research,Goodyear Tire call volume above normal and directionally bullish,,Goodyear Tire put volume heavy and directionally bearish Goodyear Tire downgraded to Peer Perform from Outperform at Wolfe Research Goodyear Tire assumed at Peer Perform from Outperform at Wolfe Research Goodyear Tire call volume above normal and directionally bullish,1,1,0,0,1,-1
17.05M,"174,698",128.15M,-1,"2,900",150.00,Strong Buy,172.67,"Aug 22, 2024",LIVN,LivaNova PLC,2.53B,46.60,1.21B,0.91%,-7.67%,-10.85%,-2.15%,-10.38%,LivaNova (LIVN) Gets a Hold from Barclays,LivaNova Hold Rating Justified by US VNS Reimbursement Uncertainty and Italian Legal Challenges,LivaNova jumps 5% to $49.15 after Baird note on CMS panel vote,"CMS vote on reimbursement could be win for LivaNova, says Baird","CMS panel votes favorable for CVRx, says Lake Street","LivaNova (LIVN) Gets a Hold from Barclays LivaNova Hold Rating Justified by US VNS Reimbursement Uncertainty and Italian Legal Challenges LivaNova jumps 5% to $49.15 after Baird note on CMS panel vote CMS vote on reimbursement could be win for LivaNova, says Baird CMS panel votes favorable for CVRx, says Lake Street",0,0,1,0,0,1
95.48M,"291,182",231.29M,$0.96,"1,112",26.77,Hold,27.33,"Oct 22, 2024",FLNC,"Fluence Energy, Inc.",2.53B,19.58,2.14B,13.10%,9.25%,-0.96%,+9.83%,+8.31%,"3 Best Stocks to Buy Now, 9/4/2024, According to Top Analysts ",Buy Rating Affirmed: Fluence Energy’s Growth Trajectory and Market Position Amid Favorable Policy Dynamics,Fluence Energy initiated with a Buy at Jefferies,Buy Rating Affirmed: Fluence Energy’s Market Leadership and Growth Trajectory,"Analysts Offer Insights on Utilities Companies: Altus Power (AMPS), Fluence Energy (FLNC) and New Fortress Energy (NFE)","3 Best Stocks to Buy Now, 9/4/2024, According to Top Analysts  Buy Rating Affirmed: Fluence Energy’s Growth Trajectory and Market Position Amid Favorable Policy Dynamics Fluence Energy initiated with a Buy at Jefferies Buy Rating Affirmed: Fluence Energy’s Market Leadership and Growth Trajectory Analysts Offer Insights on Utilities Companies: Altus Power (AMPS), Fluence Energy (FLNC) and New Fortress Energy (NFE)",1,0,1,1,1,1
90.82M,"312,666",-155.20M,-1,"1,300",28.12,Buy,26.44,"Aug 6, 2024",NARI,"Inari Medical, Inc.",2.53B,43.34,547.47M,-8.78%,-12.57%,-15.46%,-6.08%,+3.77%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Inari Medical: A Strong Buy on Robust Product Reception and Promising Financial Outlook,Inari Medical: Navigating Competitive Threats and Growth Potential in Venous Thromboembolism Treatment,Inari Medical initiated with a Market Perform at Leerink,Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Inari Medical: A Strong Buy on Robust Product Reception and Promising Financial Outlook Inari Medical: Navigating Competitive Threats and Growth Potential in Venous Thromboembolism Treatment Inari Medical initiated with a Market Perform at Leerink Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024",1,1,0,0,0,0
178.82M,"626,484",-58.94M,-1,"1,345",14.26,Buy,19.27,"Aug 14, 2024",PPBI,"Pacific Premier Bancorp, Inc.",2.52B,26.18,394.69M,1.95%,4.35%,5.13%,-4.92%,+13.80%,,,,,,,1,-1,-1,-1,-1,-1
139.68M,"1,068,105",203.58M,$0.80,"2,684",18.19,Hold,20.00,"Jul 24, 2024",FIVN,"Five9, Inc.",2.52B,33.77,968.26M,-9.95%,-18.23%,-44.18%,-27.18%,-45.77%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",The Bear Cave issues cautious report on Five9,Truist Financial Remains a Buy on Five9 (FIVN),Truist Financial Reaffirms Their Buy Rating on Five9 (FIVN),Five9 (FIVN) Gets a Buy from Piper Sandler,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more The Bear Cave issues cautious report on Five9 Truist Financial Remains a Buy on Five9 (FIVN) Truist Financial Reaffirms Their Buy Rating on Five9 (FIVN) Five9 (FIVN) Gets a Buy from Piper Sandler",1,1,0,0,0,0
26.58M,"107,217",109.27M,-1,216,95.51,Hold,90.00,"Aug 6, 2024",SBLK,Star Bulk Carriers Corp.,2.52B,21.23,1.10B,-1.40%,-8.16%,-7.87%,-8.52%,-13.65%,"Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier","Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",Buy Rating Upheld for Star Bulk Carriers on Strong Financials and Strategic Mergers,Star Bulk Carriers initiated with a Buy at Deutsche Bank,Unusually active option classes on open September 3rd,"Calls of the Day: Cisco Systems, Visa, Booking Holdings, Freeport-McMoRan and Star Bulk Carrier Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Buy Rating Upheld for Star Bulk Carriers on Strong Financials and Strategic Mergers Star Bulk Carriers initiated with a Buy at Deutsche Bank Unusually active option classes on open September 3rd",0,0,1,0,0,0
73.97M,"211,420",151.21M,$1.00,"1,102",34.31,Hold,30.00,"Jul 24, 2024",PRVA,"Privia Health Group, Inc.",2.49B,20.86,1.70B,4.56%,10.73%,4.34%,-1.40%,+10.12%,Truist Financial Sticks to Their Buy Rating for Privia Health Group (PRVA),Privia Health management to meet virtually with Truist,Privia Health Group (PRVA) Receives a Buy from J.P. Morgan,Privia Health price target raised to $24 from $23 at Baird,RBC Capital Sticks to Their Buy Rating for Privia Health Group (PRVA),Truist Financial Sticks to Their Buy Rating for Privia Health Group (PRVA) Privia Health management to meet virtually with Truist Privia Health Group (PRVA) Receives a Buy from J.P. Morgan Privia Health price target raised to $24 from $23 at Baird RBC Capital Sticks to Their Buy Rating for Privia Health Group (PRVA),0,0,0,1,0,0
284.69M,"3,243,777",-352.00M,-1,61,8.89,Strong Buy,17.23,"Jul 31, 2024",CGON,"CG Oncology, Inc.",2.48B,37.02,539.00K,7.54%,8.84%,0.49%,+10.31%,-4.34%,CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,CG Oncology initiated with a Buy at Roth MKM,"Morgan Stanley Keeps Their Buy Rating on CG Oncology, Inc. (CGON)",Buy Rating for CG Oncology: Promising CG0070 Data Signals Strong Market Potential,"Analysts’ Opinions Are Mixed on These NA Stocks: Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON)","CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference CG Oncology initiated with a Buy at Roth MKM Morgan Stanley Keeps Their Buy Rating on CG Oncology, Inc. (CGON) Buy Rating for CG Oncology: Promising CG0070 Data Signals Strong Market Potential Analysts’ Opinions Are Mixed on These NA Stocks: Solventum Corporation (SOLV) and CG Oncology, Inc. (CGON)",0,0,0,0,0,0
54.30M,"303,333",-16.59M,-1,"2,284",46.60,Buy,65.83,"Jul 31, 2024",PRGS,Progress Software Corporation,2.47B,57.80,711.72M,2.00%,5.08%,7.76%,-0.99%,+13.66%,Progress Software announces early-access release of MarkLogic Server 12,Progress Announces Powerful New Generative AI Capabilities in Latest Release of MarkLogic Server,New Progress Semaphore Release Brings to Market AI-Assisted Knowledge Modeling,Progress Software announces latest release of Progress Semaphore,,Progress Software announces early-access release of MarkLogic Server 12 Progress Announces Powerful New Generative AI Capabilities in Latest Release of MarkLogic Server New Progress Semaphore Release Brings to Market AI-Assisted Knowledge Modeling Progress Software announces latest release of Progress Semaphore,0,1,0,0,0,-1
128.99M,"2,044,828",-21.86M,-1,160,19.58,Strong Buy,27.47,"Aug 7, 2024",CLDX,"Celldex Therapeutics, Inc.",2.46B,37.17,8.30M,9.59%,4.38%,1.62%,+0.94%,-2.80%,"Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Arrowhead Pharmaceuticals (ARWR) and Nuvalent (NUVL)","Analysts Are Bullish on Top Healthcare Stocks: Celldex (CLDX), Privia Health Group (PRVA)",Analyst Cautiously Holds on Celldex Amid Upcoming Barzolvolimab Safety Data and Competitive Landscape,Celldex price target raised to $37 from $35 at Wells Fargo,Buy Rating for Celldex Reinforced by Barzolvolimab’s Clinical Progress and Phase 3 Studies Initiation,"Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Arrowhead Pharmaceuticals (ARWR) and Nuvalent (NUVL) Analysts Are Bullish on Top Healthcare Stocks: Celldex (CLDX), Privia Health Group (PRVA) Analyst Cautiously Holds on Celldex Amid Upcoming Barzolvolimab Safety Data and Competitive Landscape Celldex price target raised to $37 from $35 at Wells Fargo Buy Rating for Celldex Reinforced by Barzolvolimab’s Clinical Progress and Phase 3 Studies Initiation",1,0,1,1,0,0
58.27M,"937,090",-57.05M,-1,815,43.34,Buy,62.00,"Jul 30, 2024",VCYT,"Veracyte, Inc.",2.46B,32.00,399.58M,12.00%,28.19%,33.87%,+31.75%,+57.16%,Veracyte Announces Expansion of Board with New Appointees,Enhanced Financial Outlook for Veracyte Following Shift to Non-GAAP Reporting Metrics,Veracyte price target raised to $26 from $21 at Morgan Stanley,Analyst Issues Sell Rating for Veracyte Amidst Strong Q2 Growth but Limited Near-Term Upside,Biotech Alert: Searches spiking for these stocks today,Veracyte Announces Expansion of Board with New Appointees Enhanced Financial Outlook for Veracyte Following Shift to Non-GAAP Reporting Metrics Veracyte price target raised to $26 from $21 at Morgan Stanley Analyst Issues Sell Rating for Veracyte Amidst Strong Q2 Growth but Limited Near-Term Upside Biotech Alert: Searches spiking for these stocks today,1,1,1,0,1,1
96.42M,"371,184",-2.22M,$1.32,112,26.18,Buy,26.50,"Oct 22, 2024",PTGX,"Protagonist Therapeutics, Inc.",2.46B,41.68,319.12M,7.41%,14.61%,47.97%,+14.18%,+52.68%,,,,,,,0,-1,-1,-1,-1,-1
74.74M,"1,732,792",-52.67M,-1,38,33.77,Strong Buy,63.35,"Aug 8, 2024",GOGL,Golden Ocean Group Limited,2.45B,12.24,935.99M,5.34%,-1.30%,5.47%,-2.66%,-6.28%,Golden Ocean Group Mid-Year Financial Update,GOGL – Q2 2024 Presentation,"Golden Ocean Reports Solid Q2 Earnings, Optimistic Outlook",GOGL – Second Quarter 2024 Results,Golden Ocean Group Sets 2024 Financial Calendar,"Golden Ocean Group Mid-Year Financial Update GOGL – Q2 2024 Presentation Golden Ocean Reports Solid Q2 Earnings, Optimistic Outlook GOGL – Second Quarter 2024 Results Golden Ocean Group Sets 2024 Financial Calendar",1,1,0,1,0,1
118.83M,"2,092,532",264.30M,$2.80,901,21.23,Strong Buy,30.00,"Aug 7, 2024",DLO,DLocal Limited,2.45B,8.52,707.64M,9.99%,10.15%,-36.02%,+11.98%,-47.08%,DLocal appoints Menendez as Chief Operating Officer,dLocal appoints Carlos Menendez as Chief Operating Officer,DLocal: A Strong Buy on Robust Earnings Growth and Attractive Valuation,Largest borrow rate increases among liquid names,DLocal price target raised to $8 from $7.50 at BofA,DLocal appoints Menendez as Chief Operating Officer dLocal appoints Carlos Menendez as Chief Operating Officer DLocal: A Strong Buy on Robust Earnings Growth and Attractive Valuation Largest borrow rate increases among liquid names DLocal price target raised to $8 from $7.50 at BofA,0,0,0,1,1,0
119.56M,"574,567",14.93M,-1,"20,209",20.86,Buy,24.50,"Aug 8, 2024",MLCO,Melco Resorts & Entertainment Limited,2.43B,5.51,4.38B,-0.48%,-14.31%,-27.12%,-11.03%,-28.35%,Macau reports August casino revenue up 14.8% to 19.75B patacas,Melco Resorts Finance Unveils Mid-Year Financials,Unusually active option classes on open August 23rd,Melco Resorts Completes $44.5M Share Buyback,Bet On It: DraftKings flips script and abandons gaming tax surcharge,Macau reports August casino revenue up 14.8% to 19.75B patacas Melco Resorts Finance Unveils Mid-Year Financials Unusually active option classes on open August 23rd Melco Resorts Completes $44.5M Share Buyback Bet On It: DraftKings flips script and abandons gaming tax surcharge,1,1,1,0,1,0
67.08M,"594,008",-72.33M,-1,"1,300",37.02,Strong Buy,64.00,"Aug 8, 2024",SYM,Symbotic Inc.,2.42B,23.36,1.68B,-7.85%,-31.31%,-47.72%,-25.36%,-54.52%,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,Symbotic (SYM) Receives a Buy from TD Cowen,Short Sellers Could be Targeting AI Stocks,Symbiotic put volume heavy and directionally bearish,"Lightning Round: Elf is without a doubt one of the most shorted stocks on the market, says Jim Cramer Cramer’s Lightning Round: Dell is a buy Symbotic (SYM) Receives a Buy from TD Cowen Short Sellers Could be Targeting AI Stocks Symbiotic put volume heavy and directionally bearish",0,0,0,0,0,1
42.78M,"241,091",73.26M,$0.70,314,57.80,Buy,63.50,"Sep 24, 2024",VCEL,Vericel Corporation,2.42B,49.29,214.52M,13.34%,12.65%,21.12%,+4.06%,+2.94%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more","Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024",Buy Rating for Vericel on FDA Approval and Market Expansion Potential,Buy Rating Affirmed for Vericel Amidst FDA Approval and Promising MACI Arthro Launch,Buy Rating on Vericel: Expanding Market Reach with FDA-Approved MACI Arthro Platform,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 Buy Rating for Vericel on FDA Approval and Market Expansion Potential Buy Rating Affirmed for Vericel Amidst FDA Approval and Promising MACI Arthro Launch Buy Rating on Vericel: Expanding Market Reach with FDA-Approved MACI Arthro Platform",0,1,0,0,0,0
66.29M,"478,853",-150.22M,-1,"2,228",37.17,Buy,68.50,"Aug 8, 2024",RPD,"Rapid7, Inc.",2.41B,38.49,817.20M,3.00%,-1.91%,-20.16%,-5.57%,-23.81%,SolarWinds names Andre Cuenin new Chief Revenue Officer,Rapid7 jumps 5% to $36.86 after Jana discloses new position,"Jana added Rapid7 during Q2, sold out of Freshpet","Analysts’ Opinions Are Mixed on These Technology Stocks: Shoals Technologies Group (SHLS), Rapid7 (RPD) and Intapp (INTA)",,"SolarWinds names Andre Cuenin new Chief Revenue Officer Rapid7 jumps 5% to $36.86 after Jana discloses new position Jana added Rapid7 during Q2, sold out of Freshpet Analysts’ Opinions Are Mixed on These Technology Stocks: Shoals Technologies Group (SHLS), Rapid7 (RPD) and Intapp (INTA)",1,1,1,1,1,-1
76.81M,"485,458",-54.04M,-1,167,32.00,Buy,29.75,"Aug 6, 2024",CPRX,"Catalyst Pharmaceuticals, Inc.",2.41B,20.32,434.48M,9.71%,19.65%,31.17%,+18.21%,+34.34%,Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences,Buy Rating Affirmed for Catalyst Pharma on Agamree’s Strong Launch and Expansion Potential,Catalyst Pharmaceuticals price target raised to $30 from $26 at H.C. Wainwright,Truist Financial Issues a Buy Rating on Catalyst Pharma (CPRX),,Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences Buy Rating Affirmed for Catalyst Pharma on Agamree’s Strong Launch and Expansion Potential Catalyst Pharmaceuticals price target raised to $30 from $26 at H.C. Wainwright Truist Financial Issues a Buy Rating on Catalyst Pharma (CPRX),0,0,0,0,0,-1
58.90M,"355,342",169.95M,-1,"4,248",41.68,Strong Buy,45.50,"Aug 6, 2024",ATAT,Atour Lifestyle Holdings Limited,2.41B,17.52,742.38M,1.07%,-2.77%,-5.00%,-1.31%,-10.07%,Atour Lifestyle Holdings: A Buoyant Outlier in the Hotel Sector with Strong Retail Growth Justifying a Buy Rating,Atour Lifestyle Holdings: A Strong Buy on Upgraded Revenue and EPS Forecasts,Atour Lifestyle price target raised to $32 from $30 at Morgan Stanley,Atour Lifestyle price target raised to $25.20 from $23.50 at BofA,Atour Lifestyle Holdings: Strong Earnings and Strategic Growth Justify Buy Rating,Atour Lifestyle Holdings: A Buoyant Outlier in the Hotel Sector with Strong Retail Growth Justifying a Buy Rating Atour Lifestyle Holdings: A Strong Buy on Upgraded Revenue and EPS Forecasts Atour Lifestyle price target raised to $32 from $30 at Morgan Stanley Atour Lifestyle price target raised to $25.20 from $23.50 at BofA Atour Lifestyle Holdings: Strong Earnings and Strategic Growth Justify Buy Rating,0,1,1,0,0,1
200.03M,"1,251,096",186.48M,$1.20,"3,500",12.24,Hold,15.50,"Aug 28, 2024",AZTA,"Azenta, Inc.",2.41B,49.24,658.62M,-8.81%,-9.61%,-14.87%,-21.87%,-15.33%,John Marotta Named Azenta’s New President and CEO,Azenta appoints John Marotta as CEO,,,,John Marotta Named Azenta’s New President and CEO Azenta appoints John Marotta as CEO,1,1,1,-1,-1,-1
287.11M,"525,097",132.78M,-1,526,8.52,Hold,13.95,"Aug 14, 2024",NTLA,"Intellia Therapeutics, Inc.",2.40B,23.63,45.97M,-0.92%,-4.60%,-12.04%,-14.73%,-9.81%,Cathie Wood’s ARK Investment bought 186K shares of Intellia Therapeutics today,Intellia Therapeutics (NTLA) Receives a Buy from Truist Financial,Cathie Wood’s ARK Investment bought 237K shares of Intellia Therapeutics today,Cathie Wood’s ARK Investment bought 119K shares of Intellia Therapeutics today,"Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Genmab (GMAB) and Xoma (XOMA)","Cathie Wood’s ARK Investment bought 186K shares of Intellia Therapeutics today Intellia Therapeutics (NTLA) Receives a Buy from Truist Financial Cathie Wood’s ARK Investment bought 237K shares of Intellia Therapeutics today Cathie Wood’s ARK Investment bought 119K shares of Intellia Therapeutics today Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Genmab (GMAB) and Xoma (XOMA)",1,1,0,1,1,1
440.42M,"1,545,993",-185.63M,-1,"1,970",5.51,Strong Buy,9.85,"Aug 13, 2024",HTLF,"Heartland Financial USA, Inc.",2.40B,55.89,546.04M,6.43%,12.61%,39.22%,+1.36%,+63.01%,,,,,,,1,-1,-1,-1,-1,-1
103.78M,"1,575,046",-17.20M,-1,"1,517",23.36,Buy,43.23,"Jul 29, 2024",IBTX,"Independent Bank Group, Inc.",2.40B,57.82,473.48M,5.18%,11.96%,24.42%,-2.52%,+35.91%,,,,,,,1,-1,-1,-1,-1,-1
49.03M,"350,960","789,000",-1,64,49.29,Strong Buy,54.86,"Aug 1, 2024",JANX,"Janux Therapeutics, Inc.",2.40B,45.92,15.13M,11.35%,8.64%,43.64%,+8.89%,+25.88%,Janux Therapeutics initiated with a Buy at Stifel,"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX)",Buy Rating Affirmed on Janux Therapeutics Inc. Amidst Promising Prostate Cancer Program Developments and Unique Bispecific Platform,Janux Therapeutics price target lowered to $42 from $47 at Scotiabank,Bank of America Securities Keeps Their Buy Rating on Janux Therapeutics Inc (JANX),"Janux Therapeutics initiated with a Buy at Stifel Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX) Buy Rating Affirmed on Janux Therapeutics Inc. Amidst Promising Prostate Cancer Program Developments and Unique Bispecific Platform Janux Therapeutics price target lowered to $42 from $47 at Scotiabank Bank of America Securities Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)",1,1,0,1,1,1
62.73M,"372,013",-46.11M,-1,"34,846",38.49,Buy,47.67,"Aug 6, 2024",ADUS,Addus HomeCare Corporation,2.39B,133.58,1.11B,4.40%,8.27%,28.33%,+8.88%,+29.41%,RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS),,,,,RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS),0,0,-1,-1,-1,-1
118.69M,"770,733",68.15M,-1,"10,600",20.32,Strong Buy,29.50,"Aug 7, 2024",DRVN,Driven Brands Holdings Inc.,2.38B,14.50,2.32B,2.72%,7.31%,5.69%,+3.42%,-6.71%,Driven Brands announces the sale of its Canadian distribution business,Benchmark Co. Keeps Their Buy Rating on Driven Brands Holdings (DRVN),Driven Brands management to meet virtually with Benchmark,,,Driven Brands announces the sale of its Canadian distribution business Benchmark Co. Keeps Their Buy Rating on Driven Brands Holdings (DRVN) Driven Brands management to meet virtually with Benchmark,1,1,1,1,-1,-1
137.60M,"628,526",135.23M,$0.15,"6,300",17.52,Strong Buy,27.79,"Aug 29, 2024",CENTA,Central Garden & Pet Company,2.38B,34.26,3.28B,2.08%,2.97%,-0.80%,-0.99%,-4.22%,Central Garden Pet: Poised for Growth Amid Rising Pet Premiumization and Strategic Resilience,"Analysts Offer Insights on Consumer Goods Companies: Thai Beverage Public Co (OtherTBVPF), Central Garden Pet (CENT) and Kraft Heinz (KHC)",,,,"Central Garden Pet: Poised for Growth Amid Rising Pet Premiumization and Strategic Resilience Analysts Offer Insights on Consumer Goods Companies: Thai Beverage Public Co (OtherTBVPF), Central Garden Pet (CENT) and Kraft Heinz (KHC)",1,1,1,-1,-1,-1
48.92M,"746,690",-155.81M,-1,"2,877",49.24,Buy,67.00,"Aug 6, 2024",KLIC,"Kulicke and Soffa Industries, Inc.",2.37B,43.57,727.23M,1.21%,-6.82%,-11.33%,-10.47%,-12.35%,"Kulicke & Soffa Declares Quarterly Dividend, Rewards Shareholders",,,,,"Kulicke & Soffa Declares Quarterly Dividend, Rewards Shareholders",0,0,-1,-1,-1,-1
101.58M,"764,940",-508.80M,-1,"6,422",23.63,Buy,61.58,"Aug 8, 2024",STRA,"Strategic Education, Inc.",2.37B,97.39,1.19B,0.70%,-8.15%,-4.41%,-8.35%,-6.65%,,,,,,,1,-1,-1,-1,-1,-1
42.88M,"248,826",61.13M,$1.20,"9,325",55.89,Buy,45.60,"Jul 30, 2024",LFST,"LifeStance Health Group, Inc.",2.36B,6.18,1.16B,9.14%,14.62%,-0.18%,+13.25%,+0.97%,Lifestance Health Group: A Strong Buy on Accessible Mental Healthcare and Market Positioning,LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference,,,,Lifestance Health Group: A Strong Buy on Accessible Mental Healthcare and Market Positioning LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference,1,1,1,-1,-1,-1
41.44M,"129,057",-420.11M,$1.52,"1,800",57.82,Buy,59.14,"Oct 21, 2024",ASTH,"Astrana Health, Inc.",2.36B,48.12,1.59B,0.79%,6.13%,21.46%,-7.97%,+15.64%,Astrana Health Unveils Financial Slides for Conference,"Analysts Conflicted on These Healthcare Names: Quest Diagnostics (DGX), Astrana Health (ASTH) and Dexcom (DXCM)",Astrana Health price target raised to $67 from $54 at Baird,Astrana Health price target raised to $59 from $50 at Truist,,"Astrana Health Unveils Financial Slides for Conference Analysts Conflicted on These Healthcare Names: Quest Diagnostics (DGX), Astrana Health (ASTH) and Dexcom (DXCM) Astrana Health price target raised to $67 from $54 at Baird Astrana Health price target raised to $59 from $50 at Truist",1,0,1,0,0,-1
52.16M,"152,663",-44.05M,-1,"2,767",45.92,Strong Buy,64.00,"Aug 7, 2024",JAMF,Jamf Holding Corp.,2.36B,18.50,598.41M,2.90%,4.46%,0.81%,+0.16%,+3.09%,Maintain Position on Jamf Holdings: A Hold Rating Amid Balanced Growth Prospects and Valuation,Jamf joins Okta’s Elevate Partner Program to tighten go-to-market alignment and accelerate product innovation,Jamf Holding joins Okta’s Elevate Partner Program,Jamf Holding enters the Microsoft ISV Partner Program,Jamf Insights and Data on Mobile Security Threats Featured in 2024 Verizon Mobile Security Index,Maintain Position on Jamf Holdings: A Hold Rating Amid Balanced Growth Prospects and Valuation Jamf joins Okta’s Elevate Partner Program to tighten go-to-market alignment and accelerate product innovation Jamf Holding joins Okta’s Elevate Partner Program Jamf Holding enters the Microsoft ISV Partner Program Jamf Insights and Data on Mobile Security Threats Featured in 2024 Verizon Mobile Security Index,0,1,0,0,0,1
17.90M,"123,755",68.90M,-1,"7,000",133.58,Buy,128.29,"Aug 5, 2024",NMRK,"Newmark Group, Inc.",2.36B,13.73,2.54B,7.31%,16.67%,30.26%,+3.47%,+22.65%,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike",Keefe upgrades three to Outperform with commercial real estate bottoming,Newmark upgraded to Outperform from Market Perform at Keefe Bruyette,Newmark Group (NMRK) Gets a Buy from Piper Sandler,Newmark price target raised to $17 from $13 at Piper Sandler,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Keefe upgrades three to Outperform with commercial real estate bottoming Newmark upgraded to Outperform from Market Perform at Keefe Bruyette Newmark Group (NMRK) Gets a Buy from Piper Sandler Newmark price target raised to $17 from $13 at Piper Sandler",0,0,1,0,0,0
164.08M,"473,359",-761.68M,-1,"28,900",14.50,Buy,17.96,"Aug 1, 2024",LAUR,"Laureate Education, Inc.",2.34B,15.31,1.55B,4.18%,4.74%,9.55%,-0.77%,+3.71%,,,,,,,0,-1,-1,-1,-1,-1
67.42M,"299,982",144.98M,-1,"13,809",34.26,Strong Buy,45.75,"Aug 7, 2024",WERN,"Werner Enterprises, Inc.",2.33B,37.77,3.17B,-1.56%,0.29%,-3.91%,-4.75%,-2.10%,Friday’s stock stories: What’s likely to move the market in the next session,,,,,Friday’s stock stories: What’s likely to move the market in the next session,0,0,-1,-1,-1,-1
54.51M,"333,150",-57.77M,$0.80,"1,761",43.57,Buy,47.33,"Aug 7, 2024",AMPH,"Amphastar Pharmaceuticals, Inc.",2.33B,47.95,712.89M,10.28%,17.07%,2.11%,+11.58%,+16.20%,Amphastar Pharmaceuticals Poised for Growth: Strong Product Performance and Strategic Financial Health Drive Buy Rating,,,,,Amphastar Pharmaceuticals Poised for Growth: Strong Product Performance and Strategic Financial Health Drive Buy Rating,1,0,-1,-1,-1,-1
24.38M,"80,104",117.19M,$2.40,"1,541",97.39,Strong Buy,121.50,"Jul 31, 2024",SBCF,Seacoast Banking Corporation of Florida,2.33B,27.60,504.47M,3.09%,5.59%,8.14%,-2.30%,+13.43%,Seacoast Banking Executives to Discuss Strategy with Investors,Analysts Offer Insights on Financial Companies: Bain Capital Specialty Finance (BCSF) and Seacoast Banking Of Florida (SBCF),,,,Seacoast Banking Executives to Discuss Strategy with Investors Analysts Offer Insights on Financial Companies: Bain Capital Specialty Finance (BCSF) and Seacoast Banking Of Florida (SBCF),0,1,1,-1,-1,-1
382.62M,"2,197,316",-150.92M,-1,333,6.18,Hold,8.25,"Aug 8, 2024",USLM,"United States Lime & Minerals, Inc.",2.32B,81.38,288.80M,2.43%,3.88%,31.65%,-8.16%,+28.05%,,,,,,,1,-1,-1,-1,-1,-1
49.08M,"311,815",68.42M,-1,"2,034",48.12,Strong Buy,62.00,"Aug 7, 2024",NBTB,NBT Bancorp Inc.,2.32B,49.12,516.78M,4.16%,11.33%,25.40%,-0.71%,+36.33%,NBT Bancorp Shares Strategic Insights in Investor Presentation,,,,,NBT Bancorp Shares Strategic Insights in Investor Presentation,0,1,-1,-1,-1,-1
127.64M,"307,475",-89.47M,-1,"2,363",18.50,Strong Buy,23.71,"Aug 7, 2024",POWL,"Powell Industries, Inc.",2.31B,192.78,945.93M,9.84%,19.21%,35.89%,-10.33%,+19.14%,Jim Cramer looks at what’s behind Powell Industries’ big gains,,,,,Jim Cramer looks at what’s behind Powell Industries’ big gains,0,0,-1,-1,-1,-1
171.84M,"1,193,059",44.52M,$0.12,"15,000",13.73,Buy,13.83,"Aug 2, 2024",CMPR,Cimpress plc,2.31B,92.19,3.29B,12.07%,10.98%,15.90%,+10.70%,+4.03%,Cimpress CFO Quinn sells $2.37M of shares,Strong Q4 Performance and Positive Outlook Justify Buy Rating for Cimpress,Cimpress price target raised to $119 from $113 at Barrington,,,Cimpress CFO Quinn sells $2.37M of shares Strong Q4 Performance and Positive Outlook Justify Buy Rating for Cimpress Cimpress price target raised to $119 from $113 at Barrington,0,1,1,0,-1,-1
152.55M,"555,082",195.40M,-1,93,15.31,Buy,18.50,"Aug 1, 2024",GPCR,Structure Therapeutics Inc.,2.28B,39.79,-,11.58%,4.78%,-3.68%,+5.24%,-5.09%,Statement from President Biden on anti-obesity medications pricing,Structure Therapeutics Appoints Angus Russell to Board,Structure Therapeutics Appoints Angus C. Russell to Board of Directors,Structure Therapeutics Announces Participation in Upcoming Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and AbSci (ABSI)","Statement from President Biden on anti-obesity medications pricing Structure Therapeutics Appoints Angus Russell to Board Structure Therapeutics Appoints Angus C. Russell to Board of Directors Structure Therapeutics Announces Participation in Upcoming Investor Conferences Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and AbSci (ABSI)",1,1,1,1,1,1
61.81M,"339,566",63.05M,$0.56,"2,243",37.77,Hold,38.43,"Jul 30, 2024",APPN,Appian Corporation,2.28B,31.45,578.70M,3.34%,0.04%,-7.42%,-15.54%,-17.96%,Amazon’s $4 billion investment in AI firm Anthropic faces UK merger probe,,,,,Amazon’s $4 billion investment in AI firm Anthropic faces UK merger probe,0,0,-1,-1,-1,-1
48.68M,"334,833",166.52M,-1,"2,162",47.95,Buy,63.00,"Aug 7, 2024",FRME,First Merchants Corporation,2.25B,38.42,601.34M,4.11%,7.30%,11.87%,-3.37%,+15.94%,Piper Sandler Reaffirms Their Buy Rating on First Merchants (FRME),KBW Sticks to Their Buy Rating for First Merchants (FRME),Old Second Bancorp to purchase five Illinois branches from First Merchants,"Old Second Bancorp, Inc. and First Merchants Corporation Announce Transaction Involving Chicagoland Branch Operations",First Merchants Corporation Announces Cash Dividend,"Piper Sandler Reaffirms Their Buy Rating on First Merchants (FRME) KBW Sticks to Their Buy Rating for First Merchants (FRME) Old Second Bancorp to purchase five Illinois branches from First Merchants Old Second Bancorp, Inc. and First Merchants Corporation Announce Transaction Involving Chicagoland Branch Operations First Merchants Corporation Announces Cash Dividend",0,0,0,0,0,0
84.54M,"270,108",117.21M,$0.72,"4,788",27.60,Hold,27.90,"Jul 25, 2024",IQ,"iQIYI, Inc.",2.25B,2.34,4.28B,-26.19%,-34.33%,-45.02%,-34.83%,-51.67%,iQiyi downgraded to Neutral at Goldman Sachs amid headwinds,iQiyi downgraded to Neutral from Buy at Goldman Sachs,Maintained Buy Rating on iQiyi Amidst Revenue Challenges with Positive Content Strategy Outlook,iQiyi price target lowered to $2.50 from $3 at JPMorgan,iQIYI Q2 Financials Show Revenue and Income Dip,iQiyi downgraded to Neutral at Goldman Sachs amid headwinds iQiyi downgraded to Neutral from Buy at Goldman Sachs Maintained Buy Rating on iQiyi Amidst Revenue Challenges with Positive Content Strategy Outlook iQiyi price target lowered to $2.50 from $3 at JPMorgan iQIYI Q2 Financials Show Revenue and Income Dip,1,1,1,1,0,1
28.50M,"46,267",86.23M,$0.20,374,81.38,,,"Jul 31, 2024",RXST,"RxSight, Inc.",2.24B,56.45,115.18M,13.55%,9.82%,15.59%,+18.94%,-1.31%,RxSight’s Growth Potential and Market Expansion Drive Buy Rating,"RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences","Needham ups RxSight target to $66, adds to Conviction List",Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and RxSight (RXST),,"RxSight’s Growth Potential and Market Expansion Drive Buy Rating RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences Needham ups RxSight target to $66, adds to Conviction List Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and RxSight (RXST)",1,0,0,0,0,-1
47.17M,"159,023",121.59M,$1.36,"2,596",49.12,Buy,41.20,"Oct 22, 2024",MRCY,"Mercury Systems, Inc.",2.23B,37.49,835.28M,2.74%,13.36%,18.05%,+4.36%,+30.45%,"Stocks making the biggest moves after hours: Alphabet, Flutter, Nu Holdings and more",Mercury Systems price target raised to $36 from $26 at JPMorgan,Mercury Systems upgraded to Overweight from Neutral at Alembic Global,Sell Rating on Mercury Systems Due to Weak Financials and Overambitious Outlook,"Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz","Stocks making the biggest moves after hours: Alphabet, Flutter, Nu Holdings and more Mercury Systems price target raised to $36 from $26 at JPMorgan Mercury Systems upgraded to Overweight from Neutral at Alembic Global Sell Rating on Mercury Systems Due to Weak Financials and Overambitious Outlook Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz",1,1,1,1,0,1
11.99M,"383,686",130.23M,$1.06,"1,200",192.78,,,"Jul 30, 2024",FLYW,Flywire Corporation,2.20B,17.58,441.65M,-0.58%,2.26%,-14.51%,-5.57%,-25.57%,Seaport Global Sticks to Their Buy Rating for Flywire (FLYW),Flywire to Attend Upcoming Investor Conferences,Flywire price target raised to $21 from $18 at JPMorgan,,,Seaport Global Sticks to Their Buy Rating for Flywire (FLYW) Flywire to Attend Upcoming Investor Conferences Flywire price target raised to $21 from $18 at JPMorgan,1,0,1,0,-1,-1
25.07M,"80,361",173.68M,-1,"7,600",92.19,Strong Buy,116.50,"Jul 31, 2024",PDCO,"Patterson Companies, Inc.",2.20B,24.98,6.57B,4.02%,4.53%,-3.85%,-10.99%,-14.38%,Stifel Nicolaus Sticks to Its Hold Rating for Patterson Companies (PDCO),Buy Rating Reaffirmed for Patterson Companies Amidst Recovery from Short-Term Challenges,Patterson Companies price target lowered to $28 from $30 at Baird,Patterson Companies price target lowered to $29 from $31 at BofA,Patterson Companies: A Cautious Hold Amidst Earnings Challenges and Aggressive Cost-Cutting,Stifel Nicolaus Sticks to Its Hold Rating for Patterson Companies (PDCO) Buy Rating Reaffirmed for Patterson Companies Amidst Recovery from Short-Term Challenges Patterson Companies price target lowered to $28 from $30 at Baird Patterson Companies price target lowered to $29 from $31 at BofA Patterson Companies: A Cautious Hold Amidst Earnings Challenges and Aggressive Cost-Cutting,0,0,0,0,0,0
57.20M,"368,338",-100.44M,-1,500,39.79,Buy,81.33,"Aug 8, 2024",RXRX,"Recursion Pharmaceuticals, Inc.",2.19B,7.81,49.64M,8.29%,-1.57%,-15.84%,-10.12%,-16.91%,Cathie Wood’s ARK Investment bought 726.5K shares of Recursion Pharmaceuticals,Recursion Pharmaceuticals Maintains Buy Rating Amidst Modest Study Results and Strong Financial Position,Hold Rating on Recursion Pharmaceuticals Amidst Lukewarm Phase 2 Results and AI Platform Validation Concerns,Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals,Recursion Pharmaceuticals price target lowered to $6 from $8 at Jefferies,Cathie Wood’s ARK Investment bought 726.5K shares of Recursion Pharmaceuticals Recursion Pharmaceuticals Maintains Buy Rating Amidst Modest Study Results and Strong Financial Position Hold Rating on Recursion Pharmaceuticals Amidst Lukewarm Phase 2 Results and AI Platform Validation Concerns Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals Recursion Pharmaceuticals price target lowered to $6 from $8 at Jefferies,1,1,1,1,1,0
72.35M,"291,903",-108.77M,-1,"7,500",31.45,Hold,38.75,"Aug 1, 2024",VSAT,"Viasat, Inc.",2.19B,17.14,4.63B,-10.53%,1.12%,-12.50%,-21.51%,-5.08%,"Stocks making the biggest moves midday: Starbucks, Chipotle, Home Depot and more",ViaSat put volume heavy and directionally bearish,"ViaSat awarded five-year, $153M dollar contract",ViaSat Announces New CFO Garrett L. Chase with Incentive Package,ViaSat appoints Gary Chase as CFO,"Stocks making the biggest moves midday: Starbucks, Chipotle, Home Depot and more ViaSat put volume heavy and directionally bearish ViaSat awarded five-year, $153M dollar contract ViaSat Announces New CFO Garrett L. Chase with Incentive Package ViaSat appoints Gary Chase as CFO",1,1,1,0,1,1
58.51M,"266,464",184.84M,$1.40,"2,000",38.42,Buy,44.50,"Jul 25, 2024",IRTC,"iRhythm Technologies, Inc.",2.19B,70.01,537.09M,-5.43%,-22.85%,-31.90%,-20.51%,-38.65%,Buy Rating for Irhythm Technologies: Strategic Growth and Strong Regulatory Management,iRhythm Technologies Strikes Advanced Tech Licensing Deal,iRhythm signs exclusive license agreement with BioIntelliSense,iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring,iRhythm Technologies announces results of GUARD-AF trial,Buy Rating for Irhythm Technologies: Strategic Growth and Strong Regulatory Management iRhythm Technologies Strikes Advanced Tech Licensing Deal iRhythm signs exclusive license agreement with BioIntelliSense iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring iRhythm Technologies announces results of GUARD-AF trial,0,1,1,0,1,0
959.66M,"11,222,344",229.28M,-1,79,2.340,Hold,91.33,"Aug 22, 2024",VRNA,Verona Pharma plc,2.18B,26.88,-,10.82%,29.94%,58.94%,+18.76%,+58.11%,Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024,Piper Sandler Sticks to Its Buy Rating for Verona Pharma (VRNA),Biotech Alert: Searches spiking for these stocks today,Buy Rating Affirmed for Verona Pharma: Breakthrough COPD Treatment and Strategic Market Positioning,Piper Sandler Reaffirms Their Buy Rating on Verona Pharma (VRNA),Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024 Piper Sandler Sticks to Its Buy Rating for Verona Pharma (VRNA) Biotech Alert: Searches spiking for these stocks today Buy Rating Affirmed for Verona Pharma: Breakthrough COPD Treatment and Strategic Market Positioning Piper Sandler Reaffirms Their Buy Rating on Verona Pharma (VRNA),0,0,0,1,0,0
39.68M,"309,793",-36.77M,-1,"1,510",56.45,Strong Buy,60.14,"Aug 5, 2024",LION,Lionsgate Studios Corp.,2.18B,7.55,2.95B,3.54%,-2.60%,-22.36%,-1.38%,,Lionsgate Studios CEO Jon Feltheimer Signs New Five-Year Deal,Seaport Global Keeps Their Buy Rating on Lionsgate Studios (LION),,,,Lionsgate Studios CEO Jon Feltheimer Signs New Five-Year Deal Seaport Global Keeps Their Buy Rating on Lionsgate Studios (LION),0,0,1,-1,-1,-1
59.41M,"489,434",-137.64M,-1,342,37.49,Sell,30.00,"Aug 13, 2024",ODD,Oddity Tech Ltd.,2.16B,38.04,596.12M,-6.42%,-7.83%,-7.52%,-9.88%,-0.55%,The Big Tech deterioration raises a major red flag for the market,Class Action Lawsuit Against Oddity Tech Ltd. (NASDAQ:ODD),Short Report: Bearish positioning in Oddity Tech at record high,Evercore ISI Keeps Their Buy Rating on ODDITY Tech Ltd. Class A (ODD),Buy Rating Affirmed for ODDITY Tech Ltd. on Strong Q2 Performance and Promising Growth Outlook,The Big Tech deterioration raises a major red flag for the market Class Action Lawsuit Against Oddity Tech Ltd. (NASDAQ:ODD) Short Report: Bearish positioning in Oddity Tech at record high Evercore ISI Keeps Their Buy Rating on ODDITY Tech Ltd. Class A (ODD) Buy Rating Affirmed for ODDITY Tech Ltd. on Strong Q2 Performance and Promising Growth Outlook,0,1,0,1,0,1
125.26M,"760,849",-8.17M,-1,"1,546",17.58,Strong Buy,26.54,"Aug 6, 2024",SIMO,Silicon Motion Technology Corporation,2.16B,64.07,774.69M,-1.68%,-14.47%,-11.45%,-10.57%,-22.76%,"Applied Materials, H&R Block report quarterly beats: Morning Buzz","Cisco, Nike upgrades among today’s top calls on Wall Street",BofA double downgrades Silicon Motion to Sell on lack of AI exposure,Silicon Motion downgraded to Underperform from Buy at BofA,,"Applied Materials, H&R Block report quarterly beats: Morning Buzz Cisco, Nike upgrades among today’s top calls on Wall Street BofA double downgrades Silicon Motion to Sell on lack of AI exposure Silicon Motion downgraded to Underperform from Buy at BofA",1,1,1,0,0,-1
88.14M,"1,042,419",185.93M,$1.04,"1,215",24.98,Hold,29.33,"Aug 28, 2024",VECO,Veeco Instruments Inc.,2.16B,38.00,701.65M,-3.75%,-14.89%,-0.99%,-15.29%,+0.80%,Veeco (VECO) Receives a Buy from Northland Securities,Veeco announces agreement with IBM,Veeco Announces Agreement with IBM to Explore Wet Processing System for Advanced Packaging Applications,,,Veeco (VECO) Receives a Buy from Northland Securities Veeco announces agreement with IBM Veeco Announces Agreement with IBM to Explore Wet Processing System for Advanced Packaging Applications,1,0,0,0,-1,-1
280.97M,"3,685,320",-374.93M,-1,"35,000",7.81,Buy,12.67,"Aug 8, 2024",BTSG,"BrightSpring Health Services, Inc.",2.16B,12.57,9.94B,6.39%,9.89%,16.54%,+1.94%,+23.58%,BrightSpring Health completes acquisition of Haven Hospice,"BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida","BrightSpring inspections see ‘serious regulatory violations,’ Capitol Forum says","BrightSpring Health Services, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference",,"BrightSpring Health completes acquisition of Haven Hospice BrightSpring Health Services Announces Definitive Agreement to Acquire Haven Hospice, Expanding Hospice Services into Florida BrightSpring inspections see ‘serious regulatory violations,’ Capitol Forum says BrightSpring Health Services, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference",1,1,1,0,1,-1
127.78M,"902,573",-1.02B,-1,51,17.14,Buy,25.86,"Aug 7, 2024",VERA,"Vera Therapeutics, Inc.",2.15B,39.30,-,0.35%,3.44%,13.34%,+0.30%,-2.19%,Cantor Fitzgerald Reaffirms Their Buy Rating on Vera Therapeutics (VERA),"JPMorgan ups Vera Therapeutics target, adds Analyst Focus List",Vera Therapeutics price target lowered to $62 from $65 at JPMorgan,Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),"Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Immuneering (IMRX) and Vera Therapeutics (VERA)","Cantor Fitzgerald Reaffirms Their Buy Rating on Vera Therapeutics (VERA) JPMorgan ups Vera Therapeutics target, adds Analyst Focus List Vera Therapeutics price target lowered to $62 from $65 at JPMorgan Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Immuneering (IMRX) and Vera Therapeutics (VERA)",0,1,0,1,0,1
31.24M,"404,057",-131.59M,-1,"1,391",70.01,Strong Buy,120.78,"Aug 1, 2024",CERT,"Certara, Inc.",2.14B,13.29,363.55M,-2.20%,-7.38%,-18.27%,-20.12%,-31.29%,"Software is a good small cap play because earnings are more recurring, says Julie Biel",Certara Launches Phoenix™ Version 8.5 Drug Development Software,"Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Certara (CERT) and Harrow Health (HROW)",,,"Software is a good small cap play because earnings are more recurring, says Julie Biel Certara Launches Phoenix™ Version 8.5 Drug Development Software Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Certara (CERT) and Harrow Health (HROW)",1,0,0,0,-1,-1
81.24M,"655,766",-125.45M,-1,"2,100",26.88,Strong Buy,36.00,"Aug 8, 2024",NEO,"NeoGenomics, Inc.",2.14B,16.66,628.25M,-0.84%,8.91%,4.97%,-7.90%,+9.45%,,,,,,,0,-1,-1,-1,-1,-1
288.68M,"87,682",-116.80M,-1,,7.51,Strong Buy,11.83,"Aug 8, 2024",RZLV,Rezolve AI Limited,2.13B,10.05,-,-11.76%,-17.74%,-18.83%,,,Rezolve AI enters partnership with SPH AG,Rezolve AI and SPH AG Partner to Revolutionize Retail with Cutting-Edge AI Solutions,Rezolve AI Confirms Market Leadership Ambitions in Conversational Commerce Following Nasdaq Listing and Key Partnerships with ChatWerk and ePages,Rezolve AI Announces Strategic Partnership with ChatWerk to Revolutionize Conversational Commerce on Social Media Platforms,Rezolve AI announces partnership with ChatWerk,Rezolve AI enters partnership with SPH AG Rezolve AI and SPH AG Partner to Revolutionize Retail with Cutting-Edge AI Solutions Rezolve AI Confirms Market Leadership Ambitions in Conversational Commerce Following Nasdaq Listing and Key Partnerships with ChatWerk and ePages Rezolve AI Announces Strategic Partnership with ChatWerk to Revolutionize Conversational Commerce on Social Media Platforms Rezolve AI announces partnership with ChatWerk,0,0,0,0,0,0
56.87M,"293,717",87.42M,-1,,38.04,Buy,53.17,"Aug 7, 2024",PSEC,Prospect Capital Corporation,2.12B,5.08,870.91M,0.63%,-4.94%,-9.01%,-7.72%,-7.89%,Largest borrow rate increases among liquid names,Prospect Capital price target lowered to $4.50 from $5 at Wells Fargo,Prospect Capital: Sell Rating Justified by NAV Decline and Questionable Financial Strategies,Prospect Capital Announces Monthly Distributions and Dividends,Prospect Capital reports Q2 EPS (2c) vs. (3c) last year,Largest borrow rate increases among liquid names Prospect Capital price target lowered to $4.50 from $5 at Wells Fargo Prospect Capital: Sell Rating Justified by NAV Decline and Questionable Financial Strategies Prospect Capital Announces Monthly Distributions and Dividends Prospect Capital reports Q2 EPS (2c) vs. (3c) last year,0,1,0,0,0,0
33.68M,"117,690",78.52M,$2.00,618,64.07,Buy,85.89,"Aug 1, 2024",MBIN,Merchants Bancorp,2.12B,46.37,614.23M,7.42%,5.17%,10.87%,+0.67%,+9.47%,Merchants Bancorp Declares Quarterly Common and Preferred Dividends,,,,,Merchants Bancorp Declares Quarterly Common and Preferred Dividends,0,0,-1,-1,-1,-1
56.78M,"403,372",83.01M,-1,436,38.00,Buy,45.57,"Aug 6, 2024",BEAM,Beam Therapeutics Inc.,2.12B,26.81,352.57M,1.04%,1.73%,-4.28%,-17.67%,-7.62%,Optimistic Outlook on Beam Therapeutics: Advancements and Potential in Precision Genetic Medicines,"Analysts Are Bullish on Top Healthcare Stocks: Beam Therapeutics (BEAM), Taysha Gene Therapies (TSHA)",,,,"Optimistic Outlook on Beam Therapeutics: Advancements and Potential in Precision Genetic Medicines Analysts Are Bullish on Top Healthcare Stocks: Beam Therapeutics (BEAM), Taysha Gene Therapies (TSHA)",0,1,0,-1,-1,-1
171.46M,"686,291",-163.04M,-1,"2,110",12.57,Strong Buy,15.35,"Aug 2, 2024",ROCK,"Gibraltar Industries, Inc.",2.10B,68.88,1.37B,1.05%,-3.50%,-8.72%,-8.68%,-13.52%,Gibraltar Industries increases quarterly cash dividend 16.7% to 7c per share,Gibraltar Industries Welcomes New CFO Joseph A. Lovechio,Gibraltar Industries appoints Joseph Lovechio as CFO,,,Gibraltar Industries increases quarterly cash dividend 16.7% to 7c per share Gibraltar Industries Welcomes New CFO Joseph A. Lovechio Gibraltar Industries appoints Joseph Lovechio as CFO,0,0,0,0,-1,-1
54.83M,"197,316",-107.85M,-1,"15,800",39.30,Strong Buy,42.43,"Aug 8, 2024",TTMI,"TTM Technologies, Inc.",2.09B,20.49,2.32B,5.56%,1.03%,20.32%,+0.67%,+33.63%,CPI Aerostructures appoints Passarello as CFO,,,,,CPI Aerostructures appoints Passarello as CFO,1,1,-1,-1,-1,-1
160.89M,"731,622",-78.68M,-1,"10,200",13.29,Hold,17.79,"Aug 6, 2024",MLKN,"MillerKnoll, Inc.",2.08B,29.85,3.63B,2.69%,6.70%,8.69%,-5.22%,+9.91%,,,,,,,0,-1,-1,-1,-1,-1
128.16M,"549,120",-78.55M,-1,"4,200",16.66,Strong Buy,19.70,"Jul 29, 2024",ZD,"Ziff Davis, Inc.",2.08B,46.45,1.37B,7.89%,-2.97%,-19.75%,-2.15%,-19.15%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance","RBC Capital Sticks to Their Buy Rating for Ziff Davis, Inc. (ZD)","Analysts Offer Insights on Communication Services Companies: Ziff Davis, Inc. (ZD) and Clear Channel Outdoor (CCO)","Analysts’ Opinions Are Mixed on These Communication Services Stocks: Ziff Davis, Inc. (ZD), Gray Television (GTN) and Quebecor (OtherQBCRF)",,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance RBC Capital Sticks to Their Buy Rating for Ziff Davis, Inc. (ZD) Analysts Offer Insights on Communication Services Companies: Ziff Davis, Inc. (ZD) and Clear Channel Outdoor (CCO) Analysts’ Opinions Are Mixed on These Communication Services Stocks: Ziff Davis, Inc. (ZD), Gray Television (GTN) and Quebecor (OtherQBCRF)",1,1,0,1,1,-1
212.20M,"72,469",,-1,246,9.80,,,,HRMY,"Harmony Biosciences Holdings, Inc.",2.07B,36.36,656.11M,3.44%,8.21%,13.58%,+4.73%,+15.69%,Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY) and McKesson (MCK),,,,,Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY) and McKesson (MCK),1,1,-1,-1,-1,-1
,,,-1,"47,900",,,,,CAKE,The Cheesecake Factory Incorporated,2.07B,40.61,3.50B,9.35%,6.39%,13.39%,+2.47%,+16.21%,Jefferies Remains a Buy on Cheesecake Factory (CAKE),Cheesecake Factory management to meet with Jefferies,,,,Jefferies Remains a Buy on Cheesecake Factory (CAKE) Cheesecake Factory management to meet with Jefferies,0,0,0,-1,-1,-1
417.76M,"3,339,470",142.52M,$0.72,"15,000",5.080,Sell,5.38,"Sep 3, 2024",PTVE,Pactiv Evergreen Inc.,2.07B,11.52,5.24B,6.98%,0.25%,-11.51%,-13.39%,-23.57%,Pactiv Evergreen Inc. to Present at the 2024 Jefferies Industrials Conference,Pactiv Evergreen Launches Recycleware® Reduced-Density Polypropylene Packaging Products,Pactiv Evergreen launches Recycleware Reduced-Density Polypropylene trays,,,Pactiv Evergreen Inc. to Present at the 2024 Jefferies Industrials Conference Pactiv Evergreen Launches Recycleware® Reduced-Density Polypropylene Packaging Products Pactiv Evergreen launches Recycleware Reduced-Density Polypropylene trays,1,0,1,0,-1,-1
,,,-1,"3,650",,,,,OMCL,"Omnicell, Inc.",2.06B,44.80,1.08B,12.27%,39.25%,44.24%,+54.71%,+64.21%,Omnicell management to meet virtually with KeyBanc,Craig-Hallum Remains a Buy on Omnicell (OMCL),Piper Sandler Remains a Buy on Omnicell (OMCL),Omnicell price target raised to $37 from $26 at JPMorgan,Omnicell (OMCL) Receives a Buy from Craig-Hallum,Omnicell management to meet virtually with KeyBanc Craig-Hallum Remains a Buy on Omnicell (OMCL) Piper Sandler Remains a Buy on Omnicell (OMCL) Omnicell price target raised to $37 from $26 at JPMorgan Omnicell (OMCL) Receives a Buy from Craig-Hallum,0,1,0,0,0,0
45.76M,"128,169",286.84M,$0.36,630,46.37,Buy,57.00,"Jul 29, 2024",LMAT,"LeMaitre Vascular, Inc.",2.06B,91.67,205.62M,5.92%,6.49%,30.83%,+2.47%,+38.41%,LeMaitre to Participate at Upcoming Investor Conferences in September,Lemaitre Vascular (LMAT) Gets a Buy from Lake Street,"LeMaitre Vascular CFO Retires, Joins Board of Directors",LeMaitre price target raised to $100 from $77 at JMP Securities,Lemaitre Vascular’s Strong Financial Performance and Growth Potential Warrant a Buy Rating,"LeMaitre to Participate at Upcoming Investor Conferences in September Lemaitre Vascular (LMAT) Gets a Buy from Lake Street LeMaitre Vascular CFO Retires, Joins Board of Directors LeMaitre price target raised to $100 from $77 at JMP Securities Lemaitre Vascular’s Strong Financial Performance and Growth Potential Warrant a Buy Rating",1,0,0,1,1,1
79.06M,"643,437",-143.01M,-1,"2,800",26.81,Buy,44.11,"Aug 6, 2024",PINC,"Premier, Inc.",2.05B,20.50,1.35B,-1.86%,1.74%,-3.92%,-5.39%,-5.66%,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",Premier downgraded to Hold from Buy at Benchmark,Premier Inc.: Balancing Restructuring Challenges with Positive Performance Services Uptake,Premier’s Financial Performance and Strategy Update,Premier price target lowered to $20 from $21 at Canaccord,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Premier downgraded to Hold from Buy at Benchmark Premier Inc.: Balancing Restructuring Challenges with Positive Performance Services Uptake Premier’s Financial Performance and Strategy Update Premier price target lowered to $20 from $21 at Canaccord",1,1,1,1,1,1
30.48M,"121,851",115.86M,-1,"1,150",68.88,,,"Jul 31, 2024",NSSC,"Napco Security Technologies, Inc.",2.05B,55.47,183.15M,-13.73%,-13.38%,8.45%,-15.07%,+16.12%,Napco Counters Short-Seller Claims with Strong Financials,"Napco short report ‘fundamental misunderstanding,’ says TD Cowen","Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz",Fuzzy Panda Research issues cautious report on Napco Security,Napco Security management to meet with Stephens,"Napco Counters Short-Seller Claims with Strong Financials Napco short report ‘fundamental misunderstanding,’ says TD Cowen Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz Fuzzy Panda Research issues cautious report on Napco Security Napco Security management to meet with Stephens",0,1,1,1,0,1
101.95M,"557,859",17.09M,-1,915,20.49,Strong Buy,24.31,"Jul 31, 2024",AMBA,"Ambarella, Inc.",2.04B,49.87,218.81M,13.39%,-0.03%,-0.68%,+10.94%,+22.00%,"Stocks making the biggest moves midday: Super Micro, Abercrombie and more","Retail traders are bullish on Nvidia ahead of earnings, while others not so much","Stocks making biggest moves premarket: Super Micro, Abercrombie and more","Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more","S&P 500, Nasdaq close lower Wednesday, Nvidia tumbles before earnings","Stocks making the biggest moves midday: Super Micro, Abercrombie and more Retail traders are bullish on Nvidia ahead of earnings, while others not so much Stocks making biggest moves premarket: Super Micro, Abercrombie and more Wednesday’s top analyst calls: Nvidia, Apple, Meta, Tesla, McDonald’s and more S&P 500, Nasdaq close lower Wednesday, Nvidia tumbles before earnings",0,1,0,1,1,1
69.83M,"492,814",82.30M,$0.75,"1,966",29.85,Hold,25.00,"Sep 19, 2024",BANR,Banner Corporation,2.04B,59.15,593.74M,5.94%,10.03%,21.49%,+0.76%,+29.24%,,,,,,,0,-1,-1,-1,-1,-1
44.74M,"520,220",79.99M,-1,"2,757",46.45,Buy,71.50,"Aug 7, 2024",TRMK,Trustmark Corporation,2.03B,33.18,536.99M,2.42%,4.10%,16.28%,-4.69%,+21.96%,,,,,,,0,-1,-1,-1,-1,-1
56.83M,"184,623",114.99M,-1,"7,449",36.36,Buy,41.67,"Aug 6, 2024",YY,JOYY Inc.,2.03B,34.23,2.25B,-1.61%,2.06%,-0.24%,+3.97%,+1.61%,Joyy price target raised to $35 from $30 at JPMorgan,JOYY (YY) Receives a Hold from Benchmark Co.,"Joyy, Inc. Reported Earnings. Did it Beat Estimates?",JOYY Inc. Posts Steady Revenue Amidst Profit Dip,"JOYY Reports Second Quarter 2024 Financial Results: Total Revenues up 3.3% Year Over Year, BIGO Achieves Fourth Consecutive Quarter of Growth","Joyy price target raised to $35 from $30 at JPMorgan JOYY (YY) Receives a Hold from Benchmark Co. Joyy, Inc. Reported Earnings. Did it Beat Estimates? JOYY Inc. Posts Steady Revenue Amidst Profit Dip JOYY Reports Second Quarter 2024 Financial Results: Total Revenues up 3.3% Year Over Year, BIGO Achieves Fourth Consecutive Quarter of Growth",1,0,1,0,1,1
50.87M,"1,094,264",116.26M,$1.08,"3,700",40.61,Hold,39.69,"Jul 31, 2024",VRNT,Verint Systems Inc.,2.03B,32.89,915.10M,-2.06%,-2.47%,6.70%,-12.06%,+4.06%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more","Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more",Verint price target lowered to $30 from $34 at Evercore ISI,Evercore ISI Remains a Hold on Verint Systems (VRNT),"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Stocks making the biggest moves premarket: C3.ai, Tesla, JetBlue and more Stocks making the biggest moves after hours: C3.ai, Topgolf Callaway and more Verint price target lowered to $30 from $34 at Evercore ISI Evercore ISI Remains a Hold on Verint Systems (VRNT)",1,1,1,1,0,0
179.25M,"409,676",75.00M,$0.40,"2,845",11.52,Strong Buy,14.57,"Jul 31, 2024",TRIP,"Tripadvisor, Inc.",2.02B,14.60,1.82B,-1.76%,-12.16%,-30.24%,-18.72%,-47.39%,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more",TripAdvisor call volume above normal and directionally bullish,Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call,TripAdvisor initiated with an Underweight at Cantor Fitzgerald,TripAdvisor price target lowered to $17 from $21 at Truist,"Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more TripAdvisor call volume above normal and directionally bullish Cantor Fitzgerald Internet analyst to hold an analyst/industry conference call TripAdvisor initiated with an Underweight at Cantor Fitzgerald TripAdvisor price target lowered to $17 from $21 at Truist",0,1,1,1,1,0
45.99M,"322,980",-20.76M,-1,"2,114",44.80,Buy,36.17,"Aug 1, 2024",EXPI,"eXp World Holdings, Inc.",2.02B,13.11,4.44B,3.74%,5.85%,6.53%,-12.95%,+24.25%,,,,,,,0,-1,-1,-1,-1,-1
22.47M,"109,709",37.68M,$0.64,"5,000",91.67,Buy,85.40,"Aug 1, 2024",SPNS,Sapiens International Corporation N.V.,2.01B,36.08,532.61M,1.55%,0.78%,16.43%,-8.17%,+9.54%,Sapiens Secures Deal with Top Canadian Insurer,Sapiens Boosts Insurance Risk Insights with Addresscloud,Sapiens Launches Enhanced Insurance Suite for P&C Market,Sapiens (SPNS) Announces Q3 Dividend: Save the Dates!,Sapiens Announces Substantial Mid-Year Dividend,Sapiens Secures Deal with Top Canadian Insurer Sapiens Boosts Insurance Risk Insights with Addresscloud Sapiens Launches Enhanced Insurance Suite for P&C Market Sapiens (SPNS) Announces Q3 Dividend: Save the Dates! Sapiens Announces Substantial Mid-Year Dividend,1,0,1,1,0,1
100.19M,"895,290",119.54M,$0.84,"2,543",20.50,Hold,20.90,"Aug 20, 2024",AVPT,"AvePoint, Inc.",2.01B,10.79,299.88M,1.95%,3.42%,23.55%,+5.60%,+37.02%,AvePoint Announces Commencement of an Offer to Purchase and Consent Solicitation Relating to its Warrants,AvePoint announces commencement of offer to acquire outstanding public warrants,AvePoint price target raised to $7.50 from $7 at Goldman Sachs,"Analysts Offer Insights on Technology Companies: Viavi Solutions (VIAV), AvePoint (AVPT) and Unity Software (U)",AvePoint price target raised to $19 from $18 at Northland,"AvePoint Announces Commencement of an Offer to Purchase and Consent Solicitation Relating to its Warrants AvePoint announces commencement of offer to acquire outstanding public warrants AvePoint price target raised to $7.50 from $7 at Goldman Sachs Analysts Offer Insights on Technology Companies: Viavi Solutions (VIAV), AvePoint (AVPT) and Unity Software (U) AvePoint price target raised to $19 from $18 at Northland",1,1,1,0,1,0
36.87M,"1,560,206",49.82M,$0.40,"1,468",55.47,Strong Buy,51.00,"Aug 26, 2024",TFIN,"Triumph Financial, Inc.",2.01B,86.25,400.00M,-0.90%,-0.40%,8.59%,-8.77%,+7.44%,Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock,,,,,Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock,1,0,-1,-1,-1,-1
40.99M,"829,151",-171.45M,-1,705,49.87,Buy,70.92,"Aug 27, 2024",MGPI,"MGP Ingredients, Inc.",2.00B,91.10,787.88M,5.31%,13.36%,7.33%,+10.36%,+11.32%,,,,,,,0,-1,-1,-1,-1,-1
34.46M,"193,987",165.83M,$1.92,911,59.15,Buy,54.00,"Oct 16, 2024",MGNI,"Magnite, Inc.",2.00B,14.16,649.22M,5.38%,1.87%,29.22%,-6.53%,+38.82%,Craig-Hallum Keeps Their Buy Rating on Magnite (MGNI),Macquarie sees upside for ad tech companies if Alphabet loses court battle,Blitz selects Magnite as preferred SSP to streamline programmatic strategy,Gaming Analytics Platform Blitz Chooses Magnite as Preferred SSP to Streamline Programmatic Strategy,Magnite to Participate in Upcoming Financial Conferences,Craig-Hallum Keeps Their Buy Rating on Magnite (MGNI) Macquarie sees upside for ad tech companies if Alphabet loses court battle Blitz selects Magnite as preferred SSP to streamline programmatic strategy Gaming Analytics Platform Blitz Chooses Magnite as Preferred SSP to Streamline Programmatic Strategy Magnite to Participate in Upcoming Financial Conferences,0,0,1,0,0,0
61.21M,"182,470",185.52M,$0.92,287,33.18,Hold,34.80,"Jul 23, 2024",ENLT,Enlight Renewable Energy Ltd,1.98B,16.24,307.24M,3.02%,1.78%,-3.78%,+8.50%,+4.43%,"Analysts Are Bullish on These Utilities Stocks: Sempra Energy (SRE), Enlight Renewable Energy (ENLT)",,,,,"Analysts Are Bullish on These Utilities Stocks: Sempra Energy (SRE), Enlight Renewable Energy (ENLT)",0,1,-1,-1,-1,-1
59.32M,"367,848",366.87M,$1.73,71,34.23,Hold,35.00,"Aug 27, 2024",ROIC,Retail Opportunity Investments Corp.,1.98B,15.51,335.05M,3.23%,14.57%,19.61%,+4.68%,+27.65%,Retail Opportunity Investments (ROIC) Receives a Hold from Wells Fargo,Retail Opportunity price target raised to $16 from $13.50 at Wells Fargo,Retail Opportunity price target raised to $16 from $15 at Raymond James,,,Retail Opportunity Investments (ROIC) Receives a Hold from Wells Fargo Retail Opportunity price target raised to $16 from $13.50 at Wells Fargo Retail Opportunity price target raised to $16 from $15 at Raymond James,0,0,0,0,-1,-1
61.71M,"439,122",29.76M,-1,"18,000",32.89,Buy,36.50,"Sep 4, 2024",FTRE,Fortrea Holdings Inc.,1.97B,22.03,3.01B,-4.67%,-6.38%,-26.52%,-17.98%,-42.03%,"Starboard raised Salesforce in Q2, cut stake in this online web services stock",Fortrea price target lowered to $23 from $28 at Deutsche Bank,"Starboard boosts stake in Salesforce, cuts stake in Humana","Jana added Rapid7 during Q2, sold out of Freshpet",Fortrea Holdings Inc.: Hold Rating Affirmed Amidst Reduced Earnings Projections and Cautious Outlook,"Starboard raised Salesforce in Q2, cut stake in this online web services stock Fortrea price target lowered to $23 from $28 at Deutsche Bank Starboard boosts stake in Salesforce, cuts stake in Humana Jana added Rapid7 during Q2, sold out of Freshpet Fortrea Holdings Inc.: Hold Rating Affirmed Amidst Reduced Earnings Projections and Cautious Outlook",0,1,1,1,1,0
138.64M,"1,399,570",24.00M,-1,"1,221",14.60,Hold,19.93,"Aug 6, 2024",EFSC,Enterprise Financial Services Corp,1.97B,52.81,582.46M,4.98%,14.07%,25.67%,-0.15%,+35.12%,Enterprise Financial Services (EFSC) Receives a Buy from Piper Sandler,,,,,Enterprise Financial Services (EFSC) Receives a Buy from Piper Sandler,0,0,-1,-1,-1,-1
153.73M,"609,860",-23.10M,$0.20,48,13.11,Hold,13.50,"Jul 31, 2024",HPK,"HighPeak Energy, Inc.",1.97B,15.47,1.21B,1.82%,1.51%,3.10%,-7.73%,-3.54%,Truist Financial Reaffirms Their Hold Rating on HighPeak Energy (HPK),,,,,Truist Financial Reaffirms Their Hold Rating on HighPeak Energy (HPK),0,0,-1,-1,-1,-1
55.84M,"52,432",68.82M,$0.57,566,36.08,Buy,41.67,"Aug 1, 2024",PGNY,"Progyny, Inc.",1.97B,21.80,1.13B,-5.90%,-16.70%,-33.33%,-22.77%,-38.46%,Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity,"Analysts Are Bullish on These Healthcare Stocks: Progyny (PGNY), HCA Healthcare (HCA)","Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)","JPMorgan cuts Progyny target, removes from Analyst Focus List",Progyny’s Growth Potential Tempered by Execution Risks: Hold Rating Maintained,"Barclays sees four catalysts ahead for this ‘overlooked’ investment opportunity Analysts Are Bullish on These Healthcare Stocks: Progyny (PGNY), HCA Healthcare (HCA) Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT) JPMorgan cuts Progyny target, removes from Analyst Focus List Progyny’s Growth Potential Tempered by Execution Risks: Hold Rating Maintained",0,0,1,1,0,1
186.72M,"749,702",-14.47M,-1,"1,142",10.79,Buy,12.75,"Aug 8, 2024",TRUP,"Trupanion, Inc.",1.97B,46.63,1.20B,18.05%,37.54%,62.13%,+25.61%,+78.35%,John Gallagher Appointed as Trupanion COO with New Compensation Package,Trupanion Publishes 2024 Corporate Social Responsibility Report,"Trupanion partners with CDC, partners to launch health warning system",Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System ,Bank of America Securities Reaffirms Their Buy Rating on Trupanion (TRUP),"John Gallagher Appointed as Trupanion COO with New Compensation Package Trupanion Publishes 2024 Corporate Social Responsibility Report Trupanion partners with CDC, partners to launch health warning system Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System  Bank of America Securities Reaffirms Their Buy Rating on Trupanion (TRUP)",0,1,0,0,0,1
23.31M,"85,753",26.12M,-1,264,86.25,Sell,71.00,"Oct 17, 2024",MIRM,"Mirum Pharmaceuticals, Inc.",1.96B,41.12,264.38M,8.50%,16.69%,46.61%,+8.19%,+67.06%,Biotech Alert: Searches spiking for these stocks today,Mirum Pharmaceuticals Maintains Buy Rating with Positive Financials and Strategic Advances,,,,Biotech Alert: Searches spiking for these stocks today Mirum Pharmaceuticals Maintains Buy Rating with Positive Financials and Strategic Advances,1,1,1,-1,-1,-1
21.99M,"143,950",95.99M,$0.48,"2,849",91.10,Strong Buy,117.33,"Aug 1, 2024",EXTR,"Extreme Networks, Inc.",1.96B,15.01,1.12B,7.79%,11.47%,11.36%,+6.22%,+39.61%,Extreme Networks: NFL clubs deploying ‘Wi-Fi Solutions’ for Fan experience,"Class Action Filed Against Extreme Networks, Inc. (EXTR) – October 15, 2024 Deadline to Join – Contact Levi & Korsinsky LLP",Extreme Networks management to meet with B. Riley,,,"Extreme Networks: NFL clubs deploying ‘Wi-Fi Solutions’ for Fan experience Class Action Filed Against Extreme Networks, Inc. (EXTR) – October 15, 2024 Deadline to Join – Contact Levi & Korsinsky LLP Extreme Networks management to meet with B. Riley",0,0,1,0,-1,-1
141.15M,"1,004,947",-5.40M,-1,297,14.16,Strong Buy,17.39,"Aug 7, 2024",KNSA,"Kiniksa Pharmaceuticals International, plc",1.95B,27.38,338.93M,5.00%,18.81%,37.76%,-0.86%,+47.32%,Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference,"Analysts Offer Insights on Healthcare Companies: Kiniksa Pharmaceuticals (KNSA), Repligen (RGEN) and Teva Pharmaceutical (TEVA)",,,,"Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference Analysts Offer Insights on Healthcare Companies: Kiniksa Pharmaceuticals (KNSA), Repligen (RGEN) and Teva Pharmaceutical (TEVA)",0,0,1,-1,-1,-1
117.83M,"6,059",57.19M,-1,"1,453",16.24,Buy,18.75,"Aug 7, 2024",NVCR,NovoCure Limited,1.95B,18.02,549.96M,-5.88%,-3.43%,12.16%,-13.35%,+43.60%,NovoCure Leadership Transition Signals Stability and Earns Buy Rating,NovoCure Announces Major Leadership Restructuring and New Roles,"Novocure announces planned CEO transition, COO to step down",,,"NovoCure Leadership Transition Signals Stability and Earns Buy Rating NovoCure Announces Major Leadership Restructuring and New Roles Novocure announces planned CEO transition, COO to step down",0,0,0,0,-1,-1
127.45M,"467,401",34.36M,$0.60,"1,415",15.51,Hold,14.38,"Oct 22, 2024",GSHD,"Goosehead Insurance, Inc",1.94B,80.30,275.47M,-1.49%,17.26%,18.41%,-5.91%,+42.70%,Root teams with Goosehead to expedite sales for independent agents,"TJX downgraded, Crocs upgraded: Wall Street’s top analyst calls","TD downgrades Goosehead Insurance on valuation, execution risks",Goosehead Insurance downgraded to Hold from Buy at TD Cowen,,"Root teams with Goosehead to expedite sales for independent agents TJX downgraded, Crocs upgraded: Wall Street’s top analyst calls TD downgrades Goosehead Insurance on valuation, execution risks Goosehead Insurance downgraded to Hold from Buy at TD Cowen",1,1,1,1,1,-1
89.60M,"1,235,950",-286.10M,-1,"3,868",22.03,Hold,26.70,"Aug 12, 2024",PLUG,Plug Power Inc.,1.94B,2.20,684.49M,-4.54%,-14.90%,-36.99%,-21.46%,-38.22%,Plug Power Announces Completion of Undertakings Related to 2023 SEC Settlement,Plug Power (PLUG) Gets a Buy from Craig-Hallum,Plug Power awarded $10M DOE grant to lead hydrogen refeuling station development,Wall Street Analysts Are Bullish on Top Industrial Goods Picks,Plug Power Welcomes Colin Angle to Board of Directors,Plug Power Announces Completion of Undertakings Related to 2023 SEC Settlement Plug Power (PLUG) Gets a Buy from Craig-Hallum Plug Power awarded $10M DOE grant to lead hydrogen refeuling station development Wall Street Analysts Are Bullish on Top Industrial Goods Picks Plug Power Welcomes Colin Angle to Board of Directors,0,0,0,0,1,0
37.37M,"113,472",171.29M,$1.08,"2,321",52.81,Strong Buy,50.75,"Jul 22, 2024",WSBC,"WesBanco, Inc.",1.93B,32.46,563.25M,4.42%,7.26%,10.83%,+0.66%,+12.91%,WesBanco Declares Quarterly Cash Dividend to Its Shareholders,,,,,WesBanco Declares Quarterly Cash Dividend to Its Shareholders,1,0,-1,-1,-1,-1
127.38M,"149,183",152.17M,$0.16,652,15.47,Buy,24.10,"Aug 5, 2024",SUPN,"Supernus Pharmaceuticals, Inc.",1.93B,34.97,630.16M,8.14%,17.75%,19.32%,+16.16%,+3.25%,Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference,Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA,Supernus announces FDA acceptance of SPN-830 apomorphine infusion device NDA,,,Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA Supernus announces FDA acceptance of SPN-830 apomorphine infusion device NDA,1,0,0,0,-1,-1
90.28M,"910,736",62.75M,-1,"16,422",21.80,Buy,30.17,"Aug 6, 2024",VEON,VEON Ltd.,1.92B,27.37,3.87B,-2.39%,0.26%,13.81%,+0.90%,+13.47%,Supporting Digital Skills Development: Beeline Kazakhstan Adds New Secondary School to Award-Winning CSR Programme,VEON Ltd. Reports Mid-Year Financials to SEC,VEON Releases Mid-Year Unaudited Financials,VEON discloses its unaudited interim condensed consolidated financial statements for the six-month period ended 30 June 2024 and publishes its interim report for the same period,Tamasha Opens New Innings with First International Streaming of Cricket Matches,Supporting Digital Skills Development: Beeline Kazakhstan Adds New Secondary School to Award-Winning CSR Programme VEON Ltd. Reports Mid-Year Financials to SEC VEON Releases Mid-Year Unaudited Financials VEON discloses its unaudited interim condensed consolidated financial statements for the six-month period ended 30 June 2024 and publishes its interim report for the same period Tamasha Opens New Innings with First International Streaming of Cricket Matches,0,0,1,1,0,1
42.16M,"636,237",-18.91M,-1,"1,543",46.63,Buy,36.17,"Aug 8, 2024",NVAX,"Novavax, Inc.",1.92B,11.99,987.67M,-8.37%,-16.23%,35.52%,-13.11%,+151.81%,FDA authorizes Novavax Covid vaccine targeting JN.1,"Healthy Returns: What to know about updated Pfizer, Moderna Covid vaccines","FDA approves updated Pfizer, Moderna Covid vaccines as virus surges",Biotech Alert: Searches spiking for these stocks today,Strong Buy Rating for Novavax: Strategic Positioning and Enhanced COVID-19 Vaccine Efficacy,"FDA authorizes Novavax Covid vaccine targeting JN.1 Healthy Returns: What to know about updated Pfizer, Moderna Covid vaccines FDA approves updated Pfizer, Moderna Covid vaccines as virus surges Biotech Alert: Searches spiking for these stocks today Strong Buy Rating for Novavax: Strategic Positioning and Enhanced COVID-19 Vaccine Efficacy",1,0,1,1,1,1
47.71M,"297,747",-109.16M,-1,"2,100",41.12,Strong Buy,55.77,"Aug 7, 2024",EVCM,EverCommerce Inc.,1.92B,10.41,691.69M,-0.94%,-4.43%,4.45%,-13.27%,+15.96%,Evercommerce to Present at August 2024 Investor Conferences,,,,,Evercommerce to Present at August 2024 Investor Conferences,0,0,-1,-1,-1,-1
130.34M,"967,411",-85.96M,-1,56,15.01,Buy,15.90,"Aug 7, 2024",AKRO,"Akero Therapeutics, Inc.",1.91B,27.46,-,3.51%,5.30%,16.87%,-0.37%,+14.69%,Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,Akero Therapeutics (AKRO) Receives a Buy from Morgan Stanley,Akero Therapeutics (AKRO) Gets a Buy from Evercore ISI,"3 Best Stocks to Buy Now, 8/12/2024, According to Top Analysts ",Buy Rating Affirmed for Akero Therapeutics Amidst Advancement in Phase III NASH Trials,"Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference Akero Therapeutics (AKRO) Receives a Buy from Morgan Stanley Akero Therapeutics (AKRO) Gets a Buy from Evercore ISI 3 Best Stocks to Buy Now, 8/12/2024, According to Top Analysts  Buy Rating Affirmed for Akero Therapeutics Amidst Advancement in Phase III NASH Trials",1,1,0,0,0,1
71.24M,"254,742",-10.23M,-1,"3,801",27.38,Buy,32.00,"Jul 23, 2024",HLMN,Hillman Solutions Corp.,1.90B,9.67,1.48B,0.90%,3.26%,4.83%,-6.31%,-7.31%,"Hillman Solutions Poised for Growth: Strategic Acquisition of Intex DIY, Inc. Reinforces Buy Rating",Hillman Solutions acquires Intex DIY,"Hillman Acquires Intex DIY, Expands Position in Cleaning Products Category",Hillman Solutions: A Buy Rating Backed by Strategic Growth and Strong Management,Hillman Solutions price target raised to $10 from $9 at Barclays,"Hillman Solutions Poised for Growth: Strategic Acquisition of Intex DIY, Inc. Reinforces Buy Rating Hillman Solutions acquires Intex DIY Hillman Acquires Intex DIY, Expands Position in Cleaning Products Category Hillman Solutions: A Buy Rating Backed by Strategic Growth and Strong Management Hillman Solutions price target raised to $10 from $9 at Barclays",1,0,1,1,1,0
108.22M,"439,922",-168.70M,-1,58,18.02,Hold,25.80,"Jul 25, 2024",LGND,Ligand Pharmaceuticals Incorporated,1.90B,103.82,133.48M,3.90%,11.14%,35.17%,-2.25%,+36.66%,"Ligand, Travere Therapeutics receives full FDA approval for Filspari",Ligand Pharma (LGND) Gets a Buy from Craig-Hallum,Ligand Pharma (LGND) Receives a Buy from Benchmark Co.,Ligand price target raised to $110 from $95 at Benchmark,Ligand Pharma (LGND) Gets a Buy from RBC Capital,"Ligand, Travere Therapeutics receives full FDA approval for Filspari Ligand Pharma (LGND) Gets a Buy from Craig-Hallum Ligand Pharma (LGND) Receives a Buy from Benchmark Co. Ligand price target raised to $110 from $95 at Benchmark Ligand Pharma (LGND) Gets a Buy from RBC Capital",0,0,0,0,1,0
24.21M,"326,537",18.57M,-1,"5,268",80.30,Buy,78.58,"Jul 24, 2024",WB,Weibo Corporation,1.89B,7.77,1.74B,-3.14%,-4.67%,-11.49%,-4.92%,-16.40%,Weibo put volume heavy and directionally bearish,Unusually active option classes on open August 26th,Weibo: A Buy Rating Amidst Resilient Profitability and Strategic Partnerships,Weibo’s Struggles Continue: Underperform Rating with Downgraded Price Target Amidst Declining Ad Revenue and Tough Competition,Weibo price target lowered to $11 from $13 at Citi,Weibo put volume heavy and directionally bearish Unusually active option classes on open August 26th Weibo: A Buy Rating Amidst Resilient Profitability and Strategic Partnerships Weibo’s Struggles Continue: Underperform Rating with Downgraded Price Target Amidst Declining Ad Revenue and Tough Competition Weibo price target lowered to $11 from $13 at Citi,1,1,0,1,1,0
879.64M,"25,404,526",-1.48B,-1,10,2.200,Hold,5.40,"Aug 8, 2024",WULF,TeraWulf Inc.,1.89B,4.93,120.25M,12.37%,-1.73%,69.83%,+0.48%,+77.87%,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more",Morgan Stanley says some crypto miners could gain by turning to data centers,Crypto Currents: Riot urges change for Bitfarms board,Wall Street Analysts Are Bullish on Top Financial Picks,TeraWulf Inc Shares Operational Progress Update,"Wednesday’s top analyst calls: Nvidia, Apple, Microsoft, Amazon and more Morgan Stanley says some crypto miners could gain by turning to data centers Crypto Currents: Riot urges change for Bitfarms board Wall Street Analysts Are Bullish on Top Financial Picks TeraWulf Inc Shares Operational Progress Update",1,1,0,0,1,0
59.59M,"236,354",126.30M,$1.44,880,32.46,Hold,32.25,"Jul 26, 2024",IAS,Integral Ad Science Holding Corp.,1.88B,11.68,498.16M,5.44%,11.10%,-2.44%,+13.16%,+13.27%,Integral Ad Science (IAS): A Resilient Growth Prospect with Untapped Technological Potential,"Integral Ad Science names Marc Grabowski as COO, Srishti Gupta as CPO",Morgan Stanley Reaffirms Their Hold Rating on Integral Ad Science (IAS),,,"Integral Ad Science (IAS): A Resilient Growth Prospect with Untapped Technological Potential Integral Ad Science names Marc Grabowski as COO, Srishti Gupta as CPO Morgan Stanley Reaffirms Their Hold Rating on Integral Ad Science (IAS)",0,0,1,0,-1,-1
55.11M,"217,336",5.24M,-1,"2,703",34.97,Buy,41.00,"Aug 6, 2024",CNXN,"PC Connection, Inc.",1.88B,71.46,2.76B,2.53%,7.00%,9.52%,+0.71%,+9.91%,,,,,,,0,-1,-1,-1,-1,-1
70.24M,"18,267",-2.99B,-1,"1,383",27.37,Strong Buy,35.00,"Aug 8, 2024",SPT,"Sprout Social, Inc.",1.88B,32.91,375.30M,-3.51%,-7.51%,-33.92%,-20.22%,-44.24%,Stifel Nicolaus Remains a Buy on Sprout Social (SPT),KeyBanc Sticks to Its Sell Rating for Sprout Social (SPT),Buy/Sell: Wall Street’s top 10 stock calls this week,Sprout Social downgraded to Underweight from Sector Weight at KeyBanc,"Analysts Are Bullish on These Technology Stocks: Corpay Inc (CPAY), Nvidia (NVDA)","Stifel Nicolaus Remains a Buy on Sprout Social (SPT) KeyBanc Sticks to Its Sell Rating for Sprout Social (SPT) Buy/Sell: Wall Street’s top 10 stock calls this week Sprout Social downgraded to Underweight from Sector Weight at KeyBanc Analysts Are Bullish on These Technology Stocks: Corpay Inc (CPAY), Nvidia (NVDA)",0,1,0,0,1,1
160.09M,"3,193,186",-294.33M,-1,"2,377",11.99,Buy,15.80,"Aug 8, 2024",PSNY,Polestar Automotive Holding UK PLC,1.88B,0.89,2.18B,47.63%,40.20%,-22.94%,+28.52%,-39.42%,Polestar price target lowered to $1.50 from $2 at Piper Sandler,"Polestar Q2 report shows challenges remain, says Barclays",Polestar (NASDAQ:PSNY) Blasts Up on New CFO,Polestar appoints Mady as Chief Financial Officer,"Top Stock Gainers Today – INTC, MDB, and More","Polestar price target lowered to $1.50 from $2 at Piper Sandler Polestar Q2 report shows challenges remain, says Barclays Polestar (NASDAQ:PSNY) Blasts Up on New CFO Polestar appoints Mady as Chief Financial Officer Top Stock Gainers Today – INTC, MDB, and More",1,0,1,1,1,1
184.25M,"93,346",-43.65M,-1,124,10.41,Buy,11.45,"Aug 6, 2024",NMRA,"Neumora Therapeutics, Inc.",1.87B,11.68,-,-2.21%,4.41%,-10.21%,-10.03%,-19.26%,"RBC Capital Reaffirms Their Buy Rating on Neumora Therapeutics, Inc. (NMRA)",Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders,"Analysts Are Bullish on Top Healthcare Stocks: Stereotaxis (STXS), Neumora Therapeutics, Inc. (NMRA)",,,"RBC Capital Reaffirms Their Buy Rating on Neumora Therapeutics, Inc. (NMRA) Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders Analysts Are Bullish on Top Healthcare Stocks: Stereotaxis (STXS), Neumora Therapeutics, Inc. (NMRA)",0,0,0,1,-1,-1
69.43M,"480,510",-204.18M,-1,774,27.46,Strong Buy,41.43,"Aug 9, 2024",CLBK,"Columbia Financial, Inc.",1.87B,17.85,205.62M,2.59%,8.10%,4.06%,-2.78%,+5.29%,"Columbia Financial, Inc. Announces Receipt of Regulatory Approval for Merger of Freehold Bank Into Columbia Bank",Columbia Financial receives regulatory approval for Freehold Bank merger,,,,"Columbia Financial, Inc. Announces Receipt of Regulatory Approval for Merger of Freehold Bank Into Columbia Bank Columbia Financial receives regulatory approval for Freehold Bank merger",0,1,0,-1,-1,-1
196.22M,"808,721",6.04M,-1,561,9.67,Strong Buy,11.92,"Aug 6, 2024",ENVX,Enovix Corporation,1.86B,10.57,16.62M,-7.66%,-25.02%,-6.77%,-31.92%,+29.93%,Enovix (ENVX) Pioneering the Future of Battery Tech,Enovix’s Innovative Battery Technology and Strategic Developments Merit a Buy Rating,,,,Enovix (ENVX) Pioneering the Future of Battery Tech Enovix’s Innovative Battery Technology and Strategic Developments Merit a Buy Rating,1,1,1,-1,-1,-1
18.27M,"116,646",42.14M,-1,"3,600",103.82,Strong Buy,131.00,"Aug 6, 2024",VIAV,Viavi Solutions Inc.,1.86B,8.38,1.00B,8.81%,13.03%,-0.11%,+5.60%,-3.08%,Northland Securities Reaffirms Their Buy Rating on Viavi Solutions (VIAV),"Analysts Offer Insights on Technology Companies: Viavi Solutions (VIAV), AvePoint (AVPT) and Unity Software (U)","Analysts Offer Insights on Technology Companies: Datadog (DDOG), Amplitude (AMPL) and Viavi Solutions (VIAV)",,,"Northland Securities Reaffirms Their Buy Rating on Viavi Solutions (VIAV) Analysts Offer Insights on Technology Companies: Viavi Solutions (VIAV), AvePoint (AVPT) and Unity Software (U) Analysts Offer Insights on Technology Companies: Datadog (DDOG), Amplitude (AMPL) and Viavi Solutions (VIAV)",0,0,1,0,-1,-1
243.31M,"1,538,802",322.09M,-1,"10,600",7.77,Buy,12.41,"Aug 22, 2024",LILAK,Liberty Latin America Ltd.,1.84B,9.38,4.51B,-2.13%,-0.74%,20.80%,-10.00%,+30.68%,Liberty Latin America Subsidiary Publishes Quarterly Report,Liberty Global LiLAC Releases Quarterly Financial Report,Liberty Latin America downgraded to Neutral from Buy at Goldman Sachs,Liberty LiLAC Group (LILAK) was downgraded to a Hold Rating at Goldman Sachs,Liberty Global LiLAC Quarterly Financial Report Released,Liberty Latin America Subsidiary Publishes Quarterly Report Liberty Global LiLAC Releases Quarterly Financial Report Liberty Latin America downgraded to Neutral from Buy at Goldman Sachs Liberty LiLAC Group (LILAK) was downgraded to a Hold Rating at Goldman Sachs Liberty Global LiLAC Quarterly Financial Report Released,0,1,0,1,1,1
382.60M,"12,429,878",-51.24M,-1,"3,988",4.930,Strong Buy,5.65,"Aug 12, 2024",RNW,ReNew Energy Global Plc,1.84B,5.68,984.89M,-1.30%,-3.70%,-9.12%,-4.47%,-5.12%,ReNew Energy Global signs 437.6 MW green attribute contract with Microsoft,Roth MKM Reaffirms Their Buy Rating on ReNew Energy Global (RNW),ReNew Energy Global price target lowered to $8 from $9 at Roth MKM,Buy Rating Affirmed for ReNew Energy Global on Robust Growth and Strategic Expansion Plans,ReNew Energy Growth Amidst Net Profit Dip,ReNew Energy Global signs 437.6 MW green attribute contract with Microsoft Roth MKM Reaffirms Their Buy Rating on ReNew Energy Global (RNW) ReNew Energy Global price target lowered to $8 from $9 at Roth MKM Buy Rating Affirmed for ReNew Energy Global on Robust Growth and Strategic Expansion Plans ReNew Energy Growth Amidst Net Profit Dip,0,1,1,1,1,1
161.36M,"504,282",2.85M,-1,"10,600",11.68,Buy,16.63,"Aug 1, 2024",LILA,Liberty Latin America Ltd.,1.84B,9.37,4.51B,-1.73%,-0.44%,21.16%,-9.06%,+30.55%,Liberty Latin America Subsidiary Publishes Quarterly Report,Liberty Global LiLAC Releases Quarterly Financial Report,Liberty Latin America downgraded to Neutral from Buy at Goldman Sachs,Liberty LiLAC Group (LILAK) was downgraded to a Hold Rating at Goldman Sachs,Liberty Global LiLAC Quarterly Financial Report Released,Liberty Latin America Subsidiary Publishes Quarterly Report Liberty Global LiLAC Releases Quarterly Financial Report Liberty Latin America downgraded to Neutral from Buy at Goldman Sachs Liberty LiLAC Group (LILAK) was downgraded to a Hold Rating at Goldman Sachs Liberty Global LiLAC Quarterly Financial Report Released,1,1,0,1,1,1
26.29M,"83,281",88.69M,$0.40,"12,970",71.46,,,"Jul 31, 2024",UPBD,"Upbound Group, Inc.",1.83B,33.41,4.17B,0.80%,2.52%,2.15%,-11.29%,+1.42%,Upbound Group management to meet virtually with Loop Capital,Analysts Offer Insights on Technology Companies: Upbound Group (UPBD) and Katapult Holdings (KPLT),Upbound Group: A Strong Buy Amid Legal Challenges,Upbound brand Acima sued by New York Attorney General,,Upbound Group management to meet virtually with Loop Capital Analysts Offer Insights on Technology Companies: Upbound Group (UPBD) and Katapult Holdings (KPLT) Upbound Group: A Strong Buy Amid Legal Challenges Upbound brand Acima sued by New York Attorney General,1,1,0,1,0,-1
57.08M,"415,208",-73.56M,-1,"7,600",32.91,Buy,51.79,"Aug 1, 2024",GTX,Garrett Motion Inc.,1.82B,8.34,3.71B,2.89%,-1.82%,-5.11%,-4.34%,-14.49%,,,,,,,1,-1,-1,-1,-1,-1
2.11B,"29,816,492",-1.41B,-1,"3,584",0.890,Hold,1.93,"Sep 3, 2024",PTON,"Peloton Interactive, Inc.",1.82B,4.84,2.70B,41.60%,37.20%,10.59%,+27.25%,+25.14%,"3 Buys and a Bail: Peloton, Gap, PayPal, & Nike","Stocks making the biggest moves premarket: Peloton, Workday, Chewy and more","Friday’s analyst calls: Warby Parker to rally more than 40%, Peloton downgraded",CNBC Daily Open: Stocks slide ahead of Powell speech,CNBC Daily Open: Stocks slide ahead of Powell speech,"3 Buys and a Bail: Peloton, Gap, PayPal, & Nike Stocks making the biggest moves premarket: Peloton, Workday, Chewy and more Friday’s analyst calls: Warby Parker to rally more than 40%, Peloton downgraded CNBC Daily Open: Stocks slide ahead of Powell speech CNBC Daily Open: Stocks slide ahead of Powell speech",0,1,1,1,0,0
160.03M,"363,940",-274.18M,-1,"22,800",11.68,Strong Buy,23.14,"Aug 6, 2024",DNUT,"Krispy Kreme, Inc.",1.81B,10.69,1.74B,4.73%,2.93%,-12.53%,+2.16%,-29.16%,Buy Rating on Krispy Kreme (DNUT) Backed by Strategic Partnerships and Operational Efficiencies,"Hershey, Temu parent PDD downgraded: Wall Street’s top analyst calls",Evercore ISI Releases a Hold Rating on Krispy Kreme (DNUT),Krispy Kreme resumed with an In Line at Evercore ISI,"Analysts Conflicted on These Consumer Cyclical Names: Krispy Kreme (DNUT), Arhaus (ARHS) and FIGS (FIGS)","Buy Rating on Krispy Kreme (DNUT) Backed by Strategic Partnerships and Operational Efficiencies Hershey, Temu parent PDD downgraded: Wall Street’s top analyst calls Evercore ISI Releases a Hold Rating on Krispy Kreme (DNUT) Krispy Kreme resumed with an In Line at Evercore ISI Analysts Conflicted on These Consumer Cyclical Names: Krispy Kreme (DNUT), Arhaus (ARHS) and FIGS (FIGS)",1,1,1,0,1,1
104.54M,"99,134",19.08M,-1,430,17.85,Buy,17.00,"Jul 31, 2024",PAX,Patria Investments Limited,1.81B,11.87,316.72M,0.06%,-3.64%,-13.97%,-9.92%,-18.33%,,,,,,,1,-1,-1,-1,-1,-1
176.28M,"2,257,647",-238.40M,-1,88,10.57,Strong Buy,21.60,"Jul 31, 2024",EWTX,"Edgewise Therapeutics, Inc.",1.81B,19.33,-,11.55%,5.03%,27.60%,+10.69%,+11.14%,Optimistic Buy Rating for Edgewise Therapeutics Amid Promising EDG-7500 Developments,Wedbush Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX),"Analysts Have Conflicting Sentiments on These Healthcare Companies: Insulet (PODD), Recursion Pharmaceuticals (RXRX) and Edgewise Therapeutics (EWTX)",Edgewise Therapeutics Unveils 2024 Equity Incentive Plan,Edgewise Therapeutics (EWTX) Receives a Buy from Piper Sandler,"Optimistic Buy Rating for Edgewise Therapeutics Amid Promising EDG-7500 Developments Wedbush Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX) Analysts Have Conflicting Sentiments on These Healthcare Companies: Insulet (PODD), Recursion Pharmaceuticals (RXRX) and Edgewise Therapeutics (EWTX) Edgewise Therapeutics Unveils 2024 Equity Incentive Plan Edgewise Therapeutics (EWTX) Receives a Buy from Piper Sandler",1,1,0,1,0,0
221.91M,"1,713,675",-25.80M,-1,260,8.38,Buy,11.18,"Aug 8, 2024",SOUN,"SoundHound AI, Inc.",1.80B,5.03,55.47M,1.19%,5.08%,22.98%,-4.72%,-6.37%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Largest borrow rate increases among liquid names,"SoundHound announces partnership with MUSC Health, deploy AI agents",Blackrock Pulls the Trigger on SoundHound AI and C3.ai Shares,SoundHound AI call volume above normal and directionally bullish,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Largest borrow rate increases among liquid names SoundHound announces partnership with MUSC Health, deploy AI agents Blackrock Pulls the Trigger on SoundHound AI and C3.ai Shares SoundHound AI call volume above normal and directionally bullish",1,1,1,0,1,1
196.30M,"636,734",-86.30M,-1,445,9.38,Strong Buy,12.85,"Aug 6, 2024",ARVN,"Arvinas, Inc.",1.80B,26.18,93.30M,1.49%,-2.66%,-23.82%,-6.32%,-31.17%,Arvinas to Participate in Upcoming Investor Conferences,Arvinas Holding Company (ARVN) Receives a Buy from Truist Financial,,,,Arvinas to Participate in Upcoming Investor Conferences Arvinas Holding Company (ARVN) Receives a Buy from Truist Financial,0,0,0,-1,-1,-1
323.93M,"583,829",9.78M,-1,497,5.68,Strong Buy,8.94,"Aug 15, 2024",IMCR,Immunocore Holdings plc,1.79B,35.76,280.91M,-3.54%,-3.78%,-33.76%,-8.97%,-43.09%,Immunocore CFO Brian Di Donato to depart,Immunocore Holdings: Strong Buy on Promising Drug Pipeline and Upcoming Milestones,Buy Rating Affirmed for Immunocore Holdings on Strong Kimmtrak Performance and Market Dominance,"Analysts’ Top Healthcare Picks: Immunocore Holdings (IMCR), Praxis Precision Medicines (PRAX)","Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)","Immunocore CFO Brian Di Donato to depart Immunocore Holdings: Strong Buy on Promising Drug Pipeline and Upcoming Milestones Buy Rating Affirmed for Immunocore Holdings on Strong Kimmtrak Performance and Market Dominance Analysts’ Top Healthcare Picks: Immunocore Holdings (IMCR), Praxis Precision Medicines (PRAX) Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)",1,1,1,1,1,0
196.20M,"218,944",-86.30M,-1,"2,280",9.37,Buy,8.65,"Aug 6, 2024",ARHS,"Arhaus, Inc.",1.79B,12.71,1.28B,-1.74%,-16.23%,-6.97%,-18.10%,-20.76%,Arhaus Outlines Growth Strategy in Premium Home Furniture Market,RH price target lowered to $310 from $325 at BofA,Arhaus Debuts Fall 2024 Collection,Arhaus price target lowered to $16 from $19.50 at Stifel,Arhaus price target lowered to $14 from $21 at Craig-Hallum,Arhaus Outlines Growth Strategy in Premium Home Furniture Market RH price target lowered to $310 from $325 at BofA Arhaus Debuts Fall 2024 Collection Arhaus price target lowered to $16 from $19.50 at Stifel Arhaus price target lowered to $14 from $21 at Craig-Hallum,0,0,0,0,0,0
54.68M,"316,108",54.75M,$1.48,"1,536",33.41,Buy,43.00,"Aug 1, 2024",ALHC,"Alignment Healthcare, Inc.",1.77B,9.27,2.23B,3.43%,5.60%,26.97%,+1.14%,+88.49%,Alignment Health Plan Ranks No. 2 in Customer Satisfaction Among Medicare Advantage Plans in California in J.D. Power Study,Alignment Healthcare to Present at Baird Global Healthcare Conference,"Aging in Place, Lack of Transportation and Access, and Economic Insecurity Are Top Three Social Barriers to U.S. Senior Health","Alignment Healthcare Board Reshuffles, Secures Consulting Deal",Alignment Healthcare Updates its Board of Directors,"Alignment Health Plan Ranks No. 2 in Customer Satisfaction Among Medicare Advantage Plans in California in J.D. Power Study Alignment Healthcare to Present at Baird Global Healthcare Conference Aging in Place, Lack of Transportation and Access, and Economic Insecurity Are Top Three Social Barriers to U.S. Senior Health Alignment Healthcare Board Reshuffles, Secures Consulting Deal Alignment Healthcare Updates its Board of Directors",0,0,0,0,1,0
218.61M,"612,692",239.00M,-1,"1,445",8.34,Strong Buy,12.00,"Oct 22, 2024",FBNC,First Bancorp,1.77B,42.95,380.10M,3.10%,12.64%,20.70%,+0.29%,+23.15%,,,,,,,0,-1,-1,-1,-1,-1
376.42M,"38,356,797",-551.90M,-1,"1,075",4.840,Hold,8.10,"Aug 22, 2024",SYBT,"Stock Yards Bancorp, Inc.",1.77B,60.27,327.47M,4.08%,9.38%,21.58%,-3.78%,+29.70%,Stock Yards Bancorp to Participate in the Raymond James 2024 U.S. Bank and Banking on Tech Conferences,KBW Sticks to Their Hold Rating for Stock Yards Bancorp (SYBT),Stock Yards Bancorp Increases Quarterly Cash Dividend to $0.31 Per Common Share,Stock Yards Bancorp increases quarterly dividend to 31c per share,,Stock Yards Bancorp to Participate in the Raymond James 2024 U.S. Bank and Banking on Tech Conferences KBW Sticks to Their Hold Rating for Stock Yards Bancorp (SYBT) Stock Yards Bancorp Increases Quarterly Cash Dividend to $0.31 Per Common Share Stock Yards Bancorp increases quarterly dividend to 31c per share,0,0,0,0,0,-1
169.60M,"1,331,849",-51.87M,$0.14,"2,175",10.69,Buy,15.88,"Aug 8, 2024",ZLAB,Zai Lab Limited,1.77B,18.02,322.71M,10.89%,7.99%,-5.80%,-1.42%,+20.88%,Zai Lab announced data from Phase 1 study of ZL-1218,"3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)",,,,"Zai Lab announced data from Phase 1 study of ZL-1218 3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)",0,1,1,-1,-1,-1
152.71M,"374,230",81.70M,$0.60,"6,480",11.87,,,"Aug 1, 2024",HURN,Huron Consulting Group Inc.,1.76B,107.64,1.43B,1.73%,4.07%,8.28%,-3.01%,+13.28%,Huron management to meet with Barrington,,,,,Huron management to meet with Barrington,0,1,-1,-1,-1,-1
93.77M,"719,480",-115.88M,-1,"2,167",19.33,Strong Buy,33.40,"Aug 8, 2024",MRX,Marex Group plc,1.76B,24.24,2.08B,14.51%,20.79%,23.30%,+14.36%,,Marex Group plc to participate in upcoming Barclays Global Financial Services Conference,Marex Group price target raised to $28 from $25 at Barclays,Marex Group Forecasts Strong Continued Growth,Marex Group board approves initial dividend of 14c per share,Marex Group sees FY24 adjusted operating profit $280M-$290M,Marex Group plc to participate in upcoming Barclays Global Financial Services Conference Marex Group price target raised to $28 from $25 at Barclays Marex Group Forecasts Strong Continued Growth Marex Group board approves initial dividend of 14c per share Marex Group sees FY24 adjusted operating profit $280M-$290M,1,1,0,1,1,1
358.73M,"10,641,804",-110.16M,-1,"4,500",5.03,Strong Buy,7.08,"Aug 8, 2024",NAVI,Navient Corporation,1.76B,16.12,1.03B,4.94%,6.89%,-1.30%,-0.43%,-4.05%,"Mom co-signed daughter’s student loan. Now 85, she fears lender may take her house","Stocks making the biggest moves after hours: Alphabet, Flutter, Nu Holdings and more",Barclays Remains a Sell on Navient (NAVI),Navient (NAVI) Receives a Hold from Seaport Global,Navient declares third quarter common stock dividend,"Mom co-signed daughter’s student loan. Now 85, she fears lender may take her house Stocks making the biggest moves after hours: Alphabet, Flutter, Nu Holdings and more Barclays Remains a Sell on Navient (NAVI) Navient (NAVI) Receives a Hold from Seaport Global Navient declares third quarter common stock dividend",0,1,1,1,1,0
68.65M,"396,553",-323.40M,-1,"1,063",26.18,Strong Buy,57.50,"Jul 30, 2024",VICR,Vicor Corporation,1.76B,39.05,370.22M,1.31%,5.72%,2.77%,-9.57%,+4.85%,Vicor responds to allegations made in securities litigation,Vicor Corporation Responds to Allegations Made in Recently Filed Securities Litigation,,,,Vicor responds to allegations made in securities litigation Vicor Corporation Responds to Allegations Made in Recently Filed Securities Litigation,0,1,0,-1,-1,-1
50.02M,"494,621",-54.88M,-1,33,35.76,Strong Buy,81.27,"Aug 8, 2024",SLNO,"Soleno Therapeutics, Inc.",1.76B,45.25,-,2.38%,7.47%,16.18%,-2.51%,+12.49%,Buy Rating on Soleno Therapeutics: Advancing PWS Treatment with DCCR and Anticipating FDA Approval,Soleno Therapeutics initiated with a Buy at H.C. Wainwright,Buy Rating for Soleno Therapeutics Amidst Favorable Regulatory Developments for DCCR,Largest borrow rate increases among liquid names,"Soleno announces FDA acceptance for filing, priority review of NDA for DCCR","Buy Rating on Soleno Therapeutics: Advancing PWS Treatment with DCCR and Anticipating FDA Approval Soleno Therapeutics initiated with a Buy at H.C. Wainwright Buy Rating for Soleno Therapeutics Amidst Favorable Regulatory Developments for DCCR Largest borrow rate increases among liquid names Soleno announces FDA acceptance for filing, priority review of NDA for DCCR",0,0,0,1,1,0
140.58M,"930,375",88.29M,-1,"2,165",12.71,Buy,15.18,"Aug 8, 2024",NWBI,"Northwest Bancshares, Inc.",1.76B,13.80,491.91M,2.40%,7.71%,14.86%,-2.42%,+22.76%,Northwest Bank appoints Sean Morrow as interim treasurer,,,,,Northwest Bank appoints Sean Morrow as interim treasurer,0,0,-1,-1,-1,-1
191.30M,"338,808",-152.79M,-1,"2,765",9.27,Buy,9.68,"Aug 1, 2024",HEES,"H&E Equipment Services, Inc.",1.75B,48.55,1.53B,2.85%,2.22%,-6.07%,-9.92%,-28.20%,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer",Cramer’s Lightning Round: Dell is a buy,H&E Equipment Services Reports Quarterly Cash Dividend,"Paramount, PayPal upgraded: Wall Street’s top analyst calls",,"Lightning Round: GoDaddy is a juggernaut, says Jim Cramer Cramer’s Lightning Round: Dell is a buy H&E Equipment Services Reports Quarterly Cash Dividend Paramount, PayPal upgraded: Wall Street’s top analyst calls",1,0,0,1,1,-1
41.28M,"123,068",112.78M,$0.88,957,42.95,Strong Buy,37.00,"Jul 24, 2024",CHCO,City Holding Company,1.75B,119.15,287.62M,1.80%,3.92%,11.19%,-3.20%,+16.24%,,,,,,,1,-1,-1,-1,-1,-1
29.41M,"62,748",104.52M,$1.24,184,60.27,Hold,60.67,"Jul 24, 2024",SNDX,"Syndax Pharmaceuticals, Inc.",1.75B,20.58,3.50M,1.68%,-2.28%,-0.14%,-8.99%,-9.74%,"Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX)",Syndax price target raised to $34 from $30 at Citi,Buy Rating Affirmed for Syndax Pharmaceuticals Amid Niktimvo’s Promising Market Entry and Efficacy,Syndax price target raised to $45 from $41 at H.C. Wainwright,TD Cowen Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX),"Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX) Syndax price target raised to $34 from $30 at Citi Buy Rating Affirmed for Syndax Pharmaceuticals Amid Niktimvo’s Promising Market Entry and Efficacy Syndax price target raised to $45 from $41 at H.C. Wainwright TD Cowen Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)",1,1,1,1,1,0
98.14M,"741,708",-298.33M,-1,"3,700",18.02,Strong Buy,56.21,"Aug 6, 2024",DSGR,"Distribution Solutions Group, Inc.",1.75B,37.43,1.70B,8.62%,15.10%,16.55%,+9.63%,+4.08%,Buy Rating Affirmed for Distribution Solutions Group on Strong Q2 Results and Strategic Growth Initiatives,Distribution Solutions price target raised to $43 from $40 at Barrington,Distribution Solutions Group Expands Credit for Strategic Growth,,,Buy Rating Affirmed for Distribution Solutions Group on Strong Q2 Results and Strategic Growth Initiatives Distribution Solutions price target raised to $43 from $40 at Barrington Distribution Solutions Group Expands Credit for Strategic Growth,1,1,0,1,-1,-1
16.39M,"71,227",79.84M,-1,"1,854",107.64,Strong Buy,131.75,"Jul 30, 2024",WBTN,WEBTOON Entertainment Inc.,1.74B,13.55,1.30B,-15.25%,-27.03%,-27.03%,-38.83%,,"WEBTOON Entertainment Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky LLP Before November 04, 2024 to Discuss Your Rights – WBTN",Webtoon price target lowered to $17 from $23 at Morgan Stanley,Maintaining Hold on WEBTOON Entertainment Amidst User Growth and Monetization Challenges,"Analysts Conflicted on These Technology Names: DigitalOcean Holdings (DOCN), WEBTOON Entertainment Inc (WBTN) and CyberArk Software (CYBR)",J.P. Morgan Sticks to Their Hold Rating for WEBTOON Entertainment Inc (WBTN),"WEBTOON Entertainment Inc. Sued for Securities Law Violations – Contact Levi & Korsinsky LLP Before November 04, 2024 to Discuss Your Rights – WBTN Webtoon price target lowered to $17 from $23 at Morgan Stanley Maintaining Hold on WEBTOON Entertainment Amidst User Growth and Monetization Challenges Analysts Conflicted on These Technology Names: DigitalOcean Holdings (DOCN), WEBTOON Entertainment Inc (WBTN) and CyberArk Software (CYBR) J.P. Morgan Sticks to Their Hold Rating for WEBTOON Entertainment Inc (WBTN)",0,0,0,0,0,0
72.78M,"169,889",163.40M,$0.14,"6,130",24.24,Strong Buy,26.29,"Aug 14, 2024",UCTT,"Ultra Clean Holdings, Inc.",1.74B,38.59,1.87B,-1.93%,-17.29%,-8.30%,-14.01%,-18.56%,,,,,,,1,-1,-1,-1,-1,-1
109.41M,"482,647",160.00M,$0.64,997,16.12,Sell,14.67,"Jul 24, 2024",GO,Grocery Outlet Holding Corp.,1.74B,17.73,4.16B,-0.57%,-7.15%,-23.42%,-1.33%,-28.04%,"Grocery Outlet launches private label program, GO Brands","Grocery Outlet Launches Private Label Program, GO Brands",Grocery Outlet Holding Corp. Releases Second Annual Impact Report,Grocery Outlet Facing Headwinds: Analyst Issues Sell Rating Amid Competitive Pressure and Traffic Declines,,"Grocery Outlet launches private label program, GO Brands Grocery Outlet Launches Private Label Program, GO Brands Grocery Outlet Holding Corp. Releases Second Annual Impact Report Grocery Outlet Facing Headwinds: Analyst Issues Sell Rating Amid Competitive Pressure and Traffic Declines",0,0,0,0,1,-1
45.07M,"102,633",9.58M,-1,"1,123",39.05,Hold,35.00,"Jul 23, 2024",GLPG,Galapagos NV,1.72B,25.89,280.08M,16.40%,14.49%,-8.51%,+12.71%,-5.50%,Morgan Stanley Remains a Hold on Galapagos (GLPG),Biotech Alert: Searches spiking for these stocks today,Morgan Stanley Sticks to Its Hold Rating for Galapagos (GLPG),"Analysts Are Neutral on These Healthcare Stocks: Baxter International (BAX), Galapagos (GLPG)",Galapagos price target lowered to EUR 30 from EUR 35 at Deutsche Bank,"Morgan Stanley Remains a Hold on Galapagos (GLPG) Biotech Alert: Searches spiking for these stocks today Morgan Stanley Sticks to Its Hold Rating for Galapagos (GLPG) Analysts Are Neutral on These Healthcare Stocks: Baxter International (BAX), Galapagos (GLPG) Galapagos price target lowered to EUR 30 from EUR 35 at Deutsche Bank",0,0,1,0,1,1
38.87M,"529,225",-65.41M,-1,"4,300",45.25,Strong Buy,66.67,"Aug 7, 2024",FOXF,Fox Factory Holding Corp.,1.72B,41.21,1.35B,-6.82%,-14.58%,-25.41%,-25.49%,-12.88%,5 things to know before the stock market opens Monday,Truist Financial Reaffirms Their Buy Rating on Fox Factory Holding (FOXF),Fox Factory Publishes 2023 Sustainability Report,Fox Factory management to meet with Truist,Fox Factory Holding Announces Executive Transition and Severance Details,5 things to know before the stock market opens Monday Truist Financial Reaffirms Their Buy Rating on Fox Factory Holding (FOXF) Fox Factory Publishes 2023 Sustainability Report Fox Factory management to meet with Truist Fox Factory Holding Announces Executive Transition and Severance Details,0,1,0,0,0,0
127.37M,"612,293",101.93M,$0.80,"1,580",13.80,Hold,11.67,"Oct 21, 2024",CLMT,"Calumet, Inc.",1.72B,19.98,4.27B,33.04%,31.75%,27.63%,+38.21%,+20.03%,Largest borrow rate increases among liquid names,Buy Rating Affirmed for Calumet Specialty Products on Strong Sector Performance and Renewables Growth Potential,Calumet Specialty Products call volume above normal and directionally bullish,Calumet Specialty Products price target lowered to $18 from $20 at TD Cowen,"Analysts’ Opinions Are Mixed on These Energy Stocks: Occidental Petroleum (OXY), Calumet Specialty Products (CLMT) and Transocean (RIG)","Largest borrow rate increases among liquid names Buy Rating Affirmed for Calumet Specialty Products on Strong Sector Performance and Renewables Growth Potential Calumet Specialty Products call volume above normal and directionally bullish Calumet Specialty Products price target lowered to $18 from $20 at TD Cowen Analysts’ Opinions Are Mixed on These Energy Stocks: Occidental Petroleum (OXY), Calumet Specialty Products (CLMT) and Transocean (RIG)",1,1,1,1,1,1
36.10M,"164,259",161.55M,$1.10,136,48.55,Buy,61.67,"Jul 30, 2024",KROS,"Keros Therapeutics, Inc.",1.71B,45.51,271.00K,-2.84%,-2.95%,-9.80%,-10.17%,-28.09%,Keros Therapeutics (KROS) Receives a Buy from Truist Financial,Keros Therapeutics closes screening for Phase 2 trial of cibotercept,Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial,Keros Therapeutics CEO to Speak at Major Healthcare Conferences,Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences,Keros Therapeutics (KROS) Receives a Buy from Truist Financial Keros Therapeutics closes screening for Phase 2 trial of cibotercept Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial Keros Therapeutics CEO to Speak at Major Healthcare Conferences Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences,0,0,1,0,0,1
14.70M,"42,669",114.88M,$2.86,643,119.15,Hold,104.67,"Jul 23, 2024",LKFN,Lakeland Financial Corporation,1.70B,66.78,243.10M,4.97%,5.29%,7.02%,-1.27%,+11.37%,,,,,,,0,-1,-1,-1,-1,-1
85.10M,"685,563",-264.08M,-1,"9,000",20.58,Strong Buy,35.30,"Aug 1, 2024",MYRG,MYR Group Inc.,1.70B,102.80,3.59B,-6.07%,-21.44%,-31.35%,-29.01%,-44.04%,MYR Group Updates Investor Relations Materials for Q3 2024,,,,,MYR Group Updates Investor Relations Materials for Q3 2024,0,0,-1,-1,-1,-1
46.76M,"27,911",-21.23M,-1,268,37.43,Buy,42.50,"Aug 1, 2024",RCKT,"Rocket Pharmaceuticals, Inc.",1.69B,18.59,-,-4.05%,-10.80%,-22.44%,-23.43%,-25.91%,Biotech Alert: Searches spiking for these stocks today,Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks,Rocket Pharmaceuticals (RCKT) Receives a Buy from Bank of America Securities,,,Biotech Alert: Searches spiking for these stocks today Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks Rocket Pharmaceuticals (RCKT) Receives a Buy from Bank of America Securities,0,1,1,1,-1,-1
128.27M,"419,727",-149.24M,-1,"2,259",13.55,Buy,28.00,"Aug 8, 2024",ANDE,"The Andersons, Inc.",1.69B,49.91,12.36B,1.25%,0.65%,-4.99%,-8.11%,-12.76%,The Andersons Announce Leadership Change and Strategic Realignment,The Andersons (ANDE) Receives a Buy from Lake Street,"Andersons CEO Pat Bowe to leave role, Bill Krueger to succeed","The Andersons, Inc. Declares Cash Dividend for Fourth Quarter 2024; Announces $100 Million Share Repurchase Program",Andersons announces $100M share repurchase program,"The Andersons Announce Leadership Change and Strategic Realignment The Andersons (ANDE) Receives a Buy from Lake Street Andersons CEO Pat Bowe to leave role, Bill Krueger to succeed The Andersons, Inc. Declares Cash Dividend for Fourth Quarter 2024; Announces $100 Million Share Repurchase Program Andersons announces $100M share repurchase program",0,0,0,1,0,0
45.03M,"272,903",-8.60M,-1,158,38.59,Strong Buy,55.25,"Jul 25, 2024",RUM,Rumble Inc.,1.68B,5.93,78.58M,-1.31%,-1.08%,-1.91%,-7.59%,-9.18%,"Stocks making the biggest moves midday: Starbucks, Chipotle, Home Depot and more","Wedbush more positive on MercadoLibre, Meta, Shopify after Q2 results","Analysts Have Conflicting Sentiments on These Technology Companies: Cisco Systems (CSCO), Rumble (RUM) and CrowdStrike Holdings (CRWD)",Wedbush Releases a Hold Rating on Rumble (RUM),Closing Bell Movers: Rumble jumps 8% on earnings,"Stocks making the biggest moves midday: Starbucks, Chipotle, Home Depot and more Wedbush more positive on MercadoLibre, Meta, Shopify after Q2 results Analysts Have Conflicting Sentiments on These Technology Companies: Cisco Systems (CSCO), Rumble (RUM) and CrowdStrike Holdings (CRWD) Wedbush Releases a Hold Rating on Rumble (RUM) Closing Bell Movers: Rumble jumps 8% on earnings",1,1,1,1,1,1
97.99M,"1,101,526",54.22M,-1,"1,359",17.73,Hold,22.75,"Aug 6, 2024",HLIT,Harmonic Inc.,1.68B,14.41,555.10M,3.90%,13.24%,19.06%,-2.80%,+10.12%,,,,,,,0,-1,-1,-1,-1,-1
65.90M,"1,306,881",302.79M,-1,536,25.89,Sell,34.50,"Aug 1, 2024",BCRX,"BioCryst Pharmaceuticals, Inc.",1.68B,8.10,382.24M,6.93%,15.29%,38.28%,+17.45%,+85.87%,BioCryst presents first interim real-word evidence from APeX-N trial,BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium,BioCryst appoints Fong as Chief Medical Officer,BioCryst reports inducement grants under Nasdaq listing rule,BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),BioCryst presents first interim real-word evidence from APeX-N trial BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium BioCryst appoints Fong as Chief Medical Officer BioCryst reports inducement grants under Nasdaq listing rule BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),0,0,0,0,0,0
41.68M,"444,982",41.26M,-1,"1,200",41.21,Buy,59.57,"Aug 1, 2024",VSEC,VSE Corporation,1.68B,90.94,974.18M,3.77%,2.23%,19.10%,+0.76%,+13.55%,VSE Corporation Appoints Adam Cohn as New CFO,"VSE Corp. names Adam Cohn as CFO, Garry Snow as Chief Growth Officer","Starbucks, Chipotle upgraded: Wall Street’s top analyst calls","Analysts Are Bullish on Top Industrial Goods Stocks: Broadwind Energy (BWEN), Montrose Environmental Group (MEG)",VSE Corporation: A Strong Buy on Robust Aerospace Growth and Strategic Acquisitions,"VSE Corporation Appoints Adam Cohn as New CFO VSE Corp. names Adam Cohn as CFO, Garry Snow as Chief Growth Officer Starbucks, Chipotle upgraded: Wall Street’s top analyst calls Analysts Are Bullish on Top Industrial Goods Stocks: Broadwind Energy (BWEN), Montrose Environmental Group (MEG) VSE Corporation: A Strong Buy on Robust Aerospace Growth and Strategic Acquisitions",1,1,1,1,1,0
85.89M,"401,893",-28.40M,-1,"1,199",19.98,Strong Buy,19.33,"Aug 9, 2024",CASH,"Pathward Financial, Inc.",1.67B,67.03,695.79M,3.74%,8.20%,23.07%,-1.30%,+33.21%,"Pathward, MoneyLion extend partnership to 2029",KBW Keeps Their Hold Rating on Meta Financial Group (CASH),,,,"Pathward, MoneyLion extend partnership to 2029 KBW Keeps Their Hold Rating on Meta Financial Group (CASH)",1,1,1,-1,-1,-1
37.52M,"170,399",-168.05M,-1,643,45.51,Strong Buy,93.40,"Aug 7, 2024",CDNA,"CareDx, Inc",1.66B,31.54,297.08M,15.48%,53.97%,142.81%,+51.28%,+214.02%,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,CareDx initiated with an Underweight at Wells Fargo,"Apple, Lineage, OneStream initiated: Wall Street’s top analyst calls",Positive Outlook for CareDx: Anticipating Revenue Growth and Manageable Legal Challenges,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias CareDx initiated with an Underweight at Wells Fargo Apple, Lineage, OneStream initiated: Wall Street’s top analyst calls Positive Outlook for CareDx: Anticipating Revenue Growth and Manageable Legal Challenges",0,1,1,0,1,1
25.51M,"137,108",100.83M,$1.92,552,66.78,Hold,71.00,"Jul 25, 2024",CLOV,"Clover Health Investments, Corp.",1.66B,3.34,2.09B,33.21%,76.98%,184.10%,+62.30%,+326.70%,"Nvidia receives DOJ subpoena, Dick’s posts Q2 beat: Morning Buzz",Unusually active option classes on open September 4th,Clover Health unit Counterpart in deal with Iowa Clinic to deploy AI technology,The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest,"Clover Health Expands Board, Appoints Thomas L. Tran","Nvidia receives DOJ subpoena, Dick’s posts Q2 beat: Morning Buzz Unusually active option classes on open September 4th Clover Health unit Counterpart in deal with Iowa Clinic to deploy AI technology The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest Clover Health Expands Board, Appoints Thomas L. Tran",1,1,0,1,1,1
16.51M,"145,528",49.22M,-1,"24,000",102.80,Buy,155.00,"Jul 31, 2024",JBLU,JetBlue Airways Corporation,1.66B,4.78,9.32B,-7.93%,-14.02%,-16.22%,-24.02%,-28.38%,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree",Friday’s stock stories: What’s likely to move the market in the next session,"Final Trade: ET, META, JBLU & NDAQ",A future lift for Nvidia’s stock may come from outside the tech industry,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more","U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree Friday’s stock stories: What’s likely to move the market in the next session Final Trade: ET, META, JBLU & NDAQ A future lift for Nvidia’s stock may come from outside the tech industry Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",1,0,0,1,1,1
91.01M,"1,088,157",-253.26M,-1,"1,244",18.59,Strong Buy,53.22,"Aug 5, 2024",STBA,"S&T Bancorp, Inc.",1.66B,43.32,386.45M,2.37%,10.63%,27.50%,-4.21%,+37.62%,S&T Bancorp Unveils Investor Presentation for Financial Insight,,,,,S&T Bancorp Unveils Investor Presentation for Financial Insight,1,0,-1,-1,-1,-1
33.82M,"151,194",102.45M,$0.76,"1,600",49.91,Strong Buy,65.00,"Aug 6, 2024",AVDX,"AvidXchange Holdings, Inc.",1.64B,7.89,413.47M,-2.53%,-23.83%,-29.05%,-10.85%,-35.36%,Compass starts AvidXchange at Neutral into expected outlook cut,A Balanced Outlook on AvidXchange Holdings: Weighing Short-Term Gains Against Long-Term Growth Prospects,AvidXchange initiated with a Neutral at Compass Point,AvidXchange and Workamajig Announce Exclusive Strategic Partnership to Empower Media Companies to Manage Invoices Seamlessly,"AvidXchange, Workamajig announce exclusive strategic partnership","Compass starts AvidXchange at Neutral into expected outlook cut A Balanced Outlook on AvidXchange Holdings: Weighing Short-Term Gains Against Long-Term Growth Prospects AvidXchange initiated with a Neutral at Compass Point AvidXchange and Workamajig Announce Exclusive Strategic Partnership to Empower Media Companies to Manage Invoices Seamlessly AvidXchange, Workamajig announce exclusive strategic partnership",0,1,0,1,0,0
283.23M,"584,833",-128.37M,-1,"5,260",5.93,Hold,8.00,"Aug 12, 2024",AFYA,Afya Limited,1.64B,18.17,552.54M,1.48%,2.40%,-4.79%,-3.68%,-4.21%,Afya Limited Expands Medical Seats in Brazil,Afya announces MEC decision on medical seats reconsideration,Afya Receives R$500 Million Boost for Expansion,"Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls",Afya reports Q2 EPS R$2.29 vs. R$1.42 last year,"Afya Limited Expands Medical Seats in Brazil Afya announces MEC decision on medical seats reconsideration Afya Receives R$500 Million Boost for Expansion Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls Afya reports Q2 EPS R$2.29 vs. R$1.42 last year",0,0,0,0,1,0
116.33M,"677,165",56.73M,-1,"5,633",14.41,Strong Buy,18.50,"Jul 29, 2024",SEDG,"SolarEdge Technologies, Inc.",1.64B,28.77,1.51B,2.59%,-5.47%,-56.21%,-10.98%,-61.48%,"Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more","Stocks making biggest moves premarket: PDD Holdings, Petrobras and more",Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research",SolarEdge initiated with a Hold at Jefferies,"Stocks making the biggest moves midday: PDD Holdings, SolarEdge and more Stocks making biggest moves premarket: PDD Holdings, Petrobras and more Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness ‘Massive risk’ to number of solar players flying under radar, says GLJ Research SolarEdge initiated with a Hold at Jefferies",0,1,1,0,0,1
206.89M,"2,014,678",-145.93M,-1,"1,057",8.10,Buy,14.17,"Aug 5, 2024",STAA,STAAR Surgical Company,1.64B,33.27,332.94M,-13.12%,-20.90%,-14.21%,-22.64%,-34.45%,Staar Surgical price target lowered to $44 from $50 at Stifel,"Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)","Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)",,,"Staar Surgical price target lowered to $44 from $50 at Stifel Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI) Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)",0,0,0,0,-1,-1
18.42M,"72,447",11.77M,$0.40,"3,946",90.94,Strong Buy,99.83,"Jul 31, 2024",IART,Integra LifeSciences Holdings Corporation,1.63B,21.07,1.57B,-7.23%,-23.14%,-39.82%,-17.98%,-40.15%,Integra Lifesciences: Hold Rating Amidst Compliance Challenges and Revenue Impact with a Long-Term Recovery Outlook,Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference,Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference,BTIG Sticks to Their Sell Rating for Integra Lifesciences (IART),Integra LifeSciences price target lowered to $20 from $22 at BTIG,Integra Lifesciences: Hold Rating Amidst Compliance Challenges and Revenue Impact with a Long-Term Recovery Outlook Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference BTIG Sticks to Their Sell Rating for Integra Lifesciences (IART) Integra LifeSciences price target lowered to $20 from $22 at BTIG,0,0,0,0,0,0
24.98M,"105,999",168.95M,$0.20,"2,650",67.03,Hold,66.67,"Jul 24, 2024",TLRY,"Tilray Brands, Inc.",1.63B,1.93,788.94M,-6.99%,-3.50%,-8.21%,-16.26%,-34.49%,Election 2024: Where To Put Your Money Ahead of the Vote,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,Molson Coors Retreats on DEI Policies Amid Growing Activist Pressure,Tilray completes acquisition of craft beer brands from Molson Coors,Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company,Election 2024: Where To Put Your Money Ahead of the Vote Rising High: MINT Shango JV to acquire Cannabist’s Florida entity Molson Coors Retreats on DEI Policies Amid Growing Activist Pressure Tilray completes acquisition of craft beer brands from Molson Coors Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company,1,1,1,0,1,1
52.74M,"389,877",-159.64M,-1,"1,164",31.54,Buy,22.75,"Jul 31, 2024",INDV,Indivior PLC,1.62B,12.30,1.15B,-0.46%,-3.89%,-24.22%,-10.04%,-42.70%,Deutsche Bank Sticks to Their Buy Rating for Indivior (INDV),Craig-Hallum Keeps Their Buy Rating on Indivior (INDV),"Indivior provides update on AEF01171 trial, does not expect to exercise option",Indivior Faces Setback in Cannabis Disorder Treatment Trial,Indivior PLC Advances $100M Share Buyback Plan,"Deutsche Bank Sticks to Their Buy Rating for Indivior (INDV) Craig-Hallum Keeps Their Buy Rating on Indivior (INDV) Indivior provides update on AEF01171 trial, does not expect to exercise option Indivior Faces Setback in Cannabis Disorder Treatment Trial Indivior PLC Advances $100M Share Buyback Plan",1,0,0,1,0,1
497.47M,"12,797,349",-123.70M,-1,"5,024",3.340,,,"Aug 5, 2024",OSW,OneSpaWorld Holdings Limited,1.61B,15.39,847.19M,2.11%,0.71%,12.16%,-3.79%,+18.89%,OneSpaWorld management to meet with Truist,,,,,OneSpaWorld management to meet with Truist,1,0,-1,-1,-1,-1
346.83M,"14,589,280",-947.00M,-1,100,4.780,Hold,6.15,"Jul 30, 2024",IREN,Iris Energy Limited,1.61B,8.62,165.54M,-3.52%,-26.05%,13.25%,-26.32%,+32.50%,IREN CEO: ‘We’re running bitcoin mining machines right next to Nvidia chips training AI models’,Morgan Stanley says some crypto miners could gain by turning to data centers,Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat,Crypto Currents: Riot urges change for Bitfarms board,Iris Energy Reports Growth and Efficiency Gains,IREN CEO: ‘We’re running bitcoin mining machines right next to Nvidia chips training AI models’ Morgan Stanley says some crypto miners could gain by turning to data centers Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat Crypto Currents: Riot urges change for Bitfarms board Iris Energy Reports Growth and Efficiency Gains,0,0,0,0,0,1
38.26M,"143,495",136.07M,$1.32,"4,873",43.32,Hold,41.00,"Oct 17, 2024",CHEF,"The Chefs' Warehouse, Inc.",1.61B,40.33,3.66B,6.80%,3.61%,17.71%,+1.44%,+21.38%,Chefs’ Warehouse management to meet with BTIG,"The Chefs’ Warehouse, Inc. to Participate in CL King’s 22nd Best Ideas Conference",,,,"Chefs’ Warehouse management to meet with BTIG The Chefs’ Warehouse, Inc. to Participate in CL King’s 22nd Best Ideas Conference",0,0,0,-1,-1,-1
207.85M,"1,887,533",-13.14M,-1,515,7.89,Hold,11.92,"Jul 31, 2024",SKWD,"Skyward Specialty Insurance Group, Inc.",1.60B,39.82,1.03B,4.99%,7.17%,13.66%,+2.07%,+5.59%,Skyward Specialty Earns “Best Places to Work in Insurance” Recognition for 2024,Skyward Specialty Insurance initiated with an Equal Weight at Barclays,"Skyward Specialty Insurance, Bishop Street announce joint venture",Skyward Specialty launches aviation program in partnership with Acceleration,Skyward Specialty Launches Aviation Program in Partnership With Acceleration Aviation,"Skyward Specialty Earns “Best Places to Work in Insurance” Recognition for 2024 Skyward Specialty Insurance initiated with an Equal Weight at Barclays Skyward Specialty Insurance, Bishop Street announce joint venture Skyward Specialty launches aviation program in partnership with Acceleration Skyward Specialty Launches Aviation Program in Partnership With Acceleration Aviation",1,1,1,1,1,1
90.19M,"79,855",99.61M,-1,154,18.17,Hold,21.67,"Aug 16, 2024",AVDL,Avadel Pharmaceuticals plc,1.59B,16.50,95.15M,-2.00%,0.13%,4.18%,-9.06%,-10.96%,Avadel publishes RESTORE data on LUMRYZ for narcolepsy patients,Avadel Pharmaceuticals: A Strong Buy Amid Legal Triumph and Market Expansion,Avadel’s Favorable Legal Developments and Strong Market Potential Justify Buy Rating and $27 Price Target,"H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’",Avadel Pharmaceuticals (AVDL) Receives a Buy from Craig-Hallum,"Avadel publishes RESTORE data on LUMRYZ for narcolepsy patients Avadel Pharmaceuticals: A Strong Buy Amid Legal Triumph and Market Expansion Avadel’s Favorable Legal Developments and Strong Market Potential Justify Buy Rating and $27 Price Target H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’ Avadel Pharmaceuticals (AVDL) Receives a Buy from Craig-Hallum",1,1,1,1,1,0
56.95M,"7,356,157",-511.69M,-1,"1,830",28.77,Hold,60.71,"Aug 7, 2024",BLBD,Blue Bird Corporation,1.58B,48.96,1.30B,-0.61%,-4.24%,27.98%,-4.66%,+32.75%,Craig-Hallum Reaffirms Their Buy Rating on Blue Bird (BLBD),TipRanks’ ‘Perfect 10’ List: Analysts See Opportunity in These 2 Top-Scoring Stocks,Blue Bird price target raised to $67 from $66 at DA Davidson,,,Craig-Hallum Reaffirms Their Buy Rating on Blue Bird (BLBD) TipRanks’ ‘Perfect 10’ List: Analysts See Opportunity in These 2 Top-Scoring Stocks Blue Bird price target raised to $67 from $66 at DA Davidson,1,0,0,1,-1,-1
49.17M,"974,450",16.61M,-1,"5,700",33.27,Buy,45.00,"Aug 7, 2024",STER,Sterling Check Corp.,1.58B,16.16,736.51M,3.00%,5.38%,10.93%,+2.93%,+1.57%,Sterling Check Announces Executive Maternity Leave and Interim CFO,Sterling Check (STER) Gets a Hold from Morgan Stanley,,,,Sterling Check Announces Executive Maternity Leave and Interim CFO Sterling Check (STER) Gets a Hold from Morgan Stanley,0,0,0,-1,-1,-1
77.58M,"651,831",23.65M,-1,"1,982",21.07,Hold,31.11,"Jul 29, 2024",OPEN,Opendoor Technologies Inc.,1.58B,2.25,4.54B,23.93%,16.02%,-11.93%,-7.76%,-20.74%,Opendoor to Present at Goldman Sachs Communacopia & Technology Conference,Unusually active option classes on open August 28th,Unusually active option classes on open August 27th,Unusually active option classes on open August 22nd,,Opendoor to Present at Goldman Sachs Communacopia & Technology Conference Unusually active option classes on open August 28th Unusually active option classes on open August 27th Unusually active option classes on open August 22nd,0,0,0,0,0,-1
842.96M,"16,090,213",-244.98M,-1,"14,504",1.930,Hold,2.25,"Oct 2, 2024",THRM,Gentherm Incorporated,1.58B,50.31,1.46B,-0.59%,-0.09%,-0.85%,-9.01%,-8.24%,Gentherm Announces CFO Transition and Interim Successor,,,,,Gentherm Announces CFO Transition and Interim Successor,0,0,-1,-1,-1,-1
133.98M,"189,196",-141.00M,-1,233,12.30,Strong Buy,23.00,"Jul 25, 2024",OLPX,"Olaplex Holdings, Inc.",1.58B,2.38,438.12M,8.71%,20.12%,14.96%,+3.37%,+31.10%,Burry of ‘The Big Short’ fame makes Chinese internet companies his top bets,"Olaplex Holdings, Inc. Announces Participation in the Barclays 17th Annual Global Consumer Staples Conference on September 4th",Olaplex Holdings: Hold Rating Amidst Leadership-Driven Brand Momentum and Strategic Initiatives,Olaplex Holdings Finalizes Executive Team with New COO/CFO,,"Burry of ‘The Big Short’ fame makes Chinese internet companies his top bets Olaplex Holdings, Inc. Announces Participation in the Barclays 17th Annual Global Consumer Staples Conference on September 4th Olaplex Holdings: Hold Rating Amidst Leadership-Driven Brand Momentum and Strategic Initiatives Olaplex Holdings Finalizes Executive Team with New COO/CFO",1,1,1,1,1,-1
104.71M,"257,271",53.03M,$0.04,"4,106",15.39,Strong Buy,18.75,"Jul 31, 2024",NVEE,"NV5 Global, Inc.",1.57B,96.48,904.41M,-0.16%,0.71%,-2.47%,-8.07%,-0.65%,Lake Street Remains a Buy on NV5 Holdings (NVEE),NV5 Global to acquire California Water Resources Group in ‘accretive’ deal,NV5 Holdings Strong Buy Rating Affirmed Amid Positive Q2 Performance and Strategic Acquisitions,,,Lake Street Remains a Buy on NV5 Holdings (NVEE) NV5 Global to acquire California Water Resources Group in ‘accretive’ deal NV5 Holdings Strong Buy Rating Affirmed Amid Positive Q2 Performance and Strategic Acquisitions,1,0,0,0,-1,-1
186.83M,"12,357,369",-8.81M,-1,"1,522",8.62,Strong Buy,16.50,"Sep 11, 2024",BUSE,First Busey Corporation,1.56B,27.44,436.32M,3.64%,5.53%,12.60%,-1.35%,+17.19%,First Busey price target raised to $33 from $31 at Keefe Bruyette,First Busey (BUSE) Gets a Buy from Piper Sandler,First Busey price target raised to $29 from $28 at DA Davidson,First Busey (BUSE) Gets a Hold from D.A. Davidson,KBW Keeps Their Buy Rating on First Busey (BUSE),First Busey price target raised to $33 from $31 at Keefe Bruyette First Busey (BUSE) Gets a Buy from Piper Sandler First Busey price target raised to $29 from $28 at DA Davidson First Busey (BUSE) Gets a Hold from D.A. Davidson KBW Keeps Their Buy Rating on First Busey (BUSE),1,0,0,1,1,1
39.83M,"270,408",40.78M,-1,"8,600",40.33,Strong Buy,48.75,"Jul 31, 2024",AMWD,American Woodmark Corporation,1.55B,99.74,1.85B,-5.41%,0.95%,-1.06%,-13.57%,-13.26%,American Woodmark price target lowered to $98 from $100 at Loop Capital,American Woodmark (AMWD) Receives a Hold from Loop Capital Markets,American Woodmark price target lowered to $112 from $116 at Baird,American Woodmark sees FY25 revenue down in low single-digits,"American Woodmark reports Q1 adjusted EPS $1.89, consensus $2.40","American Woodmark price target lowered to $98 from $100 at Loop Capital American Woodmark (AMWD) Receives a Hold from Loop Capital Markets American Woodmark price target lowered to $112 from $116 at Baird American Woodmark sees FY25 revenue down in low single-digits American Woodmark reports Q1 adjusted EPS $1.89, consensus $2.40",1,1,1,1,1,1
40.10M,"205,816",118.46M,-1,"1,885",39.82,Buy,44.29,"Aug 5, 2024",PLAB,"Photronics, Inc.",1.55B,24.53,885.01M,3.53%,-2.85%,-11.19%,-5.23%,-14.64%,Analysts Offer Insights on Technology Companies: Photronics (PLAB) and MongoDB (MDB),Photronics increases share repurchase program to up to $100M,Photronics sees Q4 non-GAAP EPS 48c-54c vs. 60c last year,Photronics reports Q3 non-GAAP EPS 51c vs. 51c last year,PLAB Earnings this Week: How Will it Perform?,Analysts Offer Insights on Technology Companies: Photronics (PLAB) and MongoDB (MDB) Photronics increases share repurchase program to up to $100M Photronics sees Q4 non-GAAP EPS 48c-54c vs. 60c last year Photronics reports Q3 non-GAAP EPS 51c vs. 51c last year PLAB Earnings this Week: How Will it Perform?,1,0,0,1,1,0
96.27M,"401,071",-106.22M,-1,"1,244",16.50,Strong Buy,24.17,"Aug 8, 2024",HOPE,"Hope Bancorp, Inc.",1.55B,12.84,497.58M,2.89%,7.46%,13.41%,-3.57%,+16.96%,Territorial Bancorp price target raised to $11.27 from $9.66 at Keefe Bruyette,,,,,Territorial Bancorp price target raised to $11.27 from $9.66 at Keefe Bruyette,1,1,-1,-1,-1,-1
32.36M,"294,018",99.50M,-1,284,48.96,Strong Buy,60.00,"Aug 7, 2024",NRIX,"Nurix Therapeutics, Inc.",1.55B,24.02,62.30M,11.54%,15.84%,77.04%,+14.67%,+80.50%,Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit,Nurix Therapeutics transferred with an Outperform at Baird,Nurix Therapeutics Showcases Breakthrough BTK Degraders,Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer,Nurix Therapeutics to Participate in Upcoming Investor Conferences,Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit Nurix Therapeutics transferred with an Outperform at Baird Nurix Therapeutics Showcases Breakthrough BTK Degraders Nurix Therapeutics price target raised to $30 from $27 at Oppenheimer Nurix Therapeutics to Participate in Upcoming Investor Conferences,1,1,1,1,1,1
97.99M,"113,915",-15.22M,-1,142,16.16,Hold,15.30,"Aug 8, 2024",KURA,"Kura Oncology, Inc.",1.55B,20.18,-,3.41%,-0.61%,10.03%,-3.22%,-1.08%,"Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)","Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)","Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)",Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Aquestive Therapeutics (AQST),Kura Oncology (KURA) Gets a Buy from Stifel Nicolaus,"Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA) Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG) Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE) Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Aquestive Therapeutics (AQST) Kura Oncology (KURA) Gets a Buy from Stifel Nicolaus",0,0,0,0,0,0
703.00M,"51,199,937",-398.00M,-1,"87,000",2.250,Hold,2.76,"Aug 1, 2024",BLMN,"Bloomin' Brands, Inc.",1.54B,18.18,4.59B,-1.90%,-5.28%,-26.82%,-16.93%,-35.64%,"TikTok, fast-food rivalry fuel Chili’s as Brinker says turnaround is taking hold",Jefferies Keeps Their Buy Rating on Bloomin’ Brands (BLMN),Bloomin’ Brands’ (NASDAQ:BLMN) New CEO Has Airline Pedigree,Bloomin’ Brands Announces CEO Transition and Executive Compensation,Bloomin’ Brands price target lowered to $20 from $22 at Citi,"TikTok, fast-food rivalry fuel Chili’s as Brinker says turnaround is taking hold Jefferies Keeps Their Buy Rating on Bloomin’ Brands (BLMN) Bloomin’ Brands’ (NASDAQ:BLMN) New CEO Has Airline Pedigree Bloomin’ Brands Announces CEO Transition and Executive Compensation Bloomin’ Brands price target lowered to $20 from $22 at Citi",1,1,1,1,0,1
31.33M,"152,576",67.59M,-1,284,50.31,Buy,63.50,"Jul 31, 2024",BCYC,Bicycle Therapeutics plc,1.54B,22.38,39.57M,-2.66%,0.91%,7.48%,-8.84%,-2.51%,RBC starts Bicycle Therapeutics at Outperform on ‘novel and unique platform’,Bicycle Therapeutics initiated with an Outperform at RBC Capital,,,,RBC starts Bicycle Therapeutics at Outperform on ‘novel and unique platform’ Bicycle Therapeutics initiated with an Outperform at RBC Capital,1,0,0,-1,-1,-1
661.98M,"1,745,472",47.99M,-1,315,2.380,Hold,2.35,"Aug 6, 2024",HROW,"Harrow, Inc.",1.52B,42.70,154.15M,29.43%,61.53%,180.43%,+53.43%,+192.78%,"Not ready to chase Harrow on long-term assumptions at this point, says Jim Cramer","Lightning Round: Snap is not investable, says Jim Cramer",Harrow Health’s Promising Pipeline and Strategic Positioning Spur Buy Rating,Harrow price target raised to $45 from $30 at Craig-Hallum,Harrow price target raised to $50 from $29 at B. Riley,"Not ready to chase Harrow on long-term assumptions at this point, says Jim Cramer Lightning Round: Snap is not investable, says Jim Cramer Harrow Health’s Promising Pipeline and Strategic Positioning Spur Buy Rating Harrow price target raised to $45 from $30 at Craig-Hallum Harrow price target raised to $50 from $29 at B. Riley",0,0,0,1,0,0
16.28M,"107,308",31.57M,-1,408,96.48,Strong Buy,130.00,"Aug 7, 2024",DVAX,Dynavax Technologies Corporation,1.51B,11.49,249.69M,1.54%,1.37%,-8.80%,-1.61%,-8.63%,Lantheus appoints Eastland as new board member,,,,,Lantheus appoints Eastland as new board member,1,1,-1,-1,-1,-1
56.85M,"121,235",110.00M,$0.96,"2,296",27.44,Buy,27.25,"Jul 23, 2024",NTCT,"NetScout Systems, Inc.",1.50B,21.08,792.88M,6.72%,10.12%,2.09%,+2.90%,+4.70%,,,,,,,0,-1,-1,-1,-1,-1
15.59M,"166,898",116.22M,-1,"4,350",99.74,Buy,108.67,"Aug 27, 2024",PRDO,Perdoceo Education Corporation,1.50B,22.88,662.85M,-2.84%,-0.13%,14.10%,-9.12%,+29.56%,Outperform Rating for Perdoceo Education: Strong Position and Growth Potential Justify Buy Recommendation,Perdoceo Education management to meet virtually with Barrington,,,,Outperform Rating for Perdoceo Education: Strong Position and Growth Potential Justify Buy Recommendation Perdoceo Education management to meet virtually with Barrington,0,0,0,-1,-1,-1
63.36M,"349,653",134.00M,-1,"1,170",24.53,,,"Aug 29, 2024",SRCE,1st Source Corporation,1.50B,61.16,367.02M,3.15%,6.68%,15.90%,-4.06%,+21.14%,,,,,,,0,-1,-1,-1,-1,-1
120.73M,"474,185",107.66M,$0.56,"13,200",12.84,Buy,12.50,"Oct 21, 2024",PZZA,"Papa John's International, Inc.",1.50B,45.93,2.12B,7.12%,7.95%,-20.55%,+8.52%,-24.69%,Thursday’s big stock stories: What’s likely to move the market in the next trading session,Value: More than a buzzword. It’s how restaurants plan to win customers,Jim Cramer’s top 10 things to watch in the stock market Friday,Papa John’s announces PepsiCo as its beverage partner in North America,Papa John’s (NASDAQ:PZZA) Surges amid Takeover Speculation,Thursday’s big stock stories: What’s likely to move the market in the next trading session Value: More than a buzzword. It’s how restaurants plan to win customers Jim Cramer’s top 10 things to watch in the stock market Friday Papa John’s announces PepsiCo as its beverage partner in North America Papa John’s (NASDAQ:PZZA) Surges amid Takeover Speculation,0,0,0,0,1,0
64.41M,"663,069",-165.00M,-1,20,24.02,Strong Buy,26.69,"Oct 10, 2024",BLTE,"Belite Bio, Inc",1.50B,48.91,-,0.29%,0.80%,10.08%,-1.27%,+23.35%,Belite Bio announces appointment of Hendrik Scholl as Chief Medical Officer,"Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer","Belite Bio, Inc.: Strong Buy Rating on Robust Financials and Promising Clinical Trials","Buy Rating Affirmed for Belite Bio, Inc. ADR on Strong Clinical Progress and Financial Stability","Belite Bio, Inc. ADR (BLTE) Receives a Buy from Benchmark Co.","Belite Bio announces appointment of Hendrik Scholl as Chief Medical Officer Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer Belite Bio, Inc.: Strong Buy Rating on Robust Financials and Promising Clinical Trials Buy Rating Affirmed for Belite Bio, Inc. ADR on Strong Clinical Progress and Financial Stability Belite Bio, Inc. ADR (BLTE) Receives a Buy from Benchmark Co.",0,0,0,1,0,0
76.63M,"210,193",-181.75M,-1,267,20.18,Strong Buy,30.60,"Aug 8, 2024",ARDX,"Ardelyx, Inc.",1.49B,6.35,210.00M,5.54%,5.38%,-9.71%,+10.81%,-18.00%,Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX),Ardelyx (ARDX) Beats Expectations in Q2 and Offers Promising Outlook,"Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP",,,"Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Ardelyx (ARDX) Ardelyx (ARDX) Beats Expectations in Q2 and Offers Promising Outlook Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP",0,1,1,1,-1,-1
84.97M,"1,933,255",32.33M,$0.96,29,18.18,Hold,22.33,"Aug 6, 2024",SAVA,"Cassava Sciences, Inc.",1.48B,30.95,-,5.80%,48.41%,32.16%,+20.21%,+25.34%,Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference,Largest borrow rate increases among liquid names,Cautious Optimism Amidst Legal Challenges: Hold Rating on Cassava Sciences,,,Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference Largest borrow rate increases among liquid names Cautious Optimism Amidst Legal Challenges: Hold Rating on Cassava Sciences,0,0,1,1,-1,-1
68.99M,"190,343",-165.37M,-1,"1,207",22.38,Buy,45.75,"Aug 6, 2024",TCBK,TriCo Bancshares,1.48B,44.86,388.27M,4.13%,6.95%,17.63%,-3.14%,+32.25%,,,,,,,1,-1,-1,-1,-1,-1
35.48M,"716,624",-33.58M,-1,414,42.70,Strong Buy,40.00,"Aug 7, 2024",MNKD,MannKind Corporation,1.48B,5.37,248.37M,1.50%,0.18%,23.01%,+2.43%,+32.88%,Biotech Alert: Searches spiking for these stocks today,Oppenheimer Reaffirms Their Buy Rating on MannKind (MNKD),MannKind price target raised to $12 from $10 at Oppenheimer,MannKind to Present at Upcoming Conferences,MannKind Announces Board of Directors Transition,Biotech Alert: Searches spiking for these stocks today Oppenheimer Reaffirms Their Buy Rating on MannKind (MNKD) MannKind price target raised to $12 from $10 at Oppenheimer MannKind to Present at Upcoming Conferences MannKind Announces Board of Directors Transition,0,1,0,0,0,0
131.04M,"747,884",17.18M,-1,"4,400",11.49,Buy,23.67,"Aug 6, 2024",APOG,"Apogee Enterprises, Inc.",1.48B,67.26,1.39B,3.48%,5.02%,14.33%,-4.68%,+10.39%,,,,,,,1,-1,-1,-1,-1,-1
71.32M,"354,260",-586.91M,-1,74,21.08,Hold,22.00,"Jul 25, 2024",IRON,"Disc Medicine, Inc.",1.47B,49.41,-,8.40%,8.70%,-0.26%,+14.64%,+64.39%,"Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more","Thursday’s top analyst calls: Nvidia, Apple, Dell, Microsoft and more",Disc Medicine to Participate in Upcoming Investor Conferences,Optimistic Outlook on Disc Medicine’s Pipeline and Investment Potential,Disc Medicine initiated with an Overweight at Wells Fargo,"Friday’s top analyst calls: Nvidia, Peloton, Chewy, Uber and more Thursday’s top analyst calls: Nvidia, Apple, Dell, Microsoft and more Disc Medicine to Participate in Upcoming Investor Conferences Optimistic Outlook on Disc Medicine’s Pipeline and Investment Potential Disc Medicine initiated with an Overweight at Wells Fargo",0,1,1,0,0,0
65.67M,"273,446",136.37M,$0.52,29,22.88,Buy,30.00,"Jul 31, 2024",NAMS,NewAmsterdam Pharma Company N.V.,1.46B,16.26,7.42M,1.04%,-7.73%,-6.51%,-4.73%,-21.59%,NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),RBC Capital Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS),NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September,NewAmsterdam Pharma initiated with a Buy at Needham,Buy Rating Affirmed for NewAmsterdam Pharma on Strong Prospects for Cholesterol Drug obicetrapib,NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) RBC Capital Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS) NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September NewAmsterdam Pharma initiated with a Buy at Needham Buy Rating Affirmed for NewAmsterdam Pharma on Strong Prospects for Cholesterol Drug obicetrapib,0,0,0,0,0,0
24.51M,"80,113",126.37M,$1.44,76,61.16,Hold,64.75,"Oct 17, 2024",CNTA,Centessa Pharmaceuticals plc,1.46B,12.85,6.85M,16.81%,31.24%,46.20%,+28.02%,+25.40%,Centessa to present non-human primate data for ORX142 at Sleep Europe 2024,"Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)",Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,Buy Rating Affirmed for Centessa Pharmaceuticals Amid Strong Innovation and Promising Pipeline Progress,Centessa Pharmaceuticals (CNTA) Receives a Hold from Morgan Stanley,"Centessa to present non-human primate data for ORX142 at Sleep Europe 2024 Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024) Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Buy Rating Affirmed for Centessa Pharmaceuticals Amid Strong Innovation and Promising Pipeline Progress Centessa Pharmaceuticals (CNTA) Receives a Hold from Morgan Stanley",1,0,0,0,0,0
32.63M,"2,642,996",68.83M,$1.84,867,45.93,Buy,60.17,"Aug 8, 2024",SDGR,"Schrödinger, Inc.",1.45B,19.87,200.63M,2.85%,0.28%,-19.94%,-8.17%,-24.00%,Schrodinger price target lowered to $30 from $43 at Morgan Stanley,Analysts Conflicted on These Healthcare Names: Medtronic (MDT) and Schrodinger (SDGR),,,,Schrodinger price target lowered to $30 from $43 at Morgan Stanley Analysts Conflicted on These Healthcare Names: Medtronic (MDT) and Schrodinger (SDGR),0,0,1,-1,-1,-1
30.61M,"19,235",-35.29M,-1,"4,213",48.90,Strong Buy,59.00,"Aug 9, 2024",MRTN,"Marten Transport, Ltd.",1.44B,17.63,1.04B,-1.97%,-2.92%,-6.62%,-7.12%,-2.02%,MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND,,,,,MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND,0,0,-1,-1,-1,-1
235.43M,"2,808,726",-65.15M,-1,592,6.35,Strong Buy,13.00,"Aug 1, 2024",OPRA,Opera Limited,1.43B,16.18,427.25M,21.55%,19.40%,18.89%,+15.90%,-4.39%,Opera participates in a conference call with Lake Street,Lake Street Remains a Buy on Opera (OPRA),Opera price target raised to $24 from $22 at B. Riley,TD Cowen Sticks to Their Buy Rating for Opera (OPRA),"Opera Outperforms Q2 Expectations, Raises Outlook","Opera participates in a conference call with Lake Street Lake Street Remains a Buy on Opera (OPRA) Opera price target raised to $24 from $22 at B. Riley TD Cowen Sticks to Their Buy Rating for Opera (OPRA) Opera Outperforms Q2 Expectations, Raises Outlook",0,0,0,0,0,1
47.98M,"1,063,246",-15.37M,-1,"3,389",30.95,Buy,107.00,"Aug 8, 2024",INFN,Infinera Corporation,1.43B,6.07,1.50B,3.26%,4.30%,17.66%,+1.85%,+4.31%,Analysts Offer Insights on Technology Companies: Infinera (INFN) and Eutelsat Communications (OtherEUTLF),,,,,Analysts Offer Insights on Technology Companies: Infinera (INFN) and Eutelsat Communications (OtherEUTLF),0,0,-1,-1,-1,-1
32.99M,"100,447",113.45M,$1.32,267,44.86,Buy,49.80,"Jul 25, 2024",OCUL,"Ocular Therapeutix, Inc.",1.42B,9.11,61.10M,8.27%,18.57%,44.19%,+6.26%,+6.52%,Ocular Therapeutix™ to Present at September Retina Meetings,Ocular Therapeutix™ to Present at Two Investor Conferences in September,Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Ocular Therapeutix reports inducement grants under Nasdaq listing rule,,Ocular Therapeutix™ to Present at September Retina Meetings Ocular Therapeutix™ to Present at Two Investor Conferences in September Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Ocular Therapeutix reports inducement grants under Nasdaq listing rule,1,1,0,0,0,-1
275.00M,"1,355,573",11.74M,-1,"1,112",5.37,Strong Buy,8.00,"Aug 7, 2024",SASR,"Sandy Spring Bancorp, Inc.",1.42B,31.42,395.98M,6.59%,13.46%,28.17%,+1.57%,+46.68%,Sandy Spring shares rise after Bloomberg report on takeover talks,"Sandy Spring working with advisers on takeover talks, Bloomberg says","Sandy Spring with advisers to consider sale, Bloomberg reports",Sandy Spring jumps 2% to $31.36 after Bloomberg report on possible sale,Sandy Spring Bancorp Enhances Investor Engagement with Q3 Presentation,"Sandy Spring shares rise after Bloomberg report on takeover talks Sandy Spring working with advisers on takeover talks, Bloomberg says Sandy Spring with advisers to consider sale, Bloomberg reports Sandy Spring jumps 2% to $31.36 after Bloomberg report on possible sale Sandy Spring Bancorp Enhances Investor Engagement with Q3 Presentation",0,0,0,1,1,1
21.93M,"65,603",107.05M,$1.00,294,67.26,Hold,65.00,"Sep 17, 2024",COCO,"The Vita Coco Company, Inc.",1.41B,24.89,500.02M,0.17%,-3.89%,-0.07%,-2.63%,-4.08%,"These high-quality small-cap stocks are a buy, Bank of America says",Wall Street Analysts Are Bullish on Top Consumer Goods Picks,,,,"These high-quality small-cap stocks are a buy, Bank of America says Wall Street Analysts Are Bullish on Top Consumer Goods Picks",0,1,1,-1,-1,-1
29.73M,"155,483",-91.00M,-1,"10,848",49.41,Buy,64.13,"Aug 8, 2024",TWKS,"Thoughtworks Holding, Inc.",1.41B,4.36,1.03B,4.06%,28.75%,24.33%,+24.43%,+84.26%,,,,,,,1,-1,-1,-1,-1,-1
90.02M,"772,022",-229.40M,-1,"2,939",16.26,Strong Buy,33.25,,CENX,Century Aluminum Company,1.41B,15.16,2.11B,11.55%,-2.88%,13.54%,-4.10%,-13.23%,Unusually active option classes on open August 19th,Century Aluminum price target lowered to $22 from $24 at B. Riley,,,,Unusually active option classes on open August 19th Century Aluminum price target lowered to $22 from $24 at B. Riley,0,0,0,-1,-1,-1
113.31M,"860,219",-157.35M,-1,,12.85,Buy,12.75,"Aug 13, 2024",OCSL,Oaktree Specialty Lending Corporation,1.40B,17.02,388.87M,1.95%,-4.20%,-11.98%,-6.05%,-12.90%,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",Wells Fargo downgrades Oaktree Specialty Lending on less dividend ‘cushion’,,,,"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Wells Fargo downgrades Oaktree Specialty Lending on less dividend ‘cushion’",0,1,1,-1,-1,-1
72.80M,"522,691",-201.47M,-1,"1,867",19.87,Buy,33.44,"Jul 31, 2024",SONO,"Sonos, Inc.",1.39B,11.51,1.57B,2.09%,-9.18%,-23.60%,-11.48%,-34.70%,"Analysts Conflicted on These Technology Names: Advanced Micro Devices (AMD), Sonos (SONO) and Kingdee International Software Group Co (OtherKGDEF)","Analysts’ Opinions Are Mixed on These Technology Stocks: Lumentum Holdings (LITE), Sonos (SONO) and LiveRamp Holdings (RAMP)","Sonos lays off 6% of staff, committed to reducing real estate",,,"Analysts Conflicted on These Technology Names: Advanced Micro Devices (AMD), Sonos (SONO) and Kingdee International Software Group Co (OtherKGDEF) Analysts’ Opinions Are Mixed on These Technology Stocks: Lumentum Holdings (LITE), Sonos (SONO) and LiveRamp Holdings (RAMP) Sonos lays off 6% of staff, committed to reducing real estate",0,1,0,0,-1,-1
81.41M,"208,011",43.53M,$0.24,641,17.63,Strong Buy,22.00,"Oct 16, 2024",WABC,Westamerica Bancorporation,1.39B,52.08,312.49M,1.51%,0.87%,2.65%,-4.84%,+8.04%,,,,,,,0,-1,-1,-1,-1,-1
88.47M,"1,445,185",158.43M,$0.80,438,16.18,Strong Buy,21.83,"Aug 22, 2024",MTTR,"Matterport, Inc.",1.39B,4.35,162.28M,4.88%,4.05%,38.93%,unch,+117.65%,"Shapiro Haber & Urmy LLP Has Concluded That Legacy Matterport Shareholders May Have Valuable Claims Against Matterport, Inc.",,,,,"Shapiro Haber & Urmy LLP Has Concluded That Legacy Matterport Shareholders May Have Valuable Claims Against Matterport, Inc.",0,0,-1,-1,-1,-1
235.66M,"2,284,038",-106.22M,-1,447,6.07,Buy,6.76,"Aug 2, 2024",VITL,"Vital Farms, Inc.",1.39B,32.18,541.56M,-1.07%,-15.87%,24.06%,-15.51%,+21.28%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Friday’s analyst calls: Morgan Stanley names a top drug stock pick,Vital Farms hires Reena Van Hoven as Chief People Officer,Vital Farms Hires Reena Van Hoven as Chief People Officer,Vital Farms: A Strong Buy Amidst Market Turbulence with Robust Growth Potential,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Friday’s analyst calls: Morgan Stanley names a top drug stock pick Vital Farms hires Reena Van Hoven as Chief People Officer Vital Farms Hires Reena Van Hoven as Chief People Officer Vital Farms: A Strong Buy Amidst Market Turbulence with Robust Growth Potential",1,1,1,0,0,0
155.92M,"654,747",-138.36M,-1,155,9.11,Strong Buy,15.57,"Aug 7, 2024",DAWN,"Day One Biopharmaceuticals, Inc.",1.39B,14.09,8.19M,2.04%,-0.63%,-1.93%,-2.03%,-3.77%,Day One Biopharmaceuticals files to sell 12.07M shares of common for holders,Day One Biopharmaceuticals added to Analyst Focus List at JPMorgan,,,,Day One Biopharmaceuticals files to sell 12.07M shares of common for holders Day One Biopharmaceuticals added to Analyst Focus List at JPMorgan,0,0,1,-1,-1,-1
45.11M,"213,392",89.80M,$1.36,581,31.42,Hold,27.50,"Jul 23, 2024",INMD,InMode Ltd.,1.38B,16.25,416.63M,-4.66%,-9.43%,-21.99%,-13.58%,-19.90%,,,,,,,0,-1,-1,-1,-1,-1
56.78M,"262,170",55.27M,-1,"2,900",24.89,Buy,30.29,"Jul 31, 2024",MCRI,"Monarch Casino & Resort, Inc.",1.37B,74.24,510.95M,0.15%,4.33%,7.73%,-3.47%,+4.67%,"Spa Monarch jumps two spots to #2 best spa in the nation, as voted on by USA Today readers",,,,,"Spa Monarch jumps two spots to #2 best spa in the nation, as voted on by USA Today readers",0,0,-1,-1,-1,-1
323.16M,"608,089",-115.65M,-1,"26,420",4.360,Hold,4.18,"Aug 5, 2024",IMKTA,"Ingles Markets, Incorporated",1.37B,71.94,5.83B,-0.68%,0.92%,-4.34%,-9.52%,-2.77%,,,,,,,1,-1,-1,-1,-1,-1
92.79M,"960,278",206.30M,-1,"10,700",15.16,Buy,18.50,"Aug 8, 2024",AHCO,AdaptHealth Corp.,1.36B,10.45,3.26B,6.12%,3.82%,16.22%,-0.97%,+7.45%,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF)","AdaptHealth Welcomes New COO, Aims for Operational Excellence",AdaptHealth appoints Scott Barnhart as COO,AdaptHealth COO Shaw Rietkerk to transition to Chief Business Officer,AdaptHealth (AHCO) Gets a Buy from Truist Financial,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF) AdaptHealth Welcomes New COO, Aims for Operational Excellence AdaptHealth appoints Scott Barnhart as COO AdaptHealth COO Shaw Rietkerk to transition to Chief Business Officer AdaptHealth (AHCO) Gets a Buy from Truist Financial",0,0,0,1,0,0
82.25M,"675,510",66.94M,$2.20,50,17.02,Buy,18.42,"Aug 1, 2024",LBPH,"Longboard Pharmaceuticals, Inc.",1.35B,34.79,-,0.93%,9.12%,69.57%,+5.60%,+94.57%,Truist healthcare analyst holds an analyst/industry conference call,Buy Rating Affirmed for Longboard Pharmaceuticals Amid Promising Bexicaserin Developments and Strategic Regulatory Advancements,,,,Truist healthcare analyst holds an analyst/industry conference call Buy Rating Affirmed for Longboard Pharmaceuticals Amid Promising Bexicaserin Developments and Strategic Regulatory Advancements,1,1,0,-1,-1,-1
,,,-1,"4,693",,,,,RDFN,Redfin Corporation,1.35B,11.08,1.01B,38.71%,52.85%,55.18%,+26.54%,+66.67%,"Three-Stock Lunch: Boeing, Micron, Redfin","Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more","Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber",Redfin’s Growth and Profitability Outlook: Structural Improvements and Favorable Economic Forecast Justify Buy Rating,D.A. Davidson Remains a Hold on Redfin (RDFN),"Three-Stock Lunch: Boeing, Micron, Redfin Stocks making the biggest moves midday: Cleanspark, Vaxcyte, Unity Software and more Tuesday’s top analyst calls: Nvidia, Apple, Broadcom, Boeing, IBM, Meta, Uber Redfin’s Growth and Profitability Outlook: Structural Improvements and Favorable Economic Forecast Justify Buy Rating D.A. Davidson Remains a Hold on Redfin (RDFN)",1,1,1,1,1,0
121.01M,"1,865,401",-16.29M,-1,"20,100",11.51,Buy,20.33,"Aug 7, 2024",XRX,Xerox Holdings Corporation,1.34B,10.79,6.50B,7.39%,-2.10%,-25.95%,+1.63%,-36.69%,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box",Xerox price target lowered to $11 from $14 at Loop Capital,Loop Capital Markets Reaffirms Their Hold Rating on Xerox (XRX),,,"88 corporate leaders endorse Harris, including CEOs of Yelp, Box Xerox price target lowered to $11 from $14 at Loop Capital Loop Capital Markets Reaffirms Their Hold Rating on Xerox (XRX)",1,1,1,1,-1,-1
26.69M,"77,199",152.95M,$1.76,"3,800",52.08,Hold,54.00,"Oct 17, 2024",ANGI,Angi Inc.,1.34B,2.68,1.27B,7.12%,18.98%,12.05%,+13.79%,+16.30%,,,,,,,0,-1,-1,-1,-1,-1
319.13M,"1,022,418",-266.41M,-1,900,4.350,Hold,4.70,"Aug 6, 2024",DCBO,Docebo Inc.,1.34B,44.20,200.24M,11.85%,16.78%,3.52%,+8.12%,-10.25%,CIBC Sticks to Their Buy Rating for Docebo (DCBO),Morgan Stanley Sticks to Its Buy Rating for Docebo (DCBO),Scotiabank Remains a Buy on Docebo (DCBO),,,CIBC Sticks to Their Buy Rating for Docebo (DCBO) Morgan Stanley Sticks to Its Buy Rating for Docebo (DCBO) Scotiabank Remains a Buy on Docebo (DCBO),0,0,0,1,-1,-1
43.10M,"511,293",47.10M,-1,,32.18,Buy,31.83,"Aug 8, 2024",NMFC,New Mountain Finance Corporation,1.33B,12.36,372.54M,1.39%,0.75%,-1.52%,-1.37%,-3.09%,,,,,,,0,-1,-1,-1,-1,-1
98.31M,"874,810",-167.48M,-1,"6,000",14.09,Strong Buy,35.86,"Jul 30, 2024",CSGS,"CSG Systems International, Inc.",1.33B,47.15,1.17B,3.21%,8.91%,-0.77%,+1.64%,-2.18%,,,,,,,0,-1,-1,-1,-1,-1
84.62M,"1,023,476",149.20M,-1,826,16.25,Hold,22.40,"Aug 1, 2024",VBTX,"Veritex Holdings, Inc.",1.33B,24.45,363.13M,5.48%,8.24%,14.93%,-1.04%,+23.86%,D.A. Davidson Reaffirms Their Buy Rating on Veritex (VBTX),Veritex Engages Stakeholders with Performance and Outlook Insights,,,,D.A. Davidson Reaffirms Their Buy Rating on Veritex (VBTX) Veritex Engages Stakeholders with Performance and Outlook Insights,1,0,0,-1,-1,-1
18.45M,"93,140",83.32M,$1.20,800,74.24,Hold,73.67,"Oct 16, 2024",UPWK,Upwork Inc.,1.32B,10.02,743.73M,-3.34%,-8.31%,-21.50%,-23.02%,-21.66%,Upwork Stock (UPWK): High Quality Growth Story on Sale,Upwork to Present at Goldman Sachs Communacopia + Technology Conference,Upwork highlighted in OpenAI blog post,Upwork price target lowered to $13 from $19 at Roth MKM,Roth MKM Sticks to Their Buy Rating for Upwork (UPWK),Upwork Stock (UPWK): High Quality Growth Story on Sale Upwork to Present at Goldman Sachs Communacopia + Technology Conference Upwork highlighted in OpenAI blog post Upwork price target lowered to $13 from $19 at Roth MKM Roth MKM Sticks to Their Buy Rating for Upwork (UPWK),1,1,0,1,0,0
18.99M,"82,494",159.65M,$0.66,56,71.94,,,"Aug 8, 2024",PLSE,"Pulse Biosciences, Inc.",1.32B,21.48,-,6.73%,19.20%,71.86%,+22.26%,+141.61%,Pulse Biosciences Highlights CellFX™ Advances in Presentation,Pulse Biosciences Enhances Board with Strategic Leadership Changes,,,,Pulse Biosciences Highlights CellFX™ Advances in Presentation Pulse Biosciences Enhances Board with Strategic Leadership Changes,1,1,1,-1,-1,-1
130.53M,"743,498",-690.25M,-1,35,10.45,Buy,11.30,"Aug 6, 2024",CIFR,Cipher Mining Inc.,1.32B,4.00,158.67M,-9.87%,-21.05%,-3.44%,-32.50%,-12.84%,Morgan Stanley says some crypto miners could gain by turning to data centers,Cipher Mining (CIFR) Gets a Buy from Cantor Fitzgerald,Cipher Mining reports 160 BTC mined and 136 BTC sold in August,Cipher Mining files automatic mixed securities shelf,Buy Rating Affirmed: Cipher Mining’s Strategic Growth and Risk Management Impress Analyst,Morgan Stanley says some crypto miners could gain by turning to data centers Cipher Mining (CIFR) Gets a Buy from Cantor Fitzgerald Cipher Mining reports 160 BTC mined and 136 BTC sold in August Cipher Mining files automatic mixed securities shelf Buy Rating Affirmed: Cipher Mining’s Strategic Growth and Risk Management Impress Analyst,1,0,1,1,0,1
38.90M,"1,108,351",-64.74M,-1,130,34.79,Strong Buy,52.43,"Aug 1, 2024",ADEA,Adeia Inc.,1.31B,12.07,359.02M,7.85%,8.01%,9.45%,+4.34%,+14.69%,"Adeia Celebrates Semiconductor Technology Pioneer, Dr. Belgacem Haba, who has helped Revolutionize the Semiconductor Industry with Groundbreaking Inventions","Adeia reports Canadian Court of Appeals rulings for Videotron, Bell/Telus cases",Adeia management to meet virtually with Maxim Group,,,"Adeia Celebrates Semiconductor Technology Pioneer, Dr. Belgacem Haba, who has helped Revolutionize the Semiconductor Industry with Groundbreaking Inventions Adeia reports Canadian Court of Appeals rulings for Videotron, Bell/Telus cases Adeia management to meet virtually with Maxim Group",1,1,1,1,-1,-1
121.77M,"11,311,853",-137.50M,-1,83,11.08,Hold,7.08,"Aug 6, 2024",WINA,Winmark Corporation,1.31B,371.59,82.59M,-0.42%,-1.29%,-2.73%,-9.81%,+4.94%,,,,,,,0,-1,-1,-1,-1,-1
124.33M,"1,798,554",-118.00M,$1.00,"1,000",10.79,Sell,12.75,"Jul 25, 2024",WKME,WalkMe Ltd.,1.30B,13.85,272.99M,-0.11%,-0.20%,30.80%,-0.29%,+68.57%,WalkMe announces new capabilities of its Summer ’24 product release,"WalkMe Doubles Down on AI Innovation, Releases Enhancements to Award-Winning Copilot, WalkMe(X)",Market Perform Rating Maintained for WalkMe Amidst SAP Acquisition and Financial Uncertainty,,,"WalkMe announces new capabilities of its Summer ’24 product release WalkMe Doubles Down on AI Innovation, Releases Enhancements to Award-Winning Copilot, WalkMe(X) Market Perform Rating Maintained for WalkMe Amidst SAP Acquisition and Financial Uncertainty",0,0,0,0,-1,-1
498.67M,"823,266",-8.79M,-1,328,2.680,Strong Buy,3.78,"Aug 6, 2024",SANA,"Sana Biotechnology, Inc.",1.30B,5.84,-,11.46%,4.73%,-12.61%,-3.94%,-35.07%,Sana Biotechnology to Present at September 2024 Investor Conferences,"Sana Biotechnology appoints Dhaval Patel, M.D., CSO","Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer",Unusually active option classes on open August 22nd,"3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)","Sana Biotechnology to Present at September 2024 Investor Conferences Sana Biotechnology appoints Dhaval Patel, M.D., CSO Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer Unusually active option classes on open August 22nd 3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)",0,0,0,1,0,1
30.23M,"54,205",17.14M,-1,"23,258",44.20,Strong Buy,51.50,"Aug 8, 2024",PLAY,"Dave & Buster's Entertainment, Inc.",1.30B,32.79,2.20B,-3.94%,-13.61%,-35.39%,-16.83%,-51.59%,"Is PLAY a Buy, Before Earnings?",Topgolf Callaway price target raised to $14 from $13 at BofA,"Analysts’ Opinions Are Mixed on These Communication Services Stocks: Globalstar (GSAT), Dave & Busters Entertainment (PLAY) and Nexters (GDEV)","3 Small-Cap Stocks with Big Potential, Say Analysts (8/30/24)",Dave & Buster’s price target lowered to $59 from $64 at Truist,"Is PLAY a Buy, Before Earnings? Topgolf Callaway price target raised to $14 from $13 at BofA Analysts’ Opinions Are Mixed on These Communication Services Stocks: Globalstar (GSAT), Dave & Busters Entertainment (PLAY) and Nexters (GDEV) 3 Small-Cap Stocks with Big Potential, Say Analysts (8/30/24) Dave & Buster’s price target lowered to $59 from $64 at Truist",1,1,1,1,0,1
107.85M,"325,068",117.82M,$0.64,30,12.36,Hold,12.00,"Jul 31, 2024",SYRE,"Spyre Therapeutics, Inc.",1.30B,25.53,-,6.70%,3.41%,0.46%,+1.93%,-22.53%,Spyre Therapeutics files $500M mixed securities shelf,"Wedbush bullish on Spyre Therapeutics, initiates with an Outperform",Spyre Therapeutics initiated with an Outperform at Wedbush,Spyre Therapeutics management to meet with BTIG,,"Spyre Therapeutics files $500M mixed securities shelf Wedbush bullish on Spyre Therapeutics, initiates with an Outperform Spyre Therapeutics initiated with an Outperform at Wedbush Spyre Therapeutics management to meet with BTIG",1,1,0,1,0,-1
,,,-1,,,,,,MFIC,MidCap Financial Investment Corporation,1.30B,13.81,277.61M,2.79%,-3.53%,-2.63%,-2.75%,-6.88%,KBW Remains a Buy on MidCap Financial Investment Corporation (MFIC),MidCap Financial Investment Corporation (MFIC) Receives a Hold from J.P. Morgan,Truist Financial Gives a Buy Rating to MidCap Financial Investment Corporation (MFIC),"Analysts Have Conflicting Sentiments on These Financial Companies: MidCap Financial Investment Corporation (MFIC), goeasy (OtherEHMEF) and Open Lending (LPRO)",,"KBW Remains a Buy on MidCap Financial Investment Corporation (MFIC) MidCap Financial Investment Corporation (MFIC) Receives a Hold from J.P. Morgan Truist Financial Gives a Buy Rating to MidCap Financial Investment Corporation (MFIC) Analysts Have Conflicting Sentiments on These Financial Companies: MidCap Financial Investment Corporation (MFIC), goeasy (OtherEHMEF) and Open Lending (LPRO)",1,0,0,1,1,-1
28.26M,"165,405",64.66M,$1.20,"1,030",47.15,Strong Buy,58.80,"Aug 7, 2024",QCRH,"QCR Holdings, Inc.",1.29B,76.46,336.45M,6.80%,15.72%,30.41%,+0.60%,+33.81%,"Analysts Offer Insights on Financial Companies: Intercontinental Exchange (ICE), Swiss Life Holding AG (OtherSWSDF) and QCR Holdings (QCRH)",KBW Remains a Buy on QCR Holdings (QCRH),QCR Holdings discontinues new loans/leases through m2 finance unit,QCR Holdings Restructures for Improved Financial Performance,"QCR Holdings, Inc. to Discontinue Offering New Loans and Leases Through m2 Equipment Finance Subsidiary","Analysts Offer Insights on Financial Companies: Intercontinental Exchange (ICE), Swiss Life Holding AG (OtherSWSDF) and QCR Holdings (QCRH) KBW Remains a Buy on QCR Holdings (QCRH) QCR Holdings discontinues new loans/leases through m2 finance unit QCR Holdings Restructures for Improved Financial Performance QCR Holdings, Inc. to Discontinue Offering New Loans and Leases Through m2 Equipment Finance Subsidiary",0,0,0,1,0,1
54.39M,"290,908",87.48M,$0.80,"1,382",24.45,Buy,27.50,"Jul 23, 2024",MOMO,Hello Group Inc.,1.28B,6.92,1.63B,-3.76%,-0.10%,7.98%,-2.07%,+10.35%,Benchmark Co. Sticks to Its Buy Rating for Hello Group (MOMO),Hello Group price target lowered to $13 from $15 at Benchmark,"ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz",Hello Group price target raised to $7 from $6.50 at Jefferies,Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon,"Benchmark Co. Sticks to Its Buy Rating for Hello Group (MOMO) Hello Group price target lowered to $13 from $15 at Benchmark ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz Hello Group price target raised to $7 from $6.50 at Jefferies Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon",1,1,0,0,0,0
132.01M,"1,551,465",74.37M,-1,167,10.02,Strong Buy,15.70,"Aug 7, 2024",REAX,The Real Brokerage Inc.,1.28B,6.66,937.50M,8.97%,23.15%,83.30%,+8.74%,+58.19%,Real Brokerage management to meet with Roth MKM,,,,,Real Brokerage management to meet with Roth MKM,1,1,-1,-1,-1,-1
61.29M,"125,758",-44.02M,-1,908,21.48,,,"Aug 12, 2024",ESTA,Establishment Labs Holdings Inc.,1.28B,45.65,151.35M,10.92%,5.72%,11.95%,+3.94%,-14.72%,Establishment Labs Appoints New President Peter Caldini,Establishment Labs price target raised to $45 from $41 at Citi,Establishment Labs Holdings: A Cautious Hold Amid FDA Approval Process and High Short Interest,Citi opens ‘positive catalyst watch’ on Establishment Labs,,Establishment Labs Appoints New President Peter Caldini Establishment Labs price target raised to $45 from $41 at Citi Establishment Labs Holdings: A Cautious Hold Amid FDA Approval Process and High Short Interest Citi opens ‘positive catalyst watch’ on Establishment Labs,0,1,0,0,0,-1
328.94M,"9,742,508",16.58M,-1,539,4.000,Strong Buy,7.07,"Aug 13, 2024",SAFT,"Safety Insurance Group, Inc.",1.27B,85.83,1.03B,4.84%,7.14%,7.99%,+2.43%,+12.20%,,,,,,,1,-1,-1,-1,-1,-1
108.90M,"392,592",46.21M,$0.20,147,12.07,Strong Buy,15.67,"Aug 6, 2024",NEXT,NextDecade Corporation,1.27B,4.90,-,-16.85%,-31.64%,-18.73%,-43.16%,-16.64%,NextDecade (NEXT) Gets a Buy from Stifel Nicolaus,NextDecade withdraws carbon capture and storage application at FERC,NextDecade says made ‘excellent strides’ on Rio Grande Phase 1 goals,NextDecade Corp options imply 12.3% move in share price post-earnings,NextDecade Corp options imply 12.7% move in share price post-earnings,NextDecade (NEXT) Gets a Buy from Stifel Nicolaus NextDecade withdraws carbon capture and storage application at FERC NextDecade says made ‘excellent strides’ on Rio Grande Phase 1 goals NextDecade Corp options imply 12.3% move in share price post-earnings NextDecade Corp options imply 12.7% move in share price post-earnings,1,1,0,0,0,0
3.52M,"53,567",40.12M,$3.60,650,371.59,Strong Buy,445.00,"Oct 16, 2024",MRVI,"Maravai LifeSciences Holdings, Inc.",1.26B,8.91,278.59M,0.80%,8.86%,20.32%,-5.86%,+15.22%,"Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz","Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls","Cygnus, TriLink collaborate to launch AccusRes Host Cell DNA kits",Wells Fargo starts tools and diagnostics group with positive bias,Biotech Alert: Searches spiking for these stocks today,"Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Cygnus, TriLink collaborate to launch AccusRes Host Cell DNA kits Wells Fargo starts tools and diagnostics group with positive bias Biotech Alert: Searches spiking for these stocks today",1,1,1,1,1,1
93.90M,"312,013",-45.19M,-1,"3,191",13.85,Hold,12.00,"Aug 1, 2024",COHU,"Cohu, Inc.",1.26B,26.87,500.35M,0.28%,-12.93%,-16.74%,-19.66%,-19.99%,Cohu announces order for new Diamondx instrument and mixed signal platform,,,,,Cohu announces order for new Diamondx instrument and mixed signal platform,0,0,-1,-1,-1,-1
222.47M,"669,479",-244.90M,-1,26,5.84,Strong Buy,13.67,"Aug 8, 2024",SPRY,"ARS Pharmaceuticals, Inc.",1.26B,12.96,500.00K,17.83%,32.65%,70.82%,+26.40%,+39.21%,ARS Pharmaceuticals launches pre-ordering services for neffy,ARS Pharmaceuticals’ Market Expansion and Strategic Positioning Affirm Buy Rating,EURneffy (adrenaline nasal spray) Approved in the EU as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis),Strong Buy Rating for ARS Pharma on Neffy’s Market Potential and Strategic Launch,"Vornado upgraded, JPMorgan downgraded: Wall Street’s top analyst calls","ARS Pharmaceuticals launches pre-ordering services for neffy ARS Pharmaceuticals’ Market Expansion and Strategic Positioning Affirm Buy Rating EURneffy (adrenaline nasal spray) Approved in the EU as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) Strong Buy Rating for ARS Pharma on Neffy’s Market Potential and Strategic Launch Vornado upgraded, JPMorgan downgraded: Wall Street’s top analyst calls",1,0,1,1,0,1
39.56M,"878,201",98.20M,-1,"1,028",32.79,Buy,67.33,"Sep 9, 2024",RBCAA,"Republic Bancorp, Inc.",1.25B,64.55,315.69M,5.59%,9.69%,21.16%,-2.64%,+26.84%,,,,,,,1,-1,-1,-1,-1,-1
50.79M,"279,380",-185.98M,-1,690,25.53,Strong Buy,43.00,"Aug 7, 2024",CRCT,"Cricut, Inc.",1.25B,5.79,741.49M,-3.31%,-1.66%,2.58%,-7.73%,+15.06%,Cricut to Present at Upcoming Investor Conferences,,,,,Cricut to Present at Upcoming Investor Conferences,1,1,-1,-1,-1,-1
93.78M,"373,519",111.27M,$1.50,"1,054",13.81,Buy,14.79,"Aug 7, 2024",XPEL,"XPEL, Inc.",1.25B,45.27,408.24M,8.37%,17.27%,-3.08%,+6.17%,-26.52%,"Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of XPEL, Inc.(XPEL) Shareholders",Investors who lost money on XPEL Technologies Corp.(XPEL) should contact Levi & Korsinsky LLP about pending Class Action – XPEL,,,,"Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of XPEL, Inc.(XPEL) Shareholders Investors who lost money on XPEL Technologies Corp.(XPEL) should contact Levi & Korsinsky LLP about pending Class Action – XPEL",1,1,1,-1,-1,-1
,,,-1,140,,,,,TNGX,"Tango Therapeutics, Inc.",1.24B,11.57,42.51M,16.89%,19.53%,23.96%,+15.13%,+53.66%,Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks,,,,,Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks,0,1,-1,-1,-1,-1
16.84M,"78,461",113.82M,$0.24,"1,200",76.46,Buy,76.00,"Jul 24, 2024",ATRC,"AtriCure, Inc.",1.24B,25.44,429.95M,12.83%,12.12%,-11.03%,+18.68%,-2.51%,AtriCure announces first patient treated with AtriClip FLEX-Mini device,AtriCure receives expanded CE-Mark indication for AtriClip,Atricure’s Market Strength and Innovation Justify Buy Rating,,,AtriCure announces first patient treated with AtriClip FLEX-Mini device AtriCure receives expanded CE-Mark indication for AtriClip Atricure’s Market Strength and Innovation Justify Buy Rating,1,0,0,0,-1,-1
185.08M,"1,937,763",217.78M,$0.54,27,6.92,Buy,10.35,"Sep 3, 2024",DMLP,"Dorchester Minerals, L.P.",1.23B,30.78,155.58M,0.99%,-0.65%,-2.10%,+0.79%,-12.28%,,,,,,,1,-1,-1,-1,-1,-1
191.90M,"1,187,609",-33.30M,-1,493,6.66,Strong Buy,3.50,"Aug 7, 2024",PDFS,"PDF Solutions, Inc.",1.23B,31.81,166.45M,-0.23%,-8.37%,-4.64%,-11.97%,-4.92%,"Analysts Have Conflicting Sentiments on These Technology Companies: Stratasys (SSYS), Pure Storage (PSTG) and PDF Solutions (PDFS)",D.A. Davidson Keeps Their Buy Rating on PDF Solutions (PDFS),PDF Solutions (PDFS) Receives a Rating Update from a Top Analyst,PDF Solutions (PDFS) Gets a Buy from D.A. Davidson,,"Analysts Have Conflicting Sentiments on These Technology Companies: Stratasys (SSYS), Pure Storage (PSTG) and PDF Solutions (PDFS) D.A. Davidson Keeps Their Buy Rating on PDF Solutions (PDFS) PDF Solutions (PDFS) Receives a Rating Update from a Top Analyst PDF Solutions (PDFS) Gets a Buy from D.A. Davidson",0,1,0,0,0,-1
27.94M,"119,372",-83.20M,-1,"1,443",45.65,Buy,57.17,"Aug 6, 2024",UDMY,"Udemy, Inc.",1.22B,8.14,765.47M,4.98%,-0.85%,-26.79%,-13.53%,-23.83%,Udemy Inc Appoints New CTO to Drive Innovation,"Udemy CTO Venu Venugopal to switch roles, Eren Bali to succeed",,,,"Udemy Inc Appoints New CTO to Drive Innovation Udemy CTO Venu Venugopal to switch roles, Eren Bali to succeed",0,0,1,-1,-1,-1
14.84M,"39,432",50.70M,$3.60,"1,590",85.83,,,"Aug 7, 2024",ACMR,"ACM Research, Inc.",1.22B,19.49,693.56M,-0.23%,-11.51%,-16.99%,-0.50%,-44.26%,Roth MKM Keeps Their Buy Rating on ACM Research (ACMR),ACM Research Receives Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center,ACM Research Expands Fan-Out Panel-Level Packaging Portfolio with Launch of Ultra C bev-p Bevel Etching Tool,"3 Small-Cap Stocks with Big Potential, Say Analysts (8/30/24)",ACM Research (ACMR) Receives a Buy from Craig-Hallum,"Roth MKM Keeps Their Buy Rating on ACM Research (ACMR) ACM Research Receives Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center ACM Research Expands Fan-Out Panel-Level Packaging Portfolio with Launch of Ultra C bev-p Bevel Etching Tool 3 Small-Cap Stocks with Big Potential, Say Analysts (8/30/24) ACM Research (ACMR) Receives a Buy from Craig-Hallum",1,0,1,1,0,0
259.47M,"1,478,390",-25.89M,-1,"1,927",4.90,Hold,9.00,"Aug 14, 2024",HELE,Helen of Troy Limited,1.22B,53.36,1.95B,-1.27%,-22.02%,-47.19%,-10.56%,-50.13%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",Closing Bell Movers: Broadcom slips 7% after Q3 results,Helen of Troy announces new $500M buyback,Helen of Troy: Cost Efficiency and Strategic Capital Allocation Justify Buy Rating,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Closing Bell Movers: Broadcom slips 7% after Q3 results Helen of Troy announces new $500M buyback Helen of Troy: Cost Efficiency and Strategic Capital Allocation Justify Buy Rating",1,1,0,1,1,-1
141.55M,"1,135,471",-132.08M,-1,"48,200",8.91,Buy,10.88,"Aug 7, 2024",TASK,"TaskUs, Inc.",1.22B,13.72,925.29M,-6.34%,-6.44%,4.41%,-18.47%,+24.75%,TaskUs price target lowered to $15 from $17 at JPMorgan,"Analysts Offer Insights on Technology Companies: TaskUs (TASK), Shift4 Payments (FOUR) and Epam Systems (EPAM)",TaskUs (TASK) Receives a Hold from J.P. Morgan,TaskUs price target raised to $19 from $18 at Citi,TaskUs: Balancing Growth Momentum with Margin Pressures – A Hold Rating Analysis,"TaskUs price target lowered to $15 from $17 at JPMorgan Analysts Offer Insights on Technology Companies: TaskUs (TASK), Shift4 Payments (FOUR) and Epam Systems (EPAM) TaskUs (TASK) Receives a Hold from J.P. Morgan TaskUs price target raised to $19 from $18 at Citi TaskUs: Balancing Growth Momentum with Margin Pressures – A Hold Rating Analysis",0,0,0,0,0,0
46.92M,"189,341",-28.52M,-1,"2,300",26.87,Strong Buy,36.20,"Jul 31, 2024",SCSC,"ScanSource, Inc.",1.22B,49.19,3.46B,-0.84%,3.00%,13.29%,-0.29%,+24.82%,"Bronfman drops Paramount bid, Apple names new CFO: Morning Buzz","Scansource reports Q4 EPS 80c, consensus 93c",ScanSource Inc (SCSC) Q4 Earnings Cheat Sheet,"Scansource acquires Advantix, forms Integrated Solutions and Services Group",Raymond James downgrades ScanSource (SCSC) to a Hold,"Bronfman drops Paramount bid, Apple names new CFO: Morning Buzz Scansource reports Q4 EPS 80c, consensus 93c ScanSource Inc (SCSC) Q4 Earnings Cheat Sheet Scansource acquires Advantix, forms Integrated Solutions and Services Group Raymond James downgrades ScanSource (SCSC) to a Hold",1,1,1,1,1,0
96.94M,"869,485",-44.84M,-1,"70,000",12.96,Buy,22.25,"Aug 6, 2024",ADV,Advantage Solutions Inc.,1.21B,3.78,4.07B,1.44%,6.69%,3.06%,-4.74%,-10.33%,Advantage Solutions to Participate in the Wells Fargo 7th Annual Consumer Conference,Advantage Solutions unveils comprehensive rebrand,Buy Rating for Advantage Solutions on Strategic Realignments and Financial Strength,,,Advantage Solutions to Participate in the Wells Fargo 7th Annual Consumer Conference Advantage Solutions unveils comprehensive rebrand Buy Rating for Advantage Solutions on Strategic Realignments and Financial Strength,0,0,0,0,-1,-1
19.43M,"18,233",97.04M,$1.63,642,64.55,,,"Jul 19, 2024",ANIP,"ANI Pharmaceuticals, Inc.",1.20B,61.68,538.95M,3.95%,2.20%,4.44%,-4.56%,-7.29%,ANI Pharmaceuticals Announces Debt Clearance and Notes Sale,"ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes",,,,"ANI Pharmaceuticals Announces Debt Clearance and Notes Sale ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes",1,0,1,-1,-1,-1
216.37M,"282,258",67.93M,$0.20,587,5.79,Sell,5.09,"Aug 6, 2024",VIR,"Vir Biotechnology, Inc.",1.20B,8.77,78.88M,-5.51%,-9.15%,-13.94%,-18.60%,-11.46%,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Corvus Pharmaceuticals (CRVS), Vir Biotechnology (VIR) and Cooper Co (COO)",,,,,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Corvus Pharmaceuticals (CRVS), Vir Biotechnology (VIR) and Cooper Co (COO)",1,1,-1,-1,-1,-1
27.64M,"178,233",47.33M,-1,"7,400",45.27,Strong Buy,67.33,"Aug 8, 2024",ECPG,"Encore Capital Group, Inc.",1.20B,50.58,1.27B,2.73%,8.40%,7.63%,-1.38%,+14.47%,Encore Capital price target lowered to $64 from $70 at Truist,,,,,Encore Capital price target lowered to $64 from $70 at Truist,0,0,-1,-1,-1,-1
107.14M,"425,633",-116.49M,-1,523,11.57,Strong Buy,15.14,"Aug 7, 2024",SGML,Sigma Lithium Corporation,1.19B,10.78,215.17M,7.04%,-5.82%,-39.44%,-6.68%,-29.41%,Largest borrow rate increases among liquid names,Sigma Lithium Expands with Major BNDES Loan,Sigma Lithium announces binding commitment from BNDES for BRL 487M loan,BMO Capital Reaffirms Their Buy Rating on Sigma Lithium (SGML),Sigma Lithium Exceeds 2Q24 Expectations with Cost Cuts,Largest borrow rate increases among liquid names Sigma Lithium Expands with Major BNDES Loan Sigma Lithium announces binding commitment from BNDES for BRL 487M loan BMO Capital Reaffirms Their Buy Rating on Sigma Lithium (SGML) Sigma Lithium Exceeds 2Q24 Expectations with Cost Cuts,1,1,1,1,1,1
48.70M,"541,486",-40.12M,-1,840,25.44,Strong Buy,42.44,"Jul 30, 2024",GABC,"German American Bancorp, Inc.",1.19B,40.24,246.85M,4.28%,7.46%,19.64%,+1.45%,+20.07%,German American Bancorp Discusses Future and Merger at Conference,,,,,German American Bancorp Discusses Future and Merger at Conference,1,1,-1,-1,-1,-1
40.09M,"26,641",104.30M,$2.81,"4,600",30.78,,,"Aug 1, 2024",GIII,"G-III Apparel Group, Ltd.",1.19B,26.54,3.10B,3.10%,0.28%,-8.84%,-6.46%,-8.42%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",G-III Apparel price target raised to $32 from $29 at Telsey Advisory,G-III Apparel price target raised to $34 from $32 at KeyBanc,G-III Apparel price target raised to $27 from $23 at Barclays,KeyBanc Keeps Their Buy Rating on G-III Apparel Group (GIII),"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more G-III Apparel price target raised to $32 from $29 at Telsey Advisory G-III Apparel price target raised to $34 from $32 at KeyBanc G-III Apparel price target raised to $27 from $23 at Barclays KeyBanc Keeps Their Buy Rating on G-III Apparel Group (GIII)",1,1,1,1,1,1
38.75M,"124,047",-2.77M,-1,"5,300",31.81,Strong Buy,41.00,"Aug 8, 2024",SCVL,"Shoe Carnival, Inc.",1.19B,43.87,1.20B,4.26%,9.08%,30.90%,-4.71%,+16.59%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more",Seaport Global Remains a Buy on Shoe Carnival (SCVL),Buy Recommendation for SCVL Amid Strong Q2 Performance and Strategic Growth Initiatives,Morning Movers: JetBlue gains following Q3 guidance bump,Shoe Carnival reports Q2 SSS down 2.1%,"Stocks making biggest moves midday: JetBlue, Tesla, G-III Apparel and more Seaport Global Remains a Buy on Shoe Carnival (SCVL) Buy Recommendation for SCVL Amid Strong Q2 Performance and Strategic Growth Initiatives Morning Movers: JetBlue gains following Q3 guidance bump Shoe Carnival reports Q2 SSS down 2.1%",0,1,1,1,0,1
150.36M,"865,964",-87.17M,-1,"1,110",8.14,Buy,12.90,"Jul 31, 2024",FSUN,FirstSun Capital Bancorp,1.19B,42.89,342.97M,1.29%,12.30%,24.58%,+2.14%,+19.43%,FirstSun Capital Bancorp’s Investor Presentation Outreach,Raymond James starts FirstSun Capital at Market Perform after outperformance,,,,FirstSun Capital Bancorp’s Investor Presentation Outreach Raymond James starts FirstSun Capital at Market Perform after outperformance,0,0,0,-1,-1,-1
62.47M,"777,003",85.02M,-1,"4,000",19.49,Strong Buy,31.80,"Aug 7, 2024",KALU,Kaiser Aluminum Corporation,1.18B,74.30,2.98B,6.02%,-8.49%,-3.76%,-6.65%,-20.99%,,,,,,,1,-1,-1,-1,-1,-1
22.81M,"277,438",152.22M,-1,"6,232",53.36,Buy,74.33,"Oct 2, 2024",SABR,Sabre Corporation,1.18B,3.07,2.98B,-1.35%,0.22%,-7.05%,-13.99%,+10.90%,"Elliott will launch proxy fight at Southwest, nominate 10 directors",Sabre signs long-term distribution agreement with Delta Air Lines,"Sabre, WestJet expand long-term distribution deal",,,"Elliott will launch proxy fight at Southwest, nominate 10 directors Sabre signs long-term distribution agreement with Delta Air Lines Sabre, WestJet expand long-term distribution deal",1,0,1,1,-1,-1
88.72M,"193,643",50.36M,-1,112,13.72,Hold,15.13,"Aug 8, 2024",INVA,"Innoviva, Inc.",1.18B,18.86,330.50M,2.88%,9.05%,20.23%,+1.75%,+30.76%,Biotech Alert: Searches spiking for these stocks today,,,,,Biotech Alert: Searches spiking for these stocks today,0,1,-1,-1,-1,-1
24.71M,"215,768",79.78M,-1,197,49.19,Hold,36.00,"Aug 27, 2024",COLL,"Collegium Pharmaceutical, Inc.",1.17B,36.26,576.65M,4.77%,11.43%,13.25%,-3.84%,-7.25%,Collegium Pharmaceutical price target raised to $50 from $47 at H.C. Wainwright,Collegium Pharmaceutical Announces Major Acquisition and Financing Deal,Collegium Pharmaceutical completes acquisition of Ironshore for $525M in cash,Collegium raises FY24 revenue view to $620M-$635M from $580M-$595M,Collegium Completes Acquisition of Ironshore Therapeutics,Collegium Pharmaceutical price target raised to $50 from $47 at H.C. Wainwright Collegium Pharmaceutical Announces Major Acquisition and Financing Deal Collegium Pharmaceutical completes acquisition of Ironshore for $525M in cash Collegium raises FY24 revenue view to $620M-$635M from $580M-$595M Collegium Completes Acquisition of Ironshore Therapeutics,1,0,1,1,1,1
320.54M,"511,344",-113.05M,-1,173,3.780,Strong Buy,,"Aug 7, 2024",PRTA,Prothena Corporation plc,1.17B,21.71,217.25M,1.75%,-0.74%,-19.80%,-8.72%,-9.07%,Oppenheimer Remains a Buy on Prothena (PRTA),Prothena price target lowered to $62 from $66 at Oppenheimer,"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE)","3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24)",Prothena price target lowered to $24 from $28 at RBC Capital,"Oppenheimer Remains a Buy on Prothena (PRTA) Prothena price target lowered to $62 from $66 at Oppenheimer Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE) 3 Small-Cap Stocks with Big Potential, Say Analysts (8/13/24) Prothena price target lowered to $24 from $28 at RBC Capital",0,0,0,0,1,0
19.52M,"337,890",22.93M,-1,414,61.68,Strong Buy,83.67,"Aug 6, 2024",BLFS,"BioLife Solutions, Inc.",1.17B,25.30,139.96M,5.01%,14.50%,39.66%,+5.54%,+47.99%,BioLife Solutions price target raised to $30 from $23 at Craig-Hallum,BioLife Solutions (BLFS) Gets a Buy from Lake Street,BioLife Solutions price target raised to $28 from $26 at Northland,,,BioLife Solutions price target raised to $30 from $23 at Craig-Hallum BioLife Solutions (BLFS) Gets a Buy from Lake Street BioLife Solutions price target raised to $28 from $26 at Northland,1,0,0,0,-1,-1
136.64M,"469,074",-483.04M,-1,"5,061",8.77,Buy,33.00,"Aug 1, 2024",EVO,Evotec SE,1.16B,3.35,844.79M,6.56%,-11.64%,-44.82%,-24.37%,-52.38%,Evotec (0IRF) Gets a Buy from RBC Capital,Deutsche Bank Remains a Sell on Evotec (0IRF),Buy Rating Affirmed for Evotec Amidst Strategic Restructuring and Promising Partnerships,Evotec price target lowered to $8 from $11 at H.C. Wainwright,"Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Medtronic (MDT) and Cardinal Health (CAH)","Evotec (0IRF) Gets a Buy from RBC Capital Deutsche Bank Remains a Sell on Evotec (0IRF) Buy Rating Affirmed for Evotec Amidst Strategic Restructuring and Promising Partnerships Evotec price target lowered to $8 from $11 at H.C. Wainwright Analysts Offer Insights on Healthcare Companies: Evotec AG (EVO), Medtronic (MDT) and Cardinal Health (CAH)",1,0,1,0,0,0
23.69M,"68,386",-196.00M,-1,49,50.58,Strong Buy,62.00,"Aug 7, 2024",TYRA,"Tyra Biosciences, Inc.",1.16B,22.06,-,1.91%,10.39%,29.23%,-3.75%,+18.50%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC","Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls",Buy Rating for Tyra Biosciences Backed by TYRA-300’s Potential and FGFR Expertise,Tyra Biosciences initiated with an Overweight at Piper Sandler,Bank of America Securities Sticks to Its Hold Rating for Tyra Bioscience (TYRA),"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls Buy Rating for Tyra Biosciences Backed by TYRA-300’s Potential and FGFR Expertise Tyra Biosciences initiated with an Overweight at Piper Sandler Bank of America Securities Sticks to Its Hold Rating for Tyra Bioscience (TYRA)",0,1,1,0,0,1
110.80M,"429,620",8.83M,-1,"1,190",10.78,Strong Buy,24.50,"Aug 16, 2024",LZ,"LegalZoom.com, Inc.",1.16B,6.62,677.51M,7.38%,-4.60%,-35.01%,-1.95%,-50.04%,LegalZoom price target lowered to $8 from $9 at JPMorgan,Morgan Stanley Sticks to Their Sell Rating for LegalZoom (LZ),"LegalZoom Bolsters Leadership, CFO Watson Assumes COO Role",,,"LegalZoom price target lowered to $8 from $9 at JPMorgan Morgan Stanley Sticks to Their Sell Rating for LegalZoom (LZ) LegalZoom Bolsters Leadership, CFO Watson Assumes COO Role",1,0,0,0,-1,-1
29.68M,"93,091",82.51M,$1.08,27,40.24,Buy,44.00,"Jul 29, 2024",CSWC,Capital Southwest Corporation,1.16B,24.72,189.13M,1.00%,-2.91%,0.36%,-4.25%,-1.17%,Best Visa business credit cards,Best business credit cards for travel,Best car insurance for teens,Best car insurance,Best credit cards for Marriott stays,Best Visa business credit cards Best business credit cards for travel Best car insurance for teens Best car insurance Best credit cards for Marriott stays,1,0,0,1,1,0
44.99M,"336,107",178.73M,-1,"1,104",26.54,Hold,28.00,"Sep 9, 2024",TRNS,"Transcat, Inc.",1.16B,126.64,265.59M,6.69%,1.32%,11.56%,+4.73%,+12.66%,"Transcat files to sell 31,142 shares of common stock for holders",,,,,"Transcat files to sell 31,142 shares of common stock for holders",1,1,-1,-1,-1,-1
27.16M,"282,060",74.11M,$0.54,535,43.87,Buy,40.00,"Sep 5, 2024",IMTX,Immatics N.V.,1.16B,11.21,75.94M,-5.15%,-8.72%,-2.06%,-8.74%,+3.69%,Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024,Buy Rating for Immatics: Promising Clinical Trials and Strong Financials Signal Upside Potential,Buy Rating Justified by Immatics’ Advancing Pipeline and Strategic Financial Position,Buy Rating Affirmed on Immatics’ Promising Pipeline and Upcoming Data Catalysts,Immatics N.V. Unveils Mid-Year Financial Outlook,Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024 Buy Rating for Immatics: Promising Clinical Trials and Strong Financials Signal Upside Potential Buy Rating Justified by Immatics’ Advancing Pipeline and Strategic Financial Position Buy Rating Affirmed on Immatics’ Promising Pipeline and Upcoming Data Catalysts Immatics N.V. Unveils Mid-Year Financial Outlook,1,1,1,0,1,0
27.64M,"4,832",86.10M,-1,"21,900",42.89,,,,FORTY,Formula Systems (1985) Ltd.,1.15B,76.06,2.66B,2.12%,1.62%,9.96%,+6.74%,+29.44%,Formula Systems Reports Record Financial Growth,Formula Systems Ltd reports Q2 EPS $1.20 vs. $1.11 last year,,,,Formula Systems Reports Record Financial Growth Formula Systems Ltd reports Q2 EPS $1.20 vs. $1.11 last year,1,1,1,-1,-1,-1
15.94M,"65,137",40.60M,$3.08,296,74.30,Buy,82.33,"Jul 24, 2024",ARQT,"Arcutis Biotherapeutics, Inc.",1.15B,9.83,132.06M,14.35%,11.19%,41.09%,+6.16%,-5.73%,Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Arcutis Biotherapeutics completes enrollment of Phase 1b study on ARQ-255,Arcutis announces results from INTEGUMENT-OLE study of roflumilast cream,Arcutis Biotherapeutics initiated with a Buy at Jefferies,Arcutis jumps after Mizuho highlights ‘robust’ weekly script growth,Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Arcutis Biotherapeutics completes enrollment of Phase 1b study on ARQ-255 Arcutis announces results from INTEGUMENT-OLE study of roflumilast cream Arcutis Biotherapeutics initiated with a Buy at Jefferies Arcutis jumps after Mizuho highlights ‘robust’ weekly script growth,0,0,0,0,0,0
385.70M,"3,354,131",-449.55M,-1,219,3.070,Hold,3.67,"Aug 1, 2024",HUT,Hut 8 Corp.,1.14B,12.57,171.99M,-7.46%,-22.15%,5.75%,-29.37%,+15.14%,Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat,Hut 8 Operations Update for August 2024,Hut 8 Mining Corp: Strong Buy on Undervaluation and High-Performance Computing Focus,Here’s What You Missed in Crypto This Week,"Hut 8 (NASDAQ:HUT) Receives Upgrade from H.C. Wainwright, Shares Rise","Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat Hut 8 Operations Update for August 2024 Hut 8 Mining Corp: Strong Buy on Undervaluation and High-Performance Computing Focus Here’s What You Missed in Crypto This Week Hut 8 (NASDAQ:HUT) Receives Upgrade from H.C. Wainwright, Shares Rise",0,0,0,0,0,0
62.56M,"598,210",145.42M,-1,117,18.86,Buy,,"Jul 31, 2024",ANAB,"AnaptysBio, Inc.",1.14B,37.75,30.47M,6.80%,18.33%,52.50%,+5.54%,+74.43%,Anaptys Announces Participation in September Investor Conferences,Biotech Alert: Searches spiking for these stocks today,AnaptysBio’s Strong Investor Confidence and Promising Drug Pipeline Justify Buy Rating,AnaptysBio price target raised to $30 from $20 at Truist,AnaptysBio: Strong Buy Rating on Robust Equity Raise and Promising Clinical Pipeline,Anaptys Announces Participation in September Investor Conferences Biotech Alert: Searches spiking for these stocks today AnaptysBio’s Strong Investor Confidence and Promising Drug Pipeline Justify Buy Rating AnaptysBio price target raised to $30 from $20 at Truist AnaptysBio: Strong Buy Rating on Robust Equity Raise and Promising Clinical Pipeline,1,1,1,1,0,1
32.21M,"313,945",99.89M,-1,"1,900",36.26,Strong Buy,41.40,"Aug 8, 2024",TBLA,Taboola.com Ltd.,1.13B,3.38,1.62B,8.30%,5.47%,-11.81%,+1.15%,-20.23%,Taboola opens Maximize Conversions to all advertisers,Taboola Opens Maximize Conversions AI Bidding Technology to All Advertisers to Drive More Conversions and Lower Campaign Costs; Offering Reaches Milestone Adoption with 100% Increase in Advertiser Campaigns Quarter Over Quarter,Taboola.com (TBLA) Receives a Hold from KeyBanc,,,Taboola opens Maximize Conversions to all advertisers Taboola Opens Maximize Conversions AI Bidding Technology to All Advertisers to Drive More Conversions and Lower Campaign Costs; Offering Reaches Milestone Adoption with 100% Increase in Advertiser Campaigns Quarter Over Quarter Taboola.com (TBLA) Receives a Hold from KeyBanc,0,1,0,0,-1,-1
53.78M,"197,366",-50.92M,-1,"4,387",21.71,Buy,58.83,"Aug 8, 2024",KARO,Karooooo Ltd.,1.13B,36.68,227.97M,-0.06%,7.80%,30.23%,-2.90%,+43.92%,Morgan Stanley Sticks to Its Buy Rating for Karooooo (KARO),Karooooo Shareholders Approve All AGM Resolutions,Karooooo (KARO) Receives a Buy from Morgan Stanley,"Analysts Offer Insights on Technology Companies: Nutanix (NTNX), Endava (DAVA) and Karooooo (KARO)","Karooooo Sets Virtual AGM for August 29, 2024","Morgan Stanley Sticks to Its Buy Rating for Karooooo (KARO) Karooooo Shareholders Approve All AGM Resolutions Karooooo (KARO) Receives a Buy from Morgan Stanley Analysts Offer Insights on Technology Companies: Nutanix (NTNX), Endava (DAVA) and Karooooo (KARO) Karooooo Sets Virtual AGM for August 29, 2024",1,0,1,0,1,1
46.14M,"315,014",-73.45M,-1,"2,500",25.30,Strong Buy,26.20,"Aug 8, 2024",SSRM,SSR Mining Inc.,1.13B,5.60,1.23B,7.57%,8.92%,-20.32%,-7.36%,+6.17%,SSR Mining price target raised to C$7 from C$6 at Scotiabank,,,,,SSR Mining price target raised to C$7 from C$6 at Scotiabank,1,0,-1,-1,-1,-1
177.30M,"85,837",-182.89M,-1,"3,930",3.350,Strong Buy,8.00,"Aug 14, 2024",OPK,"OPKO Health, Inc.",1.12B,1.61,716.37M,11.09%,18.15%,29.72%,+16.20%,+22.22%,Largest borrow rate increases among liquid names,,,,,Largest borrow rate increases among liquid names,1,1,-1,-1,-1,-1
52.74M,"94,666",-81.44M,-1,164,22.06,Strong Buy,27.25,"Aug 7, 2024",COGT,"Cogent Biosciences, Inc.",1.11B,10.18,-,6.79%,10.51%,36.60%,+9.65%,+54.10%,Cogent Biosciences price target raised to $10 from $8 at Baird,Positive Outlook for Cogent Biosciences Backed by Clinical Trial Progress and Efficient Management,Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright,Cogent Biosciences announces trials in patients with GIST completes enrollment,,Cogent Biosciences price target raised to $10 from $8 at Baird Positive Outlook for Cogent Biosciences Backed by Clinical Trial Progress and Efficient Management Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright Cogent Biosciences announces trials in patients with GIST completes enrollment,0,0,0,0,0,-1
175.61M,"1,142,414",20.97M,-1,"1,004",6.62,Hold,8.13,"Aug 7, 2024",CRAI,"CRA International, Inc.",1.11B,163.48,652.40M,2.31%,-3.27%,18.30%,-6.91%,+10.53%,,,,,,,0,-1,-1,-1,-1,-1
46.87M,"196,229",73.61M,$2.53,"3,000",24.72,Buy,25.50,"Aug 5, 2024",SGH,"SMART Global Holdings, Inc.",1.11B,20.94,1.18B,-1.38%,-10.81%,-2.94%,-15.00%,-22.76%,,,,,,,1,-1,-1,-1,-1,-1
9.15M,"49,490",15.11M,-1,"1,478",126.64,Strong Buy,151.33,"Jul 29, 2024",PEBO,Peoples Bancorp Inc.,1.11B,31.85,434.19M,3.06%,2.38%,5.04%,-4.54%,+13.11%,,,,,,,0,-1,-1,-1,-1,-1
103.11M,"227,162",-78.98M,-1,474,11.21,Strong Buy,16.00,"Aug 13, 2024",SILK,"Silk Road Medical, Inc",1.11B,27.24,191.43M,0.03%,1.04%,46.41%,+0.26%,+52.74%,Silk Road Medical (SILK) Receives a Hold from Lake Street,,,,,Silk Road Medical (SILK) Receives a Hold from Lake Street,0,0,-1,-1,-1,-1
15.30M,204,67.31M,$1.26,"9,311",75.59,,,"Aug 20, 2024",ULH,"Universal Logistics Holdings, Inc.",1.11B,42.04,1.77B,2.51%,0.26%,15.16%,-3.23%,+20.24%,,,,,,,1,-1,-1,-1,-1,-1
116.89M,"3,264,250",-198.76M,-1,217,9.83,Buy,21.40,"Aug 14, 2024",CALT,Calliditas Therapeutics AB (publ),1.10B,40.47,151.09M,2.83%,3.81%,51.59%,+5.33%,+83.42%,Calliditas Therapeutics Sets Delisting Process,"Calliditas Therapeutics to apply for delisting of common shares, ADSs",Calliditas Therapeutics Sees Strong Sales Growth,"CALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,"Calliditas Therapeutics Sets Delisting Process Calliditas Therapeutics to apply for delisting of common shares, ADSs Calliditas Therapeutics Sees Strong Sales Growth CALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,1,1,1,1,-1
91.08M,"4,521,301",175.78M,-1,"2,468",12.57,Strong Buy,16.30,"Aug 13, 2024",AOSL,Alpha and Omega Semiconductor Limited,1.10B,38.33,657.27M,3.15%,-1.06%,36.03%,+1.23%,+86.18%,,,,,,,0,-1,-1,-1,-1,-1
30.20M,"206,807",-170.12M,-1,593,37.75,Buy,50.30,"Aug 5, 2024",GYRE,"Gyre Therapeutics, Inc.",1.10B,12.84,111.59M,7.17%,0.86%,-22.13%,-8.91%,-22.24%,Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update,,,,,Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update,0,0,-1,-1,-1,-1
335.68M,"665,326",-49.86M,-1,170,3.380,Strong Buy,5.45,"Aug 7, 2024",BITF,Bitfarms Ltd.,1.10B,2.44,172.70M,-1.49%,-11.37%,-2.88%,-16.60%,+3.85%,Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat,Crypto Currents: Riot urges change for Bitfarms board,Unusually active option classes on open September 6th,Bitfarms to Highlight Expertise at Global Investment Conference,Bitfarms Refutes Riot’s Takeover Bids and Strategizes Growth,Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat Crypto Currents: Riot urges change for Bitfarms board Unusually active option classes on open September 6th Bitfarms to Highlight Expertise at Global Investment Conference Bitfarms Refutes Riot’s Takeover Bids and Strategizes Growth,0,0,0,0,0,0
30.89M,"13,751",42.63M,$1.08,300,36.68,Buy,33.00,"Oct 9, 2024",PFBC,Preferred Bank,1.10B,82.29,263.71M,2.21%,2.69%,9.15%,-5.52%,+9.54%,Preferred Bank Announces Approval to Continue Share Repurchase Plan,,,,,Preferred Bank Announces Approval to Continue Share Repurchase Plan,1,0,-1,-1,-1,-1
202.10M,"1,459,603",-480.08M,$0.28,"3,619",5.60,Hold,6.89,"Jul 31, 2024",TILE,"Interface, Inc.",1.10B,18.82,1.27B,7.19%,14.04%,27.92%,+5.56%,+9.55%,Interface expands recycling capabilities in Europe,Interface launches two new carpet tile styles,,,,Interface expands recycling capabilities in Europe Interface launches two new carpet tile styles,0,0,0,-1,-1,-1
697.38M,"3,021,666",-243.10M,-1,813,1.610,Strong Buy,2.75,"Aug 7, 2024",UNIT,Uniti Group Inc.,1.10B,4.49,1.16B,6.36%,23.65%,-8.27%,+13.54%,-22.42%,Uniti Group call volume above normal and directionally bullish,Uniti Group announces contract award with large hyperscaler,RBC Capital Sticks to Their Hold Rating for Uniti Group (UNIT),Uniti Group Inc. to Participate at the Citi 2024 Global TMT Conference,"Uniti Group Inc. to Present at the BofA Securities 2024 Media, Communications and Entertainment Conference","Uniti Group call volume above normal and directionally bullish Uniti Group announces contract award with large hyperscaler RBC Capital Sticks to Their Hold Rating for Uniti Group (UNIT) Uniti Group Inc. to Participate at the Citi 2024 Global TMT Conference Uniti Group Inc. to Present at the BofA Securities 2024 Media, Communications and Entertainment Conference",1,1,0,0,1,1
109.45M,"320,726",-227.05M,-1,280,10.18,Buy,14.50,"Aug 6, 2024",XNCR,"Xencor, Inc.",1.09B,17.67,133.62M,-1.12%,-8.19%,-16.55%,-17.04%,-20.43%,Buy Rating Affirmed for Xencor on Promising XmAb819 Developments and Strong Strategic Position,,,,,Buy Rating Affirmed for Xencor on Promising XmAb819 Developments and Strong Strategic Position,0,1,-1,-1,-1,-1
6.78M,"41,160",40.15M,$1.68,"5,260",163.48,Buy,186.00,"Aug 1, 2024",BELFA,Bel Fuse Inc.,1.09B,86.99,559.99M,,-8.19%,-16.55%,-8.58%,+19.87%,,,,,,,0,-1,-1,-1,-1,-1
52.91M,"428,542",-168.77M,-1,"1,400",20.94,Strong Buy,31.00,"Oct 10, 2024",JBSS,"John B. Sanfilippo & Son, Inc.",1.09B,93.90,1.07B,-7.20%,-5.72%,-6.70%,-11.35%,-10.47%,"John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2024 Operating Results Conference Call",,,,,"John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2024 Operating Results Conference Call",0,0,-1,-1,-1,-1
34.78M,"109,970",123.31M,$1.60,355,31.85,Hold,33.67,"Jul 23, 2024",MSEX,Middlesex Water Company,1.09B,61.08,174.99M,0.47%,6.06%,8.99%,-5.69%,+29.92%,"Middlesex Water General Counsel, Jay L. Kooper, Named a 2024 New Jersey Legal Awards Finalist",Middlesex Water files for rate adjustment,,,,"Middlesex Water General Counsel, Jay L. Kooper, Named a 2024 New Jersey Legal Awards Finalist Middlesex Water files for rate adjustment",0,0,0,-1,-1,-1
40.63M,"504,842",-56.54M,-1,675,27.24,Hold,21.14,"Aug 7, 2024",AMPL,"Amplitude, Inc.",1.09B,8.81,287.96M,6.42%,5.93%,-14.97%,+3.15%,-15.01%,Amplitude (AMPL) Receives a Hold from D.A. Davidson,"Analysts’ Opinions Are Mixed on These Technology Stocks: AvePoint (AVPT), Amplitude (AMPL) and DXC Technology (DXC)",Scotiabank Reaffirms Their Hold Rating on Amplitude (AMPL),"Analysts Offer Insights on Technology Companies: Datadog (DDOG), Amplitude (AMPL) and Viavi Solutions (VIAV)",,"Amplitude (AMPL) Receives a Hold from D.A. Davidson Analysts’ Opinions Are Mixed on These Technology Stocks: AvePoint (AVPT), Amplitude (AMPL) and DXC Technology (DXC) Scotiabank Reaffirms Their Hold Rating on Amplitude (AMPL) Analysts Offer Insights on Technology Companies: Datadog (DDOG), Amplitude (AMPL) and Viavi Solutions (VIAV)",1,0,1,1,0,-1
26.32M,"21,597",127.65M,$0.42,46,42.04,Hold,46.00,"Jul 25, 2024",ELVN,"Enliven Therapeutics, Inc.",1.09B,23.00,-,-1.84%,-2.07%,24.55%,-15.09%,+15.46%,Enliven price target raised to $39 from $34 at Mizuho,Buy Rating for Enliven Therapeutics Backed by Promising Clinical Data and Market Potential,Buy Rating Justified by Enliven Therapeutics’ Drug Progress and Strong Financials,"Enliven reports Q2 EPS (41c), consensus (55c)",,"Enliven price target raised to $39 from $34 at Mizuho Buy Rating for Enliven Therapeutics Backed by Promising Clinical Data and Market Potential Buy Rating Justified by Enliven Therapeutics’ Drug Progress and Strong Financials Enliven reports Q2 EPS (41c), consensus (55c)",1,0,1,0,1,-1
54.01M,"11,998",-45.32M,-1,"33,500",40.36,Hold,41.40,"Aug 13, 2024",AVAH,Aveanna Healthcare Holdings Inc.,1.08B,5.60,1.95B,18.34%,47.32%,98.53%,+28.27%,+107.69%,Aveanna files $400M mixed securities shelf,Aveanna files to sell 54.43M shares of common stock for holders,Aveanna price target raised to $5 from $3 at RBC Capital,Aveanna price target raised to $5 from $3 at Deutsche Bank,"Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Verona Pharma (VRNA) and Aveanna Healthcare Holdings (AVAH)","Aveanna files $400M mixed securities shelf Aveanna files to sell 54.43M shares of common stock for holders Aveanna price target raised to $5 from $3 at RBC Capital Aveanna price target raised to $5 from $3 at Deutsche Bank Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Verona Pharma (VRNA) and Aveanna Healthcare Holdings (AVAH)",0,0,1,0,0,0
28.70M,"161,809",-11.08M,-1,"5,095",38.33,Buy,42.67,"Aug 7, 2024",ATSG,"Air Transport Services Group, Inc.",1.07B,16.43,2.01B,7.95%,11.73%,13.25%,+0.87%,+26.01%,Air Transport Services price target raised to $15 from $14 at Truist,Air Transport Services (ATSG) Receives a Buy from Oppenheimer,Air Transport Services (ATSG) Receives a Buy from Loop Capital Markets,"Analysts Offer Insights on Industrial Goods Companies: Air Transport Services (ATSG), EasyJet (OtherEJTTF) and AtkinsRealis (OtherSNCAF)",Truist Financial Sticks to Their Hold Rating for Air Transport Services (ATSG),"Air Transport Services price target raised to $15 from $14 at Truist Air Transport Services (ATSG) Receives a Buy from Oppenheimer Air Transport Services (ATSG) Receives a Buy from Loop Capital Markets Analysts Offer Insights on Industrial Goods Companies: Air Transport Services (ATSG), EasyJet (OtherEJTTF) and AtkinsRealis (OtherSNCAF) Truist Financial Sticks to Their Hold Rating for Air Transport Services (ATSG)",0,0,1,1,1,0
85.61M,"139,882",-85.97M,-1,822,12.84,,,"Aug 13, 2024",DGII,Digi International Inc.,1.07B,29.47,431.16M,7.28%,16.06%,9.84%,+3.59%,-8.45%,,,,,,,1,-1,-1,-1,-1,-1
451.29M,"10,761,631",-106.25M,-1,"1,759",2.440,Strong Buy,4.00,"Aug 8, 2024",MXL,"MaxLinear, Inc.",1.07B,12.76,448.14M,-3.68%,-32.36%,-38.49%,-15.63%,-47.24%,MaxLinear Initiates Workforce Reduction and Restructures Management,Loop Capital Markets Reaffirms Their Hold Rating on Maxlinear (MXL),MaxLinear price target lowered to $12 from $21 at Loop Capital,,,MaxLinear Initiates Workforce Reduction and Restructures Management Loop Capital Markets Reaffirms Their Hold Rating on Maxlinear (MXL) MaxLinear price target lowered to $12 from $21 at Loop Capital,1,0,1,1,-1,-1
13.33M,"55,497",141.09M,$2.80,"3,920",82.29,Buy,100.00,"Oct 15, 2024",GDYN,"Grid Dynamics Holdings, Inc.",1.07B,13.91,318.34M,1.16%,13.65%,12.85%,+4.50%,+15.41%,Grid Dynamics price target raised to $17 from $15 at JPMorgan,,,,,Grid Dynamics price target raised to $17 from $15 at JPMorgan,1,0,-1,-1,-1,-1
58.30M,"496,434",66.10M,$0.04,471,18.82,Buy,18.00,"Aug 2, 2024",AUTL,Autolus Therapeutics plc,1.06B,3.99,10.50M,-1.75%,-1.84%,-20.05%,-16.42%,-30.00%,Autolus presents clinical data on TB-guided dosing strategy at SOHO meetin,Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024,Buy Rating Affirmed for Autolus Therapeutics Amid Strong Commercial Prospects and Solid Financials,Autolus Therapeutics (AUTL) Gets a Buy from Truist Financial,,Autolus presents clinical data on TB-guided dosing strategy at SOHO meetin Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024 Buy Rating Affirmed for Autolus Therapeutics Amid Strong Commercial Prospects and Solid Financials Autolus Therapeutics (AUTL) Gets a Buy from Truist Financial,1,1,0,0,0,-1
244.15M,"1,556,639",-30.35M,$0.60,"5,791",4.490,Hold,6.13,"Aug 1, 2024",PNTG,"The Pennant Group, Inc.",1.06B,34.96,611.81M,11.81%,25.58%,70.54%,+13.45%,+63.22%,Pennant Group price target raised to $34 from $28 at Truist,Truist Financial Sticks to Their Hold Rating for Pennant Group (PNTG),,,,Pennant Group price target raised to $34 from $28 at Truist Truist Financial Sticks to Their Hold Rating for Pennant Group (PNTG),1,0,0,-1,-1,-1
61.83M,"394,448",-177.37M,-1,269,17.67,Strong Buy,34.67,"Aug 5, 2024",ERII,"Energy Recovery, Inc.",1.05B,18.23,133.51M,5.88%,19.35%,13.68%,+13.65%,+11.51%,,,,,,,1,-1,-1,-1,-1,-1
12.55M,"7,767",66.16M,$0.24,663,86.99,,,"Jul 24, 2024",PWP,Perella Weinberg Partners,1.05B,20.01,725.53M,8.54%,16.22%,41.03%,+5.08%,+30.31%,,,,,,,1,-1,-1,-1,-1,-1
11.60M,"87,500",60.25M,$2.25,"1,028",93.90,,,"Aug 20, 2024",ARRY,"Array Technologies, Inc.",1.05B,6.92,1.10B,-16.10%,-31.79%,-49.16%,-38.02%,-52.75%,"The long-term winners as AI boosts U.S. power needs, according to Mizuho",Jim Cramer’s top 10 things to watch in the stock market Monday,Array Technologies assumed with Buy from Hold at Jefferies,Array Technologies call volume above normal and directionally bullish,Primoris to participate in a webinar with Roth MKM,"The long-term winners as AI boosts U.S. power needs, according to Mizuho Jim Cramer’s top 10 things to watch in the stock market Monday Array Technologies assumed with Buy from Hold at Jefferies Array Technologies call volume above normal and directionally bullish Primoris to participate in a webinar with Roth MKM",1,0,0,0,1,0
17.83M,"94,512",36.87M,$1.30,"1,690",61.08,Hold,58.00,"Jul 31, 2024",ICHR,"Ichor Holdings, Ltd.",1.05B,31.07,804.85M,-0.04%,-12.95%,-14.76%,-10.53%,-19.93%,,,,,,,0,-1,-1,-1,-1,-1
123.56M,"273,999",-81.17M,-1,85,8.81,Hold,10.00,"Aug 8, 2024",CGEM,"Cullinan Therapeutics, Inc.",1.05B,18.03,-,7.95%,6.96%,13.95%,-3.36%,+9.87%,Cullinan Therapeutics to Participate in Upcoming Investor Conferences,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), 4D Molecular Therapeutics (FDMT) and Cullinan Management (CGEM)",Morgan Stanley Remains a Buy on Cullinan Management (CGEM),Wedbush Remains a Buy on Cullinan Management (CGEM),,"Cullinan Therapeutics to Participate in Upcoming Investor Conferences Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), 4D Molecular Therapeutics (FDMT) and Cullinan Management (CGEM) Morgan Stanley Remains a Buy on Cullinan Management (CGEM) Wedbush Remains a Buy on Cullinan Management (CGEM)",1,0,1,0,1,-1
47.24M,"131,065",-82.83M,-1,"2,164",23.00,Strong Buy,33.00,"Aug 13, 2024",HIMX,"Himax Technologies, Inc.",1.04B,5.96,913.37M,-0.53%,-16.37%,-3.66%,-14.66%,+7.38%,Himax Technologies Concludes Successful AGM,,,,,Himax Technologies Concludes Successful AGM,0,0,-1,-1,-1,-1
193.23M,"428,028",-125.39M,-1,"2,949",5.60,Hold,4.27,"Aug 8, 2024",ACDC,ProFrac Holding Corp.,1.04B,6.50,2.22B,-0.46%,-6.67%,-13.25%,-27.77%,-25.11%,,,,,,,1,-1,-1,-1,-1,-1
65.32M,"547,611",18.21M,-1,"14,000",16.43,Buy,20.00,"Aug 8, 2024",FWRG,"First Watch Restaurant Group, Inc.",1.04B,17.21,964.86M,5.67%,4.66%,-14.24%,+4.30%,-25.44%,"Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more",First Watch Restaurant appoints Rob Conti as Chief Information Officer,First Watch Names Rob Conti as Chief Information Officer,"First Watch Restaurant Group, Inc. to Participate at Piper Sandler’s Growth Frontiers Conference on September 10-11, 2024",Benchmark starts ‘category dominant’ First Watch Restaurant with a Buy,"Tuesday’s top analyst calls: Apple, Netflix, Nvidia, Ferrari, BlackRock and more First Watch Restaurant appoints Rob Conti as Chief Information Officer First Watch Names Rob Conti as Chief Information Officer First Watch Restaurant Group, Inc. to Participate at Piper Sandler’s Growth Frontiers Conference on September 10-11, 2024 Benchmark starts ‘category dominant’ First Watch Restaurant with a Buy",0,1,1,1,0,1
36.42M,"149,679",17.01M,-1,920,29.47,Buy,33.00,"Aug 7, 2024",OCFC,OceanFirst Financial Corp.,1.04B,17.80,376.06M,5.47%,6.11%,10.37%,-3.25%,+13.86%,OceanFirst Financial Enhances Investor Outreach and Transparency,OceanFirst Financial management to meet with Piper Sandler,,,,OceanFirst Financial Enhances Investor Outreach and Transparency OceanFirst Financial management to meet with Piper Sandler,1,1,0,-1,-1,-1
83.90M,"740,475",-189.90M,-1,211,12.76,Buy,24.63,"Jul 24, 2024",BTDR,Bitdeer Technologies Group,1.04B,7.54,420.89M,-7.39%,-24.26%,-4.43%,-27.42%,-6.52%,Morgan Stanley says some crypto miners could gain by turning to data centers,Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat,Bitdeer Launches $10M Share Buyback Plan,Roth MKM Sticks to Its Buy Rating for Bitdeer Technologies (BTDR),Bitdeer Technologies Shares Latest Operational Progress,Morgan Stanley says some crypto miners could gain by turning to data centers Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat Bitdeer Launches $10M Share Buyback Plan Roth MKM Sticks to Its Buy Rating for Bitdeer Technologies (BTDR) Bitdeer Technologies Shares Latest Operational Progress,1,0,0,1,0,1
76.67M,"307,562",-1.19M,-1,815,13.91,Strong Buy,15.50,"Aug 1, 2024",SBSI,"Southside Bancshares, Inc.",1.02B,33.84,240.49M,3.41%,11.13%,14.90%,-2.46%,+23.30%,Southside Bank Opens Commercial Loan Office in The Woodlands,Southside Bancshares Announces Strategic Executive Appointments,,,,Southside Bank Opens Commercial Loan Office in The Woodlands Southside Bancshares Announces Strategic Executive Appointments,1,1,0,-1,-1,-1
266.09M,"312,419",-233.98M,-1,895,3.990,Strong Buy,9.50,"Aug 8, 2024",MDXG,"MiMedx Group, Inc.",1.01B,6.90,340.46M,0.41%,-4.18%,-11.82%,-11.28%,-5.57%,MiMedx filed counterclaim by third former employee,MiMedx Group (MDXG) Gets a Buy from Northland Securities,,,,MiMedx filed counterclaim by third former employee MiMedx Group (MDXG) Gets a Buy from Northland Securities,0,0,1,-1,-1,-1
30.21M,"270,105",19.33M,-1,"2,844",34.96,Buy,30.67,"Aug 6, 2024",ASTL,Algoma Steel Group Inc.,1.01B,9.72,1.91B,8.42%,21.55%,22.56%,+12.54%,+21.02%,Seaport Research steel analyst to hold analyst/industry conference call,Algoma Steel to Showcase at Jefferies 2024 Industrials,Algoma Steel Group to Participate in the Jefferies 2024 Industrials Conference,Algoma Steel Launches Share Buyback Program,Algoma Steel Group Announces Renewal of Normal Course Issuer Bid,Seaport Research steel analyst to hold analyst/industry conference call Algoma Steel to Showcase at Jefferies 2024 Industrials Algoma Steel Group to Participate in the Jefferies 2024 Industrials Conference Algoma Steel Launches Share Buyback Program Algoma Steel Group Announces Renewal of Normal Course Issuer Bid,0,0,0,0,0,1
57.72M,"268,707",20.56M,-1,"12,891",18.23,Strong Buy,22.50,"Jul 31, 2024",HDL,Super Hi International Holding Ltd.,1.01B,15.55,712.07M,5.31%,-3.78%,-9.18%,-3.41%,,SUPER HI Maintains Stable Share Capital in August,"Analysts’ Top NA Picks: SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR (HDL), Astera Labs, Inc. (ALAB)",Super Hi reports Q2 EPS 0c vs. 0c last year,"SUPER HI INTERNATIONAL HOLDING LTD. to Report Second Quarter 2024 Financial Results on Tuesday, August 27, 2024",,"SUPER HI Maintains Stable Share Capital in August Analysts’ Top NA Picks: SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR (HDL), Astera Labs, Inc. (ALAB) Super Hi reports Q2 EPS 0c vs. 0c last year SUPER HI INTERNATIONAL HOLDING LTD. to Report Second Quarter 2024 Financial Results on Tuesday, August 27, 2024",1,1,0,1,1,-1
52.57M,"535,913",-114.33M,$0.28,"27,000",20.01,Hold,17.50,"Aug 2, 2024",HTZ,"Hertz Global Holdings, Inc.",1.01B,3.29,9.32B,-1.82%,-5.05%,-46.43%,-19.36%,-54.68%,Best cash-back credit cards of 2024,Best credit cards with pre-approval or pre-qualification,Best Travel Credit Cards,Best travel credit cards of 2022,Share benefits and build credit with the best credit cards for authorized users,Best cash-back credit cards of 2024 Best credit cards with pre-approval or pre-qualification Best Travel Credit Cards Best travel credit cards of 2022 Share benefits and build credit with the best credit cards for authorized users,0,0,0,0,0,0
151.93M,"6,381,724",16.63M,-1,937,6.92,Buy,14.79,"Aug 8, 2024",QNST,"QuinStreet, Inc.",1.01B,17.96,613.51M,10.07%,13.88%,26.65%,+1.02%,+10.47%,"Analysts Offer Insights on Communication Services Companies: TKO Group Holdings (TKO), KT (KT) and Quinstreet (QNST)",QuinStreet’s Growth Prospects Reinforce Buy Rating Amidst Digital Shift in Insurance and Financial Services,QuinStreet price target raised to $25 from $22 at Craig-Hallum,QuinStreet price target raised to $24 from $21.50 at B. Riley,,"Analysts Offer Insights on Communication Services Companies: TKO Group Holdings (TKO), KT (KT) and Quinstreet (QNST) QuinStreet’s Growth Prospects Reinforce Buy Rating Amidst Digital Shift in Insurance and Financial Services QuinStreet price target raised to $25 from $22 at Craig-Hallum QuinStreet price target raised to $24 from $21.50 at B. Riley",1,1,0,0,0,-1
33.69M,"187,447",-36.43M,-1,"1,200",31.07,Strong Buy,43.33,"Aug 6, 2024",CECO,CECO Environmental Corp.,1.00B,28.65,566.96M,1.35%,0.79%,21.22%,-4.45%,+17.82%,Ceco Environmental (CECO) Gets a Buy from Craig-Hallum,CECO Environmental Announces Upcoming Investor Conferences,,,,Ceco Environmental (CECO) Gets a Buy from Craig-Hallum CECO Environmental Announces Upcoming Investor Conferences,0,0,0,-1,-1,-1
57.98M,"517,412",-142.16M,-1,400,18.03,Strong Buy,32.00,"Aug 8, 2024",BHRB,Burke & Herbert Financial Services Corp.,1.00B,66.97,124.67M,6.22%,16.06%,21.77%,-1.96%,+21.29%,,,,,,,0,-1,-1,-1,-1,-1
174.72M,"354,778",76.93M,$0.29,273,5.96,,,"Aug 8, 2024",EOLS,"Evolus, Inc.",1.00B,15.86,237.26M,14.03%,27.92%,30.88%,+27.54%,+19.46%,,,,,,,0,-1,-1,-1,-1,-1
160.15M,"700,748",-193.90M,-1,425,6.50,Buy,9.63,"Aug 8, 2024",AMAL,Amalgamated Financial Corp.,995.30M,32.48,292.03M,7.23%,11.05%,26.59%,+2.11%,+44.36%,Can you get an ATM card for a savings account?,KBW Releases a Buy Rating on Amalgamated Bank (AMAL),"Analysts Are Bullish on These Financial Stocks: Amalgamated Bank (AMAL), NMI Holdings (NMIH)",,,"Can you get an ATM card for a savings account? KBW Releases a Buy Rating on Amalgamated Bank (AMAL) Analysts Are Bullish on These Financial Stocks: Amalgamated Bank (AMAL), NMI Holdings (NMIH)",0,0,0,1,-1,-1
60.41M,"295,870",24.18M,-1,992,17.21,Buy,23.00,"Aug 6, 2024",XMTR,"Xometry, Inc.",994.80M,20.18,502.36M,23.88%,40.23%,-2.19%,+37.25%,+12.43%,Xometry to Participate in Upcoming Investor Conferences,"Xometry unveils pricing, limited time offerings","Xometry Unveils Instant Pricing, Lead Time Offerings For Tube Cutting, Tube Bending","Analysts Conflicted on These Industrial Goods Names: Bloom Energy (BE), Xometry (XMTR) and Parker Hannifin (PH)",RBC Capital Sticks to Its Hold Rating for Xometry (XMTR),"Xometry to Participate in Upcoming Investor Conferences Xometry unveils pricing, limited time offerings Xometry Unveils Instant Pricing, Lead Time Offerings For Tube Cutting, Tube Bending Analysts Conflicted on These Industrial Goods Names: Bloom Energy (BE), Xometry (XMTR) and Parker Hannifin (PH) RBC Capital Sticks to Its Hold Rating for Xometry (XMTR)",0,0,0,0,1,0
58.29M,"280,751",97.37M,$0.80,"3,400",17.80,Hold,18.00,"Oct 17, 2024",TRS,TriMas Corporation,994.23M,24.46,912.50M,2.90%,-1.98%,-2.96%,+1.63%,-5.45%,,,,,,,0,-1,-1,-1,-1,-1
137.30M,"2,521,969",-23.97M,-1,172,7.54,Strong Buy,14.19,"Aug 12, 2024",WTO,UTime Limited,992.05M,2.20,23.84M,49.34%,105.14%,364.53%,-93.20%,-54.05%,UTime Shareholders Greenlight Major Corporate Reshuffle,UTime initiates financial and legal due diligence on Bowen Therapeutics,UTime signs NDA to acquire Bowen Therapeutics lab at UMASS,UTime announces collaboration on Circul VS,"UTime announces AI health strategy, strategic collaboration with Dr. Ehud Baron","UTime Shareholders Greenlight Major Corporate Reshuffle UTime initiates financial and legal due diligence on Bowen Therapeutics UTime signs NDA to acquire Bowen Therapeutics lab at UMASS UTime announces collaboration on Circul VS UTime announces AI health strategy, strategic collaboration with Dr. Ehud Baron",1,0,0,1,0,1
30.27M,"124,080",81.94M,$1.44,"20,000",33.84,,,"Jul 25, 2024",ODP,The ODP Corporation,989.97M,29.48,7.40B,-4.17%,-17.67%,-34.69%,-29.56%,-41.37%,ODP Corporation enhances customer experiences with Generative AI tech,ODP Corporation Announces CFO Transition and Interim Successor,ODP Corporation announces CFO Anthony Scaglione stepping down,,,ODP Corporation enhances customer experiences with Generative AI tech ODP Corporation Announces CFO Transition and Interim Successor ODP Corporation announces CFO Anthony Scaglione stepping down,1,1,0,1,-1,-1
146.81M,"606,565",80.67M,-1,"14,100",6.90,Strong Buy,12.00,"Jul 31, 2024",PLYA,Playa Hotels & Resorts N.V.,989.59M,7.64,980.60M,1.74%,-3.86%,-8.44%,-9.85%,-19.83%,Playa Hotels & Resorts N.V. Announces the Sale of Jewel Palm Beach,Playa Hotels & Resorts to sell the Jewel Palm Beach for $68M in cash,Citi downgrades Playa Hotels to Neutral on near-term concerns,Playa Hotels & Resorts downgraded to Neutral from Buy at Citi,,Playa Hotels & Resorts N.V. Announces the Sale of Jewel Palm Beach Playa Hotels & Resorts to sell the Jewel Palm Beach for $68M in cash Citi downgrades Playa Hotels to Neutral on near-term concerns Playa Hotels & Resorts downgraded to Neutral from Buy at Citi,1,1,1,1,1,-1
104.12M,"398,300",-14.32M,$0.20,"9,523",9.72,,,"Aug 13, 2024",JACK,Jack in the Box Inc.,989.58M,51.74,1.59B,-5.48%,-3.64%,-21.54%,-18.83%,-21.22%,"Analysts Offer Insights on Consumer Cyclical Companies: Jack In The Box (JACK), Greif Class A (GEF) and OneWater Marine (ONEW)",Loop Capital Markets Sticks to Its Buy Rating for Jack In The Box (JACK),Trejo’s Tacos® and Del Taco Bring the Flavor this Summer with NEW Roasted Pork Al Pastor,Jack in the Box price target lowered to $72 from $77 at BofA,,"Analysts Offer Insights on Consumer Cyclical Companies: Jack In The Box (JACK), Greif Class A (GEF) and OneWater Marine (ONEW) Loop Capital Markets Sticks to Its Buy Rating for Jack In The Box (JACK) Trejo’s Tacos® and Del Taco Bring the Flavor this Summer with NEW Roasted Pork Al Pastor Jack in the Box price target lowered to $72 from $77 at BofA",0,1,1,0,0,-1
445.70M,"37,394",15.58M,-1,851,15.56,,,"Aug 27, 2024",DCOM,"Dime Community Bancshares, Inc.",982.63M,25.10,320.39M,6.99%,12.50%,17.98%,+0.44%,+38.14%,KBW Releases a Buy Rating on Dime Community Bancshares (DCOM),,,,,KBW Releases a Buy Rating on Dime Community Bancshares (DCOM),0,0,-1,-1,-1,-1
306.51M,"4,564,546",-770.00M,-1,457,3.290,Hold,5.07,"Aug 1, 2024",GOGO,Gogo Inc.,978.80M,7.71,402.14M,3.39%,-7.55%,-12.71%,-15.31%,-7.35%,Gogo price target lowered to $11 from $12 at Morgan Stanley,Gogo announces partnership with Skyservice Business Aviation,,,,Gogo price target lowered to $11 from $12 at Morgan Stanley Gogo announces partnership with Skyservice Business Aviation,0,0,1,-1,-1,-1
55.98M,"323,014",-31.33M,-1,984,17.96,Strong Buy,22.25,"Aug 8, 2024",TH,Target Hospitality Corp.,976.19M,9.72,479.55M,-0.44%,6.36%,-3.48%,+2.24%,-11.80%,,,,,,,0,-1,-1,-1,-1,-1
34.96M,"129,847",13.20M,-1,700,28.65,Strong Buy,34.80,"Jul 30, 2024",FIP,FTAI Infrastructure Inc.,975.86M,9.29,329.57M,-1.58%,0.30%,44.67%,-8.54%,+46.88%,Compass Point Keeps Their Buy Rating on FTAI Infrastructure Incorporation (FIP),FTAI Infrastructure price target raised to $13 from $11 at Compass Point,,,,Compass Point Keeps Their Buy Rating on FTAI Infrastructure Incorporation (FIP) FTAI Infrastructure price target raised to $13 from $11 at Compass Point,1,0,0,-1,-1,-1
14.94M,"71,091",-2.80M,$2.12,"3,515",66.97,Hold,73.00,"Jul 26, 2024",CMCO,Columbus McKinnon Corporation,975.39M,33.81,1.02B,-1.14%,-3.84%,-13.39%,-13.05%,-20.81%,,,,,,,1,-1,-1,-1,-1,-1
63.09M,"282,233",-53.21M,-1,"6,040",15.86,Strong Buy,22.60,"Jul 31, 2024",HTLD,"Heartland Express, Inc.",971.77M,12.38,1.12B,-1.69%,-1.45%,-1.62%,-5.63%,+12.29%,"Heartland Express, Inc. Announces Participation in Upcoming Conference",,,,,"Heartland Express, Inc. Announces Participation in Upcoming Conference",0,1,-1,-1,-1,-1
30.64M,"129,707",99.00M,$0.48,244,32.48,Buy,32.17,"Jul 25, 2024",TARS,"Tarsus Pharmaceuticals, Inc.",971.21M,25.53,83.37M,7.83%,1.79%,-3.87%,+9.43%,-23.49%,Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference,Barclays Remains a Buy on Tarsus Pharmaceuticals (TARS),Bank of America Securities Sticks to Its Buy Rating for Tarsus Pharmaceuticals (TARS),Tarsus Pharmaceuticals (TARS) Receives a Buy from Oppenheimer,Strong Buy Rating for Tarsus Pharmaceuticals Amid Consistent Performance and Strategic Growth Initiatives,Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference Barclays Remains a Buy on Tarsus Pharmaceuticals (TARS) Bank of America Securities Sticks to Its Buy Rating for Tarsus Pharmaceuticals (TARS) Tarsus Pharmaceuticals (TARS) Receives a Buy from Oppenheimer Strong Buy Rating for Tarsus Pharmaceuticals Amid Consistent Performance and Strategic Growth Initiatives,0,0,0,0,0,0
49.30M,"355,113",-52.89M,-1,499,20.18,Buy,22.14,"Aug 8, 2024",CNOB,"ConnectOne Bancorp, Inc.",968.34M,25.31,251.24M,7.99%,16.12%,19.90%,+2.06%,+32.26%,"ConnectOne Bancorp, Inc. to Expand on Long Island Through Merger with The First of Long Island Corporation","ConnectOne Bancorp, First of Long Island enter $284M merger agreement",,,,"ConnectOne Bancorp, Inc. to Expand on Long Island Through Merger with The First of Long Island Corporation ConnectOne Bancorp, First of Long Island enter $284M merger agreement",0,1,1,-1,-1,-1
40.65M,"181,954",40.51M,$0.16,146,24.46,Strong Buy,40.00,"Jul 30, 2024",PCT,"PureCycle Technologies, Inc.",968.32M,5.87,-,-4.62%,-2.89%,16.76%,-23.87%,+1.21%,Largest borrow rate increases among liquid names,PureCycle Technologies put volume heavy and directionally bearish,PureCycle Technologies price target raised to $8 from $7 at Stifel,Buy Rating Justified by PureCycle Technologies’ Operational Progress and Growth Potential,PureCycle Technologies price target raised to $6 from $4 at Craig-Hallum,Largest borrow rate increases among liquid names PureCycle Technologies put volume heavy and directionally bearish PureCycle Technologies price target raised to $8 from $7 at Stifel Buy Rating Justified by PureCycle Technologies’ Operational Progress and Growth Potential PureCycle Technologies price target raised to $6 from $4 at Craig-Hallum,0,1,1,1,1,0
450.93M,"494,924",-8.43M,-1,367,2.200,,,"Sep 3, 2024",EH,EHang Holdings Limited,968.27M,15.30,34.26M,17.01%,10.34%,-0.60%,+12.46%,-25.88%,EHang ‘unequivocally denies’ unfounded rumors of link to Chris Hu investigation,"EHang Strongly Refutes False Allegations, Clarifies Misinformation Causing Stock Volatility",EHang initiated with a Buy at UBS,EHang Holdings Soars with Record Q2 Growth,Ehang Holdings Ltd (EH) Q2 Earnings Cheat Sheet,"EHang ‘unequivocally denies’ unfounded rumors of link to Chris Hu investigation EHang Strongly Refutes False Allegations, Clarifies Misinformation Causing Stock Volatility EHang initiated with a Buy at UBS EHang Holdings Soars with Record Q2 Growth Ehang Holdings Ltd (EH) Q2 Earnings Cheat Sheet",1,0,0,1,1,1
33.58M,"435,696",-26.00M,-1,300,29.48,Hold,30.00,"Aug 7, 2024",AUPH,Aurinia Pharmaceuticals Inc.,966.62M,6.76,207.11M,14.34%,17.93%,4.27%,+12.41%,+30.89%,Aurinia Pharmaceuticals call volume above normal and directionally bullish,Buy Rating Affirmed for Aurinia Pharmaceuticals on AUR200’s Clinical and Financial Promise,Aurinia Pharmaceuticals Begins AUR200 Autoimmune Therapy Trial,Aurinia Pharmaceuticals doses first participant in AUR200 trial,,Aurinia Pharmaceuticals call volume above normal and directionally bullish Buy Rating Affirmed for Aurinia Pharmaceuticals on AUR200’s Clinical and Financial Promise Aurinia Pharmaceuticals Begins AUR200 Autoimmune Therapy Trial Aurinia Pharmaceuticals doses first participant in AUR200 trial,0,1,0,0,0,-1
129.53M,"496,525",58.01M,-1,82,7.64,Strong Buy,11.00,"Aug 5, 2024",PHVS,Pharvaris N.V.,964.04M,17.85,-,5.97%,3.58%,-15.58%,+4.78%,-20.39%,Pharvaris price target raised to $42 from $38 at Oppenheimer,Sell Rating on Pharvaris Amid Competitive Market and Clinical Uncertainties,Pharvaris Reveals Positive HAE Drug Data,Buy Rating Affirmed: Pharvaris’s Deucrictibant Shows Blockbuster Potential for HAE Treatment,Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study,Pharvaris price target raised to $42 from $38 at Oppenheimer Sell Rating on Pharvaris Amid Competitive Market and Clinical Uncertainties Pharvaris Reveals Positive HAE Drug Data Buy Rating Affirmed: Pharvaris’s Deucrictibant Shows Blockbuster Potential for HAE Treatment Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study,1,0,1,1,0,0
19.13M,"350,146",-36.74M,$1.76,323,51.74,Buy,68.71,"Aug 6, 2024",RLAY,"Relay Therapeutics, Inc.",964.01M,7.20,35.21M,0.25%,-3.29%,-13.80%,-16.91%,-1.01%,,,,,,,1,-1,-1,-1,-1,-1
39.15M,"132,222",59.19M,$1.00,"1,000",25.10,Buy,27.80,"Oct 17, 2024",WGS,GeneDx Holdings Corp.,963.23M,35.76,243.66M,7.87%,13.22%,142.42%,-3.15%,+217.22%,"Wells Fargo initiates GeneDx with an Equal Weight, $34 price target",GeneDx initiated with an Equal Weight at Wells Fargo,Craig-Hallum Issues a Buy Rating on GeneDx Holdings (WGS),,,"Wells Fargo initiates GeneDx with an Equal Weight, $34 price target GeneDx initiated with an Equal Weight at Wells Fargo Craig-Hallum Issues a Buy Rating on GeneDx Holdings (WGS)",0,0,1,0,-1,-1
126.95M,"845,970",66.71M,-1,94,7.71,Buy,13.17,"Aug 7, 2024",VRDN,"Viridian Therapeutics, Inc.",961.54M,15.05,288.00K,-2.67%,4.17%,-8.96%,-11.69%,-8.82%,Buy Rating Affirmed for Viridian Therapeutics Amid Positive Outlook on VRDN-001 for Thyroid Eye Disease,"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Viridian Therapeutics (VRDN) and Impedimed Limited (OtherIPDQF)",Viridian Therapeutics’ VRDN-001 Optimism: A Buy Rating Rooted in Superior Trial Results and Market Potential,Viridian Therapeutics’ VRDN-001 Shows Promise in TED Treatment: A Comprehensive Buy Rating Analysis,Viridian Therapeutics (VRDN) Gets a Buy from RBC Capital,"Buy Rating Affirmed for Viridian Therapeutics Amid Positive Outlook on VRDN-001 for Thyroid Eye Disease Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Viridian Therapeutics (VRDN) and Impedimed Limited (OtherIPDQF) Viridian Therapeutics’ VRDN-001 Optimism: A Buy Rating Rooted in Superior Trial Results and Market Potential Viridian Therapeutics’ VRDN-001 Shows Promise in TED Treatment: A Comprehensive Buy Rating Analysis Viridian Therapeutics (VRDN) Gets a Buy from RBC Capital",0,0,0,0,0,0
100.43M,"390,549",122.19M,-1,730,9.72,Buy,12.00,"Aug 7, 2024",NRDS,"NerdWallet, Inc.",959.44M,12.19,599.00M,5.69%,-7.59%,-10.19%,-13.47%,-8.33%,Expert: Student loan forgiveness expectations may fuel more borrowing,,,,,Expert: Student loan forgiveness expectations may fuel more borrowing,1,1,-1,-1,-1,-1
105.04M,"940,134",-215.23M,$0.12,"1,219",9.29,Strong Buy,11.50,"Aug 2, 2024",FMBH,"First Mid Bancshares, Inc.",955.25M,39.96,304.67M,5.64%,12.23%,22.49%,+4.17%,+29.04%,,,,,,,0,-1,-1,-1,-1,-1
28.85M,"252,089",45.98M,$0.28,873,33.81,Strong Buy,51.50,"Jul 31, 2024",KRNT,Kornit Digital Ltd.,954.84M,20.08,208.21M,13.86%,23.63%,17.49%,+18.02%,+11.06%,"Analysts Conflicted on These Industrial Goods Names: Kornit Digital (KRNT), Titan Machinery (TITN) and Bowman Consulting Group (BWMN)",,,,,"Analysts Conflicted on These Industrial Goods Names: Kornit Digital (KRNT), Titan Machinery (TITN) and Bowman Consulting Group (BWMN)",0,1,-1,-1,-1,-1
78.50M,"330,748",-24.19M,$0.08,"20,000",12.38,Sell,12.00,"Jul 23, 2024",COMM,"CommScope Holding Company, Inc.",943.27M,4.37,5.09B,34.63%,102.42%,138.10%,+62.55%,+262.93%,"CommScope, Nokia collaborate to deliver AI-driven Wi-Fi solution",Nokia announces collaboration with Ruckus Networks,Largest borrow rate increases among liquid names,CommScope price target raised to $3 from $2 at Deutsche Bank,"Analysts Have Conflicting Sentiments on These Technology Companies: Repay Holdings (RPAY), VIZIO Holding (VZIO) and CommScope Holding (COMM)","CommScope, Nokia collaborate to deliver AI-driven Wi-Fi solution Nokia announces collaboration with Ruckus Networks Largest borrow rate increases among liquid names CommScope price target raised to $3 from $2 at Deutsche Bank Analysts Have Conflicting Sentiments on These Technology Companies: Repay Holdings (RPAY), VIZIO Holding (VZIO) and CommScope Holding (COMM)",0,1,0,1,0,1
38.04M,"886,367",-150.07M,-1,379,25.53,Strong Buy,51.17,"Aug 8, 2024",BFC,Bank First Corporation,941.79M,94.05,182.76M,7.09%,8.63%,10.99%,+0.04%,+12.60%,Bank First National’s Insightful Quarterly Shareholder Newsletter,,,,,Bank First National’s Insightful Quarterly Shareholder Newsletter,1,1,-1,-1,-1,-1
38.26M,"251,417",70.70M,$0.72,362,25.31,Buy,26.50,"Jul 25, 2024",AMSF,"AMERISAFE, Inc.",940.15M,49.33,309.13M,3.97%,6.97%,3.90%,+4.42%,+4.23%,,,,,,,0,-1,-1,-1,-1,-1
164.96M,"951,149",-154.32M,-1,70,5.87,Buy,6.13,"Aug 8, 2024",ETNB,"89bio, Inc.",937.83M,8.86,-,8.23%,8.61%,-4.13%,-1.75%,-16.36%,89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),,,,,89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),1,0,-1,-1,-1,-1
63.29M,"1,259,530",-37.73M,-1,712,15.30,Buy,27.50,"Aug 22, 2024",PGY,Pagaya Technologies Ltd.,937.19M,13.05,925.42M,3.69%,2.45%,0.45%,-12.23%,+22.40%,"3 Best Stocks to Buy Now, 9/3/2024, According to Top Analysts ",JMP Securities Sticks to Its Buy Rating for Pagaya Technologies Ltd (PGY),"Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls",Pagaya Technologies Ltd (PGY) Receives a Buy from Benchmark Co.,Pagaya assumed with a Buy at Benchmark,"3 Best Stocks to Buy Now, 9/3/2024, According to Top Analysts  JMP Securities Sticks to Its Buy Rating for Pagaya Technologies Ltd (PGY) Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Pagaya Technologies Ltd (PGY) Receives a Buy from Benchmark Co. Pagaya assumed with a Buy at Benchmark",1,0,1,1,1,0
142.99M,"1,127,483",-50.35M,-1,"130,513",6.76,Strong Buy,10.33,"Aug 1, 2024",BBSI,"Barrett Business Services, Inc.",934.95M,35.77,1.10B,2.23%,5.10%,17.39%,-0.99%,+16.90%,BBSI to Attend the 2024 Gateway Conference on September 5th,,,,,BBSI to Attend the 2024 Gateway Conference on September 5th,0,1,-1,-1,-1,-1
54.01M,"60,301",-122.25M,-1,"1,362",17.85,Buy,32.80,"Aug 14, 2024",GCT,GigaCloud Technology Inc.,932.29M,22.54,984.85M,-12.74%,-24.36%,-22.31%,-33.10%,-43.34%,"GigaCloud Technology, Inc. Class A (GCT) Receives a Buy from Lake Street",GigaCloud Technology: A Strong Buy Amidst Market Overreaction and Promising Growth Trajectory,,,,"GigaCloud Technology, Inc. Class A (GCT) Receives a Buy from Lake Street GigaCloud Technology: A Strong Buy Amidst Market Overreaction and Promising Growth Trajectory",0,0,1,-1,-1,-1
133.89M,"372,491",-322.83M,-1,452,7.20,Strong Buy,21.67,"Aug 6, 2024",PHAT,"Phathom Pharmaceuticals, Inc.",930.32M,13.84,9.92M,28.87%,35.77%,63.35%,+37.14%,+46.96%,Buy Rating for Phathom Pharmaceuticals Amid Strong Voquezna Prescription Growth,Phathom Pharmaceuticals’ V oquezna Shows Promising Market Penetration and Drives Buy Rating,Biotech Alert: Searches spiking for these stocks today,Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences,Phathom Pharmaceuticals’ V oquezna: A Rising Star in GERD Treatment Market,Buy Rating for Phathom Pharmaceuticals Amid Strong Voquezna Prescription Growth Phathom Pharmaceuticals’ V oquezna Shows Promising Market Penetration and Drives Buy Rating Biotech Alert: Searches spiking for these stocks today Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences Phathom Pharmaceuticals’ V oquezna: A Rising Star in GERD Treatment Market,1,0,0,1,0,0
26.94M,"238,153",-117.47M,-1,"7,300",35.76,Strong Buy,43.25,"Jul 30, 2024",SBGI,"Sinclair, Inc.",929.74M,14.01,3.22B,5.35%,4.54%,4.40%,-8.91%,+11.90%,"Frequent media bidder Byron Allen draws ire with late payments to ABC, CBS, NBC",Sinclair’s TBD. adds previous SNL seasons to lineup,Sinclair Broadcast expands podcast division with slate of sports programming,Deutsche Bank Reaffirms Their Hold Rating on Sinclair Broadcast (SBGI),,"Frequent media bidder Byron Allen draws ire with late payments to ABC, CBS, NBC Sinclair’s TBD. adds previous SNL seasons to lineup Sinclair Broadcast expands podcast division with slate of sports programming Deutsche Bank Reaffirms Their Hold Rating on Sinclair Broadcast (SBGI)",0,0,0,0,0,-1
63.89M,"748,918",-228.06M,-1,55,15.05,Buy,31.44,"Aug 8, 2024",IMNM,"Immunome, Inc.",927.84M,15.45,10.78M,6.46%,10.02%,-2.57%,+0.78%,-23.35%,Buy Rating Affirmed on Immunome: Promising Clinical Trials and Strategic Growth Prospects,Immunome (IMNM) Gets a Buy from Wedbush,Piper Sandler Sticks to Their Buy Rating for Immunome (IMNM),Immunome price target lowered to $23 from $27 at Piper Sandler,IMNM Upcoming Earnings Report: What to Expect?,Buy Rating Affirmed on Immunome: Promising Clinical Trials and Strategic Growth Prospects Immunome (IMNM) Gets a Buy from Wedbush Piper Sandler Sticks to Their Buy Rating for Immunome (IMNM) Immunome price target lowered to $23 from $27 at Piper Sandler IMNM Upcoming Earnings Report: What to Expect?,1,1,0,0,0,1
78.71M,"537,174",-11.10M,-1,,12.19,Buy,17.17,"Jul 31, 2024",SDA,SunCar Technology Group Inc.,923.96M,10.30,363.75M,5.18%,11.43%,28.06%,+5.49%,+44.40%,SunCar Technology partners with SAIC Maxus for auto E-insurance solutions,,,,,SunCar Technology partners with SAIC Maxus for auto E-insurance solutions,0,0,-1,-1,-1,-1
23.91M,"49,960",73.44M,$0.96,"1,147",39.96,Buy,38.00,"Aug 1, 2024",RDWR,Radware Ltd.,923.07M,22.09,259.01M,1.07%,12.38%,21.50%,-4.37%,+21.60%,Radware Sets Date for 2024 Annual General Meeting,Radware’s First Half 2024 Report: Web DDoS Attacks Climb 265%,,,,Radware Sets Date for 2024 Annual General Meeting Radware’s First Half 2024 Report: Web DDoS Attacks Climb 265%,1,0,1,-1,-1,-1
47.55M,"145,291",-49.20M,-1,,20.08,Strong Buy,23.50,"Aug 7, 2024",CPLP,Capital Product Partners L.P.,920.46M,16.77,393.20M,3.84%,1.86%,3.17%,+2.57%,-2.04%,,,,,,,1,-1,-1,-1,-1,-1
215.85M,"2,960,412",-1.73B,-1,796,4.370,Hold,1.75,"Aug 8, 2024",BASE,"Couchbase, Inc.",919.16M,18.27,190.37M,2.89%,2.43%,-18.01%,-3.07%,-30.88%,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike","Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz",Couchbase price target lowered to $25 from $30 at DA Davidson,D.A. Davidson Reaffirms Their Buy Rating on Couchbase (BASE),Couchbase price target lowered to $27 from $29 at Morgan Stanley,"Friday’s top analyst calls: Nvidia, Tesla, Microsoft, Alphabet, Fox, Walmart, Nike Verizon making $20B fiber buy, Topgolf and Fortive splitting up: Morning Buzz Couchbase price target lowered to $25 from $30 at DA Davidson D.A. Davidson Reaffirms Their Buy Rating on Couchbase (BASE) Couchbase price target lowered to $27 from $29 at Morgan Stanley",1,0,1,0,0,1
10.01M,"16,762",80.72M,$1.60,"3,213",94.05,Hold,99.00,"Oct 15, 2024",HEPS,D-Market Elektronik Hizmetler ve Ticaret A.S.,915.94M,2.85,1.21B,-6.56%,-2.87%,44.02%,-13.55%,+88.73%,Hepsiburada to Unveil Q2 Financial Results,"Hepsiburada to Announce Second Quarter 2024 Results on September 11, 2024",Hepsiburada Sets Date for 2023 Shareholders Meeting,,,"Hepsiburada to Unveil Q2 Financial Results Hepsiburada to Announce Second Quarter 2024 Results on September 11, 2024 Hepsiburada Sets Date for 2023 Shareholders Meeting",0,0,0,1,-1,-1
19.06M,"61,631",57.06M,$1.48,"1,018",49.33,Buy,65.00,"Jul 29, 2024",BRKL,"Brookline Bancorp, Inc.",909.57M,10.23,335.68M,2.57%,7.06%,4.97%,-3.53%,+7.09%,,,,,,,1,-1,-1,-1,-1,-1
105.91M,"562,021",-174.61M,-1,453,8.86,Strong Buy,30.14,"Aug 5, 2024",CFB,"CrossFirst Bankshares, Inc.",908.35M,18.43,236.86M,3.12%,9.84%,28.63%,-5.12%,+36.67%,First Busey price target raised to $33 from $31 at Keefe Bruyette,Piper Sandler Keeps Their Hold Rating on CrossFirst Bankshares (CFB),First Busey price target raised to $29 from $28 at DA Davidson,CrossFirst Bankshares (CFB) Gets a Buy from KBW,CrossFirst Bankshares Merger with First Busey Corporation,First Busey price target raised to $33 from $31 at Keefe Bruyette Piper Sandler Keeps Their Hold Rating on CrossFirst Bankshares (CFB) First Busey price target raised to $29 from $28 at DA Davidson CrossFirst Bankshares (CFB) Gets a Buy from KBW CrossFirst Bankshares Merger with First Busey Corporation,0,0,0,1,0,1
71.82M,"732,300",-132.18M,-1,"1,309",13.05,Buy,24.00,"Aug 9, 2024",SHLS,"Shoals Technologies Group, Inc.",908.22M,5.45,454.70M,-3.21%,-12.58%,-49.46%,-20.77%,-50.39%,Shoals Technologies price target lowered to $8 from $10 at Truist,Shoals Technologies price target lowered to $6 from $7 at Roth MKM,Buy Rating for Shoals Technologies Group: Strategic Growth and Competitive Edge,RBC Capital Sticks to Their Buy Rating for Shoals Technologies Group (SHLS),Optimistic Long-Term Growth and Market Expansion Outlook for Shoals Technologies Group Amidst Short-Term Challenges,Shoals Technologies price target lowered to $8 from $10 at Truist Shoals Technologies price target lowered to $6 from $7 at Roth MKM Buy Rating for Shoals Technologies Group: Strategic Growth and Competitive Edge RBC Capital Sticks to Their Buy Rating for Shoals Technologies Group (SHLS) Optimistic Long-Term Growth and Market Expansion Outlook for Shoals Technologies Group Amidst Short-Term Challenges,0,0,0,1,0,1
26.14M,"88,156",49.34M,$0.32,921,35.77,Buy,39.67,"Jul 31, 2024",GPRE,Green Plains Inc.,907.76M,14.04,2.82B,-5.57%,-10.21%,-31.85%,-21.09%,-40.32%,Oppenheimer’s picks for a Republican or Democratic election sweep,,,,,Oppenheimer’s picks for a Republican or Democratic election sweep,0,0,-1,-1,-1,-1
41.36M,"932,636",113.94M,-1,"77,000",22.54,Strong Buy,51.33,"Aug 6, 2024",CBRL,"Cracker Barrel Old Country Store, Inc.",906.52M,40.83,3.41B,-0.14%,-2.37%,-32.74%,-11.87%,-37.12%,Cracker Barrel price target lowered to $42 from $46 at Truist,"Analysts Offer Insights on Consumer Cyclical Companies: Cracker Barrel (CBRL), O-I Glass (OI) and Topgolf Callaway Brands (MODG)",Cracker Barrel (CBRL) Receives a Hold from Truist Financial,Cracker Barrel ‘disappointed’ with Biglari Holdings proxy contest,,"Cracker Barrel price target lowered to $42 from $46 at Truist Analysts Offer Insights on Consumer Cyclical Companies: Cracker Barrel (CBRL), O-I Glass (OI) and Topgolf Callaway Brands (MODG) Cracker Barrel (CBRL) Receives a Hold from Truist Financial Cracker Barrel ‘disappointed’ with Biglari Holdings proxy contest",1,0,1,0,1,-1
67.22M,"547,594",-297.11M,-1,967,13.84,Strong Buy,22.50,"Aug 8, 2024",CTBI,"Community Trust Bancorp, Inc.",905.50M,50.16,223.50M,4.41%,7.79%,16.40%,-0.61%,+22.86%,Community Bancorp Releases Crucial Investor Updates,,,,,Community Bancorp Releases Crucial Investor Updates,1,0,-1,-1,-1,-1
66.36M,"255,887",-347.00M,$1.00,"1,933",14.01,Buy,18.43,"Aug 7, 2024",PETQ,"PetIQ, Inc.",905.05M,30.52,1.13B,10.14%,25.67%,54.18%,+39.31%,+65.74%,,,,,,,0,-1,-1,-1,-1,-1
60.05M,"226,318",-262.59M,-1,"1,023",15.45,Strong Buy,28.75,"Aug 12, 2024",PFC,Premier Financial Corp.,904.21M,25.23,250.95M,3.94%,10.15%,17.63%,-1.58%,+27.31%,,,,,,,0,-1,-1,-1,-1,-1
89.71M,"201,771",-26.91M,-1,"7,362",10.30,,,"Sep 26, 2024",HA,"Hawaiian Holdings, Inc.",903.93M,17.38,2.77B,19.33%,28.58%,36.18%,+36.12%,+32.50%,"Stocks making the biggest moves midday: Palo Alto Networks, Boeing and more","Stocks making the biggest premarket moves: Eli Lilly, Paramount Global and more","Alaska Airlines and Hawaiian Airlines merger clears DOJ, now faces DOT",Tuesday’s stock stories: What’s likely to move the market in the next session,Alaska Airlines flight attendants reject new contract,"Stocks making the biggest moves midday: Palo Alto Networks, Boeing and more Stocks making the biggest premarket moves: Eli Lilly, Paramount Global and more Alaska Airlines and Hawaiian Airlines merger clears DOJ, now faces DOT Tuesday’s stock stories: What’s likely to move the market in the next session Alaska Airlines flight attendants reject new contract",1,1,1,0,0,0
,,,-1,"3,155",,,,,PRAA,"PRA Group, Inc.",901.87M,22.88,977.66M,-1.99%,2.76%,-1.52%,-13.66%,-9.02%,PRA Group price target lowered to $28 from $42 at Truist,,,,,PRA Group price target lowered to $28 from $42 at Truist,0,0,-1,-1,-1,-1
41.79M,"66,805",-12.26M,-1,"5,800",22.09,Buy,23.00,"Jul 31, 2024",GDEN,"Golden Entertainment, Inc.",895.87M,31.64,829.80M,5.39%,4.82%,-7.51%,-5.59%,-11.72%,Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL,Buy Rating on Golden Entertainment: Undervalued with Potential for Growth and Expansion,Golden Entertainment price target lowered to $41 from $44 at Macquarie,Truist Financial Gives a Buy Rating to Golden Entertainment (GDEN),,Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL Buy Rating on Golden Entertainment: Undervalued with Potential for Growth and Expansion Golden Entertainment price target lowered to $41 from $44 at Macquarie Truist Financial Gives a Buy Rating to Golden Entertainment (GDEN),1,1,1,1,1,-1
54.89M,"9,356",96.23M,$0.60,82,16.42,Strong Buy,22.00,"Aug 2, 2024",PRAX,"Praxis Precision Medicines, Inc.",894.07M,50.35,1.77M,0.53%,8.30%,27.24%,-11.52%,+1.59%,Praxis Precision price target raised to $151 from $145 at Needham,Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations,Praxis Precision price target raised to $143 from $134 at Oppenheimer,Buy Rating Affirmed for Praxis Precision Medicines Amid Promising Relutrigine Clinical Data,Praxis Precision Medicines’ Promising EMBOLD Study Outcomes,Praxis Precision price target raised to $151 from $145 at Needham Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations Praxis Precision price target raised to $143 from $134 at Oppenheimer Buy Rating Affirmed for Praxis Precision Medicines Amid Promising Relutrigine Clinical Data Praxis Precision Medicines’ Promising EMBOLD Study Outcomes,1,0,1,0,1,0
,,,-1,"6,010",,,,,SCHL,Scholastic Corporation,892.35M,31.57,1.59B,3.70%,-3.86%,-13.22%,+0.86%,-13.38%,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 26, 2024",,,,,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 26, 2024",0,0,-1,-1,-1,-1
50.31M,"152,822",-79.30M,-1,"22,234",18.27,Buy,27.54,"Sep 4, 2024",CSIQ,Canadian Solar Inc.,891.88M,13.48,6.51B,-8.98%,-14.87%,-31.32%,-25.21%,-27.70%,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research",Canadian Solar announces U.S. recycling partnership with SOLARCYCLE,Canadian Solar price target lowered to $15 from $19 at Wells Fargo,Canadian Solar price target lowered to $20 from $25 at Roth MKM,Canadian Solar (CSIQ) Receives a Buy from Roth MKM,"‘Massive risk’ to number of solar players flying under radar, says GLJ Research Canadian Solar announces U.S. recycling partnership with SOLARCYCLE Canadian Solar price target lowered to $15 from $19 at Wells Fargo Canadian Solar price target lowered to $20 from $25 at Roth MKM Canadian Solar (CSIQ) Receives a Buy from Roth MKM",0,0,0,0,0,0
321.38M,"464,927",8.33M,-1,356,2.850,,,"Sep 3, 2024",CRON,Cronos Group Inc.,888.93M,2.34,101.78M,-5.40%,-6.02%,-4.18%,-12.24%,-19.78%,Election 2024: Where To Put Your Money Ahead of the Vote,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,Rising High: SNDL announces successful bid to acquire Indiva,"Lord Jones’ Live Resin Vapes, Ice Water Hash Pre-Rolls available across Canada",Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada,"Election 2024: Where To Put Your Money Ahead of the Vote Rising High: MINT Shango JV to acquire Cannabist’s Florida entity Rising High: SNDL announces successful bid to acquire Indiva Lord Jones’ Live Resin Vapes, Ice Water Hash Pre-Rolls available across Canada Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada",0,1,1,0,0,0
88.91M,"630,527",76.63M,$0.54,"4,251",10.23,Buy,11.44,"Jul 24, 2024",FWRD,Forward Air Corporation,886.95M,32.02,1.86B,23.89%,38.88%,-7.57%,+27.92%,+15.12%,Activist Ancora joins investors’ calls for a strategic review at Forward Air,Forward Air call volume above normal and directionally bullish,Short Report: Bearish positioning in Cinemark caves as shares shine,"Medtronic, Palo Alto Networks report quarterly beats: Morning Buzz","Acora urges Forward Air to launch review, consider sale, Reuters reports","Activist Ancora joins investors’ calls for a strategic review at Forward Air Forward Air call volume above normal and directionally bullish Short Report: Bearish positioning in Cinemark caves as shares shine Medtronic, Palo Alto Networks report quarterly beats: Morning Buzz Acora urges Forward Air to launch review, consider sale, Reuters reports",1,1,1,1,1,1
49.29M,"145,368",70.74M,-1,111,18.43,Buy,18.25,"Oct 14, 2024",NN,NextNav Inc.,879.19M,6.96,4.38M,-5.73%,-11.53%,12.20%,-13.48%,-4.13%,NextNav director buys $1.7M in common stock as part of option exercise,,,,,NextNav director buys $1.7M in common stock as part of option exercise,1,1,-1,-1,-1,-1
166.65M,"2,743,982",23.33M,-1,"5,260",5.45,Buy,12.88,"Aug 6, 2024",BELFB,Bel Fuse Inc.,875.51M,66.28,559.99M,1.23%,-0.91%,5.02%,-12.66%,+5.14%,,,,,,,1,-1,-1,-1,-1,-1
64.66M,"485,041",-46.22M,-1,"1,092",14.04,Strong Buy,26.94,"Aug 6, 2024",HSTM,"HealthStream, Inc.",875.45M,28.79,285.24M,1.47%,1.15%,6.86%,-3.67%,+13.80%,,,,,,,0,-1,-1,-1,-1,-1
22.20M,"807,820",60.25M,$4.15,"2,100",40.83,Hold,54.83,"Sep 11, 2024",INNV,InnovAge Holding Corp.,860.80M,6.33,741.33M,2.82%,10.48%,20.75%,-1.59%,+37.03%,"INNV Earnings Report this Week: Is It a Buy, Ahead of Earnings?",CORRECTION — InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center,InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center,,,"INNV Earnings Report this Week: Is It a Buy, Ahead of Earnings? CORRECTION — InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center",1,1,0,0,-1,-1
18.05M,"39,327",77.47M,$1.88,429,50.16,Strong Buy,47.00,"Oct 16, 2024",AMRK,"A-Mark Precious Metals, Inc.",859.93M,37.56,10.29B,2.64%,4.17%,13.48%,-6.40%,+9.93%,A-Mark Precious Metals price target raised to $47 from $42 at DA Davidson,A-Mark Precious Metals (AMRK) Receives a Buy from D.A. Davidson,A-Mark Precious Metals: Strong Q4 Rebound Prompts Buy Recommendation and $63 Price Target,A-Mark Precious Metals participates in a conference call with Maxim Group,D.A. Davidson Keeps Their Buy Rating on A-Mark Precious Metals (AMRK),A-Mark Precious Metals price target raised to $47 from $42 at DA Davidson A-Mark Precious Metals (AMRK) Receives a Buy from D.A. Davidson A-Mark Precious Metals: Strong Q4 Rebound Prompts Buy Recommendation and $63 Price Target A-Mark Precious Metals participates in a conference call with Maxim Group D.A. Davidson Keeps Their Buy Rating on A-Mark Precious Metals (AMRK),0,0,0,0,0,0
29.65M,"825,028",13.19M,-1,"1,070",30.52,Strong Buy,29.25,"Aug 7, 2024",VMEO,"Vimeo, Inc.",858.83M,5.18,421.08M,9.48%,24.42%,27.15%,+26.12%,+34.84%,Vimeo appoints Petrocelli as Chief Product & Technology Officer,Vimeo Appoints Robert Petrocelli as Company’s First Chief Product & Technology Officer,Small Cap Stocks: VMEO Stock Continues to Stream Results and Exceed Expectations,,,Vimeo appoints Petrocelli as Chief Product & Technology Officer Vimeo Appoints Robert Petrocelli as Company’s First Chief Product & Technology Officer Small Cap Stocks: VMEO Stock Continues to Stream Results and Exceed Expectations,0,0,0,0,-1,-1
35.84M,"110,544",78.50M,$1.24,"5,688",25.23,Hold,23.33,"Oct 22, 2024",IMOS,ChipMOS TECHNOLOGIES INC.,856.49M,23.31,693.69M,0.75%,-6.45%,-13.48%,-3.46%,-24.23%,ChipMOS Technologies Reports Strong Q2 2024 Growth,ChipMOS Technologies Posts Strong H1 2024 Earnings,ChipMOS reports Q2 EPS 38c vs. 53c last year,ChipMOS REPORTS SECOND QUARTER 2024 RESULTS,ChipMOS Technologies Ltd. (IMOS) Q2 Earnings Cheat Sheet,ChipMOS Technologies Reports Strong Q2 2024 Growth ChipMOS Technologies Posts Strong H1 2024 Earnings ChipMOS reports Q2 EPS 38c vs. 53c last year ChipMOS REPORTS SECOND QUARTER 2024 RESULTS ChipMOS Technologies Ltd. (IMOS) Q2 Earnings Cheat Sheet,0,1,0,0,1,1
52.01M,"1,348,778",-355.06M,-1,,17.38,Hold,13.00,"Oct 22, 2024",CGBD,"Carlyle Secured Lending, Inc.",856.29M,16.84,243.46M,0.06%,-4.71%,1.99%,-5.04%,+2.88%,Analysts Offer Insights on Financial Companies: First Hawaiian (FHB) and TCG BDC (CGBD),,,,,Analysts Offer Insights on Financial Companies: First Hawaiian (FHB) and TCG BDC (CGBD),1,0,-1,-1,-1,-1
39.42M,"105,156",3.95M,-1,"3,403",22.88,Buy,33.00,"Aug 5, 2024",GSM,Ferroglobe PLC,852.06M,4.54,1.64B,-6.11%,-15.59%,-18.14%,-20.54%,-13.36%,,,,,,,0,-1,-1,-1,-1,-1
28.31M,"127,006",274.43M,$1.00,"1,920",31.64,Strong Buy,37.75,"Aug 8, 2024",PAHC,Phibro Animal Health Corporation,848.15M,20.94,999.56M,15.47%,17.24%,47.33%,+10.22%,+62.45%,Phibro Animal Health price target raised to $15 from $13 at BofA,Phibro Animal Health (PAHC) Receives a Sell from Barclays,Phibro Animal Health Sell Rating: Concerns Over Operating Leverage and Profitability Despite Revenue Growth,Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Veeva Systems (VEEV),"Phibro Animal Health reports Q4 EPS 41c, consensus 33c","Phibro Animal Health price target raised to $15 from $13 at BofA Phibro Animal Health (PAHC) Receives a Sell from Barclays Phibro Animal Health Sell Rating: Concerns Over Operating Leverage and Profitability Despite Revenue Growth Analysts Offer Insights on Healthcare Companies: Phibro Animal Health (PAHC) and Veeva Systems (VEEV) Phibro Animal Health reports Q4 EPS 41c, consensus 33c",1,0,1,1,0,1
17.76M,"128,308",-123.74M,-1,"1,200",50.35,Strong Buy,142.44,"Aug 13, 2024",BMBL,Bumble Inc.,844.02M,6.67,1.09B,-5.40%,-22.69%,-42.50%,-29.98%,-37.89%,Bumble’s Strategic Transition Amidst Market Challenges Prompts ‘Hold’ Rating,"Bumble CFO reiterated trends remain soft in Q3, says Citi",Bumble put volume heavy and directionally bearish,"Cisco, Nike upgrades among today’s top calls on Wall Street",TD downgrades Bumble to Hold on uncertain recovery timing,"Bumble’s Strategic Transition Amidst Market Challenges Prompts ‘Hold’ Rating Bumble CFO reiterated trends remain soft in Q3, says Citi Bumble put volume heavy and directionally bearish Cisco, Nike upgrades among today’s top calls on Wall Street TD downgrades Bumble to Hold on uncertain recovery timing",1,0,1,1,1,0
28.27M,"113,063",12.10M,$0.80,337,31.57,,,"Sep 19, 2024",AMSC,American Superconductor Corporation,842.55M,21.28,155.68M,-2.42%,-15.09%,31.70%,-19.91%,+50.82%,"AMSC files to sell common stock for holders, no amount given",AMSC files automatic mixed securities shelf,,,,"AMSC files to sell common stock for holders, no amount given AMSC files automatic mixed securities shelf",0,0,1,-1,-1,-1
66.16M,"1,826,498",36.68M,-1,,13.48,Buy,23.59,"Aug 22, 2024",SLRC,SLR Investment Corp.,842.32M,15.44,236.51M,1.75%,-1.12%,0.68%,-0.51%,+3.04%,Compass Point Remains a Hold on SLR Investment Corp. (SLRC),KBW Sticks to Its Hold Rating for SLR Investment Corp. (SLRC),Analyst Maintains Sell Rating on SLR Investment Corp. Amid Concerns Over Performance and Competitive Landscape,SLR Investment Corp.: Strong Financial Performance and Growth Prospects Justify Buy Rating,,Compass Point Remains a Hold on SLR Investment Corp. (SLRC) KBW Sticks to Its Hold Rating for SLR Investment Corp. (SLRC) Analyst Maintains Sell Rating on SLR Investment Corp. Amid Concerns Over Performance and Competitive Landscape SLR Investment Corp.: Strong Financial Performance and Growth Prospects Justify Buy Rating,0,0,0,1,1,-1
382.28M,"549,947",-57.43M,-1,,2.340,Hold,3.00,"Aug 8, 2024",DHC,Diversified Healthcare Trust,842.01M,3.50,1.46B,12.34%,14.73%,29.48%,+5.09%,+35.52%,JMP Securities Sticks to Its Hold Rating for Diversified Healthcare Trust (DHC),,,,,JMP Securities Sticks to Its Hold Rating for Diversified Healthcare Trust (DHC),1,1,-1,-1,-1,-1
27.70M,"926,511",-596.68M,$0.96,185,32.02,Buy,59.75,"Aug 7, 2024",HUMA,"Humacyte, Inc.",839.04M,7.03,-,-8.68%,-2.45%,45.34%,-31.82%,+112.17%,Benchmark Co. Remains a Buy on Humacyte (HUMA),Buy Rating Justified for HUMA: Strong Clinical Performance and Humanitarian Success in Ukraine,Humacyte presents long-term results of ATEV in vascular trauma,Wall Street Analysts Are Bullish on Top Healthcare Picks,Small Cap Stocks: FDA Delay Created Buy-On-The-Dip Opportunity for Humacyte (HUMA),Benchmark Co. Remains a Buy on Humacyte (HUMA) Buy Rating Justified for HUMA: Strong Clinical Performance and Humanitarian Success in Ukraine Humacyte presents long-term results of ATEV in vascular trauma Wall Street Analysts Are Bullish on Top Healthcare Picks Small Cap Stocks: FDA Delay Created Buy-On-The-Dip Opportunity for Humacyte (HUMA),0,1,0,0,1,0
126.32M,"651,266",-95.62M,-1,870,6.96,,,"Aug 7, 2024",NYAX,Nayax Ltd.,836.79M,23.79,268.97M,0.19%,0.75%,-1.80%,+2.41%,-12.21%,"Nayax appoints Sharir as President, CMO",Nayax Appoints Keren Sharir as President and CMO,,,,"Nayax appoints Sharir as President, CMO Nayax Appoints Keren Sharir as President and CMO",1,1,1,-1,-1,-1
12.55M,"38,202",66.16M,$0.28,53,66.28,Buy,79.50,"Jul 24, 2024",DNTH,"Dianthus Therapeutics, Inc.",830.73M,28.30,4.12M,1.73%,4.27%,32.30%,-4.67%,+13.15%,"Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH)",Promising Clinical Developments Bolster Buy Rating for Dianthus Therapeutics,Dianthus price target lowered to $36 from $38 at Wedbush,Wedbush Remains a Buy on Dianthus Therapeutics (DNTH),Dianthus Therapeutics Receives ‘Buy’ Rating on Strong Financials and Promising Drug Pipeline,"Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH) Promising Clinical Developments Bolster Buy Rating for Dianthus Therapeutics Dianthus price target lowered to $36 from $38 at Wedbush Wedbush Remains a Buy on Dianthus Therapeutics (DNTH) Dianthus Therapeutics Receives ‘Buy’ Rating on Strong Financials and Promising Drug Pipeline",1,1,1,1,1,1
30.41M,"77,004",17.85M,$0.11,979,28.79,Hold,28.00,"Oct 21, 2024",UVSP,Univest Financial Corporation,829.62M,28.44,286.64M,5.22%,11.18%,28.91%,+1.30%,+43.79%,,,,,,,1,-1,-1,-1,-1,-1
135.99M,"60,676",-30.82M,-1,"13,998",6.33,Hold,6.50,"Sep 10, 2024",EYE,"National Vision Holdings, Inc.",826.46M,10.51,2.16B,-10.18%,-16.59%,-40.66%,-27.25%,-48.30%,Analysts Offer Insights on Consumer Cyclical Companies: National Vision Holdings (EYE) and Tesla (TSLA),National Vision Holdings Optimizes Debt with Strategic Repurchase,,,,Analysts Offer Insights on Consumer Cyclical Companies: National Vision Holdings (EYE) and Tesla (TSLA) National Vision Holdings Optimizes Debt with Strategic Repurchase,1,1,1,-1,-1,-1
22.89M,"588,800",79.44M,$0.80,116,37.56,Strong Buy,51.50,"Aug 29, 2024",CRGX,"CARGO Therapeutics, Inc.",823.99M,17.95,-,4.18%,2.89%,-14.62%,-0.35%,-21.03%,"Truist Financial Reaffirms Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)",CARGO Therapeutics Inc trading resumes,"CARGO Therapeutics Inc trading halted, volatility trading pause",Cargo Therapeutics price target lowered to $34 from $37 at Piper Sandler,CARGO Therapeutics: Strong Buy on Robust Financials and Promising Clinical Trials,"Truist Financial Reaffirms Their Buy Rating on CARGO Therapeutics, Inc. (CRGX) CARGO Therapeutics Inc trading resumes CARGO Therapeutics Inc trading halted, volatility trading pause Cargo Therapeutics price target lowered to $34 from $37 at Piper Sandler CARGO Therapeutics: Strong Buy on Robust Financials and Promising Clinical Trials",0,0,0,0,0,1
165.80M,"868,535",32.39M,-1,"7,660",5.18,Buy,5.33,"Aug 5, 2024",MNRO,"Monro, Inc.",822.23M,27.48,1.24B,-0.08%,7.85%,-4.43%,-13.43%,-13.38%,Monro Muffler (MNRO) Receives a Rating Update from a Top Analyst,,,,,Monro Muffler (MNRO) Receives a Rating Update from a Top Analyst,0,0,-1,-1,-1,-1
727.24M,"15,593",60.05M,$1.11,845,23.31,,,"Aug 13, 2024",SHEN,Shenandoah Telecommunications Company,820.77M,15.04,308.62M,-5.66%,-10.40%,-17.04%,-28.14%,-4.43%,Shenandoah Telecom Announces Executive Resignation and Succession,,,,,Shenandoah Telecom Announces Executive Resignation and Succession,0,1,-1,-1,-1,-1
50.85M,"382,198",104.09M,$0.48,610,16.84,Hold,16.25,"Aug 5, 2024",CSTL,"Castle Biosciences, Inc.",820.18M,29.57,287.59M,12.00%,29.78%,34.88%,+18.65%,+37.51%,Castle Biosciences: New study shows DecisionDx-SCC test benefits SCC patients,Castle Biosciences management to meet virtually with Lake Street,,,,Castle Biosciences: New study shows DecisionDx-SCC test benefits SCC patients Castle Biosciences management to meet virtually with Lake Street,1,0,0,-1,-1,-1
,,,-1,"2,837",,,,,DXPE,"DXP Enterprises, Inc.",818.64M,51.85,1.68B,5.74%,8.62%,23.08%,-3.65%,-5.33%,DXP Enterprises authorizes new buyback of up to $85M of common shares,,,,,DXP Enterprises authorizes new buyback of up to $85M of common shares,0,1,-1,-1,-1,-1
187.89M,"1,104,945",62.62M,$0.05,158,4.535,,,"Aug 5, 2024",PLRX,"Pliant Therapeutics, Inc.",817.78M,13.45,-,0.36%,6.61%,-8.66%,-9.99%,-12.08%,Oppenheimer Reaffirms Their Buy Rating on Pliant Therapeutics (PLRX),Pliant Therapeutics to Participate in Upcoming Investor Events,Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024,Bullish Outlook on Pliant Therapeutics: Advancing Pipeline and Regulatory Confidence Fuel Buy Rating,Buy Rating Affirmed for Pliant Therapeutics Amid Progress in IPF Treatment Trials,Oppenheimer Reaffirms Their Buy Rating on Pliant Therapeutics (PLRX) Pliant Therapeutics to Participate in Upcoming Investor Events Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 Bullish Outlook on Pliant Therapeutics: Advancing Pipeline and Regulatory Confidence Fuel Buy Rating Buy Rating Affirmed for Pliant Therapeutics Amid Progress in IPF Treatment Trials,1,0,1,1,1,0
40.50M,"217,174",13.16M,$0.48,"29,000",20.94,Hold,16.67,"Aug 28, 2024",WOOF,"Petco Health and Wellness Company, Inc.",816.25M,2.99,6.23B,6.36%,-7.83%,4.00%,-10.40%,+58.97%,WOOF Upcoming Earnings Report: What to Expect?,,,,,WOOF Upcoming Earnings Report: What to Expect?,1,1,-1,-1,-1,-1
126.54M,"4,071,529",42.58M,-1,,6.67,Buy,9.30,"Aug 7, 2024",RAPP,"Rapport Therapeutics, Inc.",815.65M,22.30,-,-1.84%,-9.20%,-9.29%,-11.18%,,Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences,Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit,,,,Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit,0,0,0,-1,-1,-1
39.59M,"455,395",-8.24M,-1,40,21.28,Strong Buy,25.00,"Aug 6, 2024",AVBP,"ArriVent BioPharma, Inc.",815.13M,24.27,-,20.18%,34.98%,42.47%,+24.25%,+47.48%,ArriVent BioPharma’s Firmonertinib: A Promising Treatment for EGFR PACC Mutations in NSCLC,Corbus Pharmaceuticals appoints Kung to board of directors,Buy Rating Affirmed for ArriVent BioPharma on Strong Clinical Prospects and Financial Stability,ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright,Buy Rating Affirmed on ArriVent BioPharma’s Strong Clinical Developments and Strategic Partnerships,ArriVent BioPharma’s Firmonertinib: A Promising Treatment for EGFR PACC Mutations in NSCLC Corbus Pharmaceuticals appoints Kung to board of directors Buy Rating Affirmed for ArriVent BioPharma on Strong Clinical Prospects and Financial Stability ArriVent Biopharma price target raised to $30 from $25 at H.C. Wainwright Buy Rating Affirmed on ArriVent BioPharma’s Strong Clinical Developments and Strategic Partnerships,0,0,0,0,0,0
54.55M,"109,079",101.67M,$1.64,278,15.44,Sell,15.25,"Aug 7, 2024",ZYME,Zymeworks Inc.,809.23M,11.39,62.71M,10.32%,18.10%,17.98%,+8.80%,+17.93%,Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c),Zymeworks Appoints New EVP and CFO; Leadership Transition,"Zymeworks Engages Investors, Awaits Drug Approval",Zymeworks Announces Participation in Upcoming Investor Conferences,Buy Rating on Zymeworks Stock Amid Anticipated Zani Approval and Strategic Capital Allocation,"Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c) Zymeworks Appoints New EVP and CFO; Leadership Transition Zymeworks Engages Investors, Awaits Drug Approval Zymeworks Announces Participation in Upcoming Investor Conferences Buy Rating on Zymeworks Stock Amid Anticipated Zani Approval and Strategic Capital Allocation",1,0,1,0,1,0
,,,-1,645,,,,,FCBC,"First Community Bankshares, Inc.",809.02M,44.28,164.34M,4.61%,9.82%,22.40%,-1.30%,+34.84%,First Community Bancshares Secures Top Executive Team Stability,,,,,First Community Bancshares Secures Top Executive Team Stability,0,1,-1,-1,-1,-1
240.57M,"717,202",-352.46M,$0.04,"2,200",3.500,Buy,6.00,"Aug 1, 2024",EMBC,Embecta Corp.,807.83M,14.00,1.12B,0.97%,6.77%,0.90%,-1.66%,+20.77%,Embecta management to meet with BTIG,BTIG Reaffirms Their Hold Rating on Embecta Corporation (EMBC),Recommendation to Sell: Anticipated Costs and Competition Challenge Embecta’s New Pump Program,embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes,Embecta’s disposable pump for insulin delivery cleared by FDA,Embecta management to meet with BTIG BTIG Reaffirms Their Hold Rating on Embecta Corporation (EMBC) Recommendation to Sell: Anticipated Costs and Competition Challenge Embecta’s New Pump Program embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes Embecta’s disposable pump for insulin delivery cleared by FDA,0,0,0,0,0,0
,,,-1,839,,,,,ATEC,"Alphatec Holdings, Inc.",806.24M,5.74,540.28M,-3.21%,-29.82%,-48.20%,-38.12%,-54.71%,Buy Rating on Alphatec Holdings Backed by Strong Sales Recruitment and Market Disruption Potential,Steady Outlook with Cautious Stance: Hold Rating on Alphatec Holdings,"Lake Street trims Alphatec price target, says time to ‘buy shares aggressively’",Lake Street Sticks to Their Buy Rating for Alphatec Holdings (ATEC),Alphatec Holdings’ Journey to Free Cash Flow Breakeven by 2025: A Cautiously Optimistic Buy Rating Amid Market Skepticism,"Buy Rating on Alphatec Holdings Backed by Strong Sales Recruitment and Market Disruption Potential Steady Outlook with Cautious Stance: Hold Rating on Alphatec Holdings Lake Street trims Alphatec price target, says time to ‘buy shares aggressively’ Lake Street Sticks to Their Buy Rating for Alphatec Holdings (ATEC) Alphatec Holdings’ Journey to Free Cash Flow Breakeven by 2025: A Cautiously Optimistic Buy Rating Amid Market Skepticism",1,1,0,0,0,1
119.35M,"2,359,471",-139.66M,-1,"10,250",7.03,Buy,7.67,"Aug 13, 2024",STGW,Stagwell Inc.,802.23M,7.18,2.61B,10.86%,7.76%,15.07%,+6.89%,+23.74%,Benchmark Co. Keeps Their Buy Rating on Stagwell (STGW),,,,,Benchmark Co. Keeps Their Buy Rating on Stagwell (STGW),1,1,-1,-1,-1,-1
36.22M,595,-14.36M,-1,"33,400",23.24,Hold,25.67,"Aug 7, 2024",HCSG,"Healthcare Services Group, Inc.",800.61M,10.91,1.68B,1.45%,0.53%,0.20%,-5.42%,-11.47%,,,,,,,1,-1,-1,-1,-1,-1
29.35M,"356,342",-56.68M,-1,,28.30,Strong Buy,44.67,"Aug 8, 2024",TCPC,BlackRock TCP Capital Corp.,800.28M,9.35,232.32M,-4.48%,-12.29%,-16.89%,-14.85%,-11.24%,BlackRock TCP downgraded to Underweight from Equal Weight at Wells Fargo,BlackRock TCP Capital Showcases Strong Portfolio Management,Hold Rating on BlackRock TCP Capital Amidst Credit Challenges and Merger Instability,,,BlackRock TCP downgraded to Underweight from Equal Weight at Wells Fargo BlackRock TCP Capital Showcases Strong Portfolio Management Hold Rating on BlackRock TCP Capital Amidst Credit Challenges and Merger Instability,1,1,1,1,-1,-1
29.17M,"81,647",71.68M,$0.84,342,28.44,Hold,24.33,"Jul 24, 2024",NBBK,"NB Bancorp, Inc.",796.46M,18.65,141.69M,4.36%,11.38%,24.41%,-2.62%,+38.03%,,,,,,,1,-1,-1,-1,-1,-1
78.64M,"3,455,445",-81.23M,-1,267,10.51,Buy,15.25,"Aug 7, 2024",IRWD,"Ironwood Pharmaceuticals, Inc.",795.50M,4.98,400.57M,-6.26%,-17.62%,-45.38%,-30.45%,-41.07%,,,,,,,1,-1,-1,-1,-1,-1
45.90M,"204,216",-147.71M,-1,649,17.95,Strong Buy,30.33,"Aug 12, 2024",CFFN,"Capitol Federal Financial, Inc.",795.14M,6.13,-38.13M,3.37%,3.91%,5.95%,-5.06%,+9.89%,,,,,,,0,-1,-1,-1,-1,-1
29.92M,"398,771",33.26M,$1.12,539,27.48,Hold,35.00,"Jul 31, 2024",LAB,Standard BioTools Inc.,794.27M,2.14,136.30M,21.35%,13.31%,-5.10%,-7.14%,-24.09%,Standard BioTools Outlines Strategic Vision and Financial Goals,Standard BioTools Introduces New Executive Severance Plan,,,,Standard BioTools Outlines Strategic Vision and Financial Goals Standard BioTools Introduces New Executive Severance Plan,0,0,0,-1,-1,-1
54.57M,"200,970",206.01M,$0.09,799,15.04,Buy,25.00,"Aug 7, 2024",HFWA,Heritage Financial Corporation,793.41M,23.00,214.40M,1.71%,10.24%,15.87%,-0.73%,+27.57%,,,,,,,0,-1,-1,-1,-1,-1
27.74M,"261,806",-3.10M,-1,"5,643",29.57,Strong Buy,32.80,"Aug 5, 2024",ALGT,Allegiant Travel Company,792.13M,44.78,2.50B,1.75%,-8.28%,-31.67%,-25.59%,-36.43%,Allegiant’s Executive Resignation and Compensatory Agreement,Allegiant announces resignation of Chief Marketing Officer Scott DeAngelo,Allegiant Travel reports July 2024 total system traffic up 1.8% year-over-year,Allegiant Travel price target lowered to $40 from $55 at Susquehanna,,Allegiant’s Executive Resignation and Compensatory Agreement Allegiant announces resignation of Chief Marketing Officer Scott DeAngelo Allegiant Travel reports July 2024 total system traffic up 1.8% year-over-year Allegiant Travel price target lowered to $40 from $55 at Susquehanna,0,1,1,0,0,-1
15.79M,"78,957",60.11M,-1,948,51.85,,,"Aug 8, 2024",PUBM,"PubMatic, Inc.",790.87M,15.95,282.25M,-7.76%,-19.01%,-19.24%,-30.56%,-35.63%,Macquarie sees upside for ad tech companies if Alphabet loses court battle,"Analysts Offer Insights on Technology Companies: Calix (CALX), Workday (WDAY) and PubMatic (PUBM)",PubMatic price target lowered to $23 from $26 at RBC Capital,KeyBanc Sticks to Its Hold Rating for PubMatic (PUBM),PubMatic price target lowered to $26 from $30 at RBC Capital,"Macquarie sees upside for ad tech companies if Alphabet loses court battle Analysts Offer Insights on Technology Companies: Calix (CALX), Workday (WDAY) and PubMatic (PUBM) PubMatic price target lowered to $23 from $26 at RBC Capital KeyBanc Sticks to Its Hold Rating for PubMatic (PUBM) PubMatic price target lowered to $26 from $30 at RBC Capital",0,1,0,0,0,0
60.80M,"217,160",-185.41M,-1,"12,000",13.45,Strong Buy,42.00,"Aug 7, 2024",MATW,Matthews International Corporation,789.72M,25.81,1.83B,-1.73%,-1.44%,-14.47%,-12.23%,-8.66%,,,,,,,0,-1,-1,-1,-1,-1
272.99M,"1,749,563",-1.32B,-1,247,2.990,Hold,3.36,"Sep 10, 2024",KIDS,OrthoPediatrics Corp.,788.42M,32.56,175.07M,9.35%,4.16%,5.45%,+2.76%,+15.14%,Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS),"OrthoPediatrics has underappreciated ‘value creator,’ says Piper Sandler","OrthoPediatrics Corp. to Host Investor Day on September 12, 2024",OrthoPediatrics Enhances Investor Relations with Strategic Presentations,,"Piper Sandler Reaffirms Their Buy Rating on OrthoPediatrics (KIDS) OrthoPediatrics has underappreciated ‘value creator,’ says Piper Sandler OrthoPediatrics Corp. to Host Investor Day on September 12, 2024 OrthoPediatrics Enhances Investor Relations with Strategic Presentations",1,0,0,0,1,-1
36.58M,"121,125",-63.02M,-1,384,22.30,Strong Buy,35.00,"Aug 8, 2024",EVER,"EverQuote, Inc.",777.82M,22.17,318.92M,0.25%,3.45%,32.35%,-12.15%,+21.14%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,147,,,,,FDMT,"4D Molecular Therapeutics, Inc.",777.47M,14.96,20.22M,1.21%,-17.70%,-29.23%,-13.71%,-46.50%,4DMT to Participate in the 2024 Cantor Global Healthcare Conference,4D Molecular to host 4D-150 Wet AMD Development Day,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), 4D Molecular Therapeutics (FDMT) and Cullinan Management (CGEM)",4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference,"Analysts Conflicted on These Healthcare Names: Senseonics Holdings (SENS), PepGen Inc. (PEPG) and 4D Molecular Therapeutics (FDMT)","4DMT to Participate in the 2024 Cantor Global Healthcare Conference 4D Molecular to host 4D-150 Wet AMD Development Day Analysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), 4D Molecular Therapeutics (FDMT) and Cullinan Management (CGEM) 4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference Analysts Conflicted on These Healthcare Names: Senseonics Holdings (SENS), PepGen Inc. (PEPG) and 4D Molecular Therapeutics (FDMT)",1,1,0,1,0,1
33.59M,"756,075",-74.89M,-1,126,24.27,Strong Buy,31.40,"Aug 14, 2024",ERAS,"Erasca, Inc.",776.55M,2.75,-,-0.35%,2.00%,23.03%,-8.89%,+36.67%,Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials,Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS),Erasca’s Innovative Melanoma Treatments Prompt Buy Rating,Erasca price target raised to $6 from $5 at H.C. Wainwright,"Erasca, Inc.: A Strong Buy on Robust Pipeline and Promising Clinical Data","Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS) Erasca’s Innovative Melanoma Treatments Prompt Buy Rating Erasca price target raised to $6 from $5 at H.C. Wainwright Erasca, Inc.: A Strong Buy on Robust Pipeline and Promising Clinical Data",0,0,0,1,0,1
71.05M,"348,746",-112.51M,-1,"4,322",11.39,Strong Buy,14.75,"Aug 1, 2024",ASTE,"Astec Industries, Inc.",775.90M,34.03,1.30B,2.97%,5.69%,-4.35%,-3.88%,-24.12%,,,,,,,0,-1,-1,-1,-1,-1
18.27M,"35,644",51.96M,$1.24,483,44.28,Hold,38.00,"Jul 23, 2024",EXAI,Exscientia plc,775.53M,6.00,26.57M,11.64%,9.99%,3.90%,+4.91%,+14.67%,Morgan Stanley Sticks to Their Hold Rating for Exscientia Plc (EXAI),Exscientia Plc Backs Acquisition by Recursion Pharmaceuticals,Morgan Stanley Remains a Hold on Exscientia Plc (EXAI),Maintaining Hold Rating on Exscientia Plc Amid Anticipated Developments and Clinical Milestones,Exscientia’s Strategic Merger and Pipeline Progress,Morgan Stanley Sticks to Their Hold Rating for Exscientia Plc (EXAI) Exscientia Plc Backs Acquisition by Recursion Pharmaceuticals Morgan Stanley Remains a Hold on Exscientia Plc (EXAI) Maintaining Hold Rating on Exscientia Plc Amid Anticipated Developments and Clinical Milestones Exscientia’s Strategic Merger and Pipeline Progress,0,0,0,0,0,0
57.70M,"282,105",69.70M,$0.60,"7,214",14.00,Sell,12.00,"Aug 9, 2024",ULCC,"Frontier Group Holdings, Inc.",774.47M,3.45,3.61B,3.45%,-13.44%,-35.86%,-12.94%,-51.89%,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree",5 things to know before the stock market opens Friday,Where are low-cost airlines cutting back now? New planes,Frontier Group Holdings: Hold Rating Amidst Transformation and Mixed Performance,Frontier Group price target lowered to $6 from $7 at Barclays,"U.S. airlines cool hiring after adding 194,000 employees in post-Covid spree 5 things to know before the stock market opens Friday Where are low-cost airlines cutting back now? New planes Frontier Group Holdings: Hold Rating Amidst Transformation and Mixed Performance Frontier Group price target lowered to $6 from $7 at Barclays",0,0,1,0,1,0
140.46M,"4,208,148",-180.91M,-1,401,5.74,Strong Buy,18.50,"Jul 31, 2024",IGIC,International General Insurance Holdings Ltd.,770.05M,17.42,486.56M,9.66%,15.82%,33.99%,+4.26%,+32.12%,International General Insurance Reports Growth,IGI Holdings Announces AGM Outcomes,"IGI Announces Dividend, Boasts Strong Ratings",,,"International General Insurance Reports Growth IGI Holdings Announces AGM Outcomes IGI Announces Dividend, Boasts Strong Ratings",1,1,1,0,-1,-1
111.73M,"503,063",-2.31M,-1,960,7.18,Strong Buy,7.81,"Aug 1, 2024",TTGT,"TechTarget, Inc.",770.03M,26.95,224.97M,-3.23%,-9.94%,-12.42%,-15.88%,-12.28%,TechTarget price target lowered to $34 from $39 at Raymond James,TechTarget price target lowered to $38 from $40 at KeyBanc,TechTarget (TTGT) Receives a Buy from KeyBanc,TechTarget price target lowered to $38 from $39 at Lake Street,"Analysts Offer Insights on Communication Services Companies: Paramount Global Class B (PARA), TechTarget (TTGT) and Take-Two (TTWO)","TechTarget price target lowered to $34 from $39 at Raymond James TechTarget price target lowered to $38 from $40 at KeyBanc TechTarget (TTGT) Receives a Buy from KeyBanc TechTarget price target lowered to $38 from $39 at Lake Street Analysts Offer Insights on Communication Services Companies: Paramount Global Class B (PARA), TechTarget (TTGT) and Take-Two (TTWO)",0,0,0,0,0,0
73.38M,"264,845",31.98M,-1,586,10.91,Buy,14.50,"Jul 24, 2024",ABCL,AbCellera Biologics Inc.,769.08M,2.61,33.05M,-5.20%,-9.84%,-37.91%,-21.47%,-41.01%,KeyBanc Keeps Their Buy Rating on AbCellera Biologics (ABCL),AbCellera downgraded to Hold from Buy at Benchmark,,,,KeyBanc Keeps Their Buy Rating on AbCellera Biologics (ABCL) AbCellera downgraded to Hold from Buy at Benchmark,0,0,1,-1,-1,-1
85.59M,"1,014,225",-46.71M,$1.36,102,9.35,Hold,8.88,"Aug 7, 2024",ABL,"Abacus Life, Inc.",768.91M,10.30,95.38M,2.35%,8.32%,-0.66%,+5.81%,-14.57%,Abacus Life price target raised to $16 from $15 at B. Riley,"Abacus Life, Lorisco Life announce launch of PREADISAN",Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions,Abacus Life (ABL) Gets a Buy from Piper Sandler,"Abacus Life reports Q2 adjusted EPS 18c, consensus 13c","Abacus Life price target raised to $16 from $15 at B. Riley Abacus Life, Lorisco Life announce launch of PREADISAN Abacus Life and Lorisco Life Announce Launch of PREADISAN™ to Improve Health Predictions Abacus Life (ABL) Gets a Buy from Piper Sandler Abacus Life reports Q2 adjusted EPS 18c, consensus 13c",0,0,0,0,0,0
,,,-1,145,,,,,LQDA,Liquidia Corporation,765.63M,9.97,14.84M,-15.37%,-18.39%,-20.67%,-20.03%,-39.27%,"Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer",Cramer’s Lightning Round: Flutter is a buy,Liquidia to Present at Upcoming Investor Conferences,Biotech Alert: Searches spiking for these stocks today,Buy Rating Affirmed: Liquidia Technologies’ Proactive Legal Strategies and Favorable Outlook,"Lightning Round: Ring the register on AST SpaceMobile, says Jim Cramer Cramer’s Lightning Round: Flutter is a buy Liquidia to Present at Upcoming Investor Conferences Biotech Alert: Searches spiking for these stocks today Buy Rating Affirmed: Liquidia Technologies’ Proactive Legal Strategies and Favorable Outlook",0,1,0,0,1,0
42.71M,"143,340",13.00M,-1,"1,284",18.65,Buy,20.00,"Jul 24, 2024",HAYN,"Haynes International, Inc.",765.11M,60.25,614.33M,0.59%,1.39%,4.69%,+0.86%,-0.63%,,,,,,,1,-1,-1,-1,-1,-1
159.74M,"1,190,660",9.21M,-1,860,4.98,Strong Buy,16.25,"Aug 8, 2024",TREE,"LendingTree, Inc.",764.67M,57.31,667.45M,22.49%,27.92%,60.33%,+6.03%,+43.08%,"This common credit score myth could hurt your score, says FICO expert",,,,,"This common credit score myth could hurt your score, says FICO expert",0,1,-1,-1,-1,-1
129.71M,"620,986",-114.39M,$0.34,512,6.13,Hold,6.75,"Jul 24, 2024",RPAY,Repay Holdings Corporation,759.29M,8.66,305.93M,-2.69%,-11.17%,-7.76%,-12.68%,-16.58%,Repay Holdings (RPAY) Receives a Hold from KBW,Repay Holdings (RPAY) Receives a Hold from Morgan Stanley,Benchmark Co. Remains a Buy on Repay Holdings (RPAY),Repay Holdings price target lowered to $11 from $12 at Barclays,Repay Holdings (RPAY) Gets a Buy from Northland Securities,Repay Holdings (RPAY) Receives a Hold from KBW Repay Holdings (RPAY) Receives a Hold from Morgan Stanley Benchmark Co. Remains a Buy on Repay Holdings (RPAY) Repay Holdings price target lowered to $11 from $12 at Barclays Repay Holdings (RPAY) Gets a Buy from Northland Securities,0,0,0,1,0,1
371.15M,"1,634,443",-164.66M,-1,"2,212",2.140,Strong Buy,3.00,"Jul 31, 2024",HSII,"Heidrick & Struggles International, Inc.",758.24M,37.32,1.06B,0.38%,7.87%,18.96%,-4.56%,+19.09%,,,,,,,0,-1,-1,-1,-1,-1
34.50M,"100,172",44.36M,$0.92,"8,180",23.00,Buy,23.50,"Oct 17, 2024",PTLO,Portillo's Inc.,758.22M,12.27,702.36M,15.53%,24.26%,0.32%,+18.05%,-6.36%,Engaged Capital might have the recipe to build value at Portillo’s,"Engaged Capital has big stake in Portillo’s, pushes for turnaround, sources say",Portillo’s Inc. to Participate in September Investor Conference,"Are You Salty, Spiced or Sweet? Portillo’s New Salted Caramel Spice Cake Has it All",Closing Bell Movers: H&R Block jumps 10% after earnings beat,"Engaged Capital might have the recipe to build value at Portillo’s Engaged Capital has big stake in Portillo’s, pushes for turnaround, sources say Portillo’s Inc. to Participate in September Investor Conference Are You Salty, Spiced or Sweet? Portillo’s New Salted Caramel Spice Cake Has it All Closing Bell Movers: H&R Block jumps 10% after earnings beat",0,0,1,0,1,1
17.69M,"370,101",-14.39M,$2.40,109,44.78,Hold,65.11,"Jul 31, 2024",SLN,Silence Therapeutics plc,758.12M,16.20,22.62M,10.60%,1.23%,-2.45%,-8.10%,-10.92%,Silence Therapeutics: Strong Buy on Underappreciated Blockbuster Potential and Clinical Advancements,"Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Pharvaris (PHVS) and Stevanato Group (STVN)",Morgan Stanley Reaffirms Their Buy Rating on Silence Therapeutics (SLN),Buy Rating for Silence Therapeutics Backed by Promising Pipeline and Strategic Partnership Potential,Buy Rating Affirmed for Silence Therapeutics Amid Strong Pipeline Progress and Strategic Partnerships,"Silence Therapeutics: Strong Buy on Underappreciated Blockbuster Potential and Clinical Advancements Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Pharvaris (PHVS) and Stevanato Group (STVN) Morgan Stanley Reaffirms Their Buy Rating on Silence Therapeutics (SLN) Buy Rating for Silence Therapeutics Backed by Promising Pipeline and Strategic Partnership Potential Buy Rating Affirmed for Silence Therapeutics Amid Strong Pipeline Progress and Strategic Partnerships",0,0,0,0,0,0
49.58M,"472,037",19.99M,-1,"3,219",15.95,Buy,21.17,"Aug 8, 2024",KRUS,"Kura Sushi USA, Inc.",757.57M,67.37,226.78M,12.08%,6.34%,-21.37%,+14.54%,-40.16%,Kura Sushi USA to Participate in Two Investor Conferences in September,,,,,Kura Sushi USA to Participate in Two Investor Conferences in September,1,0,-1,-1,-1,-1
30.60M,"98,110",26.22M,$0.96,"21,230",25.81,Strong Buy,59.00,"Aug 1, 2024",BJRI,"BJ's Restaurants, Inc.",756.69M,32.68,1.33B,7.11%,-3.65%,-4.77%,+1.17%,-6.69%,"These five stocks are best positioned for growth, Goldman Sachs says",BJ’s Restaurants Welcomes Lyle Tick as New President,BJ’s Restaurants appoints Lyle Tick as President and Chief Concept Officer,"BJ’s Restaurants, Inc. Announces Appointment of President & Chief Concept Officer",Setyan Endorses BJ’s Restaurants with a Buy Rating Amidst Leadership Changes and Strategic Growth Initiatives,"These five stocks are best positioned for growth, Goldman Sachs says BJ’s Restaurants Welcomes Lyle Tick as New President BJ’s Restaurants appoints Lyle Tick as President and Chief Concept Officer BJ’s Restaurants, Inc. Announces Appointment of President & Chief Concept Officer Setyan Endorses BJ’s Restaurants with a Buy Rating Amidst Leadership Changes and Strategic Growth Initiatives",1,1,1,1,1,1
24.21M,"127,893",-25.12M,-1,"1,399",32.56,Buy,39.14,"Aug 5, 2024",WEST,Westrock Coffee Company,756.41M,8.56,835.47M,-6.96%,-12.06%,-13.96%,-12.42%,-14.41%,Stifel Nicolaus Reaffirms Their Buy Rating on Westrock Coffee (WEST),Westrock Coffee Company Commences Warrant Exchange Offer and Consent Solicitation,"Westrock Coffee commences warrant exchange offer, consent solicitation",Telsey Advisory Keeps Their Buy Rating on Westrock Coffee (WEST),Stifel Nicolaus Keeps Their Buy Rating on Westrock Coffee (WEST),"Stifel Nicolaus Reaffirms Their Buy Rating on Westrock Coffee (WEST) Westrock Coffee Company Commences Warrant Exchange Offer and Consent Solicitation Westrock Coffee commences warrant exchange offer, consent solicitation Telsey Advisory Keeps Their Buy Rating on Westrock Coffee (WEST) Stifel Nicolaus Keeps Their Buy Rating on Westrock Coffee (WEST)",1,1,1,1,1,1
35.08M,"485,570",-27.26M,-1,68,22.17,Strong Buy,29.58,"Aug 5, 2024",TRIN,Trinity Capital Inc.,752.53M,14.10,191.01M,-1.29%,-1.73%,-3.26%,-4.18%,-3.18%,Trinity Capital provides $20M in growth capital to Kymeta,Trinity Capital provides $50M in capital to LightForce,Trinity Capital commits $35M in equipment financing to ApiJect,Analysts’ Opinions Are Mixed on These Financial Stocks: Trinity Capital (TRIN) and American International Group (AIG),Trinity Capital: A Balanced View on Stability and Growth Risks,Trinity Capital provides $20M in growth capital to Kymeta Trinity Capital provides $50M in capital to LightForce Trinity Capital commits $35M in equipment financing to ApiJect Analysts’ Opinions Are Mixed on These Financial Stocks: Trinity Capital (TRIN) and American International Group (AIG) Trinity Capital: A Balanced View on Stability and Growth Risks,1,1,1,1,1,1
51.97M,"402,438",-109.89M,-1,220,14.96,Strong Buy,46.25,"Aug 8, 2024",MCBS,"MetroCity Bankshares, Inc.",751.60M,29.67,126.44M,5.68%,7.80%,20.97%,-3.20%,+28.95%,,,,,,,0,-1,-1,-1,-1,-1
282.38M,"1,715,606",-158.28M,-1,"1,760",2.750,Strong Buy,6.00,"Aug 12, 2024",SWIM,"Latham Group, Inc.",751.25M,6.50,522.40M,22.27%,57.34%,90.43%,+66.48%,+61.17%,Latham Takes the Plunge With L.C. Williams & Associates,"Latham Group, Inc. to Participate at Upcoming Conference",Latham Group price target raised to $6 from $3 at Barclays,Latham Group (SWIM) Receives a Rating Update from a Top Analyst,,"Latham Takes the Plunge With L.C. Williams & Associates Latham Group, Inc. to Participate at Upcoming Conference Latham Group price target raised to $6 from $3 at Barclays Latham Group (SWIM) Receives a Rating Update from a Top Analyst",1,1,1,0,1,-1
22.80M,"120,002",-2.30M,$0.52,4,34.03,Hold,37.00,"Aug 7, 2024",CRML,Critical Metals Corp.,751.09M,9.20,-,-8.86%,-14.69%,-17.76%,-17.46%,-27.08%,Critical Metals commences drilling at Tanbreez rare earth deposit,Critical Metals Corp. Has Commenced Drilling at the Tanbreez Rare Earth Deposit,,,,Critical Metals commences drilling at Tanbreez rare earth deposit Critical Metals Corp. Has Commenced Drilling at the Tanbreez Rare Earth Deposit,1,0,0,-1,-1,-1
129.26M,"902,186",-163.78M,-1,83,6.00,Hold,7.00,"Aug 15, 2024",MESO,Mesoblast Limited,747.71M,6.56,7.47M,0.01%,-8.00%,38.07%,-5.91%,+9.83%,Mesoblast Limited (MEOBF) was upgraded to a Buy Rating at Jefferies,Bell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF),Mesoblast Nears Major FDA Approvals and Advances Trials,Mesoblast Reports Year-End Financials and Outlook,Mesoblast Limited Files Annual SEC Report,Mesoblast Limited (MEOBF) was upgraded to a Buy Rating at Jefferies Bell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF) Mesoblast Nears Major FDA Approvals and Advances Trials Mesoblast Reports Year-End Financials and Outlook Mesoblast Limited Files Annual SEC Report,1,1,0,1,1,0
224.48M,"1,074,295",-62.00M,-1,"3,300",3.450,Hold,5.87,"Aug 8, 2024",AVO,"Mission Produce, Inc.",747.39M,10.54,1.08B,2.43%,3.13%,0.55%,-4.98%,-9.57%,Why 90% of the U.S. avocado supply comes from Mexico,Why most of the avocados in the U.S. come from Mexico,AVO Earnings this Week: How Will it Perform?,,,Why 90% of the U.S. avocado supply comes from Mexico Why most of the avocados in the U.S. come from Mexico AVO Earnings this Week: How Will it Perform?,0,0,0,0,-1,-1
44.20M,"126,488",110.20M,$0.10,665,17.42,Buy,17.00,"Aug 6, 2024",MBWM,Mercantile Bank Corporation,746.85M,46.28,220.24M,3.80%,5.76%,16.44%,-5.21%,+23.79%,,,,,,,0,-1,-1,-1,-1,-1
28.57M,"72,626",-8.64M,-1,,26.95,Buy,37.86,"Aug 8, 2024",SVC,Service Properties Trust,746.50M,4.50,1.89B,-3.39%,-9.35%,-28.51%,-19.40%,-30.76%,Service Properties files automatic mixed securities shelf,Service Properties price target lowered to $8 from $9 at B. Riley,,,,Service Properties files automatic mixed securities shelf Service Properties price target lowered to $8 from $9 at B. Riley,0,0,0,-1,-1,-1
294.67M,"1,177,705",-153.30M,-1,676,2.610,Buy,14.00,"Aug 6, 2024",CTKB,"Cytek Biosciences, Inc.",743.01M,5.65,197.71M,-0.32%,-3.50%,-17.64%,-15.50%,-13.30%,Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB),Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility,Cytek Biosciences (CTKB) Receives a Buy from Piper Sandler,Cytek Biosciences price target lowered to $8 from $8.50 at Piper Sandler,Cytek Biosciences: Hold Rating Amidst Mixed Performance and Cautious U.S. Market Outlook,Piper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB) Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility Cytek Biosciences (CTKB) Receives a Buy from Piper Sandler Cytek Biosciences price target lowered to $8 from $8.50 at Piper Sandler Cytek Biosciences: Hold Rating Amidst Mixed Performance and Cautious U.S. Market Outlook,0,0,1,0,0,0
74.65M,"29,939",-5.90M,-1,"1,172",10.30,Strong Buy,13.67,"Aug 12, 2024",CVAC,CureVac N.V.,742.48M,3.31,70.57M,-2.28%,-3.75%,-11.82%,-14.85%,+4.90%,CureVac (CVAC) Receives a Hold from Deutsche Bank,"Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)",CureVac price target lowered to $16 from $18 at JMP Securities,CureVac: A Promising Buy Amidst Financial Stability and Innovative Vaccine Pipeline,CureVac Secures Lucrative GSK Deal and Refocuses Business,"CureVac (CVAC) Receives a Hold from Deutsche Bank Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST) CureVac price target lowered to $16 from $18 at JMP Securities CureVac: A Promising Buy Amidst Financial Stability and Innovative Vaccine Pipeline CureVac Secures Lucrative GSK Deal and Refocuses Business",1,1,0,0,1,1
76.79M,"701,758",-112.11M,-1,33,9.97,Strong Buy,25.50,"Aug 7, 2024",MREO,Mereo BioPharma Group plc,741.91M,4.83,1.00M,16.60%,20.93%,48.46%,,,Biotech Alert: Searches spiking for these stocks today,Buy Rating Affirmed for Mereo Biopharma on Strong Financials and Promising Pipeline Progress,Buy Rating Affirmed for Mereo Biopharma on Strong Clinical and Financial Prospects,Mereo Biopharma Group: A Strong Buy on Promising Clinical Data and Robust Financials,Mereo BioPharma reports Q2 EPS (2c) vs 0c last year,Biotech Alert: Searches spiking for these stocks today Buy Rating Affirmed for Mereo Biopharma on Strong Financials and Promising Pipeline Progress Buy Rating Affirmed for Mereo Biopharma on Strong Clinical and Financial Prospects Mereo Biopharma Group: A Strong Buy on Promising Clinical Data and Robust Financials Mereo BioPharma reports Q2 EPS (2c) vs 0c last year,0,1,0,0,1,0
12.70M,"78,026",37.18M,$0.88,150,60.25,Hold,,"Aug 1, 2024",SRRK,Scholar Rock Holding Corporation,741.90M,9.27,-,0.35%,3.32%,-31.00%,-0.44%,-37.18%,"Scholar Rock appoints Beth Shafer, Ph.D. Chief Business Officer","Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Scholar Rock Holding (SRRK) and Iovance Biotherapeutics (IOVA)",Buy Rating Justified by Scholar Rock’s Promising Drug Trials and Market Potential,Scholar Rock price target raised to $34 from $31 at BMO Capital,,"Scholar Rock appoints Beth Shafer, Ph.D. Chief Business Officer Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Scholar Rock Holding (SRRK) and Iovance Biotherapeutics (IOVA) Buy Rating Justified by Scholar Rock’s Promising Drug Trials and Market Potential Scholar Rock price target raised to $34 from $31 at BMO Capital",1,1,1,1,0,-1
13.34M,"326,996",-126.98M,-1,"3,095",57.31,Buy,58.13,"Jul 25, 2024",MBUU,"Malibu Boats, Inc.",741.14M,36.26,1.04B,0.18%,0.02%,-14.42%,-8.41%,-19.00%,New Launch: The all-new 2025 Malibu M230,Buy Rating Affirmed for Malibu Boats Amid Prudent Guidance and Strategic Management Initiatives,Truist Financial Sticks to Its Hold Rating for Malibu Boats (MBUU),Malibu Boats: Maintaining Hold Rating Amidst Adjusted Inventories and Cautious Fiscal Outlook,Malibu Boats sees FY25 net sales increase in low single digits year-over-year,New Launch: The all-new 2025 Malibu M230 Buy Rating Affirmed for Malibu Boats Amid Prudent Guidance and Strategic Management Initiatives Truist Financial Sticks to Its Hold Rating for Malibu Boats (MBUU) Malibu Boats: Maintaining Hold Rating Amidst Adjusted Inventories and Cautious Fiscal Outlook Malibu Boats sees FY25 net sales increase in low single digits year-over-year,1,1,0,0,0,1
87.68M,"1,061,846",-88.74M,-1,834,8.66,Buy,11.57,"Aug 8, 2024",OSBC,"Old Second Bancorp, Inc.",740.92M,16.52,265.72M,4.49%,6.74%,13.68%,-0.53%,+24.76%,Piper Sandler Sticks to Their Buy Rating for Old Second Bancorp (OSBC),Old Second Bancorp Acquires First Merchants Bank Branches,Old Second Bancorp to purchase five Illinois branches from First Merchants,,,Piper Sandler Sticks to Their Buy Rating for Old Second Bancorp (OSBC) Old Second Bancorp Acquires First Merchants Bank Branches Old Second Bancorp to purchase five Illinois branches from First Merchants,0,0,0,0,-1,-1
20.32M,"109,496",38.72M,$0.60,"6,200",37.32,Buy,36.50,"Jul 29, 2024",KELYA,"Kelly Services, Inc.",739.11M,20.78,4.45B,-0.07%,-2.73%,-5.65%,-11.47%,-14.46%,Buy Rating Affirmed for Kelly Services Amid Strong Financials and Strategic Growth Initiatives,Kelly Services (KELYA) Receives a Buy from Noble Financial,,,,Buy Rating Affirmed for Kelly Services Amid Strong Financials and Strategic Growth Initiatives Kelly Services (KELYA) Receives a Buy from Noble Financial,0,1,0,-1,-1,-1
61.79M,"816,303",23.18M,-1,197,12.27,Buy,15.22,"Aug 6, 2024",SLP,"Simulations Plus, Inc.",736.88M,36.83,66.98M,-2.06%,-10.56%,-13.75%,-11.63%,-24.34%,Simulations Plus Announces Leadership Shake-Up and Strategy,,,,,Simulations Plus Announces Leadership Shake-Up and Strategy,0,0,-1,-1,-1,-1
46.80M,"326,833",-50.68M,-1,"1,400",16.20,Strong Buy,61.50,"Aug 15, 2024",LMB,"Limbach Holdings, Inc.",736.81M,65.36,511.67M,8.95%,10.34%,35.54%,+0.41%,+48.62%,Roth MKM Reaffirms Their Buy Rating on Limbach Holdings (LMB),Limbach Holdings Expands with Kent Island Mechanical Buyout,Limbach Holding acquires Kent Island Mechanical,,,Roth MKM Reaffirms Their Buy Rating on Limbach Holdings (LMB) Limbach Holdings Expands with Kent Island Mechanical Buyout Limbach Holding acquires Kent Island Mechanical,1,0,1,1,-1,-1
11.24M,"87,464","-678,000",-1,110,67.37,Buy,71.43,"Jul 9, 2024",STOK,"Stoke Therapeutics, Inc.",736.54M,13.99,15.16M,-3.19%,-2.36%,42.14%,-8.28%,+9.23%,Stoke Therapeutics appoints Eric Olson Chief Business Officer.,Buy Rating for Stoke Therapeutics: FDA Progress and Strong Financials Underpin Future Potential,,,,Stoke Therapeutics appoints Eric Olson Chief Business Officer. Buy Rating for Stoke Therapeutics: FDA Progress and Strong Financials Underpin Future Potential,1,1,0,-1,-1,-1
23.15M,"286,213",29.13M,-1,61,32.68,Hold,37.33,"Jul 25, 2024",ABVX,ABIVAX Société Anonyme,736.47M,11.60,4.97M,5.48%,-3.11%,-6.18%,+3.81%,-17.50%,Abivax SA (0RA9) Gets a Buy from Kepler Capital,,,,,Abivax SA (0RA9) Gets a Buy from Kepler Capital,0,0,-1,-1,-1,-1
88.37M,"231,426",-44.51M,-1,"6,200",8.56,Strong Buy,12.67,"Aug 8, 2024",KELYB,"Kelly Services, Inc.",735.55M,19.70,4.45B,,-3.11%,-6.18%,-15.99%,+13.22%,Buy Rating Affirmed for Kelly Services Amid Strong Financials and Strategic Growth Initiatives,Kelly Services (KELYA) Receives a Buy from Noble Financial,,,,Buy Rating Affirmed for Kelly Services Amid Strong Financials and Strategic Growth Initiatives Kelly Services (KELYA) Receives a Buy from Noble Financial,1,1,0,-1,-1,-1
53.37M,"784,574",79.86M,$2.04,736,14.10,Strong Buy,16.25,"Aug 7, 2024",MLAB,"Mesa Laboratories, Inc.",734.78M,135.84,223.71M,15.25%,30.47%,35.93%,+18.52%,+34.49%,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls",Wells Fargo starts tools and diagnostics group with positive bias,Mesa Labs initiated with an Underweight at Wells Fargo,,,"Illumina upgraded, Fiserv initiated: Wall Street’s top analyst calls Wells Fargo starts tools and diagnostics group with positive bias Mesa Labs initiated with an Underweight at Wells Fargo",1,1,1,0,-1,-1
25.33M,"39,908",54.34M,$0.80,73,29.67,Hold,32.00,"Oct 18, 2024",ABUS,Arbutus Biopharma Corporation,734.36M,3.89,10.06M,3.62%,9.43%,36.48%,+2.12%,+23.40%,Biotech Alert: Searches spiking for these stocks today,Arbutus Biopharma price target raised to $7 from $5 at Jefferies,Buy Rating Affirmed for Arbutus Biopharma Amid Positive Legal and Clinical Developments,Arbutus to Participate in Two Upcoming Investor Conferences,,Biotech Alert: Searches spiking for these stocks today Arbutus Biopharma price target raised to $7 from $5 at Jefferies Buy Rating Affirmed for Arbutus Biopharma Amid Positive Legal and Clinical Developments Arbutus to Participate in Two Upcoming Investor Conferences,0,1,0,0,0,-1
115.58M,"579,091",11.68M,-1,"2,831",6.50,Buy,4.20,"Aug 6, 2024",DAKT,"Daktronics, Inc.",734.06M,15.84,818.08M,4.77%,10.53%,45.61%,+0.40%,+46.30%,Daktronics reports Q1 revenue (11c) vs. 42c last year,Daktronics expects seasonality to ‘continue to normalize’ in FY25,Daktronics (DAKT) Q1 Earnings Cheat Sheet,"Daktronics, Inc. to Release First Quarter Fiscal 2025 Financial Results",,"Daktronics reports Q1 revenue (11c) vs. 42c last year Daktronics expects seasonality to ‘continue to normalize’ in FY25 Daktronics (DAKT) Q1 Earnings Cheat Sheet Daktronics, Inc. to Release First Quarter Fiscal 2025 Financial Results",1,1,1,1,0,-1
81.64M,"12,335",-6.90M,-1,900,9.20,,,"Sep 6, 2024",INDI,"indie Semiconductor, Inc.",733.63M,4.09,235.32M,-9.97%,-27.41%,-36.64%,-34.95%,-42.11%,"Indie Semiconductor Executives Slash Salaries, Streamline Workforce",Indie Semiconductor management to meet virtually with Benchmark,Indie Semiconductor price target lowered to $7 from $9 at Deutsche Bank,Roth MKM Reaffirms Their Buy Rating on indie Semiconductor (INDI),Indie Semiconductor price target lowered to $7 from $10 at Roth MKM,"Indie Semiconductor Executives Slash Salaries, Streamline Workforce Indie Semiconductor management to meet virtually with Benchmark Indie Semiconductor price target lowered to $7 from $9 at Deutsche Bank Roth MKM Reaffirms Their Buy Rating on indie Semiconductor (INDI) Indie Semiconductor price target lowered to $7 from $10 at Roth MKM",0,1,1,1,0,0
1.01B,"29,374",-73.06M,-1,"13,481",6.56,Strong Buy,11.00,"Sep 3, 2024",ARKO,Arko Corp.,732.83M,6.33,9.32B,-1.12%,0.48%,-4.69%,-3.66%,+21.35%,"ARKO Corp. Opens New Handy Mart Store in Newport, North Carolina",,,,,"ARKO Corp. Opens New Handy Mart Store in Newport, North Carolina",1,1,-1,-1,-1,-1
70.91M,"98,205",17.60M,-1,"1,174",10.54,Strong Buy,12.38,"Sep 9, 2024",STKL,SunOpta Inc.,728.51M,6.10,688.01M,7.44%,12.19%,8.47%,+13.77%,-7.37%,Analysts Offer Insights on Consumer Goods Companies: US Foods Holding (USFD) and SunOpta (STKL),,,,,Analysts Offer Insights on Consumer Goods Companies: US Foods Holding (USFD) and SunOpta (STKL),0,1,-1,-1,-1,-1
16.14M,"60,044",81.23M,$1.44,566,46.28,Buy,52.00,"Oct 15, 2024",CLNE,Clean Energy Fuels Corp.,726.14M,3.25,404.09M,6.54%,15.34%,8.01%,+8.77%,+25.51%,"Analysts Offer Insights on Energy Companies: Clean Energy Fuels (CLNE), Crew Energy (OtherCWEGF) and Plains All American (PAA)",,,,,"Analysts Offer Insights on Energy Companies: Clean Energy Fuels (CLNE), Crew Energy (OtherCWEGF) and Plains All American (PAA)",1,1,-1,-1,-1,-1
165.89M,"1,523,149",-199.68M,$0.80,"2,500",4.500,Hold,7.25,"Aug 6, 2024",ATRO,Astronics Corporation,725.04M,20.72,741.40M,6.86%,3.77%,15.25%,-5.69%,+22.71%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,363,,,,,WLFC,Willis Lease Finance Corporation,722.25M,109.84,481.26M,11.36%,33.49%,87.75%,+22.64%,+111.32%,"Willis Lease names Amy Ruddock SVP, sustainable aviation, corporate development","Willis Lease Finance Corporation Appoints Amy Ruddock as Senior Vice President, Sustainable Aviation & Corporate Development",,,,"Willis Lease names Amy Ruddock SVP, sustainable aviation, corporate development Willis Lease Finance Corporation Appoints Amy Ruddock as Senior Vice President, Sustainable Aviation & Corporate Development",1,1,1,-1,-1,-1
131.51M,"557,391",-17.56M,-1,"1,184",5.65,Buy,8.50,"Aug 6, 2024",FLGT,"Fulgent Genetics, Inc.",721.06M,23.80,290.71M,-3.75%,3.63%,-3.35%,-4.51%,+7.38%,,,,,,,1,-1,-1,-1,-1,-1
224.31M,"280,710",-298.33M,-1,"1,350",3.310,Hold,9.33,"Aug 15, 2024",HCKT,"The Hackett Group, Inc.",719.94M,26.04,297.42M,0.01%,8.00%,11.87%,-3.23%,+13.21%,,,,,,,0,-1,-1,-1,-1,-1
153.61M,"620,969",-36.85M,-1,37,4.830,Strong Buy,7.50,"Aug 13, 2024",SVRA,Savara Inc.,719.30M,4.37,-,0.90%,-0.44%,-4.00%,-8.48%,-11.92%,Buy Rating Backed by Molbreevi’s Promising Trial Results and Market Potential for aPAP Treatment,Evercore ISI Reaffirms Their Buy Rating on Savara (SVRA),Buy Rating Affirmed for Savara on Molbreevi’s Commercial Promise and Solid Financial Footing,"Savara reports Q2 EPS (12c), consensus (11c)",,"Buy Rating Backed by Molbreevi’s Promising Trial Results and Market Potential for aPAP Treatment Evercore ISI Reaffirms Their Buy Rating on Savara (SVRA) Buy Rating Affirmed for Savara on Molbreevi’s Commercial Promise and Solid Financial Footing Savara reports Q2 EPS (12c), consensus (11c)",1,0,0,0,1,-1
80.03M,"534,667",-203.85M,-1,19,9.27,Strong Buy,27.00,"Aug 8, 2024",CRBP,"Corbus Pharmaceuticals Holdings, Inc.",719.02M,59.70,-,1.98%,7.65%,74.74%,-6.05%,+39.78%,Corbus Pharmaceuticals participates in a conference call with Truist,RBC Capital Remains a Buy on Corbus Pharmaceuticals (CRBP),Optimistic Outlook on Corbus Pharmaceuticals’ Oncology and Obesity Drug Candidates Supports Buy Rating,Corbus Pharmaceuticals Announces Board Changes and New Compensation Plans,Corbus Pharmaceuticals appoints Kung to board of directors,Corbus Pharmaceuticals participates in a conference call with Truist RBC Capital Remains a Buy on Corbus Pharmaceuticals (CRBP) Optimistic Outlook on Corbus Pharmaceuticals’ Oncology and Obesity Drug Candidates Supports Buy Rating Corbus Pharmaceuticals Announces Board Changes and New Compensation Plans Corbus Pharmaceuticals appoints Kung to board of directors,0,0,0,0,0,0
20.44M,"153,644",-54.11M,-1,844,36.26,Buy,39.00,"Aug 29, 2024",HBT,"HBT Financial, Inc.",717.34M,22.73,213.79M,3.87%,4.85%,11.89%,-3.87%,+16.68%,,,,,,,1,-1,-1,-1,-1,-1
44.85M,"209,649",85.76M,$0.20,832,16.52,Strong Buy,18.13,"Oct 16, 2024",IBCP,Independent Bank Corporation,717.17M,34.32,212.03M,3.98%,13.10%,30.99%,-1.99%,+39.34%,,,,,,,1,-1,-1,-1,-1,-1
35.57M,"117,281",47.40M,$0.30,709,20.78,Buy,29.00,"Aug 8, 2024",ADPT,Adaptive Biotechnologies Corporation,716.71M,4.86,168.77M,1.99%,14.12%,20.44%,-0.88%,+74.81%,Adaptive Biotechnologies announces IVDR certification for clonoSEQ in EU,Adaptive Announces IVDR Certification for clonoSEQ® in European Union,Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,,,Adaptive Biotechnologies announces IVDR certification for clonoSEQ in EU Adaptive Announces IVDR Certification for clonoSEQ® in European Union Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,0,0,0,0,-1,-1
20.01M,"96,176",9.65M,$0.24,278,36.83,Buy,56.00,"Jul 2, 2024",SEZL,Sezzle Inc.,716.38M,127.93,192.69M,22.61%,39.86%,128.87%,+48.61%,+91.24%,Sezzle Inc. (SEZL) Gets a Buy from Northland Securities,Analysts Offer Insights on Financial Companies: National Bank of Canada (OtherNTIOF) and Sezzle Inc. (SEZL),Sezzle enters five-year strategic partnership with WebBank,Sezzle price target raised to $150 from $119 at Northland,Sezzle Inc. Forges Strategic Alliance with WebBank for Financing Products,Sezzle Inc. (SEZL) Gets a Buy from Northland Securities Analysts Offer Insights on Financial Companies: National Bank of Canada (OtherNTIOF) and Sezzle Inc. (SEZL) Sezzle enters five-year strategic partnership with WebBank Sezzle price target raised to $150 from $119 at Northland Sezzle Inc. Forges Strategic Alliance with WebBank for Financing Products,1,0,1,1,0,1
11.27M,"103,842",25.99M,-1,268,65.36,Strong Buy,36.00,"Aug 6, 2024",WVE,Wave Life Sciences Ltd.,716.00M,5.74,110.50M,-3.30%,-1.27%,4.24%,-15.43%,-5.41%,Best payroll services for small business,Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE),"Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)",Wave Life Sciences Shareholders Approve Key Proposals at AGM,Wave Life Sciences receives FDA RPDD for WVE-N531,"Best payroll services for small business Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE) Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE) Wave Life Sciences Shareholders Approve Key Proposals at AGM Wave Life Sciences receives FDA RPDD for WVE-N531",0,0,0,0,0,0
52.65M,"206,460",-103.57M,-1,"17,000",13.99,Strong Buy,21.40,"Aug 7, 2024",SPTN,SpartanNash Company,715.06M,21.19,9.55B,4.60%,9.12%,3.18%,+1.99%,+13.91%,Cramer’s Lightning Round: Whirlpool is ‘too inconsistent’,"SpartanNash names Erin Storm as SVP, Chief Marketing Officer",SpartanNash Co (SPTN) Receives a Hold from BMO Capital,SpartanNash Announces Second Quarter Fiscal 2024 Results,"SpartanNash sees FY24 EPS $1.85-$2.10, consensus $2.02","Cramer’s Lightning Round: Whirlpool is ‘too inconsistent’ SpartanNash names Erin Storm as SVP, Chief Marketing Officer SpartanNash Co (SPTN) Receives a Hold from BMO Capital SpartanNash Announces Second Quarter Fiscal 2024 Results SpartanNash sees FY24 EPS $1.85-$2.10, consensus $2.02",1,0,1,1,0,0
62.92M,"11,493",-163.30M,-1,507,11.60,Strong Buy,36.50,"Sep 9, 2024",CCB,Coastal Financial Corporation,713.86M,53.05,271.68M,6.88%,9.60%,23.84%,-0.11%,+36.20%,,,,,,,1,-1,-1,-1,-1,-1
35.57M,8,47.40M,$0.30,"1,504",20.25,,,"Aug 8, 2024",TIPT,Tiptree Inc.,713.72M,19.40,1.91B,5.57%,11.07%,11.31%,-0.81%,+15.30%,,,,,,,1,-1,-1,-1,-1,-1
5.41M,"24,793",-250.31M,$0.64,29,135.84,Buy,120.00,"Aug 5, 2024",FUFU,BitFuFu Inc.,708.62M,4.35,423.70M,-2.73%,-7.86%,-36.54%,-4.66%,+4.12%,BitFuFu to Attend Upcoming Investor Conferences in September,BitFuFu Reports Unaudited Second Quarter 2024 Financial Results,BitFuFu reports Q2 EPS 1c vs. 3c last year,BitFuFu Achieves Solid Revenue Growth in Q2 2024,"BitFuFu Inc. to Report Second Quarter 2024 Unaudited Financial Results on August 20, 2024","BitFuFu to Attend Upcoming Investor Conferences in September BitFuFu Reports Unaudited Second Quarter 2024 Financial Results BitFuFu reports Q2 EPS 1c vs. 3c last year BitFuFu Achieves Solid Revenue Growth in Q2 2024 BitFuFu Inc. to Report Second Quarter 2024 Unaudited Financial Results on August 20, 2024",0,1,0,1,1,1
188.78M,"763,774",-77.09M,-1,86,3.890,Strong Buy,4.67,"Aug 1, 2024",ATEX,Anterix Inc.,708.28M,38.09,5.11M,-8.17%,-7.17%,2.29%,-13.16%,+5.68%,Anterix to Present at the 2024 Gateway Conference on September 4,,,,,Anterix to Present at the 2024 Gateway Conference on September 4,1,1,-1,-1,-1,-1
46.34M,"274,845",34.62M,-1,"2,387",15.84,,,"Sep 4, 2024",CRSR,"Corsair Gaming, Inc.",707.15M,6.79,1.38B,3.09%,-20.91%,-40.62%,-17.54%,-42.82%,,,,,,,0,-1,-1,-1,-1,-1
179.37M,"2,795,014",-82.09M,-1,680,4.090,Strong Buy,10.70,"Aug 8, 2024",ROOT,"Root, Inc.",704.40M,46.96,854.20M,-10.87%,-20.49%,14.61%,-30.47%,-49.48%,Root Insurance Partners with Goosehead Insurance to Simplify Insurance Sales for Independent Agents,Root teams with Goosehead to expedite sales for independent agents,Root price target lowered to $82 from $88 at Keefe Bruyette,KBW Reaffirms Their Buy Rating on Root (ROOT),TD Cowen Reaffirms Their Hold Rating on Root (ROOT),Root Insurance Partners with Goosehead Insurance to Simplify Insurance Sales for Independent Agents Root teams with Goosehead to expedite sales for independent agents Root price target lowered to $82 from $88 at Keefe Bruyette KBW Reaffirms Their Buy Rating on Root (ROOT) TD Cowen Reaffirms Their Hold Rating on Root (ROOT),1,1,1,1,1,1
115.77M,"170,409",30.23M,$0.12,"1,133",6.33,Hold,6.13,"Aug 6, 2024",GSBC,"Great Southern Bancorp, Inc.",703.00M,60.20,219.38M,3.46%,3.51%,9.10%,-5.03%,+13.73%,"Great Southern Bancorp, Inc. Announces Third Quarter 2024 Preliminary Earnings Release Date and Conference Call",,,,,"Great Southern Bancorp, Inc. Announces Third Quarter 2024 Preliminary Earnings Release Date and Conference Call",0,0,-1,-1,-1,-1
119.43M,"334,976",-160.93M,-1,281,6.10,Strong Buy,9.25,"Aug 7, 2024",DDI,"DoubleDown Interactive Co., Ltd.",698.70M,14.10,332.46M,13.27%,15.18%,30.03%,+16.40%,+45.85%,DoubleDown price target raised to $26 from $24 at B. Riley,Doubledown Interactive Co (DDI) Receives a Buy from Wedbush,DoubleDown price target raised to $16.25 from $14.75 at Wedbush,Closing Bell Movers: Rumble jumps 8% on earnings,DoubleDown Interactive Sees Strong Q2 Growth,DoubleDown price target raised to $26 from $24 at B. Riley Doubledown Interactive Co (DDI) Receives a Buy from Wedbush DoubleDown price target raised to $16.25 from $14.75 at Wedbush Closing Bell Movers: Rumble jumps 8% on earnings DoubleDown Interactive Sees Strong Q2 Growth,1,0,1,0,1,1
223.43M,"952,596",-79.24M,-1,109,3.250,Strong Buy,5.60,"Aug 7, 2024",ALMS,Alumis Inc.,694.19M,12.76,-,0.43%,1.45%,1.45%,+4.15%,,Alumis to Participate in Upcoming September Investor Conferences,Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements,,,,Alumis to Participate in Upcoming September Investor Conferences Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements,0,0,0,-1,-1,-1
34.99M,"126,595",-11.65M,-1,59,20.72,Hold,22.00,"Aug 1, 2024",ATXS,"Astria Therapeutics, Inc.",694.03M,12.30,-,11.31%,15.51%,21.12%,+3.25%,+7.01%,Evercore ISI Keeps Their Buy Rating on Astria Therapeutics (ATXS),Astria Therapeutics price target raised to $26 from $25 at Oppenheimer,Buy Rating Affirmed for Astria Therapeutics’ Navenibart on Novel Approach and Positive Trial Data,Buy Rating for Astria Therapeutics: Strong Financials and Promising Drug Pipeline,"Analysts’ Top Healthcare Picks: Adverum Biotechnologies (ADVM), Astria Therapeutics (ATXS)","Evercore ISI Keeps Their Buy Rating on Astria Therapeutics (ATXS) Astria Therapeutics price target raised to $26 from $25 at Oppenheimer Buy Rating Affirmed for Astria Therapeutics’ Navenibart on Novel Approach and Positive Trial Data Buy Rating for Astria Therapeutics: Strong Financials and Promising Drug Pipeline Analysts’ Top Healthcare Picks: Adverum Biotechnologies (ADVM), Astria Therapeutics (ATXS)",0,0,0,0,1,0
6.58M,"43,912",85.44M,$1.00,"1,516",109.84,,,"Aug 1, 2024",SCWX,SecureWorks Corp.,693.65M,7.85,357.14M,-1.30%,2.22%,10.98%,-5.84%,+14.72%,SecureWorks: Balancing Revenue Growth and Profitability Concerns,SecureWorks Struggles: Analyst Maintains Sell Rating Amidst Revenue Decline and Prolonged Transition,Barclays Keeps Their Sell Rating on SecureWorks (SCWX),Secureworks price target raised to $7 from $6 at Barclays,Needham Keeps Their Hold Rating on SecureWorks (SCWX),SecureWorks: Balancing Revenue Growth and Profitability Concerns SecureWorks Struggles: Analyst Maintains Sell Rating Amidst Revenue Decline and Prolonged Transition Barclays Keeps Their Sell Rating on SecureWorks (SCWX) Secureworks price target raised to $7 from $6 at Barclays Needham Keeps Their Hold Rating on SecureWorks (SCWX),1,1,1,1,0,0
30.30M,"114,558",-163.43M,-1,425,23.80,Hold,30.00,"Aug 2, 2024",ORRF,"Orrstown Financial Services, Inc.",693.48M,35.80,129.78M,6.06%,15.87%,29.34%,+1.25%,+38.95%,,,,,,,1,-1,-1,-1,-1,-1
27.65M,"125,583",34.75M,$0.44,331,26.04,Strong Buy,28.00,"Aug 6, 2024",REPL,"Replimune Group, Inc.",692.78M,10.14,-,0.20%,4.73%,19.70%,+3.00%,+39.95%,Replimune appoints Balachandran to board of directors,Replimune initiated with a Buy at Roth MKM,"Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)",Replimune announces first patient dosed in IGNYTE-3 trial,Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma,"Replimune appoints Balachandran to board of directors Replimune initiated with a Buy at Roth MKM Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK) Replimune announces first patient dosed in IGNYTE-3 trial Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma",1,1,1,0,0,0
164.60M,"505,183",-75.29M,-1,597,4.370,Strong Buy,12.00,"Aug 12, 2024",RVNC,"Revance Therapeutics, Inc.",691.83M,6.60,251.18M,28.96%,66.79%,29.28%,+74.07%,+49.21%,Biotech Alert: Searches spiking for these stocks today,Maintaining Hold on Revance Therapeutics Amid Merger Developments and Positive Sales Forecast,Analyst Holds on Revance-Crown Merger Amid Strategic Fit and Revenue Concerns,Revance downgraded to Neutral from Buy at H.C. Wainwright,Revance Therapeutics (RVNC) Gets a Buy from Barclays,Biotech Alert: Searches spiking for these stocks today Maintaining Hold on Revance Therapeutics Amid Merger Developments and Positive Sales Forecast Analyst Holds on Revance-Crown Merger Amid Strategic Fit and Revenue Concerns Revance downgraded to Neutral from Buy at H.C. Wainwright Revance Therapeutics (RVNC) Gets a Buy from Barclays,1,1,0,1,1,0
12.04M,"208,246",-34.97M,-1,344,59.70,Strong Buy,76.20,"Aug 6, 2024",SIBN,"SI-BONE, Inc.",690.04M,16.55,150.71M,12.92%,14.69%,-0.72%,+5.66%,+4.56%,SI-Bone management to meet with Piper Sandler,Buy Rating Justified: SI-Bone’s Growth Potential and Market Expansion Opportunities,"SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024","SI-Bone receives 510(k) clearance, BDD for iFuse TORQ TNT Implant System","SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System","SI-Bone management to meet with Piper Sandler Buy Rating Justified: SI-Bone’s Growth Potential and Market Expansion Opportunities SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024 SI-Bone receives 510(k) clearance, BDD for iFuse TORQ TNT Implant System SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System",0,0,0,0,0,0
31.56M,"37,230",71.47M,$0.76,876,22.73,Hold,24.00,"Oct 21, 2024",HBNC,"Horizon Bancorp, Inc.",689.78M,15.78,180.00M,5.79%,12.68%,22.91%,-0.13%,+34.15%,,,,,,,1,-1,-1,-1,-1,-1
20.90M,"80,606",65.81M,$0.96,380,34.32,Hold,32.17,"Oct 22, 2024",TVTX,"Travere Therapeutics, Inc.",686.89M,8.98,177.64M,2.40%,2.55%,15.54%,-5.35%,+28.27%,Upgraded Buy Rating and Target Price for Travere Therapeutics on Filspari’s Market Expansion and Approval,Travere Therapeutics price target raised to $23 from $14 at Citi,"Ligand, Travere Therapeutics receives full FDA approval for Filspari",Travere Therapeutics price target raised to $19 from $18 at BofA,Stifel Nicolaus Keeps Their Hold Rating on Travere Therapeutics (TVTX),"Upgraded Buy Rating and Target Price for Travere Therapeutics on Filspari’s Market Expansion and Approval Travere Therapeutics price target raised to $23 from $14 at Citi Ligand, Travere Therapeutics receives full FDA approval for Filspari Travere Therapeutics price target raised to $19 from $18 at BofA Stifel Nicolaus Keeps Their Hold Rating on Travere Therapeutics (TVTX)",1,0,0,0,0,1
147.47M,"731,577",-213.47M,-1,716,4.860,Buy,6.40,"Aug 1, 2024",LQDT,"Liquidity Services, Inc.",684.84M,22.43,336.35M,1.25%,5.91%,17.41%,-3.83%,+17.64%,"Liquidity Services selected to sell workover rigs, associated surplus assets",Major Oil and Gas Partner to Sell Drilling Rigs on AllSurplus Marketplace,Craig-Hallum Remains a Buy on Liquidity Services (LQDT),Oil and gas corporation to sell unused energy assets on AllSurplus Marketplace,Major Integrated Oil and Gas Corporation to Sell Unused Energy Assets on AllSurplus Marketplace,"Liquidity Services selected to sell workover rigs, associated surplus assets Major Oil and Gas Partner to Sell Drilling Rigs on AllSurplus Marketplace Craig-Hallum Remains a Buy on Liquidity Services (LQDT) Oil and gas corporation to sell unused energy assets on AllSurplus Marketplace Major Integrated Oil and Gas Corporation to Sell Unused Energy Assets on AllSurplus Marketplace",0,0,0,0,0,0
5.60M,"99,741",41.94M,-1,74,127.93,Strong Buy,163.00,"Aug 7, 2024",OLMA,"Olema Pharmaceuticals, Inc.",683.85M,11.95,-,-10.61%,-8.84%,-6.56%,-29.21%,+6.92%,Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference,,,,Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference,1,0,0,-1,-1,-1
124.74M,"301,693",-73.49M,-1,,5.74,Strong Buy,13.00,"Aug 8, 2024",CCAP,"Crescent Capital BDC, Inc.",680.45M,18.36,197.42M,0.89%,-1.90%,5.15%,-2.90%,+7.67%,Crescent Capital BDC price target lowered to $19 from $20 at BofA,Crescent Capital BDC: A Buy Rating Backed by Strong Performance and Resilient Credit Portfolio,Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP),KBW Sticks to Its Buy Rating for Crescent Capital BDC (CCAP),"Crescent Capital BDC reports Q2 EPS 59c, consensus 58c","Crescent Capital BDC price target lowered to $19 from $20 at BofA Crescent Capital BDC: A Buy Rating Backed by Strong Performance and Resilient Credit Portfolio Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP) KBW Sticks to Its Buy Rating for Crescent Capital BDC (CCAP) Crescent Capital BDC reports Q2 EPS 59c, consensus 58c",0,0,0,0,0,0
33.75M,"184,904",45.89M,$0.87,"1,509",21.19,Hold,20.00,"Aug 15, 2024",SWBI,"Smith & Wesson Brands, Inc.",678.45M,15.05,535.83M,-0.18%,0.20%,0.45%,-9.61%,-15.62%,Lake Street Remains a Buy on Smith & Wesson Brands (SWBI),"Options Volatility and Implied Earnings Moves Today, September 05, 2024",Craig-Hallum Remains a Buy on Smith & Wesson Brands (SWBI),SWBI Upcoming Earnings Report: What to Expect?,"Options Volatility and Implied Earnings Moves This Week, September 03 – September 05, 2024","Lake Street Remains a Buy on Smith & Wesson Brands (SWBI) Options Volatility and Implied Earnings Moves Today, September 05, 2024 Craig-Hallum Remains a Buy on Smith & Wesson Brands (SWBI) SWBI Upcoming Earnings Report: What to Expect? Options Volatility and Implied Earnings Moves This Week, September 03 – September 05, 2024",0,0,0,0,1,0
13.46M,"48,767",37.68M,-1,45,53.05,Strong Buy,53.00,"Jul 29, 2024",SIGA,"SIGA Technologies, Inc.",677.29M,9.49,172.96M,-1.36%,6.70%,34.30%,-7.72%,+1.43%,"Mpox case reported at Clark County Detention Center, LV Review-Journal says",Siga Technologies put volume heavy and directionally bearish,SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®,Siga Technologies announces new DOD contract for Tpoxx,Biotech Alert: Searches spiking for these stocks today,"Mpox case reported at Clark County Detention Center, LV Review-Journal says Siga Technologies put volume heavy and directionally bearish SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® Siga Technologies announces new DOD contract for Tpoxx Biotech Alert: Searches spiking for these stocks today",0,0,1,0,1,1
36.79M,"79,944",30.69M,$0.24,100,19.40,,,"Jul 31, 2024",ORIC,"ORIC Pharmaceuticals, Inc.",677.21M,9.60,-,3.98%,8.68%,1.54%,-9.20%,-7.29%,ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4),Oric Pharmaceuticals initiated with a Buy at Stifel,ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences,Optimistic Outlook on Oric Pharmaceuticals’ Cancer Therapy Pipeline and Strategic Partnerships,Buy Rating Affirmed for Oric Pharmaceuticals with Strong Cash Position and Promising Clinical Pipeline,ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Oric Pharmaceuticals initiated with a Buy at Stifel ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences Optimistic Outlook on Oric Pharmaceuticals’ Cancer Therapy Pipeline and Strategic Partnerships Buy Rating Affirmed for Oric Pharmaceuticals with Strong Cash Position and Promising Clinical Pipeline,1,0,1,0,1,1
162.90M,"55,045",39.31M,-1,210,4.350,,,"Aug 20, 2024",LPRO,Open Lending Corporation,676.16M,5.67,98.42M,2.42%,-0.61%,-11.59%,-12.22%,+0.55%,Open Lending price target lowered to $8 from $9 at DA Davidson,Open Lending to Attend the Canaccord Genuity 44th Annual Growth Conference,Northland Securities Reaffirms Their Buy Rating on Open Lending (LPRO),Open Lending: Hold Rating Amidst Market Challenges and Modest Recovery Prospects,Open Lending (LPRO) Gets a Buy from D.A. Davidson,Open Lending price target lowered to $8 from $9 at DA Davidson Open Lending to Attend the Canaccord Genuity 44th Annual Growth Conference Northland Securities Reaffirms Their Buy Rating on Open Lending (LPRO) Open Lending: Hold Rating Amidst Market Challenges and Modest Recovery Prospects Open Lending (LPRO) Gets a Buy from D.A. Davidson,0,0,1,0,1,0
18.59M,"145,211",-22.53M,-1,572,38.09,Strong Buy,68.00,"Aug 6, 2024",LEGH,Legacy Housing Corporation,673.64M,27.89,169.39M,0.27%,5.75%,12.89%,-6.25%,+26.30%,Legacy Housing price target raised to $29 from $25 at B. Riley,Legacy Housing (LEGH) Gets a Buy from Lake Street,Legacy Housing (LEGH) Receives a Rating Update from a Top Analyst,,,Legacy Housing price target raised to $29 from $25 at B. Riley Legacy Housing (LEGH) Gets a Buy from Lake Street Legacy Housing (LEGH) Receives a Rating Update from a Top Analyst,0,0,0,0,-1,-1
104.15M,"484,547",-38.98M,-1,360,6.79,Buy,11.00,"Aug 1, 2024",DJCO,Daily Journal Corporation,672.94M,488.55,71.61M,10.97%,15.85%,34.29%,+4.56%,+31.24%,"Daily Journal Corporation Announces Financial Results for the nine months ended June 30, 2024",,,,,"Daily Journal Corporation Announces Financial Results for the nine months ended June 30, 2024",0,0,-1,-1,-1,-1
15.00M,"134,357",-83.80M,-1,"3,049",46.96,Buy,56.33,"Aug 7, 2024",THRY,"Thryv Holdings, Inc.",672.70M,18.53,877.69M,5.97%,5.06%,-5.94%,-4.88%,-15.19%,,,,,,,0,-1,-1,-1,-1,-1
11.68M,"17,015",59.42M,$1.60,371,60.20,Hold,61.00,"Oct 16, 2024",CDMO,"Avid Bioservices, Inc.",672.69M,10.58,139.91M,-3.55%,12.34%,38.21%,-2.11%,+61.20%,Avid Bioservices (CDMO) Gets a Buy from Craig-Hallum,"Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024",Avid Bioservices Amends Deferred Compensation Plan,Craig-Hallum Releases a Buy Rating on Avid Bioservices (CDMO),,"Avid Bioservices (CDMO) Gets a Buy from Craig-Hallum Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 Avid Bioservices Amends Deferred Compensation Plan Craig-Hallum Releases a Buy Rating on Avid Bioservices (CDMO)",0,0,0,0,0,-1
49.55M,"70,097",115.87M,-1,,14.10,Strong Buy,21.13,"Aug 12, 2024",EU,enCore Energy Corp.,668.33M,3.61,35.71M,9.89%,-1.71%,-10.09%,-8.97%,-21.11%,enCore Energy Shareholders Approve Key Proposals,EnCore Energy price target lowered to $7 from $7.50 at H.C. Wainwright,"enCore Energy Expands Uranium Production, Boosts Revenue",enCore Energy Reports Asset Growth Amidst Financial Shifts,enCore Energy Provides Q2 2024 Results and Operational Update,"enCore Energy Shareholders Approve Key Proposals EnCore Energy price target lowered to $7 from $7.50 at H.C. Wainwright enCore Energy Expands Uranium Production, Boosts Revenue enCore Energy Reports Asset Growth Amidst Financial Shifts enCore Energy Provides Q2 2024 Results and Operational Update",0,1,0,1,1,0
54.40M,"220,155",-189.03M,-1,121,12.76,Strong Buy,32.33,"Aug 13, 2024",APLD,Applied Digital Corporation,666.81M,4.55,143.91M,13.48%,-8.04%,-0.64%,-9.26%,+47.99%,Unusually active option classes on open September 6th,Northland Securities Remains a Buy on Applied Digital Corporation (APLD),Buy Rating Affirmed for Applied Digital Corporation Amid Strategic Partnerships and Expansion Plans,"Nvidia backing ‘endorsement of Applied at the highest order,’ says Craig-Hallum",Nvidia (NVDA) Joins $160M Funding Round for Applied Digital in AI Push,"Unusually active option classes on open September 6th Northland Securities Remains a Buy on Applied Digital Corporation (APLD) Buy Rating Affirmed for Applied Digital Corporation Amid Strategic Partnerships and Expansion Plans Nvidia backing ‘endorsement of Applied at the highest order,’ says Craig-Hallum Nvidia (NVDA) Joins $160M Funding Round for Applied Digital in AI Push",0,0,0,0,0,0
56.43M,"209,301",-93.24M,-1,452,12.30,Strong Buy,26.00,"Aug 12, 2024",EGBN,"Eagle Bancorp, Inc.",666.62M,22.09,244.03M,8.20%,9.54%,-3.50%,+1.07%,-2.12%,"EagleBank Names Industry Veteran Evelyn Lee as Chief Lending Officer for C&I, Key Growth Area for EagleBank",Eagle Bancorp Announces Executive Leadership Transition,EagleBank Names New Chief Credit Officer,EagleBank names Kevin Geoghegan as Chief Credit Officer,,"EagleBank Names Industry Veteran Evelyn Lee as Chief Lending Officer for C&I, Key Growth Area for EagleBank Eagle Bancorp Announces Executive Leadership Transition EagleBank Names New Chief Credit Officer EagleBank names Kevin Geoghegan as Chief Credit Officer",1,1,0,1,1,-1
88.36M,"25,174",-91.15M,-1,25,7.85,Hold,7.13,"Sep 5, 2024",APLT,"Applied Therapeutics, Inc.",662.66M,5.77,-333.00K,3.71%,14.87%,39.03%,+5.56%,+8.48%,Applied Therapeutics to Participate in Upcoming Investor Conferences,Applied Therapeutics price target raised to $8 from $7 at Citi,,,,Applied Therapeutics to Participate in Upcoming Investor Conferences Applied Therapeutics price target raised to $8 from $7 at Citi,0,0,0,-1,-1,-1
19.37M,"68,734",32.94M,$0.92,285,35.80,Strong Buy,32.00,"Oct 22, 2024",LXRX,"Lexicon Pharmaceuticals, Inc.",661.53M,1.83,3.64M,-2.16%,-6.54%,-4.93%,-23.56%,-16.50%,Lexicon Pharmaceuticals to Participate in Upcoming September Investor Conferences,Buy Rating Affirmed for Lexicon Pharmaceuticals on Promising INPEFA Heart Failure Treatment Data,Lexicon:INPEFA benefited heart failure patients regardless of diabetes duration,Biotech Alert: Searches spiking for these stocks today,Buy Rating for Lexicon Pharmaceuticals Amid Positive Regulatory and Clinical Developments for ZYNQUISTA,Lexicon Pharmaceuticals to Participate in Upcoming September Investor Conferences Buy Rating Affirmed for Lexicon Pharmaceuticals on Promising INPEFA Heart Failure Treatment Data Lexicon:INPEFA benefited heart failure patients regardless of diabetes duration Biotech Alert: Searches spiking for these stocks today Buy Rating for Lexicon Pharmaceuticals Amid Positive Regulatory and Clinical Developments for ZYNQUISTA,1,0,0,1,1,0
68.32M,"268,794",-220.01M,-1,,10.14,Strong Buy,25.00,"Aug 8, 2024",FDUS,Fidus Investment Corporation,660.90M,19.93,140.81M,2.31%,2.17%,2.96%,+1.64%,+1.53%,,,,,,,0,-1,-1,-1,-1,-1
104.82M,"2,396,524",-287.50M,-1,"1,634",6.60,Buy,12.33,"Aug 8, 2024",OFIX,Orthofix Medical Inc.,660.04M,17.29,771.65M,7.50%,15.05%,26.69%,+7.28%,+21.22%,Levi & Korsinsky LLP Notifies Orthofix Medical Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – OFIX,,,,,Levi & Korsinsky LLP Notifies Orthofix Medical Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – OFIX,0,0,-1,-1,-1,-1
41.69M,"314,210",-40.85M,-1,292,16.55,Strong Buy,23.43,"Aug 5, 2024",NCMI,"National CineMedia, Inc.",658.20M,6.91,207.60M,9.82%,27.70%,46.93%,+12.91%,+27.48%,"National Cinemedia Boosts CFO Compensation, Extends Tenure",Strong Buy Rating for National Cinemedia on Exclusive Advertising Agreements and Growth Prospects,Benchmark upgrades National CineMedia to Buy on growth optimism,National CineMedia upgraded to Buy from Speculative Buy at Benchmark,,"National Cinemedia Boosts CFO Compensation, Extends Tenure Strong Buy Rating for National Cinemedia on Exclusive Advertising Agreements and Growth Prospects Benchmark upgrades National CineMedia to Buy on growth optimism National CineMedia upgraded to Buy from Speculative Buy at Benchmark",1,1,1,1,1,-1
43.71M,"106,856",19.12M,$0.64,808,15.78,Hold,15.33,"Jul 24, 2024",TRST,TrustCo Bank Corp NY,654.72M,34.44,172.19M,2.28%,8.44%,17.15%,-3.43%,+27.46%,"Rendering Speculation Unnecessary, TrustCo Delivers Again With a Quarterly Dividend of $0.36 Per Share",,,,,"Rendering Speculation Unnecessary, TrustCo Delivers Again With a Quarterly Dividend of $0.36 Per Share",0,1,-1,-1,-1,-1
76.49M,"536,536",-145.91M,-1,703,8.98,Buy,15.08,"Aug 1, 2024",SMBC,"Southern Missouri Bancorp, Inc.",654.56M,58.04,163.14M,7.46%,16.89%,25.28%,-0.96%,+34.98%,Southern Missouri Bancorp initiated with an Overweight at Stephens,,,,,Southern Missouri Bancorp initiated with an Overweight at Stephens,0,1,-1,-1,-1,-1
30.53M,"99,236",19.90M,-1,712,22.43,Buy,27.00,"Aug 8, 2024",PCRX,"Pacira BioSciences, Inc.",654.54M,14.19,690.31M,-11.76%,-29.95%,-47.10%,-27.85%,-47.09%,Largest borrow rate increases among liquid names,Buy/Sell: Wall Street’s top 10 stock calls this week,"Warner Bros. downgraded, Starbucks upgraded: Wall Street’s top analyst calls",Pacira downgraded to Sell from Buy at Truist,"Analysts Are Bullish on Top Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Iovance Biotherapeutics (IOVA)","Largest borrow rate increases among liquid names Buy/Sell: Wall Street’s top 10 stock calls this week Warner Bros. downgraded, Starbucks upgraded: Wall Street’s top analyst calls Pacira downgraded to Sell from Buy at Truist Analysts Are Bullish on Top Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Iovance Biotherapeutics (IOVA)",0,1,0,1,0,1
57.23M,"452,627",-109.63M,-1,"7,500",11.95,Strong Buy,27.00,"Aug 6, 2024",EZPW,"EZCORP, Inc.",648.67M,11.85,1.14B,3.72%,10.59%,17.42%,+12.86%,+10.53%,EZCORP Poised for Growth Amidst Economic Pressures and Strategic Latin American Expansion,,,,,EZCORP Poised for Growth Amidst Economic Pressures and Strategic Latin American Expansion,0,1,-1,-1,-1,-1
37.06M,"165,704",101.87M,$1.86,970,18.36,Buy,18.80,"Aug 12, 2024",BVS,Bioventus Inc.,646.65M,9.92,536.89M,20.37%,36.90%,75.61%,+38.23%,+91.50%,Bioventus price target raised to $12 from $8 at Canaccord,,,,,Bioventus price target raised to $12 from $8 at Canaccord,0,0,-1,-1,-1,-1
,,,-1,55,,,,,CELC,Celcuity Inc.,642.47M,17.35,-,0.59%,-0.25%,5.20%,-9.49%,-16.93%,Celcuity files $400M mixed securities shelf,Celcuity initiated with an Outperform at LifeSci Capital,Gedatolisib’s Market Potential: A Buy Rating with Optimistic Trial Outcome Projections,Buy Rating Affirmed: Optimism for Celcuity’s Pipeline and Financial Stability Amid Clinical Trial Progress,Stifel Nicolaus Remains a Buy on Celcuity (CELC),Celcuity files $400M mixed securities shelf Celcuity initiated with an Outperform at LifeSci Capital Gedatolisib’s Market Potential: A Buy Rating with Optimistic Trial Outcome Projections Buy Rating Affirmed: Optimism for Celcuity’s Pipeline and Financial Stability Amid Clinical Trial Progress Stifel Nicolaus Remains a Buy on Celcuity (CELC),1,0,0,0,1,1
45.08M,"317,430",39.61M,$0.52,"2,872",15.05,Strong Buy,18.00,"Sep 5, 2024",WRLD,World Acceptance Corporation,642.37M,117.07,563.21M,7.96%,-1.53%,-5.88%,-1.28%,-13.47%,Short Report: Bearish positioning in Oddity Tech at record high,,,,,Short Report: Bearish positioning in Oddity Tech at record high,1,1,-1,-1,-1,-1
71.37M,"887,809",83.97M,$0.60,293,9.49,,,"Aug 1, 2024",EVLV,"Evolv Technologies Holdings, Inc.",641.23M,4.07,89.22M,21.72%,35.08%,7.50%,+17.29%,-12.10%,Northland Securities Sticks to Their Buy Rating for Evolv Technologies Holdings (EVLV),Craig-Hallum Sticks to Their Buy Rating for Evolv Technologies Holdings (EVLV),Craig-Hallum Sticks to Its Buy Rating for Evolv Technologies Holdings (EVLV),Evolv Technologies Holdings (EVLV) Gets a Hold from Lake Street,Evolv issued patent by USPTO for Evolv Express,Northland Securities Sticks to Their Buy Rating for Evolv Technologies Holdings (EVLV) Craig-Hallum Sticks to Their Buy Rating for Evolv Technologies Holdings (EVLV) Craig-Hallum Sticks to Its Buy Rating for Evolv Technologies Holdings (EVLV) Evolv Technologies Holdings (EVLV) Gets a Hold from Lake Street Evolv issued patent by USPTO for Evolv Express,1,0,0,0,1,0
70.54M,"343,907",-110.78M,-1,"7,400",9.60,Strong Buy,20.00,"Aug 12, 2024",CHUY,"Chuy's Holdings, Inc.",640.97M,37.20,460.07M,0.21%,16.94%,14.22%,+0.16%,+14.87%,"Chuy’s Holdings, Inc. Announces Record Date and Special Meeting of Stockholders",Chuy’s downgraded to Hold from Buy at Benchmark,Analysts Offer Insights on Consumer Cyclical Companies: Chuy’s Holdings (CHUY) and Savers Value Village Inc. (SVV),,,"Chuy’s Holdings, Inc. Announces Record Date and Special Meeting of Stockholders Chuy’s downgraded to Hold from Buy at Benchmark Analysts Offer Insights on Consumer Cyclical Companies: Chuy’s Holdings (CHUY) and Savers Value Village Inc. (SVV)",1,0,1,1,-1,-1
119.25M,"306,258",6.15M,-1,157,5.67,Buy,6.80,"Aug 8, 2024",ITOS,"iTeos Therapeutics, Inc.",638.40M,17.48,35.00M,6.98%,9.23%,34.73%,-2.50%,+38.75%,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly",iTeos to Participate in Upcoming Investor Conferences,iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024,J.P. Morgan Sticks to Its Buy Rating for iTeos Therapeutics (ITOS),iTeos Therapeutics initiated with an Overweight at Wells Fargo,"Tuesday’s top analyst calls: Netflix, Lyft, Amazon, CrowdStrike, Dell, Disney, Eli Lilly iTeos to Participate in Upcoming Investor Conferences iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024 J.P. Morgan Sticks to Its Buy Rating for iTeos Therapeutics (ITOS) iTeos Therapeutics initiated with an Overweight at Wells Fargo",0,1,0,0,0,1
24.15M,"65,192",54.49M,-1,185,27.89,Buy,29.00,"Aug 8, 2024",FSBC,Five Star Bancorp,635.54M,29.81,111.97M,5.62%,11.76%,22.03%,-0.44%,+33.05%,Five Star Bancorp Expands with New San Francisco Office,"Five Star Bancorp opens San Francisco office, bringing personalized, concierge banking services to the San Francisco Bay Area",,,,"Five Star Bancorp Expands with New San Francisco Office Five Star Bancorp opens San Francisco office, bringing personalized, concierge banking services to the San Francisco Bay Area",1,0,0,-1,-1,-1
1.38M,"26,311",44.90M,-1,151,488.55,,,"Aug 14, 2024",MNTK,"Montauk Renewables, Inc.",628.79M,4.42,184.62M,-6.93%,-13.72%,-24.98%,-25.76%,+1.38%,Opal Fuels downgraded at Scotiabank on limited near-term RNG catalysts,Montauk Renewables downgraded to Sector Perform from Outperform at Scotiabank,"Analysts Offer Insights on Utilities Companies: Montauk Renewables (MNTK), Otter Tail (OTTR) and Enel Chile SA (ENIC)",,,"Opal Fuels downgraded at Scotiabank on limited near-term RNG catalysts Montauk Renewables downgraded to Sector Perform from Outperform at Scotiabank Analysts Offer Insights on Utilities Companies: Montauk Renewables (MNTK), Otter Tail (OTTR) and Enel Chile SA (ENIC)",1,1,1,1,-1,-1
36.30M,"93,081",-270.62M,-1,"1,109",18.53,Strong Buy,28.00,"Aug 1, 2024",TIGR,UP Fintech Holding Limited,627.91M,4.02,231.79M,1.35%,-6.87%,-5.10%,-9.56%,+10.15%,UP Fintech price target lowered to $5 from $6.49 at Citi,Buy Rating Affirmed for Up Fintech Holding Amid Strong Core Performance and Growth Potential,Buy Rating Affirmed for Up Fintech Holding Amidst Client Growth and Strategic Global Expansion,"Options Volatility and Implied Earnings Moves Today, August 30, 2024",UP Fintech Reports Record Revenue and Growth,"UP Fintech price target lowered to $5 from $6.49 at Citi Buy Rating Affirmed for Up Fintech Holding Amid Strong Core Performance and Growth Potential Buy Rating Affirmed for Up Fintech Holding Amidst Client Growth and Strategic Global Expansion Options Volatility and Implied Earnings Moves Today, August 30, 2024 UP Fintech Reports Record Revenue and Growth",1,1,1,1,0,1
63.58M,"375,029",-140.75M,-1,,10.58,Buy,12.50,"Oct 5, 2024",GOOD,Gladstone Commercial Corporation,627.79M,14.76,145.15M,3.44%,4.69%,11.58%,+1.00%,+15.59%,"Gladstone Commercial acquires industrial facility in Midland, Texas",Gladstone Commercial Welcomes Katharine Gorka to Board,Gladstone Commercial executes five-year lease renewal at Ohio property,,,"Gladstone Commercial acquires industrial facility in Midland, Texas Gladstone Commercial Welcomes Katharine Gorka to Board Gladstone Commercial executes five-year lease renewal at Ohio property",1,1,1,1,-1,-1
181.73M,"1,974,030",-20.87M,-1,239,3.610,Strong Buy,6.50,"Aug 14, 2024",ADSE,ADS-TEC Energy PLC,627.76M,12.41,118.70M,-2.72%,0.55%,25.63%,-0.08%,+22.02%,ADS-TEC Energy Announces Upcoming AGM,,,,,ADS-TEC Energy Announces Upcoming AGM,0,1,-1,-1,-1,-1
,,,-1,389,,,,,BIOX,Bioceres Crop Solutions Corp.,625.31M,9.95,445.59M,-0.98%,-5.50%,-16.37%,unch,-12.25%,Bioceres Crop Solutions (BIOX) Q4 Earnings Cheat Sheet,Roth MKM Remains a Buy on Bioceres Crop Solutions (BIOX),Optimistic Outlook for Bioceres Crop Solutions Following USDA Approval of HB4 Trait,"Analysts Offer Insights on Materials Companies: Bioceres Crop Solutions (BIOX), Newmont Mining (NEM) and Barrick Gold (GOLD)",Bioceres HB4 Wheat Wins USDA Approval,"Bioceres Crop Solutions (BIOX) Q4 Earnings Cheat Sheet Roth MKM Remains a Buy on Bioceres Crop Solutions (BIOX) Optimistic Outlook for Bioceres Crop Solutions Following USDA Approval of HB4 Trait Analysts Offer Insights on Materials Companies: Bioceres Crop Solutions (BIOX), Newmont Mining (NEM) and Barrick Gold (GOLD) Bioceres HB4 Wheat Wins USDA Approval",0,0,0,0,0,0
146.55M,"3,863,752",-91.30M,-1,"2,364",4.550,Strong Buy,9.67,"Oct 7, 2024",CRESY,"Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria",625.30M,7.75,248.05M,0.12%,-2.28%,-7.45%,+0.52%,-19.58%,Cresud Announces Upcoming Notes Payment,Cresud Sociedad Reports Mixed Fiscal Year Results,Cresud price target raised to $13 from $10.50 at Jefferies,Cresud Announces Upcoming Interest Payment,,Cresud Announces Upcoming Notes Payment Cresud Sociedad Reports Mixed Fiscal Year Results Cresud price target raised to $13 from $10.50 at Jefferies Cresud Announces Upcoming Interest Payment,1,0,1,0,1,-1
30.18M,"218,368",-36.53M,$1.80,71,22.09,Hold,22.50,"Jul 24, 2024",ANNX,"Annexon, Inc.",622.30M,5.89,-,3.60%,8.75%,24.42%,-7.33%,-4.04%,"Annexon appoints Shikhar Agarwal as SVP, head of commercial","Analysts Are Bullish on Top Healthcare Stocks: GeoVax Labs (GOVX), Rohto Pharmaceutical Co (RPHCF)",Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4),Buy Rating Affirmed for Annexon Biosciences Amid Promising Clinical Trial Results,Buy Rating Justified: Undervalued Annexon Biosciences Poised for Growth with Positive Clinical Trials and Strong Cash Position,"Annexon appoints Shikhar Agarwal as SVP, head of commercial Analysts Are Bullish on Top Healthcare Stocks: GeoVax Labs (GOVX), Rohto Pharmaceutical Co (RPHCF) Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Buy Rating Affirmed for Annexon Biosciences Amid Promising Clinical Trial Results Buy Rating Justified: Undervalued Annexon Biosciences Poised for Growth with Positive Clinical Trials and Strong Cash Position",1,1,1,0,0,1
114.85M,"759,660",-161.09M,-1,224,5.77,Strong Buy,11.00,"Aug 7, 2024",IGMS,"IGM Biosciences, Inc.",619.88M,10.45,2.91M,7.08%,13.34%,10.02%,-10.66%,+13.81%,IGM Biosciences: Hold Rating Affirmed Amid Financial Challenges and Clinical Catalysts,IGM Biosciences price target lowered to $11 from $12 at H.C. Wainwright,Truist Financial Reaffirms Their Buy Rating on IGM Biosciences (IGMS),IGM Biosciences price target lowered to $24 from $25 at Truist,Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS),IGM Biosciences: Hold Rating Affirmed Amid Financial Challenges and Clinical Catalysts IGM Biosciences price target lowered to $11 from $12 at H.C. Wainwright Truist Financial Reaffirms Their Buy Rating on IGM Biosciences (IGMS) IGM Biosciences price target lowered to $24 from $25 at Truist Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS),0,1,0,0,0,0
361.49M,"2,300,285",-202.11M,-1,768,1.830,Buy,10.00,"Aug 1, 2024",SEAT,Vivid Seats Inc.,619.73M,4.70,775.60M,9.26%,-5.17%,-19.29%,-6.56%,-19.58%,Vivid Seats’ Game Center Debuts “Leagues” for NFL Season,Vivid Seats’ Game Center debuts ‘Leagues’ for NFL Season,Vivid Seats announces an exclusive multiyear media partnership with IAA,Vivid Seats Announces Exclusive Multiyear Media Partnership with I Am Athlete,Vivid Seats Releases 2024 NFL Fan Loyalty Report,Vivid Seats’ Game Center Debuts “Leagues” for NFL Season Vivid Seats’ Game Center debuts ‘Leagues’ for NFL Season Vivid Seats announces an exclusive multiyear media partnership with IAA Vivid Seats Announces Exclusive Multiyear Media Partnership with I Am Athlete Vivid Seats Releases 2024 NFL Fan Loyalty Report,0,0,0,0,0,0
33.16M,"107,487",94.95M,$2.46,565,19.93,Hold,22.00,"Aug 1, 2024",HTBI,"HomeTrust Bancshares, Inc.",619.45M,35.69,187.18M,5.96%,10.96%,29.18%,+1.16%,+40.43%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,811,,,,,METC,"Ramaco Resources, Inc.",618.88M,11.80,717.69M,-2.32%,-7.77%,-23.54%,-10.37%,-23.24%,Ramaco Resources price target lowered to $208 from $219 at B. Riley,Benchmark Co. Gives a Buy Rating to Ramaco Resources (METC),Ramaco Resources management to meet virtually with Benchmark,Ramaco Resources management to meet with B. Riley,Benchmark Co. Sticks to Their Buy Rating for Ramaco Resources (METC),Ramaco Resources price target lowered to $208 from $219 at B. Riley Benchmark Co. Gives a Buy Rating to Ramaco Resources (METC) Ramaco Resources management to meet virtually with Benchmark Ramaco Resources management to meet with B. Riley Benchmark Co. Sticks to Their Buy Rating for Ramaco Resources (METC),1,1,1,1,1,1
38.17M,"152,353",-120.49M,-1,,17.29,Buy,18.00,"Aug 6, 2024",LENZ,"LENZ Therapeutics, Inc.",618.67M,22.50,-,-5.39%,3.67%,34.72%,-10.99%,+8.71%,LENZ Therapeutics to Participate in Upcoming Investor Conferences,Buy Rating Reaffirmed for LENZ Therapeutics Amidst Strong Market Potential and Positive Product Data,Buy Rating for LENZ Therapeutics on Promising Presbyopia Treatment and Market Potential,"Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Afya (AFYA) and LENZ Therapeutics (LENZ)","Lenz Therapeutics reports Q2 EPS (40c), consensus (48c)","LENZ Therapeutics to Participate in Upcoming Investor Conferences Buy Rating Reaffirmed for LENZ Therapeutics Amidst Strong Market Potential and Positive Product Data Buy Rating for LENZ Therapeutics on Promising Presbyopia Treatment and Market Potential Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Afya (AFYA) and LENZ Therapeutics (LENZ) Lenz Therapeutics reports Q2 EPS (40c), consensus (48c)",0,0,0,0,0,1
95.32M,"283,129",162.00M,-1,770,6.91,Strong Buy,6.94,"Aug 5, 2024",BFST,"Business First Bancshares, Inc.",615.62M,24.14,247.78M,5.86%,7.25%,9.73%,-4.48%,+16.34%,Business First Bancshares gets regulatory approval for Oakwood Bancshares merger,"Business First Bancshares, Inc. Receives Regulatory Approval of its Merger with Oakwood Bancshares, Inc.","Business First Bancshares, Inc. announces the appointment of Zeenat Sidi to its Board of Directors",,,"Business First Bancshares gets regulatory approval for Oakwood Bancshares merger Business First Bancshares, Inc. Receives Regulatory Approval of its Merger with Oakwood Bancshares, Inc. Business First Bancshares, Inc. announces the appointment of Zeenat Sidi to its Board of Directors",1,0,0,0,-1,-1
19.01M,"71,687",49.21M,$1.44,349,34.44,,,"Jul 22, 2024",HTBK,Heritage Commerce Corp,615.40M,10.04,174.59M,2.59%,7.51%,13.97%,-1.93%,+24.85%,Ranson W. Webster to Retire from Heritage Commerce Corp Board of Directors and Julianne M. Biagini-Komas to be named Vice Chair of Board,,,,,Ranson W. Webster to Retire from Heritage Commerce Corp Board of Directors and Julianne M. Biagini-Komas to be named Vice Chair of Board,1,1,-1,-1,-1,-1
11.28M,"33,092",51.95M,$0.92,248,58.04,Hold,51.00,"Jul 29, 2024",DMRC,Digimarc Corporation,615.34M,28.81,38.60M,-1.59%,-6.76%,-8.96%,-15.29%,+10.66%,Craig-Hallum Reaffirms Their Hold Rating on Digimarc (DMRC),Digimarc (DMRC) Receives a Hold from Craig-Hallum,Buy Rating Affirmed for Digimarc Amidst Consistent Performance and Strategic Advancements,"Digimarc reports Q2 EPS (43c), two estimates (27c)",,"Craig-Hallum Reaffirms Their Hold Rating on Digimarc (DMRC) Digimarc (DMRC) Receives a Hold from Craig-Hallum Buy Rating Affirmed for Digimarc Amidst Consistent Performance and Strategic Advancements Digimarc reports Q2 EPS (43c), two estimates (27c)",0,0,0,0,0,-1
46.13M,"985,128",63.59M,-1,100,14.19,Buy,28.22,"Jul 30, 2024",YMAB,"Y-mAbs Therapeutics, Inc.",612.39M,13.74,86.55M,25.40%,25.80%,27.70%,+25.33%,+6.43%,"Y-mAbs Therapeutics announces new data on naxitamab, GD2-SADA",Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research,Y-mAbs to Participate in Upcoming Investor Conferences in September,"Cisco, Nike upgrades among today’s top calls on Wall Street",Cantor starts Y-mAbs with Overweight on pivot to radiopharmaceuticals,"Y-mAbs Therapeutics announces new data on naxitamab, GD2-SADA Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research Y-mAbs to Participate in Upcoming Investor Conferences in September Cisco, Nike upgrades among today’s top calls on Wall Street Cantor starts Y-mAbs with Overweight on pivot to radiopharmaceuticals",1,1,1,0,1,1
54.74M,"261,969",78.15M,-1,811,11.85,Strong Buy,17.00,"Jul 31, 2024",METCB,"Ramaco Resources, Inc.",612.08M,11.02,717.69M,,25.80%,27.70%,-5.13%,-8.80%,Ramaco Resources price target lowered to $208 from $219 at B. Riley,Benchmark Co. Gives a Buy Rating to Ramaco Resources (METC),Ramaco Resources management to meet virtually with Benchmark,Ramaco Resources management to meet with B. Riley,Benchmark Co. Sticks to Their Buy Rating for Ramaco Resources (METC),Ramaco Resources price target lowered to $208 from $219 at B. Riley Benchmark Co. Gives a Buy Rating to Ramaco Resources (METC) Ramaco Resources management to meet virtually with Benchmark Ramaco Resources management to meet with B. Riley Benchmark Co. Sticks to Their Buy Rating for Ramaco Resources (METC),1,1,1,1,1,1
65.19M,"448,116",-41.96M,-1,676,9.92,Strong Buy,12.00,"Aug 6, 2024",OSPN,OneSpan Inc.,610.48M,16.12,247.53M,2.64%,11.98%,34.26%,+6.28%,+37.86%,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more",OneSpan initiated with a Buy at Rosenblatt,,,,"Here are Friday’s biggest analyst calls: Nvidia, Nio, Apple, Tesla and more OneSpan initiated with a Buy at Rosenblatt",1,1,1,-1,-1,-1
37.03M,"256,786",-82.59M,-1,621,17.35,Strong Buy,28.67,"Aug 14, 2024",HAFC,Hanmi Financial Corporation,610.46M,20.30,237.49M,3.33%,8.55%,16.29%,-3.87%,+29.27%,,,,,,,0,-1,-1,-1,-1,-1
5.49M,"40,960",77.75M,-1,367,117.07,Sell,56.00,"Oct 18, 2024",GLDD,Great Lakes Dredge & Dock Corporation,609.40M,9.07,667.66M,13.69%,13.72%,23.12%,+5.51%,+19.88%,Great Lakes Receives S&P Global Ratings Upgrade to B-,Noble Financial Reaffirms Their Buy Rating on Great Lakes Dredge & Dock (GLDD),Great Lakes Dredge announces receipt of $256.2M in awarded work,Great Lakes Announces Receipt of $256.2 Million in Awarded Work,,Great Lakes Receives S&P Global Ratings Upgrade to B- Noble Financial Reaffirms Their Buy Rating on Great Lakes Dredge & Dock (GLDD) Great Lakes Dredge announces receipt of $256.2M in awarded work Great Lakes Announces Receipt of $256.2 Million in Awarded Work,1,0,0,1,1,-1
157.55M,"2,012,274",-19.07M,-1,"4,200",4.070,Strong Buy,5.75,"Aug 8, 2024",FLWS,"1-800-FLOWERS.COM, Inc.",608.71M,9.48,1.87B,-2.33%,-4.27%,-6.18%,-13.13%,-3.85%,Noble Financial Remains a Buy on 1-800 Flowers (FLWS),"Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls",Noble Financial Reaffirms Their Buy Rating on 1-800 Flowers (FLWS),1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson,1-800 Flowers Announces CFO Retirement and Successor Appointment,"Noble Financial Remains a Buy on 1-800 Flowers (FLWS) Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls Noble Financial Reaffirms Their Buy Rating on 1-800 Flowers (FLWS) 1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson 1-800 Flowers Announces CFO Retirement and Successor Appointment",1,0,1,0,0,1
17.23M,"256,451",26.88M,-1,"3,520",37.20,Hold,33.67,"Aug 9, 2024",PLPC,Preformed Line Products Company,606.29M,123.39,585.67M,-0.88%,-2.72%,-5.65%,-13.33%,-6.06%,,,,,,,1,-1,-1,-1,-1,-1
36.52M,"223,262",-108.14M,-1,79,17.48,Strong Buy,32.60,"Aug 8, 2024",NYMT,"New York Mortgage Trust, Inc.",602.35M,6.65,151.83M,4.55%,5.16%,-7.66%,+2.16%,-7.15%,"Lightning Round: Hold onto or buy more IBM, says Jim Cramer",Cramer’s Lightning Round: IBM is a buy,Janney starts New York Mortgage with Neutral on lack of catalysts,New York Mortgage initiated with a Neutral at Janney Montgomery Scott,,"Lightning Round: Hold onto or buy more IBM, says Jim Cramer Cramer’s Lightning Round: IBM is a buy Janney starts New York Mortgage with Neutral on lack of catalysts New York Mortgage initiated with a Neutral at Janney Montgomery Scott",1,0,0,1,1,-1
21.32M,"30,841",43.26M,$0.80,344,29.81,Buy,32.33,"Jul 24, 2024",RGNX,REGENXBIO Inc.,599.50M,12.13,89.04M,-6.75%,-6.10%,-28.60%,-17.47%,-38.65%,Positive Clinical Trials and Regulatory Milestones Bolster Buy Rating for RegenXBio,Regenxbio’s RGX-121 shows efficacy in Phase 1/2/3 Hunter syndrome trial,,,,Positive Clinical Trials and Regulatory Milestones Bolster Buy Rating for RegenXBio Regenxbio’s RGX-121 shows efficacy in Phase 1/2/3 Hunter syndrome trial,0,1,1,-1,-1,-1
142.26M,"164,045",18.87M,-1,49,4.420,Buy,7.00,"Aug 8, 2024",GHRS,GH Research PLC,597.28M,11.48,-,3.35%,-1.23%,17.72%,-11.29%,-1.26%,Understanding Incomplete Data: A Call for Comprehensive Analyst Reports,Maintaining Buy Rating on GH Research Amidst CEO Transition and Promising GH001 Trials,GH Research to Connect at Global Healthcare Conference,Buy Rating Affirmed for GH Research Amid Anticipated Clinical Advances and Strong Leadership,GH Research Reports Increased Operational Loss,Understanding Incomplete Data: A Call for Comprehensive Analyst Reports Maintaining Buy Rating on GH Research Amidst CEO Transition and Promising GH001 Trials GH Research to Connect at Global Healthcare Conference Buy Rating Affirmed for GH Research Amid Anticipated Clinical Advances and Strong Leadership GH Research Reports Increased Operational Loss,1,1,0,1,1,1
156.20M,"516,381",36.93M,-1,201,4.020,Strong Buy,6.22,"Aug 30, 2024",URGN,UroGen Pharma Ltd.,596.34M,14.16,85.01M,-4.99%,-10.80%,-5.15%,-14.41%,+3.53%,"Analysts Are Bullish on These Healthcare Stocks: Skye Bioscience (SKYE), Urogen Pharma (URGN)",UroGen Pharma completes NDA submission for UGN-102,Buy Rating Affirmed for UroGen Pharma on Strong UGN-102 Prospects and Solid Market Expansion Potential,Assessing Urogen Pharma’s Market Prospects: A Hold Rating Amidst Jelmyto’s Static Sales and UGN-102’s Regulatory Journey,TD Cowen Sticks to Their Buy Rating for Urogen Pharma (URGN),"Analysts Are Bullish on These Healthcare Stocks: Skye Bioscience (SKYE), Urogen Pharma (URGN) UroGen Pharma completes NDA submission for UGN-102 Buy Rating Affirmed for UroGen Pharma on Strong UGN-102 Prospects and Solid Market Expansion Potential Assessing Urogen Pharma’s Market Prospects: A Hold Rating Amidst Jelmyto’s Static Sales and UGN-102’s Regulatory Journey TD Cowen Sticks to Their Buy Rating for Urogen Pharma (URGN)",0,0,0,0,0,0
42.53M,"297,606",-1.41M,$1.20,180,14.76,Strong Buy,15.50,"Aug 6, 2024",ARCT,Arcturus Therapeutics Holdings Inc.,594.66M,21.99,163.87M,0.12%,-9.58%,-29.65%,-11.17%,-34.81%,Buy Rating Affirmed: Arcturus Therapeutics’ Promising Cystic Fibrosis Program Progress,Biotech Alert: Searches spiking for these stocks today,Arcturus Therapeutics Releases Updated Corporate Presentation,Wall Street Analysts Are Bullish on Top Healthcare Picks,Arcturus Therapeutics: A Strong Buy on Innovative mRNA Technology and Promising Vaccine Pipeline,Buy Rating Affirmed: Arcturus Therapeutics’ Promising Cystic Fibrosis Program Progress Biotech Alert: Searches spiking for these stocks today Arcturus Therapeutics Releases Updated Corporate Presentation Wall Street Analysts Are Bullish on Top Healthcare Picks Arcturus Therapeutics: A Strong Buy on Innovative mRNA Technology and Promising Vaccine Pipeline,0,0,1,0,1,1
,,,-1,"1,173",,,,,BLDP,Ballard Power Systems Inc.,592.01M,1.99,104.27M,-4.27%,-15.70%,-36.33%,-20.61%,-42.54%,Ballard Power price target lowered to $3 from $4 at Raymond James,Ballard Power downgraded to Underperformer from Neutral at CIBC (earlier),Assessing Ballard Power Systems: A Sell Recommendation Analysis,Ballard Power price target lowered to $2 from $3 at Truist,Ballard Power price target lowered to $10 from $15 at Lake Street,Ballard Power price target lowered to $3 from $4 at Raymond James Ballard Power downgraded to Underperformer from Neutral at CIBC (earlier) Assessing Ballard Power Systems: A Sell Recommendation Analysis Ballard Power price target lowered to $2 from $3 at Truist Ballard Power price target lowered to $10 from $15 at Lake Street,0,0,0,0,0,0
50.58M,"59,951",-60.88M,-1,"59,000",12.41,Hold,14.00,"Apr 30, 2024",CNDT,Conduent Incorporated,591.13M,3.64,3.63B,11.87%,10.32%,13.13%,-3.68%,+21.30%,Conduent selected by American Samoa DHSS to modernize ASNAP system,Conduent Announces Major Asset Sale Completion,MedRisk completes acquisition of Casualty Claims business from Conduent,"Icahn buys Caesars, exits Conduent in Q2",,"Conduent selected by American Samoa DHSS to modernize ASNAP system Conduent Announces Major Asset Sale Completion MedRisk completes acquisition of Casualty Claims business from Conduent Icahn buys Caesars, exits Conduent in Q2",1,0,1,1,1,-1
62.85M,"119,268",3.07M,-1,"8,900",9.95,Strong Buy,19.50,"Sep 9, 2024",ZUMZ,Zumiez Inc.,590.19M,29.11,869.99M,9.37%,23.94%,50.54%,+10.31%,+97.33%,Seaport Global Initiates a Hold Rating on Zumiez (ZUMZ),Zumiez price target raised to $25 from $20 at B. Riley,Closing Bell Movers: Broadcom slips 7% after Q3 results,"Zumiez reports Q2 EPS (4c), consensus (33c)",Zumiez (ZUMZ) Q2 Earnings Cheat Sheet,"Seaport Global Initiates a Hold Rating on Zumiez (ZUMZ) Zumiez price target raised to $25 from $20 at B. Riley Closing Bell Movers: Broadcom slips 7% after Q3 results Zumiez reports Q2 EPS (4c), consensus (33c) Zumiez (ZUMZ) Q2 Earnings Cheat Sheet",0,0,0,0,0,0
592.00M,"59,999",-15.46M,$0.75,"3,107",7.75,,,"Sep 5, 2024",RBBN,Ribbon Communications Inc.,589.90M,3.38,801.85M,7.88%,2.71%,13.18%,-1.18%,+12.04%,Ribbon Communications CFO Miguel Lopez Announces Retirement,Ribbon Communications CFO Mick Lopez to retire in Q4,,,,Ribbon Communications CFO Miguel Lopez Announces Retirement Ribbon Communications CFO Mick Lopez to retire in Q4,1,1,1,-1,-1,-1
105.65M,"1,140,216",-115.16M,-1,"1,316",5.89,Strong Buy,15.80,"Aug 12, 2024",CASS,"Cass Information Systems, Inc.",589.33M,43.25,218.45M,3.53%,3.58%,-2.09%,-1.02%,-10.00%,,,,,,,1,-1,-1,-1,-1,-1
59.32M,"158,515",-220.40M,-1,244,10.45,Buy,16.75,"Aug 14, 2024",VINP,Vinci Partners Investments Ltd.,587.56M,11.06,85.53M,1.07%,0.22%,1.67%,-3.55%,-2.33%,Vinci Partners Expands through Strategic Partnerships,,,,,Vinci Partners Expands through Strategic Partnerships,0,0,-1,-1,-1,-1
131.86M,"801,885",36.66M,-1,"2,841",4.700,Strong Buy,8.38,"Aug 6, 2024",ITRN,Ituran Location and Control Ltd.,587.46M,29.53,328.76M,9.09%,13.35%,11.95%,+9.10%,+4.98%,"Analysts Are Bullish on Top Technology Stocks: Ituran Location And Control (ITRN), Advanced Micro Devices (AMD)",Morning Movers: AMD gains following $4.9B pact to buy ZT Systems,Ituran Declares $8 Million Dividend Payout,Ituran Reports Growth and Optimistic Outlook,ITURAN LOCATION AND CONTROL LTD ANNOUNCES DISTRIBUTION OF A $8 MILLION DIVIDEND,"Analysts Are Bullish on Top Technology Stocks: Ituran Location And Control (ITRN), Advanced Micro Devices (AMD) Morning Movers: AMD gains following $4.9B pact to buy ZT Systems Ituran Declares $8 Million Dividend Payout Ituran Reports Growth and Optimistic Outlook ITURAN LOCATION AND CONTROL LTD ANNOUNCES DISTRIBUTION OF A $8 MILLION DIVIDEND",1,1,0,0,1,1
17.36M,"32,001",61.79M,$0.44,600,35.69,Buy,34.00,"Jul 24, 2024",CAC,Camden National Corporation,586.48M,40.24,162.23M,4.15%,9.47%,15.49%,-4.85%,+27.36%,,,,,,,1,-1,-1,-1,-1,-1
52.45M,"288,216",53.74M,$0.55,424,11.80,Strong Buy,17.50,"Aug 7, 2024",CEVA,"CEVA, Inc.",583.86M,24.65,98.74M,12.33%,17.56%,12.65%,+16.86%,+4.97%,Northland Securities Sticks to Their Buy Rating for Ceva (CEVA),,,,,Northland Securities Sticks to Their Buy Rating for Ceva (CEVA),0,0,-1,-1,-1,-1
27.50M,"157,082",-69.47M,-1,"2,837",22.50,Strong Buy,33.00,"Aug 14, 2024",HAIN,"The Hain Celestial Group, Inc.",581.29M,6.47,1.77B,16.20%,14.54%,-5.10%,+6.72%,+27.47%,"As consumers trade down to private label brands, these stocks could head up","Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more","Engaged Capital has big stake in Portillo’s, pushes for turnaround, sources say",Hain Celestial Completes the Sale of ParmCrisps® Snack Brand to Our Home,Hain Celestial: A Buy Rating with Strategic Initiatives Poised for Growth,"As consumers trade down to private label brands, these stocks could head up Stocks making the biggest moves midday: Paramount, Eli Lilly, Netflix and more Engaged Capital has big stake in Portillo’s, pushes for turnaround, sources say Hain Celestial Completes the Sale of ParmCrisps® Snack Brand to Our Home Hain Celestial: A Buy Rating with Strategic Initiatives Poised for Growth",1,1,1,1,0,0
,,,-1,159,,,,,TRDA,"Entrada Therapeutics, Inc.",581.29M,16.52,239.40M,6.51%,6.25%,14.17%,-0.91%,+18.18%,"Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program",Buy Rating Affirmed for Entrada Therapeutics on Strong Clinical Trial Data and Regulatory Prospects,TD Cowen Keeps Their Buy Rating on Entrada Therapeutics Inc (TRDA),Entrada Therapeutics Reports Second Quarter 2024 Financial Results,"Entrada Therapeutics reports Q2 EPS $1.55, consensus 14c","Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program Buy Rating Affirmed for Entrada Therapeutics on Strong Clinical Trial Data and Regulatory Prospects TD Cowen Keeps Their Buy Rating on Entrada Therapeutics Inc (TRDA) Entrada Therapeutics Reports Second Quarter 2024 Financial Results Entrada Therapeutics reports Q2 EPS $1.55, consensus 14c",1,1,0,1,0,1
25.50M,"49,921",61.65M,$0.56,148,24.14,Buy,25.00,"Jul 25, 2024",IRMD,IRADIMED CORPORATION,580.78M,45.84,69.48M,3.66%,3.69%,6.39%,+2.23%,+12.38%,,,,,,,1,-1,-1,-1,-1,-1
61.29M,"422,002",48.52M,$0.52,"10,493",10.04,Buy,11.50,"Jul 25, 2024",KC,Kingsoft Cloud Holdings Limited,580.61M,2.52,965.35M,3.07%,-0.79%,-18.23%,-11.85%,-22.73%,Kingsoft Cloud Holdings Maintains Stable Shares,Kingsoft Cloud Holdings (KC) Receives a Hold from Bank of America Securities,Kingsoft Cloud price target lowered to $3.20 from $3.80 at BofA,Hold Rating on Kingsoft Cloud Amidst Growth and Liquidity Concerns,Kingsoft Cloud Secures RMB300M Financial Lease Deal,Kingsoft Cloud Holdings Maintains Stable Shares Kingsoft Cloud Holdings (KC) Receives a Hold from Bank of America Securities Kingsoft Cloud price target lowered to $3.20 from $3.80 at BofA Hold Rating on Kingsoft Cloud Amidst Growth and Liquidity Concerns Kingsoft Cloud Secures RMB300M Financial Lease Deal,1,1,1,1,1,1
21.36M,"55,613",-40.90M,-1,66,28.81,Buy,34.00,"Aug 13, 2024",TERN,"Terns Pharmaceuticals, Inc.",578.46M,8.22,-,8.42%,3.05%,23.87%,-0.65%,+43.12%,Terns Pharmaceuticals (TERN) Gets a Buy from TD Cowen,Buy Rating Affirmed for Terns Pharmaceuticals Amid Positive Forecasts for Obesity Drug TERN-601,Largest borrow rate increases among liquid names,Market Outperform Rating for Terns Pharmaceuticals with a $15 Price Target Based on TERN-501 Clinical Trials Progress,Jefferies Sticks to Their Buy Rating for Terns Pharmaceuticals (TERN),Terns Pharmaceuticals (TERN) Gets a Buy from TD Cowen Buy Rating Affirmed for Terns Pharmaceuticals Amid Positive Forecasts for Obesity Drug TERN-601 Largest borrow rate increases among liquid names Market Outperform Rating for Terns Pharmaceuticals with a $15 Price Target Based on TERN-501 Clinical Trials Progress Jefferies Sticks to Their Buy Rating for Terns Pharmaceuticals (TERN),1,0,0,1,0,0
44.57M,"509,458",-24.61M,-1,28,13.74,Buy,19.38,"Aug 12, 2024",MLYS,"Mineralys Therapeutics, Inc.",577.33M,11.61,-,9.10%,0.17%,6.28%,-2.18%,-6.70%,"Stifel Nicolaus Reaffirms Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS)",Buy Rating for Mineralys Therapeutics Amid Strong Financials and Promising Lorundrostat Trials,"Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Durect (DRRX) and Globus Medical (GMED)",Buy Rating Justified by Lorundrostat’s Clinical Promise and Market Potential,"Mineralys Therapeutics reports Q2 EPS (83c), consensus (70c)","Stifel Nicolaus Reaffirms Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS) Buy Rating for Mineralys Therapeutics Amid Strong Financials and Promising Lorundrostat Trials Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Durect (DRRX) and Globus Medical (GMED) Buy Rating Justified by Lorundrostat’s Clinical Promise and Market Potential Mineralys Therapeutics reports Q2 EPS (83c), consensus (70c)",0,1,1,0,0,1
52.45M,"41,310",53.74M,$0.90,"1,377",11.02,Strong Buy,17.50,"Aug 7, 2024",IMXI,"International Money Express, Inc.",577.16M,17.70,666.16M,-4.08%,-10.05%,-14.51%,-20.40%,-21.39%,"Voss discloses Intermex stake, discussed take private transaction",Monness says Intermex activist could provide ‘little help with the self help’,Breach Inlet Capital tells Intermex board to pursue sale,Intermex management to meet virtually with KeyBanc,,"Voss discloses Intermex stake, discussed take private transaction Monness says Intermex activist could provide ‘little help with the self help’ Breach Inlet Capital tells Intermex board to pursue sale Intermex management to meet virtually with KeyBanc",1,1,1,1,1,-1
37.87M,"249,228",16.33M,-1,970,16.12,Buy,13.38,"Aug 1, 2024",CCBG,"Capital City Bank Group, Inc.",576.70M,34.04,221.12M,4.12%,10.48%,19.07%,-3.10%,+26.89%,Capital City Bank raises dividend 9.5% to 23c per share,"Capital City Bank Group, Inc. Increases Cash Dividend",Capital City Bank promotes Jensen to CTO,Capital City Bank Names Lynne Jensen As Chief Technology Officer,,"Capital City Bank raises dividend 9.5% to 23c per share Capital City Bank Group, Inc. Increases Cash Dividend Capital City Bank promotes Jensen to CTO Capital City Bank Names Lynne Jensen As Chief Technology Officer",1,0,1,1,1,-1
30.07M,"140,689",66.59M,$1.00,76,20.30,Hold,20.33,"Oct 22, 2024",FULC,"Fulcrum Therapeutics, Inc.",572.22M,9.17,81.63M,-2.59%,10.53%,15.36%,-4.42%,+4.11%,Fulcrum Therapeutics price target raised to $15 from $14 at RBC Capital,Biotech Alert: Searches spiking for these stocks today,Fulcrum Therapeutics to Participate in Upcoming September Conferences,Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Fulcrum appoints Isabel Kalofonos as CCO,Fulcrum Therapeutics price target raised to $15 from $14 at RBC Capital Biotech Alert: Searches spiking for these stocks today Fulcrum Therapeutics to Participate in Upcoming September Conferences Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Fulcrum appoints Isabel Kalofonos as CCO,1,0,1,0,0,1
67.19M,"1,065,230",44.10M,-1,"4,100",9.07,,,"Aug 6, 2024",LESL,"Leslie's, Inc.",571.38M,3.09,1.36B,-7.69%,-18.37%,-48.26%,-15.42%,-54.22%,"Leslie’s, Inc. to participate in Goldman Sachs 31st Annual Global Retailing Conference",Analysts Offer Insights on Consumer Cyclical Companies: Costco (COST) and Leslie’s (LESL),Maintaining Hold on Leslie’s Amid Executive Transition and Market Evaluation,Stifel Nicolaus Sticks to Its Sell Rating for Leslie’s (LESL),Closing Bell Movers: Apple down slightly on CFO change; Trip.com up on earnings,"Leslie’s, Inc. to participate in Goldman Sachs 31st Annual Global Retailing Conference Analysts Offer Insights on Consumer Cyclical Companies: Costco (COST) and Leslie’s (LESL) Maintaining Hold on Leslie’s Amid Executive Transition and Market Evaluation Stifel Nicolaus Sticks to Its Sell Rating for Leslie’s (LESL) Closing Bell Movers: Apple down slightly on CFO change; Trip.com up on earnings",0,0,1,0,1,1
64.21M,"297,974",-7.79M,-1,666,9.48,Sell,8.00,"Aug 29, 2024",FMNB,Farmers National Banc Corp.,570.78M,15.19,169.11M,4.62%,10.19%,14.34%,-1.92%,+19.61%,,,,,,,0,-1,-1,-1,-1,-1
4.91M,"15,483",40.42M,$0.80,"3,379",123.39,,,"Jul 31, 2024",LVRO,Lavoro Limited,570.21M,4.89,1.85B,-2.44%,-5.58%,-21.74%,-6.91%,-9.01%,,,,,,,1,-1,-1,-1,-1,-1
90.58M,"468,304",-157.72M,$0.80,199,6.65,Buy,8.00,"Jul 31, 2024",NBN,Northeast Bank,568.78M,69.98,152.68M,4.13%,7.88%,22.84%,-2.90%,+29.07%,,,,,,,0,-1,-1,-1,-1,-1
49.42M,"243,806",-241.08M,-1,35,12.13,Strong Buy,40.10,"Aug 1, 2024",PPTA,Perpetua Resources Corp.,568.29M,8.79,-,22.03%,34.27%,82.91%,+23.42%,+76.05%,Perpetua Resources initiated with an Outperform at National Bank,Perpetua Resources Secures Future with Stibnite Gold Project,Perpetua Resources’ Stibnite Gold Project approved by U.S. Forest Service,Roth MKM Keeps Their Buy Rating on Perpetua Resources (PPTA),Buy Rating on Perpetua Resources Amid Antimony Export Restrictions and Project Advancements,Perpetua Resources initiated with an Outperform at National Bank Perpetua Resources Secures Future with Stibnite Gold Project Perpetua Resources’ Stibnite Gold Project approved by U.S. Forest Service Roth MKM Keeps Their Buy Rating on Perpetua Resources (PPTA) Buy Rating on Perpetua Resources Amid Antimony Export Restrictions and Project Advancements,0,1,1,0,1,0
52.03M,"31,520",-32.32M,-1,"1,336",11.48,Strong Buy,36.67,"Sep 3, 2024",DOYU,DouYu International Holdings Limited,567.54M,17.94,704.53M,8.76%,41.32%,210.29%,+7.34%,+131.67%,,,,,,,1,-1,-1,-1,-1,-1
42.11M,"405,381",-113.58M,-1,314,14.16,Strong Buy,48.38,"Aug 13, 2024",NVTS,Navitas Semiconductor Corporation,566.88M,3.09,91.68M,-2.12%,-18.23%,-40.28%,-21.02%,-36.03%,Navitas Semiconductor releases portfolio of third-generation SiC MOSFETs,Navitas Qualifies Leading-edge Gen-3 Fast SiC to Auto-grade (Q101),Navitas Semiconductor to Participate in Upcoming Investor Events,,,Navitas Semiconductor releases portfolio of third-generation SiC MOSFETs Navitas Qualifies Leading-edge Gen-3 Fast SiC to Auto-grade (Q101) Navitas Semiconductor to Participate in Upcoming Investor Events,1,0,1,1,-1,-1
27.04M,"314,580",-71.96M,-1,376,21.99,Strong Buy,65.00,"Aug 5, 2024",SRDX,"Surmodics, Inc.",566.54M,39.71,120.82M,-2.46%,-4.42%,13.05%,-4.44%,+46.09%,Hold Rating Maintained Amid SurModics Acquisition Delays and FTC Scrutiny,,,,,Hold Rating Maintained Amid SurModics Acquisition Delays and FTC Scrutiny,1,0,-1,-1,-1,-1
299.41M,"2,701,155",-186.46M,-1,24,1.990,Hold,3.05,"Aug 12, 2024",BTBT,"Bit Digital, Inc.",565.55M,3.83,86.85M,8.71%,4.36%,23.69%,-12.60%,+38.17%,Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat,Crypto Currents: Riot urges change for Bitfarms board,"Bit Digital, Inc. Announces Monthly Production Update for August 2024",Bit Digital reports August BTC production down 11.7% from prior month,"Crypto Currents: Bitfarms assumes control of Sharon, PA data center","Goldman Sachs jumps into bitcoin ETFs while Morgan Stanley and rivals retreat Crypto Currents: Riot urges change for Bitfarms board Bit Digital, Inc. Announces Monthly Production Update for August 2024 Bit Digital reports August BTC production down 11.7% from prior month Crypto Currents: Bitfarms assumes control of Sharon, PA data center",0,0,0,0,0,0
162.40M,"1,117,842",22.00M,-1,15,3.640,Buy,9.00,"Aug 7, 2024",FRPH,"FRP Holdings, Inc.",564.06M,29.64,31.30M,3.08%,3.50%,0.79%,-0.63%,-1.32%,,,,,,,0,-1,-1,-1,-1,-1
20.27M,"279,026",-61.01M,-1,930,29.11,Hold,19.00,"Sep 5, 2024",LASR,"nLIGHT, Inc.",562.11M,11.68,197.56M,2.81%,0.31%,-6.59%,-3.23%,-6.18%,,,,,,,0,-1,-1,-1,-1,-1
174.53M,"185,796",-53.60M,-1,,3.380,Strong Buy,5.75,"Jul 24, 2024",ECX,ECARX Holdings Inc.,561.19M,1.66,705.23M,5.37%,3.59%,-15.56%,+8.13%,-8.95%,Ecarx powers launch of Lynk & Co. Z10 flagship luxury sedan,ECARX Powers Global Launch of the Lynk & Co. Z10 Flagship Luxury Sedan,"Ecarx, MulticoreWare announce partnership","Ecarx, MulticoreWare enter partnership for high-performannce software",,"Ecarx powers launch of Lynk & Co. Z10 flagship luxury sedan ECARX Powers Global Launch of the Lynk & Co. Z10 Flagship Luxury Sedan Ecarx, MulticoreWare announce partnership Ecarx, MulticoreWare enter partnership for high-performannce software",1,1,1,0,1,-1
13.63M,"31,336",27.44M,$1.20,"3,038",43.25,Buy,44.00,"Oct 17, 2024",VNET,"VNET Group, Inc.",560.63M,2.10,1.04B,6.34%,-2.41%,-5.15%,+14.01%,+34.09%,"VNET Group, Inc. Earns Buy Rating on Strong Q2 Performance and Robust Growth Prospects",VNET Group resumed with a Buy at Citi,Buy Rating Justified: VNET Group’s Expansion and Competitive Edge in Emerging Tech Sectors,Buy Rating Affirmed for VNET Group with Positive Growth Prospects and Expansion Strategy,"Buy Rating Affirmed for VNET Group, Inc. on Strong Q2 Performance and AI Sector Growth Potential","VNET Group, Inc. Earns Buy Rating on Strong Q2 Performance and Robust Growth Prospects VNET Group resumed with a Buy at Citi Buy Rating Justified: VNET Group’s Expansion and Competitive Edge in Emerging Tech Sectors Buy Rating Affirmed for VNET Group with Positive Growth Prospects and Expansion Strategy Buy Rating Affirmed for VNET Group, Inc. on Strong Q2 Performance and AI Sector Growth Potential",1,1,1,1,1,1
53.13M,"51,912",30.84M,$0.68,618,11.06,Strong Buy,14.33,"Aug 7, 2024",SPFI,"South Plains Financial, Inc.",559.77M,34.16,185.14M,7.11%,13.72%,23.30%,+5.67%,+33.39%,"Analysts Are Bullish on These Financial Stocks: UBS Group AG (UBS), South Plains Financial (SPFI)",,,,,"Analysts Are Bullish on These Financial Stocks: UBS Group AG (UBS), South Plains Financial (SPFI)",0,1,-1,-1,-1,-1
19.89M,"178,466",50.70M,$1.56,"2,516",29.53,Buy,35.00,"Aug 19, 2024",SNDL,SNDL Inc.,559.31M,2.11,666.29M,-8.10%,-5.49%,8.25%,-15.42%,-12.73%,SNDL Expands with Strategic Indiva Acquisition,SNDL Expands Market Presence with Indiva Acquisition,Rising High: SNDL announces successful bid to acquire Indiva,SNDL Announces Successful Bid to Purchase Indiva,SNDL makes succesful bid to acquire Indiva,SNDL Expands with Strategic Indiva Acquisition SNDL Expands Market Presence with Indiva Acquisition Rising High: SNDL announces successful bid to acquire Indiva SNDL Announces Successful Bid to Purchase Indiva SNDL makes succesful bid to acquire Indiva,0,1,1,0,0,1
14.57M,"40,911",43.51M,$1.68,91,40.24,Hold,41.00,"Jul 30, 2024",HIFS,Hingham Institution for Savings,559.08M,256.43,54.79M,7.49%,20.61%,38.35%,+4.38%,+57.33%,,,,,,,0,-1,-1,-1,-1,-1
23.69M,"200,063",-6.93M,-1,950,24.65,Strong Buy,28.67,"Aug 7, 2024",LIND,"Lindblad Expeditions Holdings, Inc.",556.99M,10.45,591.46M,34.94%,23.20%,26.15%,+22.07%,+24.53%,Lindblad Expeditions price target raised to $16 from $15 at B. Riley,Bullish Outlook for Lindblad Expeditions: A Comprehensive Buy Recommendation by Eric Wold,Stifel Nicolaus Remains a Buy on Lindblad Expeditions Holdings (LIND),,,Lindblad Expeditions price target raised to $16 from $15 at B. Riley Bullish Outlook for Lindblad Expeditions: A Comprehensive Buy Recommendation by Eric Wold Stifel Nicolaus Remains a Buy on Lindblad Expeditions Holdings (LIND),1,0,1,1,-1,-1
89.84M,"2,090,933",-90.80M,-1,217,6.47,Hold,9.63,"Aug 27, 2024",GCBC,"Greene County Bancorp, Inc.",556.78M,32.70,64.12M,-1.61%,-2.86%,7.83%,-11.09%,+23.06%,,,,,,,1,-1,-1,-1,-1,-1
35.19M,"139,304",104.44M,-1,"1,980",16.52,Strong Buy,21.67,"Aug 13, 2024",SSYS,Stratasys Ltd.,556.48M,7.90,622.27M,0.33%,-6.83%,-27.98%,-10.28%,-28.95%,Stratasys price target lowered to $7 from $9 at Loop Capital,Loop Capital Markets Keeps Their Hold Rating on Stratasys (SSYS),Stratasys (SSYS) Receives a New Rating from Cantor Fitzgerald,Stratasys price target lowered to $12 from $23 at Cantor Fitzgerald,Stratasys Reports Mid-Year Financial Highlights,Stratasys price target lowered to $7 from $9 at Loop Capital Loop Capital Markets Keeps Their Hold Rating on Stratasys (SSYS) Stratasys (SSYS) Receives a New Rating from Cantor Fitzgerald Stratasys price target lowered to $12 from $23 at Cantor Fitzgerald Stratasys Reports Mid-Year Financial Highlights,1,1,1,1,0,1
12.67M,"37,336",18.64M,$0.60,"1,269",45.84,Strong Buy,60.00,"Aug 1, 2024",FNKO,"Funko, Inc.",556.04M,10.59,1.07B,10.34%,11.08%,37.40%,+0.80%,+75.74%,Funko management to meet with B. Riley,Funko expands Pop! Yourself line through partnership with NFL,Funko (FNKO) Receives a Buy from D.A. Davidson,Analysts Offer Insights on Consumer Cyclical Companies: Funko (FNKO) and Melco Resorts & Entertainment (MLCO),Stifel Nicolaus Sticks to Its Hold Rating for Funko (FNKO),Funko management to meet with B. Riley Funko expands Pop! Yourself line through partnership with NFL Funko (FNKO) Receives a Buy from D.A. Davidson Analysts Offer Insights on Consumer Cyclical Companies: Funko (FNKO) and Melco Resorts & Entertainment (MLCO) Stifel Nicolaus Sticks to Its Hold Rating for Funko (FNKO),0,0,1,0,1,1
230.40M,"1,207,468",-245.30M,-1,"4,325",2.520,Buy,4.27,"Aug 20, 2024",INOD,Innodata Inc.,554.85M,19.14,107.34M,10.56%,15.26%,80.82%,-8.42%,+158.31%,Buy Rating Affirmed for Innodata on Strong Growth and Market Position,Innodata Isogen: Strong Buy on Surging Growth and Upward Financial Trajectory,,,,Buy Rating Affirmed for Innodata on Strong Growth and Market Position Innodata Isogen: Strong Buy on Surging Growth and Upward Financial Trajectory,0,0,1,-1,-1,-1
70.37M,"986,321",-95.90M,-1,382,8.22,Strong Buy,13.50,"Aug 5, 2024",PHAR,Pharming Group N.V.,552.39M,7.56,277.56M,3.94%,0.35%,-20.59%,-10.32%,-29.53%,,,,,,,0,-1,-1,-1,-1,-1
49.73M,"82,197",-119.67M,-1,"1,616",11.61,Strong Buy,30.00,"Aug 13, 2024",WLDN,"Willdan Group, Inc.",549.42M,39.26,551.90M,7.11%,17.51%,46.13%,+11.95%,+35.17%,Willdan Group assumed with an Outperform at Wedbush,,,,,Willdan Group assumed with an Outperform at Wedbush,0,1,-1,-1,-1,-1
32.61M,"279,424",58.47M,-1,428,17.70,Strong Buy,25.50,"Aug 7, 2024",AXGN,"AxoGen, Inc.",548.75M,12.52,173.48M,21.19%,40.26%,59.44%,+44.08%,+62.18%,AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®,Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®,AxoGen reports inducement grant under Nasdaq listing rule,Wall Street Analysts Are Bullish on Top Healthcare Picks,AxoGen Appoints New CEO and Board Chair for Strategic Renewal,AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft® Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft® AxoGen reports inducement grant under Nasdaq listing rule Wall Street Analysts Are Bullish on Top Healthcare Picks AxoGen Appoints New CEO and Board Chair for Strategic Renewal,1,0,0,1,1,1
16.94M,"47,219",51.08M,$0.84,895,34.04,Buy,34.83,"Jul 23, 2024",NEXN,Nexxen International Ltd.,548.09M,7.99,339.02M,12.29%,22.58%,46.35%,+12.35%,+48.08%,Stifel Nicolaus Remains a Hold on Nexxen International (NEXN),Nexxen International Announces Share Buyback,Nexxen International: A Strong Buy on Robust Financial Performance and Strategic Growth Initiatives,Nexxen management to meet virtually with Lake Street,Nexxen participates in a conference call with Lake Street,Stifel Nicolaus Remains a Hold on Nexxen International (NEXN) Nexxen International Announces Share Buyback Nexxen International: A Strong Buy on Robust Financial Performance and Strategic Growth Initiatives Nexxen management to meet virtually with Lake Street Nexxen participates in a conference call with Lake Street,1,1,1,1,0,0
62.40M,"1,027,692",-20.23M,-1,130,9.17,Strong Buy,14.38,"Jul 31, 2024",YORW,The York Water Company,548.06M,38.16,73.24M,-1.36%,-0.40%,3.39%,-6.68%,+11.26%,,,,,,,0,-1,-1,-1,-1,-1
184.91M,"2,795,909",3.03M,-1,"1,548",3.090,Hold,4.38,"Aug 7, 2024",OTLY,Oatly Group AB,547.09M,0.92,793.07M,-0.75%,-4.74%,-12.90%,-7.31%,-16.06%,,,,,,,1,-1,-1,-1,-1,-1
37.58M,"69,268",50.91M,$0.68,665,15.19,Hold,15.25,"Jul 24, 2024",WASH,"Washington Trust Bancorp, Inc.",546.72M,32.05,189.11M,6.41%,10.13%,15.04%,+0.72%,+28.29%,,,,,,,1,-1,-1,-1,-1,-1
116.61M,"1,520",-91.10M,-1,233,4.990,Strong Buy,8.88,"Jun 3, 2024",ALLO,"Allogene Therapeutics, Inc.",545.78M,2.61,65.00K,5.12%,3.40%,-16.73%,-12.59%,-35.10%,Buy Rating Affirmed for Allogene Therapeutics on Strong Financials and Positive Pipeline Prospects,Optimistic Outlook for Allogene Therapeutics with a Strong Buy Rating,,,,Buy Rating Affirmed for Allogene Therapeutics on Strong Financials and Positive Pipeline Prospects Optimistic Outlook for Allogene Therapeutics with a Strong Buy Rating,1,1,1,-1,-1,-1
8.13M,"25,455",58.23M,$0.04,"2,213",69.98,Buy,54.00,"Jul 29, 2024",GRPN,"Groupon, Inc.",545.26M,13.72,511.89M,8.26%,-5.74%,-0.39%,unch,+19.03%,Groupon call volume above normal and directionally bullish,,,,,Groupon call volume above normal and directionally bullish,1,1,-1,-1,-1,-1
64.60M,"273,285",-13.12M,-1,529,8.79,Strong Buy,11.63,"Aug 9, 2024",HONE,"HarborOne Bancorp, Inc.",544.87M,13.13,164.89M,3.90%,8.50%,17.41%,-2.17%,+33.81%,HarborOne Bancorp (HONE) Gets a Hold from Seaport Global,,,,,HarborOne Bancorp (HONE) Gets a Hold from Seaport Global,1,1,-1,-1,-1,-1
31.64M,"176,554",-9.27M,-1,"5,800",17.94,Sell,7.03,"Sep 3, 2024",RXT,"Rackspace Technology, Inc.",544.74M,2.41,2.83B,2.48%,-6.70%,18.69%,-3.85%,+27.12%,Rackspace Introduces On-demand Software as a Service to Seamlessly Simulate Complex Environments,Rackspace Technology Delivers on Long-standing Commitment to OpenStack Community with Launch of OpenStack Enterprise,Rackspace Technology launches Rackspace OpenStack Enterprise,Rackspace Technology Helps TrueData Achieve Cloud Cost Reduction on AWS,Cautious Optimism for Rackspace’s Future: A Hold Rating Amidst Mixed Financial Signals,Rackspace Introduces On-demand Software as a Service to Seamlessly Simulate Complex Environments Rackspace Technology Delivers on Long-standing Commitment to OpenStack Community with Launch of OpenStack Enterprise Rackspace Technology launches Rackspace OpenStack Enterprise Rackspace Technology Helps TrueData Achieve Cloud Cost Reduction on AWS Cautious Optimism for Rackspace’s Future: A Hold Rating Amidst Mixed Financial Signals,0,0,0,0,0,0
183.46M,"1,405,510",-51.07M,-1,150,3.090,Buy,5.64,"Aug 5, 2024",KALV,"KalVista Pharmaceuticals, Inc.",544.12M,12.63,-,-1.96%,-2.07%,5.08%,-11.35%,+16.23%,KalVista presents sebetralstat data at Bradykinin Symposium 2024,"Buy Rating Affirmed for KalVista Pharmaceuticals Amid Strong Prospects for Lead Drug Candidate, Sebetralstat",Buy Rating for KalVista Pharmaceuticals Amid Positive Regulatory Developments and Strong Financial Position,"KalVista reports Q1 EPS (87c), consensus (91c)",KalVista announces FDA approval of NDA for sebetralstat,"KalVista presents sebetralstat data at Bradykinin Symposium 2024 Buy Rating Affirmed for KalVista Pharmaceuticals Amid Strong Prospects for Lead Drug Candidate, Sebetralstat Buy Rating for KalVista Pharmaceuticals Amid Positive Regulatory Developments and Strong Financial Position KalVista reports Q1 EPS (87c), consensus (91c) KalVista announces FDA approval of NDA for sebetralstat",0,0,0,0,1,0
14.27M,"104,102",-1.40M,-1,"1,122",39.71,Hold,43.00,"Jul 31, 2024",HSAI,Hesai Group,543.70M,4.27,251.10M,-0.23%,-6.07%,-29.11%,-14.64%,-24.05%,Hesai Group’s Strong Q2 2024 Financial Results,Closing Bell Movers: Titan skyrockets after KE merger agreement,Hesai reports Q2 EPS (RMB0.34) vs (RMB0.32) last year,"Hesai Group Releases Inaugural Environmental, Social and Governance (ESG) Report",Hesai Group Sponsored ADR (HSAI) Q2 Earnings Cheat Sheet,"Hesai Group’s Strong Q2 2024 Financial Results Closing Bell Movers: Titan skyrockets after KE merger agreement Hesai reports Q2 EPS (RMB0.34) vs (RMB0.32) last year Hesai Group Releases Inaugural Environmental, Social and Governance (ESG) Report Hesai Group Sponsored ADR (HSAI) Q2 Earnings Cheat Sheet",0,1,1,1,0,0
147.66M,"7,593,698",28.92M,-1,71,3.830,Strong Buy,6.00,"Aug 19, 2024",ACIC,American Coastal Insurance Corporation,543.56M,11.29,261.18M,-1.62%,0.88%,4.29%,-9.75%,-1.69%,,,,,,,0,-1,-1,-1,-1,-1
19.03M,"22,532",7.48M,-1,"1,613",29.64,,,"Aug 7, 2024",CGNT,Cognyte Software Ltd.,542.08M,7.54,322.85M,1.81%,-0.42%,7.18%,-2.62%,-8.72%,Cognyte Software Ltd. (CGNT) Q2 Earnings Cheat Sheet,Cognyte Software Shareholders Approve Key Proposals,Cognyte shareholders re-elected both of company’s nominees to board,Cognyte Software Schedules Q2 Fiscal 2025 Earnings Call,Value Base: Glass Lewis recommends Cognyte shareholders vote against chairman,Cognyte Software Ltd. (CGNT) Q2 Earnings Cheat Sheet Cognyte Software Shareholders Approve Key Proposals Cognyte shareholders re-elected both of company’s nominees to board Cognyte Software Schedules Q2 Fiscal 2025 Earnings Call Value Base: Glass Lewis recommends Cognyte shareholders vote against chairman,1,1,1,1,0,1
48.13M,"145,441",-50.61M,-1,"3,180",11.68,Strong Buy,16.00,"Aug 1, 2024",CNSL,"Consolidated Communications Holdings, Inc.",541.44M,4.57,1.10B,-0.54%,1.48%,4.12%,-1.09%,+5.57%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,,,,,,YXT,YXT.COM Group Holding Limited,541.28M,9.01,53.33M,-16.86%,-16.86%,-16.86%,,,"Opening Day: Pheton, Powell Max make public debut","Opening Day: Autozi, JBDI Holdings make public debut","YXT.Com Group Holding Ltd – ADR trading halted, volatility trading pause",YXT.com Group Holding Limited Announces Closing of Initial Public Offering,Opening Day: Actuate Therapeutics makes public debut,"Opening Day: Pheton, Powell Max make public debut Opening Day: Autozi, JBDI Holdings make public debut YXT.Com Group Holding Ltd – ADR trading halted, volatility trading pause YXT.com Group Holding Limited Announces Closing of Initial Public Offering Opening Day: Actuate Therapeutics makes public debut",0,0,0,0,0,0
266.97M,"1,050,838",-403.45M,-1,400,2.100,Strong Buy,,"Aug 27, 2024",CLFD,"Clearfield, Inc.",538.91M,37.85,169.62M,-6.50%,-6.74%,12.33%,-16.45%,+21.27%,Clearfield Launches New Performance-Linked Incentive Plan,Lake Street Keeps Their Buy Rating on Clearfield (CLFD),,,,Clearfield Launches New Performance-Linked Incentive Plan Lake Street Keeps Their Buy Rating on Clearfield (CLFD),0,0,0,-1,-1,-1
16.39M,"39,761",45.83M,$0.56,676,34.16,Buy,33.50,"Jul 18, 2024",VALN,Valneva SE,537.67M,7.76,167.66M,2.76%,3.89%,-10.69%,+3.13%,-8.01%,Valneva (0OB3) Receives a Buy from Kepler Capital,H.C. Wainwright positive on second booster results for VLA15,"Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive",Buy Rating for Valneva Amid Promising VLA15 Vaccine Prospects and Strong Revenue Forecasts,Valneva Advances Lyme Disease Vaccine Candidate,"Valneva (0OB3) Receives a Buy from Kepler Capital H.C. Wainwright positive on second booster results for VLA15 Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive Buy Rating for Valneva Amid Promising VLA15 Vaccine Prospects and Strong Revenue Forecasts Valneva Advances Lyme Disease Vaccine Candidate",1,1,0,1,1,1
265.08M,"860,503",-82.49M,-1,,2.110,Buy,3.25,"Aug 1, 2024",AVXL,Anavex Life Sciences Corp.,535.91M,6.32,-,-4.40%,10.10%,9.53%,-13.47%,+33.03%,Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024,Largest borrow rate increases among liquid names,,,,Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 Largest borrow rate increases among liquid names,0,0,1,-1,-1,-1
2.18M,"20,770",20.58M,$2.52,,256.43,,,"Oct 11, 2024",SNCY,"Sun Country Airlines Holdings, Inc.",534.94M,10.13,1.06B,4.05%,-5.89%,-19.28%,-18.93%,-27.06%,Interest rates for bank accounts are rising — here’s how you can take advantage,Sun Country Airlines Will Participate at the Morgan Stanley 12th Annual Laguna Conference,,,,Interest rates for bank accounts are rising — here’s how you can take advantage Sun Country Airlines Will Participate at the Morgan Stanley 12th Annual Laguna Conference,0,0,0,-1,-1,-1
53.30M,"399,775",-54.91M,-1,,10.45,Strong Buy,13.25,"Aug 8, 2024",DH,Definitive Healthcare Corp.,530.57M,4.53,258.47M,11.18%,-8.76%,-37.20%,+14.87%,-43.43%,Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion,Definitive Healthcare expands Population Intelligence platform,Definitive Healthcare price target lowered to $5 from $7 at Deutsche Bank,,Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion Definitive Healthcare expands Population Intelligence platform Definitive Healthcare price target lowered to $5 from $7 at Deutsche Bank,1,1,0,1,1,-1
17.03M,"15,431",24.77M,$0.36,,32.70,,,"Jul 23, 2024",THRD,"Third Harmonic Bio, Inc.",529.75M,12.89,-,4.76%,1.34%,13.65%,-2.55%,+10.56%,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more",Friday’s analyst calls: Morgan Stanley names a top drug stock pick,Third Harmonic Bio to Participate in Upcoming Investor Conferences,Buy Rating Affirmed for Third Harmonic Bio Amidst Promising Clinical Developments and Market Prospects,,"Here are Friday’s biggest analyst calls: Nvidia, Chipotle, Eli Lilly and more Friday’s analyst calls: Morgan Stanley names a top drug stock pick Third Harmonic Bio to Participate in Upcoming Investor Conferences Buy Rating Affirmed for Third Harmonic Bio Amidst Promising Clinical Developments and Market Prospects",1,1,1,0,0,-1
70.44M,"150,686",-126.83M,-1,"1,029",7.90,Strong Buy,16.33,"Aug 29, 2024",CGC,Canopy Growth Corporation,529.67M,6.21,209.77M,-15.87%,-18.09%,-13.09%,-30.39%,-48.04%,Election 2024: Where To Put Your Money Ahead of the Vote,Largest borrow rate increases among liquid names,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,Canopy Growth Introduces ‘Smokeless September’ Campaign,Rising High: SNDL announces successful bid to acquire Indiva,Election 2024: Where To Put Your Money Ahead of the Vote Largest borrow rate increases among liquid names Rising High: MINT Shango JV to acquire Cannabist’s Florida entity Canopy Growth Introduces ‘Smokeless September’ Campaign Rising High: SNDL announces successful bid to acquire Indiva,1,1,1,1,0,0
52.51M,"357,449",-43.32M,-1,404,10.59,Buy,9.63,"Aug 8, 2024",NFBK,"Northfield Bancorp, Inc. (Staten Island, NY)",529.03M,12.25,126.91M,2.54%,11.14%,15.93%,-3.84%,+32.34%,,,,,,,1,-1,-1,-1,-1,-1
28.99M,"263,493",3.00M,-1,861,19.14,Strong Buy,30.00,"Aug 8, 2024",THFF,First Financial Corporation,528.92M,44.77,192.70M,4.75%,8.96%,13.40%,-1.45%,+20.87%,,,,,,,0,-1,-1,-1,-1,-1
678.35M,"8,961",-13.33M,-1,806,7.60,Strong Buy,37.00,"Aug 1, 2024",KRT,Karat Packaging Inc.,526.99M,26.33,409.32M,-2.01%,-6.46%,-1.41%,-13.69%,-10.70%,"Karat Packaging to Present at Lake Street’s 8th Annual Best Ideas Growth Conference, September 12","Analysts Offer Insights on Consumer Cyclical Companies: Century Casinos (CNTY), FIGS (FIGS) and Karat Packaging Inc (KRT)",,,,"Karat Packaging to Present at Lake Street’s 8th Annual Best Ideas Growth Conference, September 12 Analysts Offer Insights on Consumer Cyclical Companies: Century Casinos (CNTY), FIGS (FIGS) and Karat Packaging Inc (KRT)",1,0,1,-1,-1,-1
13.99M,"145,236",17.13M,-1,"3,628",39.26,Strong Buy,41.00,"Aug 1, 2024",MGIC,Magic Software Enterprises Ltd.,526.34M,10.72,523.33M,2.93%,1.50%,0.93%,-0.09%,-4.94%,Barclays Releases a Buy Rating on Magic (MGIC),Magic Software Reports Decreased Q2 Earnings,Magic Software (MGIC) Q2 Earnings Cheat Sheet,,,Barclays Releases a Buy Rating on Magic (MGIC) Magic Software Reports Decreased Q2 Earnings Magic Software (MGIC) Q2 Earnings Cheat Sheet,1,0,1,1,-1,-1
43.83M,"299,705",-16.54M,-1,90,12.52,Strong Buy,13.80,"Aug 8, 2024",PRTC,PureTech Health plc,525.22M,22.45,3.33M,12.75%,2.22%,2.62%,+4.44%,+2.17%,Optimistic Outlook for PureTech Health: Strong Pipeline and Financial Strategy Justify Buy Rating,,,,,Optimistic Outlook for PureTech Health: Strong Pipeline and Financial Strategy Justify Buy Rating,1,1,-1,-1,-1,-1
138.75M,"150,549",-1.93M,-1,435,7.99,Strong Buy,9.10,"Aug 22, 2024",NRC,National Research Corporation,522.30M,21.88,146.28M,-0.72%,-5.01%,-34.60%,-13.26%,-40.24%,,,,,,,1,-1,-1,-1,-1,-1
14.36M,"59,731",22.90M,$0.84,780,38.16,,,"Aug 2, 2024",AIOT,"PowerFleet, Inc.",519.36M,4.89,133.74M,4.55%,6.00%,25.95%,+7.95%,+3.16%,TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching,Buy Rating Affirmed for Powerfleet: Strong Q1 Performance and Strategic Growth Initiatives,Powerfleet Poised for Growth: Dylan Becker Recommends Buy on Strong Q1 Results and Positive Outlook,Northland Securities Remains a Buy on Powerfleet (AIOT),Powerfleet’s Strong Q1 Performance and Strategic Synergies Prompt a Buy Rating,TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching Buy Rating Affirmed for Powerfleet: Strong Q1 Performance and Strategic Growth Initiatives Powerfleet Poised for Growth: Dylan Becker Recommends Buy on Strong Q1 Results and Positive Outlook Northland Securities Remains a Buy on Powerfleet (AIOT) Powerfleet’s Strong Q1 Performance and Strategic Synergies Prompt a Buy Rating,1,0,1,1,0,1
596.94M,"607,903",-330.76M,-1,852,0.917,Buy,1.96,"Jul 24, 2024",UFCS,"United Fire Group, Inc.",518.63M,20.47,1.16B,1.02%,-2.45%,-5.88%,-8.34%,-3.97%,"United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share",,,,,"United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share",0,0,-1,-1,-1,-1
17.06M,"102,993",45.80M,$2.24,"13,131",32.05,Hold,,"Oct 21, 2024",CCRN,"Cross Country Healthcare, Inc.",518.62M,15.34,1.58B,-4.68%,-0.84%,-17.40%,-17.71%,-15.67%,Cross Country Healthcare Issues Non-Binding Press Release,,,,,Cross Country Healthcare Issues Non-Binding Press Release,1,0,-1,-1,-1,-1
209.11M,"2,363,355",-279.42M,-1,"1,663",2.610,Buy,10.26,"Aug 7, 2024",IIIV,"i3 Verticals, Inc.",518.60M,21.83,371.16M,-1.10%,-0.23%,4.95%,-10.85%,-3.02%,i3 Verticals management to meet with BTIG,I3 Verticals (IIIV) Gets a Buy from Benchmark Co.,"Analysts Have Conflicting Sentiments on These Technology Companies: FiscalNote Holdings (NOTE), AppFolio (APPF) and I3 Verticals (IIIV)",Benchmark Co. Reaffirms Their Buy Rating on I3 Verticals (IIIV),I3 Verticals (IIIV) Receives a Hold from Morgan Stanley,"i3 Verticals management to meet with BTIG I3 Verticals (IIIV) Gets a Buy from Benchmark Co. Analysts Have Conflicting Sentiments on These Technology Companies: FiscalNote Holdings (NOTE), AppFolio (APPF) and I3 Verticals (IIIV) Benchmark Co. Reaffirms Their Buy Rating on I3 Verticals (IIIV) I3 Verticals (IIIV) Receives a Hold from Morgan Stanley",1,1,1,1,1,1
39.74M,"763,287",-35.96M,-1,441,13.72,Hold,17.83,"Jul 30, 2024",QTRX,Quanterix Corporation,518.12M,13.50,129.33M,4.03%,-0.43%,-32.65%,-10.98%,-38.83%,"Stocks making the biggest moves after hours: Applied Materials, Autodesk, H&R Block and more","Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Doximity (DOCS) and Warby Parker (WRBY)",Quanterix price target lowered to $28 from $32 at Scotiabank,Scotiabank Keeps Their Buy Rating on Quanterix (QTRX),,"Stocks making the biggest moves after hours: Applied Materials, Autodesk, H&R Block and more Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Doximity (DOCS) and Warby Parker (WRBY) Quanterix price target lowered to $28 from $32 at Scotiabank Scotiabank Keeps Their Buy Rating on Quanterix (QTRX)",1,1,0,0,1,-1
41.50M,"121,242",15.90M,$0.32,244,13.13,Hold,14.00,"Oct 22, 2024",ALEC,"Alector, Inc.",516.77M,5.31,55.28M,0.40%,1.41%,-8.59%,-13.17%,-10.79%,TD Cowen Sticks to Its Buy Rating for Alector (ALEC),Alector to Participate in Upcoming Healthcare Conferences,,,,TD Cowen Sticks to Its Buy Rating for Alector (ALEC) Alector to Participate in Upcoming Healthcare Conferences,1,0,0,-1,-1,-1
226.03M,"426,045",-814.20M,-1,,2.410,Hold,2.15,"Aug 8, 2024",CCNE,CNB Financial Corporation,516.45M,24.82,214.48M,5.08%,10.02%,17.00%,-4.87%,+24.60%,KBW Sticks to Its Hold Rating for Cnb Financial (CCNE),CNB Financial Corporation Announces Quarterly Dividend for Common Stock,,,,KBW Sticks to Its Hold Rating for Cnb Financial (CCNE) CNB Financial Corporation Announces Quarterly Dividend for Common Stock,0,0,0,-1,-1,-1
43.08M,"133,454",-126.64M,-1,,12.63,Strong Buy,26.00,"Sep 5, 2024",CTNM,"Contineum Therapeutics, Inc.",516.01M,20.06,-,9.24%,2.66%,13.56%,-7.88%,+20.00%,Contineum price target raised to $32 from $30 at RBC Capital,"Morgan Stanley Sticks to Its Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM)",Wall Street Analysts Are Bullish on Top NA Picks,Contineum Therapeutics Announces Corporate Presentation Updates,"Contineum reports Q2 EPS (39c), consensus (35c)","Contineum price target raised to $32 from $30 at RBC Capital Morgan Stanley Sticks to Its Buy Rating for Contineum Therapeutics, Inc. Class A (CTNM) Wall Street Analysts Are Bullish on Top NA Picks Contineum Therapeutics Announces Corporate Presentation Updates Contineum reports Q2 EPS (39c), consensus (35c)",0,0,0,0,0,1
127.48M,"341,272",-63.53M,-1,,4.265,Strong Buy,12.90,"Aug 19, 2024",ATLC,Atlanticus Holdings Corporation,515.62M,34.97,362.25M,7.12%,9.79%,12.16%,-2.94%,+20.35%,JMP Securities Keeps Their Buy Rating on Atlanticus Holdings (ATLC),Atlanticus Announces Approval of Quarterly Preferred Stock Dividend,,,,JMP Securities Keeps Their Buy Rating on Atlanticus Holdings (ATLC) Atlanticus Announces Approval of Quarterly Preferred Stock Dividend,0,1,0,-1,-1,-1
48.15M,"219,601",67.51M,-1,,11.29,Buy,15.00,"Aug 7, 2024",PRME,"Prime Medicine, Inc.",514.05M,4.42,591.00K,-4.92%,-18.09%,-35.35%,-24.78%,-26.61%,"Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)",,,,,"Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)",0,1,-1,-1,-1,-1
71.89M,"108,647",-11.93M,-1,487,7.54,Hold,8.25,"Sep 10, 2024",SAGE,"Sage Therapeutics, Inc.",513.43M,8.41,97.24M,-6.93%,-21.15%,-51.48%,-27.85%,-51.89%,"Sage Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – SAGE",Sage Therapeutics price target lowered to $13 from $18 at Truist,SAGE Therapeutics (SAGE) Gets a Hold from Truist Financial,,,"Sage Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP for More Information – SAGE Sage Therapeutics price target lowered to $13 from $18 at Truist SAGE Therapeutics (SAGE) Gets a Hold from Truist Financial",1,1,0,0,-1,-1
118.48M,"457,374",-241.62M,-1,"3,352",4.570,,,"Aug 6, 2024",SHCR,"Sharecare, Inc.",511.88M,1.38,403.73M,0.40%,4.16%,36.04%,+1.46%,+105.14%,Sharecare says Salinas achieves Blue Zones Community certification,"Salinas becomes first certified Blue Zones Community® in Monterey County, California",Maintaining Hold Rating on Sharecare Amid Mixed Performance and Pending Acquisition,,,"Sharecare says Salinas achieves Blue Zones Community certification Salinas becomes first certified Blue Zones Community® in Monterey County, California Maintaining Hold Rating on Sharecare Amid Mixed Performance and Pending Acquisition",1,1,1,0,-1,-1
60.08M,"99,166",-19.98M,-1,420,8.85,,,,EOSE,"Eos Energy Enterprises, Inc.",511.43M,2.36,14.79M,21.55%,34.01%,98.43%,+11.17%,+116.83%,Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Titan Machinery (TITN) and Eos Energy Enterprises (EOSE),Stifel reiterates Buy as Eos Energy achieves first performance milestone,Eos Energy achieves performance milestones related to Cerberus investment,Eos Energy Achieves First Performance Milestones Related to Cerberus Strategic Investment,Buy Rating Affirmed for Eos Energy Enterprises on Strong Growth and Technological Edge,Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Titan Machinery (TITN) and Eos Energy Enterprises (EOSE) Stifel reiterates Buy as Eos Energy achieves first performance milestone Eos Energy achieves performance milestones related to Cerberus investment Eos Energy Achieves First Performance Milestones Related to Cerberus Strategic Investment Buy Rating Affirmed for Eos Energy Enterprises on Strong Growth and Technological Edge,1,1,1,1,1,1
,,,-1,537,,,,,AROW,Arrow Financial Corporation,511.18M,30.55,133.55M,3.14%,6.33%,15.67%,-4.95%,+27.60%,,,,,,,1,-1,-1,-1,-1,-1
14.24M,"69,933",-8.93M,-1,"4,700",37.85,Strong Buy,46.67,"Aug 1, 2024",SOHU,Sohu.com Limited,509.88M,15.76,598.51M,0.81%,5.07%,34.80%,unch,+32.75%,,,,,,,0,-1,-1,-1,-1,-1
131.55M,"2,559",-34.72M,-1,155,7.87,Strong Buy,21.50,"Aug 13, 2024",ABSI,Absci Corporation,509.87M,4.49,3.25M,11.72%,18.06%,11.35%,-0.23%,-23.52%,Truist Financial Sticks to Its Buy Rating for AbSci (ABSI),Cathie Wood’s ARK Investment bought 82.7K shares of Absci today,Absci to Participate in Upcoming Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and AbSci (ABSI)",Buy Rating Affirmed for AbSci: Promising ABS-101 Data and Strategic Partnerships Signal Growth Potential,"Truist Financial Sticks to Its Buy Rating for AbSci (ABSI) Cathie Wood’s ARK Investment bought 82.7K shares of Absci today Absci to Participate in Upcoming Investor Conferences Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR) and AbSci (ABSI) Buy Rating Affirmed for AbSci: Promising ABS-101 Data and Strategic Partnerships Signal Growth Potential",1,0,1,0,1,1
,,,-1,,,,,,PAL,"Proficient Auto Logistics, Inc.",507.53M,19.55,-,-1.38%,5.69%,11.91%,-9.08%,,"Analysts Offer Insights on NA Companies: ArriVent BioPharma, Inc. (AVBP) and Proficient Auto Logistics, Inc. (PAL)",Proficient Auto Welcomes Amy Rice as New President and COO,Strong Performance and Positive Outlook Justify Buy Rating for Proficient Auto Logistics,Proficient Auto Logistics price target raised to $21 from $18 at Raymond James,Proficient Auto Logistics Set to Expand with ATG Acquisition,"Analysts Offer Insights on NA Companies: ArriVent BioPharma, Inc. (AVBP) and Proficient Auto Logistics, Inc. (PAL) Proficient Auto Welcomes Amy Rice as New President and COO Strong Performance and Positive Outlook Justify Buy Rating for Proficient Auto Logistics Proficient Auto Logistics price target raised to $21 from $18 at Raymond James Proficient Auto Logistics Set to Expand with ATG Acquisition",1,0,1,1,0,1
,,,-1,"2,400",,,,,VREX,Varex Imaging Corporation,507.08M,12.41,832.70M,-2.67%,-11.96%,-28.55%,-16.84%,-30.31%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance","Lyft upgraded, Baidu downgraded: Wall Street’s top analyst calls",Varex Imaging initiated with a Buy at B. Riley,Buy Rating on Varex Imaging: Under-Valued Market Leader Poised for Rebound,Varex Imaging CFO buys $108.2K in common stock,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Lyft upgraded, Baidu downgraded: Wall Street’s top analyst calls Varex Imaging initiated with a Buy at B. Riley Buy Rating on Varex Imaging: Under-Valued Market Leader Poised for Rebound Varex Imaging CFO buys $108.2K in common stock",1,1,1,1,1,1
,,,-1,269,,,,,CTLP,"Cantaloupe, Inc.",506.03M,6.95,260.11M,-1.55%,-0.70%,2.27%,-12.84%,+7.78%,"Cantaloupe, Inc. (CTLP) Q4 Earnings Cheat Sheet",Cantaloupe’s Strong Financial Outlook Justifies Buy Rating and $10 Price Target,,,,"Cantaloupe, Inc. (CTLP) Q4 Earnings Cheat Sheet Cantaloupe’s Strong Financial Outlook Justifies Buy Rating and $10 Price Target",0,1,0,-1,-1,-1
,,,-1,106,,,,,OABI,"OmniAb, Inc.",505.74M,4.28,21.71M,0.74%,0.99%,-13.06%,-10.86%,-19.59%,Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and OmniAb (OABI),"Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX)","Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Avadel Pharmaceuticals (AVDL) and Regulus (RGLS)",Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI),,"Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and OmniAb (OABI) Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX) Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Avadel Pharmaceuticals (AVDL) and Regulus (RGLS) Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)",0,0,1,0,0,-1
84.86M,"1,453,633",-545.27M,-1,285,6.21,Sell,4.30,"Aug 9, 2024",DAVE,Dave Inc.,501.63M,39.44,292.68M,6.99%,5.92%,33.01%,-1.32%,-4.78%,Analysts Have Conflicting Sentiments on These Technology Companies: Dave (DAVE) and Nutanix (NTNX),Dave to Participate in Upcoming Investor Conferences in September,Dave (DAVE) Initiated with a Buy at Benchmark Co.,"Analysts Are Bullish on These Technology Stocks: NICE (NICE), Teledyne Technologies (TDY)",Dave (DAVE) Has a New Rating from Benchmark Co.,"Analysts Have Conflicting Sentiments on These Technology Companies: Dave (DAVE) and Nutanix (NTNX) Dave to Participate in Upcoming Investor Conferences in September Dave (DAVE) Initiated with a Buy at Benchmark Co. Analysts Are Bullish on These Technology Stocks: NICE (NICE), Teledyne Technologies (TDY) Dave (DAVE) Has a New Rating from Benchmark Co.",1,1,1,1,1,1
43.19M,"185,517",28.57M,$0.52,42,12.25,Hold,11.13,"Jul 24, 2024",LRMR,"Larimar Therapeutics, Inc.",501.52M,7.86,-,3.23%,-3.36%,12.98%,-5.01%,+7.12%,Buy Rating Affirmed for Larimar Therapeutics: High Potential for U.S. Approval and Market Share in Friedreich’s Ataxia Treatment,Larimar Therapeutics initiated with an Outperform at Baird,,,,Buy Rating Affirmed for Larimar Therapeutics: High Potential for U.S. Approval and Market Share in Friedreich’s Ataxia Treatment Larimar Therapeutics initiated with an Outperform at Baird,0,0,0,-1,-1,-1
11.81M,"40,779",51.00M,$1.80,288,44.77,Hold,45.00,"Jul 23, 2024",HPH,Highest Performances Holdings Inc.,501.48M,2.03,11.51M,-27.91%,-61.23%,-70.11%,-58.37%,-79.93%,,,,,,,1,-1,-1,-1,-1,-1
20.01M,"38,156",28.23M,$0.85,,26.33,Buy,30.00,"Aug 8, 2024",DGICA,Donegal Group Inc.,501.25M,14.97,961.31M,3.84%,8.83%,7.92%,+2.72%,+9.88%,,,,,,,1,-1,-1,-1,-1,-1
49.10M,"32,891",35.72M,$0.20,36,10.72,Buy,14.00,"Aug 14, 2024",OCS,Oculis Holding AG,497.96M,11.93,971.12K,1.89%,2.12%,2.72%,+4.22%,+8.43%,Optimistic Buy Rating for Oculis Holding Amidst Clinical and Regulatory Progress,Oculis to Present at Upcoming September Investor Conferences,Buy Rating Affirmed for Oculis Holdings Amid Strong Pipeline and Positive FDA Feedback,"Oculis files to sell 361,011 ordinary shares for holders",Oculis Holding Shows Strong Asset and Equity Growth,"Optimistic Buy Rating for Oculis Holding Amidst Clinical and Regulatory Progress Oculis to Present at Upcoming September Investor Conferences Buy Rating Affirmed for Oculis Holdings Amid Strong Pipeline and Positive FDA Feedback Oculis files to sell 361,011 ordinary shares for holders Oculis Holding Shows Strong Asset and Equity Growth",1,0,1,0,1,0
270.21M,"6,372",-65.70M,-1,99,22.10,,,"Aug 28, 2024",RSVR,"Reservoir Media, Inc.",497.85M,7.65,147.34M,4.47%,3.05%,5.78%,-3.02%,-3.86%,Reservoir Media Shares Performance Insights and Strategy,,,,,Reservoir Media Shares Performance Insights and Strategy,1,1,-1,-1,-1,-1
23.87M,"48,797",29.27M,$0.48,645,21.88,,,"Aug 6, 2024",MPB,"Mid Penn Bancorp, Inc.",497.39M,29.79,169.32M,7.07%,17.94%,31.68%,-0.91%,+47.94%,,,,,,,0,-1,-1,-1,-1,-1
106.21M,"983,913",-17.31M,-1,98,4.890,Buy,10.00,"Aug 22, 2024",AILE,"iLearningEngines, Inc.",495.52M,3.51,485.83M,-39.24%,-57.77%,-65.30%,-61.43%,-76.71%,iLearningEngines Forms Committee to Address Short-Seller Claims,iLearningEngines Announces Further Response to Short Report,iLearningEngines announces further response to short-seller report,iLearningEngines Announces Participation in the H.C. Wainwright Global Investment Conference,iLearningEngines Issues Statement on Short Seller Report,iLearningEngines Forms Committee to Address Short-Seller Claims iLearningEngines Announces Further Response to Short Report iLearningEngines announces further response to short-seller report iLearningEngines Announces Participation in the H.C. Wainwright Global Investment Conference iLearningEngines Issues Statement on Short Seller Report,1,0,0,0,0,0
25.34M,"81,974",36.76M,$0.64,556,20.47,Sell,19.00,"Aug 6, 2024",MRNO,Murano Global Investments Plc,495.27M,6.25,21.14M,-8.22%,-26.99%,-38.99%,-17.88%,-42.58%,Murano Global Investments Plans Debt Security Placement,,,,,Murano Global Investments Plans Debt Security Placement,0,1,-1,-1,-1,-1
33.81M,"327,129",8.49M,-1,800,15.34,Buy,19.60,"Jul 31, 2024",LAZR,"Luminar Technologies, Inc.",493.76M,1.00,76.49M,-7.45%,-26.55%,-49.18%,-39.76%,-50.00%,Largest borrow rate increases among liquid names,Luminar price target lowered to $6 from $8 at JPMorgan,Luminar price target lowered to $6 from $9 at Citi,,,Largest borrow rate increases among liquid names Luminar price target lowered to $6 from $8 at JPMorgan Luminar price target lowered to $6 from $9 at Citi,1,1,0,0,-1,-1
23.76M,"126,529","-21,000",-1,521,21.83,Buy,26.83,"Aug 8, 2024",PGC,Peapack-Gladstone Financial Corporation,493.46M,28.13,204.35M,2.92%,9.31%,8.95%,-3.93%,+15.34%,,,,,,,0,-1,-1,-1,-1,-1
38.38M,"325,181",-39.71M,-1,,13.50,Strong Buy,23.00,"Aug 8, 2024",GLAD,Gladstone Capital Corporation,493.39M,22.68,96.66M,-0.26%,-2.06%,5.35%,-5.61%,+13.60%,Gladstone Capital Welcomes Katharine Gorka to Board,,,,,Gladstone Capital Welcomes Katharine Gorka to Board,1,0,-1,-1,-1,-1
97.32M,"515,547",-160.66M,-1,59,5.31,Buy,15.00,"Aug 7, 2024",ALT,"Altimmune, Inc.",493.23M,6.94,409.00K,4.67%,1.03%,-13.43%,+1.89%,-28.71%,Altimmune call volume above normal and directionally bullish,Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 60th Annual Meeting of the European Association for the Study of Diabetes,Optimistic Buy Rating for Altimmune’s Pemvidutide on Promising Clinical and Strategic Developments,David Drutz to Exit Altimmune Board at Next Annual Meeting,B. Riley remains buyer of Altimmune into conference updates,Altimmune call volume above normal and directionally bullish Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 60th Annual Meeting of the European Association for the Study of Diabetes Optimistic Buy Rating for Altimmune’s Pemvidutide on Promising Clinical and Strategic Developments David Drutz to Exit Altimmune Board at Next Annual Meeting B. Riley remains buyer of Altimmune into conference updates,1,1,0,1,1,0
,,,-1,914,,,,,MSBI,"Midland States Bancorp, Inc.",493.11M,23.05,255.63M,3.34%,-0.54%,-6.04%,-3.92%,-5.94%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,121,,,,,EYPT,"EyePoint Pharmaceuticals, Inc.",491.83M,9.19,50.39M,4.74%,2.32%,-44.04%,-10.73%,-56.51%,EyePoint appoints Fred Hassan to board of directors,EyePoint Pharmaceuticals Appoints Esteemed Industry Leader Fred Hassan to Board of Directors,EyePoint initiated with a Buy at Jefferies,EyePoint Pharmaceuticals: A Buy Rating with a $15 Price Target Amid Promising Duravyu Prospects and Market Growth,EyePoint reports inducement grants under NASDAQ listing rule,EyePoint appoints Fred Hassan to board of directors EyePoint Pharmaceuticals Appoints Esteemed Industry Leader Fred Hassan to Board of Directors EyePoint initiated with a Buy at Jefferies EyePoint Pharmaceuticals: A Buy Rating with a $15 Price Target Amid Promising Duravyu Prospects and Market Growth EyePoint reports inducement grants under NASDAQ listing rule,0,1,1,0,0,0
,,,-1,186,,,,,CMPS,COMPASS Pathways plc,491.71M,7.19,-,12.75%,16.22%,-2.12%,+3.54%,-16.84%,Compass Pathways management to meet with BTIG,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,Rising High: SNDL announces successful bid to acquire Indiva,Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks,Buy Rating Affirmed for COMPASS Pathways Amid Progress in Pivotal Trials and Strong Financial Position,Compass Pathways management to meet with BTIG Rising High: MINT Shango JV to acquire Cannabist’s Florida entity Rising High: SNDL announces successful bid to acquire Indiva Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks Buy Rating Affirmed for COMPASS Pathways Amid Progress in Pivotal Trials and Strong Financial Position,0,0,1,0,1,1
,,,-1,57,,,,,MNMD,Mind Medicine (MindMed) Inc.,490.21M,6.02,-,-11.74%,-16.64%,-5.11%,-36.66%,-46.68%,MindMed Showcases Innovation at Investor Events,MindMed Reveals Breakthrough GAD Treatment Study,Mind Medicine Highlights GAD’s Economic Impact,MindMed Engages Investors at Upcoming Conferences,MindMed Engages in Key Industry Events for Brain Health,MindMed Showcases Innovation at Investor Events MindMed Reveals Breakthrough GAD Treatment Study Mind Medicine Highlights GAD’s Economic Impact MindMed Engages Investors at Upcoming Conferences MindMed Engages in Key Industry Events for Brain Health,1,1,0,1,0,1
61.05M,"396,977",-445.67M,-1,"2,600",8.41,Hold,16.28,"Jul 31, 2024",ZIMV,ZimVie Inc.,489.40M,17.75,453.38M,-2.87%,-5.31%,5.70%,-19.16%,+1.61%,,,,,,,1,-1,-1,-1,-1,-1
370.93M,"2,078,829",-135.82M,-1,64,1.380,Hold,1.43,"Aug 9, 2024",GLRE,"Greenlight Capital Re, Ltd.",489.20M,13.85,688.99M,4.85%,5.49%,12.54%,-0.07%,+10.06%,,,,,,,0,-1,-1,-1,-1,-1
216.71M,"4,778,200",-124.83M,-1,,2.360,Buy,5.00,"Aug 6, 2024",DGICB,Donegal Group Inc.,488.98M,12.77,961.31M,,5.49%,12.54%,+7.42%,-18.71%,,,,,,,0,-1,-1,-1,-1,-1
16.73M,"38,120",31.73M,$1.08,519,30.55,Hold,,"Oct 22, 2024",NNDM,Nano Dimension Ltd.,488.90M,2.23,54.96M,2.35%,-0.70%,-8.68%,-11.11%,-19.40%,Nano Dimension Nears Acquisition of Desktop Metal,Nano Dimension Clears Hart-Scott-Rodino (“HSR”) for Acquisition of Desktop Metal,Nano Dimension clears HSR for acquisition of Desktop Metal,Nano Dimension Hits Record Revenue and Acquires Desktop Metal,Nano Dimension reports Q2 EPS (20c) vs (4c) last year,Nano Dimension Nears Acquisition of Desktop Metal Nano Dimension Clears Hart-Scott-Rodino (“HSR”) for Acquisition of Desktop Metal Nano Dimension clears HSR for acquisition of Desktop Metal Nano Dimension Hits Record Revenue and Acquires Desktop Metal Nano Dimension reports Q2 EPS (20c) vs (4c) last year,0,1,1,0,1,1
32.35M,"140,714",-53.88M,-1,,15.76,,,"Aug 5, 2024",LAND,Gladstone Land Corporation,488.48M,13.63,89.37M,-2.00%,-2.79%,-0.46%,-9.83%,+3.00%,Gladstone Land Welcomes Katharine Gorka to Board of Directors,Oppenheimer Sticks to Their Buy Rating for Gladstone Land (LAND),Gladstone Land cut to Hold at Maxim on declining book value,Gladstone Land downgraded to Hold from Buy at Maxim,Hold Rating on Gladstone Land Corporation Amidst Underperformance and Cautious Expansion,Gladstone Land Welcomes Katharine Gorka to Board of Directors Oppenheimer Sticks to Their Buy Rating for Gladstone Land (LAND) Gladstone Land cut to Hold at Maxim on declining book value Gladstone Land downgraded to Hold from Buy at Maxim Hold Rating on Gladstone Land Corporation Amidst Underperformance and Cautious Expansion,0,0,0,0,0,0
113.56M,"657,773",-92.26M,-1,"2,670",4.490,Strong Buy,8.40,"Aug 14, 2024",SHYF,"The Shyft Group, Inc.",488.34M,14.17,794.33M,-0.09%,10.19%,17.71%,-17.89%,+15.13%,,,,,,,0,-1,-1,-1,-1,-1
25.96M,"278,982","-981,993",-1,"4,900",19.55,Strong Buy,20.67,"Aug 9, 2024",LE,"Lands' End, Inc.",485.54M,15.46,1.45B,9.15%,9.89%,44.60%,-12.21%,+38.78%,Land’s End raises Fy24 adjusted EPS view to 29c-48c from 18c-41c,"Land’s End reports Q2 adjusted EPS (2c), consensus (11c)","Land’s End sees Q3 adjusted EPS 0c-10c, consensus 4c",Lands’ End (LE) Gets a Buy from Craig-Hallum,"Is LE a Buy, Before Earnings?","Land’s End raises Fy24 adjusted EPS view to 29c-48c from 18c-41c Land’s End reports Q2 adjusted EPS (2c), consensus (11c) Land’s End sees Q3 adjusted EPS 0c-10c, consensus 4c Lands’ End (LE) Gets a Buy from Craig-Hallum Is LE a Buy, Before Earnings?",1,0,0,0,0,1
,,,-1,726,,,,,GDEV,GDEV Inc.,485.25M,2.68,452.21M,0.63%,7.28%,18.92%,-6.00%,+12.61%,"Analysts’ Opinions Are Mixed on These Communication Services Stocks: Globalstar (GSAT), Dave & Busters Entertainment (PLAY) and Nexters (GDEV)",GDEV Inc. Rebounds with Strategic Gains in Q2 2024,GDEV announces unaudited results for the second quarter and first half of 2024,Nexters Inc. (GDEV) Q2 Earnings Cheat Sheet,"GDEV Inc trading halted, news pending","Analysts’ Opinions Are Mixed on These Communication Services Stocks: Globalstar (GSAT), Dave & Busters Entertainment (PLAY) and Nexters (GDEV) GDEV Inc. Rebounds with Strategic Gains in Q2 2024 GDEV announces unaudited results for the second quarter and first half of 2024 Nexters Inc. (GDEV) Q2 Earnings Cheat Sheet GDEV Inc trading halted, news pending",1,1,0,1,1,0
40.86M,"326,233",34.20M,-1,538,12.41,Strong Buy,25.50,"Aug 1, 2024",GCMG,GCM Grosvenor Inc.,484.52M,10.87,461.33M,1.52%,4.77%,16.23%,-3.32%,+15.27%,GCM Grosvenor (GCMG) Receives a Rating Update from a Top Analyst,,,,,GCM Grosvenor (GCMG) Receives a Rating Update from a Top Analyst,0,0,-1,-1,-1,-1
72.81M,"170,696",12.04M,-1,19,6.95,Strong Buy,10.00,"Sep 4, 2024",TROO,"TROOPS, Inc.",481.57M,4.74,3.57M,13.85%,40.67%,100.39%,+25.24%,+267.15%,,,,,,,0,-1,-1,-1,-1,-1
118.16M,"444,791",-62.38M,-1,170,4.280,Strong Buy,9.00,"Aug 8, 2024",ACTG,Acacia Research Corporation,480.80M,4.79,152.55M,-1.40%,-6.59%,2.81%,-11.40%,-9.20%,,,,,,,0,-1,-1,-1,-1,-1
12.72M,"323,090",28.73M,-1,245,39.44,Strong Buy,60.00,"Aug 5, 2024",ZJYL,Jin Medical International Ltd.,480.60M,3.07,20.13M,-10.53%,-6.92%,-33.09%,+0.71%,-9.03%,,,,,,,0,-1,-1,-1,-1,-1
63.81M,"193,438",-58.34M,-1,"1,282",7.86,Strong Buy,21.33,"Aug 7, 2024",BRY,Berry Corporation,479.33M,6.23,844.47M,-0.35%,-3.03%,-10.62%,-9.91%,-28.88%,"Berry Corporation Reaffirms a Strong Liquidity Position, Balance Sheet Strength, and Ongoing Free Cash Flow Generation",Berry Corporation says production remains on track with prior guidance,Jefferies Sticks to Its Hold Rating for Berry Petroleum (BRY),Piper Sandler Reaffirms Their Hold Rating on Berry Petroleum (BRY),Berry Corporation price target lowered to $7 from $8 at Piper Sandler,"Berry Corporation Reaffirms a Strong Liquidity Position, Balance Sheet Strength, and Ongoing Free Cash Flow Generation Berry Corporation says production remains on track with prior guidance Jefferies Sticks to Its Hold Rating for Berry Petroleum (BRY) Piper Sandler Reaffirms Their Hold Rating on Berry Petroleum (BRY) Berry Corporation price target lowered to $7 from $8 at Piper Sandler",0,1,0,0,0,0
247.03M,"6,274",-6.40M,-1,204,2.000,,,,BCAL,California BanCorp.,479.16M,14.92,87.33M,1.87%,5.07%,0.22%,-5.95%,+2.27%,,,,,,,0,-1,-1,-1,-1,-1
33.48M,"73,347",7.33M,$0.69,140,14.97,,,"Jul 25, 2024",ESQ,"Esquire Financial Holdings, Inc.",479.04M,61.26,112.34M,5.30%,13.82%,23.11%,-2.19%,+29.94%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,"1,360",,,,,GRAL,"GRAIL, Inc.",478.47M,15.41,109.74M,-8.32%,-7.59%,-7.11%,-5.53%,,Grail’s multi-cancer early detection test in prostate cancer shows efficacy,Grail reports Q2 adjusted EBITDA ($139.4M) vs. ($136.5M) last year,"Closing Bell Movers: Flutter jumps 10% on earnings, guidance raise",Grail Inc trading resumes,GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update,"Grail’s multi-cancer early detection test in prostate cancer shows efficacy Grail reports Q2 adjusted EBITDA ($139.4M) vs. ($136.5M) last year Closing Bell Movers: Flutter jumps 10% on earnings, guidance raise Grail Inc trading resumes GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update",1,1,1,1,0,0
41.74M,"4,898",-65.27M,-1,168,11.95,Strong Buy,30.17,"Aug 27, 2024",OFLX,"Omega Flex, Inc.",478.27M,47.38,105.48M,-1.18%,-6.99%,-28.11%,-11.83%,-33.91%,,,,,,,0,-1,-1,-1,-1,-1
65.08M,"18,800","20,949",-1,135,7.65,Strong Buy,12.25,"Jul 31, 2024",SLRN,"Acelyrin, Inc.",478.08M,4.79,-,2.62%,-1.61%,-19.21%,-17.67%,-18.62%,"ACELYRIN, INC. to Participate in Upcoming Investor Conferences","ACELYRIN, INC.: Hold Rating Maintained Amid Strategic Pipeline Shift and Extended Cash Runway",Acelyrin price target lowered to $6 from $13 at Morgan Stanley,"Strategic Realignment Fuels Buy Rating for ACELYRIN, INC.","Piper Sandler Keeps Their Buy Rating on ACELYRIN, INC. (SLRN)","ACELYRIN, INC. to Participate in Upcoming Investor Conferences ACELYRIN, INC.: Hold Rating Maintained Amid Strategic Pipeline Shift and Extended Cash Runway Acelyrin price target lowered to $6 from $13 at Morgan Stanley Strategic Realignment Fuels Buy Rating for ACELYRIN, INC. Piper Sandler Keeps Their Buy Rating on ACELYRIN, INC. (SLRN)",1,0,1,0,1,0
16.70M,"51,967",45.24M,$0.80,37,29.79,Buy,28.50,"Jul 24, 2024",QTTB,Q32 Bio Inc.,476.24M,39.49,-12.80M,0.48%,30.60%,87.35%,+1.44%,+91.05%,Piper Sandler Sticks to Their Buy Rating for Q32 Bio (QTTB),"Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)","Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)",,,"Piper Sandler Sticks to Their Buy Rating for Q32 Bio (QTTB) Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB) Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)",1,0,0,0,-1,-1
141.17M,"216,766",-342.92M,-1,"5,860",3.510,Strong Buy,18.00,"Aug 13, 2024",SFIX,"Stitch Fix, Inc.",475.91M,3.89,1.43B,-2.48%,-10.14%,11.03%,-21.02%,+64.60%,Stitch Fix Appoints New Industry Experts to Board,"Stitch Fix adds Baxter, Tan to board of directors",Stitch Fix Adds Timothy Baxter and Fiona Tan to its Board of Directors,,,"Stitch Fix Appoints New Industry Experts to Board Stitch Fix adds Baxter, Tan to board of directors Stitch Fix Adds Timothy Baxter and Fiona Tan to its Board of Directors",0,1,0,0,-1,-1
79.24M,20,-8.37M,-1,864,6.49,,,"Sep 3, 2024",LILM,Lilium N.V.,475.80M,0.77,-,-4.61%,-10.06%,-20.42%,-17.27%,-21.76%,Lilium Schedules Extraordinary Shareholders Meeting,Horizon Aircraft appoints Tom Brassington as CTO,Lilium Starts Integration Testing of Lilium Jet Electrical Power System,Lilium starts integration testing of Lilium Jet electrical power system,,Lilium Schedules Extraordinary Shareholders Meeting Horizon Aircraft appoints Tom Brassington as CTO Lilium Starts Integration Testing of Lilium Jet Electrical Power System Lilium starts integration testing of Lilium Jet electrical power system,0,0,1,0,0,-1
493.76M,"8,083,206",-539.06M,-1,"1,100",1.000,Hold,3.60,"Aug 6, 2024",BAND,Bandwidth Inc.,473.08M,17.33,662.03M,2.64%,-2.24%,3.99%,-25.02%,-2.06%,Bandwidth CEO told JMP Securities ‘business is excellent’,JMP Securities Sticks to Their Buy Rating for Bandwidth (BAND),Analysts Offer Insights on Technology Companies: Bandwidth (BAND) and Procore Technologies (PCOR),Bandwidth participates in a conference call with JMP Securities,,Bandwidth CEO told JMP Securities ‘business is excellent’ JMP Securities Sticks to Their Buy Rating for Bandwidth (BAND) Analysts Offer Insights on Technology Companies: Bandwidth (BAND) and Procore Technologies (PCOR) Bandwidth participates in a conference call with JMP Securities,0,1,1,0,0,-1
17.54M,"67,098",33.52M,$0.20,,28.13,Buy,32.00,"Jul 23, 2024",GAIN,Gladstone Investment Corporation,471.82M,12.86,89.18M,-2.77%,-6.33%,-8.32%,-8.84%,-7.79%,Gladstone Investment Welcomes Katharine Gorka to Board,,,,,Gladstone Investment Welcomes Katharine Gorka to Board,0,0,-1,-1,-1,-1
21.75M,"95,372",75.79M,$1.98,395,22.68,,,"Aug 7, 2024",PFIS,Peoples Financial Services Corp.,470.56M,47.17,90.82M,3.87%,4.61%,10.03%,-4.97%,+21.90%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,SHBI,"Shore Bancshares, Inc.",470.43M,14.12,167.59M,5.90%,12.44%,18.09%,-2.48%,+29.91%,,,,,,,1,-1,-1,-1,-1,-1
71.07M,"1,950,072",-101.35M,-1,,6.94,Buy,18.80,"Aug 8, 2024",FFWM,First Foundation Inc.,468.86M,6.91,230.71M,7.07%,10.65%,-3.60%,-1.00%,-4.15%,,,,,,,0,-1,-1,-1,-1,-1
21.39M,"59,696",43.14M,$1.24,,23.05,Hold,26.75,"Jul 25, 2024",MOFG,"MidWestOne Financial Group, Inc.",465.63M,29.52,173.96M,3.97%,12.37%,20.76%,-2.76%,+31.70%,MidWestOne files $150M mixed securities shelf,,,,,MidWestOne files $150M mixed securities shelf,0,0,-1,-1,-1,-1
53.52M,"301,062",-86.82M,-1,"7,000",9.19,Strong Buy,32.20,"Aug 7, 2024",VLGEA,"Village Super Market, Inc.",464.95M,31.44,2.21B,9.40%,15.27%,18.36%,+1.01%,+14.08%,,,,,,,0,-1,-1,-1,-1,-1
68.39M,"2,974,222",-139.21M,-1,"2,168",7.19,Strong Buy,47.40,"Aug 1, 2024",ZEUS,"Olympic Steel, Inc.",463.34M,41.62,2.07B,-4.98%,-9.27%,-30.02%,-21.09%,-44.47%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",,,,,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",0,1,-1,-1,-1,-1
81.43M,"754,679",-102.04M,-1,731,6.02,Strong Buy,26.83,"Aug 13, 2024",SKYT,"SkyWater Technology, Inc.",462.92M,9.75,323.74M,10.31%,17.31%,6.79%,+20.27%,-13.17%,Largest borrow rate increases among liquid names,,,,,Largest borrow rate increases among liquid names,1,1,-1,-1,-1,-1
27.57M,"104,893",-351.72M,-1,145,17.75,Hold,18.33,"Aug 1, 2024",CCCC,"C4 Therapeutics, Inc.",460.40M,6.64,29.38M,5.38%,14.45%,8.64%,-4.93%,-15.29%,C4 Therapeutics (CCCC) Gets a Buy from Stifel Nicolaus,C4 Therapeutics Announces Board Changes and Strategic Shift,C4 Therapeutics appoints Stephen Fawell to board of directors,"C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors",C4 Therapeutics to Participate in Upcoming September Investor Conferences,"C4 Therapeutics (CCCC) Gets a Buy from Stifel Nicolaus C4 Therapeutics Announces Board Changes and Strategic Shift C4 Therapeutics appoints Stephen Fawell to board of directors C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors C4 Therapeutics to Participate in Upcoming September Investor Conferences",0,1,1,1,0,0
35.32M,"114,158",66.08M,-1,"1,900",13.85,,,"Aug 6, 2024",AMCX,AMC Networks Inc.,459.94M,10.43,2.54B,2.13%,1.26%,-25.00%,-8.72%,-11.65%,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance",Charter and AMC Networks to renew distribution agreement,Seaport Global Sticks to Their Hold Rating for AMC Networks (AMCX),AMC Networks Sell Rating Due to Declining Revenues and Industry Challenges,AMC Networks Sell Rating: Unsustainable Licensing Revenues and Declining AOIBDA Outlook,"S&P announces changes to S&P 400, 600 indexes for quarterly rebalance Charter and AMC Networks to renew distribution agreement Seaport Global Sticks to Their Hold Rating for AMC Networks (AMCX) AMC Networks Sell Rating Due to Declining Revenues and Industry Challenges AMC Networks Sell Rating: Unsustainable Licensing Revenues and Declining AOIBDA Outlook",1,1,0,0,1,1
33.48M,"1,498",7.33M,$0.62,143,12.88,,,"Jul 25, 2024",MXCT,"MaxCyte, Inc.",458.49M,4.35,45.44M,-0.69%,-1.67%,-4.98%,-11.67%,+2.17%,"MaxCyte Director Executes Options, Sells Shares",MaxCyte Announces Participation in Bioprocessing Conference,MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference,MaxCyte management to meet with Stephens,MaxCyte Director Executes Stock Options and Sells,"MaxCyte Director Executes Options, Sells Shares MaxCyte Announces Participation in Bioprocessing Conference MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference MaxCyte management to meet with Stephens MaxCyte Director Executes Stock Options and Sells",0,1,1,0,1,1
,,,-1,253,,,,,NIPG,NIP Group Inc.,455.53M,8.10,83.67M,-10.39%,-14.03%,-14.03%,-27.84%,,NIP Group Enters Esports Hotel Sector with Strategic Partnership with Homeinns,,,,,NIP Group Enters Esports Hotel Sector with Strategic Partnership with Homeinns,1,1,-1,-1,-1,-1
219.24M,"590,580",-146.40M,-1,"2,000",2.230,,,"Aug 20, 2024",BWMN,Bowman Consulting Group Ltd.,454.22M,24.95,386.81M,-6.82%,-18.41%,-23.09%,-33.71%,-26.96%,Craig-Hallum Reaffirms Their Buy Rating on Bowman Consulting Group (BWMN),Bowman contracted to commence roadway project in Philadelphia,"Analysts Conflicted on These Industrial Goods Names: Kornit Digital (KRNT), Titan Machinery (TITN) and Bowman Consulting Group (BWMN)",Bowman Consulting Group (BWMN) Gets a Buy from Craig-Hallum,"Analysts Conflicted on These Industrial Goods Names: Donaldson Company (DCI), Titan Machinery (TITN) and Bowman Consulting Group (BWMN)","Craig-Hallum Reaffirms Their Buy Rating on Bowman Consulting Group (BWMN) Bowman contracted to commence roadway project in Philadelphia Analysts Conflicted on These Industrial Goods Names: Kornit Digital (KRNT), Titan Machinery (TITN) and Bowman Consulting Group (BWMN) Bowman Consulting Group (BWMN) Gets a Buy from Craig-Hallum Analysts Conflicted on These Industrial Goods Names: Donaldson Company (DCI), Titan Machinery (TITN) and Bowman Consulting Group (BWMN)",1,0,0,1,0,1
35.84M,"113,021",-6.46M,$0.56,91,13.63,Strong Buy,17.33,"Aug 8, 2024",NGNE,Neurogene Inc.,454.00M,34.94,925.00K,-1.45%,-5.19%,13.63%,-13.10%,-13.46%,Three new option listings and one option delisting on August 14th,Buy Rating for Neurogene: Promising Rett Syndrome Program and Strong Financial Outlook,Buy Rating on Neurogene Backed by Strong 2Q24 Earnings and Promising Pipeline Progress,Buy Rating Affirmed for Neurogene Amid Promising Outlook for Gene Therapy Candidate NGN-401,Neurogene’s NGN-401 Wins Key FDA Designation,Three new option listings and one option delisting on August 14th Buy Rating for Neurogene: Promising Rett Syndrome Program and Strong Financial Outlook Buy Rating on Neurogene Backed by Strong 2Q24 Earnings and Promising Pipeline Progress Buy Rating Affirmed for Neurogene Amid Promising Outlook for Gene Therapy Candidate NGN-401 Neurogene’s NGN-401 Wins Key FDA Designation,0,0,0,1,0,0
,,,-1,"1,325",,,,,NWPX,Northwest Pipe Company,453.88M,45.76,471.61M,9.83%,20.98%,37.38%,+15.94%,+28.31%,,,,,,,0,-1,-1,-1,-1,-1
34.46M,"187,365",-2.40M,$0.20,"7,900",14.17,Buy,15.00,"Jul 25, 2024",KE,"Kimball Electronics, Inc.",453.61M,18.24,1.71B,-9.57%,-16.13%,-20.65%,-22.74%,-13.30%,Kimball Electronics (KE) Receives a Buy from Cantor Fitzgerald,Kimball Electronics price target lowered to $22 from $28 at Cantor Fitzgerald,Kimball Electronics price target lowered to $23 from $25 at Lake Street,Kimball Electronics price target lowered to $29 from $30 at B. Riley,Kimball Electronics downgraded to Neutral from Buy at Sidoti,Kimball Electronics (KE) Receives a Buy from Cantor Fitzgerald Kimball Electronics price target lowered to $22 from $28 at Cantor Fitzgerald Kimball Electronics price target lowered to $23 from $25 at Lake Street Kimball Electronics price target lowered to $29 from $30 at B. Riley Kimball Electronics downgraded to Neutral from Buy at Sidoti,1,1,1,1,1,1
31.41M,"78,135",-135.47M,-1,635,15.46,Strong Buy,20.00,"Sep 5, 2024",NTGR,"NETGEAR, Inc.",452.55M,15.78,695.01M,2.93%,5.00%,10.92%,+2.08%,+7.92%,Netgear teams with Samsung Electronics on interoperability and roaming,Netgear Announces Chief Revenue Officer’s Upcoming Departure,,,,Netgear teams with Samsung Electronics on interoperability and roaming Netgear Announces Chief Revenue Officer’s Upcoming Departure,0,1,1,-1,-1,-1
181.06M,988,52.85M,-1,176,2.610,Buy,6.00,"Sep 6, 2024",HNST,"The Honest Company, Inc.",452.37M,4.52,355.70M,11.53%,25.72%,38.85%,+13.40%,+11.61%,Honest Company enters collaboration with Lil’ Libros,Telsey Advisory Sticks to Its Hold Rating for Honest Company (HNST),Wall Street Analysts Are Bullish on Top Consumer Goods Picks,Honest Company price target raised to $5 from $3 at Loop Capital,,Honest Company enters collaboration with Lil’ Libros Telsey Advisory Sticks to Its Hold Rating for Honest Company (HNST) Wall Street Analysts Are Bullish on Top Consumer Goods Picks Honest Company price target raised to $5 from $3 at Loop Capital,0,0,0,1,0,-1
44.57M,"315,470",16.08M,$0.44,"1,321",10.87,Buy,11.60,"Aug 8, 2024",BIGC,"BigCommerce Holdings, Inc.",451.75M,5.81,324.38M,-3.21%,-17.86%,-24.20%,-28.52%,-10.37%,BigCommerce price target lowered to $6 from $8 at BofA,Barclays Gives a Hold Rating to BigCommerce Holdings (BIGC),KeyBanc Sticks to Their Hold Rating for BigCommerce Holdings (BIGC),Stifel Nicolaus Remains a Buy on BigCommerce Holdings (BIGC),"BigCommerce Holdings: Strong Buy Rating on Product Innovation, Enterprise Growth, and Strategic Leadership","BigCommerce price target lowered to $6 from $8 at BofA Barclays Gives a Hold Rating to BigCommerce Holdings (BIGC) KeyBanc Sticks to Their Hold Rating for BigCommerce Holdings (BIGC) Stifel Nicolaus Remains a Buy on BigCommerce Holdings (BIGC) BigCommerce Holdings: Strong Buy Rating on Product Innovation, Enterprise Growth, and Strategic Leadership",1,0,1,0,1,0
101.60M,"246,301",-1.72M,-1,24,4.740,,,"Sep 3, 2024",OPT,Opthea Limited,451.35M,2.87,390.44K,20.82%,34.75%,5.66%,+30.40%,-27.98%,Optimistic Buy Rating for Opthea Limited Amid Anticipated Success of Sozinibercept Trials,Opthea Prepares for Phase 3 Results with Leadership Revamp,Opthea announces executive leadership changes and senior hires,Opthea Announces Executive Leadership Changes and Senior Hires,Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference,Optimistic Buy Rating for Opthea Limited Amid Anticipated Success of Sozinibercept Trials Opthea Prepares for Phase 3 Results with Leadership Revamp Opthea announces executive leadership changes and senior hires Opthea Announces Executive Leadership Changes and Senior Hires Opthea to Participate in H.C. Wainwright 26th Global Investment Conference and Cantor 2024 Global Healthcare Conference,1,0,0,1,1,1
100.38M,"149,087",60.47M,-1,52,4.790,Strong Buy,7.00,"Aug 8, 2024",TSHA,"Taysha Gene Therapies, Inc.",450.88M,2.20,12.87M,-1.99%,-8.77%,-7.06%,-5.43%,-22.01%,Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),Taysha Gene Therapies announces inducement grant under Nasdaq listing rule,Buy Rating for Taysha Gene Therapies Backed by Extended Cash Runway and Promising Trial Prospects,Maintained Buy Rating on Taysha Gene Therapies Amid Progress and Solid Financials,Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord,Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Taysha Gene Therapies announces inducement grant under Nasdaq listing rule Buy Rating for Taysha Gene Therapies Backed by Extended Cash Runway and Promising Trial Prospects Maintained Buy Rating on Taysha Gene Therapies Amid Progress and Solid Financials Taysha Gene Therapies price target lowered to $6 from $7 at Canaccord,0,0,0,0,0,0
156.55M,"102,063",2.91M,-1,292,3.070,,,"Sep 6, 2024",EVGO,"EVgo, Inc.",449.74M,4.21,206.88M,15.39%,31.58%,59.28%,+7.81%,+93.46%,Needham Sticks to Their Hold Rating for EVgo (EVGO),EVgo management to meet virtually with Needham,,,,Needham Sticks to Their Hold Rating for EVgo (EVGO) EVgo management to meet virtually with Needham,0,0,0,-1,-1,-1
76.94M,"779,850",-31.36M,$0.68,499,6.23,Hold,7.00,"Aug 9, 2024",LSEA,Landsea Homes Corporation,446.19M,12.30,1.40B,7.79%,17.18%,8.64%,-1.48%,-10.58%,,,,,,,1,-1,-1,-1,-1,-1
32.12M,"46,633",16.09M,-1,,14.92,Hold,,"Jul 29, 2024",ANSC,Agriculture & Natural Solutions Acquisition Corporation,445.91M,10.34,-,0.12%,0.48%,1.22%,+0.34%,+1.77%,Agriculture & Natural Solutions’ Strategic Business Combination and Expansion,,,,,Agriculture & Natural Solutions’ Strategic Business Combination and Expansion,0,1,-1,-1,-1,-1
7.82M,"13,505",40.26M,$0.60,400,61.26,Strong Buy,63.50,"Oct 21, 2024",GRVY,"Gravity Co., Ltd.",445.77M,64.15,399.94M,-7.09%,-15.65%,-12.01%,-21.83%,-17.92%,,,,,,,0,-1,-1,-1,-1,-1
31.05M,"1,011,496",-2.88B,-1,754,15.41,,,"Aug 13, 2024",ALRS,Alerus Financial Corporation,444.60M,22.48,164.06M,3.65%,7.51%,6.89%,-0.98%,+6.62%,,,,,,,0,-1,-1,-1,-1,-1
10.09M,"17,213",19.18M,$1.36,116,47.38,,,"Oct 16, 2024",FHTX,Foghorn Therapeutics Inc.,443.18M,8.01,35.19M,23.02%,31.18%,39.76%,+8.26%,+7.04%,Foghorn Therapeutics appoints Anna Rivkin as CBO,"Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer",Foghorn Therapeutics initiated with a Buy at Jefferies,Innovative Cancer Treatments Propel Foghorn Therapeutics’ Growth Potential: Analyst Buy Rating Justified,Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in September,"Foghorn Therapeutics appoints Anna Rivkin as CBO Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer Foghorn Therapeutics initiated with a Buy at Jefferies Innovative Cancer Treatments Propel Foghorn Therapeutics’ Growth Potential: Analyst Buy Rating Justified Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in September",1,1,1,1,1,0
99.81M,"510,500",-299.80M,-1,129,4.790,Buy,10.83,"Aug 13, 2024",DHIL,"Diamond Hill Investment Group, Inc.",442.80M,160.96,142.33M,3.92%,6.92%,3.66%,+1.21%,+7.82%,,,,,,,1,-1,-1,-1,-1,-1
12.06M,"136,753",-57.05M,-1,"3,227",39.49,Strong Buy,62.25,"Aug 8, 2024",ADTN,"ADTRAN Holdings, Inc.",441.42M,5.59,949.97M,-1.20%,-2.62%,-7.28%,-20.38%,+7.16%,Adtran Executives’ Contracts Extended and Salaries Adjusted,,,,,Adtran Executives’ Contracts Extended and Salaries Adjusted,0,0,-1,-1,-1,-1
122.34M,"856,554",-121.00M,-1,"1,300",3.890,Hold,3.45,"Sep 16, 2024",HCAT,"Health Catalyst, Inc.",439.62M,7.27,299.48M,1.89%,3.25%,-9.35%,-7.46%,+3.65%,Health Catalyst price target raised to $13 from $10 at JPMorgan,Health Catalyst to Participate in Upcoming Investor Conferences,Health Catalyst price target lowered to $11 from $14 at Piper Sandler,"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)",Health Catalyst (HCAT) Receives a Buy from Barclays,"Health Catalyst price target raised to $13 from $10 at JPMorgan Health Catalyst to Participate in Upcoming Investor Conferences Health Catalyst price target lowered to $11 from $14 at Piper Sandler Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT) Health Catalyst (HCAT) Receives a Buy from Barclays",1,0,0,0,1,1
615.92M,"2,855,960",-430.11M,-1,686,0.773,Buy,1.70,"Sep 3, 2024",BYND,"Beyond Meat, Inc.",438.36M,6.74,317.78M,1.62%,-3.78%,-16.26%,-3.34%,-18.08%,Beyond Meat to launch new steak alternative as it focuses on health,Largest borrow rate increases among liquid names,Beyond Meat (BYND) Receives a Hold from BTIG,Beyond Meat price target lowered to $5 from $6 at Mizuho,Analysts Offer Insights on Consumer Goods Companies: Beyond Meat (BYND) and Target (TGT),Beyond Meat to launch new steak alternative as it focuses on health Largest borrow rate increases among liquid names Beyond Meat (BYND) Receives a Hold from BTIG Beyond Meat price target lowered to $5 from $6 at Mizuho Analysts Offer Insights on Consumer Goods Companies: Beyond Meat (BYND) and Target (TGT),1,1,1,1,1,1
27.30M,"128,073",-21.24M,-1,"1,030",17.33,Buy,25.25,"Aug 1, 2024",CYRX,"Cryoport, Inc.",437.79M,8.86,225.61M,3.24%,8.10%,-33.60%,-5.42%,-52.06%,,,,,,,0,-1,-1,-1,-1,-1
36.69M,"230,355",69.99M,$0.96,181,12.86,Hold,13.50,"Aug 5, 2024",FATE,"Fate Therapeutics, Inc.",437.29M,3.84,12.32M,-8.94%,-8.60%,-21.23%,-34.15%,-49.28%,Fate Therapeutics Strengthens Legal Safeguards for Leadership,Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Fate Therapeutics (FATE),Fate Therapeutics: Hold Rating Amid Financial Stability and Upcoming Milestones,Fate Therapeutics’ Promising Outlook: Buy Rating on Innovative Cell Therapy Programs FT819 and FT522,Fate Therapeutics (FATE) Gets a Hold from Stifel Nicolaus,Fate Therapeutics Strengthens Legal Safeguards for Leadership Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Fate Therapeutics (FATE) Fate Therapeutics: Hold Rating Amid Financial Stability and Upcoming Milestones Fate Therapeutics’ Promising Outlook: Buy Rating on Innovative Cell Therapy Programs FT819 and FT522 Fate Therapeutics (FATE) Gets a Hold from Stifel Nicolaus,1,1,1,1,1,1
,,,-1,20,,,,,GTI,Graphjet Technology,435.82M,2.97,-,7.50%,-27.22%,-66.66%,-16.15%,-64.71%,,,,,,,1,-1,-1,-1,-1,-1
9.98M,"16,725",17.12M,$1.85,590,47.17,Hold,47.00,"Jul 25, 2024",MITK,"Mitek Systems, Inc.",435.70M,9.43,166.52M,-8.01%,-15.19%,-22.26%,-30.88%,-36.99%,Craig-Hallum Keeps Their Buy Rating on Mitek Systems (MITK),Mitek Systems downgraded to Hold from Buy at Jefferies,Mitek Systems Hold Rating and Revised Financial Forecasts Amidst Strategic Uncertainty,Mitek Systems and Alogent team on expanding ‘check fraud epidemic’,"Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz","Craig-Hallum Keeps Their Buy Rating on Mitek Systems (MITK) Mitek Systems downgraded to Hold from Buy at Jefferies Mitek Systems Hold Rating and Revised Financial Forecasts Amidst Strategic Uncertainty Mitek Systems and Alogent team on expanding ‘check fraud epidemic’ Texas probes CenterPoint, Starbucks in talks with Elliott: Morning Buzz",0,0,1,1,0,1
,,,-1,"1,540",,,,,LYTS,LSI Industries Inc.,432.63M,15.39,469.64M,4.00%,4.12%,7.67%,-8.44%,+2.36%,Craig-Hallum Sticks to Their Buy Rating for Lsi Industries (LYTS),Optimistic Future and Buy Rating for LSI Industries Amid Financial Resilience and Strategic Growth,"Analysts Are Bullish on These Technology Stocks: Globant SA (GLOB), Lsi Industries (LYTS)",Buy Rating Affirmed: Strategic Acquisitions and Strong Financial Performance Propel LSI Industries’ Growth Outlook,LSI Industries Financial Results Conference Call Announcement,"Craig-Hallum Sticks to Their Buy Rating for Lsi Industries (LYTS) Optimistic Future and Buy Rating for LSI Industries Amid Financial Resilience and Strategic Growth Analysts Are Bullish on These Technology Stocks: Globant SA (GLOB), Lsi Industries (LYTS) Buy Rating Affirmed: Strategic Acquisitions and Strong Financial Performance Propel LSI Industries’ Growth Outlook LSI Industries Financial Results Conference Call Announcement",0,0,0,0,0,0
,,,-1,637,,,,,CERS,Cerus Corporation,431.74M,2.33,169.98M,5.13%,11.86%,19.08%,-0.88%,+19.79%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,115,,,,,AEHR,"Aehr Test Systems, Inc.",431.28M,14.59,66.22M,0.45%,2.18%,-10.34%,-23.58%,+27.16%,Aehr Test Systems Enhances Executive Severance Agreements,Aehr Test Systems secures first multisystem orders for Sonoma system,,,,Aehr Test Systems Enhances Executive Severance Agreements Aehr Test Systems secures first multisystem orders for Sonoma system,1,1,0,-1,-1,-1
14.79M,"28,645",48.44M,$1.00,267,31.44,,,"Oct 2, 2024",SVCO,"Silvaco Group, Inc.",430.17M,16.36,58.28M,1.13%,-7.22%,-8.77%,-9.42%,,,,,,,,1,-1,-1,-1,-1,-1
11.13M,"94,322",36.00M,$0.60,556,41.62,,,"Aug 1, 2024",KRNY,Kearny Financial Corp.,429.46M,6.88,134.38M,5.30%,7.62%,1.12%,-5.83%,+10.06%,,,,,,,0,-1,-1,-1,-1,-1
47.48M,"203,392",-25.52M,-1,"3,064",9.75,Strong Buy,12.00,"Aug 7, 2024",CVGW,"Calavo Growers, Inc.",429.16M,24.11,992.90M,3.78%,3.33%,-8.25%,-1.68%,-8.56%,Why most of the avocados in the U.S. come from Mexico,Calavo Growers (CVGW) Q3 Earnings Cheat Sheet,Calavo Growers (CVGW) Gets a Buy from Lake Street,Calavo Growers to Report Third Quarter Financial Results,Calavo Growers Streamlines Operations and Amends Credit Terms,Why most of the avocados in the U.S. come from Mexico Calavo Growers (CVGW) Q3 Earnings Cheat Sheet Calavo Growers (CVGW) Gets a Buy from Lake Street Calavo Growers to Report Third Quarter Financial Results Calavo Growers Streamlines Operations and Amends Credit Terms,0,0,0,0,0,0
69.34M,"936,903",-107.87M,-1,377,6.64,Buy,9.29,"Aug 1, 2024",XERS,"Xeris Biopharma Holdings, Inc.",429.12M,2.88,181.41M,14.22%,21.06%,27.64%,+12.50%,+36.76%,Buy Rating Affirmed: Xeris Pharmaceuticals Outperforms with Strong Sales and Promising Pipeline,"Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX)",Oppenheimer Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS),Xeris Biopharma price target raised to $5 from $4.50 at Craig-Hallum,,"Buy Rating Affirmed: Xeris Pharmaceuticals Outperforms with Strong Sales and Promising Pipeline Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX) Oppenheimer Reaffirms Their Buy Rating on Xeris Pharmaceuticals (XERS) Xeris Biopharma price target raised to $5 from $4.50 at Craig-Hallum",1,0,0,0,0,-1
44.10M,"529,444",58.18M,-1,293,10.43,Sell,11.00,"Aug 9, 2024",CWCO,Consolidated Water Co. Ltd.,426.90M,26.96,175.27M,2.95%,4.68%,-4.67%,-5.16%,+5.63%,Consolidated Water increases dividend and declares Q4 11c cash dividend,Consolidated Water Increases Dividend and Declares Fourth Quarter Cash Dividend of $0.11 per Share,"Cisco, Walmart report quarterly earnings beats: Morning Buzz","Consolidated Water reports Q2 EPS 99c, consensus 34c","Is CWCO a Buy, Before Earnings?","Consolidated Water increases dividend and declares Q4 11c cash dividend Consolidated Water Increases Dividend and Declares Fourth Quarter Cash Dividend of $0.11 per Share Cisco, Walmart report quarterly earnings beats: Morning Buzz Consolidated Water reports Q2 EPS 99c, consensus 34c Is CWCO a Buy, Before Earnings?",0,0,0,1,0,1
105.09M,"287,878",-35.43M,-1,480,4.350,Strong Buy,8.67,"Aug 6, 2024",ALTI,"AlTi Global, Inc.",426.17M,4.64,241.81M,2.28%,-7.67%,-26.53%,-15.92%,-16.43%,Alvarium Tiedemann Issues Updated Investor Presentation,,,,,Alvarium Tiedemann Issues Updated Investor Presentation,1,0,-1,-1,-1,-1
56.24M,"129,191",-57.17M,-1,796,8.10,,,,PACB,"Pacific Biosciences of California, Inc.",425.15M,1.56,188.87M,-9.23%,-8.72%,-65.86%,-34.47%,-59.70%,PacBio announces collaboration with University Hospital of Munster,PacBio price target lowered to $7 from $8 at Scotiabank,Pacific Biosciences (PACB) Receives a Buy from Scotiabank,PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference,PacBio price target lowered to $2.50 from $3.50 at Stephens,PacBio announces collaboration with University Hospital of Munster PacBio price target lowered to $7 from $8 at Scotiabank Pacific Biosciences (PACB) Receives a Buy from Scotiabank PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference PacBio price target lowered to $2.50 from $3.50 at Stephens,0,0,1,1,1,0
18.21M,"78,531",-10.17M,-1,69,24.95,Strong Buy,41.08,"Aug 6, 2024",ISPR,Ispire Technology Inc.,424.81M,7.50,147.19M,0.42%,-1.01%,-15.49%,-5.50%,+24.05%,,,,,,,1,-1,-1,-1,-1,-1
12.99M,"47,136",2.36M,-1,532,34.94,Strong Buy,49.00,"Aug 9, 2024",BSRR,Sierra Bancorp,424.42M,29.90,142.35M,5.21%,14.63%,36.95%,+0.58%,+50.98%,,,,,,,0,-1,-1,-1,-1,-1
9.92M,"57,811",25.12M,-1,564,45.76,Strong Buy,45.00,"Jul 31, 2024",FFIC,Flushing Financial Corporation,422.37M,14.53,190.70M,4.90%,3.67%,3.65%,-3.73%,+18.96%,,,,,,,0,-1,-1,-1,-1,-1
24.87M,"131,261",20.49M,-1,20,18.24,Buy,23.80,"Aug 13, 2024",HIVE,HIVE Digital Technologies Ltd.,421.90M,3.63,123.14M,8.20%,0.49%,1.30%,-14.60%,-2.52%,HIVE Digital Boosts Bitcoin Holdings and Mining Efficiency,Hive Digital announces 112 bitcoin produced in August,HIVE Digital Technologies: A Strong Buy on Undervaluation and Growth Prospects in HPC/AI,Hive Digital upgraded to Buy from Neutral at H.C. Wainwright,"Options Volatility and Implied Earnings Moves Today, August 13, 2024","HIVE Digital Boosts Bitcoin Holdings and Mining Efficiency Hive Digital announces 112 bitcoin produced in August HIVE Digital Technologies: A Strong Buy on Undervaluation and Growth Prospects in HPC/AI Hive Digital upgraded to Buy from Neutral at H.C. Wainwright Options Volatility and Implied Earnings Moves Today, August 13, 2024",1,1,0,0,0,0
28.68M,"303,334",-150.29M,-1,"3,353",15.78,Buy,15.00,"Jul 31, 2024",RDUS,"Radius Recycling, Inc.",421.71M,15.04,2.69B,2.83%,-1.15%,-25.50%,-17.00%,-24.72%,,,,,,,0,-1,-1,-1,-1,-1
100.08M,"802,737",-12.44M,-1,559,4.520,Buy,4.65,"Aug 8, 2024",CCSI,"Consensus Cloud Solutions, Inc.",421.26M,21.83,353.96M,13.87%,22.14%,23.94%,+8.64%,+69.40%,"Wednesday’s top analyst calls: Nvidia, Apple, Netflix, Sunrun, Amazon and more","AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls",Consensus Cloud Solutions upgraded to Buy from Neutral at BTIG,BTIG Sticks to Their Hold Rating for Consensus Cloud Solutions (CCSI),Wedbush Keeps Their Buy Rating on Consensus Cloud Solutions (CCSI),"Wednesday’s top analyst calls: Nvidia, Apple, Netflix, Sunrun, Amazon and more AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls Consensus Cloud Solutions upgraded to Buy from Neutral at BTIG BTIG Sticks to Their Hold Rating for Consensus Cloud Solutions (CCSI) Wedbush Keeps Their Buy Rating on Consensus Cloud Solutions (CCSI)",0,1,1,0,0,1
77.75M,"492,530",-41.13M,-1,"2,800",5.81,Hold,9.22,"Aug 1, 2024",SENEB,Seneca Foods Corporation,420.61M,57.51,1.46B,,22.14%,23.94%,+3.79%,+88.29%,,,,,,,0,-1,-1,-1,-1,-1
662.81M,"2,921",-161.61M,-1,600,2.900,Buy,16.00,"Sep 3, 2024",RMR,The RMR Group Inc.,420.46M,25.14,191.26M,2.76%,4.67%,3.33%,-2.51%,+8.45%,The RMR Group Highlights Growth and Stability in Real Estate,Oppenheimer Reaffirms Their Hold Rating on The RMR Group (RMR),RMR Group announces early renewal of Vertex Pharmaceuticals lease,,,The RMR Group Highlights Growth and Stability in Real Estate Oppenheimer Reaffirms Their Hold Rating on The RMR Group (RMR) RMR Group announces early renewal of Vertex Pharmaceuticals lease,1,1,0,0,-1,-1
204.94M,"1,132,490",-114.34M,-1,"2,800",2.200,Strong Buy,6.22,"Aug 12, 2024",SENEA,Seneca Foods Corporation,419.37M,60.50,1.46B,-0.47%,0.10%,7.89%,-0.23%,+7.94%,,,,,,,1,-1,-1,-1,-1,-1
106.83M,"4,037,740",-42.25M,-1,102,4.210,Buy,4.63,"Aug 1, 2024",KRRO,"Korro Bio, Inc.",419.28M,45.09,-,20.06%,19.52%,-2.80%,+7.35%,-26.10%,Korro Bio Board Changes and Strategic Advisor Agreement,Korro Bio appoints Katharine Knobil to board of directors,Korro to Participate in Upcoming September Investor and Scientific Conferences,Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO) and Gilead Sciences (GILD),"Starbucks, Chipotle upgraded: Wall Street’s top analyst calls","Korro Bio Board Changes and Strategic Advisor Agreement Korro Bio appoints Katharine Knobil to board of directors Korro to Participate in Upcoming September Investor and Scientific Conferences Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO) and Gilead Sciences (GILD) Starbucks, Chipotle upgraded: Wall Street’s top analyst calls",1,1,1,0,0,1
36.28M,"144,100",24.15M,-1,"3,508",12.30,Buy,14.67,"Aug 1, 2024",MERC,Mercer International Inc.,419.15M,6.27,1.99B,-7.56%,-20.20%,-32.07%,-22.57%,-41.35%,Mercer International Inc. to Present at Upcoming Jefferies 2024 Industrials Conference,CIBC Sticks to Their Hold Rating for Mercer International (MERC),Mercer price target lowered to $8.50 from $10 at CIBC,Mercer price target lowered to $8 from $10 at RBC Capital,RBC Capital Keeps Their Hold Rating on Mercer International (MERC),Mercer International Inc. to Present at Upcoming Jefferies 2024 Industrials Conference CIBC Sticks to Their Hold Rating for Mercer International (MERC) Mercer price target lowered to $8.50 from $10 at CIBC Mercer price target lowered to $8 from $10 at RBC Capital RBC Capital Keeps Their Hold Rating on Mercer International (MERC),1,0,0,0,0,0
43.13M,"12,119",7.69M,-1,255,10.33,,,,VERV,"Verve Therapeutics, Inc.",418.05M,4.94,20.65M,2.35%,-5.13%,-42.17%,-16.14%,-31.10%,Verve Therapeutics’ (VERV) Gene-Editing Therapies Could Be a Game Changer,Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4),"Levi & Korsinsky LLP Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline",Verve Therapeutics price target lowered to $29 from $30 at Canaccord,Buy Rating Affirmed for Verve Therapeutics Amidst Clinical Progress and Strong Financials,"Verve Therapeutics’ (VERV) Gene-Editing Therapies Could Be a Game Changer Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Levi & Korsinsky LLP Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline Verve Therapeutics price target lowered to $29 from $30 at Canaccord Buy Rating Affirmed for Verve Therapeutics Amidst Clinical Progress and Strong Financials",1,0,0,1,0,1
,,,-1,420,,,,,PERI,Perion Network Ltd.,417.40M,8.62,686.05M,1.18%,0.78%,-53.67%,-3.88%,-60.07%,Perion Network Sets Annual Shareholder Meeting,,,,,Perion Network Sets Annual Shareholder Meeting,1,0,-1,-1,-1,-1
6.95M,"22,372",65.29M,-1,"3,778",64.15,,,"Aug 9, 2024",RICK,"RCI Hospitality Holdings, Inc.",416.90M,46.34,297.62M,2.84%,4.49%,-12.18%,-6.59%,-15.52%,RCI Hospitality Holdings (RICK) Declares Q3 Dividend: Important Details for Shareholders,RCI Increases Quarterly Cash Dividend by 16.7%,RCI Hospitality Holdings: Strong Buy on Revenue Growth and Strategic Acquisitions,,,RCI Hospitality Holdings (RICK) Declares Q3 Dividend: Important Details for Shareholders RCI Increases Quarterly Cash Dividend by 16.7% RCI Hospitality Holdings: Strong Buy on Revenue Growth and Strategic Acquisitions,0,0,0,1,-1,-1
19.78M,"59,619",7.09M,$0.80,571,22.48,Hold,23.33,"Jul 24, 2024",ITIC,Investors Title Company,416.71M,221.20,233.77M,6.31%,14.77%,33.16%,+5.02%,+39.79%,,,,,,,0,-1,-1,-1,-1,-1
55.33M,"150,100",-86.45M,-1,,8.01,Buy,14.75,"Aug 8, 2024",SDST,Stardust Power Inc.,414.09M,8.86,-,-20.45%,-24.69%,-21.15%,-40.87%,-20.56%,Stardust Power selects Primero USA to complete engineering study,Stardust Power Selects Primero USA to complete Definitive Engineering Study,,,,Stardust Power selects Primero USA to complete engineering study Stardust Power Selects Primero USA to complete Definitive Engineering Study,0,0,0,-1,-1,-1
2.75M,"23,895",41.23M,$6.00,"2,280",160.96,,,"Jul 31, 2024",CRMT,"America's Car-Mart, Inc.",413.90M,62.51,1.39B,2.89%,1.03%,-2.13%,-11.54%,+3.78%,"America’s Car-Mart reports Q1 EPS 63c, consensus 66c","America’s Car-Mart, Inc. (CRMT) Q1 Earnings Cheat Sheet",America’s Car-Mart Shareholders Back Incentive Plan and Governance,Jefferies Sticks to Its Hold Rating for America’s Car-Mart (CRMT),America’s Car-Mart assumed with a Hold at Jefferies,"America’s Car-Mart reports Q1 EPS 63c, consensus 66c America’s Car-Mart, Inc. (CRMT) Q1 Earnings Cheat Sheet America’s Car-Mart Shareholders Back Incentive Plan and Governance Jefferies Sticks to Its Hold Rating for America’s Car-Mart (CRMT) America’s Car-Mart assumed with a Hold at Jefferies",1,1,1,1,1,1
78.97M,"388,833",-562.92M,$0.36,"1,050",5.59,Buy,7.00,"Aug 5, 2024",RWAY,Runway Growth Finance Corp.,412.84M,10.71,157.21M,-0.97%,-5.23%,-11.52%,-10.98%,-14.45%,Runway Growth Finance upgraded to Buy from Neutral at Compass Point,J.P. Morgan Reaffirms Their Hold Rating on Runway Growth Finance Corp (RWAY),Runway Growth Finance price target lowered to $11 from $12 at Wells Fargo,Runway Growth Finance Corp.: Equal Weight Rating Amidst NOI Decline and Leverage Challenges,Compass Point Reaffirms Their Hold Rating on Runway Growth Finance Corp (RWAY),Runway Growth Finance upgraded to Buy from Neutral at Compass Point J.P. Morgan Reaffirms Their Hold Rating on Runway Growth Finance Corp (RWAY) Runway Growth Finance price target lowered to $11 from $12 at Wells Fargo Runway Growth Finance Corp.: Equal Weight Rating Amidst NOI Decline and Leverage Challenges Compass Point Reaffirms Their Hold Rating on Runway Growth Finance Corp (RWAY),1,1,1,1,1,1
60.47M,"421,985",-86.45M,-1,164,7.27,Buy,11.55,"Aug 7, 2024",NNOX,Nano-X Imaging Ltd.,411.82M,7.04,10.13M,-9.14%,-11.64%,-16.12%,-27.61%,-40.91%,Largest borrow rate increases among liquid names,"Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium",Nano-X Imaging receives FDA clearance for HealthCCSng V2.0,"Nano-X Imaging reports Q2 EPS (23c), consensus (22c)","Options Volatility and Implied Earnings Moves Today, August 20, 2024","Largest borrow rate increases among liquid names Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium Nano-X Imaging receives FDA clearance for HealthCCSng V2.0 Nano-X Imaging reports Q2 EPS (23c), consensus (22c) Options Volatility and Implied Earnings Moves Today, August 20, 2024",1,1,0,0,1,1
65.04M,"1,954,260",-314.44M,-1,302,6.74,Sell,5.07,"Aug 7, 2024",STRO,"Sutro Biopharma, Inc.",410.64M,5.01,169.36M,22.48%,30.26%,22.05%,+18.39%,-3.69%,Sutro Biopharma’s Promising Oncology Prospects and Solid Financials Merit a Buy Rating,Sutro Biopharma announces initiation of REFRalphaME-L1 Phase 2 trial,Sutro Biopharma price target lowered to $15 from $18 at Truist,Truist Financial Sticks to Their Buy Rating for Sutro Biopharma (STRO),Sutro Biopharma’s Strong Financials and Clinical Progress Reinforce Buy Rating,Sutro Biopharma’s Promising Oncology Prospects and Solid Financials Merit a Buy Rating Sutro Biopharma announces initiation of REFRalphaME-L1 Phase 2 trial Sutro Biopharma price target lowered to $15 from $18 at Truist Truist Financial Sticks to Their Buy Rating for Sutro Biopharma (STRO) Sutro Biopharma’s Strong Financials and Clinical Progress Reinforce Buy Rating,0,0,0,0,0,0
49.41M,"717,455",-180.54M,-1,257,8.86,Buy,12.50,"Aug 6, 2024",LMNR,Limoneira Company,409.39M,22.73,178.27M,17.40%,18.59%,28.44%,+12.30%,+26.66%,LMNR Upcoming Earnings Report: What to Expect?,Lake Street Sticks to Their Buy Rating for Limoneira Co (LMNR),Limoneira price target raised to $28 from $24 at B. Riley,Limoneira Co Incentivizes Executives for Successful Company Sale,,LMNR Upcoming Earnings Report: What to Expect? Lake Street Sticks to Their Buy Rating for Limoneira Co (LMNR) Limoneira price target raised to $28 from $24 at B. Riley Limoneira Co Incentivizes Executives for Successful Company Sale,0,1,0,0,0,-1
113.88M,"728,217",-175.72M,-1,376,3.840,Hold,6.55,"Aug 13, 2024",RBB,RBB Bancorp,409.15M,22.98,117.60M,3.08%,9.67%,23.05%,-1.34%,+30.36%,Piper Sandler Keeps Their Hold Rating on Rbb Bancorp (RBB),KBW Gives a Hold Rating to Rbb Bancorp (RBB),RBB Bancorp announces termination of consent order,RBB Bancorp Announces Termination of Consent Order,,Piper Sandler Keeps Their Hold Rating on Rbb Bancorp (RBB) KBW Gives a Hold Rating to Rbb Bancorp (RBB) RBB Bancorp announces termination of consent order RBB Bancorp Announces Termination of Consent Order,1,0,1,0,0,-1
146.74M,"167,283",-15.07M,-1,754,2.970,,,"Aug 12, 2024",APPS,"Digital Turbine, Inc.",409.05M,3.98,516.11M,21.40%,57.10%,5.56%,+46.64%,+60.83%,Largest borrow rate increases among liquid names,Digital Turbine Shareholders Approve Equity Plan and Elect Directors,"Analysts Conflicted on These Technology Names: Kenvue, Inc. (KVUE), Super Micro Computer (SMCI) and Digital Turbine (APPS)",,,"Largest borrow rate increases among liquid names Digital Turbine Shareholders Approve Equity Plan and Elect Directors Analysts Conflicted on These Technology Names: Kenvue, Inc. (KVUE), Super Micro Computer (SMCI) and Digital Turbine (APPS)",1,1,0,1,-1,-1
46.20M,"482,720",-6.74M,-1,"2,530",9.43,Strong Buy,13.00,"Aug 8, 2024",PTSI,"P.A.M. Transportation Services, Inc.",408.00M,18.74,747.21M,-0.85%,-1.72%,-2.76%,-9.02%,+21.72%,,,,,,,1,-1,-1,-1,-1,-1
28.11M,"90,101",24.98M,$0.20,"4,362",15.34,Strong Buy,20.33,"Aug 15, 2024",LOCO,"El Pollo Loco Holdings, Inc.",407.62M,13.62,470.98M,8.83%,16.49%,38.93%,+14.05%,+50.66%,El Pollo Loco Taps Content Creator Yuri Lamasbella as New Kreative Director for its Double Chopped Salads Campaign,,,,,El Pollo Loco Taps Content Creator Yuri Lamasbella as New Kreative Director for its Double Chopped Salads Campaign,0,0,-1,-1,-1,-1
185.30M,"527,309",-24.06M,-1,365,2.330,Buy,3.25,"Aug 1, 2024",CLMB,"Climb Global Solutions, Inc.",406.73M,91.12,369.74M,16.06%,33.72%,51.89%,+29.56%,+34.57%,Climb Global Solutions: A Strong Buy on Strategic Positioning and Growth Potential,Climb Channel Solutions Announces the Launch of MSP360 Partnership in North America,Climb Channel Solutions announce launch of MSP360 partnership,Climb Global Solutions: A Strong Buy on Robust Financial Performance and Strategic Acquisitions,Climb Global price target raised to $90 from $68 at Barrington,Climb Global Solutions: A Strong Buy on Strategic Positioning and Growth Potential Climb Channel Solutions Announces the Launch of MSP360 Partnership in North America Climb Channel Solutions announce launch of MSP360 partnership Climb Global Solutions: A Strong Buy on Robust Financial Performance and Strategic Acquisitions Climb Global price target raised to $90 from $68 at Barrington,0,1,0,0,0,0
29.56M,"1,021,411",33.16M,-1,135,14.59,Hold,12.00,"Oct 3, 2024",AQST,"Aquestive Therapeutics, Inc.",406.13M,4.46,58.36M,19.47%,43.34%,49.23%,+18.49%,+10.98%,Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences,Aquestive Therapeutics reiterates expected timing for NDA filing of Anaphylm,Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™,Buy Rating Affirmed for Aquestive Therapeutics as Anaphylm™ Poised to Transform Epinephrine Market,Aquestive Therapeutics (AQST) Gets a Buy from Lake Street,Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences Aquestive Therapeutics reiterates expected timing for NDA filing of Anaphylm Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™ Buy Rating Affirmed for Aquestive Therapeutics as Anaphylm™ Poised to Transform Epinephrine Market Aquestive Therapeutics (AQST) Gets a Buy from Lake Street,1,0,1,0,0,0
26.29M,"130,341",-37.81M,-1,54,16.36,Strong Buy,25.83,"Aug 7, 2024",NVEC,NVE Corporation,406.03M,84.00,27.76M,2.74%,6.53%,6.35%,-8.29%,-3.91%,,,,,,,1,-1,-1,-1,-1,-1
62.42M,"401,484",-86.67M,$0.44,,6.88,Hold,7.00,"Jul 25, 2024",NETD,Nabors Energy Transition Corp. II,405.27M,10.63,-,0.02%,0.38%,1.53%,+0.14%,+1.68%,,,,,,,1,-1,-1,-1,-1,-1
17.80M,"115,255",-1.49M,$0.40,44,24.11,Buy,38.50,"Sep 4, 2024",TRML,"Tourmaline Bio, Inc.",404.88M,15.79,-,12.19%,12.89%,-24.97%,+4.27%,-22.16%,Tourmaline Bio Showcases Promising Candidate in Updated Presentation,Tourmaline Bio (TRML) Receives a Buy from Piper Sandler,Tourmaline Bio to Present at Upcoming Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)",Tourmaline Bio price target lowered to $15 from $18 at Truist,"Tourmaline Bio Showcases Promising Candidate in Updated Presentation Tourmaline Bio (TRML) Receives a Buy from Piper Sandler Tourmaline Bio to Present at Upcoming Investor Conferences Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA) Tourmaline Bio price target lowered to $15 from $18 at Truist",0,0,0,0,0,0
149.00M,"912,736",-59.56M,-1,28,2.880,Strong Buy,4.63,"Aug 8, 2024",IPX,IperionX Limited,403.97M,15.82,-,6.99%,7.81%,20.73%,+13.36%,+15.00%,IPX Stock trading resumes,"IPX Stock trading halted, volatility trading pause",,,,"IPX Stock trading resumes IPX Stock trading halted, volatility trading pause",0,0,0,-1,-1,-1
15.83M,"58,728",40.76M,$0.38,,26.96,,,"Aug 14, 2024",WALD,Waldencast plc,403.42M,3.29,218.14M,1.34%,-12.26%,-53.92%,-2.55%,-52.34%,Waldencast Acquisition (WALD) Gets a Buy from D.A. Davidson,Waldencast price target raised to $7.25 from $6.50 at DA Davidson,Telsey Advisory Remains a Buy on Waldencast Acquisition (WALD),Waldencast Targets Growth in Beauty Sector,Waldencast Unveils Post-Acquisition Financials,Waldencast Acquisition (WALD) Gets a Buy from D.A. Davidson Waldencast price target raised to $7.25 from $6.50 at DA Davidson Telsey Advisory Remains a Buy on Waldencast Acquisition (WALD) Waldencast Targets Growth in Beauty Sector Waldencast Unveils Post-Acquisition Financials,1,0,0,1,1,1
91.85M,"129,000",-125.58M,-1,11,4.640,Strong Buy,9.00,"Aug 9, 2024",ELYM,"Eliem Therapeutics, Inc.",402.36M,6.00,-,-8.29%,-15.36%,26.24%,-25.21%,+138.46%,Eliem Therapeutics: Executive Changes Amid Strategic Shift,Eliem Therapeutics Names Brett Kaplan as New COO,"Eliem Therapeutics appoints Kaplan as COO, Rampal as SVP, Clinical Development",,,"Eliem Therapeutics: Executive Changes Amid Strategic Shift Eliem Therapeutics Names Brett Kaplan as New COO Eliem Therapeutics appoints Kaplan as COO, Rampal as SVP, Clinical Development",0,1,1,1,-1,-1
272.53M,"5,785,736",-400.38M,-1,122,1.560,Buy,4.64,"Aug 7, 2024",VALU,"Value Line, Inc.",402.15M,42.70,37.49M,-1.10%,-3.13%,-0.29%,-13.59%,+6.55%,,,,,,,0,-1,-1,-1,-1,-1
56.64M,"28,401",-12.93M,-1,624,7.50,Strong Buy,12.50,"Sep 16, 2024",FISI,"Financial Institutions, Inc.",401.35M,25.94,220.79M,4.68%,16.24%,29.81%,-2.55%,+43.70%,Financial Institutions Declares Dividends for Shareholders,,,,,Financial Institutions Declares Dividends for Shareholders,0,0,-1,-1,-1,-1
14.19M,"36,441",35.77M,$0.96,67,29.90,Hold,29.00,"Oct 21, 2024",SERV,Serve Robotics Inc.,400.22M,10.19,1.52M,-25.66%,23.75%,65.46%,-46.63%,,"Lightning Round: Chipotle is likely done going down, says Jim Cramer",Cramer’s Lightning Round: Builders FirstSource ‘can go higher’,Serve Robotics files to sell 3.31M shares of common stock for holders,Largest borrow rate increases among liquid names,Serve Robotics Inc put volume heavy and directionally bearish,"Lightning Round: Chipotle is likely done going down, says Jim Cramer Cramer’s Lightning Round: Builders FirstSource ‘can go higher’ Serve Robotics files to sell 3.31M shares of common stock for holders Largest borrow rate increases among liquid names Serve Robotics Inc put volume heavy and directionally bearish",0,0,0,1,1,1
29.07M,"102,685",24.94M,$0.88,224,14.53,Hold,15.50,"Jul 29, 2024",LYEL,"Lyell Immunopharma, Inc.",399.36M,1.56,54.00K,1.06%,-9.34%,-28.96%,-9.94%,-30.62%,Lyell Immunopharma Announces Participation in September Investor Conferences,"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX)",Caribou Biosciences Ltp appoims Albertso as CMO,,,"Lyell Immunopharma Announces Participation in September Investor Conferences Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX) Caribou Biosciences Ltp appoims Albertso as CMO",0,1,0,0,-1,-1
118.69M,"3,827,009",-31.70M,-1,516,3.630,Strong Buy,5.67,"Aug 12, 2024",TMCI,"Treace Medical Concepts, Inc.",399.26M,6.42,198.53M,-3.22%,-9.53%,-36.93%,-13.28%,-47.79%,Maintaining Hold on Treace Medical Concepts Amidst Stable Growth and Anticipated Product Launches,Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference,,,,Maintaining Hold on Treace Medical Concepts Amidst Stable Growth and Anticipated Product Launches Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference,0,0,1,-1,-1,-1
28.04M,"132,604",-276.15M,$0.75,,15.04,Hold,,"Jul 2, 2024",HRZN,Horizon Technology Finance Corporation,399.18M,11.07,109.13M,-2.30%,-6.43%,-9.05%,-5.76%,-2.49%,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 12, 2024",,,,,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 12, 2024",0,0,-1,-1,-1,-1
19.30M,"153,050",90.99M,-1,58,21.83,Buy,24.25,"Aug 8, 2024",LXEO,"Lexeo Therapeutics, Inc.",398.39M,12.05,-,-8.95%,-18.52%,-22.18%,-8.92%,-12.01%,Lexeo Therapeutics to Participate in Upcoming Investor Conferences,Buy Rating for Lexeo Therapeutics Backed by Strong Finances and Promising Clinical Trials,Buy Rating on Lexeo Therapeutics: Promising Clinical Advancements and Strategic FDA Engagement,"Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Taysha Gene Therapies (TSHA) and Lexeo Therapeutics, Inc. (LXEO)","Lexeo Therapeutics, Inc. (LXEO) Receives a Buy from RBC Capital","Lexeo Therapeutics to Participate in Upcoming Investor Conferences Buy Rating for Lexeo Therapeutics Backed by Strong Finances and Promising Clinical Trials Buy Rating on Lexeo Therapeutics: Promising Clinical Advancements and Strategic FDA Engagement Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Taysha Gene Therapies (TSHA) and Lexeo Therapeutics, Inc. (LXEO) Lexeo Therapeutics, Inc. (LXEO) Receives a Buy from RBC Capital",0,0,1,0,0,0
6.93M,2,52.78M,-1,"2,300",61.54,,,"Sep 3, 2024",ATNI,"ATN International, Inc.",397.74M,26.82,760.08M,0.65%,9.95%,-9.30%,-10.85%,-6.54%,ATN International Secures $390M Credit for Refinancing and Growth,,,,,ATN International Secures $390M Credit for Refinancing and Growth,0,1,-1,-1,-1,-1
16.72M,"58,071",25.18M,$1.80,"2,300",25.14,Buy,32.00,"Aug 1, 2024",LINC,Lincoln Educational Services Corporation,397.53M,12.63,408.42M,0.07%,0.39%,15.66%,-12.12%,+22.29%,Lincoln Educational Services to Provide Business Overview and Highlight Growth Strategy at Midwest IDEAS Conference,,,,,Lincoln Educational Services to Provide Business Overview and Highlight Growth Strategy at Midwest IDEAS Conference,0,1,-1,-1,-1,-1
6.93M,"24,054",52.78M,-1,"2,149",60.50,,,"Aug 8, 2024",AAOI,"Applied Optoelectronics, Inc.",397.10M,9.71,206.94M,10.18%,4.07%,-31.35%,-4.50%,-27.16%,Applied Optoelectronics (AAOI) solidifies its Position in the AI Realm,Applied Optoelectronics call volume above normal and directionally bullish,"ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz",Applied Optoelectronics upgraded to Outperform from Market Perform at Raymond James,Buy Rating for Applied Optoelectronics: Market Position and Growth Potential Propel Analyst Optimism,"Applied Optoelectronics (AAOI) solidifies its Position in the AI Realm Applied Optoelectronics call volume above normal and directionally bullish ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz Applied Optoelectronics upgraded to Outperform from Market Perform at Raymond James Buy Rating for Applied Optoelectronics: Market Position and Growth Potential Propel Analyst Optimism",0,0,0,0,0,0
9.30M,"97,986",-85.30M,-1,679,45.09,Strong Buy,123.75,"Aug 13, 2024",CARE,"Carter Bankshares, Inc.",396.85M,17.20,125.73M,5.64%,9.82%,22.96%,+3.99%,+41.99%,Carter Bankshares price target raised to $21 from $20 at Raymond James,,,,,Carter Bankshares price target raised to $21 from $20 at Raymond James,1,0,-1,-1,-1,-1
66.85M,"300,201",-197.46M,$0.30,99,6.27,Hold,8.17,"Aug 8, 2024",TBPH,"Theravance Biopharma, Inc.",395.78M,8.09,62.02M,-1.64%,-5.82%,-10.76%,-19.29%,-12.35%,,,,,,,1,-1,-1,-1,-1,-1
84.62M,"1,118,361",-192.65M,-1,983,4.94,Strong Buy,25.20,"Aug 8, 2024",PRTH,"Priority Technology Holdings, Inc.",394.15M,5.13,813.88M,17.34%,14.82%,51.96%,-1.18%,+82.55%,,,,,,,0,-1,-1,-1,-1,-1
48.42M,"278,290",77.78M,-1,183,8.62,Hold,11.50,"Jul 31, 2024",RDVT,"Red Violet, Inc.",394.09M,28.70,67.47M,8.60%,12.98%,38.27%,+10.64%,+40.67%,REPEAT — IDI Now Available on Carahsoft’s GSA Schedule,Red Violet’s Interactive Data is now available on Carahsoft’s GSA schedule,,,,REPEAT — IDI Now Available on Carahsoft’s GSA Schedule Red Violet’s Interactive Data is now available on Carahsoft’s GSA schedule,0,0,0,-1,-1,-1
9.00M,"65,606",4.96M,$0.24,"6,300",46.34,Strong Buy,98.00,"Aug 8, 2024",PKOH,Park-Ohio Holdings Corp.,393.78M,30.50,1.66B,5.37%,10.82%,18.03%,-1.47%,+18.99%,,,,,,,1,-1,-1,-1,-1,-1
1.88M,"21,229",26.32M,$1.84,678,221.20,,,"Aug 6, 2024",USAP,"Universal Stainless & Alloy Products, Inc.",389.75M,42.19,311.46M,10.34%,28.52%,67.53%,+7.65%,+49.59%,,,,,,,0,-1,-1,-1,-1,-1
46.74M,"75,374",-6.66M,-1,288,8.86,,,"Aug 16, 2024",FRBA,First Bank,388.74M,15.46,114.39M,4.18%,11.09%,15.88%,-0.84%,+17.86%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,133,,,,,GLUE,"Monte Rosa Therapeutics, Inc.",388.46M,6.33,5.76M,41.68%,55.92%,34.23%,+40.04%,-10.47%,Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences,Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study,Buy Rating Affirmed: Anticipated Catalysts and Undervaluation Set to Boost Monte Rosa Therapeutics,Monte Rosa Therapeutics price target lowered to $17 from $18 at Wells Fargo,,Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study Buy Rating Affirmed: Anticipated Catalysts and Undervaluation Set to Boost Monte Rosa Therapeutics Monte Rosa Therapeutics price target lowered to $17 from $18 at Wells Fargo,0,0,0,0,0,-1
6.62M,"90,374",-31.43M,-1,862,62.51,Sell,50.00,"Sep 4, 2024",ORGO,Organogenesis Holdings Inc.,388.44M,2.93,448.39M,9.17%,6.33%,-1.89%,-2.98%,+3.53%,Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September,Organogenesis Holdings (ORGO) Receives a Buy from Lake Street,Morgan Stanley Sticks to Their Hold Rating for Organogenesis Holdings (ORGO),Organogenesis Holdings (ORGO) Receives a Buy from Cantor Fitzgerald,,Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September Organogenesis Holdings (ORGO) Receives a Buy from Lake Street Morgan Stanley Sticks to Their Hold Rating for Organogenesis Holdings (ORGO) Organogenesis Holdings (ORGO) Receives a Buy from Cantor Fitzgerald,1,0,0,0,1,-1
38.55M,"292,013",30.38M,$1.85,,10.71,Buy,11.96,"Aug 8, 2024",CWBC,Community West Bancshares,384.49M,20.30,85.23M,4.61%,6.17%,7.97%,-2.10%,+10.17%,Community West Bancshares Engages Investors at Tech Conference,,,,,Community West Bancshares Engages Investors at Tech Conference,0,0,-1,-1,-1,-1
58.50M,"670,133",-57.47M,-1,,7.04,Strong Buy,20.50,"Aug 20, 2024",AIRJ,Montana Technologies Corporation,383.74M,6.34,-,-33.60%,-42.80%,-49.33%,-46.70%,-52.96%,Montana Technologies announces MOU with Clairity Technology,Montana Technologies Announces Memorandum of Understanding with Clairity Technology to Deploy AirJoule® in Support of Direct Air Capture Carbon Dioxide Removal Projects,Montana Technologies Corp. reports Q2 EPS 24c vs. (8c) last year,Montana Technologies Corp. signs MOU with Tenx Investment,Montana Technologies Announces Memorandum of Understanding with TenX Investment to Deploy AirJoule® for Water Security and Sustainability in the United Arab Emirates,Montana Technologies announces MOU with Clairity Technology Montana Technologies Announces Memorandum of Understanding with Clairity Technology to Deploy AirJoule® in Support of Direct Air Capture Carbon Dioxide Removal Projects Montana Technologies Corp. reports Q2 EPS 24c vs. (8c) last year Montana Technologies Corp. signs MOU with Tenx Investment Montana Technologies Announces Memorandum of Understanding with TenX Investment to Deploy AirJoule® for Water Security and Sustainability in the United Arab Emirates,1,1,1,1,1,0
81.96M,"579,338",-124.45M,-1,,5.010,Strong Buy,12.13,"Aug 13, 2024",TWFG,"TWFG, Inc.",383.04M,25.86,179.39M,7.89%,10.84%,10.84%,+4.83%,,"Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks","TWFG, Inc. Class A (TWFG) Receives a Hold from KBW",TWFG price target raised to $28 from $26.50 at JPMorgan,TWFG price target raised to $30 from $29 at RBC Capital,"TWFG, Inc.: Steady Growth and Expansion Potential Balanced with Cautious Valuation Outlook","Monday’s top analyst calls: Nvidia, Apple, Qualcomm, Robinhood, Starbucks TWFG, Inc. Class A (TWFG) Receives a Hold from KBW TWFG price target raised to $28 from $26.50 at JPMorgan TWFG price target raised to $30 from $29 at RBC Capital TWFG, Inc.: Steady Growth and Expansion Potential Balanced with Cautious Valuation Outlook",1,1,0,0,0,1
18.01M,"130,877",-2.14M,$0.30,,22.73,Strong Buy,24.00,"Sep 9, 2024",DCGO,DocGo Inc.,380.62M,3.72,742.84M,6.39%,12.37%,-4.80%,unch,-4.72%,Northland Securities Sticks to Its Buy Rating for DocGo (DCGO),DocGo management to meet virtually with Northland,DocGo: A Strong Buy on Robust Financial Performance and Growth Prospects,,,Northland Securities Sticks to Its Buy Rating for DocGo (DCGO) DocGo management to meet virtually with Northland DocGo: A Strong Buy on Robust Financial Performance and Growth Prospects,1,0,0,1,-1,-1
17.80M,"46,237",35.83M,$0.64,"21,200",22.98,Hold,19.30,"Oct 21, 2024",MODV,ModivCare Inc.,380.07M,26.69,2.77B,16.96%,13.16%,-10.88%,+18.40%,+14.98%,ModivCare partners with ACC to launch Caring Hearts in New Jersey,Lake Street Sticks to Their Buy Rating for ModivCare (MODV),"ModivCare: Balancing Financial Results and Strategic Efforts, a Hold Rating Maintained",ModivCare upgraded to Outperform from Market Perform at Barrington,,"ModivCare partners with ACC to launch Caring Hearts in New Jersey Lake Street Sticks to Their Buy Rating for ModivCare (MODV) ModivCare: Balancing Financial Results and Strategic Efforts, a Hold Rating Maintained ModivCare upgraded to Outperform from Market Perform at Barrington",0,0,0,0,0,-1
102.78M,"3,454,013",-437.21M,-1,870,3.980,Hold,5.25,"Aug 7, 2024",NKLA,Nikola Corporation,379.73M,7.51,48.62M,-8.64%,-20.89%,-61.77%,-27.51%,-78.73%,Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness,Nikola appoints Thomas Schmitt as CCO,Largest borrow rate increases among liquid names,Nikola (NASDAQ:NKLA) Sinks 10% after Announcing Share Sale,"AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz","Philippe Laffont’s Coatue entered into Paramount last quarter amid weakness Nikola appoints Thomas Schmitt as CCO Largest borrow rate increases among liquid names Nikola (NASDAQ:NKLA) Sinks 10% after Announcing Share Sale AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz",1,0,1,1,0,1
21.77M,"19,652",1.24M,-1,237,18.74,Hold,17.00,"Jul 24, 2024",HDSN,"Hudson Technologies, Inc.",379.20M,8.33,261.88M,2.48%,-2.82%,-25.11%,-6.19%,-24.25%,"Analysts Have Conflicting Sentiments on These Materials Companies: MP Materials (MP), Hudson Tech (HDSN) and Silvercorp Metals (SVM)",,,,,"Analysts Have Conflicting Sentiments on These Materials Companies: MP Materials (MP), Hudson Tech (HDSN) and Silvercorp Metals (SVM)",0,1,-1,-1,-1,-1
29.93M,"232,561",27.13M,-1,357,13.62,Hold,13.00,"Aug 1, 2024",ANIK,"Anika Therapeutics, Inc.",378.65M,25.59,166.88M,-3.00%,-5.05%,1.08%,-5.14%,+0.90%,Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Buy Rating Affirmed for Anika Therapeutics Amid Solid Financials and Strong Market Outlook,,,,Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Buy Rating Affirmed for Anika Therapeutics Amid Solid Financials and Strong Market Outlook,0,0,0,-1,-1,-1
4.46M,"31,475",13.42M,$0.68,69,91.12,Buy,90.00,"Aug 6, 2024",ZVRA,"Zevra Therapeutics, Inc.",377.80M,7.18,23.69M,3.06%,20.69%,31.21%,+32.00%,+47.86%,William Blair Keeps Their Buy Rating on Zevra Therapeutics (ZVRA),"Zevra Therapeutics presents data for arimoclomol, OLPRUVA at SSIEM 2024",Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium,Zevra Therapeutics to Participate at Upcoming Investor Conferences,Buy Rating on Zevra Therapeutics Backed by Strong Financials and Promising Product Launches,"William Blair Keeps Their Buy Rating on Zevra Therapeutics (ZVRA) Zevra Therapeutics presents data for arimoclomol, OLPRUVA at SSIEM 2024 Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium Zevra Therapeutics to Participate at Upcoming Investor Conferences Buy Rating on Zevra Therapeutics Backed by Strong Financials and Promising Product Launches",1,1,0,0,0,0
91.06M,"746,242",-25.72M,-1,100,4.460,Strong Buy,8.57,"Aug 6, 2024",GTHX,"G1 Therapeutics, Inc.",376.58M,7.12,58.20M,15.00%,67.51%,97.13%,+65.97%,+48.95%,Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period,"G1 Therapeutics, Pharmacosmos announce expiration of HSR waiting period",Largest borrow rate increases among liquid names,J.P. Morgan upgrades G1 Therapeutics (GTHX) to a Hold,Biotech Alert: Searches spiking for these stocks today,"Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period G1 Therapeutics, Pharmacosmos announce expiration of HSR waiting period Largest borrow rate increases among liquid names J.P. Morgan upgrades G1 Therapeutics (GTHX) to a Hold Biotech Alert: Searches spiking for these stocks today",1,1,0,1,1,1
4.83M,"15,819",16.82M,$4.00,89,84.00,,,"Oct 16, 2024",AURA,"Aura Biosciences, Inc.",376.51M,7.59,-,-9.12%,-7.09%,-4.94%,-24.29%,+7.36%,"Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024",Aura Biosciences to Participate in Upcoming Investor Conferences,"3 Best Stocks to Buy Now, 8/28/2024, According to Top Analysts ",Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA) and Nanosonics Limited (OtherNNCSF),"Analysts’ Top Healthcare Picks: Aura Biosciences Inc (AURA), Nanosonics Limited (NNCSF)","Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024 Aura Biosciences to Participate in Upcoming Investor Conferences 3 Best Stocks to Buy Now, 8/28/2024, According to Top Analysts  Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA) and Nanosonics Limited (OtherNNCSF) Analysts’ Top Healthcare Picks: Aura Biosciences Inc (AURA), Nanosonics Limited (NNCSF)",0,0,0,0,0,0
38.13M,"973,572",10.09M,-1,"1,400",10.63,,,,JOUT,Johnson Outdoors Inc.,376.35M,36.92,583.32M,-3.85%,-2.14%,-16.60%,-14.88%,-20.08%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,255,,,,,BWB,"Bridgewater Bancshares, Inc.",376.06M,13.75,106.31M,3.67%,7.98%,13.99%,-2.03%,+16.74%,D.A. Davidson Remains a Buy on Bridgewater Bancshares (BWB),Piper Sandler Sticks to Its Buy Rating for Bridgewater Bancshares (BWB),Bridgewater Bancshares Acquires First Minnetonka City Bank,Bridgewater Bancshares Engages Investors with New Presentation,,D.A. Davidson Remains a Buy on Bridgewater Bancshares (BWB) Piper Sandler Sticks to Its Buy Rating for Bridgewater Bancshares (BWB) Bridgewater Bancshares Acquires First Minnetonka City Bank Bridgewater Bancshares Engages Investors with New Presentation,0,0,0,1,0,-1
25.64M,"197,609",-49.29M,-1,150,15.79,Strong Buy,61.80,"Aug 8, 2024",NKTX,"Nkarta, Inc.",375.37M,5.32,-,-1.10%,-8.25%,-24.65%,-18.51%,-44.20%,Nkarta to Participate in Upcoming Investor Conference,Nkarta price target lowered to $20 from $25 at Mizuho,Buy Rating Affirmed for Nkarta Amid Strategic Focus and Promising Clinical Trials,Nkarta’s NKX019 Therapy: A Promising Future in Autoimmune Disease Treatment,Buy Rating on Nkarta Amid Promising Clinical Trials and Solid Financial Position,Nkarta to Participate in Upcoming Investor Conference Nkarta price target lowered to $20 from $25 at Mizuho Buy Rating Affirmed for Nkarta Amid Strategic Focus and Promising Clinical Trials Nkarta’s NKX019 Therapy: A Promising Future in Autoimmune Disease Treatment Buy Rating on Nkarta Amid Promising Clinical Trials and Solid Financial Position,1,0,0,1,0,0
224.30M,"9,757",-19.19M,-1,65,15.64,Strong Buy,20.00,,OCGN,"Ocugen, Inc.",374.22M,1.30,7.26M,3.30%,-9.58%,18.82%,-8.19%,-29.51%,Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit,Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference,Ocugen Announces Completion of Dosing in Subjects with Stargardt Disease in High Dose Cohort of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy,"Ocugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Trial for OCU400 – Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication",Largest borrow rate increases among liquid names,"Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference Ocugen Announces Completion of Dosing in Subjects with Stargardt Disease in High Dose Cohort of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy Ocugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Trial for OCU400 – Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication Largest borrow rate increases among liquid names",0,0,0,0,0,1
122.62M,"52,026",-89.98M,-1,"1,991",3.290,Strong Buy,7.25,"Aug 27, 2024",LOVE,The Lovesac Company,373.68M,24.03,691.72M,-1.29%,-3.45%,-0.08%,-13.82%,-1.09%,Best Buy stock soars on a beat and raise. We think that’s just the beginning,The Lovesac Company Announces Second Quarter Conference Call Date,Short Report: Bearish positioning in Oddity Tech at record high,,,Best Buy stock soars on a beat and raise. We think that’s just the beginning The Lovesac Company Announces Second Quarter Conference Call Date Short Report: Bearish positioning in Oddity Tech at record high,1,1,0,1,-1,-1
,,,-1,472,,,,,NRIM,"Northrim BanCorp, Inc.",373.14M,67.82,136.39M,4.73%,8.26%,24.88%,-1.36%,+37.44%,"Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per Share",,,,,"Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per Share",1,0,-1,-1,-1,-1
67.06M,"86,684",-64.20M,-1,343,6.00,,,"Aug 14, 2024",FBIZ,"First Business Financial Services, Inc.",372.18M,44.87,139.46M,5.32%,12.49%,22.56%,-2.52%,+26.97%,,,,,,,1,-1,-1,-1,-1,-1
9.42M,"1,575",19.02M,$1.20,570,42.70,,,"Sep 10, 2024",EBTC,"Enterprise Bancorp, Inc.",372.05M,30.42,162.52M,8.83%,15.40%,13.66%,+4.03%,+24.86%,Enterprise Bancorp to Present at Upcoming Banking Conferences,,,,,Enterprise Bancorp to Present at Upcoming Banking Conferences,1,1,-1,-1,-1,-1
15.47M,"52,228",50.04M,$1.20,362,25.94,Hold,22.00,"Jul 25, 2024",RRBI,"Red River Bancshares, Inc.",371.79M,53.99,104.93M,3.18%,5.08%,5.73%,-5.69%,+8.80%,,,,,,,0,-1,-1,-1,-1,-1
39.28M,"5,090,904",-32.78M,-1,162,10.19,,,"Aug 13, 2024",VYGR,"Voyager Therapeutics, Inc.",370.83M,6.80,143.77M,-9.36%,-16.39%,-18.51%,-29.38%,-30.44%,Voyager Therapeutics enters license for capsid,Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences,Buy Rating Affirmed: Voyager Therapeutics’ Advancements and Revenue Potential in CNS Gene Therapy,Buy Rating Affirmed for Voyager Therapeutics on Robust Pipeline and Strong Financial Position,Voyager Therapeutics enters license for capsid Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences Buy Rating Affirmed: Voyager Therapeutics’ Advancements and Revenue Potential in CNS Gene Therapy Buy Rating Affirmed for Voyager Therapeutics on Robust Pipeline and Strong Financial Position,1,1,0,1,0,1
256.00M,"597,959",-210.26M,-1,88,1.560,Buy,4.00,"Aug 7, 2024",SLDB,Solid Biosciences Inc.,368.97M,9.56,-,7.67%,16.49%,14.19%,-1.91%,-28.04%,Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Solid Biosciences: A Buy Rating on Promising Gene Therapy SGT-003 and Expanding Pipeline,"Solid Biosciences SGT-003 safety signals encouraging, says H.C. Wainwright","3 Best Stocks to Buy Now, 8/14/2024, According to Top Analysts ",Buy Rating Affirmed for Solid Biosciences Amid Promising Early Data on SGT-003 DMD Therapy,"Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Solid Biosciences: A Buy Rating on Promising Gene Therapy SGT-003 and Expanding Pipeline Solid Biosciences SGT-003 safety signals encouraging, says H.C. Wainwright 3 Best Stocks to Buy Now, 8/14/2024, According to Top Analysts  Buy Rating Affirmed for Solid Biosciences Amid Promising Early Data on SGT-003 DMD Therapy",0,0,0,0,0,0
62.19M,"479,345",-63.68M,-1,489,6.42,Hold,10.25,"Aug 6, 2024",GAMB,Gambling.com Group Limited,368.89M,10.16,115.74M,5.71%,13.42%,10.57%,+1.87%,+5.60%,Bet On It: AGA estimates $35B to be wagered throughout NFL season,Bet On It: DraftKings leans into live betting opportunity with Simplebet deal,Bet On It: Missouri sports betting certification process challenged with lawsuit,Gambling.com’s (GAMB) Winning Streak Makes It a Compelling Option,Buy Rating Affirmed for Gambling.com on Strong Performance and Growth Potential,Bet On It: AGA estimates $35B to be wagered throughout NFL season Bet On It: DraftKings leans into live betting opportunity with Simplebet deal Bet On It: Missouri sports betting certification process challenged with lawsuit Gambling.com’s (GAMB) Winning Streak Makes It a Compelling Option Buy Rating Affirmed for Gambling.com on Strong Performance and Growth Potential,0,0,0,0,0,0
36.06M,"310,986",-23.12M,$1.32,412,11.07,Sell,9.70,"Jul 30, 2024",AMSWA,"American Software, Inc.",368.08M,11.06,102.81M,8.38%,15.73%,7.42%,+0.91%,-2.39%,Powell says ‘time has come’ for Fed to cut: Morning Buzz,American Software price target raised to $17 from $16 at Maxim,American Software Shareholders Approve Key Resolutions,"American Softwtare reports Q1 adjusted EPS 12c, consensus 8c","Is AMSWA a Buy, Before Earnings?","Powell says ‘time has come’ for Fed to cut: Morning Buzz American Software price target raised to $17 from $16 at Maxim American Software Shareholders Approve Key Resolutions American Softwtare reports Q1 adjusted EPS 12c, consensus 8c Is AMSWA a Buy, Before Earnings?",1,0,0,1,1,1
,,,-1,456,,,,,FMAO,"Farmers & Merchants Bancorp, Inc.",367.98M,27.20,95.41M,6.99%,11.27%,22.00%,-1.34%,+27.93%,Farmers & Merchants Bancorp Secures CEO Through 2027,,,,,Farmers & Merchants Bancorp Secures CEO Through 2027,0,0,-1,-1,-1,-1
33.06M,"154,915",-77.22M,-1,123,12.05,Strong Buy,22.14,"Aug 12, 2024",BSVN,Bank7 Corp.,367.35M,39.34,78.57M,1.64%,10.18%,33.70%,-5.40%,+43.58%,,,,,,,0,-1,-1,-1,-1,-1
14.83M,"38,920",-12.09M,$0.96,,26.82,Strong Buy,31.00,"Jul 24, 2024",CCIX,Churchill Capital Corp IX,367.17M,10.02,-,-0.04%,-0.03%,-0.03%,-0.20%,,,,,,,,1,-1,-1,-1,-1,-1
31.47M,"62,037",7.96M,-1,54,12.63,Strong Buy,15.75,"Aug 8, 2024",BDTX,"Black Diamond Therapeutics, Inc.",365.02M,6.46,-,13.39%,15.89%,40.43%,+4.52%,+25.79%,Buy Rating Reaffirmed for Black Diamond Therapeutics Amid Promising Clinical Trials and Solid Financials,,,,,Buy Rating Reaffirmed for Black Diamond Therapeutics Amid Promising Clinical Trials and Solid Financials,0,0,-1,-1,-1,-1
40.90M,"1,353,099",-72.10M,-1,413,9.71,Buy,14.67,"Aug 6, 2024",ACNB,ACNB Corporation,361.74M,42.33,106.71M,4.08%,8.83%,8.97%,+0.02%,+19.40%,ACNB Corp. management to meet virtually with Piper Sandler,ACNB Corporation Unveils Investor Presentation Online,,,,ACNB Corp. management to meet virtually with Piper Sandler ACNB Corporation Unveils Investor Presentation Online,0,0,1,-1,-1,-1
23.07M,"68,464",12.22M,-1,251,17.20,,,"Jul 25, 2024",ARTNA,Artesian Resources Corporation,360.96M,35.06,103.08M,-3.82%,-4.47%,-5.53%,-8.30%,+1.58%,,,,,,,1,-1,-1,-1,-1,-1
48.92M,"148,828",-45.65M,-1,"2,319",8.09,Buy,13.75,"Aug 5, 2024",ONEW,OneWater Marine Inc.,360.41M,24.64,1.85B,3.10%,-6.72%,-9.31%,-2.43%,-10.52%,"Analysts Offer Insights on Consumer Cyclical Companies: Jack In The Box (JACK), Greif Class A (GEF) and OneWater Marine (ONEW)",OneWater Marine management to meet with KeyBanc,,,,"Analysts Offer Insights on Consumer Cyclical Companies: Jack In The Box (JACK), Greif Class A (GEF) and OneWater Marine (ONEW) OneWater Marine management to meet with KeyBanc",1,1,1,-1,-1,-1
76.83M,"37,623",-50.56M,-1,,5.13,Buy,6.83,"Aug 8, 2024",GPAT,GP-Act III Acquisition Corp.,359.91M,10.02,-,-0.08%,0.01%,0.01%,-0.20%,,,,,,,,0,-1,-1,-1,-1,-1
13.73M,"33,656",15.85M,-1,,28.70,Strong Buy,25.00,"Aug 7, 2024",ALF,Centurion Acquisition Corp.,359.02M,9.99,-,-0.21%,-0.21%,-0.21%,,,,,,,,,0,-1,-1,-1,-1,-1
12.91M,"23,189",18.10M,$0.50,"1,892",30.50,,,"Aug 7, 2024",GGR,Gogoro Inc.,358.85M,1.29,333.94M,-9.85%,-16.97%,-34.57%,-27.81%,-34.34%,Gogoro and Nebula Energy announce commercial launch in Kathmandu for October,Gogoro Announces CPO Ming-I Peng’s Resignation,Gogoro files to sell 60.24M ordinary shares for holders,Gogoro downgraded to Hold from Buy at Benchmark,"Gogoro Faces Q2 Challenges, Eyes Future Growth","Gogoro and Nebula Energy announce commercial launch in Kathmandu for October Gogoro Announces CPO Ming-I Peng’s Resignation Gogoro files to sell 60.24M ordinary shares for holders Gogoro downgraded to Hold from Buy at Benchmark Gogoro Faces Q2 Challenges, Eyes Future Growth",1,1,1,1,1,0
9.24M,"127,489",17.53M,-1,"1,073",42.19,Buy,46.00,"Jul 31, 2024",ACB,Aurora Cannabis Inc.,356.62M,6.51,203.84M,-3.44%,5.63%,17.88%,-3.90%,-10.86%,Election 2024: Where To Put Your Money Ahead of the Vote,Largest borrow rate increases among liquid names,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,Rising High: SNDL announces successful bid to acquire Indiva,Aurora Cannabis Unveils New CBD Lozenge Partnership,Election 2024: Where To Put Your Money Ahead of the Vote Largest borrow rate increases among liquid names Rising High: MINT Shango JV to acquire Cannabist’s Florida entity Rising High: SNDL announces successful bid to acquire Indiva Aurora Cannabis Unveils New CBD Lozenge Partnership,1,1,1,1,0,1
25.14M,"61,376",30.69M,$0.24,477,15.46,Buy,18.00,"Jul 24, 2024",HBCP,"Home Bancorp, Inc.",355.05M,44.00,129.84M,5.81%,6.88%,13.04%,+0.18%,+19.75%,,,,,,,0,-1,-1,-1,-1,-1
61.37M,"358,877",-130.41M,-1,"2,400",6.33,Buy,13.75,"Aug 8, 2024",ACCD,"Accolade, Inc.",353.64M,4.42,431.53M,8.49%,2.32%,-47.83%,+2.93%,-54.08%,Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference,"Starbucks picks new CEO, Baxter divests Kidney Care segment: Morning Buzz",Accolade’s Growth and Profitability Outlook Underscored by Buy Rating,"Accolade working with Morgan Stanley to explore sale, Dealreporter says",,"Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference Starbucks picks new CEO, Baxter divests Kidney Care segment: Morning Buzz Accolade’s Growth and Profitability Outlook Underscored by Buy Rating Accolade working with Morgan Stanley to explore sale, Dealreporter says",0,1,0,1,1,-1
132.58M,"378,627",-16.55M,-1,31,2.930,Strong Buy,4.88,"Aug 8, 2024",IMMP,Immutep Limited,353.02M,2.43,2.68M,12.64%,10.44%,1.86%,+16.20%,-0.40%,Immutep Reports Increased Loss Despite Higher Income,Immutep’s Head & Neck Cancer Therapy Excels,Immutep Ltd (PRRUF) Gets a Buy from Canaccord Genuity,Immutep Launches Groundbreaking Autoimmune Therapy Trial,"Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody","Immutep Reports Increased Loss Despite Higher Income Immutep’s Head & Neck Cancer Therapy Excels Immutep Ltd (PRRUF) Gets a Buy from Canaccord Genuity Immutep Launches Groundbreaking Autoimmune Therapy Trial Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody",0,0,1,1,0,0
18.87M,"8,046",25.54M,$0.72,"2,287",17.27,Buy,23.00,"May 21, 2024",ALNT,Allient Inc.,351.87M,20.89,569.06M,-7.91%,-15.50%,-25.52%,-28.30%,-36.72%,Allient price target lowered to $28 from $39 at Roth MKM,Analysts Offer Insights on Technology Companies: Allient (ALNT) and Sunnova Energy International (NOVA),Allient price target lowered to $30 from $41 at Craig-Hallum,,,Allient price target lowered to $28 from $39 at Roth MKM Analysts Offer Insights on Technology Companies: Allient (ALNT) and Sunnova Energy International (NOVA) Allient price target lowered to $30 from $41 at Craig-Hallum,1,0,0,0,-1,-1
,,,-1,"1,744",,,,,FORR,"Forrester Research, Inc.",351.09M,18.42,453.42M,2.10%,5.46%,-9.60%,-5.45%,-5.17%,Streaming is getting more expensive for consumers. Here’s why,,,,,Streaming is getting more expensive for consumers. Here’s why,0,0,-1,-1,-1,-1
,,,-1,"1,720",,,,,BBCP,"Concrete Pumping Holdings, Inc.",350.15M,6.47,445.65M,4.14%,3.12%,-10.71%,-3.45%,-18.27%,Concrete Pumping downgraded to Neutral from Buy at UBS,D.A. Davidson Remains a Buy on Concrete Pumping Holdings (BBCP),Concrete Pumping price target lowered to $6.50 from $7.50 at Baird,"Concrete Pumping reports Q3 EPS 13c, consensus 19c","Concrete Pumping sees FY24 revenue $420M-$430M, consensus $457.51M","Concrete Pumping downgraded to Neutral from Buy at UBS D.A. Davidson Remains a Buy on Concrete Pumping Holdings (BBCP) Concrete Pumping price target lowered to $6.50 from $7.50 at Baird Concrete Pumping reports Q3 EPS 13c, consensus 19c Concrete Pumping sees FY24 revenue $420M-$430M, consensus $457.51M",1,1,1,0,1,1
,,,-1,299,,,,,CBNK,"Capital Bancorp, Inc.",349.21M,25.10,157.49M,4.08%,11.12%,17.27%,-0.86%,+23.75%,"Capital Bancorp, Integrated Financial announce receipt of approvals for merger",,,,,"Capital Bancorp, Integrated Financial announce receipt of approvals for merger",0,0,-1,-1,-1,-1
,,,-1,96,,,,,KYTX,"Kyverna Therapeutics, Inc.",349.06M,8.09,-,8.70%,-1.59%,-51.05%,-10.28%,-65.03%,Kyverna Therapeutics treatment of stiff person syndrome gets orphan designation,"Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Smith Douglas Homes Corp. Class A (SDHC) and Kayne Anderson BDC, Inc. (KBDC)",Kyverna Therapeutics price target lowered to $7 from $8 at H.C. Wainwright,Wall Street Analysts Are Bullish on Top NA Picks,"Kyverna Therapeutics reports Q2 EPS (67c), consensus (70c)","Kyverna Therapeutics treatment of stiff person syndrome gets orphan designation Analysts Offer Insights on NA Companies: Kyverna Therapeutics, Inc. (KYTX), Smith Douglas Homes Corp. Class A (SDHC) and Kayne Anderson BDC, Inc. (KBDC) Kyverna Therapeutics price target lowered to $7 from $8 at H.C. Wainwright Wall Street Analysts Are Bullish on Top NA Picks Kyverna Therapeutics reports Q2 EPS (67c), consensus (70c)",0,1,0,0,0,1
14.24M,"204,172",-160.74M,-1,33,26.69,Buy,41.00,"Aug 7, 2024",LWLG,"Lightwave Logic, Inc.",348.87M,2.89,90.27K,1.07%,-8.95%,-27.65%,-17.63%,-34.63%,,,,,,,0,-1,-1,-1,-1,-1
50.60M,"1,154,471",-860.76M,-1,,7.51,Hold,35.00,"Aug 9, 2024",AVNW,"Aviat Networks, Inc.",348.31M,27.72,385.39M,-2.80%,-4.76%,-14.08%,-12.32%,-22.83%,Aviat Networks (AVNW) Q4 Earnings Cheat Sheet,180 Degree Capital reports NAV of $4.50 as of June 30,,,,Aviat Networks (AVNW) Q4 Earnings Cheat Sheet 180 Degree Capital reports NAV of $4.50 as of June 30,0,0,0,-1,-1,-1
45.52M,"239,645",36.67M,-1,,8.33,Strong Buy,10.75,"Aug 6, 2024",ESPR,"Esperion Therapeutics, Inc.",347.32M,1.77,277.79M,-12.55%,-23.58%,-22.69%,-26.41%,-47.53%,Market Outperform: Enhanced Insurance Coverage and FDA Approvals Propel Esperion’s Growth Potential,"Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL",Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe),Esperion management to meet with Jefferies,Buy Rating Affirmed for Esperion on Robust Revenue Growth and Enhanced Market Access,"Market Outperform: Enhanced Insurance Coverage and FDA Approvals Propel Esperion’s Growth Potential Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Esperion management to meet with Jefferies Buy Rating Affirmed for Esperion on Robust Revenue Growth and Enhanced Market Access",1,1,1,1,0,1
14.80M,"79,128",-74.18M,-1,934,25.59,Buy,30.50,"Aug 8, 2024",CMPO,"CompoSecure, Inc.",347.11M,11.57,409.36M,17.74%,40.82%,86.52%,+45.03%,+72.05%,Short Report: Bearish positioning in Cinemark caves as shares shine,Largest borrow rate increases among liquid names,CompoSecure price target raised to $14.50 from $11.50 at Compass Point,CompoSecure price target raised to $12 from $8 at JPMorgan,J.P. Morgan Remains a Hold on CompoSecure (CMPO),Short Report: Bearish positioning in Cinemark caves as shares shine Largest borrow rate increases among liquid names CompoSecure price target raised to $14.50 from $11.50 at Compass Point CompoSecure price target raised to $12 from $8 at JPMorgan J.P. Morgan Remains a Hold on CompoSecure (CMPO),1,1,1,0,0,0
52.62M,"299,507",-66.81M,-1,"1,060",7.18,Strong Buy,21.00,"Aug 13, 2024",MCFT,"MasterCraft Boat Holdings, Inc.",346.07M,20.38,465.97M,1.15%,3.23%,-3.22%,-9.23%,-12.93%,MasterCraft’s Strategic Prudence Amidst Economic Challenges: A Buy Rating by Craig Kennison,"Analysts Are Bullish on Top Consumer Cyclical Stocks: Lululemon Athletica (LULU), MasterCraft Boat Holdings (MCFT)",Truist Financial Keeps Their Hold Rating on MasterCraft Boat Holdings (MCFT),"MasterCraft Boat sees Q1 adjusted EPS 4c, consensus 15c","MasterCraft Boat sees FY25 adjusted EPS 36c-87c, consensus $1.59","MasterCraft’s Strategic Prudence Amidst Economic Challenges: A Buy Rating by Craig Kennison Analysts Are Bullish on Top Consumer Cyclical Stocks: Lululemon Athletica (LULU), MasterCraft Boat Holdings (MCFT) Truist Financial Keeps Their Hold Rating on MasterCraft Boat Holdings (MCFT) MasterCraft Boat sees Q1 adjusted EPS 4c, consensus 15c MasterCraft Boat sees FY25 adjusted EPS 36c-87c, consensus $1.59",0,1,1,0,1,0
52.89M,"579,608",-44.77M,-1,190,7.12,Buy,3.50,"Aug 8, 2024",WTBA,"West Bancorporation, Inc.",344.06M,20.44,76.33M,3.87%,4.95%,7.67%,-4.29%,+16.70%,,,,,,,0,-1,-1,-1,-1,-1
49.61M,"52,859",-80.69M,-1,574,7.59,Strong Buy,20.33,"Aug 8, 2024",FSBW,"FS Bancorp, Inc.",344.00M,44.97,138.83M,6.36%,14.29%,27.84%,-0.11%,+30.08%,FS Bancorp Leaders to Attend Raymond James Conference,,,,,FS Bancorp Leaders to Attend Raymond James Conference,0,0,-1,-1,-1,-1
10.19M,"30,586",-8.27M,$1.32,46,36.92,,,"Aug 5, 2024",TMC,TMC the metals company Inc.,343.43M,1.06,-,1.42%,-15.36%,-22.24%,-9.26%,-42.01%,Largest borrow rate increases among liquid names,The Metals Company options imply 16.1% move in share price post-earnings,"TMC Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,"Largest borrow rate increases among liquid names The Metals Company options imply 16.1% move in share price post-earnings TMC Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,1,0,1,-1,-1
27.35M,"29,328",30.39M,-1,133,13.75,Strong Buy,17.00,"Jul 24, 2024",ICG,Intchains Group Limited,342.48M,5.71,26.09M,-4.94%,-18.79%,-32.83%,-21.84%,-34.35%,Intchains Group to host investor day,Intchains Group Ltd. ADR (ICG) Gets a Buy from Benchmark Co.,Intchains Group Limited Reports Second Quarter 2024 Unaudited Financial Results,Intchains Group’s Soaring Profits Amidst Innovations,,Intchains Group to host investor day Intchains Group Ltd. ADR (ICG) Gets a Buy from Benchmark Co. Intchains Group Limited Reports Second Quarter 2024 Unaudited Financial Results Intchains Group’s Soaring Profits Amidst Innovations,1,1,0,0,1,-1
70.56M,"538,641",-107.91M,-1,414,5.32,Strong Buy,17.33,"Aug 13, 2024",LNZA,"LanzaTech Global, Inc.",342.13M,1.73,67.69M,7.96%,-6.47%,-48.09%,-17.13%,-51.61%,LanzaTech Global (LNZA) Receives a Rating Update from a Top Analyst,LanzaTech signs master license agreement with Sekisui for plants in Japan,Roth MKM Sticks to Its Buy Rating for LanzaTech Global (LNZA),LanzaTech and LanzaJet Announce New Project with Wagner Sustainable Fuels in Australia,LanzaTech price target lowered to $4.75 from $5 at Seaport Research,LanzaTech Global (LNZA) Receives a Rating Update from a Top Analyst LanzaTech signs master license agreement with Sekisui for plants in Japan Roth MKM Sticks to Its Buy Rating for LanzaTech Global (LNZA) LanzaTech and LanzaJet Announce New Project with Wagner Sustainable Fuels in Australia LanzaTech price target lowered to $4.75 from $5 at Seaport Research,1,1,0,0,1,0
287.86M,"4,745,590",-44.90M,-1,253,1.300,Strong Buy,4.67,"Aug 8, 2024",CDRO,"Codere Online Luxembourg, S.A.",342.00M,7.55,151.88M,-1.41%,-1.22%,28.86%,-5.85%,+2.52%,,,,,,,0,-1,-1,-1,-1,-1
15.55M,"146,579",15.02M,-1,791,24.03,Strong Buy,33.25,"Jun 13, 2024",RGP,"Resources Connection, Inc.",341.98M,10.19,632.80M,-2.93%,-4.46%,-17.12%,-14.59%,-15.30%,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 19, 2024",,,,,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 19, 2024",1,0,-1,-1,-1,-1
5.50M,"31,876",32.21M,$2.48,214,67.82,,,"Jul 24, 2024",SGHT,"Sight Sciences, Inc.",340.08M,6.76,79.40M,7.98%,1.19%,30.55%,-13.62%,+21.08%,Sight Sciences: A Balanced View Amidst Recovery and Uncertainties,"AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls",Sight Sciences Poised for Growth: Buy Rating Affirmed Amid Market Expansion and Favorable Reimbursement Outlook,Sight Sciences initiated with a Buy at Lake Street,Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference,"Sight Sciences: A Balanced View Amidst Recovery and Uncertainties AmEx downgraded, Texas Instruments upgraded: Wall Street’s top analyst calls Sight Sciences Poised for Growth: Buy Rating Affirmed Amid Market Expansion and Favorable Reimbursement Outlook Sight Sciences initiated with a Buy at Lake Street Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference",0,0,1,0,0,1
8.29M,"14,331",37.22M,$1.00,"1,243",44.87,Strong Buy,50.75,"Jul 25, 2024",FARO,"FARO Technologies, Inc.",339.63M,17.42,351.98M,8.70%,4.64%,-11.02%,+1.81%,-14.45%,Faro Technologies Announces Senior VP of Global Sales Resignation,Faro Technologies price target lowered to $25 from $29 at Craig-Hallum,,,,Faro Technologies Announces Senior VP of Global Sales Resignation Faro Technologies price target lowered to $25 from $29 at Craig-Hallum,1,1,0,-1,-1,-1
12.23M,"33,768",35.63M,$0.96,365,30.42,,,"Jul 23, 2024",TCBX,"Third Coast Bancshares, Inc.",339.44M,24.84,151.61M,12.39%,14.69%,26.56%,+8.26%,+32.53%,,,,,,,0,-1,-1,-1,-1,-1
6.89M,"15,330",32.49M,$0.36,59,53.99,Buy,55.00,"Jul 26, 2024",INZY,"Inozyme Pharma, Inc.",338.77M,5.40,-,11.55%,11.01%,12.06%,-5.86%,-14.82%,Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference,Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks,"3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts ",Inozyme Pharma: A Buy Rating with Multi-Billion Dollar Market Potential and Upcoming Catalysts,Inozyme assumed with a Buy at Jefferies,"Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks 3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts  Inozyme Pharma: A Buy Rating with Multi-Billion Dollar Market Potential and Upcoming Catalysts Inozyme assumed with a Buy at Jefferies",1,0,1,0,1,0
54.53M,"311,974",9.02M,-1,225,6.80,Strong Buy,17.83,"Aug 6, 2024",PSNL,"Personalis, Inc.",338.48M,5.97,80.03M,28.72%,98.52%,214.75%,+60.29%,+297.84%,Personalis files to sell 3.5M shares of common stock for holders,Personalis (PSNL) Receives a Buy from BTIG,Personalis (PSNL) Receives a Buy from TD Cowen,"Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Healthequity (HQY)",Personalis price target raised to $9 from $7.50 at H.C. Wainwright,"Personalis files to sell 3.5M shares of common stock for holders Personalis (PSNL) Receives a Buy from BTIG Personalis (PSNL) Receives a Buy from TD Cowen Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Healthequity (HQY) Personalis price target raised to $9 from $7.50 at H.C. Wainwright",1,1,0,0,0,0
38.60M,"155,354",-90.69M,-1,237,9.56,Strong Buy,16.80,"Aug 13, 2024",UNTY,"Unity Bancorp, Inc.",338.41M,33.91,99.26M,3.23%,8.10%,17.81%,-3.29%,+25.49%,Unity Bank Ranked 13th Nationally and 5th in ROA Among Banks Under $5 Billion,Unity Bancorp Inc. Declares Cash Dividend,,,,Unity Bank Ranked 13th Nationally and 5th in ROA Among Banks Under $5 Billion Unity Bancorp Inc. Declares Cash Dividend,0,1,0,-1,-1,-1
36.31M,"174,954",25.62M,-1,197,10.16,Strong Buy,14.25,"Aug 15, 2024",OBT,"Orange County Bancorp, Inc.",336.37M,59.39,102.96M,5.44%,9.43%,17.97%,-5.85%,+27.03%,,,,,,,0,-1,-1,-1,-1,-1
33.28M,"464,383",10.68M,$0.44,202,11.06,Strong Buy,15.50,"Aug 22, 2024",PGEN,"Precigen, Inc.",334.15M,1.16,4.39M,-5.74%,-20.57%,-17.28%,-25.66%,-19.29%,Precigen Aligns Executive Incentives with FDA Approval Goals,Biotech Alert: Searches spiking for these stocks today,Buy Rating Affirmed for Precigen Amid Promising PRGN-2012 Clinical Data and Strategic Focus,Precigen price target lowered to $7 from $14 at JMP Securities,"Precigen reports Q2 EPS (23c), consensus (10c)","Precigen Aligns Executive Incentives with FDA Approval Goals Biotech Alert: Searches spiking for these stocks today Buy Rating Affirmed for Precigen Amid Promising PRGN-2012 Clinical Data and Strategic Focus Precigen price target lowered to $7 from $14 at JMP Securities Precigen reports Q2 EPS (23c), consensus (10c)",1,0,1,1,1,1
13.53M,"43,202",21.12M,$0.88,,27.20,Hold,26.00,"Aug 1, 2024",IPXX,Inflection Point Acquisition Corp. II,333.75M,10.68,-,0.06%,0.48%,2.07%,+0.19%,+2.05%,Inflection Point Acquisition’s Strategic Merger with USA Rare Earth,"Inflection Point Acquisition Corp., USA Rare Earth enter combination agreement",,,,"Inflection Point Acquisition’s Strategic Merger with USA Rare Earth Inflection Point Acquisition Corp., USA Rare Earth enter combination agreement",0,0,0,-1,-1,-1
9.34M,"11,499",31.73M,$0.96,,39.34,Buy,37.00,"Jul 11, 2024",ILPT,Industrial Logistics Properties Trust,333.21M,5.05,441.89M,5.53%,16.97%,26.60%,-1.36%,+33.42%,,,,,,,0,-1,-1,-1,-1,-1
36.66M,"312,751",,-1,528,10.02,,,,NEWT,"NewtekOne, Inc.",332.86M,12.82,301.04M,-0.80%,-3.53%,-0.11%,-11.58%,+2.32%,"NewtekOne, Inc. Reconfirms its 2024 Annual EPS Forecast in a Range of $1.85 to $2.05 per Basic and Diluted Common Share","NewtekOne reaffirms FY24 EPS view $1.85-$2.05, consensus $1.90",B. Riley downgrades NewtekOne on more challenging environment,NewtekOne downgraded to Neutral from Buy at B. Riley,KBW Sticks to Their Hold Rating for Newtek Business (NEWT),"NewtekOne, Inc. Reconfirms its 2024 Annual EPS Forecast in a Range of $1.85 to $2.05 per Basic and Diluted Common Share NewtekOne reaffirms FY24 EPS view $1.85-$2.05, consensus $1.90 B. Riley downgrades NewtekOne on more challenging environment NewtekOne downgraded to Neutral from Buy at B. Riley KBW Sticks to Their Hold Rating for Newtek Business (NEWT)",0,0,0,0,1,0
,,,-1,925,,,,,JFIN,Jiayin Group Inc.,331.45M,6.25,806.05M,-1.78%,-6.99%,-8.67%,-4.29%,-18.32%,Jiayin Group Optimistic After Q2 Financials,Jiayin Group Inc. Reports Second Quarter 2024 Unaudited Financial Results,Jiayin Group Announces Upcoming Cash Dividend,Jiayin Group Inc. Announces Cash Dividends,"Jiayin Group Inc. to Release Second Quarter 2024 Unaudited Financial Results on Tuesday, August 27, 2024","Jiayin Group Optimistic After Q2 Financials Jiayin Group Inc. Reports Second Quarter 2024 Unaudited Financial Results Jiayin Group Announces Upcoming Cash Dividend Jiayin Group Inc. Announces Cash Dividends Jiayin Group Inc. to Release Second Quarter 2024 Unaudited Financial Results on Tuesday, August 27, 2024",1,1,1,1,1,1
56.50M,"446,014",-80.55M,-1,329,6.46,Strong Buy,14.75,"Aug 6, 2024",BMRC,Bank of Marin Bancorp,331.29M,20.49,58.62M,7.77%,12.03%,14.64%,+1.58%,+34.49%,Bank of Marin Executives to Attend Virtual Western Bank Summit,,,,,Bank of Marin Executives to Attend Virtual Western Bank Summit,1,0,-1,-1,-1,-1
8.55M,"20,890",31.19M,$1.28,638,42.33,Buy,37.00,"Jul 24, 2024",OSUR,"OraSure Technologies, Inc.",331.08M,4.44,273.54M,1.97%,2.30%,-26.90%,-2.90%,-27.01%,J.P. Morgan Sticks to Their Hold Rating for Orasure Technologies (OSUR),,,,,J.P. Morgan Sticks to Their Hold Rating for Orasure Technologies (OSUR),1,0,-1,-1,-1,-1
10.30M,"34,828",18.29M,$1.18,10,35.06,,,"Aug 5, 2024",ALDX,"Aldeyra Therapeutics, Inc.",330.98M,5.57,-,17.80%,34.15%,49.44%,+33.25%,+11.23%,Biotech Alert: Searches spiking for these stocks today,Aldeyra Therapeutics Announces Executive Team Changes,"Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX)",,,"Biotech Alert: Searches spiking for these stocks today Aldeyra Therapeutics Announces Executive Team Changes Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX)",0,1,1,0,-1,-1
14.63M,"57,411",-95.32M,-1,13,24.64,Buy,31.25,"Jul 30, 2024",XOMA,XOMA Royalty Corporation,330.65M,28.25,15.24M,12.08%,12.83%,28.35%,+8.37%,+14.44%,XOMA Royalty to Present at Upcoming Investor Conferences in September,Risinger Affirms Buy Rating on Xoma with Increased Price Target Amid Strong Financial Performance and Unrecognized Asset Potential,Buy Rating Affirmed: Xoma’s Strategic Growth and Financial Strength Highlighted,Xoma price target raised to $117 from $74 at H.C. Wainwright,TD Cowen Keeps Their Hold Rating on Xoma (XOMA),XOMA Royalty to Present at Upcoming Investor Conferences in September Risinger Affirms Buy Rating on Xoma with Increased Price Target Amid Strong Financial Performance and Unrecognized Asset Potential Buy Rating Affirmed: Xoma’s Strategic Growth and Financial Strength Highlighted Xoma price target raised to $117 from $74 at H.C. Wainwright TD Cowen Keeps Their Hold Rating on Xoma (XOMA),1,1,1,1,1,1
35.94M,"391,764",1.70M,-1,950,10.02,,,,AUDC,AudioCodes Ltd.,329.97M,10.92,245.53M,0.74%,1.27%,-5.49%,-4.07%,-13.14%,AudioCodes Schedules 2024 Shareholder Meeting,,,,,AudioCodes Schedules 2024 Shareholder Meeting,0,0,-1,-1,-1,-1
,,,-1,382,,,,,LUNR,"Intuitive Machines, Inc.",329.72M,5.24,157.77M,17.88%,21.94%,12.11%,+17.34%,-15.40%,Unusually active option classes on open August 30th,Roth MKM Keeps Their Buy Rating on Intuitive Machines (LUNR),Closing Bell Movers: Lululemon gains 5%; Elastic falls 25% on earnings,Intuitive Machines Secures NASA Lunar Payload Contract,Intuitive Machines Strengthens Lunar Service Capabilities with $116.9 million NASA Lunar Contract Award,Unusually active option classes on open August 30th Roth MKM Keeps Their Buy Rating on Intuitive Machines (LUNR) Closing Bell Movers: Lululemon gains 5%; Elastic falls 25% on earnings Intuitive Machines Secures NASA Lunar Payload Contract Intuitive Machines Strengthens Lunar Service Capabilities with $116.9 million NASA Lunar Contract Award,1,0,1,0,1,0
35.94M,"431,928",,-1,75,9.99,,,,AVIR,"Atea Pharmaceuticals, Inc.",329.25M,3.90,-,5.84%,7.75%,5.86%,-0.52%,-0.26%,Atea Pharma publishes data on metabolic activation pathway of bemnifosbuvir,Atea Pharmaceuticals Announces Publication of Additional Data Further Highlighting Bemnifosbuvir’s Metabolic Activation Pathway,Hold Rating on Atea Pharmaceuticals Amidst Competitive Landscape and Market Uncertainties,Atea Pharmaceuticals upgraded to Equal Weight from Underweight at Morgan Stanley,,Atea Pharma publishes data on metabolic activation pathway of bemnifosbuvir Atea Pharmaceuticals Announces Publication of Additional Data Further Highlighting Bemnifosbuvir’s Metabolic Activation Pathway Hold Rating on Atea Pharmaceuticals Amidst Competitive Landscape and Market Uncertainties Atea Pharmaceuticals upgraded to Equal Weight from Underweight at Morgan Stanley,0,0,0,0,0,-1
,,,-1,107,,,,,CLPT,"ClearPoint Neuro, Inc.",327.84M,11.88,28.07M,37.15%,68.71%,91.57%,+75.42%,+95.33%,Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT),Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT),ClearPoint Neuro price target raised to $15 from $11 at Lake Street,ClearPoint Neuro Preempts Convertible Note Obligations,ClearPoint Neuro Announces Early Repayment of $10 Million Note,Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT) Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT) ClearPoint Neuro price target raised to $15 from $11 at Lake Street ClearPoint Neuro Preempts Convertible Note Obligations ClearPoint Neuro Announces Early Repayment of $10 Million Note,0,0,0,0,1,1
278.18M,"286,395",-62.98M,-1,243,1.290,Hold,2.20,"Aug 15, 2024",AIP,"Arteris, Inc.",327.40M,8.34,53.30M,9.96%,5.82%,19.69%,+0.73%,+15.38%,Northland Securities Sticks to Its Buy Rating for Arteris (AIP),,,,,Northland Securities Sticks to Its Buy Rating for Arteris (AIP),1,0,-1,-1,-1,-1
54.66M,"566,334",-23.50M,-1,608,6.51,Hold,,"Aug 7, 2024",WEYS,"Weyco Group, Inc.",326.98M,34.70,300.23M,4.17%,7.68%,11.25%,-1.84%,+12.77%,,,,,,,0,-1,-1,-1,-1,-1
8.07M,"12,290",36.46M,$1.00,932,44.00,Buy,41.50,"Oct 16, 2024",NEGG,"Newegg Commerce, Inc.",326.91M,0.86,1.50B,-1.04%,-8.31%,-13.20%,-14.72%,-10.26%,"Newegg Navigates Economic Challenges, Eyes Growth",,,,,"Newegg Navigates Economic Challenges, Eyes Growth",1,1,-1,-1,-1,-1
80.01M,"470,187",-88.99M,-1,167,4.420,Buy,10.88,"Oct 2, 2024",NAUT,"Nautilus Biotechnology, Inc.",326.07M,2.60,-,10.09%,7.32%,-2.91%,-3.32%,-1.87%,Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,,,,,Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,1,0,-1,-1,-1,-1
1.19B,"64,930",-27.61M,-1,"2,437",2.430,Buy,8.00,"Sep 3, 2024",MTLS,Materialise NV,324.87M,5.50,276.29M,-0.32%,4.19%,0.09%,-16.00%,+5.61%,,,,,,,1,-1,-1,-1,-1,-1
16.84M,"97,814",19.07M,$0.12,,20.89,Strong Buy,29.33,"Aug 7, 2024",HEAR,Turtle Beach Corporation,324.39M,15.63,291.02M,3.52%,1.60%,10.12%,+3.39%,-10.90%,Turtle Beach Enhances Financial Flexibility and Announces CFO Transition,Turtle Beach: Strong Q2 Performance and Promising Outlook Reinforce Buy Rating,Turtle Beach Corporation: Strong Q2 Performance and Strategic Acquisition Fuel Buy Rating,Stifel Nicolaus Sticks to Their Buy Rating for Turtle Beach (HEAR),Turtle Beach price target raised to $26 from $25 at Roth MKM,Turtle Beach Enhances Financial Flexibility and Announces CFO Transition Turtle Beach: Strong Q2 Performance and Promising Outlook Reinforce Buy Rating Turtle Beach Corporation: Strong Q2 Performance and Strategic Acquisition Fuel Buy Rating Stifel Nicolaus Sticks to Their Buy Rating for Turtle Beach (HEAR) Turtle Beach price target raised to $26 from $25 at Roth MKM,1,1,1,1,1,1
19.06M,"66,127",1.44M,-1,,18.42,Hold,,"Jul 30, 2024",ESEA,Euroseas Ltd.,324.34M,46.24,205.17M,8.54%,15.92%,27.60%,+22.50%,+22.27%,,,,,,,0,-1,-1,-1,-1,-1
54.12M,"98,014",16.60M,-1,,6.47,Buy,8.17,"Sep 4, 2024",MGTX,MeiraGTx Holdings plc,322.75M,4.17,8.12M,-6.83%,-7.42%,-23.81%,-21.41%,-25.27%,MeiraGTx price target lowered to $9 from $11 at RBC Capital,"Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)",MeiraGTx sees cash runway into 2Q26,MeiraGTx reports Q2 EPS (76c) vs. (53c) last year,MeiraGTx announces pricing of 12.5M shares at $4.00 in underwritten offering,"MeiraGTx price target lowered to $9 from $11 at RBC Capital Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS) MeiraGTx sees cash runway into 2Q26 MeiraGTx reports Q2 EPS (76c) vs. (53c) last year MeiraGTx announces pricing of 12.5M shares at $4.00 in underwritten offering",0,0,0,0,0,0
13.91M,"34,235",33.59M,$0.40,119,25.10,Buy,26.00,"Oct 21, 2024",VBNK,VersaBank,322.64M,12.42,82.59M,10.99%,15.08%,25.89%,+6.93%,+25.83%,VersaBank Announces Upcoming Quarterly Dividends,"VersaBank Expands into US Market, Reports Growth",VersaBank reports Q3 EPS C$0.36 vs. C$0.45 last year,VERSABANK REPORTS THIRD QUARTER FISCAL 2024 RESULTS: RESULTS CONTINUE TO DEMONSTRATE STRENGTH OF BUSINESS MODEL AS BANK ENTERS US MARKET,VERSABANK DECLARES DIVIDENDS,"VersaBank Announces Upcoming Quarterly Dividends VersaBank Expands into US Market, Reports Growth VersaBank reports Q3 EPS C$0.36 vs. C$0.45 last year VERSABANK REPORTS THIRD QUARTER FISCAL 2024 RESULTS: RESULTS CONTINUE TO DEMONSTRATE STRENGTH OF BUSINESS MODEL AS BANK ENTERS US MARKET VERSABANK DECLARES DIVIDENDS",1,1,1,1,1,0
43.15M,"313,371",-75.92M,-1,167,8.09,Buy,26.67,"Aug 12, 2024",AKBA,"Akebia Therapeutics, Inc.",321.74M,1.53,174.50M,13.07%,23.76%,14.27%,+10.87%,+2.68%,Buy Rating Reaffirmed for Akebia Therapeutics Ahead of Vafseo’s Market Launch,Akebia and U.S. Renal Care initiate trial of Vafseo for patients on dialysis,Akebia price target raised to $7.50 from $6 at H.C. Wainwright,,,Buy Rating Reaffirmed for Akebia Therapeutics Ahead of Vafseo’s Market Launch Akebia and U.S. Renal Care initiate trial of Vafseo for patients on dialysis Akebia price target raised to $7.50 from $6 at H.C. Wainwright,1,0,0,0,-1,-1
120.72M,"600,358",-21.80M,-1,378,2.890,,,"Aug 9, 2024",KMDA,Kamada Ltd.,321.62M,5.72,154.57M,2.81%,2.90%,2.09%,+1.24%,+6.32%,Buy Rating Affirmed for Kamada on Strong Clinical and Financial Performance,Kamada Ltd. Reports Substantial Growth in 2024,"Kamada sees FY24 revenue $158M-$162M, consensus $159.6M","Kamada reports Q2 EPS 8c, consensus 6c","KMDA Earnings Report this Week: Is It a Buy, Ahead of Earnings?","Buy Rating Affirmed for Kamada on Strong Clinical and Financial Performance Kamada Ltd. Reports Substantial Growth in 2024 Kamada sees FY24 revenue $158M-$162M, consensus $159.6M Kamada reports Q2 EPS 8c, consensus 6c KMDA Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,0,1,1,1,1
,,,-1,"3,500",,,,,DENN,Denny's Corporation,321.09M,6.25,455.44M,0.59%,-6.12%,-26.50%,-14.81%,-25.71%,Denny’s Celebrates HBCU Culture and Community in Its Fourth Year as Title Sponsor of the Denny’s Orange Blossom Classic,Denny’s Annual No Kid Hungry Fundraiser Returns for Fourteenth Year to Address the Most Important School Supply: Food,Denny’s Resurrects Its Iconic $2 $4 $6 $8 Value Menu in Partnership with ‘Beetlejuice Beetlejuice’,,,Denny’s Celebrates HBCU Culture and Community in Its Fourth Year as Title Sponsor of the Denny’s Orange Blossom Classic Denny’s Annual No Kid Hungry Fundraiser Returns for Fourteenth Year to Address the Most Important School Supply: Food Denny’s Resurrects Its Iconic $2 $4 $6 $8 Value Menu in Partnership with ‘Beetlejuice Beetlejuice’,0,0,0,1,-1,-1
,,,-1,"4,131",,,,,SNBR,Sleep Number Corporation,320.79M,14.35,1.78B,17.86%,35.10%,16.61%,+25.00%,+9.50%,,,,,,,1,-1,-1,-1,-1,-1
30.00M,"878,283",28.18M,-1,147,11.57,Strong Buy,12.64,"Aug 7, 2024",NATH,"Nathan's Famous, Inc.",320.76M,78.53,141.39M,2.76%,5.29%,7.98%,+1.64%,+12.31%,,,,,,,0,-1,-1,-1,-1,-1
16.98M,"84,280",38.51M,-1,"3,604",20.38,Buy,21.83,"Aug 29, 2024",TITN,Titan Machinery Inc.,319.47M,14.21,2.82B,-6.90%,-10.99%,-37.33%,-20.75%,-40.15%,Titan Machinery price target lowered to $15 from $20 at B. Riley,Northland Securities Sticks to Its Hold Rating for Titan Machinery (TITN),Titan Machinery price target raised to $25 from $15 at Northland,Baird says ‘bit too early to get more aggressive’ on Titan Machinery,Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Titan Machinery (TITN) and Eos Energy Enterprises (EOSE),Titan Machinery price target lowered to $15 from $20 at B. Riley Northland Securities Sticks to Its Hold Rating for Titan Machinery (TITN) Titan Machinery price target raised to $25 from $15 at Northland Baird says ‘bit too early to get more aggressive’ on Titan Machinery Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Titan Machinery (TITN) and Eos Energy Enterprises (EOSE),1,1,1,1,1,1
16.83M,"39,996",21.43M,$1.00,234,20.44,,,"Jul 25, 2024",NODK,"NI Holdings, Inc.",319.02M,15.45,380.70M,0.64%,-1.52%,4.27%,-8.89%,-0.40%,NI Holdings Announces CEO Transition and Interim Leadership,"NI Holdings, Inc. Announces Leadership Change",NI Holdings CEO Michael Alexander steps down,,,"NI Holdings Announces CEO Transition and Interim Leadership NI Holdings, Inc. Announces Leadership Change NI Holdings CEO Michael Alexander steps down",0,0,0,1,-1,-1
7.65M,"24,785",35.54M,$1.08,203,44.97,Hold,44.00,"Jul 23, 2024",VNDA,Vanda Pharmaceuticals Inc.,318.26M,5.46,182.02M,-0.05%,-5.94%,15.12%,-9.76%,+9.34%,,,,,,,0,-1,-1,-1,-1,-1
323.99M,"416,539",-91.29M,-1,265,1.060,Hold,4.00,"Aug 14, 2024",EDIT,"Editas Medicine, Inc.",318.26M,3.87,67.03M,-11.20%,-20.49%,-46.07%,-31.98%,-45.24%,Editas Medicine to Participate in Upcoming Investor Conferences,Editas Medicine Hold Rating with Revised Price Target Amidst Mixed Financial Signals,,,,Editas Medicine to Participate in Upcoming Investor Conferences Editas Medicine Hold Rating with Revised Price Target Amidst Mixed Financial Signals,0,0,0,-1,-1,-1
59.98M,"15,396",3.38M,-1,760,5.71,Strong Buy,11.00,"Aug 15, 2024",UXIN,Uxin Limited,317.63M,1.69,190.39M,-1.32%,-10.98%,-55.79%,-4.38%,-17.74%,Eleven option delistings on August 19th,,,,,Eleven option delistings on August 19th,0,0,-1,-1,-1,-1
197.77M,"341,517",-97.31M,-1,198,1.730,Strong Buy,6.00,"Aug 8, 2024",MAMA,"Mama's Creations, Inc.",316.36M,8.49,110.00M,3.11%,8.43%,42.90%,+4.86%,+68.57%,"Is MAMA a Buy, Before Earnings?",Mama’s Creations to Host Second Quarter Fiscal Year 2025 Earnings Call on September 10 at 4:30 p.m. Eastern Time,,,,"Is MAMA a Buy, Before Earnings? Mama’s Creations to Host Second Quarter Fiscal Year 2025 Earnings Call on September 10 at 4:30 p.m. Eastern Time",0,1,0,-1,-1,-1
45.30M,"20,279",-32.67M,-1,83,7.55,Strong Buy,9.50,"Jul 31, 2024",CRMD,CorMedix Inc.,315.61M,5.65,806.12K,34.42%,35.90%,46.67%,+31.44%,+27.81%,Biotech Alert: Searches spiking for these stocks today,CorMedix initiated with a Buy at Rodman & Renshaw,Cormedix (CRMD) Gets a Buy from Truist Financial,RBC Capital Sticks to Their Buy Rating for Cormedix (CRMD),Buy Rating Affirmed: Promising DefenCath Launch and Financial Stability Position Cormedix for Market Growth,Biotech Alert: Searches spiking for these stocks today CorMedix initiated with a Buy at Rodman & Renshaw Cormedix (CRMD) Gets a Buy from Truist Financial RBC Capital Sticks to Their Buy Rating for Cormedix (CRMD) Buy Rating Affirmed: Promising DefenCath Launch and Financial Stability Position Cormedix for Market Growth,1,1,1,0,0,1
33.56M,"186,825",21.03M,$0.56,64,10.19,Hold,13.00,"Oct 2, 2024",PEPG,PepGen Inc.,315.14M,9.67,-,-1.99%,-32.48%,-19.16%,-17.76%,-20.94%,"Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)",,,,,"Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)",0,0,-1,-1,-1,-1
50.31M,"195,154",-52.32M,-1,290,6.76,Hold,6.75,"Aug 1, 2024",INBK,First Internet Bancorp,313.78M,36.20,101.42M,3.09%,9.93%,19.72%,-2.35%,+10.00%,,,,,,,0,-1,-1,-1,-1,-1
19.50M,"178,289",-14.96M,-1,151,17.42,Strong Buy,24.00,"Aug 8, 2024",PANL,"Pangaea Logistics Solutions, Ltd.",312.84M,6.67,503.74M,2.52%,-5.26%,-10.23%,-6.20%,-1.73%,,,,,,,1,-1,-1,-1,-1,-1
13.67M,"128,662",31.69M,-1,,24.84,Buy,24.40,"Jul 24, 2024",MBAV,M3-Brigade Acquisition V Corp.,312.81M,10.01,-,,-5.26%,-10.23%,,,,,,,,,0,-1,-1,-1,-1,-1
62.73M,"225,741",-88.56M,-1,992,5.40,Strong Buy,16.17,"Aug 6, 2024",TCMD,"Tactile Systems Technology, Inc.",312.77M,13.05,281.54M,2.44%,6.93%,-4.13%,+1.49%,-17.97%,"Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)",,,,,"Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)",0,0,-1,-1,-1,-1
56.70M,"1,324,393",-81.45M,-1,,5.97,Strong Buy,6.81,"Aug 7, 2024",REFI,"Chicago Atlantic Real Estate Finance, Inc.",312.23M,15.91,55.19M,2.92%,1.99%,1.31%,-1.13%,+0.51%,Compass Point Keeps Their Hold Rating on Chicago Atlantic Real Estate ate Finance Inc (REFI),,,,,Compass Point Keeps Their Hold Rating on Chicago Atlantic Real Estate ate Finance Inc (REFI),1,1,-1,-1,-1,-1
9.98M,"12,839",38.76M,$0.52,31,33.91,Buy,39.00,"Oct 11, 2024",GMGI,"Golden Matrix Group, Inc.",311.77M,2.58,45.24M,0.02%,-6.29%,-22.09%,+9.87%,-16.67%,Golden Matrix introduces version 2.0 of casino game recommender,Golden Matrix files to sell 7.6M shares of common stock for holders,Golden Matrix Group Subsidiary Meridianbet Shortlisted for Exclusive Sports Betting and iGaming License in Brazil,"Meridianbet shortlisted for sports betting, iGaming license in Brazil",Golden Matrix Announces Participation in Benzinga All-Access Interview,"Golden Matrix introduces version 2.0 of casino game recommender Golden Matrix files to sell 7.6M shares of common stock for holders Golden Matrix Group Subsidiary Meridianbet Shortlisted for Exclusive Sports Betting and iGaming License in Brazil Meridianbet shortlisted for sports betting, iGaming license in Brazil Golden Matrix Announces Participation in Benzinga All-Access Interview",1,0,1,1,1,1
5.66M,"12,007",34.67M,$0.92,"1,448",59.39,Buy,60.00,"Jul 31, 2024",PMTS,CPI Card Group Inc.,311.68M,28.14,439.49M,4.50%,1.97%,31.91%,-3.82%,+51.26%,CPI Card Group management to meet virtually with Roth MKM,CPI Card Group joins forces with Rippleshot,,,,CPI Card Group management to meet virtually with Roth MKM CPI Card Group joins forces with Rippleshot,1,1,1,-1,-1,-1
288.06M,"694,016",-135.38M,-1,"2,376",1.160,Buy,9.33,"Aug 14, 2024",DADA,Dada Nexus Limited,310.83M,1.18,1.40B,-10.84%,-15.27%,-45.37%,-18.94%,-45.96%,Dada Nexus downgraded to Neutral from Buy at Bocom,Daiwa sees near-term downside in Dada on Walmart risk,Dada Nexus Announces Executive Leadership Changes,Dada Announces Certain Management Changes,Dada Nexus names Kevin Qing Guo to succeed Ian Su Shan as chairman of the board,Dada Nexus downgraded to Neutral from Buy at Bocom Daiwa sees near-term downside in Dada on Walmart risk Dada Nexus Announces Executive Leadership Changes Dada Announces Certain Management Changes Dada Nexus names Kevin Qing Guo to succeed Ian Su Shan as chairman of the board,1,1,1,1,1,1
31.25M,"703,747",13.24M,-1,449,10.68,,,,ADAP,Adaptimmune Therapeutics plc,309.45M,1.21,141.46M,10.37%,11.00%,19.18%,-8.27%,-10.95%,Biotech Alert: Searches spiking for these stocks today,Hold Rating on Adaptimmune Amid Commercialization and Financial Uncertainties,Scotiabank Sticks to Its Buy Rating for Adaptimmune Therapeutics (ADAP),Buy Rating Affirmed for Adaptimmune Therapeutics Amidst Promising Product Launch and Strong Pipeline,Adaptimmune Therapeutics: A Cautious Hold Amid Gradual Launch and Long-Term Growth Strategy,Biotech Alert: Searches spiking for these stocks today Hold Rating on Adaptimmune Amid Commercialization and Financial Uncertainties Scotiabank Sticks to Its Buy Rating for Adaptimmune Therapeutics (ADAP) Buy Rating Affirmed for Adaptimmune Therapeutics Amidst Promising Product Launch and Strong Pipeline Adaptimmune Therapeutics: A Cautious Hold Amid Gradual Launch and Long-Term Growth Strategy,1,1,0,1,0,0
,,,-1,748,,,,,ANGO,"AngioDynamics, Inc.",309.32M,7.68,303.91M,-1.99%,8.73%,15.21%,-5.99%,+4.84%,AngioDynamics announces CE Mark approval in Europe for Auryon System,TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching,,,,AngioDynamics announces CE Mark approval in Europe for Auryon System TipRanks ‘Perfect 10’ List: 2 Top-Scoring Stocks Worth Watching,0,0,0,-1,-1,-1
65.98M,"374,783",-103.94M,$0.04,404,5.05,Buy,10.00,"Jul 30, 2024",CZNC,Citizens & Northern Corporation,309.08M,20.08,103.19M,4.53%,6.34%,4.58%,-1.04%,+13.09%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,958,,,,,DOMO,"Domo, Inc.",308.83M,8.09,319.63M,0.41%,2.50%,-10.41%,-7.78%,-12.78%,Lake Street Sticks to Its Hold Rating for Domo (DOMO),Domo files $300M mixed securities shelf,Domo teams with Brooklyn Data to ‘simplify AI and data journey for businesses’,Domo price target raised to $8 from $7 at DA Davidson,D.A. Davidson Sticks to Their Hold Rating for Domo (DOMO),Lake Street Sticks to Its Hold Rating for Domo (DOMO) Domo files $300M mixed securities shelf Domo teams with Brooklyn Data to ‘simplify AI and data journey for businesses’ Domo price target raised to $8 from $7 at DA Davidson D.A. Davidson Sticks to Their Hold Rating for Domo (DOMO),0,0,0,0,0,0
25.96M,"108,750",40.76M,$0.76,271,12.82,Buy,14.50,"Aug 5, 2024",FNLC,"The First Bancorp, Inc.",307.69M,27.61,77.08M,5.44%,5.92%,8.80%,-3.30%,+13.28%,,,,,,,0,-1,-1,-1,-1,-1
53.03M,"243,902",178.79M,$0.90,,6.25,,,"Aug 27, 2024",VACH,Voyager Acquisition Corp.,307.54M,9.99,-,,5.92%,8.80%,,,,,,,,,1,-1,-1,-1,-1,-1
16.17M,"94,757",-13.08M,$1.00,,20.49,Hold,18.00,"Oct 21, 2024",NNE,NANO Nuclear Energy Inc.,307.30M,10.20,-,12.48%,-33.13%,-14.13%,-14.48%,,"Lightning Round: Hold onto or buy more IBM, says Jim Cramer",Cramer’s Lightning Round: IBM is a buy,NANO Nuclear Energy Bolsters its Technical Team with Highly Regarded Researchers to Advance its ‘ODIN’ Microreactor Development,Nano Nuclear Energy appoints Terry Robling as chair of Advisory Board,NANO Nuclear Energy Appoints Former Commanding General of U.S. Marine Corps Forces in the Pacific and “Top Gun” Graduate as Chair of its Executive Advisory Board for Federal and Defense Appropriations and Requirements,"Lightning Round: Hold onto or buy more IBM, says Jim Cramer Cramer’s Lightning Round: IBM is a buy NANO Nuclear Energy Bolsters its Technical Team with Highly Regarded Researchers to Advance its ‘ODIN’ Microreactor Development Nano Nuclear Energy appoints Terry Robling as chair of Advisory Board NANO Nuclear Energy Appoints Former Commanding General of U.S. Marine Corps Forces in the Pacific and “Top Gun” Graduate as Chair of its Executive Advisory Board for Federal and Defense Appropriations and Requirements",1,0,0,1,1,1
74.57M,"475,869",27.03M,-1,14,4.440,Buy,6.67,"Aug 6, 2024",IMMR,Immersion Corporation,306.38M,9.52,163.13M,-16.10%,-18.16%,6.72%,-32.58%,+17.62%,Buy Rating Affirmed for Immersion on Strong Financials and Underestimated BNED Stake Value,Immersion options imply 7.2% move in share price post-earnings,Immersion options imply 2.8% move in share price post-earnings,Craig-Hallum Keeps Their Buy Rating on Immersion (IMMR),Immersion options imply 4.3% move in share price post-earnings,Buy Rating Affirmed for Immersion on Strong Financials and Underestimated BNED Stake Value Immersion options imply 7.2% move in share price post-earnings Immersion options imply 2.8% move in share price post-earnings Craig-Hallum Keeps Their Buy Rating on Immersion (IMMR) Immersion options imply 4.3% move in share price post-earnings,0,1,0,0,0,0
59.42M,"306,850",-37.87M,-1,,5.57,Strong Buy,9.33,"Sep 3, 2024",CUB,Lionheart Holdings,306.36M,9.99,-,0.03%,0.03%,0.03%,,,,,,,,,0,-1,-1,-1,-1,-1
11.70M,"30,556",-25.10M,-1,161,28.25,Strong Buy,78.50,"Aug 13, 2024",ACIU,AC Immune SA,304.74M,3.08,17.24M,-11.53%,-16.71%,-12.40%,-23.23%,+14.18%,AC Immune’s Diagnostic Achieves FDA Fast Track Status,FDA grants AC Immune’s PI-2620 Tau-PET diagnostic fast track designations,AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions,,,AC Immune’s Diagnostic Achieves FDA Fast Track Status FDA grants AC Immune’s PI-2620 Tau-PET diagnostic fast track designations AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions,1,1,0,0,-1,-1
30.22M,"31,762",13.76M,$0.36,384,10.92,Buy,12.00,"Jul 30, 2024",SPOK,"Spok Holdings, Inc.",304.57M,15.03,138.27M,0.71%,-0.77%,-4.17%,-3.33%,-7.26%,,,,,,,0,-1,-1,-1,-1,-1
62.92M,"11,784,269",-39.38M,-1,108,5.24,Strong Buy,9.80,"Aug 13, 2024",SMTI,Sanara MedTech Inc.,304.31M,34.79,72.41M,9.66%,13.08%,0.70%,+7.09%,+0.65%,Sanara MedTech (SMTI) Q2 Earnings Cheat Sheet,,,,,Sanara MedTech (SMTI) Q2 Earnings Cheat Sheet,1,0,-1,-1,-1,-1
84.42M,"274,030",-176.00M,-1,159,3.900,Hold,6.88,"Aug 7, 2024",ALIM,"Alimera Sciences, Inc.",304.01M,5.59,99.68M,0.25%,5.04%,38.51%,-0.18%,+44.16%,,,,,,,0,-1,-1,-1,-1,-1
27.60M,"139,563",-17.98M,-1,,11.88,Strong Buy,9.00,"Aug 7, 2024",UHG,"United Homes Group, Inc.",303.34M,6.27,414.81M,4.55%,3.38%,-7.83%,-5.64%,-16.41%,,,,,,,1,-1,-1,-1,-1,-1
39.26M,"110,681",-36.44M,-1,472,8.34,Strong Buy,13.20,"Aug 1, 2024",ITI,"Iteris, Inc.",303.02M,7.08,174.22M,18.24%,39.34%,47.20%,+43.99%,+46.68%,Iteris downgraded to Neutral from Buy at B. Riley,Iteris downgraded to Hold on pending takeover at Maxim,Iteris downgraded to Hold from Buy at Maxim,Iteris downgraded to Market Perform from Outperform at Northland,Morning Movers: Iteris skyrockets following take-private agreement,Iteris downgraded to Neutral from Buy at B. Riley Iteris downgraded to Hold on pending takeover at Maxim Iteris downgraded to Hold from Buy at Maxim Iteris downgraded to Market Perform from Outperform at Northland Morning Movers: Iteris skyrockets following take-private agreement,0,1,0,1,0,0
9.42M,"14,952",30.14M,$1.04,255,34.70,,,"Aug 6, 2024",SBT,"Sterling Bancorp, Inc. (Southfield, MI)",301.93M,5.77,69.97M,2.28%,5.62%,8.46%,-0.69%,+17.72%,Sterling Bancorp Structures CFO’s Termination Compensation Plan,,,,,Sterling Bancorp Structures CFO’s Termination Compensation Plan,0,1,-1,-1,-1,-1
378.37M,"201,641",-58.99M,-1,565,0.864,,,"Sep 6, 2024",FRST,Primis Financial Corp.,301.86M,12.23,135.60M,3.30%,7.24%,7.14%,-7.27%,+8.51%,Primis Financial Strives to Resolve Nasdaq Compliance Issues,Primis Financial Addresses Filing Delay and Disclosure Updates,Primis Financial provides update on consultation with the SEC,,,Primis Financial Strives to Resolve Nasdaq Compliance Issues Primis Financial Addresses Filing Delay and Disclosure Updates Primis Financial provides update on consultation with the SEC,0,0,0,0,-1,-1
125.41M,"69,901",-69.64M,-1,600,2.600,Buy,4.50,"Jul 30, 2024",AFRI,Forafric Global PLC,301.58M,11.22,305.48M,-0.37%,0.72%,2.91%,-4.94%,+8.57%,,,,,,,1,-1,-1,-1,-1,-1
59.07M,"129,435",11.75M,-1,480,5.50,Buy,9.50,"Jul 31, 2024",QURE,uniQure N.V.,301.44M,6.19,27.71M,-13.28%,-8.19%,2.17%,-20.82%,+17.77%,Buy Rating Affirmed: uniQure’s Promising Gene Therapy Pipeline and Strategic Focus,uniQure Begins Phase I/IIa Trial for Fabry Disease Treatment,uniQure announces dosing of first patient in Phase I/IIa trial of AMT-191,uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease,,Buy Rating Affirmed: uniQure’s Promising Gene Therapy Pipeline and Strategic Focus uniQure Begins Phase I/IIa Trial for Fabry Disease Treatment uniQure announces dosing of first patient in Phase I/IIa trial of AMT-191 uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease,0,0,0,0,0,-1
,,,-1,163,,,,,PROK,ProKidney Corp.,301.26M,2.39,-,0.36%,-4.40%,7.40%,-5.56%,+48.32%,ProKidney price target lowered to $3 from $4 at BofA,Maintaining Hold on ProKidney Amid Strategic Shifts and Regulatory Uncertainties,"ProKidney to discontinue PROACT 2, focus resources on PROACT 1",ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.,ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,"ProKidney price target lowered to $3 from $4 at BofA Maintaining Hold on ProKidney Amid Strategic Shifts and Regulatory Uncertainties ProKidney to discontinue PROACT 2, focus resources on PROACT 1 ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S. ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference",0,0,0,1,0,1
,,,-1,204,,,,,EWCZ,"European Wax Center, Inc.",300.92M,6.30,223.79M,-6.02%,-23.95%,-45.17%,-28.22%,-44.48%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC",Bank of America Securities Releases a Buy Rating on European Wax Center (EWCZ),European Wax Center price target lowered to $8 from $16 at BofA,David Willis Exits European Wax Center with Benefits Package,European Wax Center price target lowered to $8 from $16 at Telsey Advisory,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Bank of America Securities Releases a Buy Rating on European Wax Center (EWCZ) European Wax Center price target lowered to $8 from $16 at BofA David Willis Exits European Wax Center with Benefits Package European Wax Center price target lowered to $8 from $16 at Telsey Advisory",0,1,0,0,1,0
,,,-1,154,,,,,TCRX,"TScan Therapeutics, Inc.",300.36M,5.67,12.20M,-8.91%,-14.16%,-16.80%,-20.31%,-19.75%,TScan Therapeutics to Participate in Upcoming Investor Conferences,TScan Therapeutics (TCRX) Gets a Buy from Morgan Stanley,Optimistic Outlook on TScan’s TCR-T Therapies: A Comprehensive Buy Rating Review,Barclays Sticks to Its Buy Rating for TScan Therapeutics (TCRX),Buy Rating Affirmed for TScan Therapeutics Amidst Strong Pipeline Progress and Robust Financial Health,TScan Therapeutics to Participate in Upcoming Investor Conferences TScan Therapeutics (TCRX) Gets a Buy from Morgan Stanley Optimistic Outlook on TScan’s TCR-T Therapies: A Comprehensive Buy Rating Review Barclays Sticks to Its Buy Rating for TScan Therapeutics (TCRX) Buy Rating Affirmed for TScan Therapeutics Amidst Strong Pipeline Progress and Robust Financial Health,1,0,0,0,0,1
25.96M,"130,709",33.48M,$0.07,472,12.50,Buy,10.00,"Sep 5, 2024",TALK,"Talkspace, Inc.",297.74M,1.77,172.54M,-0.56%,-12.33%,-29.80%,-10.95%,-50.96%,"Talkspace announces partnership with PTPA, exclusive mental health tech partner",Talkspace to Participate in Upcoming Investor Conferences,Talkspace (TALK) Gets a Hold from Barclays,,,"Talkspace announces partnership with PTPA, exclusive mental health tech partner Talkspace to Participate in Upcoming Investor Conferences Talkspace (TALK) Gets a Hold from Barclays",0,0,0,0,-1,-1
210.29M,"1,783,914",-40.44M,-1,834,1.530,Strong Buy,5.75,"Aug 8, 2024",INGN,"Inogen, Inc.",296.72M,12.51,326.65M,15.60%,34.63%,69.92%,+40.32%,+106.03%,,,,,,,0,-1,-1,-1,-1,-1
55.33M,"39,933",15.07M,-1,883,5.72,Strong Buy,14.50,"Aug 14, 2024",HMST,"HomeStreet, Inc.",296.44M,15.72,180.52M,2.38%,14.62%,27.51%,+7.64%,+11.91%,,,,,,,0,-1,-1,-1,-1,-1
51.37M,"458,255",19.07M,-1,109,6.25,Buy,10.40,"Jul 30, 2024",GWRS,"Global Water Resources, Inc.",296.18M,12.23,52.02M,2.04%,0.95%,-0.08%,-2.71%,+0.24%,Global Water Resources Declares Monthly Dividend,,,,,Global Water Resources Declares Monthly Dividend,0,0,-1,-1,-1,-1
22.36M,"380,327",-40.04M,-1,,14.35,Hold,12.83,"Jul 31, 2024",SIMA,SIM Acquisition Corp. I,296.07M,8.00,-,,0.95%,-0.08%,,,,,,,,,0,-1,-1,-1,-1,-1
4.08M,"12,141",21.51M,$2.00,103,78.03,,,"Aug 8, 2024",CABA,"Cabaletta Bio, Inc.",296.02M,6.06,-,3.92%,-15.97%,-61.70%,-19.15%,-66.20%,Cabaletta Bio to Participate in Upcoming Investor Conferences in September,Buy Rating Affirmed for Cabaletta Bio Amid Superior CD19 CAR T Therapy Efficacy in Autoimmune Disease Treatment,Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI,Cabaletta Bio: Overweight Rating Maintained Amidst ICANS Incident and Adjusted Price Target,Cabaletta Bio price target lowered to $20 from $35 at Wells Fargo,Cabaletta Bio to Participate in Upcoming Investor Conferences in September Buy Rating Affirmed for Cabaletta Bio Amid Superior CD19 CAR T Therapy Efficacy in Autoimmune Disease Treatment Cabaletta Bio price target lowered to $15 from $25 at Evercore ISI Cabaletta Bio: Overweight Rating Maintained Amidst ICANS Incident and Adjusted Price Target Cabaletta Bio price target lowered to $20 from $35 at Wells Fargo,1,0,1,0,0,1
22.48M,"237,708",93.57M,-1,126,14.21,Buy,25.33,"Aug 29, 2024",HRTX,"Heron Therapeutics, Inc.",295.75M,1.95,136.36M,-12.67%,-31.29%,-23.25%,-35.02%,-29.82%,Heron Therapeutics names Brett Fleshman as Chief Business Officer,,,,,Heron Therapeutics names Brett Fleshman as Chief Business Officer,1,1,-1,-1,-1,-1
20.65M,"13,609",-2.96M,-1,776,15.45,,,"Aug 8, 2024",VIRC,Virco Mfg. Corporation,295.63M,18.24,280.91M,1.79%,5.93%,39.03%,-13.18%,+27.44%,,,,,,,1,-1,-1,-1,-1,-1
58.29M,"571,467",-10.93M,-1,128,5.46,Buy,13.00,"Jul 31, 2024",PRLD,Prelude Therapeutics Incorporated,295.48M,5.37,-,-1.26%,11.11%,31.46%,-15.70%,+14.26%,Hold Rating on Prelude Therapeutics Pending Phase 1 Results of PRT3789,Prelude Therapeutics (PRLD) Receives a Sell from Morgan Stanley,Barclays Reaffirms Their Sell Rating on Prelude Therapeutics (PRLD),Buy Rating Affirmed for Prelude Therapeutics on Strong Pipeline and Financial Position,Prelude Therapeutics Unveils Strategic Insights for Investors,Hold Rating on Prelude Therapeutics Pending Phase 1 Results of PRT3789 Prelude Therapeutics (PRLD) Receives a Sell from Morgan Stanley Barclays Reaffirms Their Sell Rating on Prelude Therapeutics (PRLD) Buy Rating Affirmed for Prelude Therapeutics on Strong Pipeline and Financial Position Prelude Therapeutics Unveils Strategic Insights for Investors,0,0,0,1,0,0
82.24M,"1,017,279",-193.45M,-1,"29,863",3.870,Buy,11.50,"Aug 7, 2024",IBEX,IBEX Limited,295.40M,17.16,508.47M,5.61%,5.56%,6.46%,-0.80%,+22.18%,Europe stocks close mixed as investors weigh risk of wider Middle East conflict,"IBEX Limited to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on September 12, 2024",Ibex names Andreas Wilkens as Chief Technology Officer,ibex Names Andreas Wilkens as Chief Technology Officer,ibex Wins Gold Globee® at the 16th Annual 2024 Golden Bridge Awards®,"Europe stocks close mixed as investors weigh risk of wider Middle East conflict IBEX Limited to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on September 12, 2024 Ibex names Andreas Wilkens as Chief Technology Officer ibex Names Andreas Wilkens as Chief Technology Officer ibex Wins Gold Globee® at the 16th Annual 2024 Golden Bridge Awards®",1,1,0,1,1,1
187.95M,"6,840",-336.51M,-1,"3,032",1.690,,,"Jul 31, 2024",REAL,"The RealReal, Inc.",295.12M,2.72,565.28M,-5.63%,-14.50%,-8.20%,-30.75%,-26.94%,The 2024 Luxury Resale Report: The RealReal Reveals Top Brands and Trends Shaping the Market,,,,,The 2024 Luxury Resale Report: The RealReal Reveals Top Brands and Trends Shaping the Market,1,1,-1,-1,-1,-1
37.26M,"284,758",5.69M,-1,"2,303",8.49,Strong Buy,9.38,"Sep 10, 2024",LSAK,"Lesaka Technologies, Inc.",295.08M,4.88,551.33M,2.41%,1.50%,17.50%,-0.93%,+24.09%,Lesaka Technologies Revamps Leadership for Fintech Growth,"Lesaka CFO Naeem Kola appointed COO, Dan Smith to succeed",Lesaka Technologies Announces Leadership Changes as it Strengthens Executive Management Team,"Lesaka to Host Webcast and Conference Call to Review Q4 and FY 2024 Results on September 12, 2024",,"Lesaka Technologies Revamps Leadership for Fintech Growth Lesaka CFO Naeem Kola appointed COO, Dan Smith to succeed Lesaka Technologies Announces Leadership Changes as it Strengthens Executive Management Team Lesaka to Host Webcast and Conference Call to Review Q4 and FY 2024 Results on September 12, 2024",0,1,1,1,0,-1
55.86M,"1,922,889",-53.12M,-1,279,5.65,Strong Buy,12.60,"Aug 14, 2024",LUNG,Pulmonx Corporation,294.04M,7.51,76.58M,17.76%,12.99%,-19.59%,+7.96%,-9.47%,Aeriseal’s Market Potential and Safety Profile: Justifying a Hold Rating for Pulmonx,Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference,Pulmonx (LUNG) Gets a Buy from Lake Street,Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference,Buy Rating Affirmed for Pulmonx: Strong Growth and Promising Clinical Advancements,Aeriseal’s Market Potential and Safety Profile: Justifying a Hold Rating for Pulmonx Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference Pulmonx (LUNG) Gets a Buy from Lake Street Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference Buy Rating Affirmed for Pulmonx: Strong Growth and Promising Clinical Advancements,1,0,0,0,0,1
32.59M,"69,176",-89.14M,-1,38,9.67,Strong Buy,23.00,"Aug 8, 2024",RNAC,"Cartesian Therapeutics, Inc.",294.01M,13.75,54.10M,-1.39%,-20.19%,-36.26%,-12.64%,+6.99%,Cartesian Therapeutics announces employment inducement grant,Cartesian Therapeutics Announces New Employment Inducement Grant,Buy Rating on Cartesian Therapeutics: Advancing Cell Therapy with Innovative mRNA-Engineered CAR-T Treatments,Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15,Buy Recommendation for Cartesian Therapeutics on Robust Clinical Trials and Favorable Regulatory Prospects,Cartesian Therapeutics announces employment inducement grant Cartesian Therapeutics Announces New Employment Inducement Grant Buy Rating on Cartesian Therapeutics: Advancing Cell Therapy with Innovative mRNA-Engineered CAR-T Treatments Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15 Buy Recommendation for Cartesian Therapeutics on Robust Clinical Trials and Favorable Regulatory Prospects,1,1,1,1,0,1
8.67M,"36,322",18.51M,$0.24,,36.20,Buy,40.38,"Jul 24, 2024",QRTEB,"Qurate Retail, Inc.",292.56M,4.10,10.37B,,-20.19%,-36.26%,+6.28%,+0.71%,Qurate Retail Chairman to Speak at Goldman Sachs Conference,AdaptHealth appoints Scott Barnhart as COO,,,,Qurate Retail Chairman to Speak at Goldman Sachs Conference AdaptHealth appoints Scott Barnhart as COO,1,1,1,-1,-1,-1
46.90M,"141,091",35.36M,$0.40,45,6.67,Strong Buy,,"Aug 8, 2024",JSPR,"Jasper Therapeutics, Inc.",291.38M,19.29,-,13.48%,0.96%,12.93%,+7.90%,-32.37%,Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences,Jasper Therapeutics price target lowered to $68 from $70 at RBC Capital,Oppenheimer Sticks to Their Buy Rating for Jasper Therapeutics (JSPR),Buy Rating Reaffirmed for Jasper Therapeutics on Strong Clinical Performance and Market Potential,Optimistic Buy Rating for Jasper Therapeutics as Briquilimab Shows Promising Trial Progress,Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences Jasper Therapeutics price target lowered to $68 from $70 at RBC Capital Oppenheimer Sticks to Their Buy Rating for Jasper Therapeutics (JSPR) Buy Rating Reaffirmed for Jasper Therapeutics on Strong Clinical Performance and Market Potential Optimistic Buy Rating for Jasper Therapeutics as Briquilimab Shows Promising Trial Progress,0,1,0,0,0,1
31.25M,"323,923",,-1,61,,,,,ACRV,"Acrivon Therapeutics, Inc.",289.90M,9.36,-,15.36%,23.49%,44.93%,+10.62%,+43.06%,Acrivon Therapeutics: A Buy Rating Justified by Clinical Advances and Financial Stability,"Acrivon Therapeutics, Inc.: A Strong Buy on Robust Clinical Prospects and Financial Stability","Acrivon Therapeutics, Inc.: A Promising Buy Amidst Clinical Advancements and Robust Pipeline Developments","Acrivon Therapeutics, Inc.: Strong Buy Rating on Robust Financials and Promising Clinical Data",Acrivon Therapeutics price target lowered to $18 from $21 at Oppenheimer,"Acrivon Therapeutics: A Buy Rating Justified by Clinical Advances and Financial Stability Acrivon Therapeutics, Inc.: A Strong Buy on Robust Clinical Prospects and Financial Stability Acrivon Therapeutics, Inc.: A Promising Buy Amidst Clinical Advancements and Robust Pipeline Developments Acrivon Therapeutics, Inc.: Strong Buy Rating on Robust Financials and Promising Clinical Data Acrivon Therapeutics price target lowered to $18 from $21 at Oppenheimer",1,1,1,1,1,0
,,,-1,"4,268",,,,,LX,LexinFintech Holdings Ltd.,289.37M,1.76,1.84B,3.55%,3.75%,-1.71%,-4.55%,-5.62%,Lexinfintech Holdings (LX) Unveils Dividend Details for Q4: Mark Your Calendar!,,,,,Lexinfintech Holdings (LX) Unveils Dividend Details for Q4: Mark Your Calendar!,1,0,-1,-1,-1,-1
23.97M,"95,286",32.59M,-1,288,13.05,,,"Aug 5, 2024",FLIC,The First of Long Island Corporation,289.08M,12.83,86.96M,3.28%,10.73%,11.74%,-3.58%,+19.68%,KBW Keeps Their Hold Rating on The First Of Long Island (FLIC),"ConnectOne Bancorp, First of Long Island enter $284M merger agreement",The First Of Long Island Addresses Unauthorized Transfers,,,"KBW Keeps Their Hold Rating on The First Of Long Island (FLIC) ConnectOne Bancorp, First of Long Island enter $284M merger agreement The First Of Long Island Addresses Unauthorized Transfers",1,0,1,1,-1,-1
19.62M,"84,386",37.29M,$1.88,996,15.91,Buy,17.33,"Aug 7, 2024",VMD,"Viemed Healthcare, Inc.",286.92M,7.39,205.70M,3.97%,7.00%,-5.01%,+2.91%,-12.71%,Viemed Healthcare Unveils Investor Deck for Stakeholder Insights,Lake Street Releases a Buy Rating on Viemed Healthcare (VMD),,,,Viemed Healthcare Unveils Investor Deck for Stakeholder Insights Lake Street Releases a Buy Rating on Viemed Healthcare (VMD),1,0,0,-1,-1,-1
,,,-1,313,,,,,FDBC,"Fidelity D & D Bancorp, Inc.",286.79M,50.00,70.43M,6.56%,4.86%,1.36%,-3.29%,+6.72%,,,,,,,1,-1,-1,-1,-1,-1
120.84M,"111,700","-654,724",-1,820,2.580,Strong Buy,4.00,"Sep 5, 2024",BETR,Better Home & Finance Holding Company,286.69M,18.95,61.70M,-20.45%,-27.26%,-30.59%,-35.77%,-29.37%,Aurora Acquisition Announces Strategic Reverse Stock Split,"Better Home & Finance Holding Co trading halted, news pending",,,,"Aurora Acquisition Announces Strategic Reverse Stock Split Better Home & Finance Holding Co trading halted, news pending",0,1,0,-1,-1,-1
11.08M,"10,740",18.05M,-1,103,28.14,Strong Buy,32.00,"Aug 5, 2024",NWTN,NWTN Inc.,286.19M,1.00,583.00K,7.27%,-9.44%,-79.65%,+14.89%,-85.60%,NWTN Inc. Announces Leadership Reshuffle,,,,,NWTN Inc. Announces Leadership Reshuffle,0,0,-1,-1,-1,-1
264.54M,"1,670,344",-283.83M,-1,196,1.175,Buy,3.30,"Aug 20, 2024",USCB,"USCB Financial Holdings, Inc.",285.87M,14.57,66.71M,0.63%,6.95%,22.02%,-11.22%,+33.60%,,,,,,,1,-1,-1,-1,-1,-1
255.75M,"1,672,418",-72.50M,-1,445,1.210,Strong Buy,3.38,"Aug 12, 2024",CAN,Canaan Inc.,285.29M,0.99,209.48M,11.26%,1.19%,-25.70%,-3.47%,-23.99%,Canaan Inc. Demonstrates Financial Growth,Nomura Reaffirms Their Hold Rating on Canaan (CAN),"Analysts Offer Insights on Technology Companies: Canaan (CAN), Salesforce (CRM) and Coherent Corp (COHR)",Bullish on Blockchain: Buy Rating Affirmed for Canaan Amidst Revenue Growth and Product Innovation,"Options Volatility and Implied Earnings Moves Today, August 15, 2024","Canaan Inc. Demonstrates Financial Growth Nomura Reaffirms Their Hold Rating on Canaan (CAN) Analysts Offer Insights on Technology Companies: Canaan (CAN), Salesforce (CRM) and Coherent Corp (COHR) Bullish on Blockchain: Buy Rating Affirmed for Canaan Amidst Revenue Growth and Product Innovation Options Volatility and Implied Earnings Moves Today, August 15, 2024",0,1,0,0,0,0
40.28M,"329,318",-184.35M,-1,289,7.68,Strong Buy,12.25,"Oct 2, 2024",LWAY,"Lifeway Foods, Inc.",284.87M,19.26,176.78M,26.79%,41.86%,28.82%,+49.88%,-9.28%,Lifeway Foods (LWAY) Receives a Buy from Noble Financial,Lifeway Foods price target raised to $25 from $20 at Noble Capital,Smolyansky family files consent statement to change Lifeway Foods leadership,"Lifeway Foods® Announces Record Results for the Second Quarter Ended June 30, 2024",Lifeway Foods reports Q2 EPS 35c vs. 21c last year,"Lifeway Foods (LWAY) Receives a Buy from Noble Financial Lifeway Foods price target raised to $25 from $20 at Noble Capital Smolyansky family files consent statement to change Lifeway Foods leadership Lifeway Foods® Announces Record Results for the Second Quarter Ended June 30, 2024 Lifeway Foods reports Q2 EPS 35c vs. 21c last year",0,0,0,0,0,0
15.39M,"30,620",23.10M,$1.12,33,20.08,,,"Aug 7, 2024",ENGN,enGene Holdings Inc.,283.55M,6.42,-,-5.37%,-19.15%,-39.62%,-31.37%,-60.41%,enGene Holdings Unveils Updated Corporate Strategy and Lead Program,,,,,enGene Holdings Unveils Updated Corporate Strategy and Lead Program,0,0,-1,-1,-1,-1
38.17M,"280,186",-77.17M,-1,445,8.09,Hold,10.20,"Aug 29, 2024",MVBF,MVB Financial Corp.,283.25M,21.91,143.78M,0.46%,1.79%,1.58%,-7.97%,-1.90%,,,,,,,0,-1,-1,-1,-1,-1
11.14M,"13,750",26.35M,$1.44,185,27.61,,,"Oct 16, 2024",SSBK,"Southern States Bancshares, Inc.",282.65M,31.70,80.76M,4.57%,8.81%,17.90%,-4.74%,+25.43%,,,,,,,1,-1,-1,-1,-1,-1
30.80M,"256,493",,-1,381,,,,,BLZE,"Backblaze, Inc.",282.62M,6.59,115.29M,2.93%,2.44%,-18.77%,-8.31%,-40.02%,Backblaze price target raised to $10 from $9 at Craig-Hallum,Craig-Hallum Keeps Their Buy Rating on Backblaze (BLZE),Backblaze price target lowered to $10 from $11 at Oppenheimer,"Analysts Offer Insights on Technology Companies: Backblaze (BLZE), DigitalOcean Holdings (DOCN) and Unity Software (U)",Oppenheimer Keeps Their Buy Rating on Backblaze (BLZE),"Backblaze price target raised to $10 from $9 at Craig-Hallum Craig-Hallum Keeps Their Buy Rating on Backblaze (BLZE) Backblaze price target lowered to $10 from $11 at Oppenheimer Analysts Offer Insights on Technology Companies: Backblaze (BLZE), DigitalOcean Holdings (DOCN) and Unity Software (U) Oppenheimer Keeps Their Buy Rating on Backblaze (BLZE)",0,0,0,0,0,0
,,,-1,649,,,,,JRVR,"James River Group Holdings, Ltd.",282.18M,7.46,815.64M,-5.00%,-6.33%,-16.08%,-14.93%,-14.83%,,,,,,,1,-1,-1,-1,-1,-1
30.13M,"1,512,518",-9.01M,-1,270,10.20,Strong Buy,39.00,"Aug 14, 2024",PBFS,"Pioneer Bancorp, Inc.",281.78M,11.17,74.14M,1.80%,2.71%,12.58%,-1.35%,+18.15%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,14,,,,,UROY,Uranium Royalty Corp.,280.61M,2.32,31.07M,6.33%,0.63%,-11.87%,-8.71%,-14.40%,Uranium Royalty Corp. Reactivates Equity Program,,,,,Uranium Royalty Corp. Reactivates Equity Program,1,0,-1,-1,-1,-1
32.18M,"1,916,065",66.27M,$0.18,147,9.52,Strong Buy,13.50,"Aug 20, 2024",NYXH,Nyxoah S.A.,280.09M,8.23,5.13M,0.05%,-1.07%,-9.38%,+2.39%,-29.95%,"Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF), Nyxoah (NYXH) and Genfit (OtherGNFTF)",Nyxoah to Present at Investor Conferences in NYC,Nyxoah to Participate in Upcoming Investor Conferences,Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device,,"Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF), Nyxoah (NYXH) and Genfit (OtherGNFTF) Nyxoah to Present at Investor Conferences in NYC Nyxoah to Participate in Upcoming Investor Conferences Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device",1,0,0,0,1,-1
,"699,628",,-1,958,9.98,,,,PFMT,Performant Financial Corporation,279.43M,3.62,119.23M,-2.04%,9.77%,17.93%,-7.01%,+26.84%,Performant Financial (PFMT) Gets a Buy from Lake Street,Performant Financial announces multi-year RAC award from New York State,Performant Financial files $100M mixed securities shelf,Performant Financial management to meet virtually with B. Riley,,Performant Financial (PFMT) Gets a Buy from Lake Street Performant Financial announces multi-year RAC award from New York State Performant Financial files $100M mixed securities shelf Performant Financial management to meet virtually with B. Riley,1,0,0,1,0,-1
,,,-1,,,,,,LPAA,Launch One Acquisition Corp.,278.88M,9.96,-,,9.77%,17.93%,,,,,,,,,0,-1,-1,-1,-1,-1
98.94M,"35,405",-67.34M,-1,114,3.080,Strong Buy,12.00,"Aug 6, 2024",AEYE,"AudioEye, Inc.",278.33M,23.43,32.26M,6.74%,13.66%,88.66%,-10.83%,+143.93%,Craig-Hallum Sticks to Their Buy Rating for AudioEye (AEYE),,,,,Craig-Hallum Sticks to Their Buy Rating for AudioEye (AEYE),1,0,-1,-1,-1,-1
20.26M,"90,002",15.48M,$1.25,"6,037",15.03,,,"Jul 24, 2024",APEI,"American Public Education, Inc.",278.09M,15.71,610.97M,4.35%,-4.27%,21.16%,-20.44%,+19.49%,American Public Education price target lowered to $15 from $20 at Truist,Truist Financial Remains a Hold on American Public Education (APEI),,,,American Public Education price target lowered to $15 from $20 at Truist Truist Financial Remains a Hold on American Public Education (APEI),0,0,0,-1,-1,-1
8.75M,"20,845",-6.57M,-1,330,34.79,Buy,51.50,"Aug 12, 2024",PSTX,"Poseida Therapeutics, Inc.",277.76M,2.86,88.46M,-7.63%,-8.43%,-6.96%,-23.51%,-9.70%,Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial,Poseida Therapeutics’ P-BCMA-101 shows efficacy in published case study,Buy Rating for Poseida Therapeutics: Strategic Partnerships and Innovative Cell Therapy Platform,,,Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial Poseida Therapeutics’ P-BCMA-101 shows efficacy in published case study Buy Rating for Poseida Therapeutics: Strategic Partnerships and Innovative Cell Therapy Platform,1,0,1,1,-1,-1
54.38M,"164,326",-15.27M,-1,145,5.59,Hold,6.00,"Aug 6, 2024",ENTA,"Enanta Pharmaceuticals, Inc.",277.36M,13.09,71.96M,-0.01%,-4.04%,2.22%,-11.52%,-20.90%,"Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)",,,,,"Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)",0,0,-1,-1,-1,-1
48.38M,"59,251",137.78M,-1,698,6.27,,,"Aug 8, 2024",WSBF,"Waterstone Financial, Inc.",276.98M,15.25,132.56M,3.48%,7.12%,15.40%,+0.54%,+33.57%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,58,,,,,DSGN,"Design Therapeutics, Inc.",276.87M,4.89,-,5.89%,17.56%,47.04%,-7.65%,+25.27%,,,,,,,0,-1,-1,-1,-1,-1
42.80M,"686,461",1.40M,-1,135,7.08,Buy,7.10,"Aug 8, 2024",JMSB,"John Marshall Bancorp, Inc.",276.60M,19.50,35.69M,2.66%,6.58%,5.04%,-1.19%,+12.82%,,,,,,,1,-1,-1,-1,-1,-1
52.33M,"114,283",6.50M,-1,707,5.77,,,"Jul 24, 2024",ASLE,AerSale Corporation,276.15M,5.19,354.55M,-9.07%,-20.28%,-43.13%,-25.67%,-29.04%,AerSale price target lowered to $11 from $13 at Stifel,,,,,AerSale price target lowered to $11 from $13 at Stifel,0,0,-1,-1,-1,-1
24.68M,"78,600",9.94M,$0.40,270,12.23,,,"Jul 25, 2024",SLDP,"Solid Power, Inc.",275.60M,1.54,19.74M,-3.41%,-14.87%,-9.89%,-24.47%,-22.83%,Solid Power assumed with an Underperform at Wolfe Research,D.A. Davidson Keeps Their Hold Rating on Solid Power (SLDP),,,,Solid Power assumed with an Underperform at Wolfe Research D.A. Davidson Keeps Their Hold Rating on Solid Power (SLDP),0,0,0,-1,-1,-1
26.88M,"6,751",-12.68M,-1,103,11.22,,,"Apr 30, 2024",BMEA,"Biomea Fusion, Inc.",275.56M,7.61,-,30.41%,44.18%,-32.76%,+35.37%,-40.77%,Biomea Fusion’s BMF-219: A Catalyst for Growth in Metabolic Disease Treatment and Oncology,Biomea Fusion initiated with an Overweight at Capital One,Biomea Fusion price target lowered to $22 from $45 at Citi,,,Biomea Fusion’s BMF-219: A Catalyst for Growth in Metabolic Disease Treatment and Oncology Biomea Fusion initiated with an Overweight at Capital One Biomea Fusion price target lowered to $22 from $45 at Citi,1,0,1,1,-1,-1
48.70M,"442,178",-284.69M,-1,,6.19,Buy,18.60,"Aug 1, 2024",WHF,"WhiteHorse Finance, Inc.",275.20M,11.84,100.46M,0.40%,-2.99%,-6.22%,-1.93%,-4.73%,Oppenheimer Sticks to Its Buy Rating for WhiteHorse (WHF),Analysts Offer Insights on Financial Companies: P10 Holdings (PX) and WhiteHorse (WHF),,,,Oppenheimer Sticks to Its Buy Rating for WhiteHorse (WHF) Analysts Offer Insights on Financial Companies: P10 Holdings (PX) and WhiteHorse (WHF),1,0,0,-1,-1,-1
126.05M,"268,472",-38.68M,-1,271,2.390,Buy,4.33,"Aug 9, 2024",PCB,PCB Bancorp,273.62M,19.23,93.74M,2.94%,9.36%,14.14%,-2.08%,+19.66%,,,,,,,1,-1,-1,-1,-1,-1
47.76M,"679,132",12.63M,-1,"2,545",6.30,Buy,7.64,"Aug 14, 2024",MTRX,Matrix Service Company,273.09M,10.00,744.57M,3.00%,0.24%,-9.58%,-3.46%,-25.65%,"Is MTRX a Buy, Before Earnings?",Matrix Service Company to Participate at the Upcoming D. A. Davidson 23rd Annual Diversified Industrials & Services Conference,Matrix Service Company Sets Dates for Release of Fourth Quarter and Fiscal 2024 Financial Results and Conference Call,,,"Is MTRX a Buy, Before Earnings? Matrix Service Company to Participate at the Upcoming D. A. Davidson 23rd Annual Diversified Industrials & Services Conference Matrix Service Company Sets Dates for Release of Fourth Quarter and Fiscal 2024 Financial Results and Conference Call",0,1,0,0,-1,-1
52.97M,"251,006",-104.41M,-1,"1,308",5.67,Strong Buy,11.40,"Aug 12, 2024",TTSH,"Tile Shop Holdings, Inc.",272.37M,6.10,359.68M,-2.82%,-9.45%,-9.62%,-16.48%,-13.11%,,,,,,,0,-1,-1,-1,-1,-1
168.21M,"602,148",-7.66M,-1,28,1.770,Hold,3.00,"Aug 6, 2024",CRVS,"Corvus Pharmaceuticals, Inc.",268.97M,4.30,-,13.32%,53.74%,96.21%,+59.53%,+134.29%,Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Corvus Pharmaceuticals (CRVS), Vir Biotechnology (VIR) and Cooper Co (COO)",,,,"Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference Analysts Have Conflicting Sentiments on These Healthcare Companies: Corvus Pharmaceuticals (CRVS), Vir Biotechnology (VIR) and Cooper Co (COO)",0,0,1,-1,-1,-1
23.72M,"147,773",-92.44M,-1,136,12.51,Hold,7.00,"Aug 6, 2024",SCPH,scPharmaceuticals Inc.,268.65M,5.37,24.05M,6.73%,12.04%,2.06%,-2.19%,-2.19%,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH)",Buy Rating Affirmed: scPharmaceuticals’s Revenue Surge and Product Development Promise,"scPharmaceuticals reports Q2 EPS (44c), consensus (41c)",scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update,Buy Rating Affirmed for scPharmaceuticals Amidst FDA Approval and Strong Financial Performance,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH) Buy Rating Affirmed: scPharmaceuticals’s Revenue Surge and Product Development Promise scPharmaceuticals reports Q2 EPS (44c), consensus (41c) scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update Buy Rating Affirmed for scPharmaceuticals Amidst FDA Approval and Strong Financial Performance",0,1,0,1,1,0
18.86M,"65,580",-14.86M,$0.40,141,15.72,Hold,11.83,"Jul 29, 2024",NECB,"Northeast Community Bancorp, Inc.",268.24M,22.98,104.33M,4.40%,12.65%,30.38%,-0.79%,+47.81%,,,,,,,1,-1,-1,-1,-1,-1
24.22M,"50,384",6.20M,$0.30,44,12.23,,,"Aug 7, 2024",TECX,"Tectonic Therapeutic, Inc.",268.17M,18.20,-,11.13%,12.60%,16.97%,+5.75%,+24.34%,Promising Outlook for Tectonic Therapeutics’ Novel Drug TX45 in Treating PH-LHD,Tectonic Therapeutic initiated with an Overweight at Wells Fargo,Tectonic Therapeutic to Participate in September Investor Conferences,Tectonic Therapeutics: A Strong Buy on Promising Pipeline and Robust Financials,Buy Rating Affirmed on Tectonic Therapeutics’ TX45 for Promising Clinical Advancements,Promising Outlook for Tectonic Therapeutics’ Novel Drug TX45 in Treating PH-LHD Tectonic Therapeutic initiated with an Overweight at Wells Fargo Tectonic Therapeutic to Participate in September Investor Conferences Tectonic Therapeutics: A Strong Buy on Promising Pipeline and Robust Financials Buy Rating Affirmed on Tectonic Therapeutics’ TX45 for Promising Clinical Advancements,0,0,1,0,1,0
29.67M,500,,-1,106,8.00,,,,CDXC,ChromaDex Corporation,267.11M,3.51,85.58M,14.19%,20.70%,41.84%,+12.71%,-16.17%,ChromaDex broadens NAD+ precursor intellectual property portfolio with patent,ChromaDex management to meet virtually with Roth MKM,,,,ChromaDex broadens NAD+ precursor intellectual property portfolio with patent ChromaDex management to meet virtually with Roth MKM,0,1,0,-1,-1,-1
,,,-1,532,,,,,CIVB,"Civista Bancshares, Inc.",266.59M,16.94,147.54M,2.30%,4.33%,6.07%,-6.91%,+11.25%,Civista Bancshares Presents at Financial Industry Conference,,,,,Civista Bancshares Presents at Financial Industry Conference,1,0,-1,-1,-1,-1
48.85M,"643,988",-89.98M,-1,211,6.06,Strong Buy,31.44,"Aug 8, 2024",TKNO,"Alpha Teknova, Inc.",265.98M,4.99,34.94M,8.26%,65.75%,72.89%,+24.20%,+82.07%,Alpha Teknova’s Stabilizing Operations and Growth Prospects Justify Buy Rating,"Alpha Teknova backs FY24 revenue view 35M-$38M , consensus $37.39M","Alpha Teknova reports Q2 EPS (13c), consensus (16c)",Alpha Teknova launches two new offerings,TKNO Upcoming Earnings Report: What to Expect?,"Alpha Teknova’s Stabilizing Operations and Growth Prospects Justify Buy Rating Alpha Teknova backs FY24 revenue view 35M-$38M , consensus $37.39M Alpha Teknova reports Q2 EPS (13c), consensus (16c) Alpha Teknova launches two new offerings TKNO Upcoming Earnings Report: What to Expect?",0,0,0,0,0,1
151.67M,"1,366,924",-48.13M,-1,"1,046",1.950,Strong Buy,6.00,"Aug 6, 2024",CRNT,Ceragon Networks Ltd.,264.48M,3.08,362.21M,6.23%,12.60%,16.14%,+5.42%,-8.46%,Ceragon Networks Engages Investors at Big8 Conference,Ceragon Networks Mid-Year Financial Snapshot,,,,Ceragon Networks Engages Investors at Big8 Conference Ceragon Networks Mid-Year Financial Snapshot,0,0,1,-1,-1,-1
16.21M,"288,856",25.49M,$0.08,422,18.24,Buy,19.00,"Sep 9, 2024",CZFS,"Citizens Financial Services, Inc.",263.51M,55.36,98.19M,10.99%,13.44%,7.71%,-1.81%,+12.08%,,,,,,,1,-1,-1,-1,-1,-1
55.02M,"191,275",-129.85M,-1,217,5.37,Hold,5.33,"Aug 12, 2024",BDSX,"Biodesix, Inc.",262.77M,1.81,60.90M,9.24%,11.35%,16.93%,+12.46%,+32.14%,Lake Street Sticks to Its Buy Rating for Biodesix (BDSX),Biodesix Releases Updated Corporate Presentation Information,,,,Lake Street Sticks to Its Buy Rating for Biodesix (BDSX) Biodesix Releases Updated Corporate Presentation Information,0,0,0,-1,-1,-1
17.21M,"77,418",28.32M,-1,389,17.16,Buy,19.00,"Sep 11, 2024",COFS,"ChoiceOne Financial Services, Inc.",262.72M,29.33,83.14M,9.52%,9.50%,12.75%,+7.82%,+17.38%,ChoiceOne Financial Announces Cash Dividends,,,,,ChoiceOne Financial Announces Cash Dividends,1,1,-1,-1,-1,-1
108.50M,"1,615,902",-92.45M,-1,296,2.720,Buy,3.62,"Aug 6, 2024",SFST,"Southern First Bancshares, Inc.",262.68M,32.21,89.00M,-0.72%,1.52%,0.67%,-8.55%,+9.78%,,,,,,,0,-1,-1,-1,-1,-1
60.47M,"13,600",-23.09M,-1,123,4.880,,,"Sep 4, 2024",PAYS,"Paysign, Inc.",262.50M,4.94,53.61M,3.13%,7.63%,32.31%,-12.01%,+7.94%,,,,,,,1,-1,-1,-1,-1,-1
39.15M,"234,927",-57.86M,-1,453,7.51,Strong Buy,14.88,"Jul 31, 2024",CBAN,"Colony Bankcorp, Inc.",262.09M,14.90,109.42M,5.69%,11.71%,23.88%,-4.51%,+36.68%,,,,,,,1,-1,-1,-1,-1,-1
21.38M,"58,790",-267.20M,-1,"20,386",13.75,Strong Buy,41.60,"Aug 8, 2024",QRTEA,"Qurate Retail, Inc.",261.85M,0.66,10.37B,-4.54%,-9.31%,-29.35%,-18.26%,-42.57%,Qurate Retail Chairman to Speak at Goldman Sachs Conference,AdaptHealth appoints Scott Barnhart as COO,,,,Qurate Retail Chairman to Speak at Goldman Sachs Conference AdaptHealth appoints Scott Barnhart as COO,1,1,1,-1,-1,-1
396.92M,"12,733",-253.00M,-1,,4.100,,,"Aug 8, 2024",SLAM,Slam Corp.,261.50M,11.15,-,-0.09%,0.10%,1.64%,+0.27%,+1.92%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,"1,183",,,,,GILT,Gilat Satellite Networks Ltd.,261.14M,4.58,292.25M,-0.48%,-1.34%,-18.74%,-0.44%,-25.62%,Gilat Wins $12M in Satellite Communication Orders,Gilat Satellite secures over $12M orders for SkyEdge platforms,Gilat Secures Over $12 Million Orders for SkyEdge Platforms from Leading Satellite Operator,Gilat Satellite secures over $12M orders for SkyEdge Platforms,Gilat Joins WAVE Consortium Board,Gilat Wins $12M in Satellite Communication Orders Gilat Satellite secures over $12M orders for SkyEdge platforms Gilat Secures Over $12 Million Orders for SkyEdge Platforms from Leading Satellite Operator Gilat Satellite secures over $12M orders for SkyEdge Platforms Gilat Joins WAVE Consortium Board,0,0,0,0,0,0
15.11M,"181,563",-62.44M,-1,"1,100",19.29,Strong Buy,75.67,"Aug 13, 2024",ZYXI,"Zynex, Inc.",259.97M,8.19,193.61M,2.42%,-7.48%,-22.54%,-11.89%,-35.84%,Buy Rating Affirmed for Zynex on FDA Clearance and Solid Growth Prospects,Zynex obtains FDA clearance for new pain management device,,,,Buy Rating Affirmed for Zynex on FDA Clearance and Solid Growth Prospects Zynex obtains FDA clearance for new pain management device,0,0,0,-1,-1,-1
30.97M,"72,846",-69.00M,-1,381,9.36,Buy,23.60,"Aug 13, 2024",AIRS,"AirSculpt Technologies, Inc.",258.59M,4.49,193.03M,8.24%,6.81%,-18.35%,-16.10%,-24.04%,Hold Rating on Airsculpt Technologies Amidst Revenue Misses and Leadership Changes,,,,,Hold Rating on Airsculpt Technologies Amidst Revenue Misses and Leadership Changes,1,1,-1,-1,-1,-1
164.41M,"794,490",130.20M,$0.18,275,1.760,Hold,2.12,"Aug 27, 2024",AMRN,Amarin Corporation plc,258.46M,0.63,264.78M,-3.95%,-12.00%,-29.49%,-9.91%,-41.49%,Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress,"Amarin announces new data from REDUCE-IT trial, abstracts",,,,"Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress Amarin announces new data from REDUCE-IT trial, abstracts",1,0,0,-1,-1,-1
22.53M,"62,648",22.09M,$0.84,325,12.83,Hold,13.00,"Jul 25, 2024",TRUE,"TrueCar, Inc.",258.13M,2.84,165.28M,-1.48%,-6.55%,-6.32%,-20.77%,-12.91%,"TrueCar Elevates Jill Angel to COO, Affirms Compensation Plan","TrueCar names Jill Angel as COO, effective immediately",,,,"TrueCar Elevates Jill Angel to COO, Affirms Compensation Plan TrueCar names Jill Angel as COO, effective immediately",0,0,1,-1,-1,-1
38.83M,"65,153",9.47M,-1,,7.39,,,"Aug 7, 2024",RITR,Reitar Logtech Holdings Limited,257.82M,4.15,14.35M,16.20%,16.20%,16.20%,,,,,,,,,1,-1,-1,-1,-1,-1
5.74M,"2,641",15.80M,$1.52,659,50.00,,,"Jul 24, 2024",JAKK,"JAKKS Pacific, Inc.",257.58M,23.45,675.84M,8.66%,19.88%,-5.13%,+12.17%,+7.52%,"Jakks Pacific extends global rights for Stranger Things, Bridgerton","Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls","Maxim starts Jakks Pacific at Buy on toys market growth, favorable film slate",Jakks Pacific initiated with a Buy at Maxim,,"Jakks Pacific extends global rights for Stranger Things, Bridgerton Kymera upgraded, MoonLake downgraded: Wall Street’s top analyst calls Maxim starts Jakks Pacific at Buy on toys market growth, favorable film slate Jakks Pacific initiated with a Buy at Maxim",1,1,1,1,1,-1
15.13M,"60,163",-497.65M,-1,942,18.95,,,"Aug 14, 2024",OB,Outbrain Inc.,257.38M,5.23,909.36M,5.36%,6.28%,19.06%,+5.44%,+21.15%,,,,,,,1,-1,-1,-1,-1,-1
286.19M,"63,182",-100.31M,-1,"10,800",0.960,,,,IHRT,"iHeartMedia, Inc.",256.63M,1.69,3.75B,3.90%,16.65%,-19.32%,-14.61%,-25.85%,"Airtasker announces partnerships with iHeartMedia, TelevisaUnivision",iHeartMedia: Hold Rating Amidst Mixed Financial Performance and Margin Concerns,"Analysts Have Conflicting Sentiments on These Communication Services Companies: iHeartMedia (IHRT), New York Times (NYT) and Liberty LiLAC Group (LILAK)",,,"Airtasker announces partnerships with iHeartMedia, TelevisaUnivision iHeartMedia: Hold Rating Amidst Mixed Financial Performance and Margin Concerns Analysts Have Conflicting Sentiments on These Communication Services Companies: iHeartMedia (IHRT), New York Times (NYT) and Liberty LiLAC Group (LILAK)",0,0,0,1,-1,-1
19.62M,"8,446",17.36M,$0.20,358,14.57,Buy,14.83,"Jul 25, 2024",BCML,BayCom Corp,256.29M,23.15,97.49M,3.38%,6.09%,9.42%,-3.57%,+14.43%,,,,,,,1,-1,-1,-1,-1,-1
287.74M,"6,275,276",-345.36M,-1,173,0.992,Strong Buy,4.25,"Aug 15, 2024",ARQ,"Arq, Inc.",255.96M,7.01,105.08M,8.84%,10.33%,34.13%,+1.07%,+3.61%,Arq sees FY24 capital expenditures $60M-$70M,Arq reports Q2 EPS (6c) vs. (21c) last year,,,,Arq sees FY24 capital expenditures $60M-$70M Arq reports Q2 EPS (6c) vs. (21c) last year,0,1,1,-1,-1,-1
14.79M,"87,298",13.59M,-1,936,19.26,Hold,,"Aug 13, 2024",HNRG,Hallador Energy Company,255.59M,6.00,485.54M,3.60%,-10.21%,-16.65%,-17.84%,+28.74%,,,,,,,0,-1,-1,-1,-1,-1
44.17M,"37,609",-115.35M,-1,,6.42,Strong Buy,34.40,"Jun 14, 2024",HPAI,Helport AI Limited,255.06M,5.55,21.31M,-5.70%,-33.33%,-40.35%,,,,,,,,,1,-1,-1,-1,-1,-1
12.93M,"22,966",20.35M,$0.68,814,21.91,Buy,27.00,"Jul 29, 2024",NATR,"Nature's Sunshine Products, Inc.",252.26M,13.63,441.68M,-3.65%,-8.94%,-20.27%,-21.92%,-32.32%,Nature’s Sunshine Addresses Spanish Fork Manufacturing Facility Incident,Nature’s Sunshine Products announces equipment malfunction at Utah facility,"Nature’s Sunshine Products to Present at the 2024 Gateway Conference on September 4th, 2024","Analysts Offer Insights on Consumer Goods Companies: Nature’s Sunshine Products (NATR), Turning Point Brands (TPB) and Walmart (WMT)",Natures Sunshine Products price target lowered to $21 from $23 at DA Davidson,"Nature’s Sunshine Addresses Spanish Fork Manufacturing Facility Incident Nature’s Sunshine Products announces equipment malfunction at Utah facility Nature’s Sunshine Products to Present at the 2024 Gateway Conference on September 4th, 2024 Analysts Offer Insights on Consumer Goods Companies: Nature’s Sunshine Products (NATR), Turning Point Brands (TPB) and Walmart (WMT) Natures Sunshine Products price target lowered to $21 from $23 at DA Davidson",1,1,1,1,1,1
8.92M,"11,902",31.84M,$0.36,106,31.70,Buy,36.00,"Oct 21, 2024",BYRN,Byrna Technologies Inc.,252.14M,11.07,59.65M,9.91%,9.87%,11.07%,+19.62%,-15.06%,"Byrna Technologies Announces Record Preliminary Q3 2024 Results: Revenues Increase 194% Year-Over-Year, Exceed $20 Million","Byrna Technologies reports preliminary Q3 revenue $20.8M, consensus $16.06M.",Byrna Launchers Adopted by Uruguayan Ministry of the Interior for Enhanced Less-Lethal Law Enforcement,Byrna Technologies adopted by Uruguay Ministry of Interior in law enforcement,Byrna Technologies (BYRN) Initiated with a Buy at Roth MKM,"Byrna Technologies Announces Record Preliminary Q3 2024 Results: Revenues Increase 194% Year-Over-Year, Exceed $20 Million Byrna Technologies reports preliminary Q3 revenue $20.8M, consensus $16.06M. Byrna Launchers Adopted by Uruguayan Ministry of the Interior for Enhanced Less-Lethal Law Enforcement Byrna Technologies adopted by Uruguay Ministry of Interior in law enforcement Byrna Technologies (BYRN) Initiated with a Buy at Roth MKM",1,1,1,1,1,1
42.89M,"372,838",-49.66M,-1,231,6.59,Strong Buy,12.60,"Aug 8, 2024",DOGZ,Dogness (International) Corporation,251.69M,19.77,13.86M,40.79%,44.06%,171.69%,+53.66%,+208.07%,Dogness Intl Corp Class A trading resumes,"Dogness Intl Corp Class A trading halted, volatility trading pause",,,,"Dogness Intl Corp Class A trading resumes Dogness Intl Corp Class A trading halted, volatility trading pause",0,0,0,-1,-1,-1
37.83M,"113,314",-118.08M,$0.20,237,7.46,Buy,11.17,"Aug 5, 2024",PDLB,"Ponce Financial Group, Inc.",250.46M,11.16,81.74M,10.50%,16.15%,23.63%,+11.72%,+32.77%,,,,,,,0,-1,-1,-1,-1,-1
25.23M,"13,918",15.26M,-1,56,11.17,,,"Sep 6, 2024",OBIO,"Orchestra BioMed Holdings, Inc.",250.40M,6.62,2.08M,-0.14%,-11.22%,-4.93%,-12.20%,+32.52%,Orchestra BioMed initiated with a Buy at H.C. Wainwright,Buy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Developments,"Orchestra BioMed reports Q2 EPS (45c), consensus (39c)",Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update,,"Orchestra BioMed initiated with a Buy at H.C. Wainwright Buy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Developments Orchestra BioMed reports Q2 EPS (45c), consensus (39c) Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update",0,0,1,1,0,-1
121.40M,"1,370,716",7.12M,-1,"1,948",2.320,Strong Buy,7.70,"Sep 11, 2024",EGHT,"8x8, Inc.",250.24M,1.95,723.57M,-9.90%,-17.58%,-30.57%,-39.29%,-23.98%,Hold Rating on 8X8 Amid Revenue Guidance Downgrade and Market Headwinds,,,,,Hold Rating on 8X8 Amid Revenue Guidance Downgrade and Market Headwinds,1,1,-1,-1,-1,-1
34.37M,"3,081",-46.65M,-1,102,8.27,Strong Buy,16.17,"Aug 6, 2024",NBTX,Nanobiotix S.A.,249.92M,5.28,40.02M,2.30%,0.17%,-17.14%,+7.01%,-5.38%,Nanobiotix Bolsters Board with Expert Additions,NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth,Nanobiotix Engages in Premier Investment Conference,Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference,Nanobiotix initiated with a Buy at Guggenheim,Nanobiotix Bolsters Board with Expert Additions NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth Nanobiotix Engages in Premier Investment Conference Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference Nanobiotix initiated with a Buy at Guggenheim,0,1,0,0,0,1
77.19M,"206,828",-6.34M,-1,,3.620,Strong Buy,8.00,"Aug 7, 2024",SVII,Spring Valley Acquisition Corp. II,249.59M,11.19,-,-0.03%,0.18%,1.92%,+0.18%,+2.20%,,,,,,,0,-1,-1,-1,-1,-1
28.00M,"306,805",,-1,814,,,,,TOYO,"TOYO Co., Ltd",249.07M,5.17,62.38M,18.61%,18.91%,-43.69%,+85.36%,,"TOYO Co., Ltd Announces First Half 2024 Unaudited Financial Results",TOYO Co Ltd trading resumes,"TOYO Co Ltd trading halted, volatility trading pause",,,"TOYO Co., Ltd Announces First Half 2024 Unaudited Financial Results TOYO Co Ltd trading resumes TOYO Co Ltd trading halted, volatility trading pause",0,1,0,0,-1,-1
,,,-1,137,,,,,NKTR,Nektar Therapeutics,248.51M,1.35,93.16M,1.32%,-1.09%,24.60%,-5.97%,-4.55%,,,,,,,1,-1,-1,-1,-1,-1
11.88M,"337,791",-3.45M,-1,106,23.43,Strong Buy,24.13,"Jul 25, 2024",PKBK,"Parke Bancorp, Inc.",248.29M,20.73,64.61M,9.35%,15.87%,18.07%,+5.06%,+23.35%,,,,,,,0,-1,-1,-1,-1,-1
17.70M,"193,948",4.44M,-1,57,15.71,Buy,16.00,"Aug 6, 2024",SERA,"Sera Prognostics, Inc.",247.93M,7.43,107.00K,-0.80%,4.65%,0.56%,-18.70%,-28.75%,,,,,,,0,-1,-1,-1,-1,-1
97.12M,"398,023",-112.77M,-1,38,2.860,Strong Buy,14.67,"Aug 5, 2024",PCYO,Pure Cycle Corporation,247.74M,10.29,19.56M,4.20%,5.62%,6.56%,-5.00%,+8.85%,,,,,,,1,-1,-1,-1,-1,-1
21.19M,"61,720",-115.33M,-1,430,13.09,Hold,19.00,"Aug 5, 2024",SOPH,SOPHiA GENETICS SA,247.62M,3.74,64.94M,-2.95%,-15.68%,-21.24%,-13.64%,-24.45%,Sophia Genetics announces CE mark for Sophia DDM Platform under IVDR,,,,,Sophia Genetics announces CE mark for Sophia DDM Platform under IVDR,0,0,-1,-1,-1,-1
18.16M,"52,341",11.96M,$0.60,298,15.25,,,"Oct 22, 2024",TSBK,"Timberland Bancorp, Inc.",247.50M,31.07,74.39M,6.08%,9.28%,11.30%,+0.49%,+19.22%,,,,,,,0,-1,-1,-1,-1,-1
56.62M,"172,867",-50.53M,-1,,4.89,Hold,6.75,"Aug 5, 2024",RENE,Cartesian Growth Corporation II,246.26M,11.39,-,0.33%,0.75%,2.98%,+0.62%,+2.99%,,,,,,,0,-1,-1,-1,-1,-1
14.18M,"23,713",2.47M,$0.25,198,19.50,,,"Oct 16, 2024",OMER,Omeros Corporation,245.69M,4.24,-,-5.73%,-6.34%,13.90%,-25.05%,+17.78%,,,,,,,0,-1,-1,-1,-1,-1
53.21M,"189,358","-240,000",-1,274,5.19,Strong Buy,9.67,"Aug 7, 2024",TSVT,"2seventy bio, Inc.",244.62M,4.75,44.12M,1.96%,6.15%,7.91%,-5.93%,-9.76%,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy bio (TSVT) and Repare Therapeutics (RPTX)",,,,,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy bio (TSVT) and Repare Therapeutics (RPTX)",0,0,-1,-1,-1,-1
178.96M,"1,628,947",-77.67M,-1,,1.540,Strong Buy,3.67,"Aug 6, 2024",HLXB,Helix Acquisition Corp. II,244.49M,10.40,-,-0.42%,0.17%,-0.03%,+0.69%,,,,,,,,0,-1,-1,-1,-1,-1
36.21M,"1,125,415",-139.65M,-1,207,7.61,Buy,24.29,"Jul 31, 2024",RCEL,"AVITA Medical, Inc.",244.43M,9.34,54.14M,2.10%,2.77%,-23.39%,-7.04%,-40.81%,Avita Medical (RCEL) Receives a Buy from Bank of America Securities,Lake Street Issues a Buy Rating on Avita Medical (RCEL),Piper Sandler Issues a Hold Rating on Avita Medical (RCEL),Cantor Fitzgerald Keeps Their Buy Rating on Avita Medical (RCEL),,Avita Medical (RCEL) Receives a Buy from Bank of America Securities Lake Street Issues a Buy Rating on Avita Medical (RCEL) Piper Sandler Issues a Hold Rating on Avita Medical (RCEL) Cantor Fitzgerald Keeps Their Buy Rating on Avita Medical (RCEL),1,1,0,0,0,-1
23.24M,"105,622",22.83M,$1.54,"1,045",11.84,Hold,12.75,"Aug 8, 2024",TCX,Tucows Inc.,243.93M,22.22,350.81M,-2.17%,2.18%,4.63%,-13.59%,+21.17%,Tucows Expands Financing with Secured Fiber Revenue Notes,,,,,Tucows Expands Financing with Secured Fiber Revenue Notes,0,0,-1,-1,-1,-1
,,,-1,619,,,,,TLS,Telos Corporation,243.51M,3.37,135.36M,-4.96%,-14.17%,-17.96%,-13.95%,-9.31%,Telos expands enrollment and renewal options with new locations,"Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations",Telos Corporation Announces Resolution of Protest on an Award Worth up to $485 Million to Telos Over Five Years,Telos price target raised to $5 from $4 at B. Riley,Telos Corporation Receives Prime Position on Department of the Air Force Network Infrastructure Contract,"Telos expands enrollment and renewal options with new locations Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations Telos Corporation Announces Resolution of Protest on an Award Worth up to $485 Million to Telos Over Five Years Telos price target raised to $5 from $4 at B. Riley Telos Corporation Receives Prime Position on Department of the Air Force Network Infrastructure Contract",0,0,0,0,0,0
14.23M,"24,909",23.70M,$0.72,231,19.23,Hold,18.50,"Jul 25, 2024",BLDE,"Blade Air Mobility, Inc.",243.15M,3.12,238.38M,4.13%,-3.52%,-3.08%,-7.27%,-17.96%,Private jet flights are down 15% in two years as Covid-era demand wanes,Blade Air Mobility enters partnership with Qatar Airways,"BLADE extends its airline agreements through its partnership with Qatar Airways, allowing passengers to fly from anywhere in the world straight to Monaco on a single ticket",Cathie Wood’s ARK Investment buys 30K shares of Blade Air Mobility today,"Analysts Offer Insights on Industrial Goods Companies: THK Co (OtherTHKLF), Global Payments (GPN) and Blade Air Mobility (BLDE)","Private jet flights are down 15% in two years as Covid-era demand wanes Blade Air Mobility enters partnership with Qatar Airways BLADE extends its airline agreements through its partnership with Qatar Airways, allowing passengers to fly from anywhere in the world straight to Monaco on a single ticket Cathie Wood’s ARK Investment buys 30K shares of Blade Air Mobility today Analysts Offer Insights on Industrial Goods Companies: THK Co (OtherTHKLF), Global Payments (GPN) and Blade Air Mobility (BLDE)",1,1,1,1,1,1
27.31M,"113,343",-20.94M,-1,378,10.00,Strong Buy,15.00,"Sep 9, 2024",LNKB,"LINKBANCORP, Inc.",242.12M,6.48,68.14M,-1.13%,-2.09%,-5.27%,-12.76%,-6.47%,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 26, 2024",,,,,"Ex-Dividend Date Nearing for These 10 Stocks – Week of August 26, 2024",0,0,-1,-1,-1,-1
44.65M,"37,988",5.39M,-1,"5,000",6.10,,,"Aug 8, 2024",PBPB,Potbelly Corporation,241.96M,8.08,477.37M,4.86%,4.26%,-21.79%,+7.12%,-27.26%,"Analysts Offer Insights on Consumer Cyclical Companies: Dollar Tree (DLTR), Potbelly (PBPB) and Everi Holdings (EVRI)",Potbelly price target lowered to $16 from $20 at Craig-Hallum,Potbelly (PBPB) Gets a Buy from Lake Street,,,"Analysts Offer Insights on Consumer Cyclical Companies: Dollar Tree (DLTR), Potbelly (PBPB) and Everi Holdings (EVRI) Potbelly price target lowered to $16 from $20 at Craig-Hallum Potbelly (PBPB) Gets a Buy from Lake Street",0,1,0,0,-1,-1
62.55M,"336,429",-22.62M,-1,206,4.300,Buy,5.75,"Aug 6, 2024",BPRN,"Princeton Bancorp, Inc.",240.81M,38.09,71.92M,1.05%,5.08%,12.04%,-6.72%,+21.11%,,,,,,,1,-1,-1,-1,-1,-1
50.03M,"320,147",-60.64M,-1,"1,113",5.37,Strong Buy,19.00,"Aug 14, 2024",IRBT,iRobot Corporation,240.79M,7.97,810.10M,-13.91%,-19.96%,-53.29%,-37.49%,-16.63%,Plug Power appoints Angle to board of directors,iRobot Announces New Board Member and Compensation Details,,,,Plug Power appoints Angle to board of directors iRobot Announces New Board Member and Compensation Details,1,0,1,-1,-1,-1
11.67M,"60,300",48.12M,$0.40,"1,700",22.98,,,"Jul 22, 2024",INSE,"Inspired Entertainment, Inc.",238.91M,8.99,317.40M,4.01%,-0.38%,-2.17%,-4.23%,-10.89%,Macquarie Sticks to Its Hold Rating for Inspired Entertainment (INSE),Inspired Entertainment price target lowered to $10 from $11 at Macquarie,"Analysts Offer Insights on Consumer Cyclical Companies: Hilton Grand Vacations (HGV), Home Depot (HD) and Inspired Entertainment (INSE)",Inspired Entertainment (INSE) Receives a Buy from Truist Financial,,"Macquarie Sticks to Its Hold Rating for Inspired Entertainment (INSE) Inspired Entertainment price target lowered to $10 from $11 at Macquarie Analysts Offer Insights on Consumer Cyclical Companies: Hilton Grand Vacations (HGV), Home Depot (HD) and Inspired Entertainment (INSE) Inspired Entertainment (INSE) Receives a Buy from Truist Financial",0,0,0,0,0,-1
14.73M,"15,033",-45.82M,-1,84,18.20,Strong Buy,60.00,"Aug 14, 2024",ABEO,Abeona Therapeutics Inc.,238.88M,5.52,-,13.62%,15.86%,4.51%,+13.06%,-25.54%,Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences,"Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH)",Biotech Alert: Searches spiking for these stocks today,Abeona Therapeutics Enhances Board with Industry Experts,"Abeona Therapeutics appoints Zeiher, Crombez to board of directors","Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH) Biotech Alert: Searches spiking for these stocks today Abeona Therapeutics Enhances Board with Industry Experts Abeona Therapeutics appoints Zeiher, Crombez to board of directors",1,1,1,1,1,1
76.10M,"472,656",-1.35M,-1,"1,800",3.510,Strong Buy,6.00,"Aug 7, 2024",BOOM,DMC Global Inc.,238.46M,11.90,684.23M,-0.25%,-10.36%,-23.90%,-12.37%,-37.51%,,,,,,,0,-1,-1,-1,-1,-1
15.74M,"101,183",32.22M,$0.64,190,16.94,Hold,18.75,"Jul 29, 2024",UTMD,"Utah Medical Products, Inc.",238.43M,68.57,46.58M,0.76%,-0.22%,-6.89%,-1.93%,-1.16%,,,,,,,1,-1,-1,-1,-1,-1
53.30M,"154,044",-34.27M,-1,51,4.99,Buy,5.00,"Aug 13, 2024",RZLT,"Rezolute, Inc.",238.03M,4.30,-,10.11%,10.67%,87.70%,+1.63%,+97.88%,Rezolute to Participate in Upcoming Investor Conferences,Rezolute initiated with a Buy at Guggenheim on potential in CHI,,,,Rezolute to Participate in Upcoming Investor Conferences Rezolute initiated with a Buy at Guggenheim on potential in CHI,1,0,1,-1,-1,-1
85.87M,"469,809",10.40M,-1,89,3.080,Strong Buy,5.25,"Aug 7, 2024",RCAT,"Red Cat Holdings, Inc.",237.23M,3.18,17.84M,22.89%,63.07%,175.12%,+41.79%,+264.92%,Red Cat closes acquisition of FlightWave Aerospace Systems,Red Cat Closes Acquisition of FlightWave Aerospace Systems,,,,Red Cat closes acquisition of FlightWave Aerospace Systems Red Cat Closes Acquisition of FlightWave Aerospace Systems,1,1,1,-1,-1,-1
4.76M,"2,864",27.39M,$1.96,"2,100",55.36,Strong Buy,,"Oct 21, 2024",RCKY,"Rocky Brands, Inc.",236.28M,31.72,462.73M,8.24%,-3.51%,5.83%,-8.90%,+16.62%,,,,,,,0,-1,-1,-1,-1,-1
145.18M,"93,910",-44.51M,-1,211,1.810,Strong Buy,3.10,"Aug 7, 2024",LFMD,"LifeMD, Inc.",234.73M,5.45,178.28M,-13.31%,-22.93%,-36.62%,-27.98%,-46.40%,Craig-Hallum Keeps Their Buy Rating on LifeMD (LFMD),LifeMD to Participate in Three Investor Conferences During September,"LifeMD shares ‘significantly undervalued’ versus peers, says B. Riley",Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and LifeMD (LFMD),"Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Eli Lilly & Co (LLY)","Craig-Hallum Keeps Their Buy Rating on LifeMD (LFMD) LifeMD to Participate in Three Investor Conferences During September LifeMD shares ‘significantly undervalued’ versus peers, says B. Riley Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and LifeMD (LFMD) Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Eli Lilly & Co (LLY)",0,0,0,1,0,0
8.96M,"65,956",22.64M,$1.08,"6,900",29.33,Hold,24.00,"Jul 25, 2024",SGC,"Superior Group of Companies, Inc.",234.17M,13.96,553.95M,-6.05%,-20.91%,-12.27%,-28.82%,-13.64%,Buy Rating Affirmed for Superior Group of Companies Amidst Resilient Performance and Growth Prospects,Superior Group price target lowered to $20 from $22 at Barrington,Superior Group Launches $10 Million Stock Buyback Plan,Superior Group announces $10M stock repurchase plan,,Buy Rating Affirmed for Superior Group of Companies Amidst Resilient Performance and Growth Prospects Superior Group price target lowered to $20 from $22 at Barrington Superior Group Launches $10 Million Stock Buyback Plan Superior Group announces $10M stock repurchase plan,1,1,1,1,1,-1
8.16M,"9,054",13.79M,-1,175,32.21,Buy,44.00,"Oct 17, 2024",PLBC,Plumas Bancorp,232.95M,39.51,78.62M,3.63%,6.62%,10.03%,-6.66%,+11.64%,Plumas Bancorp Cancels Property Deal with Mountainseed,,,,,Plumas Bancorp Cancels Property Deal with Mountainseed,1,1,-1,-1,-1,-1
53.14M,"124,774",7.73M,-1,43,4.940,Strong Buy,6.17,"Jul 31, 2024",ARTV,"Artiva Biotherapeutics, Inc.",232.82M,10.00,32.75M,-3.25%,-5.19%,-5.19%,-7.37%,,"Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from Wedbush",Buy Rating Affirmed for Artiva Biotherapeutics Amidst Clinical Advancements and Strong Financials,Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights,Artiva Biotherapeutics reports Q2 EPS ($22.00) vs. ($14.09) last year,"Wedbush bullish on Artiva Biotherapeutics, initiates with an Outperform","Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from Wedbush Buy Rating Affirmed for Artiva Biotherapeutics Amidst Clinical Advancements and Strong Financials Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights Artiva Biotherapeutics reports Q2 EPS ($22.00) vs. ($14.09) last year Wedbush bullish on Artiva Biotherapeutics, initiates with an Outperform",0,0,0,0,0,0
17.59M,"37,214",22.21M,$0.45,581,14.90,,,"Jul 24, 2024",ASUR,"Asure Software, Inc.",232.04M,8.77,115.29M,1.25%,0.34%,4.86%,-15.34%,+16.11%,Asure Software Sets September 2024 Investor Conference Schedule,Asure (ASUR) Gets a Buy from Craig-Hallum,"Asure Software acquires HireClick, terms not disclosed","Asure Acquires HIRECLICK, Expands HCM Suite with an Intuitive, AI-Powered Applicant Tracking System",,"Asure Software Sets September 2024 Investor Conference Schedule Asure (ASUR) Gets a Buy from Craig-Hallum Asure Software acquires HireClick, terms not disclosed Asure Acquires HIRECLICK, Expands HCM Suite with an Intuitive, AI-Powered Applicant Tracking System",1,1,0,0,0,-1
396.92M,"1,975,969",-253.00M,-1,171,0.660,,,"Aug 8, 2024",NPCE,"NeuroPace, Inc.",231.24M,7.92,71.82M,8.40%,7.88%,-26.07%,-0.26%,-46.75%,NeuroPace (NPCE) Gets a Buy from Lake Street,NeuroPace Strengthens Management Team with Two Key Appointments,NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences,NeuroPace to Participate in Upcoming Healthcare Conferences in September,Morgan Stanley Sticks to Its Hold Rating for NeuroPace (NPCE),NeuroPace (NPCE) Gets a Buy from Lake Street NeuroPace Strengthens Management Team with Two Key Appointments NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences NeuroPace to Participate in Upcoming Healthcare Conferences in September Morgan Stanley Sticks to Its Hold Rating for NeuroPace (NPCE),1,0,1,0,0,0
23.45M,"77,569","149,703",-1,50,11.15,,,,EPIX,ESSA Pharma Inc.,231.16M,5.21,-,5.10%,2.50%,-22.50%,-1.87%,-37.35%,Piper Sandler Remains a Buy on ESSA Pharma (EPIX),ESSA Pharma (EPIX) Receives a Buy from Oppenheimer,,,,Piper Sandler Remains a Buy on ESSA Pharma (EPIX) ESSA Pharma (EPIX) Receives a Buy from Oppenheimer,0,0,0,-1,-1,-1
,,,-1,115,,,,,PNRG,PrimeEnergy Resources Corporation,230.95M,131.84,178.71M,11.78%,16.18%,25.88%,+12.56%,+32.94%,PrimeEnergy Resources Corporation (PNRG) Announces Second Quarter Results,,,,,PrimeEnergy Resources Corporation (PNRG) Announces Second Quarter Results,1,0,-1,-1,-1,-1
57.02M,"59,217",19.87M,-1,221,4.580,Strong Buy,8.50,"Aug 7, 2024",CLLS,Cellectis S.A.,230.80M,2.37,19.64M,10.22%,14.32%,-9.51%,+5.81%,-11.57%,Monthly information on share capital and company voting rights,Cellectis’ Breakthrough in TNBC Therapy,Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC,Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety,Cellectis Reveals Promising Cancer Therapy Breakthrough,Monthly information on share capital and company voting rights Cellectis’ Breakthrough in TNBC Therapy Cellectis publishes pre-clinical evidence MUC1 CAR T-cells reducing certain BC Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety Cellectis Reveals Promising Cancer Therapy Breakthrough,0,0,0,0,0,0
31.74M,"99,922",6.04M,-1,"5,500",8.19,Strong Buy,14.00,"Jul 25, 2024",PROC,Procaps Group S.A.,230.16M,2.04,414.10M,-3.21%,-13.40%,-30.33%,-20.33%,-34.69%,"Procaps Group Navigates Challenges, Outperforms Market",Procaps CEO says ‘working diligently’ to complete internal investigation,Procaps Group sees 1H24 adjusted EBITDA $8M-$10M,Procaps Issues Shareholder Letter,Procaps Group Negotiates Forbearance on Debt,"Procaps Group Navigates Challenges, Outperforms Market Procaps CEO says ‘working diligently’ to complete internal investigation Procaps Group sees 1H24 adjusted EBITDA $8M-$10M Procaps Issues Shareholder Letter Procaps Group Negotiates Forbearance on Debt",0,1,0,1,0,1
57.59M,"63,344",-3.42M,-1,18,4.490,Hold,5.50,"Aug 9, 2024",CDZI,Cadiz Inc.,229.49M,3.38,2.69M,3.79%,2.58%,15.21%,-9.95%,+34.00%,Cadiz announces Northern Pipeline contracted for 85% capacity,Cadiz files $200M mixed securities shelf,,,,Cadiz announces Northern Pipeline contracted for 85% capacity Cadiz files $200M mixed securities shelf,1,1,0,-1,-1,-1
411.17M,"314,051",-33.52M,-1,120,0.629,Hold,1.00,"Jul 31, 2024",FVCB,"FVCBankcorp, Inc.",229.33M,12.61,44.61M,6.41%,6.86%,1.07%,-5.21%,+0.92%,,,,,,,1,-1,-1,-1,-1,-1
90.89M,"339,151",-29.15M,-1,179,2.840,Strong Buy,3.75,"Aug 5, 2024",BLFY,Blue Foundry Bancorp,229.02M,10.80,41.85M,3.73%,8.19%,14.74%,-3.72%,+22.96%,,,,,,,0,-1,-1,-1,-1,-1
62.13M,"1,905,447",8.20M,-1,124,4.15,,,,ZNTL,"Zentalis Pharmaceuticals, Inc.",226.83M,3.19,40.56M,-8.25%,-23.86%,-71.44%,-21.34%,-79.71%,Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Wedbush upgrades Zentalis to Neutral on valuation post selloff,Zentalis price target raised to $10 from $9 at Stifel,Wells Fargo Sticks to Their Hold Rating for Zentalis Pharmaceuticals (ZNTL),Optimistic Outlook for Zentalis Pharmaceuticals Amidst Clinical Progress and Market Opportunities,Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Wedbush upgrades Zentalis to Neutral on valuation post selloff Zentalis price target raised to $10 from $9 at Stifel Wells Fargo Sticks to Their Hold Rating for Zentalis Pharmaceuticals (ZNTL) Optimistic Outlook for Zentalis Pharmaceuticals Amidst Clinical Progress and Market Opportunities,1,0,1,0,0,0
,,,-1,592,,,,,EGAN,eGain Corporation,226.38M,7.59,94.98M,3.37%,8.57%,7.62%,-0.41%,+13.88%,eGain (EGAN) Receives a Hold from Craig-Hallum,eGain price target raised to $7 from $6 at Craig-Hallum,Roth MKM Sticks to Its Buy Rating for eGain (EGAN),Closing Bell Movers: Broadcom slips 7% after Q3 results,"eGain sees Q1 EPS 1c- 2c , consensus 5c","eGain (EGAN) Receives a Hold from Craig-Hallum eGain price target raised to $7 from $6 at Craig-Hallum Roth MKM Sticks to Its Buy Rating for eGain (EGAN) Closing Bell Movers: Broadcom slips 7% after Q3 results eGain sees Q1 EPS 1c- 2c , consensus 5c",0,0,0,0,0,1
10.98M,"141,615",28.59M,-1,"1,024",23.45,Strong Buy,36.00,"Jul 31, 2024",ARAY,Accuray Incorporated,226.28M,2.28,446.55M,25.84%,27.04%,2.90%,+20.65%,-7.50%,Accuray Announces CEO Medical Leave and Interim Successor,Accuray CEO Suzanne Winter to take temporary medical leave of absence,Accuray’s new radiation delivery system receives CE mark,Lake Street Remains a Buy on Accuray (ARAY),Accuray (ARAY) Receives a Buy from Roth MKM,Accuray Announces CEO Medical Leave and Interim Successor Accuray CEO Suzanne Winter to take temporary medical leave of absence Accuray’s new radiation delivery system receives CE mark Lake Street Remains a Buy on Accuray (ARAY) Accuray (ARAY) Receives a Buy from Roth MKM,0,0,0,0,0,0
49.21M,"139,170",-2.68M,-1,162,5.23,Buy,5.50,"Aug 8, 2024",ORGN,"Origin Materials, Inc.",225.91M,1.55,34.06M,29.23%,43.40%,75.11%,+47.76%,+72.35%,Positive Report for Origin Materials (ORGN) from Bank of America Securities,"Origin Materials sees FY24 revenue $25M-$35M, one estimate $32.0M",Origin Materials reports Q2 EPS (14c) vs. (5c) last year,ORGN Upcoming Earnings Report: What to Expect?,,"Positive Report for Origin Materials (ORGN) from Bank of America Securities Origin Materials sees FY24 revenue $25M-$35M, one estimate $32.0M Origin Materials reports Q2 EPS (14c) vs. (5c) last year ORGN Upcoming Earnings Report: What to Expect?",1,1,1,1,1,-1
151.85M,"664,338",-996.10M,-1,"2,012",1.690,Hold,3.00,"Aug 8, 2024",VSTA,Vasta Platform Limited,225.79M,2.82,282.28M,-22.82%,-25.18%,-39.65%,-25.08%,-45.10%,Buy/Sell: Wall Street’s top 10 stock calls this week,Vasta Platform downgraded to Underweight from Overweight at JPMorgan,,,,Buy/Sell: Wall Street’s top 10 stock calls this week Vasta Platform downgraded to Underweight from Overweight at JPMorgan,1,0,0,-1,-1,-1
11.07M,"26,125",24.51M,$0.40,15,23.15,,,"Oct 17, 2024",ZURA,Zura Bio Limited,225.65M,3.57,-,19.66%,18.79%,9.26%,+6.84%,+54.58%,Zura Bio initiated with a Neutral at H.C. Wainwright,Zura Bio files $300M mixed securities shelf,Zura Bio Clarifies Legal Status of Information Release,Three new option listings and one option delisting on August 14th,Zura Bio Releases Updated Corporate Presentation Info,Zura Bio initiated with a Neutral at H.C. Wainwright Zura Bio files $300M mixed securities shelf Zura Bio Clarifies Legal Status of Information Release Three new option listings and one option delisting on August 14th Zura Bio Releases Updated Corporate Presentation Info,1,1,0,1,0,0
36.51M,"122,526",-4.12M,-1,140,7.01,,,"Aug 12, 2024",TNYA,"Tenaya Therapeutics, Inc.",224.83M,2.85,-,-5.64%,-13.16%,-27.60%,-24.29%,-43.50%,Tenaya Therapeutics to Participate in Upcoming Investment Conferences,"Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG)",Tenaya Therapeutics: A Buy Recommendation Based on Clinical Progress and Financial Fortitude,Buy Rating Affirmed for Tenaya Therapeutics: Strong Clinical Progress and Strategic Financial Positioning,Piper Sandler Sticks to Its Buy Rating for Tenaya Therapeutics (TNYA),"Tenaya Therapeutics to Participate in Upcoming Investment Conferences Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA), Tenaya Therapeutics (TNYA) and PepGen Inc. (PEPG) Tenaya Therapeutics: A Buy Recommendation Based on Clinical Progress and Financial Fortitude Buy Rating Affirmed for Tenaya Therapeutics: Strong Clinical Progress and Strategic Financial Positioning Piper Sandler Sticks to Its Buy Rating for Tenaya Therapeutics (TNYA)",0,0,0,0,0,0
42.60M,"301,882",-6.07M,-1,76,6.00,Strong Buy,9.00,"Aug 6, 2024",DCTH,"Delcath Systems, Inc.",224.28M,8.01,11.88M,32.30%,30.79%,92.17%,+23.43%,+112.80%,Cramer’s Lightning Round: ADMA Biologics is ‘a very speculative situation’,"Lightning Round: MP Materials needs to pull out of the ‘tailspin of losses’, says Jim Cramer",Delcath Systems Reveals Encouraging Uveal Melanoma Study Results,Strong Buy Rating for Delcath Systems Supported by High Efficacy and Safety of CHEMOSAT Platform,Delcath Systems announces outcomes from independent study on PHP,"Cramer’s Lightning Round: ADMA Biologics is ‘a very speculative situation’ Lightning Round: MP Materials needs to pull out of the ‘tailspin of losses’, says Jim Cramer Delcath Systems Reveals Encouraging Uveal Melanoma Study Results Strong Buy Rating for Delcath Systems Supported by High Efficacy and Safety of CHEMOSAT Platform Delcath Systems announces outcomes from independent study on PHP",0,0,0,0,1,0
45.96M,"12,229",8.74M,-1,621,5.51,,,,GAUZ,Gauzy Ltd.,224.27M,12.01,89.75M,5.43%,2.51%,-1.99%,+6.40%,,Gauzy Ltd. to Attend B. Riley Securities Consumer & TMT Conference,Gauzy Ltd. Soars in Aircraft Shading Market,Gauzy sees aggregated revenue of $240M over next ten years from cockpit shading,Gauzy Expects To Generate an Aggregated Revenue of $240 Million Over Next 10 Years from Aeronautic Cockpit Shading,Gauzy price target lowered to $15.50 from $21 at B. Riley,Gauzy Ltd. to Attend B. Riley Securities Consumer & TMT Conference Gauzy Ltd. Soars in Aircraft Shading Market Gauzy sees aggregated revenue of $240M over next ten years from cockpit shading Gauzy Expects To Generate an Aggregated Revenue of $240 Million Over Next 10 Years from Aeronautic Cockpit Shading Gauzy price target lowered to $15.50 from $21 at B. Riley,1,1,1,1,1,0
,,,-1,591,,,,,FCEL,"FuelCell Energy, Inc.",223.67M,0.45,87.08M,-9.71%,-26.01%,-58.15%,-18.72%,-63.58%,FuelCell price target lowered to $1.25 from $1.50 at Canaccord,KeyBanc Sticks to Its Hold Rating for Fuelcell Energy (FCEL),Hold Rating on Fuelcell Energy Amidst Growth Opportunities and Operational Challenges,FuelCell Energy Reports Revenue Dip and Wider Net Loss,"FuelCell reports Q3 EPS (7c), consensus (7c)","FuelCell price target lowered to $1.25 from $1.50 at Canaccord KeyBanc Sticks to Its Hold Rating for Fuelcell Energy (FCEL) Hold Rating on Fuelcell Energy Amidst Growth Opportunities and Operational Challenges FuelCell Energy Reports Revenue Dip and Wider Net Loss FuelCell reports Q3 EPS (7c), consensus (7c)",1,0,1,1,1,1
18.51M,"47,003",15.46M,-1,339,13.63,Strong Buy,21.00,"Aug 8, 2024",CHMG,Chemung Financial Corporation,223.53M,47.00,96.44M,3.01%,2.26%,4.44%,-3.79%,+14.78%,Chemung Financial Corporation Announces Quarterly Dividend,,,,,Chemung Financial Corporation Announces Quarterly Dividend,0,0,-1,-1,-1,-1
22.78M,"136,586",-2.83M,-1,81,11.07,Buy,16.63,"Oct 10, 2024",SHIP,Seanergy Maritime Holdings Corp.,223.23M,10.83,145.31M,9.32%,11.05%,27.83%,+20.04%,+35.19%,,,,,,,1,-1,-1,-1,-1,-1
12.73M,"338,072",-7.44M,-1,194,19.77,,,,ALCO,"Alico, Inc.",222.99M,29.23,46.39M,2.94%,7.99%,4.58%,-1.15%,unch,,,,,,,0,-1,-1,-1,-1,-1
22.44M,"148,070",8.64M,-1,256,11.16,,,"Jul 30, 2024",MBCN,Middlefield Banc Corp.,221.79M,27.48,66.74M,10.90%,13.76%,7.61%,+1.22%,+19.85%,Middlefield Banc Corp. to Celebrate 10th Anniversary of Nasdaq Listing,Middlefield Banc Corp. Announces 2024 Third-Quarter Cash Dividend Payment,,,,Middlefield Banc Corp. to Celebrate 10th Anniversary of Nasdaq Listing Middlefield Banc Corp. Announces 2024 Third-Quarter Cash Dividend Payment,0,0,0,-1,-1,-1
37.82M,"61,466",-55.58M,-1,131,6.62,Strong Buy,15.75,"Aug 12, 2024",PROF,Profound Medical Corp.,221.55M,9.03,7.88M,-5.44%,-4.20%,2.98%,-14.74%,+12.05%,Profound Medical to Attend Growth Ideas Conference,Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference,Profound Medical management to meet virtually with Lake Street,Profound Medical (PRN) Receives a Buy from Lake Street,Profound Medical (PRN) Receives a Buy from Stifel Nicolaus,Profound Medical to Attend Growth Ideas Conference Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference Profound Medical management to meet virtually with Lake Street Profound Medical (PRN) Receives a Buy from Lake Street Profound Medical (PRN) Receives a Buy from Stifel Nicolaus,1,0,0,0,0,0
128.33M,"878,731",-62.56M,-1,126,1.950,Buy,2.83,"Aug 7, 2024",BWFG,"Bankwell Financial Group, Inc.",220.75M,28.95,81.49M,5.88%,10.02%,8.46%,+2.24%,+14.21%,,,,,,,1,-1,-1,-1,-1,-1
47.11M,818,-43.88M,-1,83,5.28,Buy,11.00,"Sep 24, 2024",ATAI,Atai Life Sciences N.V.,219.82M,1.31,378.00K,-3.18%,-7.29%,-21.25%,-18.71%,-48.57%,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,Buy Rating Affirmed for ATAI Life Sciences Amid Progress in Neurology Pipeline and Potential Market Opportunities,Rising High: SNDL announces successful bid to acquire Indiva,Rising High: Clearmind granted patent approval for binge behavior treatment,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Buy Rating Affirmed for ATAI Life Sciences Amid Progress in Neurology Pipeline and Potential Market Opportunities Rising High: SNDL announces successful bid to acquire Indiva Rising High: Clearmind granted patent approval for binge behavior treatment,1,1,0,0,0,0
22.30M,875,9.89M,-1,147,11.19,,,,RIGL,"Rigel Pharmaceuticals, Inc.",219.59M,12.48,130.20M,16.99%,30.08%,14.86%,+21.93%,unch,Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial,Buy Rating Affirmed for Rigel with Positive Outlook on Asian Market Expansion and Solid NPV Valuation,Rigel Pharmaceuticals enters license and supply agreement with Kissei Pharma,,,Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial Buy Rating Affirmed for Rigel with Positive Outlook on Asian Market Expansion and Solid NPV Valuation Rigel Pharmaceuticals enters license and supply agreement with Kissei Pharma,0,0,0,0,-1,-1
,,,-1,380,,,,,LCNB,LCNB Corp.,219.36M,15.50,70.78M,6.13%,7.62%,4.00%,+1.11%,+4.04%,LCNB Prepares to Share Insightful Investor Materials,,,,,LCNB Prepares to Share Insightful Investor Materials,1,0,-1,-1,-1,-1
48.18M,"56,505",9.89M,-1,339,5.00,,,"Aug 21, 2024",MGNX,"MacroGenics, Inc.",218.90M,3.49,41.02M,-5.08%,-18.91%,-65.77%,-8.24%,-81.09%,Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Medtronic (MDT),MacroGenics price target lowered to $14 from $16 at Citi,MacroGenics management to meet virtually with B. Riley,,,Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Medtronic (MDT) MacroGenics price target lowered to $14 from $16 at Citi MacroGenics management to meet virtually with B. Riley,0,0,0,0,-1,-1
184.08M,"1,133,381",-177.08M,-1,159,1.350,Hold,1.00,"Aug 8, 2024",GNFT,Genfit S.A.,218.75M,4.35,38.12M,-4.62%,-4.59%,2.79%,+0.10%,+19.43%,"Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF), Nyxoah (NYXH) and Genfit (OtherGNFTF)",Genfit (GNFTF) Gets a Buy from Kepler Capital,,,,"Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF), Nyxoah (NYXH) and Genfit (OtherGNFTF) Genfit (GNFTF) Gets a Buy from Kepler Capital",1,0,1,-1,-1,-1
11.98M,"19,942",21.79M,$0.72,50,20.73,,,"Oct 23, 2024",PYXS,"Pyxis Oncology, Inc.",218.68M,3.71,16.15M,4.56%,7.98%,2.58%,-6.89%,-33.15%,Pyxis Oncology to Participate in Two Upcoming Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)",Analysts Offer Insights on Healthcare Companies: Gryphon Digital Mining (GRYP) and Pyxis Oncology (PYXS),"Pyxis Oncology reports Q2 EPS (29c), consensus (32c)",Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024,"Pyxis Oncology to Participate in Two Upcoming Investor Conferences Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST) Analysts Offer Insights on Healthcare Companies: Gryphon Digital Mining (GRYP) and Pyxis Oncology (PYXS) Pyxis Oncology reports Q2 EPS (29c), consensus (32c) Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024",1,0,1,0,1,1
33.37M,"54,654",-31.54M,-1,33,7.43,,,"Aug 7, 2024",STRS,Stratus Properties Inc.,217.85M,26.97,42.94M,-1.55%,-5.59%,-1.77%,-6.44%,+16.03%,Stratus Properties reports Q 2EPS (21c) vs. (66c) last year,,,,,Stratus Properties reports Q 2EPS (21c) vs. (66c) last year,0,0,-1,-1,-1,-1
24.08M,"25,288",6.06M,-1,25,10.29,,,"Jul 10, 2024",TRVI,"Trevi Therapeutics, Inc.",217.05M,2.99,-,2.60%,3.38%,23.81%,-7.23%,-3.91%,"Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls",Trevi initiated with Outperform on cough potential at Raymond James,Trevi Therapeutics initiated with an Outperform at Raymond James,Buy Rating Justified for Trevi Therapeutics Amid Promising Haduvio Trials and Market Potential,Trevi Therapeutics initiated with a Buy at H.C. Wainwright,"Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls Trevi initiated with Outperform on cough potential at Raymond James Trevi Therapeutics initiated with an Outperform at Raymond James Buy Rating Justified for Trevi Therapeutics Amid Promising Haduvio Trials and Market Potential Trevi Therapeutics initiated with a Buy at H.C. Wainwright",0,1,0,0,1,0
66.21M,"27,754",-66.78M,-1,265,3.740,Strong Buy,7.00,"Aug 6, 2024",NWFL,Norwood Financial Corp.,216.91M,26.98,61.89M,0.94%,1.24%,-1.73%,-12.35%,+1.81%,,,,,,,0,-1,-1,-1,-1,-1
7.97M,"24,975",24.57M,$0.96,23,31.07,,,"Jul 23, 2024",SWKH,SWK Holdings Corporation,216.83M,17.54,25.77M,1.57%,2.27%,2.18%,-1.25%,+2.17%,SWK Holdings: A Strong Buy on Stable Performance and Growth Potential in Healthcare Finance,SWK Holdings Enhances Investor Insights with Financial Presentation,SWK Holdings reports Q2 adjusted EPS 47c vs. 47c last year,,,SWK Holdings: A Strong Buy on Stable Performance and Growth Potential in Healthcare Finance SWK Holdings Enhances Investor Insights with Financial Presentation SWK Holdings reports Q2 adjusted EPS 47c vs. 47c last year,0,1,1,1,-1,-1
21.62M,"14,645",8.65M,-1,,11.38,,,,GASS,StealthGas Inc.,216.57M,5.98,147.03M,-1.41%,-11.30%,-11.35%,-10.44%,-2.15%,StealthGas Reports Record Earnings in Q2 2024,StealthGas: Strong Buy on Robust Earnings and Positive LPG Market Outlook,StealthGas Inc. Calls for Shareholder Votes at Annual Meeting,"STEALTHGAS INC. Announces the Date for the Release of the Second Quarter and Six Months 2024 Financial and Operating Results, Conference Call and Webcast",StealthGas Inc (GASS) Q2 Earnings Cheat Sheet,"StealthGas Reports Record Earnings in Q2 2024 StealthGas: Strong Buy on Robust Earnings and Positive LPG Market Outlook StealthGas Inc. Calls for Shareholder Votes at Annual Meeting STEALTHGAS INC. Announces the Date for the Release of the Second Quarter and Six Months 2024 Financial and Operating Results, Conference Call and Webcast StealthGas Inc (GASS) Q2 Earnings Cheat Sheet",0,1,1,0,0,1
,,,-1,174,,,,,CDXS,"Codexis, Inc.",216.33M,3.05,60.89M,-2.66%,-4.79%,-1.32%,-18.72%,-8.78%,Codexis to Participate in Upcoming Healthcare Conferences,Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting,"Apple, Lineage, OneStream initiated: Wall Street’s top analyst calls",Codexis downgraded to Hold from Buy at Benchmark,Codexis Announces New Employment Inducement Grants,"Codexis to Participate in Upcoming Healthcare Conferences Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting Apple, Lineage, OneStream initiated: Wall Street’s top analyst calls Codexis downgraded to Hold from Buy at Benchmark Codexis Announces New Employment Inducement Grants",0,0,0,1,1,0
57.95M,"215,528",-140.04M,-1,"60,000",4.240,Hold,,"Aug 7, 2024",TTEC,"TTEC Holdings, Inc.",216.19M,4.53,2.34B,-1.26%,-15.02%,-57.66%,-36.59%,-41.16%,"Analysts Conflicted on These Technology Names: TTEC Holdings (TTEC), Littelfuse (LFUS) and NEXTracker, Inc. Class A (NXT)",TTEC Holdings: Navigating Short-Term Challenges with a Resilient Digital Segment and Long-Term Growth Prospects,TTEC Holdings price target lowered to $4.50 from $8 at Canaccord,TTEC Holdings price target lowered to $5 from $7.50 at BofA,"Analysts Offer Insights on Technology Companies: Array Technologies (ARRY), TTEC Holdings (TTEC) and Arrow Electronics (ARW)","Analysts Conflicted on These Technology Names: TTEC Holdings (TTEC), Littelfuse (LFUS) and NEXTracker, Inc. Class A (NXT) TTEC Holdings: Navigating Short-Term Challenges with a Resilient Digital Segment and Long-Term Growth Prospects TTEC Holdings price target lowered to $4.50 from $8 at Canaccord TTEC Holdings price target lowered to $5 from $7.50 at BofA Analysts Offer Insights on Technology Companies: Array Technologies (ARRY), TTEC Holdings (TTEC) and Arrow Electronics (ARW)",1,1,1,1,0,1
51.50M,"280,665",-156.25M,-1,312,4.750,Buy,9.50,"Aug 7, 2024",BCBP,"BCB Bancorp, Inc.",216.10M,12.69,91.24M,4.57%,8.51%,10.29%,-1.74%,+23.37%,"BCB Bancorp, Inc. Completes Private Placement of $40.0 Million of Subordinated Notes",,,,,"BCB Bancorp, Inc. Completes Private Placement of $40.0 Million of Subordinated Notes",1,1,-1,-1,-1,-1
23.51M,705,"-41,692",-1,230,10.38,,,,OVLY,Oak Valley Bancorp,216.09M,26.14,76.55M,2.82%,4.90%,4.91%,-5.87%,+14.33%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,109,,,,,VXRT,"Vaxart, Inc.",216.07M,0.95,13.93M,23.33%,28.48%,5.06%,+26.54%,-21.30%,"Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",Vaxart reports inducement grants under Nasdaq listing rule,Vaxart: Vaccine platform may be effective for HPV-related cervical dysplasia,Vaxart’s Promising Vaccine Pipeline: Leading in Mucosal Immunity with Government Support and Competitive Advantages,"Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls","Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Vaxart reports inducement grants under Nasdaq listing rule Vaxart: Vaccine platform may be effective for HPV-related cervical dysplasia Vaxart’s Promising Vaccine Pipeline: Leading in Mucosal Immunity with Government Support and Competitive Advantages Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls",1,0,0,1,1,1
26.17M,"95,051",-49.83M,-1,,9.34,Hold,15.00,"Aug 8, 2024",MACI,Melar Acquisition Corp. I,216.00M,9.99,-,-0.17%,-0.16%,-0.16%,+0.10%,,,,,,,,0,-1,-1,-1,-1,-1
10.98M,"30,168",-91.23M,-1,"1,700",22.22,,,"Aug 8, 2024",FLXS,"Flexsteel Industries, Inc.",215.69M,41.83,412.75M,11.70%,17.71%,33.12%,+9.30%,+2.57%,Flexsteel Announces Conference Call to Discuss Latest Results,"Flexsteel Industries reports Q4 EPS 75c, one estimate 70c","Is FLXS a Buy, Before Earnings?",,,"Flexsteel Announces Conference Call to Discuss Latest Results Flexsteel Industries reports Q4 EPS 75c, one estimate 70c Is FLXS a Buy, Before Earnings?",0,0,0,1,-1,-1
72.26M,"831,353",-30.79M,-1,100,3.370,Buy,4.50,"Aug 9, 2024",RGCO,"RGC Resources, Inc.",215.21M,21.06,84.00M,1.58%,0.39%,4.05%,-8.80%,-3.57%,,,,,,,1,-1,-1,-1,-1,-1
77.93M,"503,314",-49.21M,-1,133,3.120,,,"Aug 7, 2024",EXFY,"Expensify, Inc.",215.18M,2.43,138.53M,13.39%,25.00%,22.61%,+18.92%,+43.79%,Loop Capital Markets Remains a Hold on Expensify (EXFY),,,,,Loop Capital Markets Remains a Hold on Expensify (EXFY),0,1,-1,-1,-1,-1
37.36M,"116,392","-231,000",$0.30,881,6.48,Hold,7.50,"Jul 29, 2024",SKIN,The Beauty Health Company,214.56M,1.73,366.23M,22.20%,4.48%,-34.10%,-4.32%,-52.29%,Beauty Health price target lowered to $1.20 from $3 at TD Cowen,Beauty Health price target lowered to $1.25 from $2 at Canaccord,Maintaining Hold on Beauty Health Amidst Downgraded Projections and Segment Struggles,Beauty Health (SKIN) Receives a Hold from Stifel Nicolaus,"Analysts Offer Insights on Consumer Cyclical Companies: Expedia (EXPE), Sweetgreen (SG) and Beauty Health (SKIN)","Beauty Health price target lowered to $1.20 from $3 at TD Cowen Beauty Health price target lowered to $1.25 from $2 at Canaccord Maintaining Hold on Beauty Health Amidst Downgraded Projections and Segment Struggles Beauty Health (SKIN) Receives a Hold from Stifel Nicolaus Analysts Offer Insights on Consumer Cyclical Companies: Expedia (EXPE), Sweetgreen (SG) and Beauty Health (SKIN)",1,1,1,0,0,1
29.95M,"127,705",36.17M,-1,,8.08,Strong Buy,15.67,"Aug 8, 2024",IONR,ioneer Ltd,214.24M,3.77,-,12.99%,4.82%,-7.12%,+13.66%,-9.76%,,,,,,,1,-1,-1,-1,-1,-1
6.32M,"6,740",22.35M,$1.20,706,38.09,,,"Jul 25, 2024",BLNK,Blink Charging Co.,212.42M,2.10,156.92M,-15.45%,-27.79%,-31.46%,-44.38%,-32.22%,"Blink Charging President and CEO, Brendan Jones, to Present at the H.C. Wainwright 26th Annual Global Investment Conference",Short Report: Bearish positioning in Cinemark caves as shares shine,Blink Charging Announces Major Management Shake-Up,Blink Charging Announces Retirement of President and CEO Brendan Jones and the Appointment of Michael Battaglia as Successor,"Blink Charging CEO Brendan Jones to retire, Michael Battagliato succeed","Blink Charging President and CEO, Brendan Jones, to Present at the H.C. Wainwright 26th Annual Global Investment Conference Short Report: Bearish positioning in Cinemark caves as shares shine Blink Charging Announces Major Management Shake-Up Blink Charging Announces Retirement of President and CEO Brendan Jones and the Appointment of Michael Battaglia as Successor Blink Charging CEO Brendan Jones to retire, Michael Battagliato succeed",1,1,1,0,1,1
30.23M,"724,223",-204.84M,-1,,7.97,Hold,13.00,"Aug 6, 2024",AFCG,"AFC Gamma, Inc.",210.60M,10.19,52.61M,6.65%,13.19%,22.97%,+13.38%,-15.11%,AFC Gamma price target lowered to $13 from $16 at Jefferies,"AFC Gamma provides new senior secured facility, expands existing facilities",AFC Gamma Provides a New Senior Secured Credit Facility to Private Company Q and Expands Existing Senior Secured Credit Facilities for BeLeaf Medical and Sunburn Cannabis,Compass upgrades AFC Gamma to Neutral on CEO’s ‘blank slate’,,"AFC Gamma price target lowered to $13 from $16 at Jefferies AFC Gamma provides new senior secured facility, expands existing facilities AFC Gamma Provides a New Senior Secured Credit Facility to Private Company Q and Expands Existing Senior Secured Credit Facilities for BeLeaf Medical and Sunburn Cannabis Compass upgrades AFC Gamma to Neutral on CEO’s ‘blank slate’",0,0,0,0,1,-1
26.57M,"102,050","-300,000",-1,"1,473",8.99,Strong Buy,16.00,"Aug 8, 2024",SNFCA,Security National Financial Corporation,208.48M,8.98,322.13M,7.34%,11.96%,15.12%,+7.27%,+25.91%,"Security National Financial Corporation Reports Financial Results for the Quarter Ended June 30, 2024",,,,,"Security National Financial Corporation Reports Financial Results for the Quarter Ended June 30, 2024",1,0,-1,-1,-1,-1
43.31M,"341,783",-52.60M,-1,58,5.52,Strong Buy,19.00,"Aug 12, 2024",POET,POET Technologies Inc.,208.40M,3.16,116.26K,9.51%,12.73%,78.32%,+2.44%,+145.00%,POET Technologies Unveils AI Optical Engines at CIOE 2024,POET to Demonstrate Leading-Edge Optical Engines for AI Market at CIOE 2024,POET Technologies Streamlines Operations for AI Market,POET Streamlines its Global Engineering Organization in Response to AI Market Demand,"POET reorganizes engineering team, plans closing of Allentown, PA operation","POET Technologies Unveils AI Optical Engines at CIOE 2024 POET to Demonstrate Leading-Edge Optical Engines for AI Market at CIOE 2024 POET Technologies Streamlines Operations for AI Market POET Streamlines its Global Engineering Organization in Response to AI Market Demand POET reorganizes engineering team, plans closing of Allentown, PA operation",0,0,0,0,0,0
20.04M,"153,455",12.68M,-1,984,11.90,Strong Buy,21.50,"Aug 1, 2024",OGI,Organigram Holdings Inc.,208.32M,2.02,110.30M,4.72%,10.15%,5.66%,+9.52%,-13.21%,Organigram Advances Global Cannabis Strategy with BAT Investment,Biotech Alert: Searches spiking for these stocks today,Canaccord Genuity Remains a Buy on OrganiGram Holdings (OGI),Organigram Holdings Sees Robust Growth in Q3,"Options Volatility and Implied Earnings Moves Today, August 13, 2024","Organigram Advances Global Cannabis Strategy with BAT Investment Biotech Alert: Searches spiking for these stocks today Canaccord Genuity Remains a Buy on OrganiGram Holdings (OGI) Organigram Holdings Sees Robust Growth in Q3 Options Volatility and Implied Earnings Moves Today, August 13, 2024",1,1,1,1,1,0
3.48M,"7,533",15.63M,$1.20,155,68.57,,,"Jul 25, 2024",VABK,Virginia National Bankshares Corporation,208.23M,38.77,51.88M,3.91%,8.27%,16.13%,-2.56%,+31.27%,,,,,,,0,-1,-1,-1,-1,-1
55.36M,"333,976",-58.21M,-1,,4.300,Strong Buy,10.43,"Sep 12, 2024",KVAC,Keen Vision Acquisition Corporation,206.83M,10.68,-,0.06%,0.58%,2.40%,+0.20%,+2.22%,"Keen Vision Merges with Biotech Medera, Eyes NASDAQ Listing",Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation,,,,"Keen Vision Merges with Biotech Medera, Eyes NASDAQ Listing Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation",0,0,0,-1,-1,-1
74.60M,"915,840",-24.05M,-1,"1,065",3.180,Strong Buy,4.00,"Aug 8, 2024",FSTR,L.B. Foster Company,206.31M,18.84,545.34M,-0.39%,-8.98%,-16.79%,-20.41%,-29.67%,"L.B. Foster Company to Present Virtually at Singular Research Autumn Equinox 2024 Webinar on September 11, 2024",North American rail traffic up 5.6% for the week ending August 17,North American rail traffic up 3.7% for the week ending August 10,L.B. Foster price target lowered to $21 from $27 at B. Riley,,"L.B. Foster Company to Present Virtually at Singular Research Autumn Equinox 2024 Webinar on September 11, 2024 North American rail traffic up 5.6% for the week ending August 17 North American rail traffic up 3.7% for the week ending August 10 L.B. Foster price target lowered to $21 from $27 at B. Riley",0,0,0,0,1,-1
7.45M,"23,787",14.85M,$0.62,,31.72,Hold,28.00,"Jul 30, 2024",IVCB,Investcorp Europe Acquisition Corp I,205.86M,11.43,-,0.14%,0.41%,2.88%,+0.44%,+2.66%,,,,,,,1,-1,-1,-1,-1,-1
43.07M,"277,433",-26.60M,-1,,5.45,Strong Buy,13.00,"Aug 7, 2024",SEVN,Seven Hills Realty Trust,205.68M,13.87,33.54M,5.06%,6.12%,9.21%,+2.54%,+6.60%,Seeking at Least 10% Dividend Yield? Analysts Suggest 2 Dividend Stocks to Buy,,,,,Seeking at Least 10% Dividend Yield? Analysts Suggest 2 Dividend Stocks to Buy,1,0,-1,-1,-1,-1
16.77M,"124,629",11.18M,$0.56,135,13.96,Strong Buy,22.00,"Aug 6, 2024",GOSS,"Gossamer Bio, Inc.",205.57M,0.91,95.84M,5.57%,-2.20%,-0.70%,-2.41%,-14.42%,Closing Bell Movers: Apple down slightly on CFO change; Trip.com up on earnings,Gossamer Bio announces data presentations at ERS Congress,Buy Rating Affirmed for Gossamer Bio Amidst Financial Growth and Clinical Advancements,Barclays Reaffirms Their Hold Rating on Gossamer Bio (GOSS),"Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)","Closing Bell Movers: Apple down slightly on CFO change; Trip.com up on earnings Gossamer Bio announces data presentations at ERS Congress Buy Rating Affirmed for Gossamer Bio Amidst Financial Growth and Clinical Advancements Barclays Reaffirms Their Hold Rating on Gossamer Bio (GOSS) Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)",1,1,1,0,0,0
5.90M,"11,229",28.53M,$1.08,168,39.51,Buy,40.00,"Oct 16, 2024",MOLN,Molecular Partners AG,205.57M,6.23,7.46M,6.11%,2.05%,42.86%,-26.22%,+63.14%,Molecular Partners AG (ADR) trading resumes,"Molecular Partners AG (ADR) trading halted, volatility trading pause",Molecular Partners’ Hold Rating: Balancing Drug Development Progress and Uncertain Clinical Timelines,Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan,Molecular Partners AG: Hold Rating with Adjusted Price Target Amidst Development Delays and Financial Uncertainties,"Molecular Partners AG (ADR) trading resumes Molecular Partners AG (ADR) trading halted, volatility trading pause Molecular Partners’ Hold Rating: Balancing Drug Development Progress and Uncertain Clinical Timelines Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan Molecular Partners AG: Hold Rating with Adjusted Price Target Amidst Development Delays and Financial Uncertainties",0,0,0,0,0,0
23.28M,"151,279",-25.97M,-1,92,10.00,Strong Buy,20.67,"Sep 3, 2024",SMLR,"Semler Scientific, Inc.",205.15M,29.34,61.74M,-0.74%,-10.49%,-18.56%,-15.96%,-2.89%,"Semler Scientific (NASDAQ:SMLR) Buys More Bitcoin, Shares Flat",Semler Scientific announces additional bitcoin purchases,,,,"Semler Scientific (NASDAQ:SMLR) Buys More Bitcoin, Shares Flat Semler Scientific announces additional bitcoin purchases",0,1,1,-1,-1,-1
26.46M,"65,266",-10.46M,-1,142,8.77,Strong Buy,13.50,"Aug 1, 2024",FFNW,"First Financial Northwest, Inc.",205.09M,22.36,40.29M,3.17%,3.92%,16.81%,+5.76%,+10.76%,First Financial Northwest Gains FDIC Nod for Asset Sale,First Financial Northwest announces receipt of FDIC approcal for transaction,"First Financial Northwest, Inc. Announces Receipt of Federal Deposit Insurance Corporation Approval for Transaction with Global Credit Union",,,"First Financial Northwest Gains FDIC Nod for Asset Sale First Financial Northwest announces receipt of FDIC approcal for transaction First Financial Northwest, Inc. Announces Receipt of Federal Deposit Insurance Corporation Approval for Transaction with Global Credit Union",1,1,1,1,-1,-1
29.20M,"45,496",-29.90M,-1,930,7.92,Buy,16.00,"Aug 13, 2024",GPRO,"GoPro, Inc.",204.66M,1.34,931.41M,-2.44%,-9.95%,-43.66%,-18.42%,-39.22%,Best Buy stock soars on a beat and raise. We think that’s just the beginning,Oppenheimer Remains a Hold on GoPro (GPRO),GoPro announces two new cameras,GoPro Grapples With Ongoing Competition as Stock Suffers,"GoPro announces restructuring plan, 15% workforce reduction","Best Buy stock soars on a beat and raise. We think that’s just the beginning Oppenheimer Remains a Hold on GoPro (GPRO) GoPro announces two new cameras GoPro Grapples With Ongoing Competition as Stock Suffers GoPro announces restructuring plan, 15% workforce reduction",1,1,0,0,0,0
44.37M,"9,528",-27.67M,-1,,5.21,Buy,17.00,"Aug 5, 2024",NVX,NOVONIX Limited,204.07M,1.67,6.88M,-4.49%,-10.73%,-21.47%,-17.24%,-36.84%,NOVONIX Director’s Equity Interest Shifts,NOVONIX Reports Lapse of Millions in Securities,NOVONIX Ltd Advances Despite Market Challenges,,,NOVONIX Director’s Equity Interest Shifts NOVONIX Reports Lapse of Millions in Securities NOVONIX Ltd Advances Despite Market Challenges,0,0,0,1,-1,-1
1.75M,"7,303",47.65M,-1,340,131.84,,,"Aug 14, 2024",MVIS,"MicroVision, Inc.",203.58M,0.96,9.00M,-1.38%,-11.05%,-47.92%,-17.76%,-47.62%,,,,,,,1,-1,-1,-1,-1,-1
100.09M,"32,716",-78.91M,-1,,2.370,Buy,8.00,"Aug 6, 2024",GHIX,"Gores Holdings IX, Inc.",202.85M,10.59,-,-0.31%,-0.17%,0.93%,-0.19%,+0.95%,,,,,,,0,-1,-1,-1,-1,-1
112.82M,831,52.20M,-1,312,2.100,Hold,4.50,"Sep 3, 2024",SSTI,"SoundThinking, Inc.",202.61M,15.85,102.39M,0.85%,8.52%,-15.18%,-6.92%,-6.07%,Cantor Fitzgerald Sticks to Its Buy Rating for SoundThinking Inc (SSTI),"Independent Research Demonstrates ShotSpotter’s Impact, Effectiveness, Success and Value in Winston-Salem",SoundThinking Expands Leadership Team with the Appointment of Industry Veteran Adan Pope as SVP of Data Science and AI,"SoundThinking appoints Adan Pope as SVP, data science and AI",SoundThinking Inc. Poised for Growth: Buy Rating Affirmed Despite Short-Term Hurdles,"Cantor Fitzgerald Sticks to Its Buy Rating for SoundThinking Inc (SSTI) Independent Research Demonstrates ShotSpotter’s Impact, Effectiveness, Success and Value in Winston-Salem SoundThinking Expands Leadership Team with the Appointment of Industry Veteran Adan Pope as SVP of Data Science and AI SoundThinking appoints Adan Pope as SVP, data science and AI SoundThinking Inc. Poised for Growth: Buy Rating Affirmed Despite Short-Term Hurdles",1,1,0,1,1,0
67.90M,"159,480",-34.52M,-1,82,3.380,,,"Aug 13, 2024",XBIT,XBiotech Inc.,200.45M,6.58,-,-1.04%,5.09%,5.18%,-13.34%,-18.51%,,,,,,,0,-1,-1,-1,-1,-1
18.19M,"22,555",4.46M,-1,100,12.61,,,"Oct 22, 2024",MDWD,MediWound Ltd.,200.09M,18.55,20.14M,11.12%,12.75%,36.06%,-0.31%,+26.87%,MediWound files to sell 1.45M ordinary shares for holders,Mediwound Poised for Growth: Buy Rating Backed by NexoBrid Expansion and EscharEx Market Potential,MediWound’s NexoBrid Gains FDA Pediatric Approval,MediWound announces FDA approval for pediatric indication for NexoBrid,MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns,MediWound files to sell 1.45M ordinary shares for holders Mediwound Poised for Growth: Buy Rating Backed by NexoBrid Expansion and EscharEx Market Potential MediWound’s NexoBrid Gains FDA Pediatric Approval MediWound announces FDA approval for pediatric indication for NexoBrid MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns,0,1,0,0,0,0
21.21M,"86,517",-9.55M,-1,434,10.80,Hold,10.63,"Jul 24, 2024",CDLX,"Cardlytics, Inc.",199.86M,4.01,305.42M,-23.24%,-44.50%,-55.85%,-52.83%,-71.40%,Northland Securities downgrades Cardlytics (CDLX) to a Hold,Bank of America Securities Remains a Sell on Cardlytics (CDLX),Cardlytics downgraded to Underperform from Neutral at BofA,Craig-Hallum Sticks to Its Hold Rating for Cardlytics (CDLX),"3 Penny Stocks to Watch Now, 8/13/24","Northland Securities downgrades Cardlytics (CDLX) to a Hold Bank of America Securities Remains a Sell on Cardlytics (CDLX) Cardlytics downgraded to Underperform from Neutral at BofA Craig-Hallum Sticks to Its Hold Rating for Cardlytics (CDLX) 3 Penny Stocks to Watch Now, 8/13/24",0,0,1,1,0,0
71.11M,"589,680",-194.65M,-1,158,3.190,Buy,11.57,"Aug 9, 2024",CRBU,"Caribou Biosciences, Inc.",199.70M,2.21,33.11M,3.87%,7.55%,-49.75%,-9.91%,-53.56%,Caribou treatment of acute myeloid leukemia designated for FDA orphan status,Truist Financial Reaffirms Their Buy Rating on Caribou Biosciences (CRBU),Caribou Biosciences Announces CFO Resignation and Succession Plan,Caribou Biosciences CFO Jason O’Byrne resigns,Caribou Biosciences (CRBU) Receives a Buy from H.C. Wainwright,Caribou treatment of acute myeloid leukemia designated for FDA orphan status Truist Financial Reaffirms Their Buy Rating on Caribou Biosciences (CRBU) Caribou Biosciences Announces CFO Resignation and Succession Plan Caribou Biosciences CFO Jason O’Byrne resigns Caribou Biosciences (CRBU) Receives a Buy from H.C. Wainwright,0,0,0,1,1,0
29.83M,"42,856",8.88M,-1,710,7.59,Buy,9.50,"Sep 12, 2024",MYPS,"PLAYSTUDIOS, Inc.",198.21M,1.59,303.39M,-8.19%,-19.46%,-32.10%,-30.41%,-46.83%,,,,,,,0,-1,-1,-1,-1,-1
99.24M,"747,228",-15.55M,-1,"2,926",2.280,Strong Buy,8.25,"Aug 14, 2024",NNBR,"NN, Inc.",197.69M,3.95,481.17M,9.90%,14.62%,6.10%,-0.26%,-9.28%,Noble Financial Sticks to Its Buy Rating for NN (NNBR),NN (NNBR) Receives a Buy from Noble Financial,,,,Noble Financial Sticks to Its Buy Rating for NN (NNBR) NN (NNBR) Receives a Buy from Noble Financial,1,0,0,-1,-1,-1
145.75M,"793,947",-12.92M,-1,7,1.550,Strong Buy,3.00,"Aug 14, 2024",GLSI,"Greenwich LifeSciences, Inc.",195.59M,14.88,-,-1.57%,-8.74%,4.64%,-15.20%,-21.35%,Greenwich LifeSciences price target raised to $38 from $36 at H.C. Wainwright,,,,,Greenwich LifeSciences price target raised to $38 from $36 at H.C. Wainwright,1,0,-1,-1,-1,-1
80.07M,"25,061",-8.31M,-1,479,2.820,Hold,4.50,"Aug 7, 2024",ESCA,"Escalade, Incorporated",195.39M,14.08,258.69M,1.23%,-0.06%,-12.15%,-7.93%,+3.63%,Escalade CEO Walter P. Glazer Plans Retirement by 2024,Escalade announces retirement of CEO Walter Glazer at end of 2024,Escalade Closes Sale of Mexico Facility and Related Assets,,,Escalade CEO Walter P. Glazer Plans Retirement by 2024 Escalade announces retirement of CEO Walter Glazer at end of 2024 Escalade Closes Sale of Mexico Facility and Related Assets,1,1,1,1,-1,-1
63.21M,"885,983",-27.94M,-1,122,3.570,Strong Buy,19.00,"Aug 13, 2024",INO,"Inovio Pharmaceuticals, Inc.",194.99M,7.51,591.86K,-12.04%,-18.21%,-14.42%,-33.11%,-39.55%,Analysts Offer Insights on Healthcare Companies: Universal Health (UHS) and Inovio Pharmaceuticals (INO),Inovio Pharmaceuticals (INO) Receives a Buy from Oppenheimer,Inovio price target lowered to $33 from $40 at Oppenheimer,Inovio Pharmaceuticals: Hold Rating Amidst Financial Concerns and INO-3107 Development Delays,Inovio price target lowered to $12 from $15 at H.C. Wainwright,Analysts Offer Insights on Healthcare Companies: Universal Health (UHS) and Inovio Pharmaceuticals (INO) Inovio Pharmaceuticals (INO) Receives a Buy from Oppenheimer Inovio price target lowered to $33 from $40 at Oppenheimer Inovio Pharmaceuticals: Hold Rating Amidst Financial Concerns and INO-3107 Development Delays Inovio price target lowered to $12 from $15 at H.C. Wainwright,0,0,0,0,1,0
78.89M,"448,659",-120.74M,-1,225,2.850,Strong Buy,15.25,"Aug 8, 2024",NKSH,"National Bankshares, Inc.",194.64M,30.62,42.85M,4.26%,2.18%,-0.62%,-6.70%,-5.27%,,,,,,,0,-1,-1,-1,-1,-1
28.00M,"386,111",-56.33M,-1,790,8.01,Strong Buy,21.50,"Aug 5, 2024",API,"Agora, Inc.",194.07M,2.11,138.29M,-8.07%,-10.79%,-19.59%,-24.40%,-25.88%,Hold Rating on Agora Amid Subdued Growth and Profitability Outlook,Agora downgraded to Neutral at BofA on low growth visibility,Agora downgraded to Neutral from Buy at BofA,"Agora, Inc. Reports Growth Amidst Economic Challenges","Agora sees Q3 revenue $31.5M-$33.5M, one estimate $40M","Hold Rating on Agora Amid Subdued Growth and Profitability Outlook Agora downgraded to Neutral at BofA on low growth visibility Agora downgraded to Neutral from Buy at BofA Agora, Inc. Reports Growth Amidst Economic Challenges Agora sees Q3 revenue $31.5M-$33.5M, one estimate $40M",1,1,1,1,1,1
18.68M,"47,960",-78.28M,-1,"1,199",11.97,Strong Buy,21.75,"Aug 8, 2024",EML,The Eastern Company,193.64M,31.09,273.70M,4.76%,8.64%,15.41%,+2.72%,-5.97%,,,,,,,1,-1,-1,-1,-1,-1
497.05M,"15,729,690",-109.78M,-1,172,0.450,Hold,1.25,"Sep 9, 2024",INBX,"Inhibrx Biosciences, Inc.",193.11M,13.34,1.69M,11.86%,5.63%,1.21%,-3.79%,,JMP Securities Remains a Hold on Inhibrx Biosciences Inc (INBX),Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights,Inhibrx Biosciences Reveals Updated Corporate Presentation,,,JMP Securities Remains a Hold on Inhibrx Biosciences Inc (INBX) Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights Inhibrx Biosciences Reveals Updated Corporate Presentation,1,1,0,1,-1,-1
4.76M,"14,693",24.78M,$1.24,594,47.00,Hold,49.00,"Jul 18, 2024",CFFI,C&F Financial Corporation,192.71M,58.99,113.65M,4.05%,11.82%,10.19%,-1.73%,+22.84%,C&F Financial Announces Cash Dividend for Shareholders,C&F Financial Corporation Announces Quarterly Dividend,,,,C&F Financial Announces Cash Dividend for Shareholders C&F Financial Corporation Announces Quarterly Dividend,1,1,0,-1,-1,-1
20.61M,"104,723",28.90M,$0.52,123,10.83,Strong Buy,12.50,"Aug 6, 2024",MRSN,"Mersana Therapeutics, Inc.",191.37M,1.56,29.94M,3.04%,-14.61%,-44.33%,-25.50%,-65.19%,Truist Financial Sticks to Its Buy Rating for Mersana Therapeutics (MRSN),Mersana Therapeutics price target lowered to $5 from $6 at Citi,"Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Chimerix (CMRX) and Mersana Therapeutics (MRSN)","Analysts Conflicted on These Healthcare Names: MiNK Therapeutics (INKT), Silence Therapeutics (SLN) and Mersana Therapeutics (MRSN)",Truist Financial Issues a Buy Rating on Mersana Therapeutics (MRSN),"Truist Financial Sticks to Its Buy Rating for Mersana Therapeutics (MRSN) Mersana Therapeutics price target lowered to $5 from $6 at Citi Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Chimerix (CMRX) and Mersana Therapeutics (MRSN) Analysts Conflicted on These Healthcare Names: MiNK Therapeutics (INKT), Silence Therapeutics (SLN) and Mersana Therapeutics (MRSN) Truist Financial Issues a Buy Rating on Mersana Therapeutics (MRSN)",1,0,1,0,1,0
7.63M,"23,224",26.04M,$0.20,580,29.23,,,"Aug 5, 2024",KLTR,"Kaltura, Inc.",190.71M,1.28,176.83M,6.22%,6.19%,-9.26%,-4.51%,-5.93%,Kaltura to Debut New GenAI Features for Streaming Services at IBC2024,Kaltura Named Best Overall Event Management Solution Provider in 2024 MarTech Breakthrough Awards Program,"Analysts’ Top Technology Picks: Mitek Systems (MITK), Trade Desk (TTD)",,,"Kaltura to Debut New GenAI Features for Streaming Services at IBC2024 Kaltura Named Best Overall Event Management Solution Provider in 2024 MarTech Breakthrough Awards Program Analysts’ Top Technology Picks: Mitek Systems (MITK), Trade Desk (TTD)",1,0,0,0,-1,-1
8.07M,"8,466",15.71M,$0.80,176,27.48,Hold,25.00,"Oct 21, 2024",AGBA,AGBA Group Holding Limited,190.62M,2.33,38.32M,0.76%,-10.22%,54.36%,+15.74%,+508.65%,AGBA Acquisition Granted ‘Foreign Private Issuer’ Status,"AGBA Acquisition Merges with Triller, Changes Identity","AGBA Acquisition, Triller announce amended, restated merger agreement",Agba and Triller Announce Amended and Restated Merger Agreement,AGBA Acquisition Shareholders Back New Equity Plan and Board,"AGBA Acquisition Granted ‘Foreign Private Issuer’ Status AGBA Acquisition Merges with Triller, Changes Identity AGBA Acquisition, Triller announce amended, restated merger agreement Agba and Triller Announce Amended and Restated Merger Agreement AGBA Acquisition Shareholders Back New Equity Plan and Board",0,1,1,0,0,1
24.48M,"24,268",-27.59M,-1,45,9.03,Strong Buy,11.40,"Aug 8, 2024",MHLD,"Maiden Holdings, Ltd.",190.57M,1.91,96.35M,1.26%,-4.83%,-5.17%,-12.80%,-12.80%,,,,,,,1,-1,-1,-1,-1,-1
7.63M,"27,493",22.58M,$0.80,"3,198",28.95,Buy,34.00,"Jul 24, 2024",EM,Smart Share Global Limited,190.41M,0.74,269.75M,-6.15%,-16.74%,-3.86%,-16.70%,+0.41%,Smart Share Global Reports Profitability and Growth,Smart Share reports Q2 EPS RMB 0.05 vs RMB 0.02 last year,EM Upcoming Earnings Report: What to Expect?,"Smart Share Global Limited to Report Second Quarter 2024 Results on August 22, 2024",Energy Monster Faces Nasdaq Compliance Challenge,"Smart Share Global Reports Profitability and Growth Smart Share reports Q2 EPS RMB 0.05 vs RMB 0.02 last year EM Upcoming Earnings Report: What to Expect? Smart Share Global Limited to Report Second Quarter 2024 Results on August 22, 2024 Energy Monster Faces Nasdaq Compliance Challenge",0,1,0,1,0,1
167.80M,"395,623",-58.07M,-1,222,1.310,Strong Buy,10.50,"Aug 13, 2024",OPBK,OP Bancorp,190.33M,12.85,77.02M,2.09%,12.87%,22.64%,+1.28%,+31.97%,KBW Remains a Hold on OP Bancorp (OPBK),OP Bancorp announces Sang Oh to succeed Min Kim as CEO,,,,KBW Remains a Hold on OP Bancorp (OPBK) OP Bancorp announces Sang Oh to succeed Min Kim as CEO,1,1,1,-1,-1,-1
17.59M,"201,142",-14.23M,-1,200,12.48,Buy,34.88,"Aug 6, 2024",CVRX,"CVRx, Inc.",190.19M,8.73,44.39M,14.88%,1.00%,-41.82%,+16.14%,-43.83%,CVRx Enhances Board with Strategic New Appointments,"CVRx appoints Kevin Ballinger, Mitch Hill to board of directors",CVRx Announces Appointment of Two New Board Members,"CMS panel approving CVRx motions a ‘positive sign,’ says Canaccord","CMS panel votes favorable for CVRx, says Lake Street","CVRx Enhances Board with Strategic New Appointments CVRx appoints Kevin Ballinger, Mitch Hill to board of directors CVRx Announces Appointment of Two New Board Members CMS panel approving CVRx motions a ‘positive sign,’ says Canaccord CMS panel votes favorable for CVRx, says Lake Street",1,1,1,1,1,1
14.15M,"13,672",6.58M,$0.88,103,15.50,,,"Oct 21, 2024",GEVO,"Gevo, Inc.",190.19M,0.82,18.15M,42.41%,48.87%,13.85%,+53.58%,+18.77%,Gevo announces fuel blendstock purchase agreement with Shell,Gevo to Supply Renewable Hydrocarbon-Based Low-Carbon Intensity Racing Fuel Blendstock to Shell,Gevo wins $16.8M grant from FAA to convert facility to alcohol-to-jet production,Gevo Updates Executive Compensation and Severance Agreements,New Report Finds There are $4-6 in Benefits to the U.S. Economy for Every $1 of Federal SAF Incentives at Gevo’s Net-Zero 1 Facility,Gevo announces fuel blendstock purchase agreement with Shell Gevo to Supply Renewable Hydrocarbon-Based Low-Carbon Intensity Racing Fuel Blendstock to Shell Gevo wins $16.8M grant from FAA to convert facility to alcohol-to-jet production Gevo Updates Executive Compensation and Severance Agreements New Report Finds There are $4-6 in Benefits to the U.S. Economy for Every $1 of Federal SAF Incentives at Gevo’s Net-Zero 1 Facility,1,1,1,0,1,1
62.72M,"465,544",-136.37M,-1,182,3.490,Buy,8.89,"Aug 6, 2024",SMID,Smith-Midland Corporation,189.89M,35.81,68.43M,6.52%,8.98%,-6.11%,-0.23%,-24.28%,,,,,,,0,-1,-1,-1,-1,-1
49.71M,"1,647",-31.94M,-1,237,4.400,Strong Buy,13.00,"Sep 18, 2024",DIBS,"1stdibs.Com, Inc.",189.73M,4.78,85.88M,11.98%,7.96%,-3.03%,+5.46%,-18.14%,,,,,,,1,-1,-1,-1,-1,-1
58.94M,"320,531",-59.20M,-1,179,3.710,Strong Buy,9.00,"Aug 14, 2024",IPHA,Innate Pharma S.A.,188.92M,2.21,68.13M,-2.57%,0.12%,-12.86%,+5.13%,-10.96%,Innate Pharma SA to Unveil H1 2024 Financials,Innate Pharma Joins Major Global Investment Conference,,,,Innate Pharma SA to Unveil H1 2024 Financials Innate Pharma Joins Major Global Investment Conference,0,0,0,-1,-1,-1
8.08M,"6,671","-878,000",-1,"2,383",26.97,,,"Aug 12, 2024",RILY,"B. Riley Financial, Inc.",188.29M,6.22,1.22B,-50.51%,-62.58%,-72.75%,-71.88%,-76.90%,"Stocks making the biggest moves midday: Starbucks, Chipotle, Home Depot and more","Stocks making the biggest moves premarket: Home Depot, On Holding, Hormel Foods",Largest borrow rate increases among liquid names,B Riley Financial options imply 12.5% move in share price post-earnings,B Riley Financial options imply 9.4% move in share price post-earnings,"Stocks making the biggest moves midday: Starbucks, Chipotle, Home Depot and more Stocks making the biggest moves premarket: Home Depot, On Holding, Hormel Foods Largest borrow rate increases among liquid names B Riley Financial options imply 12.5% move in share price post-earnings B Riley Financial options imply 9.4% move in share price post-earnings",0,1,0,1,0,0
72.59M,"85,954",-38.77M,-1,348,2.990,Strong Buy,11.25,"Aug 8, 2024",WNEB,"Western New England Bancorp, Inc.",188.24M,8.83,74.44M,9.40%,16.16%,14.89%,+7.85%,+22.33%,,,,,,,0,-1,-1,-1,-1,-1
8.04M,"5,608",13.12M,$1.20,,26.98,,,"Oct 22, 2024",OXSQ,Oxford Square Capital Corp.,188.09M,2.95,47.49M,-1.29%,-1.17%,-2.87%,-2.98%,-7.57%,Oxford Square Capital Announces End-of-Year Distributions,Oxford Square Capital reports Q2 NII 13c vs. 11c last quarter,,,,Oxford Square Capital Announces End-of-Year Distributions Oxford Square Capital reports Q2 NII 13c vs. 11c last quarter,0,1,1,-1,-1,-1
12.36M,"3,860",11.84M,-1,"12,300",17.54,,,"Aug 15, 2024",TPIC,"TPI Composites, Inc.",186.41M,3.92,1.29B,8.89%,1.46%,22.75%,-3.76%,+46.95%,Seaport Research oilfield services analyst has analyst/industry conference call,Roth MKM Releases a Hold Rating on TPI Composites (TPIC),Seaport Global Sticks to Their Hold Rating for TPI Composites (TPIC),J.P. Morgan Reaffirms Their Buy Rating on TPI Composites (TPIC),TPI Composites: Balancing Operational Challenges with Margin Recovery Potential,Seaport Research oilfield services analyst has analyst/industry conference call Roth MKM Releases a Hold Rating on TPI Composites (TPIC) Seaport Global Sticks to Their Hold Rating for TPI Composites (TPIC) J.P. Morgan Reaffirms Their Buy Rating on TPI Composites (TPIC) TPI Composites: Balancing Operational Challenges with Margin Recovery Potential,0,1,0,0,0,0
36.22M,"78,289",52.04M,-1,925,5.98,Strong Buy,8.00,"Sep 3, 2024",HFFG,HF Foods Group Inc.,186.14M,3.53,1.16B,3.03%,5.12%,-12.90%,-15.29%,-0.88%,HF Foods Group files $100M mixed securities shelf,,,,,HF Foods Group files $100M mixed securities shelf,1,1,-1,-1,-1,-1
,,,-1,"5,200",,,,,SSP,The E.W. Scripps Company,186.01M,2.16,2.32B,-21.10%,-27.97%,-56.93%,-45.48%,-40.23%,Thursday’s stock stories: What’s likely to move the market in the next session,"E. W. Scripps Phases Out COO Role, Plans Executive Severance",E.W. Scripps price target lowered to $11 from $14 at Benchmark,,,"Thursday’s stock stories: What’s likely to move the market in the next session E. W. Scripps Phases Out COO Role, Plans Executive Severance E.W. Scripps price target lowered to $11 from $14 at Benchmark",1,0,1,0,-1,-1
70.93M,"221,025",-76.36M,-1,5,3.050,Buy,10.50,"Aug 8, 2024",CNTX,Context Therapeutics Inc.,186.00M,2.48,-,4.08%,13.29%,65.82%,+13.89%,+93.70%,Context Therapeutics Bolsters Board with Industry Veterans,"Context Therapeutics appoints Smith, Walker to board of directors",Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors,Buy Rating Affirmed for Context Therapeutics Amid Strong Financials and Promising CLDN6-Targeting Therapies,,"Context Therapeutics Bolsters Board with Industry Veterans Context Therapeutics appoints Smith, Walker to board of directors Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors Buy Rating Affirmed for Context Therapeutics Amid Strong Financials and Promising CLDN6-Targeting Therapies",1,1,0,1,0,-1
47.72M,"698,281",-313.27M,$0.58,,4.53,Hold,8.50,"Aug 8, 2024",IVCA,Investcorp India Acquisition Corp,185.99M,11.44,-,-0.95%,0.24%,3.69%,+0.35%,+4.00%,,,,,,,0,-1,-1,-1,-1,-1
17.03M,"77,733",20.22M,$0.64,96,12.69,Buy,13.50,"Oct 17, 2024",HQI,"HireQuest, Inc.",185.98M,13.31,36.13M,4.76%,5.75%,1.80%,+2.68%,+5.02%,HireQuest price target raised to $17 from $16 at Barrington,"HireQuest Announces Quarterly Cash Dividend, Future Payments Uncertain",,,,"HireQuest price target raised to $17 from $16 at Barrington HireQuest Announces Quarterly Cash Dividend, Future Payments Uncertain",1,0,1,-1,-1,-1
8.27M,"23,015",24.84M,$0.45,13,26.14,,,"Oct 17, 2024",FTEL,Fitell Corporation,185.70M,16.70,3.87M,7.16%,-23.05%,69.44%,+0.06%,+115.39%,"Bleecker Street goes short Fitell, says ‘substantially overvalued’",Bleecker Street announces short position in Fitell,Fitell Corp trading resumes,"Fitell Corp trading halted, volatility trading pause",,"Bleecker Street goes short Fitell, says ‘substantially overvalued’ Bleecker Street announces short position in Fitell Fitell Corp trading resumes Fitell Corp trading halted, volatility trading pause",1,1,0,0,0,-1
227.44M,"2,417,357",-75.66M,-1,536,0.948,Strong Buy,3.00,"Aug 8, 2024",ULBI,Ultralife Corporation,185.68M,11.17,168.95M,0.15%,-0.76%,13.49%,-11.52%,+14.22%,,,,,,,0,-1,-1,-1,-1,-1
21.62M,219,,-1,338,9.98,,,,FUNC,First United Corporation,185.56M,28.70,69.63M,3.56%,17.82%,28.59%,+1.96%,+27.24%,Best Chase travel rewards credit cards,,,,,Best Chase travel rewards credit cards,1,0,-1,-1,-1,-1
,,,-1,733,,,,,TUSK,"Mammoth Energy Services, Inc.",185.29M,3.85,212.46M,0.25%,7.71%,1.22%,-5.97%,+4.42%,Mammoth Energy Services Unveils New Investor Presentation,,,,,Mammoth Energy Services Unveils New Investor Presentation,1,1,-1,-1,-1,-1
5.16M,"70,356",10.53M,$0.60,374,41.83,,,"Aug 19, 2024",POWW,"AMMO, Inc.",185.26M,1.56,135.50M,-4.12%,-9.95%,-31.26%,-15.38%,-42.11%,Mark Smith Reaffirms Buy Rating on AMMO Inc. with a Positive Outlook for Recovery and Growth,"Analysts Offer Insights on Industrial Goods Companies: Forward Air (FWRD), CoreCivic (CXW) and AMMO (POWW)",AMMO (POWW) Receives a Hold from Roth MKM,AMMO reports Q1 EPS 1c vs. 5c last year,AMMO price target lowered to $1.60 from $2 at Roth MKM,"Mark Smith Reaffirms Buy Rating on AMMO Inc. with a Positive Outlook for Recovery and Growth Analysts Offer Insights on Industrial Goods Companies: Forward Air (FWRD), CoreCivic (CXW) and AMMO (POWW) AMMO (POWW) Receives a Hold from Roth MKM AMMO reports Q1 EPS 1c vs. 5c last year AMMO price target lowered to $1.60 from $2 at Roth MKM",0,0,1,0,1,0
10.22M,"4,517",12.63M,$0.80,459,21.06,,,"Aug 5, 2024",LFCR,"Lifecore Biomedical, Inc.",185.22M,6.00,121.52M,-16.55%,-12.13%,-25.58%,-37.28%,-35.34%,Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference,"Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls","Craig-Hallum bullish on Lifecore, initiates with a Buy",Lifecore Biomedical Welcomes Ryan Lake as New CFO,"Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls Craig-Hallum bullish on Lifecore, initiates with a Buy Lifecore Biomedical Welcomes Ryan Lake as New CFO",0,0,0,1,0,0
88.55M,"237,930",-30.75M,-1,194,2.430,Hold,2.63,"Aug 8, 2024",BTMD,biote Corp.,184.72M,5.96,187.23M,-5.15%,-14.87%,4.06%,-23.08%,+3.74%,"Analysts Are Bullish on These Healthcare Stocks: biote (BTMD), Ardent Health Partners, Inc. (ARDT)",Roth MKM Keeps Their Buy Rating on biote (BTMD),,,,"Analysts Are Bullish on These Healthcare Stocks: biote (BTMD), Ardent Health Partners, Inc. (ARDT) Roth MKM Keeps Their Buy Rating on biote (BTMD)",1,0,0,-1,-1,-1
124.02M,"1,457,380",-83.70M,-1,134,1.730,Hold,3.39,"Aug 8, 2024",RGTI,"Rigetti Computing, Inc.",184.72M,0.97,12.62M,2.63%,-6.61%,-23.48%,-16.51%,-35.83%,"Rigetti Introduces Novel Chip Fabrication Process For Scalable, High Performing QPUs",,,,,"Rigetti Introduces Novel Chip Fabrication Process For Scalable, High Performing QPUs",0,0,-1,-1,-1,-1
2.11B,"11,066",-3.33M,-1,739,3.800,,,,TWIN,"Twin Disc, Incorporated",184.58M,13.19,295.13M,0.20%,0.08%,-13.11%,-10.06%,-26.26%,Twin Disc to Present Non-GAAP Metrics at Investor Conferences,Twin Disc Issues Caution with Forward-Looking Statements,Twin Disc reports Q4 EPS 53c vs 62c last year,,,Twin Disc to Present Non-GAAP Metrics at Investor Conferences Twin Disc Issues Caution with Forward-Looking Statements Twin Disc reports Q4 EPS 53c vs 62c last year,0,0,1,0,-1,-1
,,,-1,748,,,,,SANG,Sangoma Technologies Corporation,184.39M,5.32,250.03M,6.34%,6.80%,32.40%,-2.62%,+11.55%,,,,,,,0,-1,-1,-1,-1,-1
101.15M,"3,715,975",-169.64M,-1,122,2.100,Strong Buy,6.13,"Aug 7, 2024",BTOC,Armlogi Holding Corp.,184.29M,4.43,169.77M,-2.09%,-3.60%,-4.20%,-4.98%,,Armlogi announces warehouse at Port of Savannah is fully operational,Armlogi’s New Warehouse at Port of Savannah Becomes Fully Operational,,,,Armlogi announces warehouse at Port of Savannah is fully operational Armlogi’s New Warehouse at Port of Savannah Becomes Fully Operational,1,1,1,-1,-1,-1
20.67M,"104,305",14.86M,$1.76,68,10.19,Hold,9.00,"Aug 7, 2024",CGEN,Compugen Ltd.,182.65M,2.04,42.72M,11.33%,11.59%,6.18%,+7.34%,-21.49%,Truist Financial Keeps Their Buy Rating on Compugen (CGEN),,,,,Truist Financial Keeps Their Buy Rating on Compugen (CGEN),0,0,-1,-1,-1,-1
,,,-1,"1,750",,,,,LAKE,"Lakeland Industries, Inc.",182.34M,24.72,132.30M,0.77%,2.33%,27.01%,+0.68%,+27.60%,Lakeland Industries Earnings Call Insights and Strategies,LAKE Earnings this Week: How Will it Perform?,,,,Lakeland Industries Earnings Call Insights and Strategies LAKE Earnings this Week: How Will it Perform?,0,0,0,-1,-1,-1
23.22M,"28,662",21.65M,-1,51,8.98,,,"Aug 14, 2024",BYU,"BAIYU Holdings, Inc.",182.30M,3.65,120.09M,130.57%,197.40%,200.95%,+266.67%,+252.25%,"Bleecker Street goes short Fitell, says ‘substantially overvalued’",BAIYU Holdings Inc trading resumes,"BAIYU Holdings Inc trading halted, volatility trading pause",BAIYU Holdings subsidiary signs LOI with Adler International,BAIYU Holdings secures $60M electric lithium battery contract in U.S.,"Bleecker Street goes short Fitell, says ‘substantially overvalued’ BAIYU Holdings Inc trading resumes BAIYU Holdings Inc trading halted, volatility trading pause BAIYU Holdings subsidiary signs LOI with Adler International BAIYU Holdings secures $60M electric lithium battery contract in U.S.",1,1,0,0,1,1
61.69M,"771,331",-24.30M,-1,42,3.160,Strong Buy,7.50,"Aug 14, 2024",CADL,"Candel Therapeutics, Inc.",182.24M,5.68,-,7.62%,-1.19%,40.86%,+5.73%,-5.57%,Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights,Candel Therapeutics reports Q2 EPS (74c) vs (33c) last year,,,,Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights Candel Therapeutics reports Q2 EPS (74c) vs (33c) last year,0,1,1,-1,-1,-1
81.16M,"433,273",-169.64M,-1,,2.020,,,"Aug 13, 2024",STHO,Star Holdings,182.08M,13.67,136.77M,5.31%,8.25%,7.19%,+0.59%,+7.21%,,,,,,,0,-1,-1,-1,-1,-1
5.37M,"4,153",15.63M,$1.32,11,38.77,,,"Oct 18, 2024",SKYE,"Skye Bioscience, Inc.",180.51M,5.95,-,19.17%,-2.34%,-19.25%,+17.41%,-32.93%,Cantor Fitzgerald Reaffirms Their Buy Rating on Skye Bioscience (SKYE),Skye Bioscience Welcomes New CMO Dr. Puneet Arora,"Skye Bioscience names Puneet Arora, MD as Chief Medical Officer",Craig-Hallum Keeps Their Buy Rating on Skye Bioscience (SKYE),Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences,"Cantor Fitzgerald Reaffirms Their Buy Rating on Skye Bioscience (SKYE) Skye Bioscience Welcomes New CMO Dr. Puneet Arora Skye Bioscience names Puneet Arora, MD as Chief Medical Officer Craig-Hallum Keeps Their Buy Rating on Skye Bioscience (SKYE) Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences",0,0,0,0,0,0
19.37M,"50,000",6.50M,-1,333,10.69,,,,DSP,Viant Technology Inc.,180.37M,11.09,243.25M,5.60%,5.57%,23.57%,-7.22%,-1.91%,Viant Technology’s Strong Q2 Performance and AI Advancements Merit a Hold Rating with a $11 Price Target,Strong Q2 Performance and Strategic Growth Propel Viant Technology to a ‘Buy’ Rating,Closing Bell Movers: Rumble jumps 8% on earnings,"Viant sees Q3 revenue $67.5M-$70.5M, consensus $67.97M","Viant reports Q2 adjusted EPS 8c, consensus 1c","Viant Technology’s Strong Q2 Performance and AI Advancements Merit a Hold Rating with a $11 Price Target Strong Q2 Performance and Strategic Growth Propel Viant Technology to a ‘Buy’ Rating Closing Bell Movers: Rumble jumps 8% on earnings Viant sees Q3 revenue $67.5M-$70.5M, consensus $67.97M Viant reports Q2 adjusted EPS 8c, consensus 1c",0,0,0,1,1,1
,,,-1,331,,,,,ISTR,Investar Holding Corporation,180.07M,18.32,80.65M,7.97%,11.14%,18.40%,+0.22%,+16.38%,,,,,,,0,-1,-1,-1,-1,-1
10.95M,"30,788",7.37M,-1,,18.84,Hold,21.00,"Aug 6, 2024",HOND,HCM II Acquisition Corp.,179.75M,7.19,-,,11.14%,18.40%,,,,,,,,,1,-1,-1,-1,-1,-1
18.01M,"5,116",5.11M,-1,890,11.38,,,,CPSS,"Consumer Portfolio Services, Inc.",179.15M,8.40,188.42M,-3.89%,-10.84%,-6.54%,-12.79%,+4.30%,Consumer Portfolio Services Releases Financial Update Presentation,,,,,Consumer Portfolio Services Releases Financial Update Presentation,1,0,-1,-1,-1,-1
,,,-1,12,,,,,ATOS,"Atossa Therapeutics, Inc.",178.58M,1.42,-,4.85%,6.84%,13.91%,+2.22%,-26.20%,Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference,Atos Shares Drop on Reduced Financial Targets,Atossa Therapeutics Granted Additional Patent Protection for Endoxifen,Atossa Therapeutics granted U.S. patent for endoxifen,Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer,Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference Atos Shares Drop on Reduced Financial Targets Atossa Therapeutics Granted Additional Patent Protection for Endoxifen Atossa Therapeutics granted U.S. patent for endoxifen Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Combining (Z)-Endoxifen with Abemaciclib for ER+/HER2- Breast Cancer,0,0,1,1,1,0
14.83M,"100,113",22.77M,$1.40,405,13.87,Strong Buy,14.50,"Jul 29, 2024",SGMO,"Sangamo Therapeutics, Inc.",178.57M,0.86,12.28M,-6.25%,32.06%,36.47%,+0.95%,+40.77%,Strong Buy Recommendation for Sangamo Biosciences Amidst Strategic Partnerships and Promising Gene Therapy Advancements,Biotech Alert: Searches spiking for these stocks today,,,,Strong Buy Recommendation for Sangamo Biosciences Amidst Strategic Partnerships and Promising Gene Therapy Advancements Biotech Alert: Searches spiking for these stocks today,1,0,1,-1,-1,-1
,,,-1,195,,,,,PVBC,"Provident Bancorp, Inc.",178.24M,10.67,58.74M,-0.85%,-3.55%,2.92%,-1.47%,+19.22%,,,,,,,1,-1,-1,-1,-1,-1
226.23M,"784,655",-80.85M,-1,24,0.909,Strong Buy,9.20,"Aug 12, 2024",OTLK,"Outlook Therapeutics, Inc.",178.13M,7.53,-,0.89%,-2.76%,-7.96%,-2.84%,-18.68%,Buy Rating Affirmed for Outlook Therapeutics Amid Strong Market Potential and Upcoming Milestones for ONS-5010/Lytenava,Outlook Therapeutics announces completion of enrollment in NORSE EIGHT trial,Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial,Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference,"Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS)","Buy Rating Affirmed for Outlook Therapeutics Amid Strong Market Potential and Upcoming Milestones for ONS-5010/Lytenava Outlook Therapeutics announces completion of enrollment in NORSE EIGHT trial Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS)",0,0,0,0,0,0
32.87M,"2,620",-64.89M,-1,63,6.23,Hold,4.50,"Sep 3, 2024",PLL,Piedmont Lithium Inc.,178.08M,9.19,66.45M,-2.61%,-14.62%,-46.94%,-19.56%,-36.88%,Piedmont Lithium price target lowered to $8.50 from $15 at BMO Capital,Piedmont Lithium: Strategic Delays and Uncertainties Prompt Hold Rating,Sayona Mining’s Lithium Resource Surges by 51%,Piedmont Lithium Expands Equity with New Issuance,Piedmont Lithium (PLLTL) was downgraded to a Hold Rating at Macquarie,Piedmont Lithium price target lowered to $8.50 from $15 at BMO Capital Piedmont Lithium: Strategic Delays and Uncertainties Prompt Hold Rating Sayona Mining’s Lithium Resource Surges by 51% Piedmont Lithium Expands Equity with New Issuance Piedmont Lithium (PLLTL) was downgraded to a Hold Rating at Macquarie,1,1,1,1,1,1
6.99M,"79,039",15.82M,-1,169,29.34,,,"Aug 5, 2024",MFIN,Medallion Financial Corp.,177.80M,7.98,286.47M,0.42%,0.16%,-7.07%,-3.50%,+0.13%,Medallion Financial Corp. to Participate in Upcoming Investor Conference,,,,,Medallion Financial Corp. to Participate in Upcoming Investor Conference,1,0,-1,-1,-1,-1
9.17M,"56,313",3.17M,$0.52,251,22.36,Hold,23.00,"Jul 25, 2024",ESSA,"ESSA Bancorp, Inc.",177.06M,18.64,68.48M,0.23%,-0.86%,-0.17%,-6.25%,+4.41%,,,,,,,0,-1,-1,-1,-1,-1
152.73M,"1,444,143",-393.01M,-1,174,1.340,Sell,2.25,"Aug 6, 2024",GBIO,Generation Bio Co.,176.86M,2.65,13.17M,0.53%,-3.30%,3.33%,-23.65%,-35.61%,"Analysts’ Top Healthcare Picks: Generation Bio (GBIO), Bristol-Myers Squibb (BMY)",,,,,"Analysts’ Top Healthcare Picks: Generation Bio (GBIO), Bristol-Myers Squibb (BMY)",1,0,-1,-1,-1,-1
489.00M,"10,147",-46.86M,-1,310,1.650,Strong Buy,4.00,,MYFW,"First Western Financial, Inc.",176.79M,18.30,80.15M,5.13%,1.82%,6.62%,-0.06%,+30.81%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,500,,,,,CLAR,Clarus Corporation,176.47M,4.60,283.60M,-8.51%,-23.55%,-29.01%,-29.64%,-35.31%,,,,,,,0,-1,-1,-1,-1,-1
212.75M,"977,216",-93.45M,-1,"1,835",0.957,Hold,3.00,"Aug 7, 2024",FLL,"Full House Resorts, Inc.",176.44M,5.07,274.99M,-2.52%,-2.38%,-1.86%,-13.32%,-10.29%,Craig-Hallum Keeps Their Buy Rating on Full House Resorts (FLL),JMP Securities Sticks to Its Buy Rating for Full House Resorts (FLL),Full House Resorts Sells Stockman’s Casino for $9.2M,Full House Resorts announces sale of Stockman’s Casino for $9.2M,"$1.1 Million Jackpot Hit at Grand Lodge Casino Near Lake Tahoe, Nevada","Craig-Hallum Keeps Their Buy Rating on Full House Resorts (FLL) JMP Securities Sticks to Its Buy Rating for Full House Resorts (FLL) Full House Resorts Sells Stockman’s Casino for $9.2M Full House Resorts announces sale of Stockman’s Casino for $9.2M $1.1 Million Jackpot Hit at Grand Lodge Casino Near Lake Tahoe, Nevada",1,0,1,1,1,1
19.15M,"100,123",-14.82M,-1,"2,135",10.60,,,,VRA,"Vera Bradley, Inc.",176.34M,5.98,457.03M,-6.12%,-7.73%,-18.50%,-17.59%,-15.37%,Vera Bradley teams with Urban Outfitters to launch vintage-inspired collection,Vera Bradley Launches Limited-Edition Collection in Collaboration With Urban Outfitters,,,,Vera Bradley teams with Urban Outfitters to launch vintage-inspired collection Vera Bradley Launches Limited-Edition Collection in Collaboration With Urban Outfitters,0,1,0,-1,-1,-1
,,,-1,,,,,,HCVI,Hennessy Capital Investment Corp. VI,176.31M,10.60,-,0.14%,0.53%,1.86%,+0.57%,+2.21%,,,,,,,1,-1,-1,-1,-1,-1
12.78M,"55,356",-1.89M,-1,198,15.85,Buy,22.70,"Aug 6, 2024",QRHC,Quest Resource Holding Corporation,175.71M,8.62,285.56M,9.33%,5.18%,11.12%,+3.67%,-1.80%,Quest Resource Launches Long-Term Incentive Plan for Executives,"Quest Resource Holding Corporation to Present and Host 1×1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th and 29th in Chicago, IL",Quest Resource price target lowered to $13 from $15 at Craig-Hallum,,,"Quest Resource Launches Long-Term Incentive Plan for Executives Quest Resource Holding Corporation to Present and Host 1×1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th and 29th in Chicago, IL Quest Resource price target lowered to $13 from $15 at Craig-Hallum",0,0,1,0,-1,-1
30.46M,"91,804",-35.01M,-1,297,6.58,,,"Aug 12, 2024",PESI,"Perma-Fix Environmental Services, Inc.",175.07M,11.08,72.20M,-1.80%,4.35%,11.96%,-15.92%,-13.60%,Craig-Hallum Sticks to Their Buy Rating for Perma-Fix (PESI),,,,,Craig-Hallum Sticks to Their Buy Rating for Perma-Fix (PESI),0,0,-1,-1,-1,-1
10.79M,"37,355",-19.97M,-1,"3,219",18.55,Strong Buy,32.00,"Aug 14, 2024",TBRG,"TruBridge, Inc.",174.95M,12.21,336.56M,2.93%,8.57%,19.59%,+5.97%,+34.05%,TruBridge Financial Analysis: Hold Rating Amidst Mixed Performance and Strategic Growth Initiatives,RBC Capital Sticks to Their Buy Rating for TruBridge (TBRG),TruBridge (TBRG) Gets a Hold from Barclays,Cantor Fitzgerald Reaffirms Their Buy Rating on TruBridge (TBRG),,TruBridge Financial Analysis: Hold Rating Amidst Mixed Performance and Strategic Growth Initiatives RBC Capital Sticks to Their Buy Rating for TruBridge (TBRG) TruBridge (TBRG) Gets a Hold from Barclays Cantor Fitzgerald Reaffirms Their Buy Rating on TruBridge (TBRG),0,0,0,0,1,-1
49.84M,"773,322",-153.33M,-1,52,4.010,Hold,6.38,"Aug 7, 2024",ABOS,"Acumen Pharmaceuticals, Inc.",174.83M,2.91,-,-1.13%,2.64%,-12.37%,-16.06%,-28.05%,Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference,Buy Rating for Acumen Pharmaceuticals Backed by Promising Alzheimer’s Treatment Advances and Strong Financials,Acumen Pharmaceuticals Unveils Updated Corporate Presentation and Financials,"Acumen reports Q2 EPS (34c), consensus (28c)","Acumen Pharmaceuticals, Inc. (ABOS) Q2 Earnings Cheat Sheet","Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference Buy Rating for Acumen Pharmaceuticals Backed by Promising Alzheimer’s Treatment Advances and Strong Financials Acumen Pharmaceuticals Unveils Updated Corporate Presentation and Financials Acumen reports Q2 EPS (34c), consensus (28c) Acumen Pharmaceuticals, Inc. (ABOS) Q2 Earnings Cheat Sheet",1,0,1,0,1,0
90.36M,"817,442",-123.44M,-1,9,2.210,Strong Buy,14.00,"Aug 6, 2024",AHG,Akso Health Group,174.81M,1.05,2.41M,1.81%,2.25%,-7.73%,+7.66%,-23.02%,,,,,,,0,-1,-1,-1,-1,-1
124.66M,"320,233",-19.24M,-1,157,1.590,Buy,3.33,"Aug 5, 2024",PRQR,ProQR Therapeutics N.V.,174.80M,2.14,16.90M,-0.78%,8.00%,2.19%,+2.59%,-10.41%,,,,,,,1,-1,-1,-1,-1,-1
50.05M,"136,628",-54.70M,-1,32,3.950,,,"Aug 7, 2024",CMPX,"Compass Therapeutics, Inc.",173.36M,1.26,850.00K,13.71%,19.69%,-15.29%,+15.53%,-30.00%,Compass Therapeutics to Participate in Upcoming Investor Events,Compass Therapeutics files $300M mixed securities shelf,Compass Therapeutics Strategy Pivot and Outperform Rating Amidst Clinical Setbacks,Compass Therapeutics (CMPX) Gets a Buy from Stifel Nicolaus,Buy Rating Affirmed: Compass Therapeutics’ Promising Pipeline and Prudent Financial Outlook,Compass Therapeutics to Participate in Upcoming Investor Events Compass Therapeutics files $300M mixed securities shelf Compass Therapeutics Strategy Pivot and Outperform Rating Amidst Clinical Setbacks Compass Therapeutics (CMPX) Gets a Buy from Stifel Nicolaus Buy Rating Affirmed: Compass Therapeutics’ Promising Pipeline and Prudent Financial Outlook,1,1,1,1,1,1
13.14M,"15,861",-10.22M,-1,442,14.88,Strong Buy,38.00,"Aug 14, 2024",RELL,"Richardson Electronics, Ltd.",173.24M,12.05,196.46M,3.02%,1.69%,9.18%,-1.25%,+29.32%,"Richardson Electronics, Ltd. Introduces Ultracapacitor Pitch Energy Modules into the European Market for Five Wind Turbine Platforms",,,,,"Richardson Electronics, Ltd. Introduces Ultracapacitor Pitch Energy Modules into the European Market for Five Wind Turbine Platforms",0,0,-1,-1,-1,-1
13.88M,"10,520",11.76M,$0.60,13,14.08,,,"Jul 25, 2024",PTMN,Portman Ridge Finance Corporation,172.77M,18.69,69.23M,-2.83%,-4.00%,-1.14%,-7.10%,-3.71%,KBW Releases a Hold Rating on Portman Ridge Finance (PTMN),Portman Ridge Finance (PTMN) Unveils Dividend Details for Q3: Mark Your Calendar!,,,,KBW Releases a Hold Rating on Portman Ridge Finance (PTMN) Portman Ridge Finance (PTMN) Unveils Dividend Details for Q3: Mark Your Calendar!,0,0,0,-1,-1,-1
25.96M,"179,314",-121.64M,-1,794,7.51,Buy,21.33,"Aug 8, 2024",JYNT,The Joint Corp.,171.86M,11.46,120.07M,-6.57%,-14.23%,-5.27%,-23.65%,-13.58%,The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference,Joint (JYNT) Receives a Hold from Maxim Group,"Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Immuneering (IMRX) and Vera Therapeutics (VERA)",Joint Corp. price target raised to $20 from $15 at Lake Street,,"The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference Joint (JYNT) Receives a Hold from Maxim Group Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Immuneering (IMRX) and Vera Therapeutics (VERA) Joint Corp. price target raised to $20 from $15 at Lake Street",1,1,1,1,1,-1
6.36M,"4,495",9.13M,$1.51,"1,439",30.62,,,"Aug 14, 2024",DXLG,"Destination XL Group, Inc.",171.79M,2.95,511.86M,-10.71%,-18.18%,-25.67%,-25.07%,-18.51%,Destination XL price target lowered to $4 from $6 at DA Davidson,D.A. Davidson Sticks to Its Buy Rating for Destination XL (DXLG),"Analysts Offer Insights on Consumer Cyclical Companies: Foot Locker (FL), Guess?, Inc. (GES) and Destination XL (DXLG)",Destination XL cuts FY24 sales view to $470M-$490M from $500M,Destination XL reports Q2 EPS 4c vs 18c last year,"Destination XL price target lowered to $4 from $6 at DA Davidson D.A. Davidson Sticks to Its Buy Rating for Destination XL (DXLG) Analysts Offer Insights on Consumer Cyclical Companies: Foot Locker (FL), Guess?, Inc. (GES) and Destination XL (DXLG) Destination XL cuts FY24 sales view to $470M-$490M from $500M Destination XL reports Q2 EPS 4c vs 18c last year",1,0,0,1,1,1
91.98M,"127,369",-43.83M,-1,,2.110,Hold,3.20,"Aug 19, 2024",SPKL,Spark I Acquisition Corporation,171.77M,10.46,-,0.15%,0.61%,1.59%,+0.38%,+1.95%,,,,,,,0,-1,-1,-1,-1,-1
6.23M,"28,525",12.03M,$0.44,,31.09,,,"Aug 6, 2024",SKGR,SK Growth Opportunities Corporation,171.63M,11.22,-,0.27%,0.58%,1.94%,+0.40%,+1.54%,,,,,,,1,-1,-1,-1,-1,-1
14.48M,"116,075",1.72B,-1,76,13.34,Hold,,"Aug 13, 2024",ASPI,ASP Isotopes Inc.,171.39M,2.57,2.30M,13.08%,-9.62%,-15.36%,-12.45%,-36.61%,,,,,,,1,-1,-1,-1,-1,-1
3.27M,"11,096",19.27M,$1.76,183,58.99,,,"Jul 24, 2024",CBUS,"Cibus, Inc.",171.20M,7.56,2.96M,-9.37%,-17.93%,-50.68%,-29.68%,-64.98%,Cibus Announces CFO Wade King’s Leave and Interim Successor,Cibus to Participate in Upcoming August Investor Events,Cibus price target lowered to $21 from $22 at Canaccord,,,Cibus Announces CFO Wade King’s Leave and Interim Successor Cibus to Participate in Upcoming August Investor Events Cibus price target lowered to $21 from $22 at Canaccord,1,0,1,1,-1,-1
122.68M,"1,035,130",-104.77M,-1,19,1.560,Buy,6.00,"Aug 13, 2024",DMAC,DiaMedica Therapeutics Inc.,170.99M,4.00,-,10.77%,21.74%,35.65%,+21.65%,+33.89%,,,,,,,0,-1,-1,-1,-1,-1
148.99M,"105,247",-43.89M,-1,,1.280,Buy,2.67,"Aug 8, 2024",BRKH,BurTech Acquisition Corp.,169.82M,11.20,-,0.20%,0.39%,3.33%,+0.18%,+2.94%,,,,,,,0,-1,-1,-1,-1,-1
81.81M,"260,055",-45.98M,-1,,2.330,,,"Aug 14, 2024",MRCC,Monroe Capital Corporation,169.65M,7.83,61.96M,2.58%,2.83%,5.96%,+0.26%,+7.17%,Monroe Capital Corporation Announces Third Quarter Distribution of $0.25 Per Share,Oppenheimer Keeps Their Hold Rating on Monroe Capital (MRCC),,,,Monroe Capital Corporation Announces Third Quarter Distribution of $0.25 Per Share Oppenheimer Keeps Their Hold Rating on Monroe Capital (MRCC),0,0,0,-1,-1,-1
99.77M,"120,100",-32.82M,-1,"1,813",1.910,,,"Aug 8, 2024",CSTE,Caesarstone Ltd.,169.23M,4.90,508.64M,-0.63%,-5.09%,3.28%,-22.24%,+16.82%,,,,,,,1,-1,-1,-1,-1,-1
258.19M,"28,196",8.43M,-1,162,0.738,Strong Buy,1.00,"Aug 22, 2024",FINW,FinWise Bancorp,169.10M,12.80,67.15M,4.12%,12.24%,13.53%,+1.66%,+32.34%,,,,,,,0,-1,-1,-1,-1,-1
14.81M,"26,220",20.57M,$0.48,"2,120",12.85,Hold,13.00,"Jul 25, 2024",RMNI,"Rimini Street, Inc.",168.70M,1.86,429.43M,-4.60%,-28.69%,-37.46%,-22.97%,-40.63%,,,,,,,0,-1,-1,-1,-1,-1
21.79M,"953,548",-54.39M,-1,"2,412",8.73,Buy,13.60,"Jul 29, 2024",RMBL,"RumbleOn, Inc.",167.61M,4.75,1.29B,20.19%,13.42%,-19.83%,+10.32%,-23.10%,RumbleON files $250M mixed securities shelf,,,,,RumbleON files $250M mixed securities shelf,0,0,-1,-1,-1,-1
232.99M,"10,077,477",-74.05M,-1,82,0.816,Strong Buy,5.68,"Aug 8, 2024",DSY,Big Tree Cloud Holdings Limited,167.25M,2.93,7.98M,149.53%,164.55%,-44.47%,+324.76%,,Big Tree Cloud Holdings Ltd trading resumes,"Big Tree Cloud Holdings Ltd trading halted, volatility trading pause",,,,"Big Tree Cloud Holdings Ltd trading resumes Big Tree Cloud Holdings Ltd trading halted, volatility trading pause",1,0,0,-1,-1,-1
5.30M,"63,577",4.63M,-1,75,35.81,,,"Aug 14, 2024",STTK,"Shattuck Labs, Inc.",167.05M,3.50,4.12M,4.44%,-9.48%,-47.89%,-14.32%,-63.37%,Shattuck Labs’s SL-172154: A Novel CD47 Therapy Overcoming Previous Challenges with Promising Clinical Prospects,Shattuck Labs price target lowered to $8 from $9 at Citi,,,,Shattuck Labs’s SL-172154: A Novel CD47 Therapy Overcoming Previous Challenges with Promising Clinical Prospects Shattuck Labs price target lowered to $8 from $9 at Citi,0,0,0,-1,-1,-1
39.69M,"94,392",-13.99M,-1,76,4.780,Buy,8.00,"Aug 6, 2024",ATLX,Atlas Lithium Corporation,166.99M,10.95,374.11K,12.49%,4.32%,-36.42%,-8.66%,-41.38%,,,,,,,1,-1,-1,-1,-1,-1
80.86M,364,-8.37M,-1,282,2.260,Strong Buy,11.50,"Sep 12, 2024",FCCO,First Community Corporation,166.83M,21.85,59.23M,2.80%,10.51%,19.14%,-2.36%,+31.64%,,,,,,,1,-1,-1,-1,-1,-1
30.30M,"2,483,464",-174.29M,$2.00,"1,282",6.22,,,"Sep 3, 2024",ESOA,Energy Services of America Corporation,166.54M,10.05,352.07M,23.69%,34.78%,49.82%,+25.16%,+16.75%,Energy Services Of America Corp trading resumes,"Energy Services Of America Corp trading halted, volatility trading pause",Closing Bell Movers: Rumble jumps 8% on earnings,Energy Services of America Reports Fiscal Third Quarter 2024 Results,Energy Services of America reports Q3 EPS $1.06 vs. 21c last year,"Energy Services Of America Corp trading resumes Energy Services Of America Corp trading halted, volatility trading pause Closing Bell Movers: Rumble jumps 8% on earnings Energy Services of America Reports Fiscal Third Quarter 2024 Results Energy Services of America reports Q3 EPS $1.06 vs. 21c last year",1,1,0,1,1,1
21.32M,"28,877",13.48M,$0.28,"1,230",8.83,Hold,8.50,"Jul 23, 2024",LCUT,"Lifetime Brands, Inc.",166.41M,7.51,678.72M,-2.61%,-9.15%,-15.26%,-17.13%,-32.13%,Lifetime Brands Announces Participation in the Sidoti Virtual Small-Cap Investor Conference,Lifetime Brands price target raised to $14 from $13.50 at DA Davidson,,,,Lifetime Brands Announces Participation in the Sidoti Virtual Small-Cap Investor Conference Lifetime Brands price target raised to $14 from $13.50 at DA Davidson,0,1,0,-1,-1,-1
63.76M,"367,873",2.87M,$0.42,"1,518",2.950,,,"Aug 13, 2024",III,"Information Services Group, Inc.",166.23M,3.40,266.49M,3.12%,4.84%,-11.77%,-1.73%,-14.75%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,308,,,,,PWOD,"Penns Woods Bancorp, Inc.",166.13M,22.02,64.82M,0.42%,3.38%,9.51%,-3.57%,+21.47%,Penns Woods Bancorp Shares Informal Performance Insights,,,,,Penns Woods Bancorp Shares Informal Performance Insights,1,1,-1,-1,-1,-1
47.55M,"785,687",-212.03M,-1,148,3.920,Buy,5.09,"Aug 8, 2024",BAER,"Bridger Aerospace Group Holdings, Inc.",165.88M,3.12,73.25M,-9.26%,-13.85%,-38.83%,-18.15%,-45.76%,Bridger Aerospace Shares Investor Presentation Details,Bridger Aerospace Poised for Growth Amid Increased Wildfire Activity: A ‘Buy’ Recommendation,,,,Bridger Aerospace Shares Investor Presentation Details Bridger Aerospace Poised for Growth Amid Increased Wildfire Activity: A ‘Buy’ Recommendation,0,0,1,-1,-1,-1
52.73M,"37,331",3.93M,-1,,3.530,,,"Aug 6, 2024",BRLS,Borealis Foods Inc.,165.69M,7.75,28.40M,-18.03%,-19.54%,-19.27%,-14.06%,+14.71%,,,,,,,1,-1,-1,-1,-1,-1
86.12M,"528,068",-310.32M,-1,140,2.160,Buy,7.75,"Aug 8, 2024",LVO,"LiveOne, Inc.",165.47M,1.75,123.75M,10.78%,14.82%,15.57%,+2.35%,-10.77%,LiveOne (Nasdaq: LVO) Launched Price Increases for Plus and Premium Membership Plans,"LiveOne launches price increases for Plus, Premium membership plans","PodcastOne renews exclusive sales agreement with Welch, Sullivan","PodcastOne, Nic and Ryan Nemeth announce joint venture","LiveOne, Kartoon Studios to collaborate on custome audio, video channels","LiveOne (Nasdaq: LVO) Launched Price Increases for Plus and Premium Membership Plans LiveOne launches price increases for Plus, Premium membership plans PodcastOne renews exclusive sales agreement with Welch, Sullivan PodcastOne, Nic and Ryan Nemeth announce joint venture LiveOne, Kartoon Studios to collaborate on custome audio, video channels",1,0,0,0,1,1
75.00M,"106,037",-18.57M,-1,"1,203",2.480,Strong Buy,6.50,"Aug 7, 2024",HOFT,Hooker Furnishings Corporation,165.45M,15.74,404.98M,7.06%,8.68%,-19.52%,+3.73%,-31.34%,Hooker Furniture Restructures Leadership for Cost Efficiency,Hooker Furniture reports Q2 EPS (19c) vs. 7c last year,Hooker Furnishings Declares Quarterly Dividend,Hooker Furniture (HOFT) Q2 Earnings Cheat Sheet,Hooker Furnishings to Host Second Quarter Earnings Call September 5th,Hooker Furniture Restructures Leadership for Cost Efficiency Hooker Furniture reports Q2 EPS (19c) vs. 7c last year Hooker Furnishings Declares Quarterly Dividend Hooker Furniture (HOFT) Q2 Earnings Cheat Sheet Hooker Furnishings to Host Second Quarter Earnings Call September 5th,1,1,1,0,0,1
16.26M,135,5.33M,-1,,11.45,,,,MCAA,Mountain & Co. I Acquisition Corp.,165.32M,11.70,-,-0.00%,0.26%,2.74%,+0.09%,+2.82%,Mountain & Co. I Announces Amicable Director Resignation,Mountain & Co. Announces Amicable Director Resignation,,,,Mountain & Co. I Announces Amicable Director Resignation Mountain & Co. Announces Amicable Director Resignation,1,1,1,-1,-1,-1
,,,-1,112,,,,,TLSI,"TriSalus Life Sciences, Inc.",164.58M,5.62,24.74M,-6.06%,-4.74%,-29.22%,-12.46%,-49.08%,TriSalus price target lowered to $11 from $16 at JonesResearch,TriSalus Life Sciences: A Strong Buy on Robust Revenue Growth and Promising Clinical Advancements,TriSalus Life Sciences: Outperforming Expectations with a Buy Rating Despite Adjusted Price Target,Buy Rating Affirmed on TriSalus Life Sciences Amid Strong Financials and Strategic Growth Initiatives,"TriSalus Life Sciences reports Q2 EPS (21c), consensus (49c)","TriSalus price target lowered to $11 from $16 at JonesResearch TriSalus Life Sciences: A Strong Buy on Robust Revenue Growth and Promising Clinical Advancements TriSalus Life Sciences: Outperforming Expectations with a Buy Rating Despite Adjusted Price Target Buy Rating Affirmed on TriSalus Life Sciences Amid Strong Financials and Strategic Growth Initiatives TriSalus Life Sciences reports Q2 EPS (21c), consensus (49c)",0,0,1,0,0,0
13.97M,"39,922",5.16M,$0.24,582,13.31,Strong Buy,18.00,"Aug 8, 2024",ME,23andMe Holding Co.,163.64M,0.32,199.19M,-9.72%,-20.57%,-44.91%,-22.38%,-35.18%,23andMe updates clinical immuno-oncology programs 23ME-00610 at ESMO,23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024,23andMe unit Lemonaid Health offering GLP-1 medication Ozempic and Wegovy,Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program,,23andMe updates clinical immuno-oncology programs 23ME-00610 at ESMO 23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024 23andMe unit Lemonaid Health offering GLP-1 medication Ozempic and Wegovy Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program,1,1,1,1,0,-1
11.12M,"89,737",-4.20M,-1,273,16.70,,,"Sep 3, 2024",ATLO,Ames National Corporation,163.30M,18.16,51.28M,-4.36%,-8.99%,-9.16%,-15.35%,-6.62%,"Ames National Announces Dividend, CEO Updates Investors",,,,,"Ames National Announces Dividend, CEO Updates Investors",0,1,-1,-1,-1,-1
16.62M,"44,352",10.06M,-1,116,11.17,Strong Buy,14.00,"Jul 25, 2024",BVFL,"BV Financial, Inc.",162.39M,14.26,37.41M,0.98%,7.97%,15.46%,-0.42%,+37.16%,BV Financial Shareholders Approve 2024 Equity Incentive Plan,,,,,BV Financial Shareholders Approve 2024 Equity Incentive Plan,0,1,-1,-1,-1,-1
6.47M,"37,517",14.88M,$0.80,,28.70,,,"Jul 22, 2024",ALCY,Alchemy Investments Acquisition Corp 1,161.91M,10.82,-,0.14%,0.61%,2.42%,+0.48%,+2.38%,,,,,,,0,-1,-1,-1,-1,-1
48.13M,"136,113",-174.85M,-1,137,3.850,,,"Aug 9, 2024",ARBE,Arbe Robotics Ltd.,161.82M,2.00,1.37M,-3.62%,-4.78%,1.12%,-6.60%,-1.00%,Arbe Robotics signs framework agreement with Tianyi Transportation Technology,Arbe Robotics Sets Annual Shareholder Meeting for 2024,,,,Arbe Robotics signs framework agreement with Tianyi Transportation Technology Arbe Robotics Sets Annual Shareholder Meeting for 2024,1,0,0,-1,-1,-1
118.76M,"553,762",-24.66M,-1,105,1.560,Hold,1.60,"Aug 8, 2024",SCLX,Scilex Holding Company,160.70M,1.22,50.83M,-15.34%,-30.68%,-21.94%,-30.19%,-27.45%,Scilex announces acceptance of presentation at ACRC conference,Scilex’s Semnur Pharmaceuticals Set for Strategic Merger with Denali,"Denali Capital Acquisition, Semnur Pharmaceuticals sing merger agreement","Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion","Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024","Scilex announces acceptance of presentation at ACRC conference Scilex’s Semnur Pharmaceuticals Set for Strategic Merger with Denali Denali Capital Acquisition, Semnur Pharmaceuticals sing merger agreement Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024",1,0,0,0,0,0
30.87M,"147,540",-20.19M,-1,306,6.00,Buy,9.50,"Aug 9, 2024",CHRS,"Coherus BioSciences, Inc.",160.14M,1.39,308.13M,0.85%,-7.89%,-32.68%,-11.69%,-44.03%,Barclays Keeps Their Buy Rating on Coherus Biosciences (CHRS),Coherus Biosciences downgraded to Neutral from Buy at UBS,Coherus Biosciences: Hold Rating with Downward Revenue Projections and Price Target Revision,Strong Performance and Promising Outlook Justify Outperform Rating for Coherus Biosciences,Strong Financial Performance and Market Share Growth Underpin Buy Rating for Coherus Biosciences,Barclays Keeps Their Buy Rating on Coherus Biosciences (CHRS) Coherus Biosciences downgraded to Neutral from Buy at UBS Coherus Biosciences: Hold Rating with Downward Revenue Projections and Price Target Revision Strong Performance and Promising Outlook Justify Outperform Rating for Coherus Biosciences Strong Financial Performance and Market Share Growth Underpin Buy Rating for Coherus Biosciences,0,0,1,0,0,0
30.99M,"193,771",6.87M,-1,422,5.96,Strong Buy,8.39,"Aug 8, 2024",FSFG,"First Savings Financial Group, Inc.",160.01M,23.44,72.09M,3.55%,17.25%,35.60%,+9.38%,+44.21%,"First Savings Financial Group, Inc. Announces Quarterly Cash Dividend",,,,,"First Savings Financial Group, Inc. Announces Quarterly Cash Dividend",0,1,-1,-1,-1,-1
191.24M,"1,426,471",-67.98M,-1,345,0.966,Strong Buy,2.88,"Aug 8, 2024",INSG,Inseego Corp.,159.92M,13.02,195.50M,26.93%,29.34%,163.06%,+38.41%,+417.25%,Inseego price target raised to $15 from $13.50 at TD Cowen,,,,,Inseego price target raised to $15 from $13.50 at TD Cowen,1,0,-1,-1,-1,-1
13.99M,"32,176",10.99M,$0.16,116,13.19,,,"Aug 15, 2024",MDIA,MediaCo Holding Inc.,159.73M,3.42,31.76M,-14.07%,-2.69%,112.05%,-3.57%,-9.54%,MediaCo receives non-compliance letter from NASDAQ,MediaCo files $24.66M mixed securities shelf,,,,MediaCo receives non-compliance letter from NASDAQ MediaCo files $24.66M mixed securities shelf,0,0,0,-1,-1,-1
33.33M,"2,588",-30.58M,-1,80,5.43,Buy,5.63,"Sep 25, 2024",VTYX,"Ventyx Biosciences, Inc.",159.71M,2.26,-,7.27%,-6.77%,-38.48%,-5.17%,-54.55%,Ventyx Biosciences announces first patient dosed in Phase 2a trial of VTX3232,Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease,Ventyx Biosciences Announces Executive Financial Officer Changes,Ventyx Biosciences Announces Departure of Chief Financial Officer,Ventyx Biosciences announces departure of CFO Auster,Ventyx Biosciences announces first patient dosed in Phase 2a trial of VTX3232 Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease Ventyx Biosciences Announces Executive Financial Officer Changes Ventyx Biosciences Announces Departure of Chief Financial Officer Ventyx Biosciences announces departure of CFO Auster,1,0,0,1,0,1
41.60M,"7,817",12.14M,-1,,4.430,,,"Sep 3, 2024",SHMD,SCHMID Group N.V.,159.46M,3.99,-,-5.06%,-10.17%,-52.94%,-13.53%,,,,,,,,0,-1,-1,-1,-1,-1
89.54M,"333,694",-9.53M,-1,840,2.040,Strong Buy,4.00,"Aug 6, 2024",KNDI,"Kandi Technologies Group, Inc.",158.99M,1.82,124.61M,0.43%,-4.70%,-23.56%,-7.81%,-13.66%,Morning Movers: MSG Entertainment rises following quarterly release,Kandi Technologies Forges U.S. Market Partnership,Kandi Technologies: Mixed Q2 Results with Strategic Growth,"Options Volatility and Implied Earnings Moves Today, August 16, 2024",Kandi Technologies reports Q2 EPS 2c vs. 6c last year,"Morning Movers: MSG Entertainment rises following quarterly release Kandi Technologies Forges U.S. Market Partnership Kandi Technologies: Mixed Q2 Results with Strategic Growth Options Volatility and Implied Earnings Moves Today, August 16, 2024 Kandi Technologies reports Q2 EPS 2c vs. 6c last year",1,0,1,1,0,1
7.38M,"95,435",5.76M,$0.12,128,24.72,Strong Buy,26.50,"Sep 4, 2024",TAYD,"Taylor Devices, Inc.",158.96M,50.97,44.58M,11.46%,16.02%,37.43%,+5.98%,-10.48%,"TAYLOR DEVICES ANNOUNCES RECORD HIGH FULL YEAR SALES, PROFIT AND FIRM ORDER BACKLOG FOR FISCAL YEAR 2024 CONCURRENT WITH STRONG FOURTH QUARTER RESULTS",,,,,"TAYLOR DEVICES ANNOUNCES RECORD HIGH FULL YEAR SALES, PROFIT AND FIRM ORDER BACKLOG FOR FISCAL YEAR 2024 CONCURRENT WITH STRONG FOURTH QUARTER RESULTS",0,0,-1,-1,-1,-1
49.95M,"578,078",8.22M,-1,,3.650,,,"Aug 12, 2024",IBAC,IB Acquisition Corp.,157.81M,10.02,-,-0.14%,0.07%,0.15%,-0.20%,,,,,,,,0,-1,-1,-1,-1,-1
32.08M,"357,318",-49.99M,-1,136,5.68,Strong Buy,11.00,"Aug 13, 2024",OPRX,OptimizeRx Corporation,157.57M,8.60,83.20M,-7.64%,-15.63%,-29.76%,-25.11%,-28.14%,OptimizeRx price target lowered to $14 from $17 at RBC Capital,"Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX)",OptimizeRx price target lowered to $11 from $15 at Barclays,Roth MKM Sticks to Its Buy Rating for OptimizeRx (OPRX),Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX),"OptimizeRx price target lowered to $14 from $17 at RBC Capital Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), OmniAb (OABI) and Syndax Pharmaceuticals (SNDX) OptimizeRx price target lowered to $11 from $15 at Barclays Roth MKM Sticks to Its Buy Rating for OptimizeRx (OPRX) Stifel Nicolaus Reaffirms Their Buy Rating on OptimizeRx (OPRX)",1,0,1,1,1,1
13.32M,"45,603",-91.78M,-1,540,13.67,,,"Aug 6, 2024",TATT,TAT Technologies Ltd.,157.54M,15.95,122.67M,10.04%,9.97%,27.57%,+3.75%,+31.87%,TAT Technologies Raises $10M in Private Placement,TAT Technologies Launches Private Share Placement,TAT Technologies reports Q2 EPS 25c vs. 15c last year,Tat Techno Reports Strong Financial Growth,TAT Technologies Posts Strong Q2 2024 Growth,TAT Technologies Raises $10M in Private Placement TAT Technologies Launches Private Share Placement TAT Technologies reports Q2 EPS 25c vs. 15c last year Tat Techno Reports Strong Financial Growth TAT Technologies Posts Strong Q2 2024 Growth,1,1,1,1,1,1
,,,-1,"1,226",,,,,MOND,"Mondee Holdings, Inc.",157.31M,1.90,232.97M,-19.31%,-23.62%,-25.99%,-39.13%,-12.92%,Mondee Holdings Revamps Financial Strategy Until 2028,Mondee price target lowered to $3.25 from $4.10 at Roth MKM,Mondee Holdings (MOND) Gets a Buy from Roth MKM,,,Mondee Holdings Revamps Financial Strategy Until 2028 Mondee price target lowered to $3.25 from $4.10 at Roth MKM Mondee Holdings (MOND) Gets a Buy from Roth MKM,0,1,0,0,-1,-1
30.34M,"290,293",-42.29M,-1,106,5.95,Strong Buy,19.25,"Aug 9, 2024",EUDA,EUDA Health Holdings Limited,156.86M,4.53,3.71M,10.48%,22.52%,113.58%,+36.46%,+183.91%,,,,,,,0,-1,-1,-1,-1,-1
16.26M,"131,010","-792,000",-1,,11.09,Strong Buy,11.80,"Aug 12, 2024",FLD,FTAC Emerald Acquisition Corp.,156.75M,10.92,-,-0.33%,0.53%,2.89%,-0.52%,+4.21%,,,,,,,1,-1,-1,-1,-1,-1
9.83M,"66,809",15.08M,$0.40,"3,200",18.32,Buy,13.50,"Oct 17, 2024",DLHC,DLH Holdings Corp.,156.30M,11.02,401.04M,4.80%,1.56%,-15.99%,-5.36%,-16.03%,,,,,,,0,-1,-1,-1,-1,-1
25.00M,,,-1,"3,361",7.19,,,,STRT,Strattec Security Corporation,156.14M,38.38,537.77M,18.06%,36.64%,51.52%,+51.55%,+52.30%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,29,,,,,FENC,Fennec Pharmaceuticals Inc.,155.95M,5.70,48.89M,-2.68%,-7.70%,-33.78%,-15.92%,-49.11%,Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences,Buy Rating Affirmed for Fennec Pharmaceuticals Amidst PEDMARK’s Long-Term Growth Potential,Fennec price target lowered to $13 from $15 at H.C. Wainwright,Buy Rating for Fennec Pharmaceuticals Bolstered by Pedmark’s Market Expansion and New Leadership,Fennec price target lowered to $15 from $17 at Craig-Hallum,Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences Buy Rating Affirmed for Fennec Pharmaceuticals Amidst PEDMARK’s Long-Term Growth Potential Fennec price target lowered to $13 from $15 at H.C. Wainwright Buy Rating for Fennec Pharmaceuticals Bolstered by Pedmark’s Market Expansion and New Leadership Fennec price target lowered to $15 from $17 at Craig-Hallum,0,0,0,0,0,0
21.33M,"37,639",26.83M,-1,284,8.40,,,"Jul 30, 2024",HWBK,"Hawthorn Bancshares, Inc.",155.73M,22.29,56.22M,4.67%,8.08%,5.25%,+7.79%,+10.53%,"Bob Regnier Joins the Board of Directors of Each of Hawthorn Bank and Hawthorn Bancshares, Inc. Underscoring Their Commitment to Community Banking",,,,,"Bob Regnier Joins the Board of Directors of Each of Hawthorn Bank and Hawthorn Bancshares, Inc. Underscoring Their Commitment to Community Banking",0,1,-1,-1,-1,-1
125.76M,"650,542",-25.91M,-1,9,1.420,Strong Buy,6.13,"Aug 12, 2024",TELO,"Telomir Pharmaceuticals, Inc.",155.45M,5.25,-,20.02%,20.67%,-11.98%,+41.27%,-28.17%,Telomir Pharmaceuticals appoints Itzchak Angel as chief scientific advisor,Telomir Pharmaceuticals’s Telomir-1 featured in local ABC exclusive,Telomir Pharmaceuticals announces passing of CEO Christopher Chapman,Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman,,Telomir Pharmaceuticals appoints Itzchak Angel as chief scientific advisor Telomir Pharmaceuticals’s Telomir-1 featured in local ABC exclusive Telomir Pharmaceuticals announces passing of CEO Christopher Chapman Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman,1,1,0,0,1,-1
208.22M,"4,866,168",-249.68M,-1,"1,550",0.858,Buy,2.67,"Aug 6, 2024",HITI,High Tide Inc.,155.34M,1.96,366.55M,0.53%,-5.75%,-2.39%,+4.35%,-23.81%,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,"High Tide Expands with New Store in Lucan, Ontario",High Tide to launch next-gen Canna Cabana 2.0 website,High Tide Readies Q3 Financials and Expands in Mississauga,,"Rising High: MINT Shango JV to acquire Cannabist’s Florida entity High Tide Expands with New Store in Lucan, Ontario High Tide to launch next-gen Canna Cabana 2.0 website High Tide Readies Q3 Financials and Expands in Mississauga",1,1,1,1,1,-1
16.70M,"63,782",7.06M,-1,22,10.67,Hold,11.00,"Jul 29, 2024",ACHV,"Achieve Life Sciences, Inc.",154.88M,4.51,-,0.67%,-2.59%,-1.65%,-9.44%,+1.12%,Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV),Buy Rating for Achieve Life Sciences: Strategic Growth and Solid Financials Amidst Leadership Transition,Achieve Life Sciences Announces Leadership Shake-Up and Board Reshuffle,Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors,Oppenheimer Remains a Buy on Achieve Life Sciences (ACHV),Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV) Buy Rating for Achieve Life Sciences: Strategic Growth and Solid Financials Amidst Leadership Transition Achieve Life Sciences Announces Leadership Shake-Up and Board Reshuffle Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors Oppenheimer Remains a Buy on Achieve Life Sciences (ACHV),0,0,0,0,0,0
23.66M,"120,394",-94.05M,-1,,7.53,Strong Buy,45.55,"Aug 14, 2024",ESHA,ESH Acquisition Corp.,154.69M,10.55,-,0.19%,0.84%,2.72%,+0.91%,+2.47%,,,,,,,1,-1,-1,-1,-1,-1
1.94B,"395,570",-39.44M,-1,5,9.19,Buy,26.55,"Aug 8, 2024",ACTU,"Actuate Therapeutics, Inc.",154.42M,8.08,-,-5.62%,-5.62%,-5.62%,,,"Opening Day: Pheton, Powell Max make public debut",Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Opening Day: Actuate Therapeutics makes public debut,"Actuate Therapeutics opens at $9.88, IPO priced at $8.00",,"Opening Day: Pheton, Powell Max make public debut Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference Opening Day: Actuate Therapeutics makes public debut Actuate Therapeutics opens at $9.88, IPO priced at $8.00",1,0,0,0,1,-1
22.28M,"67,667",42.67M,$0.40,292,7.98,,,"Jul 30, 2024",PEBK,"Peoples Bancorp of North Carolina, Inc.",154.40M,29.18,79.20M,-0.94%,-1.72%,1.76%,-8.59%,+4.12%,Peoples Bancorp Announces Cash Dividend,,,,,Peoples Bancorp Announces Cash Dividend,1,1,-1,-1,-1,-1
9.50M,"26,045",17.44M,$0.60,121,18.64,,,"Jul 24, 2024",DRTS,Alpha Tau Medical Ltd.,153.83M,2.20,-,3.88%,2.34%,-18.05%,+4.13%,-21.72%,Alpha Tau Medical to Showcase Cancer Therapy at Global Conferences,"Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference",Buy Rating on Alpha Tau Medical Ltd. Amidst Promising Alpha DaRT Cancer Treatment Trials and Solid Financials,Alpha Tau resumed with a Buy at Citi,Piper Sandler Reaffirms Their Buy Rating on Alpha Tau Medical Ltd (DRTS),"Alpha Tau Medical to Showcase Cancer Therapy at Global Conferences Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference Buy Rating on Alpha Tau Medical Ltd. Amidst Promising Alpha DaRT Cancer Treatment Trials and Solid Financials Alpha Tau resumed with a Buy at Citi Piper Sandler Reaffirms Their Buy Rating on Alpha Tau Medical Ltd (DRTS)",0,0,0,0,0,0
66.74M,"74,391",-158.43M,-1,152,2.650,Buy,7.50,"Aug 7, 2024",SAMG,Silvercrest Asset Management Group Inc.,152.95M,16.02,119.51M,2.86%,1.86%,1.14%,-10.21%,+6.49%,Chip Kelleher Joins Silvercrest Asset Management Group as Managing Director and Opens New Atlanta Office,Silvercrest Asset Management Group Inc. Announces $12 Million Common Stock Repurchase Program,,,,Chip Kelleher Joins Silvercrest Asset Management Group as Managing Director and Opens New Atlanta Office Silvercrest Asset Management Group Inc. Announces $12 Million Common Stock Repurchase Program,0,1,0,-1,-1,-1
9.66M,"31,508",3.49M,-1,11,18.30,Buy,20.67,"Oct 17, 2024",PROP,Prairie Operating Co.,152.56M,9.21,1.55M,-2.23%,-9.20%,-17.33%,-12.12%,-22.91%,Prairie Operating Co. spuds first well at Shelduck South,Prairie Operating Co. Spuds its First Well at Shelduck South in the DJ Basin,Prairie Operating Co. Announces Warrant Exercise Resulting in $24 Million of Proceeds,Prairie Operating Co. announces warrant exercise for $24M in proceeds,,Prairie Operating Co. spuds first well at Shelduck South Prairie Operating Co. Spuds its First Well at Shelduck South in the DJ Basin Prairie Operating Co. Announces Warrant Exercise Resulting in $24 Million of Proceeds Prairie Operating Co. announces warrant exercise for $24M in proceeds,1,0,0,1,1,-1
38.36M,"567,973",6.74M,$0.10,,4.600,Strong Buy,7.80,"Aug 1, 2024",RFAI,RF Acquisition Corp II,152.35M,10.15,-,0.11%,0.21%,0.21%,+0.03%,,,,,,,,0,-1,-1,-1,-1,-1
34.80M,"111,931",-27.79M,-1,121,5.070,Buy,6.50,"Aug 6, 2024",ADVM,"Adverum Biotechnologies, Inc.",152.26M,7.32,-,3.84%,-1.12%,-31.54%,-6.74%,-45.17%,Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Adverum Biotechnologies reports inducement grants under Nasdaq listing rule,Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences,Adverum Biotechnologies: A Strong Buy on Promising Gene Therapy Prospects and Financial Stability,Adverum Biotechnologies price target lowered to $40 from $60 at Truist,Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Adverum Biotechnologies reports inducement grants under Nasdaq listing rule Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences Adverum Biotechnologies: A Strong Buy on Promising Gene Therapy Prospects and Financial Stability Adverum Biotechnologies price target lowered to $40 from $60 at Truist,0,0,0,0,0,0
29.49M,"327,438",4.40M,-1,361,5.98,Strong Buy,10.00,"Sep 11, 2024",RTC,Baijiayun Group Ltd,151.91M,7.37,71.90M,-24.93%,-4.28%,-17.30%,-28.77%,+11.64%,,,,,,,1,-1,-1,-1,-1,-1
16.63M,156,-6.17M,-1,384,10.64,,,,AMLX,"Amylyx Pharmaceuticals, Inc.",151.82M,2.23,298.76M,3.01%,8.34%,-71.58%,+1.46%,-20.23%,Largest borrow rate increases among liquid names,Cautious Optimism Amidst Uncertainty: Assessing Amylyx Pharmaceuticals’ Future Prospects,"Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Taysha Gene Therapies (TSHA) and Lexeo Therapeutics, Inc. (LXEO)",Bank of America Securities Keeps Their Hold Rating on Amylyx Pharmaceuticals Inc (AMLX),,"Largest borrow rate increases among liquid names Cautious Optimism Amidst Uncertainty: Assessing Amylyx Pharmaceuticals’ Future Prospects Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Taysha Gene Therapies (TSHA) and Lexeo Therapeutics, Inc. (LXEO) Bank of America Securities Keeps Their Hold Rating on Amylyx Pharmaceuticals Inc (AMLX)",1,1,0,0,1,-1
,,,-1,165,,,,,IPSC,"Century Therapeutics, Inc.",151.64M,1.79,2.04M,1.82%,-19.07%,-39.89%,-26.01%,-54.55%,Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright,Wall Street Analysts Are Bullish on Top Healthcare Picks,,,,Century Therapeutics price target lowered to $9 from $11 at H.C. Wainwright Wall Street Analysts Are Bullish on Top Healthcare Picks,0,0,1,-1,-1,-1
20.38M,"61,290",-6.55M,-1,295,8.62,Strong Buy,13.00,"Aug 8, 2024",RDCM,RADCOM Ltd.,151.57M,9.70,56.13M,5.08%,6.50%,9.38%,-2.34%,-7.19%,Leadership Change at RADCOM Amidst Growth,RADCOM Sets 2024 Shareholders Meeting Agenda,,,,Leadership Change at RADCOM Amidst Growth RADCOM Sets 2024 Shareholders Meeting Agenda,1,1,1,-1,-1,-1
15.80M,"95,999",-7.09M,-1,226,11.08,Strong Buy,18.00,"Aug 8, 2024",BFIN,BankFinancial Corporation,151.27M,12.14,55.75M,1.67%,8.12%,15.79%,+4.44%,+18.26%,,,,,,,0,-1,-1,-1,-1,-1
14.33M,"39,055",-52.30M,-1,37,12.21,Buy,13.50,"Aug 8, 2024",FTLF,"FitLife Brands, Inc.",151.19M,32.88,60.68M,7.02%,4.55%,28.35%,+2.12%,+19.52%,FitLife Brands initiated with a Buy at Roth MKM,FitLife Brands Poised for Growth: McGowan Reiterates Buy Rating with $40 Price Target,"FitLife Brands Shareholders Elect Directors, Approve Auditors",FitLife Brands reports Q2 EPS 53c vs 40c last year,,"FitLife Brands initiated with a Buy at Roth MKM FitLife Brands Poised for Growth: McGowan Reiterates Buy Rating with $40 Price Target FitLife Brands Shareholders Elect Directors, Approve Auditors FitLife Brands reports Q2 EPS 53c vs 40c last year",0,1,1,1,1,-1
60.08M,"125,812",-64.86M,-1,"1,700",2.910,Strong Buy,9.00,"Aug 13, 2024",CRNC,Cerence Inc.,150.91M,3.61,357.46M,11.77%,8.57%,-71.10%,+3.14%,-76.98%,"Analysts Offer Insights on Technology Companies: Genpact (G), Trade Desk (TTD) and Cerence (CRNC)",,,,,"Analysts Offer Insights on Technology Companies: Genpact (G), Trade Desk (TTD) and Cerence (CRNC)",0,0,-1,-1,-1,-1
166.48M,"9,136",-9.46M,-1,111,1.040,,,"Sep 3, 2024",KOD,Kodiak Sciences Inc.,150.64M,2.87,-,0.00%,-1.87%,-26.22%,-9.28%,-35.92%,Evaluating Kodiak Sciences: A Hold Rating Amidst Clinical Setbacks and Competitive Pressures,Kodiak Sciences initiated with a Neutral at H.C. Wainwright,Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD) and Pro Medicus Limited (OtherPMCUF),"Kodiak Sciences reports Q2 EPS (86c), consensus (87c)",Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results,"Evaluating Kodiak Sciences: A Hold Rating Amidst Clinical Setbacks and Competitive Pressures Kodiak Sciences initiated with a Neutral at H.C. Wainwright Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD) and Pro Medicus Limited (OtherPMCUF) Kodiak Sciences reports Q2 EPS (86c), consensus (87c) Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results",1,1,1,0,1,0
81.68M,"133,662",-23.08M,-1,307,2.140,Strong Buy,3.38,"Aug 8, 2024",EDAP,EDAP TMS S.A.,150.27M,4.05,65.31M,-34.75%,-40.39%,-51.22%,-38.79%,-63.31%,EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,EDAP TMS: Strategic Growth and Diverse Revenue Streams Support Buy Rating,EDAP TMS Reports Strong Growth and Clinical Advances,EDAP TMS chairman Marc Oczachowski resigns,EDAP TMS reports Q2 EPS (EUR 0.16) vs. (EUR 0.13) last year,EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference EDAP TMS: Strategic Growth and Diverse Revenue Streams Support Buy Rating EDAP TMS Reports Strong Growth and Clinical Advances EDAP TMS chairman Marc Oczachowski resigns EDAP TMS reports Q2 EPS (EUR 0.16) vs. (EUR 0.13) last year,0,0,1,1,1,1
137.59M,"366,992",-47.24M,-1,225,1.260,Strong Buy,9.00,"Aug 12, 2024",SOWG,Sow Good Inc.,148.76M,14.52,41.61M,-16.61%,-26.80%,5.73%,-27.62%,-25.94%,Sow Good management to meet virtually with Roth MKM,Craig-Hallum Remains a Buy on Sow Good (SOWG),Craig-Hallum Keeps Their Buy Rating on Sow Good (SOWG),Sow Good (SOWG) Gets a Buy from Roth MKM,"Sow Good to Present at the 2024 Gateway Conference on September 4th, 2024","Sow Good management to meet virtually with Roth MKM Craig-Hallum Remains a Buy on Sow Good (SOWG) Craig-Hallum Keeps Their Buy Rating on Sow Good (SOWG) Sow Good (SOWG) Gets a Buy from Roth MKM Sow Good to Present at the 2024 Gateway Conference on September 4th, 2024",0,0,0,0,0,0
14.38M,"37,020","61,000",$0.24,"1,006",12.05,,,"Oct 9, 2024",KEQU,Kewaunee Scientific Corporation,148.54M,52.30,203.76M,8.60%,15.06%,57.48%,-0.86%,+52.74%,Kewaunee Scientific Shares Future Financial Outlook,,,,,Kewaunee Scientific Shares Future Financial Outlook,0,1,-1,-1,-1,-1
9.24M,"54,169",12.55M,$2.76,102,18.69,Hold,20.00,"Aug 8, 2024",CAPR,"Capricor Therapeutics, Inc.",148.38M,4.56,27.15M,18.00%,7.76%,0.82%,+15.52%,-30.21%,Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences,Capricor Therapeutics’ Strong Potential Justifies Buy Rating Amidst Strategic Progress and Positive Clinical Developments,,,,Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences Capricor Therapeutics’ Strong Potential Justifies Buy Rating Amidst Strategic Progress and Positive Clinical Developments,1,1,1,-1,-1,-1
15.00M,"41,166",-14.41M,-1,52,11.46,Strong Buy,18.00,"Aug 8, 2024",ALAR,Alarum Technologies Ltd.,146.92M,21.60,29.22M,-37.15%,-52.61%,-32.31%,-48.62%,-46.83%,"Analysts Offer Insights on Technology Companies: Megaport Ltd. (OtherMGPPF), AAC Technologies Holdings (OtherAACAF) and Alarum Technologies (ALAR)",Alarum price target lowered to $28 from $42 at Canaccord,Alarum price target lowered to $20 from $34 at Alliance Global Partners,Morning Movers: SolarEdge climbs following CEO stepping down,Alarum Technologies Hits Record Q2 Revenue,"Analysts Offer Insights on Technology Companies: Megaport Ltd. (OtherMGPPF), AAC Technologies Holdings (OtherAACAF) and Alarum Technologies (ALAR) Alarum price target lowered to $28 from $42 at Canaccord Alarum price target lowered to $20 from $34 at Alliance Global Partners Morning Movers: SolarEdge climbs following CEO stepping down Alarum Technologies Hits Record Q2 Revenue",1,1,1,0,0,1
58.24M,"177,231",24.68M,-1,223,2.950,Hold,3.00,"Aug 29, 2024",TZOO,Travelzoo,146.87M,11.95,84.87M,10.91%,31.61%,33.90%,+16.91%,+19.50%,,,,,,,0,-1,-1,-1,-1,-1
16.42M,"93,800",1.71M,-1,"3,770",10.44,,,,RCMT,"RCM Technologies, Inc.",146.02M,19.14,270.18M,8.36%,8.19%,-11.49%,+2.21%,-2.07%,Rcm Technologies (RCMT) Gets a Buy from Benchmark Co.,,,,,Rcm Technologies (RCMT) Gets a Buy from Benchmark Co.,1,1,-1,-1,-1,-1
,,,-1,26,,,,,SCWO,374Water Inc.,146.00M,1.10,244.73K,-2.78%,-6.98%,-15.61%,-12.40%,-11.67%,374Water Enhances Leadership with New General Counsel,"374Water, Inc. appoints Peter Mandel as general counsel","374Water, Inc. reports Q2 EPS (2c) vs. (1c) last year",SCWO Earnings this Week: How Will it Perform?,,"374Water Enhances Leadership with New General Counsel 374Water, Inc. appoints Peter Mandel as general counsel 374Water, Inc. reports Q2 EPS (2c) vs. (1c) last year SCWO Earnings this Week: How Will it Perform?",1,1,1,1,0,-1
15.30M,"25,196",5.02M,-1,32,11.22,,,,PGHL,Primega Group Holdings Limited,145.92M,6.08,13.46M,9.67%,15.08%,15.08%,+42.74%,,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,BCSA,Blockchain Coinvestors Acquisition Corp. I,144.68M,11.22,-,-0.02%,0.06%,1.71%,+0.31%,+2.23%,,,,,,,1,-1,-1,-1,-1,-1
66.69M,"524,733",-27.05M,-1,,2.570,Strong Buy,4.50,"Aug 19, 2024",MMLP,Martin Midstream Partners L.P.,144.30M,3.70,723.16M,-2.90%,1.93%,27.52%,-8.99%,+35.15%,,,,,,,0,-1,-1,-1,-1,-1
22.65M,"100,854",-291.86M,-1,102,7.56,Strong Buy,23.67,"Aug 8, 2024",GUTS,"Fractyl Health, Inc.",144.26M,3.01,119.00K,34.98%,-6.60%,-43.17%,+5.64%,-54.21%,Fractyl Health to Participate in Upcoming September Investor Conferences,"Analysts Offer Insights on NA Companies: Fractyl Health, Inc. (GUTS) and GE Vernova Inc. (GEV)",Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates,,,"Fractyl Health to Participate in Upcoming September Investor Conferences Analysts Offer Insights on NA Companies: Fractyl Health, Inc. (GUTS) and GE Vernova Inc. (GEV) Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates",1,0,0,0,-1,-1
42.75M,"35,755",-19.90M,-1,452,4.000,Strong Buy,7.00,"Aug 7, 2024",LOGC,ContextLogic Inc.,143.99M,5.48,156.00M,0.57%,-3.48%,-1.50%,+0.56%,-4.74%,,,,,,,1,-1,-1,-1,-1,-1
15.16M,"5,897","-945,267",-1,14,11.23,,,,GALT,Galectin Therapeutics Inc.,143.86M,2.31,-,16.59%,12.67%,12.31%,+14.40%,-23.32%,Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Buy Rating Affirmed for Galectin Therapeutics Ahead of Phase 2b Interim Analysis and with Strong Cash Position,"Galectin Therapeutics sees cash runway through May 15, 2025",Galectin Therapeutics reports Q2 EPS (20c) vs. (15c) last year,,"Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference Buy Rating Affirmed for Galectin Therapeutics Ahead of Phase 2b Interim Analysis and with Strong Cash Position Galectin Therapeutics sees cash runway through May 15, 2025 Galectin Therapeutics reports Q2 EPS (20c) vs. (15c) last year",1,0,0,1,1,-1
,,,-1,,,,,,BANX,ArrowMark Financial Corp.,143.80M,20.21,29.95M,3.96%,6.05%,10.07%,+4.44%,+9.18%,ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of July 2024,,,,,ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of July 2024,0,0,-1,-1,-1,-1
21.67M,"26,310",7.80M,$1.00,159,7.83,Strong Buy,9.00,"Aug 7, 2024",QSI,Quantum-Si incorporated,143.78M,1.01,1.70M,3.93%,-5.07%,-36.44%,-12.72%,-47.73%,Quantum-Si Announces Executive Leadership Transition,Quantum-Si names Todd Bennet chief commercial officer,Quantum-Si Shares Updated Corporate Presentation,,,Quantum-Si Announces Executive Leadership Transition Quantum-Si names Todd Bennet chief commercial officer Quantum-Si Shares Updated Corporate Presentation,0,0,0,0,-1,-1
,,,-1,59,,,,,ATYR,"aTyr Pharma, Inc.",143.25M,1.89,588.00K,-0.48%,5.52%,12.21%,-6.57%,-0.54%,"Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls",aTyr Pharma initiated with a Buy at Jefferies,aTyr Pharma to Participate in September Investor Conferences,Buy Rating on aTyr Pharma Anchored by Upcoming Clinical Trials and Strong Financials,RBC Capital Reaffirms Their Buy Rating on aTyr Pharma (ATYR),"Dollar Tree downgraded, Roku upgraded: Wall Street’s top analyst calls aTyr Pharma initiated with a Buy at Jefferies aTyr Pharma to Participate in September Investor Conferences Buy Rating on aTyr Pharma Anchored by Upcoming Clinical Trials and Strong Financials RBC Capital Reaffirms Their Buy Rating on aTyr Pharma (ATYR)",0,1,0,0,0,0
34.54M,"90,422",-66.21M,-1,550,4.90,Buy,5.50,"Aug 7, 2024",NIU,Niu Technologies,142.78M,1.84,392.32M,1.76%,-1.31%,-5.60%,-7.58%,-4.69%,Value Meets High Tech As NIU Debuts New Series of Electric Kick Scooters and a Nationwide Launch Within Top US Retailers,Niu Technologies Sees Revenue Rise Amidst Growing Losses,,,,Value Meets High Tech As NIU Debuts New Series of Electric Kick Scooters and a Nationwide Launch Within Top US Retailers Niu Technologies Sees Revenue Rise Amidst Growing Losses,1,1,1,-1,-1,-1
13.21M,"3,061",15.17M,-1,,12.80,Buy,17.00,"Jul 25, 2024",ISRL,Israel Acquisitions Corp,142.62M,11.13,-,0.33%,0.88%,3.18%,+1.18%,+3.73%,Israel Acquisitions Corp. Abandons Pomvom Merger Plans,"Israel Acquisitions, Pomvom terminate business combination agreement",,,,"Israel Acquisitions Corp. Abandons Pomvom Merger Plans Israel Acquisitions, Pomvom terminate business combination agreement",0,0,0,-1,-1,-1
90.70M,"243,282",16.32M,-1,230,1.860,Hold,,"Jul 31, 2024",MASS,908 Devices Inc.,142.44M,4.11,52.69M,-9.72%,-18.74%,-37.75%,-29.88%,-37.85%,908 Devices Updates Investors with New Presentation,,,,,908 Devices Updates Investors with New Presentation,1,0,-1,-1,-1,-1
35.32M,"70,062",-196.00M,-1,651,4.745,Strong Buy,8.67,"Aug 7, 2024",TRVG,trivago N.V.,141.85M,2.03,503.10M,-4.06%,-4.91%,-17.99%,-5.66%,-26.47%,,,,,,,0,-1,-1,-1,-1,-1
57.08M,"521,778","599,611",-1,394,2.930,,,"Sep 3, 2024",DTI,Drilling Tools International Corporation,141.25M,4.07,147.83M,-8.42%,-19.95%,-4.24%,-29.20%,-13.46%,,,,,,,1,-1,-1,-1,-1,-1
47.73M,"143,012",-85.28M,-1,114,3.500,Strong Buy,10.67,"Aug 1, 2024",UBFO,United Security Bancshares,140.83M,8.13,51.73M,1.91%,4.66%,4.25%,+0.99%,+10.88%,,,,,,,1,-1,-1,-1,-1,-1
15.25M,"40,045",-52.88M,-1,490,10.95,Strong Buy,40.50,"Sep 6, 2024",TSAT,Telesat Corporation,140.43M,10.18,471.70M,23.08%,27.24%,17.71%,+34.11%,+31.22%,Short Report: Bearish positioning in Madrigal Pharmaceuticals at 3-month high,Hold Rating on Telesat: Weighing Solid Performance Against Future Challenges and Competition,"Telesat Reports Q2 Revenue Decline, Eyes Future Growth",Telesat sees FY24 revenue C$545M-C$565M,Telesat reports Q2 EPS C$2.45 vs. C$10.05 last year,"Short Report: Bearish positioning in Madrigal Pharmaceuticals at 3-month high Hold Rating on Telesat: Weighing Solid Performance Against Future Challenges and Competition Telesat Reports Q2 Revenue Decline, Eyes Future Growth Telesat sees FY24 revenue C$545M-C$565M Telesat reports Q2 EPS C$2.45 vs. C$10.05 last year",0,0,0,1,1,0
7.64M,"15,965",10.92M,$0.60,132,21.85,Buy,21.00,"Oct 16, 2024",OPTN,"OptiNose, Inc.",139.69M,0.93,75.06M,6.94%,-1.09%,-16.34%,-1.90%,-21.97%,Optinose announces peer-review publication on EDS-FLU efficacy,New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery,Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference,,,Optinose announces peer-review publication on EDS-FLU efficacy New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus Surgery Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference,1,0,0,0,-1,-1
16.57M,"461,477",24.17M,$0.06,69,10.05,,,"Aug 12, 2024",VIGL,"Vigil Neuroscience, Inc.",139.16M,3.51,-,-1.82%,-10.92%,-1.62%,-15.83%,+5.41%,Vigil Neuroscience to Present at Upcoming September Investor Conferences,Morgan Stanley Reaffirms Their Sell Rating on Vigil Neuroscience Inc (VIGL),Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim,Buy Rating Affirmed for Vigil Neuroscience Inc on Promising Drug Trials and Regulatory Prospects,Buy Rating Affirmed for Vigil Neuroscience Amid Strong Clinical Progress and Robust Financial Position,Vigil Neuroscience to Present at Upcoming September Investor Conferences Morgan Stanley Reaffirms Their Sell Rating on Vigil Neuroscience Inc (VIGL) Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim Buy Rating Affirmed for Vigil Neuroscience Inc on Promising Drug Trials and Regulatory Prospects Buy Rating Affirmed for Vigil Neuroscience Amid Strong Clinical Progress and Robust Financial Position,0,0,0,0,0,0
22.16M,"58,448",-17.51M,$0.17,,7.51,Strong Buy,13.00,"Aug 8, 2024",CZWI,"Citizens Community Bancorp, Inc.",138.71M,13.47,60.69M,5.08%,10.06%,15.52%,+3.17%,+13.81%,,,,,,,1,-1,-1,-1,-1,-1
48.89M,"61,187",-1.02M,$0.18,,3.400,Buy,3.50,"Aug 5, 2024",CRDL,Cardiol Therapeutics Inc.,138.69M,1.98,-,-4.37%,-6.25%,17.12%,-11.11%,+1.05%,Cardiol Therapeutics Inc.: Financial Update,,,,,Cardiol Therapeutics Inc.: Financial Update,0,0,-1,-1,-1,-1
7.54M,"7,507",16.98M,$1.28,6,22.02,,,"Oct 23, 2024",VOXR,Vox Royalty Corp.,138.03M,2.74,12.23M,-1.40%,1.12%,24.01%,-8.39%,+30.00%,Vox Royalty Gold Assets Shine in Western Australia,Vox Royalty provides development update on Western Australia gold royalty assets,Buy Rating on Vox Royalty: Strong Financials and Growth Prospects,,,Vox Royalty Gold Assets Shine in Western Australia Vox Royalty provides development update on Western Australia gold royalty assets Buy Rating on Vox Royalty: Strong Financials and Growth Prospects,0,0,0,1,-1,-1
53.17M,"43,646",-68.20M,-1,370,3.120,Strong Buy,5.25,"Aug 12, 2024",LTRX,"Lantronix, Inc.",137.92M,3.67,146.18M,-2.37%,-3.39%,-18.46%,-12.68%,+12.93%,Lantronix (LTRX) Receives a Buy from Craig-Hallum,Closing Bell Movers: Broadcom slips 7% after Q3 results,Lantronix Reports Record Revenue and EPS Growth,"Lantronix sees Q1 EPS 7c-11c, consensus 9c","Lantronix reports Q4 EPS 15c, consensus 15c","Lantronix (LTRX) Receives a Buy from Craig-Hallum Closing Bell Movers: Broadcom slips 7% after Q3 results Lantronix Reports Record Revenue and EPS Growth Lantronix sees Q1 EPS 7c-11c, consensus 9c Lantronix reports Q4 EPS 15c, consensus 15c",0,0,0,1,1,1
21.38M,737,-27.97M,-1,79,7.79,,,"Aug 14, 2024",SMXT,"SolarMax Technology, Inc.",137.76M,3.06,36.74M,-17.61%,-22.20%,-58.17%,-59.91%,-84.96%,SolarMax expands U.S. footprint with new solar project in California,SolarMax Technology Expands US Footprint with New Commercial Solar Project in California,SolarMax Technology Reports Second Quarter 2024 Financial Results,,,SolarMax expands U.S. footprint with new solar project in California SolarMax Technology Expands US Footprint with New Commercial Solar Project in California SolarMax Technology Reports Second Quarter 2024 Financial Results,1,0,1,0,-1,-1
,,,-1,,,,,,CFBK,CF Bankshares Inc.,137.73M,21.56,43.66M,-2.16%,3.97%,9.97%,+2.66%,-3.59%,,,,,,,1,-1,-1,-1,-1,-1
94.55M,"372,837",-16.06M,-1,,1.750,Strong Buy,3.50,"Aug 13, 2024",INMB,"INmune Bio, Inc.",137.34M,6.95,85.00K,-2.98%,-10.59%,-29.80%,-20.49%,-33.95%,INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference,INmune Bio initiated with an Outperform at Scotiabank on Alzheimer’s potential,Scotiabank starts INmune with Outperform on Alzheimer’s potential,INmune Bio initiated with an Outperform at Scotiabank,,INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference INmune Bio initiated with an Outperform at Scotiabank on Alzheimer’s potential Scotiabank starts INmune with Outperform on Alzheimer’s potential INmune Bio initiated with an Outperform at Scotiabank,1,0,1,1,1,-1
10.51M,"36,302",4.02M,$0.92,54,15.74,,,"Sep 5, 2024",ELUT,Elutia Inc.,137.26M,4.03,24.99M,16.49%,4.49%,25.57%,+9.04%,+28.80%,Elutia Celebrates First Year,Aziyo Biologics (ELUT) Receives a Buy from Lake Street,Aziyo Biologics (ELUT) Receives a Buy from Cantor Fitzgerald,Elutia:1st patient implanted with biologic envelope EluPro for pacemakers,"Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators","Elutia Celebrates First Year Aziyo Biologics (ELUT) Receives a Buy from Lake Street Aziyo Biologics (ELUT) Receives a Buy from Cantor Fitzgerald Elutia:1st patient implanted with biologic envelope EluPro for pacemakers Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators",0,1,0,1,0,0
14.13M,104,4.71M,-1,126,11.72,,,,MAMO,Massimo Group,137.19M,3.32,135.02M,-9.65%,-14.63%,-16.55%,-20.25%,-17.90%,Massimo Group Reports Second Quarter 2024 Financial Results,,,,,Massimo Group Reports Second Quarter 2024 Financial Results,0,1,-1,-1,-1,-1
,,,-1,93,,,,,AFBI,"Affinity Bancshares, Inc.",136.65M,21.31,30.15M,0.44%,0.77%,21.69%,-0.70%,+32.46%,,,,,,,1,-1,-1,-1,-1,-1
29.31M,"118,632",-57.21M,-1,"7,827",5.75,Strong Buy,14.00,"Aug 14, 2024",BZUN,Baozun Inc.,136.19M,2.29,1.23B,-0.48%,-5.43%,-10.79%,-6.33%,-4.72%,Baozun Inc. Modifies Share Capital Through Repurchases,Baozun Conducts Share Buyback,Baozun Inc. Maintains Stable Share Capital,Baozun Executes Strategic Share Repurchases,Baozun downgraded to Hold from Outperform at CLSA,Baozun Inc. Modifies Share Capital Through Repurchases Baozun Conducts Share Buyback Baozun Inc. Maintains Stable Share Capital Baozun Executes Strategic Share Repurchases Baozun downgraded to Hold from Outperform at CLSA,1,0,1,1,1,1
506.01M,"2,293,921",-631.48M,-1,400,0.323,Hold,0.47,"Aug 8, 2024",GRWG,GrowGeneration Corp.,136.09M,2.30,206.55M,-4.98%,-11.10%,-16.98%,-13.42%,-29.33%,Lake Street Issues a Buy Rating on GrowGeneration (GRWG),Roth MKM Reaffirms Their Hold Rating on GrowGeneration (GRWG),,,,Lake Street Issues a Buy Rating on GrowGeneration (GRWG) Roth MKM Reaffirms Their Hold Rating on GrowGeneration (GRWG),0,0,0,-1,-1,-1
8.99M,"17,623",9.55M,$1.01,112,18.16,,,"Aug 9, 2024",CSPI,CSP Inc.,135.81M,13.91,57.51M,-4.26%,-6.17%,-5.12%,-9.70%,-25.98%,CSP Inc. reports Q3 EPS (2c) vs. 26c last year,,,,,CSP Inc. reports Q3 EPS (2c) vs. 26c last year,0,1,-1,-1,-1,-1
11.39M,"6,690",12.67M,-1,927,14.26,,,"Jul 18, 2024",BIRD,"Allbirds, Inc.",135.65M,0.86,220.14M,12.61%,21.72%,-3.64%,+18.10%,+13.36%,"Allbirds trading halted, news pending",Allbirds Announces Reverse Stock Split and SEC Updates,Allbirds Announces 1-For-20 Reverse Stock Split,Allbirds announces 1-for-20 reverse stock split,"Allbirds: Ravi Thanawala, Chief Financial Officer of Papa John’s joins board","Allbirds trading halted, news pending Allbirds Announces Reverse Stock Split and SEC Updates Allbirds Announces 1-For-20 Reverse Stock Split Allbirds announces 1-for-20 reverse stock split Allbirds: Ravi Thanawala, Chief Financial Officer of Papa John’s joins board",1,0,0,0,0,1
14.97M,"633,943",5.45M,-1,8,10.82,,,,CRVO,CervoMed Inc.,134.70M,16.32,9.65M,15.84%,4.46%,6.92%,+25.31%,-20.54%,CervoMed to Participate in Upcoming Investor Conferences,CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies,CervoMed’s Neflamapimod Shows Promise in DLB: A Buy Rating with a $65 Price Target,CervoMed Updates Investors on Business and Clinical Progress,Morgan Stanley Sticks to Their Buy Rating for CervoMed (CRVO),CervoMed to Participate in Upcoming Investor Conferences CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies CervoMed’s Neflamapimod Shows Promise in DLB: A Buy Rating with a $65 Price Target CervoMed Updates Investors on Business and Clinical Progress Morgan Stanley Sticks to Their Buy Rating for CervoMed (CRVO),1,0,1,0,1,0
,,,-1,895,,,,,PRCH,"Porch Group, Inc.",134.62M,1.34,470.46M,-3.57%,-15.24%,-43.88%,-36.10%,-69.82%,Porch Group management to meet virtually with Stephens,Craig-Hallum Remains a Buy on Porch Group (PRCH),,,,Porch Group management to meet virtually with Stephens Craig-Hallum Remains a Buy on Porch Group (PRCH),1,1,0,-1,-1,-1
80.91M,"20,107",-45.53M,-1,134,2.000,Strong Buy,3.00,"Aug 6, 2024",BWAY,BrainsWay Ltd.,134.12M,8.02,36.43M,9.35%,18.02%,31.69%,+9.12%,+47.66%,BrainsWay Welcomes New Chief Medical Officer,Brainsway appoints Bermudes as CMO,"BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer",,,"BrainsWay Welcomes New Chief Medical Officer Brainsway appoints Bermudes as CMO BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer",0,0,1,0,-1,-1
131.72M,"975,944",-171.53M,-1,182,1.220,Strong Buy,8.00,"Aug 13, 2024",CXDO,"Crexendo, Inc.",133.84M,5.01,57.01M,8.86%,27.59%,15.93%,+23.50%,-2.65%,Crexendo surpasses 5M global users,,,,,Crexendo surpasses 5M global users,1,1,-1,-1,-1,-1
115.21M,"1,402,925",-29.34M,-1,207,1.390,Buy,7.10,"Aug 8, 2024",WILC,G. Willi-Food International Ltd.,133.68M,9.64,144.85M,5.26%,7.92%,6.58%,+4.55%,-2.39%,Willi-Food Reports Strong Growth in Q2 2024,G. WILLI-FOOD INTERNATIONAL REPORTS THE RESULTS OF SECOND QUARTER 2024,,,,Willi-Food Reports Strong Growth in Q2 2024 G. WILLI-FOOD INTERNATIONAL REPORTS THE RESULTS OF SECOND QUARTER 2024,0,0,0,-1,-1,-1
6.83M,"8,999",9.17M,$0.60,49,23.44,Buy,26.50,"Jul 25, 2024",QUIK,QuickLogic Corporation,133.66M,9.24,24.28M,-6.19%,-15.91%,-31.45%,-24.44%,-42.86%,Craig-Hallum Remains a Buy on QuickLogic (QUIK),QuickLogic price target lowered to $12 from $16 at Craig-Hallum,Oppenheimer Sticks to Their Buy Rating for QuickLogic (QUIK),QuickLogic price target lowered to $13 from $16 at Oppenheimer,"Closing Bell Movers: Flutter jumps 10% on earnings, guidance raise","Craig-Hallum Remains a Buy on QuickLogic (QUIK) QuickLogic price target lowered to $12 from $16 at Craig-Hallum Oppenheimer Sticks to Their Buy Rating for QuickLogic (QUIK) QuickLogic price target lowered to $13 from $16 at Oppenheimer Closing Bell Movers: Flutter jumps 10% on earnings, guidance raise",1,0,0,0,0,1
12.28M,"182,615",-43.10M,-1,"1,321",13.02,Hold,12.50,"Aug 7, 2024",SNCR,"Synchronoss Technologies, Inc.",133.37M,12.85,167.62M,20.87%,36.56%,73.17%,+31.29%,+71.50%,Synchronoss Technologies to Present at the Sidoti Virtual Investor Conference,,,,,Synchronoss Technologies to Present at the Sidoti Virtual Investor Conference,1,1,-1,-1,-1,-1
46.70M,"9,733",-11.75M,-1,,3.380,,,"Sep 6, 2024",CTOR,"Citius Oncology, Inc.",133.34M,1.87,-,-83.06%,-83.56%,-83.17%,-85.89%,-85.21%,"Citius Pharmaceuticals selloff since spinout an opportunity, says EF Hutton",,,,,"Citius Pharmaceuticals selloff since spinout an opportunity, says EF Hutton",1,0,-1,-1,-1,-1
70.67M,"1,055,119",-171.30M,-1,"5,900",2.260,Buy,12.50,"Aug 8, 2024",MPAA,"Motorcar Parts of America, Inc.",133.34M,6.75,727.87M,8.59%,9.07%,-9.73%,+11.57%,-4.12%,,,,,,,0,-1,-1,-1,-1,-1
39.97M,"83,894",,-1,"1,700",3.970,,,"Sep 3, 2024",PRPL,"Purple Innovation, Inc.",133.30M,1.24,526.24M,11.30%,12.21%,3.40%,-7.25%,-34.69%,"Airbnb, Booking Holdings downgraded: Wall Street’s top analyst calls",Wedbush downgrades Purple Innovation on slot loss at retailers,Purple Innovation downgraded to Neutral from Outperform at Wedbush,Purple Innovation (PRPL) Receives a Rating Update from a Top Analyst,Purple Innovation Restructures for Operational Efficiency,"Airbnb, Booking Holdings downgraded: Wall Street’s top analyst calls Wedbush downgrades Purple Innovation on slot loss at retailers Purple Innovation downgraded to Neutral from Outperform at Wedbush Purple Innovation (PRPL) Receives a Rating Update from a Top Analyst Purple Innovation Restructures for Operational Efficiency",0,1,0,1,0,0
,,,-1,15,,,,,SUUN,SolarBank Corporation,133.29M,4.30,44.05M,-9.97%,-20.69%,-21.13%,-21.08%,-19.43%,SolarBank Corp. to Energize 800+ Homes in New York,SolarBank to develop 6.41 MW community solar power project in New York state,SolarBank Corp. Launches Green Energy Initiative in NY,,,SolarBank Corp. to Energize 800+ Homes in New York SolarBank to develop 6.41 MW community solar power project in New York state SolarBank Corp. Launches Green Energy Initiative in NY,0,0,0,1,-1,-1
87.36M,"73,821",-1.37M,-1,162,1.820,,,"Aug 16, 2024",CBFV,"CB Financial Services, Inc.",133.07M,25.88,66.58M,8.18%,13.44%,17.34%,+12.35%,+24.51%,,,,,,,0,-1,-1,-1,-1,-1
3.12M,"25,667",9.00M,-1,123,50.97,,,"Aug 15, 2024",IVA,Inventiva S.A.,133.04M,2.40,25.60M,7.35%,-3.62%,-30.47%,+4.61%,-34.56%,Inventiva’s Lanifibranor: A Buy Rating with a $20 PT on Strong Phase III Prospects and Combination Therapy Potential,,,,,Inventiva’s Lanifibranor: A Buy Rating with a $20 PT on Strong Phase III Prospects and Combination Therapy Potential,1,1,-1,-1,-1,-1
15.75M,101,"824,630",-1,533,10.02,,,,LGO,Largo Inc.,132.93M,2.07,158.90M,6.20%,4.35%,4.05%,-1.90%,+33.77%,Largo Inc. Advances Cost-Cutting Measures in Brazil,Largo provides update on cost reduction initiatives at Brazil vanadium operation,Largo Resources Faces Q2 Revenue Decline,Largo price target lowered to $4.40 from $4.70 at H.C. Wainwright,,Largo Inc. Advances Cost-Cutting Measures in Brazil Largo provides update on cost reduction initiatives at Brazil vanadium operation Largo Resources Faces Q2 Revenue Decline Largo price target lowered to $4.40 from $4.70 at H.C. Wainwright,1,0,0,1,0,-1
,,,-1,,,,,,FRAF,Franklin Financial Services Corporation,132.93M,30.15,69.34M,-2.02%,2.23%,3.26%,-8.90%,+18.67%,UBS Sticks to Their Buy Rating for AIR France KLM (0LN7),Declaration of number of voting rights,Air France-KLM upgraded to Neutral from Sell at Redburn Atlantic,Buy Rating Justified: AIR France-KLM’s Resilience and Strategic Growth Prospects,Air France-KLM Expands Reach with SAS Stake Acquisition,UBS Sticks to Their Buy Rating for AIR France KLM (0LN7) Declaration of number of voting rights Air France-KLM upgraded to Neutral from Sell at Redburn Atlantic Buy Rating Justified: AIR France-KLM’s Resilience and Strategic Growth Prospects Air France-KLM Expands Reach with SAS Stake Acquisition,1,1,0,1,1,1
18.32M,"67,104",-17.91M,-1,,8.60,Buy,13.50,"Aug 8, 2024",BLUE,"bluebird bio, Inc.",132.74M,0.69,21.73M,-29.39%,-36.41%,-57.04%,-46.27%,-49.33%,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC",Bluebird Bio Works to Resolve Financial Reporting Delays,Bluebird Bio receives noncompliance notices from Nasdaq,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), ImmunityBio (IBRX) and Neurocrine (NBIX)",Bluebird Bio: A Hold Rating Amid Operational Challenges and Financial Uncertainty,"Thursday’s top analyst calls: Apple, Dell, Amazon, Broadcom, CrowdStrike, PNC Bluebird Bio Works to Resolve Financial Reporting Delays Bluebird Bio receives noncompliance notices from Nasdaq Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), ImmunityBio (IBRX) and Neurocrine (NBIX) Bluebird Bio: A Hold Rating Amid Operational Challenges and Financial Uncertainty",1,1,1,1,1,1
9.88M,"12,493",6.12M,-1,13,15.83,,,"Sep 3, 2024",NVCT,"Nuvectis Pharma, Inc.",132.43M,7.10,-,4.57%,5.07%,-7.69%,+10.55%,-9.77%,Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference,"Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers",Nuvectis Pharma announces U.S. FDA granted ODD for NXP800,Nuvectis Pharma cancer treatment granted FDA orphan designation,,"Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers Nuvectis Pharma announces U.S. FDA granted ODD for NXP800 Nuvectis Pharma cancer treatment granted FDA orphan designation",1,0,0,0,0,-1
82.79M,"91,315",-92.40M,-1,116,1.900,Buy,4.70,"Aug 14, 2024",FBYD,"Falcon's Beyond Global, Inc.",132.30M,11.50,7.04M,-3.41%,-4.53%,-6.21%,-8.21%,-2.39%,,,,,,,0,-1,-1,-1,-1,-1
34.63M,"59,767",-10.04M,-1,"4,800",4.555,,,"Sep 3, 2024",CTRN,"Citi Trends, Inc.",132.14M,15.95,754.54M,-7.62%,-18.28%,-36.73%,-26.98%,-42.90%,You’ll need this credit score for the Citi Simplicity,"Earn 5% cash back with PayPal’s debit card, even if you have bad credit",Citi names 2 stocks that are unlikely to be affected by political or rate changes,Analysts like these stocks which are cheaper and expected to enjoy earnings growth,Best cash-back credit cards of 2024,"You’ll need this credit score for the Citi Simplicity Earn 5% cash back with PayPal’s debit card, even if you have bad credit Citi names 2 stocks that are unlikely to be affected by political or rate changes Analysts like these stocks which are cheaper and expected to enjoy earnings growth Best cash-back credit cards of 2024",1,1,1,1,1,0
14.35M,"30,837","400,351",-1,233,10.93,,,,MCRB,"Seres Therapeutics, Inc.",132.11M,0.87,374.00K,-16.06%,-15.84%,-17.42%,-39.64%,+6.06%,Seres Therapeutics strength attributed to Betaville rumor mention,Buy Rating Affirmed for Seres Therapeutics’ SER-155 Amid Anticipated Positive Impact on Infection and GvHD Rates,Seres Therapeutics Releases Financial Statements Ahead of Asset Sale,Seres Therapeutics (MCRB) Gets a Hold from Oppenheimer,Buy Rating on Seres Therapeutics: Strategic Growth and Promising Clinical Trials Fuel Analyst Confidence,Seres Therapeutics strength attributed to Betaville rumor mention Buy Rating Affirmed for Seres Therapeutics’ SER-155 Amid Anticipated Positive Impact on Infection and GvHD Rates Seres Therapeutics Releases Financial Statements Ahead of Asset Sale Seres Therapeutics (MCRB) Gets a Hold from Oppenheimer Buy Rating on Seres Therapeutics: Strategic Growth and Promising Clinical Trials Fuel Analyst Confidence,1,1,0,1,0,1
,,,-1,434,,,,,ALLT,Allot Ltd.,131.66M,3.43,93.91M,6.21%,17.26%,55.47%,+11.26%,+40.52%,Allot (ALLT) Receives a Rating Update from a Top Analyst,Allot Ltd. reports Q2 EPS (9c) vs (55c) last year,Allot Announces Second Quarter 2024 Financial Results,Allot Steadies in Q2 with Growth in SECaaS,"Allot to Release Second Quarter 2024 Earnings and Host Conference Call on August 27, 2024","Allot (ALLT) Receives a Rating Update from a Top Analyst Allot Ltd. reports Q2 EPS (9c) vs (55c) last year Allot Announces Second Quarter 2024 Financial Results Allot Steadies in Q2 with Growth in SECaaS Allot to Release Second Quarter 2024 Earnings and Host Conference Call on August 27, 2024",1,0,1,0,1,1
14.18M,"34,674",2.47M,-1,77,11.02,,,"Jul 31, 2024",IMUX,"Immunic, Inc.",131.52M,1.46,-,1.70%,7.83%,9.84%,-1.40%,+10.16%,Piper Sandler Sticks to Their Buy Rating for Immunic (IMUX),Immunic enrolls first patient in vidofludimus calcium trial,Immunic CEO Says “Right Time” to Buy the Stock Now – Part 2,Immunic initiated with a Buy at B. Riley,Buy Rating Affirmed for Immunic’s MS Treatment Vido with Unique Dual Mechanism and Promising Clinical Data,Piper Sandler Sticks to Their Buy Rating for Immunic (IMUX) Immunic enrolls first patient in vidofludimus calcium trial Immunic CEO Says “Right Time” to Buy the Stock Now – Part 2 Immunic initiated with a Buy at B. Riley Buy Rating Affirmed for Immunic’s MS Treatment Vido with Unique Dual Mechanism and Promising Clinical Data,0,0,0,0,0,0
4.07M,"25,665",16.31M,-1,174,38.38,,,"Aug 8, 2024",ADAG,Adagene Inc.,130.60M,2.95,815.75K,18.56%,12.59%,15.69%,+11.76%,+0.35%,,,,,,,1,-1,-1,-1,-1,-1
27.36M,"112,918",2.74M,-1,,5.70,Strong Buy,14.00,"Aug 13, 2024",GATE,Marblegate Acquisition Corp.,130.60M,11.02,-,2.08%,4.40%,7.58%,+6.12%,+9.05%,,,,,,,1,-1,-1,-1,-1,-1
6.99M,"6,099",4.22M,$0.76,207,22.29,,,"Jul 30, 2024",FEIM,"Frequency Electronics, Inc.",130.47M,13.68,55.27M,12.74%,34.83%,48.55%,+4.56%,+39.69%,"Frequency Electronics Announces First Quarter Fiscal 2025 Financial Results Conference Call: Tuesday, September 10, 2024, at 4:30 PM ET","Frequency Electronics, Inc. Announces Inaugural Quantum Sensing Summit: A Pioneering Event to Shape the Future of Quantum Technology",,,,"Frequency Electronics Announces First Quarter Fiscal 2025 Financial Results Conference Call: Tuesday, September 10, 2024, at 4:30 PM ET Frequency Electronics, Inc. Announces Inaugural Quantum Sensing Summit: A Pioneering Event to Shape the Future of Quantum Technology",1,1,0,-1,-1,-1
29.61M,"84,799",-18.74M,-1,,5.25,,,"Aug 13, 2024",HBIO,"Harvard Bioscience, Inc.",130.40M,2.99,101.13M,1.65%,0.42%,-23.11%,-6.88%,-34.07%,"Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference",,,,,"Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference",0,0,-1,-1,-1,-1
79.36M,"170,969",-24.99M,-1,,1.960,Strong Buy,4.50,"Sep 16, 2024",GEOS,Geospace Technologies Corporation,130.38M,10.10,129.48M,9.44%,8.93%,-14.26%,+9.22%,-27.16%,Geospace signs $11.9M OBX rental agreement,,,,,Geospace signs $11.9M OBX rental agreement,1,1,-1,-1,-1,-1
34.34M,"95,249",-27.54M,-1,,4.510,Strong Buy,14.00,"Aug 13, 2024",FNGR,"FingerMotion, Inc.",130.20M,2.47,32.00M,18.79%,8.85%,-19.47%,+6.60%,-14.39%,FingerMotion’s Partner Earns China’s First MIIT Vehicle Tech Certification,,,,,FingerMotion’s Partner Earns China’s First MIIT Vehicle Tech Certification,1,0,-1,-1,-1,-1
14.66M,"252,293",4.09M,-1,,10.57,,,,FGBI,"First Guaranty Bancshares, Inc.",130.05M,10.40,95.59M,-2.04%,4.37%,-3.32%,-0.29%,+5.42%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,EHTH,"eHealth, Inc.",129.38M,4.40,471.20M,-7.41%,-11.06%,-32.20%,-23.73%,-22.41%,Ehealth (EHTH) Receives a Hold from Craig-Hallum,eHealth price target lowered to $2 from $5 at Deutsche Bank,,,,Ehealth (EHTH) Receives a Hold from Craig-Hallum eHealth price target lowered to $2 from $5 at Deutsche Bank,1,0,1,-1,-1,-1
19.11M,"185,299",-27.77M,-1,187,8.08,,,,GNSS,Genasys Inc.,129.35M,2.90,27.97M,12.92%,21.77%,48.15%,+13.73%,+23.93%,Genasys Receives ACOUSTICS Order from Alabama-Coushatta Tribe of Texas,Genasys announces order from Port of Houston,,,,Genasys Receives ACOUSTICS Order from Alabama-Coushatta Tribe of Texas Genasys announces order from Port of Houston,0,0,1,-1,-1,-1
5.29M,"48,274",16.40M,$0.76,,29.18,,,"Jul 22, 2024",CEP,"Cantor Equity Partners, Inc.",128.26M,10.02,-,0.02%,0.02%,0.02%,,,,,,,,,0,-1,-1,-1,-1,-1
69.92M,"8,952",-27.63M,-1,179,2.170,Strong Buy,11.75,"Aug 14, 2024",RPTX,Repare Therapeutics Inc.,127.76M,3.01,68.68M,-3.15%,-11.07%,-36.50%,-19.25%,-24.12%,Buy Rating on Repare Therapeutics: Strategic Reprioritization and Upcoming Catalysts Bolster Long-Term Prospects,Buy Rating on Repare Therapeutics Amidst Promising Clinical Trials and Strong Financials,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy bio (TSVT) and Repare Therapeutics (RPTX)",Stifel Nicolaus Reaffirms Their Buy Rating on Repare Therapeutics (RPTX),Strategic Restructuring and Promising Pipeline Underpin Buy Rating for Repare Therapeutics,"Buy Rating on Repare Therapeutics: Strategic Reprioritization and Upcoming Catalysts Bolster Long-Term Prospects Buy Rating on Repare Therapeutics Amidst Promising Clinical Trials and Strong Financials Analysts’ Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy bio (TSVT) and Repare Therapeutics (RPTX) Stifel Nicolaus Reaffirms Their Buy Rating on Repare Therapeutics (RPTX) Strategic Restructuring and Promising Pipeline Underpin Buy Rating for Repare Therapeutics",1,1,1,0,1,1
9.55M,"22,505",8.47M,$0.80,330,16.02,,,"Aug 1, 2024",AKYA,"Akoya Biosciences, Inc.",127.71M,2.58,93.22M,8.37%,7.55%,-35.73%,+4.05%,-41.06%,Piper Sandler Sticks to Their Buy Rating for Akoya Biosciences (AKYA),Akoya Biosciences price target lowered to $4 from $6 at Piper Sandler,,,,Piper Sandler Sticks to Their Buy Rating for Akoya Biosciences (AKYA) Akoya Biosciences price target lowered to $4 from $6 at Piper Sandler,0,0,0,-1,-1,-1
16.56M,"38,587",-75.42M,-1,67,9.21,,,,ATHA,"Athira Pharma, Inc.",127.62M,3.32,-,4.95%,10.01%,23.73%,+3.13%,+33.20%,Goldman Sachs moves Athira Pharma to Not Rated,Stifel Nicolaus Keeps Their Hold Rating on Athira Pharma (ATHA),Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw,Athira Pharma downgraded to Market Perform from Outperform at JMP Securities,Athira Pharma (ATHA) was downgraded to a Hold Rating at JMP Securities,Goldman Sachs moves Athira Pharma to Not Rated Stifel Nicolaus Keeps Their Hold Rating on Athira Pharma (ATHA) Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw Athira Pharma downgraded to Market Perform from Outperform at JMP Securities Athira Pharma (ATHA) was downgraded to a Hold Rating at JMP Securities,1,0,1,1,1,1
15.01M,"1,710",,-1,"1,456",10.12,,,,AXTI,"AXT, Inc.",127.44M,2.94,88.41M,-3.59%,-18.13%,-16.41%,-27.47%,-15.11%,AXT (AXTI) Gets a Buy from Craig-Hallum,,,,,AXT (AXTI) Gets a Buy from Craig-Hallum,1,0,-1,-1,-1,-1
,,,-1,324,,,,,MRBK,Meridian Corporation,126.70M,11.50,90.80M,6.16%,6.80%,6.94%,-0.43%,+26.09%,,,,,,,0,-1,-1,-1,-1,-1
20.80M,"229,235",-99.86M,-1,189,7.32,Strong Buy,28.17,"Aug 12, 2024",VERU,Veru Inc.,126.53M,0.86,14.09M,-0.02%,-3.67%,-3.04%,-13.62%,-12.58%,"Veru Ends Sales Agreement with Jefferies, Halts Stock Sales",Analysts Offer Insights on Healthcare Companies: Veru (VERU) and ACADIA Pharmaceuticals (ACAD),,,,"Veru Ends Sales Agreement with Jefferies, Halts Stock Sales Analysts Offer Insights on Healthcare Companies: Veru (VERU) and ACADIA Pharmaceuticals (ACAD)",0,0,0,-1,-1,-1
20.62M,"8,197",-28.77M,-1,93,7.12,,,"Mar 14, 2024",XFOR,"X4 Pharmaceuticals, Inc.",126.37M,0.75,563.00K,0.67%,-6.09%,-22.72%,-13.76%,-49.64%,X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences,X4 Pharmaceuticals Unveils Corporate Presentation for Investors,Stifel Nicolaus Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR),,X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences X4 Pharmaceuticals Unveils Corporate Presentation for Investors Stifel Nicolaus Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR),0,0,0,0,1,-1
68.08M,"364,074",-165.87M,-1,224,2.230,Buy,5.20,"Aug 8, 2024",NTIC,Northern Technologies International Corporation,126.13M,13.36,82.42M,3.09%,-6.94%,-6.13%,+1.59%,+13.39%,,,,,,,1,-1,-1,-1,-1,-1
84.72M,"556,054",-131.39M,-1,72,1.790,Strong Buy,12.50,"Aug 8, 2024",ALXO,ALX Oncology Holdings Inc.,125.89M,2.39,-,-12.63%,-51.00%,-77.45%,-51.25%,-80.87%,Largest borrow rate increases among liquid names,Maintaining Buy Rating on ALX Oncology: Promising Clinical Data and Anticipated Progress of Evorpacept,ALX Oncology Holdings (ALXO) Receives a Hold from Stifel Nicolaus,,,Largest borrow rate increases among liquid names Maintaining Buy Rating on ALX Oncology: Promising Clinical Data and Anticipated Progress of Evorpacept ALX Oncology Holdings (ALXO) Receives a Hold from Stifel Nicolaus,1,1,0,1,-1,-1
15.63M,"177,268",4.78M,-1,696,9.70,Strong Buy,14.00,"Aug 7, 2024",VERI,"Veritone, Inc.",125.66M,3.30,131.96M,1.17%,4.98%,5.87%,+9.89%,-55.78%,Veritone and Nuix team on AI expertise for investigations and eDiscovery,Veritone announces multi-year agreement with NCAA,,,,Veritone and Nuix team on AI expertise for investigations and eDiscovery Veritone announces multi-year agreement with NCAA,0,0,1,-1,-1,-1
12.46M,"6,676",8.29M,$0.40,"1,919",12.14,,,"Jul 31, 2024",KLXE,"KLX Energy Services Holdings, Inc.",125.64M,7.45,769.70M,13.85%,28.82%,-2.26%,+3.19%,-6.57%,,,,,,,0,-1,-1,-1,-1,-1
4.60M,"2,141",7.96M,-1,,32.88,,,"Aug 14, 2024",YIBO,Planet Image International Limited,125.54M,2.33,150.22M,-23.06%,-9.70%,-11.70%,-50.23%,-21.03%,,,,,,,0,-1,-1,-1,-1,-1
41.80M,"1,412,031",-579.21M,-1,,3.610,Hold,6.33,"Aug 8, 2024",AGEN,Agenus Inc.,125.12M,5.80,159.63M,5.17%,-43.06%,-54.17%,-15.40%,-49.28%,Agenus price target lowered to $18 from $42 at B. Riley,Agenus: Strong Clinical Potential Amidst Regulatory Challenges and Revised Market Entry Forecast,,,,Agenus price target lowered to $18 from $42 at B. Riley Agenus: Strong Clinical Potential Amidst Regulatory Challenges and Revised Market Entry Forecast,1,0,1,-1,-1,-1
52.49M,"120,245",-197.68M,-1,83,2.870,Sell,3.33,"Aug 14, 2024",MRAM,"Everspin Technologies, Inc.",125.02M,5.75,58.24M,1.41%,-5.05%,-24.23%,-10.79%,-28.15%,Craig-Hallum Sticks to Their Buy Rating for Everspin Technologies (MRAM),Everspin awarded $14.55M to provide stable on-shore MRAM manufacturing,Everspin Technologies (MRAM) Receives a Buy from Craig-Hallum,,,Craig-Hallum Sticks to Their Buy Rating for Everspin Technologies (MRAM) Everspin awarded $14.55M to provide stable on-shore MRAM manufacturing Everspin Technologies (MRAM) Receives a Buy from Craig-Hallum,1,0,0,0,-1,-1
37.10M,"521,174",-19.67M,-1,,4.050,Strong Buy,14.00,"Aug 28, 2024",HNVR,"Hanover Bancorp, Inc.",124.70M,17.50,61.91M,-0.95%,1.06%,1.37%,+8.70%,+21.46%,,,,,,,0,-1,-1,-1,-1,-1
10.25M,"41,207",5.51M,-1,,14.52,Strong Buy,23.00,"Aug 14, 2024",RMBI,"Richmond Mutual Bancorporation, Inc.",124.67M,12.57,41.64M,2.37%,4.96%,8.94%,+3.89%,+6.81%,"RICHMOND MUTUAL BANCORPORATION, INC. ANNOUNCES QUARTERLY DIVIDEND",,,,,"RICHMOND MUTUAL BANCORPORATION, INC. ANNOUNCES QUARTERLY DIVIDEND",1,1,-1,-1,-1,-1
2.84M,"43,786",18.75M,-1,205,52.30,,,"Sep 3, 2024",AMTX,"Aemetis, Inc.",124.60M,2.64,278.65M,-8.13%,-19.11%,-35.70%,-24.92%,-53.83%,"Analysts Conflicted on These Energy Names: Ovintiv (OVV), Aemetis (AMTX) and Riley Exploration Permian (REPX)",Aemetis files $234M mixed securities shelf,,,,"Analysts Conflicted on These Energy Names: Ovintiv (OVV), Aemetis (AMTX) and Riley Exploration Permian (REPX) Aemetis files $234M mixed securities shelf",1,1,0,-1,-1,-1
32.54M,"318,297",-27.95M,-1,185,4.560,Strong Buy,21.75,"Aug 7, 2024",PBYI,"Puma Biotechnology, Inc.",124.58M,2.54,219.14M,-21.24%,-23.03%,-42.35%,-31.66%,-56.71%,,,,,,,0,-1,-1,-1,-1,-1
64.10M,"2,015,201",-3.40M,-1,,21.60,Strong Buy,32.50,"Aug 26, 2024",QIPT,Quipt Home Medical Corp.,124.13M,2.86,244.23M,-10.80%,-11.76%,-28.75%,-27.72%,-31.11%,Quipt Home Medical price target lowered to $7 from $9 at Benchmark,Quipt Home Medical (QIPT) Gets a Buy from Benchmark Co.,Quipt Home Medical price target lowered to C$8.50 from C$9.50 at Stifel,Stifel Nicolaus Keeps Their Buy Rating on Quipt Home Medical (QIPT),Quipt Home Medical price target lowered to $6 from $8 at Canaccord,Quipt Home Medical price target lowered to $7 from $9 at Benchmark Quipt Home Medical (QIPT) Gets a Buy from Benchmark Co. Quipt Home Medical price target lowered to C$8.50 from C$9.50 at Stifel Stifel Nicolaus Keeps Their Buy Rating on Quipt Home Medical (QIPT) Quipt Home Medical price target lowered to $6 from $8 at Canaccord,0,0,0,0,0,0
12.29M,"119,887",13.23M,-1,9,11.95,Strong Buy,15.00,"Oct 22, 2024",TLSA,Tiziana Life Sciences Ltd,123.85M,1.22,-,3.74%,24.49%,76.47%,+11.21%,+164.09%,Tiziana Life Sciences Welcomes New CEO,Tiziana Life Sciences Appoints New Chief Executive Officer,Tiziana Life Sciences appoints Elrifi as CEO,Tiziana Life Sciences Secures Nasdaq Listing Compliance,Tiziana Life Sciences regains compliance with Nasdaq min bid price requirement,Tiziana Life Sciences Welcomes New CEO Tiziana Life Sciences Appoints New Chief Executive Officer Tiziana Life Sciences appoints Elrifi as CEO Tiziana Life Sciences Secures Nasdaq Listing Compliance Tiziana Life Sciences regains compliance with Nasdaq min bid price requirement,1,0,0,0,0,0
7.63M,"67,100",16.73M,-1,186,19.14,Strong Buy,33.00,"Aug 7, 2024",MNSB,"MainStreet Bancshares, Inc.",123.83M,16.81,68.67M,-0.40%,-2.63%,-11.47%,-5.43%,-5.22%,"MainStreet Bancshares Announces Director Retirement, Dividend Payout",,,,,"MainStreet Bancshares Announces Director Retirement, Dividend Payout",1,1,-1,-1,-1,-1
132.73M,"91,194",-9.77M,-1,351,1.100,Strong Buy,3.00,"Aug 14, 2024",REKR,"Rekor Systems, Inc.",123.69M,1.40,42.39M,-14.86%,-21.80%,-43.95%,-32.42%,-48.96%,Rekor Systems CEO outlines strategic vision in shareholder letter,"Rekor Systems appoints Rish Malhotra as EVP, global strategic growth",Rekor Systems secures SOC2 Type II certification,William Blair Remains a Buy on Rekor Systems (REKR),Rekor Systems secures PPA facility for up to $35M in financing,"Rekor Systems CEO outlines strategic vision in shareholder letter Rekor Systems appoints Rish Malhotra as EVP, global strategic growth Rekor Systems secures SOC2 Type II certification William Blair Remains a Buy on Rekor Systems (REKR) Rekor Systems secures PPA facility for up to $35M in financing",1,0,1,0,1,0
24.00M,"87,385",1.09M,-1,"5,000",6.09,,,"Sep 6, 2024",STKS,"The ONE Group Hospitality, Inc.",123.65M,3.97,424.31M,-2.03%,-10.74%,-18.87%,-27.61%,-35.73%,Balancing Short-Term Challenges with Long-Term Potential: A Hold Rating for The ONE Group Hospitality,,,,,Balancing Short-Term Challenges with Long-Term Potential: A Hold Rating for The ONE Group Hospitality,1,1,-1,-1,-1,-1
12.90M,"58,067",5.48M,-1,25,11.24,,,,PDSB,PDS Biotechnology Corporation,123.35M,3.35,-,-3.55%,-6.54%,-26.51%,-13.20%,-4.33%,PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference,PDS Biotechnology price target raised to $7 from $5 at Alliance Global Partners,Noble Financial Sticks to Their Buy Rating for PDS Biotechnology (PDSB),PDS Biotechnology Enhances and Modulates Stock Sales Agreement,PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results,PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference PDS Biotechnology price target raised to $7 from $5 at Alliance Global Partners Noble Financial Sticks to Their Buy Rating for PDS Biotechnology (PDSB) PDS Biotechnology Enhances and Modulates Stock Sales Agreement PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results,0,0,0,0,0,0
,,,-1,68,,,,,ECBK,"ECB Bancorp, Inc.",123.12M,13.40,24.75M,1.98%,5.29%,9.05%,-4.13%,+5.08%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,464,,,,,BRAG,Bragg Gaming Group Inc.,122.85M,4.88,101.36M,-2.99%,-9.63%,-10.20%,-15.44%,-26.97%,Bragg Gaming Grows Presence in North America,Bet On It: Missouri sports betting certification process challenged with lawsuit,Bragg Gaming Broadens Reach with Caesars in Key Markets,"Bragg Gaming expands partnership with Caesars to Pennsylvania, Ontario",Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL,"Bragg Gaming Grows Presence in North America Bet On It: Missouri sports betting certification process challenged with lawsuit Bragg Gaming Broadens Reach with Caesars in Key Markets Bragg Gaming expands partnership with Caesars to Pennsylvania, Ontario Bet On It: Circa Sports throws hat in Kentucky sports betting ring ahead of NFL",1,1,0,0,0,1
47.93M,"772,511",-65.88M,-1,"1,095",3.010,Buy,18.00,"Aug 14, 2024",LPSN,"LivePerson, Inc.",122.85M,1.38,361.82M,0.04%,27.94%,-23.10%,+5.39%,+62.11%,Craig-Hallum Sticks to Their Buy Rating for Liveperson (LPSN),LivePerson founder Robert LoCascio nominates two candidates for board,,,,Craig-Hallum Sticks to Their Buy Rating for Liveperson (LPSN) LivePerson founder Robert LoCascio nominates two candidates for board,1,0,0,-1,-1,-1
26.27M,"180,894",-220.00M,-1,143,5.48,,,"Aug 8, 2024",ACET,"Adicet Bio, Inc.",122.78M,1.49,-,-1.74%,3.51%,-23.07%,-3.31%,-35.11%,Adicet Bio Boardroom Changes as Leadership Transitions,JMP Securities Remains a Hold on Adicet Bio (ACET),Adicet Bio’s Innovative Immunology and CAR T Cell Therapies: A Buy Rating from Analyst Soumit Roy,Adicet Bio Receives Buy Rating Amidst Expanding Pipeline and Promising Market Potential,Buy Rating Affirmed for Adicet Bio Amidst Strategic Expansion and Promising Clinical Advancements,Adicet Bio Boardroom Changes as Leadership Transitions JMP Securities Remains a Hold on Adicet Bio (ACET) Adicet Bio’s Innovative Immunology and CAR T Cell Therapies: A Buy Rating from Analyst Soumit Roy Adicet Bio Receives Buy Rating Amidst Expanding Pipeline and Promising Market Potential Buy Rating Affirmed for Adicet Bio Amidst Strategic Expansion and Promising Clinical Advancements,1,1,1,1,1,0
62.28M,"146,295",-48.03M,-1,379,2.310,Strong Buy,11.00,"Aug 13, 2024",RDZN,"Roadzen, Inc.",122.51M,1.79,50.04M,51.96%,21.45%,-45.30%,+53.90%,-64.47%,"Roadzen to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024",,,,,"Roadzen to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024",1,0,-1,-1,-1,-1
7.12M,"25,229",18.61M,$1.80,,20.21,,,"Sep 3, 2024",OPI,Office Properties Income Trust,122.10M,2.43,530.26M,3.46%,3.76%,-27.01%,-8.84%,+22.70%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,53,,,,,ASRT,"Assertio Holdings, Inc.",122.03M,1.28,132.19M,-0.96%,-9.35%,12.99%,-15.83%,+23.44%,"Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024",Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth,Assertio Holdings management to meet virtually with Lake Street,,,"Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024 Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth Assertio Holdings management to meet virtually with Lake Street",0,0,1,0,-1,-1
142.36M,"815,441",-89.35M,-1,361,1.010,Buy,3.00,"Aug 7, 2024",LGCL,Lucas GC Limited,121.73M,1.53,207.87M,-5.07%,-20.31%,-35.51%,-39.20%,-28.97%,,,,,,,1,-1,-1,-1,-1,-1
75.80M,"180,079",-57.90M,-1,,1.890,Strong Buy,25.50,"Aug 13, 2024",PLMI,Plum Acquisition Corp. I,121.24M,10.79,-,-3.36%,-4.01%,-7.00%,+23.33%,+1.09%,,,,,,,1,-1,-1,-1,-1,-1
77.60M,"218,241",-39.81M,-1,98,1.840,,,"Aug 12, 2024",ISSC,"Innovative Solutions and Support, Inc.",121.10M,6.92,44.81M,4.30%,11.95%,-2.33%,+14.15%,-3.02%,,,,,,,1,-1,-1,-1,-1,-1
12.81M,"167,703",4.81M,-1,146,11.12,,,,SFBC,"Sound Financial Bancorp, Inc.",120.93M,47.48,35.14M,7.85%,13.79%,23.89%,+21.40%,+32.50%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,95,,,,,IVVD,"Invivyd, Inc.",120.64M,1.01,2.26M,-11.69%,-20.62%,-64.05%,-28.00%,-72.73%,Invivyd to Participate in Upcoming Investor Conferences,Invivyd doses first participants in Phase 1 trial of VYD2311,"Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™","Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variants KP.3.1.1 and LB.1, and Other Variants of Interest",Buy Rating on Invivyd Backed by Strong Phase 3 Data and Market Catalysts,"Invivyd to Participate in Upcoming Investor Conferences Invivyd doses first participants in Phase 1 trial of VYD2311 Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™ Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variants KP.3.1.1 and LB.1, and Other Variants of Interest Buy Rating on Invivyd Backed by Strong Phase 3 Data and Market Catalysts",1,0,0,0,0,1
34.66M,"212,843",-37.99M,-1,236,4.110,Buy,14.00,"Aug 6, 2024",MGX,"Metagenomi, Inc.",120.52M,3.22,55.93M,-4.98%,-20.21%,-55.79%,-22.42%,-69.38%,"Buy Rating on Metagenomi, Inc. for Promising Hemophilia A Gene Editing Strategy and Strong Financial Position",Buy Rating Justified by Metagenomi’s Promising Gene Therapy and Strategic Market Positioning in Hemophilia A Treatment,Buy Rating Justified by Metagenomi’s Breakthrough in Long-term Gene Therapy Efficacy and Safety,Metagenomi announces data from hemophilia study supporting MGX-001,Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference,"Buy Rating on Metagenomi, Inc. for Promising Hemophilia A Gene Editing Strategy and Strong Financial Position Buy Rating Justified by Metagenomi’s Promising Gene Therapy and Strategic Market Positioning in Hemophilia A Treatment Buy Rating Justified by Metagenomi’s Breakthrough in Long-term Gene Therapy Efficacy and Safety Metagenomi announces data from hemophilia study supporting MGX-001 Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference",0,0,0,0,0,0
69.88M,"35,259",-207.29M,-1,100,2.030,Buy,2.75,"Jul 30, 2024",VRCA,Verrica Pharmaceuticals Inc.,120.33M,2.82,13.91M,-43.78%,-61.06%,-59.68%,-64.64%,-65.38%,Verrica Pharmaceuticals Finalizes Agreements with Former Officer,Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York,"Verrica Pharmaceuticals CCO Joe Bonaccorso Resigns, Assumes Consulting Role",Biotech Alert: Searches spiking for these stocks today,"Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)","Verrica Pharmaceuticals Finalizes Agreements with Former Officer Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York Verrica Pharmaceuticals CCO Joe Bonaccorso Resigns, Assumes Consulting Role Biotech Alert: Searches spiking for these stocks today Analysts Conflicted on These Healthcare Names: Verrica Pharmaceuticals (VRCA), Celcuity (CELC) and Bluebird Bio (BLUE)",0,0,0,0,1,1
34.70M,"40,477",11.60M,-1,144,4.070,Strong Buy,7.50,"Aug 6, 2024",KOPN,Kopin Corporation,120.10M,1.04,41.55M,5.34%,5.59%,-33.67%,-11.18%,-42.59%,Kopin awarded first order for 2K-R11 FLCoS Spatial Light Modulator,Kopin gets Nasdaq letter informing that compliance regained on bid rule,,,,Kopin awarded first order for 2K-R11 FLCoS Spatial Light Modulator Kopin gets Nasdaq letter informing that compliance regained on bid rule,0,0,0,-1,-1,-1
17.32M,"15,489",17.71M,$0.48,750,8.13,,,"Jul 18, 2024",VIOT,"Viomi Technology Co., Ltd",120.09M,1.76,351.63M,50.29%,80.17%,122.84%,+57.95%,+179.90%,Viomi Technology Sharpens Focus on Global Water Solutions,Viomi Technology Back in Nasdaq Compliance,,,,Viomi Technology Sharpens Focus on Global Water Solutions Viomi Technology Back in Nasdaq Compliance,0,0,0,-1,-1,-1
14.05M,"9,282",21.97M,-1,148,10.06,Hold,9.00,"Aug 14, 2024",ZBAO,Zhibao Technology Inc.,119.79M,3.80,18.98M,8.30%,8.15%,8.21%,-8.93%,+7.94%,Zhibao Technology Leads Digital Insurance Innovation,,,,,Zhibao Technology Leads Digital Insurance Innovation,1,0,-1,-1,-1,-1
150.78M,"247,133",-40.91M,-1,,0.927,Strong Buy,4.00,"Aug 8, 2024",BSLK,"Bolt Projects Holdings, Inc.",119.65M,3.59,3.44M,-74.78%,-78.88%,-79.76%,-81.68%,-80.72%,Bolt Projects Holdings Inc trading resumes,"Bolt Projects Holdings Inc trading halted, volatility trading pause",,,,"Bolt Projects Holdings Inc trading resumes Bolt Projects Holdings Inc trading halted, volatility trading pause",0,0,0,-1,-1,-1
39.65M,"51,101",-83.84M,-1,134,3.510,Buy,16.60,"Aug 13, 2024",CSLR,"Complete Solaria, Inc.",119.59M,1.88,59.85M,24.07%,29.26%,61.25%,+43.61%,+255.94%,Cantor Fitzgerald Remains a Buy on Complete Solaria (CSLR),Complete Solaria COO Brian Wuebbels to depart,Complete Solaria provides update on headcount reductions,Complete Solaria reports Q2 revenue $4.5M vs. $10M last quarter,SunPower seeks to designate Complete Solar as stalking horse in APA,Cantor Fitzgerald Remains a Buy on Complete Solaria (CSLR) Complete Solaria COO Brian Wuebbels to depart Complete Solaria provides update on headcount reductions Complete Solaria reports Q2 revenue $4.5M vs. $10M last quarter SunPower seeks to designate Complete Solar as stalking horse in APA,0,1,0,0,1,0
,,,-1,"1,400",,,,,VFF,"Village Farms International, Inc.",119.55M,1.07,313.99M,-3.57%,-3.09%,2.13%,-7.49%,-22.79%,Village Farms Secures New CEO Employment Agreement,Village Farms Eyes Global Cannabis Market Expansion,Village Farms Files Current Report with SEC,,,Village Farms Secures New CEO Employment Agreement Village Farms Eyes Global Cannabis Market Expansion Village Farms Files Current Report with SEC,0,0,0,0,-1,-1
,,,-1,"7,700",,,,,CVGI,"Commercial Vehicle Group, Inc.",119.42M,3.69,931.75M,-8.00%,-21.67%,-38.17%,-34.68%,-43.94%,"Volvo to invest $700M in Mexican plant, to acquire plant in North Carolina",,,,,"Volvo to invest $700M in Mexican plant, to acquire plant in North Carolina",0,0,-1,-1,-1,-1
50.24M,"121,834","53,595",$0.05,32,2.740,Buy,,"Aug 7, 2024",HAO,Haoxi Health Technology Limited,118.97M,3.69,42.57M,-3.11%,-23.04%,-40.84%,-14.29%,-20.35%,,,,,,,0,-1,-1,-1,-1,-1
37.58M,"252,945",-6.56M,-1,10,3.670,Strong Buy,7.80,"Sep 5, 2024",EPSN,Epsilon Energy Ltd.,118.82M,5.41,30.17M,2.08%,0.58%,3.29%,-0.18%,-1.81%,Epsilon Energy Ltd. Announces Quarterly Dividend,"Epsilon Energy Q2 Results: Oil Up, Gas Down",,,,"Epsilon Energy Ltd. Announces Quarterly Dividend Epsilon Energy Q2 Results: Oil Up, Gas Down",1,1,0,-1,-1,-1
45.02M,"69,682",-19.89M,-1,,3.060,,,"Aug 14, 2024",PLAO,Patria Latin American Opportunity Acquisition Corp.,118.76M,11.54,-,-0.22%,0.35%,3.01%,unch,+3.04%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,"2,323",,,,,DLTH,Duluth Holdings Inc.,118.70M,3.39,639.61M,-1.92%,-8.36%,-25.99%,-11.26%,-33.81%,Duluth Holdings: Hold Rating Affirmed Amid Revenue Growth and Inventory Challenges,Duluth Trading Projects Growth Amid Economic Uncertainties,"Duluth Holdings backs FY24 adjusted EPS view (22c), consensus (33c)","Duluth Holdings reports Q2 adjusted EPS (2c), consensus (15c)","Is DLTH a Buy, Before Earnings?","Duluth Holdings: Hold Rating Affirmed Amid Revenue Growth and Inventory Challenges Duluth Trading Projects Growth Amid Economic Uncertainties Duluth Holdings backs FY24 adjusted EPS view (22c), consensus (33c) Duluth Holdings reports Q2 adjusted EPS (2c), consensus (15c) Is DLTH a Buy, Before Earnings?",1,1,1,1,0,1
,,,-1,304,,,,,FNWD,Finward Bancorp,118.12M,27.38,70.04M,-1.16%,4.66%,13.74%,-4.27%,+10.02%,Finward Bancorp upgraded to Outperform from Market Perform at Hovde Group,Finward Bancorp Bolsters Board with Three Expert Directors,FINWARD BANCORP ANNOUNCES THE APPOINTMENT OF THREE NEW DIRECTORS,Finward Bancorp Unveils Future Strategies at Bank Conference,Finward Bancorp Enhances Executive Severance Plan Benefits,Finward Bancorp upgraded to Outperform from Market Perform at Hovde Group Finward Bancorp Bolsters Board with Three Expert Directors FINWARD BANCORP ANNOUNCES THE APPOINTMENT OF THREE NEW DIRECTORS Finward Bancorp Unveils Future Strategies at Bank Conference Finward Bancorp Enhances Executive Severance Plan Benefits,1,0,0,0,0,1
34.06M,"12,374",-65.24M,-1,30,4.030,Strong Buy,10.00,"Aug 7, 2024",ETON,"Eton Pharmaceuticals, Inc.",117.30M,4.54,31.38M,16.75%,25.65%,16.34%,+27.78%,+28.13%,Eton Pharmaceuticals: A Strong Buy on Niche Market Leadership and Robust Growth Prospects,Eton Pharmaceuticals assumed with a Buy at H.C. Wainwright,Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference,,,Eton Pharmaceuticals: A Strong Buy on Niche Market Leadership and Robust Growth Prospects Eton Pharmaceuticals assumed with a Buy at H.C. Wainwright Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference,0,0,0,0,-1,-1
41.32M,"8,600",13.79M,-1,289,3.230,,,"Aug 12, 2024",AOUT,"American Outdoor Brands, Inc.",117.29M,9.11,201.10M,5.28%,6.39%,10.21%,+0.21%,+6.50%,American Outdoor Brands Capitalizes on Innovation for Growth,American Outdoor Brands (AOUT) Receives a Buy from Lake Street,Closing Bell Movers: Broadcom slips 7% after Q3 results,American Outdoor Brands reports Q1 adjusted EPS 6c vs. 1c last year,"American Outdoor Brands CFO sees growth in net sales, profitability in FY25","American Outdoor Brands Capitalizes on Innovation for Growth American Outdoor Brands (AOUT) Receives a Buy from Lake Street Closing Bell Movers: Broadcom slips 7% after Q3 results American Outdoor Brands reports Q1 adjusted EPS 6c vs. 1c last year American Outdoor Brands CFO sees growth in net sales, profitability in FY25",1,1,1,0,1,1
6.41M,"9,336",5.50M,-1,488,21.31,,,"Jul 26, 2024",INVZ,Innoviz Technologies Ltd.,116.80M,0.70,32.12M,-10.26%,-21.02%,-53.75%,-21.12%,-56.85%,,,,,,,1,-1,-1,-1,-1,-1
59.47M,"237,749",-36.22M,-1,"1,389",2.290,Buy,4.20,"Aug 28, 2024",BSET,"Bassett Furniture Industries, Incorporated",116.41M,13.24,351.88M,2.04%,-2.21%,-10.93%,+3.20%,-4.37%,,,,,,,0,-1,-1,-1,-1,-1
59.17M,"339,973",-49.40M,-1,161,2.300,Hold,2.75,"Aug 8, 2024",HMNF,"HMN Financial, Inc.",116.27M,26.71,38.26M,5.37%,11.53%,24.89%,+2.05%,+26.01%,,,,,,,0,-1,-1,-1,-1,-1
9.76M,"33,242",2.56M,$0.12,"2,023",13.91,,,"Aug 13, 2024",RAIL,"FreightCar America, Inc.",116.26M,6.16,496.97M,54.94%,81.06%,109.02%,+107.49%,+81.36%,North American rail traffic up 5.2% for the week ending August 31,North American rail traffic up 1.3% for the week ending August 24,Noble Financial Reaffirms Their Buy Rating on Freightcar America (RAIL),"FreightCar America, Inc. to Present at Midwest IDEAS Conference",North American rail traffic up 5.6% for the week ending August 17,"North American rail traffic up 5.2% for the week ending August 31 North American rail traffic up 1.3% for the week ending August 24 Noble Financial Reaffirms Their Buy Rating on Freightcar America (RAIL) FreightCar America, Inc. to Present at Midwest IDEAS Conference North American rail traffic up 5.6% for the week ending August 17",0,0,0,0,1,0
157.74M,"651,096",-134.82M,-1,407,0.860,Hold,1.08,"Aug 7, 2024",EBMT,"Eagle Bancorp Montana, Inc.",115.99M,14.80,80.56M,6.93%,8.54%,10.74%,+1.78%,+17.33%,Eagle Bancorp Montana Executives Meet Institutional Investors,,,,,Eagle Bancorp Montana Executives Meet Institutional Investors,0,1,-1,-1,-1,-1
8.25M,"73,303",-5.04M,-1,30,16.32,Strong Buy,58.25,"Aug 9, 2024",RGLS,Regulus Therapeutics Inc.,115.87M,1.77,-,11.28%,0.44%,-0.36%,-7.78%,-34.65%,"Analysts’ Top Healthcare Picks: Sonnet BioTherapeutics Holdings (SONN), Agilent (A)",Regulus (RGLS) Receives a Buy from Oppenheimer,"Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Avadel Pharmaceuticals (AVDL) and Regulus (RGLS)",Buy Rating Affirmed for Regulus Amidst Minor Clinical Delay and Strong Financial Position,"Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Regulus (RGLS) and Canopy Growth (CGC)","Analysts’ Top Healthcare Picks: Sonnet BioTherapeutics Holdings (SONN), Agilent (A) Regulus (RGLS) Receives a Buy from Oppenheimer Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Avadel Pharmaceuticals (AVDL) and Regulus (RGLS) Buy Rating Affirmed for Regulus Amidst Minor Clinical Delay and Strong Financial Position Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Regulus (RGLS) and Canopy Growth (CGC)",1,0,0,0,0,0
100.46M,"1,309,799",-85.92M,-1,,1.340,Buy,4.18,"Aug 6, 2024",APXI,APx Acquisition Corp. I,115.55M,11.66,-,0.01%,0.52%,4.16%,+0.65%,+3.29%,APx Acquisition Corp. I Merger Proceeds Without MultiplAI,,,,,APx Acquisition Corp. I Merger Proceeds Without MultiplAI,1,0,-1,-1,-1,-1
30.00M,"81,716","608,000",-1,,8.02,Buy,12.67,"Aug 6, 2024",OVBC,Ohio Valley Banc Corp.,115.37M,24.49,55.88M,0.74%,7.94%,2.72%,+4.29%,+1.26%,Ohio Valley Banc Corp extends stock buyback program,Ohio Valley Banc Extends $5 Million Share Buyback Program,,,,Ohio Valley Banc Corp extends stock buyback program Ohio Valley Banc Extends $5 Million Share Buyback Program,0,1,1,-1,-1,-1
26.71M,"196,119",2.79M,-1,,5.010,Strong Buy,6.50,"Aug 6, 2024",IMPP,Imperial Petroleum Inc.,115.37M,3.92,159.51M,8.73%,8.12%,27.76%,+1.51%,+9.78%,Imperial Petroleum Announces 2024 Annual Meeting,Imperial Petroleum Inc. (IMPP) Receives ‘Buy’ Rating on Strong Q2 Results and Positive Industry Outlook,Imperial Petroleum Achieves Strong Q2 Results,Imperial Petroleum reports Q2 adjusted EPS 73c vs. $1.46 last year,Imperial Petroleum Inc. Announces the Date for the Release of Second Quarter and Six Months 2024,Imperial Petroleum Announces 2024 Annual Meeting Imperial Petroleum Inc. (IMPP) Receives ‘Buy’ Rating on Strong Q2 Results and Positive Industry Outlook Imperial Petroleum Achieves Strong Q2 Results Imperial Petroleum reports Q2 adjusted EPS 73c vs. $1.46 last year Imperial Petroleum Inc. Announces the Date for the Release of Second Quarter and Six Months 2024,0,0,0,1,0,0
13.87M,"56,443",10.98M,$0.39,,9.64,,,"Aug 13, 2024",ELDN,"Eledon Pharmaceuticals, Inc.",115.00M,2.90,-,3.54%,5.52%,37.30%,-3.06%,+65.70%,Eledon Pharmaceuticals completes enrollment for Phase 2 BESTOW trial,Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients,Buy Rating Justified by Eledon Pharmaceuticals’ Strategic Progress and Growth Potential,Eledon Pharmaceuticals provides Q2 corporate update,Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results,Eledon Pharmaceuticals completes enrollment for Phase 2 BESTOW trial Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients Buy Rating Justified by Eledon Pharmaceuticals’ Strategic Progress and Growth Potential Eledon Pharmaceuticals provides Q2 corporate update Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results,0,0,0,0,0,0
14.47M,"110,353",1.79M,-1,,9.24,Strong Buy,12.50,"Aug 13, 2024",KGEI,Kolibri Global Energy Inc.,114.59M,3.15,54.39M,-2.13%,-7.13%,-10.06%,-7.37%,+2.95%,Roth MKM Sticks to Its Buy Rating for Kolibri Global Energy (KEI),Roth MKM Reaffirms Their Buy Rating on Kolibri Global Energy (KEI),Kolibri Global Energy Reports Strong Mid-Year Growth,,,Roth MKM Sticks to Its Buy Rating for Kolibri Global Energy (KEI) Roth MKM Reaffirms Their Buy Rating on Kolibri Global Energy (KEI) Kolibri Global Energy Reports Strong Mid-Year Growth,0,1,1,1,-1,-1
10.38M,"131,620",-37.75M,-1,651,12.85,,,"Aug 6, 2024",GOEV,Canoo Inc.,114.50M,1.47,1.49M,-9.32%,-24.13%,-56.12%,-28.36%,-32.39%,Canoo to Participate in Upcoming Investor Conferences,Canoo price target lowered to $4 from $7 at H.C. Wainwright,Roth MKM Releases a Hold Rating on Canoo (GOEV),Canoo price target lowered to $1.50 from $3 at Roth MKM,Canoo price target lowered to $14 from $18.50 at Alliance Global Partners,Canoo to Participate in Upcoming Investor Conferences Canoo price target lowered to $4 from $7 at H.C. Wainwright Roth MKM Releases a Hold Rating on Canoo (GOEV) Canoo price target lowered to $1.50 from $3 at Roth MKM Canoo price target lowered to $14 from $18.50 at Alliance Global Partners,0,0,0,0,0,0
71.30M,"157,007",-17.48M,-1,"4,095",1.870,Strong Buy,6.00,"Aug 12, 2024",CAAS,"China Automotive Systems, Inc.",113.80M,3.77,594.70M,-0.90%,8.58%,22.04%,-4.91%,-1.34%,China Automotive backs FY24 revenue view $605M,China Automotive reports Q2 EPS 24c vs. 35c last year,China Automotive Systems Reports Income From Operations Increased by 38.7% in the Second Quarter of 2024,,,China Automotive backs FY24 revenue view $605M China Automotive reports Q2 EPS 24c vs. 35c last year China Automotive Systems Reports Income From Operations Increased by 38.7% in the Second Quarter of 2024,1,1,1,1,-1,-1
,,,-1,197,,,,,UNB,"Union Bankshares, Inc.",113.55M,25.10,47.53M,14.81%,18.74%,1.77%,+10.70%,-10.01%,Union Bankshares announces balance sheet repositioning,Union Bankshares Announces Balance Sheet Repositioning,,,,Union Bankshares announces balance sheet repositioning Union Bankshares Announces Balance Sheet Repositioning,1,0,0,-1,-1,-1
19.75M,"70,495",-65.92M,-1,,6.75,,,"Aug 8, 2024",CFFS,CF Acquisition Corp. VII,113.49M,11.04,-,0.39%,0.78%,2.79%,+0.55%,+2.70%,,,,,,,0,-1,-1,-1,-1,-1
107.50M,"426,616",-104.53M,-1,58,1.240,Buy,2.81,"Aug 5, 2024",ORKT,Orangekloud Technology Inc.,113.48M,4.99,4.61M,4.02%,3.60%,3.60%,+9.39%,,OrangeKloud partners with AI Singapore (AISG) to enhance No-Code App Building Technology with Artificial Intelligence,Orangekloud Technology Inc trading resumes,"Orangekloud Technology Inc trading halted, volatility trading pause",,,"OrangeKloud partners with AI Singapore (AISG) to enhance No-Code App Building Technology with Artificial Intelligence Orangekloud Technology Inc trading resumes Orangekloud Technology Inc trading halted, volatility trading pause",0,0,0,0,-1,-1
27.19M,"12,161",3.25M,-1,"1,430",4.300,,,,AUGX,"Augmedix, Inc.",112.77M,2.29,51.58M,0.99%,40.42%,-31.89%,+0.88%,-43.18%,"Augmedix reports Q2 EPS (16c), consensus (13c)",,,,,"Augmedix reports Q2 EPS (16c), consensus (13c)",1,1,-1,-1,-1,-1
5.14M,"1,509",22.48M,$1.00,,25.88,Hold,24.67,"Jul 24, 2024",PFTA,Perception Capital Corp. III,111.98M,10.78,-,-1.97%,-1.25%,1.48%,-4.00%,+1.89%,Perception Capital III receives noncompliance notice from Nasdaq,Perception Capital Corp. III received written notice from Nasdaq related to delayed filing of quarterly report on Form 10-Q,,,,Perception Capital III receives noncompliance notice from Nasdaq Perception Capital Corp. III received written notice from Nasdaq related to delayed filing of quarterly report on Form 10-Q,0,0,0,-1,-1,-1
52.01M,"1,473",-122.06M,-1,"4,177",2.400,Strong Buy,18.00,"Sep 26, 2024",UEIC,Universal Electronics Inc.,111.50M,8.59,387.04M,-7.91%,-17.16%,-8.59%,-22.62%,-8.91%,,,,,,,1,-1,-1,-1,-1,-1
64.11M,"125,353",-50.59M,-1,,2.070,Strong Buy,4.40,"Aug 8, 2024",PCSC,Perceptive Capital Solutions Corp,111.45M,10.07,-,-0.12%,-0.12%,-0.12%,-0.10%,,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,561,,,,,FONR,FONAR Corporation,111.37M,17.25,102.72M,0.86%,2.84%,-5.72%,-6.22%,-11.31%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,32,,,,,CRDF,"Cardiff Oncology, Inc.",111.25M,2.39,665.00K,2.40%,0.46%,-12.92%,-2.14%,-60.79%,Coinbase and Robinhood upgraded: Wall Street’s top analyst calls,Craig-Hallum starts Cardiff at Buy with onvansertib ‘nearing promised land’,,,,Coinbase and Robinhood upgraded: Wall Street’s top analyst calls Craig-Hallum starts Cardiff at Buy with onvansertib ‘nearing promised land’,1,1,0,-1,-1,-1
18.65M,"81,657",-21.10M,-1,270,7.10,Strong Buy,21.00,"Aug 6, 2024",LARK,"Landmark Bancorp, Inc.",111.09M,20.19,55.91M,-0.06%,1.82%,3.74%,-0.52%,+4.43%,,,,,,,1,-1,-1,-1,-1,-1
11.50M,"41,258",-393.87M,-1,,10.92,,,"Aug 13, 2024",PITA,Heramba Electric plc,111.02M,2.36,-,-17.74%,-70.47%,-76.27%,-50.54%,,"Heramba Electric wins $26M e-mobility contract in Seattle, Washington area",,,,,"Heramba Electric wins $26M e-mobility contract in Seattle, Washington area",0,1,-1,-1,-1,-1
8.28M,"209,579",-8.77M,-1,460,15.95,Buy,30.00,"Aug 27, 2024",ALTO,"Alto Ingredients, Inc.",110.91M,1.45,1.07B,-1.90%,-3.02%,-26.91%,-13.21%,-37.56%,"Alto Ingredients, Inc. to Present in the 26th Annual H.C. Wainwright Global Investment Conference",,,,,"Alto Ingredients, Inc. to Present in the 26th Annual H.C. Wainwright Global Investment Conference",0,0,-1,-1,-1,-1
151.73M,"1,854,678",-162.11M,-1,,0.871,Buy,4.17,"Aug 13, 2024",PLMJ,Plum Acquisition Corp. III,110.80M,10.85,-,-0.04%,0.12%,1.47%,+0.28%,+0.93%,Tactical Resources to list on Nasdaq through Plum Acquisition Corp. III pact,,,,,Tactical Resources to list on Nasdaq through Plum Acquisition Corp. III pact,1,1,-1,-1,-1,-1
38.44M,"433,741",-53.95M,-1,"2,465",3.425,Strong Buy,7.75,"Aug 27, 2024",OPRT,Oportun Financial Corporation,110.74M,3.10,824.04M,-1.53%,0.45%,-6.20%,-3.26%,+36.24%,Oportun Completes $223 Million Asset Backed Securitization,Oportun Named a Bay Area Top Workplace for 2024,Oportun Financial (OPRT) Receives a Hold from JMP Securities,,,Oportun Completes $223 Million Asset Backed Securitization Oportun Named a Bay Area Top Workplace for 2024 Oportun Financial (OPRT) Receives a Hold from JMP Securities,1,1,1,1,-1,-1
90.08M,"101,143",-95.31M,-1,365,1.460,Strong Buy,15.00,"Aug 8, 2024",ALOT,"AstroNova, Inc.",110.37M,14.69,145.63M,-0.49%,-1.99%,-11.48%,-8.34%,-18.40%,,,,,,,0,-1,-1,-1,-1,-1
44.27M,"18,352",-31.85M,-1,127,2.950,Strong Buy,5.00,"Jul 25, 2024",ANL,Adlai Nortye Ltd.,110.33M,2.99,5.00M,-6.21%,-10.46%,-63.15%,-8.86%,-66.35%,Buy Rating Affirmed for Adlai Nortye Amid Strong Pipeline and Strategic Immuno-Oncology Focus,Adlai Nortye initiated with a Buy at H.C. Wainwright,,,,Buy Rating Affirmed for Adlai Nortye Amid Strong Pipeline and Strategic Immuno-Oncology Focus Adlai Nortye initiated with a Buy at H.C. Wainwright,0,0,0,-1,-1,-1
11.85M,957,-3.02M,-1,716,11.00,,,,HURC,"Hurco Companies, Inc.",110.24M,16.90,209.54M,1.54%,3.16%,-14.58%,-0.58%,-11.26%,Hurco Companies reports Q3 EPS ($1.47) vs 4c last year,Hurco’s Unique Expertise in Control Technology and Dedication to Product Development to Be on Display at IMTS,,,,Hurco Companies reports Q3 EPS ($1.47) vs 4c last year Hurco’s Unique Expertise in Control Technology and Dedication to Product Development to Be on Display at IMTS,0,0,0,-1,-1,-1
,,,-1,95,,,,,WMPN,William Penn Bancorporation,109.79M,11.75,20.56M,-0.44%,1.23%,-1.92%,-3.10%,-3.26%,NFL season expected to spur record $35 billion in legal sports wagers,,,,,NFL season expected to spur record $35 billion in legal sports wagers,1,1,-1,-1,-1,-1
9.54M,"85,995",5.59M,$1.00,800,13.68,,,"Sep 12, 2024",NUTX,Nutex Health Inc.,109.57M,21.63,275.93M,77.98%,163.97%,47.02%,+168.38%,+81.09%,Nutex Health price target raised to $45 from $30 at Benchmark,Benchmark Co. Sticks to Its Buy Rating for Clinigence Holdings (NUTX),Nutex Health Inc trading resumes,"Nutex Health Inc trading halted, volatility trading pause",,"Nutex Health price target raised to $45 from $30 at Benchmark Benchmark Co. Sticks to Its Buy Rating for Clinigence Holdings (NUTX) Nutex Health Inc trading resumes Nutex Health Inc trading halted, volatility trading pause",1,0,1,0,0,-1
,,,-1,51,,,,,RR,Richtech Robotics Inc.,109.37M,1.38,9.11M,58.39%,37.25%,-36.97%,-2.68%,-17.14%,Richtech Robotics Announces Closing of $21 Million Public Offering,"Richtech Robotics files to sell 14.5M shares of Class B common stock, warrants",Richtech Robotics announces ADAM installation at One Kitchen,"Richtech Robotics Announces ADAM Installation at One Kitchen in Rockford, IL Walmart, Marking First Humanoid Drink Robot in the State",,"Richtech Robotics Announces Closing of $21 Million Public Offering Richtech Robotics files to sell 14.5M shares of Class B common stock, warrants Richtech Robotics announces ADAM installation at One Kitchen Richtech Robotics Announces ADAM Installation at One Kitchen in Rockford, IL Walmart, Marking First Humanoid Drink Robot in the State",1,1,1,0,0,-1
,,,-1,248,,,,,LFVN,LifeVantage Corporation,109.22M,8.60,205.45M,8.29%,22.28%,32.14%,+7.70%,+42.10%,LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,LifeVantage welcomes back AXIO Lemonade,Lifevantage trading resumes,"Lifevantage trading halted, volatility trading pause",LifeVantage sees FY25 EPS 70c-80c vs. 59c last year,"LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference LifeVantage welcomes back AXIO Lemonade Lifevantage trading resumes Lifevantage trading halted, volatility trading pause LifeVantage sees FY25 EPS 70c-80c vs. 59c last year",0,0,0,0,0,1
,,,-1,156,,,,,FXNC,First National Corporation,109.09M,17.37,49.19M,0.90%,6.74%,-1.73%,+2.91%,+9.86%,First National Corp. and Touchstone announce shareholders approval of mergerFirst National Corp.,"First National Corporation and Touchstone Bankshares, Inc. Announce Receipt of Shareholders Approvals for Merger",,,,"First National Corp. and Touchstone announce shareholders approval of mergerFirst National Corp. First National Corporation and Touchstone Bankshares, Inc. Announce Receipt of Shareholders Approvals for Merger",1,1,1,-1,-1,-1
,,,-1,28,,,,,MGRM,Monogram Technologies Inc.,109.05M,3.44,365.00K,3.84%,17.13%,5.86%,+8.06%,+15.20%,Monogram Orthopaedics announces collaboration with Shalby Limited,Monogram Orthopaedics Announces Strategic Collaboration with Shalby,,,,Monogram Orthopaedics announces collaboration with Shalby Limited Monogram Orthopaedics Announces Strategic Collaboration with Shalby,0,0,0,-1,-1,-1
,,,-1,,,,,,TLGY,TLGY Acquisition Corporation,108.97M,11.51,-,0.23%,0.65%,4.86%,+0.70%,+4.64%,,,,,,,0,-1,-1,-1,-1,-1
44.60M,"93,320",-30.41M,-1,"4,621",2.900,Strong Buy,4.13,"Aug 6, 2024",THCH,TH International Limited,108.83M,0.69,219.67M,14.60%,9.06%,-38.68%,+16.69%,-29.77%,Tims China Partners with Panda Superstar Meng Lan to Celebrate Bagel Maverick,TH International Marks First EBITDA Profit,TH International reports Q2 adjusted EPS (RMB 0.30) vs. (RMB 0. 56) last year,"Tims China Registration & Webcast details for Q2 2024 Results Conference Call on Thursday, August 29, 2024",,"Tims China Partners with Panda Superstar Meng Lan to Celebrate Bagel Maverick TH International Marks First EBITDA Profit TH International reports Q2 adjusted EPS (RMB 0.30) vs. (RMB 0. 56) last year Tims China Registration & Webcast details for Q2 2024 Results Conference Call on Thursday, August 29, 2024",1,0,1,1,0,-1
12.80M,"19,543","-263,250",-1,,10.05,,,,GECC,Great Elm Capital Corp.,108.42M,10.38,36.90M,3.20%,2.02%,0.83%,-4.19%,-5.76%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,68,,,,,IOBT,"IO Biotech, Inc.",108.04M,1.64,-,11.58%,18.82%,8.05%,+17.04%,unch,Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT),IO Biotech price target lowered to $4 from $7 at Morgan Stanley,Optimistic Outlook on IO Biotech’s PFS Improvements Despite ORR Setback,Buy Rating Affirmed for IO Biotech Amid Positive Phase 3 Trial Progress and Historical Data,IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma,Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT) IO Biotech price target lowered to $4 from $7 at Morgan Stanley Optimistic Outlook on IO Biotech’s PFS Improvements Despite ORR Setback Buy Rating Affirmed for IO Biotech Amid Positive Phase 3 Trial Progress and Historical Data IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma,0,0,0,1,0,0
42.45M,"51,245",-68.52M,-1,35,3.010,Strong Buy,17.33,"Aug 6, 2024",SRTS,"Sensus Healthcare, Inc.",107.84M,6.58,36.37M,-0.41%,7.59%,52.17%,+1.10%,+86.67%,Sensus Healthcare: A Strong Buy on Robust Financials and Strategic Expansion,Sensus Healthcare: Strong Buy on Robust Growth and Innovative Revenue Strategies,Roth MKM Remains a Buy on Sensus Healthcare (SRTS),,,Sensus Healthcare: A Strong Buy on Robust Financials and Strategic Expansion Sensus Healthcare: Strong Buy on Robust Growth and Innovative Revenue Strategies Roth MKM Remains a Buy on Sensus Healthcare (SRTS),1,1,1,0,-1,-1
49.50M,"158,765",-60.35M,-1,82,2.580,Buy,6.08,"Aug 5, 2024",KRMD,"KORU Medical Systems, Inc.",107.76M,2.35,30.82M,2.55%,-3.20%,4.30%,+5.17%,-2.01%,REPRO-MED Systems Launches Employee Equity Incentive Program,,,,,REPRO-MED Systems Launches Employee Equity Incentive Program,0,0,-1,-1,-1,-1
38.44M,"115,910",-113.45M,-1,326,3.320,Strong Buy,20.50,"Aug 1, 2024",OPAL,OPAL Fuels Inc.,107.72M,3.79,294.01M,-4.07%,-9.71%,-24.93%,-13.80%,-27.35%,Opal Fuels downgraded at Scotiabank on limited near-term RNG catalysts,Montauk Renewables downgraded to Sector Perform from Outperform at Scotiabank,Opal Fuels downgraded to Sector Perform from Outperform at Scotiabank,,,Opal Fuels downgraded at Scotiabank on limited near-term RNG catalysts Montauk Renewables downgraded to Sector Perform from Outperform at Scotiabank Opal Fuels downgraded to Sector Perform from Outperform at Scotiabank,0,1,1,1,-1,-1
43.35M,"223,264",-13.22M,-1,51,2.940,Strong Buy,5.38,"Aug 1, 2024",OFS,OFS Capital Corporation,107.72M,8.04,53.53M,-1.25%,-6.84%,-20.64%,-7.30%,-18.62%,,,,,,,0,-1,-1,-1,-1,-1
11.02M,"11,325",10.58M,$0.50,,11.50,Hold,13.00,"Jul 26, 2024",CSLM,CSLM Acquisition Corp.,107.63M,11.31,-,0.26%,0.88%,4.14%,+0.09%,+3.58%,Consilium Acquisition Corp. Seeks Shareholder Approval for Extension,,,,,Consilium Acquisition Corp. Seeks Shareholder Approval for Extension,0,1,-1,-1,-1,-1
146.38M,"433,427",-37.40M,-1,22,0.864,Strong Buy,4.00,"Aug 8, 2024",CTXR,"Citius Pharmaceuticals, Inc.",107.53M,0.60,-,-20.80%,-18.78%,-20.07%,-36.19%,-42.22%,"Citius Pharmaceuticals selloff since spinout an opportunity, says EF Hutton",Buy Rating Affirmed for Citius Pharmaceuticals Amid Strategic Oncology Spinout and Promising Lead Product Data,Lymphir: A Promising Contender in the r/r CTCL Market with Strong Commercial Prospects,"Citius Pharmaceuticals reports Q3 EPS (6c), two estimates (5c)","Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update","Citius Pharmaceuticals selloff since spinout an opportunity, says EF Hutton Buy Rating Affirmed for Citius Pharmaceuticals Amid Strategic Oncology Spinout and Promising Lead Product Data Lymphir: A Promising Contender in the r/r CTCL Market with Strong Commercial Prospects Citius Pharmaceuticals reports Q3 EPS (6c), two estimates (5c) Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update",0,0,0,1,0,0
168.50M,"640,219",17.63M,-1,440,0.750,Buy,3.67,"Aug 8, 2024",MAPS,"WM Technology, Inc.",106.64M,1.10,183.45M,-7.44%,-8.44%,-4.47%,-9.06%,-24.16%,,,,,,,1,-1,-1,-1,-1,-1
9.44M,"26,216",4.51M,$0.28,212,13.36,Buy,20.00,"Jul 11, 2024",FCAP,"First Capital, Inc.",106.59M,31.80,40.80M,1.74%,4.70%,12.60%,+5.47%,+15.64%,"First Capital, Inc. Announces Quarterly Dividend Increase",First Capital increases quarterly dividend 7.4% to 29c per share,,,,"First Capital, Inc. Announces Quarterly Dividend Increase First Capital increases quarterly dividend 7.4% to 29c per share",1,1,0,-1,-1,-1
52.67M,"912,282",-171.44M,-1,12,2.390,Strong Buy,14.83,"Aug 8, 2024",RGC,Regencell Bioscience Holdings Limited,106.32M,8.17,-,-9.00%,21.07%,-11.23%,-16.82%,+33.50%,Regencell Bioscience Holdings Ltd trading resumes,"Regencell Bioscience Holdings Ltd trading halted, volatility trading pause",,,,"Regencell Bioscience Holdings Ltd trading resumes Regencell Bioscience Holdings Ltd trading halted, volatility trading pause",1,0,0,-1,-1,-1
38.08M,"465,434",-59.80M,-1,,3.300,Hold,2.25,"Aug 8, 2024",NNAG,99 Acquisition Group Inc.,106.09M,10.53,-,0.05%,0.33%,2.24%,+0.18%,+2.60%,99 Acquisition Group’s Merger Termination and Strategy Shift,,,,,99 Acquisition Group’s Merger Termination and Strategy Shift,0,0,-1,-1,-1,-1
16.86M,"103,962",-31.80M,-1,,7.45,Hold,4.50,"Aug 7, 2024",PPYA,Papaya Growth Opportunity Corp. I,106.04M,11.04,-,-2.02%,-1.14%,2.60%,+0.27%,+3.37%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,251,,,,,SBFG,"SB Financial Group, Inc.",105.97M,15.75,55.94M,-0.12%,5.69%,10.30%,-1.86%,+18.16%,SB Financial Group Announces Strategic Acquisition of Marblehead Bancorp,,,,,SB Financial Group Announces Strategic Acquisition of Marblehead Bancorp,0,1,-1,-1,-1,-1
,,,-1,23,,,,,BROG,Brooge Energy Limited,105.24M,0.96,116.05M,1.03%,4.08%,-54.84%,+12.36%,-38.65%,Brooge Energy Announces Major Corporate Updates,Brooge Energy Schedules Shareholder Meeting,Brooge Energy Announces New Registered Office,,,Brooge Energy Announces Major Corporate Updates Brooge Energy Schedules Shareholder Meeting Brooge Energy Announces New Registered Office,0,1,0,0,-1,-1
21.74M,"78,690",1.70M,-1,"1,715",5.75,Strong Buy,9.00,"Jul 31, 2024",WPRT,Westport Fuel Systems Inc.,105.10M,6.08,325.50M,4.43%,3.26%,-1.49%,-1.51%,-4.54%,Westport price target lowered to $8 from $9 at RBC Capital,Westport Fuel Systems (WPRT) Receives a Hold from RBC Capital,Buy Rating Affirmed for Westport Fuel Systems Amidst Operational Restructuring and Strategic Volvo Joint Venture,Westport Fuel Systems: Strategic Steps Forward Amidst Profitability and Sales Challenges,Westport Fuel Systems: Q2 Results and Strategic Reorganization,Westport price target lowered to $8 from $9 at RBC Capital Westport Fuel Systems (WPRT) Receives a Hold from RBC Capital Buy Rating Affirmed for Westport Fuel Systems Amidst Operational Restructuring and Strategic Volvo Joint Venture Westport Fuel Systems: Strategic Steps Forward Amidst Profitability and Sales Challenges Westport Fuel Systems: Q2 Results and Strategic Reorganization,1,0,1,1,1,1
,,,-1,"1,215",,,,,XNET,Xunlei Limited,105.06M,1.65,320.12M,0.49%,-3.00%,1.90%,-7.56%,+5.30%,Xunlei Reports Diverse Q2 2024 Financials,,,,,Xunlei Reports Diverse Q2 2024 Financials,1,1,-1,-1,-1,-1
,,,-1,,,,,,DHAI,"DIH Holding US, Inc.",104.61M,2.58,67.62M,-14.82%,-25.49%,-47.44%,-30.98%,+86.36%,DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence,,,,,DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence,1,0,-1,-1,-1,-1
47.20M,"358,327",-48.14M,-1,47,2.640,Strong Buy,11.44,"Aug 1, 2024",HOWL,"Werewolf Therapeutics, Inc.",104.45M,2.39,9.28M,8.08%,-5.45%,-46.42%,+1.33%,-61.49%,Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL) and Chimerix (CMRX),,,,Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL) and Chimerix (CMRX),1,0,0,-1,-1,-1
49.05M,"594,515",8.72M,-1,54,2.540,Strong Buy,7.00,"Aug 1, 2024",LPTX,"Leap Therapeutics, Inc.",104.08M,2.72,-,22.52%,35.74%,11.00%,+34.11%,+12.99%,Optimistic Buy Rating on Leap Therapeutics Amid Promising Phase 2 Cancer Trial Outcomes,Maintained Buy Rating for Leap Therapeutics Amid Promising Clinical and Financial Outlook,Leap Therapeutics Reports Second Quarter 2024 Financial Results,"Leap Therapeutics reports Q2 EPS (52c), consensus (43c)",,"Optimistic Buy Rating on Leap Therapeutics Amid Promising Phase 2 Cancer Trial Outcomes Maintained Buy Rating for Leap Therapeutics Amid Promising Clinical and Financial Outlook Leap Therapeutics Reports Second Quarter 2024 Financial Results Leap Therapeutics reports Q2 EPS (52c), consensus (43c)",1,1,0,0,1,-1
43.09M,"219,151",-4.98M,-1,"1,341",2.860,Strong Buy,7.67,"Aug 14, 2024",SFWL,Shengfeng Development Limited,103.95M,1.26,404.12M,0.95%,0.93%,-60.61%,unch,-34.20%,Shengfeng Reports Stable Mid-Year Financials,,,,,Shengfeng Reports Stable Mid-Year Financials,0,1,-1,-1,-1,-1
,,,-1,325,,,,,KPTI,Karyopharm Therapeutics Inc.,103.92M,0.83,145.67M,-5.86%,-11.06%,-21.59%,-20.91%,-42.50%,Michael Mason Resigns as CFO of Karyopharm Therapeutics,,,,,Michael Mason Resigns as CFO of Karyopharm Therapeutics,1,1,-1,-1,-1,-1
101.51M,"21,970",-17.69M,-1,"2,006",1.220,,,"Sep 3, 2024",MVST,"Microvast Holdings, Inc.",103.82M,0.32,349.72M,-11.61%,-24.30%,-57.80%,-29.87%,-44.35%,"Microvast reports Q2 EPS (25c), consensus (7c)",Microvast exploring strategic alternatives to enhance liquidity,"Microvast sees Q3 revenue $85M-$90M, consensus $99.7M",,,"Microvast reports Q2 EPS (25c), consensus (7c) Microvast exploring strategic alternatives to enhance liquidity Microvast sees Q3 revenue $85M-$90M, consensus $99.7M",1,1,0,1,-1,-1
7.37M,"43,637",15.25M,$0.40,84,16.81,,,"Oct 21, 2024",KINS,"Kingstone Companies, Inc.",103.57M,9.36,143.11M,10.46%,43.55%,118.90%,+34.42%,+119.17%,Kingstone Companies Restructures Debt and Extends Warrants,"Kingstone Companies reduces debt by 25%, extends maturity to June 2026",Kingstone Companies Announces Executive Chair Transition and Bylaw Amendments,Kingstone Companies chairman Barry Goldstein to retire,Kingstone Companies Issues Informal Informational Release,"Kingstone Companies Restructures Debt and Extends Warrants Kingstone Companies reduces debt by 25%, extends maturity to June 2026 Kingstone Companies Announces Executive Chair Transition and Bylaw Amendments Kingstone Companies chairman Barry Goldstein to retire Kingstone Companies Issues Informal Informational Release",1,1,0,1,1,0
88.35M,"1,230,219",-50.30M,-1,925,1.400,Buy,,"Aug 14, 2024",BZFD,"BuzzFeed, Inc.",103.56M,2.74,227.33M,1.30%,-0.57%,49.43%,-5.54%,+62.48%,Largest borrow rate increases among liquid names,BuzzFeed Enhances Investor Communication and Compliance,"BuzzFeed sees Q3 revenue $58M-$63M, one estimate $73.0M",BuzzFeed reports Q2 EPS (18c) vs. (63c) last year,Buzzfeed options imply 18.0% move in share price post-earnings,"Largest borrow rate increases among liquid names BuzzFeed Enhances Investor Communication and Compliance BuzzFeed sees Q3 revenue $58M-$63M, one estimate $73.0M BuzzFeed reports Q2 EPS (18c) vs. (63c) last year Buzzfeed options imply 18.0% move in share price post-earnings",1,1,1,1,1,0
31.15M,"38,882",-11.99M,-1,971,3.970,Buy,8.00,"Aug 6, 2024",TOUR,Tuniu Corporation,103.54M,0.84,69.22M,-4.65%,-8.84%,-0.57%,-7.95%,+4.69%,Tuniu enters strategic cooperation with Tourism Authority of Thailand,,,,,Tuniu enters strategic cooperation with Tourism Authority of Thailand,0,1,-1,-1,-1,-1
36.82M,"266,940",-40.68M,-1,517,3.350,Strong Buy,16.67,"Aug 13, 2024",ACNT,Ascent Industries Co.,102.77M,10.15,182.26M,-0.12%,1.77%,3.20%,-0.79%,-8.17%,5 best installment loans for bad credit of September 2024,Best medical school loans,Best student loans for bad or no credit,Best student loans without a co-signer,Ascent Industries announces new corporate office,5 best installment loans for bad credit of September 2024 Best medical school loans Best student loans for bad or no credit Best student loans without a co-signer Ascent Industries announces new corporate office,0,0,0,0,0,0
9.19M,"5,350",3.54M,-1,"3,888",13.52,,,"Aug 9, 2024",MAXN,"Maxeon Solar Technologies, Ltd.",102.26M,0.18,992.23M,-0.79%,-57.82%,-94.79%,-15.15%,-94.68%,Largest borrow rate increases among liquid names,Maxeon Solar withdraws FY24 revenue and adjusted EBITDA guidance,"Maxeon Solar reports Q2 EPS 3c, consensus ($1.12)",Maxeon Solar Updates Shareholder Agreement Post-Investment,Maxeon Solar Technologies Announces Note Exchange,"Largest borrow rate increases among liquid names Maxeon Solar withdraws FY24 revenue and adjusted EBITDA guidance Maxeon Solar reports Q2 EPS 3c, consensus ($1.12) Maxeon Solar Updates Shareholder Agreement Post-Investment Maxeon Solar Technologies Announces Note Exchange",0,1,0,0,0,0
24.95M,"6,494",-8.62M,-1,23,4.900,Buy,8.00,"Aug 8, 2024",CKPT,"Checkpoint Therapeutics, Inc.",101.97M,2.27,78.00K,-0.64%,-0.82%,9.09%,-7.11%,+21.31%,Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference,Checkpoint Therapeutics files to sell 6.2M shares of common stock for holders,Lake Street Keeps Their Buy Rating on Checkpoint Therapeutics (CKPT),Checkpoint Therapeutics price target lowered to $20 from $34 at H.C. Wainwright,Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates,Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference Checkpoint Therapeutics files to sell 6.2M shares of common stock for holders Lake Street Keeps Their Buy Rating on Checkpoint Therapeutics (CKPT) Checkpoint Therapeutics price target lowered to $20 from $34 at H.C. Wainwright Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates,1,0,1,0,0,0
89.02M,"2,498,064",-87.67M,-1,5,1.380,Hold,1.18,"Jul 31, 2024",ANIX,"Anixa Biosciences, Inc.",101.78M,3.18,-,5.58%,17.59%,0.83%,-0.90%,+2.81%,,,,,,,0,-1,-1,-1,-1,-1
82.40M,"256,326",-137.29M,-1,,1.490,Strong Buy,15.25,"Aug 13, 2024",ORMP,Oramed Pharmaceuticals Inc.,101.11M,2.48,-,0.76%,-2.01%,-3.78%,-5.88%,-8.05%,,,,,,,0,-1,-1,-1,-1,-1
68.44M,"682,304",-144.00M,-1,12,1.790,Strong Buy,10.00,"Aug 13, 2024",RENB,Renovaro Inc.,100.98M,0.68,-,4.23%,-39.92%,-70.71%,-8.47%,-75.79%,Renovaro Biosciences Sues Over Concealed Merger Conspiracy,,,,,Renovaro Biosciences Sues Over Concealed Merger Conspiracy,1,0,-1,-1,-1,-1
50.25M,"317,867",13.71M,$0.04,41,2.430,Buy,4.30,"Jul 31, 2024",DERM,Journey Medical Corporation,100.11M,4.83,77.68M,9.15%,1.69%,13.88%,-7.21%,+39.95%,Journey Medical initiated with a Buy at Lake Street,Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Journey Medical initiated with a Buy at Rodman & Renshaw,Roth MKM Issues a Buy Rating on Journey Medical Corp (DERM),Closing Bell Movers: Rumble jumps 8% on earnings,Journey Medical initiated with a Buy at Lake Street Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference Journey Medical initiated with a Buy at Rodman & Renshaw Roth MKM Issues a Buy Rating on Journey Medical Corp (DERM) Closing Bell Movers: Rumble jumps 8% on earnings,0,0,0,0,0,1
,,,-1,"2,530",,,,,GOCO,"GoHealth, Inc.",99.89M,9.93,700.20M,-17.78%,-24.60%,-30.42%,-37.73%,-22.34%,GoHealth Subsidiary to Acquire Major e-TeleQuote Stake,"GoHealth Acquiring e-TeleQuote, Strengthening Position as Leading Medicare Insurance Marketplace",GoHealth entered agreement to acquire e-TeleQuote Insurance,GoHealth Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference,"GoHealth to Present and Host 1×1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th in Chicago, IL","GoHealth Subsidiary to Acquire Major e-TeleQuote Stake GoHealth Acquiring e-TeleQuote, Strengthening Position as Leading Medicare Insurance Marketplace GoHealth entered agreement to acquire e-TeleQuote Insurance GoHealth Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference GoHealth to Present and Host 1×1 Investor Meetings at the 15th Annual Midwest IDEAS Investor Conference on August 28th in Chicago, IL",1,1,1,1,0,1
95.34M,"478,613",-345.11M,-1,,1.280,Strong Buy,3.35,"Aug 7, 2024",THCP,Thunder Bridge Capital Partners IV Inc.,99.51M,10.49,-,-0.19%,-0.58%,1.63%,-1.13%,+2.64%,,,,,,,1,-1,-1,-1,-1,-1
79.56M,"854,920",10.95M,-1,40,1.530,,,"Sep 6, 2024",VTGN,"Vistagen Therapeutics, Inc.",99.29M,3.67,971.00K,3.34%,0.79%,-17.60%,+2.62%,-30.16%,Buy Rating Affirmed on VistaGen Therapeutics Amid Strong Financials and Promising Clinical Trials,"Vistagen reports Q1 EPS (35c), two estimates (40c)",,,,"Buy Rating Affirmed on VistaGen Therapeutics Amid Strong Financials and Promising Clinical Trials Vistagen reports Q1 EPS (35c), two estimates (40c)",1,1,0,-1,-1,-1
11.24M,"1,683",-3.82M,-1,765,10.85,,,,CPHC,Canterbury Park Holding Corporation,99.21M,19.81,62.10M,-3.19%,-6.00%,-7.05%,-6.37%,-5.05%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,19,,,,,XHG,XChange TEC.INC,99.10M,0.88,10.63M,-17.14%,-11.19%,-31.37%,-15.89%,+40.63%,XChange TEC.INC Charts New Course in Insurance Tech,XChange TEC.INC Regains Nasdaq Compliance,,,,XChange TEC.INC Charts New Course in Insurance Tech XChange TEC.INC Regains Nasdaq Compliance,1,1,0,-1,-1,-1
17.50M,"35,005",6.45M,-1,73,6.92,Strong Buy,12.00,"Aug 9, 2024",VSTM,"Verastem, Inc.",99.00M,2.46,10.00M,2.53%,-12.93%,-68.96%,-6.54%,-78.76%,Outperform Rating and $7 Target for Verastem Amidst LGSOC Treatment Potential and Stock Valuation Opportunity,Buy Rating Affirmed for Verastem: Financial Stability and Promising Drug Pipeline Fuel Optimism,Verastem price target lowered to $7 from $17.50 at H.C. Wainwright,,,Outperform Rating and $7 Target for Verastem Amidst LGSOC Treatment Potential and Stock Valuation Opportunity Buy Rating Affirmed for Verastem: Financial Stability and Promising Drug Pipeline Fuel Optimism Verastem price target lowered to $7 from $17.50 at H.C. Wainwright,1,1,1,0,-1,-1
2.55M,"3,471",3.92M,$0.76,291,47.34,,,"Jul 29, 2024",OPOF,Old Point Financial Corporation,98.98M,19.50,58.41M,0.44%,12.37%,14.06%,+5.32%,+13.50%,Old Point Financial Corporation Announces Quarterly Dividend,,,,,Old Point Financial Corporation Announces Quarterly Dividend,0,0,-1,-1,-1,-1
119.44M,"1,363,026",-203.84M,-1,,1.010,Strong Buy,9.50,"Aug 14, 2024",TVGN,Tevogen Bio Holdings Inc.,98.98M,0.58,-,-17.10%,-25.83%,-89.37%,-24.53%,-83.46%,Tevogen Bio Holdings Announces Key Financial and Governance Moves,Tevogen Bio Secures $6 Million Series C Preferred Stock Investment,Tevogen secures $6M Series C Preferred Stock Investment,"CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares","Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares","Tevogen Bio Holdings Announces Key Financial and Governance Moves Tevogen Bio Secures $6 Million Series C Preferred Stock Investment Tevogen secures $6M Series C Preferred Stock Investment CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares",0,1,0,0,0,0
37.43M,"62,951",-75.00M,-1,"1,029",3.220,Strong Buy,15.50,"Aug 14, 2024",QSG,QuantaSing Group Limited,98.91M,1.75,501.85M,1.48%,1.91%,-32.84%,+4.60%,-52.60%,QuantaSing Group Limited Filed Fiscal Year 2024 Annual Report on Form 20-F,QuantaSing Group files FY24 annual report on Form 20-F,QuantaSing Reports Robust Growth in 2024,"QuantaSing to Report Fourth Fiscal Quarter and Full Fiscal Year 2024 Financial Results on August 28, 2024",,"QuantaSing Group Limited Filed Fiscal Year 2024 Annual Report on Form 20-F QuantaSing Group files FY24 annual report on Form 20-F QuantaSing Reports Robust Growth in 2024 QuantaSing to Report Fourth Fiscal Quarter and Full Fiscal Year 2024 Financial Results on August 28, 2024",0,0,1,1,0,-1
42.67M,"1,144,520",-86.93M,-1,147,2.820,Strong Buy,12.00,"Aug 14, 2024",SEER,"Seer, Inc.",98.90M,1.61,14.74M,-1.06%,-2.37%,-4.32%,-15.66%,-2.91%,Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,"Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors",Seer Appoints Nicolas Roelofs to its Board of Directors,Seer price target lowered to $3 from $7 at Morgan Stanley,,"Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Seer, Inc. Appoints Dr. Nicolas Roelofs to Board of Directors Seer Appoints Nicolas Roelofs to its Board of Directors Seer price target lowered to $3 from $7 at Morgan Stanley",1,1,1,1,0,-1
115.48M,"318,797",-47.41M,-1,126,1.040,Strong Buy,2.67,"Aug 8, 2024",IVAC,"Intevac, Inc.",98.85M,3.67,54.98M,-3.11%,-6.12%,-9.18%,-8.29%,-7.09%,Intevac Board Expansion Welcomes New Member Eiji Miyanaga,,,,,Intevac Board Expansion Welcomes New Member Eiji Miyanaga,0,1,-1,-1,-1,-1
68.23M,"460,065",-3.27M,-1,,1.760,,,"Aug 26, 2024",IXAQ,IX Acquisition Corp.,98.77M,11.49,-,0.26%,0.69%,4.15%,+0.09%,+3.71%,,,,,,,1,-1,-1,-1,-1,-1
31.52M,"1,908",-8.54M,-1,109,3.640,,,"Sep 3, 2024",GAIA,"Gaia, Inc.",98.56M,4.20,84.71M,5.86%,-0.92%,24.98%,-7.71%,+30.00%,Gaia Announces September Conference Schedule,Gaia to Present at the 2024 Gateway Conference on September 4th,,,,Gaia Announces September Conference Schedule Gaia to Present at the 2024 Gateway Conference on September 4th,0,0,1,-1,-1,-1
33.33M,"89,004",158.67M,-1,226,3.570,,,,RVSB,"Riverview Bancorp, Inc.",98.31M,4.66,46.87M,1.63%,8.33%,-4.74%,+1.30%,-0.21%,Riverview Bancorp Executives Present at Upcoming Conferences,,,,,Riverview Bancorp Executives Present at Upcoming Conferences,1,0,-1,-1,-1,-1
,,,-1,,,,,,TBMC,Trailblazer Merger Corporation I,98.22M,10.89,-,0.28%,0.57%,2.96%,+0.32%,+3.36%,,,,,,,1,-1,-1,-1,-1,-1
63.61M,"640,559",-260.01M,-1,220,1.880,Buy,6.00,"Aug 14, 2024",IMAB,I-Mab,98.05M,1.22,3.90M,7.21%,-11.34%,-24.81%,-15.83%,-36.07%,I-MAB Engages Interim CEO in Strategic Agreement,I-Mab Highlights Pipeline Success and Strong Finances,"I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates",,,"I-MAB Engages Interim CEO in Strategic Agreement I-Mab Highlights Pipeline Success and Strong Finances I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates",0,0,0,0,-1,-1
111.73M,"212,594",-50.18M,-1,24,1.070,Strong Buy,1.48,"Aug 8, 2024",ZTEK,Zentek Ltd.,97.86M,0.95,25.80K,-0.52%,-5.54%,-17.28%,-3.07%,-17.70%,Zentek Ltd. Convenes Shareholder Meeting for 2024,Zentek Ltd. Secures Funding Through Private Placement,Zentek Secures Over $3M for Market Expansion,Zentek announces normal course issuer bid,Zentek Expands Private Placement to Raise $3.07M,Zentek Ltd. Convenes Shareholder Meeting for 2024 Zentek Ltd. Secures Funding Through Private Placement Zentek Secures Over $3M for Market Expansion Zentek announces normal course issuer bid Zentek Expands Private Placement to Raise $3.07M,1,0,1,0,1,1
32.36M,"147,360",31.91M,-1,,3.690,Buy,10.00,"Aug 5, 2024",BOWN,Bowen Acquisition Corp,97.81M,10.67,-,0.32%,0.77%,2.59%,+0.85%,+2.90%,,,,,,,1,-1,-1,-1,-1,-1
32.24M,"599,136",1.28M,-1,174,3.690,,,"Sep 3, 2024",PBHC,"Pathfinder Bancorp, Inc.",97.50M,16.00,41.44M,-0.96%,7.54%,17.28%,-1.02%,+30.13%,,,,,,,1,-1,-1,-1,-1,-1
21.96M,"302,634",5.31M,$0.25,"1,300",5.41,,,"Aug 13, 2024",SHIM,Shimmick Corporation,97.41M,2.90,524.16M,-10.78%,12.17%,-32.85%,-19.02%,-31.43%,Shimmick price target lowered to $3 from $4 at Craig-Hallum,Morning Movers: MSG Entertainment rises following quarterly release,Closing Bell Movers: H&R Block jumps 10% after earnings beat,Shimmick comments on Legacy Projects and backlog begun with AECOM,Shimmick reports Q2 EPS ($1.60) vs. (31c) last year,Shimmick price target lowered to $3 from $4 at Craig-Hallum Morning Movers: MSG Entertainment rises following quarterly release Closing Bell Movers: H&R Block jumps 10% after earnings beat Shimmick comments on Legacy Projects and backlog begun with AECOM Shimmick reports Q2 EPS ($1.60) vs. (31c) last year,1,0,0,1,0,1
10.29M,"33,351",8.36M,-1,47,11.54,,,,MIST,Milestone Pharmaceuticals Inc.,97.28M,1.47,-,5.45%,3.62%,-16.78%,+0.69%,-19.44%,Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China,Milestone Pharmaceuticals Welcomes New Directors and Auditor,Milestone Pharmaceuticals appoints Joseph Papa to board of directors,Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors,Milestone Pharmaceuticals: A Buy Rating on CARDAMYST’s Market Potential and FDA Progress,Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China Milestone Pharmaceuticals Welcomes New Directors and Auditor Milestone Pharmaceuticals appoints Joseph Papa to board of directors Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors Milestone Pharmaceuticals: A Buy Rating on CARDAMYST’s Market Potential and FDA Progress,0,0,0,0,0,0
,,,-1,176,,,,,CASI,"CASI Pharmaceuticals, Inc.",97.06M,6.45,23.10M,-1.30%,10.57%,30.95%,-12.00%,+99.38%,Casi Pharmaceuticals files to sell 3M ordinary shares for holders,"CASI Pharmaceuticals Shifts Focus, Garners Investment",Morning Movers: MSG Entertainment rises following quarterly release,Casi Pharmaceuticals reports Q2 EPS (52c) vs. (77c) last year,,"Casi Pharmaceuticals files to sell 3M ordinary shares for holders CASI Pharmaceuticals Shifts Focus, Garners Investment Morning Movers: MSG Entertainment rises following quarterly release Casi Pharmaceuticals reports Q2 EPS (52c) vs. (77c) last year",0,1,0,0,0,-1
35.07M,"371,765",-13.36M,-1,178,3.385,Hold,4.50,"Aug 29, 2024",XTKG,X3 Holdings Co Ltd.,96.39M,0.35,16.82M,-26.16%,-37.71%,-60.52%,-25.04%,-55.79%,,,,,,,0,-1,-1,-1,-1,-1
4.31M,"3,497",13.13M,$0.48,"1,456",27.38,,,"Sep 3, 2024",CBAT,"CBAK Energy Technology, Inc.",96.23M,1.07,226.24M,-6.99%,-17.90%,-9.32%,-17.13%,+7.00%,,,,,,,0,-1,-1,-1,-1,-1
25.84M,"127,662",-6.69M,-1,270,4.540,Strong Buy,9.00,"Aug 8, 2024",INCR,InterCure Ltd.,96.11M,2.11,98.73M,6.38%,-1.74%,5.13%,+3.20%,-11.20%,Rising High: SNDL announces successful bid to acquire Indiva,InterCure announces expansion of partnership with Cookies to Germany,,,,Rising High: SNDL announces successful bid to acquire Indiva InterCure announces expansion of partnership with Cookies to Germany,0,0,0,-1,-1,-1
12.87M,"27,576",-12.25M,-1,688,9.11,Strong Buy,12.00,"Sep 5, 2024",BRID,Bridgford Foods Corporation,95.94M,10.57,236.66M,10.96%,9.22%,2.48%,+31.52%,+14.88%,,,,,,,0,-1,-1,-1,-1,-1
166.86M,"1,492,827",-108.79M,-1,274,0.700,Buy,3.85,"Aug 7, 2024",SATL,Satellogic Inc.,95.66M,1.05,13.72M,-1.72%,-6.79%,-26.23%,-2.94%,-36.13%,"Satellogic Appoints New Director, Bids Farewell to Another",Satellogic Inc. Reveals First Half 2024 Financials,,,,"Satellogic Appoints New Director, Bids Farewell to Another Satellogic Inc. Reveals First Half 2024 Financials",1,1,1,-1,-1,-1
8.79M,"19,239",-15.09M,$0.80,9,13.24,Hold,,"Jul 10, 2024",PFX,PhenixFIN Corporation,95.42M,47.25,22.29M,-0.61%,1.01%,11.65%,unch,+5.52%,,,,,,,1,-1,-1,-1,-1,-1
4.35M,"4,090",5.24M,$0.40,"1,076",26.71,,,"Oct 17, 2024",ZENV,Zenvia Inc.,95.19M,1.84,167.71M,1.67%,-14.83%,-6.49%,-10.53%,-22.02%,Zenvia Inc. Complies with SEC’s September Filing,Zenvia Inc. Reports Mid-Year Financial Performance,Zenvia Inc. Soars with Robust Q2 2024 Earnings,Zenvia Reports Revenue and Profit Growth,Maintaining Hold on Zenvia: Weighing Operational Success Against Financial Uncertainties,Zenvia Inc. Complies with SEC’s September Filing Zenvia Inc. Reports Mid-Year Financial Performance Zenvia Inc. Soars with Robust Q2 2024 Earnings Zenvia Reports Revenue and Profit Growth Maintaining Hold on Zenvia: Weighing Operational Success Against Financial Uncertainties,0,0,1,1,1,0
18.87M,"612,513",-20.32M,-1,841,6.16,,,"Aug 12, 2024",GIFI,"Gulf Island Fabrication, Inc.",94.97M,5.75,133.72M,1.49%,-3.63%,3.32%,-6.73%,-19.50%,,,,,,,0,-1,-1,-1,-1,-1
7.84M,"19,749",8.44M,$0.57,"1,718",14.80,,,"Jul 23, 2024",CMTL,Comtech Telecommunications Corp.,94.88M,3.33,563.03M,0.01%,-0.66%,-39.45%,-3.40%,+19.01%,Comtech relocates headquarters to Arizona,,,,,Comtech relocates headquarters to Arizona,1,0,-1,-1,-1,-1
65.47M,"409,875",-35.39M,-1,161,1.770,Strong Buy,10.33,"Aug 8, 2024",PROV,"Provident Financial Holdings, Inc.",94.85M,13.79,38.93M,3.19%,6.07%,5.14%,+6.47%,+4.04%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,405,,,,,ASYS,"Amtech Systems, Inc.",94.84M,6.67,104.81M,7.69%,6.34%,18.81%,+14.46%,+25.86%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,122,,,,,CTMX,"CytomX Therapeutics, Inc.",94.52M,1.21,119.57M,-3.64%,-8.87%,-30.02%,-15.94%,-43.69%,Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX),CytomX Therapeutics (CTMX) Gets a Buy from Wedbush,,,,Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX) CytomX Therapeutics (CTMX) Gets a Buy from Wedbush,0,0,0,-1,-1,-1
,,,-1,237,,,,,RMTI,"Rockwell Medical, Inc.",94.33M,3.04,94.37M,30.20%,48.57%,76.89%,+65.57%,+83.64%,Buy Rating Justified by Rockwell Medical’s Growth Prospects and Strategic Partnerships,Rockwell Medical signs distribution agreement with Nipro Medical,Rockwell Med Secures Buy Rating on Strong Financials and Strategic Growth Prospects,Maxim Group Reaffirms Their Buy Rating on Rockwell Med (RMTI),,Buy Rating Justified by Rockwell Medical’s Growth Prospects and Strategic Partnerships Rockwell Medical signs distribution agreement with Nipro Medical Rockwell Med Secures Buy Rating on Strong Financials and Strategic Growth Prospects Maxim Group Reaffirms Their Buy Rating on Rockwell Med (RMTI),0,0,0,1,0,-1
,,,-1,,,,,,AFJK,"Aimei Health Technology Co., Ltd",94.23M,10.44,-,0.39%,0.80%,1.64%,+0.77%,+2.66%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,GSIW,Garden Stage Limited,94.22M,7.39,1.41M,2.57%,3.28%,-14.13%,+0.42%,+4.53%,,,,,,,1,-1,-1,-1,-1,-1
77.89M,"2,587,238",-258.61M,-1,833,1.470,Strong Buy,23.54,"Aug 14, 2024",SGA,"Saga Communications, Inc.",94.17M,15.04,111.70M,-2.05%,-2.53%,-24.51%,-2.58%,-32.89%,"Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA)",Noble Financial Remains a Buy on Saga Communications (SGA),,,,"Analysts Have Conflicting Sentiments on These Communication Services Companies: Saga Communications (SGA), Yelp (YELP) and Liberty Broadband (LBRDA) Noble Financial Remains a Buy on Saga Communications (SGA)",0,1,0,-1,-1,-1
30.19M,"22,239",35.78M,-1,671,3.760,,,"Aug 13, 2024",BCOV,Brightcove Inc.,93.89M,2.09,200.86M,7.62%,1.95%,5.90%,-5.04%,+22.83%,Brightcove management to meet virtually with Lake Street,,,,,Brightcove management to meet virtually with Lake Street,0,0,-1,-1,-1,-1
4.52M,"19,440",10.02M,$1.44,60,25.10,,,"Oct 16, 2024",SKYX,SKYX Platforms Corp.,93.88M,0.92,84.22M,-9.27%,-9.40%,-27.64%,-22.16%,-21.43%,"Analysts’ Top Industrial Goods Picks: Lennox International (LII), SQL Technologies (SKYX)","SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans",SKYX Platforms to collaborate with EGLO,Buy Rating Justified: SQL Technologies’ Strong Growth and Strategic Partnerships,SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products,"Analysts’ Top Industrial Goods Picks: Lennox International (LII), SQL Technologies (SKYX) SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans SKYX Platforms to collaborate with EGLO Buy Rating Justified: SQL Technologies’ Strong Growth and Strategic Partnerships SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products",1,1,1,1,1,1
10.28M,"1,728",-1.81M,-1,65,11.04,,,,SRBK,"SR Bancorp, Inc.",93.84M,9.87,22.61M,0.97%,3.53%,4.90%,+0.61%,+5.11%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,10,,,,,SGMT,Sagimet Biosciences Inc.,93.83M,2.94,2.00M,3.99%,-6.63%,-39.32%,-12.80%,-44.82%,"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Sagimet Biosciences, Inc. Class A (SGMT)",SGMT Earnings this Week: How Will it Perform?,Buy Rating Affirmed for Sagimet Biosciences on Robust Denifanstat Prospects and Strategic Advancements,Sagimet Biosciences files $300M mixed securities shelf,Buy Rating Backed by Positive Phase 2b Results and Potential for MASH Backbone Therapy,"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Sagimet Biosciences, Inc. Class A (SGMT) SGMT Earnings this Week: How Will it Perform? Buy Rating Affirmed for Sagimet Biosciences on Robust Denifanstat Prospects and Strategic Advancements Sagimet Biosciences files $300M mixed securities shelf Buy Rating Backed by Positive Phase 2b Results and Potential for MASH Backbone Therapy",0,0,0,0,0,1
22.75M,"65,168","-990,722",-1,11,4.99,,,"Sep 6, 2024",SSSS,SuRo Capital Corp.,93.75M,4.01,6.48M,1.45%,-0.46%,-2.41%,-1.52%,-5.11%,,,,,,,1,-1,-1,-1,-1,-1
49.24M,"104,280",-23.85M,-1,,2.290,Buy,5.25,"Aug 12, 2024",EVGR,Evergreen Corporation,93.71M,11.61,-,0.08%,0.61%,3.09%,+0.09%,+2.75%,Evergreen Corporation and Forekast Limited Announce Definitive Business Combination Agreement,,,,,Evergreen Corporation and Forekast Limited Announce Definitive Business Combination Agreement,1,1,-1,-1,-1,-1
10.39M,"1,476",4.55M,-1,70,10.80,,,,BSBK,Bogota Financial Corp.,93.53M,7.35,12.65M,0.17%,2.74%,0.37%,+2.80%,+7.30%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,GLAC,Global Lights Acquisition Corp,93.52M,10.42,-,0.20%,0.67%,1.72%,+0.68%,+2.56%,,,,,,,1,-1,-1,-1,-1,-1
12.98M,"100,894",-43.31M,-1,"1,619",8.59,Hold,13.00,"Aug 8, 2024",AERT,"Aeries Technology, Inc",93.50M,2.12,67.88M,-4.93%,3.24%,1.45%,-18.41%,-14.85%,Aeries Technology announces hub in Guadalajara’s La Colonia Americana,Aeries Establishes New Hub in Guadalajara’s La Colonia Americana to Support Growing Nearshore Demand,Aeries Technology to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Aeries Technology selectd by Diligent to establish customer success center,,Aeries Technology announces hub in Guadalajara’s La Colonia Americana Aeries Establishes New Hub in Guadalajara’s La Colonia Americana to Support Growing Nearshore Demand Aeries Technology to Present at the H.C. Wainwright 26th Annual Global Investment Conference Aeries Technology selectd by Diligent to establish customer success center,1,0,0,0,0,-1
11.07M,"20,022",,-1,8,10.06,,,,COYA,"Coya Therapeutics, Inc.",93.46M,6.14,9.55M,-1.33%,-9.14%,-20.52%,-12.24%,-37.03%,"Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed","Coya Therapeutics reports Q2 EPS (19c), consensus (31c)",,,,"Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed Coya Therapeutics reports Q2 EPS (19c), consensus (31c)",0,0,0,-1,-1,-1
,,,-1,,,,,,AMLI,American Lithium Corp.,93.45M,0.42,-,-3.45%,-19.55%,-48.02%,-13.47%,-45.92%,American Lithium’s Falchani Project Valuation Soars,"American Lithium Undergoes CEO Change, Seeks Nasdaq Extension",American Lithium Announces Management Changes and Applies to Nasdaq for Extension to Minimum Price Requirement,,,"American Lithium’s Falchani Project Valuation Soars American Lithium Undergoes CEO Change, Seeks Nasdaq Extension American Lithium Announces Management Changes and Applies to Nasdaq for Extension to Minimum Price Requirement",1,1,1,1,-1,-1
6.46M,"14,725",10.46M,-1,270,17.25,,,"Sep 26, 2024",FNWB,First Northwest Bancorp,93.39M,10.64,60.10M,5.49%,8.57%,-15.60%,+7.93%,-27.88%,,,,,,,0,-1,-1,-1,-1,-1
46.55M,"304,366",-40.88M,-1,62,2.390,Strong Buy,10.50,"Aug 8, 2024",IFRX,InflaRx N.V.,93.04M,1.58,113.02K,13.35%,6.41%,6.86%,+7.33%,+3.87%,InflaRx presents new preclinical findings for INF904,InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases,InflaRx Announces Participation in September Investor Events,InflaRx Buy Rating Backed by Promising Drug Prospects and Financial Stability,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Krystal Biotech (KRYS) and InflaRx (IFRX)","InflaRx presents new preclinical findings for INF904 InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases InflaRx Announces Participation in September Investor Events InflaRx Buy Rating Backed by Promising Drug Prospects and Financial Stability Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Krystal Biotech (KRYS) and InflaRx (IFRX)",1,0,0,1,1,1
5.50M,"2,264",11.31M,$0.84,,20.05,,,"Aug 5, 2024",QETA,Quetta Acquisition Corporation,92.78M,10.37,-,0.22%,0.29%,1.28%,-0.10%,+2.37%,,,,,,,1,-1,-1,-1,-1,-1
47.04M,"100,589",-3.44M,-1,65,2.360,,,,ASMB,"Assembly Biosciences, Inc.",92.71M,14.61,21.48M,15.05%,12.83%,29.97%,+14.62%,+21.57%,Eleven option delistings on August 19th,H.C. Wainwright Remains a Hold on Assembly Biosciences (ASMB),,,,Eleven option delistings on August 19th H.C. Wainwright Remains a Hold on Assembly Biosciences (ASMB),1,0,0,-1,-1,-1
,,,-1,90,,,,,HLVX,"HilleVax, Inc.",92.58M,1.94,-,9.22%,-62.52%,-84.44%,+4.37%,-86.85%,"HilleVax, Inc.: Prudent Cost Management Amidst Trial Setbacks – Hold Rating Justified","HilleVax, Inc: Hold Rating Amid Vaccine Efficacy Concerns and Financial Uncertainty",,,,"HilleVax, Inc.: Prudent Cost Management Amidst Trial Setbacks – Hold Rating Justified HilleVax, Inc: Hold Rating Amid Vaccine Efficacy Concerns and Financial Uncertainty",1,1,1,-1,-1,-1
76.49M,"217,281",-38.53M,-1,819,1.450,Strong Buy,5.00,"Aug 6, 2024",PPIH,"Perma-Pipe International Holdings, Inc.",92.21M,11.50,155.33M,16.36%,17.02%,27.76%,+10.64%,+29.95%,Perma-Pipe International awarded two MENA region projects valued over $46M,,,,,Perma-Pipe International awarded two MENA region projects valued over $46M,1,1,-1,-1,-1,-1
10.21M,"4,352",10.42M,-1,,10.85,,,,DYCQ,DT Cloud Acquisition Corporation,92.18M,10.29,-,0.41%,0.75%,0.88%,+0.68%,,DT Cloud Acquisition Corp. Eyes Strategic Business Combination,DT Cloud Acquisition Corporation Signs Letter of Intent for a Business Combination,,,,DT Cloud Acquisition Corp. Eyes Strategic Business Combination DT Cloud Acquisition Corporation Signs Letter of Intent for a Business Combination,1,1,1,-1,-1,-1
,,,-1,,,,,,SUNS,"Sunrise Realty Trust, Inc.",91.97M,13.28,734.23K,14.73%,15.25%,15.25%,+14.58%,,Sunrise Realty Trust reports Q2 EPS 22c,"Sunrise Realty Trust, Inc. Provides Quarterly Business Update and Declares Dividends for Third and Fourth Quarters of 2024",,,,"Sunrise Realty Trust reports Q2 EPS 22c Sunrise Realty Trust, Inc. Provides Quarterly Business Update and Declares Dividends for Third and Fourth Quarters of 2024",0,1,0,-1,-1,-1
35.72M,"57,918",-120.43M,-1,"2,377",3.100,Hold,5.50,"Aug 8, 2024",TDUP,ThredUp Inc.,91.83M,0.82,322.79M,-22.33%,-46.65%,-57.76%,-62.87%,-56.44%,,,,,,,1,-1,-1,-1,-1,-1
7.51M,"12,808",5.03M,-1,69,14.69,,,"Sep 4, 2024",CDTX,"Cidara Therapeutics, Inc.",91.36M,12.98,53.87M,4.29%,6.40%,-6.35%,-1.15%,-44.14%,Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer,Cidara Therapeutics names Jim Beitel CBO,Cidara Therapeutics upgraded to Buy from Neutral at H.C. Wainwright,Cidara Therapeutics: A Strong Buy on Promising Trials and Strategic Milestones,Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results,Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer Cidara Therapeutics names Jim Beitel CBO Cidara Therapeutics upgraded to Buy from Neutral at H.C. Wainwright Cidara Therapeutics: A Strong Buy on Promising Trials and Strategic Milestones Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results,0,1,1,0,1,0
36.90M,"46,555",-54.07M,-1,65,2.990,Buy,,"Sep 3, 2024",BCAB,"BioAtla, Inc.",91.35M,1.89,-,6.58%,11.12%,-17.18%,-1.10%,-52.89%,Burry of ‘The Big Short’ fame makes Chinese internet companies his top bets,Buy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic Outlook,Reni Benjamin’s Buy Rating for BioAtla: Strong Pipeline and Financial Health Signal Upside Potential,,,Burry of ‘The Big Short’ fame makes Chinese internet companies his top bets Buy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic Outlook Reni Benjamin’s Buy Rating for BioAtla: Strong Pipeline and Financial Health Signal Upside Potential,1,1,1,1,-1,-1
6.52M,"17,256",-2.93M,$0.64,18,16.90,,,"Sep 6, 2024",BNTC,Benitec Biopharma Inc.,91.28M,9.05,7.00K,6.62%,8.47%,58.77%,+4.52%,+61.76%,Benitec Biopharma Shareholders Approve Key Proposals,,,,,Benitec Biopharma Shareholders Approve Key Proposals,0,1,-1,-1,-1,-1
9.34M,"14,871","168,000",$0.12,338,11.75,Buy,14.00,"Oct 16, 2024",KVHI,"KVH Industries, Inc.",91.08M,4.62,122.59M,0.60%,-0.70%,-6.83%,+0.22%,-11.86%,,,,,,,0,-1,-1,-1,-1,-1
5.07M,"159,370",-37.89M,-1,,21.63,Strong Buy,45.00,"Aug 8, 2024",BKHA,Black Hawk Acquisition Corporation,90.99M,10.19,-,0.24%,0.46%,0.46%,+0.54%,,,,,,,,1,-1,-1,-1,-1,-1
79.26M,"56,979,066",-2.98M,-1,,1.380,,,"May 15, 2024",CITE,Cartica Acquisition Corp,90.87M,11.36,-,-0.10%,1.10%,4.36%,+1.97%,+5.47%,,,,,,,1,-1,-1,-1,-1,-1
12.70M,"65,166",3.60M,$0.16,,8.60,,,"Aug 28, 2024",ACAB,Atlantic Coastal Acquisition Corp. II,90.66M,11.06,-,0.31%,0.39%,3.97%,+0.37%,+3.88%,Atlantic Coastal’s Strategic Amendments and Equity Moves,Atlantic Coastal Acquisition’s Strategic Equity Sales and Partnerships,,,,Atlantic Coastal’s Strategic Amendments and Equity Moves Atlantic Coastal Acquisition’s Strategic Equity Sales and Partnerships,0,1,1,-1,-1,-1
6.28M,"1,543",7.92M,$0.60,105,17.37,Strong Buy,21.00,"Jul 31, 2024",DBVT,DBV Technologies S.A.,90.45M,0.92,13.81M,-5.45%,-2.43%,-36.69%,-10.12%,-43.44%,DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,,,,,DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,0,0,-1,-1,-1,-1
31.70M,"269,594",-11.69M,-1,,3.440,,,"Aug 14, 2024",TMTC,TMT Acquisition Corp,90.27M,11.09,-,0.13%,0.97%,4.42%,+0.31%,+5.07%,,,,,,,1,-1,-1,-1,-1,-1
9.47M,"5,235",5.75M,-1,29,11.51,,,,EPRX,Eupraxia Pharmaceuticals Inc.,90.22M,2.67,-,3.94%,4.49%,-18.11%,-4.91%,-13.98%,Eupraxia Pharma Showcases Innovation at Global Conference,,,,,Eupraxia Pharma Showcases Innovation at Global Conference,0,0,-1,-1,-1,-1
,,,-1,378,,,,,SND,"Smart Sand, Inc.",90.15M,2.10,295.70M,6.16%,2.37%,4.53%,+3.37%,-1.38%,"Smart Sand reports Q EPS (1c), two estimates (1c)","Smart Sand, Inc. Announces Second Quarter 2024 Results","SND Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,"Smart Sand reports Q EPS (1c), two estimates (1c) Smart Sand, Inc. Announces Second Quarter 2024 Results SND Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,0,0,1,-1,-1
158.00M,"166,420",-117.08M,-1,173,0.689,,,"Aug 29, 2024",RBKB,"Rhinebeck Bancorp, Inc.",89.94M,8.35,40.86M,-3.35%,-1.19%,3.19%,-6.43%,+1.27%,,,,,,,1,-1,-1,-1,-1,-1
10.45M,"29,406",10.19M,$1.40,140,10.45,,,"Aug 1, 2024",RANI,"Rani Therapeutics Holdings, Inc.",89.92M,3.07,-,22.66%,2.36%,-11.59%,+6.38%,-18.63%,Rani Therapeutics to Participate in September Investor Conferences,"Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)",Buy Rating Maintained for Rani Therapeutics: A Financial and Risk Analysis Amidst Recent Equity Financing,Rani Therapeutics price target lowered to $9 from $13 at H.C. Wainwright,"Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)","Rani Therapeutics to Participate in September Investor Conferences Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI) Buy Rating Maintained for Rani Therapeutics: A Financial and Risk Analysis Amidst Recent Equity Financing Rani Therapeutics price target lowered to $9 from $13 at H.C. Wainwright Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)",0,0,0,0,0,0
,,,-1,,,,,,IROH,Iron Horse Acquisitions Corp.,89.91M,10.14,-,0.05%,0.38%,0.79%,+0.30%,+1.20%,,,,,,,1,-1,-1,-1,-1,-1
65.88M,"86,031",-88.00M,-1,344,1.640,Strong Buy,11.00,"Aug 13, 2024",LUNA,Luna Innovations Incorporated,89.87M,2.59,116.61M,-8.87%,-17.73%,-47.62%,-21.33%,-19.18%,Luna Innovations Struggles with Nasdaq Compliance and Delisting Risk,Luna Innovations receives noncompliance notice from Nasdaq,,,,Luna Innovations Struggles with Nasdaq Compliance and Delisting Risk Luna Innovations receives noncompliance notice from Nasdaq,0,1,0,-1,-1,-1
16.39M,"129,177",6.65M,-1,9,6.58,Strong Buy,10.00,"Aug 8, 2024",MFH,Mercurity Fintech Holding Inc.,89.71M,1.48,445.93K,-9.13%,-12.60%,-15.57%,-24.61%,+14.75%,,,,,,,1,-1,-1,-1,-1,-1
45.86M,"68,812",-11.76M,-1,,2.350,Strong Buy,3.70,"Aug 7, 2024",ONYX,Onyx Acquisition Co. I,89.55M,11.27,-,0.25%,0.64%,3.47%,+0.27%,+3.58%,,,,,,,1,-1,-1,-1,-1,-1
28.42M,"72,205",2.12M,-1,505,3.790,Buy,8.40,"Aug 7, 2024",FFIE,Faraday Future Intelligent Electric Inc.,89.51M,7.23,1.08M,-14.65%,-47.44%,-65.46%,-55.36%,+99.30%,Faraday Future Secures $30M to Boost Global EV Expansion,Morning Movers: Broadcom sinks after earnings,Faraday Future receives noncompliance notification from Nasdaq,Unusually active option classes on open August 26th,Faraday Future Intelligent Electric call volume above normal and directionally bullish,Faraday Future Secures $30M to Boost Global EV Expansion Morning Movers: Broadcom sinks after earnings Faraday Future receives noncompliance notification from Nasdaq Unusually active option classes on open August 26th Faraday Future Intelligent Electric call volume above normal and directionally bullish,0,0,0,0,0,1
13.40M,"74,421",-1.03M,$1.36,"7,390",8.04,,,"Aug 1, 2024",FAT,FAT Brands Inc.,89.49M,5.26,572.01M,-1.33%,0.93%,-19.09%,-1.90%,-31.33%,Fat Brands’ wing concepts gear up for football season with new menu items,FAT Brands’ Wing Concepts Gear up for Fall and Football Season with New Menu Items,Fazoli’s Expands Georgia Presence with Latest Opening in Newnan,"Fazoli’s opens new location in Newnan, Georgia","FAT Brands appoints Ammy Harrison as SVP, non-traditional development","Fat Brands’ wing concepts gear up for football season with new menu items FAT Brands’ Wing Concepts Gear up for Fall and Football Season with New Menu Items Fazoli’s Expands Georgia Presence with Latest Opening in Newnan Fazoli’s opens new location in Newnan, Georgia FAT Brands appoints Ammy Harrison as SVP, non-traditional development",1,1,1,1,1,1
9.52M,"3,456",1.49M,-1,"7,390",11.24,,,,FATBB,FAT Brands Inc.,89.48M,5.25,572.01M,,0.93%,-19.09%,-2.91%,-25.93%,Fat Brands’ wing concepts gear up for football season with new menu items,FAT Brands’ Wing Concepts Gear up for Fall and Football Season with New Menu Items,Fazoli’s Expands Georgia Presence with Latest Opening in Newnan,"Fazoli’s opens new location in Newnan, Georgia","FAT Brands appoints Ammy Harrison as SVP, non-traditional development","Fat Brands’ wing concepts gear up for football season with new menu items FAT Brands’ Wing Concepts Gear up for Fall and Football Season with New Menu Items Fazoli’s Expands Georgia Presence with Latest Opening in Newnan Fazoli’s opens new location in Newnan, Georgia FAT Brands appoints Ammy Harrison as SVP, non-traditional development",1,1,1,1,1,1
,,,-1,,,,,,FSHP,Flag Ship Acquisition Corporation,88.63M,10.00,-,-0.09%,-0.09%,-0.09%,,,,,,,,,0,-1,-1,-1,-1,-1
180.73M,"1,741,835",-39.77M,-1,22,0.595,Strong Buy,5.00,"Aug 12, 2024",AUID,authID Inc.,88.46M,8.10,553.11K,-5.23%,-12.07%,-7.27%,-15.09%,-4.99%,,,,,,,1,-1,-1,-1,-1,-1
96.95M,"457,275",-6.69M,-1,7,1.100,Buy,2.61,"Aug 8, 2024",NEOV,NeoVolta Inc.,88.41M,2.66,2.79M,-5.05%,-2.73%,27.27%,-1.86%,+26.32%,NeoVolta secures $5M line of credit,"NeoVolta Secures $5 Million Line of Credit, Strengthens Financial Position",,,,"NeoVolta secures $5M line of credit NeoVolta Secures $5 Million Line of Credit, Strengthens Financial Position",1,1,1,-1,-1,-1
3.35M,"3,527",12.03M,$1.16,49,31.30,,,"Jul 26, 2024",TIL,"Instil Bio, Inc.",88.13M,13.55,-,11.67%,14.02%,24.68%,+3.86%,+13.35%,Instil Bio price target raised to $25 from $18 at H.C. Wainwright,Instil Bio’s Strategic Licensing and Financial Stability Underpin Buy Rating,Instil Bio Presents Latest Updates with Investor Disclaimer,"Instil Bio reports Q2 EPS ($2.29), two estimates ($2.98)",Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update,"Instil Bio price target raised to $25 from $18 at H.C. Wainwright Instil Bio’s Strategic Licensing and Financial Stability Underpin Buy Rating Instil Bio Presents Latest Updates with Investor Disclaimer Instil Bio reports Q2 EPS ($2.29), two estimates ($2.98) Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update",0,0,1,0,0,0
13.01M,"27,152",-4.71M,-1,,8.17,,,"Jun 20, 2024",GAQ,Generation Asia I Acquisition Limited,87.96M,11.22,-,-0.34%,0.15%,3.20%,-0.36%,+3.32%,,,,,,,0,-1,-1,-1,-1,-1
10.08M,"3,120",1.12M,-1,705,10.54,,,,MNTX,"Manitex International, Inc.",87.91M,4.31,299.56M,0.46%,-4.88%,-32.07%,-14.15%,-31.50%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,72,,,,,CMRX,"Chimerix, Inc.",87.85M,0.98,144.00K,8.76%,10.04%,1.54%,+12.03%,-3.24%,Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),Biotech Alert: Searches spiking for these stocks today,Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX) and Ocuphire Pharma (OCUP),"Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Chimerix (CMRX) and Mersana Therapeutics (MRSN)",Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL) and Chimerix (CMRX),"Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Biotech Alert: Searches spiking for these stocks today Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX) and Ocuphire Pharma (OCUP) Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Chimerix (CMRX) and Mersana Therapeutics (MRSN) Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL) and Chimerix (CMRX)",0,0,1,0,0,0
9.60M,"1,700",2.13M,-1,,11.04,,,,HSPO,Horizon Space Acquisition I Corp.,87.80M,11.21,-,0.38%,0.88%,3.65%,+0.99%,+3.90%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,,,,,,BYNO,byNordic Acquisition Corporation,87.60M,11.38,-,-0.98%,0.25%,4.02%,+0.31%,+3.88%,,,,,,,1,-1,-1,-1,-1,-1
6.73M,"12,839",12.04M,$0.56,30,15.74,,,"Jul 18, 2024",MAYS,"J.W. Mays, Inc.",87.34M,43.33,21.51M,-1.56%,-1.71%,-4.66%,+1.86%,-10.24%,,,,,,,0,-1,-1,-1,-1,-1
109.59M,"8,744",60.70M,-1,,0.960,,,"Sep 3, 2024",PWUP,PowerUp Acquisition Corp.,87.20M,11.23,-,-0.51%,-0.88%,3.05%,-0.27%,+3.41%,"PowerUp Acquisition, Aspire Biopharma enter business combination agreement","Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements",,,,"PowerUp Acquisition, Aspire Biopharma enter business combination agreement Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements",0,1,0,-1,-1,-1
17.26M,"6,302",-33.71M,-1,122,6.08,Buy,16.33,"Aug 13, 2024",AIRG,"Airgain, Inc.",86.57M,7.66,53.18M,4.05%,10.35%,51.37%,-3.07%,+33.27%,,,,,,,0,-1,-1,-1,-1,-1
63.67M,"26,128",14.49M,-1,91,1.630,,,"Aug 13, 2024",ACRS,"Aclaris Therapeutics, Inc.",86.33M,1.21,32.02M,-2.98%,-4.02%,-2.24%,-10.45%,+0.84%,H.C. Wainwright Reaffirms Their Hold Rating on Aclaris Therapeutics (ACRS),,,,,H.C. Wainwright Reaffirms Their Hold Rating on Aclaris Therapeutics (ACRS),1,0,-1,-1,-1,-1
40.54M,"16,379",-6.14M,-1,"1,357",2.580,,,"Aug 19, 2024",SY,So-Young International Inc.,86.10M,0.84,206.62M,2.25%,-5.40%,-14.47%,-5.98%,-23.65%,So-Young Faces Nasdaq Compliance Challenge,So-Young receives noncompliance notification from Nasdaq,"Options Volatility and Implied Earnings Moves Today, August 23, 2024",So-Young’s Strategic Shift Leads to Profitable Q2,,"So-Young Faces Nasdaq Compliance Challenge So-Young receives noncompliance notification from Nasdaq Options Volatility and Implied Earnings Moves Today, August 23, 2024 So-Young’s Strategic Shift Leads to Profitable Q2",1,0,0,0,0,-1
,,,-1,40,,,,,OVID,Ovid Therapeutics Inc.,85.88M,1.21,567.70K,23.66%,29.14%,-52.45%,+23.08%,-60.62%,Ovid Therapeutics to Present at Upcoming September Investor Conferences,H.C. Wainwright Reaffirms Their Buy Rating on Ovid Therapeutics (OVID),Buy Rating Affirmed for Ovid Therapeutics Amid Promising Pipeline and Stable Financial Outlook,Wedbush Remains a Buy on Ovid Therapeutics (OVID),Buy Rating Affirmed for Ovid Therapeutics Amid Strong Clinical Progress and Promising Neurological Pipeline,Ovid Therapeutics to Present at Upcoming September Investor Conferences H.C. Wainwright Reaffirms Their Buy Rating on Ovid Therapeutics (OVID) Buy Rating Affirmed for Ovid Therapeutics Amid Promising Pipeline and Stable Financial Outlook Wedbush Remains a Buy on Ovid Therapeutics (OVID) Buy Rating Affirmed for Ovid Therapeutics Amid Strong Clinical Progress and Promising Neurological Pipeline,0,0,0,0,0,0
43.70M,"314,756",-53.73M,-1,112,2.390,Strong Buy,12.00,"Aug 8, 2024",ALVR,"AlloVir, Inc.",85.59M,0.75,-,2.19%,1.33%,-16.91%,+2.56%,+1.75%,Maintaining Hold on AlloVir Amid Financial Performance and Strategic Uncertainty,Morgan Stanley Sticks to Its Sell Rating for AlloVir (ALVR),,,,Maintaining Hold on AlloVir Amid Financial Performance and Strategic Uncertainty Morgan Stanley Sticks to Its Sell Rating for AlloVir (ALVR),0,0,0,-1,-1,-1
38.26M,"53,974",-60.34M,-1,94,2.720,Strong Buy,10.40,"Aug 12, 2024",OMGA,"Omega Therapeutics, Inc.",85.49M,1.55,6.31M,-6.89%,-20.12%,-44.80%,-22.04%,-50.85%,Omega Therapeutics appoints Nelson as SVP of Research,"Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research",,,,"Omega Therapeutics appoints Nelson as SVP of Research Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research",1,1,1,-1,-1,-1
82.50M,"35,990",10.29M,-1,,1.280,,,"Sep 3, 2024",EMCG,Embrace Change Acquisition Corp.,85.44M,11.51,-,0.74%,1.65%,4.60%,+1.77%,+4.26%,Embrace Change Acquisition Corp. Receives Additional Staff Determination Notice from Nasdaq Related to Delayed Quarterly Report,,,,,Embrace Change Acquisition Corp. Receives Additional Staff Determination Notice from Nasdaq Related to Delayed Quarterly Report,1,0,-1,-1,-1,-1
124.68M,"413,830",-89.91M,-1,31,0.834,Strong Buy,5.00,"Aug 6, 2024",KOSS,Koss Corporation,85.42M,9.23,12.45M,18.56%,25.05%,124.37%,-5.84%,+255.82%,Koss Corporation Releases Fourth Quarter and Full Year Results,,,,,Koss Corporation Releases Fourth Quarter and Full Year Results,1,0,-1,-1,-1,-1
322.13M,"1,063,043",-153.93M,-1,66,0.322,Buy,4.50,"Aug 8, 2024",ALGS,"Aligos Therapeutics, Inc.",85.26M,13.83,7.97M,-0.40%,6.65%,-23.49%,+0.38%,-49.81%,Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS),Aligos Therapeutics initiated with a Buy at H.C. Wainwright,"Aligos Therapeutics trading halted, news pending",Aligos Therapeutics announces 1-for-25 reverse stock split,Aligos Therapeutics Announces Reverse Stock Split,"Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS) Aligos Therapeutics initiated with a Buy at H.C. Wainwright Aligos Therapeutics trading halted, news pending Aligos Therapeutics announces 1-for-25 reverse stock split Aligos Therapeutics Announces Reverse Stock Split",1,0,0,0,0,0
11.06M,"262,707",5.35M,-1,"5,400",9.36,Buy,4.13,"Aug 12, 2024",SPWH,"Sportsman's Warehouse Holdings, Inc.",84.93M,2.25,1.26B,9.48%,0.81%,-32.79%,-12.55%,-41.62%,Sportsman’s Warehouse price target lowered to $3 from $4 at Craig-Hallum,"Sportsman’s Warehouse slides after reporting Q2 results, lowering FY24 guidance",Sportsman’s Warehouse price target lowered to $3 from $5 at Lake Street,Sportsman’s Warehouse price target lowered to $2.50 from $4 at Baird,"Options Volatility and Implied Earnings Moves Today, September 03, 2024","Sportsman’s Warehouse price target lowered to $3 from $4 at Craig-Hallum Sportsman’s Warehouse slides after reporting Q2 results, lowering FY24 guidance Sportsman’s Warehouse price target lowered to $3 from $5 at Lake Street Sportsman’s Warehouse price target lowered to $2.50 from $4 at Baird Options Volatility and Implied Earnings Moves Today, September 03, 2024",0,0,0,0,0,0
37.79M,"437,290",-67.96M,-1,16,2.740,,,"Aug 12, 2024",SLS,"SELLAS Life Sciences Group, Inc.",84.92M,1.32,-,8.54%,12.51%,21.46%,+12.07%,-2.99%,Largest borrow rate increases among liquid names,Buy Rating Affirmed for SELLAS Life Sciences Amid Strong Financial Position and Promising Clinical Trials,SELLAS Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Update,,,Largest borrow rate increases among liquid names Buy Rating Affirmed for SELLAS Life Sciences Amid Strong Financial Position and Promising Clinical Trials SELLAS Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Update,0,1,0,0,-1,-1
123.97M,"133,351",-4.95M,-1,773,0.853,,,"Aug 6, 2024",LSB,"LakeShore Biopharma Co., Ltd",84.91M,0.45,79.42M,4.05%,-8.08%,-24.05%,-1.65%,-49.87%,LakeShore Biopharma Unveils Top Management Reshuffle,LakeShore Biopharma Targets Growth in 2025,LakeShore Biopharma Announces Financial Results for Fiscal Year 2024,YS Earnings this Week: How Will it Perform?,,LakeShore Biopharma Unveils Top Management Reshuffle LakeShore Biopharma Targets Growth in 2025 LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 YS Earnings this Week: How Will it Perform?,0,0,0,0,0,-1
10.12M,"29,150",-13.21M,-1,145,10.15,,,"Aug 6, 2024",RSSS,"Research Solutions, Inc.",84.88M,2.80,42.45M,2.40%,5.00%,0.99%,-0.35%,-16.71%,Analysts Offer Insights on Technology Companies: Research Solutions (RSSS) and Quantum (QMCO),"Research Solutions sees Q3 revenue $12.1M, consensus $11.74M",Research Solutions Reports Preliminary Fourth Quarter and Fiscal Year 2024 Results,,,"Analysts Offer Insights on Technology Companies: Research Solutions (RSSS) and Quantum (QMCO) Research Solutions sees Q3 revenue $12.1M, consensus $11.74M Research Solutions Reports Preliminary Fourth Quarter and Fiscal Year 2024 Results",1,0,1,0,-1,-1
577.77M,"63,342,532",-376.25M,-1,164,0.177,Sell,4.82,"Sep 3, 2024",MCHX,"Marchex, Inc.",84.84M,1.97,48.82M,1.50%,16.62%,34.27%,+12.64%,+32.43%,,,,,,,0,-1,-1,-1,-1,-1
45.02M,"297,417",-42.47M,-1,11,2.265,Strong Buy,12.00,"Aug 12, 2024",TOP,TOP Financial Group Limited,84.79M,2.29,8.04M,0.90%,-6.72%,-24.45%,-10.83%,-20.15%,,,,,,,0,-1,-1,-1,-1,-1
32.01M,"108,675",-11.60M,-1,,3.180,Strong Buy,8.50,"Sep 4, 2024",VMCA,Valuence Merger Corp. I,84.68M,11.49,-,0.17%,0.29%,4.12%,+0.58%,+4.03%,,,,,,,0,-1,-1,-1,-1,-1
40.77M,"72,530",20.86M,-1,30,2.480,Hold,,"Aug 16, 2024",ARBK,Argo Blockchain plc,84.13M,1.49,56.13M,5.30%,3.47%,-20.55%,-10.64%,-20.75%,Argo Blockchain’s August Performance and Share Expansion,"Crypto Currents: Bitfarms assumes control of Sharon, PA data center",Argo Blockchain Announces Q2 Results Webcast,Argo Blockchain Announces New Block Listing,Argo Blockchain Clears $35M Debt Early,"Argo Blockchain’s August Performance and Share Expansion Crypto Currents: Bitfarms assumes control of Sharon, PA data center Argo Blockchain Announces Q2 Results Webcast Argo Blockchain Announces New Block Listing Argo Blockchain Clears $35M Debt Early",1,0,0,0,1,0
,,,-1,21,,,,,ATOM,Atomera Incorporated,83.97M,3.02,640.00K,-3.22%,-17.45%,-47.14%,-22.79%,-54.38%,,,,,,,1,-1,-1,-1,-1,-1
147.50M,"219,034",-88.12M,-1,240,0.685,,,"Sep 30, 2024",TBNK,Territorial Bancorp Inc.,83.90M,9.75,39.01M,3.62%,8.80%,9.46%,-2.79%,+25.61%,Territorial Bancorp price target raised to $11.27 from $9.66 at Keefe Bruyette,,,,,Territorial Bancorp price target raised to $11.27 from $9.66 at Keefe Bruyette,1,1,-1,-1,-1,-1
20.73M,"49,257","843,000",-1,83,4.830,Strong Buy,8.50,"Aug 12, 2024",CODA,"Coda Octopus Group, Inc.",83.84M,7.50,18.24M,1.77%,10.08%,17.52%,+0.14%,+14.57%,,,,,,,0,-1,-1,-1,-1,-1
10.06M,"50,266",-63.93M,-1,,9.93,Hold,13.00,"Aug 8, 2024",CDAQ,Compass Digital Acquisition Corp.,83.84M,10.76,-,-1.48%,-0.98%,1.29%,-1.28%,+1.89%,Compass Digital and EEW Renewables Announce Merger Deal,"Compass Digital Acquisition, EEW Renewables enter combination agreement","EEW Renewables, a Global Renewable Energy Developer, and Compass Digital Acquisition Corp. Announce Definitive Business Combination Agreement",,,"Compass Digital and EEW Renewables Announce Merger Deal Compass Digital Acquisition, EEW Renewables enter combination agreement EEW Renewables, a Global Renewable Energy Developer, and Compass Digital Acquisition Corp. Announce Definitive Business Combination Agreement",1,1,1,1,-1,-1
9.49M,"1,177","-181,481",-1,,10.51,,,,FIAC,Focus Impact Acquisition Corp.,83.71M,11.21,-,0.13%,1.18%,5.20%,+1.08%,+6.25%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,20,,,,,RLMD,"Relmada Therapeutics, Inc.",83.58M,2.77,-,-6.96%,-17.23%,-28.25%,-29.23%,-43.57%,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity,Relmada Therapeutics files $250M mixed securities shelf,Rising High: Clearmind granted patent approval for binge behavior treatment,Rising High: Exclusive talk with psilocybin CPG brand PATOO,,Rising High: MINT Shango JV to acquire Cannabist’s Florida entity Relmada Therapeutics files $250M mixed securities shelf Rising High: Clearmind granted patent approval for binge behavior treatment Rising High: Exclusive talk with psilocybin CPG brand PATOO,0,1,1,0,0,-1
27.06M,"117,641",-33.19M,-1,72,3.670,Strong Buy,19.00,"Aug 13, 2024",BOLD,"Boundless Bio, Inc.",83.23M,3.74,-,13.09%,-4.29%,-48.14%,-6.75%,-72.84%,Boundless Bio Adjusts Stock Options to Incentivize Key Staff,"Boundless Bio reports Q2 EPS (77c), consensus (80c)",Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results,,,"Boundless Bio Adjusts Stock Options to Incentivize Key Staff Boundless Bio reports Q2 EPS (77c), consensus (80c) Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results",0,0,0,0,-1,-1
5.01M,"4,230",3.84M,$0.28,,19.68,,,"Aug 8, 2024",NPAB,New Providence Acquisition Corp. II,83.19M,12.00,-,-3.63%,3.09%,14.95%,-0.08%,+17.70%,,,,,,,0,-1,-1,-1,-1,-1
112.62M,"18,390",49.78M,-1,43,0.880,,,"Sep 3, 2024",IKNA,"Ikena Oncology, Inc.",83.00M,1.72,1.84M,3.07%,3.28%,9.41%,+3.57%,+28.89%,Ikena Oncology’s IK-595 Shows Promising Potential as a Best-in-Class Dual RAF/MEK Inhibitor: Analyst Maintains Buy Rating,Wedbush Sticks to Its Hold Rating for Ikena Oncology (IKNA),,,,Ikena Oncology’s IK-595 Shows Promising Potential as a Best-in-Class Dual RAF/MEK Inhibitor: Analyst Maintains Buy Rating Wedbush Sticks to Its Hold Rating for Ikena Oncology (IKNA),0,1,0,-1,-1,-1
40.24M,"763,937",-89.49M,-1,,2.460,Strong Buy,17.86,"Aug 8, 2024",OAKU,Oak Woods Acquisition Corporation,82.69M,10.98,-,1.21%,2.08%,4.78%,+0.92%,+4.47%,,,,,,,0,-1,-1,-1,-1,-1
5.08M,"1,057",7.09M,$0.56,107,19.40,,,"Jul 25, 2024",WIMI,WiMi Hologram Cloud Inc.,82.64M,0.84,82.55M,1.34%,-4.70%,-6.47%,-3.52%,+3.66%,,,,,,,0,-1,-1,-1,-1,-1
170.65M,"92,614",-2.49M,-1,,0.580,,,"Aug 14, 2024",LATG,Chenghe Acquisition I Co.,82.63M,11.49,-,0.87%,1.92%,6.35%,+1.68%,+6.78%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,,,,,,DPCS,DP Cap Acquisition Corp I,82.43M,11.37,-,0.89%,2.35%,6.44%,+2.25%,+7.26%,,,,,,,1,-1,-1,-1,-1,-1
56.48M,"7,296",33.48M,-1,7,1.740,,,"Aug 28, 2024",NB,NioCorp Developments Ltd.,82.22M,2.17,-,-2.70%,-1.67%,-29.14%,+2.91%,-30.86%,NioCorp Reports Decreased Annual Losses,Boeing’s Starliner to return without astronauts: Morning Buzz,NioCorp Reports Reduced Preliminary Fiscal Losses,NioCorp reports 2024 EPS (30c) vs. ($1.34) last year,,NioCorp Reports Decreased Annual Losses Boeing’s Starliner to return without astronauts: Morning Buzz NioCorp Reports Reduced Preliminary Fiscal Losses NioCorp reports 2024 EPS (30c) vs. ($1.34) last year,1,0,1,1,1,-1
61.43M,"486,599",-82.42M,-1,"4,850",1.610,Hold,3.00,"Aug 8, 2024",WW,"WW International, Inc.",82.12M,1.03,829.45M,9.91%,-8.51%,-69.44%,-20.59%,-48.81%,Oppenheimer Remains a Hold on WW International (WW),,,,,Oppenheimer Remains a Hold on WW International (WW),0,0,-1,-1,-1,-1
26.94M,"34,625",-8.29M,-1,394,3.670,,,"Aug 5, 2024",INVE,"Identiv, Inc.",81.93M,3.49,109.42M,-3.20%,-12.29%,-42.94%,-15.09%,-40.29%,Lake Street Issues a Buy Rating on Identiv (INVE),CFIUS gives clearance for Identiv’s sale of ‘Physical Security Business’,Identiv price target lowered to $6 from $8 at Craig-Hallum,"Analysts’ Top Technology Picks: Mitek Systems (MITK), Five9 (FIVN)",,"Lake Street Issues a Buy Rating on Identiv (INVE) CFIUS gives clearance for Identiv’s sale of ‘Physical Security Business’ Identiv price target lowered to $6 from $8 at Craig-Hallum Analysts’ Top Technology Picks: Mitek Systems (MITK), Five9 (FIVN)",0,0,1,0,0,-1
8.60M,"1,313",-1.15M,-1,,11.49,,,,BLEU,bleuacacia ltd,81.75M,10.82,-,-0.04%,0.54%,3.45%,+0.65%,+4.95%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,28,,,,,QMMM,QMMM Holdings Limited,81.73M,4.75,2.81M,14.51%,16.33%,16.33%,+25.61%,,Morning Movers: Broadcom sinks after earnings,QMMM Holdings files to sell 5.24M ordinary shares for holders,QMMM Holdings Ltd trading resumes,"QMMM Holdings Ltd trading halted, volatility trading pause",,"Morning Movers: Broadcom sinks after earnings QMMM Holdings files to sell 5.24M ordinary shares for holders QMMM Holdings Ltd trading resumes QMMM Holdings Ltd trading halted, volatility trading pause",1,0,1,0,0,-1
23.47M,"43,355",-5.85M,-1,,4.200,,,"Aug 5, 2024",GTAC,Global Technology Acquisition Corp. I,81.68M,11.52,-,1.49%,3.12%,9.16%,+3.60%,+10.36%,"Global Technology Acquisition Corp. Ends Merger, Collects Fees",,,,,"Global Technology Acquisition Corp. Ends Merger, Collects Fees",0,0,-1,-1,-1,-1
21.10M,"25,328",1.92M,$0.20,,4.660,,,"Jul 25, 2024",AITR,AI Transportation Acquisition Corp,81.67M,10.42,-,0.24%,0.52%,1.22%,+0.68%,+1.46%,,,,,,,0,-1,-1,-1,-1,-1
9.02M,224,1.80M,-1,11,10.85,,,,OMEX,"Odyssey Marine Exploration, Inc.",81.35M,3.95,761.11K,3.99%,-9.32%,-4.19%,-0.37%,+0.50%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,131,,,,,RAPT,"RAPT Therapeutics, Inc.",81.33M,2.33,-,-8.23%,-20.70%,-78.47%,-27.71%,-71.27%,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), RAPT Therapeutics (RAPT) and Liquidia Technologies (LQDA)",Barclays Remains a Hold on RAPT Therapeutics (RAPT),Rapt Therapeutics price target lowered to $17 from $24 at Wells Fargo,,,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), RAPT Therapeutics (RAPT) and Liquidia Technologies (LQDA) Barclays Remains a Hold on RAPT Therapeutics (RAPT) Rapt Therapeutics price target lowered to $17 from $24 at Wells Fargo",0,0,1,0,-1,-1
80.70M,"242,748",-206.70M,-1,"8,360",1.220,Strong Buy,12.25,"Aug 28, 2024",PLCE,"The Children's Place, Inc.",81.08M,6.38,1.55B,-12.25%,-20.51%,-58.02%,-26.15%,-31.74%,Childrens Place options imply 5.6% move in share price post-earnings,Childrens Place options imply 9.5% move in share price post-earnings,Claudia Lima-Guinehut Rejoins the Children’s Place as Brand President,Children’s Place appoints Claudia Lima-Guinehut as brand president,Childrens Place options imply 8.1% move in share price post-earnings,Childrens Place options imply 5.6% move in share price post-earnings Childrens Place options imply 9.5% move in share price post-earnings Claudia Lima-Guinehut Rejoins the Children’s Place as Brand President Children’s Place appoints Claudia Lima-Guinehut as brand president Childrens Place options imply 8.1% move in share price post-earnings,0,0,0,0,0,0
101.69M,"43,952",-8.11M,-1,112,0.950,,,"Aug 14, 2024",VTSI,"VirTra, Inc.",80.97M,7.25,31.85M,-12.43%,-16.71%,-33.73%,-24.97%,-54.31%,VirTra to Participate in the 2024 Gateway Conference on September 4-5,Lake Street Sticks to Their Buy Rating for VirTra (VTSI),VirTra price target lowered to $10 from $16 at Lake Street,Analysts Offer Insights on Industrial Goods Companies: Vestis Corporation (VSTS) and VirTra (VTSI),Closing Bell Movers: Rumble jumps 8% on earnings,VirTra to Participate in the 2024 Gateway Conference on September 4-5 Lake Street Sticks to Their Buy Rating for VirTra (VTSI) VirTra price target lowered to $10 from $16 at Lake Street Analysts Offer Insights on Industrial Goods Companies: Vestis Corporation (VSTS) and VirTra (VTSI) Closing Bell Movers: Rumble jumps 8% on earnings,0,0,0,0,1,1
9.17M,"24,769",3.39M,-1,298,10.72,,,,BEEM,Beam Global,80.85M,5.53,65.89M,-5.17%,-8.37%,-17.14%,-19.54%,-23.08%,Analysts Offer Insights on Technology Companies: Beam Global (BEEM) and Adyen (OtherADYYF),Beam Global Expands Reach with Strategic Telcom Acquisition,Beam Global closes acquisition of Europe-based Telcom,Beam Global Closes Acquisition of Europe Based Telcom,"City of Pueblo, Colorado Deploys Beam Global EV ARC™ Off-Grid Solar EV Charging Systems","Analysts Offer Insights on Technology Companies: Beam Global (BEEM) and Adyen (OtherADYYF) Beam Global Expands Reach with Strategic Telcom Acquisition Beam Global closes acquisition of Europe-based Telcom Beam Global Closes Acquisition of Europe Based Telcom City of Pueblo, Colorado Deploys Beam Global EV ARC™ Off-Grid Solar EV Charging Systems",1,1,1,1,1,0
,,,-1,,,,,,TGAA,Target Global Acquisition I Corp.,80.76M,11.29,-,-0.34%,-0.73%,2.65%,-1.66%,+2.74%,,,,,,,1,-1,-1,-1,-1,-1
6.09M,"1,185",6.57M,$0.40,,15.63,,,"Jul 29, 2024",XFIN,ExcelFin Acquisition Corp.,80.62M,11.06,-,-0.15%,0.14%,3.00%,-0.48%,+3.67%,ExcelFin and Baird Medical Advance Towards Merger,Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement,,,,ExcelFin and Baird Medical Advance Towards Merger Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement,0,0,0,-1,-1,-1
33.59M,"9,823",-67.63M,-1,47,2.900,Hold,3.00,"Aug 15, 2024",AISP,"Airship AI Holdings, Inc.",80.47M,3.39,23.57M,-7.90%,-17.00%,-43.25%,-25.88%,-69.87%,Airship AI Announces Closing of $8.0 Million Public Offering,Airship AI Announces Pricing of $8.0 Million Public Offering Priced At-Market According to Nasdaq Rules,Airship AI selected by DoD for Brand Name Only award,Airship AI Selected by the Department of Defense for Brand Name Only Award of Acropolis Enterprise Video and Data Management Platform,Airship AI Holdings Offers Informal Financial Insights,Airship AI Announces Closing of $8.0 Million Public Offering Airship AI Announces Pricing of $8.0 Million Public Offering Priced At-Market According to Nasdaq Rules Airship AI selected by DoD for Brand Name Only award Airship AI Selected by the Department of Defense for Brand Name Only Award of Acropolis Enterprise Video and Data Management Platform Airship AI Holdings Offers Informal Financial Insights,0,0,0,0,0,1
66.18M,"107,102",-48.41M,-1,400,1.470,Strong Buy,13.00,"Aug 8, 2024",PIII,P3 Health Partners Inc.,80.38M,0.50,1.40B,-12.37%,-10.49%,-41.28%,-25.43%,-41.78%,P3 Health Partners (PIII) Gets a Buy from Lake Street,Lake Street Reaffirms Their Buy Rating on P3 Health Partners (PIII),P3 Health Partners Announces New CFO and Compensation Details,P3 Health Partners names Leif Pederson CFO,,P3 Health Partners (PIII) Gets a Buy from Lake Street Lake Street Reaffirms Their Buy Rating on P3 Health Partners (PIII) P3 Health Partners Announces New CFO and Compensation Details P3 Health Partners names Leif Pederson CFO,0,0,0,0,1,-1
15.05M,"13,768",-27.21M,-1,64,6.45,Strong Buy,6.00,"Aug 16, 2024",RSTN,"RDE, Inc.",80.33M,3.10,83.44M,-3.35%,-10.20%,-13.91%,-12.56%,-16.55%,,,,,,,1,-1,-1,-1,-1,-1
275.40M,"353,502",-109.60M,-1,97,0.347,,,"Sep 3, 2024",MGYR,"Magyar Bancorp, Inc.",80.28M,12.37,30.04M,-0.37%,4.07%,10.96%,-2.77%,+11.32%,,,,,,,1,-1,-1,-1,-1,-1
89.94M,"123,718",17.85M,-1,350,1.070,,,"Aug 9, 2024",CRGO,Freightos Limited,80.14M,1.67,21.38M,-2.03%,-13.85%,-36.31%,-4.00%,-30.86%,Freightos’ WebCargo platform adopted by Pacific Air Cargo,Freightos Limited (CRGO) Receives a Buy from Oppenheimer,Freightos price target lowered to $3.50 from $4.50 at Oppenheimer,"AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz",Morning Movers: AMD gains following $4.9B pact to buy ZT Systems,"Freightos’ WebCargo platform adopted by Pacific Air Cargo Freightos Limited (CRGO) Receives a Buy from Oppenheimer Freightos price target lowered to $3.50 from $4.50 at Oppenheimer AMD to acquire ZY Systems, Estee Lauder reports Q4 beat: Morning Buzz Morning Movers: AMD gains following $4.9B pact to buy ZT Systems",0,1,0,0,1,0
45.57M,"5,942",-17.20M,-1,,2.110,,,"Sep 23, 2024",BAYA,Bayview Acquisition Corp,79.95M,10.35,-,0.32%,0.81%,1.45%,+0.78%,,,,,,,,1,-1,-1,-1,-1,-1
9.08M,"3,597",1.43M,-1,63,10.57,,,"Aug 23, 2024",PMVP,"PMV Pharmaceuticals, Inc.",79.86M,1.55,-,2.83%,0.18%,-15.91%,-4.22%,-0.62%,Buy Rating Affirmed for PMV Pharmaceuticals: Strong Financials and Promising Drug Candidate Despite Risks,PMV Pharmaceuticals (PMVP) Gets a Buy from Craig-Hallum,,,,Buy Rating Affirmed for PMV Pharmaceuticals: Strong Financials and Promising Drug Candidate Despite Risks PMV Pharmaceuticals (PMVP) Gets a Buy from Craig-Hallum,0,0,0,-1,-1,-1
91.10M,"47,595",-64.45M,-1,197,1.050,,,"Sep 19, 2024",SILC,Silicom Ltd.,79.83M,13.09,77.69M,3.09%,-9.17%,-17.37%,unch,-14.47%,,,,,,,0,-1,-1,-1,-1,-1
2.02M,"2,291",19.86M,-1,,46.67,,,"Aug 6, 2024",PRLH,Pearl Holdings Acquisition Corp,79.27M,11.06,-,0.13%,0.31%,2.30%,+0.45%,+3.36%,,,,,,,1,-1,-1,-1,-1,-1
51.73M,"18,492",-19.97M,-1,,1.840,,,"Sep 5, 2024",INAQ,Insight Acquisition Corp.,79.11M,11.30,-,-0.33%,-0.64%,4.38%,-0.53%,+5.40%,,,,,,,0,-1,-1,-1,-1,-1
16.52M,"18,825",-18.02M,-1,,5.75,Buy,,"Aug 6, 2024",JVSA,JVSPAC Acquisition Corp.,78.78M,10.25,-,0.28%,0.63%,1.07%,+0.79%,,,,,,,,1,-1,-1,-1,-1,-1
28.49M,"101,754",-40.17M,-1,6,3.330,Strong Buy,18.25,"Oct 10, 2024",REFR,Research Frontiers Incorporated,78.77M,2.35,1.28M,6.03%,13.27%,53.37%,+14.21%,+77.17%,,,,,,,1,-1,-1,-1,-1,-1
6.88M,"6,452",7.35M,$0.56,677,13.78,Hold,14.00,"Jul 29, 2024",GAN,GAN Limited,78.67M,1.73,126.74M,6.65%,12.34%,18.46%,+9.15%,+27.21%,Bet On It: AGA estimates $35B to be wagered throughout NFL season,Bet On It: DraftKings leans into live betting opportunity with Simplebet deal,Nevada reports July statewide gaming win down 6.91% to $1.306B,Bet On It: Missouri sports betting certification process challenged with lawsuit,Craig-Hallum Releases a Hold Rating on GAN (GAN),Bet On It: AGA estimates $35B to be wagered throughout NFL season Bet On It: DraftKings leans into live betting opportunity with Simplebet deal Nevada reports July statewide gaming win down 6.91% to $1.306B Bet On It: Missouri sports betting certification process challenged with lawsuit Craig-Hallum Releases a Hold Rating on GAN (GAN),0,0,0,0,0,0
14.22M,"24,450",-19.97M,-1,"1,520",6.67,Hold,,"Aug 7, 2024",YI,"111, Inc.",78.60M,0.92,2.05B,-12.27%,-14.52%,-32.19%,-25.22%,-23.21%,"111, Inc. Reports Continued Profitability and Efficiency","111, Inc. reports Q2 EPS (RMB 0.16) vs. (RMB 0.68) last year",,,,"111, Inc. Reports Continued Profitability and Efficiency 111, Inc. reports Q2 EPS (RMB 0.16) vs. (RMB 0.68) last year",0,1,0,-1,-1,-1
78.12M,"395,390",11.09M,-1,140,1.210,Buy,5.77,"Aug 8, 2024",NHTC,Natural Health Trends Corp.,78.57M,6.85,42.98M,-1.42%,-1.49%,6.31%,-6.30%,-2.29%,,,,,,,1,-1,-1,-1,-1,-1
31.03M,"565,227",-4.92M,-1,115,3.040,Strong Buy,7.00,"Aug 8, 2024",SDIG,"Stronghold Digital Mining, Inc.",78.50M,5.42,86.09M,56.09%,36.35%,16.87%,+56.54%,+34.55%,Crypto Currents: Riot urges change for Bitfarms board,Stronghold Digital Mining Regulation FD Financial Update,Stronghold Digital Mining mines 63 bitcoin in August,Bitfarms addresses ‘misleading claims’ from Riot Platforms,"Crypto Currents: Bitfarms assumes control of Sharon, PA data center","Crypto Currents: Riot urges change for Bitfarms board Stronghold Digital Mining Regulation FD Financial Update Stronghold Digital Mining mines 63 bitcoin in August Bitfarms addresses ‘misleading claims’ from Riot Platforms Crypto Currents: Bitfarms assumes control of Sharon, PA data center",0,0,0,0,0,0
9.03M,"6,371",1.63M,-1,37,10.44,,,,FORA,Forian Inc.,78.38M,2.52,20.37M,0.40%,-3.27%,-9.03%,+5.11%,-15.70%,Forian (FORA) Receives a Buy from Roth MKM,FORA Upcoming Earnings Report: What to Expect?,,,,Forian (FORA) Receives a Buy from Roth MKM FORA Upcoming Earnings Report: What to Expect?,1,0,1,-1,-1,-1
,,,-1,300,,,,,MDXH,MDxHealth SA,78.32M,2.87,80.74M,3.74%,7.67%,-4.30%,+1.06%,+9.58%,MDxHealth: A Strong Buy on Robust Growth and Undervaluation,MDxHealth (MDXH) Receives a Buy from Piper Sandler,"MDxHealth reports Q2 EPS ,(42c) consensus (26c)",MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21,,"MDxHealth: A Strong Buy on Robust Growth and Undervaluation MDxHealth (MDXH) Receives a Buy from Piper Sandler MDxHealth reports Q2 EPS ,(42c) consensus (26c) MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21",1,1,0,1,1,-1
12.75M,"2,177",-4.59M,-1,,7.38,,,"Sep 3, 2024",ATMV,AlphaVest Acquisition Corp,77.84M,11.11,-,,7.67%,-4.30%,+0.68%,+4.37%,(UPDATED) AlphaVest Acquisition Corp Announces Entering into a Merger Agreement with AMC Corporation,AlphaVest Acquisition Corp Announces Merger with AMC Corporation,AlphaVest Acquisition Corp Announces Entering into a Merger Agreement with AMC Corporation,AlphaVest Acquisition enters merger agreement with AMC Corporation,,(UPDATED) AlphaVest Acquisition Corp Announces Entering into a Merger Agreement with AMC Corporation AlphaVest Acquisition Corp Announces Merger with AMC Corporation AlphaVest Acquisition Corp Announces Entering into a Merger Agreement with AMC Corporation AlphaVest Acquisition enters merger agreement with AMC Corporation,0,0,0,0,0,-1
,,,-1,,,,,,AEAE,AltEnergy Acquisition Corp.,77.79M,11.99,-,-2.64%,-0.86%,5.29%,+4.72%,+10.51%,,,,,,,0,-1,-1,-1,-1,-1
6.26M,"13,590",6.04M,$0.99,271,15.04,,,"Aug 8, 2024",FEBO,Fenbo Holdings Limited,77.55M,7.01,15.25M,-36.30%,-51.35%,-39.87%,-62.34%,-34.98%,Fenbo Holdings Invests in AI’s Future Potential,Fenbo Holdings Limited Taps into AI Innovations through Investment in a U.S. AI Focused Fund,Fenbo Holdings makes investment in U.S. AI focused fund,Fenbo Holdings Ltd trading resumes,"Fenbo Holdings Ltd trading halted, volatility trading pause","Fenbo Holdings Invests in AI’s Future Potential Fenbo Holdings Limited Taps into AI Innovations through Investment in a U.S. AI Focused Fund Fenbo Holdings makes investment in U.S. AI focused fund Fenbo Holdings Ltd trading resumes Fenbo Holdings Ltd trading halted, volatility trading pause",0,1,0,0,0,0
44.92M,"161,999",-8.61M,-1,"1,268",2.090,Buy,4.00,"Aug 7, 2024",YTRA,"Yatra Online, Inc.",77.51M,1.33,49.60M,2.60%,8.44%,-6.69%,-2.11%,-14.72%,Yatra Online Expands with Strategic Acquisition,Yatra entered agreement to caquire 100% of Globe All India Services for $15.15M,Yatra Online Poised for Growth with Strategic Acquisition and Expanding Corporate Travel Market Presence,Optimistic Outlook for Yatra Online Amidst B2C Challenges: Strategic Growth in B2B and MICE Segments,Yatra Online Reports Mixed Quarterly Performance,Yatra Online Expands with Strategic Acquisition Yatra entered agreement to caquire 100% of Globe All India Services for $15.15M Yatra Online Poised for Growth with Strategic Acquisition and Expanding Corporate Travel Market Presence Optimistic Outlook for Yatra Online Amidst B2C Challenges: Strategic Growth in B2B and MICE Segments Yatra Online Reports Mixed Quarterly Performance,1,1,0,1,1,1
101.59M,"159,445",-36.64M,-1,123,0.924,Strong Buy,5.00,"Aug 12, 2024",PFIE,"Profire Energy, Inc.",77.26M,1.65,57.77M,6.34%,8.11%,4.51%,+2.40%,-6.04%,,,,,,,0,-1,-1,-1,-1,-1
9.51M,"57,470",-7.29M,-1,"4,664",9.88,,,,FANH,Fanhua Inc.,77.12M,1.36,451.06M,-1.49%,-17.89%,-67.20%,-15.29%,-70.44%,Fanhua announces partnership with Shanghai Biotecan Pharmaceuticals,Fanhua BluePlus Forming Strategic Partnerships with Shanghai Biotecan Pharmaceuticals,Fanhua to Unveil H1 2024 Financial Outlook,,,Fanhua announces partnership with Shanghai Biotecan Pharmaceuticals Fanhua BluePlus Forming Strategic Partnerships with Shanghai Biotecan Pharmaceuticals Fanhua to Unveil H1 2024 Financial Outlook,0,0,0,0,-1,-1
31.91M,"184,271",-29.25M,-1,225,2.940,Buy,28.00,"Aug 14, 2024",UPC,Universe Pharmaceuticals INC,77.09M,3.26,32.31M,-13.36%,-6.57%,39.11%,-13.01%,+50.00%,Universe Pharmaceuticals’ Key Shareholder Meeting,,,,,Universe Pharmaceuticals’ Key Shareholder Meeting,1,0,-1,-1,-1,-1
23.38M,"38,988",-16.65M,-1,23,4.010,Buy,6.00,"Aug 7, 2024",GNLX,Genelux Corporation,77.07M,2.26,8.00K,3.44%,-2.24%,-68.31%,+1.54%,-59.84%,Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference,Genelux initiated with a Buy at Roth MKM,Maxim Group Sticks to Their Buy Rating for Genelux Corp. (GNLX),"Genelux reports Q2 EPS (22c), consensus (19c)",,"Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference Genelux initiated with a Buy at Roth MKM Maxim Group Sticks to Their Buy Rating for Genelux Corp. (GNLX) Genelux reports Q2 EPS (22c), consensus (19c)",0,0,1,0,0,-1
8.07M,593,3.35M,-1,,11.57,,,"Oct 22, 2024",FNVT,Finnovate Acquisition Corp.,76.84M,11.45,-,0.47%,1.17%,5.24%,+0.70%,+5.04%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,,,,,,TETE,Technology & Telecommunication Acquisition Corporation,76.74M,12.02,-,0.30%,0.81%,3.47%,+0.58%,+3.42%,,,,,,,0,-1,-1,-1,-1,-1
12.72M,"2,829",-2.08M,-1,,7.24,,,"Jul 31, 2024",ATMC,AlphaTime Acquisition Corp,76.71M,11.16,-,0.60%,0.97%,4.77%,+0.81%,+4.30%,,,,,,,1,-1,-1,-1,-1,-1
8.98M,203,1.51M,-1,406,10.41,,,,LICN,Lichen China Limited,76.63M,2.03,39.76M,4.09%,18.53%,44.49%,-0.67%,+114.56%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,29,,,,,ONCY,Oncolytics Biotech Inc.,76.40M,0.99,-,-1.41%,-3.99%,-14.98%,-7.76%,-16.58%,Oncolytics Biotech Engages Investors at Key Conferences,Buy Rating Affirmed for Oncolytics Biotech with Promising Developments in Cancer Therapy Trials,Optimistic Outlook for Oncolytics Biotech with Continued Buy Rating Amidst Promising Trial Results,,,Oncolytics Biotech Engages Investors at Key Conferences Buy Rating Affirmed for Oncolytics Biotech with Promising Developments in Cancer Therapy Trials Optimistic Outlook for Oncolytics Biotech with Continued Buy Rating Amidst Promising Trial Results,1,0,1,1,-1,-1
44.10M,"21,034",-16.07M,-1,40,2.120,,,"Sep 23, 2024",MDBH,"MDB Capital Holdings, LLC",76.29M,8.21,1.78M,-13.97%,-6.09%,-15.22%,-18.03%,-14.35%,,,,,,,0,-1,-1,-1,-1,-1
15.22M,"27,576",-10.10M,-1,30,6.14,Strong Buy,16.00,"Aug 12, 2024",CLSD,"Clearside Biomedical, Inc.",76.24M,1.02,7.52M,-4.67%,-11.62%,-19.60%,-12.28%,-23.08%,Buy Rating for Clearside Biomedical’s CLS-AX Based on Superior Efficacy and Market Adoption Potential,"Clearside Biomedical’s CLS-AX Shows Promise in Phase 2b Trials, Yi Chen Maintains Buy Rating with $5 Price Target",Clearside Biomedical: A Strong Buy on Promising ODYSSEY Trial Outcomes and Market Re-Rating Potential,Optimistic Buy Rating for Clearside Biomedical Amid Promising ODYSSEY Trial Results and Strong Financial Position,Clearside completes final participant visit in CLS-AX trial for wet AMD,"Buy Rating for Clearside Biomedical’s CLS-AX Based on Superior Efficacy and Market Adoption Potential Clearside Biomedical’s CLS-AX Shows Promise in Phase 2b Trials, Yi Chen Maintains Buy Rating with $5 Price Target Clearside Biomedical: A Strong Buy on Promising ODYSSEY Trial Outcomes and Market Re-Rating Potential Optimistic Buy Rating for Clearside Biomedical Amid Promising ODYSSEY Trial Results and Strong Financial Position Clearside completes final participant visit in CLS-AX trial for wet AMD",1,1,0,0,0,1
217.56M,"443,090",-26.37M,-1,20,0.425,Strong Buy,3.25,"Oct 14, 2024",CLRB,"Cellectar Biosciences, Inc.",76.00M,2.12,-,8.32%,-6.87%,-26.42%,+2.33%,-41.49%,Cellectar Biosciences Faces Nasdaq Compliance Issue,"Cellectar Biosciences receives noncompliance notification, to restate financials",Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq,Strong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid Financials,Oppenheimer Keeps Their Buy Rating on Cellectar Biosciences (CLRB),"Cellectar Biosciences Faces Nasdaq Compliance Issue Cellectar Biosciences receives noncompliance notification, to restate financials Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq Strong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid Financials Oppenheimer Keeps Their Buy Rating on Cellectar Biosciences (CLRB)",1,0,0,0,0,0
,,,-1,53,,,,,NEON,Neonode Inc.,75.94M,4.91,4.43M,76.32%,105.61%,177.51%,+134.11%,+392.96%,,,,,,,0,-1,-1,-1,-1,-1
8.78M,"79,559",-1.19M,$0.28,131,10.64,Hold,12.25,"Jul 25, 2024",HYPR,"Hyperfine, Inc.",75.53M,1.04,11.94M,0.46%,5.11%,6.15%,-10.26%,+10.51%,Hyperfine management to meet virtually with BTIG,Hyperfine management to meet virtually with Lake Street,Hyperfine participates in a conference call with Lake Street,"Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)",Hyperfine price target raised to $1.50 from $1.30 at B. Riley,"Hyperfine management to meet virtually with BTIG Hyperfine management to meet virtually with Lake Street Hyperfine participates in a conference call with Lake Street Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB) Hyperfine price target raised to $1.50 from $1.30 at B. Riley",0,0,0,0,0,0
58.88M,"58,468",-50.24M,-1,,1.580,Strong Buy,13.50,"Aug 8, 2024",CBRG,Chain Bridge I,75.47M,11.17,-,0.00%,0.08%,4.21%,-1.67%,+3.52%,,,,,,,1,-1,-1,-1,-1,-1
8.95M,"183,057","802,814",-1,,10.38,,,,IRAA,Iris Acquisition Corp,75.46M,10.50,-,-3.00%,-2.38%,1.81%,-6.03%,+4.17%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,IVCP,Swiftmerge Acquisition Corp.,75.44M,11.03,-,0.26%,1.14%,3.70%,+0.55%,+6.06%,,,,,,,0,-1,-1,-1,-1,-1
6.35M,"34,221",-45.61M,-1,66,14.61,Hold,,"Aug 8, 2024",NSPR,"InspireMD, Inc.",75.32M,2.93,6.57M,-1.28%,5.98%,11.10%,-1.39%,+24.02%,,,,,,,0,-1,-1,-1,-1,-1
47.72M,"271,481",-156.27M,-1,44,1.940,Hold,2.33,"Aug 8, 2024",VANI,"Vivani Medical, Inc.",75.15M,1.36,-,7.96%,6.08%,-4.51%,+7.32%,-34.00%,Buy Rating Affirmed for Vivani Medical on Strong Potential of NPM-115 Implant for Metabolic Disease Treatment,Vivani Medical reports positive preclinical liver fat results exenatide implant,Innovative Obesity Treatment Promises High Compliance: Buy Recommendation for Vivani Medical,Vivani Medical’s Regular Industry Conference Presentations Update,Vivani Medical reports Q2 EPS (10c) vs. (13c) last year,Buy Rating Affirmed for Vivani Medical on Strong Potential of NPM-115 Implant for Metabolic Disease Treatment Vivani Medical reports positive preclinical liver fat results exenatide implant Innovative Obesity Treatment Promises High Compliance: Buy Recommendation for Vivani Medical Vivani Medical’s Regular Industry Conference Presentations Update Vivani Medical reports Q2 EPS (10c) vs. (13c) last year,1,0,1,0,0,1
8.02M,"49,570",13.04M,-1,36,11.40,,,"Sep 12, 2024",BYSI,BeyondSpring Inc.,74.94M,1.92,1.75M,6.09%,-7.76%,6.43%,+2.06%,-27.21%,,,,,,,0,-1,-1,-1,-1,-1
8.96M,"1,000","785,727",-1,104,10.27,,,,SLNG,"Stabilis Solutions, Inc.",74.90M,4.03,71.73M,-4.67%,-3.54%,-7.45%,+2.81%,-4.51%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,14,,,,,GNTA,Genenta Science S.p.A.,74.62M,4.08,-,-5.77%,6.20%,-3.27%,-9.33%,+2.00%,,,,,,,1,-1,-1,-1,-1,-1
6.93M,"53,196","703,866",$0.63,"1,000",13.28,,,"Aug 14, 2024",STCN,"Steel Connect, Inc.",74.38M,11.90,169.04M,-0.10%,-3.73%,12.90%,-7.99%,+29.19%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,BOCN,Blue Ocean Acquisition Corp.,74.29M,11.28,-,1.00%,1.79%,4.95%,+1.97%,+5.57%,,,,,,,0,-1,-1,-1,-1,-1
112.43M,"431,515",-63.20M,-1,"4,153",0.817,Buy,3.33,"Aug 5, 2024",CNTY,"Century Casinos, Inc.",74.25M,2.42,587.39M,1.43%,-2.76%,-24.92%,-23.38%,-26.02%,Century Casinos: A Buy Rating on Value and Growth Potential Amidst Transitional Challenges,Century Casinos price target lowered to $4 from $5 at Macquarie,,,,Century Casinos: A Buy Rating on Value and Growth Potential Amidst Transitional Challenges Century Casinos price target lowered to $4 from $5 at Macquarie,1,1,0,-1,-1,-1
7.04M,"8,116",-113.86M,-1,,12.98,Strong Buy,29.67,"Aug 13, 2024",BHAC,Focus Impact BH3 Acquisition Company,74.25M,10.68,-,-2.51%,-0.56%,1.71%,+0.66%,+2.30%,,,,,,,1,-1,-1,-1,-1,-1
48.34M,"562,949",-104.56M,-1,46,1.890,Strong Buy,8.67,"Aug 8, 2024",SPRO,"Spero Therapeutics, Inc.",74.05M,1.37,118.46M,5.99%,3.02%,-4.59%,-2.84%,-16.97%,,,,,,,1,-1,-1,-1,-1,-1
10.09M,"12,996",-21.69M,-1,17,9.05,Buy,19.67,"Sep 19, 2024",HNNA,"Hennessy Advisors, Inc.",73.89M,9.62,27.13M,10.85%,23.59%,40.54%,+18.44%,+40.51%,Hennessy Advisors Inc trading resumes,"Hennessy Advisors Inc trading halted, volatility trading pause",,,,"Hennessy Advisors Inc trading resumes Hennessy Advisors Inc trading halted, volatility trading pause",0,0,0,-1,-1,-1
19.71M,"34,278",-22.10M,-1,,4.620,Strong Buy,7.00,"Aug 1, 2024",EURK,Eureka Acquisition Corp,73.54M,10.19,-,,23.59%,40.54%,,,,,,,,,1,-1,-1,-1,-1,-1
8.93M,102,"-113,118",-1,31,10.19,,,,NVNO,enVVeno Medical Corporation,73.45M,5.51,-,4.77%,3.09%,10.66%,-1.30%,+3.51%,"enVVeno Medical appoints Sandy Prietto as VP, marketing",enVVeno provides update on FDA premarket approval application for VenoValve,,,,"enVVeno Medical appoints Sandy Prietto as VP, marketing enVVeno provides update on FDA premarket approval application for VenoValve",0,0,0,-1,-1,-1
,,,-1,,,,,,MITA,Coliseum Acquisition Corp.,73.42M,11.08,-,4.22%,5.34%,7.99%,+4.83%,+7.77%,,,,,,,1,-1,-1,-1,-1,-1
8.00M,1,-6.58M,-1,176,11.48,,,,TYGO,"Tigo Energy, Inc.",73.18M,1.21,48.85M,-8.81%,-18.85%,-22.04%,-28.75%,+11.22%,Tigo Energy files patent infringement lawsuit against Zhejiang Benyi New Energy,Tigo Energy to Present at the 2024 Gateway Conference on September 5th,,,,Tigo Energy files patent infringement lawsuit against Zhejiang Benyi New Energy Tigo Energy to Present at the 2024 Gateway Conference on September 5th,0,1,1,-1,-1,-1
,,,-1,227,,,,,TELA,"TELA Bio, Inc.",73.15M,2.96,64.74M,-18.67%,-31.86%,-46.22%,-34.16%,-41.75%,Tela Bio price target lowered to $8 from $14 at Lake Street,Optimistic Buy Rating for TELA Bio Amidst Recovery and Strong Growth Prospects,Tela Bio price target lowered to $12 from $14 at Canaccord,TELA Bio (TELA) Receives a Buy from Piper Sandler,Tela Bio price target lowered to $8 from $10 at Piper Sandler,Tela Bio price target lowered to $8 from $14 at Lake Street Optimistic Buy Rating for TELA Bio Amidst Recovery and Strong Growth Prospects Tela Bio price target lowered to $12 from $14 at Canaccord TELA Bio (TELA) Receives a Buy from Piper Sandler Tela Bio price target lowered to $8 from $10 at Piper Sandler,0,0,0,0,0,0
8.17M,"1,837",-1.44M,-1,,10.97,,,,MSSA,Metal Sky Star Acquisition Corporation,72.72M,11.35,-,-0.31%,0.18%,3.79%,-0.18%,+3.94%,Metal Sky Star Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Delayed Filings and Failure to Close One Or More Business Combinations,,,,,Metal Sky Star Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Delayed Filings and Failure to Close One Or More Business Combinations,0,0,-1,-1,-1,-1
,,,-1,761,,,,,AENT,Alliance Entertainment Holding Corporation,72.33M,1.42,1.11B,-21.80%,-45.92%,-31.19%,-25.61%,-31.34%,Alliance Entertainment to Host Fourth Quarter and Fiscal Year 2024 Results Conference Call on September 19 at 4:30 p.m. Eastern Time,,,,,Alliance Entertainment to Host Fourth Quarter and Fiscal Year 2024 Results Conference Call on September 19 at 4:30 p.m. Eastern Time,0,0,-1,-1,-1,-1
96.50M,"11,783",-88.38M,-1,97,0.950,Strong Buy,5.00,"Jul 30, 2024",ELVA,Electrovaya Inc.,71.79M,2.11,49.49M,-4.10%,-14.71%,-34.37%,-18.57%,-42.17%,Electrovaya management to meet virtually with Craig-Hallum,Electrovaya management to meet virtually with Roth MKM,Electrovaya price target lowered to $5 from $7 at Seaport Research,Buy Rating Affirmed for Electrovaya Amid Revenue Diversification and Margin Improvement Prospects,"Electrovaya Optimistic Despite Delays, Advances Growth","Electrovaya management to meet virtually with Craig-Hallum Electrovaya management to meet virtually with Roth MKM Electrovaya price target lowered to $5 from $7 at Seaport Research Buy Rating Affirmed for Electrovaya Amid Revenue Diversification and Margin Improvement Prospects Electrovaya Optimistic Despite Delays, Advances Growth",1,0,0,0,0,1
8.14M,263,1.96M,-1,117,11.13,,,,LSBK,"Lake Shore Bancorp, Inc.",71.76M,12.72,26.03M,0.28%,1.67%,10.98%,+1.92%,+11.25%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,126,,,,,UBCP,"United Bancorp, Inc.",71.71M,12.05,29.50M,1.12%,-1.13%,-0.80%,-1.70%,-15.99%,United Bancorp raises quarterly dividend to 17.75c per share,,,,,United Bancorp raises quarterly dividend to 17.75c per share,0,0,-1,-1,-1,-1
35.62M,469,-27.00M,-1,"1,398",2.690,,,,UONE,"Urban One, Inc.",71.68M,2.10,460.32M,-2.66%,-0.30%,-29.38%,-0.48%,-13.45%,,,,,,,0,-1,-1,-1,-1,-1
42.93M,"53,448",1.30M,-1,45,2.100,Hold,2.63,"Aug 13, 2024",GRDI,Griid Infrastructure Inc.,71.67M,1.00,20.94M,-3.31%,-11.29%,-41.60%,-16.39%,-26.67%,,,,,,,0,-1,-1,-1,-1,-1
10.77M,"12,437",4.26M,-1,146,8.27,,,"Jul 25, 2024",PDEX,"Pro-Dex, Inc.",71.63M,20.95,49.46M,9.70%,13.17%,16.41%,+8.68%,+22.42%,"Is PDEX a Buy, Before Earnings?",Pro-Dex Executives Awarded Bonuses for Strong Fiscal Performance,,,,"Is PDEX a Buy, Before Earnings? Pro-Dex Executives Awarded Bonuses for Strong Fiscal Performance",0,1,0,-1,-1,-1
29.29M,"23,469",-30.58M,-1,166,3.070,Strong Buy,12.67,"Aug 6, 2024",MRNS,"Marinus Pharmaceuticals, Inc.",71.61M,1.30,30.26M,15.34%,11.59%,-72.93%,-0.71%,-82.18%,Truist healthcare analyst holds an analyst/industry conference call,Buy Rating Affirmed for Marinus Pharmaceuticals on Strong Ztalmy Sales and Promising Pipeline Developments,Cautious Optimism Amidst Clinical Uncertainties: A Hold Rating for Marinus Pharmaceuticals,Oppenheimer Keeps Their Hold Rating on Marinus (MRNS),Ladenburg downgrades Marinus on balance sheet concerns,Truist healthcare analyst holds an analyst/industry conference call Buy Rating Affirmed for Marinus Pharmaceuticals on Strong Ztalmy Sales and Promising Pipeline Developments Cautious Optimism Amidst Clinical Uncertainties: A Hold Rating for Marinus Pharmaceuticals Oppenheimer Keeps Their Hold Rating on Marinus (MRNS) Ladenburg downgrades Marinus on balance sheet concerns,0,1,0,0,0,0
8.87M,"124,760","811,402",-1,,10.13,,,,SSIC,Silver Spike Investment Corp.,71.60M,11.52,12.42M,-1.81%,-2.38%,13.04%,-4.73%,+16.53%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,145,,,,,VBFC,Village Bank and Trust Financial Corp.,71.44M,47.94,26.09M,2.12%,6.54%,6.09%,-0.92%,+7.21%,,,,,,,0,-1,-1,-1,-1,-1
34.70M,"152,765",-2.12M,-1,,2.590,Strong Buy,8.00,"Sep 3, 2024",DTSQ,DT Cloud Star Acquisition Corporation,71.25M,10.05,-,,6.54%,6.09%,,,,,,,,,1,-1,-1,-1,-1,-1
60.82M,356,-9.36M,-1,635,1.475,,,"Apr 22, 2024",CCG,Cheche Group Inc.,71.20M,0.94,458.27M,5.00%,8.24%,-72.78%,-1.78%,-71.46%,Cheche Group Expands Into NEV Sector with JI YUE,Cheche Technology announces partnership with NEV company JI YUE,Cheche Group Shows Resilience in Q2 2024 Financials,Cheche Group Reports Second Quarter 2024 Unaudited Financial Results,Cheche Group Expands NEV Insurance Offerings,Cheche Group Expands Into NEV Sector with JI YUE Cheche Technology announces partnership with NEV company JI YUE Cheche Group Shows Resilience in Q2 2024 Financials Cheche Group Reports Second Quarter 2024 Unaudited Financial Results Cheche Group Expands NEV Insurance Offerings,1,1,0,1,1,1
7.95M,2,"-521,717",-1,98,11.29,,,,ABLV,Able View Global Inc.,71.18M,1.69,149.00M,17.65%,32.89%,-20.86%,+44.64%,-26.70%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,333,,,,,ELTK,Eltek Ltd.,70.98M,10.58,46.43M,5.31%,6.84%,-12.81%,+8.35%,-0.75%,Eltek Secures $3.5 Million in Defense Orders,Eltek receives purchase orders for $3.5M,Eltek Corrects Bonus Terms in Shareholder Agreement,Eltek Ltd. Reports 2024 Second Quarter Financial Results,Eltek reports Q2 GAAP EPS 11c vs. 22c last year,Eltek Secures $3.5 Million in Defense Orders Eltek receives purchase orders for $3.5M Eltek Corrects Bonus Terms in Shareholder Agreement Eltek Ltd. Reports 2024 Second Quarter Financial Results Eltek reports Q2 GAAP EPS 11c vs. 22c last year,0,0,0,0,0,1
12.38M,"26,507,342",-318.75M,-1,,7.23,,,"Aug 14, 2024",FRLA,Fortune Rise Acquisition Corporation,70.68M,11.27,-,0.33%,0.39%,3.05%,-0.27%,+3.02%,"Fortune Rise Acquisition Extends Timeline, Boosts Trust Funds",,,,,"Fortune Rise Acquisition Extends Timeline, Boosts Trust Funds",0,1,-1,-1,-1,-1
17.01M,"17,212",-136.00M,$0.56,69,5.39,,,"Jul 31, 2024",WRAP,"Wrap Technologies, Inc.",70.30M,1.59,9.13M,-2.16%,-9.02%,-34.98%,-14.75%,-30.36%,Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1),Wrap Technologies receives Nasdaq notification of non-compliance,,,,Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) Wrap Technologies receives Nasdaq notification of non-compliance,0,0,0,-1,-1,-1
17.01M,"17,420",-136.00M,$0.56,"7,600",5.03,,,,NDLS,Noodles & Company,70.28M,1.54,500.92M,-4.59%,-8.86%,-29.23%,-13.22%,-2.58%,,,,,,,0,-1,-1,-1,-1,-1
8.86M,"34,486","-118,268",-1,109,10.00,,,,DTIL,"Precision BioSciences, Inc.",70.10M,9.69,87.64M,6.48%,1.47%,-14.98%,+1.99%,-31.89%,"Precision BioSciences Secures Funds, Bolsters Oncology Partnership",Buy Rating on Precision BioSciences Highlighted by Promising Gene Editing Pipeline and Potential Hepatitis B Cure,,,,"Precision BioSciences Secures Funds, Bolsters Oncology Partnership Buy Rating on Precision BioSciences Highlighted by Promising Gene Editing Pipeline and Potential Hepatitis B Cure",0,0,0,-1,-1,-1
,,,-1,200,,,,,CHCI,"Comstock Holding Companies, Inc.",69.82M,7.08,46.87M,5.90%,9.40%,27.01%,+11.02%,+33.52%,,,,,,,1,-1,-1,-1,-1,-1
10.92M,"12,723",-13.26M,-1,,8.10,,,"Aug 8, 2024",ADGM,"Adagio Medical Holdings, Inc.",69.62M,5.20,266.00K,-27.69%,-53.12%,-58.79%,,,,,,,,,0,-1,-1,-1,-1,-1
33.24M,"66,348",-1.90M,-1,120,2.670,,,"Sep 20, 2024",CELU,Celularity Inc.,69.48M,3.16,22.77M,1.13%,0.12%,-9.21%,-8.57%,-45.86%,Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference,Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing,Celularity receives noncompliance notification from Nasdaq,,,Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing Celularity receives noncompliance notification from Nasdaq,1,0,0,0,-1,-1
6.50M,"28,539",-119.58M,-1,,13.55,Buy,22.67,"Aug 13, 2024",DIST,Distoken Acquisition Corporation,69.44M,10.80,-,-0.31%,-0.03%,1.53%,unch,+1.98%,,,,,,,0,-1,-1,-1,-1,-1
7.84M,"7,555",3.06M,-1,124,11.22,,,,SIEB,Siebert Financial Corp.,69.16M,1.73,78.88M,-0.05%,-2.43%,-11.11%,-0.78%,-16.50%,Siebert Financial reports Q2 operating income $5.6M vs. $4.7M last year,,,,,Siebert Financial reports Q2 operating income $5.6M vs. $4.7M last year,0,0,-1,-1,-1,-1
,,,-1,56,,,,,LOOP,"Loop Industries, Inc.",68.91M,1.45,132.00K,0.77%,-13.63%,-43.10%,-18.37%,-45.02%,,,,,,,1,-1,-1,-1,-1,-1
20.40M,"94,940",10.67M,-1,,4.310,Strong Buy,8.00,"Aug 7, 2024",NVAC,NorthView Acquisition Corporation,68.81M,11.60,-,-0.20%,1.79%,8.37%,+2.56%,+10.37%,,,,,,,1,-1,-1,-1,-1,-1
89.64M,"328,846",-84.70M,-1,82,0.980,Strong Buy,8.50,"Aug 13, 2024",HGBL,Heritage Global Inc.,68.72M,1.86,55.02M,-14.74%,-23.01%,-31.77%,-28.40%,-34.09%,Heritage Global: Resilient Growth and Undervaluation Signal a Strong Buy,Heritage Global price target lowered to $3.50 from $4 at Craig-Hallum,Craig-Hallum Remains a Buy on Heritage Global (HGBL),,,Heritage Global: Resilient Growth and Undervaluation Signal a Strong Buy Heritage Global price target lowered to $3.50 from $4 at Craig-Hallum Craig-Hallum Remains a Buy on Heritage Global (HGBL),1,1,0,0,-1,-1
7.83M,64,2.82M,-1,"22,516",11.19,,,,RRGB,"Red Robin Gourmet Burgers, Inc.",68.38M,4.34,1.28B,-24.01%,-35.84%,-52.13%,-39.57%,-46.53%,Craig-Hallum Sticks to Their Buy Rating for Red Robin Gourmet (RRGB),Powell says ‘time has come’ for Fed to cut: Morning Buzz,Red Robin price target lowered to $10 from $16 at Benchmark,"Morning Movers: Workday, Cava rise after earnings",Red Robin price target lowered to $16 from $17 at Lake Street,"Craig-Hallum Sticks to Their Buy Rating for Red Robin Gourmet (RRGB) Powell says ‘time has come’ for Fed to cut: Morning Buzz Red Robin price target lowered to $10 from $16 at Benchmark Morning Movers: Workday, Cava rise after earnings Red Robin price target lowered to $16 from $17 at Lake Street",1,0,0,0,0,0
,,,-1,106,,,,,ICCH,"ICC Holdings, Inc.",68.18M,22.98,87.93M,0.70%,1.41%,30.17%,+1.42%,+49.71%,,,,,,,1,-1,-1,-1,-1,-1
7.70M,"52,493",1.14M,-1,"1,695",11.42,,,,SOND,Sonder Holdings Inc.,68.06M,6.77,573.81M,133.67%,126.36%,120.48%,+159.09%,+91.47%,Largest borrow rate increases among liquid names,Sonder Holdings Announces COO Deeksha Hebbar’s Resignation,Sonder Holdings Struggles with SEC Reporting Compliance,Sonder Holdings receives notification of deficiency from Nasdaq,Sonder Holdings Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q,Largest borrow rate increases among liquid names Sonder Holdings Announces COO Deeksha Hebbar’s Resignation Sonder Holdings Struggles with SEC Reporting Compliance Sonder Holdings receives notification of deficiency from Nasdaq Sonder Holdings Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q,0,1,1,0,0,0
,,,-1,11,,,,,PAVS,Paranovus Entertainment Technology Ltd.,68.01M,1.01,6.54M,-6.68%,0.00%,-42.60%,-4.76%,-42.53%,,,,,,,1,-1,-1,-1,-1,-1
2.02M,62,"-523,542",-1,,44.00,,,"Oct 17, 2024",PTWO,"Pono Capital Two, Inc.",67.81M,13.00,-,0.91%,-1.07%,10.00%,+20.40%,+28.42%,Pono Capital Two Inc trading resumes,"Pono Capital Two Inc trading halted, volatility trading pause",Pono Capital Two Secures Share Deal for SBC Merger,,,"Pono Capital Two Inc trading resumes Pono Capital Two Inc trading halted, volatility trading pause Pono Capital Two Secures Share Deal for SBC Merger",0,0,0,0,-1,-1
7.77M,100,-3.29M,-1,,11.23,,,,GLLI,Globalink Investment Inc.,67.59M,11.25,-,0.49%,1.00%,3.74%,+0.90%,+3.97%,"Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to October 9, 2024","Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2024",,,,"Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to October 9, 2024 Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2024",1,1,1,-1,-1,-1
,,,-1,,,,,,AFAR,Aura FAT Projects Acquisition Corp,67.53M,11.68,-,1.79%,3.45%,7.94%,+3.27%,+8.55%,,,,,,,1,-1,-1,-1,-1,-1
11.30M,"26,403",-12.33M,-1,,7.66,Strong Buy,8.00,"Aug 6, 2024",CLOE,Clover Leaf Capital Corp.,67.52M,13.60,-,-6.46%,-6.41%,-1.41%,+1.45%,+9.36%,"Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to September 17, 2024","Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to September 5, 2024","Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to August 27, 2024","Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to August 22, 2024",,"Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to September 17, 2024 Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to September 5, 2024 Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to August 27, 2024 Clover Leaf Capital Corp. Announces Postponement of Special Meeting of Stockholders Date to August 22, 2024",1,0,0,0,0,-1
71.34M,"167,051",-58.68M,-1,,1.210,Hold,11.50,"Aug 7, 2024",HAIA,Healthcare AI Acquisition Corp.,67.48M,11.28,-,-0.44%,0.50%,3.27%,+1.35%,+3.58%,Healthcare AI Acquisition Corp. Announces Strategic Merger,Healthcare AI Acquisition Corp trading resumes,Healthcare AI Acquisition signs merger agreement with Leading Group Ltd.,"Leading Group, an Insurance Channel Specialist in China, to be Publicly Listed through a Merger with Healthcare AI Acquisition Corp. (NASDAQ: HAIA)","Healthcare AI Acquisition Corp trading halted, news pending","Healthcare AI Acquisition Corp. Announces Strategic Merger Healthcare AI Acquisition Corp trading resumes Healthcare AI Acquisition signs merger agreement with Leading Group Ltd. Leading Group, an Insurance Channel Specialist in China, to be Publicly Listed through a Merger with Healthcare AI Acquisition Corp. (NASDAQ: HAIA) Healthcare AI Acquisition Corp trading halted, news pending",0,0,0,0,1,0
102.01M,"69,021",4.61M,-1,50,0.844,,,"Aug 23, 2024",NCTY,The9 Limited,67.31M,7.49,25.25M,4.04%,-7.44%,3.70%,-8.55%,+12.21%,The9 Announces Lucrative Gaming Joint Venture,"The9, Huanyu establish joint venture to operate new MIR game",,,,"The9 Announces Lucrative Gaming Joint Venture The9, Huanyu establish joint venture to operate new MIR game",0,1,1,-1,-1,-1
70.97M,"373,660",-29.75M,-1,148,1.210,Strong Buy,4.04,"Aug 13, 2024",GSIT,"GSI Technology, Inc.",67.18M,2.64,20.85M,3.77%,-4.09%,-12.39%,-1.79%,-47.01%,GSI Technology Updates Executive Plan and Elects Directors,"GSI Technology to Participate Virtually In the 5th Annual Needham Semiconductor & SemiCap 1×1 Conference on August 21, 2024",,,,"GSI Technology Updates Executive Plan and Elects Directors GSI Technology to Participate Virtually In the 5th Annual Needham Semiconductor & SemiCap 1×1 Conference on August 21, 2024",0,0,0,-1,-1,-1
114.12M,"444,210",-140.34M,-1,150,0.750,Sell,1.17,"Aug 9, 2024",AUBN,"Auburn National Bancorporation, Inc.",65.72M,18.81,22.22M,0.52%,-0.11%,-6.56%,-0.73%,-4.15%,"Auburn National Bancorporation, Inc. Declares Quarterly Dividend",,,,,"Auburn National Bancorporation, Inc. Declares Quarterly Dividend",1,1,-1,-1,-1,-1
55.15M,"60,512",-78.90M,-1,,1.550,Strong Buy,10.20,"Aug 6, 2024",AIMAU,Aimfinity Investment Corp. I,65.44M,11.65,-,,-0.11%,-6.56%,+4.95%,,,,,,,,1,-1,-1,-1,-1,-1
7.42M,"5,097",2.04M,-1,,11.51,,,,RFAC,RF Acquisition Corp.,65.41M,11.24,-,0.23%,1.26%,5.25%,+0.91%,+5.19%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,911,,,,,VOXX,VOXX International Corporation,65.41M,2.91,448.65M,80.18%,68.76%,-29.31%,+100.39%,-38.12%,"3 Penny Stocks to Watch Now, 8/29/24","Bronfman drops Paramount bid, Apple names new CFO: Morning Buzz","Voxx jumps after Gentex buys shares at $5, offers buyout","Gentex raises stake in Voxx, submitted proposal to acquire all shares","Voxx announces exploration of strategic alternatives, including sale of company","3 Penny Stocks to Watch Now, 8/29/24 Bronfman drops Paramount bid, Apple names new CFO: Morning Buzz Voxx jumps after Gentex buys shares at $5, offers buyout Gentex raises stake in Voxx, submitted proposal to acquire all shares Voxx announces exploration of strategic alternatives, including sale of company",0,0,1,1,1,1
9.25M,"1,037,312",-1.12M,-1,"6,100",9.23,,,"Sep 3, 2024",FOSL,"Fossil Group, Inc.",65.36M,1.23,1.28B,-2.52%,-12.83%,-4.78%,-8.26%,+16.77%,Fossil Group Announces Executive Shakeup and New CEO Compensation,Fossil appoints Franco Fogliato as CEO,"Fossil Group, Inc. Appoints Brand Veteran Franco Fogliato as CEO",,,"Fossil Group Announces Executive Shakeup and New CEO Compensation Fossil appoints Franco Fogliato as CEO Fossil Group, Inc. Appoints Brand Veteran Franco Fogliato as CEO",0,1,1,0,-1,-1
6.16M,"17,197",-75.74M,-1,"1,398",13.83,Strong Buy,75.00,"Aug 6, 2024",UONEK,"Urban One, Inc.",65.27M,1.36,460.32M,0.23%,-5.69%,-45.69%,-5.71%,-33.33%,,,,,,,1,-1,-1,-1,-1,-1
37.75M,"124,955",-31.42M,-1,168,2.250,Buy,4.40,"Sep 3, 2024",VOR,Vor Biopharma Inc.,65.25M,0.95,-,-0.54%,-8.27%,-48.61%,-7.41%,-60.19%,Evercore ISI Keeps Their Buy Rating on Vor Biopharma (VOR),Vor Biopharma’s Promising Clinical Trials and Strategic Developments Merit a Buy Rating,Vor Biopharma: Promising Clinical Data and Strategic Advancements Support Buy Rating,Vor Bio announces new clinical data from VBP101 study,Vor Biopharma (VOR) Receives a Buy from Barclays,Evercore ISI Keeps Their Buy Rating on Vor Biopharma (VOR) Vor Biopharma’s Promising Clinical Trials and Strategic Developments Merit a Buy Rating Vor Biopharma: Promising Clinical Data and Strategic Advancements Support Buy Rating Vor Bio announces new clinical data from VBP101 study Vor Biopharma (VOR) Receives a Buy from Barclays,0,0,0,0,0,0
64.33M,"304,699",-34.44M,-1,94,1.320,Buy,3.00,"Aug 13, 2024",SOTK,Sono-Tek Corporation,65.21M,4.14,21.13M,5.82%,3.73%,-12.58%,+4.52%,-5.91%,Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event,Sono-Tek announces additional $2.95M order from clean energy customer,Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer,,,Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event Sono-Tek announces additional $2.95M order from clean energy customer Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer,1,0,1,1,-1,-1
190.81M,"5,379",-60.03M,-1,48,0.450,,,"Sep 3, 2024",QUBT,Quantum Computing Inc.,65.00M,0.69,264.84K,4.19%,5.68%,-16.29%,-10.70%,-36.06%,Quantum Computing receives noncompliance notice from Nasdaq,Quantum Computing (QUBT) Q2 Earnings Cheat Sheet,,,,Quantum Computing receives noncompliance notice from Nasdaq Quantum Computing (QUBT) Q2 Earnings Cheat Sheet,1,0,0,-1,-1,-1
30.32M,"3,433","-589,624",-1,,2.800,Strong Buy,5.18,"Sep 11, 2024",ASCB,A SPAC II Acquisition Corp.,64.90M,11.41,-,-2.08%,-0.96%,1.76%,-5.02%,+2.48%,,,,,,,0,-1,-1,-1,-1,-1
43.07M,"5,936",-4.90M,-1,6,2.000,,,"Aug 8, 2024",USGO,U.S. GoldMining Inc.,64.47M,5.20,-,-5.15%,-11.06%,-15.96%,-17.18%,-22.98%,Buy Rating Affirmed for U.S. GoldMining Inc. Amidst Operational Progress and Expansion Potential at Whistler Project,U.S. GoldMining Reports Progress on Alaskan Project,,,,Buy Rating Affirmed for U.S. GoldMining Inc. Amidst Operational Progress and Expansion Potential at Whistler Project U.S. GoldMining Reports Progress on Alaskan Project,1,0,0,-1,-1,-1
37.03M,"73,444",1.05M,-1,48,2.290,,,"Sep 3, 2024",CURI,CuriosityStream Inc.,64.43M,1.18,54.80M,15.83%,15.13%,53.19%,+31.82%,+40.78%,Curiosity to launch Curiosity University on Prime Video,CuriosityStream (CURI) Receives a Hold from Barrington,"Analysts Offer Insights on Communication Services Companies: CuriosityStream (CURI), IHS Holding (IHS) and Madison Square Garden Sports (MSGS)","CuriosityStream sees Q3 revenue $12M-$14M, two estimates $16.24M","CuriosityStream reports Q2 EPS (4c), two estimates (5c)","Curiosity to launch Curiosity University on Prime Video CuriosityStream (CURI) Receives a Hold from Barrington Analysts Offer Insights on Communication Services Companies: CuriosityStream (CURI), IHS Holding (IHS) and Madison Square Garden Sports (MSGS) CuriosityStream sees Q3 revenue $12M-$14M, two estimates $16.24M CuriosityStream reports Q2 EPS (4c), two estimates (5c)",0,1,0,1,0,0
7.37M,"3,200",2.17M,-1,179,11.49,,,,HOOK,HOOKIPA Pharma Inc.,64.13M,5.32,52.16M,11.28%,-1.95%,-17.33%,-11.17%,-31.37%,Hookipa Pharma Announces Board Restructuring and Appointments,HOOKIPA Pharma Announces Board of Directors Changes,HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,"Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)",,"Hookipa Pharma Announces Board Restructuring and Appointments HOOKIPA Pharma Announces Board of Directors Changes HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)",0,0,0,0,0,-1
,,,-1,76,,,,,AFMD,Affimed N.V.,64.11M,4.21,10.06M,-3.24%,-16.07%,-19.65%,-17.75%,-35.65%,Buy Rating Justified by Promising Clinical Data and Solid Progress in Affimed’s Drug Developments,Affimed N.V. Faces Substantial Mid-Year Losses,Affimed reports Q2 EPS (EUR1.01) vs. (EUR1.97) last year,Affimed Appoints Shawn M. Leland as Chief Executive Officer,Affimed appoints Shawn Leland as Chief Executive Officer,Buy Rating Justified by Promising Clinical Data and Solid Progress in Affimed’s Drug Developments Affimed N.V. Faces Substantial Mid-Year Losses Affimed reports Q2 EPS (EUR1.01) vs. (EUR1.97) last year Affimed Appoints Shawn M. Leland as Chief Executive Officer Affimed appoints Shawn Leland as Chief Executive Officer,0,0,0,1,1,1
315.50M,"445,456",-29.00M,-1,26,1.490,Buy,2.10,"Aug 28, 2024",BNAI,"Brand Engagement Network, Inc.",64.01M,1.78,85.00K,-21.90%,-45.12%,-77.92%,-32.21%,-76.50%,BEN to Present at Upcoming Investor Conference,BEN contracts with IntelliTek to broaden AI healthcare,BEN Contracts with INTERVENT® and Members Only Health® to Elevate Professional Development and Healthcare Access with AI,Brand Engagement Network appoints Richard Isaacs to board of directors,"BEN Welcomes Former Permanente CEO and Healthcare Leader, Richard S. Isaacs, to Board of Directors","BEN to Present at Upcoming Investor Conference BEN contracts with IntelliTek to broaden AI healthcare BEN Contracts with INTERVENT® and Members Only Health® to Elevate Professional Development and Healthcare Access with AI Brand Engagement Network appoints Richard Isaacs to board of directors BEN Welcomes Former Permanente CEO and Healthcare Leader, Richard S. Isaacs, to Board of Directors",0,1,0,1,0,0
27.80M,"98,389",-18.80M,-1,287,3.020,Strong Buy,7.00,"Jul 30, 2024",PETS,"PetMed Express, Inc.",63.65M,3.10,270.77M,-6.98%,-17.41%,-40.55%,-18.21%,-32.17%,"PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference",,,,,"PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference",1,1,-1,-1,-1,-1
8.61M,"6,795","-63,000",$0.04,,9.75,Hold,9.89,"Jul 26, 2024",FTII,FutureTech II Acquisition Corp.,63.60M,10.91,-,-0.99%,-1.85%,0.27%,-1.09%,-0.23%,,,,,,,1,-1,-1,-1,-1,-1
11.18M,"7,732",2.76M,-1,131,7.53,Strong Buy,10.00,"Sep 11, 2024",ALLK,Allakos Inc.,63.54M,0.72,-,-6.46%,-17.76%,-51.37%,-17.01%,-37.24%,,,,,,,0,-1,-1,-1,-1,-1
7.79M,109,1.35M,-1,40,10.76,,,,UBXG,U-BX Technology Ltd.,63.45M,2.35,67.13M,-85.35%,-81.34%,-75.25%,-77.58%,-70.28%,U-BX Technology Unveils New Equity Incentive Plan,U-BX Technology Ltd trading resumes,"U-BX Technology Ltd trading halted, volatility trading pause",U-BX Technology Announces Accountant Change,,"U-BX Technology Unveils New Equity Incentive Plan U-BX Technology Ltd trading resumes U-BX Technology Ltd trading halted, volatility trading pause U-BX Technology Announces Accountant Change",0,0,0,0,0,-1
,,,-1,58,,,,,SELX,Semilux International Ltd.,63.25M,1.69,1.07M,3.10%,-7.79%,-67.58%,+21.71%,unch,,,,,,,1,-1,-1,-1,-1,-1
7.47M,"15,022",-3.88M,-1,324,11.18,,,,PRE,Prenetics Global Limited,63.04M,5.16,23.23M,-13.38%,-17.60%,-6.82%,-16.69%,+30.20%,"Prenetics Acquires Europa, Eyes Wellness Market Growth",Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry,Prenetics announces acquisition of Europa Sports Partners,,,"Prenetics Acquires Europa, Eyes Wellness Market Growth Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry Prenetics announces acquisition of Europa Sports Partners",1,0,1,0,-1,-1
,,,-1,210,,,,,CSBR,"Champions Oncology, Inc.",63.01M,4.64,50.16M,2.48%,-2.09%,-9.57%,-9.64%,-10.36%,,,,,,,1,-1,-1,-1,-1,-1
30.17M,"52,283",-86.76M,-1,980,2.770,Strong Sell,2.00,"Aug 7, 2024",EGIO,"Edgio, Inc.",63.00M,10.76,403.59M,18.36%,9.01%,-5.91%,+1.47%,-11.31%,Edgio discloses Nasdaq listing compliance notice,,,,,Edgio discloses Nasdaq listing compliance notice,0,0,-1,-1,-1,-1
22.25M,"35,910",-57.72M,-1,147,3.740,Strong Buy,23.00,"Aug 12, 2024",ARQQ,Arqit Quantum Inc.,62.94M,0.38,740.00K,4.80%,1.68%,-26.83%,-14.20%,-45.52%,Arqit Quantum Schedules Crucial Shareholder Meeting,,,,,Arqit Quantum Schedules Crucial Shareholder Meeting,1,0,-1,-1,-1,-1
6.93M,2,"573,881",-1,11,12.33,,,,IPWR,Ideal Power Inc.,62.94M,8.18,143.11K,-3.95%,1.73%,-5.91%,+1.89%,-5.28%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,29,,,,,SCYX,"SCYNEXIS, Inc.",62.84M,1.66,9.67M,-18.71%,-24.11%,-19.97%,-31.22%,-14.33%,SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference,Buy Rating Affirmed for SCYNEXIS Amid Antifungal Progress and Market Potential,"SCYX Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,"SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference Buy Rating Affirmed for SCYNEXIS Amid Antifungal Progress and Market Potential SCYX Earnings Report this Week: Is It a Buy, Ahead of Earnings?",0,0,0,1,-1,-1
48.26M,"214,676",-66.71M,-1,56,1.720,Buy,3.00,"Aug 8, 2024",ABAT,American Battery Technology Company,62.70M,1.07,-,6.02%,3.84%,-50.88%,+1.87%,-38.07%,American Battery Technology Appoints Steven Wu as New COO,"American Battery COO Andres Meza steps down, Steven Wu succeeds",,,,"American Battery Technology Appoints Steven Wu as New COO American Battery COO Andres Meza steps down, Steven Wu succeeds",0,1,1,-1,-1,-1
7.53M,"25,298","720,696",-1,15,11.00,,,,BEAT,"HeartBeam, Inc.",62.42M,2.35,-,-1.83%,-10.30%,9.38%,-15.33%,+3.76%,"HeartBeam reports Q2 EPS (19c), two estimates (16c)",BEAT Upcoming Earnings Report: What to Expect?,,,,"HeartBeam reports Q2 EPS (19c), two estimates (16c) BEAT Upcoming Earnings Report: What to Expect?",0,0,1,-1,-1,-1
,,,-1,624,,,,,AIRT,"Air T, Inc.",62.18M,22.53,281.81M,-0.06%,-4.00%,8.19%,-5.25%,+4.52%,Air T Secures New Credit Facility and Enhances Capital Structure,Air T Updates Investor Presentation and Enhances Engagement,,,,Air T Secures New Credit Facility and Enhances Capital Structure Air T Updates Investor Presentation and Enhances Engagement,1,1,1,-1,-1,-1
98.21M,"194,991",-59.40M,-1,18,0.842,,,,ENTX,Entera Bio Ltd.,62.12M,1.71,57.00K,6.31%,-2.26%,15.51%,+2.67%,-16.73%,Entera Bio to Participate in Upcoming Investor and Scientific Conferences,Entera Bio Receives Strong Buy Rating Amid Anticipated FDA Ruling and Pipeline Progress,Entera Bio Clarifies Non-Binding Information Disclosure,Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates,,Entera Bio to Participate in Upcoming Investor and Scientific Conferences Entera Bio Receives Strong Buy Rating Amid Anticipated FDA Ruling and Pipeline Progress Entera Bio Clarifies Non-Binding Information Disclosure Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates,0,0,0,1,0,-1
7.19M,"1,000",-3.15M,-1,79,11.50,,,"May 17, 2024",BLRX,BioLineRx Ltd.,61.87M,0.74,17.05M,-4.11%,-0.11%,-32.13%,-17.75%,-20.33%,BioLineRx initiated with a Buy at JonesResearch,Buy Rating Affirmed for Bioline RX Ltd on FDA Approval and Market Expansion Potential,BioLineRx’s Strong Quarter with APHEXDA Growth,BioLineRx reports Q2 EPS 0c vs. (2c),BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates,BioLineRx initiated with a Buy at JonesResearch Buy Rating Affirmed for Bioline RX Ltd on FDA Approval and Market Expansion Potential BioLineRx’s Strong Quarter with APHEXDA Growth BioLineRx reports Q2 EPS 0c vs. (2c) BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates,0,1,0,1,1,0
,,,-1,65,,,,,MTC,"MMTec, Inc.",61.75M,0.31,869.94K,-2.31%,-19.22%,-79.86%,-19.22%,-85.63%,,,,,,,0,-1,-1,-1,-1,-1
7.25M,"5,738","270,230",-1,,11.35,,,,TORO,Toro Corp.,61.71M,3.61,34.93M,0.70%,-4.30%,-24.00%,-8.15%,-30.88%,Toro Corp. Faces Drastic Decline in Q2 Earnings,Toro Corp. Reports Strong Asset Growth,Toro Corp. reports Q2 EPS 0.1c vs 94c last year,,,Toro Corp. Faces Drastic Decline in Q2 Earnings Toro Corp. Reports Strong Asset Growth Toro Corp. reports Q2 EPS 0.1c vs 94c last year,1,0,1,1,-1,-1
,,,-1,25,,,,,UG,"United-Guardian, Inc.",61.61M,13.41,12.31M,20.90%,33.23%,63.68%,+32.55%,+92.89%,Best Chase travel rewards credit cards,Airline credit cards that offer free checked bags,Best disability insurance companies,Best credit cards with roadside assistance,Best term life insurance companies,Best Chase travel rewards credit cards Airline credit cards that offer free checked bags Best disability insurance companies Best credit cards with roadside assistance Best term life insurance companies,0,0,0,1,0,0
37.89M,"53,393",-12.66M,-1,786,2.170,Strong Buy,8.00,"Oct 4, 2024",BNR,Burning Rock Biotech Limited,61.55M,6.00,70.15M,-8.27%,-10.54%,-24.29%,-12.38%,-20.05%,Burning Rock Biotech Announces Board Resignation,Burning Rock Biotech to Delist from LSE,Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares,,,Burning Rock Biotech Announces Board Resignation Burning Rock Biotech to Delist from LSE Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares,0,1,1,1,-1,-1
79.73M,"935,091",-369.04M,-1,113,1.030,Buy,3.44,"Aug 1, 2024",TTOO,"T2 Biosystems, Inc.",61.35M,3.51,7.16M,-6.67%,-21.72%,-16.08%,-31.15%,+18.73%,T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,,,,,T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,1,0,-1,-1,-1,-1
23.48M,"21,224",-13.52M,-1,"1,061",3.490,Strong Buy,7.25,"Aug 8, 2024",UPLD,"Upland Software, Inc.",61.35M,2.25,286.37M,5.35%,-3.71%,-29.62%,-6.72%,-25.61%,,,,,,,1,-1,-1,-1,-1,-1
7.56M,67,"669,111",-1,"4,319",10.82,,,,SIFY,Sify Technologies Limited,61.18M,0.33,437.96M,-2.28%,-12.28%,-69.35%,-18.77%,-73.80%,Unusually active option classes on open September 3rd,Sify becomes First in India to Achieve NVIDIA DGX-Ready Data Center Certification for Liquid Cooling to Enable Breakthrough AI Performance,"Sify Technologies appoints Sharad Agarwal as CEO, Sify Infinit Spaces",Sify Technologies announces the appointment of Sharad Agarwal as CEO of Sify Infinit Spaces Limited,,"Unusually active option classes on open September 3rd Sify becomes First in India to Achieve NVIDIA DGX-Ready Data Center Certification for Liquid Cooling to Enable Breakthrough AI Performance Sify Technologies appoints Sharad Agarwal as CEO, Sify Infinit Spaces Sify Technologies announces the appointment of Sharad Agarwal as CEO of Sify Infinit Spaces Limited",1,0,0,1,1,-1
,,,-1,181,,,,,BOTJ,"Bank of the James Financial Group, Inc.",60.97M,13.42,43.41M,0.72%,8.74%,18.64%,-1.26%,+27.14%,,,,,,,1,-1,-1,-1,-1,-1
17.21M,"259,229",-1.29M,-1,153,4.77,,,"Sep 6, 2024",FUSB,"First US Bancshares, Inc.",60.95M,10.61,40.51M,3.46%,5.94%,8.29%,+6.00%,+14.47%,"FIRST US BANCSHARES, INC. DECLARES CASH DIVIDEND",,,,,"FIRST US BANCSHARES, INC. DECLARES CASH DIVIDEND",0,1,-1,-1,-1,-1
7.09M,"1,000",-2.36M,-1,,11.57,,,,GBBK,Global Blockchain Acquisition Corp.,60.81M,11.04,-,-0.07%,-0.07%,3.24%,+0.36%,+4.45%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,103,,,,,THTX,Theratechnologies Inc.,60.61M,1.33,82.57M,-3.97%,-7.19%,-10.98%,-10.14%,-14.90%,,,,,,,0,-1,-1,-1,-1,-1
7.84M,"5,333","-35,880",-1,4,10.41,,,,USAU,U.S. Gold Corp.,60.53M,5.64,-,4.25%,-0.56%,25.46%,-7.36%,+32.16%,Optimization and Strategic Location Bolster Buy Rating for US Gold Corp’s CK Gold Project,,,,,Optimization and Strategic Location Bolster Buy Rating for US Gold Corp’s CK Gold Project,1,1,-1,-1,-1,-1
,,,-1,5,,,,,ABIO,"ARCA biopharma, Inc.",60.35M,4.16,-,22.25%,17.33%,53.35%,+16.33%,+12.94%,,,,,,,0,-1,-1,-1,-1,-1
20.59M,"58,058",-10.06M,-1,102,3.950,,,"Aug 9, 2024",WFCF,"Where Food Comes From, Inc.",60.27M,11.25,25.72M,0.19%,-3.02%,-11.52%,unch,+2.96%,,,,,,,1,-1,-1,-1,-1,-1
34.90M,"359,253",-120.43M,-1,,2.330,Hold,9.25,"Aug 8, 2024",JUNE,Junee Limited,59.93M,4.62,4.79M,3.63%,1.40%,4.92%,+0.22%,,Junee Limited Announces New Office Location,Junee Limited in MOU with AI firm PanaAI Technology,Junee Limited Explores AI Supercomputing Expansion,Goldman Sachs Remains a Buy on Junee Limited (JUNE),,Junee Limited Announces New Office Location Junee Limited in MOU with AI firm PanaAI Technology Junee Limited Explores AI Supercomputing Expansion Goldman Sachs Remains a Buy on Junee Limited (JUNE),0,0,0,0,0,-1
12.71M,"368,490",-163.50M,-1,112,6.38,Hold,9.33,"Sep 6, 2024",SSBI,Summit State Bank,59.90M,8.83,33.98M,-2.28%,-5.24%,-17.19%,-6.88%,-18.89%,,,,,,,1,-1,-1,-1,-1,-1
11.17M,"208,774",6.85M,-1,611,7.25,Strong Buy,14.50,"Aug 12, 2024",NAAS,NaaS Technology Inc.,59.87M,4.53,58.24M,-9.67%,-9.18%,-81.14%,-21.12%,-81.33%,NaaS Technology Launches Updated Incentive Plan,NaaS Technology Financials Show Revenue Growth,"NaaS CFO Alex Wu resigns, Steven Sim to succeed",,,"NaaS Technology Launches Updated Incentive Plan NaaS Technology Financials Show Revenue Growth NaaS CFO Alex Wu resigns, Steven Sim to succeed",1,0,1,1,-1,-1
14.62M,"55,340",-16.65M,-1,13,5.53,Strong Buy,16.33,"Aug 13, 2024",MNOV,"MediciNova, Inc.",59.84M,1.22,1.00M,20.81%,11.68%,1.61%,+2.24%,-8.05%,MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting,MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition,,,,MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition,0,0,0,-1,-1,-1
7.15M,"9,077","713,405",-1,5,11.29,,,,LOAN,"Manhattan Bridge Capital, Inc.",59.71M,5.22,7.44M,-1.70%,-1.46%,3.94%,-2.95%,+1.15%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,13,,,,,NTRB,Nutriband Inc.,59.71M,5.41,2.02M,-2.31%,-8.72%,40.30%,-25.46%,-1.97%,Nutriband reports Q2 EPS (15c) vs. (11c) last year,,,,,Nutriband reports Q2 EPS (15c) vs. (11c) last year,1,1,-1,-1,-1,-1
7.29M,19,-4.88M,-1,,11.04,,,,HHGC,HHG Capital Corporation,59.32M,11.74,-,0.76%,0.40%,3.11%,-1.22%,+1.88%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,134,,,,,EGRX,"Eagle Pharmaceuticals, Inc.",59.22M,4.56,257.55M,8.27%,-3.85%,-10.24%,+7.88%,+1.56%,Eagle Pharmaceuticals Struggles with Financial Compliance and Nasdaq Listing,Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq,Eagle Pharmaceuticals announces receipt of delisting notification from Nasdaq,,,Eagle Pharmaceuticals Struggles with Financial Compliance and Nasdaq Listing Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq Eagle Pharmaceuticals announces receipt of delisting notification from Nasdaq,0,0,1,1,-1,-1
23.74M,"406,782",7.68M,-1,7,3.390,Strong Buy,12.00,"Aug 14, 2024",INTS,"Intensity Therapeutics, Inc.",59.22M,4.30,-,-3.99%,-8.59%,-7.68%,-12.19%,-5.56%,,,,,,,0,-1,-1,-1,-1,-1
161.76M,"416,484",-69.48M,-1,94,0.508,Buy,4.50,"Aug 7, 2024",VUZI,Vuzix Corporation,59.20M,0.90,6.34M,-13.81%,-28.02%,-45.28%,-30.33%,-40.14%,"Analysts Have Conflicting Sentiments on These Technology Companies: Vuzix (VUZI), CI&T (CINT) and Zscaler (ZS)",BTIG Sticks to Their Hold Rating for Vuzix (VUZI),Quanta Computer invests $20M in Vuzix,Vuzix’s Z100 smart glasses selected by GPS TUNER,Vuzix price target lowered to $2 from $3 at Craig-Hallum,"Analysts Have Conflicting Sentiments on These Technology Companies: Vuzix (VUZI), CI&T (CINT) and Zscaler (ZS) BTIG Sticks to Their Hold Rating for Vuzix (VUZI) Quanta Computer invests $20M in Vuzix Vuzix’s Z100 smart glasses selected by GPS TUNER Vuzix price target lowered to $2 from $3 at Craig-Hallum",1,1,0,0,0,0
25.91M,"2,714",-14.96M,-1,63,3.100,,,,KRON,"Kronos Bio, Inc.",59.08M,0.98,8.41M,-7.74%,-13.95%,-10.72%,-23.44%,-19.08%,Kronos Bio Announces Participation in Medical and Investor Conferences in September,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH)",,,,"Kronos Bio Announces Participation in Medical and Investor Conferences in September Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH)",1,0,1,-1,-1,-1
6.49M,"2,110",7.43M,$0.20,17,12.30,,,"Jul 25, 2024",IMMX,"Immix Biopharma, Inc.",59.02M,2.15,-,5.49%,3.83%,-33.39%,+7.25%,-22.65%,Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2,Immix Biopharma announces three more sites for NEXICART-2 trial,"Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)",,,"Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2 Immix Biopharma announces three more sites for NEXICART-2 trial Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)",0,0,0,0,-1,-1
47.99M,"36,807",-21.04M,-1,117,1.650,Strong Buy,4.75,"Aug 19, 2024",MURA,Mural Oncology plc,58.95M,3.46,-,-0.06%,0.77%,-18.20%,-11.27%,-27.25%,Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Mural Oncology reports Q2 EPS ($1.86) vs ($3.01) last year,Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress,MURA Earnings this Week: How Will it Perform?,,Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mural Oncology reports Q2 EPS ($1.86) vs ($3.01) last year Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress MURA Earnings this Week: How Will it Perform?,1,0,1,0,0,-1
7.73M,79,1.28M,-1,186,10.33,,,,CTSO,Cytosorbents Corporation,58.78M,1.08,37.16M,-1.64%,6.02%,1.35%,-15.83%,unch,CytoSorbents Announces CFO Transition and New Financial Leadership,CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),CytoSorbents Stability and Growth Prospects Maintain ‘Hold’ Rating Amid FDA Submission Uncertainty,CytoSorbents appoints Peter Mariani as Chief Financial Officer,"CytoSorbents reports Q2 EPS (8c), consensus (10c)","CytoSorbents Announces CFO Transition and New Financial Leadership CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CytoSorbents Stability and Growth Prospects Maintain ‘Hold’ Rating Amid FDA Submission Uncertainty CytoSorbents appoints Peter Mariani as Chief Financial Officer CytoSorbents reports Q2 EPS (8c), consensus (10c)",0,0,0,1,1,1
,,,-1,146,,,,,ANGH,Anghami Inc.,58.76M,0.88,41.38M,1.35%,-5.66%,-20.86%,-5.26%,-22.41%,Anghami Reports Substantial Growth Post OSN+ Deal,Anghami Faces Nasdaq Compliance Challenge,,,,Anghami Reports Substantial Growth Post OSN+ Deal Anghami Faces Nasdaq Compliance Challenge,0,1,0,-1,-1,-1
51.52M,"201,805",-48.88M,-1,98,1.550,Strong Buy,5.75,"Aug 8, 2024",BYFC,Broadway Financial Corporation,58.69M,6.76,33.87M,38.65%,45.89%,35.26%,+49.32%,+33.74%,,,,,,,1,-1,-1,-1,-1,-1
6.10M,"21,817",-38.70M,-1,231,13.09,Hold,,"Jul 29, 2024",GRTS,"Gritstone bio, Inc.",58.66M,0.50,14.61M,-6.21%,-19.93%,-65.56%,-23.14%,-52.38%,Buy Rating Affirmed on Gritstone Oncology Amidst Promising GRANITE Program Milestones and Upcoming PFS Data Release,"Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS)",Buy Rating Affirmed on Gritstone Oncology Amid Promising Trial Updates and Strong Financials,"Analysts Offer Insights on Healthcare Companies: IO Biotech (IOBT), Gritstone Oncology (GRTS) and Korro Bio (KRRO)","Gritstone reports Q2 EPS (16c), consensus (28c)","Buy Rating Affirmed on Gritstone Oncology Amidst Promising GRANITE Program Milestones and Upcoming PFS Data Release Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS) Buy Rating Affirmed on Gritstone Oncology Amid Promising Trial Updates and Strong Financials Analysts Offer Insights on Healthcare Companies: IO Biotech (IOBT), Gritstone Oncology (GRTS) and Korro Bio (KRRO) Gritstone reports Q2 EPS (16c), consensus (28c)",0,0,0,0,0,1
7.17M,4,3.64M,-1,108,11.14,,,,ONDS,Ondas Holdings Inc.,58.42M,0.84,9.21M,2.15%,7.82%,-16.18%,-18.45%,-24.55%,Ondas Holdings (ONDS) Gets a Buy from Maxim Group,Ondas sees recovery in revenue growth in 2H24,"Ondas reports Q2 EPS (14c), consensus (15c)",Ondas secures expansion of initial purchase order from military customer,,"Ondas Holdings (ONDS) Gets a Buy from Maxim Group Ondas sees recovery in revenue growth in 2H24 Ondas reports Q2 EPS (14c), consensus (15c) Ondas secures expansion of initial purchase order from military customer",1,1,1,1,1,-1
,,,-1,,,,,,FDSB,"Fifth District Bancorp, Inc.",58.40M,10.51,10.35M,2.46%,2.46%,2.46%,,,,,,,,,1,-1,-1,-1,-1,-1
7.00M,271,-3.59M,-1,993,11.33,,,,FARM,Farmer Bros. Co.,58.26M,2.74,342.19M,6.68%,3.12%,-9.78%,+2.21%,-20.57%,Farmer Brothers to report fourth quarter and fiscal 2024 financial results,,,,,Farmer Brothers to report fourth quarter and fiscal 2024 financial results,0,0,-1,-1,-1,-1
,,,-1,35,,,,,SELF,"Global Self Storage, Inc.",58.25M,5.17,12.21M,4.28%,5.58%,12.71%,+4.20%,+20.18%,Global Self Storage Offers Insight into Future Prospects,,,,,Global Self Storage Offers Insight into Future Prospects,1,1,-1,-1,-1,-1
7.69M,"64,527","696,641",-1,306,10.22,,,,BAFN,BayFirst Financial Corp.,58.17M,14.07,77.69M,6.69%,11.87%,15.73%,+5.69%,+5.86%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,CCTS,Cactus Acquisition Corp. 1 Limited,58.06M,11.44,-,-0.61%,-0.54%,4.05%,+0.70%,+5.06%,Cactus Acquisition and Tembo e-LV Announce Strategic Merger,VivoPower’s Tembo executes combination agreement with Cactus Acquisition,,,,Cactus Acquisition and Tembo e-LV Announce Strategic Merger VivoPower’s Tembo executes combination agreement with Cactus Acquisition,0,0,1,-1,-1,-1
33.52M,"6,055",-1.49M,-1,,2.350,,,"Aug 1, 2024",LRFC,Logan Ridge Finance Corporation,57.96M,21.66,19.95M,-1.38%,-2.88%,-3.51%,-3.35%,-3.74%,Logan Ridge Finance Enhances Borrowing Terms and Capacity,Logan Ridge Finance Corporation Amends and Extends its Existing Senior Secured Revolving Credit Facility,,,,Logan Ridge Finance Enhances Borrowing Terms and Capacity Logan Ridge Finance Corporation Amends and Extends its Existing Senior Secured Revolving Credit Facility,1,1,1,-1,-1,-1
45.47M,"64,937",-23.43M,-1,75,1.730,,,"Aug 9, 2024",CLGN,CollPlant Biotechnologies Ltd.,57.96M,5.06,689.00K,9.55%,5.16%,-4.53%,+22.67%,+2.94%,Buy Rating Affirmed for Collplant Holdings Amid Advancing Biotech Prospects and Promising Financial Outlook,CollPlant Announces Upcoming Shareholder Meeting,CollPlant Pursues $3B Market with 3D-Printed Implants,COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE,CollPlant reports Q2 non-GAAP EPS 33c vs. 53c last year,Buy Rating Affirmed for Collplant Holdings Amid Advancing Biotech Prospects and Promising Financial Outlook CollPlant Announces Upcoming Shareholder Meeting CollPlant Pursues $3B Market with 3D-Printed Implants COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE CollPlant reports Q2 non-GAAP EPS 33c vs. 53c last year,0,0,0,0,0,1
85.66M,"40,485",-51.89M,-1,"1,751",0.920,,,"Aug 29, 2024",LIVE,Live Ventures Incorporated,57.90M,18.49,463.64M,1.23%,-9.23%,-25.10%,+2.52%,-32.67%,,,,,,,1,-1,-1,-1,-1,-1
11.47M,"12,572","891,000",$0.80,130,6.85,,,"Jul 31, 2024",BCG,"Binah Capital Group, Inc.",57.78M,3.48,161.90M,-4.73%,-28.34%,-59.25%,-14.29%,-56.08%,,,,,,,1,-1,-1,-1,-1,-1
14.48M,"976,179",-27.04M,-1,28,5.42,Buy,7.25,"Aug 14, 2024",BMR,Beamr Imaging Ltd.,57.70M,3.72,2.96M,-3.79%,-22.00%,-18.44%,-28.13%,-42.33%,Beamr Cloud Innovates with Automated AV1 Video Encoding,Beamr Imaging’s Beamr Cloud now supports AV1 format,"Stop Experimenting with AV1, Start Working with it on Beamr Cloud",,,"Beamr Cloud Innovates with Automated AV1 Video Encoding Beamr Imaging’s Beamr Cloud now supports AV1 format Stop Experimenting with AV1, Start Working with it on Beamr Cloud",1,1,1,1,-1,-1
31.10M,"7,730",1.97M,-1,40,2.570,Strong Buy,5.00,"Aug 14, 2024",MODD,"Modular Medical, Inc.",57.31M,1.76,-,12.29%,15.08%,11.43%,+14.65%,+13.21%,Modular Medical Inc trading resumes,"Modular Medical Inc trading halted, news pending",Modular Medical Incentivizes FDA Milestones with Stock Options,,,"Modular Medical Inc trading resumes Modular Medical Inc trading halted, news pending Modular Medical Incentivizes FDA Milestones with Stock Options",0,0,0,0,-1,-1
27.29M,"20,457",-40.80M,-1,110,2.840,Strong Buy,7.50,"Aug 21, 2024",IROQ,"IF Bancorp, Inc.",57.04M,17.75,22.41M,3.75%,5.53%,12.24%,+4.71%,+8.96%,,,,,,,1,-1,-1,-1,-1,-1
7.01M,"73,001",2.29M,-1,,11.14,,,,EDRY,EuroDry Ltd.,56.79M,20.37,57.77M,-2.32%,-9.42%,-2.13%,-7.92%,-1.94%,Noble Financial Sticks to Its Buy Rating for EuroDry (EDRY),Buy Rating Affirmed for EuroDry Amid Rising TCE Rates and Strong Financial Strategy,,,,Noble Financial Sticks to Its Buy Rating for EuroDry (EDRY) Buy Rating Affirmed for EuroDry Amid Rising TCE Rates and Strong Financial Strategy,0,0,0,-1,-1,-1
,,,-1,76,,,,,FAAS,DigiAsia Corp.,56.72M,0.97,57.73M,-22.15%,-69.50%,-86.62%,-46.28%,-84.29%,DigiAsia Corp. Appoints Andreas Gregori to its AI Strategic Advisory Board,DigiAsia’s Strategic Expansion in Southeast Asia’s Fintech,DigiAsia Amends Note Terms with Greenhaven,,,DigiAsia Corp. Appoints Andreas Gregori to its AI Strategic Advisory Board DigiAsia’s Strategic Expansion in Southeast Asia’s Fintech DigiAsia Amends Note Terms with Greenhaven,1,1,1,0,-1,-1
6.49M,4,-1.73M,-1,106,11.99,,,,OPXS,"Optex Systems Holdings, Inc",56.48M,8.29,32.63M,3.43%,5.90%,21.44%,+2.80%,+11.31%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,78,,,,,HYMC,Hycroft Mining Holding Corporation,56.45M,2.35,-,-2.34%,-7.60%,-11.41%,-13.83%,-30.79%,,,,,,,0,-1,-1,-1,-1,-1
11.06M,"331,244","-187,152",-1,81,7.010,,,"Sep 3, 2024",CNTB,Connect Biopharma Holdings Limited,56.32M,1.02,-,-9.11%,-19.65%,-25.44%,-15.04%,-53.55%,Connect Biopharma Welcomes New Finance VP,Optimistic Buy Rating for Connect Biopharma: Strategic Partnerships and Regulatory Progress Fuel Potential for Rademikibart,Connect Biopharma Pivots to U.S. Market Strategy,Connect Biopharma reports 1H net income $7.6M vs. net loss ($30.5M) 1H last year,Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update,Connect Biopharma Welcomes New Finance VP Optimistic Buy Rating for Connect Biopharma: Strategic Partnerships and Regulatory Progress Fuel Potential for Rademikibart Connect Biopharma Pivots to U.S. Market Strategy Connect Biopharma reports 1H net income $7.6M vs. net loss ($30.5M) 1H last year Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update,0,0,1,0,0,0
58.28M,"35,421",-4.22M,-1,133,1.330,Strong Buy,4.00,"Aug 12, 2024",FLUX,"Flux Power Holdings, Inc.",56.22M,3.37,63.85M,-1.08%,-4.35%,-16.55%,-9.56%,-33.27%,Flux Power Holdings (FLUX) Gets a Buy from Craig-Hallum,Flux Power Announces Inventory Write-Down and Financial Restatements,Flux Power to write down $1.7M in inventory,Flux Power expands commitment to sustainability with new partnership,,Flux Power Holdings (FLUX) Gets a Buy from Craig-Hallum Flux Power Announces Inventory Write-Down and Financial Restatements Flux Power to write down $1.7M in inventory Flux Power expands commitment to sustainability with new partnership,1,0,0,0,0,-1
46.83M,"97,583",8.83M,-1,583,1.650,Strong Buy,3.50,"Aug 7, 2024",SHLT,SHL Telemedicine Ltd.,56.07M,3.70,57.08M,-21.49%,-29.17%,-53.53%,-34.18%,-45.53%,,,,,,,1,-1,-1,-1,-1,-1
56.71M,"114,291",39.55M,-1,241,1.360,,,"Sep 3, 2024",FTHM,Fathom Holdings Inc.,55.88M,2.66,327.31M,16.41%,37.12%,17.17%,+21.03%,+30.81%,"Fathom Holdings Strengthens Incentives, Affirms Leadership at Annual Meeting",D.A. Davidson Remains a Buy on Fathom Holdings (FTHM),Fathom Holdings: A Strong Buy on Growth and Profitability Prospects,Fathom Holdings Reports Second Quarter 2024 Results,Fathom withholds Q3 guidance,"Fathom Holdings Strengthens Incentives, Affirms Leadership at Annual Meeting D.A. Davidson Remains a Buy on Fathom Holdings (FTHM) Fathom Holdings: A Strong Buy on Growth and Profitability Prospects Fathom Holdings Reports Second Quarter 2024 Results Fathom withholds Q3 guidance",1,0,1,1,1,0
23.65M,"1,018,774",-6.16M,-1,"2,025",3.260,,,"Sep 3, 2024",RDIB,"Reading International, Inc.",55.87M,10.90,203.74M,,37.12%,17.17%,-26.40%,-33.86%,Reading International reports Q2 EPS (42c) vs (12c) last year,,,,,Reading International reports Q2 EPS (42c) vs (12c) last year,1,1,-1,-1,-1,-1
34.10M,"131,353",-26.54M,-1,7,2.260,Strong Buy,32.33,"Aug 14, 2024",AIRE,reAlpha Tech Corp.,55.85M,1.26,99.04K,-1.43%,2.64%,-26.51%,-15.54%,+10.13%,ReAlpha Tech Corp. Welcomes William B. Miller as New CFO,reAlpha appoints William Brent Miller as CFO,reAlpha Appoints Former CFO of KKR Real Estate Finance Trust as CFO,reAlpha Tech Corp. Unveils AI-Powered Homebuying Super App,"reAlpha Launches AI-Powered Real Estate Super App™ on Tailwinds of Effectiveness of NAR Rule Changes on August 17, 2024","ReAlpha Tech Corp. Welcomes William B. Miller as New CFO reAlpha appoints William Brent Miller as CFO reAlpha Appoints Former CFO of KKR Real Estate Finance Trust as CFO reAlpha Tech Corp. Unveils AI-Powered Homebuying Super App reAlpha Launches AI-Powered Real Estate Super App™ on Tailwinds of Effectiveness of NAR Rule Changes on August 17, 2024",1,1,1,1,0,1
6.71M,"5,287","281,026",-1,155,11.49,,,,CODX,"Co-Diagnostics, Inc.",55.84M,1.75,9.14M,17.67%,16.54%,23.05%,+36.52%,+28.69%,Co-Diagnostics completes updated clade Ib analysis of 2-Gene Mpox RUO test,Hold Rating Maintained for Co-Diagnostics Amidst Revenue Growth and Development Progress,Co-Diagnostics price target lowered to $1.50 from $2 at H.C. Wainwright,,,Co-Diagnostics completes updated clade Ib analysis of 2-Gene Mpox RUO test Hold Rating Maintained for Co-Diagnostics Amidst Revenue Growth and Development Progress Co-Diagnostics price target lowered to $1.50 from $2 at H.C. Wainwright,1,1,1,0,-1,-1
,,,-1,148,,,,,OPTX,"Syntec Optics Holdings, Inc.",55.58M,1.52,28.13M,3.05%,-22.98%,-62.25%,-7.84%,-61.85%,Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update,,,,,Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Update,1,0,-1,-1,-1,-1
6.38M,400,"21,012",-1,10,12.02,,,,FBLG,"FibroBiologics, Inc.",55.55M,1.58,-,-33.78%,-57.36%,-79.95%,-69.29%,-85.48%,FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference,FibroBiologics initiated with a Buy at EF Hutton,FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology,FibroBiologics announces filing of patent application for wound healing,,FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference FibroBiologics initiated with a Buy at EF Hutton FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology FibroBiologics announces filing of patent application for wound healing,0,0,1,1,0,-1
,,,-1,,,,,,ROCL,Roth Ch Acquisition V Co.,55.30M,11.24,-,-0.41%,0.89%,4.65%,+2.83%,+5.73%,,,,,,,1,-1,-1,-1,-1,-1
6.87M,245,1.54M,-1,5,11.15,,,,VIVK,"Vivakor, Inc.",55.18M,1.89,62.39M,-1.62%,-8.54%,49.09%,-9.68%,+142.21%,Vivakor forms petroleum marketing division,,,,,Vivakor forms petroleum marketing division,1,0,-1,-1,-1,-1
,,,-1,"1,962",,,,,HHS,"Harte Hanks, Inc.",54.96M,7.54,187.09M,-2.44%,-6.23%,0.18%,-12.32%,+6.02%,"Harte Hanks, Outreach partner to deliver sales engagement solutions",,,,,"Harte Hanks, Outreach partner to deliver sales engagement solutions",0,0,-1,-1,-1,-1
37.75M,"85,595",8.34M,-1,130,2.010,,,"Sep 6, 2024",LNSR,"LENSAR, Inc.",54.79M,4.72,45.12M,4.04%,0.66%,20.88%,-6.41%,+49.68%,LENSAR (LNSR) Gets a Buy from Lake Street,,,,,LENSAR (LNSR) Gets a Buy from Lake Street,1,0,-1,-1,-1,-1
76.99M,"118,657",-20.48M,-1,,0.990,Strong Buy,4.00,"Aug 1, 2024",NBST,Newbury Street Acquisition Corporation,54.59M,11.03,-,0.26%,0.43%,2.21%,+0.28%,+1.77%,Newbury Street Partners with Google for Immersive Tech Revolution,,,,,Newbury Street Partners with Google for Immersive Tech Revolution,0,0,-1,-1,-1,-1
9.30M,"11,602",-20.05M,-1,34,8.05,,,"Aug 13, 2024",COCH,"Envoy Medical, Inc.",54.49M,2.78,302.00K,16.86%,23.98%,3.94%,+39.72%,-51.46%,Envoy Medical (COCH) Receives a Buy from Lake Street,Envoy Medical secures lending facility of $10M,"Envoy Medical reports Q2 EPS (27c), consensus (25c)",,,"Envoy Medical (COCH) Receives a Buy from Lake Street Envoy Medical secures lending facility of $10M Envoy Medical reports Q2 EPS (27c), consensus (25c)",1,0,1,1,-1,-1
74.75M,"155,253",-33.46M,-1,"3,342",1.020,Strong Buy,4.83,"Aug 12, 2024",LEE,"Lee Enterprises, Incorporated",54.48M,8.80,616.82M,-4.99%,-15.74%,-19.89%,-13.87%,-29.15%,,,,,,,1,-1,-1,-1,-1,-1
35.85M,"135,050",-50.98M,-1,,2.120,Strong Buy,20.00,"Aug 13, 2024",PXS,Pyxis Tankers Inc.,54.39M,5.20,50.06M,-0.27%,0.53%,9.89%,-3.07%,+6.99%,Pyxis Tankers Sets Q2 2024 Results Release,Pyxis Tankers reports Q2 EPS 43c vs. 23c last year,,,,Pyxis Tankers Sets Q2 2024 Results Release Pyxis Tankers reports Q2 EPS 43c vs. 23c last year,0,1,1,-1,-1,-1
15.47M,"5,545,326",-10.97M,-1,179,4.91,,,"Aug 8, 2024",XGN,Exagen Inc.,54.25M,3.12,56.66M,8.80%,32.96%,58.50%,+48.21%,+92.67%,Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference,,,,,Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference,1,1,-1,-1,-1,-1
72.62M,"28,188",-41.45M,-1,2,1.040,Hold,1.43,"Aug 8, 2024",ANEB,"Anebulo Pharmaceuticals, Inc.",54.20M,2.09,-,-1.54%,-9.33%,-16.08%,-16.99%,-26.88%,,,,,,,1,-1,-1,-1,-1,-1
6.76M,302,1.32M,-1,,11.16,,,,BRAC,Broad Capital Acquisition Corp.,54.15M,11.50,-,0.70%,1.53%,5.92%,+0.88%,+5.02%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,24,,,,,GEG,"Great Elm Group, Inc.",54.15M,1.80,11.94M,-0.96%,-0.52%,-5.12%,-2.73%,-6.81%,Great Elm Group Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results,,,,,Great Elm Group Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results,0,0,-1,-1,-1,-1
7.19M,661,-2.20M,-1,51,10.86,,,,AVTE,"Aerovate Therapeutics, Inc.",53.98M,1.87,-,6.03%,-14.61%,-88.26%,+2.20%,-92.57%,"Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (ORIC), Aerovate Therapeutics (AVTE) and McKesson (MCK)",AVTE Upcoming Earnings Report: What to Expect?,,,,"Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (ORIC), Aerovate Therapeutics (AVTE) and McKesson (MCK) AVTE Upcoming Earnings Report: What to Expect?",0,1,1,-1,-1,-1
,,,-1,,,,,,BUJA,Bukit Jalil Global Acquisition 1 Ltd,53.42M,10.81,-,0.06%,0.60%,2.83%,+1.03%,+3.53%,"Bukit Jalil Global Merges with Global IBO, Eyes Nasdaq Listing",,,,,"Bukit Jalil Global Merges with Global IBO, Eyes Nasdaq Listing",0,0,-1,-1,-1,-1
6.84M,"2,070",2.22M,-1,8,11.03,,,,GDC,GD Culture Group Limited,53.17M,5.45,-150.00K,150.94%,253.95%,237.37%,+323.40%,+548.91%,"GD Culture Group Unveils AI-Driven Video Tech, Expands Online Presence",GD Culture Group Ltd trading resumes,"GD Culture Group Ltd trading halted, volatility trading pause",GDC Announces SyncWaveX: Redefining Video Production with Direct Audio-to-Video AI Technology,GD Culture Group announces SyncWaveX application,"GD Culture Group Unveils AI-Driven Video Tech, Expands Online Presence GD Culture Group Ltd trading resumes GD Culture Group Ltd trading halted, volatility trading pause GDC Announces SyncWaveX: Redefining Video Production with Direct Audio-to-Video AI Technology GD Culture Group announces SyncWaveX application",1,1,0,0,1,1
,,,-1,320,,,,,LPTH,"LightPath Technologies, Inc.",53.17M,1.37,32.78M,-2.67%,0.54%,-2.54%,-9.72%,-13.91%,,,,,,,1,-1,-1,-1,-1,-1
25.71M,"8,752",-25.52M,-1,,2.930,Buy,4.50,"Aug 6, 2024",AOGO,Arogo Capital Acquisition Corp.,53.07M,10.96,-,0.17%,0.33%,1.93%,-0.36%,+1.39%,Arogo Capital Acquisition Corp. Announces Receipt of Nasdaq Delisting Notice,Arogo Capital Acquisition receives Nasdaq delisting notice,,,,Arogo Capital Acquisition Corp. Announces Receipt of Nasdaq Delisting Notice Arogo Capital Acquisition receives Nasdaq delisting notice,1,1,1,-1,-1,-1
55.26M,"43,206",-24.20M,-1,393,1.360,,,"Aug 13, 2024",UCL,uCloudlink Group Inc.,52.86M,1.41,86.08M,-1.11%,-10.72%,-15.63%,-10.69%,-7.79%,UCLOUDlink Reports Growth and Profit in Q2 2024,"uCloudlink Group, Inc. (UCL) Q2 Earnings Cheat Sheet",,,,"UCLOUDlink Reports Growth and Profit in Q2 2024 uCloudlink Group, Inc. (UCL) Q2 Earnings Cheat Sheet",0,1,1,-1,-1,-1
39.03M,"18,662",-21.03M,-1,,1.920,,,,CLRC,ClimateRock,52.58M,11.55,-,0.06%,0.91%,5.50%,+0.96%,+5.58%,,,,,,,0,-1,-1,-1,-1,-1
18.59M,"9,203",2.71M,-1,435,4.030,,,"Aug 7, 2024",RGS,Regis Corporation,52.58M,23.06,209.32M,-4.38%,3.73%,98.19%,-17.06%,+221.87%,Regis Corporation Announces Strategic Executive Team Reshuffle,,,,,Regis Corporation Announces Strategic Executive Team Reshuffle,0,0,-1,-1,-1,-1
18.29M,298,-12.87M,-1,"2,303",4.090,Strong Buy,25.00,,MESA,"Mesa Air Group, Inc.",52.47M,1.27,479.42M,-3.18%,-13.26%,21.10%,-19.75%,+46.51%,Wednesday’s big stock stories: What’s likely to move the market in the next trading session,Mesa Air Group Faces Nasdaq Compliance Challenge,Mesa Air receives non-compliance letter from NASDAQ,,,Wednesday’s big stock stories: What’s likely to move the market in the next trading session Mesa Air Group Faces Nasdaq Compliance Challenge Mesa Air receives non-compliance letter from NASDAQ,0,0,0,0,-1,-1
6.25M,"3,962",20.87M,-1,"6,400",11.90,,,"Jun 6, 2024",VCSA,"Vacasa, Inc.",52.44M,3.38,1.01B,10.13%,-10.45%,-44.49%,-21.50%,-48.58%,Vacasa files to sell 10.93M shares of Class A common stock for holders,Vacasa’s Principal Accounting Officer Craig Gracey Steps Down,Vacasa price target lowered to $2.50 from $6.50 at Deutsche Bank,,,Vacasa files to sell 10.93M shares of Class A common stock for holders Vacasa’s Principal Accounting Officer Craig Gracey Steps Down Vacasa price target lowered to $2.50 from $6.50 at Deutsche Bank,1,0,0,0,-1,-1
6.59M,74,"823,707",-1,104,11.38,,,,STBX,Starbox Group Holdings Ltd.,52.42M,0.16,12.21M,9.37%,1.97%,-23.69%,+0.61%,-24.86%,Starbox Group Facilitates Key Software Acquisition,"Starbox Acquires New Software, Issues Shares",,,,"Starbox Group Facilitates Key Software Acquisition Starbox Acquires New Software, Issues Shares",1,1,1,-1,-1,-1
,,,-1,216,,,,,WOK,WORK Medical Technology Group LTD,52.20M,3.60,9.86M,-3.29%,-3.29%,-3.29%,,,Work Medical Technology Group Ltd trading resumes,"Work Medical Technology Group Ltd trading halted, volatility trading pause","Opening Day: Autozi, JBDI Holdings make public debut",WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option,,"Work Medical Technology Group Ltd trading resumes Work Medical Technology Group Ltd trading halted, volatility trading pause Opening Day: Autozi, JBDI Holdings make public debut WORK Medical Technology Group LTD Announces Partial Exercise of Underwriters’ Over-Allotment Option",0,0,0,0,1,-1
30.68M,"45,367",-80.15M,-1,8,2.420,Buy,4.00,"Aug 8, 2024",RPHM,"Reneo Pharmaceuticals, Inc.",51.81M,1.55,-,5.83%,3.42%,-30.27%,-2.01%,-14.62%,Reneo Pharmaceuticals reports Q2 EPS (16c) vs (65c) last year,,,,,Reneo Pharmaceuticals reports Q2 EPS (16c) vs (65c) last year,0,0,-1,-1,-1,-1
6.95M,105,1.44M,-1,48,10.68,,,,CLST,"Catalyst Bancorp, Inc.",51.78M,11.65,4.39M,-1.90%,-0.82%,0.18%,-3.14%,-1.19%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,98,,,,,CAPT,Captivision Inc.,51.68M,1.78,14.64M,3.64%,-15.34%,-54.54%,-9.09%,-67.24%,Captivision Elevates Mohegan Resort With Innovative Media Glass,Captivision announces collab with Mohegan INSPIRE resort,Captivision Announces Collaboration with Mohegan INSPIRE Entertainment Resort,,,Captivision Elevates Mohegan Resort With Innovative Media Glass Captivision announces collab with Mohegan INSPIRE resort Captivision Announces Collaboration with Mohegan INSPIRE Entertainment Resort,1,1,1,1,-1,-1
54.05M,"149,439",17.46M,-1,35,1.370,Strong Buy,7.00,"Aug 5, 2024",MSAI,"MultiSensor AI Holdings, Inc.",51.59M,2.17,7.51M,26.57%,27.55%,-37.89%,+40.56%,-30.15%,,,,,,,0,-1,-1,-1,-1,-1
7.68M,"17,597",6.11M,$0.55,113,9.75,,,"Aug 8, 2024",PRPH,"ProPhase Labs, Inc.",51.32M,2.69,17.97M,-12.76%,-28.35%,-49.16%,-23.53%,-65.59%,ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event,ProPhase Labs reports Q2 EPS (33c) vs (20c) last year,ProPhase Labs announces collaboration with Forward Heathcare Consultants,,,ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event ProPhase Labs reports Q2 EPS (33c) vs (20c) last year ProPhase Labs announces collaboration with Forward Heathcare Consultants,1,0,0,1,-1,-1
7.22M,"1,426","-15,975",-1,686,,,,,LVLU,"Lulu's Fashion Lounge Holdings, Inc.",51.32M,1.23,327.30M,3.11%,-14.24%,-23.68%,-17.20%,-9.72%,"Lulu’s Fashion Lounge Streamlines Board, Cuts Costs",Lulu’s Fashion Lounge cuts board size to six from 11,Lulus Announces Reduction in Size of its Board of Directors,"Analysts Conflicted on These Consumer Cyclical Names: Lulu’s Fashion Lounge Holdings (LVLU), Chewy (CHWY) and Amcor (AMCR)",Lulu’s Fashion Lounge Holdings (LVLU) Gets a Hold from Telsey Advisory,"Lulu’s Fashion Lounge Streamlines Board, Cuts Costs Lulu’s Fashion Lounge cuts board size to six from 11 Lulus Announces Reduction in Size of its Board of Directors Analysts Conflicted on These Consumer Cyclical Names: Lulu’s Fashion Lounge Holdings (LVLU), Chewy (CHWY) and Amcor (AMCR) Lulu’s Fashion Lounge Holdings (LVLU) Gets a Hold from Telsey Advisory",1,1,1,0,1,1
,,,-1,444,,,,,BWEN,"Broadwind, Inc.",51.23M,2.33,177.83M,-14.52%,-28.88%,-19.87%,-33.13%,-14.84%,Roth MKM Sticks to Its Buy Rating for Broadwind Energy (BWEN),Broadwind price target lowered to $4 from $5 at Craig-Hallum,Broadwind price target lowered to $3.50 from $4 at Roth MKM,"Analysts Are Bullish on Top Industrial Goods Stocks: Broadwind Energy (BWEN), Montrose Environmental Group (MEG)",Broadwind Energy: A Strong Buy on Operational Efficiency and Growth Outlook,"Roth MKM Sticks to Its Buy Rating for Broadwind Energy (BWEN) Broadwind price target lowered to $4 from $5 at Craig-Hallum Broadwind price target lowered to $3.50 from $4 at Roth MKM Analysts Are Bullish on Top Industrial Goods Stocks: Broadwind Energy (BWEN), Montrose Environmental Group (MEG) Broadwind Energy: A Strong Buy on Operational Efficiency and Growth Outlook",1,0,0,0,1,1
13.33M,"39,879",-20.60M,-1,70,5.51,,,"Jul 31, 2024",PDYN,Palladyne AI Corp.,51.13M,1.91,8.73M,1.97%,-4.28%,28.30%,-16.50%,-32.11%,,,,,,,0,-1,-1,-1,-1,-1
6.63M,"2,603","362,699",-1,"1,104",11.22,,,,RENT,"Rent the Runway, Inc.",50.99M,13.70,299.00M,3.65%,-17.70%,-8.41%,-19.46%,+151.05%,JMP Securities Sticks to Their Buy Rating for Rent the Runway (RENT),Rent The Runway price target lowered to $26 from $34 at Jefferies,Closing Bell Movers: Broadcom slips 7% after Q3 results,"Rent The Runway sees Q3 revenue $75M-$77M, consensus $75.57M",Rent The Runway narrows FY24 revenue view to up 2%-6% from up 1%-6%,"JMP Securities Sticks to Their Buy Rating for Rent the Runway (RENT) Rent The Runway price target lowered to $26 from $34 at Jefferies Closing Bell Movers: Broadcom slips 7% after Q3 results Rent The Runway sees Q3 revenue $75M-$77M, consensus $75.57M Rent The Runway narrows FY24 revenue view to up 2%-6% from up 1%-6%",0,1,0,0,1,1
,,,-1,43,,,,,FEAM,"5E Advanced Materials, Inc.",50.67M,0.80,-,-26.99%,-37.92%,-52.44%,-36.36%,-54.35%,5E Advanced Materials Ramps Up Boron Production and Secures Funding,"5E Advanced Materials, Inc. (FEAM) Gets a Buy from D.A. Davidson","5E Advanced Materials Provides Shareholder Update for the Quarter and Year Ended June 30, 2024",5E Advanced Materials to Host Fourth Quarter Conference Call for Fiscal Year 2024,5E Advanced Materials Announces Pricing of $4.0 Million Registered Direct Offering and Execution of Debt Commitment Letter to Issue $6.0 Million of Senior Secured Convertible Notes,"5E Advanced Materials Ramps Up Boron Production and Secures Funding 5E Advanced Materials, Inc. (FEAM) Gets a Buy from D.A. Davidson 5E Advanced Materials Provides Shareholder Update for the Quarter and Year Ended June 30, 2024 5E Advanced Materials to Host Fourth Quarter Conference Call for Fiscal Year 2024 5E Advanced Materials Announces Pricing of $4.0 Million Registered Direct Offering and Execution of Debt Commitment Letter to Issue $6.0 Million of Senior Secured Convertible Notes",0,0,0,0,0,0
60.48M,"2,805",-7.13M,-1,243,1.250,Buy,3.00,"Aug 6, 2024",NCSM,"NCS Multistage Holdings, Inc.",50.55M,20.20,147.07M,14.77%,21.55%,32.38%,+15.03%,+33.38%,,,,,,,0,-1,-1,-1,-1,-1
24.71M,"84,292",-42.11M,-1,10,2.960,Strong Buy,10.00,"Aug 12, 2024",BRFH,"Barfresh Food Group, Inc.",50.47M,3.42,8.82M,-5.44%,-6.60%,67.10%,-14.58%,+203.64%,Barfresh Food Group upgraded to Buy from Hold at Greenridge,Buy Rating Affirmed: Barfresh’s Strong Outlook and Strategic Expansion Despite Short-term Challenges,Barfresh Food Group’s Recent Regulatory Financial Disclosure,Barfresh Food Group sees ‘record’ FY24 revenue,Barfresh Food Group announces non-dilutive litigation financing,Barfresh Food Group upgraded to Buy from Hold at Greenridge Buy Rating Affirmed: Barfresh’s Strong Outlook and Strategic Expansion Despite Short-term Challenges Barfresh Food Group’s Recent Regulatory Financial Disclosure Barfresh Food Group sees ‘record’ FY24 revenue Barfresh Food Group announces non-dilutive litigation financing,0,0,0,0,0,0
6.41M,"8,804",2.60M,-1,,11.34,,,,AQU,Aquaron Acquisition Corp.,50.27M,11.04,-,0.80%,1.39%,4.22%,+1.19%,+3.85%,Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination,Aquaron Acquisition receives delisting notification from Nasdaq,Aquaron Acquisition Corp. Announces Receipt of Delisting Notification from Nasdaq,,,Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination Aquaron Acquisition receives delisting notification from Nasdaq Aquaron Acquisition Corp. Announces Receipt of Delisting Notification from Nasdaq,1,1,1,1,-1,-1
,,,-1,15,,,,,ALRN,"Aileron Therapeutics, Inc.",50.26M,2.32,-,11.99%,-7.37%,-34.45%,+7.73%,-58.13%,Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights,"Aileron Therapeutics reports Q2 EPS (45c), one estimate (42c)",,,,"Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights Aileron Therapeutics reports Q2 EPS (45c), one estimate (42c)",1,1,1,-1,-1,-1
50.94M,"13,615",-2.56M,-1,625,1.430,Strong Buy,6.00,"Oct 17, 2024",CMBM,Cambium Networks Corporation,50.22M,1.78,171.54M,-8.57%,-23.37%,-55.36%,-18.78%,-58.81%,Cambium Networks collaborates with nonprofits for digital equity in Chicago,Cambium Networks Hires New Global Controller and CAO,,,,Cambium Networks collaborates with nonprofits for digital equity in Chicago Cambium Networks Hires New Global Controller and CAO,0,0,1,-1,-1,-1
34.13M,"10,916","592,000",-1,21,2.120,Strong Buy,9.25,"Aug 13, 2024",LTRN,Lantern Pharma Inc.,50.06M,4.65,-,4.56%,-0.03%,-14.92%,-0.95%,-46.39%,,,,,,,0,-1,-1,-1,-1,-1
5.64M,"3,661",4.45M,$0.72,312,12.72,,,"Jul 24, 2024",SWVL,Swvl Holdings Corp.,49.99M,5.87,22.85M,-3.92%,-11.21%,-10.20%,-28.80%,-66.78%,,,,,,,0,-1,-1,-1,-1,-1
5.95M,"4,804",8.18M,$0.71,75,12.00,,,"Aug 7, 2024",IPW,iPower Inc.,49.84M,1.56,90.02M,-1.98%,-16.38%,38.41%,-19.88%,+202.27%,,,,,,,1,-1,-1,-1,-1,-1
48.09M,"34,577",-103.33M,-1,37,2.100,,,"Aug 8, 2024",LVTX,LAVA Therapeutics N.V.,49.70M,1.89,7.40M,-0.53%,-3.72%,-14.20%,-16.82%,-41.64%,LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,LAVA Therapeutics Faces Financial Hurdles,LAVA Reports Second Quarter 2024 Financial Results and Business Update,Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year,,LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference LAVA Therapeutics Faces Financial Hurdles LAVA Reports Second Quarter 2024 Financial Results and Business Update Lava Therapeutics reports Q2 EPS (31c) vs (48c) last year,1,0,0,0,1,-1
71.88M,"19,452",21.62M,-1,366,1.010,,,,MNY,MoneyHero Limited,49.68M,1.26,84.94M,-12.70%,-29.56%,-35.89%,-27.85%,-47.71%,MoneyHero Group to Announce Second Quarter 2024 Results,MoneyHero Proposes $8M Acquisition of MoneySmart,MoneyHero Group Announces Non-Binding Offer to Acquire MoneySmart,MoneyHero announces non-binding offer to acquire MoneySmart,,MoneyHero Group to Announce Second Quarter 2024 Results MoneyHero Proposes $8M Acquisition of MoneySmart MoneyHero Group Announces Non-Binding Offer to Acquire MoneySmart MoneyHero announces non-binding offer to acquire MoneySmart,0,0,1,1,0,-1
3.42M,"6,091",2.04M,-1,"1,050",20.95,,,"Oct 10, 2024",HSON,"Hudson Global, Inc.",49.44M,17.97,142.97M,-1.34%,1.30%,9.07%,-1.72%,-2.53%,,,,,,,1,-1,-1,-1,-1,-1
55.08M,"884,664",-149.24M,-1,87,1.300,Buy,10.50,"Aug 13, 2024",CPTN,"Cepton, Inc.",49.41M,3.08,21.16M,0.47%,10.21%,5.23%,+2.36%,-6.77%,Cepton’s Financial Review and Acquisition Outlook: A Hold Rating Justified,"Cepton reports Q2 adjusted EPS 3c, consensus (32c)",,,,"Cepton’s Financial Review and Acquisition Outlook: A Hold Rating Justified Cepton reports Q2 adjusted EPS 3c, consensus (32c)",0,0,0,-1,-1,-1
6.21M,722,5.58M,$1.00,,11.45,,,"Aug 8, 2024",GODN,Golden Star Acquisition Corporation,49.33M,10.88,-,-0.21%,0.42%,3.57%,+0.46%,+4.51%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,"1,695",,,,,PRTS,"CarParts.com, Inc.",49.08M,0.86,633.82M,-1.20%,-16.66%,-55.98%,-19.83%,-48.43%,,,,,,,1,-1,-1,-1,-1,-1
1.50M,12,2.56M,$0.72,162,48.49,,,"Oct 24, 2024",CRWS,"Crown Crafts, Inc.",49.08M,4.76,86.72M,-1.10%,-2.70%,-6.27%,-3.81%,-8.60%,Crown Crafts to Present at the 15th Annual Midwest IDEAS Investor Conference,Crown Crafts Announces Financial Results for First Quarter Fiscal 2025,"Crown Crafts to Announce First Quarter Fiscal Year 2025 Results on August 14, 2024",,,"Crown Crafts to Present at the 15th Annual Midwest IDEAS Investor Conference Crown Crafts Announces Financial Results for First Quarter Fiscal 2025 Crown Crafts to Announce First Quarter Fiscal Year 2025 Results on August 14, 2024",0,1,0,0,-1,-1
7.09M,"10,125","-14,179",-1,,,,,,MARX,Mars Acquisition Corp.,48.91M,10.93,-,0.06%,0.81%,2.89%,+1.23%,+2.56%,Mars to acquire snack maker Kellanova in $36 billion deal,Mars Acquisition Corp. Announces Strategic Merger with ScanTech AI,,,,Mars to acquire snack maker Kellanova in $36 billion deal Mars Acquisition Corp. Announces Strategic Merger with ScanTech AI,1,1,1,-1,-1,-1
,,,-1,69,,,,,FKWL,Franklin Wireless Corp.,48.90M,4.15,41.68M,0.69%,7.00%,28.64%,-4.88%,+39.59%,,,,,,,1,-1,-1,-1,-1,-1
75.74M,"384,608",-123.06M,-1,178,0.960,,,"Aug 29, 2024",HOUR,"Hour Loop, Inc.",48.83M,1.39,141.39M,13.89%,25.87%,8.14%,+23.00%,+26.80%,,,,,,,1,-1,-1,-1,-1,-1
42.12M,"4,816",9.44M,-1,86,1.650,,,,BCOW,"1895 Bancorp of Wisconsin, Inc.",48.79M,8.78,9.90M,0.96%,5.97%,21.38%,-3.21%,+31.51%,,,,,,,1,-1,-1,-1,-1,-1
6.71M,"15,589",5.97M,$0.22,73,10.58,,,"Aug 15, 2024",AWRE,"Aware, Inc.",48.72M,2.30,19.50M,-0.83%,10.12%,25.51%,+7.66%,+25.00%,,,,,,,0,-1,-1,-1,-1,-1
6.27M,"1,808",-1.41M,-1,8,11.24,,,,SHOT,"Safety Shot, Inc.",48.70M,0.94,1.03M,13.95%,-9.84%,-59.73%,+19.96%,-55.36%,"Safety Shot Secures U.S. Patent, Enhances Market Leadership",Safety Shot announces Notice of Allowance of for a U.S. patent,Safety Shot announces notice of allowance for new patent to secure IP,Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims,Safety Shot Secures Funding for Wellness Drink Expansion,"Safety Shot Secures U.S. Patent, Enhances Market Leadership Safety Shot announces Notice of Allowance of for a U.S. patent Safety Shot announces notice of allowance for new patent to secure IP Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims Safety Shot Secures Funding for Wellness Drink Expansion",0,0,0,0,0,0
,,,-1,90,,,,,KPLT,"Katapult Holdings, Inc.",48.57M,11.65,236.29M,-16.85%,-22.85%,-4.62%,-37.92%,+26.82%,Katapult to Participate in H.C. Wainwright 26th Annual Global Investment Conference,Katapult Holdings Elevates Derek Medlin to President,"Katapult promotes Medlin to President, CGO",Katapult Promotes Derek Medlin to President and Chief Growth Officer,Katapult price target lowered to $15 from $20 at Loop Capital,"Katapult to Participate in H.C. Wainwright 26th Annual Global Investment Conference Katapult Holdings Elevates Derek Medlin to President Katapult promotes Medlin to President, CGO Katapult Promotes Derek Medlin to President and Chief Growth Officer Katapult price target lowered to $15 from $20 at Loop Capital",0,0,1,1,1,1
44.21M,"51,397",-15.35M,-1,73,1.590,,,"Sep 6, 2024",AGAE,Allied Gaming & Entertainment Inc.,48.50M,1.27,8.21M,-1.06%,1.32%,23.23%,-20.26%,+27.08%,,,,,,,1,-1,-1,-1,-1,-1
45.64M,"32,809",-25.20M,-1,75,1.540,Strong Buy,3.67,"Aug 7, 2024",CPBI,"Central Plains Bancshares, Inc.",48.33M,11.70,17.81M,1.96%,8.64%,14.00%,+4.11%,+15.72%,,,,,,,0,-1,-1,-1,-1,-1
7.23M,"76,082",16.97M,-1,,9.69,Strong Buy,39.50,"Aug 1, 2024",ALSA,Alpha Star Acquisition Corporation,48.23M,11.74,-,-0.37%,1.67%,6.34%,+1.29%,+6.12%,,,,,,,0,-1,-1,-1,-1,-1
9.86M,"9,332",8.41M,-1,,7.08,,,"Aug 8, 2024",ESLA,"Estrella Immunopharma, Inc.",48.20M,1.33,-,-22.23%,-16.28%,-6.43%,-24.36%,+2.61%,"Estrella Immunopharma Welcomes New Chairperson, Expands Board",Estrella Immunopharma names Hong Zhang as chairperson,,,,"Estrella Immunopharma Welcomes New Chairperson, Expands Board Estrella Immunopharma names Hong Zhang as chairperson",1,0,1,-1,-1,-1
13.39M,"16,890",-36.89M,-1,,5.20,,,"Sep 3, 2024",VSAC,Vision Sensing Acquisition Corp.,48.19M,11.65,-,0.30%,2.24%,7.41%,+0.61%,+7.99%,"Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024","Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to October 3, 2024",Vision Sensing Acquisition extends period to enter business combination,"Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc.","Vision Sensing Acquisition, Mediforum terminate merger agreement","Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to October 3, 2024 Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to October 3, 2024 Vision Sensing Acquisition extends period to enter business combination Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc. Vision Sensing Acquisition, Mediforum terminate merger agreement",1,1,1,1,1,0
,,,-1,,,,,,TRSG,Tungray Technologies Inc.,48.08M,2.94,14.36M,3.19%,-10.77%,-30.86%,-1.85%,,,,,,,,0,-1,-1,-1,-1,-1
21.98M,"35,363",-196.30M,-1,5,3.250,,,"Sep 3, 2024",LEXX,Lexaria Bioscience Corp.,47.90M,3.03,411.02K,-14.51%,-6.00%,10.55%,-28.61%,-4.26%,Lexaria Bioscience Appoints New CEO for Growth Era,Lexaria Bioscience Ushers in New Leadership and Focus,"Lexaria Bioscience CEO Chris Bunka steps down, Richard Christopher to succeed",Lexaria Bioscience Advances Drug Delivery with PharmaCO Partnership,Lexaria Bioscience enters material transfer agreement for DehydraTECH research,"Lexaria Bioscience Appoints New CEO for Growth Era Lexaria Bioscience Ushers in New Leadership and Focus Lexaria Bioscience CEO Chris Bunka steps down, Richard Christopher to succeed Lexaria Bioscience Advances Drug Delivery with PharmaCO Partnership Lexaria Bioscience enters material transfer agreement for DehydraTECH research",1,1,1,1,1,1
6.43M,"3,242","520,671",-1,4,10.80,,,,RAND,Rand Capital Corporation,47.85M,18.54,7.87M,7.86%,15.08%,32.72%,+10.80%,+39.06%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,29,,,,,ELEV,"Elevation Oncology, Inc.",47.81M,0.81,-,-35.19%,-63.60%,-70.90%,-72.10%,-85.05%,,,,,,,1,-1,-1,-1,-1,-1
39.98M,"2,280",9.66M,-1,186,1.720,,,"Aug 14, 2024",FBIO,"Fortress Biotech, Inc.",47.68M,2.09,82.62M,6.37%,5.78%,1.37%,-2.39%,+9.09%,Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference,"Fortress Biotech reports Q2 EPS (73c), consensus ($1.22)",Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights,"Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference Fortress Biotech reports Q2 EPS (73c), consensus ($1.22) Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights",1,1,0,0,1,1
47.62M,"61,305",-19.28M,-1,99,1.460,,,"Oct 14, 2024",PPSI,"Pioneer Power Solutions, Inc.",47.49M,4.35,41.49M,-2.92%,-1.99%,-11.41%,-10.23%,-2.05%,,,,,,,1,-1,-1,-1,-1,-1
5.93M,2,1.16M,-1,15,12.00,,,,DGHI,Digihost Technology Inc.,47.36M,1.45,38.33M,15.22%,5.84%,-6.30%,-0.74%,-7.59%,Digihost provides Bitcoin production results for August,Digihost Announces 50% Increase in Cash and Crypto Position Over Previous Month-End and Provides August 2024 Production Update,Digihost Completes $4M Fundraising for Expansion,Digihost Announces Closing of US$4 Million Private Placement,Digihost Technology Reports Significant Revenue Growth,Digihost provides Bitcoin production results for August Digihost Announces 50% Increase in Cash and Crypto Position Over Previous Month-End and Provides August 2024 Production Update Digihost Completes $4M Fundraising for Expansion Digihost Announces Closing of US$4 Million Private Placement Digihost Technology Reports Significant Revenue Growth,0,0,0,1,1,1
,,,-1,281,,,,,DWSN,Dawson Geophysical Company,47.29M,1.53,91.32M,-12.48%,-17.53%,-2.06%,-21.54%,-7.83%,DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2024 RESULTS,,,,,DAWSON GEOPHYSICAL REPORTS SECOND QUARTER 2024 RESULTS,1,1,-1,-1,-1,-1
36.95M,"79,812",11.16M,-1,107,1.860,,,"Aug 8, 2024",RECT,Rectitude Holdings Ltd,47.11M,3.25,30.67M,2.34%,-1.79%,-1.79%,-3.20%,,,,,,,,1,-1,-1,-1,-1,-1
15.76M,"1,078,763",-40.84M,-1,107,4.340,Strong Buy,11.63,"Aug 22, 2024",CARM,"Carisma Therapeutics, Inc.",46.95M,1.13,20.71M,10.96%,1.72%,-39.60%,+8.41%,-36.26%,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX)","Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)",,,,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Carisma Therapeutics (CARM) and Recursion Pharmaceuticals (RXRX) Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Arcellx Inc (ACLX)",0,1,1,-1,-1,-1
2.97M,641,3.60M,-1,"5,447",22.82,,,"Aug 13, 2024",KTCC,Key Tronic Corporation,46.92M,4.36,559.40M,6.20%,10.92%,2.97%,+16.02%,-4.06%,Key Tronic says most unfulfilled orders recoverable in FY25,Key Tronic reports Q4 adjusted EPS 10c vs. 9c last year,Key Tronic Corporation Announces Results for the Fourth Quarter of Fiscal Year 2024,,,Key Tronic says most unfulfilled orders recoverable in FY25 Key Tronic reports Q4 adjusted EPS 10c vs. 9c last year Key Tronic Corporation Announces Results for the Fourth Quarter of Fiscal Year 2024,1,0,1,0,-1,-1
10.05M,"819,810",-253.38M,-1,130,6.77,Hold,4.00,"Sep 3, 2024",BRNS,Barinthus Biotherapeutics plc,46.90M,1.19,-,-6.94%,-11.30%,-48.17%,-14.43%,-61.36%,Barinthus Biotherapeutics Elevates Griffiths to COO,Barclays Remains a Buy on Barinthus Biotherapeutics (BRNS),Barinthus price target lowered to $9.50 from $11 at Alliance Global Partners,Wall Street Analysts Are Bullish on Top Healthcare Picks,,Barinthus Biotherapeutics Elevates Griffiths to COO Barclays Remains a Buy on Barinthus Biotherapeutics (BRNS) Barinthus price target lowered to $9.50 from $11 at Alliance Global Partners Wall Street Analysts Are Bullish on Top Healthcare Picks,0,0,0,0,1,-1
67.34M,"3,525",-10.13M,-1,43,1.020,,,"Sep 3, 2024",RLYB,Rallybio Corporation,46.88M,1.13,299.00K,5.62%,-4.18%,-30.25%,-16.55%,-28.83%,Buy Rating on Rallybio Stock Fueled by Promising RLYB212 Trial Outcomes and Potential FNAIT Treatment Breakthrough,Buy Rating on Rallybio: Promising RLYB212 Developments Signal Strong Market Potential,Rallybio announces data from Phase 1 PoC sudy of RLYB212,Rallybio price target lowered to $6 from $9 at H.C. Wainwright,,Buy Rating on Rallybio Stock Fueled by Promising RLYB212 Trial Outcomes and Potential FNAIT Treatment Breakthrough Buy Rating on Rallybio: Promising RLYB212 Developments Signal Strong Market Potential Rallybio announces data from Phase 1 PoC sudy of RLYB212 Rallybio price target lowered to $6 from $9 at H.C. Wainwright,0,0,1,0,0,-1
5.22M,"15,786",-1.07M,-1,"3,600",13.00,,,,CCLD,"CareCloud, Inc.",46.86M,2.89,111.75M,12.01%,21.79%,61.73%,+29.58%,+130.00%,CareCloud (CCLD) Receives a Buy from Benchmark Co.,CareCloud Shareholders Address Preferred Stock Changes,"Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th",Buy Rating Affirmed: CareCloud’s Financial Strength and Attractive Valuation Signal Growth Potential,Roth MKM Keeps Their Buy Rating on CareCloud (CCLD),"CareCloud (CCLD) Receives a Buy from Benchmark Co. CareCloud Shareholders Address Preferred Stock Changes Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th Buy Rating Affirmed: CareCloud’s Financial Strength and Attractive Valuation Signal Growth Potential Roth MKM Keeps Their Buy Rating on CareCloud (CCLD)",1,1,0,0,1,0
,,,-1,5,,,,,BGXX,Bright Green Corporation,46.84M,0.25,-,-5.68%,-11.92%,-12.13%,-11.28%,-16.87%,"BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.",Bright Green enters partnership with Benuvia Pharmaceuticals,BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.,,,"BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY. Bright Green enters partnership with Benuvia Pharmaceuticals BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.",1,1,1,1,-1,-1
6.01M,948,"-242,739",-1,60,11.25,,,,OPHC,"OptimumBank Holdings, Inc.",46.74M,4.83,30.17M,0.78%,4.81%,11.74%,+4.71%,+10.93%,"Two Weeks Away, Two Panels, One Place: The Best of the Best in Economics at the Inaugural Virtual Banking Conference on September 12, 2024, via Live Webcast",OptimumBank announces inaugural Virtual Banking Conference,OptimumBank Holdings files to sell $25M of common stock,,,"Two Weeks Away, Two Panels, One Place: The Best of the Best in Economics at the Inaugural Virtual Banking Conference on September 12, 2024, via Live Webcast OptimumBank announces inaugural Virtual Banking Conference OptimumBank Holdings files to sell $25M of common stock",1,0,1,1,-1,-1
,,,-1,32,,,,,ELTX,"Elicio Therapeutics, Inc.",46.70M,4.34,-,-11.61%,-18.26%,-35.27%,-23.17%,-55.03%,Elicio Therapeutics CFO Brian Piekos Resigns Amicably,Elicio Therapeutics: A Strong Buy on Improved Financials and Promising Clinical Trials,Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates,,,Elicio Therapeutics CFO Brian Piekos Resigns Amicably Elicio Therapeutics: A Strong Buy on Improved Financials and Promising Clinical Trials Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates,1,1,1,0,-1,-1
5.78M,,1.05M,-1,46,11.53,,,,HOLO,MicroCloud Hologram Inc.,46.69M,0.57,28.71M,4.16%,-31.94%,-89.84%,-23.96%,-89.68%,"3 Penny Stocks to Watch Now, 9/05/24",MicroCloud Hologram Launches Convertible Notes,"3 Penny Stocks to Watch Now, 8/22/24",MicroCloud Hologram Unveils Convertible Securities Deal,MicroCloud Faces Nasdaq Minimum Bid Hurdle,"3 Penny Stocks to Watch Now, 9/05/24 MicroCloud Hologram Launches Convertible Notes 3 Penny Stocks to Watch Now, 8/22/24 MicroCloud Hologram Unveils Convertible Securities Deal MicroCloud Faces Nasdaq Minimum Bid Hurdle",0,0,0,0,0,0
,,,-1,,,,,,ICMB,"Investcorp Credit Management BDC, Inc.",46.66M,3.24,25.36M,-1.37%,-2.64%,-2.78%,-3.99%,-1.67%,"Is ICMB a Buy, Before Earnings?",,,,,"Is ICMB a Buy, Before Earnings?",0,1,-1,-1,-1,-1
4.96M,"8,011",-1.17M,-1,277,12.33,,,"Aug 15, 2024",FLNT,"Fluent, Inc.",46.57M,2.76,263.70M,-4.94%,-13.76%,-15.75%,-15.85%,-10.17%,"Fluent, Inc. to Participate in the 17th Annual Barrington Research Virtual Fall Investment Conference",Fluent files $50M mixed securities shelf,Analysts Offer Insights on Communication Services Companies: IHS Holding (IHS) and Fluent (FLNT),Fluent Inc.: Hold Rating Amidst Revenue Decline and Strategic Shifts,Fluent price target lowered to $4 from $4.50 at Canaccord,"Fluent, Inc. to Participate in the 17th Annual Barrington Research Virtual Fall Investment Conference Fluent files $50M mixed securities shelf Analysts Offer Insights on Communication Services Companies: IHS Holding (IHS) and Fluent (FLNT) Fluent Inc.: Hold Rating Amidst Revenue Decline and Strategic Shifts Fluent price target lowered to $4 from $4.50 at Canaccord",1,0,0,0,1,0
,,,-1,58,,,,,PASG,"Passage Bio, Inc.",46.50M,0.75,-,-7.60%,-14.44%,-29.37%,-20.22%,-50.35%,Passage Bio initiated with a Buy at Rodman & Renshaw,Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference,,,,Passage Bio initiated with a Buy at Rodman & Renshaw Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference,1,0,0,-1,-1,-1
5.98M,351,4.09M,-1,1,11.39,,,,CTRM,Castor Maritime Inc.,46.48M,4.81,84.44M,-2.82%,0.43%,12.43%,-13.15%,+28.14%,Castor Maritime Inc. Announces Delivery of the M/V Magic Celeste,Castor Maritime announces delivery of M/V Magic Celeste,,,,Castor Maritime Inc. Announces Delivery of the M/V Magic Celeste Castor Maritime announces delivery of M/V Magic Celeste,0,0,0,-1,-1,-1
,,,-1,,,,,,ACAC,Acri Capital Acquisition Corporation,46.47M,11.70,-,-0.87%,0.57%,4.00%,+16.29%,+22.33%,ACRI Capital Acquisition Corp trading resumes,"ACRI Capital Acquisition Corp trading halted, volatility trading pause",Acri Capital Acquisition’s Strategic Merger and Expansion,Acri Capital Acquisition Corporation and Foxx Development Inc. Announce Business Combination Approval by Acri Capital Acquisition Corporation Stockholders,,"ACRI Capital Acquisition Corp trading resumes ACRI Capital Acquisition Corp trading halted, volatility trading pause Acri Capital Acquisition’s Strategic Merger and Expansion Acri Capital Acquisition Corporation and Foxx Development Inc. Announce Business Combination Approval by Acri Capital Acquisition Corporation Stockholders",0,0,0,0,0,-1
8.99M,"6,677",2.82M,-1,47,7.33,,,,ADD,"Color Star Technology Co., Ltd.",46.39M,0.87,1.06M,39.33%,128.78%,180.32%,+113.59%,+196.94%,Color Star Technology Proposes Share Consolidation,Color Star Announces the Appointment of New Vice President,Color Star Technology Schedules Key AGM,Color Star Announces Unregistered Share Offering,Color Star Technology files $100M mixed securities shelf,Color Star Technology Proposes Share Consolidation Color Star Announces the Appointment of New Vice President Color Star Technology Schedules Key AGM Color Star Announces Unregistered Share Offering Color Star Technology files $100M mixed securities shelf,0,0,1,0,0,0
25.45M,"49,888",-13.90M,-1,"1,993",2.640,,,"Jul 25, 2024",ARKR,Ark Restaurants Corp.,46.35M,12.86,184.54M,-0.63%,-6.49%,-11.61%,-0.97%,-4.95%,ARK Restaurants reports Q2 EPS 18c vs. 88c last year,,,,,ARK Restaurants reports Q2 EPS 18c vs. 88c last year,0,1,-1,-1,-1,-1
3.49M,"5,717","608,000",$1.08,46,18.85,,,"Jul 23, 2024",NSTS,"NSTS Bancorp, Inc.",46.18M,10.00,5.57M,-2.96%,-1.32%,3.54%,-4.95%,+3.84%,,,,,,,1,-1,-1,-1,-1,-1
5.62M,502,1.47M,-1,17,11.65,,,,GOVX,"GeoVax Labs, Inc.",46.07M,6.39,300.68K,54.83%,91.36%,79.58%,+140.38%,+164.55%,GeoVax to Participate in Upcoming Investor Conferences in September,GeoVax Labs Accelerates Capital Raise with Multiple Offerings,GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market,"Mpox case reported at Clark County Detention Center, LV Review-Journal says",GeoVax Labs Secures Growth Funding Through Equity Sales,"GeoVax to Participate in Upcoming Investor Conferences in September GeoVax Labs Accelerates Capital Raise with Multiple Offerings GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market Mpox case reported at Clark County Detention Center, LV Review-Journal says GeoVax Labs Secures Growth Funding Through Equity Sales",0,0,0,1,0,0
,,,-1,20,,,,,CETY,"Clean Energy Technologies, Inc.",45.91M,1.03,13.55M,-2.03%,-12.27%,-16.13%,unch,-27.85%,Clean Energy Technologies signs service agreement with Green Energy Ventures,"Clean Energy Technologies, Inc. Expands Waste Heat to Power Operations to Brazil Through Strategic Partnership with Green Energy Ventures",,,,"Clean Energy Technologies signs service agreement with Green Energy Ventures Clean Energy Technologies, Inc. Expands Waste Heat to Power Operations to Brazil Through Strategic Partnership with Green Energy Ventures",1,1,1,-1,-1,-1
5.82M,1,"-530,902",-1,12,11.24,,,,AKTX,"Akari Therapeutics, Plc",45.90M,3.84,-,4.93%,8.37%,44.12%,-1.81%,+169.50%,Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights,Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy,Akari receives positive Pre-IND feedback from FDA for PAS-nomacopan,,,Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of Geographic Atrophy Akari receives positive Pre-IND feedback from FDA for PAS-nomacopan,1,0,0,0,-1,-1
,,,-1,58,,,,,KZR,"Kezar Life Sciences, Inc.",45.87M,0.63,7.00M,4.28%,2.29%,-19.82%,-5.48%,-22.96%,Buy Rating Affirmed for Kezar Life Sciences Amidst Strong Clinical Progress and Strategic Focus,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Achieve Life Sciences (ACHV) and Kezar Life Sciences (KZR)",Buy Rating on Kezar Life Sciences Backed by Promising Zetomipzomib Clinical Trials,"Kezar Life Sciences reports Q2 EPS (30c), consensus (32c)",,"Buy Rating Affirmed for Kezar Life Sciences Amidst Strong Clinical Progress and Strategic Focus Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Achieve Life Sciences (ACHV) and Kezar Life Sciences (KZR) Buy Rating on Kezar Life Sciences Backed by Promising Zetomipzomib Clinical Trials Kezar Life Sciences reports Q2 EPS (30c), consensus (32c)",1,0,1,0,0,-1
22.48M,"74,067",-39.38M,-1,128,2.910,,,"Oct 8, 2024",EHGO,Eshallgo Inc.,45.86M,2.11,16.96M,17.97%,12.34%,12.34%,+22.42%,,,,,,,,1,-1,-1,-1,-1,-1
53.13M,"130,466",-152.38M,-1,,1.230,,,"Aug 8, 2024",BNIX,Bannix Acquisition Corp.,45.47M,11.14,-,0.60%,1.07%,4.08%,+1.55%,+4.10%,Bannix Acquisition Corp. Extends Deadline for Business Deal,Bannix Acquisition announces monthly extension to complete business combination,Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination,,,Bannix Acquisition Corp. Extends Deadline for Business Deal Bannix Acquisition announces monthly extension to complete business combination Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination,1,1,1,1,-1,-1
48.00M,"33,341",-103.33M,-1,152,1.360,,,"Aug 8, 2024",CREX,"Creative Realities, Inc.",45.44M,4.35,51.43M,3.46%,-0.34%,30.06%,-8.52%,+26.44%,Creative Realities price target raised to $7 from $6.50 at Alliance Global,Creative Realities reports Q2 EPS (6c) vs (19c) last year,Creative Realities (CREX) Gets a Buy from Craig-Hallum,CREX Upcoming Earnings Report: What to Expect?,,Creative Realities price target raised to $7 from $6.50 at Alliance Global Creative Realities reports Q2 EPS (6c) vs (19c) last year Creative Realities (CREX) Gets a Buy from Craig-Hallum CREX Upcoming Earnings Report: What to Expect?,0,0,0,0,1,-1
68.40M,"525,983",-118.09M,-1,,0.954,Strong Buy,10.92,"Aug 8, 2024",INTE,Integral Acquisition Corporation 1,45.30M,11.12,-,0.03%,0.78%,3.17%,+0.73%,+3.26%,,,,,,,1,-1,-1,-1,-1,-1
15.75M,"2,288",1.72M,-1,344,4.140,,,"Oct 10, 2024",BNGO,"Bionano Genomics, Inc.",45.23M,0.53,36.58M,0.97%,-14.24%,-51.72%,-25.42%,-53.12%,Bionano Genomics downgraded at Scotiabank on limited capital market visibility,Bionano Genomics downgraded to Sector Perform from Outperform at Scotiabank,Buy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial Planning,Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO),,Bionano Genomics downgraded at Scotiabank on limited capital market visibility Bionano Genomics downgraded to Sector Perform from Outperform at Scotiabank Buy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial Planning Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO),1,1,1,1,1,-1
94.21M,"501,323",-28.92M,-1,17,0.690,Strong Buy,8.75,"Sep 3, 2024",PALT,"Paltalk, Inc.",45.19M,4.90,10.28M,12.69%,13.02%,34.78%,+2.35%,+46.48%,Maxim Group Reaffirms Their Hold Rating on Paltalk (PALT),"Paltalk Holdings, Inc. Awarded $65.7 Million Jury Verdict Against Cisco Systems Inc.",Paltalk awarded $65.7M jury verdict against Cisco Systems in patent suit,Paltalk Inc trading resumes,"Paltalk Inc trading halted, volatility trading pause","Maxim Group Reaffirms Their Hold Rating on Paltalk (PALT) Paltalk Holdings, Inc. Awarded $65.7 Million Jury Verdict Against Cisco Systems Inc. Paltalk awarded $65.7M jury verdict against Cisco Systems in patent suit Paltalk Inc trading resumes Paltalk Inc trading halted, volatility trading pause",1,1,1,1,0,0
5.69M,11,1.44M,-1,82,11.41,,,,NXTC,"NextCure, Inc.",45.04M,1.61,-,-0.63%,-0.88%,6.45%,-2.47%,-27.52%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,252,,,,,APYX,Apyx Medical Corporation,45.04M,1.30,49.03M,9.87%,1.67%,-25.42%,-2.94%,-12.00%,Apyx Medical price target lowered to $6 from $8 at Craig-Hallum,Lake Street Sticks to Its Buy Rating for Apyx Medical (APYX),,,,Apyx Medical price target lowered to $6 from $8 at Craig-Hallum Lake Street Sticks to Its Buy Rating for Apyx Medical (APYX),0,0,0,-1,-1,-1
12.40M,880,-9.36M,-1,315,5.17,Strong Buy,23.50,"Oct 18, 2024",CENN,Cenntro Inc.,45.01M,1.46,26.08M,-2.23%,-11.49%,-10.81%,-15.69%,-23.67%,,,,,,,1,-1,-1,-1,-1,-1
54.60M,"148,661",-38.29M,$0.10,,1.180,Strong Buy,1.35,"Aug 13, 2024",FORL,Four Leaf Acquisition Corporation,44.90M,11.01,-,0.16%,0.55%,3.15%,+0.41%,+3.53%,,,,,,,1,-1,-1,-1,-1,-1
12.05M,"10,200",-48.60M,-1,"2,500",5.32,Strong Buy,39.40,"Aug 8, 2024",GENK,"GEN Restaurant Group, Inc.",44.88M,9.23,195.29M,12.55%,10.64%,8.80%,+12.72%,-16.95%,"GEN Restaurant Group, Inc. Announces September Investor Marketing Schedule",,,,,"GEN Restaurant Group, Inc. Announces September Investor Marketing Schedule",1,1,-1,-1,-1,-1
15.23M,"37,239",-100.47M,-1,,4.210,Strong Buy,16.25,"Sep 3, 2024",NOVV,Nova Vision Acquisition Corporation,44.81M,12.70,-,-0.04%,2.33%,11.14%,+0.83%,+8.52%,"Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to September 10, 2024",,,,,"Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to September 10, 2024",0,1,-1,-1,-1,-1
35.96M,"3,810,110",-15.92M,-1,69,1.780,Strong Buy,6.00,"Aug 14, 2024",ICAD,"iCAD, Inc.",44.80M,1.70,18.80M,8.65%,14.69%,3.58%,+17.42%,-3.73%,Buy Rating Affirmed for iCAD on Strong Financials and Cloud Platform Success,"iCAD reports Q2 EPS (7c), consensus (7c)",Craig-Hallum Sticks to Their Buy Rating for iCAD (ICAD),,,"Buy Rating Affirmed for iCAD on Strong Financials and Cloud Platform Success iCAD reports Q2 EPS (7c), consensus (7c) Craig-Hallum Sticks to Their Buy Rating for iCAD (ICAD)",0,0,1,0,-1,-1
20.53M,"135,864",-2.57M,$1.20,27,3.100,Sell,3.50,"Aug 6, 2024",TARA,"Protara Therapeutics, Inc.",44.77M,2.17,-,-0.00%,-5.45%,-20.78%,-10.76%,-45.18%,Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Protara Therapeutics price target lowered to $25 from $30 at Oppenheimer,,,,Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference Protara Therapeutics price target lowered to $25 from $30 at Oppenheimer,0,0,0,-1,-1,-1
5.83M,650,1.35M,-1,57,10.91,,,,EYEN,"Eyenovia, Inc.",44.76M,0.58,31.41K,-33.95%,-37.40%,-53.32%,-58.68%,-41.97%,Eyenovia announces Formosa granted Taiwan Export License,Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.,Eyenovia Announces CFO Transition and New Financial Leadership,Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer,Eyenovia Announces Closing of Public Offering,Eyenovia announces Formosa granted Taiwan Export License Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S. Eyenovia Announces CFO Transition and New Financial Leadership Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer Eyenovia Announces Closing of Public Offering,0,1,0,0,1,0
,,,-1,,,,,,KACL,Kairous Acquisition Corp. Limited,44.76M,12.15,-,1.26%,3.13%,12.36%,+4.11%,+13.66%,Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination,Kairous Acquisition announces additional contribution to trust account,,,,Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination Kairous Acquisition announces additional contribution to trust account,1,1,1,-1,-1,-1
88.85M,"773,670",-206.00M,-1,,0.715,Hold,1.67,"Aug 7, 2024",GLST,"Global Star Acquisition, Inc.",44.67M,11.03,-,0.09%,-0.07%,2.82%,-0.09%,+3.47%,,,,,,,1,-1,-1,-1,-1,-1
27.00M,"33,437,307","-190,579",-1,5,2.350,,,"Sep 3, 2024",CMCT,Creative Media & Community Trust Corporation,44.66M,1.96,126.53M,-5.47%,-14.77%,-38.33%,-7.90%,-49.30%,,,,,,,1,-1,-1,-1,-1,-1
37.43M,"1,042",-1.63M,-1,69,1.590,,,,DRCT,"Direct Digital Holdings, Inc.",44.62M,3.11,157.11M,-3.19%,-13.76%,-65.85%,-29.26%,-75.65%,Direct Digital Holdings Faces Nasdaq Compliance Challenges,Direct Digital receives additional delinquency notice from Nasdaq,,,,Direct Digital Holdings Faces Nasdaq Compliance Challenges Direct Digital receives additional delinquency notice from Nasdaq,1,0,0,-1,-1,-1
12.22M,"29,177",-60.89M,-1,,5.210,Buy,9.00,"Sep 13, 2024",YOTA,Yotta Acquisition Corporation,44.58M,11.30,-,0.12%,1.24%,5.12%,+0.63%,+7.73%,"Yotta Acquisition Corporation Announces Entering into a Merger Agreement with DRIVEiT Financial Auto Group, Inc., an Operator of Electric Vehicle Superstores",,,,,"Yotta Acquisition Corporation Announces Entering into a Merger Agreement with DRIVEiT Financial Auto Group, Inc., an Operator of Electric Vehicle Superstores",0,1,-1,-1,-1,-1
13.59M,"3,345",-7.28M,-1,48,4.800,Buy,7.50,"Sep 11, 2024",HKIT,Hitek Global Inc.,44.54M,1.52,4.56M,22.96%,10.99%,19.54%,+12.11%,+1.89%,Hitek Global files to sell up to $20M of Class A ordinary shares,Hitek Global files to sell 14.9M Class A ordinary shares for holders,Hitek Global Announces New Share Purchase Warrants,,,Hitek Global files to sell up to $20M of Class A ordinary shares Hitek Global files to sell 14.9M Class A ordinary shares for holders Hitek Global Announces New Share Purchase Warrants,1,1,1,1,-1,-1
5.86M,"32,929",-141.65M,-1,68,10.76,Hold,8.50,"Sep 10, 2024",SYRS,"Syros Pharmaceuticals, Inc.",44.50M,1.66,4.15M,-55.73%,-67.76%,-71.10%,-73.50%,-65.95%,Syros Pharmaceuticals Reports SELECT-AML-1 Trial Outcomes,Biotech Alert: Searches spiking for these stocks today,TD Cowen Keeps Their Buy Rating on Syros Pharmaceuticals (SYRS),Piper Sandler Keeps Their Buy Rating on Syros Pharmaceuticals (SYRS),Optimistic Outlook for Syros Pharmaceuticals’ SELECT-MDS-1 Study Despite SELECT-AML-1 Setback,Syros Pharmaceuticals Reports SELECT-AML-1 Trial Outcomes Biotech Alert: Searches spiking for these stocks today TD Cowen Keeps Their Buy Rating on Syros Pharmaceuticals (SYRS) Piper Sandler Keeps Their Buy Rating on Syros Pharmaceuticals (SYRS) Optimistic Outlook for Syros Pharmaceuticals’ SELECT-MDS-1 Study Despite SELECT-AML-1 Setback,0,0,1,0,0,0
167.84M,"420,132",-99.74M,-1,117,0.375,Strong Buy,2.00,"May 20, 2024",TACT,TransAct Technologies Incorporated,44.49M,4.45,52.74M,3.18%,9.87%,-20.95%,+4.51%,-15.07%,TransAct Technologies Reinforces Leadership with New Executive Agreements,"CasinoTrac, TransAct report results from SlotSUITE deployment",Transact Technologies (TACT) Receives a Buy from Craig-Hallum,,,"TransAct Technologies Reinforces Leadership with New Executive Agreements CasinoTrac, TransAct report results from SlotSUITE deployment Transact Technologies (TACT) Receives a Buy from Craig-Hallum",1,1,0,0,-1,-1
7.69M,"11,153",-10.28M,-1,58,8.18,Strong Buy,14.00,"Aug 14, 2024",DRRX,DURECT Corporation,44.39M,1.43,8.41M,2.75%,-0.20%,37.67%,-14.72%,+49.19%,Durect files $250M mixed securities shelf,"Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Durect (DRRX) and Globus Medical (GMED)",DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update,"Durect reports Q2 EPS (12c), consensus (17c)",,"Durect files $250M mixed securities shelf Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Durect (DRRX) and Globus Medical (GMED) DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update Durect reports Q2 EPS (12c), consensus (17c)",0,0,0,0,1,-1
37.86M,"285,170",-35.39M,-1,70,1.660,Buy,,"Aug 8, 2024",LUCD,Lucid Diagnostics Inc.,44.22M,0.82,3.80M,-1.33%,-1.49%,-25.10%,-2.19%,-15.92%,Lucid Diagnostics partnering with Front Line Mobile Health in esophageal cancer,Lucid Diagnostics’ EsoGuard cancer diagnosis test highlighted in publication,Buy Rating Affirmed for Lucid Diagnostics Amidst Growth and Strategic Advances,PAVmed Provides Business Update and Second Quarter 2024 Financial Results,Lucid Diagnostics: Strong Buy Rating on Rising Test Volume and Promising Coverage Prospects,Lucid Diagnostics partnering with Front Line Mobile Health in esophageal cancer Lucid Diagnostics’ EsoGuard cancer diagnosis test highlighted in publication Buy Rating Affirmed for Lucid Diagnostics Amidst Growth and Strategic Advances PAVmed Provides Business Update and Second Quarter 2024 Financial Results Lucid Diagnostics: Strong Buy Rating on Rising Test Volume and Promising Coverage Prospects,0,1,1,1,0,1
58.60M,"311,979",-36.16M,-1,,1.070,,,"Sep 3, 2024",IGTA,Inception Growth Acquisition Limited,44.15M,11.32,-,-0.06%,-0.08%,3.25%,+0.09%,+4.24%,,,,,,,1,-1,-1,-1,-1,-1
26.56M,"67,316",-16.91M,-1,"1,113",2.350,Buy,8.00,"Aug 14, 2024",HUIZ,Huize Holding Limited,44.14M,0.89,167.16M,-8.10%,-14.40%,0.95%,-12.10%,+35.00%,Huize Expands ASEAN Footprint with Vietnam Insurtech Acquisition,"Huize Holding Limited to Report Second Quarter 2024 Financial Results on September 25, 2024","Huize’s International Arm Poni Insurtech Completes Acquisition of Controlling Stake in Global Care, a Leading Insurtech Platform in Vietnam",Huize Partners with CPIC P&C to Launch “Little Scholar” – A Customized Student Accident Insurance Product,,"Huize Expands ASEAN Footprint with Vietnam Insurtech Acquisition Huize Holding Limited to Report Second Quarter 2024 Financial Results on September 25, 2024 Huize’s International Arm Poni Insurtech Completes Acquisition of Controlling Stake in Global Care, a Leading Insurtech Platform in Vietnam Huize Partners with CPIC P&C to Launch “Little Scholar” – A Customized Student Accident Insurance Product",0,1,0,1,0,-1
2.76M,"43,306",-6.62M,-1,51,22.53,,,"Aug 14, 2024",IDN,"Intellicheck, Inc.",43.95M,2.25,19.29M,-8.91%,-23.62%,-9.30%,-24.26%,-33.62%,,,,,,,0,-1,-1,-1,-1,-1
36.32M,"14,383",-8.54M,-1,323,1.730,Strong Buy,10.00,"Aug 9, 2024",ASRV,"AmeriServ Financial, Inc.",43.78M,2.65,45.27M,10.54%,10.22%,-0.23%,+7.57%,+8.87%,AmeriServ Financial Shares Investor Presentation Insights,,,,,AmeriServ Financial Shares Investor Presentation Insights,0,0,-1,-1,-1,-1
1.20B,"350,608",-30.12M,-1,,0.735,Strong Buy,21.00,"Aug 15, 2024",BLAC,Bellevue Life Sciences Acquisition Corp.,43.67M,10.81,-,0.12%,0.58%,3.34%,+0.19%,+3.20%,,,,,,,1,-1,-1,-1,-1,-1
199.15M,"1,233,450",48.96M,-1,106,0.310,,,"Sep 3, 2024",OSS,"One Stop Systems, Inc.",43.55M,2.07,52.76M,24.67%,15.07%,4.48%,+22.07%,-15.84%,One Stop Systems to Participate at the Lake Street Best Ideas Growth Conference on September 12,OSS Receives Order for Rugged Enterprise Class Servers to Support U.S. Army,One Stop Systems announces initial purchase order from U.S. Army,,,One Stop Systems to Participate at the Lake Street Best Ideas Growth Conference on September 12 OSS Receives Order for Rugged Enterprise Class Servers to Support U.S. Army One Stop Systems announces initial purchase order from U.S. Army,0,0,0,0,-1,-1
17.09M,"15,797",77.78M,-1,23,3.610,,,"Aug 12, 2024",AREC,American Resources Corporation,43.51M,0.56,5.97M,-0.37%,-15.18%,-55.49%,-15.78%,-62.14%,American Resources provides business outlook,"American Resources reports Q2 EPS (9c), consensus (7c)","Is AREC a Buy, Before Earnings?",,,"American Resources provides business outlook American Resources reports Q2 EPS (9c), consensus (7c) Is AREC a Buy, Before Earnings?",1,1,1,1,-1,-1
,,,-1,628,,,,,PLBY,"PLBY Group, Inc.",43.49M,0.59,125.85M,-19.13%,-27.86%,-38.15%,-32.28%,-50.16%,,,,,,,0,-1,-1,-1,-1,-1
4.59M,"20,851",3.25M,$0.60,,13.42,,,"Aug 9, 2024",VSTE,Vast Renewables Limited,43.46M,1.45,-,-41.72%,-48.85%,-73.03%,-52.44%,-83.88%,,,,,,,0,-1,-1,-1,-1,-1
10.26M,"14,616",-77.99M,-1,239,6.40,,,"Sep 3, 2024",PXLW,"Pixelworks, Inc.",43.33M,0.74,60.70M,-14.35%,-23.50%,-54.18%,-28.98%,-69.05%,,,,,,,0,-1,-1,-1,-1,-1
17.48M,"124,008",-48.26M,-1,12,3.510,Hold,5.00,"Jul 29, 2024",CALC,"CalciMedica, Inc.",43.12M,4.01,-,-3.78%,-4.94%,-5.09%,-8.35%,-1.61%,CalciMedica Shareholders Back Expansion and Elect Directors,CalciMedica director buys $201K in common stock,Oppenheimer Sticks to Their Buy Rating for CalciMedica (CALC),CalciMedica: Strong Q2 Financials and Promising Clinical Trials Underpin Buy Rating,CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates,CalciMedica Shareholders Back Expansion and Elect Directors CalciMedica director buys $201K in common stock Oppenheimer Sticks to Their Buy Rating for CalciMedica (CALC) CalciMedica: Strong Q2 Financials and Promising Clinical Trials Underpin Buy Rating CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates,1,0,0,0,1,0
27.27M,"59,794",-137.72M,-1,481,2.250,Hold,3.75,"Aug 1, 2024",VTNR,"Vertex Energy, Inc.",43.02M,0.46,3.20B,-18.52%,-42.67%,-73.51%,-45.62%,-69.04%,Vertex Energy Announces Leadership Shakeup and Strategic Focus,Craig-Hallum Sticks to Their Hold Rating for Vertex Energy (VTNR),"Vertex chief commercial officer Doug Haugh steps down, Joshua Foster succeeds",Craig-Hallum Remains a Buy on Vertex Energy (VTNR),Vertex Energy Enhances Liquidity and Leadership Structure,"Vertex Energy Announces Leadership Shakeup and Strategic Focus Craig-Hallum Sticks to Their Hold Rating for Vertex Energy (VTNR) Vertex chief commercial officer Doug Haugh steps down, Joshua Foster succeeds Craig-Hallum Remains a Buy on Vertex Energy (VTNR) Vertex Energy Enhances Liquidity and Leadership Structure",0,0,0,1,0,1
183.33M,"139,527",-1.45M,-1,507,0.335,,,"Oct 18, 2024",NVNI,Nvni Group Limited,42.95M,1.50,23.56M,-2.81%,2.82%,-23.98%,-15.16%,-36.61%,,,,,,,0,-1,-1,-1,-1,-1
4.54M,697,8.52M,$0.40,303,13.15,,,"Oct 18, 2024",EBON,Ebang International Holdings Inc.,42.93M,6.56,3.59M,3.58%,-1.95%,-28.10%,-6.93%,-37.01%,"Ebang International Holdings Shifts Focus, Cuts Losses",Ebang reports 1H EPS (99c) vs. ($1.25) last year,,,,"Ebang International Holdings Shifts Focus, Cuts Losses Ebang reports 1H EPS (99c) vs. ($1.25) last year",1,1,1,-1,-1,-1
5.74M,228,8.62M,$0.20,161,10.60,,,"Jul 24, 2024",XOS,"Xos, Inc.",42.90M,5.36,63.77M,-4.95%,-16.41%,-36.42%,-14.71%,-42.00%,Charged: Analyst âbefuddledâ on FSD ahead of Tesla robotaxi event,"Cisco, Nike upgrades among today’s top calls on Wall Street",Xos downgraded to Neutral from Buy at DA Davidson,Xos price target lowered to $12 from $15 at Wedbush,"Xos sees FY24 revenue $66.7M-$100.4M, consensus $80.98M","Charged: Analyst âbefuddledâ on FSD ahead of Tesla robotaxi event Cisco, Nike upgrades among today’s top calls on Wall Street Xos downgraded to Neutral from Buy at DA Davidson Xos price target lowered to $12 from $15 at Wedbush Xos sees FY24 revenue $66.7M-$100.4M, consensus $80.98M",1,1,1,1,0,1
5.51M,"6,035","467,715",-1,7,11.45,,,,DYAI,"Dyadic International, Inc.",42.74M,1.45,1.80M,9.92%,2.01%,-5.58%,-3.55%,-24.86%,Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress,,,,,Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress,0,0,-1,-1,-1,-1
,,,-1,29,,,,,CFSB,"CFSB Bancorp, Inc.",42.37M,6.62,7.69M,-4.71%,-3.67%,-6.02%,-2.24%,-15.48%,,,,,,,1,-1,-1,-1,-1,-1
45.98M,"26,570",-7.00M,-1,89,1.330,,,"Sep 24, 2024",ECDA,"ECD Automotive Design, Inc.",42.27M,1.22,25.73M,13.74%,8.33%,-44.45%,-0.85%,+21.22%,"ECD Auto Design’s Newest Beach Runner Rolls Off the Line, Ready for the Coast",ECD Automotive Design announces The Beach Runner 3,ECD Automotive Design enters licensing agreement with Blackbridge Motors,ECD Auto Design Adds Blackbridge Motors Defenders to Product Lineup,ECD Auto Design Reports Second Quarter 2024 Financial Results; Revenues Increase 129% to Record $8.9 Million,"ECD Auto Design’s Newest Beach Runner Rolls Off the Line, Ready for the Coast ECD Automotive Design announces The Beach Runner 3 ECD Automotive Design enters licensing agreement with Blackbridge Motors ECD Auto Design Adds Blackbridge Motors Defenders to Product Lineup ECD Auto Design Reports Second Quarter 2024 Financial Results; Revenues Increase 129% to Record $8.9 Million",1,1,1,1,1,1
10.73M,"53,613",-6.90M,-1,96,5.64,Strong Buy,11.00,"Sep 12, 2024",KSCP,"Knightscope, Inc.",42.24M,0.28,11.79M,17.49%,6.90%,-40.06%,+11.69%,-51.78%,Knightscope announces three new contracts for ECDs,Knightscope says four clients have upgraded to fifth-gen K5 ASR,Knightscope announces two new contracts for ECDs,Knightscope reports California healthcare provider expands robot contract,Knightscope secures two new contracts for Emergency Communication Devices,Knightscope announces three new contracts for ECDs Knightscope says four clients have upgraded to fifth-gen K5 ASR Knightscope announces two new contracts for ECDs Knightscope reports California healthcare provider expands robot contract Knightscope secures two new contracts for Emergency Communication Devices,0,0,0,0,1,0
14.51M,"492,442",-7.20M,-1,134,4.160,,,"Oct 16, 2024",AXDX,"Accelerate Diagnostics, Inc.",42.15M,1.78,12.23M,22.31%,42.03%,-1.34%,+40.00%,+125.81%,,,,,,,0,-1,-1,-1,-1,-1
5.36M,"3,814",2.17M,-1,14,11.11,,,"Aug 8, 2024",MATH,Metalpha Technology Holding Limited,42.12M,1.14,5.26M,1.75%,-4.69%,-17.62%,-14.57%,-25.83%,Metalpha Faces Nasdaq Compliance Challenge,Metalpha Technology receives non-compliace letter from NASDAQ,,,,Metalpha Faces Nasdaq Compliance Challenge Metalpha Technology receives non-compliace letter from NASDAQ,1,0,0,-1,-1,-1
12.98M,"25,919","-137,034",-1,,4.700,,,"Sep 6, 2024",BGM,Qilian International Holding Group Limited,41.90M,5.86,29.87M,-6.23%,10.89%,58.70%,-3.74%,+104.14%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,206,,,,,NISN,"Nisun International Enterprise Development Group Co., Ltd",41.85M,10.59,386.67M,-7.59%,23.47%,75.29%,-18.17%,+64.49%,Nisun International achieves cumulative revenue of $240M in gold supply business,Nisun International Achieves Cumulative Revenue of RMB 1.75 Billion (Approximately USD 240 Million) in Gold Supply Chain Business,Nisun International announces increased ownership by largest shareholder,,,Nisun International achieves cumulative revenue of $240M in gold supply business Nisun International Achieves Cumulative Revenue of RMB 1.75 Billion (Approximately USD 240 Million) in Gold Supply Chain Business Nisun International announces increased ownership by largest shareholder,1,1,1,1,-1,-1
6.78M,753,6.04M,$0.48,"7,900",8.75,,,"Jul 31, 2024",BGFV,Big 5 Sporting Goods Corporation,41.80M,1.90,829.49M,6.20%,-20.28%,-52.62%,-9.76%,-46.69%,,,,,,,1,-1,-1,-1,-1,-1
13.22M,"129,582",-168.64M,-1,76,4.530,,,"Jul 24, 2024",FSEA,"First Seacoast Bancorp, Inc.",41.67M,9.30,10.82M,1.03%,2.36%,13.53%,+0.83%,+12.36%,,,,,,,0,-1,-1,-1,-1,-1
49.05M,"76,221",-8.16M,-1,46,1.230,,,"Aug 8, 2024",OCX,OncoCyte Corporation,41.58M,3.11,1.02M,2.35%,3.04%,3.80%,-3.50%,+4.48%,Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study,,,,,Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study,1,0,-1,-1,-1,-1
11.44M,"27,419",5.68M,$0.46,25,5.22,,,"Jul 22, 2024",SWIN,Solowin Holdings,41.55M,2.60,3.44M,15.19%,-8.03%,-58.96%,+4.46%,-54.38%,,,,,,,0,-1,-1,-1,-1,-1
11.04M,"25,779",-6.37M,-1,272,5.41,,,"Sep 9, 2024",SJ,Scienjoy Holding Corporation,41.44M,1.00,204.54M,-3.63%,1.20%,-34.45%,+6.64%,-1.45%,Scienjoy Reports Growth Amidst Metaverse Focus,Scienjoy Holding Corporation Reports Second Quarter and First Half 2024 Unaudited Financial Results,Scienjoy Regains Nasdaq Compliance Status,Scienjoy regains compliance with Nasdaq listing requirement,,Scienjoy Reports Growth Amidst Metaverse Focus Scienjoy Holding Corporation Reports Second Quarter and First Half 2024 Unaudited Financial Results Scienjoy Regains Nasdaq Compliance Status Scienjoy regains compliance with Nasdaq listing requirement,1,1,0,0,0,-1
5.05M,176,1.44M,-1,16,11.75,,,,VTVT,vTv Therapeutics Inc.,40.86M,16.79,1.00M,12.94%,-7.60%,-1.80%,+4.69%,-40.47%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,15,,,,,CLIR,ClearSign Technologies Corporation,40.72M,0.81,2.51M,-1.71%,-7.38%,-22.03%,-18.02%,-28.48%,ClearSign Combustion Reveals Quarterly Results and Insights,ClearSign Combustion’s Strong Market Position and Growth Prospects Affirm Buy Rating,ClearSign Technologies Corporation Provides Second Quarter 2024 Update,ClearSign provides Q2 update,,ClearSign Combustion Reveals Quarterly Results and Insights ClearSign Combustion’s Strong Market Position and Growth Prospects Affirm Buy Rating ClearSign Technologies Corporation Provides Second Quarter 2024 Update ClearSign provides Q2 update,1,1,1,0,0,-1
12.99M,"155,002",11.95M,-1,7,4.560,,,"Sep 6, 2024",NICK,"Nicholas Financial, Inc.",40.69M,5.57,18.74M,-9.25%,-12.02%,-15.73%,-6.82%,-12.87%,,,,,,,1,-1,-1,-1,-1,-1
13.77M,"3,875",-15.08M,-1,67,4.300,Buy,12.00,"Aug 8, 2024",TCBS,"Texas Community Bancshares, Inc.",40.61M,13.80,9.79M,1.18%,-1.23%,2.60%,+2.90%,-1.76%,"Texas Community Bancshares, Inc. Announces Quarterly Cash Dividend",,,,,"Texas Community Bancshares, Inc. Announces Quarterly Cash Dividend",1,0,-1,-1,-1,-1
65.97M,"456,939",-81.52M,-1,"2,025",0.898,Buy,2.00,"Aug 14, 2024",RDI,"Reading International, Inc.",40.59M,1.81,203.74M,13.01%,18.46%,0.16%,+14.38%,-6.70%,Reading International reports Q2 EPS (42c) vs (12c) last year,,,,,Reading International reports Q2 EPS (42c) vs (12c) last year,0,1,-1,-1,-1,-1
60.29M,"104,582",-102.85M,-1,"2,055",0.980,Strong Buy,4.13,"Aug 8, 2024",NOTV,"Inotiv, Inc.",40.57M,1.56,501.06M,-13.92%,-20.44%,-63.26%,-27.08%,-80.39%,Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference,Inotiv (NOTV) Gets a Hold from Lake Street,,,,Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference Inotiv (NOTV) Gets a Hold from Lake Street,0,0,0,-1,-1,-1
27.45M,"28,165",-19.02M,-1,136,2.150,Strong Buy,7.00,"Aug 12, 2024",SNT,Senstar Technologies Corporation,40.56M,1.74,33.86M,3.90%,1.23%,26.66%,+1.20%,+35.20%,Senstar Technologies Reports Solid Q2 2024,Senstar Technologies Corporation,Senstar Technologies Announces Q2 Results Date,,,Senstar Technologies Reports Solid Q2 2024 Senstar Technologies Corporation Senstar Technologies Announces Q2 Results Date,0,0,1,0,-1,-1
17.04M,"85,452",-173.30M,-1,32,3.460,Strong Buy,14.00,"Aug 13, 2024",INTG,The InterGroup Corporation,40.55M,18.54,57.70M,0.87%,-8.90%,-17.69%,-8.96%,-12.31%,,,,,,,1,-1,-1,-1,-1,-1
54.43M,"12,950",-25.53M,-1,126,1.080,Strong Buy,4.50,"Aug 13, 2024",USIO,"Usio, Inc.",40.49M,1.48,80.69M,0.10%,-2.46%,-7.74%,-2.53%,+3.36%,Usio (USIO) Receives a Rating Update from a Top Analyst,Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW) and Usio (USIO),Buy Rating Maintained on Usio Amid Positive Profitability Signals and Future Growth Prospects,Usio price target lowered to $9 from $12.50 at Ladenburg,Usio raises FY24 adjusted EBITDA view to $4.25M-$5M,Usio (USIO) Receives a Rating Update from a Top Analyst Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW) and Usio (USIO) Buy Rating Maintained on Usio Amid Positive Profitability Signals and Future Growth Prospects Usio price target lowered to $9 from $12.50 at Ladenburg Usio raises FY24 adjusted EBITDA view to $4.25M-$5M,0,0,0,0,0,0
66.70M,"5,139",-15.81M,-1,107,0.900,,,"Sep 3, 2024",LINK,"Interlink Electronics, Inc.",40.44M,4.10,12.64M,-11.60%,-9.15%,-40.82%,-13.27%,-45.82%,"Interlink Electronics, Inc. to Present at the 2024 Gateway Conference on September 4th",Interlink Electronics: Strong Buy Rating on Strategic Cost-Cutting and Growth Potential,,,,"Interlink Electronics, Inc. to Present at the 2024 Gateway Conference on September 4th Interlink Electronics: Strong Buy Rating on Strategic Cost-Cutting and Growth Potential",1,1,1,-1,-1,-1
8.69M,"2,993",2.77M,-1,114,6.83,,,"Jul 30, 2024",SYT,"SYLA Technologies Co., Ltd.",40.42M,1.55,161.34M,13.17%,-5.49%,-44.21%,+4.24%,-37.45%,SYLA Technologies Director Resigns for New Role,SYLA Technologies Announces Increased Interim Dividend,SYLA Technologies Announces Interim Dividend of ¥100 per Share,Syla Technologies board declares interim dividend of Y100 per share,,SYLA Technologies Director Resigns for New Role SYLA Technologies Announces Increased Interim Dividend SYLA Technologies Announces Interim Dividend of ¥100 per Share Syla Technologies board declares interim dividend of Y100 per share,0,1,0,0,0,-1
118.11M,"430,074",-133.03M,-1,486,0.497,Strong Buy,4.75,"Aug 13, 2024",FGEN,"FibroGen, Inc.",40.37M,0.40,173.82M,-13.69%,-51.65%,-66.99%,-32.38%,-77.46%,FibroGen Executives Depart Amid U.S. Operations Overhaul,"FibroGen CFO, Chief Medical Officer to leave",,,,"FibroGen Executives Depart Amid U.S. Operations Overhaul FibroGen CFO, Chief Medical Officer to leave",1,0,0,-1,-1,-1
69.96M,"130,195",-43.17M,-1,,0.835,Strong Buy,2.50,"Aug 14, 2024",DXR,Daxor Corporation,40.16M,8.30,163.42K,-7.52%,-9.87%,-9.23%,-11.11%,+3.09%,Daxor Corporation: A Buy Rating Justified by Strong Performance and Promising Medical Technology Outlook,Daxor receives $300K matching fund award from Launch Tennessee,Central Florida hospital implements Daxor BVA-100 blood volume diagnostic,Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care,Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time,Daxor Corporation: A Buy Rating Justified by Strong Performance and Promising Medical Technology Outlook Daxor receives $300K matching fund award from Launch Tennessee Central Florida hospital implements Daxor BVA-100 blood volume diagnostic Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time,0,0,0,1,0,0
5.56M,"110,964","-231,558",-1,321,10.50,,,,RFIL,"RF Industries, Ltd.",40.10M,3.87,61.09M,2.52%,-0.92%,17.19%,-9.83%,+23.28%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,25,,,,,PHUN,"Phunware, Inc.",39.91M,3.52,4.12M,-3.62%,-24.62%,-52.86%,-22.80%,-55.00%,,,,,,,1,-1,-1,-1,-1,-1
21.26M,"84,470",-46.06M,-1,14,2.740,Strong Buy,6.00,"Sep 10, 2024",EVTV,"Envirotech Vehicles, Inc.",39.86M,2.54,1.83M,15.31%,21.82%,15.59%,+12.20%,-36.55%,Envirotech Vehicles appoints Brock Pierce to board of directors,,,,,Envirotech Vehicles appoints Brock Pierce to board of directors,0,1,-1,-1,-1,-1
11.27M,"23,580",2.20M,$0.29,73,5.17,,,"Aug 9, 2024",XLO,"Xilio Therapeutics, Inc.",39.66M,0.90,2.36M,2.61%,-1.94%,-1.13%,-14.72%,-32.50%,Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference,TD Cowen Remains a Buy on Xilio Therapeutics (XLO),,,,Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference TD Cowen Remains a Buy on Xilio Therapeutics (XLO),1,1,1,-1,-1,-1
4.13M,"2,942",3.95M,$0.32,,13.93,,,"Jul 25, 2024",DUET,DUET Acquisition Corp.,39.60M,11.24,-,0.63%,1.54%,4.85%,+1.17%,+5.04%,,,,,,,1,-1,-1,-1,-1,-1
5.07M,2,"188,000",-1,79,11.44,,,,HFBL,"Home Federal Bancorp, Inc. of Louisiana",39.59M,13.11,20.50M,-1.30%,5.07%,-4.77%,+9.95%,-1.21%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,244,,,,,REE,REE Automotive Ltd.,39.36M,3.64,1.77M,9.76%,1.23%,-19.35%,-0.52%,-20.21%,"Is REE a Buy, Before Earnings?",,,,,"Is REE a Buy, Before Earnings?",1,1,-1,-1,-1,-1
2.68M,"5,302",-3.88M,$1.32,921,21.58,,,"Aug 8, 2024",DSWL,"Deswell Industries, Inc.",39.04M,2.45,69.37M,4.04%,1.97%,2.23%,-2.90%,+8.00%,Deswell Industries Files Annual Financial Report,,,,,Deswell Industries Files Annual Financial Report,1,0,-1,-1,-1,-1
,,,-1,6,,,,,LTBR,Lightbridge Corporation,38.97M,2.67,-,-2.13%,-14.83%,-13.87%,-22.98%,-10.14%,,,,,,,1,-1,-1,-1,-1,-1
11.45M,"1,763",-17.47M,-1,,5.16,Strong Buy,12.50,"Aug 20, 2024",WINV,WinVest Acquisition Corp.,38.89M,11.46,-,-0.09%,1.22%,4.71%,-1.28%,+5.00%,WinVest Corp Extends Initial Business Combination Deadline,WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date,,,,WinVest Corp Extends Initial Business Combination Deadline WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date,1,1,1,-1,-1,-1
3.13M,"9,375",-11.38M,-1,89,18.49,,,"Aug 8, 2024",AADI,"Aadi Bioscience, Inc.",38.89M,1.58,23.82M,13.51%,10.80%,-23.91%,+8.39%,-21.13%,Aadi Bioscience downgraded to Neutral from Overweight at Piper Sandler,Hold Rating for Aadi Bioscience Amid Clinical Setbacks and Modest Revenue Projections,Aadi Bioscience downgraded to Hold from Buy at Jefferies,Morning Movers: Target surges and Macy’s falls following earnings,Aadi Bioscience downgraded to Hold from Buy at TD Cowen,Aadi Bioscience downgraded to Neutral from Overweight at Piper Sandler Hold Rating for Aadi Bioscience Amid Clinical Setbacks and Modest Revenue Projections Aadi Bioscience downgraded to Hold from Buy at Jefferies Morning Movers: Target surges and Macy’s falls following earnings Aadi Bioscience downgraded to Hold from Buy at TD Cowen,0,1,1,1,0,1
16.60M,"7,317",-3.68M,-1,7,3.390,,,"Aug 15, 2024",PMN,"ProMIS Neurosciences, Inc.",38.85M,1.30,-,-0.28%,-20.27%,-26.47%,-6.62%,-33.40%,ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference,,,,,ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference,0,0,-1,-1,-1,-1
15.51M,"79,829",-1.88M,-1,,3.720,,,"Sep 3, 2024",STI,Solidion Technology Inc.,38.84M,0.42,6.64K,8.02%,-18.67%,-89.09%,-12.83%,-89.25%,Solidion Technology Secures Funding and Shareholder Support,"Solidion Technology, Inc. Announces Pricing of $4 Million Private Placement",Solidion Offers Strategic Partnership Opportunities on Next-Gen EV Batteries,Solidion Granted 20 Patents on Next-Gen Batteries by the US Patent and Trademark Office During First 8 Months of 2024,Solidion granted 20 patents on next-gen batteries during first 8 months of 2024,"Solidion Technology Secures Funding and Shareholder Support Solidion Technology, Inc. Announces Pricing of $4 Million Private Placement Solidion Offers Strategic Partnership Opportunities on Next-Gen EV Batteries Solidion Granted 20 Patents on Next-Gen Batteries by the US Patent and Trademark Office During First 8 Months of 2024 Solidion granted 20 patents on next-gen batteries during first 8 months of 2024",1,0,1,1,1,1
32.56M,"50,277",-17.87M,-1,84,1.760,Buy,4.25,"Aug 14, 2024",PET,Wag! Group Co.,38.81M,0.80,85.34M,-11.18%,-32.49%,-51.04%,-30.34%,-60.71%,Wag! Group (PET) Gets a Buy from Craig-Hallum,,,,,Wag! Group (PET) Gets a Buy from Craig-Hallum,0,0,-1,-1,-1,-1
3.21M,"1,573",1.96M,$0.40,87,17.79,,,"Sep 3, 2024",CXAI,CXApp Inc.,38.78M,2.54,7.07M,1.83%,0.21%,-1.46%,+0.97%,-57.98%,Largest borrow rate increases among liquid names,"Joy Mbanugo Named CXApp CFO, Bolsters Leadership Team",CXApp appoints Joy Mbanugo as CFO,Buy Rating on CXApp Inc. Justified by Strong ARR Growth and Strategic Partnerships,Closing Bell Movers: Rumble jumps 8% on earnings,"Largest borrow rate increases among liquid names Joy Mbanugo Named CXApp CFO, Bolsters Leadership Team CXApp appoints Joy Mbanugo as CFO Buy Rating on CXApp Inc. Justified by Strong ARR Growth and Strategic Partnerships Closing Bell Movers: Rumble jumps 8% on earnings",0,1,1,1,1,1
2.79M,"2,719",-2.38M,-1,752,20.30,Strong Buy,30.00,"Aug 8, 2024",SYPR,"Sypris Solutions, Inc.",38.62M,1.68,139.39M,-3.69%,-11.41%,-11.95%,-11.05%,-1.23%,"Sypris Solutions appoints Rebecca Eckert as VP, CAO and controller",Sypris Solutions backs FY24 revenue view up 10%-15%,Sypris Solutions reports Q2 EPS 0c vs. 1c last year,,,"Sypris Solutions appoints Rebecca Eckert as VP, CAO and controller Sypris Solutions backs FY24 revenue view up 10%-15% Sypris Solutions reports Q2 EPS 0c vs. 1c last year",1,0,1,1,-1,-1
,,,-1,44,,,,,EQ,"Equillium, Inc.",38.60M,1.09,42.62M,31.33%,34.47%,-16.36%,+36.51%,-52.22%,"Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)","Is EQ a Buy, Before Earnings?",,,,"Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX) Is EQ a Buy, Before Earnings?",1,0,1,-1,-1,-1
58.48M,"220,249",-5.89M,-1,,1.000,,,"Sep 3, 2024",GDST,Goldenstone Acquisition Limited,38.59M,11.21,-,0.27%,1.05%,4.19%,+0.81%,+4.37%,,,,,,,0,-1,-1,-1,-1,-1
6.81M,"14,521",4.19M,-1,68,8.29,,,"Aug 13, 2024",ECOR,"electroCore, Inc.",38.46M,5.97,21.28M,-1.01%,-3.23%,-5.97%,-0.70%,+0.16%,ElectroCore Announces CFO Transition and Shareholder Meeting Outcomes,electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,,,,ElectroCore Announces CFO Transition and Shareholder Meeting Outcomes electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,1,0,0,-1,-1,-1
24.02M,"98,875",-61.16M,-1,22,2.350,,,"Aug 6, 2024",SURG,"SurgePays, Inc.",38.31M,1.94,112.99M,-21.08%,-34.90%,-61.96%,-43.39%,-57.51%,SurgePays commences $5M share repurchase program,Maxim Group Sticks to Their Hold Rating for SurgePays (SURG),Morning Movers: Kellanova climbs following deal to be acquired by Mars,SurgePays Announces Second Quarter 2024 Financial Results,"SurgePays reports Q2 EPS (66c), consensus (7c)","SurgePays commences $5M share repurchase program Maxim Group Sticks to Their Hold Rating for SurgePays (SURG) Morning Movers: Kellanova climbs following deal to be acquired by Mars SurgePays Announces Second Quarter 2024 Financial Results SurgePays reports Q2 EPS (66c), consensus (7c)",0,0,0,1,0,1
55.10M,"3,880",-59.50M,-1,151,1.040,Strong Buy,6.50,"Sep 10, 2024",DFLI,Dragonfly Energy Holdings Corp.,38.24M,0.61,52.04M,-10.00%,-24.64%,-15.66%,-25.67%,+17.13%,Maintaining a Buy Rating: Dragonfly Energy’s Potential to Revolutionize Battery Tech Despite Financial Hurdles,Roth MKM Reaffirms Their Buy Rating on Dragonfly Energy Holdings Corp (DFLI),Dragonfly Energy price target lowered to $1.25 from $1.75 at Alliance Global,Dragonfly Energy Shares Investor Presentation Update,"Dragonfly Energy sees Q3 revenue $$13.5M – $15M, consensus $18.27M","Maintaining a Buy Rating: Dragonfly Energy’s Potential to Revolutionize Battery Tech Despite Financial Hurdles Roth MKM Reaffirms Their Buy Rating on Dragonfly Energy Holdings Corp (DFLI) Dragonfly Energy price target lowered to $1.25 from $1.75 at Alliance Global Dragonfly Energy Shares Investor Presentation Update Dragonfly Energy sees Q3 revenue $$13.5M – $15M, consensus $18.27M",1,1,1,0,1,1
16.68M,"24,507",-7.04M,-1,36,3.370,Strong Buy,9.50,"Sep 19, 2024",PBBK,"PB Bankshares, Inc.",37.85M,16.04,11.90M,5.88%,13.53%,26.45%,+6.80%,+25.71%,,,,,,,0,-1,-1,-1,-1,-1
16.39M,"2,860",-7.06M,-1,92,3.450,Strong Buy,11.00,"Sep 19, 2024",LGCB,Linkage Global Inc,37.84M,1.76,12.73M,-18.27%,-40.06%,-31.15%,-40.23%,-53.97%,Linkage Global Inc Announces Board and CFO Changes,,,,,Linkage Global Inc Announces Board and CFO Changes,0,1,-1,-1,-1,-1
21.01M,"126,626",-21.16M,-1,,2.660,Strong Buy,4.25,"Aug 12, 2024",WTMA,Welsbach Technology Metals Acquisition Corp.,37.71M,11.20,-,0.27%,0.86%,3.58%,+0.90%,+4.77%,,,,,,,1,-1,-1,-1,-1,-1
22.43M,"29,241",-39.35M,-1,144,11.00,,,"Sep 3, 2024",MNDO,MIND C.T.I. Ltd,37.54M,1.86,21.89M,1.11%,0.23%,-3.31%,-1.06%,-6.03%,,,,,,,1,-1,-1,-1,-1,-1
44.32M,"122,352",-8.56M,-1,53,1.260,,,"Aug 14, 2024",CUE,"Cue Biopharma, Inc.",37.43M,0.77,8.30M,0.62%,-19.75%,-60.98%,-16.17%,-62.16%,"Cue Biopharma to present on CUE-401, CUE-100 series at conference","Analysts’ Top Healthcare Picks: EKSO BIONICS (EKSO), Aziyo Biologics (ELUT)",Oppenheimer Reaffirms Their Buy Rating on Cue Biopharma (CUE),"Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR)",Cue Biopharma price target lowered to $4 from $8 at Stifel,"Cue Biopharma to present on CUE-401, CUE-100 series at conference Analysts’ Top Healthcare Picks: EKSO BIONICS (EKSO), Aziyo Biologics (ELUT) Oppenheimer Reaffirms Their Buy Rating on Cue Biopharma (CUE) Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR) Cue Biopharma price target lowered to $4 from $8 at Stifel",1,1,0,1,1,1
31.91M,"1,042,479",-37.57M,-1,,1.750,Hold,1.50,"Aug 8, 2024",XBP,"XBP Europe Holdings, Inc.",37.41M,1.24,157.86M,-3.74%,-10.98%,-70.34%,-10.99%,-38.89%,XBP Europe Holdings Unveils Investor Presentation Insights,,,,,XBP Europe Holdings Unveils Investor Presentation Insights,1,0,-1,-1,-1,-1
36.69M,"11,203","428,346",-1,49,1.530,,,"Aug 14, 2024",CRIS,"Curis, Inc.",37.37M,6.25,10.16M,21.46%,-2.01%,-41.09%,+4.56%,-65.89%,Truist Financial Sticks to Its Buy Rating for Curis (CRIS),,,,,Truist Financial Sticks to Its Buy Rating for Curis (CRIS),1,0,-1,-1,-1,-1
35.16M,"149,818",-19.47M,-1,,1.580,,,"Aug 7, 2024",WAVS,Western Acquisition Ventures Corp.,37.12M,10.53,-,-2.89%,-4.31%,-3.26%,-6.01%,-3.73%,,,,,,,0,-1,-1,-1,-1,-1
4.92M,1,-4.80M,-1,9,11.25,,,,OCEA,"Ocean Biomedical, Inc.",37.07M,1.07,-,-14.92%,-20.32%,-37.31%,-21.70%,-65.96%,"Ocean Biomedical: Dr. Jonathan Kurtis, MD issued patent for malaria treatment","Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms",Ocean Biomedical Faces Nasdaq Compliance Challenges,Ocean Biomedical receives noncompliance notification from Nasdaq,"Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q","Ocean Biomedical: Dr. Jonathan Kurtis, MD issued patent for malaria treatment Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms Ocean Biomedical Faces Nasdaq Compliance Challenges Ocean Biomedical receives noncompliance notification from Nasdaq Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q",0,0,0,0,0,0
,,,-1,"5,600",,,,,JRSH,"Jerash Holdings (US), Inc.",37.07M,3.02,123.39M,1.86%,0.76%,-0.73%,-2.16%,-4.96%,Jerash Holdings price target lowered to $3.50 from $4 at DA Davidson,D.A. Davidson Sticks to Its Buy Rating for Jerash Holdings (US) (JRSH),Jerash Holdings sees Q2 revenue up 11%-13% vs. 2Q24,Jerash Holdings reports Q1 EPS (11c) vs. 4c last year,Lake Street Sticks to Their Buy Rating for Jerash Holdings (US) (JRSH),Jerash Holdings price target lowered to $3.50 from $4 at DA Davidson D.A. Davidson Sticks to Its Buy Rating for Jerash Holdings (US) (JRSH) Jerash Holdings sees Q2 revenue up 11%-13% vs. 2Q24 Jerash Holdings reports Q1 EPS (11c) vs. 4c last year Lake Street Sticks to Their Buy Rating for Jerash Holdings (US) (JRSH),1,0,1,1,1,1
29.28M,"38,431",-11.55M,-1,114,1.890,,,"Aug 16, 2024",CDTG,CDT Environmental Technology Investment Holdings Limited,36.92M,3.45,34.21M,-2.87%,-2.90%,-5.31%,unch,,,,,,,,1,-1,-1,-1,-1,-1
7.29M,"26,733",-29.36M,-1,480,7.54,,,"Aug 8, 2024",OM,"Outset Medical, Inc.",36.91M,0.71,116.43M,-62.47%,-78.91%,-81.90%,-82.54%,-69.76%,"Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP",Outset Medical management to meet virtually with BTIG,Outset Medical Announces Board and Committee Leadership Changes,,,"Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP Outset Medical management to meet virtually with BTIG Outset Medical Announces Board and Committee Leadership Changes",1,0,0,0,-1,-1
11.61M,"26,506",-12.56M,-1,24,4.720,,,"Aug 8, 2024",LGVN,Longeveron Inc.,36.90M,2.57,1.23M,-13.65%,-15.90%,-65.11%,-32.27%,-3.64%,Buy Rating Affirmed for Longeveron on Favorable Lomecel-B Regulatory Outlook and Trial Progress,Longeveron announces type C meeting with FDA for Lomecel-B BLA,Longeveron price target lowered to $6 from $15 at Maxim,Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Buy Rating Reaffirmed for Longeveron on Strong Clinical Trial Prospects and Regulatory Advantages,Buy Rating Affirmed for Longeveron on Favorable Lomecel-B Regulatory Outlook and Trial Progress Longeveron announces type C meeting with FDA for Lomecel-B BLA Longeveron price target lowered to $6 from $15 at Maxim Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference Buy Rating Reaffirmed for Longeveron on Strong Clinical Trial Prospects and Regulatory Advantages,0,0,0,0,0,0
4.95M,1,"-483,513",-1,4,11.03,,,,ACXP,"Acurx Pharmaceuticals, Inc.",36.88M,2.27,-,2.66%,-2.98%,-23.40%,+1.39%,+13.47%,Ibezapolstat’s Strategic Advancements and Market Potential Bolster Buy Rating for Acurx Pharmaceuticals,,,,,Ibezapolstat’s Strategic Advancements and Market Potential Bolster Buy Rating for Acurx Pharmaceuticals,0,0,-1,-1,-1,-1
,,,-1,584,,,,,MKTW,"MarketWise, Inc.",36.51M,0.83,432.34M,-11.76%,-23.78%,-56.09%,-32.16%,-52.84%,MarketWise COO Chad Curlett Resigns with Severance Deal,Analysts Offer Insights on Technology Companies: MarketWise (MKTW) and Exlservice Holdings (EXLS),MarketWise names David Eifrig as interim CEO,MarketWise reports Q2 EPS 4c,MarketWise – Quarterly Report and Shareholder Letter,MarketWise COO Chad Curlett Resigns with Severance Deal Analysts Offer Insights on Technology Companies: MarketWise (MKTW) and Exlservice Holdings (EXLS) MarketWise names David Eifrig as interim CEO MarketWise reports Q2 EPS 4c MarketWise – Quarterly Report and Shareholder Letter,1,1,0,1,1,1
19.60M,"7,061",-16.36M,-1,6,2.800,Strong Buy,7.25,"Aug 12, 2024",VGAS,"Verde Clean Fuels, Inc.",36.29M,3.80,-,-10.95%,-15.42%,-5.80%,-17.89%,-14.56%,,,,,,,0,-1,-1,-1,-1,-1
6.19M,"25,592",-17.74M,-1,,8.80,,,"Aug 1, 2024",AIFF,"Firefly Neuroscience, Inc.",36.20M,4.60,64.00K,-21.54%,-21.38%,-26.22%,-34.75%,-51.80%,Firefly Neuroscience appoints Stella Vnook to board of directors,Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors,Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11,"Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th",Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders,"Firefly Neuroscience appoints Stella Vnook to board of directors Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11 Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders",0,0,0,0,0,0
10.46M,"15,265",33.23M,-1,153,5.20,Strong Buy,10.00,"Aug 12, 2024",IZEA,"IZEA Worldwide, Inc.",36.19M,2.20,32.83M,1.87%,-0.82%,-2.83%,-2.78%,-6.83%,IZEA’s IZZY Influencer Marketing AI Assistant Now Available in IZEA Flex Platform,IZEA Report Finds 85% of China Consumers Have Purchased Products After Seeing Influencers Use Them,IZEA Report Finds 46% of Social Media Users Ages 18-60 Have Changed Their Political Opinions Due to Influencer Content,IZEA Flex Named Best Influencer Marketing Platform in 2024 MarTech Breakthrough Awards,IZEA Welcomes Justin Teo as Country Manager for China,IZEA’s IZZY Influencer Marketing AI Assistant Now Available in IZEA Flex Platform IZEA Report Finds 85% of China Consumers Have Purchased Products After Seeing Influencers Use Them IZEA Report Finds 46% of Social Media Users Ages 18-60 Have Changed Their Political Opinions Due to Influencer Content IZEA Flex Named Best Influencer Marketing Platform in 2024 MarTech Breakthrough Awards IZEA Welcomes Justin Teo as Country Manager for China,0,0,0,0,0,0
,,,-1,281,,,,,AIXI,Xiao-I Corporation,36.06M,4.31,59.17M,26.21%,-10.27%,-63.69%,+5.17%,-64.91%,Xiao-I sees FY24 revenue $73M vs. $59M last year,Xiao-I to change its ADS ratio on August 23,,,,Xiao-I sees FY24 revenue $73M vs. $59M last year Xiao-I to change its ADS ratio on August 23,1,1,1,-1,-1,-1
17.39M,"23,120",-17.31M,-1,193,3.120,Buy,7.00,"Aug 5, 2024",RPID,"Rapid Micro Biosystems, Inc.",36.05M,0.84,24.71M,6.10%,15.88%,-4.76%,+27.08%,-15.99%,Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,,,,,Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference,1,1,-1,-1,-1,-1
25.93M,301,-9.35M,-1,45,2.080,Strong Buy,6.67,"Sep 18, 2024",SHFS,"SHF Holdings, Inc.",36.03M,0.65,16.72M,-6.44%,-4.22%,-29.38%,-7.69%,-26.47%,SHF Holdings Updates Key Executive Agreements and Disclosures,Safe Harbor Financial announces executive contract extensions,Safe Harbor Financial Secures Key Executive Team with Strategic Contract Extensions,,,SHF Holdings Updates Key Executive Agreements and Disclosures Safe Harbor Financial announces executive contract extensions Safe Harbor Financial Secures Key Executive Team with Strategic Contract Extensions,1,1,1,1,-1,-1
4.71M,550,-1.12M,-1,,11.54,,,,MCAG,Mountain Crest Acquisition Corp. V,35.89M,10.81,-,-0.18%,0.02%,2.63%,+0.28%,+1.41%,Mountain Crest Acquisition V Announces Merger with CUBEBIO,CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed,,,,Mountain Crest Acquisition V Announces Merger with CUBEBIO CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed,0,0,1,-1,-1,-1
,,,-1,17,,,,,TPST,"Tempest Therapeutics, Inc.",35.80M,1.42,-,-6.14%,-27.40%,-58.63%,-24.72%,-63.98%,Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4),Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance,"Tempest Therapeutics appoints Troy Wagner as VP, quality assurance",Scotiabank Keeps Their Buy Rating on Tempest Therapeutics (TPST),"Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance Tempest Therapeutics appoints Troy Wagner as VP, quality assurance Scotiabank Keeps Their Buy Rating on Tempest Therapeutics (TPST)",1,0,1,1,1,1
30.16M,894,-5.93M,-1,155,1.800,,,"Sep 18, 2024",TPCS,TechPrecision Corporation,35.78M,3.67,30.50M,-5.12%,0.32%,-17.50%,-11.65%,+4.49%,TechPrecision discloses Nasdaq listing deficiency notice,,,,,TechPrecision discloses Nasdaq listing deficiency notice,0,0,-1,-1,-1,-1
28.87M,"317,147",-87.94M,-1,14,1.870,Hold,11.75,"Aug 12, 2024",UNCY,"Unicycive Therapeutics, Inc.",35.67M,0.38,-,-3.02%,-19.93%,-58.85%,-23.70%,-76.51%,Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Unicycive Therapeutics submits NDA to FDA for oxylanthanum carbonate,Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis,Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024,Unicycive price target lowered to $2.50 from $4.50 at H.C. Wainwright,Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference Unicycive Therapeutics submits NDA to FDA for oxylanthanum carbonate Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024 Unicycive price target lowered to $2.50 from $4.50 at H.C. Wainwright,0,0,0,0,1,0
4.94M,"5,321",2.29M,-1,"1,463",10.82,,,,SGRP,"SPAR Group, Inc.",35.54M,1.60,258.42M,-16.48%,-25.21%,0.64%,-21.47%,-19.79%,Spar Group to be acquired by Highwire Capital for $2.50 per share,SPAR Group Enters into Definitive Agreement to be Acquired by Highwire Capital for $2.50 Per Share,,,,Spar Group to be acquired by Highwire Capital for $2.50 per share SPAR Group Enters into Definitive Agreement to be Acquired by Highwire Capital for $2.50 Per Share,0,0,0,-1,-1,-1
,,,-1,515,,,,,TLF,"Tandy Leather Factory, Inc.",35.36M,4.20,74.95M,-3.64%,-5.73%,-8.57%,-4.83%,-10.97%,,,,,,,0,-1,-1,-1,-1,-1
9.76M,"4,138,036",-19.91M,-1,24,5.45,,,"Aug 14, 2024",GROW,"U.S. Global Investors, Inc.",35.34M,2.54,11.85M,-0.56%,-1.54%,-5.53%,-3.02%,-7.89%,Kanen Wealth Management calls for sale of U.S. Global Investors,U.S. Global Investors launches Jets ETF on Colombian Securities Exchange,"U.S. Global Investors Launches Its Airlines JETS ETF on Colombia Securities Exchange, Offering Investors Exposure to $2 Trillion Tourism Industry",,,"Kanen Wealth Management calls for sale of U.S. Global Investors U.S. Global Investors launches Jets ETF on Colombian Securities Exchange U.S. Global Investors Launches Its Airlines JETS ETF on Colombia Securities Exchange, Offering Investors Exposure to $2 Trillion Tourism Industry",1,1,0,1,-1,-1
38.81M,"119,894",-6.46M,-1,8,1.380,Strong Buy,3.00,"Sep 12, 2024",OKYO,OKYO Pharma Limited,35.19M,1.04,-,8.38%,-10.13%,-25.43%,-11.38%,-22.14%,"OKYO Pharma Chairman Boosts Stake, Advances Trials",Okyo Pharma announces acquisition of shares by chairman,Buy Rating on OKYO Pharma: U.S. Patent and Strong Trial Results for OK-101 Boosts Market Potential,OKYO Pharma Secures U.S. Patent for DED Therapy,Okyo granted U.S. patent covering OK-101’s for DED treatment,"OKYO Pharma Chairman Boosts Stake, Advances Trials Okyo Pharma announces acquisition of shares by chairman Buy Rating on OKYO Pharma: U.S. Patent and Strong Trial Results for OK-101 Boosts Market Potential OKYO Pharma Secures U.S. Patent for DED Therapy Okyo granted U.S. patent covering OK-101’s for DED treatment",1,1,1,0,0,1
4.84M,"5,170","-612,575",-1,775,10.96,,,,NSYS,Nortech Systems Incorporated,35.11M,12.71,137.53M,-3.72%,-7.55%,1.86%,-13.49%,-15.79%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,225,,,,,ATRA,"Atara Biotherapeutics, Inc.",35.09M,7.14,62.39M,-13.60%,-23.03%,-52.85%,-29.81%,-64.35%,Biotech Alert: Searches spiking for these stocks today,"Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings",Atara Biotherapeutics Announces Board Appointment and Capital Raise,Atara Biotherapeutics announces $36M registered direct offering,Atara Biotherapeutics: Hold Rating Maintained Amid Financial Shortfalls and Regulatory Uncertainties,"Biotech Alert: Searches spiking for these stocks today Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings Atara Biotherapeutics Announces Board Appointment and Capital Raise Atara Biotherapeutics announces $36M registered direct offering Atara Biotherapeutics: Hold Rating Maintained Amid Financial Shortfalls and Regulatory Uncertainties",1,1,1,1,0,0
37.49M,"22,576",4.32M,-1,85,1.350,,,"Aug 14, 2024",CLNN,Clene Inc.,34.94M,5.40,442.00K,13.31%,-0.10%,-25.45%,+24.18%,-31.71%,Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference,,,,,Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference,1,0,-1,-1,-1,-1
4.55M,1,"-657,054",-1,"1,250",11.63,,,,SCOR,"comScore, Inc.",34.86M,7.13,358.73M,-23.00%,-41.24%,-52.26%,-52.04%,-57.64%,"Tesla initiated, Foot Locker upgraded: Wall Street’s top analyst calls",Analysts Offer Insights on Communication Services Companies: comScore (SCOR) and CD Projekt SA (OtherOTGLF),Comscore downgraded to Hold from Buy at Craig-Hallum,"Comscore and FreeWheel Forge Next-Gen Partnership, Further Enhancing Privacy-Resilient CTV and Contextual Advertising","Comscore, FreeWheel announe partnership to enhance privacy-resilient CTV","Tesla initiated, Foot Locker upgraded: Wall Street’s top analyst calls Analysts Offer Insights on Communication Services Companies: comScore (SCOR) and CD Projekt SA (OtherOTGLF) Comscore downgraded to Hold from Buy at Craig-Hallum Comscore and FreeWheel Forge Next-Gen Partnership, Further Enhancing Privacy-Resilient CTV and Contextual Advertising Comscore, FreeWheel announe partnership to enhance privacy-resilient CTV",0,1,0,0,1,0
,,,-1,56,,,,,LASE,Laser Photonics Corporation,34.53M,2.82,4.01M,11.73%,42.36%,94.19%,+102.59%,+177.30%,Laser Photonics regains compliance with Nasdaq,Laser Photonics Corp. Achieves Nasdaq Compliance and Restores Trust,Laser Photonics Corp. Stockholders Show Strong Confidence at Annual Meeting,Laser Photonics reports Q2 EPS (20c) vs. (9c) last year,Laser Photonics Corp. Welcomes Industry Expert to Board,Laser Photonics regains compliance with Nasdaq Laser Photonics Corp. Achieves Nasdaq Compliance and Restores Trust Laser Photonics Corp. Stockholders Show Strong Confidence at Annual Meeting Laser Photonics reports Q2 EPS (20c) vs. (9c) last year Laser Photonics Corp. Welcomes Industry Expert to Board,1,1,1,1,1,1
2.28M,"91,459",-4.94M,-1,188,23.06,,,"Aug 28, 2024",RCON,"Recon Technology, Ltd.",34.52M,2.31,9.42M,41.82%,72.40%,8.95%,+63.13%,+20.16%,,,,,,,0,-1,-1,-1,-1,-1
41.31M,"110,598",-122.10M,-1,146,1.270,,,"Sep 3, 2024",ORGS,Orgenesis Inc.,34.40M,0.73,662.00K,-7.73%,5.08%,29.39%,-11.78%,+34.33%,Orgenesis Releases Investor Presentation and Regulatory Update,Orgenesis announces results for study of CD19 CAR-T therapy,Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia,Biotech Alert: Searches spiking for these stocks today,Orgenesis announces JV partnership with Harley Street Healthcare Group,Orgenesis Releases Investor Presentation and Regulatory Update Orgenesis announces results for study of CD19 CAR-T therapy Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia Biotech Alert: Searches spiking for these stocks today Orgenesis announces JV partnership with Harley Street Healthcare Group,0,0,0,1,1,1
15.51M,"94,482",-366.32M,-1,77,3.380,Buy,7.50,"Aug 8, 2024",ICCM,IceCure Medical Ltd,34.39M,0.72,3.34M,5.92%,-3.41%,-33.43%,-7.29%,-47.79%,IceCure Medical Strengthens Patent Portfolio,Icecure Medical Poised for Growth: A Comprehensive Buy Recommendation,Icecure Medical: A Strong Buy on Robust Financials and Regulatory Advancements,Icecure Medical Reports Mid-Year Financial Dip,IceCure Medical’s 1H24 ProSense System and probe sales up 20%,IceCure Medical Strengthens Patent Portfolio Icecure Medical Poised for Growth: A Comprehensive Buy Recommendation Icecure Medical: A Strong Buy on Robust Financials and Regulatory Advancements Icecure Medical Reports Mid-Year Financial Dip IceCure Medical’s 1H24 ProSense System and probe sales up 20%,0,0,0,0,1,0
323.00M,"546,411",-12.62M,-1,14,0.164,,,"Sep 3, 2024",OCUP,"Ocuphire Pharma, Inc.",34.32M,1.31,16.45M,-20.66%,-26.88%,-43.70%,-38.69%,-36.13%,Ocuphire Pharma initiates VEGA-3 Phase 3 trial,Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX) and Ocuphire Pharma (OCUP),"Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Chimerix (CMRX) and Mersana Therapeutics (MRSN)",Ocuphire Pharma price target lowered to $18 from $20 at H.C. Wainwright,Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update,"Ocuphire Pharma initiates VEGA-3 Phase 3 trial Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX) and Ocuphire Pharma (OCUP) Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Chimerix (CMRX) and Mersana Therapeutics (MRSN) Ocuphire Pharma price target lowered to $18 from $20 at H.C. Wainwright Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update",0,0,0,0,0,0
14.50M,"380,231",-1.14M,-1,78,3.600,,,,FRGT,"Freight Technologies, Inc.",34.25M,0.21,17.06M,-0.96%,-27.40%,-87.47%,-18.89%,-84.79%,Fr8Tech Announces Strong Mid-Year Growth and New Software,Freight Technologies sees FY24 revenue $15M-$20M,Freight Technologies Reports Strong Preliminary 2024 Mid-Year Results and Announces Exciting Advances in its Product Offerings,Freight Technologies Cancels $1.3M in Debt,Freight Technologies announces extinguishment of $1.1M of outstanding debt,Fr8Tech Announces Strong Mid-Year Growth and New Software Freight Technologies sees FY24 revenue $15M-$20M Freight Technologies Reports Strong Preliminary 2024 Mid-Year Results and Announces Exciting Advances in its Product Offerings Freight Technologies Cancels $1.3M in Debt Freight Technologies announces extinguishment of $1.1M of outstanding debt,1,1,1,1,1,1
33.43M,"77,228",-56.54M,-1,30,1.550,Buy,8.58,"Aug 13, 2024",MOVE,Movano Inc.,34.21M,0.35,852.00K,-9.65%,-8.71%,-39.55%,-22.36%,-43.26%,Movano reports on FDA meeting on EvieMED Ring application,Movano Health Reports Q2 2024 Financial Results and Provides Business Update,,,,Movano reports on FDA meeting on EvieMED Ring application Movano Health Reports Q2 2024 Financial Results and Provides Business Update,0,0,0,-1,-1,-1
4.44M,"2,752",-3.63M,-1,201,11.67,,,"Jul 31, 2024",AZ,A2Z Smart Technologies Corp.,34.11M,0.65,7.14M,-14.87%,-3.43%,-26.31%,-19.99%,+23.08%,A2Z Unveils Next-Gen Smart Carts in Paris Monoprix,A2Z Cust2Mate launches smart carts at Monoprix in France,A2Z Smart Technologies Announces Key Corporate Updates,,,A2Z Unveils Next-Gen Smart Carts in Paris Monoprix A2Z Cust2Mate launches smart carts at Monoprix in France A2Z Smart Technologies Announces Key Corporate Updates,0,1,0,1,-1,-1
29.03M,"239,012",-74.73M,-1,8,1.780,,,,TURN,180 Degree Capital Corp.,33.90M,3.39,129.30K,-0.46%,-4.55%,-13.10%,-3.30%,-19.30%,180 Degree Capital notes average discount of NAV per share to stock price,180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Eighth Month of Initial Measurement Period of Its Discount Management Program,180 Degree Capital reports NAV of $4.50 as of June 30,"180 Degree Capital Corp. Reports Net Asset Value Per Share (“NAV”) of $4.50 as of June 30, 2024","180 Degree Capital Corp. to Report Second Quarter 2024 Financial Results on Monday, August 19, 2024, and to Host a Conference Call on Tuesday, August 20, 2024","180 Degree Capital notes average discount of NAV per share to stock price 180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Eighth Month of Initial Measurement Period of Its Discount Management Program 180 Degree Capital reports NAV of $4.50 as of June 30 180 Degree Capital Corp. Reports Net Asset Value Per Share (“NAV”) of $4.50 as of June 30, 2024 180 Degree Capital Corp. to Report Second Quarter 2024 Financial Results on Monday, August 19, 2024, and to Host a Conference Call on Tuesday, August 20, 2024",0,0,0,0,0,0
23.83M,"28,111",-29.02M,-1,12,2.150,Strong Buy,8.00,"Aug 14, 2024",NCNC,noco-noco Inc.,33.90M,0.19,-,-2.25%,-2.06%,-10.94%,-38.92%,-29.94%,noco-noco Inc Announces Grant of Temporary Exception to remain listed on Nasdaq,noco-noco announces grant of temporary exception to remain listed on Nasdaq,noco-noco Inc. Announces Key Shareholder Meeting,noco-noco Inc Risks Nasdaq Delisting,noco-noco Inc. Secures $4.6M Share Subscription,noco-noco Inc Announces Grant of Temporary Exception to remain listed on Nasdaq noco-noco announces grant of temporary exception to remain listed on Nasdaq noco-noco Inc. Announces Key Shareholder Meeting noco-noco Inc Risks Nasdaq Delisting noco-noco Inc. Secures $4.6M Share Subscription,1,1,1,1,1,1
19.08M,"25,706",-26.31M,-1,7,2.690,Strong Buy,11.00,"Aug 14, 2024",XTLB,XTL Biopharmaceuticals Ltd.,33.23M,2.65,-,-1.26%,3.75%,43.78%,-12.19%,-21.47%,XTL Biopharmaceuticals Expands with AI Company Acquisition,XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million,XTL Biopharmaceuticals completes acquisition of The Social Proxy,,,XTL Biopharmaceuticals Expands with AI Company Acquisition XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million XTL Biopharmaceuticals completes acquisition of The Social Proxy,1,0,1,1,-1,-1
41.72M,"37,545",-27.65M,-1,175,1.220,Hold,1.58,"Aug 14, 2024",GAME,"GameSquare Holdings, Inc.",33.06M,1.06,84.16M,-4.76%,-6.30%,-26.61%,-8.11%,-39.64%,"FaZe Media enters multi-year sponsorship, licensing deal with G Fuel","FaZe Clan, Rollbit announce multi-year expansion of sponsorship deal","Zoned, 5-Hour ENERGY partner to host Fortnite competition",,,"FaZe Media enters multi-year sponsorship, licensing deal with G Fuel FaZe Clan, Rollbit announce multi-year expansion of sponsorship deal Zoned, 5-Hour ENERGY partner to host Fortnite competition",1,1,1,0,-1,-1
21.99M,"136,970",7.46M,-1,85,2.330,Strong Buy,5.17,"Aug 13, 2024",POCI,"Precision Optics Corporation, Inc.",33.02M,5.20,19.41M,-9.18%,-14.57%,-13.67%,-12.62%,-6.90%,"Precision Optics to sell 265,868 shares at $5.25 in registered direct offering",,,,,"Precision Optics to sell 265,868 shares at $5.25 in registered direct offering",1,0,-1,-1,-1,-1
26.77M,"78,279",-78.01M,-1,32,1.910,,,"Aug 7, 2024",GANX,"Gain Therapeutics, Inc.",32.94M,1.29,-,14.69%,10.25%,-52.77%,+24.07%,-62.36%,Buy Rating Affirmed for Gain Therapeutics on Promising Phase 1 Results and Solid Financial Outlook,"Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease",Gain Therapeutics announces reuslts from Phase 1 study of GT-02287,Gain Therapeutics assumed with an Outperform at Oppenheimer,,"Buy Rating Affirmed for Gain Therapeutics on Promising Phase 1 Results and Solid Financial Outlook Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease Gain Therapeutics announces reuslts from Phase 1 study of GT-02287 Gain Therapeutics assumed with an Outperform at Oppenheimer",0,0,0,0,0,-1
3.72M,"55,240",-105.10M,-1,72,13.70,Buy,26.88,"Sep 5, 2024",ESGL,ESGL Holdings Limited,32.89M,1.43,6.22M,4.94%,11.16%,82.25%,+12.14%,+204.57%,ESGL Holdings Announces Multi-Million Share Sale,,,,,ESGL Holdings Announces Multi-Million Share Sale,0,1,-1,-1,-1,-1
63.49M,"285,642",-56.14M,-1,41,0.798,Strong Buy,4.90,"Sep 3, 2024",ANTX,"AN2 Therapeutics, Inc.",32.83M,1.10,-,-29.35%,-45.12%,-84.96%,-55.69%,-62.46%,AN2 Therapeutics adopts limited duration stockholder rights plan,Strong Cash Reserves and Promising Pipeline Justify Buy Rating for AN2 Therapeutics,"Oppenheimer Sticks to Their Hold Rating for AN2 Therapeutics, Inc. (ANTX)","AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)",,"AN2 Therapeutics adopts limited duration stockholder rights plan Strong Cash Reserves and Promising Pipeline Justify Buy Rating for AN2 Therapeutics Oppenheimer Sticks to Their Hold Rating for AN2 Therapeutics, Inc. (ANTX) AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)",0,0,1,0,1,-1
2.50M,"2,924",43.02M,-1,45,20.20,,,"Jul 31, 2024",MLEC,Moolec Science SA,32.76M,0.87,5.01M,-2.06%,-11.54%,-45.81%,-12.49%,-30.57%,Moolec Science and Bunge’s Strategic Safflower Venture,,,,,Moolec Science and Bunge’s Strategic Safflower Venture,1,0,-1,-1,-1,-1
14.75M,"8,675",-2.64M,-1,8,3.400,Strong Buy,4.50,"Aug 14, 2024",MRKR,"Marker Therapeutics, Inc.",32.70M,3.67,3.73M,-6.55%,-20.85%,-13.90%,-27.61%,-24.20%,Marker Therapeutics Excels in Lymphoma Treatment Study,Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates,Marker Therapeutics Receives $2M NIH Grant for Lymphoma Study,Marker Therapeutics awarded $2M grant from NIH SBIR program,Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma,Marker Therapeutics Excels in Lymphoma Treatment Study Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Marker Therapeutics Receives $2M NIH Grant for Lymphoma Study Marker Therapeutics awarded $2M grant from NIH SBIR program Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma,0,1,0,1,1,1
4.55M,"1,075","944,925",-1,46,11.02,,,,PODC,"PodcastOne, Inc.",32.67M,1.36,45.82M,-2.61%,-6.51%,-23.76%,+2.65%,-26.54%,"PodcastOne renews exclusive sales agreement with Welch, Sullivan","PodcastOne, Nic and Ryan Nemeth announce joint venture",PodcastOne (Nasdaq: PODC) and Nic and Ryan Nemeth Tag Team for Joint Venture Nemeth Bros Podcast,Courtside Group Eyes Acquisitions Amid Market Uncertainties,"LiveOne provides updates on cash position, repurchasing program","PodcastOne renews exclusive sales agreement with Welch, Sullivan PodcastOne, Nic and Ryan Nemeth announce joint venture PodcastOne (Nasdaq: PODC) and Nic and Ryan Nemeth Tag Team for Joint Venture Nemeth Bros Podcast Courtside Group Eyes Acquisitions Amid Market Uncertainties LiveOne provides updates on cash position, repurchasing program",1,0,1,1,0,0
,,,-1,"1,071",,,,,ASPS,Altisource Portfolio Solutions S.A.,32.53M,1.20,148.96M,-4.88%,-10.07%,-49.43%,-10.53%,-30.81%,,,,,,,1,-1,-1,-1,-1,-1
21.67M,"29,648",-25.22M,-1,,2.320,Strong Buy,19.00,"Aug 14, 2024",MTEN,Mingteng International Corporation Inc.,32.53M,5.24,8.16M,20.95%,47.66%,22.56%,+42.74%,,,,,,,,0,-1,-1,-1,-1,-1
28.21M,"98,615",-114.64M,-1,"1,210",1.780,Buy,6.13,"Aug 8, 2024",APWC,Asia Pacific Wire & Cable Corporation Limited,32.48M,1.58,425.77M,-6.63%,-6.87%,-0.01%,-7.84%,+9.28%,APWC Reports Revenue Growth Amidst Profitability Challenges,Asia Pacific Wire & Cable Corp reports 1H24 EPS (2c) vs. 0c last year,,,,APWC Reports Revenue Growth Amidst Profitability Challenges Asia Pacific Wire & Cable Corp reports 1H24 EPS (2c) vs. 0c last year,0,1,1,-1,-1,-1
10.76M,"81,848",-17.75M,-1,5,4.650,Hold,,"Aug 8, 2024",ALTS,ALT5 Sigma Corporation,32.43M,2.54,2.17M,25.99%,19.45%,29.86%,+40.61%,-7.20%,ALT5 Sigma Corporation Appoints Tassiopoulos as New CEO,ALT5 Sigma Corporation appoints Peter Tassiopoulus as CEO,ALT5 Sigma Corporation reports 114% y/y increase in July transaction volume,,,ALT5 Sigma Corporation Appoints Tassiopoulos as New CEO ALT5 Sigma Corporation appoints Peter Tassiopoulus as CEO ALT5 Sigma Corporation reports 114% y/y increase in July transaction volume,1,1,1,1,-1,-1
8.52M,"10,165",3.06M,-1,,5.87,,,"Apr 30, 2024",MOBX,"Mobix Labs, Inc.",32.42M,1.06,3.92M,17.06%,-9.70%,-66.08%,-6.50%,-40.41%,Mobix Lab files to sell 8.83M shares of common stock for holders,,,,,Mobix Lab files to sell 8.83M shares of common stock for holders,1,1,-1,-1,-1,-1
31.95M,"176,275",-5.15M,-1,31,1.560,Strong Buy,2.75,"Sep 12, 2024",INKT,"MiNK Therapeutics, Inc.",32.42M,0.82,-,-2.58%,-8.42%,-13.98%,-15.44%,-49.04%,MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference,"Analysts Conflicted on These Healthcare Names: MiNK Therapeutics (INKT), Silence Therapeutics (SLN) and Mersana Therapeutics (MRSN)",MiNK Therapeutics files to sell 4.64M shares of common stock for holders,MiNK Therapeutics’ Promising Clinical Trials and Strategic Expansion Set to Enhance Stock Value,"MiNK Therapeutics reports Q2 EPS (7c), consensus (10c)","MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference Analysts Conflicted on These Healthcare Names: MiNK Therapeutics (INKT), Silence Therapeutics (SLN) and Mersana Therapeutics (MRSN) MiNK Therapeutics files to sell 4.64M shares of common stock for holders MiNK Therapeutics’ Promising Clinical Trials and Strategic Expansion Set to Enhance Stock Value MiNK Therapeutics reports Q2 EPS (7c), consensus (10c)",0,0,1,1,0,1
26.30M,"27,812",-24.18M,-1,317,1.900,Strong Buy,6.00,"Aug 20, 2024",NAII,"Natural Alternatives International, Inc.",32.37M,5.22,120.20M,3.18%,-2.08%,-9.09%,-5.76%,-19.16%,CarnoSyn Brands showcases TriBsyn at 46th ESPEN Congresss,CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism,,,,CarnoSyn Brands showcases TriBsyn at 46th ESPEN Congresss CarnoSyn® Brands Showcasing TriBsyn™ at the 46th ESPEN Congress On Clinical Nutrition & Metabolism,0,1,1,-1,-1,-1
39.42M,"65,760",-183.17M,-1,"2,245",1.260,,,"Sep 3, 2024",GTIM,Good Times Restaurants Inc.,32.37M,3.01,140.81M,12.86%,17.21%,20.49%,+15.99%,+22.35%,,,,,,,1,-1,-1,-1,-1,-1
2.75M,"21,629",-2.07M,-1,490,17.94,,,"Aug 8, 2024",QH,Quhuo Limited,32.36M,0.36,522.13M,-3.65%,-15.69%,-58.91%,-26.29%,-42.79%,Quhuo files to sell 79.39M American depositary shares for holders,"Quhuo International, Get Holdings establish pact in Azerbaijan with Volt Auto",Quhuo Limited Reports Mid-Year Financials,Quhuo Reports Unaudited Financial Results for the First Half of 2024,Quhuo Announces Unaudited Financial Results for the First Half of 2024: Precise Strategy Spurs Strong Growth in Mobility Service and Homestay,"Quhuo files to sell 79.39M American depositary shares for holders Quhuo International, Get Holdings establish pact in Azerbaijan with Volt Auto Quhuo Limited Reports Mid-Year Financials Quhuo Reports Unaudited Financial Results for the First Half of 2024 Quhuo Announces Unaudited Financial Results for the First Half of 2024: Precise Strategy Spurs Strong Growth in Mobility Service and Homestay",0,1,1,1,1,1
16.04M,"38,881",-26.58M,-1,20,3.080,Hold,2.50,"Aug 12, 2024",ONMD,OneMedNet Corporation,32.34M,1.03,1.02M,-11.04%,-2.95%,-16.85%,-28.37%,+26.25%,OneMedNet Announces CFO Transition and New Appointment,"OneMedNet Board Changes: Huh Resigns, Zeinfeld Appointed","OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X",,,"OneMedNet Announces CFO Transition and New Appointment OneMedNet Board Changes: Huh Resigns, Zeinfeld Appointed OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X",0,0,1,1,-1,-1
4.53M,16,2.12M,-1,,10.88,,,,DECA,Denali Capital Acquisition Corp.,32.31M,11.48,-,0.48%,27.24%,34.59%,+0.97%,+88.20%,Denali Capital Merges with Semnur in $2.5 Billion Deal,"Denali Capital Acquisition, Semnur Pharmaceuticals sing merger agreement","Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination",Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination,,"Denali Capital Merges with Semnur in $2.5 Billion Deal Denali Capital Acquisition, Semnur Pharmaceuticals sing merger agreement Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination",0,0,0,0,1,-1
,,,-1,,,,,,ABVE,Above Food Ingredients Inc.,32.24M,1.13,275.38M,-18.28%,-68.21%,-87.74%,-26.16%,-91.60%,Above Food management to meet virtually with Roth MKM,Above Food Ingredients Seeks New Insurance Coverage,Above Food Strengthens its Pet Food Ingredient Platform with Recent Montana-Based Asset Acquisition,Above Food announces additional details regarding TRG acquisition,Above Food’s Seed Labs collaborates with BASF Canada,Above Food management to meet virtually with Roth MKM Above Food Ingredients Seeks New Insurance Coverage Above Food Strengthens its Pet Food Ingredient Platform with Recent Montana-Based Asset Acquisition Above Food announces additional details regarding TRG acquisition Above Food’s Seed Labs collaborates with BASF Canada,0,0,0,0,0,0
57.29M,"482,813",-23.77M,-1,23,0.857,Buy,2.33,"Jul 30, 2024",ATGL,Alpha Technology Group Limited,32.20M,2.11,1.11M,-20.76%,-24.34%,-66.53%,-37.85%,-34.55%,,,,,,,1,-1,-1,-1,-1,-1
10.31M,"55,368",4.21M,$0.32,15,4.760,,,"Aug 14, 2024",RVPH,"Reviva Pharmaceuticals Holdings, Inc.",32.07M,0.97,-,11.17%,-8.54%,-65.94%,-13.68%,-71.79%,Maxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH),Reviva Pharmaceuticals to hold a virtual key opinon leader event,Reviva to host KOL event on vocal biomarker data from RECOVER trial,Reviva Pharmaceuticals 4.76M share Secondary priced at $1.05,Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules,Maxim Group Reaffirms Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH) Reviva Pharmaceuticals to hold a virtual key opinon leader event Reviva to host KOL event on vocal biomarker data from RECOVER trial Reviva Pharmaceuticals 4.76M share Secondary priced at $1.05 Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At-the-Market Under Nasdaq Rules,0,0,0,0,0,0
4.47M,3,1.75M,-1,77,10.95,,,,STRM,"Streamline Health Solutions, Inc.",31.96M,0.53,21.59M,15.71%,15.58%,34.52%,+4.65%,+17.39%,Craig-Hallum Keeps Their Buy Rating on Streamline Health Solutions (STRM),Streamline Health® To Report Fiscal Second Quarter 2024 Financial Performance,,,,Craig-Hallum Keeps Their Buy Rating on Streamline Health Solutions (STRM) Streamline Health® To Report Fiscal Second Quarter 2024 Financial Performance,0,0,0,-1,-1,-1
,,,-1,894,,,,,ICLK,iClick Interactive Asia Group Limited,31.95M,3.15,133.22M,1.12%,44.33%,7.71%,+13.16%,-23.41%,,,,,,,1,-1,-1,-1,-1,-1
11.78M,"2,985",-3.80M,-1,68,4.140,,,"Sep 26, 2024",IMRX,Immuneering Corporation,31.73M,1.07,-,-0.79%,-7.28%,-69.52%,unch,-48.40%,,,,,,,1,-1,-1,-1,-1,-1
35.13M,"9,166",1.29M,-1,111,1.390,,,"Aug 9, 2024",IRIX,IRIDEX Corporation,31.70M,1.92,49.70M,2.68%,-1.42%,-21.00%,-1.49%,-35.50%,Iridex files ot sell 4.95M shares of common stock for holders,,,,,Iridex files ot sell 4.95M shares of common stock for holders,1,1,-1,-1,-1,-1
5.56M,"5,703",-6.75M,-1,53,8.78,,,"Aug 8, 2024",AQMS,"Aqua Metals, Inc.",31.68M,0.23,25.00K,-3.08%,-22.54%,-55.39%,-25.51%,-65.78%,"Aqua Metals Arranges New Funding, Ends Prior Agreement",,,,,"Aqua Metals Arranges New Funding, Ends Prior Agreement",1,0,-1,-1,-1,-1
21.18M,"261,872",-5.17M,-1,24,2.300,,,"Aug 8, 2024",GLBS,Globus Maritime Limited,31.59M,1.54,30.34M,-5.09%,-13.41%,-27.63%,-11.49%,-28.37%,Globus Maritime Schedules Annual Shareholder Meeting,Globus Maritime Announces Annual Meeting of Shareholders,,,,Globus Maritime Schedules Annual Shareholder Meeting Globus Maritime Announces Annual Meeting of Shareholders,0,0,0,-1,-1,-1
52.02M,"383,275",-37.36M,-1,314,0.936,,,"Aug 14, 2024",MYNA,Mynaric AG,31.54M,1.23,5.96M,-70.02%,-73.07%,-78.64%,-77.73%,-79.67%,"Space stock Mynaric tanks after slashing annual revenue guidance, CFO leaves",Mynaric AG Undergoes Management Shake-Up,"Mynaric CEO Mustafa Veziroglu departs, Andreas Reif appointed as CRO",Mynaric AG Adjusts 2024 Financial Forecasts,,"Space stock Mynaric tanks after slashing annual revenue guidance, CFO leaves Mynaric AG Undergoes Management Shake-Up Mynaric CEO Mustafa Veziroglu departs, Andreas Reif appointed as CRO Mynaric AG Adjusts 2024 Financial Forecasts",0,1,0,1,0,-1
4.17M,"97,176",-26.14M,-1,155,11.65,,,"Aug 14, 2024",AAME,Atlantic American Corporation,31.42M,1.54,186.00M,3.98%,-0.61%,-21.63%,+1.30%,-28.44%,Atlantic American Corporation Reports Second Quarter Results for 2024,,,,,Atlantic American Corporation Reports Second Quarter Results for 2024,1,1,-1,-1,-1,-1
38.19M,"67,642",-6.51M,-1,72,1.270,,,"Aug 19, 2024",FTEK,"Fuel Tech, Inc.",31.32M,1.02,26.33M,2.46%,-0.41%,-6.02%,-1.95%,-18.52%,Fuel Tech Releases Corporate Presentation for Investors,,,,,Fuel Tech Releases Corporate Presentation for Investors,0,1,-1,-1,-1,-1
4.13M,"2,666",3.72M,-1,2,11.70,,,,GRYP,"Gryphon Digital Mining, Inc.",31.31M,0.77,24.57M,2.75%,-20.76%,-74.08%,-18.94%,-44.71%,"Gryphon Digital Mining Faces Nasdaq Delisting Risk, Updates Investors",Gryphon Digital Mining expects to have produced 20 bitcoin in August,"Gryphon Digital Mining Expands Board, Amends Purchase Agreement",Crypto Currents: Bitfarms to acquire Stronghold in stock-for-stock merger,H.C. Wainwright Sticks to Their Hold Rating for Gryphon Digital Mining (GRYP),"Gryphon Digital Mining Faces Nasdaq Delisting Risk, Updates Investors Gryphon Digital Mining expects to have produced 20 bitcoin in August Gryphon Digital Mining Expands Board, Amends Purchase Agreement Crypto Currents: Bitfarms to acquire Stronghold in stock-for-stock merger H.C. Wainwright Sticks to Their Hold Rating for Gryphon Digital Mining (GRYP)",0,0,0,0,0,0
4.11M,195,3.90M,-1,213,11.64,,,,FTCI,"FTC Solar, Inc.",31.28M,0.25,77.77M,-13.36%,-27.48%,-48.12%,-41.47%,-55.71%,FTC Solar to Participate at RE+ Event September 9-12,FTC Solar Welcomes New Director and Audit Committee Member,FTC Solar Announces Inducement Grant of Employee Inducement Award,FTC Solar Appoints Pablo Barahona to Board of Directors,FTC Solar appoints Pablo Barahona to board of directors,FTC Solar to Participate at RE+ Event September 9-12 FTC Solar Welcomes New Director and Audit Committee Member FTC Solar Announces Inducement Grant of Employee Inducement Award FTC Solar Appoints Pablo Barahona to Board of Directors FTC Solar appoints Pablo Barahona to board of directors,0,0,0,0,0,0
,,,-1,362,,,,,HUDI,"Huadi International Group Co., Ltd.",31.05M,2.18,83.46M,-5.34%,-8.52%,-20.07%,-17.24%,-18.80%,,,,,,,1,-1,-1,-1,-1,-1
36.38M,"13,935",-6.09M,-1,87,1.350,,,"Sep 3, 2024",WHLM,"Wilhelmina International, Inc.",30.94M,6.00,17.00M,-2.63%,-2.94%,14.56%,-4.02%,+26.79%,Wilhelmina trading resumes,"Wilhelmina trading halted, volatility trading pause",,,,"Wilhelmina trading resumes Wilhelmina trading halted, volatility trading pause",0,0,0,-1,-1,-1
,,,-1,108,,,,,LFWD,ReWalk Robotics Ltd.,30.90M,3.52,23.28M,-8.31%,-11.77%,-32.82%,-27.73%,-40.14%,"Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury",ReWalk Robotics Approves Directors and Company Renaming at Annual Meeting,Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference,"Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)",Lake Street Remains a Buy on Rewalk Robotics (LFWD),"Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury ReWalk Robotics Approves Directors and Company Renaming at Annual Meeting Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference Analysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI) Lake Street Remains a Buy on Rewalk Robotics (LFWD)",0,0,0,0,0,0
4.14M,"5,634","-617,603",-1,16,11.64,,,,BHAT,Blue Hat Interactive Entertainment Technology,30.89M,0.53,73.69M,0.67%,-31.35%,-41.01%,-32.30%,-46.02%,Blue Hat Interactive announces execution of $66.49M gold acquisition,Blue Hat Announced Execution of $66.49 Million Gold Acquisition,Blue Hat Interactive expands into gold trading with partnerships,Blue Hat Expands into Gold Trading with Strategic Partnerships As Gold Prices Rise Amid Economic Optimism,,Blue Hat Interactive announces execution of $66.49M gold acquisition Blue Hat Announced Execution of $66.49 Million Gold Acquisition Blue Hat Interactive expands into gold trading with partnerships Blue Hat Expands into Gold Trading with Strategic Partnerships As Gold Prices Rise Amid Economic Optimism,0,1,1,1,1,-1
,,,-1,124,,,,,BTM,Bitcoin Depot Inc.,30.87M,1.73,629.50M,-4.24%,-6.39%,-23.91%,-2.96%,-6.29%,The big risks of bitcoin ATMs,Here’s What You Missed in Crypto This Week,"Bitcoin Depot to Present at the 2024 Gateway Conference on September 5th, 2024",Bitcoin Depot reports Q2 revenue $163.1M vs. $197.5M last year,"BTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?","The big risks of bitcoin ATMs Here’s What You Missed in Crypto This Week Bitcoin Depot to Present at the 2024 Gateway Conference on September 5th, 2024 Bitcoin Depot reports Q2 revenue $163.1M vs. $197.5M last year BTM Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,1,0,1,1,1
16.35M,"17,491","915,422",-1,261,2.900,,,"Sep 6, 2024",MOGO,Mogo Inc.,30.75M,1.28,30.11M,-2.64%,-11.76%,-24.41%,-10.87%,-38.50%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,"1,770",,,,,NTWK,"NetSol Technologies, Inc.",30.68M,2.69,58.73M,-1.12%,-1.46%,5.24%,-7.14%,-11.26%,,,,,,,0,-1,-1,-1,-1,-1
15.81M,"131,158",-4.85M,-1,30,3.030,Strong Buy,11.00,"Jul 12, 2024",MIGI,Mawson Infrastructure Group Inc.,30.61M,1.65,57.23M,15.29%,5.46%,-1.18%,+15.57%,+11.02%,Mawson Infrastructure Announces Expansion and Diversified Growth Strategy,Mawson Infrastructure Group Expands to Ohio for AI/HPC Expansion,Mawson Infrastructure announces expansion of lease in Phio,Mawson Infrastructure Group Inc. Announces Monthly Operational Update for July 2024,Mawson Infrastructure reports July revenue $3.94M,Mawson Infrastructure Announces Expansion and Diversified Growth Strategy Mawson Infrastructure Group Expands to Ohio for AI/HPC Expansion Mawson Infrastructure announces expansion of lease in Phio Mawson Infrastructure Group Inc. Announces Monthly Operational Update for July 2024 Mawson Infrastructure reports July revenue $3.94M,0,0,0,0,0,0
2.58M,"5,591",10.82M,$1.16,,18.91,,,"Aug 6, 2024",QOMO,Qomolangma Acquisition Corp.,30.56M,12.22,-,2.40%,4.84%,9.93%,+5.42%,+11.69%,Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q,Qomolangma Acquisition announces receipt of notice from Nasdaq,,,,Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q Qomolangma Acquisition announces receipt of notice from Nasdaq,1,0,1,-1,-1,-1
59.11M,"330,002",-39.70M,-1,37,0.809,Strong Buy,7.80,"Aug 6, 2024",ELBM,Electra Battery Materials Corporation,30.51M,0.54,-,45.30%,41.35%,30.62%,+65.84%,+28.04%,Electra Engages in Global Battery Material Supply Talks,Electra to Discuss Partnership Opportunities at Indonesian Critical Minerals Summit,Electra to discuss opportunities at Indonesian Critical Minerals Summit,Electra Battery Materials Bolsters Strategic Market Position,Electra Battery signs strategic advisory agreement with Altitude Capital,Electra Engages in Global Battery Material Supply Talks Electra to Discuss Partnership Opportunities at Indonesian Critical Minerals Summit Electra to discuss opportunities at Indonesian Critical Minerals Summit Electra Battery Materials Bolsters Strategic Market Position Electra Battery signs strategic advisory agreement with Altitude Capital,0,0,0,0,0,1
22.81M,"315,678",-49.27M,-1,215,2.090,Strong Buy,16.33,"Aug 13, 2024",ACHL,Achilles Therapeutics plc,30.47M,0.74,-,-1.76%,-7.18%,-17.99%,-13.50%,-14.73%,Achilles Therapeutics Excels in Q2 with Promising Trials,Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year,Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates,,,Achilles Therapeutics Excels in Q2 with Promising Trials Achilles Therapeutics reports Q2 EPS (41c) vs (42c) last year Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates,1,1,1,0,-1,-1
10.92M,"63,189",-1.90M,-1,26,4.350,Strong Buy,10.50,"Aug 12, 2024",DARE,"Daré Bioscience, Inc.",30.34M,3.55,2.84M,-0.63%,-8.72%,-22.48%,-0.73%,-42.32%,Dare Bioscience announces publication in The Journal of Sexual Medicine,Daré Bioscience (DARE) was downgraded to a Hold Rating at Maxim Group,Biotech Alert: Searches spiking for these stocks today,Dare Bioscience downgraded to Hold from Buy at Maxim,Wall Street Analysts Are Bullish on Top Healthcare Picks,Dare Bioscience announces publication in The Journal of Sexual Medicine Daré Bioscience (DARE) was downgraded to a Hold Rating at Maxim Group Biotech Alert: Searches spiking for these stocks today Dare Bioscience downgraded to Hold from Buy at Maxim Wall Street Analysts Are Bullish on Top Healthcare Picks,1,1,1,1,1,1
30.02M,"83,235",-9.40M,-1,175,1.450,Strong Buy,2.50,"Aug 15, 2024",FGF,Fundamental Global Inc.,29.99M,1.05,33.50M,5.34%,4.31%,-18.16%,+4.48%,-27.27%,"Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A",,,,,"Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A",1,0,-1,-1,-1,-1
30.91M,"4,945",-5.00M,-1,,1.530,,,"Aug 12, 2024",AIEV,"Thunder Power Holdings, Inc.",29.87M,0.62,-,0.64%,-60.74%,-92.68%,-4.21%,-94.16%,Thunder Power Reports Unaudited Second Quarter 2024 Financial Results,Thunder Power Holdings Secures $100M Investment Deal,,,,Thunder Power Reports Unaudited Second Quarter 2024 Financial Results Thunder Power Holdings Secures $100M Investment Deal,0,0,0,-1,-1,-1
14.50M,"1,564",2.49M,-1,33,3.090,,,"Sep 3, 2024",LUMO,"Lumos Pharma, Inc.",29.65M,3.65,1.49M,57.29%,81.48%,44.94%,+117.74%,+47.81%,Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference,,,,,Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference,0,0,-1,-1,-1,-1
41.54M,"179,794",-72.50M,-1,28,1.130,Strong Buy,8.00,"Aug 8, 2024",CGTX,"Cognition Therapeutics, Inc.",29.62M,0.74,-,-2.67%,-50.83%,-60.60%,-31.50%,-66.59%,Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences,Cognition Therapeutics Shares Investor Presentation Update,Cognition Therapeutics announces results from the SEQUEL study of CT1812,Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease,,Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences Cognition Therapeutics Shares Investor Presentation Update Cognition Therapeutics announces results from the SEQUEL study of CT1812 Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease,1,0,0,0,0,-1
10.76M,"5,557","-764,000",-1,6,4.360,,,"Aug 13, 2024",RAY,Raytech Holding Limited,29.58M,1.69,8.56M,-35.75%,-50.08%,-53.26%,-57.55%,,,,,,,,0,-1,-1,-1,-1,-1
39.41M,"24,905",-63.79M,-1,"3,509",1.250,Strong Buy,4.00,"Aug 8, 2024",CLPS,CLPS Incorporation,29.51M,1.06,145.37M,33.63%,29.67%,16.08%,+44.64%,+13.55%,,,,,,,0,-1,-1,-1,-1,-1
41.49M,"83,368",-73.88M,-1,142,1.130,Buy,8.30,"Aug 8, 2024",GRRR,Gorilla Technology Group Inc.,29.33M,2.64,64.69M,15.29%,5.00%,-48.81%,+14.72%,-63.81%,Gorilla Technology Welcomes New Interim CFO,,,,,Gorilla Technology Welcomes New Interim CFO,0,0,-1,-1,-1,-1
16.21M,"193,373",-58.08M,-1,203,2.890,Strong Buy,3.50,"Aug 13, 2024",STIM,"Neuronetics, Inc.",29.24M,0.97,72.07M,-31.13%,-44.17%,-65.19%,-53.04%,-78.48%,Neuronetics honors Suicide Prevention Month,Neuronetics announces two-year anniversary of NeuroStar University,Neuronetics Virtual Event to Discuss Greenbrook Merger Risks,Neuronetics Outlines Future Plans and Merger Prospects,Neuronetics price target lowered to $3 from $7 at JMP Securities,Neuronetics honors Suicide Prevention Month Neuronetics announces two-year anniversary of NeuroStar University Neuronetics Virtual Event to Discuss Greenbrook Merger Risks Neuronetics Outlines Future Plans and Merger Prospects Neuronetics price target lowered to $3 from $7 at JMP Securities,1,0,0,0,0,1
191.17M,"503,213",-9.92M,-1,8,0.245,,,"Aug 19, 2024",NRBO,"NeuroBo Pharmaceuticals, Inc.",28.86M,3.40,-,-8.02%,-16.84%,-14.98%,-14.50%,-10.31%,Buy Rating for NeuroBo Pharmaceuticals Based on Financial Stability and Promising Developmental Pipeline,"NeuroBo Pharmaceuticals reports Q2 EPS ($1.85), consensus ($1.12)",NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update,NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial,NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726,"Buy Rating for NeuroBo Pharmaceuticals Based on Financial Stability and Promising Developmental Pipeline NeuroBo Pharmaceuticals reports Q2 EPS ($1.85), consensus ($1.12) NeuroBo Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Update NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726",1,1,0,0,0,0
9.68M,"26,087",9.69M,-1,79,4.830,Hold,5.25,"Aug 6, 2024",ICCC,ImmuCell Corporation,28.83M,3.68,23.22M,9.87%,1.53%,-12.67%,-6.40%,-26.50%,"ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024",,,,,"ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024",0,0,-1,-1,-1,-1
10.76M,"20,837",-38.67M,-1,36,4.340,Buy,10.00,"Aug 13, 2024",SLNH,"Soluna Holdings, Inc.",28.78M,5.00,38.14M,4.26%,-11.46%,30.17%,-16.83%,+58.09%,,,,,,,1,-1,-1,-1,-1,-1
81.99M,"45,199,000",-11.48M,-1,140,0.569,,,"Sep 3, 2024",TKLF,"Yoshitsu Co., Ltd",28.71M,0.68,195.68M,0.83%,33.33%,43.95%,+11.77%,+153.98%,Yoshitsu files to sell 5.97M American depositary shares for holders,Yoshitsu estanblishes franchise network for Southeast Asia expansion,"Yoshitsu Co., Ltd Establishes Franchise Network for Southeast Asia Expansion",,,"Yoshitsu files to sell 5.97M American depositary shares for holders Yoshitsu estanblishes franchise network for Southeast Asia expansion Yoshitsu Co., Ltd Establishes Franchise Network for Southeast Asia Expansion",1,1,1,1,-1,-1
14.40M,"17,503","-76,043",$0.59,325,3.260,,,"Sep 16, 2024",GTEC,Greenland Technologies Holding Corporation,28.68M,2.11,90.36M,16.10%,22.15%,-11.05%,+19.39%,-7.94%,"3 Penny Stocks to Watch Now, 8/20/24",Greenland Reports 99.7% YoY Increase in 2Q 2024 Net Income,,,,"3 Penny Stocks to Watch Now, 8/20/24 Greenland Reports 99.7% YoY Increase in 2Q 2024 Net Income",0,0,0,-1,-1,-1
,,,-1,32,,,,,QNCX,"Quince Therapeutics, Inc.",28.56M,0.66,-,5.09%,-1.92%,-29.71%,-12.59%,-36.05%,Quince Therapeutics announces Phase 3 ATTeST trial for A-T evaluated in Lancet,,,,,Quince Therapeutics announces Phase 3 ATTeST trial for A-T evaluated in Lancet,0,0,-1,-1,-1,-1
16.87M,"8,270",-53.43M,-1,260,2.760,Hold,4.00,"Aug 19, 2024",OESX,"Orion Energy Systems, Inc.",28.52M,0.87,92.87M,-10.20%,-17.10%,-10.51%,-20.37%,-4.44%,LED Lighting and EV Charging Solutions Provider Orion Energy Systems to Attend H.C. Wainwright Investment Conference Sept. 9th and 10th in New York City,,,,,LED Lighting and EV Charging Solutions Provider Orion Energy Systems to Attend H.C. Wainwright Investment Conference Sept. 9th and 10th in New York City,1,1,-1,-1,-1,-1
61.77M,"171,434",-76.57M,-1,5,0.753,Strong Buy,9.00,"Aug 8, 2024",CGBS,Crown LNG Holdings Limited,28.17M,0.40,-,-15.16%,-88.75%,-95.69%,-33.03%,,,,,,,,0,-1,-1,-1,-1,-1
9.66M,"39,844",61.64M,-1,679,4.810,,,"Aug 8, 2024",BRLT,"Brilliant Earth Group, Inc.",28.16M,2.10,441.26M,-13.68%,-14.62%,-28.38%,-20.00%,-30.74%,Brilliant Earth announces expansion of international shopping capabilities,Brilliant Earth Announces International Shopping Expansion Partners With Leading E-commerce Platform Global-e,Brilliant Earth Group (BRLT) Gets a Buy from Telsey Advisory,Brilliant Earth Announces Participation in Goldman Sachs 31st Annual Global Retailing Conference,"Brilliant Earth promotes Catlett to CBO, Dziesietnik to COO","Brilliant Earth announces expansion of international shopping capabilities Brilliant Earth Announces International Shopping Expansion Partners With Leading E-commerce Platform Global-e Brilliant Earth Group (BRLT) Gets a Buy from Telsey Advisory Brilliant Earth Announces Participation in Goldman Sachs 31st Annual Global Retailing Conference Brilliant Earth promotes Catlett to CBO, Dziesietnik to COO",0,0,0,0,0,0
3.97M,"5,926","289,115",-1,38,11.57,,,,GMM,Global Mofy Metaverse Limited,28.09M,0.93,33.99M,-2.49%,2.57%,-73.02%,-5.34%,-1.82%,Global Mofy Unveils 2024 Equity Incentive Plan,Global Mofy AI Adopts New Corporate Structure,,,,Global Mofy Unveils 2024 Equity Incentive Plan Global Mofy AI Adopts New Corporate Structure,1,0,1,-1,-1,-1
,,,-1,134,,,,,PLUR,Pluri Inc.,28.02M,5.20,341.00K,1.23%,0.54%,-1.18%,-1.86%,+16.00%,,,,,,,1,-1,-1,-1,-1,-1
53.56M,"871,028",-46.80M,-1,96,0.866,,,"Sep 3, 2024",EPOW,"Sunrise New Energy Co., Ltd.",27.97M,1.07,45.05M,24.45%,33.38%,18.16%,+66.67%,+24.26%,Sunrise New Energy Calls Meeting for Share Consolidation,"Sunrise Records 132% Surge in First-Half Sales Volume, Featured in Guizhou TV Report as a Leading Anode Materials Manufacturer",,,,"Sunrise New Energy Calls Meeting for Share Consolidation Sunrise Records 132% Surge in First-Half Sales Volume, Featured in Guizhou TV Report as a Leading Anode Materials Manufacturer",0,1,0,-1,-1,-1
3.60M,673,-9.80M,$0.75,"3,367",13.20,,,"Aug 12, 2024",CMLS,Cumulus Media Inc.,27.94M,1.65,833.62M,1.22%,-10.40%,-50.81%,-15.50%,-45.48%,Cumulus Media’s Westwood One Launches 38th Consecutive Season as the Exclusive Primetime Network Radio Partner of the NFL,The Dan Bongino Show to Drop Special Two-Hour Podcast on First Day of Hearings for House Republicans’ Independent Forum on the Assassination Attempt on Former President Donald J. Trump,Cumulus Media’s Westwood One Presents National Audio Coverage of the 2024 College Football Season,Cumulus Media Announces Leadership Changes to the Cumulus Podcast Network,,Cumulus Media’s Westwood One Launches 38th Consecutive Season as the Exclusive Primetime Network Radio Partner of the NFL The Dan Bongino Show to Drop Special Two-Hour Podcast on First Day of Hearings for House Republicans’ Independent Forum on the Assassination Attempt on Former President Donald J. Trump Cumulus Media’s Westwood One Presents National Audio Coverage of the 2024 College Football Season Cumulus Media Announces Leadership Changes to the Cumulus Podcast Network,0,0,1,1,1,-1
4.62M,"2,824",-4.57M,-1,3,9.88,,,"Aug 9, 2024",IXHL,Incannex Healthcare Inc.,27.94M,1.76,661.15K,4.44%,-18.43%,-42.03%,-7.85%,-45.85%,,,,,,,0,-1,-1,-1,-1,-1
7.21M,"6,282,917",-26.92M,-1,800,6.39,Strong Buy,15.33,"Aug 6, 2024",TOI,"The Oncology Institute, Inc.",27.92M,0.37,361.07M,-20.77%,-24.17%,-72.11%,-36.67%,-76.95%,,,,,,,0,-1,-1,-1,-1,-1
44.58M,"9,259",-6.08M,-1,294,1.030,,,"Aug 19, 2024",DRIO,DarioHealth Corp.,27.91M,0.93,19.15M,-9.60%,-22.76%,-43.34%,-24.07%,-39.26%,DarioHealth price target lowered to $3 from $5 at TD Cowen,DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability,,,,DarioHealth price target lowered to $3 from $5 at TD Cowen DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability,0,0,1,-1,-1,-1
11.95M,"14,328",-20.13M,-1,28,3.720,,,"Aug 19, 2024",AGMH,AGM Group Holdings Inc.,27.89M,1.15,92.91M,16.05%,48.86%,-17.63%,+48.68%,-29.81%,AGM Holdings Appoints New CEO for Canadian Growth,,,,,AGM Holdings Appoints New CEO for Canadian Growth,1,1,-1,-1,-1,-1
72.96M,"605,001",-98.57M,-1,"1,300",0.629,Buy,4.50,"Aug 13, 2024",GORV,"Lazydays Holdings, Inc.",27.77M,1.96,987.99M,-22.19%,-34.35%,-58.13%,-42.14%,-54.83%,Lazydays downgraded to Market Perform from Outperform at CJS Securities,Lazydays price target lowered to $2 from $4 at Truist,Lazydays reports Q2 EPS ($1.42) consensus (24c),LAZYDAYS REPORTS SECOND QUARTER 2024 RESULTS,Analysts Offer Insights on Consumer Cyclical Companies: Lazydays Holdings (GORV) and Dollar General (DG),Lazydays downgraded to Market Perform from Outperform at CJS Securities Lazydays price target lowered to $2 from $4 at Truist Lazydays reports Q2 EPS ($1.42) consensus (24c) LAZYDAYS REPORTS SECOND QUARTER 2024 RESULTS Analysts Offer Insights on Consumer Cyclical Companies: Lazydays Holdings (GORV) and Dollar General (DG),0,1,0,1,1,1
21.74M,"14,970","8,652",-1,43,2.100,,,"Sep 6, 2024",KALA,"KALA BIO, Inc.",27.69M,6.01,-,-0.68%,-5.35%,-11.56%,-9.23%,-22.37%,Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress,,,,,Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress,1,0,-1,-1,-1,-1
4.08M,"1,301","-187,466",-1,74,11.15,,,,BTAI,"BioXcel Therapeutics, Inc.",27.67M,0.68,2.40M,-17.91%,-36.49%,-72.88%,-46.00%,-77.26%,Bioxcel Therapeutics Earns Buy Rating on Promising Clinical Trials and Market Potential,BioXcel Therapeutics announces initiation of SERENITY Phase 3 trial,BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia,Bioxcel Therapeutics (BTAI) Receives a Hold from Mizuho Securities,,Bioxcel Therapeutics Earns Buy Rating on Promising Clinical Trials and Market Potential BioXcel Therapeutics announces initiation of SERENITY Phase 3 trial BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia Bioxcel Therapeutics (BTAI) Receives a Hold from Mizuho Securities,0,1,0,0,0,-1
,,,-1,10,,,,,VYNE,VYNE Therapeutics Inc.,27.58M,1.87,486.00K,-0.14%,-6.46%,-25.20%,-5.26%,-36.40%,Buy Rating for VYNE Therapeutics Amid Strong Financial Footing and Promising Clinical Trials,Buy Rating Affirmed for VYNE Therapeutics on Strong Financials and Promising Drug Trials,VYNE Therapeutics sees cash runway through end of 2025,VYNE Therapeutics reports Q2 EPS (22c) vs. ($3.09) last year,VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update,Buy Rating for VYNE Therapeutics Amid Strong Financial Footing and Promising Clinical Trials Buy Rating Affirmed for VYNE Therapeutics on Strong Financials and Promising Drug Trials VYNE Therapeutics sees cash runway through end of 2025 VYNE Therapeutics reports Q2 EPS (22c) vs. ($3.09) last year VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update,1,1,1,1,1,0
10.45M,"27,826",-1.24M,-1,14,4.350,Strong Buy,10.00,"Aug 14, 2024",ITRM,Iterum Therapeutics plc,27.47M,1.21,-,-6.55%,-9.22%,-25.12%,-7.95%,-37.50%,Buy Rating Justified for Iterum Therapeutics Amid Strong Sulopenem Prospects and Upcoming FDA Advisory Committee Review,Iterum Therapeutics price target lowered to $5 from $6 at H.C. Wainwright,Iterum Therapeutics Reports Second Quarter 2024 Financial Results,Iterum Therapeutics reports Q2 EPS (23c) vs (77c) last year,,Buy Rating Justified for Iterum Therapeutics Amid Strong Sulopenem Prospects and Upcoming FDA Advisory Committee Review Iterum Therapeutics price target lowered to $5 from $6 at H.C. Wainwright Iterum Therapeutics Reports Second Quarter 2024 Financial Results Iterum Therapeutics reports Q2 EPS (23c) vs (77c) last year,0,0,0,0,1,-1
4.07M,118,"967,934",-1,42,11.12,,,,SRZN,"Surrozen, Inc.",27.47M,8.57,-,23.62%,5.68%,-3.07%,+15.88%,-16.08%,Surrozen Provides Second Quarter 2024 Financial Results and Business Update,,,,,Surrozen Provides Second Quarter 2024 Financial Results and Business Update,0,0,-1,-1,-1,-1
,,,-1,234,,,,,UTSI,UTStarcom Holdings Corp.,27.36M,2.90,15.75M,3.37%,3.45%,-3.20%,-3.52%,+5.79%,UTStarcom Reports Decreased Mid-Year Financials,,,,,UTStarcom Reports Decreased Mid-Year Financials,1,1,-1,-1,-1,-1
86.00M,"1,286,593",-204.10M,-1,3,0.526,Buy,4.00,"Aug 7, 2024",MIRA,"MIRA Pharmaceuticals, Inc.",27.34M,1.85,-,-4.75%,30.22%,47.19%,-18.10%,+68.63%,MIRA says it achieves 100% reversal of neuropathic pain with oral Ketamir-2,Mira Pharmaceuticals provides update on preparing IND submission,Mira Pharmaceuticals announces preclinical data on Ketamir-2,Telomir Pharmaceuticals announces passing of CEO Christopher Chapman,Mira Pharmaceuticals files $100M mixed securities shelf,MIRA says it achieves 100% reversal of neuropathic pain with oral Ketamir-2 Mira Pharmaceuticals provides update on preparing IND submission Mira Pharmaceuticals announces preclinical data on Ketamir-2 Telomir Pharmaceuticals announces passing of CEO Christopher Chapman Mira Pharmaceuticals files $100M mixed securities shelf,0,1,0,0,0,1
9.22M,"477,587",-1.89M,-1,128,4.90,Hold,,"Aug 13, 2024",CVV,CVD Equipment Corporation,27.11M,3.94,21.61M,2.72%,-1.13%,-16.48%,-4.69%,-37.95%,,,,,,,0,-1,-1,-1,-1,-1
27.98M,"14,530",-61.28M,-1,,1.610,Strong Buy,6.00,"Aug 1, 2024",MNDR,Mobile-health Network Solutions,27.00M,0.79,11.53M,-9.90%,-32.47%,-83.47%,-30.35%,,,,,,,,0,-1,-1,-1,-1,-1
34.64M,"17,289",-28.37M,-1,29,1.310,Buy,5.00,"Aug 8, 2024",BCLI,Brainstorm Cell Therapeutics Inc.,26.85M,0.34,-,-1.51%,-10.96%,-16.93%,-6.49%,-50.84%,BrainStorm files $172.56M mixed securities shelf,Buy Rating Affirmed for Brainstorm Cell Therapeutics Amid Strategic Advances and Robust Financials,BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update,BrainStorm reports Q2 EPS (4c) vs. (13c) last year.,,BrainStorm files $172.56M mixed securities shelf Buy Rating Affirmed for Brainstorm Cell Therapeutics Amid Strategic Advances and Robust Financials BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update BrainStorm reports Q2 EPS (4c) vs. (13c) last year.,0,0,1,1,1,-1
30.83M,"142,640",-47.58M,-1,12,1.460,,,"Aug 13, 2024",ICU,SeaStar Medical Holding Corporation,26.68M,6.40,-,-22.63%,-26.86%,-58.70%,-41.36%,-70.41%,SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference,SeaStar Medical eliminates all long-term debt,SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt,Buy Rating Affirmed for SeaStar Medical on Strong Pediatric Milestone and AKI Market Opportunity,SeaStar Medical reports Q2 EPS ($1.03) vs. ($4.10) last year,SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference SeaStar Medical eliminates all long-term debt SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt Buy Rating Affirmed for SeaStar Medical on Strong Pediatric Milestone and AKI Market Opportunity SeaStar Medical reports Q2 EPS ($1.03) vs. ($4.10) last year,0,0,0,0,0,0
4.08M,"4,010","721,716",-1,114,11.01,,,,NWGL,Nature Wood Group Limited,26.65M,1.61,25.46M,-4.64%,-20.08%,-79.07%,-15.68%,-89.30%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,43,,,,,AEHL,Antelope Enterprise Holdings Limited,26.55M,2.18,72.00M,-25.89%,-29.96%,4.20%,-52.42%,+34.01%,,,,,,,0,-1,-1,-1,-1,-1
4.86M,"81,718",-7.00M,-1,51,9.23,Strong Buy,13.17,"Jul 31, 2024",DTST,Data Storage Corporation,26.51M,3.79,25.32M,-14.27%,-31.42%,-21.93%,-29.76%,-34.93%,Analysts Offer Insights on Technology Companies: Data Storage (DTST) and WNS (WNS),Data Storage reports Q2 EPS (4c) vs 3c last year,"Is DTST a Buy, Before Earnings?",,,"Analysts Offer Insights on Technology Companies: Data Storage (DTST) and WNS (WNS) Data Storage reports Q2 EPS (4c) vs 3c last year Is DTST a Buy, Before Earnings?",1,0,1,1,-1,-1
3.53M,401,"90,487",-1,19,13.28,,,,UBX,"Unity Biotechnology, Inc.",26.45M,1.57,-,12.65%,15.84%,2.43%,+9.15%,+6.37%,Unity Biotechnology initiated with a Buy at Rodman & Renshaw,,,,,Unity Biotechnology initiated with a Buy at Rodman & Renshaw,0,0,-1,-1,-1,-1
,,,-1,100,,,,,BOLT,"Bolt Biotherapeutics, Inc.",26.31M,0.69,11.17M,-2.10%,-4.80%,-29.70%,-8.53%,-48.50%,Bolt Biotherapeutics Announces Board Reshuffle and New Appointment,Bolt Biotherapeutics names Brian O’Callaghan chairman,Bolt Biotherapeutics Announces Changes to its Board of Directors,Bolt Biotherapeutics to Participate in Upcoming September Conferences,Bolt Biotherapeutics: Hold Rating Amid Clinical Delays and Restructuring Efforts,Bolt Biotherapeutics Announces Board Reshuffle and New Appointment Bolt Biotherapeutics names Brian O’Callaghan chairman Bolt Biotherapeutics Announces Changes to its Board of Directors Bolt Biotherapeutics to Participate in Upcoming September Conferences Bolt Biotherapeutics: Hold Rating Amid Clinical Delays and Restructuring Efforts,0,0,1,0,0,0
26.35M,"243,564",-2.28M,-1,25,1.700,,,"Aug 13, 2024",RAVE,"Rave Restaurant Group, Inc.",26.26M,1.80,11.84M,1.99%,-0.90%,-8.43%,-1.29%,-16.67%,Pizza Inn enters Master Franchise Agreement with Al Ruwad Hospitality,,,,,Pizza Inn enters Master Franchise Agreement with Al Ruwad Hospitality,0,0,-1,-1,-1,-1
20.63M,"192,398",-40.69M,-1,78,2.170,Strong Buy,24.00,"Aug 6, 2024",MDAI,"Spectral AI, Inc.",26.23M,1.49,22.53M,-3.46%,-11.23%,-28.07%,-11.98%,-38.24%,Northland Securities Remains a Buy on Spectral AI (MDAI),Spectral AI awarded additional funding from MTEC,Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®,Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study,Spectral AI completes burn center enrollment for U.S. Burn Pivotal Study,Northland Securities Remains a Buy on Spectral AI (MDAI) Spectral AI awarded additional funding from MTEC Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M® Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study Spectral AI completes burn center enrollment for U.S. Burn Pivotal Study,0,0,0,0,0,0
76.91M,"1,809,242",-37.28M,-1,62,0.582,Strong Buy,10.00,"Aug 12, 2024",KFFB,Kentucky First Federal Bancorp,26.20M,3.24,7.30M,0.66%,2.72%,-13.99%,-7.65%,-19.49%,Kentucky First Federal Bancorp Announces Board Changes,,,,,Kentucky First Federal Bancorp Announces Board Changes,1,1,-1,-1,-1,-1
3.68M,102,"232,716",-1,55,12.14,,,,APDN,"Applied DNA Sciences, Inc.",26.16M,2.54,3.40M,169.67%,287.72%,-68.48%,+543.62%,-68.98%,Applied DNA Sciences receives subcontract award from LRQA,Applied DNA submits validation package to NYS Department of Health,Applied DNA Sciences rating updated to Under Review at H.C. Wainwright,"3 Penny Stocks to Watch Now, 8/20/24",Applied DNA Sciences to seek expansion of use of Linea Mpox Virus 1.0 Assay,"Applied DNA Sciences receives subcontract award from LRQA Applied DNA submits validation package to NYS Department of Health Applied DNA Sciences rating updated to Under Review at H.C. Wainwright 3 Penny Stocks to Watch Now, 8/20/24 Applied DNA Sciences to seek expansion of use of Linea Mpox Virus 1.0 Assay",0,0,0,0,0,0
,,,-1,97,,,,,SNAL,"Snail, Inc.",26.10M,0.71,73.27M,22.13%,13.55%,-7.64%,+17.28%,-10.29%,"Noble Financial Remains a Buy on Snail, Inc. Class A (SNAL)",,,,,"Noble Financial Remains a Buy on Snail, Inc. Class A (SNAL)",1,0,-1,-1,-1,-1
4.05M,"1,360","-216,090",-1,41,11.03,,,,USEG,U.S. Energy Corp.,26.02M,0.93,25.74M,-1.88%,-7.94%,-13.02%,-13.06%,-27.49%,US Energy CEO Ryan Smith’s Contract Extended with New Terms,,,,,US Energy CEO Ryan Smith’s Contract Extended with New Terms,1,1,-1,-1,-1,-1
,,,-1,369,,,,,HYFM,"Hydrofarm Holdings Group, Inc.",25.94M,0.56,210.32M,-9.29%,-20.34%,-39.04%,-24.68%,-51.63%,,,,,,,0,-1,-1,-1,-1,-1
22.79M,"23,143",-61.16M,$0.34,127,2.000,,,"Aug 8, 2024",CHR,"Cheer Holding, Inc.",25.92M,2.52,155.95M,-8.25%,-6.67%,-13.03%,-16.56%,-6.10%,Cheer Holding Releasing the AI-based Classical Literature Series – Liaozhai Tales,Cheer Holding releases AI-based Liaozhai Tales classical literature series,Cheer Holding Unveils Key Decisions Post AGM,Cheer Holding Announces Results of 2024 Annual General Meeting,Cheer Holding granted patent in China for AI operation data management system,Cheer Holding Releasing the AI-based Classical Literature Series – Liaozhai Tales Cheer Holding releases AI-based Liaozhai Tales classical literature series Cheer Holding Unveils Key Decisions Post AGM Cheer Holding Announces Results of 2024 Annual General Meeting Cheer Holding granted patent in China for AI operation data management system,0,0,0,1,0,0
14.35M,"28,481",1.99M,-1,,3.110,Strong Buy,21.00,"Sep 3, 2024",MKDW,MKDWELL Tech Inc.,25.87M,1.34,-,-32.69%,-79.71%,-86.94%,,,,,,,,,1,-1,-1,-1,-1,-1
3.94M,417,1.31M,-1,71,11.30,,,,ENLV,Enlivex Therapeutics Ltd.,25.69M,1.23,-,-0.89%,-6.43%,-41.96%,-5.97%,-68.50%,Enlivex Therapeutics Financials Indicate Net Loss,,,,,Enlivex Therapeutics Financials Indicate Net Loss,1,0,-1,-1,-1,-1
,,,-1,,,,,,YYGH,YY Group Holding Limited,25.47M,0.74,31.77M,-5.04%,-3.81%,-33.60%,-27.88%,,YY Group Announces Board of Directors Reshuffle,,,,,YY Group Announces Board of Directors Reshuffle,0,0,-1,-1,-1,-1
29.30M,"165,202",1.05M,-1,50,1.530,,,"Sep 3, 2024",ZOOZ,ZOOZ Power Ltd.,25.34M,2.10,506.66K,0.62%,-4.16%,-17.47%,+4.96%,,ZOOZ Power Appoints Erez Zimerman as New CEO,ZOOZ Power appoints Zimerman as new CEO,"ZOOZ Power Reports Financial Results for the Six Months Ended June 30, 2024",ZOOZ Power reports 1H EPS (59c) vs. (91c) last year,,"ZOOZ Power Appoints Erez Zimerman as New CEO ZOOZ Power appoints Zimerman as new CEO ZOOZ Power Reports Financial Results for the Six Months Ended June 30, 2024 ZOOZ Power reports 1H EPS (59c) vs. (91c) last year",1,0,0,0,0,-1
26.81M,"206,620",-131.56M,-1,601,1.660,Strong Buy,9.50,"Jul 31, 2024",DALN,DallasNews Corporation,25.16M,4.70,131.65M,-2.00%,12.49%,8.74%,-4.73%,+13.63%,,,,,,,0,-1,-1,-1,-1,-1
10.00M,"21,552","-511,000",-1,40,4.450,Strong Buy,7.50,"Aug 8, 2024",VSEE,"VSee Health, Inc.",25.12M,1.71,5.74M,-28.53%,-70.38%,-84.55%,-35.74%,-87.11%,,,,,,,1,-1,-1,-1,-1,-1
31.04M,"44,102",-15.80M,-1,"2,744",1.430,Hold,5.00,"Aug 13, 2024",PMEC,Primech Holdings Ltd.,25.11M,0.66,72.52M,-7.74%,2.18%,-58.92%,-25.81%,-18.99%,Primech Holdings Shareholders Approve Key Resolutions,,,,,Primech Holdings Shareholders Approve Key Resolutions,1,1,-1,-1,-1,-1
53.99M,"201,510",-54.15M,-1,31,0.819,Strong Buy,4.25,"Aug 12, 2024",INAB,"IN8bio, Inc.",25.03M,0.54,-,-22.04%,-34.31%,-51.89%,-37.49%,-52.27%,IN8bio Revises Executive Compensation and Severance Terms,"IN8bio suspends patient enrollment in INB-400, to focus on INB-100",IN8bio to reduce workforce by 49%,IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia,IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference,"IN8bio Revises Executive Compensation and Severance Terms IN8bio suspends patient enrollment in INB-400, to focus on INB-100 IN8bio to reduce workforce by 49% IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia IN8bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference",1,1,0,0,1,0
3.90M,107,"647,142",-1,25,11.31,,,,LSTA,"Lisata Therapeutics, Inc.",24.96M,3.00,-,-4.84%,-13.30%,-3.65%,-14.48%,-8.94%,Lisata Therapeutics granted FDA Orphan Drug Designation for certepetide,Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma,Lisata Therapeutics: Strong Buy Rating on Robust Financials and Promising Clinical Trials,Lisata Therapeutics Announces Q2 2024 Financial Results,LSTA Earnings this Week: How Will it Perform?,Lisata Therapeutics granted FDA Orphan Drug Designation for certepetide Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma Lisata Therapeutics: Strong Buy Rating on Robust Financials and Promising Clinical Trials Lisata Therapeutics Announces Q2 2024 Financial Results LSTA Earnings this Week: How Will it Perform?,1,1,1,1,0,0
,,,-1,32,,,,,ACST,Acasti Pharma Inc.,24.84M,2.45,-,-0.50%,-11.30%,-11.32%,-6.30%,-25.59%,Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference,Acasti Pharma Appoints Prashant Kohli as CEO with Incentives,Craig-Hallum Issues a Buy Rating on Acasti Pharma (ACST),,,Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Acasti Pharma Appoints Prashant Kohli as CEO with Incentives Craig-Hallum Issues a Buy Rating on Acasti Pharma (ACST),0,0,0,0,-1,-1
49.60M,"31,285",8.20M,-1,,0.900,,,"Sep 3, 2024",NVA,Nova Minerals Limited,24.80M,6.19,32.33K,14.08%,15.50%,15.50%,+17.65%,,"Nova Minerals Collects Bulk Antimony Material for Test Work at its Estelle Gold-Antimony Project, in Alaska",Nova Minerals Eyes Fast-Track Antimony Production,"Nova Minerals Provides an Update on its Estelle Gold-Antimony Project, in Alaska",Nova Minerals Advances Gold Project Amid High Prices,Nova Minerals to Present at Investor Conference,"Nova Minerals Collects Bulk Antimony Material for Test Work at its Estelle Gold-Antimony Project, in Alaska Nova Minerals Eyes Fast-Track Antimony Production Nova Minerals Provides an Update on its Estelle Gold-Antimony Project, in Alaska Nova Minerals Advances Gold Project Amid High Prices Nova Minerals to Present at Investor Conference",0,0,0,0,0,0
19.53M,"35,930","-309,000",-1,58,2.250,Buy,3.33,"Aug 8, 2024",BIOR,"Biora Therapeutics, Inc.",24.73M,0.68,860.00K,5.56%,3.19%,-24.97%,+0.70%,-6.39%,Biora Therapeutics granted extension to regain compliance with Nasdaq,Biora Therapeutics: Outperforming with Strong Q2 Financials and Clinical Advancements,"Biora Therapeutics reports Q2 EPS (4c), consensus (45c)",Biora Therapeutics Restructures Debt and Issues New Securities,Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results,"Biora Therapeutics granted extension to regain compliance with Nasdaq Biora Therapeutics: Outperforming with Strong Q2 Financials and Clinical Advancements Biora Therapeutics reports Q2 EPS (4c), consensus (45c) Biora Therapeutics Restructures Debt and Issues New Securities Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results",1,1,1,0,1,0
16.52M,"26,557",-3.15M,$0.12,,2.650,,,"Oct 15, 2024",SUGP,SU Group Holdings Limited,24.70M,1.81,20.25M,-14.61%,-19.99%,-24.85%,-27.63%,-13.03%,,,,,,,0,-1,-1,-1,-1,-1
4.04M,"7,171","-165,714",-1,57,10.81,,,,SABS,"SAB Biotherapeutics, Inc.",24.55M,2.66,2.78M,-2.77%,-9.55%,-48.62%,+6.30%,-32.03%,SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting,Buy Rating on SAB Biotherapeutics: Promising Developments in Type 1 Diabetes Treatment,SAB Biotherapeutics initiated with an Outperform at Oppenheimer,Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and SAB Biotherapeutics (SABS),,SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting Buy Rating on SAB Biotherapeutics: Promising Developments in Type 1 Diabetes Treatment SAB Biotherapeutics initiated with an Outperform at Oppenheimer Analysts Offer Insights on Healthcare Companies: Sandoz Group Ltd (OtherSDZXF) and SAB Biotherapeutics (SABS),0,0,1,0,0,-1
,,,-1,209,,,,,PSHG,Performance Shipping Inc.,24.49M,1.97,90.83M,3.84%,-0.26%,-0.44%,-5.74%,-8.37%,,,,,,,0,-1,-1,-1,-1,-1
21.04M,"30,831",-7.60M,-1,33,2.070,Strong Buy,5.25,"Aug 8, 2024",PSIG,PS International Group Ltd.,24.46M,0.97,140.02M,-29.36%,-85.25%,-90.88%,-27.88%,,,,,,,,1,-1,-1,-1,-1,-1
77.42M,"97,737",-14.08M,-1,9,0.562,Strong Buy,4.31,"Aug 19, 2024",SOHO,Sotherly Hotels Inc.,24.37M,1.25,178.34M,1.35%,2.27%,-8.34%,-1.56%,-9.68%,Sotherly Hotels price target lowered to $1.50 from $2 at Piper Sandler,Sotherly Hotels Faces NASDAQ Compliance Challenges,Sotherly Hotels Inc. Receives Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q,"Sotherly Hotels sees 2024 adjusted FFO 64c-69c, consensus 64c",,"Sotherly Hotels price target lowered to $1.50 from $2 at Piper Sandler Sotherly Hotels Faces NASDAQ Compliance Challenges Sotherly Hotels Inc. Receives Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q Sotherly Hotels sees 2024 adjusted FFO 64c-69c, consensus 64c",0,0,0,0,0,-1
73.89M,"322,464",-44.02M,-1,100,0.589,Buy,2.35,"Aug 8, 2024",DAIO,Data I/O Corporation,24.36M,2.64,24.60M,5.91%,-1.07%,-13.75%,-0.77%,-30.00%,,,,,,,0,-1,-1,-1,-1,-1
29.97M,"172,170",,-1,8,1.500,,,,RNXT,"RenovoRx, Inc.",24.22M,1.01,-,-14.74%,-18.19%,-20.69%,-16.67%,-13.42%,"RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York",Buy Rating Backed by RenovoRx’s Clinical Advancements and Sustained Financial Health,RenovoRx announces first patient enrolled at UNMC for Phase III TIGeR-PaC trial,RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial,"Is RNXT a Buy, Before Earnings?","RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York Buy Rating Backed by RenovoRx’s Clinical Advancements and Sustained Financial Health RenovoRx announces first patient enrolled at UNMC for Phase III TIGeR-PaC trial RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial Is RNXT a Buy, Before Earnings?",1,0,1,0,0,1
,,,-1,16,,,,,NMTC,NeuroOne Medical Technologies Corporation,24.15M,0.78,3.92M,4.26%,-2.75%,-30.47%,+2.69%,-37.89%,NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference,NeuroOne Medical files to sell 5.55M shares of common stock for holders,NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update,NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14,,NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference NeuroOne Medical files to sell 5.55M shares of common stock for holders NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14,1,0,0,0,0,-1
58.55M,"524,617",-25.96M,-1,34,0.740,Strong Buy,2.33,"Aug 7, 2024",CACO,Caravelle International Group,24.05M,0.43,133.78M,-9.10%,-23.49%,-36.90%,-11.54%,-36.33%,Caravelle International Gains CPA Firm’s Support,Caravelle International Simplifies Capital Structure,,,,Caravelle International Gains CPA Firm’s Support Caravelle International Simplifies Capital Structure,0,0,1,-1,-1,-1
10.75M,"24,633",-12.59M,-1,116,4.110,Strong Buy,20.50,"Aug 12, 2024",GP,GreenPower Motor Company Inc.,23.93M,0.91,24.69M,0.68%,-12.08%,-53.45%,-12.21%,-48.42%,GreenPower Motor Reveals Executive Compensation Strategy,GreenPower Motor price target lowered to $1.65 from $3 at Roth MKM,GreenPower Motor (GPV) Receives a Buy from Roth MKM,GreenPower Motor (GPV) Receives a Hold from BTIG,GreenPower Boosts California Schools with Electric Buses,GreenPower Motor Reveals Executive Compensation Strategy GreenPower Motor price target lowered to $1.65 from $3 at Roth MKM GreenPower Motor (GPV) Receives a Buy from Roth MKM GreenPower Motor (GPV) Receives a Hold from BTIG GreenPower Boosts California Schools with Electric Buses,1,1,1,1,0,1
93.51M,"1,050,748",-115.46M,-1,109,0.460,Buy,3.17,"Aug 8, 2024",IZM,ICZOOM Group Inc.,23.87M,2.17,181.92M,-0.42%,2.38%,-71.97%,-1.85%,-89.18%,ICZOOM Group Back in Nasdaq Compliance,ICZOOM regains compliance with Nasdaq’s annual shareholder meeting requirement,ICZOOM Group Strengthens Governance and Flexibility,,,ICZOOM Group Back in Nasdaq Compliance ICZOOM regains compliance with Nasdaq’s annual shareholder meeting requirement ICZOOM Group Strengthens Governance and Flexibility,0,0,0,1,-1,-1
28.62M,"6,549",-21.64M,-1,50,1.360,Strong Buy,5.00,"Sep 3, 2024",PIRS,"Pieris Pharmaceuticals, Inc.",23.86M,18.07,20.87M,5.77%,43.89%,33.93%,+3.25%,+24.71%,,,,,,,1,-1,-1,-1,-1,-1
6.54M,"14,876",-35.18M,-1,34,6.50,,,"Aug 23, 2024",FEMY,Femasys Inc.,23.79M,1.07,950.10K,2.05%,-1.86%,-10.25%,-7.08%,-37.87%,Femasys to exhibit at CFAS Annual Meeting,Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting,Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference,"Femasys announces CE Mark, Canadian approval of FemVue MINI","Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution","Femasys to exhibit at CFAS Annual Meeting Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference Femasys announces CE Mark, Canadian approval of FemVue MINI Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution",0,1,0,0,0,0
8.00M,"13,049",-48.60M,-1,204,5.36,Buy,15.00,"Aug 13, 2024",FPAY,"FlexShopper, Inc.",23.67M,1.10,127.36M,-1.68%,-6.17%,-13.66%,-4.05%,-21.69%,FlexShopper to Present at H.C. Wainwright’s 26th Annual Global Investor Conference,FlexShopper partners with Terrace Finance to expand merchant opportunities,FlexShopper Partners with Terrace Finance to Expand Merchant Opportunities,FlexShopper partners with PayTomorrow to enhance consumer payment options,FlexShopper Partners with PayTomorrow to Enhance Consumer Payment Options,FlexShopper to Present at H.C. Wainwright’s 26th Annual Global Investor Conference FlexShopper partners with Terrace Finance to expand merchant opportunities FlexShopper Partners with Terrace Finance to Expand Merchant Opportunities FlexShopper partners with PayTomorrow to enhance consumer payment options FlexShopper Partners with PayTomorrow to Enhance Consumer Payment Options,1,0,1,1,0,0
29.48M,"16,948",-7.74M,-1,11,1.470,Strong Buy,6.00,"Aug 13, 2024",VRAX,Virax Biolabs Group Limited,23.66M,5.45,156.42K,101.88%,182.71%,273.05%,+291.16%,+493.90%,Virax Biolabs signs distribution agreement for Mpox virus detection kits,Virax Biolabs Group Ltd trading resumes,"Virax Biolabs Group Ltd trading halted, volatility trading pause",Virax Biolabs Introduces New Share Purchase Warrant,Virax Biolabs to sell 1.108M shares at $4.50 in registered direct offering,"Virax Biolabs signs distribution agreement for Mpox virus detection kits Virax Biolabs Group Ltd trading resumes Virax Biolabs Group Ltd trading halted, volatility trading pause Virax Biolabs Introduces New Share Purchase Warrant Virax Biolabs to sell 1.108M shares at $4.50 in registered direct offering",0,0,0,0,0,0
6.40M,"13,273","33,000",-1,610,6.62,,,"Jul 30, 2024",GDHG,Golden Heaven Group Holdings Ltd.,23.59M,0.12,25.55M,-9.93%,-26.42%,-95.39%,-31.37%,-66.06%,Golden Heaven granted plot in China for amusement complex,"Golden Heaven receives delisting determination from Nasdaq, intends to appeal",Golden Heaven Group Holdings Ltd. Announces Receipt of Nasdaq Delisting Determination and Plans to Appeal,Golden Heaven Group Plans Share Structure Changes,,"Golden Heaven granted plot in China for amusement complex Golden Heaven receives delisting determination from Nasdaq, intends to appeal Golden Heaven Group Holdings Ltd. Announces Receipt of Nasdaq Delisting Determination and Plans to Appeal Golden Heaven Group Plans Share Structure Changes",1,1,1,1,1,-1
34.65M,"91,370",-2.99M,-1,102,1.220,Strong Buy,9.00,"Aug 19, 2024",RNLX,Renalytix Plc,23.58M,0.32,2.22M,-11.37%,-5.98%,-40.48%,-28.67%,-59.88%,Renalytix AI Announces Brokerage Changes,Renalytix Reveals Total Share Capital and Voting Rights,Renalytix Welcomes New Joint Corporate Broker,,,Renalytix AI Announces Brokerage Changes Renalytix Reveals Total Share Capital and Voting Rights Renalytix Welcomes New Joint Corporate Broker,1,1,1,1,-1,-1
152.82M,"2,198,632",-28.74M,-1,154,0.276,Strong Buy,4.00,"Aug 14, 2024",CNTM,"ConnectM Technology Solutions, Inc.",23.55M,0.95,20.10M,-15.03%,-81.81%,-90.86%,-11.85%,-92.62%,ConnectM Technology Solutions Bolsters Finances and Confidence,ConnectM Prepares to Deleverage Balance Sheet with Board’s Approval of Debt-to-Equity Conversion,ConnectM board approves debt-to-equity conversion,ConnectM Tech Solutions Shares New Investor Presentation,ConnectM Publishes New Investor Materials,ConnectM Technology Solutions Bolsters Finances and Confidence ConnectM Prepares to Deleverage Balance Sheet with Board’s Approval of Debt-to-Equity Conversion ConnectM board approves debt-to-equity conversion ConnectM Tech Solutions Shares New Investor Presentation ConnectM Publishes New Investor Materials,0,1,0,1,1,1
23.68M,"13,867",-37.91M,-1,33,1.780,Hold,1.00,"Aug 8, 2024",JZXN,"Jiuzi Holdings, Inc.",23.52M,2.26,5.93M,-31.71%,-47.10%,-82.91%,-35.68%,-85.24%,Jiuzi Holdings Announces New CFO and Employment Terms,,,,,Jiuzi Holdings Announces New CFO and Employment Terms,0,1,-1,-1,-1,-1
36.95M,"7,072",-19.04M,-1,74,1.140,,,"Sep 3, 2024",GBNY,"Generations Bancorp NY, Inc.",23.45M,10.46,9.06M,-2.17%,-0.93%,6.61%,-0.96%,+2.17%,,,,,,,1,-1,-1,-1,-1,-1
7.15M,"10,945",-7.86M,-1,166,5.60,,,"Sep 3, 2024",NXPL,NextPlat Corp,23.34M,1.23,66.40M,12.40%,10.71%,-11.24%,+8.93%,-18.67%,NextPlat Reports 474% Increase in Consolidated Q2 Revenues to $17 Million and Record 34.2% Quarterly Margins; $70 Million in 2024 Annual Revenues Expected,"Progressive Care Inc. Announces Second Quarter 2024 Revenues of $13.5 Million, an Increase of 17% as Gross Margin Expands to 35%",,,,"NextPlat Reports 474% Increase in Consolidated Q2 Revenues to $17 Million and Record 34.2% Quarterly Margins; $70 Million in 2024 Annual Revenues Expected Progressive Care Inc. Announces Second Quarter 2024 Revenues of $13.5 Million, an Increase of 17% as Gross Margin Expands to 35%",1,1,1,-1,-1,-1
,,,-1,40,,,,,GREE,Greenidge Generation Holdings Inc.,23.25M,2.18,72.91M,-2.63%,-21.79%,-43.50%,-30.66%,-40.90%,Crypto Currents: Riot urges change for Bitfarms board,"Crypto Currents: Bitfarms assumes control of Sharon, PA data center",Crypto Currents: Bitfarms to acquire Stronghold in stock-for-stock merger,Here’s What You Missed in Crypto This Week,,"Crypto Currents: Riot urges change for Bitfarms board Crypto Currents: Bitfarms assumes control of Sharon, PA data center Crypto Currents: Bitfarms to acquire Stronghold in stock-for-stock merger Here’s What You Missed in Crypto This Week",0,0,0,0,0,-1
3.95M,"36,741",17.58M,-1,14,10.59,,,"Jul 12, 2024",BIAF,"bioAffinity Technologies, Inc.",23.24M,1.72,7.32M,-12.23%,-23.54%,-17.18%,-36.55%,-41.26%,BioAffinity Technologies CFO Michael Dougherty resigns,"Maxim Group Remains a Buy on bioAffinity Technologies, Inc. (BIAF)","Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz","BioAffinity Technologies reports Q2 EPS (19c), consensus (17c)",,"BioAffinity Technologies CFO Michael Dougherty resigns Maxim Group Remains a Buy on bioAffinity Technologies, Inc. (BIAF) Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz BioAffinity Technologies reports Q2 EPS (19c), consensus (17c)",0,1,1,1,0,-1
22.00M,"130,000",-25.28M,$0.20,42,1.900,,,"Jul 30, 2024",VINC,"Vincerx Pharma, Inc.",23.15M,0.75,-,22.02%,17.58%,-52.58%,+23.94%,-85.77%,Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval,Buy Rating Affirmed for Vincerx Pharma Amid Positive Clinical Progress and Stable Financial Outlook,,,,Vincerx Pharma Announces Stock Option Repricing and Shareholder Approval Buy Rating Affirmed for Vincerx Pharma Amid Positive Clinical Progress and Stable Financial Outlook,0,0,0,-1,-1,-1
4.48M,"12,925",-9.73M,-1,9,9.30,,,"Aug 9, 2024",GHSI,"Guardion Health Sciences, Inc.",23.11M,18.00,12.23M,22.01%,23.82%,53.88%,+18.29%,+25.82%,Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock,"Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024",,,,"Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024",0,0,0,-1,-1,-1
13.37M,"3,977",-36.80M,-1,77,3.110,Buy,4.06,"Aug 8, 2024",UCAR,U Power Limited,23.09M,6.84,2.79M,2.73%,-5.51%,-74.76%,-11.03%,+35.53%,U Power Limited Shareholders Approve Major Resolutions,,,,,U Power Limited Shareholders Approve Major Resolutions,0,0,-1,-1,-1,-1
15.98M,"159,976",-4.56M,-1,,2.600,,,"Sep 3, 2024",HUDA,Hudson Acquisition I Corp.,22.81M,12.55,-,-7.44%,-3.31%,12.19%,-5.56%,+18.38%,,,,,,,1,-1,-1,-1,-1,-1
41.44M,"7,451",-2.92M,-1,5,1.010,,,"Sep 4, 2024",USEA,United Maritime Corporation,22.80M,2.53,46.28M,2.61%,-0.01%,-0.87%,-1.75%,+3.91%,Easiest credit card sign-up bonuses to earn,The best credit cards to use when you need to rent a car,Best credit card welcome bonuses,,,Easiest credit card sign-up bonuses to earn The best credit cards to use when you need to rent a car Best credit card welcome bonuses,0,0,0,0,-1,-1
2.43M,"16,061",-20.18M,-1,,17.19,,,"Aug 8, 2024",COOT,Australian Oilseeds Holdings Limited,22.76M,0.96,-,4.18%,2.17%,-82.93%,+1.41%,-31.91%,Australian Oilseeds Faces Nasdaq Compliance Challenge,Australian Oilseeds Announces Attendance at Sidoti Micro-Cap Investor Conference,,,,Australian Oilseeds Faces Nasdaq Compliance Challenge Australian Oilseeds Announces Attendance at Sidoti Micro-Cap Investor Conference,1,0,1,-1,-1,-1
50.21M,"62,657",-5.27M,-1,121,0.811,Strong Buy,6.00,"Aug 14, 2024",SWAG,"Stran & Company, Inc.",22.70M,1.22,75.89M,10.99%,14.76%,1.21%,+3.15%,-2.96%,Stran & Company Faces Compliance Hurdles and Nasdaq Notice,Stran & Company receives Nasdaq deficiency notification,Stran & Company Expands Through Strategic Acquisition,"Stran Announces Acquisition of Strategic Assets of Gander Group™, Strengthening Foothold in the Gaming and Entertainment Industries",Stran & Company announces acquisition of strategic assets of Gander Group,"Stran & Company Faces Compliance Hurdles and Nasdaq Notice Stran & Company receives Nasdaq deficiency notification Stran & Company Expands Through Strategic Acquisition Stran Announces Acquisition of Strategic Assets of Gander Group™, Strengthening Foothold in the Gaming and Entertainment Industries Stran & Company announces acquisition of strategic assets of Gander Group",0,0,0,0,0,0
7.31M,"22,665",-20.80M,-1,,5.91,,,"Sep 6, 2024",NRXP,"NRx Pharmaceuticals, Inc.",22.52M,2.08,-,-2.63%,-16.37%,-46.51%,-17.90%,-64.53%,"HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics",NRX Pharmaceuticals Seeks New CEO for Drug Launches,NRx Pharmaceuticals reports Q2 net loss $7.9M vs. $8.7M last year,NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update,,"HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics NRX Pharmaceuticals Seeks New CEO for Drug Launches NRx Pharmaceuticals reports Q2 net loss $7.9M vs. $8.7M last year NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update",0,0,0,1,0,-1
2.94M,"15,642",-2.21M,$0.16,630,13.80,,,"Aug 13, 2024",ISPO,Inspirato Incorporated,22.42M,4.35,300.94M,-12.53%,-0.40%,-0.88%,-44.17%,+4.69%,Inspirato files $50M mixed securities shelf,Inspirato Expands its Luxury Portfolio With 17 Exquisite Vacation Homes This Year,Inspirato Introduces “Inspirato Invited”,Inspirato introduces ‘Inspirato Invited’ membership program,Inspirato Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Inspirato files $50M mixed securities shelf Inspirato Expands its Luxury Portfolio With 17 Exquisite Vacation Homes This Year Inspirato Introduces “Inspirato Invited” Inspirato introduces ‘Inspirato Invited’ membership program Inspirato Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),0,0,0,0,0,0
22.43M,"11,406",-39.35M,-1,8,1.810,Hold,2.40,"Aug 14, 2024",CYTH,"Cyclo Therapeutics, Inc.",22.38M,0.78,1.13M,-29.50%,-32.99%,-43.79%,-31.96%,-39.12%,"Cyclo Therapeutics presents data from study, substudy of Trappsol Cyclo",Cyclo Therapeutics downgraded to Hold from Buy at Maxim,Cyclo Therapeutics Acquisition by Rafael Holdings: A Revised Hold Rating and Price Target Adjustment,Cyclo Therapeutics downgraded to Neutral from Buy at H.C. Wainwright,Cyclo Therapeutics’ Merger and Financial Arrangements with Rafael Holdings,"Cyclo Therapeutics presents data from study, substudy of Trappsol Cyclo Cyclo Therapeutics downgraded to Hold from Buy at Maxim Cyclo Therapeutics Acquisition by Rafael Holdings: A Revised Hold Rating and Price Target Adjustment Cyclo Therapeutics downgraded to Neutral from Buy at H.C. Wainwright Cyclo Therapeutics’ Merger and Financial Arrangements with Rafael Holdings",1,0,1,1,1,0
26.00M,"128,394",-99.22M,-1,163,1.560,Buy,5.25,"Aug 8, 2024",HLP,Hongli Group Inc.,22.27M,1.82,16.00M,25.71%,16.55%,2.81%,+31.91%,+73.83%,,,,,,,1,-1,-1,-1,-1,-1
23.31M,"53,864","-160,000",-1,410,1.730,,,"Aug 26, 2024",CHSN,Chanson International Holding,22.24M,1.79,17.25M,6.48%,-13.48%,-14.70%,-7.84%,-0.29%,"Chanson International files to sell 10M Class A ordinary shares, warrants",Chanson International Holding Announces Board Changes,,,,"Chanson International files to sell 10M Class A ordinary shares, warrants Chanson International Holding Announces Board Changes",1,1,1,-1,-1,-1
2.19M,"19,111",-13.99M,-1,63,18.54,,,"Oct 14, 2024",NKGN,"NKGen Biotech, Inc.",22.16M,0.86,-,-19.85%,-30.91%,-58.23%,-30.79%,-44.83%,NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference,NKGen Biotech Faces Nasdaq Compliance Challenges,NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report,NKGen Biotech receives noncompliance notice from Nasdaq,"NKGen Biotech COO Pierre Gagnon Steps Down, Remains Advisor","NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference NKGen Biotech Faces Nasdaq Compliance Challenges NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report NKGen Biotech receives noncompliance notice from Nasdaq NKGen Biotech COO Pierre Gagnon Steps Down, Remains Advisor",0,0,0,1,0,1
27.36M,"5,265","-869,674",-1,102,1.480,Strong Buy,5.00,"Aug 14, 2024",IPA,ImmunoPrecise Antibodies Ltd.,22.11M,0.81,17.84M,-5.12%,-14.56%,-42.24%,-0.99%,-45.75%,ImmunoPrecise Joins Prestigious Global Investment Conference,ImmunoPrecise Shares Puzzling Update,ImmunoPrecise’s Breakthrough in Cancer Antibody Engineering,,,ImmunoPrecise Joins Prestigious Global Investment Conference ImmunoPrecise Shares Puzzling Update ImmunoPrecise’s Breakthrough in Cancer Antibody Engineering,1,1,0,0,-1,-1
9.86M,"9,050",-2.02M,-1,20,4.100,,,"Aug 8, 2024",HOVR,New Horizon Aircraft Ltd.,22.05M,1.03,-,30.18%,45.61%,-71.18%,+42.86%,-58.16%,"Horizon Aircraft commissions survey on small, micro-cap fund managers",Horizon Aircraft Positioned for Increased Investment as a Small-Cap Stock with its Disruptive Aerospace Technology,New Horizon Aircraft Announces Public Offering Success,New Horizon Aircraft Announces Closing of $2.9 Million Public Offering,Horizon Aircraft appoints Tom Brassington as CTO,"Horizon Aircraft commissions survey on small, micro-cap fund managers Horizon Aircraft Positioned for Increased Investment as a Small-Cap Stock with its Disruptive Aerospace Technology New Horizon Aircraft Announces Public Offering Success New Horizon Aircraft Announces Closing of $2.9 Million Public Offering Horizon Aircraft appoints Tom Brassington as CTO",1,1,1,1,1,1
26.07M,"13,966",4.83M,$0.01,327,1.560,,,"Sep 3, 2024",OCC,Optical Cable Corporation,21.78M,2.76,65.24M,0.70%,1.24%,-0.01%,+4.34%,-3.83%,,,,,,,0,-1,-1,-1,-1,-1
100.40M,"1,167,850",-168.32M,-1,12,0.402,,,"Aug 6, 2024",TWG,Top Wealth Group Holding Limited,21.75M,0.75,16.94M,-8.52%,-9.55%,-27.78%,+5.75%,,,,,,,,0,-1,-1,-1,-1,-1
4.84M,350,"280,640",-1,131,8.59,,,,WETH,Wetouch Technology Inc.,21.72M,1.82,40.61M,-2.09%,-22.52%,-65.87%,-8.72%,-23.41%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,37,,,,,SAI,SAI.TECH Global Corporation,21.68M,0.88,6.78M,-0.11%,-5.46%,-12.43%,-10.00%,-25.00%,SAI.TECH Joins World Nuclear Association as New Member and to Participate in World Nuclear Symposium 2024,SAITECH joins World Nuclear Association,SAI.TECH Pioneers Eco-Friendly Aquatic Center Heating,SAI.TECH Announces the Signing of an MOU with Idaho Central Aquatic Center Project for SAI US Idaho Node Project,SAITECH Global Becomes SAIHEAT Limited,SAI.TECH Joins World Nuclear Association as New Member and to Participate in World Nuclear Symposium 2024 SAITECH joins World Nuclear Association SAI.TECH Pioneers Eco-Friendly Aquatic Center Heating SAI.TECH Announces the Signing of an MOU with Idaho Central Aquatic Center Project for SAI US Idaho Node Project SAITECH Global Becomes SAIHEAT Limited,1,1,1,0,1,0
10.36M,"7,954",-8.15M,-1,123,3.870,Strong Buy,4.00,"Sep 12, 2024",COSM,Cosmos Health Inc.,21.65M,1.22,56.45M,4.42%,10.27%,28.69%,-4.13%,+67.41%,Cosmos Health regains Nasdaq compliance,"Cosmos’ Cana completes facility upgrades, secures manufacturing agreement",Cosmos Health reports Q1 EPS (11c) vs. (4c) last year,,,"Cosmos Health regains Nasdaq compliance Cosmos’ Cana completes facility upgrades, secures manufacturing agreement Cosmos Health reports Q1 EPS (11c) vs. (4c) last year",0,0,1,1,-1,-1
11.34M,"283,043",-46.92M,-1,114,3.520,Strong Buy,17.33,"Aug 8, 2024",ATER,"Aterian, Inc.",21.64M,3.03,120.62M,3.09%,10.12%,-10.15%,-4.01%,+12.99%,"Aterian Engages Advisor, Elects Director, and Ratifies Accountant",,,,,"Aterian Engages Advisor, Elects Director, and Ratifies Accountant",0,0,-1,-1,-1,-1
15.69M,"76,097",-14.45M,-1,"2,950",2.530,,,"Oct 14, 2024",SGMA,"SigmaTron International, Inc.",21.63M,3.55,401.03M,14.86%,-20.48%,-9.60%,+2.09%,-5.00%,Sigmatron International reports Q4 EPS (55c) vs. 87c last year,"SigmaTron International, Inc. Reports Financial Results for Fiscal 2024",Sigmatron International receives noncompliance notification from Nasdaq,,,"Sigmatron International reports Q4 EPS (55c) vs. 87c last year SigmaTron International, Inc. Reports Financial Results for Fiscal 2024 Sigmatron International receives noncompliance notification from Nasdaq",1,1,1,1,-1,-1
43.95M,"37,195",-65.53M,-1,107,0.915,,,"Aug 8, 2024",XAIR,"Beyond Air, Inc.",21.59M,0.46,1.78M,-7.55%,-30.75%,-67.47%,-27.76%,-74.46%,Beyond Air files to sell 1.72M shares of common stock for holders,"Cisco, Nike upgrades among today’s top calls on Wall Street",Beyond Air resumed with a Buy at Roth MKM,Beyond Air Faces Nasdaq Delisting Risk and Executive Resignation,,"Beyond Air files to sell 1.72M shares of common stock for holders Cisco, Nike upgrades among today’s top calls on Wall Street Beyond Air resumed with a Buy at Roth MKM Beyond Air Faces Nasdaq Delisting Risk and Executive Resignation",1,1,1,1,1,-1
3.52M,"1,000","129,686",-1,42,11.24,,,,IINN,Inspira Technologies Oxy B.H.N. Ltd.,21.52M,1.18,-,4.81%,-9.11%,-23.40%,+3.05%,-41.36%,Inspira Set to Unveil HYLA™ Blood Sensor Results,Inspira Technologies Launches FDA-Listed Medical Cart,Inspira Technologies announces FDA listing of medical cart,Inspira Technologies Financial Update Revealed,Inspira Technologies’ ART100 Shows Promising Evaluation Results,Inspira Set to Unveil HYLA™ Blood Sensor Results Inspira Technologies Launches FDA-Listed Medical Cart Inspira Technologies announces FDA listing of medical cart Inspira Technologies Financial Update Revealed Inspira Technologies’ ART100 Shows Promising Evaluation Results,0,1,0,0,0,1
,,,-1,62,,,,,LRE,"Lead Real Estate Co., Ltd",21.49M,1.58,118.41M,-10.01%,-35.81%,-65.43%,-20.71%,-58.36%,Lead Real Estate Announces Director Resignation,Lead Real Estate Co. Appoints New Auditor,Lead Real Estate receives noncompliance notification,"Lead Real Estate Co., Ltd Receives Notification Regarding Non-Compliance of Nasdaq Global Market Minimum Market Value of Publicly Held Shares Requirement",,"Lead Real Estate Announces Director Resignation Lead Real Estate Co. Appoints New Auditor Lead Real Estate receives noncompliance notification Lead Real Estate Co., Ltd Receives Notification Regarding Non-Compliance of Nasdaq Global Market Minimum Market Value of Publicly Held Shares Requirement",1,1,1,1,1,-1
3.02M,183,3.59M,$0.52,35,12.25,,,"Jul 26, 2024",BANL,CBL International Limited,21.48M,0.78,435.90M,33.49%,35.90%,-1.55%,-2.34%,-17.83%,CBL International Reveals Interim Report and Webcast,Banle Group Announces 2024 Interim Results at Webcast,Banle Group Boosts Global Port Presence,"Banle Group Expands Global Port Coverage to Over 60 Ports, Solidifying Leadership in the Marine Fuel Bunkering Industry",CBL International Secures Private Funding Boost,"CBL International Reveals Interim Report and Webcast Banle Group Announces 2024 Interim Results at Webcast Banle Group Boosts Global Port Presence Banle Group Expands Global Port Coverage to Over 60 Ports, Solidifying Leadership in the Marine Fuel Bunkering Industry CBL International Secures Private Funding Boost",1,1,0,1,1,1
10.83M,"35,405",-110.77M,-1,,3.635,Buy,9.25,"Sep 6, 2024",,Nano Labs Ltd,21.40M,0.31,11.05M,0.57%,1.39%,5.33%,+1.19%,+5.76%,,,,,,,1,-1,-1,-1,-1,-1
15.94M,"10,674",7.71M,$0.20,5,2.450,,,"Jun 20, 2024",ANY,Sphere 3D Corp.,21.37M,1.03,25.03M,10.19%,-0.98%,-30.24%,-10.91%,-26.22%,"Sphere 3D: A Buy Rating on Strong Leadership, Robust Financials, and Strategic Crypto Mining Expansion",Sphere 3D Corp. Bolsters Mining Fleet and Explores Growth,Sphere 3D price target lowered to $3 from $4 at H.C. Wainwright,Sphere 3D Shows Profitable Q2 Amidst Mining Challenges,Sphere 3D Corp (ANY) Q2 Earnings Cheat Sheet,"Sphere 3D: A Buy Rating on Strong Leadership, Robust Financials, and Strategic Crypto Mining Expansion Sphere 3D Corp. Bolsters Mining Fleet and Explores Growth Sphere 3D price target lowered to $3 from $4 at H.C. Wainwright Sphere 3D Shows Profitable Q2 Amidst Mining Challenges Sphere 3D Corp (ANY) Q2 Earnings Cheat Sheet",0,0,0,0,0,0
14.60M,"80,434",-9.40M,-1,,2.670,,,"Jul 31, 2024",SDOT,Sadot Group Inc.,21.23M,0.46,636.38M,-2.62%,-2.29%,15.41%,-12.93%,+27.32%,Sadot files $50M mixed securities shelf,Sadot Group Shares Strategic Insights in Investor Update,"Sadot reports Q2 EPS 5c, two estimates (4c)",,,"Sadot files $50M mixed securities shelf Sadot Group Shares Strategic Insights in Investor Update Sadot reports Q2 EPS 5c, two estimates (4c)",1,0,1,0,-1,-1
3.37M,"1,200","-831,218",-1,276,11.50,,,,JFU,9F Inc.,21.19M,1.80,58.17M,-6.19%,-10.25%,-39.20%,+1.35%,-46.43%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,18,,,,,APCX,AppTech Payments Corp.,21.17M,0.85,462.00K,-20.55%,-23.46%,-43.27%,-23.92%,-27.21%,AppTech Payments Reports Positive Second Quarter Financial Results and Strategic Progress,,,,,AppTech Payments Reports Positive Second Quarter Financial Results and Strategic Progress,0,0,-1,-1,-1,-1
24.61M,"333,361",-65.44M,-1,5,1.580,Hold,5.00,"Aug 7, 2024",BTCS,BTCS Inc.,21.03M,1.30,1.65M,-8.26%,-14.85%,-19.69%,-22.37%,-28.48%,BTCS Inc. Releases Updated Corporate Presentation Online,Ethereum Block-Building Drives BTCS Revenue Growth and Earns Buy Rating,BTCS reports Q2 EPS (43c) vs (8c),,,BTCS Inc. Releases Updated Corporate Presentation Online Ethereum Block-Building Drives BTCS Revenue Growth and Earns Buy Rating BTCS reports Q2 EPS (43c) vs (8c),1,1,1,1,-1,-1
29.89M,"36,115",-12.20M,-1,46,1.300,Strong Buy,8.00,"Aug 8, 2024",MEIP,"MEI Pharma, Inc.",20.92M,3.14,66.75M,-4.16%,2.15%,-22.82%,-16.17%,-17.07%,MEIP Earnings this Week: How Will it Perform?,MEI Pharma engages financial advisor to evaluate strategic alternatives,,,,MEIP Earnings this Week: How Will it Perform? MEI Pharma engages financial advisor to evaluate strategic alternatives,1,0,0,-1,-1,-1
92.48M,"473,671",-10.30M,-1,371,0.420,,,"Aug 13, 2024",JG,Aurora Mobile Limited,20.89M,3.49,40.07M,8.83%,21.26%,22.11%,+34.28%,+15.04%,Aurora Mobile Reports Strong Q2 Revenue Growth,Aurora Mobile’s CTO Comments on JPush’s Inclusion on HUAWEI Developers Platform,Aurora Mobile enters strategic agreement with Closeli,Aurora Mobile Partners with Closeli to Create a New Way to Experience its Intelligent Visual Cloud Platform,Aurora Mobile enters strategic agreement with Zhongda Yingcai,Aurora Mobile Reports Strong Q2 Revenue Growth Aurora Mobile’s CTO Comments on JPush’s Inclusion on HUAWEI Developers Platform Aurora Mobile enters strategic agreement with Closeli Aurora Mobile Partners with Closeli to Create a New Way to Experience its Intelligent Visual Cloud Platform Aurora Mobile enters strategic agreement with Zhongda Yingcai,1,1,1,1,1,1
,,,-1,88,,,,,LYRA,"Lyra Therapeutics, Inc.",20.68M,0.32,1.82M,6.57%,11.98%,-89.28%,-2.09%,-93.65%,Lyra Therapeutics (LYRA) Receives a Hold from BTIG,"Lyra Therapeutics reports Q2 EPS (74c), consensus (33c)",Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update,,,"Lyra Therapeutics (LYRA) Receives a Hold from BTIG Lyra Therapeutics reports Q2 EPS (74c), consensus (33c) Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update",1,0,1,0,-1,-1
48.81M,"238,374",-12.15M,-1,"1,127",0.795,Strong Buy,4.40,"Aug 7, 2024",BBGI,"Beasley Broadcast Group, Inc.",20.62M,0.67,240.68M,4.62%,3.16%,-11.92%,+4.87%,-14.47%,Beasley Broadcast Group’s Multifaceted Debt Restructuring Plan,"Beasley Broadcast launches exchange ofer, new notes offer, tender offer","Beasley Broadcast Group Launches Exchange Offer, New Notes Offer, Tender Offer and Consent Solicitations Relating to Existing Notes",Beasley Broadcast reports Q2 EPS (1c) vs (35c) last year,,"Beasley Broadcast Group’s Multifaceted Debt Restructuring Plan Beasley Broadcast launches exchange ofer, new notes offer, tender offer Beasley Broadcast Group Launches Exchange Offer, New Notes Offer, Tender Offer and Consent Solicitations Relating to Existing Notes Beasley Broadcast reports Q2 EPS (1c) vs (35c) last year",0,0,0,0,0,-1
15.27M,"653,193",-47.69M,-1,"4,100",2.540,,,"Aug 12, 2024",KIRK,"Kirkland's, Inc.",20.47M,1.57,463.57M,8.00%,1.13%,-26.76%,-10.00%,-28.63%,Kirkland’s price target lowered to $2 from $2.50 at Craig-Hallum,Kirkland’s (KIRK) Receives a Hold from Craig-Hallum,"Kirkland’s reports Q2 EPS ($1.11), consensus ($1.31)",KIRKLAND’S HOME REPORTS SECOND QUARTER 2024 RESULTS,"Is KIRK a Buy, Before Earnings?","Kirkland’s price target lowered to $2 from $2.50 at Craig-Hallum Kirkland’s (KIRK) Receives a Hold from Craig-Hallum Kirkland’s reports Q2 EPS ($1.11), consensus ($1.31) KIRKLAND’S HOME REPORTS SECOND QUARTER 2024 RESULTS Is KIRK a Buy, Before Earnings?",0,0,0,0,0,1
22.97M,"13,185",-3.84M,-1,1,1.710,,,"Aug 13, 2024",TXMD,"TherapeuticsMD, Inc.",20.41M,1.77,996.00K,12.31%,9.45%,-9.50%,+10.86%,-12.02%,TherapeuticsMD Releases Preliminary Quarterly Financial Results,,,,,TherapeuticsMD Releases Preliminary Quarterly Financial Results,1,0,-1,-1,-1,-1
35.42M,"307,915",-8.32M,-1,81,1.080,Strong Buy,5.00,"Aug 8, 2024",MMV,MultiMetaVerse Holdings Limited,20.16M,0.61,9.01M,-0.44%,-0.58%,-31.01%,-17.57%,-30.33%,MultiMetaVerse Appoints New CFO Amidst Growth,MultiMetaVerse Expands into Digital Assets Sphere,MultiMetaVerse establishes joint venture Gold ABC,,,MultiMetaVerse Appoints New CFO Amidst Growth MultiMetaVerse Expands into Digital Assets Sphere MultiMetaVerse establishes joint venture Gold ABC,1,1,0,1,-1,-1
3.44M,"30,002",1.33M,-1,12,11.25,,,,WAVE,Eco Wave Power Global AB (publ),20.14M,3.63,306.00K,21.26%,40.22%,81.00%,+42.36%,+205.97%,Eco Wave Power Global Reports Mid-Year Financials,Eco Wave Power announces green light for share repurchase program,Eco Wave Power reports Q2 EPS (1c) vs (1c) last year,,,Eco Wave Power Global Reports Mid-Year Financials Eco Wave Power announces green light for share repurchase program Eco Wave Power reports Q2 EPS (1c) vs (1c) last year,0,0,0,0,-1,-1
,,,-1,12,,,,,COCP,"Cocrystal Pharma, Inc.",20.14M,1.98,-,2.32%,-12.20%,3.83%,-2.62%,+16.61%,Buy Rating Affirmed for Cocrystal Pharma Amid Promising Drug Pipeline and Strong Clinical Results,Cocrystal Pharma price target lowered to $7 from $10 at H.C. Wainwright,Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS),"Cocrystal Pharma reports Q2 EPS (54c), consensus (48c)",COCP Upcoming Earnings Report: What to Expect?,"Buy Rating Affirmed for Cocrystal Pharma Amid Promising Drug Pipeline and Strong Clinical Results Cocrystal Pharma price target lowered to $7 from $10 at H.C. Wainwright Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS) Cocrystal Pharma reports Q2 EPS (54c), consensus (48c) COCP Upcoming Earnings Report: What to Expect?",1,0,0,0,0,1
6.45M,"7,376",-14.23M,-1,581,5.95,Strong Buy,15.00,"Aug 7, 2024",AACG,ATA Creativity Global,20.13M,0.64,33.43M,-6.27%,-17.07%,-38.30%,-8.52%,-43.39%,,,,,,,1,-1,-1,-1,-1,-1
19.74M,"157,772",-1.54M,-1,770,1.940,Buy,9.50,"Aug 13, 2024",QMCO,Quantum Corporation,20.11M,0.21,290.45M,-35.16%,-48.83%,-54.14%,-52.60%,-68.18%,"Quantum Corp trading halted, news pending",Quantum implements1-for-20 reverse stock split,Analysts Offer Insights on Technology Companies: Research Solutions (RSSS) and Quantum (QMCO),Quantum’s Financial Flexibility Amidst Margin Pressures Justifies Hold Rating with Lowered Price Target,Quantum Corporation Announces Loan Amendments and COO Appointment,"Quantum Corp trading halted, news pending Quantum implements1-for-20 reverse stock split Analysts Offer Insights on Technology Companies: Research Solutions (RSSS) and Quantum (QMCO) Quantum’s Financial Flexibility Amidst Margin Pressures Justifies Hold Rating with Lowered Price Target Quantum Corporation Announces Loan Amendments and COO Appointment",0,0,0,0,0,0
62.59M,"95,437",-30.69M,-1,11,0.611,Strong Buy,1.61,"Aug 14, 2024",BFRG,"Bullfrog AI Holdings, Inc.",20.10M,2.56,65.00K,-3.76%,6.46%,-19.77%,-20.00%,-28.27%,BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference,,,,,BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference,1,0,-1,-1,-1,-1
2.36M,"1,318",1.61M,-1,20,15.78,,,"Aug 14, 2024",CMMB,Chemomab Therapeutics Ltd.,19.91M,1.40,-,45.34%,50.76%,108.68%,+58.97%,+132.50%,Chemomab Therapeutics to Present at September 2024 Investor Conferences,Chemomab Therapeutics: Strong Buy Rating on Robust Financials and Positive Clinical Trial Outcomes,Chemomab Therapeutics (CMMB) Gets a Buy from Oppenheimer,Chemomab Therapeutics Reports Mid-Year Financials,Chemomab Therapeutics sees cash runway through beginning of 2026,Chemomab Therapeutics to Present at September 2024 Investor Conferences Chemomab Therapeutics: Strong Buy Rating on Robust Financials and Positive Clinical Trial Outcomes Chemomab Therapeutics (CMMB) Gets a Buy from Oppenheimer Chemomab Therapeutics Reports Mid-Year Financials Chemomab Therapeutics sees cash runway through beginning of 2026,1,0,1,0,1,1
21.50M,"6,894","-652,728",-1,71,1.720,,,"Sep 6, 2024",DUOT,"Duos Technologies Group, Inc.",19.84M,2.58,5.64M,-4.90%,-10.70%,-23.44%,-16.38%,-26.94%,Duos Technologies Presents Future Outlook at Gateway Conference,Duos Technologies Group launches first edge data center,Northland Securities Keeps Their Buy Rating on Duos Technologies Group (DUOT),Duos Technologies Releases Key Financial Update,Duos Technologies Group CEO discusses recurring revenues and EDC business,Duos Technologies Presents Future Outlook at Gateway Conference Duos Technologies Group launches first edge data center Northland Securities Keeps Their Buy Rating on Duos Technologies Group (DUOT) Duos Technologies Releases Key Financial Update Duos Technologies Group CEO discusses recurring revenues and EDC business,1,1,1,1,0,1
3.37M,39,"-16,081",-1,142,11.02,,,,EVGN,Evogene Ltd.,19.83M,3.88,9.19M,-14.72%,-33.53%,-49.02%,-26.91%,-52.40%,Evogene Issues Series A Share Purchase Warrants,Evogene price target lowered to $12 from $30 at Lake Street,Evogene announces pricing of $5.5M registered direct offering,Evogene Reports Growth and R&D Progress,Evogene reports Q2 EPS ($1.68) vs. ($5.20) last year,Evogene Issues Series A Share Purchase Warrants Evogene price target lowered to $12 from $30 at Lake Street Evogene announces pricing of $5.5M registered direct offering Evogene Reports Growth and R&D Progress Evogene reports Q2 EPS ($1.68) vs. ($5.20) last year,0,1,0,0,1,0
,,,-1,100,,,,,CPSH,CPS Technologies Corporation,19.76M,1.36,23.98M,-7.59%,-15.74%,-30.97%,-18.86%,-24.72%,,,,,,,0,-1,-1,-1,-1,-1
20.18M,"10,588",5.16M,$0.24,18,1.870,,,"Aug 6, 2024",BIVI,BioVie Inc.,19.74M,3.23,-,-2.99%,-23.40%,-70.50%,-29.64%,-42.87%,BioVie announces FDA authorization of IND for Phase 2 trial of bezisterim,BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID,BioVie to give data for epigenetic basis for bezisterim and aging at ARDD 2024,BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting,,BioVie announces FDA authorization of IND for Phase 2 trial of bezisterim BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID BioVie to give data for epigenetic basis for bezisterim and aging at ARDD 2024 BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting,0,0,0,0,0,-1
48.64M,"204,427",-46.96M,-1,72,0.770,Strong Buy,5.00,"Aug 14, 2024",EKSO,"Ekso Bionics Holdings, Inc.",19.74M,1.07,18.16M,14.31%,3.55%,-23.98%,+4.76%,-22.54%,Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering,"Analysts’ Top Healthcare Picks: EKSO BIONICS (EKSO), Aziyo Biologics (ELUT)",Ekso Bionics announces receipt of initial CMS reimbursement for Ekso Indego,,,"Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering Analysts’ Top Healthcare Picks: EKSO BIONICS (EKSO), Aziyo Biologics (ELUT) Ekso Bionics announces receipt of initial CMS reimbursement for Ekso Indego",0,0,0,0,-1,-1
30.17M,"24,904",-14.91M,-1,29,1.240,,,"Aug 12, 2024",SPRB,"Spruce Biosciences, Inc.",19.72M,0.48,9.57M,3.09%,-7.91%,-70.97%,-9.28%,-44.17%,"Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)","Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH)","Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS)",Buy Rating Affirmed for Spruce Biosciences Amid Anticipated Positive Clinical Trial Outcomes and Strong Financial Position,"Spruce Biosciences reports Q2 EPS (22c), consensus (32c)","Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST) Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH) Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX), Spruce Biosciences (SPRB) and Gossamer Bio (GOSS) Buy Rating Affirmed for Spruce Biosciences Amid Anticipated Positive Clinical Trial Outcomes and Strong Financial Position Spruce Biosciences reports Q2 EPS (22c), consensus (32c)",1,1,1,0,1,1
,,,-1,17,,,,,LPCN,Lipocine Inc.,19.63M,3.67,4.80M,-17.26%,-42.39%,-25.61%,-28.98%,-22.92%,,,,,,,1,-1,-1,-1,-1,-1
5.98M,"102,911",-47.57M,-1,83,6.25,Strong Buy,37.33,"Aug 1, 2024",PXDT,"Pixie Dust Technologies, Inc.",19.48M,1.31,6.30M,2.46%,-9.54%,-66.35%,-2.96%,-47.39%,Pixie Dust Technologies: Innovating for Social Good,Pixie Dust Technologies Posts Strong Revenue Growth,"Pixie Dust Technologies, Inc. Announces Fiscal Year 2024 Financial Results",,,"Pixie Dust Technologies: Innovating for Social Good Pixie Dust Technologies Posts Strong Revenue Growth Pixie Dust Technologies, Inc. Announces Fiscal Year 2024 Financial Results",0,0,1,1,-1,-1
3.53M,210,"-454,602",-1,8,10.60,,,,YYAI,Connexa Sports Technologies Inc.,19.46M,7.32,8.40M,-38.82%,-41.15%,-29.75%,-59.94%,+8.57%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,792,,,,,MGIH,Millennium Group International Holdings Limited,19.46M,1.73,43.08M,13.58%,13.78%,20.60%,+9.52%,+17.09%,,,,,,,0,-1,-1,-1,-1,-1
34.65M,"73,023",-98.59M,-1,91,1.080,,,"Sep 6, 2024",CPIX,Cumberland Pharmaceuticals Inc.,19.45M,1.38,37.79M,-1.41%,-4.45%,-18.36%,-4.90%,-23.60%,,,,,,,0,-1,-1,-1,-1,-1
12.29M,"4,781",-3.85M,$0.20,145,3.000,,,"Aug 13, 2024",GNLN,"Greenlane Holdings, Inc.",19.42M,6.67,29.37M,-10.44%,24.02%,7.97%,+76.22%,-11.94%,Greenlane files to sell 7.09M shares of common stock for holders,Greenlane Holdings Executes Major Stock Deal and Appoints Agent,Greenlane Holdings trading resumes,"Greenlane Holdings trading halted, volatility trading pause",Greenlane announces purchases of shares by CEO Barbara Sher,"Greenlane files to sell 7.09M shares of common stock for holders Greenlane Holdings Executes Major Stock Deal and Appoints Agent Greenlane Holdings trading resumes Greenlane Holdings trading halted, volatility trading pause Greenlane announces purchases of shares by CEO Barbara Sher",0,1,1,0,0,0
10.70M,"3,614",7.42M,-1,31,3.450,,,"Sep 3, 2024",NEPH,"Nephros, Inc.",19.40M,1.84,13.77M,-6.37%,-10.23%,-25.91%,-15.30%,-14.52%,Nephros Shares 2024 Corporate Outlook and Plans,Nephros’s Strong Fundamentals and Growth Prospects Merit a Buy Rating,,,,Nephros Shares 2024 Corporate Outlook and Plans Nephros’s Strong Fundamentals and Growth Prospects Merit a Buy Rating,1,1,0,-1,-1,-1
52.09M,"1,828,341",-159.18M,-1,72,0.709,Buy,4.42,"Aug 7, 2024",WKSP,Worksport Ltd.,19.34M,0.65,3.73M,-12.45%,-15.91%,-38.63%,-18.84%,-6.34%,"Worksport Unveils New Models, Expands Product Range","Worksport Ltd. Unveils New Models, Driving Rapid Product Expansion",Worksport Reports Early Success in New Sales Initiative,Worksport announces ‘successful’ launch of Dealer Sales Initiative,Worksport publishes investor Q&A responses,"Worksport Unveils New Models, Expands Product Range Worksport Ltd. Unveils New Models, Driving Rapid Product Expansion Worksport Reports Early Success in New Sales Initiative Worksport announces ‘successful’ launch of Dealer Sales Initiative Worksport publishes investor Q&A responses",0,0,0,0,0,0
14.36M,"999,635",-27.90M,-1,102,2.570,Strong Buy,10.00,"Aug 14, 2024",VCIG,VCI Global Limited,19.13M,0.22,23.55M,-22.01%,-55.60%,-84.40%,-42.47%,-82.90%,VCI Global announces $18M contract for IPO deals,VCI Global Secures Approximately US$18 Million Contract for IPO Deals,"VCI Global CEO, Dato’ Victor Hoo, boosts shareholding by 15.27%",VCI Global Announces Strong Mid-Year Growth,VCI Global Limited Reports Strong Mid-Year Profits,"VCI Global announces $18M contract for IPO deals VCI Global Secures Approximately US$18 Million Contract for IPO Deals VCI Global CEO, Dato’ Victor Hoo, boosts shareholding by 15.27% VCI Global Announces Strong Mid-Year Growth VCI Global Limited Reports Strong Mid-Year Profits",1,1,1,1,1,1
16.25M,"50,659",-16.73M,-1,298,2.270,Strong Buy,12.00,"Aug 9, 2024",WKHS,Workhorse Group Inc.,19.10M,0.78,9.62M,-30.92%,-70.19%,-99.07%,-50.82%,-82.55%,Workhorse Group Maintains Hold Rating Amidst Revenue Forecast Cuts and Valuation Concerns,Roth MKM Reaffirms Their Hold Rating on Workhorse Group (WKHS),Workhorse Group price target lowered to 25c from $3 at TD Cowen,Workhorse Group: Balancing Progress and Financial Hurdles – A Hold Recommendation,"Medtronic, Palo Alto Networks report quarterly beats: Morning Buzz","Workhorse Group Maintains Hold Rating Amidst Revenue Forecast Cuts and Valuation Concerns Roth MKM Reaffirms Their Hold Rating on Workhorse Group (WKHS) Workhorse Group price target lowered to 25c from $3 at TD Cowen Workhorse Group: Balancing Progress and Financial Hurdles – A Hold Recommendation Medtronic, Palo Alto Networks report quarterly beats: Morning Buzz",1,1,1,1,1,1
43.93M,"280,574",3.48M,$0.04,,0.831,Buy,2.50,"Aug 14, 2024",ZPTA,Zapata Computing Holdings Inc.,19.09M,0.49,5.96M,-3.55%,-12.88%,-91.33%,-18.55%,-84.20%,Zapata AI files to sell 13M shares of common stock for holders,Zapata AI reports Q2 EPS (48c) vs. ($1.01) last year,Zapata AI enters CRADA with U.S. Special Operations Command,Cantor starts Zapata AI with Overweight on ‘hyper’ revenue growth in 2025,Zapata AI initiated with an Overweight at Cantor Fitzgerald,Zapata AI files to sell 13M shares of common stock for holders Zapata AI reports Q2 EPS (48c) vs. ($1.01) last year Zapata AI enters CRADA with U.S. Special Operations Command Cantor starts Zapata AI with Overweight on ‘hyper’ revenue growth in 2025 Zapata AI initiated with an Overweight at Cantor Fitzgerald,0,1,1,1,1,1
9.55M,"12,759",-3.10M,-1,55,3.800,,,"Aug 13, 2024",CARA,"Cara Therapeutics, Inc.",19.09M,0.35,11.00M,4.33%,9.48%,-46.67%,+2.13%,-59.35%,,,,,,,1,-1,-1,-1,-1,-1
7.87M,"44,638",-4.11M,-1,7,4.57,,,"Aug 19, 2024",APRE,"Aprea Therapeutics, Inc.",19.07M,3.51,1.28M,-0.95%,-7.93%,-29.14%,-3.31%,-44.44%,Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference,Aprea Therapeutics management to meet virtually with B. Riley,Buy Rating Justified by Aprea Therapeutics’ Financial Health and Innovative Clinical Trials,"Analysts Are Bullish on These Healthcare Stocks: Aprea Therapeutics (APRE), TScan Therapeutics (TCRX)",Aprea Therapeutics sees cash runway into 4Q25,"Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference Aprea Therapeutics management to meet virtually with B. Riley Buy Rating Justified by Aprea Therapeutics’ Financial Health and Innovative Clinical Trials Analysts Are Bullish on These Healthcare Stocks: Aprea Therapeutics (APRE), TScan Therapeutics (TCRX) Aprea Therapeutics sees cash runway into 4Q25",1,0,0,1,1,1
,,,-1,380,,,,,TRIB,Trinity Biotech plc,18.93M,2.00,58.65M,-1.43%,-3.44%,10.70%,-27.18%,+9.60%,Trinity Biotech Announces Upcoming AGM,Trinity Biotech Releases 2023 Annual Report,Trinity Biotech Welcomes New Chief Commercial Officer,Trinity Biotech names Adrian Donohue as Chief Commercial Officer,"3 Penny Stocks to Watch Now, 8/29/24","Trinity Biotech Announces Upcoming AGM Trinity Biotech Releases 2023 Annual Report Trinity Biotech Welcomes New Chief Commercial Officer Trinity Biotech names Adrian Donohue as Chief Commercial Officer 3 Penny Stocks to Watch Now, 8/29/24",1,1,1,1,1,0
16.45M,"13,472",-8.97M,-1,22,2.200,,,"Aug 14, 2024",ASTC,Astrotech Corporation,18.91M,11.47,2.00M,23.10%,26.34%,30.76%,+35.67%,+28.60%,,,,,,,1,-1,-1,-1,-1,-1
8.37M,"502,300",-26.46M,-1,63,4.310,,,"Sep 23, 2024",SEED,Origin Agritech Limited,18.84M,2.98,16.52M,13.18%,-17.75%,-7.98%,-1.42%,-14.77%,Origin Agritech Seizes GMO Corn Opportunities,Origin Agritech Announces Leadership Changes and Share Sale,Origin Agritech Bolsters Board with Expert Executives,Origin Agritech names Weibin Yan as CEO,,Origin Agritech Seizes GMO Corn Opportunities Origin Agritech Announces Leadership Changes and Share Sale Origin Agritech Bolsters Board with Expert Executives Origin Agritech names Weibin Yan as CEO,1,1,1,1,1,-1
42.91M,"86,532",-50.46M,-1,84,0.840,,,"Aug 2, 2024",FLYE,"Fly-E Group, Inc.",18.80M,0.76,32.24M,-12.54%,-78.43%,-78.91%,-26.51%,,Fly-E Group Announces Board Reshuffle with Finance Expert,"Fly-E Group, Inc. Announces First Quarter of Fiscal Year 2025 Financial Results",,,,"Fly-E Group Announces Board Reshuffle with Finance Expert Fly-E Group, Inc. Announces First Quarter of Fiscal Year 2025 Financial Results",1,1,1,-1,-1,-1
55.43M,"38,360",4.73M,-1,280,0.650,,,"Aug 14, 2024",ZKIN,"ZK International Group Co., Ltd.",18.80M,0.52,111.60M,1.97%,-2.71%,-25.75%,-10.32%,-14.46%,ZK International provides update on Nasdaq bid price compliance plan,ZK International achieves Nasdaq compliance with filing requirements,"ZK International Group Co., Ltd. Announces Record Revenues of $111.60 Million for the Fiscal Year 2023",ZK International Group reports 2023 EPS ($1.94) vs. (21c) last year,,"ZK International provides update on Nasdaq bid price compliance plan ZK International achieves Nasdaq compliance with filing requirements ZK International Group Co., Ltd. Announces Record Revenues of $111.60 Million for the Fiscal Year 2023 ZK International Group reports 2023 EPS ($1.94) vs. (21c) last year",1,0,1,1,1,-1
3.32M,13,-2.25M,-1,12,10.81,,,,CSCI,COSCIENS Biopharma Inc.,18.74M,6.18,4.92M,-32.69%,-29.91%,-45.69%,-34.66%,-54.88%,COSCIENS Biopharma’s Unexpected Trial Outcomes,COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency,Cosciens Biopharma says primary efficacy endpoint of DETECT-trial not met,COSCIENS Biopharma Inc (USA) trading resumes,"COSCIENS Biopharma Inc (USA) trading halted, volatility trading pause","COSCIENS Biopharma’s Unexpected Trial Outcomes COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency Cosciens Biopharma says primary efficacy endpoint of DETECT-trial not met COSCIENS Biopharma Inc (USA) trading resumes COSCIENS Biopharma Inc (USA) trading halted, volatility trading pause",1,0,0,0,0,0
,,,-1,"1,428",,,,,CJET,"Chijet Motor Company, Inc.",18.69M,3.49,9.48M,9.88%,-41.94%,-79.62%,+4.55%,-99.01%,Chijet Motor receives two Nasdaq deficiency notices,Chijet Motor Faces Nasdaq Compliance Challenge,,,,Chijet Motor receives two Nasdaq deficiency notices Chijet Motor Faces Nasdaq Compliance Challenge,0,0,0,-1,-1,-1
25.21M,"373,747",-31.75M,-1,617,1.420,Strong Buy,20.75,"Aug 8, 2024",MHUA,"Meihua International Medical Technologies Co., Ltd.",18.56M,0.73,97.10M,52.29%,31.95%,11.62%,-11.97%,+34.01%,,,,,,,0,-1,-1,-1,-1,-1
9.76M,"18,370",-2.92M,-1,,3.680,,,"Sep 3, 2024",GDTC,CytoMed Therapeutics Limited,18.46M,1.60,384.67K,-5.62%,-15.93%,-40.22%,-14.36%,-30.80%,,,,,,,1,-1,-1,-1,-1,-1
94.36M,"2,709,140",-24.41M,-1,76,0.378,Strong Buy,5.13,"Aug 14, 2024",TRUG,"TruGolf Holdings, Inc.",18.42M,1.39,19.11M,2.79%,9.39%,-69.61%,-0.86%,-18.56%,,,,,,,0,-1,-1,-1,-1,-1
22.21M,"46,295",12.65M,-1,9,1.600,,,"Aug 14, 2024",NERV,"Minerva Neurosciences, Inc.",18.39M,2.63,-,-1.00%,-9.66%,-36.75%,-6.40%,+9.45%,,,,,,,1,-1,-1,-1,-1,-1
8.42M,"4,851",3.20M,-1,346,4.340,,,"Aug 7, 2024",WVVI,"Willamette Valley Vineyards, Inc.",18.37M,3.70,39.24M,-0.27%,-2.59%,-19.06%,unch,-19.15%,Willamette Valley Vineyards Posts Results for Q2 2024,,,,,Willamette Valley Vineyards Posts Results for Q2 2024,0,0,-1,-1,-1,-1
13.91M,"8,356",1.65M,$0.09,71,2.540,,,"May 9, 2024",EDTK,Skillful Craftsman Education Technology Limited,18.32M,1.15,2.00M,-6.30%,-1.56%,8.68%,-6.17%,+20.00%,,,,,,,1,-1,-1,-1,-1,-1
33.84M,"200,180",-16.83M,-1,33,1.040,Strong Buy,7.00,"Sep 3, 2024",LSH,Lakeside Holding Limited,18.23M,2.52,17.62M,15.36%,12.37%,12.37%,-7.63%,,,,,,,,1,-1,-1,-1,-1,-1
2.76M,"2,764",6.48M,-1,30,12.83,,,"Aug 8, 2024",PEV,Phoenix Motor Inc.,18.17M,0.52,3.12M,10.14%,8.49%,-39.84%,+41.30%,-33.33%,Phoenix Motor receives noncompliance notification from Nasdaq,,,,,Phoenix Motor receives noncompliance notification from Nasdaq,0,0,-1,-1,-1,-1
4.92M,"50,277",-181.05M,-1,33,7.14,Hold,24.88,"Aug 12, 2024",IMNN,"Imunon, Inc.",18.15M,1.26,-,-9.20%,-7.75%,8.91%,-15.56%,-30.06%,Imunon files to sell 5M shares of common stock for holders,IMUNON to Host R&D Day on September 18th,"Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz",IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update,Imunon sees cash runway into 3Q25,"Imunon files to sell 5M shares of common stock for holders IMUNON to Host R&D Day on September 18th Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update Imunon sees cash runway into 3Q25",1,1,0,1,0,1
6.47M,"155,923",-30.46M,-1,36,5.40,Strong Buy,106.25,"Aug 7, 2024",SLGL,Sol-Gel Technologies Ltd.,18.00M,0.65,6.56M,47.04%,-1.17%,-30.96%,+54.92%,-33.08%,Sol-Gel Technologies Announces Key Shareholder Decisions,Biotech Alert: Searches spiking for these stocks today,Sol-Gel Technologies downgraded to Outperform from Strong Buy at Raymond James,UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates,Morning Movers: MSG Entertainment rises following quarterly release,Sol-Gel Technologies Announces Key Shareholder Decisions Biotech Alert: Searches spiking for these stocks today Sol-Gel Technologies downgraded to Outperform from Strong Buy at Raymond James UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates Morning Movers: MSG Entertainment rises following quarterly release,1,1,1,0,0,0
4.89M,"2,658",-45.60M,-1,26,7.13,Strong Buy,16.17,"Aug 6, 2024",TOMZ,"TOMI Environmental Solutions, Inc.",17.96M,0.90,7.13M,12.25%,8.16%,9.88%,+13.29%,+36.51%,TOMI Environmental Solutions to Present at the H.C. Wainwright Annual Global Investment Conference,TOMI Environmental Solutions Expands Partnership With A Global Leader in Laboratory Services,Tomi Environmental Solutions expands partnership with leader in lab services,,,TOMI Environmental Solutions to Present at the H.C. Wainwright Annual Global Investment Conference TOMI Environmental Solutions Expands Partnership With A Global Leader in Laboratory Services Tomi Environmental Solutions expands partnership with leader in lab services,0,0,0,1,-1,-1
12.25M,"486,481",-3.05M,-1,4,2.820,,,"Sep 3, 2024",BLMZ,BloomZ Inc.,17.91M,1.44,859.07K,-20.38%,-32.83%,-32.83%,-42.17%,,,,,,,,1,-1,-1,-1,-1,-1
14.98M,"38,786",-7.31M,-1,273,2.290,,,"Jun 28, 2024",CCTG,CCSC Technology International Holdings Limited,17.84M,1.54,14.75M,-5.60%,-21.45%,-53.91%,-21.30%,-60.65%,CCSC Technology International’s Key AGM Proposals,,,,,CCSC Technology International’s Key AGM Proposals,1,1,-1,-1,-1,-1
46.93M,"104,097",-29.02M,-1,6,0.760,,,"Aug 8, 2024",GYRO,"Gyrodyne, LLC",17.81M,8.10,2.74M,-1.22%,-0.39%,-10.55%,unch,-18.59%,,,,,,,0,-1,-1,-1,-1,-1
49.52M,"310,338",-13.69M,-1,186,0.727,Strong Buy,2.70,"Aug 20, 2024",VRAR,"The Glimpse Group, Inc.",17.78M,0.98,9.99M,12.20%,1.82%,-16.78%,+10.28%,-20.85%,Brightline Interactive expands partnership with GSI for VR training,,,,,Brightline Interactive expands partnership with GSI for VR training,1,1,-1,-1,-1,-1
26.20M,"109,447",-14.11M,-1,45,1.310,Strong Buy,19.33,"Aug 13, 2024",HCWB,HCW Biologics Inc.,17.78M,0.47,3.92M,-13.38%,-26.12%,-58.21%,-18.83%,-70.48%,HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights – Correction,HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights,,,,HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights – Correction HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights,1,0,0,-1,-1,-1
166.44M,"623,014",-9.33M,-1,360,0.206,,,"Sep 3, 2024",HYZN,Hyzon Motors Inc.,17.65M,0.07,10.59M,-13.96%,-65.38%,-87.48%,-51.55%,-91.18%,Hyzon Motors announces 1-for-50 reverse stock split,Morning Movers: Starbucks climbs following poaching of Chipotle’s CEO,Hyzon Motors Q2 Financial Results and Strategic Outlook,"Hyzon Motors reports Q2 EPS (21c), consensus (15c)",HYZON ANNOUNCES SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS,"Hyzon Motors announces 1-for-50 reverse stock split Morning Movers: Starbucks climbs following poaching of Chipotle’s CEO Hyzon Motors Q2 Financial Results and Strategic Outlook Hyzon Motors reports Q2 EPS (21c), consensus (15c) HYZON ANNOUNCES SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS",0,0,0,1,1,0
98.95M,"82,135",-26.83M,-1,15,0.346,Buy,2.00,"Aug 14, 2024",TAIT,Taitron Components Incorporated,17.64M,2.93,4.72M,1.59%,3.52%,-6.45%,-1.03%,-9.13%,,,,,,,0,-1,-1,-1,-1,-1
52.23M,"95,778",-7.92M,-1,67,0.680,,,"Aug 14, 2024",CPOP,"Pop Culture Group Co., Ltd",17.63M,1.18,31.30M,-0.99%,-8.14%,-31.67%,-4.17%,-48.43%,Pop Culture Group Raises $10M in Private Placement,,,,,Pop Culture Group Raises $10M in Private Placement,1,1,-1,-1,-1,-1
10.00M,"58,366",-17.17M,-1,37,3.400,,,"Aug 19, 2024",ZAPP,Zapp Electric Vehicles Group Limited,17.61M,4.18,-,-40.55%,-41.72%,-18.06%,-61.55%,-22.04%,,,,,,,0,-1,-1,-1,-1,-1
177.56M,"25,679,252",-23.89M,-1,57,0.193,,,,YHGJ,Yunhong Green CTI Ltd.,17.61M,0.85,17.80M,36.82%,10.07%,-30.69%,+28.52%,-25.98%,"Yunhong Green CTI Ltd. Receives Non-Compliance Notification from Nasdaq Related to its Inability to file its 10-Q for the Period Ended June 30, 2024",Yunhong Green CTI receives non-compliance notification from Nasdaq,,,,"Yunhong Green CTI Ltd. Receives Non-Compliance Notification from Nasdaq Related to its Inability to file its 10-Q for the Period Ended June 30, 2024 Yunhong Green CTI receives non-compliance notification from Nasdaq",0,0,0,-1,-1,-1
544.91M,"14,211","-378,000",-1,54,2.550,,,"Sep 3, 2024",EZFL,EZFill Holdings Inc.,17.60M,3.10,25.85M,0.32%,-27.01%,-35.69%,-8.72%,-43.93%,"EzFill Holdings Regains Nasdaq Compliance, Faces Monitoring",EzFill regains compliance with Nasdaq listing standard," EzFill Holdings, Inc. Announces Strategic Transactions and Debt Restructuring","EzFill announces strategic transactions, debt restructuring",EzFill Holdings’ Strategic Efforts to Sustain Nasdaq Listing,"EzFill Holdings Regains Nasdaq Compliance, Faces Monitoring EzFill regains compliance with Nasdaq listing standard  EzFill Holdings, Inc. Announces Strategic Transactions and Debt Restructuring EzFill announces strategic transactions, debt restructuring EzFill Holdings’ Strategic Efforts to Sustain Nasdaq Listing",0,0,0,0,0,0
31.19M,"181,709",-39.73M,-1,19,1.060,Strong Buy,5.00,"Aug 14, 2024",NXGL,"NEXGEL, Inc.",17.60M,2.60,5.01M,-1.88%,9.71%,17.40%,-9.24%,+32.56%,NexGel Inc: Strong Buy Rating on Robust Revenue Growth and Strategic Initiatives,NEXGEL to Report Second Quarter 2024 Financial Results on August 14th,"NexGel to sell 444,000 shares at $2.50 in registered direct offering",,,"NexGel Inc: Strong Buy Rating on Robust Revenue Growth and Strategic Initiatives NEXGEL to Report Second Quarter 2024 Financial Results on August 14th NexGel to sell 444,000 shares at $2.50 in registered direct offering",0,1,0,0,-1,-1
6.35M,"3,205",-1.64M,-1,6,5.20,,,"Sep 26, 2024",SYBX,"Synlogic, Inc.",17.54M,1.50,3.17M,-2.49%,-3.31%,-30.28%,-11.24%,-15.73%,Maintaining Hold on Synlogic Amid Strategic Reassessment and Financial Uncertainty,,,,,Maintaining Hold on Synlogic Amid Strategic Reassessment and Financial Uncertainty,0,0,-1,-1,-1,-1
25.54M,"123,601",-21.60M,-1,49,1.290,Strong Buy,8.20,"Aug 8, 2024",EVAX,Evaxion Biotech A/S,17.51M,3.14,278.00K,11.92%,9.52%,-29.43%,+6.74%,-18.43%,Evaxion Biotech’s Strategic Capital Incentives,Buy Rating Affirmed for Evaxion Biotech on Strong Financials and Promising Clinical Trials,Evaxion Biotech Advances with Promising Q2 2024 Update,Evaxion Biotech Reports Mid-Year Financial Losses,Evaxion Biotech reports Q2 EPS (12c) vs (21c) last year,Evaxion Biotech’s Strategic Capital Incentives Buy Rating Affirmed for Evaxion Biotech on Strong Financials and Promising Clinical Trials Evaxion Biotech Advances with Promising Q2 2024 Update Evaxion Biotech Reports Mid-Year Financial Losses Evaxion Biotech reports Q2 EPS (12c) vs (21c) last year,1,0,1,1,1,1
23.00M,"1,125",-94.98M,-1,80,1.430,,,"Sep 3, 2024",TSBX,Turnstone Biologics Corp.,17.51M,0.76,-,-56.70%,-66.62%,-71.97%,-70.69%,-78.27%,Turnstone Biologics price target lowered to $10 from $12 at BofA,Piper Sandler Remains a Buy on Turnstone Biologics Corp. (TSBX),Turnstone Biologics price target lowered to $3.75 from $20 at Piper Sandler,Turnstone Biologics Corp. (TSBX) Gets a Hold from Leerink Partners,Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Turnstone Biologics Corp. (TSBX),Turnstone Biologics price target lowered to $10 from $12 at BofA Piper Sandler Remains a Buy on Turnstone Biologics Corp. (TSBX) Turnstone Biologics price target lowered to $3.75 from $20 at Piper Sandler Turnstone Biologics Corp. (TSBX) Gets a Hold from Leerink Partners Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Turnstone Biologics Corp. (TSBX),0,0,0,0,0,0
29.84M,"854,170",-64.66M,-1,130,1.100,Buy,2.50,"Aug 13, 2024",UGRO,"urban-gro, Inc.",17.49M,1.42,70.32M,2.18%,-0.45%,-13.29%,-4.29%,-18.29%,Urban-Gro awarded first project under MSA with P.F. Chang’s,"Urban-gro Receives Nasdaq Notice, Addresses Financial Report Errors","Buy Rating Maintained for urban-gro Amid Re-audit, Backed by Strong Backlog and Favorable Market Prospects","urban-gro Announces Restatement of Financials, Warns Investors","Urban-Gro sees Q2 revenue exceeding $17.5M, consensus $18.78M","Urban-Gro awarded first project under MSA with P.F. Chang’s Urban-gro Receives Nasdaq Notice, Addresses Financial Report Errors Buy Rating Maintained for urban-gro Amid Re-audit, Backed by Strong Backlog and Favorable Market Prospects urban-gro Announces Restatement of Financials, Warns Investors Urban-Gro sees Q2 revenue exceeding $17.5M, consensus $18.78M",0,0,0,0,0,0
37.56M,"6,619",-7.52M,-1,123,0.847,Strong Buy,6.00,"Sep 18, 2024",MNTS,Momentus Inc.,17.46M,1.05,3.09M,77.12%,86.90%,7.24%,+44.60%,+96.33%,Momentus Nears Settlement and Reveals Preliminary Financials,"Momentus Faces Nasdaq Issues, Secures NASA VADR Launch Deal",,,,"Momentus Nears Settlement and Reveals Preliminary Financials Momentus Faces Nasdaq Issues, Secures NASA VADR Launch Deal",0,1,0,-1,-1,-1
8.92M,"17,714",-10.37M,-1,101,3.650,Strong Buy,11.00,"Aug 14, 2024",EDUC,Educational Development Corporation,17.45M,2.03,46.50M,-6.07%,-3.62%,10.73%,-6.76%,-26.34%,,,,,,,0,-1,-1,-1,-1,-1
24.02M,"1,782",-15.89M,-1,83,1.350,Strong Buy,4.75,"Aug 13, 2024",BOSC,B.O.S. Better Online Solutions Ltd.,17.42M,3.03,40.44M,1.05%,0.59%,3.47%,-2.03%,+3.20%,BOS Sees Steady Income Amidst Demand Resurgence,BOS Better Online Solutions reports Q2 EPS 9c vs 11c last year,,,,BOS Sees Steady Income Amidst Demand Resurgence BOS Better Online Solutions reports Q2 EPS 9c vs 11c last year,0,0,1,-1,-1,-1
27.11M,"102,281",-42.00M,-1,175,1.200,,,"Jul 25, 2024",JYD,Jayud Global Logistics Limited,17.30M,0.81,70.21M,19.09%,25.34%,-27.60%,+15.68%,-26.14%,Jayud Global Logistics to Provide Complete Supply Chain Solutions for iMile Within China,Jayud Global Logistics to provide supply chain solutions for iMile,,,,Jayud Global Logistics to Provide Complete Supply Chain Solutions for iMile Within China Jayud Global Logistics to provide supply chain solutions for iMile,0,0,0,-1,-1,-1
6.21M,"34,729",1.51M,-1,112,5.38,,,"Sep 6, 2024",VISL,"Vislink Technologies, Inc.",17.29M,7.02,32.55M,1.45%,19.44%,63.22%,-6.79%,+109.86%,Vislink names Joseph Lipowski as new Chief Technology Officer,Vislink Announces Appointment of Joseph Lipowski as Chief Technology Officer,"Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)",Vislink to Participate at the 2024 Gateway Conference on September 4th,Vislink reports Q2 EPS (93c) vs. ($1.27) last year,"Vislink names Joseph Lipowski as new Chief Technology Officer Vislink Announces Appointment of Joseph Lipowski as Chief Technology Officer Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Vislink to Participate at the 2024 Gateway Conference on September 4th Vislink reports Q2 EPS (93c) vs. ($1.27) last year",1,1,0,1,1,1
,,,-1,11,,,,,ABTS,Abits Group Inc.,17.24M,0.49,5.34M,-4.96%,-3.31%,-37.45%,-13.11%,-23.72%,Abits Group Inc Reports Unaudited Financial Results for the First Half of 2024,Abits Group Reports Revenue Growth Amidst Challenges,,,,Abits Group Inc Reports Unaudited Financial Results for the First Half of 2024 Abits Group Reports Revenue Growth Amidst Challenges,1,1,1,-1,-1,-1
20.62M,"11,059",3.87M,-1,64,1.580,,,"Aug 26, 2024",AWH,Aspira Women's Health Inc.,17.18M,1.07,8.92M,-8.75%,-20.97%,-65.38%,-23.08%,-62.12%,Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Aspira Women’s Health selected as a spoke for Investor Catalyst Hub,Aspira Women’s Health Selected as a Spoke for the Investor Catalyst Hub,Aspira Women’s Health partners with Dorsata to create clinical workflow tool,Aspira price target lowered to $5.50 from $7 at Alliance Global Partners,Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference Aspira Women’s Health selected as a spoke for Investor Catalyst Hub Aspira Women’s Health Selected as a Spoke for the Investor Catalyst Hub Aspira Women’s Health partners with Dorsata to create clinical workflow tool Aspira price target lowered to $5.50 from $7 at Alliance Global Partners,0,0,1,1,0,0
12.77M,"725,510",-19.57M,-1,430,2.540,,,"Aug 19, 2024",CUTR,"Cutera, Inc.",17.11M,0.85,169.19M,-16.91%,-37.69%,-61.98%,-46.43%,-51.92%,Cutera’s Hold Rating Affirmed Amid Financial Challenges and Operational Headwinds,,,,,Cutera’s Hold Rating Affirmed Amid Financial Challenges and Operational Headwinds,0,1,-1,-1,-1,-1
30.59M,"420,811",-16.24M,-1,3,1.080,,,"Aug 14, 2024",APM,Aptorum Group Limited,16.96M,3.10,431.38K,-1.31%,-17.78%,-21.14%,-7.27%,-70.43%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,255,,,,,ILAG,Intelligent Living Application Group Inc.,16.80M,0.93,6.44M,19.50%,45.20%,54.57%,+50.95%,+106.84%,Intelligent Living Group Calls for Share Consolidation Vote,Intelligent Living Teams Up with AI Robotics Firm,"Intelligent Living Application Group, Specifix enter cooperation agreement",,,"Intelligent Living Group Calls for Share Consolidation Vote Intelligent Living Teams Up with AI Robotics Firm Intelligent Living Application Group, Specifix enter cooperation agreement",1,1,1,1,-1,-1
39.54M,"11,098",-17.09M,-1,38,0.820,Strong Buy,9.00,"Aug 13, 2024",TURB,"Turbo Energy, S.A.",16.75M,1.52,14.53M,23.04%,34.60%,32.65%,+42.23%,+41.00%,,,,,,,1,-1,-1,-1,-1,-1
6.20M,"13,240",-3.31M,-1,85,5.28,,,"Sep 19, 2024",LOBO,Lobo EV Technologies Ltd.,16.73M,2.15,15.47M,-12.15%,-15.03%,-23.80%,-24.00%,-48.14%,LOBO EV Launches Innovative Solar-Powered Golf Cart to Address Increasing Market Demand for Sustainable Transportation Solutions,LOBO EV launches solar-powered golf cart,,,,LOBO EV Launches Innovative Solar-Powered Golf Cart to Address Increasing Market Demand for Sustainable Transportation Solutions LOBO EV launches solar-powered golf cart,0,0,0,-1,-1,-1
10.75M,"17,076",1.13M,-1,22,3.050,,,"Aug 1, 2024",MBOT,Microbot Medical Inc.,16.66M,1.01,-,-0.29%,-4.10%,-15.39%,-5.28%,-22.99%,Microbot Medical Advances Telesurgery with Corewell Health Collaboration,Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System,Microbot Medical signs Phase 2 agreement with Corewell Health,"Microbot Medical Nears Global Compliance, Eyes Future Goals",Microbot receives certification to support future regulatory submissions,"Microbot Medical Advances Telesurgery with Corewell Health Collaboration Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System Microbot Medical signs Phase 2 agreement with Corewell Health Microbot Medical Nears Global Compliance, Eyes Future Goals Microbot receives certification to support future regulatory submissions",0,1,0,0,0,0
89.70M,"45,461","470,180",-1,7,0.358,,,"Aug 28, 2024",INDP,"Indaptus Therapeutics, Inc.",16.62M,1.63,-,-5.23%,-18.74%,-21.35%,-22.53%,-35.25%,Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses,Indaptus Therapeutics to initiate dosing of patients at higher Decoy20 dose,Buy Rating Affirmed for Indaptus Therapeutics Amid Positive Decoy20 Clinical Developments,Indaptus Therapeutics sees cash runway into 1Q25,Indaptus Therapeutics reports Q2 EPS (47c) vs. (39c) last year,Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses Indaptus Therapeutics to initiate dosing of patients at higher Decoy20 dose Buy Rating Affirmed for Indaptus Therapeutics Amid Positive Decoy20 Clinical Developments Indaptus Therapeutics sees cash runway into 1Q25 Indaptus Therapeutics reports Q2 EPS (47c) vs. (39c) last year,1,0,0,1,1,1
31.40M,"66,423",-23.21M,-1,"1,682",1.030,,,"Sep 3, 2024",VRM,"Vroom, Inc.",16.59M,9.12,900.45M,9.63%,0.01%,-58.91%,-6.66%,-30.55%,,,,,,,0,-1,-1,-1,-1,-1
2.81M,"5,002",1.90M,-1,,11.41,,,,ALCE,Alternus Clean Energy Inc,16.55M,0.23,-,2.49%,-20.57%,-85.83%,-20.00%,-47.25%,Alternus Clean Energy Navigates Bond Covenant Breaches and Growth,,,,,Alternus Clean Energy Navigates Bond Covenant Breaches and Growth,1,1,-1,-1,-1,-1
,,,-1,119,,,,,LIQT,"LiqTech International, Inc.",16.44M,2.83,17.72M,18.05%,26.87%,-0.32%,+27.06%,+0.17%,LiqTech price target lowered to $9 from $10 at Lake Street,LiqTech sees Q3 revenue $4.0M-$5.0M,LiqTech reports Q2 EPS (36c) vs. (27c) last year,LiqTech obtains NSF certification for pool system solution in U.S.,LiqTech awarded order for pilot system for produced water treatment in the U.S,LiqTech price target lowered to $9 from $10 at Lake Street LiqTech sees Q3 revenue $4.0M-$5.0M LiqTech reports Q2 EPS (36c) vs. (27c) last year LiqTech obtains NSF certification for pool system solution in U.S. LiqTech awarded order for pilot system for produced water treatment in the U.S,0,0,1,1,0,0
28.53M,"66,298",-39.85M,-1,62,1.120,,,"Sep 6, 2024",PYPD,PolyPid Ltd.,16.31M,3.40,-,-0.78%,-6.49%,-24.51%,-0.28%,-22.84%,PolyPid to Participate in Three Upcoming Fall Investor Conferences,PolyPid (PYPD) Receives a Hold from Barclays,Buy Rating Affirmed for PolyPid on D-PLEX Clinical Progress and Potential Early Approval,Buy Rating Affirmed for PolyPid Amidst Strong Trial Progress and Robust Financial Position,PolyPid Reports Growth in Mid-Year Assets,PolyPid to Participate in Three Upcoming Fall Investor Conferences PolyPid (PYPD) Receives a Hold from Barclays Buy Rating Affirmed for PolyPid on D-PLEX Clinical Progress and Potential Early Approval Buy Rating Affirmed for PolyPid Amidst Strong Trial Progress and Robust Financial Position PolyPid Reports Growth in Mid-Year Assets,0,0,1,0,0,0
,,,-1,3,,,,,MCVT,"Mill City Ventures III, Ltd.",16.28M,2.55,3.25M,6.85%,4.88%,1.99%,-4.48%,+3.75%,Mill City Ventures III reports 1H EPS 12c vs. (10c) last year,,,,,Mill City Ventures III reports 1H EPS 12c vs. (10c) last year,0,1,-1,-1,-1,-1
15.26M,"13,972","-892,290",-1,,2.070,,,"Sep 3, 2024",FMST,Foremost Lithium Resource & Technology Ltd.,16.28M,2.95,-,5.38%,5.38%,4.85%,+1.20%,-4.10%,Foremost Lithium to Engage Investors at Global Conference,Foremost Lithium to Attend H.C. Wainwright 26th Annual Global Investment Conference,Foremost Lithium Strikes High-Grade Lithium in Manitoba,Foremost Lithium appoints Dong Shim as CFO,Foremost Lithium announces drill results from Zoro Property,Foremost Lithium to Engage Investors at Global Conference Foremost Lithium to Attend H.C. Wainwright 26th Annual Global Investment Conference Foremost Lithium Strikes High-Grade Lithium in Manitoba Foremost Lithium appoints Dong Shim as CFO Foremost Lithium announces drill results from Zoro Property,1,1,1,1,1,1
33.09M,"414,549",-35.99M,-1,70,0.969,Strong Buy,14.33,"Aug 14, 2024",PT,Pintec Technology Holdings Limited,16.27M,1.02,7.43M,-0.73%,-2.65%,-7.12%,-0.97%,-7.27%,Mizuho Securities Issues a Hold Rating on Pintec Technology Holdings (PT),,,,,Mizuho Securities Issues a Hold Rating on Pintec Technology Holdings (PT),0,0,-1,-1,-1,-1
60.64M,"86,690",-18.54M,-1,6,0.528,,,"Sep 11, 2024",IMRN,Immuron Limited,16.25M,2.69,2.44M,4.20%,9.35%,18.64%,+2.31%,unch,Immuron plans Phase 2 trial for IMM-529 following FDA review,Immuron Plans Phase 2 Trial for IMM-529 following FDA review,Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®,Immuron announces new DoD research award for NMRC,"Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference","Immuron plans Phase 2 trial for IMM-529 following FDA review Immuron Plans Phase 2 Trial for IMM-529 following FDA review Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan® Immuron announces new DoD research award for NMRC Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference",0,0,0,0,0,1
10.14M,"35,860",-38.69M,-1,18,3.190,,,"Sep 3, 2024",NRSN,NeuroSense Therapeutics Ltd.,16.16M,0.83,-,0.82%,-13.47%,-33.61%,-6.69%,-58.29%,NeuroSense Eyes Lucrative Pharma Partnerships for ALS Drug,NeuroSense Therapeutics Gains Nasdaq Extension,NeuroSense Therapeutics Announces Share Issuance,,,NeuroSense Eyes Lucrative Pharma Partnerships for ALS Drug NeuroSense Therapeutics Gains Nasdaq Extension NeuroSense Therapeutics Announces Share Issuance,1,0,1,0,-1,-1
29.65M,"442,019",-56.07M,-1,62,1.070,Buy,12.60,"Aug 6, 2024",JZ,Jianzhi Education Technology Group Company Limited,16.15M,0.80,62.13M,2.67%,-8.86%,-52.96%,+7.10%,-61.14%,Jianzhi Aims to Resolve Nasdaq Price Deficiency,Jianzhi Education receives written notification from the staff of Nasdaq,Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency,,,Jianzhi Aims to Resolve Nasdaq Price Deficiency Jianzhi Education receives written notification from the staff of Nasdaq Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency,0,0,0,0,-1,-1
16.51M,"18,044",-10.86M,-1,16,1.920,Hold,2.00,"Aug 8, 2024",BCTX,BriaCell Therapeutics Corp.,16.11M,0.86,-,21.40%,-6.36%,-70.01%,+5.65%,-70.77%,,,,,,,1,-1,-1,-1,-1,-1
135.80M,"219,055",-26.48M,-1,589,0.233,Strong Buy,1.50,"Aug 5, 2024",HUBC,HUB Cyber Security Ltd.,16.07M,0.53,42.66M,-22.44%,-30.01%,-62.86%,-38.46%,-68.83%,HUB Security receives noncompliance notification from Nasdaq,HUB Receives Nasdaq Notification Regarding Total Assets and Total Revenue Non-compliance,HUB Security Formalizes Collaboration with Blackswan Technologies to Lead the Rapidly Growing Secured Data Fabric (SDF) Multi-Billion Dollar Market,HUB Security formalizes collaboration with Blackswan Technologies,HUB Security announces $3.3M investment to accelerate growth,HUB Security receives noncompliance notification from Nasdaq HUB Receives Nasdaq Notification Regarding Total Assets and Total Revenue Non-compliance HUB Security Formalizes Collaboration with Blackswan Technologies to Lead the Rapidly Growing Secured Data Fabric (SDF) Multi-Billion Dollar Market HUB Security formalizes collaboration with Blackswan Technologies HUB Security announces $3.3M investment to accelerate growth,1,1,1,1,1,1
20.58M,"10,924",2.39M,-1,42,1.530,,,"Sep 10, 2024",LRHC,La Rosa Holdings Corp.,16.07M,1.00,50.37M,-6.66%,-25.27%,-31.24%,-20.33%,-36.77%,La Rosa Holdings onboards over 400 agents since June,La Rosa to Present at the H.C. Wainwright 26th Annual Global Investment Conference on September 10th,La Rosa Holdings Corp. Announces Strategic Acquisition and Equity Deals,La Rosa Holdings completes acquisition of Nona Title Agency,La Rosa Holdings Expands Portfolio and Revises Payment Terms,La Rosa Holdings onboards over 400 agents since June La Rosa to Present at the H.C. Wainwright 26th Annual Global Investment Conference on September 10th La Rosa Holdings Corp. Announces Strategic Acquisition and Equity Deals La Rosa Holdings completes acquisition of Nona Title Agency La Rosa Holdings Expands Portfolio and Revises Payment Terms,1,0,0,0,0,0
6.32M,"201,386",-103.38M,-1,245,1.230,,,"Sep 12, 2024",DLPN,"Dolphin Entertainment, Inc.",15.99M,0.72,48.89M,-9.66%,-18.09%,-44.80%,-11.89%,-39.13%,"Is DLPN a Buy, Before Earnings?",,,,,"Is DLPN a Buy, Before Earnings?",1,1,-1,-1,-1,-1
20.40M,"1,410",-3.55M,$0.04,36,1.560,,,"Aug 14, 2024",XELB,"Xcel Brands, Inc.",15.95M,0.68,10.06M,4.38%,7.39%,-19.80%,-1.68%,-17.20%,Noble Financial Reaffirms Their Buy Rating on XCel Brands (XELB),Xcel Brands reports Q2 adjusted EPS (1c) vs. (10c) last year,"Xcel Brands to Host Second Quarter 2024 Earnings Call on August 14, 2024",,,"Noble Financial Reaffirms Their Buy Rating on XCel Brands (XELB) Xcel Brands reports Q2 adjusted EPS (1c) vs. (10c) last year Xcel Brands to Host Second Quarter 2024 Earnings Call on August 14, 2024",1,1,1,1,-1,-1
30.71M,"63,650","-220,000",-1,28,1.020,Strong Buy,4.00,"Aug 6, 2024",NCNA,NuCana plc,15.93M,7.09,-,59.26%,105.47%,26.01%,+103.57%,+27.37%,NuCana price target lowered to $25 from $150 at Oppenheimer,NuCana PLC (ADR) trading resumes,"Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls","NuCana PLC (ADR) trading halted, volatility trading pause",Closing Bell Movers: Lululemon gains 5%; Elastic falls 25% on earnings,"NuCana price target lowered to $25 from $150 at Oppenheimer NuCana PLC (ADR) trading resumes Abercrombie upgraded, Dollar General downgraded: Wall Street’s top analyst calls NuCana PLC (ADR) trading halted, volatility trading pause Closing Bell Movers: Lululemon gains 5%; Elastic falls 25% on earnings",0,0,0,1,0,0
40.43M,"307,724",-34.82M,-1,255,0.775,Hold,,"Aug 14, 2024",OMIC,"Singular Genomics Systems, Inc.",15.82M,6.34,2.72M,0.10%,-12.23%,-41.43%,-19.86%,-54.62%,"Singular Genomics reports Q2 EPS ($8.57), consensus ($8.86)","OMIC Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,,"Singular Genomics reports Q2 EPS ($8.57), consensus ($8.86) OMIC Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,1,1,-1,-1,-1
127.37M,"793,241",-49.13M,-1,7,0.246,Buy,1.11,"Aug 8, 2024",CDT,Conduit Pharmaceuticals Inc.,15.81M,0.16,-,-12.06%,-69.28%,-94.06%,-37.45%,-95.56%,Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders,,,,Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders,0,0,0,-1,-1,-1
14.26M,"11,681",2.63M,-1,102,2.160,,,"Sep 4, 2024",WKEY,WISeKey International Holding AG,15.67M,2.32,30.92M,3.17%,3.68%,5.45%,+9.45%,-4.35%,WISeKey Presents Digital Transformation Initiatives at APBA Event in Spain,Bernardino Abad Grupo Logístico becomes the primary reference for the WISeContainer platform and sensors,WISeKey Subsidiary WISeSAT Announces the Signing of a Proof of Concept Agreement with Tránsitos y Transportes Logísticos S.L. for its WISeTruck IoT Sensors and Tracking Platform,WISeKey Subsidiary WISeSAT.Space Announces Strategic Alliance with Global Radio Systems,WISeKey Subsidiary WISe.ART Presents NFTs from The Three Gates of Wisdom,WISeKey Presents Digital Transformation Initiatives at APBA Event in Spain Bernardino Abad Grupo Logístico becomes the primary reference for the WISeContainer platform and sensors WISeKey Subsidiary WISeSAT Announces the Signing of a Proof of Concept Agreement with Tránsitos y Transportes Logísticos S.L. for its WISeTruck IoT Sensors and Tracking Platform WISeKey Subsidiary WISeSAT.Space Announces Strategic Alliance with Global Radio Systems WISeKey Subsidiary WISe.ART Presents NFTs from The Three Gates of Wisdom,0,0,0,1,1,1
5.16M,727,"626,000",-1,162,6.00,,,"Aug 14, 2024",SYRA,Syra Health Corp.,15.66M,1.11,7.07M,-16.92%,-19.66%,-25.25%,-25.45%,-22.52%,"Syra Health Corp. Navigates Nasdaq Compliance, Eyes Revenue Growth","Syra Health files to sell 3.79M shares Class A common stock, warrants",,,,"Syra Health Corp. Navigates Nasdaq Compliance, Eyes Revenue Growth Syra Health files to sell 3.79M shares Class A common stock, warrants",0,1,1,-1,-1,-1
8.77M,"28,861",-23.75M,-1,99,3.540,Strong Buy,13.00,"Aug 15, 2024",HTCR,"HeartCore Enterprises, Inc.",15.44M,0.74,17.13M,-2.64%,-8.80%,-10.14%,-11.27%,-33.54%,"HeartCore to Present at the H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024",HeartCore Enterprises Unveils 2024 Revenue Projections,HeartCore Enterprises reports Q2 EPS (9c) vs (4c) last year,,,"HeartCore to Present at the H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024 HeartCore Enterprises Unveils 2024 Revenue Projections HeartCore Enterprises reports Q2 EPS (9c) vs (4c) last year",0,0,0,1,-1,-1
58.40M,"238,103",-19.30M,-1,28,0.529,,,"Apr 30, 2024",SGLY,Singularity Future Technology Ltd.,15.43M,4.41,3.37M,24.10%,-0.23%,-5.49%,+1.92%,-11.66%,Sino-Global Shipping America trading resumes,"Sino-Global Shipping America trading halted, volatility trading pause",,,,"Sino-Global Shipping America trading resumes Sino-Global Shipping America trading halted, volatility trading pause",1,0,0,-1,-1,-1
17.84M,"38,678",-10.80M,-1,15,1.730,Strong Buy,5.00,"Aug 13, 2024",TLPH,"Talphera, Inc.",15.29M,0.90,398.00K,5.25%,6.58%,1.96%,-6.07%,-22.50%,Talphera enrolls first patient in NEPHRO CRRT study,Bullish Outlook on Talphera’s Niyad: Phase 3 Trial Advancements and Market Potential Justify Buy Rating,Buy Rating Affirmed for Talphera Amid Strategic Advancements in NEPHRO CRRT Study,Talphera price target lowered to $3.50 from $4.25 at Alliance Global Partners,Talphera Announces CMO Retirement and Successor Appointment,Talphera enrolls first patient in NEPHRO CRRT study Bullish Outlook on Talphera’s Niyad: Phase 3 Trial Advancements and Market Potential Justify Buy Rating Buy Rating Affirmed for Talphera Amid Strategic Advancements in NEPHRO CRRT Study Talphera price target lowered to $3.50 from $4.25 at Alliance Global Partners Talphera Announces CMO Retirement and Successor Appointment,0,0,0,0,0,1
24.28M,"23,991",-12.39M,-1,68,1.280,Strong Buy,6.00,"Aug 8, 2024",JCTCF,Jewett-Cameron Trading Company Ltd.,15.25M,4.35,48.55M,6.84%,-3.14%,-11.63%,+12.05%,-13.57%,Jewett-Cameron Appoints New VP of Sales and Marketing,Jewett-Cameron Rolls Out Successful Fence Displays,Jewett-Cameron Trading Company Ltd. launches in-store fence product displays,,,Jewett-Cameron Appoints New VP of Sales and Marketing Jewett-Cameron Rolls Out Successful Fence Displays Jewett-Cameron Trading Company Ltd. launches in-store fence product displays,1,1,0,0,-1,-1
11.41M,"4,385",-4.31M,-1,45,2.650,,,"Sep 20, 2024",APLM,"Apollomics, Inc.",15.18M,0.14,2.10M,-11.78%,-26.72%,-75.06%,-35.32%,-78.66%,Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress,Apollomics announces preliminary data on vebreltinib,Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial,,Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress Apollomics announces preliminary data on vebreltinib Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial,0,0,1,1,0,-1
18.55M,"538,633",-61.36M,-1,10,1.650,Hold,1.00,"Aug 19, 2024",CTCX,Carmell Corporation,14.96M,0.72,12.32K,-31.82%,-47.46%,-73.03%,-48.86%,-79.15%,Carmell Therapeutics launches skincare partnership with Ladies Playbook,Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community,,,,Carmell Therapeutics launches skincare partnership with Ladies Playbook Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community,0,0,0,-1,-1,-1
2.50M,15,"82,211",-1,28,11.76,,,,SNSE,"Sensei Biotherapeutics, Inc.",14.96M,0.59,-,-1.15%,-4.20%,-26.45%,-8.82%,-40.42%,Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference,Sensei Biotherapeutics to Present at Upcoming Conferences,,,,Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference Sensei Biotherapeutics to Present at Upcoming Conferences,0,0,0,-1,-1,-1
,,,-1,1,,,,,WENA,"Anew Medical, Inc.",14.88M,1.17,-,-1.03%,-38.67%,-84.90%,-24.26%,-91.86%,"ANEW Medical announces goals for cell, gene therapy development",Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy,"ANEW MEDICAL, INC. Appoints New CFO","ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases",,"ANEW Medical announces goals for cell, gene therapy development Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy ANEW MEDICAL, INC. Appoints New CFO ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases",0,0,0,0,0,-1
57.23M,"125,792",-54.08M,-1,98,0.539,Strong Buy,1.40,"Aug 14, 2024",HOFV,Hall of Fame Resort & Entertainment Company,14.87M,2.27,23.77M,-5.54%,-17.17%,-28.79%,-21.22%,-36.24%,James Dolan Resigns from Hall of Fame Resort Board,Hall of Fame Resort & Entertainment: Operational Efficiency and Strategic Financing Bolster Buy Rating,Hall of Fame Resort & Entertainment reports Q2 EPS ($2.41) vs. ($2.39) last year,Hall Of Fame Resort & Entertainment Company (HOFV) Q2 Earnings Cheat Sheet,,James Dolan Resigns from Hall of Fame Resort Board Hall of Fame Resort & Entertainment: Operational Efficiency and Strategic Financing Bolster Buy Rating Hall of Fame Resort & Entertainment reports Q2 EPS ($2.41) vs. ($2.39) last year Hall Of Fame Resort & Entertainment Company (HOFV) Q2 Earnings Cheat Sheet,1,1,1,1,1,-1
41.09M,"5,225",-63.97M,-1,96,0.740,Hold,2.83,"Aug 14, 2024",GIGM,GigaMedia Limited,14.81M,1.34,3.39M,-1.81%,-0.23%,-3.21%,-2.22%,-1.49%,,,,,,,1,-1,-1,-1,-1,-1
8.55M,"51,889",-7.20M,-1,,3.550,Strong Buy,40.33,"Aug 12, 2024",ZEO,Zeo Energy Corp.,14.80M,2.55,95.46M,-32.01%,-33.01%,-69.20%,-43.03%,-63.57%,Zeo Energy Corp. to Present at the 2024 Gateway Conference on September 5ᵗʰ,Zeo Energy Appoints Cannon Holbrook as New CFO,Zeo Energy appoints Cannon Holbrook as CFO,Zeo Energy reports Q2 EPS 3c vs. 0c last year,,Zeo Energy Corp. to Present at the 2024 Gateway Conference on September 5ᵗʰ Zeo Energy Appoints Cannon Holbrook as New CFO Zeo Energy appoints Cannon Holbrook as CFO Zeo Energy reports Q2 EPS 3c vs. 0c last year,1,1,1,1,1,-1
28.57M,"39,935","595,000",-1,6,1.050,,,"Aug 14, 2024",GCTK,"GlucoTrack, Inc.",14.79M,2.70,-,59.74%,55.13%,57.80%,+125.00%,+8.24%,GlucoTrack appoints John Ballantyne to board of directors,"JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS",GlucoTrack Welcomes New VP of Clinical Operations,GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS,"GlucoTrack appoints Sandie Martha as VP, clinical operations","GlucoTrack appoints John Ballantyne to board of directors JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS GlucoTrack Welcomes New VP of Clinical Operations GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS GlucoTrack appoints Sandie Martha as VP, clinical operations",0,1,0,0,1,1
48.17M,"132,628",,-1,13,0.620,,,"Sep 6, 2024",GLTO,"Galecto, Inc.",14.65M,0.54,-,3.21%,5.12%,-12.39%,-7.80%,-31.58%,"Galecto trading halted, news pending",Galecto announces 1-for-25 reverse stock split,Galecto Announces Reverse Stock Split,,,"Galecto trading halted, news pending Galecto announces 1-for-25 reverse stock split Galecto Announces Reverse Stock Split",1,0,0,0,-1,-1
,,,-1,30,,,,,ONCT,"Oncternal Therapeutics, Inc.",14.65M,4.95,1.85M,-12.73%,-32.63%,-45.58%,-34.33%,-52.61%,,,,,,,1,-1,-1,-1,-1,-1
8.12M,"484,991",-35.75M,-1,99,3.650,Strong Buy,20.50,"Aug 1, 2024",CWD,CaliberCos Inc.,14.60M,0.66,72.10M,8.40%,-12.27%,-40.01%,+11.27%,-36.25%,CaliberCos Clarifies Legal Status of Information Disclosures,"CaliberCos reports Q2 EPS (22c), consensus (29c)",,,,"CaliberCos Clarifies Legal Status of Information Disclosures CaliberCos reports Q2 EPS (22c), consensus (29c)",1,1,1,-1,-1,-1
40.13M,"446,685",-31.08M,-1,150,0.738,Buy,8.00,"Aug 8, 2024",AYTU,"Aytu BioPharma, Inc.",14.57M,2.44,93.76M,-6.61%,-12.89%,-16.59%,-9.05%,-25.15%,,,,,,,0,-1,-1,-1,-1,-1
17.50M,"122,681",1.27M,-1,75,1.700,,,"Sep 3, 2024",REBN,"Reborn Coffee, Inc.",14.52M,3.87,6.20M,-5.40%,-34.54%,-0.64%,-19.04%,+191.74%,"Reborn Coffee closes master license agreement for Sichuan Province, China","Reborn Coffee Closes Master License Agreement for Sichuan Province, China",Reborn Coffee Optimizes Capital with Strategic Financial Moves,Reborn Coffee Announces Completion of Private Placement of Convertible Note,Reborn Coffee completes private placement of convertible note,"Reborn Coffee closes master license agreement for Sichuan Province, China Reborn Coffee Closes Master License Agreement for Sichuan Province, China Reborn Coffee Optimizes Capital with Strategic Financial Moves Reborn Coffee Announces Completion of Private Placement of Convertible Note Reborn Coffee completes private placement of convertible note",1,1,1,1,1,1
27.84M,"37,515",-2.56M,$0.10,16,1.030,,,"Sep 3, 2024",EDSA,"Edesa Biotech, Inc.",14.45M,4.45,-,0.21%,2.87%,5.81%,-18.11%,-7.17%,Edesa Biotech Showcases Steady Q3 2024 Financials,Edesa Biotech reports Q3 EPS (52c) vs (68c) last year,,,,Edesa Biotech Showcases Steady Q3 2024 Financials Edesa Biotech reports Q3 EPS (52c) vs (68c) last year,0,0,1,-1,-1,-1
11.11M,"402,377",13.50M,-1,"1,727",2.640,,,"Sep 6, 2024",GFAI,"Guardforce AI Co., Limited",14.43M,1.45,36.28M,0.20%,-22.51%,-45.80%,-25.76%,-60.80%,Guardforce AI Expands AIoT Robot Advertising to U.S. Market and Prepares to Launch Decentralized Spatial Computing Solution in Late August,Guardforce AI expands AIoT Robot Advertising in U.S.,,,,Guardforce AI Expands AIoT Robot Advertising to U.S. Market and Prepares to Launch Decentralized Spatial Computing Solution in Late August Guardforce AI expands AIoT Robot Advertising in U.S.,0,0,1,-1,-1,-1
30.30M,"298,319",-32.47M,-1,6,0.965,Buy,4.67,"Aug 12, 2024",TENX,"Tenax Therapeutics, Inc.",14.39M,4.22,-,3.88%,15.26%,-54.94%,+13.82%,+1.31%,"Tenax Therapeutics reports Q2 EPS ($1.83), consensus ($1.98)",Tenax announces plans to accelerate oral levosimendan Phase 3 program,Biotech Alert: Searches spiking for these stocks today,,,"Tenax Therapeutics reports Q2 EPS ($1.83), consensus ($1.98) Tenax announces plans to accelerate oral levosimendan Phase 3 program Biotech Alert: Searches spiking for these stocks today",1,1,0,1,-1,-1
8.49M,"17,668",-25.90M,-1,84,3.400,Strong Buy,10.00,"Aug 14, 2024",GLBZ,Glen Burnie Bancorp,14.36M,4.95,11.58M,10.01%,17.27%,-2.68%,+11.16%,-1.52%,,,,,,,0,-1,-1,-1,-1,-1
7.83M,"36,240",-4.05M,-1,14,3.680,,,"Aug 13, 2024",QTI,"QT Imaging Holdings, Inc.",14.31M,0.67,3.11M,12.22%,-6.40%,-87.26%,-8.67%,-44.66%,QT Imaging Holdings Bolsters Investor Relations with Web Presentation,,,,,QT Imaging Holdings Bolsters Investor Relations with Web Presentation,0,1,-1,-1,-1,-1
5.76M,"26,387",-37.76M,-1,61,5.000,,,"Aug 14, 2024",LAES,SEALSQ Corp,14.30M,0.62,30.06M,49.02%,13.15%,-39.97%,-9.62%,-55.56%,SEALSQ Demonstrates Enhanced IoT Security with ESP32 and VaultIC292 Secure Element for Matter Commissioning Process,SEALSQ testing QS7001 RISC V quantum-resistant platform,SEALSQ Testing its QS7001 RISC V Quantum-Resistant Platform I the Next Generation WISeSat Satellites; Prototype to Launch in November 2024,SEALSQ-Enabled Digital Crypto Wallet Features Designed to Safeguard Against Potential Quantum Computing Threats,"Sealsq utilizes Swiss data centers to store, process data from sensors, semis","SEALSQ Demonstrates Enhanced IoT Security with ESP32 and VaultIC292 Secure Element for Matter Commissioning Process SEALSQ testing QS7001 RISC V quantum-resistant platform SEALSQ Testing its QS7001 RISC V Quantum-Resistant Platform I the Next Generation WISeSat Satellites; Prototype to Launch in November 2024 SEALSQ-Enabled Digital Crypto Wallet Features Designed to Safeguard Against Potential Quantum Computing Threats Sealsq utilizes Swiss data centers to store, process data from sensors, semis",1,1,1,0,0,0
42.22M,"87,135",7.48M,-1,11,0.690,,,"Jul 16, 2024",MTEK,Maris-Tech Ltd.,14.26M,1.81,4.03M,1.60%,11.72%,31.14%,+13.95%,+26.45%,Maris-Tech Secures Patent for Streamlined Media Streaming,Maris-Tech receives patent for forward error correction optimization method,Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization Method,Maris-Tech Reports Soaring Revenues and Profits,"Maris-Tech Announces Financial Results and Net Profit for the Six Months Ended June 30, 2024","Maris-Tech Secures Patent for Streamlined Media Streaming Maris-Tech receives patent for forward error correction optimization method Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization Method Maris-Tech Reports Soaring Revenues and Profits Maris-Tech Announces Financial Results and Net Profit for the Six Months Ended June 30, 2024",1,0,1,1,1,0
13.59M,"298,461",-12.57M,-1,"1,450",2.110,,,"Aug 15, 2024",CMAX,"CareMax, Inc.",14.12M,3.70,784.55M,-23.57%,-7.43%,-61.80%,-52.41%,-31.80%,Truist Financial Sticks to Its Hold Rating for CareMax (CMAX),CareMax down 4% at $4.35 after Q2 results,CareMax reports Q2 adjusted EBITDA ($11.2M) vs. $7.0M last year.,CareMax’s Q2 2024 Earnings Details Released Unofficially,,Truist Financial Sticks to Its Hold Rating for CareMax (CMAX) CareMax down 4% at $4.35 after Q2 results CareMax reports Q2 adjusted EBITDA ($11.2M) vs. $7.0M last year. CareMax’s Q2 2024 Earnings Details Released Unofficially,1,0,1,1,1,-1
43.28M,"87,246",-53.12M,-1,271,0.660,,,"Aug 13, 2024",GVP,"GSE Systems, Inc.",14.06M,4.05,44.79M,10.01%,9.25%,40.22%,+24.61%,+29.87%,GSE Systems Reports Second Quarter 2024 Financial Results,,,,,GSE Systems Reports Second Quarter 2024 Financial Results,1,0,-1,-1,-1,-1
32.74M,"30,972",-8.79M,-1,,0.871,Strong Buy,3.00,"Aug 7, 2024",MDRR,"Medalist Diversified REIT, Inc.",14.04M,12.56,10.17M,7.56%,7.17%,14.91%,+6.33%,+6.96%,,,,,,,1,-1,-1,-1,-1,-1
70.07M,"1,071,678",-10.01M,-1,336,0.408,,,,GSUN,Golden Sun Health Technology Group Limited,13.99M,7.33,6.34M,-1.05%,3.61%,17.98%,-12.44%,+46.99%,Golden Sun Group Schedules 2024 Shareholder Meeting,Golden Sun Health established strategic joint venture,Golden Sun Health Technology Group Limited Announces Joint Venture to Enter the Cultural Tourism Market,Golden Sun Health Technology Group Ltd trading resumes,"Golden Sun Health Technology Group Ltd trading halted, volatility trading pause","Golden Sun Group Schedules 2024 Shareholder Meeting Golden Sun Health established strategic joint venture Golden Sun Health Technology Group Limited Announces Joint Venture to Enter the Cultural Tourism Market Golden Sun Health Technology Group Ltd trading resumes Golden Sun Health Technology Group Ltd trading halted, volatility trading pause",0,0,1,1,1,0
13.41M,"58,397","812,000",-1,,2.100,Buy,3.00,"Aug 8, 2024",JDZG,JIADE Limited,13.98M,0.58,2.20M,9.25%,-16.88%,-78.19%,-8.58%,,,,,,,,1,-1,-1,-1,-1,-1
30.20M,"328,487",16.34M,-1,82,0.930,,,"Sep 3, 2024",CLRO,"ClearOne, Inc.",13.97M,0.58,14.97M,-12.28%,-17.16%,-26.15%,-19.37%,-63.15%,,,,,,,0,-1,-1,-1,-1,-1
5.39M,"4,448",-21.62M,-1,82,5.03,,,"Sep 10, 2024",SIDU,"Sidus Space, Inc.",13.92M,3.33,4.31M,33.40%,37.36%,-20.04%,+32.03%,-3.15%,Sidus Space appoints Coffey as Independent Director,Morning Movers: Lowe’s moves lower after guidance cut,Craig Technologies awards Sidus Space $2M deal for U.S. Navy propulsion program,Closing Bell Movers: Titan skyrockets after KE merger agreement,Sidus Space reports Q2 EPS (99c) vs ($6.85) last year,Sidus Space appoints Coffey as Independent Director Morning Movers: Lowe’s moves lower after guidance cut Craig Technologies awards Sidus Space $2M deal for U.S. Navy propulsion program Closing Bell Movers: Titan skyrockets after KE merger agreement Sidus Space reports Q2 EPS (99c) vs ($6.85) last year,1,1,1,1,1,1
26.14M,"104,253",-27.55M,-1,80,1.070,,,"Sep 3, 2024",MBIO,"Mustang Bio, Inc.",13.90M,0.37,-,-12.09%,-24.91%,-64.10%,-11.61%,-61.28%,"MBIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,,,"MBIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,1,-1,-1,-1,-1
16.94M,"7,128",-137.20M,-1,108,1.650,Hold,,"Aug 2, 2024",FLGC,Flora Growth Corp.,13.81M,1.04,69.01M,12.48%,6.95%,-13.77%,+6.00%,-55.46%,Flora Growth Approves Stock Rights Plan for Executives,Flora Growth Board Changes Ensure Nasdaq Compliance,Flora Growth downgraded to Neutral from Buy at Alliance Global Partners,Flora Growth Reports Strategic Expansions in Q2 2024,FLGC Upcoming Earnings Report: What to Expect?,Flora Growth Approves Stock Rights Plan for Executives Flora Growth Board Changes Ensure Nasdaq Compliance Flora Growth downgraded to Neutral from Buy at Alliance Global Partners Flora Growth Reports Strategic Expansions in Q2 2024 FLGC Upcoming Earnings Report: What to Expect?,1,1,1,0,1,1
15.87M,"17,323",19.61M,-1,171,1.760,,,"Sep 6, 2024",STRR,"Star Equity Holdings, Inc.",13.78M,4.26,47.15M,-3.41%,-4.16%,-10.73%,-15.05%,-10.43%,Star Equity Holdings Unveils Strategic and Financial Outlook,"Star Equity Holdings, Inc. Adopts Rights Agreement to Protect its Net Operating Losses",Star Equity adopts Rights Agreement to protect net operating losses,"Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock",Maxim Group Keeps Their Buy Rating on Star Equity Holdings (STRR),"Star Equity Holdings Unveils Strategic and Financial Outlook Star Equity Holdings, Inc. Adopts Rights Agreement to Protect its Net Operating Losses Star Equity adopts Rights Agreement to protect net operating losses Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock Maxim Group Keeps Their Buy Rating on Star Equity Holdings (STRR)",0,0,0,0,0,0
75.49M,"121,152",-58.51M,-1,96,0.370,Strong Buy,2.50,"Aug 13, 2024",JVA,"Coffee Holding Co., Inc.",13.70M,2.40,73.06M,10.16%,11.34%,66.15%,+3.61%,+62.67%,,,,,,,0,-1,-1,-1,-1,-1
30.03M,"71,998",-36.16M,-1,"14,100",0.921,Strong Buy,4.00,"Aug 8, 2024",XELA,"Exela Technologies, Inc.",13.69M,2.15,1.02B,-1.74%,-5.59%,-15.49%,-13.06%,-6.99%,"Exela Technologies, Inc. to Host Second Quarter 2024 Financial Results Conference Call",,,,,"Exela Technologies, Inc. to Host Second Quarter 2024 Financial Results Conference Call",1,1,-1,-1,-1,-1
24.25M,"19,458",-7.44M,-1,8,1.150,,,"Jun 18, 2024",AMIX,"Autonomix Medical, Inc.",13.64M,0.59,-,-16.90%,-34.85%,-75.60%,-45.22%,-79.53%,Autonomix initiated with a Buy at Ladenburg,"Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference","Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress",Autonomix announces upcoming milestones,"Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones","Autonomix initiated with a Buy at Ladenburg Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress Autonomix announces upcoming milestones Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones",0,1,0,0,0,0
14.17M,"56,006",-186.19M,-1,,1.960,Hold,2.00,"Aug 16, 2024",NIVF,NewGenIvf Group Limited,13.62M,1.13,-,7.53%,0.47%,-83.81%,-2.64%,-9.65%,NewGenIvf Group reports 2023 revenue $5.1M vs. $5.9M last year,NewGenIvf Announces Filing of 2023 Annual Report with the SEC,,,,NewGenIvf Group reports 2023 revenue $5.1M vs. $5.9M last year NewGenIvf Announces Filing of 2023 Annual Report with the SEC,1,1,1,-1,-1,-1
4.61M,"9,693",-38.72M,-1,153,6.01,Strong Buy,16.50,"Aug 6, 2024",SANW,S&W Seed Company,13.58M,0.31,68.68M,-11.20%,-7.41%,-34.58%,-27.37%,-38.68%,,,,,,,0,-1,-1,-1,-1,-1
40.74M,"385,748",-107.83M,-1,4,0.679,Strong Buy,5.50,"Aug 6, 2024",GIPR,"Generation Income Properties, Inc.",13.50M,2.49,9.66M,8.24%,-21.31%,-32.77%,-6.21%,-33.82%,Generation Income Properties Secures Retail Asset with Strategic Acquisition,Generation Income Properties (GIPR) Receives a Hold from Maxim Group,Generation Income Properties Clarifies Disclosure Regulations,,,Generation Income Properties Secures Retail Asset with Strategic Acquisition Generation Income Properties (GIPR) Receives a Hold from Maxim Group Generation Income Properties Clarifies Disclosure Regulations,0,0,0,0,-1,-1
14.75M,"8,805",-28.58M,-1,326,1.890,Strong Buy,5.75,"Aug 14, 2024",MULN,"Mullen Automotive, Inc.",13.47M,0.34,156.57K,-48.97%,-79.75%,-95.49%,-76.42%,-93.16%,Mullen Automotive files to sell 350M shares of common stock for holders,Largest borrow rate increases among liquid names,Mullen’s Bollinger Motors enters partnership with Texas Consulting & Development,"3 Penny Stocks to Watch Now, 9/05/24",Mullen ships initial commercial EVs under contract with Volt Mobility,"Mullen Automotive files to sell 350M shares of common stock for holders Largest borrow rate increases among liquid names Mullen’s Bollinger Motors enters partnership with Texas Consulting & Development 3 Penny Stocks to Watch Now, 9/05/24 Mullen ships initial commercial EVs under contract with Volt Mobility",1,1,1,1,0,1
22.71M,"251,940",-28.34M,-1,60,1.210,Strong Buy,5.00,"Aug 14, 2024",AEI,Alset Inc.,13.39M,1.45,9.22M,26.73%,6.86%,29.12%,+17.59%,+103.14%,,,,,,,0,-1,-1,-1,-1,-1
3.21M,"10,581",-53.45M,-1,50,8.57,,,"Aug 12, 2024",VRME,"VerifyMe, Inc.",13.29M,1.28,25.43M,19.30%,7.96%,5.13%,+18.52%,-14.10%,Buy Rating Reaffirmed for VerifyMe Amidst Revenue Consistency and EBITDA Outperformance,VerifyMe price target lowered to $1.50 from $2 at Barrington,VerifyMe: Unveiling Earnings Call Insights for Investors,VerifyMe Reports Second Quarter 2024 Financial Results,"Is VRME a Buy, Before Earnings?","Buy Rating Reaffirmed for VerifyMe Amidst Revenue Consistency and EBITDA Outperformance VerifyMe price target lowered to $1.50 from $2 at Barrington VerifyMe: Unveiling Earnings Call Insights for Investors VerifyMe Reports Second Quarter 2024 Financial Results Is VRME a Buy, Before Earnings?",1,1,0,0,0,1
9.44M,"1,437",-3.85M,-1,116,2.940,,,"Sep 3, 2024",PMD,Psychemedics Corporation,13.28M,2.28,20.79M,8.68%,2.17%,-14.78%,+1.11%,-19.12%,Psychemedics launches ketamine hair testing service,Psychemedics Corporation Launches New Ketamine Hair Testing Service,Psychemedics Corporation Reports Second Quarter 2024 Financial Results,Psychemedics board approves plan to terminate registration of common stock,,Psychemedics launches ketamine hair testing service Psychemedics Corporation Launches New Ketamine Hair Testing Service Psychemedics Corporation Reports Second Quarter 2024 Financial Results Psychemedics board approves plan to terminate registration of common stock,1,0,0,0,1,-1
14.78M,"27,571,454",-12.78M,-1,48,1.850,Strong Buy,11.00,"Aug 13, 2024",SNTI,"Senti Biosciences, Inc.",13.23M,2.89,338.00K,27.06%,6.62%,-25.41%,+11.47%,-29.10%,Senti Bio to Participate in Upcoming Investor Conferences,Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights,,,,Senti Bio to Participate in Upcoming Investor Conferences Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights,0,0,1,-1,-1,-1
6.88M,"27,179",-5.26M,-1,22,3.940,,,"Aug 13, 2024",NCRA,"Nocera, Inc.",13.23M,0.97,26.40M,4.69%,-3.32%,-18.17%,+4.48%,-23.08%,,,,,,,1,-1,-1,-1,-1,-1
34.00M,"92,835",-3.38M,-1,160,0.794,,,"Sep 3, 2024",RMCF,"Rocky Mountain Chocolate Factory, Inc.",13.21M,1.74,27.92M,2.99%,-7.29%,-45.96%,-3.16%,-50.05%,Rocky Mountain Chocolate files to sell 1.25M shares of common stock for holders,,,,,Rocky Mountain Chocolate files to sell 1.25M shares of common stock for holders,1,1,-1,-1,-1,-1
,,,-1,970,,,,,DXYN,"The Dixie Group, Inc.",13.21M,0.90,271.01M,14.60%,20.87%,26.09%,+29.67%,+58.10%,,,,,,,1,-1,-1,-1,-1,-1
79.73M,"415,935",-12.75M,-1,35,0.337,Strong Buy,2.00,"Aug 14, 2024",ELSE,"Electro-Sensors, Inc.",13.20M,3.85,8.83M,-0.72%,-3.44%,-4.48%,-1.02%,-4.89%,"Electro-Sensors, Inc. Announces Second Quarter 2024 Financial Results",,,,,"Electro-Sensors, Inc. Announces Second Quarter 2024 Financial Results",1,0,-1,-1,-1,-1
4.17M,"100,263",-32.62M,-1,213,6.40,,,"Aug 13, 2024",MTEX,"Mannatech, Incorporated",13.19M,7.00,122.38M,5.12%,4.61%,-17.10%,+8.43%,-15.67%,,,,,,,1,-1,-1,-1,-1,-1
16.55M,"3,184",-11.93M,-1,56,1.610,,,"Sep 6, 2024",PETZ,"TDH Holdings, Inc.",13.11M,1.27,3.18M,-2.16%,-6.18%,-1.52%,-5.54%,-1.64%,,,,,,,1,-1,-1,-1,-1,-1
12.18M,"316,445",-2.02M,-1,11,2.180,,,"Sep 30, 2024",MDJH,MDJM Ltd,13.08M,1.12,144.86K,-2.91%,-7.17%,-12.41%,-36.65%,-15.00%,,,,,,,1,-1,-1,-1,-1,-1
7.00M,"28,175","216,948",-1,20,3.790,,,"Aug 14, 2024",PPBT,Purple Biotech Ltd,13.01M,0.40,-,13.20%,7.24%,-34.29%,+12.78%,-37.86%,Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference,Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS),Purple Biotech Targets Key Oncology Milestones,Purple Biotech price target lowered to $8 from $10 at H.C. Wainwright,"Applied Materials, H&R Block report quarterly beats: Morning Buzz","Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS) Purple Biotech Targets Key Oncology Milestones Purple Biotech price target lowered to $8 from $10 at H.C. Wainwright Applied Materials, H&R Block report quarterly beats: Morning Buzz",1,0,0,1,0,1
16.85M,"119,747",-30.19M,-1,174,1.570,Strong Buy,9.00,"Aug 6, 2024",MSS,Maison Solutions Inc.,13.00M,0.66,58.04M,-24.15%,-41.33%,-75.54%,-36.88%,-48.83%,,,,,,,0,-1,-1,-1,-1,-1
38.26M,"126,960",-66.17M,-1,87,0.688,Hold,1.25,"Aug 13, 2024",SLE,"Super League Enterprise, Inc.",12.99M,1.23,25.03M,-1.01%,7.95%,-25.24%,-13.26%,-45.48%,Super League Enterprise files to sell 2.63M shares of common stock for holders,Super League Enterprise Maintains Buy Rating Amidst Revenue Growth and Lucrative Deals,Buy Rating Affirmed: Anticipated Revenue Growth and Path to Profitability for Super League Enterprise,Super League Announces Second Quarter 2024 Financial Results,,Super League Enterprise files to sell 2.63M shares of common stock for holders Super League Enterprise Maintains Buy Rating Amidst Revenue Growth and Lucrative Deals Buy Rating Affirmed: Anticipated Revenue Growth and Path to Profitability for Super League Enterprise Super League Announces Second Quarter 2024 Financial Results,1,1,1,1,1,-1
14.59M,"32,001",2.23M,-1,81,1.800,,,"Sep 19, 2024",FRSX,Foresight Autonomous Holdings Ltd.,12.93M,0.79,666.00K,-1.75%,-13.36%,-28.74%,-16.75%,-33.04%,Foresight Receives Nasdaq Notification Regarding Minimum Bid Requirements,Foresight Autonomous Revamps Executive Compensation Plan,Foresight Autonomous Showcases Growth and Partnerships,,,Foresight Receives Nasdaq Notification Regarding Minimum Bid Requirements Foresight Autonomous Revamps Executive Compensation Plan Foresight Autonomous Showcases Growth and Partnerships,0,0,1,0,-1,-1
17.61M,"104,498",-20.24M,-1,179,1.490,Strong Buy,4.50,"Aug 12, 2024",CNVS,Cineverse Corp.,12.88M,0.82,45.28M,-0.14%,-2.07%,-27.18%,-2.64%,-43.67%,Cineverse announces partnership with Wurl for FAST channe portfolio,Cineverse price target lowered to $4 from $5.50 at Alliance Global Partners,Cineverse Reports First Quarter Fiscal Year 2025 Results,Cineverse reports Q1 EPS (20c) vs. (37c) last year,"Cineverse’s FAST channels report 2.26B minutes watched in Q2, up 73% y/y","Cineverse announces partnership with Wurl for FAST channe portfolio Cineverse price target lowered to $4 from $5.50 at Alliance Global Partners Cineverse Reports First Quarter Fiscal Year 2025 Results Cineverse reports Q1 EPS (20c) vs. (37c) last year Cineverse’s FAST channels report 2.26B minutes watched in Q2, up 73% y/y",0,0,0,0,1,0
8.10M,277,"-601,000",$0.40,49,3.350,,,"Sep 4, 2024",RVSN,Rail Vision Ltd.,12.86M,0.64,142.00K,-7.23%,-15.98%,-73.03%,-26.87%,-68.74%,Rail Vision granted U.S. patent for AI-powered obstacle detection system,"Rail Vision Granted U.S. Patent for AI-Powered Railway Obstacle Detection System, Revolutionizing Rail Safety",North American rail traffic up 5.2% for the week ending August 31,Rail Vision Steers Ahead with AI Safety Systems,North American rail traffic up 1.3% for the week ending August 24,"Rail Vision granted U.S. patent for AI-powered obstacle detection system Rail Vision Granted U.S. Patent for AI-Powered Railway Obstacle Detection System, Revolutionizing Rail Safety North American rail traffic up 5.2% for the week ending August 31 Rail Vision Steers Ahead with AI Safety Systems North American rail traffic up 1.3% for the week ending August 24",0,0,0,0,0,0
10.30M,"7,444,417",-7.52M,-1,150,2.540,Strong Buy,1.50,"Aug 8, 2024",LDTC,LeddarTech Holdings Inc.,12.85M,0.44,6.05M,-22.02%,-40.72%,-83.93%,-38.41%,-83.00%,Roth MKM Keeps Their Buy Rating on LeddarTech Holdings (LDTC),LeddarTech Secures Bridge Financing for Nasdaq Offering,LeddarTech files to sell 18.18M units,LeddarTech announces up to $9M financing,Roth MKM Sticks to Its Buy Rating for LeddarTech Holdings (LDTC),Roth MKM Keeps Their Buy Rating on LeddarTech Holdings (LDTC) LeddarTech Secures Bridge Financing for Nasdaq Offering LeddarTech files to sell 18.18M units LeddarTech announces up to $9M financing Roth MKM Sticks to Its Buy Rating for LeddarTech Holdings (LDTC),0,0,0,0,1,0
36.77M,"12,507",-1.56M,-1,753,0.752,,,"Aug 13, 2024",ULY,Urgent.ly Inc.,12.81M,0.95,165.73M,-12.08%,-30.72%,-56.74%,-39.47%,-48.66%,Urgently price target lowered to $2 from $5 at Needham,Analysts Offer Insights on Technology Companies: Intel (INTC) and Urgent.ly Inc (ULY),Closing Bell Movers: Rumble jumps 8% on earnings,"Urgently renews, expands five-year partnership with global automotive OEM",Urgently Announces Second Quarter 2024 Financial Results,"Urgently price target lowered to $2 from $5 at Needham Analysts Offer Insights on Technology Companies: Intel (INTC) and Urgent.ly Inc (ULY) Closing Bell Movers: Rumble jumps 8% on earnings Urgently renews, expands five-year partnership with global automotive OEM Urgently Announces Second Quarter 2024 Financial Results",0,0,0,1,1,0
28.05M,"25,535",-40.11M,-1,2,0.934,Strong Buy,2.00,"Aug 7, 2024",PMCB,"PharmaCyte Biotech, Inc.",12.80M,1.66,-,-20.67%,-24.94%,-30.40%,-21.94%,-36.78%,,,,,,,1,-1,-1,-1,-1,-1
45.98M,"30,042",-71.16M,-1,4,0.564,Hold,0.70,"Aug 8, 2024",OXBR,Oxbridge Re Holdings Limited,12.80M,2.12,-8.37M,-24.82%,-26.94%,20.63%,-32.38%,+77.57%,Oxbridge & Zoniqx announce their upcoming joint participation in key industry events,,,,,Oxbridge & Zoniqx announce their upcoming joint participation in key industry events,1,1,-1,-1,-1,-1
10.29M,"24,291",34.15M,-1,18,2.520,,,"Sep 3, 2024",MBRX,"Moleculin Biotech, Inc.",12.69M,2.39,-,0.65%,-23.73%,-60.74%,-20.32%,-51.73%,Moleculin Biotech Raises Capital with Public Offering,Moleculin Biotech prices $16.5M public offering,Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update,Moleculin Biotech reports Q2 EPS ($1.70) vs. ($3.02) last year,Moleculin Biotech (MBRX) Q2 Earnings Cheat Sheet,Moleculin Biotech Raises Capital with Public Offering Moleculin Biotech prices $16.5M public offering Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update Moleculin Biotech reports Q2 EPS ($1.70) vs. ($3.02) last year Moleculin Biotech (MBRX) Q2 Earnings Cheat Sheet,0,0,0,0,0,1
19.31M,"49,085",,-1,,1.340,,,"Sep 3, 2024",RMCO,Royalty Management Holding Corporation,12.62M,0.84,644.29K,-5.36%,-5.44%,-48.28%,-16.00%,-28.21%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,12,,,,,JEWL,Adamas One Corp.,12.53M,0.45,501.38K,7.42%,21.32%,4.35%,-5.52%,+19.04%,Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1),,,,,Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1),1,0,-1,-1,-1,-1
20.88M,"51,315",-25.99M,-1,99,1.230,Strong Buy,6.00,"Sep 6, 2024",SSKN,"STRATA Skin Sciences, Inc.",12.47M,2.99,32.73M,13.45%,8.90%,-22.89%,+1.66%,-30.73%,STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference,STRATA Skin Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference,Strata Skin Sciences Initiates Legal Action for Unfair Competition,"Strata Skin files complaint against LaserOptek, MLS, Pinnacle",Strata Skin Sciences Shares Q1 Operational Results,"STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference STRATA Skin Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference Strata Skin Sciences Initiates Legal Action for Unfair Competition Strata Skin files complaint against LaserOptek, MLS, Pinnacle Strata Skin Sciences Shares Q1 Operational Results",0,0,0,0,0,0
34.43M,"5,625","852,334",-1,2,0.740,,,"Sep 6, 2024",KTRA,"Kintara Therapeutics, Inc.",12.46M,0.23,-,-3.23%,-17.55%,3.87%,-16.11%,+42.89%,Kintara Therapeutics: Clinical Trial Resumes Amid Merger Uncertainties,Kintara announces Kineta reopens enrollment for VISTA-101 clinical trial,Kintara and TuHURA announce reopening of enrollment for VISTA-101 clinical trial,,,Kintara Therapeutics: Clinical Trial Resumes Amid Merger Uncertainties Kintara announces Kineta reopens enrollment for VISTA-101 clinical trial Kintara and TuHURA announce reopening of enrollment for VISTA-101 clinical trial,0,0,0,0,-1,-1
,,,-1,9,,,,,BTOG,Bit Origin Ltd,12.46M,1.96,7.09M,9.43%,-20.41%,-48.30%,+4.60%,-55.83%,Bit Origin files to sell 55.68M ordinary shares for holders,,,,,Bit Origin files to sell 55.68M ordinary shares for holders,0,1,-1,-1,-1,-1
12.07M,483,-13.07M,-1,,2.100,,,"Sep 3, 2024",OP,OceanPal Inc.,12.44M,1.67,22.10M,-0.33%,-8.32%,-26.64%,-6.53%,-41.87%,OceanPal Inc. Reveals Fleet Charter Rates,OceanPal Inc (OP) Gets a Hold from Leerink Partners,,,,OceanPal Inc. Reveals Fleet Charter Rates OceanPal Inc (OP) Gets a Hold from Leerink Partners,0,1,0,-1,-1,-1
5.35M,"21,668",-3.53M,$0.64,9,4.700,,,"Oct 21, 2024",DPRO,Draganfly Inc.,12.33M,0.14,4.47M,-22.37%,-39.19%,-62.67%,-40.97%,-53.19%,Draganfly price target adjusted to $7 at H.C. Wainwright,Draganfly Drones Set to Enhance U.S. Defense Operations,Draganfly Receives Purchase Order for its Commander 3XL and Draganfly Flex FPV Drones for deployment within the U.S. Department of Defense,"Draganfly receives purchase order for Commander 3XL, Flex FPV Drones","Draganfly trading halted, news pending","Draganfly price target adjusted to $7 at H.C. Wainwright Draganfly Drones Set to Enhance U.S. Defense Operations Draganfly Receives Purchase Order for its Commander 3XL and Draganfly Flex FPV Drones for deployment within the U.S. Department of Defense Draganfly receives purchase order for Commander 3XL, Flex FPV Drones Draganfly trading halted, news pending",0,0,0,0,0,0
14.69M,"78,228",-3.00M,-1,52,1.710,,,"Sep 6, 2024",HRYU,"Hanryu Holdings, Inc.",12.27M,0.23,794.17K,2.26%,-4.84%,-48.68%,-14.50%,+5.65%,,,,,,,1,-1,-1,-1,-1,-1
38.05M,"88,578",-3.24M,-1,35,0.660,,,"Sep 26, 2024",GLYC,"GlycoMimetics, Inc.",12.25M,0.19,10.00K,-4.04%,-26.09%,-88.74%,-21.66%,-93.82%,,,,,,,1,-1,-1,-1,-1,-1
46.79M,"305,283",-31.96M,-1,443,0.535,Strong Buy,10.00,"Aug 8, 2024",CREV,Carbon Revolution Public Limited Company,12.21M,6.51,39.26M,-12.44%,-11.07%,-63.96%,-30.08%,-63.07%,Carbon Revolution Secures Further Release of $5 Million from OIC as Company Launches Key Programs,Carbon Revolution’s carbon fiber wheels selected by Rover,,,,Carbon Revolution Secures Further Release of $5 Million from OIC as Company Launches Key Programs Carbon Revolution’s carbon fiber wheels selected by Rover,1,1,0,-1,-1,-1
8.32M,"9,266",-21.07M,-1,46,3.000,Strong Buy,15.00,"Aug 12, 2024",FCUV,Focus Universal Inc.,12.17M,0.19,839.62K,-9.62%,-22.77%,-73.41%,-24.43%,-43.96%,"3 Penny Stocks to Watch Now, 9/03/24",Focus Universal announces ‘faster’ operation of SEC financial reporting software,,,,"3 Penny Stocks to Watch Now, 9/03/24 Focus Universal announces ‘faster’ operation of SEC financial reporting software",1,0,1,-1,-1,-1
10.14M,"4,905",-11.45M,-1,191,2.420,Strong Buy,6.00,"Aug 9, 2024",ZCAR,"Zoomcar Holdings, Inc.",12.15M,0.16,9.52M,17.45%,7.21%,-93.90%,+12.71%,-67.16%,"3 Penny Stocks to Watch Now, 8/20/24",Zoomcar Reports Robust Performance in its First Quarter 2024 Results,,,,"3 Penny Stocks to Watch Now, 8/20/24 Zoomcar Reports Robust Performance in its First Quarter 2024 Results",1,0,1,-1,-1,-1
210.89M,"17,963",-10.07M,-1,47,6.15,,,,CLWT,Euro Tech Holdings Company Limited,12.11M,1.57,17.94M,2.93%,0.23%,4.04%,+6.76%,-1.25%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,"1,012",,,,,MRM,MEDIROM Healthcare Technologies Inc.,12.11M,2.48,48.44M,94.65%,57.06%,15.45%,+64.95%,-1.94%,MEDIROM Reports Key July 2024 Performance Metrics,Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies,"MEDIROM Forms Alliance with NFES, Boosts Series A Funding",,,"MEDIROM Reports Key July 2024 Performance Metrics Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies MEDIROM Forms Alliance with NFES, Boosts Series A Funding",0,0,0,0,-1,-1
36.47M,"96,441",-86.59M,-1,67,0.678,Strong Buy,15.00,"Aug 12, 2024",SONM,"Sonim Technologies, Inc.",12.09M,2.50,69.29M,-20.11%,-52.14%,-60.43%,-33.78%,-58.50%,AT&T Business customers get Sonim XP10 for 99c with 3-year plan,SONM Earnings this Week: How Will it Perform?,,,,AT&T Business customers get Sonim XP10 for 99c with 3-year plan SONM Earnings this Week: How Will it Perform?,0,0,0,-1,-1,-1
13.65M,"71,201",1.26M,-1,727,1.810,,,"Sep 3, 2024",LKCO,Luokung Technology Corp.,11.95M,0.68,36.98M,5.85%,2.15%,7.18%,+18.11%,+10.23%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,17,,,,,INTJ,Intelligent Group Limited,11.90M,0.91,2.63M,-5.21%,-7.92%,-24.09%,-10.89%,-44.10%,,,,,,,0,-1,-1,-1,-1,-1
9.23M,"8,767",-40.32M,-1,425,2.660,Strong Buy,13.00,"Aug 8, 2024",YJ,Yunji Inc.,11.84M,0.60,72.68M,-6.80%,-17.41%,-26.40%,-13.56%,-33.34%,Yunji Inc: Strategic Shift Amid Revenue Decline,Yunji Announces Second Quarter 2024 Unaudited Financial Results,,,,Yunji Inc: Strategic Shift Amid Revenue Decline Yunji Announces Second Quarter 2024 Unaudited Financial Results,0,0,0,-1,-1,-1
12.43M,"43,047",55.09M,-1,11,1.980,Strong Buy,6.50,"Jul 25, 2024",BRTX,"BioRestorative Therapies, Inc.",11.76M,1.70,174.10K,12.66%,-0.43%,8.06%,+10.46%,+27.07%,Buy Rating Affirmed for BioRestorative Therapies Amid Strong Financials and Clinical Progress,BioRestorative Therapies Clarifies Press Release Usage in Filings,,,,Buy Rating Affirmed for BioRestorative Therapies Amid Strong Financials and Clinical Progress BioRestorative Therapies Clarifies Press Release Usage in Filings,1,0,0,-1,-1,-1
25.22M,"98,431",4.58M,-1,,0.970,,,"Aug 30, 2024",SLXN,Silexion Therapeutics Corp,11.72M,1.41,-,-82.18%,-85.76%,-86.06%,,,Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference,Biomotion Sciences’ Strategic Merger and Corporate Restructuring,,,,Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference Biomotion Sciences’ Strategic Merger and Corporate Restructuring,1,1,0,-1,-1,-1
19.50M,"34,809",-4.62M,-1,435,1.250,,,"Aug 13, 2024",GURE,"Gulf Resources, Inc.",11.68M,1.12,41.76M,-0.16%,-4.31%,-21.30%,-0.93%,-22.46%,Gulf Resources Struggles with Nasdaq Compliance and Reporting Issues,Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice,Gulf Resources receives noncompliance notification from Nasdaq,,,Gulf Resources Struggles with Nasdaq Compliance and Reporting Issues Gulf Resources Announces Receipt of Nasdaq Non-Compliance Notice Gulf Resources receives noncompliance notification from Nasdaq,0,0,1,0,-1,-1
9.24M,"28,435",-1.51M,-1,290,2.640,Strong Buy,4.00,"Jul 25, 2024",RAYA,Erayak Power Solution Group Inc.,11.64M,0.97,20.32M,17.76%,17.71%,28.30%,+15.90%,+72.04%,,,,,,,0,-1,-1,-1,-1,-1
23.99M,"21,846",-8.11M,-1,23,1.010,Strong Buy,6.00,"Aug 13, 2024",VERB,"Verb Technology Company, Inc.",11.59M,0.08,102.00K,0.88%,-22.89%,-51.55%,-22.85%,-70.30%,VERB’s MARKET.live Partners with BeautyStat and TikTok to Bring Exclusive Skincare Event to TikTok Audience,"Verb’s MARKET.live partners with BeautyStat, TikTok for skincare event",,,,"VERB’s MARKET.live Partners with BeautyStat and TikTok to Bring Exclusive Skincare Event to TikTok Audience Verb’s MARKET.live partners with BeautyStat, TikTok for skincare event",0,0,0,-1,-1,-1
30.81M,"27,911",-12.10M,-1,9,0.819,,,"Aug 14, 2024",FBRX,"Forte Biosciences, Inc.",11.56M,0.32,-,-16.69%,-29.86%,-43.98%,-43.81%,-55.76%,"Forte Biosciences trading halted, news pending",Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested,Forte Biosciences: Key Outcomes from 2024 Stockholders Meeting,Forte Biosciences price target raised to $6 from $4 at Brookline,"Forte Biosciences reports Q2 EPS (27c), consensus (17c)","Forte Biosciences trading halted, news pending Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested Forte Biosciences: Key Outcomes from 2024 Stockholders Meeting Forte Biosciences price target raised to $6 from $4 at Brookline Forte Biosciences reports Q2 EPS (27c), consensus (17c)",0,0,0,0,0,0
55.79M,"123,205",2.34M,-1,53,0.430,,,"Oct 23, 2024",RDHL,RedHill Biopharma Ltd.,11.55M,9.02,6.53M,-29.08%,-23.63%,-52.49%,-12.94%,-36.79%,RedHill Biopharma Announces ADS Ratio Change,RedHill Biopharma Achieves Nasdaq Compliance,RedHill Biopharma regains Nasdaq compliance,RedHill Reports Opaganib Reduces COVID-19 Deaths,RedHill Biopharma’s opaganib shows COVID-19 mortality reduction,RedHill Biopharma Announces ADS Ratio Change RedHill Biopharma Achieves Nasdaq Compliance RedHill Biopharma regains Nasdaq compliance RedHill Reports Opaganib Reduces COVID-19 Deaths RedHill Biopharma’s opaganib shows COVID-19 mortality reduction,1,0,0,0,1,0
26.49M,"27,269",-20.92M,-1,8,0.910,Strong Buy,3.83,"Aug 14, 2024",MEDS,"TRxADE HEALTH, Inc.",11.54M,7.91,7.45M,0.48%,-29.96%,10.33%,-20.25%,-17.34%,,,,,,,1,-1,-1,-1,-1,-1
11.00M,"21,876","102,708",-1,222,2.180,,,"Oct 3, 2024",AKTS,"Akoustis Technologies, Inc.",11.38M,0.10,29.86M,-2.22%,-19.52%,-79.90%,-32.34%,-85.85%,Akoustis receives an additional purchase order for $13M XBAW filters,,,,,Akoustis receives an additional purchase order for $13M XBAW filters,0,0,-1,-1,-1,-1
1.32M,"51,239",-23.82M,-1,60,18.07,,,"Aug 14, 2024",LIDR,"AEye, Inc.",11.37M,1.32,309.00K,4.09%,-16.26%,-36.13%,-9.93%,+3.25%,,,,,,,0,-1,-1,-1,-1,-1
22.23M,"58,498",-16.69M,-1,104,1.070,Strong Buy,9.75,"Aug 8, 2024",OTRK,"Ontrak, Inc.",11.21M,0.23,12.39M,-1.65%,-1.75%,-26.94%,-20.18%,-38.11%,Ontrak Health and MosaicVoice team on efficient approach to healthcare,,,,,Ontrak Health and MosaicVoice team on efficient approach to healthcare,1,1,-1,-1,-1,-1
21.62M,"36,745",-4.82M,-1,12,1.090,Strong Buy,2.50,"Aug 6, 2024",KPRX,"Kiora Pharmaceuticals, Inc.",11.20M,3.77,16.02M,-0.97%,-9.47%,-23.79%,-19.01%,-30.32%,Buy Rating on Kiora Pharmaceuticals Amid Promising Clinical Trials and Strong Financials,Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg,,,,Buy Rating on Kiora Pharmaceuticals Amid Promising Clinical Trials and Strong Financials Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg,1,1,0,-1,-1,-1
4.34M,"4,047,448",-6.73M,-1,40,5.450,,,"Sep 3, 2024",VIRX,"Viracta Therapeutics, Inc.",11.11M,0.28,-,-42.64%,-53.38%,-65.98%,-53.17%,-78.01%,Viracta Therapeutics downgraded to Market Perform from Outperform at Leerink,Viracta Therapeutics price target lowered to $4 from $6 at RBC Capital,Viracta Therapeutics announces data from Phase 2 NAVAL-1 trial,Viracta Therapeutics reports Q2 EPS (25c) vs (32c) lastyear,Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update,Viracta Therapeutics downgraded to Market Perform from Outperform at Leerink Viracta Therapeutics price target lowered to $4 from $6 at RBC Capital Viracta Therapeutics announces data from Phase 2 NAVAL-1 trial Viracta Therapeutics reports Q2 EPS (25c) vs (32c) lastyear Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update,1,1,0,0,1,0
196.55M,"1,462,429",1.68M,-1,57,0.120,,,"Jul 30, 2024",JXJT,JX Luxventure Limited,11.10M,1.83,31.84M,10.55%,28.51%,35.55%,+7.98%,+41.94%,JX Luxventure Issues $3M Promissory Note,,,,,JX Luxventure Issues $3M Promissory Note,0,1,-1,-1,-1,-1
154.37M,"100,709",-37.49M,-1,495,0.323,Strong Buy,3.00,"Sep 26, 2024",ALPP,"Alpine 4 Holdings, Inc.",11.09M,0.41,104.20M,4.77%,-7.08%,-37.41%,-4.39%,-50.05%,Alpine 4 Technologies Risks Nasdaq Delisting Amid Report Delays,Alpine 4 Technologies Implements Executive Pay Cuts,,,,Alpine 4 Technologies Risks Nasdaq Delisting Amid Report Delays Alpine 4 Technologies Implements Executive Pay Cuts,1,1,1,-1,-1,-1
24.79M,"186,127",-11.56M,-1,85,0.950,,,"Aug 14, 2024",CHEK,Check-Cap Ltd.,11.06M,1.89,-,-0.72%,-4.72%,-16.56%,-9.45%,-26.02%,,,,,,,0,-1,-1,-1,-1,-1
10.41M,"32,651",-9.39M,-1,156,2.250,,,"Sep 3, 2024",IVP,"Inspire Veterinary Partners, Inc.",11.05M,3.05,17.13M,-57.44%,-56.63%,-85.23%,-76.98%,-58.66%,Inspire Veterinary enters non-binding LOI to acquire Vetsie.ai,Inspire Veterinary unveils plans for new verticals,Inspire Veterinary nominates Phillip Balatsos to board of directors,Inspire Veterinary reports Q2 (70c) vs. (85c) last year,,Inspire Veterinary enters non-binding LOI to acquire Vetsie.ai Inspire Veterinary unveils plans for new verticals Inspire Veterinary nominates Phillip Balatsos to board of directors Inspire Veterinary reports Q2 (70c) vs. (85c) last year,1,1,1,0,1,-1
2.24M,903,-2.64M,-1,316,10.45,,,,SPI,"SPI Energy Co., Ltd.",11.03M,0.35,209.53M,6.84%,-12.79%,-42.11%,-2.50%,-40.46%,SPI Energy Co Receives Nasdaq Compliance Extension,SPI Energy discloses Nasdaq non-compliance notice,,,,SPI Energy Co Receives Nasdaq Compliance Extension SPI Energy discloses Nasdaq non-compliance notice,1,1,1,-1,-1,-1
18.97M,"13,807",-5.04M,-1,116,1.240,,,"Aug 14, 2024",HTOO,Fusion Fuel Green PLC,10.98M,0.63,4.58M,-8.41%,-21.05%,-43.05%,-26.16%,-59.37%,"HTOO Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,,,"HTOO Earnings Report this Week: Is It a Buy, Ahead of Earnings?",1,1,-1,-1,-1,-1
10.67M,"158,924",-20.81M,-1,112,2.180,Strong Buy,4.00,"Aug 14, 2024",OMH,Ohmyhome Limited,10.92M,0.48,3.79M,-8.10%,-13.66%,-51.88%,-20.00%,-50.03%,,,,,,,1,-1,-1,-1,-1,-1
13.49M,"44,142",-8.74M,-1,11,1.730,Strong Buy,6.00,"Aug 14, 2024",ATHE,Alterity Therapeutics Limited,10.84M,1.30,2.34M,13.93%,-5.10%,-22.23%,-11.87%,-23.37%,Alterity Therapeutics Options Expire Unexercised,Alterity Therapeutics Unveils Annual Financial Results,,,,Alterity Therapeutics Options Expire Unexercised Alterity Therapeutics Unveils Annual Financial Results,1,0,0,-1,-1,-1
30.88M,"273,150",-28.19M,-1,8,0.750,Buy,,"Aug 8, 2024",NXTT,Next Technology Holding Inc.,10.81M,1.55,2.63M,14.41%,-51.22%,-60.89%,-4.32%,-74.52%,Next Technology Holding Announces Key Leadership Changes,,,,,Next Technology Holding Announces Key Leadership Changes,1,1,-1,-1,-1,-1
1.28M,"1,105,854",6.37M,-1,49,18.00,Hold,,"Aug 13, 2024",JAGX,"Jaguar Health, Inc.",10.81M,1.17,10.19M,0.65%,-54.23%,-84.79%,-8.13%,-77.58%,Jaguar Health celebrates National Service Dog Month,Jaguar Health announces patent issued in Jordan for SBS treatment,Jaguar Health’s Napo Pharmaceuticals issues Hong Kong patent for SBS treatment,Jaguar Health reports Q2 EPS ($4.04) vs. ($41.35) last year,,Jaguar Health celebrates National Service Dog Month Jaguar Health announces patent issued in Jordan for SBS treatment Jaguar Health’s Napo Pharmaceuticals issues Hong Kong patent for SBS treatment Jaguar Health reports Q2 EPS ($4.04) vs. ($41.35) last year,1,1,0,0,1,-1
3.38M,"12,008",-2.73M,-1,"2,905",6.81,,,"Oct 8, 2024",STEC,Santech Holdings Limited,10.78M,0.39,260.47M,113.80%,89.01%,-62.06%,+134.10%,-54.74%,Santech Holdings Launches $5M Share Buyback,Santech Holdings Board Member Resigns,,,,Santech Holdings Launches $5M Share Buyback Santech Holdings Board Member Resigns,0,1,1,-1,-1,-1
1.82M,,"-420,789",-1,95,12.78,,,,ARTW,"Art's-Way Manufacturing Co., Inc.",10.75M,2.12,27.42M,31.66%,31.42%,8.59%,+36.42%,+0.24%,,,,,,,0,-1,-1,-1,-1,-1
,,,-1,,,,,,KZIA,Kazia Therapeutics Limited,10.73M,0.36,382.00,18.58%,14.58%,19.23%,+4.02%,+6.65%,Kazia Therapeutics files to sell $100M of American Depositary Shares,,,,,Kazia Therapeutics files to sell $100M of American Depositary Shares,1,1,-1,-1,-1,-1
9.01M,"26,666",7.45M,$0.30,9,2.530,Strong Buy,6.00,"Aug 6, 2024",IKT,"Inhibikase Therapeutics, Inc.",10.67M,1.43,79.57K,4.21%,0.91%,-17.10%,-1.84%,-37.09%,"Inhibikase Therapeutics reports Q2 EPS (66c), consensus (67c)",Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity,"IKT Earnings Report this Week: Is It a Buy, Ahead of Earnings?",,,"Inhibikase Therapeutics reports Q2 EPS (66c), consensus (67c) Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity IKT Earnings Report this Week: Is It a Buy, Ahead of Earnings?",0,1,0,1,-1,-1
23.75M,"7,902",,-1,503,0.950,,,,YQ,17 Education & Technology Group Inc.,10.55M,2.10,25.92M,-0.82%,-3.98%,-18.02%,-6.98%,-31.27%,17EdTech Q2 Results: Revenue Stable Amidst Rising Losses,,,,,17EdTech Q2 Results: Revenue Stable Amidst Rising Losses,0,1,-1,-1,-1,-1
,,,-1,53,,,,,ARBB,ARB IOT Group Limited,10.55M,0.40,32.75M,20.83%,-6.59%,-59.31%,-23.92%,-76.42%,,,,,,,1,-1,-1,-1,-1,-1
18.61M,"169,604","35,058",-1,108,1.210,,,"Sep 3, 2024",VVPR,VivoPower International PLC,10.43M,2.35,12.24M,12.07%,8.90%,4.32%,+7.09%,-61.51%,VivoPower Announces Strategic Business Merger,"VivoPower Shifts Focus, Bolsters EV Business","VivoPower International PLC Reports Preliminary Estimated Unaudited Financial Results for the Fiscal Year Ended June 30, 2024",VivoPower Subsidiary Tembo Strikes $904M Merger Deal,"Tembo E-LV, a subsidiary of Nasdaq-listed VivoPower International PLC (“VVPR”) executes a definitive Business Combination Agreement with CCTS for a combined enterprise value of US$904 million","VivoPower Announces Strategic Business Merger VivoPower Shifts Focus, Bolsters EV Business VivoPower International PLC Reports Preliminary Estimated Unaudited Financial Results for the Fiscal Year Ended June 30, 2024 VivoPower Subsidiary Tembo Strikes $904M Merger Deal Tembo E-LV, a subsidiary of Nasdaq-listed VivoPower International PLC (“VVPR”) executes a definitive Business Combination Agreement with CCTS for a combined enterprise value of US$904 million",1,0,0,0,1,1
10.83M,"392,429",-24.83M,-1,7,2.090,Strong Buy,31.00,"Aug 14, 2024",MGOL,"MGO Global, Inc.",10.30M,3.95,5.69M,-9.80%,-19.47%,-13.83%,+26.81%,+25.00%,"MGO Global, Heidma submit draft registration statement for combination",MGO Global reports Q2 EPS ($1.35) vs. (94c) last year,,,,"MGO Global, Heidma submit draft registration statement for combination MGO Global reports Q2 EPS ($1.35) vs. (94c) last year",1,1,1,-1,-1,-1
,,,-1,62,,,,,JL,J-Long Group Limited,10.30M,0.33,28.38M,8.26%,-10.17%,-86.02%,-16.65%,-55.84%,J-Long Group receives non-compliance notice from Nasdaq,,,,,J-Long Group receives non-compliance notice from Nasdaq,0,0,-1,-1,-1,-1
5.15M,"93,510",-32.88M,-1,572,4.350,Buy,10.50,"Aug 13, 2024",KRKR,36Kr Holdings Inc.,10.29M,0.26,47.97M,0.89%,-11.96%,-40.64%,-3.21%,-32.27%,36Kr Holdings Inc. Navigates Economic Challenges,"36Kr Holdings Inc. to Report 2024 First Half Financial Results on Tuesday, September 3, 2024",,,,"36Kr Holdings Inc. Navigates Economic Challenges 36Kr Holdings Inc. to Report 2024 First Half Financial Results on Tuesday, September 3, 2024",1,1,1,-1,-1,-1
28.70M,"100,275",-20.74M,-1,28,0.780,Strong Buy,1.97,"Aug 14, 2024",DOMH,Dominari Holdings Inc.,10.23M,1.63,9.51M,-3.97%,-12.71%,-27.52%,-9.46%,-49.37%,Dominari Holdings Subsidiary Earns Nasdaq Underwriting Status,,,,,Dominari Holdings Subsidiary Earns Nasdaq Underwriting Status,1,1,-1,-1,-1,-1
12.24M,"6,413","864,722",-1,20,1.810,,,"Sep 3, 2024",CTNT,Cheetah Net Supply Chain Service Inc.,10.22M,0.26,17.68M,22.51%,-20.19%,-78.66%,-13.41%,-86.83%,Cheetah Net Supply Chain Service files $70M mixed securities shelf,"Cheetah Net CFO Resigns, CEO Assumes Interim Role",Cheetah Net Supply Chain Service announces CFO Robert Cook resigns,"Maxim Group Reaffirms Their Hold Rating on Cheetah Net Supply Chain Service, Inc. Class A (CTNT)",Cheetah Net Supply Chain Service Inc. Announces Second Quarter 2024 Results and Provides Corporate Update,"Cheetah Net Supply Chain Service files $70M mixed securities shelf Cheetah Net CFO Resigns, CEO Assumes Interim Role Cheetah Net Supply Chain Service announces CFO Robert Cook resigns Maxim Group Reaffirms Their Hold Rating on Cheetah Net Supply Chain Service, Inc. Class A (CTNT) Cheetah Net Supply Chain Service Inc. Announces Second Quarter 2024 Results and Provides Corporate Update",0,0,0,0,0,0
12.43M,"26,709","33,588",-1,113,1.740,,,"Sep 6, 2024",CARV,"Carver Bancorp, Inc.",10.21M,2.00,28.90M,2.82%,15.41%,14.82%,-0.51%,+23.27%,,,,,,,1,-1,-1,-1,-1,-1
25.77M,"229,152",-80.01M,-1,6,0.860,,,"Sep 3, 2024",NXL,"Nexalin Technology, Inc.",10.20M,0.96,150.16K,-7.84%,-28.44%,3.90%,-19.13%,-62.65%,Nexalin Technology participates in Congressional roundtable,Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment,,,,Nexalin Technology participates in Congressional roundtable Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment,0,0,0,-1,-1,-1
27.30M,"65,938",-19.77M,-1,15,0.817,Strong Buy,6.00,"Sep 12, 2024",ELWS,"Earlyworks Co., Ltd",10.19M,3.38,1.14M,13.55%,25.58%,7.56%,+22.62%,-22.88%,,,,,,,0,-1,-1,-1,-1,-1
21.41M,"151,306",-5.98M,-1,11,1.030,,,"Sep 3, 2024",INHD,Inno Holdings Inc.,10.18M,0.49,693.57K,-15.15%,-25.94%,-49.43%,-33.90%,-22.90%,,,,,,,0,-1,-1,-1,-1,-1
7.89M,856,-4.19M,-1,371,2.830,,,"Sep 10, 2024",EMKR,EMCORE Corporation,10.15M,1.12,90.96M,0.68%,-7.09%,-65.10%,-15.08%,-65.71%,,,,,,,0,-1,-1,-1,-1,-1
29.00M,"10,213",2.44M,-1,62,0.750,,,"Sep 6, 2024",MTEM,"Molecular Templates, Inc.",10.14M,1.54,25.47M,3.70%,13.00%,-41.36%,+4.20%,-23.48%,"Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update",,,,,"Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update",1,0,-1,-1,-1,-1
11.93M,"48,786",4.06M,-1,9,1.820,,,"Aug 19, 2024",CDIO,"Cardio Diagnostics Holdings, Inc.",10.11M,0.42,39.14K,-8.23%,-19.88%,-68.16%,-16.09%,-66.29%,,,,,,,0,-1,-1,-1,-1,-1
24.63M,"18,557",-6.12M,-1,57,0.851,,,"Sep 3, 2024",PRPO,"Precipio, Inc.",10.08M,6.80,16.72M,10.35%,17.21%,0.84%,+21.54%,-0.87%,Precipio Incentivizes Staff with Strategic Stock Option Repricing,Precipio Announces Employee Stock Option Plan Repricing,Precipio Announces Q2-2024 Shareholder Update Call,,,Precipio Incentivizes Staff with Strategic Stock Option Repricing Precipio Announces Employee Stock Option Plan Repricing Precipio Announces Q2-2024 Shareholder Update Call,0,0,0,0,-1,-1
17.75M,"574,573",-28.80M,-1,699,1.220,,,"Aug 19, 2024",SOGP,Sound Group Inc.,10.05M,1.90,306.52M,-2.95%,-10.26%,-31.99%,-14.29%,-45.29%,,,,,,,0,-1,-1,-1,-1,-1
7.14M,"39,965",-22.77M,-1,8,3.030,Strong Buy,,"Aug 8, 2024",ERNA,Eterna Therapeutics Inc.,10.01M,1.85,162.00K,1.19%,-3.43%,-0.52%,-1.10%,-22.17%,,,,,,,0,-1,-1,-1,-1,-1
6.09M,"30,422",1.14M,-1,8,3.550,,,"Sep 9, 2024",MEGL,Magic Empire Global Limited,9.95M,0.49,1.77M,-3.36%,-10.38%,-33.92%,-16.56%,-29.61%,Magic Empire Global Granted Nasdaq Compliance Extension,Nasdaq notifies Magic Empire of 180 calendar days for minimum bid compliance,Magic Empire Global Limited Announces Receipt of Nasdaq Notification of additional 180 calendar day period to regain compliance of minimum bid price requirement,,,Magic Empire Global Granted Nasdaq Compliance Extension Nasdaq notifies Magic Empire of 180 calendar days for minimum bid compliance Magic Empire Global Limited Announces Receipt of Nasdaq Notification of additional 180 calendar day period to regain compliance of minimum bid price requirement,0,1,0,0,-1,-1
46.52M,"257,325",-58.35M,-1,7,0.464,Strong Buy,3.67,"Aug 6, 2024",GVH,Globavend Holdings Limited,9.90M,0.68,18.59M,25.98%,2.63%,-35.31%,+4.06%,-56.81%,Globavend Holdings Faces Nasdaq Compliance Challenge,Globavend announces notice of non-compliance from Nasdaq,,,,Globavend Holdings Faces Nasdaq Compliance Challenge Globavend announces notice of non-compliance from Nasdaq,1,0,0,-1,-1,-1
18.23M,"55,228",-11.29M,-1,55,1.180,,,"Sep 3, 2024",AIHS,Senmiao Technology Limited,9.88M,0.94,5.84M,27.17%,26.12%,62.32%,+32.42%,+38.71%,,,,,,,0,-1,-1,-1,-1,-1
13.64M,"11,305",3.29M,-1,65,1.520,,,,KDLY,"Kindly MD, Inc.",9.86M,1.66,3.10M,-9.05%,-32.83%,-35.71%,-20.53%,,KindlyMD appoints Jeremy Joyal as medical director,"Kindly MD, Inc. Embraces Social Media for Investor Updates",KindlyMD sees cash runway for at least 12-month period,KindlyMD reports Q2 EPS (26c) vs. (13c) last year.,,"KindlyMD appoints Jeremy Joyal as medical director Kindly MD, Inc. Embraces Social Media for Investor Updates KindlyMD sees cash runway for at least 12-month period KindlyMD reports Q2 EPS (26c) vs. (13c) last year.",1,0,0,1,1,-1
27.50M,"243,799",1.14M,-1,32,0.781,,,"Sep 12, 2024",MFI,mF International Limited,9.81M,0.74,4.09M,6.32%,-9.43%,-49.09%,-7.94%,,mF International Limited Rings Nasdaq Closing Bell,mF International Sets Key Resolutions for 2024 AGM,,,,mF International Limited Rings Nasdaq Closing Bell mF International Sets Key Resolutions for 2024 AGM,1,1,1,-1,-1,-1
,,,-1,72,,,,,KITT,"Nauticus Robotics, Inc.",9.76M,2.10,3.62M,-18.61%,-48.69%,-86.69%,-46.08%,-82.16%,Nauticus Robotics appoints John Symington as General Counsel,Nauticus Robotics reports Q2 EPS ($2.75) vs. ($4.06) last year,"3 Penny Stocks to Watch Now, 8/13/24",,,"Nauticus Robotics appoints John Symington as General Counsel Nauticus Robotics reports Q2 EPS ($2.75) vs. ($4.06) last year 3 Penny Stocks to Watch Now, 8/13/24",1,1,0,0,-1,-1
20.74M,"338,760",-17.43M,-1,131,1.030,Strong Buy,3.00,"Aug 13, 2024",GWAV,"Greenwave Technology Solutions, Inc.",9.76M,0.48,33.59M,-10.05%,-56.17%,-98.82%,-60.50%,-97.81%,John Wood Resigns from Greenwave Technology Solutions Board,,,,,John Wood Resigns from Greenwave Technology Solutions Board,1,1,-1,-1,-1,-1
45.97M,"117,841",-4.84M,-1,152,0.462,Hold,,"Aug 13, 2024",LEDS,SemiLEDs Corporation,9.72M,1.35,5.31M,-3.02%,-2.07%,-5.51%,-14.10%,-13.20%,,,,,,,1,-1,-1,-1,-1,-1
,,,-1,46,,,,,WISA,"WiSA Technologies, Inc.",9.61M,1.71,1.79M,-14.66%,-30.38%,-80.81%,-36.52%,-55.76%,Morning Movers: Nvidia dips after report of DOJ subpoena,"WiSA Technologies to acquire assets, IP from Datavault in $210M transaction",WiSA Technologies VP of Finance Gary Williams to Resign,"WiSA Technologies, Inc. (WISA) Q2 Earnings Cheat Sheet",,"Morning Movers: Nvidia dips after report of DOJ subpoena WiSA Technologies to acquire assets, IP from Datavault in $210M transaction WiSA Technologies VP of Finance Gary Williams to Resign WiSA Technologies, Inc. (WISA) Q2 Earnings Cheat Sheet",0,0,1,1,1,-1
11.77M,"1,452",-19.77M,-1,43,1.800,,,"Sep 3, 2024",ASNS,"Actelis Networks, Inc.",9.57M,1.59,6.02M,24.86%,10.51%,48.31%,+11.26%,+68.00%,Actelis Networks to Participate in H.C. Wainwright 26th Annual Global Investment Conference,Actelis Networks Navigates Acquisition of Quality Industrial Corp,Actelis Receives New Order for Intelligent Traffic System (ITS) Networking in New York City Metro Area,"Actelis Networks receives new order for ITS networking in NYC, no terms",Actelis Networks Unveils Investor Communication Strategy,"Actelis Networks to Participate in H.C. Wainwright 26th Annual Global Investment Conference Actelis Networks Navigates Acquisition of Quality Industrial Corp Actelis Receives New Order for Intelligent Traffic System (ITS) Networking in New York City Metro Area Actelis Networks receives new order for ITS networking in NYC, no terms Actelis Networks Unveils Investor Communication Strategy",0,0,1,1,0,1
24.84M,"154,677",-12.24M,-1,19,0.852,,,"Aug 14, 2024",AVTX,"Avalo Therapeutics, Inc.",9.51M,9.20,807.00K,9.14%,-4.46%,-0.15%,-16.52%,-42.07%,Avalo Therapeutics trading resumes,"Avalo Therapeutics trading halted, volatility trading pause",Oppenheimer Sticks to Their Buy Rating for Avalo Therapeutics (AVTX),Avalo Therapeutics Shareholders Back Board and Strategies,Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates,"Avalo Therapeutics trading resumes Avalo Therapeutics trading halted, volatility trading pause Oppenheimer Sticks to Their Buy Rating for Avalo Therapeutics (AVTX) Avalo Therapeutics Shareholders Back Board and Strategies Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates",0,0,0,0,1,0
